The DRUGA are a rapidly growing class of DRUGB with a broad spectrum of activity against gram negative and some gram positive aerobic bacteria .
fluoroquinolones	group	antibiotics	group
false

Antimicrobial activity of DRUGA alone and in combination with some DRUGB .
Ganoderma lucidum extract	drug_n	antibiotics	group
false

The antimicrobial combinations of DRUGA with four DRUGB resulted in additive effect in most instances , synergism in two instances , and antagonism in two instances .
GL	drug_n	antibiotics	group
effect

Synergism was observed when DRUGA was combined with DRUGB against Bacillus subtilis and Klebsiella oxytoca .
GL	drug_n	cefazolin	drug
effect

However , the absolute number of DRUGA related deaths is far greater than the number of deaths in DRUGB or DRUGN users .
alcohol	drug	amphetamine	drug
false

However , the absolute number of DRUGA related deaths is far greater than the number of deaths in DRUGN or DRUGB users .
alcohol	drug	heroin	drug_n
false

However , the absolute number of DRUGN related deaths is far greater than the number of deaths in DRUGA or DRUGB users .
amphetamine	drug	heroin	drug_n
false

Differential regulation of tyrosine phosphorylation in tumor cells by DRUGA , a homodimeric disintegrin , and monomeric disintegrins DRUGB and DRUGN .
contortrostatin	drug_n	echistatin	drug_n
false

Differential regulation of tyrosine phosphorylation in tumor cells by DRUGA , a homodimeric disintegrin , and monomeric disintegrins DRUGN and DRUGB .
contortrostatin	drug_n	flavoridin	drug_n
false

Differential regulation of tyrosine phosphorylation in tumor cells by DRUGN , a homodimeric disintegrin , and monomeric disintegrins DRUGA and DRUGB .
echistatin	drug_n	flavoridin	drug_n
false

The homodimeric disintegrin DRUGA was compared directly to the monomeric disintegrins DRUGB and DRUGN for the ability to affect protein tyrosine phosphorylation in tumor cells .
contortrostatin	drug_n	echistatin	drug_n
false

The homodimeric disintegrin DRUGA was compared directly to the monomeric disintegrins DRUGN and DRUGB for the ability to affect protein tyrosine phosphorylation in tumor cells .
contortrostatin	drug_n	flavoridin	drug_n
false

The homodimeric disintegrin DRUGN was compared directly to the monomeric disintegrins DRUGA and DRUGB for the ability to affect protein tyrosine phosphorylation in tumor cells .
echistatin	drug_n	flavoridin	drug_n
false

DRUGA alone had no effect on tyrosine phosphorylation in Tdgb cells , but dose dependently inhibits the effects of DRUGB when both are added simultaneously .
Echistatin	drug_n	contortrostatin	drug_n
effect

DRUGA alone was found to have no effect on CAS , but can completely block DRUGB induced phosphorylation of this protein in MDA MB dgb cells .
Flavoridin	drug_n	contortrostatin	drug_n
effect

DRUGA , at pH dga , was used to chemically modify exposed histidine residues on DRUGB .
Diethyl pyrocarbonate	drug_n	toxin A	drug_n
false

Modification of DRUGA with DRUGB abolished both its cytotoxic activity and the ability of the toxin to bind Zn Sepharose gel .
toxin A	drug_n	diethyl pyrocarbonate	drug_n
false

Treatment of DRUGA with [ ( dgb ) C ] DRUGB revealed concentration dependent labelling of histidine residues on the toxin molecules .
toxin A	drug_n	diethyl pyrocarbonate	drug_n
false

The effects of DRUGA could be reversed by DRUGB treatment .
diethyl pyrocarbonate	drug_n	hydroxylamine	drug_n
false

Exposed histidines on DRUGA are available for DRUGB chelation , and these have been exploited in the development of a novel purification protocol for DRUGN using DRUGN chelating chromatography .
toxin A	drug_n	zinc	drug
false

Exposed histidines on DRUGA are available for DRUGN chelation , and these have been exploited in the development of a novel purification protocol for DRUGN using DRUGB chelating chromatography .
toxin A	drug_n	zinc	drug
false

Exposed histidines on DRUGN are available for DRUGA chelation , and these have been exploited in the development of a novel purification protocol for DRUGB using DRUGN chelating chromatography .
zinc	drug	toxin A	drug_n
false

Exposed histidines on DRUGN are available for DRUGN chelation , and these have been exploited in the development of a novel purification protocol for DRUGA using DRUGB chelating chromatography .
toxin A	drug_n	zinc	drug
false

Note : dissolution of aerosol particles of DRUGA in DRUGB , a model DRUGN .
budesonide	drug	Survanta	brand
false

Note : dissolution of aerosol particles of DRUGA in DRUGN , a model DRUGB .
budesonide	drug	lung surfactant	group
false

Note : dissolution of aerosol particles of DRUGN in DRUGA , a model DRUGB .
Survanta	brand	lung surfactant	group
false

The effect of a DRUGA extract from bovine lung , DRUGB , on the dissolution rate of aerosol particles of DRUGN was determined .
pulmonary surfactant	group	Survanta	brand
false

The effect of a DRUGA extract from bovine lung , DRUGN , on the dissolution rate of aerosol particles of DRUGB was determined .
pulmonary surfactant	group	budesonide	drug
false

The effect of a DRUGN extract from bovine lung , DRUGA , on the dissolution rate of aerosol particles of DRUGB was determined .
Survanta	brand	budesonide	drug
false

Aerosol particles of DRUGA were generated from an DRUGB solution , dried , and collected by a cascade impactor for characterization or by a liquid impinger for dissolution experiments .
budesonide	drug	ethanol	drug
false

DRUGA increased the extent of dissolution of DRUGB in proportion to the added concentration , which was also verified by equilibrium solubilization studies .
Survanta	brand	budesonide	drug
false

DRUGA also increased rate of dissolution , in a manner similar to DRUGB .
Survanta	brand	sodium dodecyl sulfate	drug_n
false

Analysis of the concentration of DRUGA following ultracentrifugation indicated that there is rapid equilibration of DRUGN between the DRUGB and aqueous phase .
budesonide	drug	Survanta	brand
false

Analysis of the concentration of DRUGN following ultracentrifugation indicated that there is rapid equilibration of DRUGA between the DRUGB and aqueous phase .
budesonide	drug	Survanta	brand
false

The effects of DRUGA and DRUGB upon DRUGN ( DRUGN ) induced locomotion and behavioral changes in mice .
DCG-IV	drug_n	L-CCG-1	drug_n
false

The effects of DRUGA and DRUGN upon DRUGB ( DRUGN ) induced locomotion and behavioral changes in mice .
DCG-IV	drug_n	phencyclidine	drug_n
false

The effects of DRUGA and DRUGN upon DRUGN ( DRUGB ) induced locomotion and behavioral changes in mice .
DCG-IV	drug_n	PCP	drug_n
false

The effects of DRUGN and DRUGA upon DRUGB ( DRUGN ) induced locomotion and behavioral changes in mice .
L-CCG-1	drug_n	phencyclidine	drug_n
false

The effects of DRUGN and DRUGA upon DRUGN ( DRUGB ) induced locomotion and behavioral changes in mice .
L-CCG-1	drug_n	PCP	drug_n
false

The effects of DRUGN and DRUGN upon DRUGA ( DRUGB ) induced locomotion and behavioral changes in mice .
phencyclidine	drug_n	PCP	drug_n
false

injection of DRUGA ( DRUGB ) were observed by measuring locomotor activity and stereotyped behavior .
phencyclidine	drug_n	PCP	drug_n
false

Then , the effects of metabotropic glutamate receptor ( mGluR ) agonists , DRUGA and DRUGB , on the above behavioral changes induced by DRUGN were found .
DCG-IV	drug_n	L-CCG-1	drug_n
false

Then , the effects of metabotropic glutamate receptor ( mGluR ) agonists , DRUGA and DRUGN , on the above behavioral changes induced by DRUGB were found .
DCG-IV	drug_n	PCP	drug_n
false

Then , the effects of metabotropic glutamate receptor ( mGluR ) agonists , DRUGN and DRUGA , on the above behavioral changes induced by DRUGB were found .
L-CCG-1	drug_n	PCP	drug_n
false

The effects of DRUGA were very strong and completely depressed the DRUGB induced hyperlocomotion .
DCG-IV	drug_n	PCP	drug_n
effect

In order to examine some molecular mechanisms of DRUGA induced behavioral changes , Northern blot analysis of total RNA from prefrontal cortical tissues of mice treated with DRUGN , DRUGB , and DRUGN was carried out .
PCP	drug_n	DCG-IV	drug_n
false

In order to examine some molecular mechanisms of DRUGA induced behavioral changes , Northern blot analysis of total RNA from prefrontal cortical tissues of mice treated with DRUGN , DRUGN , and DRUGB was carried out .
PCP	drug_n	L-CCG-1	drug_n
false

In order to examine some molecular mechanisms of DRUGN induced behavioral changes , Northern blot analysis of total RNA from prefrontal cortical tissues of mice treated with DRUGA , DRUGB , and DRUGN was carried out .
PCP	drug_n	DCG-IV	drug_n
false

In order to examine some molecular mechanisms of DRUGN induced behavioral changes , Northern blot analysis of total RNA from prefrontal cortical tissues of mice treated with DRUGA , DRUGN , and DRUGB was carried out .
PCP	drug_n	L-CCG-1	drug_n
false

In order to examine some molecular mechanisms of DRUGN induced behavioral changes , Northern blot analysis of total RNA from prefrontal cortical tissues of mice treated with DRUGN , DRUGA , and DRUGB was carried out .
DCG-IV	drug_n	L-CCG-1	drug_n
false

Behavioral responses to repeated DRUGA exposure in mice selectively bred for differential sensitivity to DRUGB .
cocaine	drug	pentobarbital	drug
false

DRUGA ( DRUGB ) and DRUGN : comparison of antiaddictive efficacy , toxicity , and mechanisms of action .
18-Methoxycoronaridine	drug_n	18-MC	drug_n
false

DRUGA ( DRUGN ) and DRUGB : comparison of antiaddictive efficacy , toxicity , and mechanisms of action .
18-Methoxycoronaridine	drug_n	ibogaine	drug_n
false

DRUGN ( DRUGA ) and DRUGB : comparison of antiaddictive efficacy , toxicity , and mechanisms of action .
18-MC	drug_n	ibogaine	drug_n
false

Like DRUGA ( dgb mg / kg ) , DRUGB ( dgb mg / kg ) decreases the intravenous self administration of DRUGN and DRUGN and the oral self administration of DRUGN and DRUGN in rats ;
ibogaine	drug_n	18-MC	drug_n
false

Like DRUGA ( dgb mg / kg ) , DRUGN ( dgb mg / kg ) decreases the intravenous self administration of DRUGB and DRUGN and the oral self administration of DRUGN and DRUGN in rats ;
ibogaine	drug_n	morphine	drug
false

Like DRUGA ( dgb mg / kg ) , DRUGN ( dgb mg / kg ) decreases the intravenous self administration of DRUGN and DRUGB and the oral self administration of DRUGN and DRUGN in rats ;
ibogaine	drug_n	cocaine	drug
false

Like DRUGA ( dgb mg / kg ) , DRUGN ( dgb mg / kg ) decreases the intravenous self administration of DRUGN and DRUGN and the oral self administration of DRUGB and DRUGN in rats ;
ibogaine	drug_n	ethanol	drug
false

Like DRUGA ( dgb mg / kg ) , DRUGN ( dgb mg / kg ) decreases the intravenous self administration of DRUGN and DRUGN and the oral self administration of DRUGN and DRUGB in rats ;
ibogaine	drug_n	nicotine	drug
false

Like DRUGN ( dgb mg / kg ) , DRUGA ( dgb mg / kg ) decreases the intravenous self administration of DRUGB and DRUGN and the oral self administration of DRUGN and DRUGN in rats ;
18-MC	drug_n	morphine	drug
false

Like DRUGN ( dgb mg / kg ) , DRUGA ( dgb mg / kg ) decreases the intravenous self administration of DRUGN and DRUGB and the oral self administration of DRUGN and DRUGN in rats ;
18-MC	drug_n	cocaine	drug
false

Like DRUGN ( dgb mg / kg ) , DRUGA ( dgb mg / kg ) decreases the intravenous self administration of DRUGN and DRUGN and the oral self administration of DRUGB and DRUGN in rats ;
18-MC	drug_n	ethanol	drug
false

Like DRUGN ( dgb mg / kg ) , DRUGA ( dgb mg / kg ) decreases the intravenous self administration of DRUGN and DRUGN and the oral self administration of DRUGN and DRUGB in rats ;
18-MC	drug_n	nicotine	drug
false

Like DRUGN ( dgb mg / kg ) , DRUGN ( dgb mg / kg ) decreases the intravenous self administration of DRUGA and DRUGB and the oral self administration of DRUGN and DRUGN in rats ;
morphine	drug	cocaine	drug
false

Like DRUGN ( dgb mg / kg ) , DRUGN ( dgb mg / kg ) decreases the intravenous self administration of DRUGA and DRUGN and the oral self administration of DRUGB and DRUGN in rats ;
morphine	drug	ethanol	drug
false

Like DRUGN ( dgb mg / kg ) , DRUGN ( dgb mg / kg ) decreases the intravenous self administration of DRUGA and DRUGN and the oral self administration of DRUGN and DRUGB in rats ;
morphine	drug	nicotine	drug
false

Like DRUGN ( dgb mg / kg ) , DRUGN ( dgb mg / kg ) decreases the intravenous self administration of DRUGN and DRUGA and the oral self administration of DRUGB and DRUGN in rats ;
cocaine	drug	ethanol	drug
false

Like DRUGN ( dgb mg / kg ) , DRUGN ( dgb mg / kg ) decreases the intravenous self administration of DRUGN and DRUGA and the oral self administration of DRUGN and DRUGB in rats ;
cocaine	drug	nicotine	drug
false

Like DRUGN ( dgb mg / kg ) , DRUGN ( dgb mg / kg ) decreases the intravenous self administration of DRUGN and DRUGN and the oral self administration of DRUGA and DRUGB in rats ;
ethanol	drug	nicotine	drug
false

unlike DRUGA , DRUGB does not affect responding for a nondrug reinforcer ( water ) .
ibogaine	drug_n	18-MC	drug_n
false

Both DRUGA and DRUGB ameliorate DRUGN withdrawal signs .
ibogaine	drug_n	18-MC	drug_n
false

Both DRUGA and DRUGN ameliorate DRUGB withdrawal signs .
ibogaine	drug_n	opioid	group
false

Both DRUGN and DRUGA ameliorate DRUGB withdrawal signs .
18-MC	drug_n	opioid	group
false

Both DRUGA and DRUGB decrease extracellular levels of dopamine in the nucleus accumbens , but only DRUGN increases extracellular levels of serotonin in the nucleus accumbens .
ibogaine	drug_n	18-MC	drug_n
false

Both DRUGN and DRUGA decrease extracellular levels of dopamine in the nucleus accumbens , but only DRUGB increases extracellular levels of serotonin in the nucleus accumbens .
18-MC	drug_n	ibogaine	drug_n
false

Both DRUGA and DRUGB block DRUGN induced and DRUGN induced dopamine release in the nucleus accumbens ;
ibogaine	drug_n	18-MC	drug_n
false

Both DRUGA and DRUGN block DRUGB induced and DRUGN induced dopamine release in the nucleus accumbens ;
ibogaine	drug_n	morphine	drug
effect

Both DRUGA and DRUGN block DRUGN induced and DRUGB induced dopamine release in the nucleus accumbens ;
ibogaine	drug_n	nicotine	drug
effect

Both DRUGN and DRUGA block DRUGB induced and DRUGN induced dopamine release in the nucleus accumbens ;
18-MC	drug_n	morphine	drug
effect

Both DRUGN and DRUGA block DRUGN induced and DRUGB induced dopamine release in the nucleus accumbens ;
18-MC	drug_n	nicotine	drug
effect

Both DRUGN and DRUGN block DRUGA induced and DRUGB induced dopamine release in the nucleus accumbens ;
morphine	drug	nicotine	drug
false

only DRUGA enhances DRUGB induced increases in accumbal dopamine .
ibogaine	drug_n	cocaine	drug
effect

Both DRUGA and DRUGB enhance the locomotor and / or stereotypic effects of stimulants .
ibogaine	drug_n	18-MC	drug_n
false

DRUGA attenuates , but DRUGB potentiates , the acute locomotor effects of DRUGN ;
Ibogaine	drug_n	18-MC	drug_n
false

DRUGA attenuates , but DRUGN potentiates , the acute locomotor effects of DRUGB ;
Ibogaine	drug_n	morphine	drug
effect

DRUGN attenuates , but DRUGA potentiates , the acute locomotor effects of DRUGB ;
18-MC	drug_n	morphine	drug
effect

DRUGA , but not DRUGB , decreases heart rate at high doses .
Ibogaine	drug_n	18-MC	drug_n
false

While DRUGA and DRUGB have similar affinities for kappa opioid and possibly nicotinic receptors , DRUGN has much lower affinities than DRUGN for NMDA and sigma dgb receptors , sodium channels , and the dgb HT transporter .
18-MC	drug_n	ibogaine	drug_n
false

While DRUGA and DRUGN have similar affinities for kappa opioid and possibly nicotinic receptors , DRUGN has much lower affinities than DRUGB for NMDA and sigma dgb receptors , sodium channels , and the dgb HT transporter .
18-MC	drug_n	ibogaine	drug_n
false

While DRUGN and DRUGA have similar affinities for kappa opioid and possibly nicotinic receptors , DRUGB has much lower affinities than DRUGN for NMDA and sigma dgb receptors , sodium channels , and the dgb HT transporter .
ibogaine	drug_n	18-MC	drug_n
false

While DRUGN and DRUGN have similar affinities for kappa opioid and possibly nicotinic receptors , DRUGA has much lower affinities than DRUGB for NMDA and sigma dgb receptors , sodium channels , and the dgb HT transporter .
18-MC	drug_n	ibogaine	drug_n
false

Both DRUGA and DRUGB are sequestered in fat and , like DRUGN , DRUGN probably has an active metabolite .
18-MC	drug_n	ibogaine	drug_n
false

Both DRUGA and DRUGN are sequestered in fat and , like DRUGB , DRUGN probably has an active metabolite .
18-MC	drug_n	ibogaine	drug_n
false

Both DRUGN and DRUGA are sequestered in fat and , like DRUGN , DRUGB probably has an active metabolite .
ibogaine	drug_n	18-MC	drug_n
false

Both DRUGN and DRUGN are sequestered in fat and , like DRUGA , DRUGB probably has an active metabolite .
ibogaine	drug_n	18-MC	drug_n
false

The data suggest that DRUGA has a narrower spectrum of actions and will have a substantially greater therapeutic index than DRUGB .
18-MC	drug_n	ibogaine	drug_n
false

Clinical implications of DRUGA interactions with five DRUGB .
warfarin	drug	sedatives	group
int

The intensity , uniformity and time course of DRUGA interference by DRUGB , DRUGN , DRUGN , DRUGN and DRUGN were systematically investigated in dgb patients receiving DRUGN therapy .
anticoagulant	group	phenobarbital	drug
false

The intensity , uniformity and time course of DRUGA interference by DRUGN , DRUGB , DRUGN , DRUGN and DRUGN were systematically investigated in dgb patients receiving DRUGN therapy .
anticoagulant	group	secobarbital	drug
false

The intensity , uniformity and time course of DRUGA interference by DRUGN , DRUGN , DRUGB , DRUGN and DRUGN were systematically investigated in dgb patients receiving DRUGN therapy .
anticoagulant	group	glutethimide	drug
false

The intensity , uniformity and time course of DRUGA interference by DRUGN , DRUGN , DRUGN , DRUGB and DRUGN were systematically investigated in dgb patients receiving DRUGN therapy .
anticoagulant	group	chloral hydrate	drug
false

The intensity , uniformity and time course of DRUGA interference by DRUGN , DRUGN , DRUGN , DRUGN and DRUGB were systematically investigated in dgb patients receiving DRUGN therapy .
anticoagulant	group	methaqualone	drug
false

The intensity , uniformity and time course of DRUGA interference by DRUGN , DRUGN , DRUGN , DRUGN and DRUGN were systematically investigated in dgb patients receiving DRUGB therapy .
anticoagulant	group	coumarin	group
false

The intensity , uniformity and time course of DRUGN interference by DRUGA , DRUGB , DRUGN , DRUGN and DRUGN were systematically investigated in dgb patients receiving DRUGN therapy .
phenobarbital	drug	secobarbital	drug
false

The intensity , uniformity and time course of DRUGN interference by DRUGA , DRUGN , DRUGB , DRUGN and DRUGN were systematically investigated in dgb patients receiving DRUGN therapy .
phenobarbital	drug	glutethimide	drug
false

The intensity , uniformity and time course of DRUGN interference by DRUGA , DRUGN , DRUGN , DRUGB and DRUGN were systematically investigated in dgb patients receiving DRUGN therapy .
phenobarbital	drug	chloral hydrate	drug
false

The intensity , uniformity and time course of DRUGN interference by DRUGA , DRUGN , DRUGN , DRUGN and DRUGB were systematically investigated in dgb patients receiving DRUGN therapy .
phenobarbital	drug	methaqualone	drug
false

The intensity , uniformity and time course of DRUGN interference by DRUGA , DRUGN , DRUGN , DRUGN and DRUGN were systematically investigated in dgb patients receiving DRUGB therapy .
phenobarbital	drug	coumarin	group
false

The intensity , uniformity and time course of DRUGN interference by DRUGN , DRUGA , DRUGB , DRUGN and DRUGN were systematically investigated in dgb patients receiving DRUGN therapy .
secobarbital	drug	glutethimide	drug
false

The intensity , uniformity and time course of DRUGN interference by DRUGN , DRUGA , DRUGN , DRUGB and DRUGN were systematically investigated in dgb patients receiving DRUGN therapy .
secobarbital	drug	chloral hydrate	drug
false

The intensity , uniformity and time course of DRUGN interference by DRUGN , DRUGA , DRUGN , DRUGN and DRUGB were systematically investigated in dgb patients receiving DRUGN therapy .
secobarbital	drug	methaqualone	drug
false

The intensity , uniformity and time course of DRUGN interference by DRUGN , DRUGA , DRUGN , DRUGN and DRUGN were systematically investigated in dgb patients receiving DRUGB therapy .
secobarbital	drug	coumarin	group
false

The intensity , uniformity and time course of DRUGN interference by DRUGN , DRUGN , DRUGA , DRUGB and DRUGN were systematically investigated in dgb patients receiving DRUGN therapy .
glutethimide	drug	chloral hydrate	drug
false

The intensity , uniformity and time course of DRUGN interference by DRUGN , DRUGN , DRUGA , DRUGN and DRUGB were systematically investigated in dgb patients receiving DRUGN therapy .
glutethimide	drug	methaqualone	drug
false

The intensity , uniformity and time course of DRUGN interference by DRUGN , DRUGN , DRUGA , DRUGN and DRUGN were systematically investigated in dgb patients receiving DRUGB therapy .
glutethimide	drug	coumarin	group
false

The intensity , uniformity and time course of DRUGN interference by DRUGN , DRUGN , DRUGN , DRUGA and DRUGB were systematically investigated in dgb patients receiving DRUGN therapy .
chloral hydrate	drug	methaqualone	drug
false

The intensity , uniformity and time course of DRUGN interference by DRUGN , DRUGN , DRUGN , DRUGA and DRUGN were systematically investigated in dgb patients receiving DRUGB therapy .
chloral hydrate	drug	coumarin	group
false

The intensity , uniformity and time course of DRUGN interference by DRUGN , DRUGN , DRUGN , DRUGN and DRUGA were systematically investigated in dgb patients receiving DRUGB therapy .
methaqualone	drug	coumarin	group
false

Anticoagulant inhibition was observed during the administration of DRUGA , DRUGB and DRUGN ;
phenobarbital	drug	secobarbital	drug
false

Anticoagulant inhibition was observed during the administration of DRUGA , DRUGN and DRUGB ;
phenobarbital	drug	glutethimide	drug
false

Anticoagulant inhibition was observed during the administration of DRUGN , DRUGA and DRUGB ;
secobarbital	drug	glutethimide	drug
false

there was no significant change in prothrombin test results during the trials of DRUGA and DRUGB .
chloral hydrate	drug	methaqualone	drug
false

DRUGA and DRUGB should not be administered to patients receiving DRUGN .
Barbiturates	group	glutethimide	drug
false

DRUGA and DRUGN should not be administered to patients receiving DRUGB .
Barbiturates	group	coumarin drugs	group
advise

DRUGN and DRUGA should not be administered to patients receiving DRUGB .
glutethimide	drug	coumarin drugs	group
advise

DRUGA and DRUGB interact pharmacologically with orally administered DRUGN , but the effect is not clinically significant .
Chloral hydrate	drug	methaqualone	drug
false

DRUGA and DRUGN interact pharmacologically with orally administered DRUGB , but the effect is not clinically significant .
Chloral hydrate	drug	anticoagulant agents	group
int

DRUGN and DRUGA interact pharmacologically with orally administered DRUGB , but the effect is not clinically significant .
methaqualone	drug	anticoagulant agents	group
int

It is concluded that DRUGA and DRUGB may be administered safely without additional caution in prothrombin test monitoring during oral DRUGN therapy .
chloral hydrate	drug	methaqualone	drug
false

It is concluded that DRUGA and DRUGN may be administered safely without additional caution in prothrombin test monitoring during oral DRUGB therapy .
chloral hydrate	drug	anticoagulant	group
false

It is concluded that DRUGN and DRUGA may be administered safely without additional caution in prothrombin test monitoring during oral DRUGB therapy .
methaqualone	drug	anticoagulant	group
false

Concomitantly given DRUGA did not interfere with the absorption of a tablet of DRUGB .
thiazide diuretics	group	digoxin	drug
false

Combinations of DRUGA and DRUGB : effects on drug discrimination and behavioral inhibition in rats .
clozapine	drug	phencyclidine	drug_n
false

DRUGA ( DRUGB ) produces psychotomimetic effects in humans that resemble schizophrenia symptoms .
Phencyclidine	drug_n	PCP	drug_n
false

In the present study , the DRUGA DRUGB was tested in combination with an active dose of DRUGN in two lever drug discrimination and mixed signalled unsignalled differential reinforcement of low rates ( DRL ) procedures .
atypical antipsychotic	group	clozapine	drug
false

In the present study , the DRUGA DRUGN was tested in combination with an active dose of DRUGB in two lever drug discrimination and mixed signalled unsignalled differential reinforcement of low rates ( DRL ) procedures .
atypical antipsychotic	group	PCP	drug_n
false

In the present study , the DRUGN DRUGA was tested in combination with an active dose of DRUGB in two lever drug discrimination and mixed signalled unsignalled differential reinforcement of low rates ( DRL ) procedures .
clozapine	drug	PCP	drug_n
false

Acute dosing with DRUGA failed to alter the behavioral effects of DRUGB in either procedure even when tested up to doses that produced pharmacological effects alone .
clozapine	drug	PCP	drug_n
false

These results suggest that acute dosing with DRUGA would not affect behaviors most closely associated with DRUGB intoxication .
clozapine	drug	PCP	drug_n
false

Since chronic dosing is required for therapeutic efficacy of DRUGA , future studies should focus on investigation of chronic dosing effects of these drugs in combination with DRUGB .
antipsychotics	group	PCP	drug_n
false

DRUGA ( dgb dgb micromol / l ) induced concentration dependent relaxation of mesenteric arteries preconstricted with DRUGB ( dgb micromol / l ) or DRUGN ( dgb mmol / l ) from both lean and dietary obese rats .
Resveratrol	drug_n	noradrenaline	drug
false

DRUGA ( dgb dgb micromol / l ) induced concentration dependent relaxation of mesenteric arteries preconstricted with DRUGN ( dgb micromol / l ) or DRUGB ( dgb mmol / l ) from both lean and dietary obese rats .
Resveratrol	drug_n	KCl	drug
false

DRUGN ( dgb dgb micromol / l ) induced concentration dependent relaxation of mesenteric arteries preconstricted with DRUGA ( dgb micromol / l ) or DRUGB ( dgb mmol / l ) from both lean and dietary obese rats .
noradrenaline	drug	KCl	drug
false

However , DRUGA ( dgb and dgb micromol / l ) did not alter the effects of DRUGB on arteries from dietary obese rats , giving superimposed concentration responses curves .
L-NAME	drug_n	reseveratrol	drug_n
false

DRUGA was also ineffective in altering DRUGB activity in arteries from both lean and dietary obese rats .
Indomethacin	drug	resveratrol	drug_n
false

In DRUGA precontracted arteries from dietary obese rats , responses to DRUGB were not attenuated by endothelial denudation , indicating an action independent of the endothelium .
noradrenaline	drug	resveratrol	drug_n
false

If taken dgb hour before DRUGA ( DRUGB ) , DRUGN does not affect DRUGN exposure , despite persistent buffering effects .
indinavir	drug	IDV	drug
false

If taken dgb hour before DRUGA ( DRUGN ) , DRUGB does not affect DRUGN exposure , despite persistent buffering effects .
indinavir	drug	didanosine	drug
false

If taken dgb hour before DRUGA ( DRUGN ) , DRUGN does not affect DRUGB exposure , despite persistent buffering effects .
indinavir	drug	IDV	drug
false

If taken dgb hour before DRUGN ( DRUGA ) , DRUGB does not affect DRUGN exposure , despite persistent buffering effects .
IDV	drug	didanosine	drug
false

If taken dgb hour before DRUGN ( DRUGN ) , DRUGA does not affect DRUGB exposure , despite persistent buffering effects .
didanosine	drug	IDV	drug
false

Concurrent administration of DRUGA and DRUGB significantly reduces the level of exposure to DRUGN , but it is unclear how soon after DRUGN administration DRUGN may be given safely .
indinavir	drug	didanosine	drug
mechanism

Concurrent administration of DRUGA and DRUGN significantly reduces the level of exposure to DRUGN , but it is unclear how soon after DRUGB administration DRUGN may be given safely .
indinavir	drug	didanosine	drug
false

Concurrent administration of DRUGN and DRUGA significantly reduces the level of exposure to DRUGB , but it is unclear how soon after DRUGN administration DRUGN may be given safely .
didanosine	drug	indinavir	drug
false

Concurrent administration of DRUGN and DRUGA significantly reduces the level of exposure to DRUGN , but it is unclear how soon after DRUGN administration DRUGB may be given safely .
didanosine	drug	indinavir	drug
false

Concurrent administration of DRUGN and DRUGN significantly reduces the level of exposure to DRUGA , but it is unclear how soon after DRUGB administration DRUGN may be given safely .
indinavir	drug	didanosine	drug
false

Concurrent administration of DRUGN and DRUGN significantly reduces the level of exposure to DRUGN , but it is unclear how soon after DRUGA administration DRUGB may be given safely .
didanosine	drug	indinavir	drug
false

We compared DRUGA pharmacokinetics and gastric pH in dgb human immunodeficiency virus positive patients by use of dgb mg of DRUGN alone versus dgb mg of DRUGN administered dgb h after DRUGB administration .
indinavir	drug	didanosine	drug
false

We compared DRUGN pharmacokinetics and gastric pH in dgb human immunodeficiency virus positive patients by use of dgb mg of DRUGA alone versus dgb mg of DRUGN administered dgb h after DRUGB administration .
indinavir	drug	didanosine	drug
false

We compared DRUGN pharmacokinetics and gastric pH in dgb human immunodeficiency virus positive patients by use of dgb mg of DRUGN alone versus dgb mg of DRUGA administered dgb h after DRUGB administration .
indinavir	drug	didanosine	drug
false

Median gastric pH was significantly higher when DRUGA was taken after DRUGB administration ;
indinavir	drug	didanosine	drug
mechanism

DRUGA may be taken with a light meal dgb h following the administration of dgb mg of DRUGB .
Indinavir	drug	didanosine	drug
advise

DRUGA at dgb microM preferentially blocked the secretory effect of DRUGB and its synergism with cAMP , whereas it had no effect on histamine or cAMP stimulated acid secretion within dgb min .
Cytochalasin D	drug_n	carbachol	drug
effect

DRUGA inhibited the DRUGB stimulated intracellular Ca ( dgb+ ) concentration ( [ Ca ( dgb+ ) ] ( i ) ) increase due to release from the Ca ( dgb+ ) store .
Cytochalasin D	drug_n	carbachol	drug
effect

The percentage of neurons hyperpolarized by DRUGA , DRUGB , and DRUGN was significantly reduced when dgb % but not <
mu-selective opioids	group	delta(1)-selective opioids	group
false

The percentage of neurons hyperpolarized by DRUGA , DRUGN , and DRUGB was significantly reduced when dgb % but not <
mu-selective opioids	group	kappa-selective opioids	group
false

The percentage of neurons hyperpolarized by DRUGN , DRUGA , and DRUGB was significantly reduced when dgb % but not <
delta(1)-selective opioids	group	kappa-selective opioids	group
false

Suppression by DRUGA of DRUGB enhanced peritoneal metastasis of intestinal adenocarcinomas induced by DRUGN in wistar rats .
verapamil	drug	bombesin	drug_n
effect

Suppression by DRUGA of DRUGN enhanced peritoneal metastasis of intestinal adenocarcinomas induced by DRUGB in wistar rats .
verapamil	drug	azoxymethane	drug_n
false

Suppression by DRUGN of DRUGA enhanced peritoneal metastasis of intestinal adenocarcinomas induced by DRUGB in wistar rats .
bombesin	drug_n	azoxymethane	drug_n
false

DRUGA also significantly decreased the incidence of lymphatic invasion of adenocarcinomas , which was enhanced by DRUGB .
Verapamil	drug	bombesin	drug_n
effect

In vitro interaction of DRUGA and DRUGB in placental vessels .
prostaglandin F2alpha	drug	oxytocin	drug
int

The interaction of DRUGA and synthetic DRUGB on placental vessels was studied in vitro .
prostaglandin F2alpha	drug	oxytocin	drug
false

In seven experiments reactions to DRUGA and DRUGB were DRUGN .
norepinephrine	drug	oxytocin	drug
false

In seven experiments reactions to DRUGA and DRUGN were DRUGB .
norepinephrine	drug	PGF2alpha	drug
false

In seven experiments reactions to DRUGN and DRUGA were DRUGB .
oxytocin	drug	PGF2alpha	drug
false

DRUGA produced significantly increased vasoconstriction after a single administration of DRUGB .
PGF2alpha	drug	oxytocin	drug
effect

There is thus an enhancement effect of DRUGA upon the reaction of placental vessels to DRUGB in vitro .
PGF2alpha	drug	oxytocin	drug
effect

DRUGA overdose recognized by a DRUGB assay .
Carbamazepine	drug	tricyclic antidepressant	group
false

We report the case of an adolescent with altered consciousness caused by DRUGA overdose with a positive DRUGB level to alert clinicians to the cross reactivity of DRUGN with a toxicology screen for DRUGN .
carbamazepine	drug	tricyclic antidepressant	group
effect

We report the case of an adolescent with altered consciousness caused by DRUGA overdose with a positive DRUGN level to alert clinicians to the cross reactivity of DRUGN with a toxicology screen for DRUGB .
carbamazepine	drug	tricyclic antidepressants	group
false

We report the case of an adolescent with altered consciousness caused by DRUGN overdose with a positive DRUGA level to alert clinicians to the cross reactivity of DRUGB with a toxicology screen for DRUGN .
tricyclic antidepressant	group	carbamazepine	drug
false

We report the case of an adolescent with altered consciousness caused by DRUGN overdose with a positive DRUGA level to alert clinicians to the cross reactivity of DRUGN with a toxicology screen for DRUGB .
tricyclic antidepressant	group	tricyclic antidepressants	group
false

We report the case of an adolescent with altered consciousness caused by DRUGN overdose with a positive DRUGN level to alert clinicians to the cross reactivity of DRUGA with a toxicology screen for DRUGB .
carbamazepine	drug	tricyclic antidepressants	group
advise

DRUGA induced oxidative stress in rat brain and liver is prevented by DRUGB or DRUGN .
Cypermethrin	drug	vitamin E	drug
effect

DRUGA induced oxidative stress in rat brain and liver is prevented by DRUGN or DRUGB .
Cypermethrin	drug	allopurinol	drug
effect

DRUGN induced oxidative stress in rat brain and liver is prevented by DRUGA or DRUGB .
vitamin E	drug	allopurinol	drug
false

Considering that the involvement of reactive oxygen species ( ROS ) has been implicated in the toxicity of various pesticides , this study was designed to investigate the possibility of oxidative stress induction by DRUGA , a DRUGB .
cypermethrin	drug	Type II pyrethroid	drug_n
false

Thus , the results suggest that DRUGA exposure of rats results in free radical mediated tissue damage , as indicated by elevated cerebral and hepatic lipid peroxidation , which was prevented by DRUGB and DRUGN .
cypermethrin	drug	allopurinol	drug
effect

Thus , the results suggest that DRUGA exposure of rats results in free radical mediated tissue damage , as indicated by elevated cerebral and hepatic lipid peroxidation , which was prevented by DRUGN and DRUGB .
cypermethrin	drug	Vitamin E	drug
effect

Thus , the results suggest that DRUGN exposure of rats results in free radical mediated tissue damage , as indicated by elevated cerebral and hepatic lipid peroxidation , which was prevented by DRUGA and DRUGB .
allopurinol	drug	Vitamin E	drug
false

DRUGA had no effect on DRUGB response .
Nimodipine	drug	ginsenosides	drug_n
false

Thus , the selective regulation of voltage dependent Ca ( dgb+ ) subtypes by DRUGA in bovine chromaffin cell could be the cellular basis of antistress effects induced by DRUGB .
ginsenosides	drug_n	ginseng	drug
false

In vitro activity of DRUGA , either singly or in combination with DRUGB , against Mycobacterium ulcerans .
KRM-1648	drug_n	ofloxacin	drug
false

The antimicrobial effect of a DRUGA , DRUGB , either alone or in combination with DRUGN , was evaluated in vitro against two type strains and six clinical isolates of Mycobacterium ulcerans .
benzoxazinorifamycin	drug_n	KRM-1648	drug_n
false

The antimicrobial effect of a DRUGA , DRUGN , either alone or in combination with DRUGB , was evaluated in vitro against two type strains and six clinical isolates of Mycobacterium ulcerans .
benzoxazinorifamycin	drug_n	ofloxacin	drug
false

The antimicrobial effect of a DRUGN , DRUGA , either alone or in combination with DRUGB , was evaluated in vitro against two type strains and six clinical isolates of Mycobacterium ulcerans .
KRM-1648	drug_n	ofloxacin	drug
false

ulcerans was between dga and dga mg / l , while corresponding values for DRUGA and DRUGB were in the range of dga dga mg / l and dga dga mg / l respectively .
rifampicin	drug	rifabutin	drug
false

When combined with DRUGA , DRUGB exhibited strong synergistic activity while only additive effects were observed with the combination of DRUGN ( or DRUGN ) and DRUGN .
ofloxacin	drug	KRM-1648	drug_n
effect

When combined with DRUGA , DRUGN exhibited strong synergistic activity while only additive effects were observed with the combination of DRUGB ( or DRUGN ) and DRUGN .
ofloxacin	drug	rifampicin	drug
false

When combined with DRUGA , DRUGN exhibited strong synergistic activity while only additive effects were observed with the combination of DRUGN ( or DRUGB ) and DRUGN .
ofloxacin	drug	rifabutin	drug
false

When combined with DRUGN , DRUGA exhibited strong synergistic activity while only additive effects were observed with the combination of DRUGB ( or DRUGN ) and DRUGN .
KRM-1648	drug_n	rifampicin	drug
false

When combined with DRUGN , DRUGA exhibited strong synergistic activity while only additive effects were observed with the combination of DRUGN ( or DRUGB ) and DRUGN .
KRM-1648	drug_n	rifabutin	drug
false

When combined with DRUGN , DRUGA exhibited strong synergistic activity while only additive effects were observed with the combination of DRUGN ( or DRUGN ) and DRUGB .
KRM-1648	drug_n	ofloxacin	drug
false

When combined with DRUGN , DRUGN exhibited strong synergistic activity while only additive effects were observed with the combination of DRUGA ( or DRUGB ) and DRUGN .
rifampicin	drug	rifabutin	drug
false

When combined with DRUGN , DRUGN exhibited strong synergistic activity while only additive effects were observed with the combination of DRUGA ( or DRUGN ) and DRUGB .
rifampicin	drug	ofloxacin	drug
effect

When combined with DRUGN , DRUGN exhibited strong synergistic activity while only additive effects were observed with the combination of DRUGN ( or DRUGA ) and DRUGB .
rifabutin	drug	ofloxacin	drug
effect

The effects of DRUGA ( DRUGB ) on DRUGN ( DRUGN ) induced responses were studied in rat bone marrow megakaryocytes with the patch clamp whole cell recording technique in combination with fura dgb microfluorometry .
ruthenium red	drug_n	RR	drug_n
false

The effects of DRUGA ( DRUGN ) on DRUGB ( DRUGN ) induced responses were studied in rat bone marrow megakaryocytes with the patch clamp whole cell recording technique in combination with fura dgb microfluorometry .
ruthenium red	drug_n	inositol 1,4,5-trisphosphate	drug_n
false

The effects of DRUGA ( DRUGN ) on DRUGN ( DRUGB ) induced responses were studied in rat bone marrow megakaryocytes with the patch clamp whole cell recording technique in combination with fura dgb microfluorometry .
ruthenium red	drug_n	InsP(3)	drug_n
false

The effects of DRUGN ( DRUGA ) on DRUGB ( DRUGN ) induced responses were studied in rat bone marrow megakaryocytes with the patch clamp whole cell recording technique in combination with fura dgb microfluorometry .
RR	drug_n	inositol 1,4,5-trisphosphate	drug_n
false

The effects of DRUGN ( DRUGA ) on DRUGN ( DRUGB ) induced responses were studied in rat bone marrow megakaryocytes with the patch clamp whole cell recording technique in combination with fura dgb microfluorometry .
RR	drug_n	InsP(3)	drug_n
false

The effects of DRUGN ( DRUGN ) on DRUGA ( DRUGB ) induced responses were studied in rat bone marrow megakaryocytes with the patch clamp whole cell recording technique in combination with fura dgb microfluorometry .
inositol 1,4,5-trisphosphate	drug_n	InsP(3)	drug_n
false

Administering DRUGA together with DRUGB ( dgb dgb microM ) inhibited InsP ( dgb ) induced responses ( both Ca ( dgb+ ) and current responses ) in a dose dependent fashion .
InsP(3)	drug_n	RR	drug_n
effect

Pretreatment of megakaryocytes with extracellular DRUGA ( dgb microM ) also inhibited DRUGB induced responses .
RR	drug_n	InsP(3)	drug_n
effect

In contrast , in isolated single pancreatic acinar cells , DRUGA had no effect on DRUGB induced responses .
RR	drug_n	InsP(3)	drug_n
false

In addition , we have shown that DRUGA is a useful pharmacological tool with which to examine the DRUGB mediated responses of megakaryocytes .
RR	drug_n	InsP(3)	drug_n
false

Effect of DRUGA on the pharmacokinetics of DRUGB in healthy volunteers .
rofecoxib	drug	digoxin	drug
false

The authors examined the effect of the cyclooxygenase dgb ( COX dgb ) inhibitor , DRUGA , at steady state on the pharmacokinetics of DRUGB following a single dose in healthy subjects .
rofecoxib	drug	digoxin	drug
false

The harmonic mean elimination half life was dga and dga hours for DRUGA + DRUGB and placebo + DRUGN treatments , respectively .
rofecoxib	drug	digoxin	drug
false

The harmonic mean elimination half life was dga and dga hours for DRUGA + DRUGN and placebo + DRUGB treatments , respectively .
rofecoxib	drug	digoxin	drug
false

The mean ( SD ) cumulative urinary excretion of immunoreactive DRUGA after concurrent treatment with DRUGB or placebo was dga ( + / dga ) and dga ( + / dga ) micrograms / dgb hours , respectively .
digoxin	drug	rofecoxib	drug
false

DRUGA did not influence the plasma pharmacokinetics or renal elimination of a single oral dose of DRUGB .
Rofecoxib	drug	digoxin	drug
false

Concomitant DRUGA , DRUGB , DRUGN , and DRUGN chemotherapy plus DRUGN therapy in patients with human immunodeficiency virus related , non Hodgkin lymphoma .
cyclophosphamide	drug	doxorubicin	drug
false

Concomitant DRUGA , DRUGN , DRUGB , and DRUGN chemotherapy plus DRUGN therapy in patients with human immunodeficiency virus related , non Hodgkin lymphoma .
cyclophosphamide	drug	vincristine	drug
false

Concomitant DRUGA , DRUGN , DRUGN , and DRUGB chemotherapy plus DRUGN therapy in patients with human immunodeficiency virus related , non Hodgkin lymphoma .
cyclophosphamide	drug	prednisone	drug
false

Concomitant DRUGA , DRUGN , DRUGN , and DRUGN chemotherapy plus DRUGB therapy in patients with human immunodeficiency virus related , non Hodgkin lymphoma .
cyclophosphamide	drug	highly active antiretroviral	group
false

Concomitant DRUGN , DRUGA , DRUGB , and DRUGN chemotherapy plus DRUGN therapy in patients with human immunodeficiency virus related , non Hodgkin lymphoma .
doxorubicin	drug	vincristine	drug
false

Concomitant DRUGN , DRUGA , DRUGN , and DRUGB chemotherapy plus DRUGN therapy in patients with human immunodeficiency virus related , non Hodgkin lymphoma .
doxorubicin	drug	prednisone	drug
false

Concomitant DRUGN , DRUGA , DRUGN , and DRUGN chemotherapy plus DRUGB therapy in patients with human immunodeficiency virus related , non Hodgkin lymphoma .
doxorubicin	drug	highly active antiretroviral	group
false

Concomitant DRUGN , DRUGN , DRUGA , and DRUGB chemotherapy plus DRUGN therapy in patients with human immunodeficiency virus related , non Hodgkin lymphoma .
vincristine	drug	prednisone	drug
false

Concomitant DRUGN , DRUGN , DRUGA , and DRUGN chemotherapy plus DRUGB therapy in patients with human immunodeficiency virus related , non Hodgkin lymphoma .
vincristine	drug	highly active antiretroviral	group
false

Concomitant DRUGN , DRUGN , DRUGN , and DRUGA chemotherapy plus DRUGB therapy in patients with human immunodeficiency virus related , non Hodgkin lymphoma .
prednisone	drug	highly active antiretroviral	group
false

DRUGA regimens consisted of two DRUGB and one DRUGN .
Antiretroviral	group	reverse transcriptase inhibitors	group
false

DRUGA regimens consisted of two DRUGN and one DRUGB .
Antiretroviral	group	protease inhibitor	group
false

DRUGN regimens consisted of two DRUGA and one DRUGB .
reverse transcriptase inhibitors	group	protease inhibitor	group
false

However , careful attention must be directed to cross toxicity and possible pharmacokinetic interactions between DRUGA and DRUGB .
antiretroviral drugs	group	antineoplastic drugs	group
advise

Treatment with DRUGA can directly interfere with blood glucose levels or may interact with DRUGB .
antidepressant drugs	group	hypoglycemic agents	group
int

DRUGA and DRUGB did not change fasting or overload glycemia .
Imipramine	drug	clonazepam	drug
false

DRUGA and DRUGB increased blood DRUGN at different times after the glucose overload .
Fluoxetine	drug	moclobemide	drug
false

DRUGA and DRUGN increased blood DRUGB at different times after the glucose overload .
Fluoxetine	drug	glucose	drug
false

DRUGN and DRUGA increased blood DRUGB at different times after the glucose overload .
moclobemide	drug	glucose	drug
false

DRUGA neutralized the increase of glycemia induced by oral DRUGB overload .
Sertraline	drug	glucose	drug
false

Again , DRUGA neutralized the increase in glycemia after DRUGB overload both in diabetic and non diabetic rats .
sertraline	drug	glucose	drug
false

Activity of DRUGA alone and in combination with DRUGB and DRUGN against Cryptosporidium parvum in cell culture .
buforin II	drug_n	azithromycin	drug
false

Activity of DRUGA alone and in combination with DRUGN and DRUGB against Cryptosporidium parvum in cell culture .
buforin II	drug_n	minocycline	drug
false

Activity of DRUGN alone and in combination with DRUGA and DRUGB against Cryptosporidium parvum in cell culture .
azithromycin	drug	minocycline	drug
false

The in vitro anti cryptosporidial activity of DRUGA alone and in combination with DRUGB and DRUGN was investigated .
buforin II	drug_n	azithromycin	drug
false

The in vitro anti cryptosporidial activity of DRUGA alone and in combination with DRUGN and DRUGB was investigated .
buforin II	drug_n	minocycline	drug
false

The in vitro anti cryptosporidial activity of DRUGN alone and in combination with DRUGA and DRUGB was investigated .
azithromycin	drug	minocycline	drug
false

Moreover , its activity was enhanced when it was combined with either DRUGA or DRUGB with dgb % parasite reduction at the highest concentration tested .
azithromycin	drug	minocycline	drug
false

DRUGA may be active in inhibiting Cryptosporidium parvum growth in vitro upon combination with either DRUGB or DRUGN .
Buforin II	drug_n	azithromycin	drug
effect

DRUGA may be active in inhibiting Cryptosporidium parvum growth in vitro upon combination with either DRUGN or DRUGB .
Buforin II	drug_n	minocycline	drug
effect

DRUGN may be active in inhibiting Cryptosporidium parvum growth in vitro upon combination with either DRUGA or DRUGB .
azithromycin	drug	minocycline	drug
false

Effect of DRUGA on the pharmacokinetics of DRUGB .
dofetillide	drug	digoxin	drug
false

The effect of DRUGA on the steady state pharmacokinetics of DRUGB was evaluated in a randomized , double blind study .
dofetilide	drug	digoxin	drug
false

Five days of DRUGA treatment did not significantly affect steady state pharmacokinetic variables of DRUGB compared with placebo ;
dofetilide	drug	digoxin	drug
false

therefore , the use of DRUGA does not necessitate an adjustment in DRUGB dose to maintain therapeutic digoxin levels .
dofetilide	drug	digoxin	drug
false

Numerous drug interactions are possible with some DRUGA , such as DRUGB and DRUGN , which affect hepatic microsomal enzyme systems .
anticonvulsant agents	group	phenobarbitone	drug
false

Numerous drug interactions are possible with some DRUGA , such as DRUGN and DRUGB , which affect hepatic microsomal enzyme systems .
anticonvulsant agents	group	phenytoin	drug
false

Numerous drug interactions are possible with some DRUGN , such as DRUGA and DRUGB , which affect hepatic microsomal enzyme systems .
phenobarbitone	drug	phenytoin	drug
false

Interaction of DRUGA and DRUGB in rats .
ketamine	drug	halothane	drug
int

The interaction of intramuscularly injected DRUGA and its N demethylated metabolite ( metabolite I ) with DRUGB was evaluated in rats .
ketamine	drug	halothane	drug
false

The half life of DRUGA in plasma and brain was longer in the presence of DRUGB than when DRUGN was given alone .
ketamine	drug	halothane	drug
mechanism

The half life of DRUGN in plasma and brain was longer in the presence of DRUGA than when DRUGB was given alone .
halothane	drug	ketamine	drug
false

It is concluded that DRUGA is not a short acting drug and that concomitant use with DRUGB would be expected to prolong further the duration of its action on the central nervous system .
ketamine	drug	halothane	drug
effect

DRUGA and DRUGB : a drug interaction .
Rifampin	drug	warfarin	drug
int

The drug interaction between DRUGA and DRUGB is not well known .
warfarin	drug	rifampin	drug
int

DRUGA has been reported to increase the DRUGB requirements in human subjects ingesting these agents simultaneously .
Rifampin	drug	warfarin	drug
mechanism

The concomitant administration of DRUGA and DRUGB resulted in the need for an unusually high maintenance dose of DRUGN ( dgb mg per day ) in order to produce a therapeutic effect .
rifampin	drug	warfarin	drug
mechanism

The concomitant administration of DRUGA and DRUGN resulted in the need for an unusually high maintenance dose of DRUGB ( dgb mg per day ) in order to produce a therapeutic effect .
rifampin	drug	warfarin	drug
false

Withdrawal of DRUGA decreased the DRUGB requirement by dgb % .
rifampin	drug	warfarin	drug
mechanism

This effect may be mediated by the ability of DRUGA to induce microsomal enzymes and , thus , the catabolism of DRUGB .
rifampin	drug	warfarin	drug
mechanism

The effect of DRUGA on the DRUGB requirement of our patient appeared to be maximal dgb to dgb days after the initiation of DRUGN and extended a similar length of time after DRUGN withdrawal .
rifampin	drug	warfarin	drug
effect

The effect of DRUGN on the DRUGA requirement of our patient appeared to be maximal dgb to dgb days after the initiation of DRUGB and extended a similar length of time after DRUGN withdrawal .
warfarin	drug	rifampin	drug
false

The effect of DRUGN on the DRUGA requirement of our patient appeared to be maximal dgb to dgb days after the initiation of DRUGN and extended a similar length of time after DRUGB withdrawal .
warfarin	drug	rifampin	drug
false

The purpose of this study was to evaluate the effect of DRUGA ( DRUGB ) and DRUGN ( DRUGN ) conjugates on the intestinal permeation of DRUGN ( DRUGN ) and model peptide drugs , DRUGN and DRUGN .
sodium carboxymethylcellulose	drug_n	NaCMC	drug_n
false

The purpose of this study was to evaluate the effect of DRUGA ( DRUGN ) and DRUGB ( DRUGN ) conjugates on the intestinal permeation of DRUGN ( DRUGN ) and model peptide drugs , DRUGN and DRUGN .
sodium carboxymethylcellulose	drug_n	carboxymethylcellulose-cysteine	drug_n
false

The purpose of this study was to evaluate the effect of DRUGA ( DRUGN ) and DRUGN ( DRUGB ) conjugates on the intestinal permeation of DRUGN ( DRUGN ) and model peptide drugs , DRUGN and DRUGN .
sodium carboxymethylcellulose	drug_n	CMC-Cys	drug_n
false

The purpose of this study was to evaluate the effect of DRUGA ( DRUGN ) and DRUGN ( DRUGN ) conjugates on the intestinal permeation of DRUGB ( DRUGN ) and model peptide drugs , DRUGN and DRUGN .
sodium carboxymethylcellulose	drug_n	sodium fluorescein	drug
false

The purpose of this study was to evaluate the effect of DRUGA ( DRUGN ) and DRUGN ( DRUGN ) conjugates on the intestinal permeation of DRUGN ( DRUGB ) and model peptide drugs , DRUGN and DRUGN .
sodium carboxymethylcellulose	drug_n	NaFlu	drug
false

The purpose of this study was to evaluate the effect of DRUGA ( DRUGN ) and DRUGN ( DRUGN ) conjugates on the intestinal permeation of DRUGN ( DRUGN ) and model peptide drugs , DRUGB and DRUGN .
sodium carboxymethylcellulose	drug_n	bacitracin	drug
false

The purpose of this study was to evaluate the effect of DRUGA ( DRUGN ) and DRUGN ( DRUGN ) conjugates on the intestinal permeation of DRUGN ( DRUGN ) and model peptide drugs , DRUGN and DRUGB .
sodium carboxymethylcellulose	drug_n	insulin	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGA ) and DRUGB ( DRUGN ) conjugates on the intestinal permeation of DRUGN ( DRUGN ) and model peptide drugs , DRUGN and DRUGN .
NaCMC	drug_n	carboxymethylcellulose-cysteine	drug_n
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGA ) and DRUGN ( DRUGB ) conjugates on the intestinal permeation of DRUGN ( DRUGN ) and model peptide drugs , DRUGN and DRUGN .
NaCMC	drug_n	CMC-Cys	drug_n
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGA ) and DRUGN ( DRUGN ) conjugates on the intestinal permeation of DRUGB ( DRUGN ) and model peptide drugs , DRUGN and DRUGN .
NaCMC	drug_n	sodium fluorescein	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGA ) and DRUGN ( DRUGN ) conjugates on the intestinal permeation of DRUGN ( DRUGB ) and model peptide drugs , DRUGN and DRUGN .
NaCMC	drug_n	NaFlu	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGA ) and DRUGN ( DRUGN ) conjugates on the intestinal permeation of DRUGN ( DRUGN ) and model peptide drugs , DRUGB and DRUGN .
NaCMC	drug_n	bacitracin	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGA ) and DRUGN ( DRUGN ) conjugates on the intestinal permeation of DRUGN ( DRUGN ) and model peptide drugs , DRUGN and DRUGB .
NaCMC	drug_n	insulin	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGN ) and DRUGA ( DRUGB ) conjugates on the intestinal permeation of DRUGN ( DRUGN ) and model peptide drugs , DRUGN and DRUGN .
carboxymethylcellulose-cysteine	drug_n	CMC-Cys	drug_n
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGN ) and DRUGA ( DRUGN ) conjugates on the intestinal permeation of DRUGB ( DRUGN ) and model peptide drugs , DRUGN and DRUGN .
carboxymethylcellulose-cysteine	drug_n	sodium fluorescein	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGN ) and DRUGA ( DRUGN ) conjugates on the intestinal permeation of DRUGN ( DRUGB ) and model peptide drugs , DRUGN and DRUGN .
carboxymethylcellulose-cysteine	drug_n	NaFlu	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGN ) and DRUGA ( DRUGN ) conjugates on the intestinal permeation of DRUGN ( DRUGN ) and model peptide drugs , DRUGB and DRUGN .
carboxymethylcellulose-cysteine	drug_n	bacitracin	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGN ) and DRUGA ( DRUGN ) conjugates on the intestinal permeation of DRUGN ( DRUGN ) and model peptide drugs , DRUGN and DRUGB .
carboxymethylcellulose-cysteine	drug_n	insulin	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGN ) and DRUGN ( DRUGA ) conjugates on the intestinal permeation of DRUGB ( DRUGN ) and model peptide drugs , DRUGN and DRUGN .
CMC-Cys	drug_n	sodium fluorescein	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGN ) and DRUGN ( DRUGA ) conjugates on the intestinal permeation of DRUGN ( DRUGB ) and model peptide drugs , DRUGN and DRUGN .
CMC-Cys	drug_n	NaFlu	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGN ) and DRUGN ( DRUGA ) conjugates on the intestinal permeation of DRUGN ( DRUGN ) and model peptide drugs , DRUGB and DRUGN .
CMC-Cys	drug_n	bacitracin	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGN ) and DRUGN ( DRUGA ) conjugates on the intestinal permeation of DRUGN ( DRUGN ) and model peptide drugs , DRUGN and DRUGB .
CMC-Cys	drug_n	insulin	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGN ) and DRUGN ( DRUGN ) conjugates on the intestinal permeation of DRUGA ( DRUGB ) and model peptide drugs , DRUGN and DRUGN .
sodium fluorescein	drug	NaFlu	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGN ) and DRUGN ( DRUGN ) conjugates on the intestinal permeation of DRUGA ( DRUGN ) and model peptide drugs , DRUGB and DRUGN .
sodium fluorescein	drug	bacitracin	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGN ) and DRUGN ( DRUGN ) conjugates on the intestinal permeation of DRUGA ( DRUGN ) and model peptide drugs , DRUGN and DRUGB .
sodium fluorescein	drug	insulin	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGN ) and DRUGN ( DRUGN ) conjugates on the intestinal permeation of DRUGN ( DRUGA ) and model peptide drugs , DRUGB and DRUGN .
NaFlu	drug	bacitracin	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGN ) and DRUGN ( DRUGN ) conjugates on the intestinal permeation of DRUGN ( DRUGA ) and model peptide drugs , DRUGN and DRUGB .
NaFlu	drug	insulin	drug
false

The purpose of this study was to evaluate the effect of DRUGN ( DRUGN ) and DRUGN ( DRUGN ) conjugates on the intestinal permeation of DRUGN ( DRUGN ) and model peptide drugs , DRUGA and DRUGB .
bacitracin	drug	insulin	drug
false

DRUGA was covalently linked to carbodiimide activated DRUGB .
Cysteine	drug	NaCMC	drug_n
false

DRUGA at dgb % ( m / v ) in the presence of free DRUGB had no significant effect on the R value of DRUGN compared to DRUGN alone .
NaCMC	drug_n	cysteine	drug
false

DRUGA at dgb % ( m / v ) in the presence of free DRUGN had no significant effect on the R value of DRUGB compared to DRUGN alone .
NaCMC	drug_n	NaFlu	drug
false

DRUGN at dgb % ( m / v ) in the presence of free DRUGA had no significant effect on the R value of DRUGB compared to DRUGN alone .
cysteine	drug	NaFlu	drug
false

DRUGN at dgb % ( m / v ) in the presence of free DRUGA had no significant effect on the R value of DRUGN compared to DRUGB alone .
cysteine	drug	NaCMC	drug_n
false

DRUGN at dgb % ( m / v ) in the presence of free DRUGN had no significant effect on the R value of DRUGA compared to DRUGB alone .
NaFlu	drug	NaCMC	drug_n
false

Pharmacokinetic Interaction between DRUGA and DRUGB or DRUGN in healthy males .
amprenavir	drug	rifabutin	drug
false

Pharmacokinetic Interaction between DRUGA and DRUGN or DRUGB in healthy males .
amprenavir	drug	rifampin	drug
false

Pharmacokinetic Interaction between DRUGN and DRUGA or DRUGB in healthy males .
rifabutin	drug	rifampin	drug
false

The objective of this study was to determine if there is a pharmacokinetic interaction when DRUGA is given with DRUGB or DRUGN and to determine the effects of these drugs on the erythromycin breath test ( ERMBT ) .
amprenavir	drug	rifabutin	drug
false

The objective of this study was to determine if there is a pharmacokinetic interaction when DRUGA is given with DRUGN or DRUGB and to determine the effects of these drugs on the erythromycin breath test ( ERMBT ) .
amprenavir	drug	rifampin	drug
false

The objective of this study was to determine if there is a pharmacokinetic interaction when DRUGN is given with DRUGA or DRUGB and to determine the effects of these drugs on the erythromycin breath test ( ERMBT ) .
rifabutin	drug	rifampin	drug
false

Cohort dgb then received DRUGA plus DRUGB for dgb days , and cohort dgb received DRUGN plus DRUGN for dgb days .
amprenavir	drug	rifabutin	drug
false

Cohort dgb then received DRUGA plus DRUGN for dgb days , and cohort dgb received DRUGN plus DRUGB for dgb days .
amprenavir	drug	rifampin	drug
false

Cohort dgb then received DRUGN plus DRUGA for dgb days , and cohort dgb received DRUGB plus DRUGN for dgb days .
rifabutin	drug	amprenavir	drug
false

Cohort dgb then received DRUGN plus DRUGA for dgb days , and cohort dgb received DRUGN plus DRUGB for dgb days .
rifabutin	drug	rifampin	drug
false

Cohort dgb then received DRUGN plus DRUGN for dgb days , and cohort dgb received DRUGA plus DRUGB for dgb days .
amprenavir	drug	rifampin	drug
false

Serial plasma and urine samples for measurement of DRUGA , DRUGB , and DRUGN and their DRUGN , were measured by high performance liquid chromatography .
amprenavir	drug	rifabutin	drug
false

Serial plasma and urine samples for measurement of DRUGA , DRUGN , and DRUGB and their DRUGN , were measured by high performance liquid chromatography .
amprenavir	drug	rifampin	drug
false

Serial plasma and urine samples for measurement of DRUGA , DRUGN , and DRUGN and their DRUGB , were measured by high performance liquid chromatography .
amprenavir	drug	25-O-desacetyl metabolites	drug_n
false

Serial plasma and urine samples for measurement of DRUGN , DRUGA , and DRUGB and their DRUGN , were measured by high performance liquid chromatography .
rifabutin	drug	rifampin	drug
false

Serial plasma and urine samples for measurement of DRUGN , DRUGA , and DRUGN and their DRUGB , were measured by high performance liquid chromatography .
rifabutin	drug	25-O-desacetyl metabolites	drug_n
false

Serial plasma and urine samples for measurement of DRUGN , DRUGN , and DRUGA and their DRUGB , were measured by high performance liquid chromatography .
rifampin	drug	25-O-desacetyl metabolites	drug_n
false

DRUGA did not significantly affect DRUGB 's pharmacokinetics .
Rifabutin	drug	amprenavir	drug
false

DRUGA significantly increased the area under the curve at steady state ( AUC ( ss ) ) of DRUGB by dga fold and the AUC ( ss ) of DRUGN by dga fold .
Amprenavir	drug	rifabutin	drug
mechanism

DRUGA significantly increased the area under the curve at steady state ( AUC ( ss ) ) of DRUGN by dga fold and the AUC ( ss ) of DRUGB by dga fold .
Amprenavir	drug	25-O-desacetylrifabutin	drug_n
mechanism

DRUGN significantly increased the area under the curve at steady state ( AUC ( ss ) ) of DRUGA by dga fold and the AUC ( ss ) of DRUGB by dga fold .
rifabutin	drug	25-O-desacetylrifabutin	drug_n
false

DRUGA significantly decreased the AUC ( ss ) of DRUGB by dgb % , but DRUGN had no effect on DRUGN pharmacokinetics .
Rifampin	drug	amprenavir	drug
mechanism

DRUGA significantly decreased the AUC ( ss ) of DRUGN by dgb % , but DRUGB had no effect on DRUGN pharmacokinetics .
Rifampin	drug	amprenavir	drug
false

DRUGA significantly decreased the AUC ( ss ) of DRUGN by dgb % , but DRUGN had no effect on DRUGB pharmacokinetics .
Rifampin	drug	rifampin	drug
false

DRUGN significantly decreased the AUC ( ss ) of DRUGA by dgb % , but DRUGN had no effect on DRUGB pharmacokinetics .
amprenavir	drug	rifampin	drug
false

DRUGN significantly decreased the AUC ( ss ) of DRUGN by dgb % , but DRUGA had no effect on DRUGB pharmacokinetics .
amprenavir	drug	rifampin	drug
false

The results of the ERMBT after dgb weeks of DRUGA and DRUGB therapy were increased dgb and dgb % , respectively .
rifabutin	drug	rifampin	drug
false

DRUGA plus DRUGB was well tolerated .
Amprenavir	drug	rifampin	drug
false

DRUGA plus DRUGB was poorly tolerated , and dgb of dgb subjects discontinued therapy .
Amprenavir	drug	rifabutin	drug
effect

DRUGA markedly increases the metabolic clearance of DRUGB , and coadministration is contraindicated .
Rifampin	drug	amprenavir	drug
mechanism

DRUGA significantly decreases clearance of DRUGB and DRUGN , and the combination is poorly tolerated .
Amprenavir	drug	rifabutin	drug
mechanism

DRUGA significantly decreases clearance of DRUGN and DRUGB , and the combination is poorly tolerated .
Amprenavir	drug	25-O-desacetylrifabutin	drug_n
mechanism

DRUGN significantly decreases clearance of DRUGA and DRUGB , and the combination is poorly tolerated .
rifabutin	drug	25-O-desacetylrifabutin	drug_n
false

DRUGA inhibits the ERMBT , and DRUGB and DRUGN are equipotent inducers of the ERMBT .
Amprenavir	drug	rifampin	drug
false

DRUGA inhibits the ERMBT , and DRUGN and DRUGB are equipotent inducers of the ERMBT .
Amprenavir	drug	rifabutin	drug
false

DRUGN inhibits the ERMBT , and DRUGA and DRUGB are equipotent inducers of the ERMBT .
rifampin	drug	rifabutin	drug
false

The DRUGA ( DRUGB and DRUGN ) , a new class of oral DRUGN , are `` insulin sensitizers ''
thiazolidinediones	group	rosiglitazone	drug
false

The DRUGA ( DRUGN and DRUGB ) , a new class of oral DRUGN , are `` insulin sensitizers ''
thiazolidinediones	group	pioglitazone	drug
false

The DRUGA ( DRUGN and DRUGN ) , a new class of oral DRUGB , are `` insulin sensitizers ''
thiazolidinediones	group	antidiabetic agents	group
false

The DRUGN ( DRUGA and DRUGB ) , a new class of oral DRUGN , are `` insulin sensitizers ''
rosiglitazone	drug	pioglitazone	drug
false

The DRUGN ( DRUGA and DRUGN ) , a new class of oral DRUGB , are `` insulin sensitizers ''
rosiglitazone	drug	antidiabetic agents	group
false

The DRUGN ( DRUGN and DRUGA ) , a new class of oral DRUGB , are `` insulin sensitizers ''
pioglitazone	drug	antidiabetic agents	group
false

DRUGA , alone and in the presence of DRUGB , caused subnormal insulin release and less suppression of glucagon release in the diabectics than in the normals .
Glucose	drug	theophylline	drug
false

DRUGA , in the presence of DRUGB and DRUGN , caused excessive glucagon release but nearly normal insulin release in the diabetics .
Arginine	drug	glucose	drug
false

DRUGA , in the presence of DRUGN and DRUGB , caused excessive glucagon release but nearly normal insulin release in the diabetics .
Arginine	drug	theophylline	drug
false

DRUGN , in the presence of DRUGA and DRUGB , caused excessive glucagon release but nearly normal insulin release in the diabetics .
glucose	drug	theophylline	drug
false

DRUGA , in the absence of DRUGB or DRUGN , caused excessive glucagon release in the diabetics and undetectable insulin release in either diabetics or normals .
Arginine	drug	glucose	drug
false

DRUGA , in the absence of DRUGN or DRUGB , caused excessive glucagon release in the diabetics and undetectable insulin release in either diabetics or normals .
Arginine	drug	theophylline	drug
false

DRUGN , in the absence of DRUGA or DRUGB , caused excessive glucagon release in the diabetics and undetectable insulin release in either diabetics or normals .
glucose	drug	theophylline	drug
false

Further , these results confirm that the diabetic Chinese hamster 's alpha and beta cells respond normally to DRUGA , but are relatively insensitive to DRUGB .
theophylline	drug	glucose	drug
false

DRUGA elicited dgb % enhancement of post DRUGB lipolytic activity and dgb % increase of dgbH triglyceride fractional clearance rate compared with placebo treatment .
Etofibrate	drug	heparin	drug
effect

The mode of toxic action of the pesticide DRUGA : the metabolism of DRUGB to DRUGN .
gliftor	drug_n	1,3-difluoroacetone	drug_n
false

The mode of toxic action of the pesticide DRUGA : the metabolism of DRUGN to DRUGB .
gliftor	drug_n	(-)-erythro-fluorocitrate	drug_n
false

The mode of toxic action of the pesticide DRUGN : the metabolism of DRUGA to DRUGB .
1,3-difluoroacetone	drug_n	(-)-erythro-fluorocitrate	drug_n
false

The biochemical toxicology of DRUGA , a known metabolite of the major ingredient of the pesticide DRUGB ( DRUGN ) , was investigated in vivo and in vitro .
1,3-difluoroacetone	drug_n	Gliftor	drug_n
false

The biochemical toxicology of DRUGA , a known metabolite of the major ingredient of the pesticide DRUGN ( DRUGB ) , was investigated in vivo and in vitro .
1,3-difluoroacetone	drug_n	1,3-difluoro-2-propanol	drug_n
false

The biochemical toxicology of DRUGN , a known metabolite of the major ingredient of the pesticide DRUGA ( DRUGB ) , was investigated in vivo and in vitro .
Gliftor	drug_n	1,3-difluoro-2-propanol	drug_n
false

Rat kidney homogenates supplemented with coenzyme A , ATP , oxaloacetate , and Mgdgb+ converted DRUGA to DRUGB in vitro .
1,3-difluoroacetone	drug_n	(-)-erythro-fluorocitrate	drug_n
false

Administration of DRUGA ( dgb mg kg ( dgb ) body weight ) to rats in vivo resulted in DRUGB synthesis in the kidney , which was preceded by an elevation in fluoride levels and followed by citrate accumulation .
1,3-difluoroacetone	drug_n	(-)-erythro-fluorocitrate	drug_n
false

Animals dosed with DRUGA did not display the dgb dgb hour lag phase in either DRUGB synthesis or in citrate and fluoride accumulation characteristic of animals dosed with DRUGN .
1,3-difluoroacetone	drug_n	(-)-erythro-fluorocitrate	drug_n
false

Animals dosed with DRUGA did not display the dgb dgb hour lag phase in either DRUGN synthesis or in citrate and fluoride accumulation characteristic of animals dosed with DRUGB .
1,3-difluoroacetone	drug_n	1,3-difluoro-2-propanol	drug_n
false

Animals dosed with DRUGN did not display the dgb dgb hour lag phase in either DRUGA synthesis or in citrate and fluoride accumulation characteristic of animals dosed with DRUGB .
(-)-erythro-fluorocitrate	drug_n	1,3-difluoro-2-propanol	drug_n
false

We demonstrate that the conversion of DRUGA to DRUGB by an NAD+ dependent oxidation is the rate limiting step in the synthesis of the toxic product , DRUGN from DRUGN .
1,3-difluoro-2-propanol	drug_n	1,3-difluoroacetone	drug_n
false

We demonstrate that the conversion of DRUGA to DRUGN by an NAD+ dependent oxidation is the rate limiting step in the synthesis of the toxic product , DRUGB from DRUGN .
1,3-difluoro-2-propanol	drug_n	(-)-erythro-fluorocitrate	drug_n
false

We demonstrate that the conversion of DRUGN to DRUGA by an NAD+ dependent oxidation is the rate limiting step in the synthesis of the toxic product , DRUGB from DRUGN .
1,3-difluoroacetone	drug_n	(-)-erythro-fluorocitrate	drug_n
false

We demonstrate that the conversion of DRUGN to DRUGA by an NAD+ dependent oxidation is the rate limiting step in the synthesis of the toxic product , DRUGN from DRUGB .
1,3-difluoroacetone	drug_n	1,3-difluoro-2-propanol	drug_n
false

We demonstrate that the conversion of DRUGN to DRUGN by an NAD+ dependent oxidation is the rate limiting step in the synthesis of the toxic product , DRUGA from DRUGB .
(-)-erythro-fluorocitrate	drug_n	1,3-difluoro-2-propanol	drug_n
false

DRUGA as potent DRUGB of glucocorticoid induced mouse mammary tumor virus gene expression .
Green tea polyphenols	drug	enhancers	drug
false

DRUGA showed the most potent inhibition ( dgb % inhibition at dgb microM ) , which was far more potent than that of crude DRUGB .
n-dodecyl gallate	drug	tannic acid	drug
false

Pharmacokinetic interaction between single oral doses of DRUGA and DRUGB in healthy volunteers .
diltiazem	drug	sirolimus	drug
mechanism

AIM AND BACKGROUND : The pharmacokinetic interaction between DRUGA , a DRUGB metabolized by CYPdgbAdgb , and the DRUGN DRUGN was studied in dgb healthy subjects .
sirolimus	drug	macrolide immunosuppressant	group
false

AIM AND BACKGROUND : The pharmacokinetic interaction between DRUGA , a DRUGN metabolized by CYPdgbAdgb , and the DRUGB DRUGN was studied in dgb healthy subjects .
sirolimus	drug	calcium channel blocker	group
false

AIM AND BACKGROUND : The pharmacokinetic interaction between DRUGA , a DRUGN metabolized by CYPdgbAdgb , and the DRUGN DRUGB was studied in dgb healthy subjects .
sirolimus	drug	diltiazem	drug
false

AIM AND BACKGROUND : The pharmacokinetic interaction between DRUGN , a DRUGA metabolized by CYPdgbAdgb , and the DRUGB DRUGN was studied in dgb healthy subjects .
macrolide immunosuppressant	group	calcium channel blocker	group
false

AIM AND BACKGROUND : The pharmacokinetic interaction between DRUGN , a DRUGA metabolized by CYPdgbAdgb , and the DRUGN DRUGB was studied in dgb healthy subjects .
macrolide immunosuppressant	group	diltiazem	drug
false

AIM AND BACKGROUND : The pharmacokinetic interaction between DRUGN , a DRUGN metabolized by CYPdgbAdgb , and the DRUGA DRUGB was studied in dgb healthy subjects .
calcium channel blocker	group	diltiazem	drug
false

Several clinically important interactions have previously been reported for other DRUGA that are metabolized by the same enzyme and for DRUGB .
immunosuppressive drugs	group	calcium antagonists	group
false

Apparent oral clearance and volume of distribution of DRUGA decreased with dgb % and dgb % , respectively , when DRUGN was given with DRUGB .
sirolimus	drug	diltiazem	drug
false

Apparent oral clearance and volume of distribution of DRUGN decreased with dgb % and dgb % , respectively , when DRUGA was given with DRUGB .
sirolimus	drug	diltiazem	drug
mechanism

CONCLUSIONS : Single dose DRUGA coadministration leads to higher DRUGB exposure , presumably by inhibition of the first pass metabolism of DRUGN .
diltiazem	drug	sirolimus	drug
mechanism

CONCLUSIONS : Single dose DRUGA coadministration leads to higher DRUGN exposure , presumably by inhibition of the first pass metabolism of DRUGB .
diltiazem	drug	sirolimus	drug
false

Because of the pronounced intersubject variability in the extent of the DRUGA DRUGB interaction , whole blood DRUGN concentrations should be monitored closely in patients treated with the two drugs .
sirolimus	drug	diltiazem	drug
advise

Because of the pronounced intersubject variability in the extent of the DRUGN DRUGA interaction , whole blood DRUGB concentrations should be monitored closely in patients treated with the two drugs .
diltiazem	drug	sirolimus	drug
false

DRUGA inhibits the CYPdgbCdgb catalyzed biotransformation of DRUGB .
Fluvoxamine	drug	tolbutamide	drug
mechanism

OBJECTIVE : Our objective was to examine the interaction between DRUGA and DRUGB to confirm that DRUGN inhibits CYPdgbCdga
fluvoxamine	drug	tolbutamide	drug
false

OBJECTIVE : Our objective was to examine the interaction between DRUGN and DRUGA to confirm that DRUGB inhibits CYPdgbCdga
tolbutamide	drug	fluvoxamine	drug
false

Plasma was analyzed for DRUGA , and urine was analyzed for DRUGN and its two metabolites , DRUGB and DRUGN by means of HPLC .
tolbutamide	drug	4-hydroxytolbutamide	drug_n
false

Plasma was analyzed for DRUGA , and urine was analyzed for DRUGN and its two metabolites , DRUGN and DRUGB by means of HPLC .
tolbutamide	drug	carboxytolbutamide	drug_n
false

Plasma was analyzed for DRUGN , and urine was analyzed for DRUGA and its two metabolites , DRUGB and DRUGN by means of HPLC .
tolbutamide	drug	4-hydroxytolbutamide	drug_n
false

Plasma was analyzed for DRUGN , and urine was analyzed for DRUGA and its two metabolites , DRUGN and DRUGB by means of HPLC .
tolbutamide	drug	carboxytolbutamide	drug_n
false

Plasma was analyzed for DRUGN , and urine was analyzed for DRUGN and its two metabolites , DRUGA and DRUGB by means of HPLC .
4-hydroxytolbutamide	drug_n	carboxytolbutamide	drug_n
false

Longitudinal assessment of DRUGA in de novo renal transplant recipients over the first post transplant year : pharmacokinetics , exposure response relationships , and influence on DRUGB .
everolimus	drug	cyclosporine	drug
false

OBJECTIVE : Our objective was to characterize the steady state pharmacokinetics of DRUGA and DRUGB ( INN , DRUGN ) when coadministered in de novo kidney allograft recipients during the first year after transplantation .
everolimus	drug	cyclosporine	drug
false

OBJECTIVE : Our objective was to characterize the steady state pharmacokinetics of DRUGA and DRUGN ( INN , DRUGB ) when coadministered in de novo kidney allograft recipients during the first year after transplantation .
everolimus	drug	ciclosporin	drug
false

OBJECTIVE : Our objective was to characterize the steady state pharmacokinetics of DRUGN and DRUGA ( INN , DRUGB ) when coadministered in de novo kidney allograft recipients during the first year after transplantation .
cyclosporine	drug	ciclosporin	drug
false

Blood sampling for the pharmacokinetics of DRUGA and DRUGB was performed on day dgb , on weeks dgb , dgb , dgb , and dgb , and on months dgb , dgb , dgb , dgb , and dga
everolimus	drug	cyclosporine	drug
false

Potential differences in DRUGA dosing and pharmacokinetics at different levels of DRUGB exposure were assessed in the context of ANOVA .
cyclosporine	drug	everolimus	drug
false

DRUGA doses , trough concentrations , and AUC exhibited similar temporal patterns during the course of the study regardless of the co administered DRUGB dose level ( P = .dgb , .dgb , and .dgb , respectively ) .
Cyclosporine	drug	everolimus	drug
false

For a dgb fold range of DRUGA doses there were no differential effects on DRUGB dosing or pharmacokinetics .
everolimus	drug	cyclosporine	drug
false

DRUGA , a trans dgb , dgb dimethyl dgb ( dgb hydroxyphenyl ) piperidine , prevents gastrointestinal effects of intravenous DRUGB without affecting analgesia .
ADL 8-2698	drug	morphine	drug
effect

DRUGA is a novel DRUGB that may selectively prevent DRUGN induced gastrointestinal effects without reversing analgesia .
ADL-8-2698	drug	peripherally restricted opioid antagonist	group
false

DRUGA is a novel DRUGN that may selectively prevent DRUGB induced gastrointestinal effects without reversing analgesia .
ADL-8-2698	drug	opioid	group
effect

DRUGN is a novel DRUGA that may selectively prevent DRUGB induced gastrointestinal effects without reversing analgesia .
peripherally restricted opioid antagonist	group	opioid	group
false

DRUGA prolonged gastrointestinal transit time from dgb to dgb minutes ( P = .dgb ) ; this was prevented by DRUGB ( P = .dgb ) .
Morphine	drug	ADL 8-2698	drug
effect

Postoperatively , dgb patients were randomly assigned in a double blind fashion to receive DRUGA ( dgb mg ) or placebo and intravenous DRUGB ( dga mg / kg ) or to receive oral and intravenous placebo .
ADL 8-2698	drug	morphine	drug
false

DRUGA analgesia and pupil constriction were unaffected by DRUGB and differed from placebo ( P < .dgb ) .
Morphine	drug	ADL 8-2698	drug
false

We conclude that DRUGA prevents DRUGB induced increases in gastrointestinal transit time by means of selective peripheral opioid anitagonism without affecting central opioid analgesia .
ADL 8-2698	drug	morphine	drug
effect

Rhabdomyolysis secondary to a drug interaction between DRUGA and DRUGB .
simvastatin	drug	clarithromycin	drug
effect

OBJECTIVE : To report a case of rhabdomyolysis resulting from concomitant use of DRUGA and DRUGB .
clarithromycin	drug	simvastatin	drug
false

DISCUSSION : DRUGA is a potent inhibitor of CYPdgbAdgb , the major enzyme responsible for DRUGB metabolism .
Clarithromycin	drug	simvastatin	drug
mechanism

The concomitant administration of DRUGA and other DRUGB have resulted in previous reports of rhabdomyolysis .
macrolide antibiotics	group	hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors	group
effect

CONCLUSIONS : DRUGA inhibit the metabolism of DRUGB that are metabolized by CYPdgbAdgb ( i.e . , DRUGN , DRUGN , DRUGN , DRUGN ) .
Macrolide antibiotics	group	HMG-CoA reductase inhibitors	group
false

CONCLUSIONS : DRUGA inhibit the metabolism of DRUGN that are metabolized by CYPdgbAdgb ( i.e . , DRUGB , DRUGN , DRUGN , DRUGN ) .
Macrolide antibiotics	group	atorvastatin	drug
mechanism

CONCLUSIONS : DRUGA inhibit the metabolism of DRUGN that are metabolized by CYPdgbAdgb ( i.e . , DRUGN , DRUGB , DRUGN , DRUGN ) .
Macrolide antibiotics	group	cerivastatin	drug
mechanism

CONCLUSIONS : DRUGA inhibit the metabolism of DRUGN that are metabolized by CYPdgbAdgb ( i.e . , DRUGN , DRUGN , DRUGB , DRUGN ) .
Macrolide antibiotics	group	lovastatin	drug
mechanism

CONCLUSIONS : DRUGA inhibit the metabolism of DRUGN that are metabolized by CYPdgbAdgb ( i.e . , DRUGN , DRUGN , DRUGN , DRUGB ) .
Macrolide antibiotics	group	simvastatin	drug
mechanism

CONCLUSIONS : DRUGN inhibit the metabolism of DRUGA that are metabolized by CYPdgbAdgb ( i.e . , DRUGB , DRUGN , DRUGN , DRUGN ) .
HMG-CoA reductase inhibitors	group	atorvastatin	drug
false

CONCLUSIONS : DRUGN inhibit the metabolism of DRUGA that are metabolized by CYPdgbAdgb ( i.e . , DRUGN , DRUGB , DRUGN , DRUGN ) .
HMG-CoA reductase inhibitors	group	cerivastatin	drug
false

CONCLUSIONS : DRUGN inhibit the metabolism of DRUGA that are metabolized by CYPdgbAdgb ( i.e . , DRUGN , DRUGN , DRUGB , DRUGN ) .
HMG-CoA reductase inhibitors	group	lovastatin	drug
false

CONCLUSIONS : DRUGN inhibit the metabolism of DRUGA that are metabolized by CYPdgbAdgb ( i.e . , DRUGN , DRUGN , DRUGN , DRUGB ) .
HMG-CoA reductase inhibitors	group	simvastatin	drug
false

CONCLUSIONS : DRUGN inhibit the metabolism of DRUGN that are metabolized by CYPdgbAdgb ( i.e . , DRUGA , DRUGB , DRUGN , DRUGN ) .
atorvastatin	drug	cerivastatin	drug
false

CONCLUSIONS : DRUGN inhibit the metabolism of DRUGN that are metabolized by CYPdgbAdgb ( i.e . , DRUGA , DRUGN , DRUGB , DRUGN ) .
atorvastatin	drug	lovastatin	drug
false

CONCLUSIONS : DRUGN inhibit the metabolism of DRUGN that are metabolized by CYPdgbAdgb ( i.e . , DRUGA , DRUGN , DRUGN , DRUGB ) .
atorvastatin	drug	simvastatin	drug
false

CONCLUSIONS : DRUGN inhibit the metabolism of DRUGN that are metabolized by CYPdgbAdgb ( i.e . , DRUGN , DRUGA , DRUGB , DRUGN ) .
cerivastatin	drug	lovastatin	drug
false

CONCLUSIONS : DRUGN inhibit the metabolism of DRUGN that are metabolized by CYPdgbAdgb ( i.e . , DRUGN , DRUGA , DRUGN , DRUGB ) .
cerivastatin	drug	simvastatin	drug
false

CONCLUSIONS : DRUGN inhibit the metabolism of DRUGN that are metabolized by CYPdgbAdgb ( i.e . , DRUGN , DRUGN , DRUGA , DRUGB ) .
lovastatin	drug	simvastatin	drug
false

The effects of concomitant DRUGA administration on the steady state pharmacokinetics of DRUGB .
phenytoin	drug	quetiapine	drug
false

DRUGA ( ' DRUGB ' ) is a newly introduced DRUGN with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia .
Quetiapine fumarate	drug	Seroquel	brand
false

DRUGA ( ' DRUGN ' ) is a newly introduced DRUGB with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia .
Quetiapine fumarate	drug	atypical antipsychotic	group
false

DRUGN ( ' DRUGA ' ) is a newly introduced DRUGB with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia .
Seroquel	brand	atypical antipsychotic	group
false

DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN were added to pooled human serum at therapeutic concentrations .
Acetaminophen	drug	lidocaine	drug
false

DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN were added to pooled human serum at therapeutic concentrations .
Acetaminophen	drug	phenobarbital	drug
false

DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN were added to pooled human serum at therapeutic concentrations .
Acetaminophen	drug	quinidine	drug
false

DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN were added to pooled human serum at therapeutic concentrations .
Acetaminophen	drug	theophylline	drug
false

DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB were added to pooled human serum at therapeutic concentrations .
Acetaminophen	drug	valproic acid	drug
false

DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN were added to pooled human serum at therapeutic concentrations .
lidocaine	drug	phenobarbital	drug
false

DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN were added to pooled human serum at therapeutic concentrations .
lidocaine	drug	quinidine	drug
false

DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN were added to pooled human serum at therapeutic concentrations .
lidocaine	drug	theophylline	drug
false

DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB were added to pooled human serum at therapeutic concentrations .
lidocaine	drug	valproic acid	drug
false

DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN were added to pooled human serum at therapeutic concentrations .
phenobarbital	drug	quinidine	drug
false

DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN were added to pooled human serum at therapeutic concentrations .
phenobarbital	drug	theophylline	drug
false

DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB were added to pooled human serum at therapeutic concentrations .
phenobarbital	drug	valproic acid	drug
false

DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN were added to pooled human serum at therapeutic concentrations .
quinidine	drug	theophylline	drug
false

DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB were added to pooled human serum at therapeutic concentrations .
quinidine	drug	valproic acid	drug
false

DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB were added to pooled human serum at therapeutic concentrations .
theophylline	drug	valproic acid	drug
false

The following eight target drug / added drug combinations were studied : DRUGA / DRUGB .
acetaminophen	drug	phenobarbital	drug
false

DRUGA / DRUGB , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
acetaminophen	drug	theophylline	drug
false

DRUGA / DRUGN , DRUGB / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
acetaminophen	drug	lidocaine	drug
false

DRUGA / DRUGN , DRUGN / DRUGB , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
acetaminophen	drug	quinidine	drug
false

DRUGA / DRUGN , DRUGN / DRUGN , DRUGB / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
acetaminophen	drug	phenobarbital	drug
false

DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGB / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
acetaminophen	drug	phenobarbital	drug
false

DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGB , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
acetaminophen	drug	valproic acid	drug
false

DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGB / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
acetaminophen	drug	quinidine	drug
false

DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGB , DRUGN / DRUGN , and DRUGN / DRUGN .
acetaminophen	drug	lidocaine	drug
false

DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGB / DRUGN , and DRUGN / DRUGN .
acetaminophen	drug	theophylline	drug
false

DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGB / DRUGN .
acetaminophen	drug	valproic acid	drug
false

DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGB .
acetaminophen	drug	phenobarbital	drug
false

DRUGN / DRUGA , DRUGB / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
theophylline	drug	lidocaine	drug
false

DRUGN / DRUGA , DRUGN / DRUGB , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
theophylline	drug	quinidine	drug
false

DRUGN / DRUGA , DRUGN / DRUGN , DRUGB / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
theophylline	drug	phenobarbital	drug
false

DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGB , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
theophylline	drug	acetaminophen	drug
false

DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGN , DRUGB / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
theophylline	drug	phenobarbital	drug
false

DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGB , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
theophylline	drug	valproic acid	drug
false

DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGB / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
theophylline	drug	quinidine	drug
false

DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGB , DRUGN / DRUGN , and DRUGN / DRUGN .
theophylline	drug	lidocaine	drug
false

DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGB , and DRUGN / DRUGN .
theophylline	drug	acetaminophen	drug
false

DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGB / DRUGN .
theophylline	drug	valproic acid	drug
false

DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGB .
theophylline	drug	phenobarbital	drug
false

DRUGN / DRUGN , DRUGA / DRUGB , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
lidocaine	drug	quinidine	drug
false

DRUGN / DRUGN , DRUGA / DRUGN , DRUGB / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
lidocaine	drug	phenobarbital	drug
false

DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGB , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
lidocaine	drug	acetaminophen	drug
false

DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , DRUGB / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
lidocaine	drug	phenobarbital	drug
false

DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGB , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
lidocaine	drug	valproic acid	drug
false

DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGB / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
lidocaine	drug	quinidine	drug
false

DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGB / DRUGN , and DRUGN / DRUGN .
lidocaine	drug	theophylline	drug
false

DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGB , and DRUGN / DRUGN .
lidocaine	drug	acetaminophen	drug
false

DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGB / DRUGN .
lidocaine	drug	valproic acid	drug
false

DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGB .
lidocaine	drug	phenobarbital	drug
false

DRUGN / DRUGN , DRUGN / DRUGA , DRUGB / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
quinidine	drug	phenobarbital	drug
false

DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGB , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
quinidine	drug	acetaminophen	drug
false

DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , DRUGB / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
quinidine	drug	phenobarbital	drug
false

DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGB , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
quinidine	drug	valproic acid	drug
false

DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGB , DRUGN / DRUGN , and DRUGN / DRUGN .
quinidine	drug	lidocaine	drug
false

DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGB / DRUGN , and DRUGN / DRUGN .
quinidine	drug	theophylline	drug
false

DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGB , and DRUGN / DRUGN .
quinidine	drug	acetaminophen	drug
false

DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGB / DRUGN .
quinidine	drug	valproic acid	drug
false

DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGB .
quinidine	drug	phenobarbital	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGB , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
phenobarbital	drug	acetaminophen	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGB , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
phenobarbital	drug	valproic acid	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , DRUGB / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
phenobarbital	drug	quinidine	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGB , DRUGN / DRUGN , and DRUGN / DRUGN .
phenobarbital	drug	lidocaine	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGB / DRUGN , and DRUGN / DRUGN .
phenobarbital	drug	theophylline	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGB , and DRUGN / DRUGN .
phenobarbital	drug	acetaminophen	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGB / DRUGN .
phenobarbital	drug	valproic acid	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , DRUGB / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
acetaminophen	drug	phenobarbital	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGB , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
acetaminophen	drug	valproic acid	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , DRUGB / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
acetaminophen	drug	quinidine	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGB , DRUGN / DRUGN , and DRUGN / DRUGN .
acetaminophen	drug	lidocaine	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGN , DRUGB / DRUGN , and DRUGN / DRUGN .
acetaminophen	drug	theophylline	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGB / DRUGN .
acetaminophen	drug	valproic acid	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGB .
acetaminophen	drug	phenobarbital	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGB , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
phenobarbital	drug	valproic acid	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , DRUGB / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
phenobarbital	drug	quinidine	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGB , DRUGN / DRUGN , and DRUGN / DRUGN .
phenobarbital	drug	lidocaine	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , DRUGB / DRUGN , and DRUGN / DRUGN .
phenobarbital	drug	theophylline	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGB , and DRUGN / DRUGN .
phenobarbital	drug	acetaminophen	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGB / DRUGN .
phenobarbital	drug	valproic acid	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , DRUGB / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGN .
valproic acid	drug	quinidine	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGB , DRUGN / DRUGN , and DRUGN / DRUGN .
valproic acid	drug	lidocaine	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , DRUGB / DRUGN , and DRUGN / DRUGN .
valproic acid	drug	theophylline	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGB , and DRUGN / DRUGN .
valproic acid	drug	acetaminophen	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGB .
valproic acid	drug	phenobarbital	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGB , DRUGN / DRUGN , and DRUGN / DRUGN .
quinidine	drug	lidocaine	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , DRUGB / DRUGN , and DRUGN / DRUGN .
quinidine	drug	theophylline	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGB , and DRUGN / DRUGN .
quinidine	drug	acetaminophen	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , and DRUGB / DRUGN .
quinidine	drug	valproic acid	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , DRUGN / DRUGN , and DRUGN / DRUGB .
quinidine	drug	phenobarbital	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , DRUGB / DRUGN , and DRUGN / DRUGN .
lidocaine	drug	theophylline	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGB , and DRUGN / DRUGN .
lidocaine	drug	acetaminophen	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , and DRUGB / DRUGN .
lidocaine	drug	valproic acid	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , DRUGN / DRUGN , and DRUGN / DRUGB .
lidocaine	drug	phenobarbital	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGB , and DRUGN / DRUGN .
theophylline	drug	acetaminophen	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , and DRUGB / DRUGN .
theophylline	drug	valproic acid	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGA / DRUGN , and DRUGN / DRUGB .
theophylline	drug	phenobarbital	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , and DRUGB / DRUGN .
acetaminophen	drug	valproic acid	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGA , and DRUGN / DRUGB .
acetaminophen	drug	phenobarbital	drug
false

DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , DRUGN / DRUGN , and DRUGA / DRUGB .
valproic acid	drug	phenobarbital	drug
false

Similarly dialyzed were DRUGA , DRUGB , and DRUGN , both alone at therapeutic concentrations in serum and with DRUGN at three different concentrations in serum .
phenobarbital	drug	quinidine	drug
false

Similarly dialyzed were DRUGA , DRUGN , and DRUGB , both alone at therapeutic concentrations in serum and with DRUGN at three different concentrations in serum .
phenobarbital	drug	theophylline	drug
false

Similarly dialyzed were DRUGA , DRUGN , and DRUGN , both alone at therapeutic concentrations in serum and with DRUGB at three different concentrations in serum .
phenobarbital	drug	ethanol	drug
false

Similarly dialyzed were DRUGN , DRUGA , and DRUGB , both alone at therapeutic concentrations in serum and with DRUGN at three different concentrations in serum .
quinidine	drug	theophylline	drug
false

Similarly dialyzed were DRUGN , DRUGA , and DRUGN , both alone at therapeutic concentrations in serum and with DRUGB at three different concentrations in serum .
quinidine	drug	ethanol	drug
false

Similarly dialyzed were DRUGN , DRUGN , and DRUGA , both alone at therapeutic concentrations in serum and with DRUGB at three different concentrations in serum .
theophylline	drug	ethanol	drug
false

DRUGA decreased the binding of DRUGB by a net change of dga % ( percentage increase in FDF , dga % ) at dga micromol / L ;
Theophylline	drug	acetaminophen	drug
mechanism

DRUGA diminished binding of DRUGB by a net change of dga % ( percentage increase in FDF , dga % ) at dgb micromol / L .
Valproic acid	drug	phenobarbital	drug
mechanism

Coingestion of DRUGA with DRUGB , DRUGN with DRUGN , and DRUGN with DRUGN at high to toxic concentrations decreases the binding of the target drug .
acetaminophen	drug	theophylline	drug
effect

Coingestion of DRUGA with DRUGN , DRUGB with DRUGN , and DRUGN with DRUGN at high to toxic concentrations decreases the binding of the target drug .
acetaminophen	drug	phenobarbital	drug
false

Coingestion of DRUGA with DRUGN , DRUGN with DRUGN , and DRUGB with DRUGN at high to toxic concentrations decreases the binding of the target drug .
acetaminophen	drug	valproic acid	drug
false

Coingestion of DRUGA with DRUGN , DRUGN with DRUGN , and DRUGN with DRUGB at high to toxic concentrations decreases the binding of the target drug .
acetaminophen	drug	phenobarbital	drug
false

Coingestion of DRUGN with DRUGA , DRUGB with DRUGN , and DRUGN with DRUGN at high to toxic concentrations decreases the binding of the target drug .
theophylline	drug	phenobarbital	drug
false

Coingestion of DRUGN with DRUGA , DRUGN with DRUGB , and DRUGN with DRUGN at high to toxic concentrations decreases the binding of the target drug .
theophylline	drug	acetaminophen	drug
false

Coingestion of DRUGN with DRUGA , DRUGN with DRUGN , and DRUGB with DRUGN at high to toxic concentrations decreases the binding of the target drug .
theophylline	drug	valproic acid	drug
false

Coingestion of DRUGN with DRUGA , DRUGN with DRUGN , and DRUGN with DRUGB at high to toxic concentrations decreases the binding of the target drug .
theophylline	drug	phenobarbital	drug
false

Coingestion of DRUGN with DRUGN , DRUGA with DRUGB , and DRUGN with DRUGN at high to toxic concentrations decreases the binding of the target drug .
phenobarbital	drug	acetaminophen	drug
effect

Coingestion of DRUGN with DRUGN , DRUGA with DRUGN , and DRUGB with DRUGN at high to toxic concentrations decreases the binding of the target drug .
phenobarbital	drug	valproic acid	drug
false

Coingestion of DRUGN with DRUGN , DRUGN with DRUGA , and DRUGB with DRUGN at high to toxic concentrations decreases the binding of the target drug .
acetaminophen	drug	valproic acid	drug
false

Coingestion of DRUGN with DRUGN , DRUGN with DRUGA , and DRUGN with DRUGB at high to toxic concentrations decreases the binding of the target drug .
acetaminophen	drug	phenobarbital	drug
false

Coingestion of DRUGN with DRUGN , DRUGN with DRUGN , and DRUGA with DRUGB at high to toxic concentrations decreases the binding of the target drug .
valproic acid	drug	phenobarbital	drug
effect

The serum concentration of DRUGA increased dramatically from dga to dga microg / mL when DRUGB was coadministered , although the daily dosage of DRUGN and other DRUGN had not changed .
phenytoin	drug	fluvoxamine	drug
false

The serum concentration of DRUGA increased dramatically from dga to dga microg / mL when DRUGN was coadministered , although the daily dosage of DRUGN and other DRUGB had not changed .
phenytoin	drug	drugs	drug
false

The serum concentration of DRUGN increased dramatically from dga to dga microg / mL when DRUGA was coadministered , although the daily dosage of DRUGB and other DRUGN had not changed .
fluvoxamine	drug	phenytoin	drug
false

The serum concentration of DRUGN increased dramatically from dga to dga microg / mL when DRUGA was coadministered , although the daily dosage of DRUGN and other DRUGB had not changed .
fluvoxamine	drug	drugs	drug
false

The serum concentration of DRUGN increased dramatically from dga to dga microg / mL when DRUGN was coadministered , although the daily dosage of DRUGA and other DRUGB had not changed .
phenytoin	drug	drugs	drug
false

The interaction may be a result of inhibition of both DRUGA and dgbCdgb by DRUGB .
CYP2C9	drug	fluvoxamine	drug
false

Here we show that a combination of DRUGA or dgb , dgb dihydroxyflavone with DRUGB may be used to sensitize resistant strains of Enterococcus faecalis and Enterococcus faecium to the level of vancomycin sensitive strains .
galangin	drug	vancomycin	drug
false

DRUGA and DRUGB exert additive ocular and renal vasodilator effects on healthy humans .
Glucose	drug	insulin	drug
false

AIMS / HYPOTHESIS : There is evidence that DRUGA and DRUGB cause renal and ocular vasodilation .
insulin	drug	glucose	drug
false

Haemodynamic effects of DRUGA and DRUGB were additive when DRUGN was co administered but not under basal conditions .
glucose	drug	insulin	drug
false

Haemodynamic effects of DRUGA and DRUGN were additive when DRUGB was co administered but not under basal conditions .
glucose	drug	somatostatin	drug
false

Haemodynamic effects of DRUGN and DRUGA were additive when DRUGB was co administered but not under basal conditions .
insulin	drug	somatostatin	drug
false

CONCLUSIONS / INTERPRETATION : DRUGA and DRUGB can exert additive vasodilator properties on renal and ocular circulation .
Glucose	drug	insulin	drug
false

Lack of interaction between DRUGA and DRUGB : pharmacokinetics and drug disposition .
levofloxacin	drug	oxycodone	drug
false

Previous studies have demonstrated a significant reduction in the oral bioavailability of DRUGA and DRUGB when administered concomitantly with an intravenous DRUGN such as DRUGN .
trovafloxacin	drug	ciprofloxacin	drug
false

Previous studies have demonstrated a significant reduction in the oral bioavailability of DRUGA and DRUGN when administered concomitantly with an intravenous DRUGB such as DRUGN .
trovafloxacin	drug	opiate	group
mechanism

Previous studies have demonstrated a significant reduction in the oral bioavailability of DRUGA and DRUGN when administered concomitantly with an intravenous DRUGN such as DRUGB .
trovafloxacin	drug	morphine	drug
mechanism

Previous studies have demonstrated a significant reduction in the oral bioavailability of DRUGN and DRUGA when administered concomitantly with an intravenous DRUGB such as DRUGN .
ciprofloxacin	drug	opiate	group
mechanism

Previous studies have demonstrated a significant reduction in the oral bioavailability of DRUGN and DRUGA when administered concomitantly with an intravenous DRUGN such as DRUGB .
ciprofloxacin	drug	morphine	drug
mechanism

Previous studies have demonstrated a significant reduction in the oral bioavailability of DRUGN and DRUGN when administered concomitantly with an intravenous DRUGA such as DRUGB .
opiate	group	morphine	drug
false

This decrease in absorption results in a dgb % and dgb % lower AUC for DRUGA and DRUGB , respectively , which could cause clinical failures .
trovafloxacin	drug	ciprofloxacin	drug
false

The authors investigated the possibility of a similar interaction between DRUGA and DRUGB .
oxycodone	drug	levofloxacin	drug
false

dgb hour after starting the DRUGA or DRUGB dgb mg p.o .
oxycodone	drug	levofloxacin	drug
false

It was concluded that oral DRUGA and DRUGB can be administered concomitantly without a significant decrease in AUC , Cmax , or tmax .
oxycodone	drug	levofloxacin	drug
false

Lack of an effect of DRUGA on the disposition of DRUGB and DRUGN in HIV infected patients .
azithromycin	drug	zidovudine	drug
false

Lack of an effect of DRUGA on the disposition of DRUGN and DRUGB in HIV infected patients .
azithromycin	drug	dideoxyinosine	drug
false

Lack of an effect of DRUGN on the disposition of DRUGA and DRUGB in HIV infected patients .
zidovudine	drug	dideoxyinosine	drug
false

Two studies were conducted in HIV infected subjects to assess the potential for DRUGA to interact with DRUGB and DRUGN .
azithromycin	drug	zidovudine	drug
false

Two studies were conducted in HIV infected subjects to assess the potential for DRUGA to interact with DRUGN and DRUGB .
azithromycin	drug	dideoxyinosine	drug
false

Two studies were conducted in HIV infected subjects to assess the potential for DRUGN to interact with DRUGA and DRUGB .
zidovudine	drug	dideoxyinosine	drug
false

Subjects treated with dgb mg of DRUGA twice daily for dgb days received dgb mg of DRUGB or an equivalent amount of placebo / day for Days dgb to dga
dideoxyinosine	drug	azithromycin	drug
false

DRUGA plasma and urine sampling were conducted on Days dgb , dgb , and dgb for DRUGB and on Days dgb and dgb for DRUGN .
Antiretroviral	group	zidovudine	drug
false

DRUGA plasma and urine sampling were conducted on Days dgb , dgb , and dgb for DRUGN and on Days dgb and dgb for DRUGB .
Antiretroviral	group	dideoxyinosine	drug
false

DRUGN plasma and urine sampling were conducted on Days dgb , dgb , and dgb for DRUGA and on Days dgb and dgb for DRUGB .
zidovudine	drug	dideoxyinosine	drug
false

DRUGA had no significant impact on the Cmax and AUC of DRUGB , although it significantly decreased the DRUGN tmax by dgb % and increased the intracellular exposure to phosphorylated DRUGN by dgb % .
Azithromycin	drug	zidovudine	drug
false

DRUGA had no significant impact on the Cmax and AUC of DRUGN , although it significantly decreased the DRUGB tmax by dgb % and increased the intracellular exposure to phosphorylated DRUGN by dgb % .
Azithromycin	drug	zidovudine	drug
mechanism

DRUGA had no significant impact on the Cmax and AUC of DRUGN , although it significantly decreased the DRUGN tmax by dgb % and increased the intracellular exposure to phosphorylated DRUGB by dgb % .
Azithromycin	drug	zidovudine	drug
mechanism

DRUGA had no significant effect on DRUGB pharmacokinetics .
Azithromycin	drug	dideoxyinosine	drug
false

Based on the results of these studies , it is concluded that DRUGA may be safely coadministered with both DRUGB and DRUGN .
azithromycin	drug	zidovudine	drug
false

Based on the results of these studies , it is concluded that DRUGA may be safely coadministered with both DRUGN and DRUGB .
azithromycin	drug	dideoxyinosine	drug
false

Based on the results of these studies , it is concluded that DRUGN may be safely coadministered with both DRUGA and DRUGB .
zidovudine	drug	dideoxyinosine	drug
false

Effect of DRUGA and DRUGB on the antinociceptive effect of DRUGN , DRUGN and DRUGN in mice .
diazepam	drug	midazolam	drug
false

Effect of DRUGA and DRUGN on the antinociceptive effect of DRUGB , DRUGN and DRUGN in mice .
diazepam	drug	morphine	drug
false

Effect of DRUGA and DRUGN on the antinociceptive effect of DRUGN , DRUGB and DRUGN in mice .
diazepam	drug	metamizol	drug
false

Effect of DRUGA and DRUGN on the antinociceptive effect of DRUGN , DRUGN and DRUGB in mice .
diazepam	drug	indomethacin	drug
false

Effect of DRUGN and DRUGA on the antinociceptive effect of DRUGB , DRUGN and DRUGN in mice .
midazolam	drug	morphine	drug
false

Effect of DRUGN and DRUGA on the antinociceptive effect of DRUGN , DRUGB and DRUGN in mice .
midazolam	drug	metamizol	drug
false

Effect of DRUGN and DRUGA on the antinociceptive effect of DRUGN , DRUGN and DRUGB in mice .
midazolam	drug	indomethacin	drug
false

Effect of DRUGN and DRUGN on the antinociceptive effect of DRUGA , DRUGB and DRUGN in mice .
morphine	drug	metamizol	drug
false

Effect of DRUGN and DRUGN on the antinociceptive effect of DRUGA , DRUGN and DRUGB in mice .
morphine	drug	indomethacin	drug
false

Effect of DRUGN and DRUGN on the antinociceptive effect of DRUGN , DRUGA and DRUGB in mice .
metamizol	drug	indomethacin	drug
false

DRUGA were administered to mice dgb min before applying the DRUGB .
Benzodiazepines	group	analgesic drugs	group
false

DRUGA at doses of dga mg / kg and dga mg / kg injected with DRUGB was found to decrease the antinociceptive effect of DRUGN .
Diazepam	drug	morphine	drug
effect

DRUGA at doses of dga mg / kg and dga mg / kg injected with DRUGN was found to decrease the antinociceptive effect of DRUGB .
Diazepam	drug	morphine	drug
false

Similarly , DRUGA decreased the antinociceptive effect of DRUGB ( only in the tail flick test ) and DRUGN .
diazepam	drug	metamizol	drug
effect

Similarly , DRUGA decreased the antinociceptive effect of DRUGN ( only in the tail flick test ) and DRUGB .
diazepam	drug	indomethacin	drug
effect

Similarly , DRUGN decreased the antinociceptive effect of DRUGA ( only in the tail flick test ) and DRUGB .
metamizol	drug	indomethacin	drug
false

DRUGA used at doses of dga mg / kg and dga mg / kg decreased the antinociceptive effect of DRUGB , DRUGN ( only in the tail flick test ) and DRUGN .
Midazolam	drug	morphine	drug
effect

DRUGA used at doses of dga mg / kg and dga mg / kg decreased the antinociceptive effect of DRUGN , DRUGB ( only in the tail flick test ) and DRUGN .
Midazolam	drug	metamizol	drug
effect

DRUGA used at doses of dga mg / kg and dga mg / kg decreased the antinociceptive effect of DRUGN , DRUGN ( only in the tail flick test ) and DRUGB .
Midazolam	drug	indomethacin	drug
effect

DRUGN used at doses of dga mg / kg and dga mg / kg decreased the antinociceptive effect of DRUGA , DRUGB ( only in the tail flick test ) and DRUGN .
morphine	drug	metamizol	drug
false

DRUGN used at doses of dga mg / kg and dga mg / kg decreased the antinociceptive effect of DRUGA , DRUGN ( only in the tail flick test ) and DRUGB .
morphine	drug	indomethacin	drug
false

DRUGN used at doses of dga mg / kg and dga mg / kg decreased the antinociceptive effect of DRUGN , DRUGA ( only in the tail flick test ) and DRUGB .
metamizol	drug	indomethacin	drug
false

Influence of DRUGA and DRUGB on the sensitivity of rat thoracic aorta to DRUGN .
estradiol	drug	progesterone	drug
false

Influence of DRUGA and DRUGN on the sensitivity of rat thoracic aorta to DRUGB .
estradiol	drug	noradrenaline	drug
false

Influence of DRUGN and DRUGA on the sensitivity of rat thoracic aorta to DRUGB .
progesterone	drug	noradrenaline	drug
false

The aim of this study was to investigate the effects of low and high doses of DRUGA , and of DRUGB on the response to DRUGN in rat thoracic aorta .
estradiol	drug	progesterone	drug
false

The aim of this study was to investigate the effects of low and high doses of DRUGA , and of DRUGN on the response to DRUGB in rat thoracic aorta .
estradiol	drug	noradrenaline	drug
false

The aim of this study was to investigate the effects of low and high doses of DRUGN , and of DRUGA on the response to DRUGB in rat thoracic aorta .
progesterone	drug	noradrenaline	drug
false

DRUGA is contraindicated in patients using DRUGB or who may need to use DRUGN , because the combination may cause a sharp fall of the blood pressure .
Sildenafil	drug	long-acting nitrates	group
advise

DRUGA is contraindicated in patients using DRUGN or who may need to use DRUGB , because the combination may cause a sharp fall of the blood pressure .
Sildenafil	drug	short-acting nitrates	group
advise

DRUGN is contraindicated in patients using DRUGA or who may need to use DRUGB , because the combination may cause a sharp fall of the blood pressure .
long-acting nitrates	group	short-acting nitrates	group
false

No interactions have been observed with DRUGA , DRUGB , DRUGN and DRUGN and DRUGN .
beta-receptor blockers	group	calcium antagonists	group
false

No interactions have been observed with DRUGA , DRUGN , DRUGB and DRUGN and DRUGN .
beta-receptor blockers	group	thiazide diuretics	group
false

No interactions have been observed with DRUGA , DRUGN , DRUGN and DRUGB and DRUGN .
beta-receptor blockers	group	loop diuretics	group
false

No interactions have been observed with DRUGA , DRUGN , DRUGN and DRUGN and DRUGB .
beta-receptor blockers	group	ACE inhibitors	group
false

No interactions have been observed with DRUGN , DRUGA , DRUGB and DRUGN and DRUGN .
calcium antagonists	group	thiazide diuretics	group
false

No interactions have been observed with DRUGN , DRUGA , DRUGN and DRUGB and DRUGN .
calcium antagonists	group	loop diuretics	group
false

No interactions have been observed with DRUGN , DRUGA , DRUGN and DRUGN and DRUGB .
calcium antagonists	group	ACE inhibitors	group
false

No interactions have been observed with DRUGN , DRUGN , DRUGA and DRUGB and DRUGN .
thiazide diuretics	group	loop diuretics	group
false

No interactions have been observed with DRUGN , DRUGN , DRUGA and DRUGN and DRUGB .
thiazide diuretics	group	ACE inhibitors	group
false

No interactions have been observed with DRUGN , DRUGN , DRUGN and DRUGA and DRUGB .
loop diuretics	group	ACE inhibitors	group
false

Influence of coadministration of DRUGA on DRUGB pharmacokinetics and QTc intervals in healthy volunteers .
fluoxetine	drug	cisapride	drug
false

STUDY OBJECTIVE : To evaluate the effect of DRUGA on the pharmacokinetics and cardiovascular safety of DRUGB at steady state in healthy men .
fluoxetine	drug	cisapride	drug
false

and phase dgb ( days dgb dgb ) : DRUGA dgb mg dgb times / day ( days dgb dgb ) plus DRUGB dgb mg / day ( days dgb dgb ) .
cisapride	drug	fluoxetine	drug
false

Coadministration of DRUGA significantly decreased DRUGB plasma concentrations .
fluoxetine	drug	cisapride	drug
mechanism

There were no clinically significant changes in corrected QT intervals during administration of DRUGA alone or with DRUGB .
cisapride	drug	fluoxetine	drug
false

DRUGA was well tolerated when administered alone or with DRUGB .
Cisapride	drug	fluoxetine	drug
false

CONCLUSION : DRUGA can be administered safely to patients receiving low therapeutic dosages of DRUGB .
Cisapride	drug	fluoxetine	drug
false

DRUGA , a DRUGB , is a DRUGN which has proven efficacy against the positive and negative symptoms of schizophrenia .
Olanzapine	drug	thienobenzodiazepine derivative	group
false

DRUGA , a DRUGN , is a DRUGB which has proven efficacy against the positive and negative symptoms of schizophrenia .
Olanzapine	drug	second generation (atypical) antipsychotic agent	group
false

DRUGN , a DRUGA , is a DRUGB which has proven efficacy against the positive and negative symptoms of schizophrenia .
thienobenzodiazepine derivative	group	second generation (atypical) antipsychotic agent	group
false

The dgb year risk of relapse ( rehospitalisation ) was significantly lower with DRUGA than with DRUGB treatment .
olanzapine	drug	haloperidol	drug
false

Improvements in general cognitive function seen with DRUGA treatment in a dgb year controlled study of patients with early phase schizophrenia , were significantly greater than changes seen with either DRUGB or DRUGN .
olanzapine	drug	risperidone	drug
false

Improvements in general cognitive function seen with DRUGA treatment in a dgb year controlled study of patients with early phase schizophrenia , were significantly greater than changes seen with either DRUGN or DRUGB .
olanzapine	drug	haloperidol	drug
false

Improvements in general cognitive function seen with DRUGN treatment in a dgb year controlled study of patients with early phase schizophrenia , were significantly greater than changes seen with either DRUGA or DRUGB .
risperidone	drug	haloperidol	drug
false

However , preliminary results from an dgb week trial showed comparable cognitive enhancing effects of DRUGA and DRUGB treatment in patients with schizophrenia or schizoaffective disorder .
olanzapine	drug	risperidone	drug
false

DRUGA is associated with significantly fewer extrapyramidal symptoms than DRUGB and DRUGN .
Olanzapine	drug	haloperidol	drug
false

DRUGA is associated with significantly fewer extrapyramidal symptoms than DRUGN and DRUGB .
Olanzapine	drug	risperidone	drug
false

DRUGN is associated with significantly fewer extrapyramidal symptoms than DRUGA and DRUGB .
haloperidol	drug	risperidone	drug
false

In addition , DRUGA is not associated with a risk of agranulocytosis as seen with DRUGB or clinically significant hyperprolactinaemia as seen with DRUGN or prolongation of the QT interval .
olanzapine	drug	clozapine	drug
false

In addition , DRUGA is not associated with a risk of agranulocytosis as seen with DRUGN or clinically significant hyperprolactinaemia as seen with DRUGB or prolongation of the QT interval .
olanzapine	drug	risperidone	drug
false

In addition , DRUGN is not associated with a risk of agranulocytosis as seen with DRUGA or clinically significant hyperprolactinaemia as seen with DRUGB or prolongation of the QT interval .
clozapine	drug	risperidone	drug
false

Pharmacoeconomic analyses indicate that DRUGA does not significantly increase , and may even decrease , the overall direct treatment costs of schizophrenia , compared with DRUGB .
olanzapine	drug	haloperidol	drug
false

Compared with DRUGA , DRUGB has also been reported to decrease overall treatment costs , despite the several fold higher daily acquisition cost of the drug .
risperidone	drug	olanzapine	drug
false

DRUGA treatment improves quality of life in patients with schizophrenia and related psychoses to a greater extent than DRUGB , and to broadly the same extent as DRUGN .
Olanzapine	drug	haloperidol	drug
false

DRUGA treatment improves quality of life in patients with schizophrenia and related psychoses to a greater extent than DRUGN , and to broadly the same extent as DRUGB .
Olanzapine	drug	risperidone	drug
false

DRUGN treatment improves quality of life in patients with schizophrenia and related psychoses to a greater extent than DRUGA , and to broadly the same extent as DRUGB .
haloperidol	drug	risperidone	drug
false

CONCLUSIONS : DRUGA demonstrated superior antipsychotic efficacy compared with DRUGB in the treatment of acute phase schizophrenia , and in the treatment of some patients with first episode or treatment resistant schizophrenia .
Olanzapine	drug	haloperidol	drug
false

The emerging roles of DRUGA in DRUGB therapy .
non-nucleoside reverse transcriptase inhibitors	group	antiretroviral	group
false

The availability of potent DRUGA ( DRUGB ) based regimens for DRUGN therapy and concerns regarding DRUGN ( DRUGN ) related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .
non-nucleoside reverse transcriptase inhibitor	group	NNRTI	group
false

The availability of potent DRUGA ( DRUGN ) based regimens for DRUGB therapy and concerns regarding DRUGN ( DRUGN ) related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .
non-nucleoside reverse transcriptase inhibitor	group	antiretroviral	group
false

The availability of potent DRUGA ( DRUGN ) based regimens for DRUGN therapy and concerns regarding DRUGB ( DRUGN ) related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .
non-nucleoside reverse transcriptase inhibitor	group	protease inhibitor	group
false

The availability of potent DRUGA ( DRUGN ) based regimens for DRUGN therapy and concerns regarding DRUGN ( DRUGB ) related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .
non-nucleoside reverse transcriptase inhibitor	group	PI	group
false

The availability of potent DRUGN ( DRUGA ) based regimens for DRUGB therapy and concerns regarding DRUGN ( DRUGN ) related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .
NNRTI	group	antiretroviral	group
false

The availability of potent DRUGN ( DRUGA ) based regimens for DRUGN therapy and concerns regarding DRUGB ( DRUGN ) related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .
NNRTI	group	protease inhibitor	group
false

The availability of potent DRUGN ( DRUGA ) based regimens for DRUGN therapy and concerns regarding DRUGN ( DRUGB ) related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .
NNRTI	group	PI	group
false

The availability of potent DRUGN ( DRUGN ) based regimens for DRUGA therapy and concerns regarding DRUGB ( DRUGN ) related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .
antiretroviral	group	protease inhibitor	group
false

The availability of potent DRUGN ( DRUGN ) based regimens for DRUGA therapy and concerns regarding DRUGN ( DRUGB ) related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .
antiretroviral	group	PI	group
false

The availability of potent DRUGN ( DRUGN ) based regimens for DRUGN therapy and concerns regarding DRUGA ( DRUGB ) related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .
protease inhibitor	group	PI	group
false

DRUGA based regimens may have several advantages over DRUGB based therapy for initial or prolonged therapy , including more convenient administration regimens , lower tablet volume , fewer drug interactions , and central nervous system penetration .
NNRTI	group	PI	group
false

No data from prospective clinical trials currently exist comparing the dgb approved agents ( DRUGA , DRUGB or DRUGN ) .
efavirenz	drug	nevirapine	drug
false

No data from prospective clinical trials currently exist comparing the dgb approved agents ( DRUGA , DRUGN or DRUGB ) .
efavirenz	drug	delavirdine	drug
false

No data from prospective clinical trials currently exist comparing the dgb approved agents ( DRUGN , DRUGA or DRUGB ) .
nevirapine	drug	delavirdine	drug
false

Both DRUGA and DRUGB have been compared to triple therapy with the DRUGN DRUGN over dgb weeks as initial therapy , with similar responses being observed with DRUGN regimens and superiority observed with DRUGN .
efavirenz	drug	nevirapine	drug
false

Both DRUGA and DRUGN have been compared to triple therapy with the DRUGB DRUGN over dgb weeks as initial therapy , with similar responses being observed with DRUGN regimens and superiority observed with DRUGN .
efavirenz	drug	PI	group
false

Both DRUGA and DRUGN have been compared to triple therapy with the DRUGN DRUGB over dgb weeks as initial therapy , with similar responses being observed with DRUGN regimens and superiority observed with DRUGN .
efavirenz	drug	indinavir	drug
false

Both DRUGA and DRUGN have been compared to triple therapy with the DRUGN DRUGN over dgb weeks as initial therapy , with similar responses being observed with DRUGB regimens and superiority observed with DRUGN .
efavirenz	drug	nevirapine	drug
false

Both DRUGN and DRUGA have been compared to triple therapy with the DRUGB DRUGN over dgb weeks as initial therapy , with similar responses being observed with DRUGN regimens and superiority observed with DRUGN .
nevirapine	drug	PI	group
false

Both DRUGN and DRUGA have been compared to triple therapy with the DRUGN DRUGB over dgb weeks as initial therapy , with similar responses being observed with DRUGN regimens and superiority observed with DRUGN .
nevirapine	drug	indinavir	drug
false

Both DRUGN and DRUGA have been compared to triple therapy with the DRUGN DRUGN over dgb weeks as initial therapy , with similar responses being observed with DRUGN regimens and superiority observed with DRUGB .
nevirapine	drug	efavirenz	drug
false

Both DRUGN and DRUGN have been compared to triple therapy with the DRUGA DRUGB over dgb weeks as initial therapy , with similar responses being observed with DRUGN regimens and superiority observed with DRUGN .
PI	group	indinavir	drug
false

Both DRUGN and DRUGN have been compared to triple therapy with the DRUGA DRUGN over dgb weeks as initial therapy , with similar responses being observed with DRUGB regimens and superiority observed with DRUGN .
PI	group	nevirapine	drug
false

Both DRUGN and DRUGN have been compared to triple therapy with the DRUGA DRUGN over dgb weeks as initial therapy , with similar responses being observed with DRUGN regimens and superiority observed with DRUGB .
PI	group	efavirenz	drug
false

Both DRUGN and DRUGN have been compared to triple therapy with the DRUGN DRUGA over dgb weeks as initial therapy , with similar responses being observed with DRUGB regimens and superiority observed with DRUGN .
indinavir	drug	nevirapine	drug
false

Both DRUGN and DRUGN have been compared to triple therapy with the DRUGN DRUGA over dgb weeks as initial therapy , with similar responses being observed with DRUGN regimens and superiority observed with DRUGB .
indinavir	drug	efavirenz	drug
false

Both DRUGN and DRUGN have been compared to triple therapy with the DRUGN DRUGN over dgb weeks as initial therapy , with similar responses being observed with DRUGA regimens and superiority observed with DRUGB .
nevirapine	drug	efavirenz	drug
false

A smaller dgb week study has suggested DRUGA may be superior to the DRUGB DRUGN .
nevirapine	drug	PI	group
false

A smaller dgb week study has suggested DRUGA may be superior to the DRUGN DRUGB .
nevirapine	drug	nelfinavir	drug
false

A smaller dgb week study has suggested DRUGN may be superior to the DRUGA DRUGB .
PI	group	nelfinavir	drug
false

Limited comparative data in patients with high viral loads treated with DRUGA or DRUGB based regimens currently exist .
nevirapine	drug	delavirdine	drug
false

The superiority of DRUGA over DRUGB based regimens has been observed in comparative data in a subset of patients with high viral loads .
efavirenz	drug	indinavir	drug
false

DRUGA has demonstrated superiority over DRUGB in nucleoside experienced patients , although combining these dgb agents may represent the best approach in these circumstances .
Efavirenz	drug	nelfinavir	drug
false

RESULTS : DRUGA has demonstrated effectiveness in men with erectile dysfunction associated with prostatectomy , radiation therapy , diabetes mellitus , certain neurologic disorders , and drug therapy ( eg , DRUGB [ DRUGN ] ) .
Sildenafil	drug	selective serotonin reuptake inhibitors	group
false

RESULTS : DRUGA has demonstrated effectiveness in men with erectile dysfunction associated with prostatectomy , radiation therapy , diabetes mellitus , certain neurologic disorders , and drug therapy ( eg , DRUGN [ DRUGB ] ) .
Sildenafil	drug	SSRIs	group
false

RESULTS : DRUGN has demonstrated effectiveness in men with erectile dysfunction associated with prostatectomy , radiation therapy , diabetes mellitus , certain neurologic disorders , and drug therapy ( eg , DRUGA [ DRUGB ] ) .
selective serotonin reuptake inhibitors	group	SSRIs	group
false

however , patients with moderate to severe cardiovascular disease or those taking DRUGA therapy are at increased risk for potentially serious cardiovascular adverse effects with DRUGB therapy .
nitrate	group	sildenafil	drug
effect

Acute DRUGA administration does not affect subjective responses to DRUGB in humans .
hydrocortisone	drug	d-amphetamine	drug
false

However , the effects of stress and DRUGA on the subjective and behavioral effects of DRUGB have not been well studied in humans .
glucocorticoids	group	psychostimulants	group
false

OBJECTIVES : To examine the effects of acute DRUGA pretreatment on the subjective and behavioral effects of DRUGB .
hydrocortisone	drug	d-amphetamine	drug
false

METHODS : DRUGA ( dgb mg ) and DRUGB ( dgb mg ) were administered orally to dgb healthy male and female volunteers in a four session , placebo controlled , within subject , crossover design .
Hydrocortisone	drug	d-amphetamine	drug
false

However , DRUGA pretreatment did not affect any of the physiological , behavioral , or subjective effects of DRUGB .
hydrocortisone	drug	d-amphetamine	drug
false

CONCLUSIONS : In contrast to the effects of DRUGA in rodent studies , these results indicate that an acute increase in cortisol does not enhance the psychostimulant effects of DRUGB in humans .
glucocorticoids	group	d-amphetamine	drug
false

The effects of DRUGA and of DRUGB anesthesia on DRUGN tolerance in dogs .
ketamine	drug	Innovar	brand
false

The effects of DRUGA and of DRUGN anesthesia on DRUGB tolerance in dogs .
ketamine	drug	digitalis	group
false

The effects of DRUGN and of DRUGA anesthesia on DRUGB tolerance in dogs .
Innovar	brand	digitalis	group
false

Ventricular tachycardia induced by DRUGA was generally converted to sinus rhythm following administration of DRUGB , DRUGN , or DRUGN but not after administration of DRUGN alone or after DRUGN .
ouabain	drug	Innovar	brand
effect

Ventricular tachycardia induced by DRUGA was generally converted to sinus rhythm following administration of DRUGN , DRUGB , or DRUGN but not after administration of DRUGN alone or after DRUGN .
ouabain	drug	ketamine	drug
effect

Ventricular tachycardia induced by DRUGA was generally converted to sinus rhythm following administration of DRUGN , DRUGN , or DRUGB but not after administration of DRUGN alone or after DRUGN .
ouabain	drug	droperidol	drug
effect

Ventricular tachycardia induced by DRUGA was generally converted to sinus rhythm following administration of DRUGN , DRUGN , or DRUGN but not after administration of DRUGB alone or after DRUGN .
ouabain	drug	fentayl	drug
false

Ventricular tachycardia induced by DRUGA was generally converted to sinus rhythm following administration of DRUGN , DRUGN , or DRUGN but not after administration of DRUGN alone or after DRUGB .
ouabain	drug	pentobarbital	drug
false

Ventricular tachycardia induced by DRUGN was generally converted to sinus rhythm following administration of DRUGA , DRUGB , or DRUGN but not after administration of DRUGN alone or after DRUGN .
Innovar	brand	ketamine	drug
false

Ventricular tachycardia induced by DRUGN was generally converted to sinus rhythm following administration of DRUGA , DRUGN , or DRUGB but not after administration of DRUGN alone or after DRUGN .
Innovar	brand	droperidol	drug
false

Ventricular tachycardia induced by DRUGN was generally converted to sinus rhythm following administration of DRUGA , DRUGN , or DRUGN but not after administration of DRUGB alone or after DRUGN .
Innovar	brand	fentayl	drug
false

Ventricular tachycardia induced by DRUGN was generally converted to sinus rhythm following administration of DRUGA , DRUGN , or DRUGN but not after administration of DRUGN alone or after DRUGB .
Innovar	brand	pentobarbital	drug
false

Ventricular tachycardia induced by DRUGN was generally converted to sinus rhythm following administration of DRUGN , DRUGA , or DRUGB but not after administration of DRUGN alone or after DRUGN .
ketamine	drug	droperidol	drug
false

Ventricular tachycardia induced by DRUGN was generally converted to sinus rhythm following administration of DRUGN , DRUGA , or DRUGN but not after administration of DRUGB alone or after DRUGN .
ketamine	drug	fentayl	drug
false

Ventricular tachycardia induced by DRUGN was generally converted to sinus rhythm following administration of DRUGN , DRUGA , or DRUGN but not after administration of DRUGN alone or after DRUGB .
ketamine	drug	pentobarbital	drug
false

Ventricular tachycardia induced by DRUGN was generally converted to sinus rhythm following administration of DRUGN , DRUGN , or DRUGA but not after administration of DRUGB alone or after DRUGN .
droperidol	drug	fentayl	drug
false

Ventricular tachycardia induced by DRUGN was generally converted to sinus rhythm following administration of DRUGN , DRUGN , or DRUGA but not after administration of DRUGN alone or after DRUGB .
droperidol	drug	pentobarbital	drug
false

Ventricular tachycardia induced by DRUGN was generally converted to sinus rhythm following administration of DRUGN , DRUGN , or DRUGN but not after administration of DRUGA alone or after DRUGB .
fentayl	drug	pentobarbital	drug
false

Interaction of DRUGA and DRUGB in vitro .
clindamycin	drug	gentamicin	drug
int

The minimal inhibitory concentrations of DRUGA and DRUGB alone and in combinations were determined by a microdilution method for dgb aerobic , facultative , and anaerobic clinical isolates .
clindamycin	drug	gentamicin	drug
false

DRUGA did not interfere with the activity of DRUGB within the range of concentrations tested ( dga to dgb mug / ml ) ;
Gentamicin	drug	clindamycin	drug
false

Combinations of DRUGA and DRUGB were indifferent for dgb strains and synergistic for dgb strains .
clindamycin	drug	gentamicin	drug
effect

Combinations of DRUGA and DRUGB were indifferent for dgb and synergistic for dgb of the resistant strains .
clindamycin	drug	gentamicin	drug
effect

Molecular basis for the selective toxicity of DRUGA for yeast and DRUGB for animal cells .
amphotericin B	drug	filipin	drug_n
false

Among the DRUGA , many , like DRUGB , can not be used clinically because they are toxic ;
polyene antibiotics	group	filipin	drug_n
false

Both the toxicity of DRUGA and the therapeutic value of DRUGB can be rationalized at the cellular and molecular level by the following observations : ( i ) these DRUGN showed differential effects on cells ;
filipin	drug_n	amphotericin B	drug
false

Both the toxicity of DRUGA and the therapeutic value of DRUGN can be rationalized at the cellular and molecular level by the following observations : ( i ) these DRUGB showed differential effects on cells ;
filipin	drug_n	polyene antibiotics	group
false

Both the toxicity of DRUGN and the therapeutic value of DRUGA can be rationalized at the cellular and molecular level by the following observations : ( i ) these DRUGB showed differential effects on cells ;
amphotericin B	drug	polyene antibiotics	group
false

DRUGA was more potent in lysing human red blood cells , whereas DRUGB was more potent in inhibiting yeast cell growth ;
filipin	drug_n	amphotericin B	drug
false

The DRUGA , DRUGB , inhibits the growth of several species of Candida .
antifungal drug	group	miconazole nitrate	drug
false

Effect of DRUGA on the apparent volume of distribution and elimination of DRUGB .
probenecid	drug	cloxacillin	drug
false

( dgb , dgb ) , the higher serum concentrations of DRUGA and DRUGB reached after administration of DRUGN are due not only to slower renal elimination but also to an altered distribution in the body .
penicillins	group	cephaloridine	drug
false

( dgb , dgb ) , the higher serum concentrations of DRUGA and DRUGN reached after administration of DRUGB are due not only to slower renal elimination but also to an altered distribution in the body .
penicillins	group	probenecid	drug
mechanism

( dgb , dgb ) , the higher serum concentrations of DRUGN and DRUGA reached after administration of DRUGB are due not only to slower renal elimination but also to an altered distribution in the body .
cephaloridine	drug	probenecid	drug
mechanism

No significant difference was found between the mean values of the volume of distribution of DRUGA with and without DRUGB ( dga and dga liters , respectively ) .
cloxacillin	drug	probenecid	drug
false

This might be explained by a blockade by DRUGA of the elimination of DRUGB by the liver .
probenecid	drug	cloxacillin	drug
mechanism

Many people use both DRUGA and DRUGB ( i.e . , cigarettes and other tobacco products ) .
alcohol	drug	nicotine	drug
false

The initiation of DRUGA or DRUGB use may be precipitated by similar personality characteristics in the user , such as impulsivity and sensation seeking .
alcohol	drug	nicotine	drug
false

Moreover , the mechanisms underlying the development of dependence may be similar for DRUGA and DRUGB .
alcohol	drug	nicotine	drug
false

An intravenous dose of dgb mg DRUGA was in respect of competitive suppression of organs actively concentrating DRUGB as effective as intravenous dgb mg ClO dgb simultaneously or dgb mg orally dgb min before the injection of DRUGN .
perchlorate	drug_n	pertechnetate	drug
false

An intravenous dose of dgb mg DRUGA was in respect of competitive suppression of organs actively concentrating DRUGN as effective as intravenous dgb mg ClO dgb simultaneously or dgb mg orally dgb min before the injection of DRUGB .
perchlorate	drug_n	radiopertechnetate	drug
false

An intravenous dose of dgb mg DRUGN was in respect of competitive suppression of organs actively concentrating DRUGA as effective as intravenous dgb mg ClO dgb simultaneously or dgb mg orally dgb min before the injection of DRUGB .
pertechnetate	drug	radiopertechnetate	drug
false

DRUGA : mammalian target of DRUGB inhibitor to prevent kidney rejection .
Sirolimus	drug	rapamycin	drug
false

DRUGA works differently from the DRUGB currently available , and except for increased lipid levels , the adverse reaction profile of DRUGN does not appear to overlap to any great extent with that associated with DRUGN or DRUGN .
Sirolimus	drug	immunosuppressants	group
false

DRUGA works differently from the DRUGN currently available , and except for increased lipid levels , the adverse reaction profile of DRUGB does not appear to overlap to any great extent with that associated with DRUGN or DRUGN .
Sirolimus	drug	sirolimus	drug
false

DRUGA works differently from the DRUGN currently available , and except for increased lipid levels , the adverse reaction profile of DRUGN does not appear to overlap to any great extent with that associated with DRUGB or DRUGN .
Sirolimus	drug	cyclosporine	drug
false

DRUGA works differently from the DRUGN currently available , and except for increased lipid levels , the adverse reaction profile of DRUGN does not appear to overlap to any great extent with that associated with DRUGN or DRUGB .
Sirolimus	drug	tacrolimus	drug
false

DRUGN works differently from the DRUGA currently available , and except for increased lipid levels , the adverse reaction profile of DRUGB does not appear to overlap to any great extent with that associated with DRUGN or DRUGN .
immunosuppressants	group	sirolimus	drug
false

DRUGN works differently from the DRUGA currently available , and except for increased lipid levels , the adverse reaction profile of DRUGN does not appear to overlap to any great extent with that associated with DRUGB or DRUGN .
immunosuppressants	group	cyclosporine	drug
false

DRUGN works differently from the DRUGA currently available , and except for increased lipid levels , the adverse reaction profile of DRUGN does not appear to overlap to any great extent with that associated with DRUGN or DRUGB .
immunosuppressants	group	tacrolimus	drug
false

DRUGN works differently from the DRUGN currently available , and except for increased lipid levels , the adverse reaction profile of DRUGA does not appear to overlap to any great extent with that associated with DRUGB or DRUGN .
sirolimus	drug	cyclosporine	drug
false

DRUGN works differently from the DRUGN currently available , and except for increased lipid levels , the adverse reaction profile of DRUGA does not appear to overlap to any great extent with that associated with DRUGN or DRUGB .
sirolimus	drug	tacrolimus	drug
false

DRUGN works differently from the DRUGN currently available , and except for increased lipid levels , the adverse reaction profile of DRUGN does not appear to overlap to any great extent with that associated with DRUGA or DRUGB .
cyclosporine	drug	tacrolimus	drug
false

The effects of DRUGA , DRUGB and DRUGN on bar press behavior in normal and genetically nervous dogs .
chlordiazepoxide	drug	amphetamine	drug
false

The effects of DRUGA , DRUGN and DRUGB on bar press behavior in normal and genetically nervous dogs .
chlordiazepoxide	drug	cocaine	drug
false

The effects of DRUGN , DRUGA and DRUGB on bar press behavior in normal and genetically nervous dogs .
amphetamine	drug	cocaine	drug
false

Studies on two strains of pointer dogs have demonstrated that administration of a DRUGA ( DRUGB ) facilitates acquisition of goal directed behavior in `` genetically nervous ''
benzodiazepine	group	chlordiazepoxide	drug
false

The concomitant administration of either DRUGA or DRUGB , compounds which inhibit neuronal reuptake of norepinephrine , disrupts the behavioral response of the genetically nervous E strain subjects to a far greater extent than the stable A strain subjects .
cocaine	drug	amphetamine	drug
false

DRUGA is the first DRUGB to be approved for clinical use , and has been studied extensively in humans since dga
Fluvastatin	drug	synthetic 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase inhibitor	group
false

It is structurally distinct from the other currently available DRUGA ( DRUGB , DRUGN , and DRUGN ) , leading to unique biopharmaceutical properties relative to the other agents of this class .
HMGCoA reductase inhibitors	group	lovastatin	drug
false

It is structurally distinct from the other currently available DRUGA ( DRUGN , DRUGB , and DRUGN ) , leading to unique biopharmaceutical properties relative to the other agents of this class .
HMGCoA reductase inhibitors	group	simvastatin	drug
false

It is structurally distinct from the other currently available DRUGA ( DRUGN , DRUGN , and DRUGB ) , leading to unique biopharmaceutical properties relative to the other agents of this class .
HMGCoA reductase inhibitors	group	pravastatin	drug
false

It is structurally distinct from the other currently available DRUGN ( DRUGA , DRUGB , and DRUGN ) , leading to unique biopharmaceutical properties relative to the other agents of this class .
lovastatin	drug	simvastatin	drug
false

It is structurally distinct from the other currently available DRUGN ( DRUGA , DRUGN , and DRUGB ) , leading to unique biopharmaceutical properties relative to the other agents of this class .
lovastatin	drug	pravastatin	drug
false

It is structurally distinct from the other currently available DRUGN ( DRUGN , DRUGA , and DRUGB ) , leading to unique biopharmaceutical properties relative to the other agents of this class .
simvastatin	drug	pravastatin	drug
false

DRUGA , an anionic binding resin , has a considerable effect in lowering the rate and extent of DRUGB bioavailability .
Cholestyramine	drug	fluvastatin	drug
mechanism

Although this effect was noted even when DRUGA was given dgb hours prior to DRUGB , this regimen did not result in diminished efficacy .
cholestyramine	drug	fluvastatin	drug
effect

Further , no effects on either DRUGA levels or prothrombin times were observed in a study involving concomitant administration of DRUGN and DRUGB .
warfarin	drug	fluvastatin	drug
false

Further , no effects on either DRUGN levels or prothrombin times were observed in a study involving concomitant administration of DRUGA and DRUGB .
warfarin	drug	fluvastatin	drug
false

The literature provides considerable evidence indicating that several , but not all DRUGA , are indeed DRUGB and some are DRUGN as well .
antihistaminics	group	analgesic agents	group
false

The literature provides considerable evidence indicating that several , but not all DRUGA , are indeed DRUGN and some are DRUGB as well .
antihistaminics	group	analgesic adjuvants	group
false

The literature provides considerable evidence indicating that several , but not all DRUGN , are indeed DRUGA and some are DRUGB as well .
analgesic agents	group	analgesic adjuvants	group
false

Those for which effectiveness is reported includes DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diphenhydramine	drug	hydroxyzine	drug
false

Those for which effectiveness is reported includes DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diphenhydramine	drug	orphenadrine	drug
false

Those for which effectiveness is reported includes DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
diphenhydramine	drug	pyrilamine	drug
false

Those for which effectiveness is reported includes DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
diphenhydramine	drug	phenyltoloxamine	drug_n
false

Those for which effectiveness is reported includes DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
diphenhydramine	drug	promethazine	drug
false

Those for which effectiveness is reported includes DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
diphenhydramine	drug	methdilazine	drug
false

Those for which effectiveness is reported includes DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
diphenhydramine	drug	tripelennamine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
hydroxyzine	drug	orphenadrine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
hydroxyzine	drug	pyrilamine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
hydroxyzine	drug	phenyltoloxamine	drug_n
false

Those for which effectiveness is reported includes DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
hydroxyzine	drug	promethazine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
hydroxyzine	drug	methdilazine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
hydroxyzine	drug	tripelennamine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
orphenadrine	drug	pyrilamine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
orphenadrine	drug	phenyltoloxamine	drug_n
false

Those for which effectiveness is reported includes DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
orphenadrine	drug	promethazine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
orphenadrine	drug	methdilazine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
orphenadrine	drug	tripelennamine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
pyrilamine	drug	phenyltoloxamine	drug_n
false

Those for which effectiveness is reported includes DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
pyrilamine	drug	promethazine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
pyrilamine	drug	methdilazine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
pyrilamine	drug	tripelennamine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
phenyltoloxamine	drug_n	promethazine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
phenyltoloxamine	drug_n	methdilazine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
phenyltoloxamine	drug_n	tripelennamine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
promethazine	drug	methdilazine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
promethazine	drug	tripelennamine	drug
false

Those for which effectiveness is reported includes DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
methdilazine	drug	tripelennamine	drug
false

After prolonged administration of DRUGA the displacing effect of DRUGB , an analog of cholecystokinin octapeptide , was replaced by the stimulant action on DRUGN binding .
neuroleptics	group	cerulein	drug_n
false

After prolonged administration of DRUGA the displacing effect of DRUGN , an analog of cholecystokinin octapeptide , was replaced by the stimulant action on DRUGB binding .
neuroleptics	group	3H-spiroperidol	drug_n
false

After prolonged administration of DRUGN the displacing effect of DRUGA , an analog of cholecystokinin octapeptide , was replaced by the stimulant action on DRUGB binding .
cerulein	drug_n	3H-spiroperidol	drug_n
false

It is assumed that increased interaction between DRUGA and high affinity binding sites for DRUGB on dopaminedgb and serotonindgb receptors underlies the antipsychotic action of DRUGN after their prolonged administration .
3H-spiroperidol	drug_n	apomorphine	drug
false

It is assumed that increased interaction between DRUGA and high affinity binding sites for DRUGN on dopaminedgb and serotonindgb receptors underlies the antipsychotic action of DRUGB after their prolonged administration .
3H-spiroperidol	drug_n	neuroleptics	group
false

It is assumed that increased interaction between DRUGN and high affinity binding sites for DRUGA on dopaminedgb and serotonindgb receptors underlies the antipsychotic action of DRUGB after their prolonged administration .
apomorphine	drug	neuroleptics	group
false

Dual effect of DRUGA on the DRUGB induced contraction and norepinephrine release in the guinea pig vas deferens .
ouabain	drug	palytoxin	drug_n
false

DRUGA ( DRUGB ) , CdgbHdgbNdgbOdgb , isolated from marine coelenterates of Palythoa tuberculosa , caused a first rapid contraction followed by the slow phasic contraction of guinea pig vas deferens .
Palytoxin	drug_n	PTX	drug_n
false

In the presence of DRUGA ( dgb ( dgb ) M ) , DRUGB ( dgb ( dgb ) M ) failed to cause the first contraction ;
ouabain	drug	PTX	drug_n
effect

When DRUGA was applied to the muscle in the presence of DRUGB , both first and second contractile responses to DRUGN were abolished .
ouabain	drug	phentolamine	drug
effect

When DRUGA was applied to the muscle in the presence of DRUGN , both first and second contractile responses to DRUGB were abolished .
ouabain	drug	PTX	drug_n
false

When DRUGN was applied to the muscle in the presence of DRUGA , both first and second contractile responses to DRUGB were abolished .
phentolamine	drug	PTX	drug_n
false

Exposure of the muscle to DRUGA ( dgb ( dgb ) M ) markedly increased the DRUGB induced release .
ouabain	drug	PTX	drug_n
effect

The intestinal absorption of DRUGA ( DRUGB ) has been investigated in the chick by means of the in situ ligated duodenal loop technique .
arsenate	drug_n	As(V)	drug_n
false

Furthermore , DRUGA and DRUGB do not appear to share a common transport pathway in the duodenum and no evidence was obtained for any interaction between the two at this level .
arsenate	drug_n	phosphate	drug
false

DRUGA administration to rachitic chicks was effective in significantly elevating duodenal DRUGB absorption , acting primarily to enhance serosal transport .
Vitamin D3	drug	arsenate	drug_n
mechanism

By contrast , DRUGA ( dgb mM ) and DRUGB ( dgb mM ) had no significant effect on the translocation when added alone .
spermidine	drug_n	putrescine	drug_n
false

DRUGA , and to a lesser extent , DRUGB , enhanced the translocating action of oleate and increased its effectiveness in transferring the phosphohydrolase from the soluble to the microsomal fraction .
Spermine	drug	spermidine	drug_n
false

DRUGA , such as DRUGB , DRUGN and DRUGN , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .
Slow-channel calcium blockers	group	verapamil	drug
false

DRUGA , such as DRUGN , DRUGB and DRUGN , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .
Slow-channel calcium blockers	group	diltiazem	drug
false

DRUGA , such as DRUGN , DRUGN and DRUGB , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .
Slow-channel calcium blockers	group	nifedipine	drug
false

DRUGN , such as DRUGA , DRUGB and DRUGN , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .
verapamil	drug	diltiazem	drug
false

DRUGN , such as DRUGA , DRUGN and DRUGB , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .
verapamil	drug	nifedipine	drug
false

DRUGN , such as DRUGN , DRUGA and DRUGB , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .
diltiazem	drug	nifedipine	drug
false

Differential actions of intrathecal DRUGA on blocking the tail flick inhibition induced by intraventricular DRUGB and DRUGN in rats .
naloxone	drug	beta-endorphin	drug_n
false

Differential actions of intrathecal DRUGA on blocking the tail flick inhibition induced by intraventricular DRUGN and DRUGB in rats .
naloxone	drug	morphine	drug
false

Differential actions of intrathecal DRUGN on blocking the tail flick inhibition induced by intraventricular DRUGA and DRUGB in rats .
beta-endorphin	drug_n	morphine	drug
false

The blockade of the spinal endorphinergic system by intrathecal DRUGA on the production of tail flick inhibition induced by intraventricular DRUGB and DRUGN was then studied .
naloxone	drug	beta-endorphin	drug_n
false

The blockade of the spinal endorphinergic system by intrathecal DRUGA on the production of tail flick inhibition induced by intraventricular DRUGN and DRUGB was then studied .
naloxone	drug	morphine	drug
false

The blockade of the spinal endorphinergic system by intrathecal DRUGN on the production of tail flick inhibition induced by intraventricular DRUGA and DRUGB was then studied .
beta-endorphin	drug_n	morphine	drug
false

Intraventricular injection of DRUGA and DRUGB produced an inhibition of the tail flick response to the heat stimulus in rats .
beta-endorphin	drug_n	morphine	drug
false

On the other hand , intrathecal DRUGA ( dgb dgb micrograms ) had only a very weak effect on the tail flick inhibition induced by intraventricular DRUGB ( dgb micrograms ) .
naloxone	drug	morphine	drug
effect

Intraventricular injection of DRUGA at doses of dga to dgb micrograms equally antagonized in a dose dependent manner the tail flick inhibition induced by intraventricular DRUGB and DRUGN .
naloxone	drug	beta-endorphin	drug_n
effect

Intraventricular injection of DRUGA at doses of dga to dgb micrograms equally antagonized in a dose dependent manner the tail flick inhibition induced by intraventricular DRUGN and DRUGB .
naloxone	drug	morphine	drug
effect

Intraventricular injection of DRUGN at doses of dga to dgb micrograms equally antagonized in a dose dependent manner the tail flick inhibition induced by intraventricular DRUGA and DRUGB .
beta-endorphin	drug_n	morphine	drug
false

descending epsilon and mu systems for DRUGA and DRUGB , respectively , are proposed .
beta-endorphin	drug_n	morphine	drug
false

Neurochemical and functional consequences following DRUGA ( DRUGB ) and DRUGN .
1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine	drug_n	MPTP	drug_n
false

Neurochemical and functional consequences following DRUGA ( DRUGN ) and DRUGB .
1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine	drug_n	methamphetamine	drug
false

Neurochemical and functional consequences following DRUGN ( DRUGA ) and DRUGB .
MPTP	drug_n	methamphetamine	drug
false

The neurochemical and functional consequences following DRUGA administration to the rat were evaluated and compared to similar effects following DRUGB administration .
MPTP	drug_n	methamphetamine	drug
false

It was observed that DRUGA induced long lasting depletions of striatal dopamine concentrations and this neurotoxic effect could be prevented by DRUGB pretreatment .
MPTP	drug_n	pargyline	drug
effect

The DRUGA induced neuronal damage produced a tolerance to the disruptive effects of DRUGB and a supersensitivity to the disruptive effects of DRUGN in rats responding in a schedule controlled paradigm .
MPTP	drug	amphetamine	drug
effect

The DRUGA induced neuronal damage produced a tolerance to the disruptive effects of DRUGN and a supersensitivity to the disruptive effects of DRUGB in rats responding in a schedule controlled paradigm .
MPTP	drug	apomorphine	drug
effect

The DRUGN induced neuronal damage produced a tolerance to the disruptive effects of DRUGA and a supersensitivity to the disruptive effects of DRUGB in rats responding in a schedule controlled paradigm .
amphetamine	drug	apomorphine	drug
false

DRUGA , like DRUGB , produced depletions of striatal dopamine but these actions were potentiated by DRUGN pretreatment .
Methamphetamine	drug	MPTP	drug_n
false

DRUGA , like DRUGN , produced depletions of striatal dopamine but these actions were potentiated by DRUGB pretreatment .
Methamphetamine	drug	pargyline	drug
effect

DRUGN , like DRUGA , produced depletions of striatal dopamine but these actions were potentiated by DRUGB pretreatment .
MPTP	drug_n	pargyline	drug
false

DRUGA and DRUGB similarly inhibit and stimulate DRUGN or DRUGN induced proliferation of prostatic epithelium .
Dexamethasone	drug	retinyl acetate	drug
false

DRUGA and DRUGN similarly inhibit and stimulate DRUGB or DRUGN induced proliferation of prostatic epithelium .
Dexamethasone	drug	EGF	drug_n
effect

DRUGA and DRUGN similarly inhibit and stimulate DRUGN or DRUGB induced proliferation of prostatic epithelium .
Dexamethasone	drug	insulin	drug
effect

DRUGN and DRUGA similarly inhibit and stimulate DRUGB or DRUGN induced proliferation of prostatic epithelium .
retinyl acetate	drug	EGF	drug_n
effect

DRUGN and DRUGA similarly inhibit and stimulate DRUGN or DRUGB induced proliferation of prostatic epithelium .
retinyl acetate	drug	insulin	drug
effect

DRUGN and DRUGN similarly inhibit and stimulate DRUGA or DRUGB induced proliferation of prostatic epithelium .
EGF	drug_n	insulin	drug
false

Although neither DRUGA nor DRUGB affected the proliferation of prostatic epithelium in RPMIdgb containing DRUGN alone , they modify the mitogenic effect of DRUGN and DRUGN .
dexamethasone	drug	retinyl acetate	drug
false

Although neither DRUGA nor DRUGN affected the proliferation of prostatic epithelium in RPMIdgb containing DRUGB alone , they modify the mitogenic effect of DRUGN and DRUGN .
dexamethasone	drug	transferrin	drug_n
false

Although neither DRUGA nor DRUGN affected the proliferation of prostatic epithelium in RPMIdgb containing DRUGN alone , they modify the mitogenic effect of DRUGB and DRUGN .
dexamethasone	drug	EGF	drug_n
effect

Although neither DRUGA nor DRUGN affected the proliferation of prostatic epithelium in RPMIdgb containing DRUGN alone , they modify the mitogenic effect of DRUGN and DRUGB .
dexamethasone	drug	insulin	drug
effect

Although neither DRUGN nor DRUGA affected the proliferation of prostatic epithelium in RPMIdgb containing DRUGB alone , they modify the mitogenic effect of DRUGN and DRUGN .
retinyl acetate	drug	transferrin	drug_n
false

Although neither DRUGN nor DRUGA affected the proliferation of prostatic epithelium in RPMIdgb containing DRUGN alone , they modify the mitogenic effect of DRUGB and DRUGN .
retinyl acetate	drug	EGF	drug_n
effect

Although neither DRUGN nor DRUGA affected the proliferation of prostatic epithelium in RPMIdgb containing DRUGN alone , they modify the mitogenic effect of DRUGN and DRUGB .
retinyl acetate	drug	insulin	drug
effect

Although neither DRUGN nor DRUGN affected the proliferation of prostatic epithelium in RPMIdgb containing DRUGA alone , they modify the mitogenic effect of DRUGB and DRUGN .
transferrin	drug_n	EGF	drug_n
false

Although neither DRUGN nor DRUGN affected the proliferation of prostatic epithelium in RPMIdgb containing DRUGA alone , they modify the mitogenic effect of DRUGN and DRUGB .
transferrin	drug_n	insulin	drug
false

Although neither DRUGN nor DRUGN affected the proliferation of prostatic epithelium in RPMIdgb containing DRUGN alone , they modify the mitogenic effect of DRUGA and DRUGB .
EGF	drug_n	insulin	drug
false

DRUGA at dgb ( dgb ) M or DRUGB at about dgb X dgb ( dgb ) M inhibits proliferation stimulated by DRUGN .
Dexamethasone	drug	retinyl acetate	drug
false

DRUGA at dgb ( dgb ) M or DRUGN at about dgb X dgb ( dgb ) M inhibits proliferation stimulated by DRUGB .
Dexamethasone	drug	EGF	drug_n
effect

DRUGN at dgb ( dgb ) M or DRUGA at about dgb X dgb ( dgb ) M inhibits proliferation stimulated by DRUGB .
retinyl acetate	drug	EGF	drug_n
effect

Higher concentrations of DRUGA ( dgb ( dgb ) dgb ( dgb ) M ) or DRUGB ( dgb X dgb ( dgb ) dgb ( dgb ) M ) enhance the mitogenic activity of DRUGN .
dexamethasone	drug	retinyl acetate	drug
false

Higher concentrations of DRUGA ( dgb ( dgb ) dgb ( dgb ) M ) or DRUGN ( dgb X dgb ( dgb ) dgb ( dgb ) M ) enhance the mitogenic activity of DRUGB .
dexamethasone	drug	EGF	drug_n
effect

Higher concentrations of DRUGN ( dgb ( dgb ) dgb ( dgb ) M ) or DRUGA ( dgb X dgb ( dgb ) dgb ( dgb ) M ) enhance the mitogenic activity of DRUGB .
retinyl acetate	drug	EGF	drug_n
effect

DRUGA had a similar effect in the presence of DRUGB .
Dexamethasone	drug	insulin	drug
false

However , DRUGA stimulated , but did not significantly inhibit , proliferation in the presence of DRUGB .
retinyl acetate	drug	insulin	drug
effect

These results suggest that both DRUGA and DRUGB , and possibly other DRUGN and DRUGN , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of DRUGN and DRUGN .
dexamethasone	drug	retinyl acetate	drug
false

These results suggest that both DRUGA and DRUGN , and possibly other DRUGB and DRUGN , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of DRUGN and DRUGN .
dexamethasone	drug	glucocorticoids	group
false

These results suggest that both DRUGA and DRUGN , and possibly other DRUGN and DRUGB , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of DRUGN and DRUGN .
dexamethasone	drug	retinoids	group
false

These results suggest that both DRUGA and DRUGN , and possibly other DRUGN and DRUGN , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of DRUGB and DRUGN .
dexamethasone	drug	insulin	drug
effect

These results suggest that both DRUGA and DRUGN , and possibly other DRUGN and DRUGN , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of DRUGN and DRUGB .
dexamethasone	drug	EGF	drug_n
effect

These results suggest that both DRUGN and DRUGA , and possibly other DRUGB and DRUGN , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of DRUGN and DRUGN .
retinyl acetate	drug	glucocorticoids	group
false

These results suggest that both DRUGN and DRUGA , and possibly other DRUGN and DRUGB , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of DRUGN and DRUGN .
retinyl acetate	drug	retinoids	group
false

These results suggest that both DRUGN and DRUGA , and possibly other DRUGN and DRUGN , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of DRUGB and DRUGN .
retinyl acetate	drug	insulin	drug
effect

These results suggest that both DRUGN and DRUGA , and possibly other DRUGN and DRUGN , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of DRUGN and DRUGB .
retinyl acetate	drug	EGF	drug_n
effect

These results suggest that both DRUGN and DRUGN , and possibly other DRUGA and DRUGB , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of DRUGN and DRUGN .
glucocorticoids	group	retinoids	group
false

These results suggest that both DRUGN and DRUGN , and possibly other DRUGA and DRUGN , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of DRUGB and DRUGN .
glucocorticoids	group	insulin	drug
effect

These results suggest that both DRUGN and DRUGN , and possibly other DRUGA and DRUGN , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of DRUGN and DRUGB .
glucocorticoids	group	EGF	drug_n
effect

These results suggest that both DRUGN and DRUGN , and possibly other DRUGN and DRUGA , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of DRUGB and DRUGN .
retinoids	group	insulin	drug
effect

These results suggest that both DRUGN and DRUGN , and possibly other DRUGN and DRUGA , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of DRUGN and DRUGB .
retinoids	group	EGF	drug_n
effect

These results suggest that both DRUGN and DRUGN , and possibly other DRUGN and DRUGN , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of DRUGA and DRUGB .
insulin	drug	EGF	drug_n
false

For the DRUGA now available in the United States ( DRUGB , DRUGN and DRUGN ) , these data appeared well after clinical patterns of use evolved .
calcium-entry blocking agents	group	verapamil	drug
false

For the DRUGA now available in the United States ( DRUGN , DRUGB and DRUGN ) , these data appeared well after clinical patterns of use evolved .
calcium-entry blocking agents	group	nifedipine	drug
false

For the DRUGA now available in the United States ( DRUGN , DRUGN and DRUGB ) , these data appeared well after clinical patterns of use evolved .
calcium-entry blocking agents	group	diltiazem	drug
false

For the DRUGN now available in the United States ( DRUGA , DRUGB and DRUGN ) , these data appeared well after clinical patterns of use evolved .
verapamil	drug	nifedipine	drug
false

For the DRUGN now available in the United States ( DRUGA , DRUGN and DRUGB ) , these data appeared well after clinical patterns of use evolved .
verapamil	drug	diltiazem	drug
false

For the DRUGN now available in the United States ( DRUGN , DRUGA and DRUGB ) , these data appeared well after clinical patterns of use evolved .
nifedipine	drug	diltiazem	drug
false

by the nonlinear kinetic characteristics for DRUGA and DRUGB ( and probably for DRUGN , as well ) and the derivative implications for decreased dosing frequency requirements ;
verapamil	drug	diltiazem	drug
false

by the nonlinear kinetic characteristics for DRUGA and DRUGN ( and probably for DRUGB , as well ) and the derivative implications for decreased dosing frequency requirements ;
verapamil	drug	nifedipine	drug
false

by the nonlinear kinetic characteristics for DRUGN and DRUGA ( and probably for DRUGB , as well ) and the derivative implications for decreased dosing frequency requirements ;
diltiazem	drug	nifedipine	drug
false

Selective survival in DRUGA and DRUGB of Pseudomonas aeruginosa serotype Odgb from drug addicts .
pentazocine	drug	tripelennamine	drug
false

The growth of Pseudomonas aeruginosa , particularly serotype Odgb , in DRUGA and DRUGB
pentazocine	drug	tripelennamine	drug
false

Twelve strains of Staphylococcus aureus ( a frequent cause of infection in DRUGA , but not in DRUGB and DRUGN , addicts ) were completely inhibited by the drug combination .
heroin	drug_n	pentazocine	drug
false

Twelve strains of Staphylococcus aureus ( a frequent cause of infection in DRUGA , but not in DRUGN and DRUGB , addicts ) were completely inhibited by the drug combination .
heroin	drug_n	tripelennamine	drug
false

Twelve strains of Staphylococcus aureus ( a frequent cause of infection in DRUGN , but not in DRUGA and DRUGB , addicts ) were completely inhibited by the drug combination .
pentazocine	drug	tripelennamine	drug
effect

Dose response curves ( derived from the results of using the tablets as well as pure powders ) showed that DRUGA was responsible for the inhibitory activity , which was partially antagonized by DRUGB .
tripelennamine	drug	pentazocine	drug
effect

aureus , to survive in DRUGA and DRUGB may explain in part a shift from S .
pentazocine	drug	tripelennamine	drug
false

Pharmacokinetic evaluation of the DRUGA DRUGB interaction .
digoxin	drug	amiodarone	drug
false

DRUGA is known to raise serum DRUGB levels .
Amiodarone	drug	digoxin	drug
mechanism

The pharmacokinetic variables for DRUGA were determined after a dga mg intravenous dose of DRUGN in each subject , before and after oral DRUGB , dgb mg daily for dgb weeks .
digoxin	drug	amiodarone	drug
false

The pharmacokinetic variables for DRUGN were determined after a dga mg intravenous dose of DRUGA in each subject , before and after oral DRUGB , dgb mg daily for dgb weeks .
digoxin	drug	amiodarone	drug
false

During DRUGA administration , systemic clearance of DRUGB was reduced from dgb + / dgb ml / min ( mean + / standard deviation ) to dgb + / dgb ml / min ( p less than dga ) .
amiodarone	drug	digoxin	drug
mechanism

DRUGA caused a three to fivefold increase in serum reverse triiodothyronine levels , but changes in thyroid function were not quantitatively related to the changes in DRUGB pharmacokinetics .
Amiodarone	drug	digoxin	drug
false

These alterations in DRUGA pharmacokinetics produced by DRUGB explain the increase in serum DRUGN level that has been observed when this drug combination has been used clinically .
digoxin	drug	amiodarone	drug
mechanism

These alterations in DRUGN pharmacokinetics produced by DRUGA explain the increase in serum DRUGB level that has been observed when this drug combination has been used clinically .
amiodarone	drug	digoxin	drug
false

DRUGA protects mouse tumour and normal tissues from the toxicity of oral DRUGB .
Misonidazole	drug_n	CCNU	drug
effect

DRUGA reduced the antitumour activity of oral DRUGB by dose modifying factors ( DMF ) of dga dga .
Misonidazole	drug_n	CCNU	drug
effect

DRUGA has a complex effect on oral DRUGB pharmacokinetics .
Misonidazole	drug_n	CCNU	drug
mechanism

We propose these pharmacokinetic changes to be the underlying mechanism for the reduction of oral DRUGA cytotoxicity by DRUGB .
CCNU	drug	misonidazole	drug_n
mechanism

Enhanced DRUGA clearance secondary to DRUGB therapy .
theophylline	drug	phenytoin	drug
mechanism

This report describes two cases in which DRUGA clearance accelerated markedly with concomitant DRUGB administration .
theophylline	drug	phenytoin	drug
mechanism

With combined use , clinicians should be aware , when DRUGA is added , of the potential for reexacerbation of pulmonary symptomatology due to lowered serum DRUGB concentrations .
phenytoin	drug	theophylline	drug
effect

Intermediate doses of DRUGA or DRUGB produced transient increases in FI responding in monkeys and sustained increases in FI responding in pigeons ;
(+)-NANM	drug_n	PCP	drug_n
false

In monkeys , DRUGA was about dgb times more potent than DRUGB in decreasing responding , whereas in pigeons DRUGN was about equipotent with DRUGN .
(-)-NANM	drug_n	(+)-NANM	drug_n
false

In monkeys , DRUGA was about dgb times more potent than DRUGN in decreasing responding , whereas in pigeons DRUGN was about equipotent with DRUGB .
(-)-NANM	drug_n	(+)-NANM	drug_n
false

In monkeys , DRUGN was about dgb times more potent than DRUGA in decreasing responding , whereas in pigeons DRUGB was about equipotent with DRUGN .
(+)-NANM	drug_n	(-)-NANM	drug_n
false

In monkeys , DRUGN was about dgb times more potent than DRUGN in decreasing responding , whereas in pigeons DRUGA was about equipotent with DRUGB .
(-)-NANM	drug_n	(+)-NANM	drug_n
false

In both species , DRUGA , but not DRUGB , antagonized the rate decreasing effects of DRUGN on FI and FR responding .
(-)-NANM	drug_n	(+)-NANM	drug_n
false

In both species , DRUGA , but not DRUGN , antagonized the rate decreasing effects of DRUGB on FI and FR responding .
(-)-NANM	drug_n	morphine	drug
effect

In both species , DRUGN , but not DRUGA , antagonized the rate decreasing effects of DRUGB on FI and FR responding .
(+)-NANM	drug_n	morphine	drug
false

In monkeys , the effects of DRUGA , but not DRUGB or DRUGN , were antagonized by DRUGN ;
(-)-NANM	drug_n	(+)-NANM	drug_n
false

In monkeys , the effects of DRUGA , but not DRUGN or DRUGB , were antagonized by DRUGN ;
(-)-NANM	drug_n	PCP	drug_n
false

In monkeys , the effects of DRUGA , but not DRUGN or DRUGN , were antagonized by DRUGB ;
(-)-NANM	drug_n	naloxone	drug
effect

In monkeys , the effects of DRUGN , but not DRUGA or DRUGB , were antagonized by DRUGN ;
(+)-NANM	drug_n	PCP	drug_n
false

In monkeys , the effects of DRUGN , but not DRUGA or DRUGN , were antagonized by DRUGB ;
(+)-NANM	drug_n	naloxone	drug
false

In monkeys , the effects of DRUGN , but not DRUGN or DRUGA , were antagonized by DRUGB ;
PCP	drug_n	naloxone	drug
false

the doses of DRUGA required to antagonize the effects of DRUGB were more than dgb times higher than those required to antagonize the effects of DRUGN .
naloxone	drug	(-)-NANM	drug_n
effect

the doses of DRUGA required to antagonize the effects of DRUGN were more than dgb times higher than those required to antagonize the effects of DRUGB .
naloxone	drug	morphine	drug
effect

the doses of DRUGN required to antagonize the effects of DRUGA were more than dgb times higher than those required to antagonize the effects of DRUGB .
(-)-NANM	drug_n	morphine	drug
false

In pigeons , DRUGA did not systematically alter the effects of DRUGB , DRUGN or DRUGN .
naloxone	drug	(-)-NANM	drug_n
false

In pigeons , DRUGA did not systematically alter the effects of DRUGN , DRUGB or DRUGN .
naloxone	drug	(+)-NANM	drug_n
false

In pigeons , DRUGA did not systematically alter the effects of DRUGN , DRUGN or DRUGB .
naloxone	drug	PCP	drug_n
false

In pigeons , DRUGN did not systematically alter the effects of DRUGA , DRUGB or DRUGN .
(-)-NANM	drug_n	(+)-NANM	drug_n
false

In pigeons , DRUGN did not systematically alter the effects of DRUGA , DRUGN or DRUGB .
(-)-NANM	drug_n	PCP	drug_n
false

In pigeons , DRUGN did not systematically alter the effects of DRUGN , DRUGA or DRUGB .
(+)-NANM	drug_n	PCP	drug_n
false

Increased hepatotoxicity of DRUGA by concomitant administration of DRUGB in the rat .
acetaminophen	drug	caffeine	drug
effect

Since DRUGA is frequently co administered with DRUGB , it is of clinical interest to study the effect of DRUGN on the hepatotoxicity of DRUGN .
caffeine	drug	acetaminophen	drug
false

Since DRUGA is frequently co administered with DRUGN , it is of clinical interest to study the effect of DRUGN on the hepatotoxicity of DRUGB .
caffeine	drug	acetaminophen	drug
false

Since DRUGN is frequently co administered with DRUGA , it is of clinical interest to study the effect of DRUGB on the hepatotoxicity of DRUGN .
acetaminophen	drug	caffeine	drug
false

Since DRUGN is frequently co administered with DRUGN , it is of clinical interest to study the effect of DRUGA on the hepatotoxicity of DRUGB .
caffeine	drug	acetaminophen	drug
false

Careful observations on hepatotoxicity are suggested when DRUGA is prescribed with DRUGB .
acetaminophen	drug	caffeine	drug
effect

High dose DRUGA with DRUGB protection .
cisplatin	drug	sodium thiosulfate	drug
effect

DRUGA is a neutralizing agent for DRUGB that protects against renal damage .
Sodium thiosulfate	drug	cisplatin	drug
effect

To determine whether injection of DRUGA would permit larger doses of DRUGB to be administered , a fixed dga g / mdgb dose of DRUGN was given intravenously over three hours concurrently with escalating doses of DRUGN .
thiosulfate	drug	cisplatin	drug
false

To determine whether injection of DRUGA would permit larger doses of DRUGN to be administered , a fixed dga g / mdgb dose of DRUGN was given intravenously over three hours concurrently with escalating doses of DRUGB .
thiosulfate	drug	cisplatin	drug
false

To determine whether injection of DRUGN would permit larger doses of DRUGA to be administered , a fixed dga g / mdgb dose of DRUGB was given intravenously over three hours concurrently with escalating doses of DRUGN .
cisplatin	drug	thiosulfate	drug
false

To determine whether injection of DRUGN would permit larger doses of DRUGN to be administered , a fixed dga g / mdgb dose of DRUGA was given intravenously over three hours concurrently with escalating doses of DRUGB .
thiosulfate	drug	cisplatin	drug
false

DRUGA was administered over the last two hours of the DRUGB infusion .
Cisplatin	drug	thiosulfate	drug
false

This study demonstrates that concurrent administration of DRUGA permits at least a twofold increase in dose and total exposure to DRUGB .
thiosulfate	drug	cisplatin	drug
mechanism

Repeated oral administration of DRUGA in sheep : interactions of DRUGN with DRUGB , DRUGN , and DRUGN .
coumaphos	drug_n	bishydroxycoumarin	drug
false

Repeated oral administration of DRUGA in sheep : interactions of DRUGN with DRUGN , DRUGB , and DRUGN .
coumaphos	drug_n	trichlorfon	drug_n
false

Repeated oral administration of DRUGA in sheep : interactions of DRUGN with DRUGN , DRUGN , and DRUGB .
coumaphos	drug_n	phenobarbital sodium	drug
false

Repeated oral administration of DRUGN in sheep : interactions of DRUGA with DRUGB , DRUGN , and DRUGN .
coumaphos	drug_n	bishydroxycoumarin	drug
false

Repeated oral administration of DRUGN in sheep : interactions of DRUGA with DRUGN , DRUGB , and DRUGN .
coumaphos	drug_n	trichlorfon	drug_n
false

Repeated oral administration of DRUGN in sheep : interactions of DRUGA with DRUGN , DRUGN , and DRUGB .
coumaphos	drug_n	phenobarbital sodium	drug
false

Repeated oral administration of DRUGN in sheep : interactions of DRUGN with DRUGA , DRUGB , and DRUGN .
bishydroxycoumarin	drug	trichlorfon	drug_n
false

Repeated oral administration of DRUGN in sheep : interactions of DRUGN with DRUGA , DRUGN , and DRUGB .
bishydroxycoumarin	drug	phenobarbital sodium	drug
false

Repeated oral administration of DRUGN in sheep : interactions of DRUGN with DRUGN , DRUGA , and DRUGB .
trichlorfon	drug_n	phenobarbital sodium	drug
false

Interactions between treatments with DRUGA , DRUGB ( an DRUGN ) , DRUGN ( an DRUGN ) , and DRUGN ( an inducer of microsomal enzymes ) were investigated in sheep .
coumaphos	drug_n	bishydroxycoumarin	drug
false

Interactions between treatments with DRUGA , DRUGN ( an DRUGB ) , DRUGN ( an DRUGN ) , and DRUGN ( an inducer of microsomal enzymes ) were investigated in sheep .
coumaphos	drug_n	anticoagulant	group
false

Interactions between treatments with DRUGA , DRUGN ( an DRUGN ) , DRUGB ( an DRUGN ) , and DRUGN ( an inducer of microsomal enzymes ) were investigated in sheep .
coumaphos	drug_n	trichlorfon	drug_n
false

Interactions between treatments with DRUGA , DRUGN ( an DRUGN ) , DRUGN ( an DRUGB ) , and DRUGN ( an inducer of microsomal enzymes ) were investigated in sheep .
coumaphos	drug_n	organophosphorous compound	group
false

Interactions between treatments with DRUGA , DRUGN ( an DRUGN ) , DRUGN ( an DRUGN ) , and DRUGB ( an inducer of microsomal enzymes ) were investigated in sheep .
coumaphos	drug_n	phenobarbital sodium	drug
false

Interactions between treatments with DRUGN , DRUGA ( an DRUGB ) , DRUGN ( an DRUGN ) , and DRUGN ( an inducer of microsomal enzymes ) were investigated in sheep .
bishydroxycoumarin	drug	anticoagulant	group
false

Interactions between treatments with DRUGN , DRUGA ( an DRUGN ) , DRUGB ( an DRUGN ) , and DRUGN ( an inducer of microsomal enzymes ) were investigated in sheep .
bishydroxycoumarin	drug	trichlorfon	drug_n
false

Interactions between treatments with DRUGN , DRUGA ( an DRUGN ) , DRUGN ( an DRUGB ) , and DRUGN ( an inducer of microsomal enzymes ) were investigated in sheep .
bishydroxycoumarin	drug	organophosphorous compound	group
false

Interactions between treatments with DRUGN , DRUGA ( an DRUGN ) , DRUGN ( an DRUGN ) , and DRUGB ( an inducer of microsomal enzymes ) were investigated in sheep .
bishydroxycoumarin	drug	phenobarbital sodium	drug
false

Interactions between treatments with DRUGN , DRUGN ( an DRUGA ) , DRUGB ( an DRUGN ) , and DRUGN ( an inducer of microsomal enzymes ) were investigated in sheep .
anticoagulant	group	trichlorfon	drug_n
false

Interactions between treatments with DRUGN , DRUGN ( an DRUGA ) , DRUGN ( an DRUGB ) , and DRUGN ( an inducer of microsomal enzymes ) were investigated in sheep .
anticoagulant	group	organophosphorous compound	group
false

Interactions between treatments with DRUGN , DRUGN ( an DRUGA ) , DRUGN ( an DRUGN ) , and DRUGB ( an inducer of microsomal enzymes ) were investigated in sheep .
anticoagulant	group	phenobarbital sodium	drug
false

Interactions between treatments with DRUGN , DRUGN ( an DRUGN ) , DRUGA ( an DRUGB ) , and DRUGN ( an inducer of microsomal enzymes ) were investigated in sheep .
trichlorfon	drug_n	organophosphorous compound	group
false

Interactions between treatments with DRUGN , DRUGN ( an DRUGN ) , DRUGA ( an DRUGN ) , and DRUGB ( an inducer of microsomal enzymes ) were investigated in sheep .
trichlorfon	drug_n	phenobarbital sodium	drug
false

Interactions between treatments with DRUGN , DRUGN ( an DRUGN ) , DRUGN ( an DRUGA ) , and DRUGB ( an inducer of microsomal enzymes ) were investigated in sheep .
organophosphorous compound	group	phenobarbital sodium	drug
false

A daily dose of dgb mg of DRUGA / kg of body weight for dgb days did not affect the plasma enzymes or the antiprothrombinemic effect of DRUGB in wethers .
coumaphos	drug_n	bishydroxy-coumarin	drug
false

In ewes given dgb mg of DRUGA / kg for dgb days intraperitoneally ( IP ) , the anticholinesterase effect of dgb mg of DRUGB / kg was significantly reduced and signs of toxicity were not present .
phenobarbital sodium	drug	coumaphos	drug_n
effect

Failure of DRUGA to modify DRUGB induced hypertension in sheep .
neomycin	drug	ACTH	group
false

Studies in rats have shown that DRUGA administration attenuates certain types of DRUGB dependent hypertension , including DRUGN hypertension .
neomycin	drug	adrenocortical steroid	group
false

Studies in rats have shown that DRUGA administration attenuates certain types of DRUGN dependent hypertension , including DRUGB hypertension .
neomycin	drug	ACTH	drug
effect

Studies in rats have shown that DRUGN administration attenuates certain types of DRUGA dependent hypertension , including DRUGB hypertension .
adrenocortical steroid	group	ACTH	drug
false

The effects of oral DRUGA on DRUGB induced hypertension were examined in conscious sheep .
neomycin	drug	ACTH	group
false

DRUGA has no effect on the blood pressure or metabolic responses to DRUGB in sheep .
Neomycin	drug	ACTH	group
false

Changes in urinary homocysteine following DRUGA and DRUGB administration to rats .
synthetic steroidal estrogen	group	synthetic steroidal progestogen	group
false

The present work involved the administration of both DRUGA and DRUGB to groups of rats , followed by determination of the homocysteine excretion rate in urine .
ethynyl estradiol	drug	levonorgestrel	drug
false

The results indicate that a statistically significant difference exists between the excreted levels of homocysteine in the urine of both control and DRUGA treated rats and the levels shown by rats treated with DRUGB .
levonorgestrel	drug	ethynyl estradiol	drug
false

Thirty male rats of the Fischer dgb strain were divided into three equal groups and were given injections of DRUGA ( DRUGB ) ( dga or dga mg / kg / ml SC ) or the saline vehicle .
trimethyl lead	drug_n	TML	drug_n
false

The dgb % v / v solution of DRUGA was prepared in water from a stock solution of dgb % DRUGB .
alcohol	drug	ethanol	drug
false

These results suggest that exposure to environmental DRUGA may alter the biological and behavioral responsiveness of an animal to DRUGB .
lead	drug_n	alcohol	drug
effect

DRUGA pretreatment augmented the depressant effect of DRUGB on the early components Pdgb and Ndgb , while attenuating DRUGN 's influence on components Pdgb and Pdga
Physostigmine	drug	alcohol	drug
effect

DRUGA pretreatment augmented the depressant effect of DRUGN on the early components Pdgb and Ndgb , while attenuating DRUGB 's influence on components Pdgb and Pdga
Physostigmine	drug	alcohol	drug
effect

DRUGA , either alone or in combination with DRUGB , produced approximately the same degree of enhancement of component Pdga
Atropine	drug	alcohol	drug
false

Hypothermia as an index of the DRUGA DRUGB reaction in the rat .
disulfiram	drug	ethanol	drug
false

Decreased core temperature in female rats was investigated as one possible index of the DRUGA DRUGB reaction ( DER ) .
disulfiram	drug	ethanol	drug
false

Core temperature was decreased in rats in a dose dependent manner when DRUGA was administered to rats treated with DRUGB dgb hours before the DRUGN challenge .
ethanol	drug	disulfiram	drug
effect

Core temperature was decreased in rats in a dose dependent manner when DRUGN was administered to rats treated with DRUGA dgb hours before the DRUGB challenge .
disulfiram	drug	ethanol	drug
false

Interaction on the antinociceptive effect between DRUGA and DRUGB or DRUGN .
neurotensin	drug_n	enkephalins	drug_n
effect

Interaction on the antinociceptive effect between DRUGA and DRUGN or DRUGB .
neurotensin	drug_n	tuftsin	drug_n
effect

Interaction on the antinociceptive effect between DRUGN and DRUGA or DRUGB .
enkephalins	drug_n	tuftsin	drug_n
false

The aim of this paper was to study the interaction between DRUGA and both DRUGB or its synthetic analogue DRUGN , or DRUGN , on the antinonciceptive effect of these peptides in mice after intracisternal injection .
neurotensin	drug_n	enkephalins	drug_n
false

The aim of this paper was to study the interaction between DRUGA and both DRUGN or its synthetic analogue DRUGB , or DRUGN , on the antinonciceptive effect of these peptides in mice after intracisternal injection .
neurotensin	drug_n	D-Ala2-metenkephalinamide	drug_n
false

The aim of this paper was to study the interaction between DRUGA and both DRUGN or its synthetic analogue DRUGN , or DRUGB , on the antinonciceptive effect of these peptides in mice after intracisternal injection .
neurotensin	drug_n	tuftsin	drug_n
false

The aim of this paper was to study the interaction between DRUGN and both DRUGA or its synthetic analogue DRUGB , or DRUGN , on the antinonciceptive effect of these peptides in mice after intracisternal injection .
enkephalins	drug_n	D-Ala2-metenkephalinamide	drug_n
false

The aim of this paper was to study the interaction between DRUGN and both DRUGA or its synthetic analogue DRUGN , or DRUGB , on the antinonciceptive effect of these peptides in mice after intracisternal injection .
enkephalins	drug_n	tuftsin	drug_n
false

The aim of this paper was to study the interaction between DRUGN and both DRUGN or its synthetic analogue DRUGA , or DRUGB , on the antinonciceptive effect of these peptides in mice after intracisternal injection .
D-Ala2-metenkephalinamide	drug_n	tuftsin	drug_n
false

It was shown that DRUGA antagonized evidently the antinociceptive effect of DRUGB and their analogue .
neurotensin	drug_n	enkephalins	drug_n
effect

On the contrary , DRUGA and DRUGB were agonists in induction of analgesia .
neurotensin	drug_n	tuftsin	drug_n
effect

It is concluded that DRUGA modulates in an opposite way the function of the enkephalinergic neurons and the central action of DRUGB .
neurotensin	drug_n	tuftsin	drug_n
effect

Among the risk factors studied , two appear to increase the risk of ARE : the prescription of DRUGA to treat strongyloidiasis during the DRUGB cure and the bad general clinical conditions of patients .
thiabendazole	drug	melarsoprol	drug
effect

Recommendations were to avoid administration of diffusible DRUGA treatment during the cure , and to improve the general conditions of patients before the cure of DRUGB .
anti-helminthic	group	melarsoprol	drug
false

Interactions of DRUGA and DRUGB in absorption and retention .
cobalt	drug	iron	drug
mechanism

DRUGA excretion was enhanced by supplementary DRUGB ;
Cobalt	drug	cobalt	drug
false

Additional DRUGA significantly inhibited the absorption of DRUGB in both dietary DRUGN treatments .
iron	drug	cobalt	drug
mechanism

Additional DRUGA significantly inhibited the absorption of DRUGN in both dietary DRUGB treatments .
iron	drug	cobalt	drug
mechanism

The lower rate of absorption in the groups receiving dgb mg DRUGA instead of dgb mg of DRUGN per kg diet resulted in a decreased renal excretion of DRUGB .
Fe	drug	cobalt	drug
mechanism

The lower rate of absorption in the groups receiving dgb mg DRUGN instead of dgb mg of DRUGA per kg diet resulted in a decreased renal excretion of DRUGB .
Fe	drug	cobalt	drug
false

Consequently , the effect of DRUGA on the retention of DRUGB was lower than on absorption .
iron	drug	cobalt	drug
mechanism

Because of the low dietary DRUGA concentration as compared to the DRUGB contents of the diets , no effect of DRUGN on DRUGN absorption and excretion occurred .
cobalt	drug	iron	drug
false

Because of the low dietary DRUGA concentration as compared to the DRUGN contents of the diets , no effect of DRUGN on DRUGB absorption and excretion occurred .
cobalt	drug	iron	drug
false

Because of the low dietary DRUGN concentration as compared to the DRUGA contents of the diets , no effect of DRUGB on DRUGN absorption and excretion occurred .
iron	drug	cobalt	drug
false

Because of the low dietary DRUGN concentration as compared to the DRUGN contents of the diets , no effect of DRUGA on DRUGB absorption and excretion occurred .
cobalt	drug	iron	drug
false

Differences in DRUGA balance were only observed between both dietary concentrations , showing a higher absolute but a lower relative absorption as well as retention in the groups fed further DRUGB . ( ABSTRACT TRUNCATED AT dgb WORDS )
iron	drug	Fe	drug
false

Effect of DRUGA on DRUGB induced changes in steroid hormone levels and lethality in male rats .
estradiol	drug	endotoxin	drug_n
false

We examined the effect of exogenous DRUGA on the changes in serum steroid hormone levels induced by a nonlethal dose of Escherichia coli DRUGB in male rats and the deaths due to nonlethal and lethal doses of DRUGN .
estradiol	drug	endotoxin	drug_n
false

We examined the effect of exogenous DRUGA on the changes in serum steroid hormone levels induced by a nonlethal dose of Escherichia coli DRUGN in male rats and the deaths due to nonlethal and lethal doses of DRUGB .
estradiol	drug	endotoxin	drug_n
false

Injection of DRUGA dgb min before a nonlethal dose of DRUGB changed the serum sex steroid hormone response of male rats to DRUGN .
estradiol	drug	endotoxin	drug_n
effect

Injection of DRUGA dgb min before a nonlethal dose of DRUGN changed the serum sex steroid hormone response of male rats to DRUGB .
estradiol	drug	endotoxin	drug_n
false

The serum estrogen concentrations of DRUGA + DRUGB treated rats decreased by dgb % , while those of the DRUGN treated rats increased ( dgb to dgb fold ) .
estradiol	drug	endotoxin	drug_n
mechanism

The serum estrogen concentrations of DRUGA + DRUGN treated rats decreased by dgb % , while those of the DRUGB treated rats increased ( dgb to dgb fold ) .
estradiol	drug	endotoxin	drug_n
false

The serum androgen concentrations of DRUGA + DRUGB treated rats did not change significantly , while those of DRUGN treated rats dropped to dgb dgb %
estradiol	drug	endotoxin	drug_n
false

The serum androgen concentrations of DRUGA + DRUGN treated rats did not change significantly , while those of DRUGB treated rats dropped to dgb dgb %
estradiol	drug	endotoxin	drug_n
false

Exogenous DRUGA also appeared to influence the percentage of DRUGB induced deaths in a dose dependent manner .
estradiol	drug	endotoxin	drug_n
effect

These results , together with the known relationships between DRUGA and the immune response , suggest that DRUGB affect the course of septic shock in a complex fashion and may have either protective or deleterious effect .
estrogen	group	estrogens	group
false

The DRUGA ( DRUGB ) induced diarrhea was analyzed in cecectomized rats prepared by resecting the cecum and its vasculature without disturbing the ileocecal junction .
16,16-dimethylprostaglandin E2	drug_n	dmPGE2	drug_n
false

DRUGA and DRUGB ( dga and dga mg / kg , s.c . )
Loperamide	drug	morphine	drug
false

DRUGA and DRUGB ( dga and dga mg / kg , s.c. ) inhibited the DRUGN ( dga mg / kg , p.o . ) induced diarrhea in cecectomized rats .
Loperamide	drug	morphine	drug
false

DRUGA and DRUGN ( dga and dga mg / kg , s.c. ) inhibited the DRUGB ( dga mg / kg , p.o . ) induced diarrhea in cecectomized rats .
Loperamide	drug	dmPGE2	drug_n
effect

DRUGN and DRUGA ( dga and dga mg / kg , s.c. ) inhibited the DRUGB ( dga mg / kg , p.o . ) induced diarrhea in cecectomized rats .
morphine	drug	dmPGE2	drug_n
effect

DRUGA ( dgb mg / kg , s.c. ) completely antagonized the inhibitory effect of DRUGB and partly antagonized the effect of DRUGN .
N-methyllevallorphan	drug_n	loperamide	drug
effect

DRUGA ( dgb mg / kg , s.c. ) completely antagonized the inhibitory effect of DRUGN and partly antagonized the effect of DRUGB .
N-methyllevallorphan	drug_n	morphine	drug
effect

DRUGN ( dgb mg / kg , s.c. ) completely antagonized the inhibitory effect of DRUGA and partly antagonized the effect of DRUGB .
loperamide	drug	morphine	drug
false

Therapeutic drug monitoring can avoid iatrogenic alterations caused by DRUGA ( MDP ) DRUGB interaction .
99mTc-methylene diphosphonate	drug	gentamicin	drug
effect

DRUGA is an DRUGB used to treat a wide variety of infections caused by gram negative organisms , but it is potentially toxic to the kidneys .
Gentamicin	drug	aminoglycoside antibiotic	group
false

Due to its nephrotoxicity , DRUGA may cause abnormal renal uptake to be seen on DRUGB bone scintigraphy .
gentamicin	drug	99mTc-MDP	drug
mechanism

Therapeutic drug monitoring ( TDM ) of DRUGA therapy , and bone scintigraphy employing DRUGB as the DRUGN was carried out in dgb patients .
gentamicin	drug	99mTc-MDP	drug
false

Therapeutic drug monitoring ( TDM ) of DRUGA therapy , and bone scintigraphy employing DRUGN as the DRUGB was carried out in dgb patients .
gentamicin	drug	radiopharmaceutical	group
false

Therapeutic drug monitoring ( TDM ) of DRUGN therapy , and bone scintigraphy employing DRUGA as the DRUGB was carried out in dgb patients .
99mTc-MDP	drug	radiopharmaceutical	group
false

Little has been studied of the adverse effects of the exposure of the liver to the interaction of DRUGA with its congeners and DRUGB , coexisting in the contents of alcoholic beverages .
ethanol	drug	acetaldehyde	drug_n
false

These results suggest that the hepatoxicity of DRUGA in alcoholic beverages is enhanced by interaction with its congeners and DRUGB ;
ethanol	drug	acetaldehyde	drug_n
effect

Induction of apoptosis in breast cancer cells in response to DRUGA and DRUGB .
vitamin D	group	antiestrogens	group
false

dgb , DRUGA ( DRUGB ) , the active metabolite of DRUGN , is a potent inhibitor of breast cancer cell growth both in vivo and in vitro .
25-Dihydroxycholecalciferol D3	drug	1,25(OH)2D3	drug
false

dgb , DRUGA ( DRUGN ) , the active metabolite of DRUGB , is a potent inhibitor of breast cancer cell growth both in vivo and in vitro .
25-Dihydroxycholecalciferol D3	drug	vitamin D	group
false

dgb , DRUGN ( DRUGA ) , the active metabolite of DRUGB , is a potent inhibitor of breast cancer cell growth both in vivo and in vitro .
1,25(OH)2D3	drug	vitamin D	group
false

In the experiments reported here , we examined the interactions between DRUGA and the DRUGB DRUGN ( DRUGN ) , which also induces apoptosis in MCF dgb cells .
1,25(OH)2D3	drug	antiestrogen	group
false

In the experiments reported here , we examined the interactions between DRUGA and the DRUGN DRUGB ( DRUGN ) , which also induces apoptosis in MCF dgb cells .
1,25(OH)2D3	drug	4-hydroxytamoxifen	drug_n
false

In the experiments reported here , we examined the interactions between DRUGA and the DRUGN DRUGN ( DRUGB ) , which also induces apoptosis in MCF dgb cells .
1,25(OH)2D3	drug	TAM	drug_n
false

In the experiments reported here , we examined the interactions between DRUGN and the DRUGA DRUGB ( DRUGN ) , which also induces apoptosis in MCF dgb cells .
antiestrogen	group	4-hydroxytamoxifen	drug_n
false

In the experiments reported here , we examined the interactions between DRUGN and the DRUGA DRUGN ( DRUGB ) , which also induces apoptosis in MCF dgb cells .
antiestrogen	group	TAM	drug_n
false

In the experiments reported here , we examined the interactions between DRUGN and the DRUGN DRUGA ( DRUGB ) , which also induces apoptosis in MCF dgb cells .
4-hydroxytamoxifen	drug_n	TAM	drug_n
false

Our data suggest that DRUGA significantly potentiates the reduction in cell number induced by DRUGB alone .
TAM	drug_n	1,25(OH)2D3	drug
effect

Combined treatment with DRUGA and DRUGB enhances the degree of apoptosis assessed using morphological markers that identify chromatin and nuclear matrix protein condensation .
1,25(OH)2D3	drug	TAM	drug_n
effect

These data emphasize that apoptosis can be induced in MCF dgb cells either by activation of DRUGA mediated signalling or disruption of DRUGB dependent signalling .
vitamin-D	group	estrogen	group
false

We investigated the effects of adenosine receptor antagonists , DRUGA , DRUGB , DRUGN , and DRUGN ( DRUGN ) , in a light / dark test in mice .
caffeine	drug	theophylline	drug
false

We investigated the effects of adenosine receptor antagonists , DRUGA , DRUGN , DRUGB , and DRUGN ( DRUGN ) , in a light / dark test in mice .
caffeine	drug	8-phenyltheophylline	drug_n
false

We investigated the effects of adenosine receptor antagonists , DRUGA , DRUGN , DRUGN , and DRUGB ( DRUGN ) , in a light / dark test in mice .
caffeine	drug	8-cyclopentyl-1,3-dipropylxanthine	drug_n
false

We investigated the effects of adenosine receptor antagonists , DRUGA , DRUGN , DRUGN , and DRUGN ( DRUGB ) , in a light / dark test in mice .
caffeine	drug	DPCPX	drug_n
false

We investigated the effects of adenosine receptor antagonists , DRUGN , DRUGA , DRUGB , and DRUGN ( DRUGN ) , in a light / dark test in mice .
theophylline	drug	8-phenyltheophylline	drug_n
false

We investigated the effects of adenosine receptor antagonists , DRUGN , DRUGA , DRUGN , and DRUGB ( DRUGN ) , in a light / dark test in mice .
theophylline	drug	8-cyclopentyl-1,3-dipropylxanthine	drug_n
false

We investigated the effects of adenosine receptor antagonists , DRUGN , DRUGA , DRUGN , and DRUGN ( DRUGB ) , in a light / dark test in mice .
theophylline	drug	DPCPX	drug_n
false

We investigated the effects of adenosine receptor antagonists , DRUGN , DRUGN , DRUGA , and DRUGB ( DRUGN ) , in a light / dark test in mice .
8-phenyltheophylline	drug_n	8-cyclopentyl-1,3-dipropylxanthine	drug_n
false

We investigated the effects of adenosine receptor antagonists , DRUGN , DRUGN , DRUGA , and DRUGN ( DRUGB ) , in a light / dark test in mice .
8-phenyltheophylline	drug_n	DPCPX	drug_n
false

We investigated the effects of adenosine receptor antagonists , DRUGN , DRUGN , DRUGN , and DRUGA ( DRUGB ) , in a light / dark test in mice .
8-cyclopentyl-1,3-dipropylxanthine	drug_n	DPCPX	drug_n
false

The anxiogenic effects of DRUGA were reduced by pretreatment with DRUGB , an Adgb selective agonist , but not by DRUGN ( DRUGN ) , an Adgb selective agonist .
theophylline	drug	CGS 21680	drug_n
effect

The anxiogenic effects of DRUGA were reduced by pretreatment with DRUGN , an Adgb selective agonist , but not by DRUGB ( DRUGN ) , an Adgb selective agonist .
theophylline	drug	N6-cyclopentyladenosine	drug_n
false

The anxiogenic effects of DRUGA were reduced by pretreatment with DRUGN , an Adgb selective agonist , but not by DRUGN ( DRUGB ) , an Adgb selective agonist .
theophylline	drug	CPA	drug_n
false

The anxiogenic effects of DRUGN were reduced by pretreatment with DRUGA , an Adgb selective agonist , but not by DRUGB ( DRUGN ) , an Adgb selective agonist .
CGS 21680	drug_n	N6-cyclopentyladenosine	drug_n
false

The anxiogenic effects of DRUGN were reduced by pretreatment with DRUGA , an Adgb selective agonist , but not by DRUGN ( DRUGB ) , an Adgb selective agonist .
CGS 21680	drug_n	CPA	drug_n
false

The anxiogenic effects of DRUGN were reduced by pretreatment with DRUGN , an Adgb selective agonist , but not by DRUGA ( DRUGB ) , an Adgb selective agonist .
N6-cyclopentyladenosine	drug_n	CPA	drug_n
false

However , the antagonism of the DRUGA induced anxiogenic effects by DRUGB was only observed in the time spent in the light zone , and DRUGN induced anxiogenic effects were neither reversed by DRUGN nor by DRUGN .
theophylline	drug	CGS21680	drug_n
effect

However , the antagonism of the DRUGA induced anxiogenic effects by DRUGN was only observed in the time spent in the light zone , and DRUGB induced anxiogenic effects were neither reversed by DRUGN nor by DRUGN .
theophylline	drug	DPCPX	drug_n
false

However , the antagonism of the DRUGA induced anxiogenic effects by DRUGN was only observed in the time spent in the light zone , and DRUGN induced anxiogenic effects were neither reversed by DRUGB nor by DRUGN .
theophylline	drug	CGS 21680	drug
false

However , the antagonism of the DRUGA induced anxiogenic effects by DRUGN was only observed in the time spent in the light zone , and DRUGN induced anxiogenic effects were neither reversed by DRUGN nor by DRUGB .
theophylline	drug	CPA	drug_n
false

However , the antagonism of the DRUGN induced anxiogenic effects by DRUGA was only observed in the time spent in the light zone , and DRUGB induced anxiogenic effects were neither reversed by DRUGN nor by DRUGN .
CGS21680	drug_n	DPCPX	drug_n
false

However , the antagonism of the DRUGN induced anxiogenic effects by DRUGA was only observed in the time spent in the light zone , and DRUGN induced anxiogenic effects were neither reversed by DRUGB nor by DRUGN .
CGS21680	drug_n	CGS 21680	drug
false

However , the antagonism of the DRUGN induced anxiogenic effects by DRUGA was only observed in the time spent in the light zone , and DRUGN induced anxiogenic effects were neither reversed by DRUGN nor by DRUGB .
CGS21680	drug_n	CPA	drug_n
false

However , the antagonism of the DRUGN induced anxiogenic effects by DRUGN was only observed in the time spent in the light zone , and DRUGA induced anxiogenic effects were neither reversed by DRUGB nor by DRUGN .
DPCPX	drug_n	CGS 21680	drug
false

However , the antagonism of the DRUGN induced anxiogenic effects by DRUGN was only observed in the time spent in the light zone , and DRUGA induced anxiogenic effects were neither reversed by DRUGN nor by DRUGB .
DPCPX	drug_n	CPA	drug_n
false

However , the antagonism of the DRUGN induced anxiogenic effects by DRUGN was only observed in the time spent in the light zone , and DRUGN induced anxiogenic effects were neither reversed by DRUGA nor by DRUGB .
CGS 21680	drug	CPA	drug_n
false

[ The effect of DRUGA on the activity of mixed function mono oxidases in the liver microsomes ] ; The effects of the i DRUGB the drug s DRUGN on hepatic microsomal monooxygenase activities were studied .
sandimmune	brand	immunodepressant	group
false

[ The effect of DRUGN on the activity of mixed function mono oxidases in the liver microsomes ] ; The effects of the i DRUGA the drug s DRUGB on hepatic microsomal monooxygenase activities were studied .
immunodepressant	group	sandimmune	brand
false

The higher DRUGA and DRUGB excretion was due to their increased renal tubular secretion .
verografine	drug	iodamide	drug
false

In dogs , DRUGA unchanged the secretion of DRUGB , a test agent for anionic transport .
cimetidine	drug	cardiotrast	drug
false

Possible extrarenal mechanisms of action of DRUGA on DRUGB and DRUGN transport were also examined .
cimetidine	drug	verografine	drug
false

Possible extrarenal mechanisms of action of DRUGA on DRUGN and DRUGB transport were also examined .
cimetidine	drug	iodamide	drug
false

Possible extrarenal mechanisms of action of DRUGN on DRUGA and DRUGB transport were also examined .
verografine	drug	iodamide	drug
false

Physiological oral DRUGA supplementation ( dgb mg / kg / day ) is easy and can be carried out in the diet or with DRUGB s , with practically only one contra indication : overt renal failure .
magnesium	drug	magnesium salt	drug
false

Specific and aspecific treatments of DRUGA depletion are tricky using for example DRUGB , pharmacological doses of DRUGN , physiological doses of DRUGN and of DRUGN .
magnesium	drug	magnesium sparing diuretics	group
false

Specific and aspecific treatments of DRUGA depletion are tricky using for example DRUGN , pharmacological doses of DRUGB , physiological doses of DRUGN and of DRUGN .
magnesium	drug	vitamin B6	drug
false

Specific and aspecific treatments of DRUGA depletion are tricky using for example DRUGN , pharmacological doses of DRUGN , physiological doses of DRUGB and of DRUGN .
magnesium	drug	vitamin D	group
false

Specific and aspecific treatments of DRUGA depletion are tricky using for example DRUGN , pharmacological doses of DRUGN , physiological doses of DRUGN and of DRUGB .
magnesium	drug	selenium	drug
false

Specific and aspecific treatments of DRUGN depletion are tricky using for example DRUGA , pharmacological doses of DRUGB , physiological doses of DRUGN and of DRUGN .
magnesium sparing diuretics	group	vitamin B6	drug
false

Specific and aspecific treatments of DRUGN depletion are tricky using for example DRUGA , pharmacological doses of DRUGN , physiological doses of DRUGB and of DRUGN .
magnesium sparing diuretics	group	vitamin D	group
false

Specific and aspecific treatments of DRUGN depletion are tricky using for example DRUGA , pharmacological doses of DRUGN , physiological doses of DRUGN and of DRUGB .
magnesium sparing diuretics	group	selenium	drug
false

Specific and aspecific treatments of DRUGN depletion are tricky using for example DRUGN , pharmacological doses of DRUGA , physiological doses of DRUGB and of DRUGN .
vitamin B6	drug	vitamin D	group
false

Specific and aspecific treatments of DRUGN depletion are tricky using for example DRUGN , pharmacological doses of DRUGA , physiological doses of DRUGN and of DRUGB .
vitamin B6	drug	selenium	drug
false

Specific and aspecific treatments of DRUGN depletion are tricky using for example DRUGN , pharmacological doses of DRUGN , physiological doses of DRUGA and of DRUGB .
vitamin D	group	selenium	drug
false

Lastly local use of the mucocutaneous and cytoprotective properties of DRUGA is still valid , in DRUGB and for preservation of transplants particularly .
magnesium	drug	cardioplegic solutions	drug
false

Interaction between DRUGA and DRUGB in the development of spontaneous motility in chick embryos .
glycine	drug	glutamate	drug
effect

The ECdgb values for DRUGA , which is not a substrate for DRUGB uptake dgb , were reduced in myocardium in functional classes II to III and IV compared with those in nonfailing myocardium .
isoproterenol	drug	norepinephrine	drug
false

The uptake inhibitors DRUGA and DRUGB ( dgb mumol / liter ) potentiated the positive inotropic effects of DRUGN in nonfailing myocardium ( p < dga ) but not in functional class IV myocardium .
cocaine	drug	desipramine	drug
false

The uptake inhibitors DRUGA and DRUGN ( dgb mumol / liter ) potentiated the positive inotropic effects of DRUGB in nonfailing myocardium ( p < dga ) but not in functional class IV myocardium .
cocaine	drug	norepinephrine	drug
effect

The uptake inhibitors DRUGN and DRUGA ( dgb mumol / liter ) potentiated the positive inotropic effects of DRUGB in nonfailing myocardium ( p < dga ) but not in functional class IV myocardium .
desipramine	drug	norepinephrine	drug
effect

This defect in the failing heart can be mimicked by the effects of uptake blocking agents , such as DRUGA and DRUGB , in the nonfailing heart only .
cocaine	drug	desipramine	drug
false

Compromised DRUGA uptake dgb in functional class IV can not be further increased by DRUGB and DRUGN .
norepinephrine	drug	cocaine	drug
false

Compromised DRUGA uptake dgb in functional class IV can not be further increased by DRUGN and DRUGB .
norepinephrine	drug	desipramine	drug
false

Compromised DRUGN uptake dgb in functional class IV can not be further increased by DRUGA and DRUGB .
cocaine	drug	desipramine	drug
false

It was established that both angiotensins inhibited gastric acid secretion stimulated by DRUGA but not by DRUGB .
pentagastrin	drug	histamine	drug
false

Comparative analysis of the effects of stimulation and inhibition of cholino and adrenoreceptors on this inhibitory action of DRUGA suggested the mediation of DRUGB influence through the modulation of cholinergic reactions of parietal cells in the stomach .
angiotensins	drug_n	angiotensin	drug_n
false

Interaction of DRUGA and DRUGB in anaesthetised horses .
gentamycin	drug	atracurium	drug
int

Evoked hind limb digital extensor tension ( hoof twitch ) was maintained at dgb % of baseline for dgb h by DRUGA infusion in dgb horses anaesthetised with DRUGB .
atracurium	drug	halothane	drug
false

DRUGA was again given by infusion to maintain dgb % twitch for a second hour , then dgb mg DRUGB / kg bwt were given i.v .
Atracurium	drug	gentamycin	drug
false

Recovery of hoof twitch from dgb % to dgb % took dga + / dga min for DRUGA alone and dga + / dga min for DRUGN plus DRUGB ( P = dga ) .
atracurium	drug	gentamycin	drug
false

Recovery of hoof twitch from dgb % to dgb % took dga + / dga min for DRUGN alone and dga + / dga min for DRUGA plus DRUGB ( P = dga ) .
atracurium	drug	gentamycin	drug
effect

Recovery from dgb % twitch to dgb % fade recovery took dga + / dga min for DRUGA alone and dga + / dga min for DRUGN plus DRUGB .
atracurium	drug	gentamycin	drug
false

Recovery from dgb % twitch to dgb % fade recovery took dga + / dga min for DRUGN alone and dga + / dga min for DRUGA plus DRUGB .
atracurium	drug	gentamycin	drug
effect

At dgb % recovery of fade , hoof twitch was dgb + / dgb % for DRUGA alone and dgb + / dgb % for DRUGN plus DRUGB .
atracurium	drug	gentamycin	drug
false

At dgb % recovery of fade , hoof twitch was dgb + / dgb % for DRUGN alone and dgb + / dgb % for DRUGA plus DRUGB .
atracurium	drug	gentamycin	drug
effect

It was concluded that , although DRUGA did augment the neuromuscular blockade of DRUGB , the effect was minimal .
gentamycin	drug	atracurium	drug
effect

Acid catalyzed ethanolysis of DRUGA in anhydrous and aqueous DRUGB solutions .
temazepam	drug	ethanol	drug
mechanism

The DRUGA are a family of DRUGB and DRUGN .
benzodiazepines	group	anxiolytic	group
false

The DRUGA are a family of DRUGN and DRUGB .
benzodiazepines	group	hypnotic drugs	group
false

The DRUGN are a family of DRUGA and DRUGB .
anxiolytic	group	hypnotic drugs	group
false

In addition to this pharmacological interaction , this report describes a novel chemical reaction between DRUGA ( a DRUGB ) and DRUGN under acidic conditions similar to those found in vivo , resulting in a dgb ethoxylated product .
temazepam	drug	benzodiazepine	group
false

In addition to this pharmacological interaction , this report describes a novel chemical reaction between DRUGA ( a DRUGN ) and DRUGB under acidic conditions similar to those found in vivo , resulting in a dgb ethoxylated product .
temazepam	drug	ethanol	drug
mechanism

In addition to this pharmacological interaction , this report describes a novel chemical reaction between DRUGN ( a DRUGA ) and DRUGB under acidic conditions similar to those found in vivo , resulting in a dgb ethoxylated product .
benzodiazepine	group	ethanol	drug
false

The results raise the possibility that the ethanolysis reaction may occur in the stomach of people who consume DRUGA and DRUGB on a regular basis .
alcohol	drug	3-hydroxy-1,4-benzodiazepine	group
mechanism

Laboratory Tests Response to DRUGA should be monitored by measuring serum total DRUGB concentrations just prior to administration on Day dgb and every dgb weeks thereafter .
Plenaxis	brand	testosterone	drug
false

Population pharmacokinetic analyses revealed that DRUGA , DRUGB , DRUGN , and DRUGN did not influence DRUGN clearance .
MTX	drug	NSAIDs	group
false

Population pharmacokinetic analyses revealed that DRUGA , DRUGN , DRUGB , and DRUGN did not influence DRUGN clearance .
MTX	drug	corticosteroids	group
false

Population pharmacokinetic analyses revealed that DRUGA , DRUGN , DRUGN , and DRUGB did not influence DRUGN clearance .
MTX	drug	TNF blocking agents	group
false

Population pharmacokinetic analyses revealed that DRUGA , DRUGN , DRUGN , and DRUGN did not influence DRUGB clearance .
MTX	drug	abatacept	drug
false

Population pharmacokinetic analyses revealed that DRUGN , DRUGA , DRUGB , and DRUGN did not influence DRUGN clearance .
NSAIDs	group	corticosteroids	group
false

Population pharmacokinetic analyses revealed that DRUGN , DRUGA , DRUGN , and DRUGB did not influence DRUGN clearance .
NSAIDs	group	TNF blocking agents	group
false

Population pharmacokinetic analyses revealed that DRUGN , DRUGA , DRUGN , and DRUGN did not influence DRUGB clearance .
NSAIDs	group	abatacept	drug
false

Population pharmacokinetic analyses revealed that DRUGN , DRUGN , DRUGA , and DRUGB did not influence DRUGN clearance .
corticosteroids	group	TNF blocking agents	group
false

Population pharmacokinetic analyses revealed that DRUGN , DRUGN , DRUGA , and DRUGN did not influence DRUGB clearance .
corticosteroids	group	abatacept	drug
false

Population pharmacokinetic analyses revealed that DRUGN , DRUGN , DRUGN , and DRUGA did not influence DRUGB clearance .
TNF blocking agents	group	abatacept	drug
false

Concurrent administration of a DRUGA with DRUGB has been associated with an increased risk of serious infections and no significant additional efficacy over use of the DRUGN alone .
TNF antagonist	group	ORENCIA	brand
effect

Concurrent administration of a DRUGA with DRUGN has been associated with an increased risk of serious infections and no significant additional efficacy over use of the DRUGB alone .
TNF antagonist	group	TNF antagonists	group
false

Concurrent administration of a DRUGN with DRUGA has been associated with an increased risk of serious infections and no significant additional efficacy over use of the DRUGB alone .
ORENCIA	brand	TNF antagonists	group
false

Concurrent therapy with DRUGA and DRUGB is not recommended .
ORENCIA	brand	TNF antagonists	group
advise

There is insufficient experience to assess the safety and efficacy of DRUGA administered concurrently with DRUGB , and therefore such use is not recommended .
ORENCIA	brand	anakinra	drug
advise

These medications have included DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , intravenous and oral DRUGN , DRUGN , and DRUGN .
heparin	drug	warfarin	drug
false

These medications have included DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , intravenous and oral DRUGN , DRUGN , and DRUGN .
heparin	drug	beta-adrenergic receptor blockers	group
false

These medications have included DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , intravenous and oral DRUGN , DRUGN , and DRUGN .
heparin	drug	calcium channel antagonists	group
false

These medications have included DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , intravenous and oral DRUGN , DRUGN , and DRUGN .
heparin	drug	angiotensin converting enzyme inhibitors	group
false

These medications have included DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , intravenous and oral DRUGB , DRUGN , and DRUGN .
heparin	drug	nitrates	group
false

These medications have included DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , intravenous and oral DRUGN , DRUGB , and DRUGN .
heparin	drug	ticlopidine	drug
false

These medications have included DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , intravenous and oral DRUGN , DRUGN , and DRUGB .
heparin	drug	aspirin	brand
false

These medications have included DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , intravenous and oral DRUGN , DRUGN , and DRUGN .
warfarin	drug	beta-adrenergic receptor blockers	group
false

These medications have included DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , intravenous and oral DRUGN , DRUGN , and DRUGN .
warfarin	drug	calcium channel antagonists	group
false

These medications have included DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , intravenous and oral DRUGN , DRUGN , and DRUGN .
warfarin	drug	angiotensin converting enzyme inhibitors	group
false

These medications have included DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , intravenous and oral DRUGB , DRUGN , and DRUGN .
warfarin	drug	nitrates	group
false

These medications have included DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , intravenous and oral DRUGN , DRUGB , and DRUGN .
warfarin	drug	ticlopidine	drug
false

These medications have included DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , intravenous and oral DRUGN , DRUGN , and DRUGB .
warfarin	drug	aspirin	brand
false

These medications have included DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , intravenous and oral DRUGN , DRUGN , and DRUGN .
beta-adrenergic receptor blockers	group	calcium channel antagonists	group
false

These medications have included DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , intravenous and oral DRUGN , DRUGN , and DRUGN .
beta-adrenergic receptor blockers	group	angiotensin converting enzyme inhibitors	group
false

These medications have included DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , intravenous and oral DRUGB , DRUGN , and DRUGN .
beta-adrenergic receptor blockers	group	nitrates	group
false

These medications have included DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , intravenous and oral DRUGN , DRUGB , and DRUGN .
beta-adrenergic receptor blockers	group	ticlopidine	drug
false

These medications have included DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , intravenous and oral DRUGN , DRUGN , and DRUGB .
beta-adrenergic receptor blockers	group	aspirin	brand
false

These medications have included DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , intravenous and oral DRUGN , DRUGN , and DRUGN .
calcium channel antagonists	group	angiotensin converting enzyme inhibitors	group
false

These medications have included DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , intravenous and oral DRUGB , DRUGN , and DRUGN .
calcium channel antagonists	group	nitrates	group
false

These medications have included DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , intravenous and oral DRUGN , DRUGB , and DRUGN .
calcium channel antagonists	group	ticlopidine	drug
false

These medications have included DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , intravenous and oral DRUGN , DRUGN , and DRUGB .
calcium channel antagonists	group	aspirin	brand
false

These medications have included DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , intravenous and oral DRUGB , DRUGN , and DRUGN .
angiotensin converting enzyme inhibitors	group	nitrates	group
false

These medications have included DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , intravenous and oral DRUGN , DRUGB , and DRUGN .
angiotensin converting enzyme inhibitors	group	ticlopidine	drug
false

These medications have included DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , intravenous and oral DRUGN , DRUGN , and DRUGB .
angiotensin converting enzyme inhibitors	group	aspirin	brand
false

These medications have included DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , intravenous and oral DRUGA , DRUGB , and DRUGN .
nitrates	group	ticlopidine	drug
false

These medications have included DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , intravenous and oral DRUGA , DRUGN , and DRUGB .
nitrates	group	aspirin	brand
false

These medications have included DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , intravenous and oral DRUGN , DRUGA , and DRUGB .
ticlopidine	drug	aspirin	brand
false

DRUGA , other DRUGB , DRUGN , and DRUGN are associated with an increase in bleeding .
Heparin	drug	anticoagulants	group
false

DRUGA , other DRUGN , DRUGB , and DRUGN are associated with an increase in bleeding .
Heparin	drug	thrombolytics	group
false

DRUGA , other DRUGN , DRUGN , and DRUGB are associated with an increase in bleeding .
Heparin	drug	anti platelet agents	group
false

DRUGN , other DRUGA , DRUGB , and DRUGN are associated with an increase in bleeding .
anticoagulants	group	thrombolytics	group
false

DRUGN , other DRUGA , DRUGN , and DRUGB are associated with an increase in bleeding .
anticoagulants	group	anti platelet agents	group
false

DRUGN , other DRUGN , DRUGA , and DRUGB are associated with an increase in bleeding .
thrombolytics	group	anti platelet agents	group
false

Patients with HACA titers may have allergic or hypersensitivity reactions when treated with other DRUGA or DRUGB .
diagnostic monoclonal antibodies	group	therapeutic monoclonal antibodies	group
false

The concomitant intake of DRUGA and DRUGB does not affect the pharmacokinetics of either DRUGN or DRUGN .
alcohol	drug	Acamprosate	drug
false

The concomitant intake of DRUGA and DRUGN does not affect the pharmacokinetics of either DRUGN or DRUGB .
alcohol	drug	acamprosate	drug
false

The concomitant intake of DRUGN and DRUGA does not affect the pharmacokinetics of either DRUGB or DRUGN .
Acamprosate	drug	alcohol	drug
false

The concomitant intake of DRUGN and DRUGA does not affect the pharmacokinetics of either DRUGN or DRUGB .
Acamprosate	drug	acamprosate	drug
false

The concomitant intake of DRUGN and DRUGN does not affect the pharmacokinetics of either DRUGA or DRUGB .
alcohol	drug	acamprosate	drug
false

Pharmacokinetic studies indicate that administration of DRUGA or DRUGB does not affect the pharmacokinetics of DRUGN .
disulfiram	drug	diazepam	drug
false

Pharmacokinetic studies indicate that administration of DRUGA or DRUGN does not affect the pharmacokinetics of DRUGB .
disulfiram	drug	acamprosate	drug
false

Pharmacokinetic studies indicate that administration of DRUGN or DRUGA does not affect the pharmacokinetics of DRUGB .
diazepam	drug	acamprosate	drug
false

Co administration of DRUGA with DRUGB produced a dgb % increase in AUC and a dgb % increase in the Cmax of DRUGN .
naltrexone	drug	Acamprosate	drug
mechanism

Co administration of DRUGA with DRUGN produced a dgb % increase in AUC and a dgb % increase in the Cmax of DRUGB .
naltrexone	drug	acamprosate	drug
false

Co administration of DRUGN with DRUGA produced a dgb % increase in AUC and a dgb % increase in the Cmax of DRUGB .
Acamprosate	drug	acamprosate	drug
false

The pharmacokinetics of DRUGA and its major metabolite DRUGB were unaffected following co administration with DRUGN .
naltrexone	drug	6-beta-naltrexol	drug_n
false

The pharmacokinetics of DRUGA and its major metabolite DRUGN were unaffected following co administration with DRUGB .
naltrexone	drug	Acamprosate	drug
false

The pharmacokinetics of DRUGN and its major metabolite DRUGA were unaffected following co administration with DRUGB .
6-beta-naltrexol	drug_n	Acamprosate	drug
false

Patients taking DRUGA concomitantly with DRUGB more commonly reported both weight gain and weight loss , compared with patients taking either medication alone .
Acamprosate	drug	antidepressants	group
effect

These drugs include the DRUGA and other DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	diuretics	group
false

These drugs include the DRUGA and other DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	corticosteroids	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	phenothiazines	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	thyroid products	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	estrogens	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	contraceptives	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	phenytoin	drug
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
thiazides	group	nicotinic acid	drug
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
thiazides	group	sympathomimetics	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
thiazides	group	calcium channel-blocking drugs	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
thiazides	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	corticosteroids	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	phenothiazines	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	thyroid products	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	estrogens	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
diuretics	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
diuretics	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
diuretics	group	calcium channel-blocking drugs	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
diuretics	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	phenothiazines	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	thyroid products	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	estrogens	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
corticosteroids	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
corticosteroids	group	calcium channel-blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
corticosteroids	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
phenothiazines	group	thyroid products	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
phenothiazines	group	estrogens	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
phenothiazines	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
phenothiazines	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
phenothiazines	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
phenothiazines	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
phenothiazines	group	calcium channel-blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
phenothiazines	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thyroid products	group	estrogens	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thyroid products	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
thyroid products	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
thyroid products	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
thyroid products	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
thyroid products	group	calcium channel-blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
thyroid products	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
estrogens	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
estrogens	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
estrogens	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
estrogens	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
estrogens	group	calcium channel-blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
estrogens	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
contraceptives	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
contraceptives	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
contraceptives	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
contraceptives	group	calcium channel-blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
contraceptives	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
phenytoin	drug	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
phenytoin	drug	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
phenytoin	drug	calcium channel-blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
phenytoin	drug	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
nicotinic acid	drug	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
nicotinic acid	drug	calcium channel-blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
nicotinic acid	drug	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
sympathomimetics	group	calcium channel-blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
sympathomimetics	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
calcium channel-blocking drugs	group	isoniazid	drug
false

When such drugs are withdrawn from patients receiving DRUGA in combination with DRUGB or DRUGN , patients should be observed closely for any evidence of hypoglycemia .
Acarbose	drug	sulfonylureas	group
false

When such drugs are withdrawn from patients receiving DRUGA in combination with DRUGN or DRUGB , patients should be observed closely for any evidence of hypoglycemia .
Acarbose	drug	insulin	drug
false

When such drugs are withdrawn from patients receiving DRUGN in combination with DRUGA or DRUGB , patients should be observed closely for any evidence of hypoglycemia .
sulfonylureas	group	insulin	drug
false

DRUGA ( e. g. , DRUGB ) and DRUGN containing carbohydrate splitting enzymes ( e. g. , DRUGN , DRUGN ) may reduce the effect of DRUGN and should not be taken concomitantly .
Intestinal adsorbents	group	charcoal	drug
false

DRUGA ( e. g. , DRUGN ) and DRUGB containing carbohydrate splitting enzymes ( e. g. , DRUGN , DRUGN ) may reduce the effect of DRUGN and should not be taken concomitantly .
Intestinal adsorbents	group	digestive enzyme preparations	group
false

DRUGA ( e. g. , DRUGN ) and DRUGN containing carbohydrate splitting enzymes ( e. g. , DRUGB , DRUGN ) may reduce the effect of DRUGN and should not be taken concomitantly .
Intestinal adsorbents	group	amylase	drug
false

DRUGA ( e. g. , DRUGN ) and DRUGN containing carbohydrate splitting enzymes ( e. g. , DRUGN , DRUGB ) may reduce the effect of DRUGN and should not be taken concomitantly .
Intestinal adsorbents	group	pancreatin	drug
false

DRUGA ( e. g. , DRUGN ) and DRUGN containing carbohydrate splitting enzymes ( e. g. , DRUGN , DRUGN ) may reduce the effect of DRUGB and should not be taken concomitantly .
Intestinal adsorbents	group	Acarbose	drug
mechanism

DRUGN ( e. g. , DRUGA ) and DRUGB containing carbohydrate splitting enzymes ( e. g. , DRUGN , DRUGN ) may reduce the effect of DRUGN and should not be taken concomitantly .
charcoal	drug	digestive enzyme preparations	group
false

DRUGN ( e. g. , DRUGA ) and DRUGN containing carbohydrate splitting enzymes ( e. g. , DRUGB , DRUGN ) may reduce the effect of DRUGN and should not be taken concomitantly .
charcoal	drug	amylase	drug
false

DRUGN ( e. g. , DRUGA ) and DRUGN containing carbohydrate splitting enzymes ( e. g. , DRUGN , DRUGB ) may reduce the effect of DRUGN and should not be taken concomitantly .
charcoal	drug	pancreatin	drug
false

DRUGN ( e. g. , DRUGA ) and DRUGN containing carbohydrate splitting enzymes ( e. g. , DRUGN , DRUGN ) may reduce the effect of DRUGB and should not be taken concomitantly .
charcoal	drug	Acarbose	drug
mechanism

DRUGN ( e. g. , DRUGN ) and DRUGA containing carbohydrate splitting enzymes ( e. g. , DRUGB , DRUGN ) may reduce the effect of DRUGN and should not be taken concomitantly .
digestive enzyme preparations	group	amylase	drug
false

DRUGN ( e. g. , DRUGN ) and DRUGA containing carbohydrate splitting enzymes ( e. g. , DRUGN , DRUGB ) may reduce the effect of DRUGN and should not be taken concomitantly .
digestive enzyme preparations	group	pancreatin	drug
false

DRUGN ( e. g. , DRUGN ) and DRUGA containing carbohydrate splitting enzymes ( e. g. , DRUGN , DRUGN ) may reduce the effect of DRUGB and should not be taken concomitantly .
digestive enzyme preparations	group	Acarbose	drug
false

DRUGN ( e. g. , DRUGN ) and DRUGN containing carbohydrate splitting enzymes ( e. g. , DRUGA , DRUGB ) may reduce the effect of DRUGN and should not be taken concomitantly .
amylase	drug	pancreatin	drug
false

DRUGN ( e. g. , DRUGN ) and DRUGN containing carbohydrate splitting enzymes ( e. g. , DRUGA , DRUGN ) may reduce the effect of DRUGB and should not be taken concomitantly .
amylase	drug	Acarbose	drug
mechanism

DRUGN ( e. g. , DRUGN ) and DRUGN containing carbohydrate splitting enzymes ( e. g. , DRUGN , DRUGA ) may reduce the effect of DRUGB and should not be taken concomitantly .
pancreatin	drug	Acarbose	drug
mechanism

DRUGA has been shown to change the bioavailabillty DRUGB when they are co administered , which may require DRUGN dose adjustment .
Acarbose	drug	digoxin	drug
mechanism

DRUGA has been shown to change the bioavailabillty DRUGN when they are co administered , which may require DRUGB dose adjustment .
Acarbose	drug	digoxin	drug
false

Studies in healthy volunteers have shown that DRUGA has no effect on either the pharmacokinetics or pharmacodynamics of DRUGB , DRUGN , DRUGN , or DRUGN .
Acarbose	drug	digoxin	drug
false

Studies in healthy volunteers have shown that DRUGA has no effect on either the pharmacokinetics or pharmacodynamics of DRUGN , DRUGB , DRUGN , or DRUGN .
Acarbose	drug	nifedipine	drug
false

Studies in healthy volunteers have shown that DRUGA has no effect on either the pharmacokinetics or pharmacodynamics of DRUGN , DRUGN , DRUGB , or DRUGN .
Acarbose	drug	propranolol	drug
false

Studies in healthy volunteers have shown that DRUGA has no effect on either the pharmacokinetics or pharmacodynamics of DRUGN , DRUGN , DRUGN , or DRUGB .
Acarbose	drug	ranitidine	drug
false

Studies in healthy volunteers have shown that DRUGN has no effect on either the pharmacokinetics or pharmacodynamics of DRUGA , DRUGB , DRUGN , or DRUGN .
digoxin	drug	nifedipine	drug
false

Studies in healthy volunteers have shown that DRUGN has no effect on either the pharmacokinetics or pharmacodynamics of DRUGA , DRUGN , DRUGB , or DRUGN .
digoxin	drug	propranolol	drug
false

Studies in healthy volunteers have shown that DRUGN has no effect on either the pharmacokinetics or pharmacodynamics of DRUGA , DRUGN , DRUGN , or DRUGB .
digoxin	drug	ranitidine	drug
false

Studies in healthy volunteers have shown that DRUGN has no effect on either the pharmacokinetics or pharmacodynamics of DRUGN , DRUGA , DRUGB , or DRUGN .
nifedipine	drug	propranolol	drug
false

Studies in healthy volunteers have shown that DRUGN has no effect on either the pharmacokinetics or pharmacodynamics of DRUGN , DRUGA , DRUGN , or DRUGB .
nifedipine	drug	ranitidine	drug
false

Studies in healthy volunteers have shown that DRUGN has no effect on either the pharmacokinetics or pharmacodynamics of DRUGN , DRUGN , DRUGA , or DRUGB .
propranolol	drug	ranitidine	drug
false

DRUGA did not interfere with the absorption or disposition of the DRUGB DRUGN in diabetic patients .
Acarbose	drug	sulfonylurea	drug
false

DRUGA did not interfere with the absorption or disposition of the DRUGN DRUGB in diabetic patients .
Acarbose	drug	glyburide	drug
false

DRUGN did not interfere with the absorption or disposition of the DRUGA DRUGB in diabetic patients .
sulfonylurea	drug	glyburide	drug
false

The amount of DRUGA absorbed while taking DRUGB was bioequivalent to the amount absorbed when taking placebo , as indicated by the plasma AUC values .
metformin	drug	Acarbose	drug
false

However , the peak plasma level of DRUGA was reduced by approximately dgb % when taking DRUGB due to a slight delay in the absorption of DRUGN .
metformin	drug	Acarbose	drug
mechanism

However , the peak plasma level of DRUGN was reduced by approximately dgb % when taking DRUGA due to a slight delay in the absorption of DRUGB .
Acarbose	drug	metformin	drug
mechanism

There is little if any clinically significant interaction between DRUGA and DRUGB .
Acarbose	drug	metformin	drug
false

DRUGA , such as DRUGB , may have an additive effect when given with DRUGN .
Catecholamine-depleting drugs	group	reserpine	drug
false

DRUGA , such as DRUGN , may have an additive effect when given with DRUGB .
Catecholamine-depleting drugs	group	beta-blocking agents	group
effect

DRUGN , such as DRUGA , may have an additive effect when given with DRUGB .
reserpine	drug	beta-blocking agents	group
effect

Patients treated with DRUGA plus DRUGB should , therefore , be observed closely for evidence of marked bradycardia or hypotension which may present as vertigo , syncope / presyncope , or orthostatic changes in blood pressure without compensatory tachycardia .
acebutolol	drug	catecholamine depletors	group
advise

Exaggerated hypertensive responses have been reported from the combined use of DRUGA and DRUGB , including those contained in proprietary cold remedies and vasoconstrictive nasal drops .
beta-adrenergic antagonists	group	alpha-adrenergic stimulants	group
effect

Blunting of the antihypertensive effect of DRUGA by DRUGB has been reported .
beta-adrenoceptor blocking agents	group	nonsteroidal anti-inflammatory drugs	group
effect

No significant interactions with DRUGA , DRUGB , DRUGN , DRUGN , oral DRUGN , DRUGN , or DRUGN have been observed .
digoxin	drug	hydrochlorothiazide	drug
false

No significant interactions with DRUGA , DRUGN , DRUGB , DRUGN , oral DRUGN , DRUGN , or DRUGN have been observed .
digoxin	drug	hydralazine	drug
false

No significant interactions with DRUGA , DRUGN , DRUGN , DRUGB , oral DRUGN , DRUGN , or DRUGN have been observed .
digoxin	drug	sulfinpyrazone	drug
false

No significant interactions with DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGB , DRUGN , or DRUGN have been observed .
digoxin	drug	contraceptives	group
false

No significant interactions with DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGB , or DRUGN have been observed .
digoxin	drug	tolbutamide	drug
false

No significant interactions with DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , or DRUGB have been observed .
digoxin	drug	warfarin	drug
false

No significant interactions with DRUGN , DRUGA , DRUGB , DRUGN , oral DRUGN , DRUGN , or DRUGN have been observed .
hydrochlorothiazide	drug	hydralazine	drug
false

No significant interactions with DRUGN , DRUGA , DRUGN , DRUGB , oral DRUGN , DRUGN , or DRUGN have been observed .
hydrochlorothiazide	drug	sulfinpyrazone	drug
false

No significant interactions with DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGB , DRUGN , or DRUGN have been observed .
hydrochlorothiazide	drug	contraceptives	group
false

No significant interactions with DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGN , DRUGB , or DRUGN have been observed .
hydrochlorothiazide	drug	tolbutamide	drug
false

No significant interactions with DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGN , DRUGN , or DRUGB have been observed .
hydrochlorothiazide	drug	warfarin	drug
false

No significant interactions with DRUGN , DRUGN , DRUGA , DRUGB , oral DRUGN , DRUGN , or DRUGN have been observed .
hydralazine	drug	sulfinpyrazone	drug
false

No significant interactions with DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGB , DRUGN , or DRUGN have been observed .
hydralazine	drug	contraceptives	group
false

No significant interactions with DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGN , DRUGB , or DRUGN have been observed .
hydralazine	drug	tolbutamide	drug
false

No significant interactions with DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGN , DRUGN , or DRUGB have been observed .
hydralazine	drug	warfarin	drug
false

No significant interactions with DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGB , DRUGN , or DRUGN have been observed .
sulfinpyrazone	drug	contraceptives	group
false

No significant interactions with DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGN , DRUGB , or DRUGN have been observed .
sulfinpyrazone	drug	tolbutamide	drug
false

No significant interactions with DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGN , DRUGN , or DRUGB have been observed .
sulfinpyrazone	drug	warfarin	drug
false

No significant interactions with DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGA , DRUGB , or DRUGN have been observed .
contraceptives	group	tolbutamide	drug
false

No significant interactions with DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGA , DRUGN , or DRUGB have been observed .
contraceptives	group	warfarin	drug
false

No significant interactions with DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGA , or DRUGB have been observed .
tolbutamide	drug	warfarin	drug
false

DRUGA modifies DRUGB metabolism with increased serum levels of DRUGN .
DIAMOX	brand	phenytoin	drug
mechanism

DRUGA modifies DRUGN metabolism with increased serum levels of DRUGB .
DIAMOX	brand	phenytoin	drug
mechanism

By decreasing the gastrointestinal absorption of DRUGA , DRUGB may decrease serum concentrations of DRUGN and its metabolites , with a consequent possible decrease in anticonvulsant effect .
primidone	drug	DIAMOX	brand
false

By decreasing the gastrointestinal absorption of DRUGN , DRUGA may decrease serum concentrations of DRUGB and its metabolites , with a consequent possible decrease in anticonvulsant effect .
DIAMOX	brand	primidone	drug
mechanism

Caution is advised when beginning , discontinuing , or changing the dose of DRUGA in patients receiving DRUGB .
DIAMOX	brand	primidone	drug
advise

DRUGA may increase the effects of other DRUGB .
Acetazolamide	drug	folic acid antagonists	group
effect

DRUGA decreases urinary excretion of DRUGB and may enhance the magnitude and duration of their effect .
Acetazolamide	drug	amphetamine	drug
mechanism

DRUGA reduces urinary excretion of DRUGB and may enhance its effect .
Acetazolamide	drug	quinidine	drug
mechanism

DRUGA may prevent the urinary antiseptic effect of DRUGB .
Acetazolamide	drug	methenamine	drug
effect

DRUGA increases DRUGB excretion and the DRUGN may be decreased .
Acetazolamide	drug	lithium	drug
mechanism

DRUGA increases DRUGN excretion and the DRUGB may be decreased .
Acetazolamide	drug	lithium	drug
false

DRUGA and DRUGB used concurrently increases the risk of renal calculus formation .
Acetazolamide	drug	sodium bicarbonate	drug
effect

DRUGA may elevate DRUGB levels .
Acetazolamide	drug	cyclosporine	drug
mechanism

Concomitant use with DRUGA s may result in the reduced absorption of DRUGB .
iron supplement	group	iron	drug
false

Co administration of DRUGA with DRUGB has been shown to increase the mean half life and the area under the concentration time curve .
probenecid	drug	acyclovir	drug
mechanism

DRUGA : Clinical evidence has shown that DRUGB can be formed with concurrent ingestion of DRUGN and DRUGN .
Ethanol	drug	etretinate	drug
false

DRUGA : Clinical evidence has shown that DRUGN can be formed with concurrent ingestion of DRUGB and DRUGN .
Ethanol	drug	acitretin	drug
false

DRUGA : Clinical evidence has shown that DRUGN can be formed with concurrent ingestion of DRUGN and DRUGB .
Ethanol	drug	ethanol	drug
false

DRUGN : Clinical evidence has shown that DRUGA can be formed with concurrent ingestion of DRUGB and DRUGN .
etretinate	drug	acitretin	drug
false

DRUGN : Clinical evidence has shown that DRUGA can be formed with concurrent ingestion of DRUGN and DRUGB .
etretinate	drug	ethanol	drug
false

DRUGN : Clinical evidence has shown that DRUGN can be formed with concurrent ingestion of DRUGA and DRUGB .
acitretin	drug	ethanol	drug
mechanism

DRUGA : In a study of dgb healthy male volunteers , DRUGB treatment potentiated the blood glucose lowering effect of DRUGN ( a DRUGN similar to DRUGN ) in dgb of the dgb subjects .
Glibenclamide	drug	acitretin	drug
false

DRUGA : In a study of dgb healthy male volunteers , DRUGN treatment potentiated the blood glucose lowering effect of DRUGB ( a DRUGN similar to DRUGN ) in dgb of the dgb subjects .
Glibenclamide	drug	glibenclamide	drug
false

DRUGA : In a study of dgb healthy male volunteers , DRUGN treatment potentiated the blood glucose lowering effect of DRUGN ( a DRUGB similar to DRUGN ) in dgb of the dgb subjects .
Glibenclamide	drug	sulfonylurea	group
false

DRUGA : In a study of dgb healthy male volunteers , DRUGN treatment potentiated the blood glucose lowering effect of DRUGN ( a DRUGN similar to DRUGB ) in dgb of the dgb subjects .
Glibenclamide	drug	chlorpropamide	drug
false

DRUGN : In a study of dgb healthy male volunteers , DRUGA treatment potentiated the blood glucose lowering effect of DRUGB ( a DRUGN similar to DRUGN ) in dgb of the dgb subjects .
acitretin	drug	glibenclamide	drug
effect

DRUGN : In a study of dgb healthy male volunteers , DRUGA treatment potentiated the blood glucose lowering effect of DRUGN ( a DRUGB similar to DRUGN ) in dgb of the dgb subjects .
acitretin	drug	sulfonylurea	group
false

DRUGN : In a study of dgb healthy male volunteers , DRUGA treatment potentiated the blood glucose lowering effect of DRUGN ( a DRUGN similar to DRUGB ) in dgb of the dgb subjects .
acitretin	drug	chlorpropamide	drug
false

DRUGN : In a study of dgb healthy male volunteers , DRUGN treatment potentiated the blood glucose lowering effect of DRUGA ( a DRUGB similar to DRUGN ) in dgb of the dgb subjects .
glibenclamide	drug	sulfonylurea	group
false

DRUGN : In a study of dgb healthy male volunteers , DRUGN treatment potentiated the blood glucose lowering effect of DRUGA ( a DRUGN similar to DRUGB ) in dgb of the dgb subjects .
glibenclamide	drug	chlorpropamide	drug
false

DRUGN : In a study of dgb healthy male volunteers , DRUGN treatment potentiated the blood glucose lowering effect of DRUGN ( a DRUGA similar to DRUGB ) in dgb of the dgb subjects .
sulfonylurea	group	chlorpropamide	drug
false

Repeating the study with dgb healthy male volunteers in the absence of DRUGA did not detect an effect of DRUGB on glucose tolerance .
glibenclamide	drug	acitretin	drug
false

DRUGA : It has not been established if there is a pharmacokinetic interaction between DRUGB and DRUGN .
Hormonal Contraceptives	group	acitretin	drug
false

DRUGA : It has not been established if there is a pharmacokinetic interaction between DRUGN and DRUGB .
Hormonal Contraceptives	group	combined oral contraceptives	group
false

DRUGN : It has not been established if there is a pharmacokinetic interaction between DRUGA and DRUGB .
acitretin	drug	combined oral contraceptives	group
false

However , it has been established that DRUGA interferes with the contraceptive effect of microdosed DRUGB minipill preparations .
acitretin	drug	progestin	drug
effect

Microdosed minipill DRUGA preparations are not recommended for use with DRUGB .
progestin	drug	Soriatane	drug
advise

It is not known whether other DRUGA , such as implants and injectables , are adequate methods of contraception during DRUGB therapy .
progestational contraceptives	group	acitretin	drug
false

DRUGA : An increased risk of hepatitis has been reported to result from combined use of DRUGB and DRUGN .
Methotrexate	drug	methotrexate	drug
false

DRUGA : An increased risk of hepatitis has been reported to result from combined use of DRUGN and DRUGB .
Methotrexate	drug	etretinate	drug
false

DRUGN : An increased risk of hepatitis has been reported to result from combined use of DRUGA and DRUGB .
methotrexate	drug	etretinate	drug
effect

Consequently , the combination of DRUGA with DRUGB is also contraindicated .
methotrexate	drug	acitretin	drug
advise

DRUGA : If DRUGB is given concurrently with DRUGN , the protein binding of DRUGN may be reduced .
Phenytoin	drug	acitretin	drug
false

DRUGA : If DRUGN is given concurrently with DRUGB , the protein binding of DRUGN may be reduced .
Phenytoin	drug	phenytoin	drug
false

DRUGA : If DRUGN is given concurrently with DRUGN , the protein binding of DRUGB may be reduced .
Phenytoin	drug	phenytoin	drug
false

DRUGN : If DRUGA is given concurrently with DRUGB , the protein binding of DRUGN may be reduced .
acitretin	drug	phenytoin	drug
mechanism

DRUGN : If DRUGA is given concurrently with DRUGN , the protein binding of DRUGB may be reduced .
acitretin	drug	phenytoin	drug
false

DRUGA : Since both DRUGB and DRUGN can cause increased intracranial pressure , their combined use is contraindicated .
Tetracyclines	group	acitretin	drug
false

DRUGA : Since both DRUGN and DRUGB can cause increased intracranial pressure , their combined use is contraindicated .
Tetracyclines	group	tetracyclines	group
false

DRUGN : Since both DRUGA and DRUGB can cause increased intracranial pressure , their combined use is contraindicated .
acitretin	drug	tetracyclines	group
effect

DRUGA and oral DRUGB : Concomitant administration of DRUGN and / or other oral DRUGN with DRUGN must be avoided because of the risk of hypervitaminosis A .
Vitamin A	group	retinoids	group
false

DRUGA and oral DRUGN : Concomitant administration of DRUGB and / or other oral DRUGN with DRUGN must be avoided because of the risk of hypervitaminosis A .
Vitamin A	group	vitamin A	group
false

DRUGA and oral DRUGN : Concomitant administration of DRUGN and / or other oral DRUGB with DRUGN must be avoided because of the risk of hypervitaminosis A .
Vitamin A	group	retinoids	group
false

DRUGA and oral DRUGN : Concomitant administration of DRUGN and / or other oral DRUGN with DRUGB must be avoided because of the risk of hypervitaminosis A .
Vitamin A	group	acitretin	drug
false

DRUGN and oral DRUGA : Concomitant administration of DRUGB and / or other oral DRUGN with DRUGN must be avoided because of the risk of hypervitaminosis A .
retinoids	group	vitamin A	group
false

DRUGN and oral DRUGA : Concomitant administration of DRUGN and / or other oral DRUGN with DRUGB must be avoided because of the risk of hypervitaminosis A .
retinoids	group	acitretin	drug
false

DRUGN and oral DRUGN : Concomitant administration of DRUGA and / or other oral DRUGB with DRUGN must be avoided because of the risk of hypervitaminosis A .
vitamin A	group	retinoids	group
false

DRUGN and oral DRUGN : Concomitant administration of DRUGA and / or other oral DRUGN with DRUGB must be avoided because of the risk of hypervitaminosis A .
vitamin A	group	acitretin	drug
advise

DRUGN and oral DRUGN : Concomitant administration of DRUGN and / or other oral DRUGA with DRUGB must be avoided because of the risk of hypervitaminosis A .
retinoids	group	acitretin	drug
advise

Other : There appears to be no pharmacokinetic interaction between DRUGA and DRUGB , DRUGN , or DRUGN .
acitretin	drug	cimetidine	drug
false

Other : There appears to be no pharmacokinetic interaction between DRUGA and DRUGN , DRUGB , or DRUGN .
acitretin	drug	digoxin	drug
false

Other : There appears to be no pharmacokinetic interaction between DRUGA and DRUGN , DRUGN , or DRUGB .
acitretin	drug	glyburide	drug
false

Other : There appears to be no pharmacokinetic interaction between DRUGN and DRUGA , DRUGB , or DRUGN .
cimetidine	drug	digoxin	drug
false

Other : There appears to be no pharmacokinetic interaction between DRUGN and DRUGA , DRUGN , or DRUGB .
cimetidine	drug	glyburide	drug
false

Other : There appears to be no pharmacokinetic interaction between DRUGN and DRUGN , DRUGA , or DRUGB .
digoxin	drug	glyburide	drug
false

Investigations into the effect of DRUGA on the protein binding of DRUGB ( DRUGN ) revealed no interaction .
acitretin	drug	anticoagulants of the coumarin type	group
false

Investigations into the effect of DRUGA on the protein binding of DRUGN ( DRUGB ) revealed no interaction .
acitretin	drug	warfarin	drug
false

Investigations into the effect of DRUGN on the protein binding of DRUGA ( DRUGB ) revealed no interaction .
anticoagulants of the coumarin type	group	warfarin	drug
false

DRUGA : DRUGB has been studied in rheumatoid arthritis patients taking concomitant DRUGN .
Methotrexate	drug	HUMIRA	brand
false

DRUGA : DRUGN has been studied in rheumatoid arthritis patients taking concomitant DRUGB .
Methotrexate	drug	MTX	drug
false

DRUGN : DRUGA has been studied in rheumatoid arthritis patients taking concomitant DRUGB .
HUMIRA	brand	MTX	drug
false

The data do not suggest the need for dose adjustment of either DRUGA or DRUGB .
HUMIRA	brand	MTX	drug
false

DRUGA : Concurrent administration of DRUGB ( an DRUGN ) and another DRUGN has been associated with an increased risk of serious infections , an increased risk of neutropenia and no additional benefit compared to these medicinal products alone .
Anakinra	drug	anakinra	drug
false

DRUGA : Concurrent administration of DRUGN ( an DRUGB ) and another DRUGN has been associated with an increased risk of serious infections , an increased risk of neutropenia and no additional benefit compared to these medicinal products alone .
Anakinra	drug	interleukin-1 antagonist	group
false

DRUGA : Concurrent administration of DRUGN ( an DRUGN ) and another DRUGB has been associated with an increased risk of serious infections , an increased risk of neutropenia and no additional benefit compared to these medicinal products alone .
Anakinra	drug	TNF-blocking agent	group
false

DRUGN : Concurrent administration of DRUGA ( an DRUGB ) and another DRUGN has been associated with an increased risk of serious infections , an increased risk of neutropenia and no additional benefit compared to these medicinal products alone .
anakinra	drug	interleukin-1 antagonist	group
false

DRUGN : Concurrent administration of DRUGA ( an DRUGN ) and another DRUGB has been associated with an increased risk of serious infections , an increased risk of neutropenia and no additional benefit compared to these medicinal products alone .
anakinra	drug	TNF-blocking agent	group
effect

DRUGN : Concurrent administration of DRUGN ( an DRUGA ) and another DRUGB has been associated with an increased risk of serious infections , an increased risk of neutropenia and no additional benefit compared to these medicinal products alone .
interleukin-1 antagonist	group	TNF-blocking agent	group
effect

The safety and efficacy of DRUGA used in combination with DRUGB has not been studied .
anakinra	drug	HUMIRA	brand
false

Therefore the , combination of DRUGA with other DRUGB , including DRUGN , may also result i n similar toxicities .
anakinra	drug	TNF-blocking agents	group
effect

Therefore the , combination of DRUGA with other DRUGN , including DRUGB , may also result i n similar toxicities .
anakinra	drug	HUMIRA	brand
effect

Therefore the , combination of DRUGN with other DRUGA , including DRUGB , may also result i n similar toxicities .
TNF-blocking agents	group	HUMIRA	brand
false

Particular caution should be exercised in using preparations containing DRUGA , DRUGB , or DRUGN in combination with DRUGN Gel .
sulfur	drug	resorcinol	drug
false

Particular caution should be exercised in using preparations containing DRUGA , DRUGN , or DRUGB in combination with DRUGN Gel .
sulfur	drug	salicylic acid	drug
false

Particular caution should be exercised in using preparations containing DRUGA , DRUGN , or DRUGN in combination with DRUGB Gel .
sulfur	drug	DIFFERIN	brand
false

Particular caution should be exercised in using preparations containing DRUGN , DRUGA , or DRUGB in combination with DRUGN Gel .
resorcinol	drug	salicylic acid	drug
false

Particular caution should be exercised in using preparations containing DRUGN , DRUGA , or DRUGN in combination with DRUGB Gel .
resorcinol	drug	DIFFERIN	brand
false

Particular caution should be exercised in using preparations containing DRUGN , DRUGN , or DRUGA in combination with DRUGB Gel .
salicylic acid	drug	DIFFERIN	brand
false

Intravenous DRUGA ( DRUGB ) has been effectively administered in the presence of other cardioactive drugs , such as DRUGN , DRUGN , DRUGN , and DRUGN , without any change in the adverse reaction profile .
Adenocard	brand	adenosine	drug
false

Intravenous DRUGA ( DRUGN ) has been effectively administered in the presence of other cardioactive drugs , such as DRUGB , DRUGN , DRUGN , and DRUGN , without any change in the adverse reaction profile .
Adenocard	brand	quinidine	drug
false

Intravenous DRUGA ( DRUGN ) has been effectively administered in the presence of other cardioactive drugs , such as DRUGN , DRUGB , DRUGN , and DRUGN , without any change in the adverse reaction profile .
Adenocard	brand	beta-adrenergic blocking agents	group
false

Intravenous DRUGA ( DRUGN ) has been effectively administered in the presence of other cardioactive drugs , such as DRUGN , DRUGN , DRUGB , and DRUGN , without any change in the adverse reaction profile .
Adenocard	brand	calcium channel blocking agents	group
false

Intravenous DRUGA ( DRUGN ) has been effectively administered in the presence of other cardioactive drugs , such as DRUGN , DRUGN , DRUGN , and DRUGB , without any change in the adverse reaction profile .
Adenocard	brand	angiotensin converting enzyme inhibitors	group
false

Intravenous DRUGN ( DRUGA ) has been effectively administered in the presence of other cardioactive drugs , such as DRUGB , DRUGN , DRUGN , and DRUGN , without any change in the adverse reaction profile .
adenosine	drug	quinidine	drug
false

Intravenous DRUGN ( DRUGA ) has been effectively administered in the presence of other cardioactive drugs , such as DRUGN , DRUGB , DRUGN , and DRUGN , without any change in the adverse reaction profile .
adenosine	drug	beta-adrenergic blocking agents	group
false

Intravenous DRUGN ( DRUGA ) has been effectively administered in the presence of other cardioactive drugs , such as DRUGN , DRUGN , DRUGB , and DRUGN , without any change in the adverse reaction profile .
adenosine	drug	calcium channel blocking agents	group
false

Intravenous DRUGN ( DRUGA ) has been effectively administered in the presence of other cardioactive drugs , such as DRUGN , DRUGN , DRUGN , and DRUGB , without any change in the adverse reaction profile .
adenosine	drug	angiotensin converting enzyme inhibitors	group
false

Intravenous DRUGN ( DRUGN ) has been effectively administered in the presence of other cardioactive drugs , such as DRUGA , DRUGB , DRUGN , and DRUGN , without any change in the adverse reaction profile .
quinidine	drug	beta-adrenergic blocking agents	group
false

Intravenous DRUGN ( DRUGN ) has been effectively administered in the presence of other cardioactive drugs , such as DRUGA , DRUGN , DRUGB , and DRUGN , without any change in the adverse reaction profile .
quinidine	drug	calcium channel blocking agents	group
false

Intravenous DRUGN ( DRUGN ) has been effectively administered in the presence of other cardioactive drugs , such as DRUGA , DRUGN , DRUGN , and DRUGB , without any change in the adverse reaction profile .
quinidine	drug	angiotensin converting enzyme inhibitors	group
false

Intravenous DRUGN ( DRUGN ) has been effectively administered in the presence of other cardioactive drugs , such as DRUGN , DRUGA , DRUGB , and DRUGN , without any change in the adverse reaction profile .
beta-adrenergic blocking agents	group	calcium channel blocking agents	group
false

Intravenous DRUGN ( DRUGN ) has been effectively administered in the presence of other cardioactive drugs , such as DRUGN , DRUGA , DRUGN , and DRUGB , without any change in the adverse reaction profile .
beta-adrenergic blocking agents	group	angiotensin converting enzyme inhibitors	group
false

Intravenous DRUGN ( DRUGN ) has been effectively administered in the presence of other cardioactive drugs , such as DRUGN , DRUGN , DRUGA , and DRUGB , without any change in the adverse reaction profile .
calcium channel blocking agents	group	angiotensin converting enzyme inhibitors	group
false

DRUGA and DRUGB use may be rarely associated with ventricular fibrillation when combined with DRUGN .
Digoxin	drug	verapamil	drug
false

DRUGA and DRUGN use may be rarely associated with ventricular fibrillation when combined with DRUGB .
Digoxin	drug	Adenocard	brand
effect

DRUGN and DRUGA use may be rarely associated with ventricular fibrillation when combined with DRUGB .
verapamil	drug	Adenocard	brand
effect

The use of DRUGA in patients receiving DRUGB may be rarely associated with ventricular fibrillation .
Adenocard	brand	digitalis	group
effect

The effects of DRUGA are antagonized by DRUGB such as DRUGN and DRUGN .
adenosine	drug	methylxanthines	group
effect

The effects of DRUGA are antagonized by DRUGN such as DRUGB and DRUGN .
adenosine	drug	caffeine	drug
effect

The effects of DRUGA are antagonized by DRUGN such as DRUGN and DRUGB .
adenosine	drug	theophylline	drug
effect

The effects of DRUGN are antagonized by DRUGA such as DRUGB and DRUGN .
methylxanthines	group	caffeine	drug
false

The effects of DRUGN are antagonized by DRUGA such as DRUGN and DRUGB .
methylxanthines	group	theophylline	drug
false

The effects of DRUGN are antagonized by DRUGN such as DRUGA and DRUGB .
caffeine	drug	theophylline	drug
false

In the presence of these DRUGA , larger doses of DRUGB may be required or DRUGN may not be effective .
methylxanthines	group	adenosine	drug
advise

In the presence of these DRUGA , larger doses of DRUGN may be required or DRUGB may not be effective .
methylxanthines	group	adenosine	drug
advise

DRUGA effects are potentiated by DRUGB .
Adenosine	drug	dipyridamole	drug
effect

Thus , smaller doses of DRUGA may be effective in the presence of DRUGB .
adenosine	drug	dipyridamole	drug
effect

As the primary effect of DRUGA is to decrease conduction through the A V node , higher degrees of heart block may be produced in the presence of DRUGB .
adenosine	drug	carbamazepine	drug
effect

Co administration with DRUGA such as DRUGB or DRUGN is not recommended .
antifungal agents	group	ketoconazole	drug
false

Co administration with DRUGA such as DRUGN or DRUGB is not recommended .
antifungal agents	group	itraconazole	drug
false

Co administration with DRUGN such as DRUGA or DRUGB is not recommended .
ketoconazole	drug	itraconazole	drug
false

DRUGA , DRUGB , DRUGN ( consider DRUGN dose reduction ) .
Nafazodone	drug	fluvoxamine	drug
false

DRUGA , DRUGN , DRUGB ( consider DRUGN dose reduction ) .
Nafazodone	drug	cimetidine	drug
false

DRUGA , DRUGN , DRUGN ( consider DRUGB dose reduction ) .
Nafazodone	drug	Xanax	brand
advise

DRUGN , DRUGA , DRUGB ( consider DRUGN dose reduction ) .
fluvoxamine	drug	cimetidine	drug
false

DRUGN , DRUGA , DRUGN ( consider DRUGB dose reduction ) .
fluvoxamine	drug	Xanax	brand
advise

DRUGN , DRUGN , DRUGA ( consider DRUGB dose reduction ) .
cimetidine	drug	Xanax	brand
advise

DRUGA , DRUGB , DRUGN , DRUGN , DRUGN ( exercise caution ) .
Fluoxetine	drug	OCs	group
false

DRUGA , DRUGN , DRUGB , DRUGN , DRUGN ( exercise caution ) .
Fluoxetine	drug	sertraline	drug
false

DRUGA , DRUGN , DRUGN , DRUGB , DRUGN ( exercise caution ) .
Fluoxetine	drug	diltiazem	drug
false

DRUGA , DRUGN , DRUGN , DRUGN , DRUGB ( exercise caution ) .
Fluoxetine	drug	macrolide antibiotics	group
false

DRUGN , DRUGA , DRUGB , DRUGN , DRUGN ( exercise caution ) .
OCs	group	sertraline	drug
false

DRUGN , DRUGA , DRUGN , DRUGB , DRUGN ( exercise caution ) .
OCs	group	diltiazem	drug
false

DRUGN , DRUGA , DRUGN , DRUGN , DRUGB ( exercise caution ) .
OCs	group	macrolide antibiotics	group
false

DRUGN , DRUGN , DRUGA , DRUGB , DRUGN ( exercise caution ) .
sertraline	drug	diltiazem	drug
false

DRUGN , DRUGN , DRUGA , DRUGN , DRUGB ( exercise caution ) .
sertraline	drug	macrolide antibiotics	group
false

DRUGN , DRUGN , DRUGN , DRUGA , DRUGB ( exercise caution ) .
diltiazem	drug	macrolide antibiotics	group
false

DRUGA : Steady state trough concentrations of DRUGB were about dgb % higher when dgb mg DRUGN was coadministered with each dose of DRUGN ( dgb mg / kg / day ) in eight neurocysticercosis patients .
Dexamethasone	drug	albendazole sulfoxide	drug
false

DRUGA : Steady state trough concentrations of DRUGN were about dgb % higher when dgb mg DRUGB was coadministered with each dose of DRUGN ( dgb mg / kg / day ) in eight neurocysticercosis patients .
Dexamethasone	drug	dexamethasone	drug
false

DRUGA : Steady state trough concentrations of DRUGN were about dgb % higher when dgb mg DRUGN was coadministered with each dose of DRUGB ( dgb mg / kg / day ) in eight neurocysticercosis patients .
Dexamethasone	drug	albendazole	drug
false

DRUGN : Steady state trough concentrations of DRUGA were about dgb % higher when dgb mg DRUGB was coadministered with each dose of DRUGN ( dgb mg / kg / day ) in eight neurocysticercosis patients .
albendazole sulfoxide	drug	dexamethasone	drug
false

DRUGN : Steady state trough concentrations of DRUGA were about dgb % higher when dgb mg DRUGN was coadministered with each dose of DRUGB ( dgb mg / kg / day ) in eight neurocysticercosis patients .
albendazole sulfoxide	drug	albendazole	drug
false

DRUGN : Steady state trough concentrations of DRUGN were about dgb % higher when dgb mg DRUGA was coadministered with each dose of DRUGB ( dgb mg / kg / day ) in eight neurocysticercosis patients .
dexamethasone	drug	albendazole	drug
mechanism

The pharmacokinetics of DRUGA were unchanged following coadministration with DRUGB ( dgb mg ) .
praziquantel	drug	albendazole	drug
false

DRUGA : The pharmacokinetics of DRUGB ( DRUGN dga mg / kg infused over dgb minutes ) were unchanged following a single oral dose of DRUGN ( dgb mg ) in dgb healthy subjects .
Theophylline	drug	theophylline	drug
false

DRUGA : The pharmacokinetics of DRUGN ( DRUGB dga mg / kg infused over dgb minutes ) were unchanged following a single oral dose of DRUGN ( dgb mg ) in dgb healthy subjects .
Theophylline	drug	aminophylline	drug
false

DRUGA : The pharmacokinetics of DRUGN ( DRUGN dga mg / kg infused over dgb minutes ) were unchanged following a single oral dose of DRUGB ( dgb mg ) in dgb healthy subjects .
Theophylline	drug	albendazole	drug
false

DRUGN : The pharmacokinetics of DRUGA ( DRUGB dga mg / kg infused over dgb minutes ) were unchanged following a single oral dose of DRUGN ( dgb mg ) in dgb healthy subjects .
theophylline	drug	aminophylline	drug
false

DRUGN : The pharmacokinetics of DRUGA ( DRUGN dga mg / kg infused over dgb minutes ) were unchanged following a single oral dose of DRUGB ( dgb mg ) in dgb healthy subjects .
theophylline	drug	albendazole	drug
false

DRUGN : The pharmacokinetics of DRUGN ( DRUGA dga mg / kg infused over dgb minutes ) were unchanged following a single oral dose of DRUGB ( dgb mg ) in dgb healthy subjects .
aminophylline	drug	albendazole	drug
false

Therefore , interactions could occur following concomitant administration of DRUGA ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN ) .
psychotropic drugs	group	narcotics	group
false

Therefore , interactions could occur following concomitant administration of DRUGA ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN ) .
psychotropic drugs	group	analgesics	group
false

Therefore , interactions could occur following concomitant administration of DRUGA ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN ) .
psychotropic drugs	group	antiemetics	group
false

Therefore , interactions could occur following concomitant administration of DRUGA ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN ) .
psychotropic drugs	group	sedatives	group
false

Therefore , interactions could occur following concomitant administration of DRUGA ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB ) .
psychotropic drugs	group	tranquilizers	group
false

Therefore , interactions could occur following concomitant administration of DRUGN ( e.g . , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN ) .
narcotics	group	analgesics	group
false

Therefore , interactions could occur following concomitant administration of DRUGN ( e.g . , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN ) .
narcotics	group	antiemetics	group
false

Therefore , interactions could occur following concomitant administration of DRUGN ( e.g . , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN ) .
narcotics	group	sedatives	group
false

Therefore , interactions could occur following concomitant administration of DRUGN ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB ) .
narcotics	group	tranquilizers	group
false

Therefore , interactions could occur following concomitant administration of DRUGN ( e.g . , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN ) .
analgesics	group	antiemetics	group
false

Therefore , interactions could occur following concomitant administration of DRUGN ( e.g . , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN ) .
analgesics	group	sedatives	group
false

Therefore , interactions could occur following concomitant administration of DRUGN ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB ) .
analgesics	group	tranquilizers	group
false

Therefore , interactions could occur following concomitant administration of DRUGN ( e.g . , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN ) .
antiemetics	group	sedatives	group
false

Therefore , interactions could occur following concomitant administration of DRUGN ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB ) .
antiemetics	group	tranquilizers	group
false

Therefore , interactions could occur following concomitant administration of DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB ) .
sedatives	group	tranquilizers	group
false

The safety and efficacy of DRUGA in combination with any DRUGB have not been established .
PROLEUKIN	brand	antineoplastic agents	group
false

Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose DRUGA and DRUGB , specifically , DRUGN , DRUGN , DRUGN and DRUGN .
PROLEUKIN	brand	antineoplastic agents	group
effect

Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose DRUGA and DRUGN , specifically , DRUGB , DRUGN , DRUGN and DRUGN .
PROLEUKIN	brand	dacarbazine	drug
effect

Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose DRUGA and DRUGN , specifically , DRUGN , DRUGB , DRUGN and DRUGN .
PROLEUKIN	brand	cis-platinum	drug
effect

Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose DRUGA and DRUGN , specifically , DRUGN , DRUGN , DRUGB and DRUGN .
PROLEUKIN	brand	tamoxifen	drug
effect

Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose DRUGA and DRUGN , specifically , DRUGN , DRUGN , DRUGN and DRUGB .
PROLEUKIN	brand	interferon-alfa	drug
effect

Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose DRUGN and DRUGA , specifically , DRUGB , DRUGN , DRUGN and DRUGN .
antineoplastic agents	group	dacarbazine	drug
false

Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose DRUGN and DRUGA , specifically , DRUGN , DRUGB , DRUGN and DRUGN .
antineoplastic agents	group	cis-platinum	drug
false

Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose DRUGN and DRUGA , specifically , DRUGN , DRUGN , DRUGB and DRUGN .
antineoplastic agents	group	tamoxifen	drug
false

Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose DRUGN and DRUGA , specifically , DRUGN , DRUGN , DRUGN and DRUGB .
antineoplastic agents	group	interferon-alfa	drug
false

Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose DRUGN and DRUGN , specifically , DRUGA , DRUGB , DRUGN and DRUGN .
dacarbazine	drug	cis-platinum	drug
false

Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose DRUGN and DRUGN , specifically , DRUGA , DRUGN , DRUGB and DRUGN .
dacarbazine	drug	tamoxifen	drug
false

Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose DRUGN and DRUGN , specifically , DRUGA , DRUGN , DRUGN and DRUGB .
dacarbazine	drug	interferon-alfa	drug
false

Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose DRUGN and DRUGN , specifically , DRUGN , DRUGA , DRUGB and DRUGN .
cis-platinum	drug	tamoxifen	drug
false

Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose DRUGN and DRUGN , specifically , DRUGN , DRUGA , DRUGN and DRUGB .
cis-platinum	drug	interferon-alfa	drug
false

Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose DRUGN and DRUGN , specifically , DRUGN , DRUGN , DRUGA and DRUGB .
tamoxifen	drug	interferon-alfa	drug
false

Myocardial injury , including myocardial infarction , myocarditis , ventricular hypokinesia , and severe rhabdomyolysis appear to be increased in patients receiving DRUGA and DRUGB concurrently .
PROLEUKIN	brand	interferon-alfa	drug
effect

The duration of the period following treatment with DRUGA before one should consider starting other DRUGB therapy has not been evaluated .
AMEVIVE	brand	immunosuppressive	group
false

An immune response to DRUGA may interfere with subsequent diagnostic serum tests that utilize DRUGB
Campath	brand	antibodies	group
false

Intravenous DRUGA was shown to double the bioavailability of oral DRUGB .
ranitidine	drug	alendronate	drug
mechanism

Products containing DRUGA and other DRUGB likely will interfere with absorption of DRUGN .
calcium	drug	multivalent cations	drug
false

Products containing DRUGA and other DRUGN likely will interfere with absorption of DRUGB .
calcium	drug	alendronate	drug
mechanism

Products containing DRUGN and other DRUGA likely will interfere with absorption of DRUGB .
multivalent cations	drug	alendronate	drug
mechanism

Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when DRUGA is administered in combination with other DRUGB such as DRUGN , DRUGN , DRUGN , or inhalation general DRUGN .
ALFENTA	brand	CNS depressants	group
effect

Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when DRUGA is administered in combination with other DRUGN such as DRUGB , DRUGN , DRUGN , or inhalation general DRUGN .
ALFENTA	brand	barbiturates	group
effect

Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when DRUGA is administered in combination with other DRUGN such as DRUGN , DRUGB , DRUGN , or inhalation general DRUGN .
ALFENTA	brand	tranquilizers	group
effect

Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when DRUGA is administered in combination with other DRUGN such as DRUGN , DRUGN , DRUGB , or inhalation general DRUGN .
ALFENTA	brand	opioids	group
effect

Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when DRUGA is administered in combination with other DRUGN such as DRUGN , DRUGN , DRUGN , or inhalation general DRUGB .
ALFENTA	brand	anesthetics	group
effect

Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when DRUGN is administered in combination with other DRUGA such as DRUGB , DRUGN , DRUGN , or inhalation general DRUGN .
CNS depressants	group	barbiturates	group
false

Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when DRUGN is administered in combination with other DRUGA such as DRUGN , DRUGB , DRUGN , or inhalation general DRUGN .
CNS depressants	group	tranquilizers	group
false

Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when DRUGN is administered in combination with other DRUGA such as DRUGN , DRUGN , DRUGB , or inhalation general DRUGN .
CNS depressants	group	opioids	group
false

Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when DRUGN is administered in combination with other DRUGA such as DRUGN , DRUGN , DRUGN , or inhalation general DRUGB .
CNS depressants	group	anesthetics	group
false

Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when DRUGN is administered in combination with other DRUGN such as DRUGA , DRUGB , DRUGN , or inhalation general DRUGN .
barbiturates	group	tranquilizers	group
false

Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when DRUGN is administered in combination with other DRUGN such as DRUGA , DRUGN , DRUGB , or inhalation general DRUGN .
barbiturates	group	opioids	group
false

Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when DRUGN is administered in combination with other DRUGN such as DRUGA , DRUGN , DRUGN , or inhalation general DRUGB .
barbiturates	group	anesthetics	group
false

Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when DRUGN is administered in combination with other DRUGN such as DRUGN , DRUGA , DRUGB , or inhalation general DRUGN .
tranquilizers	group	opioids	group
false

Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when DRUGN is administered in combination with other DRUGN such as DRUGN , DRUGA , DRUGN , or inhalation general DRUGB .
tranquilizers	group	anesthetics	group
false

Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when DRUGN is administered in combination with other DRUGN such as DRUGN , DRUGN , DRUGA , or inhalation general DRUGB .
opioids	group	anesthetics	group
false

DRUGA reduces the clearance of DRUGB .
Cimetidine	drug	ALFENTA	brand
mechanism

Drug Drug Interactions : The pharmacokinetic and pharmacodynamic interactions between DRUGA and other DRUGB have not been determined .
UROXATRAL	brand	alpha-blockers	group
false

However , interactions may be expected , and DRUGA should NOT be used in combination with other DRUGB .
UROXATRAL	brand	alpha-blockers	group
advise

Effects of Other Drugs on DRUGA Based on in vitro studies , DRUGB is metabolized by CYP dgbAdga
Aliskiren	drug	aliskiren	drug
false

Co administration of DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
lovastatin	drug	atenolol	drug
false

Co administration of DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
lovastatin	drug	warfarin	drug
false

Co administration of DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
lovastatin	drug	furosemide	drug
false

Co administration of DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
lovastatin	drug	digoxin	drug
false

Co administration of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
lovastatin	drug	celecoxib	drug
false

Co administration of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
lovastatin	drug	hydrochlorothiazide	drug
false

Co administration of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
lovastatin	drug	ramipril	drug
false

Co administration of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
lovastatin	drug	valsartan	drug
false

Co administration of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB and DRUGN did not result in clinically significant increases in DRUGN exposure .
lovastatin	drug	metformin	drug
false

Co administration of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGB did not result in clinically significant increases in DRUGN exposure .
lovastatin	drug	amlodipine	drug
false

Co administration of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGB exposure .
lovastatin	drug	aliskiren	drug
false

Co administration of DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
atenolol	drug	warfarin	drug
false

Co administration of DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
atenolol	drug	furosemide	drug
false

Co administration of DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
atenolol	drug	digoxin	drug
false

Co administration of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
atenolol	drug	celecoxib	drug
false

Co administration of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
atenolol	drug	hydrochlorothiazide	drug
false

Co administration of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
atenolol	drug	ramipril	drug
false

Co administration of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
atenolol	drug	valsartan	drug
false

Co administration of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB and DRUGN did not result in clinically significant increases in DRUGN exposure .
atenolol	drug	metformin	drug
false

Co administration of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGB did not result in clinically significant increases in DRUGN exposure .
atenolol	drug	amlodipine	drug
false

Co administration of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGB exposure .
atenolol	drug	aliskiren	drug
false

Co administration of DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
warfarin	drug	furosemide	drug
false

Co administration of DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
warfarin	drug	digoxin	drug
false

Co administration of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
warfarin	drug	celecoxib	drug
false

Co administration of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
warfarin	drug	hydrochlorothiazide	drug
false

Co administration of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
warfarin	drug	ramipril	drug
false

Co administration of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
warfarin	drug	valsartan	drug
false

Co administration of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB and DRUGN did not result in clinically significant increases in DRUGN exposure .
warfarin	drug	metformin	drug
false

Co administration of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGB did not result in clinically significant increases in DRUGN exposure .
warfarin	drug	amlodipine	drug
false

Co administration of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGB exposure .
warfarin	drug	aliskiren	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
furosemide	drug	digoxin	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
furosemide	drug	celecoxib	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
furosemide	drug	hydrochlorothiazide	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
furosemide	drug	ramipril	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
furosemide	drug	valsartan	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB and DRUGN did not result in clinically significant increases in DRUGN exposure .
furosemide	drug	metformin	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGB did not result in clinically significant increases in DRUGN exposure .
furosemide	drug	amlodipine	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGB exposure .
furosemide	drug	aliskiren	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
digoxin	drug	celecoxib	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
digoxin	drug	hydrochlorothiazide	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
digoxin	drug	ramipril	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
digoxin	drug	valsartan	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB and DRUGN did not result in clinically significant increases in DRUGN exposure .
digoxin	drug	metformin	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGB did not result in clinically significant increases in DRUGN exposure .
digoxin	drug	amlodipine	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGB exposure .
digoxin	drug	aliskiren	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
celecoxib	drug	hydrochlorothiazide	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
celecoxib	drug	ramipril	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
celecoxib	drug	valsartan	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB and DRUGN did not result in clinically significant increases in DRUGN exposure .
celecoxib	drug	metformin	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN and DRUGB did not result in clinically significant increases in DRUGN exposure .
celecoxib	drug	amlodipine	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGB exposure .
celecoxib	drug	aliskiren	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
hydrochlorothiazide	drug	ramipril	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
hydrochlorothiazide	drug	valsartan	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB and DRUGN did not result in clinically significant increases in DRUGN exposure .
hydrochlorothiazide	drug	metformin	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN and DRUGB did not result in clinically significant increases in DRUGN exposure .
hydrochlorothiazide	drug	amlodipine	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGB exposure .
hydrochlorothiazide	drug	aliskiren	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN and DRUGN did not result in clinically significant increases in DRUGN exposure .
ramipril	drug	valsartan	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB and DRUGN did not result in clinically significant increases in DRUGN exposure .
ramipril	drug	metformin	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN and DRUGB did not result in clinically significant increases in DRUGN exposure .
ramipril	drug	amlodipine	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN and DRUGN did not result in clinically significant increases in DRUGB exposure .
ramipril	drug	aliskiren	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB and DRUGN did not result in clinically significant increases in DRUGN exposure .
valsartan	drug	metformin	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN and DRUGB did not result in clinically significant increases in DRUGN exposure .
valsartan	drug	amlodipine	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN and DRUGN did not result in clinically significant increases in DRUGB exposure .
valsartan	drug	aliskiren	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA and DRUGB did not result in clinically significant increases in DRUGN exposure .
metformin	drug	amlodipine	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA and DRUGN did not result in clinically significant increases in DRUGB exposure .
metformin	drug	aliskiren	drug
false

Co administration of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGA did not result in clinically significant increases in DRUGB exposure .
amlodipine	drug	aliskiren	drug
false

Co administration of DRUGA reduced DRUGB Cmax up to dgb % after multiple dosing .
irbesartan	drug	aliskiren	drug
mechanism

Co administration of DRUGA resulted in about a dgb % increase in DRUGB Cmax and AUC after multiple dosing .
atorvastatin	drug	aliskiren	drug
mechanism

DRUGA : Co administration of dgb mg twice daily DRUGB with DRUGN resulted in an approximate dgb % increase in plasma levels of DRUGN .
Ketoconazole	drug	ketoconazole	drug
false

DRUGA : Co administration of dgb mg twice daily DRUGN with DRUGB resulted in an approximate dgb % increase in plasma levels of DRUGN .
Ketoconazole	drug	aliskiren	drug
false

DRUGA : Co administration of dgb mg twice daily DRUGN with DRUGN resulted in an approximate dgb % increase in plasma levels of DRUGB .
Ketoconazole	drug	aliskiren	drug
false

DRUGN : Co administration of dgb mg twice daily DRUGA with DRUGB resulted in an approximate dgb % increase in plasma levels of DRUGN .
ketoconazole	drug	aliskiren	drug
mechanism

DRUGN : Co administration of dgb mg twice daily DRUGA with DRUGN resulted in an approximate dgb % increase in plasma levels of DRUGB .
ketoconazole	drug	aliskiren	drug
false

Co administration of DRUGA did not significantly affect the pharmacokinetics of DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
aliskiren	drug	lovastatin	drug
false

Co administration of DRUGA did not significantly affect the pharmacokinetics of DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
aliskiren	drug	digoxin	drug
false

Co administration of DRUGA did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
aliskiren	drug	valsartan	drug
false

Co administration of DRUGA did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
aliskiren	drug	amlodipine	drug
false

Co administration of DRUGA did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
aliskiren	drug	metformin	drug
false

Co administration of DRUGA did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN or DRUGN .
aliskiren	drug	celecoxib	drug
false

Co administration of DRUGA did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN or DRUGN .
aliskiren	drug	atenolol	drug
false

Co administration of DRUGA did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN or DRUGN .
aliskiren	drug	atorvastatin	drug
false

Co administration of DRUGA did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB or DRUGN .
aliskiren	drug	ramipril	drug
false

Co administration of DRUGA did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGB .
aliskiren	drug	hydrochlorothiazide	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
lovastatin	drug	digoxin	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
lovastatin	drug	valsartan	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
lovastatin	drug	amlodipine	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
lovastatin	drug	metformin	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN or DRUGN .
lovastatin	drug	celecoxib	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN or DRUGN .
lovastatin	drug	atenolol	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN or DRUGN .
lovastatin	drug	atorvastatin	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB or DRUGN .
lovastatin	drug	ramipril	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGB .
lovastatin	drug	hydrochlorothiazide	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
digoxin	drug	valsartan	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
digoxin	drug	amlodipine	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
digoxin	drug	metformin	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN or DRUGN .
digoxin	drug	celecoxib	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN or DRUGN .
digoxin	drug	atenolol	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN or DRUGN .
digoxin	drug	atorvastatin	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB or DRUGN .
digoxin	drug	ramipril	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGB .
digoxin	drug	hydrochlorothiazide	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
valsartan	drug	amlodipine	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
valsartan	drug	metformin	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN or DRUGN .
valsartan	drug	celecoxib	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN or DRUGN .
valsartan	drug	atenolol	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN or DRUGN .
valsartan	drug	atorvastatin	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB or DRUGN .
valsartan	drug	ramipril	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGB .
valsartan	drug	hydrochlorothiazide	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
amlodipine	drug	metformin	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN or DRUGN .
amlodipine	drug	celecoxib	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN or DRUGN .
amlodipine	drug	atenolol	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN or DRUGN .
amlodipine	drug	atorvastatin	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB or DRUGN .
amlodipine	drug	ramipril	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGB .
amlodipine	drug	hydrochlorothiazide	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN or DRUGN .
metformin	drug	celecoxib	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN or DRUGN .
metformin	drug	atenolol	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN or DRUGN .
metformin	drug	atorvastatin	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB or DRUGN .
metformin	drug	ramipril	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN or DRUGB .
metformin	drug	hydrochlorothiazide	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN or DRUGN .
celecoxib	drug	atenolol	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN or DRUGN .
celecoxib	drug	atorvastatin	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB or DRUGN .
celecoxib	drug	ramipril	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN or DRUGB .
celecoxib	drug	hydrochlorothiazide	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN or DRUGN .
atenolol	drug	atorvastatin	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB or DRUGN .
atenolol	drug	ramipril	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN or DRUGB .
atenolol	drug	hydrochlorothiazide	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB or DRUGN .
atorvastatin	drug	ramipril	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN or DRUGB .
atorvastatin	drug	hydrochlorothiazide	drug
false

Co administration of DRUGN did not significantly affect the pharmacokinetics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA or DRUGB .
ramipril	drug	hydrochlorothiazide	drug
false

DRUGA : The effects of DRUGB on DRUGN pharmacokinetics have not been evaluated in a well controlled clinical trial .
Warfarin	drug	aliskiren	drug
false

DRUGA : The effects of DRUGN on DRUGB pharmacokinetics have not been evaluated in a well controlled clinical trial .
Warfarin	drug	warfarin	drug
false

DRUGN : The effects of DRUGA on DRUGB pharmacokinetics have not been evaluated in a well controlled clinical trial .
aliskiren	drug	warfarin	drug
false

DRUGA : When DRUGB was co administered with DRUGN , the AUC and Cmax of DRUGN were reduced by about dgb % and dgb % , respectively .
Furosemide	drug	aliskiren	drug
false

DRUGA : When DRUGN was co administered with DRUGB , the AUC and Cmax of DRUGN were reduced by about dgb % and dgb % , respectively .
Furosemide	drug	furosemide	drug
false

DRUGA : When DRUGN was co administered with DRUGN , the AUC and Cmax of DRUGB were reduced by about dgb % and dgb % , respectively .
Furosemide	drug	furosemide	drug
false

DRUGN : When DRUGA was co administered with DRUGB , the AUC and Cmax of DRUGN were reduced by about dgb % and dgb % , respectively .
aliskiren	drug	furosemide	drug
mechanism

DRUGN : When DRUGA was co administered with DRUGN , the AUC and Cmax of DRUGB were reduced by about dgb % and dgb % , respectively .
aliskiren	drug	furosemide	drug
false

Patients who are applying DRUGA gel should not concurrently use products that contain DRUGB ( N , DRUGN ) , a common component of insect repellent products .
Panretin	brand	DEET	drug
advise

Patients who are applying DRUGA gel should not concurrently use products that contain DRUGN ( N , DRUGB ) , a common component of insect repellent products .
Panretin	brand	N-diethyl-m-toluamide	drug
advise

Patients who are applying DRUGN gel should not concurrently use products that contain DRUGA ( N , DRUGB ) , a common component of insect repellent products .
DEET	drug	N-diethyl-m-toluamide	drug
false

DRUGA / DRUGB : DRUGN inhibits the enzymatic oxidation of DRUGN and DRUGN to DRUGN .
Mercaptopurine	drug	Azathioprine	drug
false

DRUGA / DRUGN : DRUGB inhibits the enzymatic oxidation of DRUGN and DRUGN to DRUGN .
Mercaptopurine	drug	Allopurinol	drug
false

DRUGA / DRUGN : DRUGN inhibits the enzymatic oxidation of DRUGB and DRUGN to DRUGN .
Mercaptopurine	drug	mercaptopurine	drug
false

DRUGA / DRUGN : DRUGN inhibits the enzymatic oxidation of DRUGN and DRUGB to DRUGN .
Mercaptopurine	drug	azathioprine	drug
false

DRUGA / DRUGN : DRUGN inhibits the enzymatic oxidation of DRUGN and DRUGN to DRUGB .
Mercaptopurine	drug	6-thiouric acid	drug
false

DRUGN / DRUGA : DRUGB inhibits the enzymatic oxidation of DRUGN and DRUGN to DRUGN .
Azathioprine	drug	Allopurinol	drug
false

DRUGN / DRUGA : DRUGN inhibits the enzymatic oxidation of DRUGB and DRUGN to DRUGN .
Azathioprine	drug	mercaptopurine	drug
false

DRUGN / DRUGA : DRUGN inhibits the enzymatic oxidation of DRUGN and DRUGB to DRUGN .
Azathioprine	drug	azathioprine	drug
false

DRUGN / DRUGA : DRUGN inhibits the enzymatic oxidation of DRUGN and DRUGN to DRUGB .
Azathioprine	drug	6-thiouric acid	drug
false

DRUGN / DRUGN : DRUGA inhibits the enzymatic oxidation of DRUGB and DRUGN to DRUGN .
Allopurinol	drug	mercaptopurine	drug
mechanism

DRUGN / DRUGN : DRUGA inhibits the enzymatic oxidation of DRUGN and DRUGB to DRUGN .
Allopurinol	drug	azathioprine	drug
mechanism

DRUGN / DRUGN : DRUGA inhibits the enzymatic oxidation of DRUGN and DRUGN to DRUGB .
Allopurinol	drug	6-thiouric acid	drug
false

DRUGN / DRUGN : DRUGN inhibits the enzymatic oxidation of DRUGA and DRUGB to DRUGN .
mercaptopurine	drug	azathioprine	drug
false

DRUGN / DRUGN : DRUGN inhibits the enzymatic oxidation of DRUGA and DRUGN to DRUGB .
mercaptopurine	drug	6-thiouric acid	drug
false

DRUGN / DRUGN : DRUGN inhibits the enzymatic oxidation of DRUGN and DRUGA to DRUGB .
azathioprine	drug	6-thiouric acid	drug
false

Subsequent adjustment of doses of DRUGA or DRUGB should be made on the basis of therapeutic response and the appearance of toxic effects .
mercaptopurine	drug	azathioprine	drug
false

DRUGA : It has been reported that DRUGB prolongs the half life of the DRUGN , DRUGN .
Dicumarol	drug	allopurinol	drug
false

DRUGA : It has been reported that DRUGN prolongs the half life of the DRUGB , DRUGN .
Dicumarol	drug	anticoagulant	group
false

DRUGA : It has been reported that DRUGN prolongs the half life of the DRUGN , DRUGB .
Dicumarol	drug	dicumarol	drug
false

DRUGN : It has been reported that DRUGA prolongs the half life of the DRUGB , DRUGN .
allopurinol	drug	anticoagulant	group
false

DRUGN : It has been reported that DRUGA prolongs the half life of the DRUGN , DRUGB .
allopurinol	drug	dicumarol	drug
mechanism

DRUGN : It has been reported that DRUGN prolongs the half life of the DRUGA , DRUGB .
anticoagulant	group	dicumarol	drug
false

The clinical basis of this drug interaction has not been established but should be noted when DRUGA is given to patients already on DRUGB therapy .
allopurinol	drug	dicumarol	drug
false

The concomitant administration of DRUGA and DRUGB has been associated with a decrease in the excretion of oxypurines ( hypoxanthine and xanthine ) and an increase in urinary uric acid excretion compared with that observed with DRUGN alone .
uricosuric agents	group	allopurinol	drug
mechanism

The concomitant administration of DRUGA and DRUGN has been associated with a decrease in the excretion of oxypurines ( hypoxanthine and xanthine ) and an increase in urinary uric acid excretion compared with that observed with DRUGB alone .
uricosuric agents	group	allopurinol	drug
false

Although clinical evidence to date has not demonstrated renal precipitation of oxypurines in patients either on DRUGA alone or in combination with DRUGB , the possibility should be kept in mind .
allopurinol	drug	uricosuric agents	group
false

DRUGA / DRUGB : An increase in the frequency of skin rash has been reported among patients receiving DRUGN or DRUGN concurrently with DRUGN compared to patients who are not receiving both drugs .
Ampicillin	drug	Amoxicillin	drug
false

DRUGA / DRUGN : An increase in the frequency of skin rash has been reported among patients receiving DRUGB or DRUGN concurrently with DRUGN compared to patients who are not receiving both drugs .
Ampicillin	drug	ampicillin	drug
false

DRUGA / DRUGN : An increase in the frequency of skin rash has been reported among patients receiving DRUGN or DRUGB concurrently with DRUGN compared to patients who are not receiving both drugs .
Ampicillin	drug	amoxicillin	drug
false

DRUGA / DRUGN : An increase in the frequency of skin rash has been reported among patients receiving DRUGN or DRUGN concurrently with DRUGB compared to patients who are not receiving both drugs .
Ampicillin	drug	allopurinol	drug
false

DRUGN / DRUGA : An increase in the frequency of skin rash has been reported among patients receiving DRUGB or DRUGN concurrently with DRUGN compared to patients who are not receiving both drugs .
Amoxicillin	drug	ampicillin	drug
false

DRUGN / DRUGA : An increase in the frequency of skin rash has been reported among patients receiving DRUGN or DRUGB concurrently with DRUGN compared to patients who are not receiving both drugs .
Amoxicillin	drug	amoxicillin	drug
false

DRUGN / DRUGA : An increase in the frequency of skin rash has been reported among patients receiving DRUGN or DRUGN concurrently with DRUGB compared to patients who are not receiving both drugs .
Amoxicillin	drug	allopurinol	drug
false

DRUGN / DRUGN : An increase in the frequency of skin rash has been reported among patients receiving DRUGA or DRUGB concurrently with DRUGN compared to patients who are not receiving both drugs .
ampicillin	drug	amoxicillin	drug
false

DRUGN / DRUGN : An increase in the frequency of skin rash has been reported among patients receiving DRUGA or DRUGN concurrently with DRUGB compared to patients who are not receiving both drugs .
ampicillin	drug	allopurinol	drug
effect

DRUGN / DRUGN : An increase in the frequency of skin rash has been reported among patients receiving DRUGN or DRUGA concurrently with DRUGB compared to patients who are not receiving both drugs .
amoxicillin	drug	allopurinol	drug
effect

DRUGA : Enhanced bone marrow suppression by DRUGB and other DRUGN has been reported among patients with neoplastic disease , except leukemia , in the presence of DRUGN .
Cytotoxic Agents	group	cyclophosphamide	drug
false

DRUGA : Enhanced bone marrow suppression by DRUGN and other DRUGB has been reported among patients with neoplastic disease , except leukemia , in the presence of DRUGN .
Cytotoxic Agents	group	cytotoxic agents	group
false

DRUGA : Enhanced bone marrow suppression by DRUGN and other DRUGN has been reported among patients with neoplastic disease , except leukemia , in the presence of DRUGB .
Cytotoxic Agents	group	allopurinol	drug
false

DRUGN : Enhanced bone marrow suppression by DRUGA and other DRUGB has been reported among patients with neoplastic disease , except leukemia , in the presence of DRUGN .
cyclophosphamide	drug	cytotoxic agents	group
false

DRUGN : Enhanced bone marrow suppression by DRUGA and other DRUGN has been reported among patients with neoplastic disease , except leukemia , in the presence of DRUGB .
cyclophosphamide	drug	allopurinol	drug
effect

DRUGN : Enhanced bone marrow suppression by DRUGN and other DRUGA has been reported among patients with neoplastic disease , except leukemia , in the presence of DRUGB .
cytotoxic agents	group	allopurinol	drug
effect

However , in a well controlled study of patients with lymphoma on combination therapy , DRUGA did not increase the marrow toxicity of patients treated with DRUGB , DRUGN , DRUGN , DRUGN and / or DRUGN .
allopurinol	drug	cyclophosphamide	drug
false

However , in a well controlled study of patients with lymphoma on combination therapy , DRUGA did not increase the marrow toxicity of patients treated with DRUGN , DRUGB , DRUGN , DRUGN and / or DRUGN .
allopurinol	drug	doxorubicin	drug
false

However , in a well controlled study of patients with lymphoma on combination therapy , DRUGA did not increase the marrow toxicity of patients treated with DRUGN , DRUGN , DRUGB , DRUGN and / or DRUGN .
allopurinol	drug	bleomycin	drug
false

However , in a well controlled study of patients with lymphoma on combination therapy , DRUGA did not increase the marrow toxicity of patients treated with DRUGN , DRUGN , DRUGN , DRUGB and / or DRUGN .
allopurinol	drug	procarbazine	drug
false

However , in a well controlled study of patients with lymphoma on combination therapy , DRUGA did not increase the marrow toxicity of patients treated with DRUGN , DRUGN , DRUGN , DRUGN and / or DRUGB .
allopurinol	drug	mechlorethamine	drug
false

However , in a well controlled study of patients with lymphoma on combination therapy , DRUGN did not increase the marrow toxicity of patients treated with DRUGA , DRUGB , DRUGN , DRUGN and / or DRUGN .
cyclophosphamide	drug	doxorubicin	drug
false

However , in a well controlled study of patients with lymphoma on combination therapy , DRUGN did not increase the marrow toxicity of patients treated with DRUGA , DRUGN , DRUGB , DRUGN and / or DRUGN .
cyclophosphamide	drug	bleomycin	drug
false

However , in a well controlled study of patients with lymphoma on combination therapy , DRUGN did not increase the marrow toxicity of patients treated with DRUGA , DRUGN , DRUGN , DRUGB and / or DRUGN .
cyclophosphamide	drug	procarbazine	drug
false

However , in a well controlled study of patients with lymphoma on combination therapy , DRUGN did not increase the marrow toxicity of patients treated with DRUGA , DRUGN , DRUGN , DRUGN and / or DRUGB .
cyclophosphamide	drug	mechlorethamine	drug
false

However , in a well controlled study of patients with lymphoma on combination therapy , DRUGN did not increase the marrow toxicity of patients treated with DRUGN , DRUGA , DRUGB , DRUGN and / or DRUGN .
doxorubicin	drug	bleomycin	drug
false

However , in a well controlled study of patients with lymphoma on combination therapy , DRUGN did not increase the marrow toxicity of patients treated with DRUGN , DRUGA , DRUGN , DRUGB and / or DRUGN .
doxorubicin	drug	procarbazine	drug
false

However , in a well controlled study of patients with lymphoma on combination therapy , DRUGN did not increase the marrow toxicity of patients treated with DRUGN , DRUGA , DRUGN , DRUGN and / or DRUGB .
doxorubicin	drug	mechlorethamine	drug
false

However , in a well controlled study of patients with lymphoma on combination therapy , DRUGN did not increase the marrow toxicity of patients treated with DRUGN , DRUGN , DRUGA , DRUGB and / or DRUGN .
bleomycin	drug	procarbazine	drug
false

However , in a well controlled study of patients with lymphoma on combination therapy , DRUGN did not increase the marrow toxicity of patients treated with DRUGN , DRUGN , DRUGA , DRUGN and / or DRUGB .
bleomycin	drug	mechlorethamine	drug
false

However , in a well controlled study of patients with lymphoma on combination therapy , DRUGN did not increase the marrow toxicity of patients treated with DRUGN , DRUGN , DRUGN , DRUGA and / or DRUGB .
procarbazine	drug	mechlorethamine	drug
false

DRUGA : DRUGN s plasma half life may be prolonged by DRUGB , since DRUGN and DRUGN may compete for excretion in the renal tubule .
Chlorpropamide	drug	allopurinol	drug
false

DRUGA : DRUGN s plasma half life may be prolonged by DRUGN , since DRUGB and DRUGN may compete for excretion in the renal tubule .
Chlorpropamide	drug	allopurinol	drug
false

DRUGA : DRUGN s plasma half life may be prolonged by DRUGN , since DRUGN and DRUGB may compete for excretion in the renal tubule .
Chlorpropamide	drug	chlorpropamide	drug
false

DRUGN : DRUGA s plasma half life may be prolonged by DRUGB , since DRUGN and DRUGN may compete for excretion in the renal tubule .
Chlorpropamide	drug	allopurinol	drug
mechanism

DRUGN : DRUGA s plasma half life may be prolonged by DRUGN , since DRUGB and DRUGN may compete for excretion in the renal tubule .
Chlorpropamide	drug	allopurinol	drug
false

DRUGN : DRUGA s plasma half life may be prolonged by DRUGN , since DRUGN and DRUGB may compete for excretion in the renal tubule .
Chlorpropamide	drug	chlorpropamide	drug
false

DRUGN : DRUGN s plasma half life may be prolonged by DRUGA , since DRUGN and DRUGB may compete for excretion in the renal tubule .
allopurinol	drug	chlorpropamide	drug
false

DRUGN : DRUGN s plasma half life may be prolonged by DRUGN , since DRUGA and DRUGB may compete for excretion in the renal tubule .
allopurinol	drug	chlorpropamide	drug
mechanism

The risk of hypoglycemia secondary to this mechanism may be increased if DRUGA and DRUGB are given concomitantly in the presence of renal insufficiency .
allopurinol	drug	chlorpropamide	drug
effect

DRUGA : Reports indicate that DRUGB levels may be increased during concomitant treatment with DRUGN for injection .
Cyclosporin	drug	cyclosporine	drug
false

DRUGA : Reports indicate that DRUGN levels may be increased during concomitant treatment with DRUGB for injection .
Cyclosporin	drug	allopurinol sodium	drug
false

DRUGN : Reports indicate that DRUGA levels may be increased during concomitant treatment with DRUGB for injection .
cyclosporine	drug	allopurinol sodium	drug
mechanism

Because there is a theoretical basis that these effects may be additive , use of DRUGA containing or DRUGB ( like DRUGN or DRUGN ) and DRUGN within dgb hours of each other should be avoided .
ergotamine	drug	ergot-type medications	group
false

Because there is a theoretical basis that these effects may be additive , use of DRUGA containing or DRUGN ( like DRUGB or DRUGN ) and DRUGN within dgb hours of each other should be avoided .
ergotamine	drug	dihydroergotamine	drug
false

Because there is a theoretical basis that these effects may be additive , use of DRUGA containing or DRUGN ( like DRUGN or DRUGB ) and DRUGN within dgb hours of each other should be avoided .
ergotamine	drug	methysergide	drug
false

Because there is a theoretical basis that these effects may be additive , use of DRUGA containing or DRUGN ( like DRUGN or DRUGN ) and DRUGB within dgb hours of each other should be avoided .
ergotamine	drug	AXERT	brand
advise

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGA ( like DRUGB or DRUGN ) and DRUGN within dgb hours of each other should be avoided .
ergot-type medications	group	dihydroergotamine	drug
false

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGA ( like DRUGN or DRUGB ) and DRUGN within dgb hours of each other should be avoided .
ergot-type medications	group	methysergide	drug
false

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGA ( like DRUGN or DRUGN ) and DRUGB within dgb hours of each other should be avoided .
ergot-type medications	group	AXERT	brand
advise

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGN ( like DRUGA or DRUGB ) and DRUGN within dgb hours of each other should be avoided .
dihydroergotamine	drug	methysergide	drug
false

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGN ( like DRUGA or DRUGN ) and DRUGB within dgb hours of each other should be avoided .
dihydroergotamine	drug	AXERT	brand
advise

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGN ( like DRUGN or DRUGA ) and DRUGB within dgb hours of each other should be avoided .
methysergide	drug	AXERT	brand
advise

DRUGA : Coadministration of DRUGB resulted in a dgb % decrease in DRUGN clearance and an increase in Cmax of approximately dgb % .
Monoamine Oxidase Inhibitors	group	moclobemide	drug
false

DRUGA : Coadministration of DRUGN resulted in a dgb % decrease in DRUGB clearance and an increase in Cmax of approximately dgb % .
Monoamine Oxidase Inhibitors	group	almotriptan	drug
false

DRUGN : Coadministration of DRUGA resulted in a dgb % decrease in DRUGB clearance and an increase in Cmax of approximately dgb % .
moclobemide	drug	almotriptan	drug
mechanism

Other DRUGA Concomitant use of other DRUGB within dgb hours of treatment with DRUGN is contraindicated .
5-HT1B/1D Agonists	group	5-HT1B/1D agonists	group
false

Other DRUGA Concomitant use of other DRUGN within dgb hours of treatment with DRUGB is contraindicated .
5-HT1B/1D Agonists	group	AXERT	brand
false

Other DRUGN Concomitant use of other DRUGA within dgb hours of treatment with DRUGB is contraindicated .
5-HT1B/1D agonists	group	AXERT	brand
advise

DRUGA : The pharmacokinetics of DRUGB were not affected by coadministration of DRUGN .
Propanolol	drug	almotriptan	drug
false

DRUGA : The pharmacokinetics of DRUGN were not affected by coadministration of DRUGB .
Propanolol	drug	propranolol	drug
false

DRUGN : The pharmacokinetics of DRUGA were not affected by coadministration of DRUGB .
almotriptan	drug	propranolol	drug
false

DRUGA ( DRUGB ) : DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
Selective Serotonin Reuptake Inhibitors	group	SSRIs	group
false

DRUGA ( DRUGN ) : DRUGB ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
Selective Serotonin Reuptake Inhibitors	group	SSRIs	group
false

DRUGA ( DRUGN ) : DRUGN ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
Selective Serotonin Reuptake Inhibitors	group	fluoxetine	drug
false

DRUGA ( DRUGN ) : DRUGN ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
Selective Serotonin Reuptake Inhibitors	group	fluvoxamine	drug
false

DRUGA ( DRUGN ) : DRUGN ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
Selective Serotonin Reuptake Inhibitors	group	paroxetine	drug
false

DRUGA ( DRUGN ) : DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
Selective Serotonin Reuptake Inhibitors	group	sertraline	drug
false

DRUGA ( DRUGN ) : DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGB .
Selective Serotonin Reuptake Inhibitors	group	5-HT1 agonists	group
false

DRUGN ( DRUGA ) : DRUGN ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
SSRIs	group	fluoxetine	drug
false

DRUGN ( DRUGA ) : DRUGN ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
SSRIs	group	fluvoxamine	drug
false

DRUGN ( DRUGA ) : DRUGN ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
SSRIs	group	paroxetine	drug
false

DRUGN ( DRUGA ) : DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
SSRIs	group	sertraline	drug
false

DRUGN ( DRUGA ) : DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGB .
SSRIs	group	5-HT1 agonists	group
false

DRUGN ( DRUGN ) : DRUGA ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
SSRIs	group	fluoxetine	drug
false

DRUGN ( DRUGN ) : DRUGA ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
SSRIs	group	fluvoxamine	drug
false

DRUGN ( DRUGN ) : DRUGA ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
SSRIs	group	paroxetine	drug
false

DRUGN ( DRUGN ) : DRUGA ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
SSRIs	group	sertraline	drug
false

DRUGN ( DRUGN ) : DRUGA ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGB .
SSRIs	group	5-HT1 agonists	group
effect

DRUGN ( DRUGN ) : DRUGN ( e.g . , DRUGA , DRUGB , DRUGN , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
fluoxetine	drug	fluvoxamine	drug
false

DRUGN ( DRUGN ) : DRUGN ( e.g . , DRUGA , DRUGN , DRUGB , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
fluoxetine	drug	paroxetine	drug
false

DRUGN ( DRUGN ) : DRUGN ( e.g . , DRUGA , DRUGN , DRUGN , DRUGB ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
fluoxetine	drug	sertraline	drug
false

DRUGN ( DRUGN ) : DRUGN ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGB .
fluoxetine	drug	5-HT1 agonists	group
effect

DRUGN ( DRUGN ) : DRUGN ( e.g . , DRUGN , DRUGA , DRUGB , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
fluvoxamine	drug	paroxetine	drug
false

DRUGN ( DRUGN ) : DRUGN ( e.g . , DRUGN , DRUGA , DRUGN , DRUGB ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
fluvoxamine	drug	sertraline	drug
false

DRUGN ( DRUGN ) : DRUGN ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGB .
fluvoxamine	drug	5-HT1 agonists	group
effect

DRUGN ( DRUGN ) : DRUGN ( e.g . , DRUGN , DRUGN , DRUGA , DRUGB ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
paroxetine	drug	sertraline	drug
false

DRUGN ( DRUGN ) : DRUGN ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGB .
paroxetine	drug	5-HT1 agonists	group
effect

DRUGN ( DRUGN ) : DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGB .
sertraline	drug	5-HT1 agonists	group
effect

If concomitant treatment with DRUGA and an DRUGB is clinically warranted , appropriate observation of the patient is advised .
AXERT	brand	SSRI	group
advise

DRUGA : Coadministration of DRUGB and DRUGN resulted in a dgb % increase in plasma concentrations of DRUGN .
Verapamil	drug	almotriptan	drug
false

DRUGA : Coadministration of DRUGN and DRUGB resulted in a dgb % increase in plasma concentrations of DRUGN .
Verapamil	drug	verapamil	drug
false

DRUGA : Coadministration of DRUGN and DRUGN resulted in a dgb % increase in plasma concentrations of DRUGB .
Verapamil	drug	almotriptan	drug
false

DRUGN : Coadministration of DRUGA and DRUGB resulted in a dgb % increase in plasma concentrations of DRUGN .
almotriptan	drug	verapamil	drug
mechanism

DRUGN : Coadministration of DRUGN and DRUGA resulted in a dgb % increase in plasma concentrations of DRUGB .
verapamil	drug	almotriptan	drug
false

In a pharmacokinetic study , dgb healthy female subjects received DRUGA in escalating doses from dgb to dgb mg per day for dgb days , with coadministration of DRUGB dgb mg on the last day .
fluvoxamine	drug	alosetron	drug
false

DRUGA increased mean DRUGB plasma concentrations ( AUC ) approximately dgb fold and prolonged the half life by approximately dgb fold .
Fluvoxamine	drug	alosetron	drug
mechanism

Concomitant administration of DRUGA and DRUGB is contraindicated .
alosetron	drug	fluvoxamine	drug
advise

Concomitant administration of DRUGA and moderate CYPdgbAdgb inhibitors , including DRUGB and DRUGN , has not been evaluated , but should be avoided unless clinically necessary because of similar potential drug interactions .
alosetron	drug	quinolone antibiotics	group
advise

Concomitant administration of DRUGA and moderate CYPdgbAdgb inhibitors , including DRUGN and DRUGB , has not been evaluated , but should be avoided unless clinically necessary because of similar potential drug interactions .
alosetron	drug	cimetidine	drug
advise

Concomitant administration of DRUGN and moderate CYPdgbAdgb inhibitors , including DRUGA and DRUGB , has not been evaluated , but should be avoided unless clinically necessary because of similar potential drug interactions .
quinolone antibiotics	group	cimetidine	drug
false

In a pharmacokinetic study , dgb healthy female subjects received DRUGA dgb mg twice daily for dgb days , with coadministration of DRUGB dgb mg on the last day .
ketoconazole	drug	alosetron	drug
false

DRUGA increased mean DRUGB plasma concentrations ( AUC ) by dgb % .
Ketoconazole	drug	alosetron	drug
mechanism

Caution should be used when DRUGA and DRUGB are administered concomitantly .
alosetron	drug	ketoconazole	drug
advise

Coadministration of DRUGA and strong CYPdgbAdgb inhibitors , such as DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
alosetron	drug	clarithromycin	drug
advise

Coadministration of DRUGA and strong CYPdgbAdgb inhibitors , such as DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
alosetron	drug	telithromycin	drug
advise

Coadministration of DRUGA and strong CYPdgbAdgb inhibitors , such as DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
alosetron	drug	protease inhibitors	group
advise

Coadministration of DRUGA and strong CYPdgbAdgb inhibitors , such as DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
alosetron	drug	voriconazole	drug
advise

Coadministration of DRUGA and strong CYPdgbAdgb inhibitors , such as DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
alosetron	drug	itraconazole	drug
advise

Coadministration of DRUGN and strong CYPdgbAdgb inhibitors , such as DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
clarithromycin	drug	telithromycin	drug
false

Coadministration of DRUGN and strong CYPdgbAdgb inhibitors , such as DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
clarithromycin	drug	protease inhibitors	group
false

Coadministration of DRUGN and strong CYPdgbAdgb inhibitors , such as DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
clarithromycin	drug	voriconazole	drug
false

Coadministration of DRUGN and strong CYPdgbAdgb inhibitors , such as DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
clarithromycin	drug	itraconazole	drug
false

Coadministration of DRUGN and strong CYPdgbAdgb inhibitors , such as DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
telithromycin	drug	protease inhibitors	group
false

Coadministration of DRUGN and strong CYPdgbAdgb inhibitors , such as DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
telithromycin	drug	voriconazole	drug
false

Coadministration of DRUGN and strong CYPdgbAdgb inhibitors , such as DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
telithromycin	drug	itraconazole	drug
false

Coadministration of DRUGN and strong CYPdgbAdgb inhibitors , such as DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
protease inhibitors	group	voriconazole	drug
false

Coadministration of DRUGN and strong CYPdgbAdgb inhibitors , such as DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
protease inhibitors	group	itraconazole	drug
false

Coadministration of DRUGN and strong CYPdgbAdgb inhibitors , such as DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
voriconazole	drug	itraconazole	drug
false

Although not studied with DRUGA , inhibition of N acetyltransferase may have clinically relevant consequences for drugs such as DRUGB , DRUGN , and DRUGN .
alosetron	drug	isoniazid	drug
effect

Although not studied with DRUGA , inhibition of N acetyltransferase may have clinically relevant consequences for drugs such as DRUGN , DRUGB , and DRUGN .
alosetron	drug	procainamide	drug
effect

Although not studied with DRUGA , inhibition of N acetyltransferase may have clinically relevant consequences for drugs such as DRUGN , DRUGN , and DRUGB .
alosetron	drug	hydralazine	drug
effect

Although not studied with DRUGN , inhibition of N acetyltransferase may have clinically relevant consequences for drugs such as DRUGA , DRUGB , and DRUGN .
isoniazid	drug	procainamide	drug
false

Although not studied with DRUGN , inhibition of N acetyltransferase may have clinically relevant consequences for drugs such as DRUGA , DRUGN , and DRUGB .
isoniazid	drug	hydralazine	drug
false

Although not studied with DRUGN , inhibition of N acetyltransferase may have clinically relevant consequences for drugs such as DRUGN , DRUGA , and DRUGB .
procainamide	drug	hydralazine	drug
false

Another study showed that DRUGA had no clinically significant effect on plasma concentrations of the oral DRUGB DRUGN and DRUGN ( CYPdgbAdgb substrates ) .
alosetron	drug	contraceptive agents	group
false

Another study showed that DRUGA had no clinically significant effect on plasma concentrations of the oral DRUGN DRUGB and DRUGN ( CYPdgbAdgb substrates ) .
alosetron	drug	ethinyl estradiol	drug
false

Another study showed that DRUGA had no clinically significant effect on plasma concentrations of the oral DRUGN DRUGN and DRUGB ( CYPdgbAdgb substrates ) .
alosetron	drug	levonorgestrel	drug
false

Another study showed that DRUGN had no clinically significant effect on plasma concentrations of the oral DRUGA DRUGB and DRUGN ( CYPdgbAdgb substrates ) .
contraceptive agents	group	ethinyl estradiol	drug
false

Another study showed that DRUGN had no clinically significant effect on plasma concentrations of the oral DRUGA DRUGN and DRUGB ( CYPdgbAdgb substrates ) .
contraceptive agents	group	levonorgestrel	drug
false

Another study showed that DRUGN had no clinically significant effect on plasma concentrations of the oral DRUGN DRUGA and DRUGB ( CYPdgbAdgb substrates ) .
ethinyl estradiol	drug	levonorgestrel	drug
false

A clinical interaction study was also conducted with DRUGA and the CYPdgbAdgb substrate DRUGB .
alosetron	drug	cisapride	drug
false

The DRUGA , including DRUGB , produce additive CNS depressant effects when co administered with other DRUGN , DRUGN , DRUGN , DRUGN , and other drugs which themselves produce CNS depression .
benzodiazepines	group	alprazolam	drug
false

The DRUGA , including DRUGN , produce additive CNS depressant effects when co administered with other DRUGB , DRUGN , DRUGN , DRUGN , and other drugs which themselves produce CNS depression .
benzodiazepines	group	psychotropic medications	group
effect

The DRUGA , including DRUGN , produce additive CNS depressant effects when co administered with other DRUGN , DRUGB , DRUGN , DRUGN , and other drugs which themselves produce CNS depression .
benzodiazepines	group	anticonvulsants	group
effect

The DRUGA , including DRUGN , produce additive CNS depressant effects when co administered with other DRUGN , DRUGN , DRUGB , DRUGN , and other drugs which themselves produce CNS depression .
benzodiazepines	group	antihistaminics	group
effect

The DRUGA , including DRUGN , produce additive CNS depressant effects when co administered with other DRUGN , DRUGN , DRUGN , DRUGB , and other drugs which themselves produce CNS depression .
benzodiazepines	group	ethanol	drug
effect

The DRUGN , including DRUGA , produce additive CNS depressant effects when co administered with other DRUGB , DRUGN , DRUGN , DRUGN , and other drugs which themselves produce CNS depression .
alprazolam	drug	psychotropic medications	group
effect

The DRUGN , including DRUGA , produce additive CNS depressant effects when co administered with other DRUGN , DRUGB , DRUGN , DRUGN , and other drugs which themselves produce CNS depression .
alprazolam	drug	anticonvulsants	group
effect

The DRUGN , including DRUGA , produce additive CNS depressant effects when co administered with other DRUGN , DRUGN , DRUGB , DRUGN , and other drugs which themselves produce CNS depression .
alprazolam	drug	antihistaminics	group
effect

The DRUGN , including DRUGA , produce additive CNS depressant effects when co administered with other DRUGN , DRUGN , DRUGN , DRUGB , and other drugs which themselves produce CNS depression .
alprazolam	drug	ethanol	drug
effect

The DRUGN , including DRUGN , produce additive CNS depressant effects when co administered with other DRUGA , DRUGB , DRUGN , DRUGN , and other drugs which themselves produce CNS depression .
psychotropic medications	group	anticonvulsants	group
false

The DRUGN , including DRUGN , produce additive CNS depressant effects when co administered with other DRUGA , DRUGN , DRUGB , DRUGN , and other drugs which themselves produce CNS depression .
psychotropic medications	group	antihistaminics	group
false

The DRUGN , including DRUGN , produce additive CNS depressant effects when co administered with other DRUGA , DRUGN , DRUGN , DRUGB , and other drugs which themselves produce CNS depression .
psychotropic medications	group	ethanol	drug
false

The DRUGN , including DRUGN , produce additive CNS depressant effects when co administered with other DRUGN , DRUGA , DRUGB , DRUGN , and other drugs which themselves produce CNS depression .
anticonvulsants	group	antihistaminics	group
false

The DRUGN , including DRUGN , produce additive CNS depressant effects when co administered with other DRUGN , DRUGA , DRUGN , DRUGB , and other drugs which themselves produce CNS depression .
anticonvulsants	group	ethanol	drug
false

The DRUGN , including DRUGN , produce additive CNS depressant effects when co administered with other DRUGN , DRUGN , DRUGA , DRUGB , and other drugs which themselves produce CNS depression .
antihistaminics	group	ethanol	drug
false

Drugs That Inhibit DRUGA Metabolism Via Cytochrome Pdgb dgbA : The initial step in DRUGB metabolism is hydroxylation catalyzed by cytochrome Pdgb dgbA ( CYP dgbA ) .
Alprazolam	drug	alprazolam	drug
false

Coadministration of DRUGA decreased the maximum plasma concentration of DRUGB by dgb % , decreased clearance by dgb % , and increased half life by dgb % .
propoxyphene	drug	alprazolam	drug
mechanism

Coadministration of oral DRUGA increased the maximum plasma concentration of DRUGB by dgb % , decreased clearance by dgb % , and increased half life by dgb % .
contraceptives	group	alprazolam	drug
mechanism

Data from in vitro studies of DRUGA suggest a possible drug interaction with DRUGN for the following : DRUGB and DRUGN .
alprazolam	drug	sertraline	drug
false

Data from in vitro studies of DRUGA suggest a possible drug interaction with DRUGN for the following : DRUGN and DRUGB .
alprazolam	drug	paroxetine	drug
false

Data from in vitro studies of DRUGN suggest a possible drug interaction with DRUGA for the following : DRUGB and DRUGN .
alprazolam	drug	sertraline	drug
int

Data from in vitro studies of DRUGN suggest a possible drug interaction with DRUGA for the following : DRUGN and DRUGB .
alprazolam	drug	paroxetine	drug
int

Data from in vitro studies of DRUGN suggest a possible drug interaction with DRUGN for the following : DRUGA and DRUGB .
sertraline	drug	paroxetine	drug
false

Data from in vitro studies of DRUGA other than DRUGB suggest a possible drug interaction for the following : DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
benzodiazepines	group	alprazolam	drug
false

Data from in vitro studies of DRUGA other than DRUGN suggest a possible drug interaction for the following : DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
benzodiazepines	group	ergotamine	drug
int

Data from in vitro studies of DRUGA other than DRUGN suggest a possible drug interaction for the following : DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
benzodiazepines	group	cyclosporine	drug
int

Data from in vitro studies of DRUGA other than DRUGN suggest a possible drug interaction for the following : DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
benzodiazepines	group	amiodarone	drug
int

Data from in vitro studies of DRUGA other than DRUGN suggest a possible drug interaction for the following : DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
benzodiazepines	group	nicardipine	drug
int

Data from in vitro studies of DRUGA other than DRUGN suggest a possible drug interaction for the following : DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
benzodiazepines	group	nifedipine	drug
int

Data from in vitro studies of DRUGN other than DRUGA suggest a possible drug interaction for the following : DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
alprazolam	drug	ergotamine	drug
int

Data from in vitro studies of DRUGN other than DRUGA suggest a possible drug interaction for the following : DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
alprazolam	drug	cyclosporine	drug
int

Data from in vitro studies of DRUGN other than DRUGA suggest a possible drug interaction for the following : DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
alprazolam	drug	amiodarone	drug
int

Data from in vitro studies of DRUGN other than DRUGA suggest a possible drug interaction for the following : DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
alprazolam	drug	nicardipine	drug
int

Data from in vitro studies of DRUGN other than DRUGA suggest a possible drug interaction for the following : DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
alprazolam	drug	nifedipine	drug
int

Data from in vitro studies of DRUGN other than DRUGN suggest a possible drug interaction for the following : DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
ergotamine	drug	cyclosporine	drug
false

Data from in vitro studies of DRUGN other than DRUGN suggest a possible drug interaction for the following : DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
ergotamine	drug	amiodarone	drug
false

Data from in vitro studies of DRUGN other than DRUGN suggest a possible drug interaction for the following : DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
ergotamine	drug	nicardipine	drug
false

Data from in vitro studies of DRUGN other than DRUGN suggest a possible drug interaction for the following : DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
ergotamine	drug	nifedipine	drug
false

Data from in vitro studies of DRUGN other than DRUGN suggest a possible drug interaction for the following : DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
cyclosporine	drug	amiodarone	drug
false

Data from in vitro studies of DRUGN other than DRUGN suggest a possible drug interaction for the following : DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
cyclosporine	drug	nicardipine	drug
false

Data from in vitro studies of DRUGN other than DRUGN suggest a possible drug interaction for the following : DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
cyclosporine	drug	nifedipine	drug
false

Data from in vitro studies of DRUGN other than DRUGN suggest a possible drug interaction for the following : DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
amiodarone	drug	nicardipine	drug
false

Data from in vitro studies of DRUGN other than DRUGN suggest a possible drug interaction for the following : DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
amiodarone	drug	nifedipine	drug
false

Data from in vitro studies of DRUGN other than DRUGN suggest a possible drug interaction for the following : DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
nicardipine	drug	nifedipine	drug
false

Standard therapy includes DRUGA , such as DRUGB and DRUGN ;
antibiotics	group	penicillin	drug
false

Standard therapy includes DRUGA , such as DRUGN and DRUGB ;
antibiotics	group	gentamicin	drug
false

Standard therapy includes DRUGN , such as DRUGA and DRUGB ;
penicillin	drug	gentamicin	drug
false

DRUGA , such as DRUGB and DRUGN ;
vasopressors	group	dopamine	drug
false

DRUGA , such as DRUGN and DRUGB ;
vasopressors	group	isoproterenol	drug
false

DRUGN , such as DRUGA and DRUGB ;
dopamine	drug	isoproterenol	drug
false

and DRUGA , such as DRUGB .
diuretics	group	furosemide	drug
false

DRUGA : The potential for pharmacokinetic drug drug interactions between DRUGB and other agents has not been formally studied .
Caverject	brand	alprostadil	drug
false

Use of DRUGA DRUGB and DRUGN have been administered concomitantly with and following infusions of DRUGN in the management of acute myocardial infarction or pulmonary embolism .
Antithrombotics	group	Aspirin	brand
false

Use of DRUGA DRUGN and DRUGB have been administered concomitantly with and following infusions of DRUGN in the management of acute myocardial infarction or pulmonary embolism .
Antithrombotics	group	heparin	drug
false

Use of DRUGA DRUGN and DRUGN have been administered concomitantly with and following infusions of DRUGB in the management of acute myocardial infarction or pulmonary embolism .
Antithrombotics	group	Activase	brand
false

Use of DRUGN DRUGA and DRUGB have been administered concomitantly with and following infusions of DRUGN in the management of acute myocardial infarction or pulmonary embolism .
Aspirin	brand	heparin	drug
false

Use of DRUGN DRUGA and DRUGN have been administered concomitantly with and following infusions of DRUGB in the management of acute myocardial infarction or pulmonary embolism .
Aspirin	brand	Activase	brand
false

Use of DRUGN DRUGN and DRUGA have been administered concomitantly with and following infusions of DRUGB in the management of acute myocardial infarction or pulmonary embolism .
heparin	drug	Activase	brand
false

Because DRUGA , DRUGB , or DRUGN may cause bleeding complications , careful monitoring for bleeding is advised , especially at arterial puncture sites .
heparin	drug	aspirin	brand
false

Because DRUGA , DRUGN , or DRUGB may cause bleeding complications , careful monitoring for bleeding is advised , especially at arterial puncture sites .
heparin	drug	Activase	brand
false

Because DRUGN , DRUGA , or DRUGB may cause bleeding complications , careful monitoring for bleeding is advised , especially at arterial puncture sites .
aspirin	brand	Activase	brand
false

The concomitant use of DRUGA or DRUGB during the first dgb hours following symptom onset were prohibited in The NINDS t PA Stroke Trial .
heparin	drug	aspirin	brand
false

Concurrent administration of DRUGA and DRUGB may cause severe orthostatic hypotension . DRUGN , an inhibitor of microsomal drug metabolism , increased DRUGN s half life and toxicity in a rat model .
HEXALEN	brand	antidepressants of the MAO inhibitor class	group
effect

Concurrent administration of DRUGA and DRUGN may cause severe orthostatic hypotension . DRUGB , an inhibitor of microsomal drug metabolism , increased DRUGN s half life and toxicity in a rat model .
HEXALEN	brand	Cimetidine	drug
false

Concurrent administration of DRUGA and DRUGN may cause severe orthostatic hypotension . DRUGN , an inhibitor of microsomal drug metabolism , increased DRUGB s half life and toxicity in a rat model .
HEXALEN	brand	altretamine	drug
false

Concurrent administration of DRUGN and DRUGA may cause severe orthostatic hypotension . DRUGB , an inhibitor of microsomal drug metabolism , increased DRUGN s half life and toxicity in a rat model .
antidepressants of the MAO inhibitor class	group	Cimetidine	drug
false

Concurrent administration of DRUGN and DRUGA may cause severe orthostatic hypotension . DRUGN , an inhibitor of microsomal drug metabolism , increased DRUGB s half life and toxicity in a rat model .
antidepressants of the MAO inhibitor class	group	altretamine	drug
false

Concurrent administration of DRUGN and DRUGN may cause severe orthostatic hypotension . DRUGA , an inhibitor of microsomal drug metabolism , increased DRUGB s half life and toxicity in a rat model .
Cimetidine	drug	altretamine	drug
mechanism

Data from a randomized trial of DRUGA and DRUGB plus or minus DRUGN in ovarian cancer indicated that DRUGN significantly reduced neurotoxicity ;
HEXALEN	brand	cisplatin	drug
effect

Data from a randomized trial of DRUGA and DRUGN plus or minus DRUGB in ovarian cancer indicated that DRUGN significantly reduced neurotoxicity ;
HEXALEN	brand	pyridoxine	drug
false

Data from a randomized trial of DRUGA and DRUGN plus or minus DRUGN in ovarian cancer indicated that DRUGB significantly reduced neurotoxicity ;
HEXALEN	brand	pyridoxine	drug
false

Data from a randomized trial of DRUGN and DRUGA plus or minus DRUGB in ovarian cancer indicated that DRUGN significantly reduced neurotoxicity ;
cisplatin	drug	pyridoxine	drug
false

Data from a randomized trial of DRUGN and DRUGA plus or minus DRUGN in ovarian cancer indicated that DRUGB significantly reduced neurotoxicity ;
cisplatin	drug	pyridoxine	drug
false

however , it adversely affected response duration suggesting that DRUGA should not be administered with DRUGB and / or DRUGN .dgb
pyridoxine	drug	HEXALEN	brand
advise

however , it adversely affected response duration suggesting that DRUGA should not be administered with DRUGN and / or DRUGB .dgb
pyridoxine	drug	cisplatin	drug
advise

however , it adversely affected response duration suggesting that DRUGN should not be administered with DRUGA and / or DRUGB .dgb
HEXALEN	brand	cisplatin	drug
false

Careful observation is required when DRUGA is administered concurrently with DRUGB .
amantadine	drug	central nervous system stimulants	group
advise

Special consideration should be given to the administration of DRUGA in patients receiving DRUGB or other drugs that could cause or potentiate hypotension .
ETHYOL	brand	antihypertensive medications	group
advise

When DRUGA HCl is administered concomitantly with an DRUGB , the risk of hyperkalemia may be increased .
amiloride	drug	angiotensin-converting enzyme inhibitor	group
effect

DRUGA generally should not be given with DRUGB because they reduce its renal clearance and add a high risk of lithium toxicity .
Lithium	drug	diuretics	group
advise

In some patients , the administration of a DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGB , DRUGN and DRUGN .
non-steroidal anti-inflammatory agent	group	loop diuretics	group
effect

In some patients , the administration of a DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGB and DRUGN .
non-steroidal anti-inflammatory agent	group	potassium-sparing diuretics	group
effect

In some patients , the administration of a DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGN and DRUGB .
non-steroidal anti-inflammatory agent	group	thiazide diuretics	group
effect

In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGA , DRUGB and DRUGN .
loop diuretics	group	potassium-sparing diuretics	group
false

In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGA , DRUGN and DRUGB .
loop diuretics	group	thiazide diuretics	group
false

In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGA and DRUGB .
potassium-sparing diuretics	group	thiazide diuretics	group
false

Therefore , when DRUGA and DRUGB are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGN is obtained .
MIDAMOR	brand	non-steroidal anti-inflammatory agents	group
advise

Therefore , when DRUGA and DRUGN are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGB is obtained .
MIDAMOR	brand	diuretic	group
false

Therefore , when DRUGN and DRUGA are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGB is obtained .
non-steroidal anti-inflammatory agents	group	diuretic	group
false

Since DRUGA and DRUGB , including DRUGN , may each be associated with increased serum potassium levels , the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently .
indomethacin	drug	potassium-sparing diuretics	group
effect

Since DRUGA and DRUGN , including DRUGB , may each be associated with increased serum potassium levels , the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently .
indomethacin	drug	MIDAMOR	brand
effect

Since DRUGN and DRUGA , including DRUGB , may each be associated with increased serum potassium levels , the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently .
potassium-sparing diuretics	group	MIDAMOR	brand
false

DRUGA accelerates the metabolism of DRUGB ;
Cytadren	brand	dexamethasone	drug
mechanism

therefore , if DRUGA replacement is needed , DRUGB should be prescribed .
glucocorticoid	group	hydrocortisone	drug
false

DRUGA diminishes the effect of DRUGB and DRUGN .
Aminoglutethimide	drug	coumarin	group
effect

DRUGA diminishes the effect of DRUGN and DRUGB .
Aminoglutethimide	drug	warfarin	drug
effect

DRUGN diminishes the effect of DRUGA and DRUGB .
coumarin	group	warfarin	drug
false

Renal clearance measurements of DRUGA can not be made with any significant accuracy in patients receiving DRUGB , DRUGN , or DRUGN .
PAH	drug	sulfonamides	group
effect

Renal clearance measurements of DRUGA can not be made with any significant accuracy in patients receiving DRUGN , DRUGB , or DRUGN .
PAH	drug	procaine	drug
effect

Renal clearance measurements of DRUGA can not be made with any significant accuracy in patients receiving DRUGN , DRUGN , or DRUGB .
PAH	drug	thiazolesulfone	drug
effect

Renal clearance measurements of DRUGN can not be made with any significant accuracy in patients receiving DRUGA , DRUGB , or DRUGN .
sulfonamides	group	procaine	drug
false

Renal clearance measurements of DRUGN can not be made with any significant accuracy in patients receiving DRUGA , DRUGN , or DRUGB .
sulfonamides	group	thiazolesulfone	drug
false

Renal clearance measurements of DRUGN can not be made with any significant accuracy in patients receiving DRUGN , DRUGA , or DRUGB .
procaine	drug	thiazolesulfone	drug
false

DRUGA depresses tubular secretion of certain weak acids such as DRUGB .
Probenecid	drug	PAH	drug
mechanism

Therefore , patients receiving DRUGA will have erroneously low ERPF and Tm DRUGB values .
probenecid	drug	PAH	drug
effect

DRUGA may decrease the amount of DRUGB ( DRUGN , DRUGN ) that gets absorbed into your body .
Aminosalicylic acid	drug	digoxin	drug
mechanism

DRUGA may decrease the amount of DRUGN ( DRUGB , DRUGN ) that gets absorbed into your body .
Aminosalicylic acid	drug	Lanoxin	brand
mechanism

DRUGA may decrease the amount of DRUGN ( DRUGN , DRUGB ) that gets absorbed into your body .
Aminosalicylic acid	drug	Lanoxicaps	drug
false

DRUGN may decrease the amount of DRUGA ( DRUGB , DRUGN ) that gets absorbed into your body .
digoxin	drug	Lanoxin	brand
false

DRUGN may decrease the amount of DRUGA ( DRUGN , DRUGB ) that gets absorbed into your body .
digoxin	drug	Lanoxicaps	drug
false

DRUGN may decrease the amount of DRUGN ( DRUGA , DRUGB ) that gets absorbed into your body .
Lanoxin	brand	Lanoxicaps	drug
false

In the case that you are taking DRUGA while taking DRUGB , higher doses of DRUGN may be needed .
digoxin	drug	aminosalicylic acid	drug
advise

In the case that you are taking DRUGN while taking DRUGA , higher doses of DRUGB may be needed .
aminosalicylic acid	drug	digoxin	drug
false

DRUGA may also decrease the absorption of DRUGB , which can lead to a deficiency .
Aminosalicylic acid	drug	vitamin B12	drug
mechanism

Therefore you may need to take a DRUGA supplement while taking DRUGB .
vitamin B12	drug	aminosalicylic acid	drug
advise

DRUGA is metabolized to DRUGB by the cytochrome Pdgb ( CYPdgb ) enzyme group , specifically cytochromes Pdgb dgbAdgb ( CYPdgbAdgb ) and CYPdgbCdga
Amiodarone	drug	desethylamiodarone	drug
false

Reported examples include the following : DRUGA : DRUGB are known to inhibit CYPdgbAdgb to varying degrees .
Protease Inhibitors	group	Protease inhibitors	group
false

A case report of one patient taking DRUGA dgb mg and DRUGB dgb mg three times a day resulted in increases in DRUGN concentrations from dga mg / L to dga mg / L .
amiodarone	drug	indinavir	drug
mechanism

A case report of one patient taking DRUGN dgb mg and DRUGA dgb mg three times a day resulted in increases in DRUGB concentrations from dga mg / L to dga mg / L .
indinavir	drug	amiodarone	drug
false

Monitoring for DRUGA toxicity and serial measurement of DRUGN serum concentration during concomitant DRUGB therapy should be considered .
amiodarone	drug	protease inhibitor	group
false

Monitoring for DRUGN toxicity and serial measurement of DRUGA serum concentration during concomitant DRUGB therapy should be considered .
amiodarone	drug	protease inhibitor	group
advise

DRUGA : DRUGB inhibits CYPdgbAdgb and can increase serum DRUGN levels .
Histamine H2 antagonists	group	Cimetidine	drug
mechanism

DRUGA : DRUGN inhibits CYPdgbAdgb and can increase serum DRUGB levels .
Histamine H2 antagonists	group	amiodarone	drug
false

DRUGN : DRUGA inhibits CYPdgbAdgb and can increase serum DRUGB levels .
Cimetidine	drug	amiodarone	drug
false

DRUGA may suppress certain CYPdgb enzymes , including DRUGB , DRUGN , DRUGN , and DRUGN .
Amiodarone	drug	CYP1A2	drug
false

DRUGA may suppress certain CYPdgb enzymes , including DRUGN , DRUGB , DRUGN , and DRUGN .
Amiodarone	drug	CYP2C9	drug
false

DRUGA may suppress certain CYPdgb enzymes , including DRUGN , DRUGN , DRUGB , and DRUGN .
Amiodarone	drug	CYP2D6	drug
false

DRUGA may suppress certain CYPdgb enzymes , including DRUGN , DRUGN , DRUGN , and DRUGB .
Amiodarone	drug	CYP3A4	drug
false

DRUGN may suppress certain CYPdgb enzymes , including DRUGA , DRUGB , DRUGN , and DRUGN .
CYP1A2	drug	CYP2C9	drug
false

DRUGN may suppress certain CYPdgb enzymes , including DRUGA , DRUGN , DRUGB , and DRUGN .
CYP1A2	drug	CYP2D6	drug
false

DRUGN may suppress certain CYPdgb enzymes , including DRUGA , DRUGN , DRUGN , and DRUGB .
CYP1A2	drug	CYP3A4	drug
false

DRUGN may suppress certain CYPdgb enzymes , including DRUGN , DRUGA , DRUGB , and DRUGN .
CYP2C9	drug	CYP2D6	drug
false

DRUGN may suppress certain CYPdgb enzymes , including DRUGN , DRUGA , DRUGN , and DRUGB .
CYP2C9	drug	CYP3A4	drug
false

DRUGN may suppress certain CYPdgb enzymes , including DRUGN , DRUGN , DRUGA , and DRUGB .
CYP2D6	drug	CYP3A4	drug
false

DRUGA : DRUGB ( DRUGN substrate ) in combination with DRUGN has been associated with reports of myopathy / rhabdomyolysis .
HMG-CoA Reductase Inhibitors	drug	Simvastatin	drug
false

DRUGA : DRUGN ( DRUGB substrate ) in combination with DRUGN has been associated with reports of myopathy / rhabdomyolysis .
HMG-CoA Reductase Inhibitors	drug	CYP3A4	drug
false

DRUGA : DRUGN ( DRUGN substrate ) in combination with DRUGB has been associated with reports of myopathy / rhabdomyolysis .
HMG-CoA Reductase Inhibitors	drug	amiodarone	drug
false

DRUGN : DRUGA ( DRUGB substrate ) in combination with DRUGN has been associated with reports of myopathy / rhabdomyolysis .
Simvastatin	drug	CYP3A4	drug
false

DRUGN : DRUGA ( DRUGN substrate ) in combination with DRUGB has been associated with reports of myopathy / rhabdomyolysis .
Simvastatin	drug	amiodarone	drug
false

DRUGN : DRUGN ( DRUGA substrate ) in combination with DRUGB has been associated with reports of myopathy / rhabdomyolysis .
CYP3A4	drug	amiodarone	drug
false

Cardiovasculars : DRUGA : In patients receiving DRUGB therapy , administration of oral DRUGN regularly results in an increase in serum DRUGN concentration that may reach toxic levels with resultant clinical toxicity .
Cardiac glycosides	drug	digoxin	drug
false

Cardiovasculars : DRUGA : In patients receiving DRUGN therapy , administration of oral DRUGB regularly results in an increase in serum DRUGN concentration that may reach toxic levels with resultant clinical toxicity .
Cardiac glycosides	drug	amiodarone	drug
false

Cardiovasculars : DRUGA : In patients receiving DRUGN therapy , administration of oral DRUGN regularly results in an increase in serum DRUGB concentration that may reach toxic levels with resultant clinical toxicity .
Cardiac glycosides	drug	digoxin	drug
false

Cardiovasculars : DRUGN : In patients receiving DRUGA therapy , administration of oral DRUGB regularly results in an increase in serum DRUGN concentration that may reach toxic levels with resultant clinical toxicity .
digoxin	drug	amiodarone	drug
false

Cardiovasculars : DRUGN : In patients receiving DRUGN therapy , administration of oral DRUGA regularly results in an increase in serum DRUGB concentration that may reach toxic levels with resultant clinical toxicity .
amiodarone	drug	digoxin	drug
false

DRUGA taken concomitantly with DRUGB increases the serum DRUGN concentration by dgb % after one day .
Amiodarone	drug	digoxin	drug
false

DRUGA taken concomitantly with DRUGN increases the serum DRUGB concentration by dgb % after one day .
Amiodarone	drug	digoxin	drug
false

On administration of oral DRUGA , the need for DRUGB therapy should be reviewed and the dose reduced by approximately dgb % or discontinued .
amiodarone	drug	digitalis	group
advise

DRUGA : Other DRUGB drugs , such as DRUGN , DRUGN , DRUGN , and DRUGN , have been used concurrently with DRUGN .
Antiarrhythmics	drug	antiarrhythmic	drug
false

DRUGA : Other DRUGN drugs , such as DRUGB , DRUGN , DRUGN , and DRUGN , have been used concurrently with DRUGN .
Antiarrhythmics	drug	quinidine	drug
false

DRUGA : Other DRUGN drugs , such as DRUGN , DRUGB , DRUGN , and DRUGN , have been used concurrently with DRUGN .
Antiarrhythmics	drug	procainamide	drug
false

DRUGA : Other DRUGN drugs , such as DRUGN , DRUGN , DRUGB , and DRUGN , have been used concurrently with DRUGN .
Antiarrhythmics	drug	disopyramide	drug
false

DRUGA : Other DRUGN drugs , such as DRUGN , DRUGN , DRUGN , and DRUGB , have been used concurrently with DRUGN .
Antiarrhythmics	drug	phenytoin	drug
false

DRUGA : Other DRUGN drugs , such as DRUGN , DRUGN , DRUGN , and DRUGN , have been used concurrently with DRUGB .
Antiarrhythmics	drug	amiodarone	drug
false

DRUGN : Other DRUGA drugs , such as DRUGB , DRUGN , DRUGN , and DRUGN , have been used concurrently with DRUGN .
antiarrhythmic	drug	quinidine	drug
false

DRUGN : Other DRUGA drugs , such as DRUGN , DRUGB , DRUGN , and DRUGN , have been used concurrently with DRUGN .
antiarrhythmic	drug	procainamide	drug
false

DRUGN : Other DRUGA drugs , such as DRUGN , DRUGN , DRUGB , and DRUGN , have been used concurrently with DRUGN .
antiarrhythmic	drug	disopyramide	drug
false

DRUGN : Other DRUGA drugs , such as DRUGN , DRUGN , DRUGN , and DRUGB , have been used concurrently with DRUGN .
antiarrhythmic	drug	phenytoin	drug
false

DRUGN : Other DRUGA drugs , such as DRUGN , DRUGN , DRUGN , and DRUGN , have been used concurrently with DRUGB .
antiarrhythmic	drug	amiodarone	drug
false

DRUGN : Other DRUGN drugs , such as DRUGA , DRUGB , DRUGN , and DRUGN , have been used concurrently with DRUGN .
quinidine	drug	procainamide	drug
false

DRUGN : Other DRUGN drugs , such as DRUGA , DRUGN , DRUGB , and DRUGN , have been used concurrently with DRUGN .
quinidine	drug	disopyramide	drug
false

DRUGN : Other DRUGN drugs , such as DRUGA , DRUGN , DRUGN , and DRUGB , have been used concurrently with DRUGN .
quinidine	drug	phenytoin	drug
false

DRUGN : Other DRUGN drugs , such as DRUGA , DRUGN , DRUGN , and DRUGN , have been used concurrently with DRUGB .
quinidine	drug	amiodarone	drug
false

DRUGN : Other DRUGN drugs , such as DRUGN , DRUGA , DRUGB , and DRUGN , have been used concurrently with DRUGN .
procainamide	drug	disopyramide	drug
false

DRUGN : Other DRUGN drugs , such as DRUGN , DRUGA , DRUGN , and DRUGB , have been used concurrently with DRUGN .
procainamide	drug	phenytoin	drug
false

DRUGN : Other DRUGN drugs , such as DRUGN , DRUGA , DRUGN , and DRUGN , have been used concurrently with DRUGB .
procainamide	drug	amiodarone	drug
false

DRUGN : Other DRUGN drugs , such as DRUGN , DRUGN , DRUGA , and DRUGB , have been used concurrently with DRUGN .
disopyramide	drug	phenytoin	drug
false

DRUGN : Other DRUGN drugs , such as DRUGN , DRUGN , DRUGA , and DRUGN , have been used concurrently with DRUGB .
disopyramide	drug	amiodarone	drug
false

DRUGN : Other DRUGN drugs , such as DRUGN , DRUGN , DRUGN , and DRUGA , have been used concurrently with DRUGB .
phenytoin	drug	amiodarone	drug
false

There have been case reports of increased steady state levels of DRUGA , DRUGB , and DRUGN during concomitant therapy with DRUGN .
quinidine	drug	procainamide	drug
false

There have been case reports of increased steady state levels of DRUGA , DRUGN , and DRUGB during concomitant therapy with DRUGN .
quinidine	drug	phenytoin	drug
false

There have been case reports of increased steady state levels of DRUGA , DRUGN , and DRUGN during concomitant therapy with DRUGB .
quinidine	drug	amiodarone	drug
false

There have been case reports of increased steady state levels of DRUGN , DRUGA , and DRUGB during concomitant therapy with DRUGN .
procainamide	drug	phenytoin	drug
false

There have been case reports of increased steady state levels of DRUGN , DRUGA , and DRUGN during concomitant therapy with DRUGB .
procainamide	drug	amiodarone	drug
false

There have been case reports of increased steady state levels of DRUGN , DRUGN , and DRUGA during concomitant therapy with DRUGB .
phenytoin	drug	amiodarone	drug
false

DRUGA taken concomitantly with DRUGB increases DRUGN serum concentration by dgb % after two days .
Amiodarone	drug	quinidine	drug
false

DRUGA taken concomitantly with DRUGN increases DRUGB serum concentration by dgb % after two days .
Amiodarone	drug	quinidine	drug
false

DRUGA taken concomitantly with DRUGB for less than seven days increases plasma concentrations of DRUGN and n acetyl DRUGN by dgb % and dgb % , respectively .
Amiodarone	drug	procainamide	drug
false

DRUGA taken concomitantly with DRUGN for less than seven days increases plasma concentrations of DRUGB and n acetyl DRUGN by dgb % and dgb % , respectively .
Amiodarone	drug	procainamide	drug
false

DRUGA taken concomitantly with DRUGN for less than seven days increases plasma concentrations of DRUGN and n acetyl DRUGB by dgb % and dgb % , respectively .
Amiodarone	drug	procainamide	drug
false

DRUGA and procainamide doses should be reduced by one third when either is administered with DRUGB .
Quinidine	drug	amiodarone	drug
false

Plasma levels of DRUGA have been reported to increase in the presence of oral DRUGB ;
flecainide	drug	amiodarone	drug
false

because of this , the dosage of DRUGA should be adjusted when these DRUGB are administered concomitantly .
flecainide	drug	drugs	drug
false

Combination of DRUGA with other DRUGB therapy should be reserved for patients with life threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to DRUGN .
amiodarone	drug	antiarrhythmic	drug
false

Combination of DRUGN with other DRUGA therapy should be reserved for patients with life threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to DRUGB .
antiarrhythmic	drug	amiodarone	drug
false

The continued need for the other DRUGA agent should be reviewed after the effects of DRUGB have been established , and discontinuation ordinarily should be attempted .
antiarrhythmic	drug	amiodarone	drug
false

In DRUGA treated patients who require additional DRUGB therapy , the initial dose of such agents should be approximately half of the usual recommended dose .
amiodarone	drug	antiarrhythmic	drug
false

DRUGA : Potentiation of DRUGB type ( DRUGN and DRUGN substrate ) DRUGN response is almost always seen in patients receiving DRUGN and can result in serious or fatal bleeding .
Anticoagulants	drug	warfarin	drug
false

DRUGA : Potentiation of DRUGN type ( DRUGB and DRUGN substrate ) DRUGN response is almost always seen in patients receiving DRUGN and can result in serious or fatal bleeding .
Anticoagulants	drug	CYP2C9	drug
false

DRUGA : Potentiation of DRUGN type ( DRUGN and DRUGB substrate ) DRUGN response is almost always seen in patients receiving DRUGN and can result in serious or fatal bleeding .
Anticoagulants	drug	CYP3A4	drug
false

DRUGA : Potentiation of DRUGN type ( DRUGN and DRUGN substrate ) DRUGB response is almost always seen in patients receiving DRUGN and can result in serious or fatal bleeding .
Anticoagulants	drug	anticoagulant	drug
false

DRUGA : Potentiation of DRUGN type ( DRUGN and DRUGN substrate ) DRUGN response is almost always seen in patients receiving DRUGB and can result in serious or fatal bleeding .
Anticoagulants	drug	amiodarone	drug
false

DRUGN : Potentiation of DRUGA type ( DRUGB and DRUGN substrate ) DRUGN response is almost always seen in patients receiving DRUGN and can result in serious or fatal bleeding .
warfarin	drug	CYP2C9	drug
false

DRUGN : Potentiation of DRUGA type ( DRUGN and DRUGB substrate ) DRUGN response is almost always seen in patients receiving DRUGN and can result in serious or fatal bleeding .
warfarin	drug	CYP3A4	drug
false

DRUGN : Potentiation of DRUGA type ( DRUGN and DRUGN substrate ) DRUGB response is almost always seen in patients receiving DRUGN and can result in serious or fatal bleeding .
warfarin	drug	anticoagulant	drug
false

DRUGN : Potentiation of DRUGA type ( DRUGN and DRUGN substrate ) DRUGN response is almost always seen in patients receiving DRUGB and can result in serious or fatal bleeding .
warfarin	drug	amiodarone	drug
false

DRUGN : Potentiation of DRUGN type ( DRUGA and DRUGB substrate ) DRUGN response is almost always seen in patients receiving DRUGN and can result in serious or fatal bleeding .
CYP2C9	drug	CYP3A4	drug
false

DRUGN : Potentiation of DRUGN type ( DRUGA and DRUGN substrate ) DRUGB response is almost always seen in patients receiving DRUGN and can result in serious or fatal bleeding .
CYP2C9	drug	anticoagulant	drug
false

DRUGN : Potentiation of DRUGN type ( DRUGA and DRUGN substrate ) DRUGN response is almost always seen in patients receiving DRUGB and can result in serious or fatal bleeding .
CYP2C9	drug	amiodarone	drug
false

DRUGN : Potentiation of DRUGN type ( DRUGN and DRUGA substrate ) DRUGB response is almost always seen in patients receiving DRUGN and can result in serious or fatal bleeding .
CYP3A4	drug	anticoagulant	drug
false

DRUGN : Potentiation of DRUGN type ( DRUGN and DRUGA substrate ) DRUGN response is almost always seen in patients receiving DRUGB and can result in serious or fatal bleeding .
CYP3A4	drug	amiodarone	drug
false

DRUGN : Potentiation of DRUGN type ( DRUGN and DRUGN substrate ) DRUGA response is almost always seen in patients receiving DRUGB and can result in serious or fatal bleeding .
anticoagulant	drug	amiodarone	drug
false

Some DRUGA / substances are known to accelerate the metabolism of DRUGB by stimulating the synthesis of DRUGN ( enzyme induction ) .
drugs	drug	amiodarone	drug
false

Some DRUGA / substances are known to accelerate the metabolism of DRUGN by stimulating the synthesis of DRUGB ( enzyme induction ) .
drugs	drug	CYP3A4	drug
false

Some DRUGN / substances are known to accelerate the metabolism of DRUGA by stimulating the synthesis of DRUGB ( enzyme induction ) .
amiodarone	drug	CYP3A4	drug
false

Reported examples of this interaction include the following : DRUGA : DRUGB is a potent inducer of DRUGN .
Antibiotics	drug	Rifampin	drug
false

Reported examples of this interaction include the following : DRUGA : DRUGN is a potent inducer of DRUGB .
Antibiotics	drug	CYP3A4	drug
false

Reported examples of this interaction include the following : DRUGN : DRUGA is a potent inducer of DRUGB .
Rifampin	drug	CYP3A4	drug
false

Administration of DRUGA concomitantly with oral DRUGB has been shown to result in decreases in serum concentrations of DRUGN and DRUGN .
rifampin	drug	amiodarone	drug
false

Administration of DRUGA concomitantly with oral DRUGN has been shown to result in decreases in serum concentrations of DRUGB and DRUGN .
rifampin	drug	amiodarone	drug
false

Administration of DRUGA concomitantly with oral DRUGN has been shown to result in decreases in serum concentrations of DRUGN and DRUGB .
rifampin	drug	desethylamiodarone	drug
false

Administration of DRUGN concomitantly with oral DRUGA has been shown to result in decreases in serum concentrations of DRUGN and DRUGB .
amiodarone	drug	desethylamiodarone	drug
false

Administration of DRUGN concomitantly with oral DRUGN has been shown to result in decreases in serum concentrations of DRUGA and DRUGB .
amiodarone	drug	desethylamiodarone	drug
false

Since DRUGA is a substrate for DRUGB , there is the potential that the use of St. John s Wort in patients receiving DRUGN could result in reduced DRUGN levels .
amiodarone	drug	CYP3A4	drug
false

Since DRUGN is a substrate for DRUGA , there is the potential that the use of St. John s Wort in patients receiving DRUGB could result in reduced DRUGN levels .
CYP3A4	drug	amiodarone	drug
false

Since DRUGN is a substrate for DRUGA , there is the potential that the use of St. John s Wort in patients receiving DRUGN could result in reduced DRUGB levels .
CYP3A4	drug	amiodarone	drug
false

Other reported interactions with DRUGA : DRUGB ( DRUGN substrate ) in combination with DRUGN may cause hypotension , bradycardia , and decreased cardiac output .
amiodarone	drug	Fentanyl	drug
false

Other reported interactions with DRUGA : DRUGN ( DRUGB substrate ) in combination with DRUGN may cause hypotension , bradycardia , and decreased cardiac output .
amiodarone	drug	CYP3A4	drug
false

Other reported interactions with DRUGN : DRUGA ( DRUGB substrate ) in combination with DRUGN may cause hypotension , bradycardia , and decreased cardiac output .
Fentanyl	drug	CYP3A4	drug
false

Other reported interactions with DRUGN : DRUGA ( DRUGN substrate ) in combination with DRUGB may cause hypotension , bradycardia , and decreased cardiac output .
Fentanyl	drug	amiodarone	drug
false

Other reported interactions with DRUGN : DRUGN ( DRUGA substrate ) in combination with DRUGB may cause hypotension , bradycardia , and decreased cardiac output .
CYP3A4	drug	amiodarone	drug
false

Sinus bradycardia has been reported with oral DRUGA in combination with DRUGB ( DRUGN substrate ) given for local DRUGN .
amiodarone	drug	lidocaine	drug
false

Sinus bradycardia has been reported with oral DRUGA in combination with DRUGN ( DRUGB substrate ) given for local DRUGN .
amiodarone	drug	CYP3A4	drug
false

Sinus bradycardia has been reported with oral DRUGA in combination with DRUGN ( DRUGN substrate ) given for local DRUGB .
amiodarone	drug	anesthesia	drug
false

Sinus bradycardia has been reported with oral DRUGN in combination with DRUGA ( DRUGB substrate ) given for local DRUGN .
lidocaine	drug	CYP3A4	drug
false

Sinus bradycardia has been reported with oral DRUGN in combination with DRUGA ( DRUGN substrate ) given for local DRUGB .
lidocaine	drug	anesthesia	drug
false

Sinus bradycardia has been reported with oral DRUGN in combination with DRUGN ( DRUGA substrate ) given for local DRUGB .
CYP3A4	drug	anesthesia	drug
false

Seizure , associated with increased DRUGA concentrations , has been reported with concomitant administration of intravenous DRUGB .
lidocaine	drug	amiodarone	drug
false

DRUGA is a substrate for both DRUGB and DRUGN .
Dextromethorphan	drug	CYP2D6	drug
false

DRUGA is a substrate for both DRUGN and DRUGB .
Dextromethorphan	drug	CYP3A4	drug
false

DRUGN is a substrate for both DRUGA and DRUGB .
CYP2D6	drug	CYP3A4	drug
false

DRUGA inhibits DRUGB .
Amiodarone	drug	CYP2D6	drug
false

DRUGA increases enterohepatic elimination of DRUGB and may reduce its serum levels and DRUGN / dga
Cholestyramine	drug	amiodarone	drug
false

DRUGA increases enterohepatic elimination of DRUGN and may reduce its serum levels and DRUGB / dga
Cholestyramine	drug	t1	drug
false

DRUGN increases enterohepatic elimination of DRUGA and may reduce its serum levels and DRUGB / dga
amiodarone	drug	t1	drug
false

DRUGA , DRUGB , and azoles are known to cause QTc prolongation .
Fluoroquinolones	drug	macrolide antibiotics	drug
false

There have been reports of QTc prolongation , with or without TdP , in patients taking DRUGA when DRUGB , DRUGN , or azoles were administered concomitantly .
amiodarone	drug	fluoroquinolones	drug
false

There have been reports of QTc prolongation , with or without TdP , in patients taking DRUGA when DRUGN , DRUGB , or azoles were administered concomitantly .
amiodarone	drug	macrolide antibiotics	drug
false

There have been reports of QTc prolongation , with or without TdP , in patients taking DRUGN when DRUGA , DRUGB , or azoles were administered concomitantly .
fluoroquinolones	drug	macrolide antibiotics	drug
false

Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with DRUGA , DRUGB , and DRUGN .
propranolol	drug	diltiazem	drug
false

Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with DRUGA , DRUGN , and DRUGB .
propranolol	drug	verapamil	drug
false

Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with DRUGN , DRUGA , and DRUGB .
diltiazem	drug	verapamil	drug
false

In addition to the interactions noted above , chronic ( dgb weeks ) oral DRUGA administration impairs metabolism of DRUGB , DRUGN , and DRUGN .
Cordarone	drug	phenytoin	drug
false

In addition to the interactions noted above , chronic ( dgb weeks ) oral DRUGA administration impairs metabolism of DRUGN , DRUGB , and DRUGN .
Cordarone	drug	dextromethorphan	drug
false

In addition to the interactions noted above , chronic ( dgb weeks ) oral DRUGA administration impairs metabolism of DRUGN , DRUGN , and DRUGB .
Cordarone	drug	methotrexate	drug
false

In addition to the interactions noted above , chronic ( dgb weeks ) oral DRUGN administration impairs metabolism of DRUGA , DRUGB , and DRUGN .
phenytoin	drug	dextromethorphan	drug
false

In addition to the interactions noted above , chronic ( dgb weeks ) oral DRUGN administration impairs metabolism of DRUGA , DRUGN , and DRUGB .
phenytoin	drug	methotrexate	drug
false

In addition to the interactions noted above , chronic ( dgb weeks ) oral DRUGN administration impairs metabolism of DRUGN , DRUGA , and DRUGB .
dextromethorphan	drug	methotrexate	drug
false

Poor metabolizers have higher than expected plasma concentrations of DRUGA ( DRUGB ) when given usual doses .
tricyclic antidepressants	group	TCAs	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGB , DRUGN , and the DRUGN DRUGN and DRUGN ) .
cimetidine	drug	antidepressants	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGB , and the DRUGN DRUGN and DRUGN ) .
cimetidine	drug	phenothiazines	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGB DRUGN and DRUGN ) .
cimetidine	drug	Type 1C antiarrhythmics	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGN DRUGB and DRUGN ) .
cimetidine	drug	propafenone	drug
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGN DRUGN and DRUGB ) .
cimetidine	drug	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGB , and the DRUGN DRUGN and DRUGN ) .
antidepressants	group	phenothiazines	group
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGN , and the DRUGB DRUGN and DRUGN ) .
antidepressants	group	Type 1C antiarrhythmics	group
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGN , and the DRUGN DRUGB and DRUGN ) .
antidepressants	group	propafenone	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGN , and the DRUGN DRUGN and DRUGB ) .
antidepressants	group	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGA , and the DRUGB DRUGN and DRUGN ) .
phenothiazines	group	Type 1C antiarrhythmics	group
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGA , and the DRUGN DRUGB and DRUGN ) .
phenothiazines	group	propafenone	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGA , and the DRUGN DRUGN and DRUGB ) .
phenothiazines	group	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGA DRUGB and DRUGN ) .
Type 1C antiarrhythmics	group	propafenone	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGA DRUGN and DRUGB ) .
Type 1C antiarrhythmics	group	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGN DRUGA and DRUGB ) .
propafenone	drug	flecainide	drug
false

While all the selective DRUGA ( DRUGB ) , e.g . , DRUGN , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
serotonin reuptake inhibitors	group	SSRIs	group
false

While all the selective DRUGA ( DRUGN ) , e.g . , DRUGB , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
serotonin reuptake inhibitors	group	fluoxetine	drug
false

While all the selective DRUGA ( DRUGN ) , e.g . , DRUGN , DRUGB , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
serotonin reuptake inhibitors	group	sertraline	drug
false

While all the selective DRUGA ( DRUGN ) , e.g . , DRUGN , DRUGN , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
serotonin reuptake inhibitors	group	paroxetine	drug
false

While all the selective DRUGN ( DRUGA ) , e.g . , DRUGB , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	fluoxetine	drug
false

While all the selective DRUGN ( DRUGA ) , e.g . , DRUGN , DRUGB , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	sertraline	drug
false

While all the selective DRUGN ( DRUGA ) , e.g . , DRUGN , DRUGN , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	paroxetine	drug
false

While all the selective DRUGN ( DRUGN ) , e.g . , DRUGA , DRUGB , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
fluoxetine	drug	sertraline	drug
false

While all the selective DRUGN ( DRUGN ) , e.g . , DRUGA , DRUGN , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
fluoxetine	drug	paroxetine	drug
false

While all the selective DRUGN ( DRUGN ) , e.g . , DRUGN , DRUGA , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
sertraline	drug	paroxetine	drug
false

The extent to which DRUGA DRUGB interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the DRUGN involved .
SSRI	group	TCA	group
effect

The extent to which DRUGN DRUGA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the DRUGB involved .
TCA	group	SSRI	group
false

Nevertheless , caution is indicated in the coadministration of DRUGA with any of the DRUGB and also in switching from one class to the other .
TCAs	group	SSRIs	group
advise

Concomitant use of DRUGA with drugs that can inhibit cytochrome Pdgb dgbDdgb may require lower doses than usually prescribed for either the DRUGB or the other drug .
tricyclic antidepressants	group	tricyclic antidepressant	group
false

DRUGA : DRUGB or similarly acting compounds ;
Monoamine Oxidase Inhibitors	drug	Guanethidine	drug
false

DRUGA , DRUGB and other DRUGN ;
alcohol	drug	barbiturates	drug
false

DRUGA , DRUGN and other DRUGB ;
alcohol	drug	CNS depressants	drug
false

DRUGN , DRUGA and other DRUGB ;
barbiturates	drug	CNS depressants	drug
false

and DRUGA When DRUGB is given with DRUGN agents or DRUGN drugs , including DRUGN combined with local DRUGN , close supervision and careful adjustment of dosages are required .
disulfiram	drug	amitriptyline HCl	drug
false

and DRUGA When DRUGN is given with DRUGB agents or DRUGN drugs , including DRUGN combined with local DRUGN , close supervision and careful adjustment of dosages are required .
disulfiram	drug	anticholinergic	drug
false

and DRUGA When DRUGN is given with DRUGN agents or DRUGB drugs , including DRUGN combined with local DRUGN , close supervision and careful adjustment of dosages are required .
disulfiram	drug	sympathomimetic	drug
false

and DRUGA When DRUGN is given with DRUGN agents or DRUGN drugs , including DRUGB combined with local DRUGN , close supervision and careful adjustment of dosages are required .
disulfiram	drug	epinephrine	drug
false

and DRUGA When DRUGN is given with DRUGN agents or DRUGN drugs , including DRUGN combined with local DRUGB , close supervision and careful adjustment of dosages are required .
disulfiram	drug	anesthetics	drug
false

and DRUGN When DRUGA is given with DRUGB agents or DRUGN drugs , including DRUGN combined with local DRUGN , close supervision and careful adjustment of dosages are required .
amitriptyline HCl	drug	anticholinergic	drug
false

and DRUGN When DRUGA is given with DRUGN agents or DRUGB drugs , including DRUGN combined with local DRUGN , close supervision and careful adjustment of dosages are required .
amitriptyline HCl	drug	sympathomimetic	drug
false

and DRUGN When DRUGA is given with DRUGN agents or DRUGN drugs , including DRUGB combined with local DRUGN , close supervision and careful adjustment of dosages are required .
amitriptyline HCl	drug	epinephrine	drug
false

and DRUGN When DRUGA is given with DRUGN agents or DRUGN drugs , including DRUGN combined with local DRUGB , close supervision and careful adjustment of dosages are required .
amitriptyline HCl	drug	anesthetics	drug
false

and DRUGN When DRUGN is given with DRUGA agents or DRUGB drugs , including DRUGN combined with local DRUGN , close supervision and careful adjustment of dosages are required .
anticholinergic	drug	sympathomimetic	drug
false

and DRUGN When DRUGN is given with DRUGA agents or DRUGN drugs , including DRUGB combined with local DRUGN , close supervision and careful adjustment of dosages are required .
anticholinergic	drug	epinephrine	drug
false

and DRUGN When DRUGN is given with DRUGA agents or DRUGN drugs , including DRUGN combined with local DRUGB , close supervision and careful adjustment of dosages are required .
anticholinergic	drug	anesthetics	drug
false

and DRUGN When DRUGN is given with DRUGN agents or DRUGA drugs , including DRUGB combined with local DRUGN , close supervision and careful adjustment of dosages are required .
sympathomimetic	drug	epinephrine	drug
false

and DRUGN When DRUGN is given with DRUGN agents or DRUGA drugs , including DRUGN combined with local DRUGB , close supervision and careful adjustment of dosages are required .
sympathomimetic	drug	anesthetics	drug
false

and DRUGN When DRUGN is given with DRUGN agents or DRUGN drugs , including DRUGA combined with local DRUGB , close supervision and careful adjustment of dosages are required .
epinephrine	drug	anesthetics	drug
false

Hyperpyrexia has been reported when DRUGA is administered with DRUGB agents or with DRUGN drugs , particularly during hot weather .
amitriptyline HCl	drug	anticholinergic	drug
effect

Hyperpyrexia has been reported when DRUGA is administered with DRUGN agents or with DRUGB drugs , particularly during hot weather .
amitriptyline HCl	drug	neuroleptic	drug
false

Hyperpyrexia has been reported when DRUGN is administered with DRUGA agents or with DRUGB drugs , particularly during hot weather .
anticholinergic	drug	neuroleptic	drug
false

Paralytic ileus may occur in patients taking DRUGA in combination with DRUGB type drugs .
tricyclic antidepressants	drug	anticholinergic	drug
effect

DRUGA is reported to reduce hepatic metabolism of certain DRUGB , thereby delaying elimination and increasing steady state concentrations of these DRUGN .
Cimetidine	drug	tricyclic antidepressants	drug
mechanism

DRUGA is reported to reduce hepatic metabolism of certain DRUGN , thereby delaying elimination and increasing steady state concentrations of these DRUGB .
Cimetidine	drug	drugs	drug
false

DRUGN is reported to reduce hepatic metabolism of certain DRUGA , thereby delaying elimination and increasing steady state concentrations of these DRUGB .
tricyclic antidepressants	drug	drugs	drug
false

Clinically significant effects have been reported with the DRUGA when used concomitantly with DRUGB .
tricyclic antidepressants	drug	cimetidine	drug
effect

Increases in plasma levels of DRUGA , and in the frequency and severity of side effects , particularly DRUGB , have been reported when DRUGN was added to the DRUGN regimen .
tricyclic antidepressants	drug	anticholinergic	drug
false

Increases in plasma levels of DRUGA , and in the frequency and severity of side effects , particularly DRUGN , have been reported when DRUGB was added to the DRUGN regimen .
tricyclic antidepressants	drug	cimetidine	drug
mechanism

Increases in plasma levels of DRUGA , and in the frequency and severity of side effects , particularly DRUGN , have been reported when DRUGN was added to the DRUGB regimen .
tricyclic antidepressants	drug	drug	drug
false

Increases in plasma levels of DRUGN , and in the frequency and severity of side effects , particularly DRUGA , have been reported when DRUGB was added to the DRUGN regimen .
anticholinergic	drug	cimetidine	drug
false

Increases in plasma levels of DRUGN , and in the frequency and severity of side effects , particularly DRUGA , have been reported when DRUGN was added to the DRUGB regimen .
anticholinergic	drug	drug	drug
false

Increases in plasma levels of DRUGN , and in the frequency and severity of side effects , particularly DRUGN , have been reported when DRUGA was added to the DRUGB regimen .
cimetidine	drug	drug	drug
false

Discontinuation of DRUGA in well controlled patients receiving DRUGB and DRUGN may decrease the plasma levels and efficacy of the DRUGN .
cimetidine	drug	tricyclic antidepressants	drug
false

Discontinuation of DRUGA in well controlled patients receiving DRUGN and DRUGN may decrease the plasma levels and efficacy of the DRUGB .
cimetidine	drug	antidepressants	drug
false

Discontinuation of DRUGN in well controlled patients receiving DRUGA and DRUGB may decrease the plasma levels and efficacy of the DRUGN .
tricyclic antidepressants	drug	cimetidine	drug
mechanism

Discontinuation of DRUGN in well controlled patients receiving DRUGA and DRUGN may decrease the plasma levels and efficacy of the DRUGB .
tricyclic antidepressants	drug	antidepressants	drug
false

Discontinuation of DRUGN in well controlled patients receiving DRUGN and DRUGA may decrease the plasma levels and efficacy of the DRUGB .
cimetidine	drug	antidepressants	drug
false

Transient delirium has been reported in patients who were treated with one gram of DRUGA and dgb dgb mg of DRUGB .
ethchlorvynol	drug	amitriptyline HCl	drug
effect

When administered concurrently , the following drugs may interact with DRUGA : DRUGB : may enhance the potential for renal toxicity , bronchospasm and hypotension .
amphotericin B	drug	Antineoplastic agents	group
effect

DRUGA ( e. g. , DRUGB , etc . ) should be given concomitantly only with great caution .
Antineoplastic agents	group	nitrogen mustard	drug
false

DRUGA and DRUGB ( DRUGN ) : may potentiate DRUGN induced hypokalemia which may predispose the patient to cardiac dysfunction .
Corticosteroids	group	Corticotropin	drug
false

DRUGA and DRUGN ( DRUGB ) : may potentiate DRUGN induced hypokalemia which may predispose the patient to cardiac dysfunction .
Corticosteroids	group	ACTH	group
false

DRUGA and DRUGN ( DRUGN ) : may potentiate DRUGB induced hypokalemia which may predispose the patient to cardiac dysfunction .
Corticosteroids	group	amphotericin B	drug
effect

DRUGN and DRUGA ( DRUGB ) : may potentiate DRUGN induced hypokalemia which may predispose the patient to cardiac dysfunction .
Corticotropin	drug	ACTH	group
false

DRUGN and DRUGA ( DRUGN ) : may potentiate DRUGB induced hypokalemia which may predispose the patient to cardiac dysfunction .
Corticotropin	drug	amphotericin B	drug
effect

DRUGN and DRUGN ( DRUGA ) : may potentiate DRUGB induced hypokalemia which may predispose the patient to cardiac dysfunction .
ACTH	group	amphotericin B	drug
effect

DRUGA : DRUGB induced hypokalemia may potentiate DRUGN toxicity .
Digitalis glycosides	group	amphotericin B	drug
false

DRUGA : DRUGN induced hypokalemia may potentiate DRUGB toxicity .
Digitalis glycosides	group	digitalis	group
false

DRUGN : DRUGA induced hypokalemia may potentiate DRUGB toxicity .
amphotericin B	drug	digitalis	group
effect

DRUGA : while a synergistic relationship with DRUGB has been reported , concomitant use may increase the toxicity of DRUGN by possibly increasing its cellular uptake and / or impairing its renal excretion .
Flucytosine	drug	amphotericin B	drug
false

DRUGA : while a synergistic relationship with DRUGN has been reported , concomitant use may increase the toxicity of DRUGB by possibly increasing its cellular uptake and / or impairing its renal excretion .
Flucytosine	drug	flucytosine	drug
false

DRUGN : while a synergistic relationship with DRUGA has been reported , concomitant use may increase the toxicity of DRUGB by possibly increasing its cellular uptake and / or impairing its renal excretion .
amphotericin B	drug	flucytosine	drug
effect

DRUGA ( e. g. , DRUGB , DRUGN , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGN may induce fungal resistance to DRUGN .
Imidazoles	group	ketoconazole	drug
false

DRUGA ( e. g. , DRUGN , DRUGB , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGN may induce fungal resistance to DRUGN .
Imidazoles	group	miconazole	drug
false

DRUGA ( e. g. , DRUGN , DRUGN , DRUGB , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGN may induce fungal resistance to DRUGN .
Imidazoles	group	clotrimazole	drug
false

DRUGA ( e. g. , DRUGN , DRUGN , DRUGN , DRUGB , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGN may induce fungal resistance to DRUGN .
Imidazoles	group	fluconazole	drug
false

DRUGA ( e. g. , DRUGN , DRUGN , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGB and DRUGN suggest that DRUGN may induce fungal resistance to DRUGN .
Imidazoles	group	amphotericin B	drug
false

DRUGA ( e. g. , DRUGN , DRUGN , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGB suggest that DRUGN may induce fungal resistance to DRUGN .
Imidazoles	group	imidazoles	group
false

DRUGA ( e. g. , DRUGN , DRUGN , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGB may induce fungal resistance to DRUGN .
Imidazoles	group	imidazoles	group
false

DRUGA ( e. g. , DRUGN , DRUGN , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGN may induce fungal resistance to DRUGB .
Imidazoles	group	amphotericin B	drug
false

DRUGN ( e. g. , DRUGA , DRUGB , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGN may induce fungal resistance to DRUGN .
ketoconazole	drug	miconazole	drug
false

DRUGN ( e. g. , DRUGA , DRUGN , DRUGB , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGN may induce fungal resistance to DRUGN .
ketoconazole	drug	clotrimazole	drug
false

DRUGN ( e. g. , DRUGA , DRUGN , DRUGN , DRUGB , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGN may induce fungal resistance to DRUGN .
ketoconazole	drug	fluconazole	drug
false

DRUGN ( e. g. , DRUGA , DRUGN , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGB and DRUGN suggest that DRUGN may induce fungal resistance to DRUGN .
ketoconazole	drug	amphotericin B	drug
false

DRUGN ( e. g. , DRUGA , DRUGN , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGB suggest that DRUGN may induce fungal resistance to DRUGN .
ketoconazole	drug	imidazoles	group
false

DRUGN ( e. g. , DRUGA , DRUGN , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGB may induce fungal resistance to DRUGN .
ketoconazole	drug	imidazoles	group
false

DRUGN ( e. g. , DRUGA , DRUGN , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGN may induce fungal resistance to DRUGB .
ketoconazole	drug	amphotericin B	drug
false

DRUGN ( e. g. , DRUGN , DRUGA , DRUGB , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGN may induce fungal resistance to DRUGN .
miconazole	drug	clotrimazole	drug
false

DRUGN ( e. g. , DRUGN , DRUGA , DRUGN , DRUGB , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGN may induce fungal resistance to DRUGN .
miconazole	drug	fluconazole	drug
false

DRUGN ( e. g. , DRUGN , DRUGA , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGB and DRUGN suggest that DRUGN may induce fungal resistance to DRUGN .
miconazole	drug	amphotericin B	drug
false

DRUGN ( e. g. , DRUGN , DRUGA , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGB suggest that DRUGN may induce fungal resistance to DRUGN .
miconazole	drug	imidazoles	group
false

DRUGN ( e. g. , DRUGN , DRUGA , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGB may induce fungal resistance to DRUGN .
miconazole	drug	imidazoles	group
false

DRUGN ( e. g. , DRUGN , DRUGA , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGN may induce fungal resistance to DRUGB .
miconazole	drug	amphotericin B	drug
false

DRUGN ( e. g. , DRUGN , DRUGN , DRUGA , DRUGB , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGN may induce fungal resistance to DRUGN .
clotrimazole	drug	fluconazole	drug
false

DRUGN ( e. g. , DRUGN , DRUGN , DRUGA , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGB and DRUGN suggest that DRUGN may induce fungal resistance to DRUGN .
clotrimazole	drug	amphotericin B	drug
false

DRUGN ( e. g. , DRUGN , DRUGN , DRUGA , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGB suggest that DRUGN may induce fungal resistance to DRUGN .
clotrimazole	drug	imidazoles	group
false

DRUGN ( e. g. , DRUGN , DRUGN , DRUGA , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGB may induce fungal resistance to DRUGN .
clotrimazole	drug	imidazoles	group
false

DRUGN ( e. g. , DRUGN , DRUGN , DRUGA , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGN may induce fungal resistance to DRUGB .
clotrimazole	drug	amphotericin B	drug
false

DRUGN ( e. g. , DRUGN , DRUGN , DRUGN , DRUGA , etc . ) : in vitro and animal studies with the combination of DRUGB and DRUGN suggest that DRUGN may induce fungal resistance to DRUGN .
fluconazole	drug	amphotericin B	drug
false

DRUGN ( e. g. , DRUGN , DRUGN , DRUGN , DRUGA , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGB suggest that DRUGN may induce fungal resistance to DRUGN .
fluconazole	drug	imidazoles	group
false

DRUGN ( e. g. , DRUGN , DRUGN , DRUGN , DRUGA , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGB may induce fungal resistance to DRUGN .
fluconazole	drug	imidazoles	group
false

DRUGN ( e. g. , DRUGN , DRUGN , DRUGN , DRUGA , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGN may induce fungal resistance to DRUGB .
fluconazole	drug	amphotericin B	drug
false

DRUGN ( e. g. , DRUGN , DRUGN , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGA and DRUGB suggest that DRUGN may induce fungal resistance to DRUGN .
amphotericin B	drug	imidazoles	group
false

DRUGN ( e. g. , DRUGN , DRUGN , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGA and DRUGN suggest that DRUGB may induce fungal resistance to DRUGN .
amphotericin B	drug	imidazoles	group
false

DRUGN ( e. g. , DRUGN , DRUGN , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGA suggest that DRUGN may induce fungal resistance to DRUGB .
imidazoles	group	amphotericin B	drug
false

DRUGN ( e. g. , DRUGN , DRUGN , DRUGN , DRUGN , etc . ) : in vitro and animal studies with the combination of DRUGN and DRUGN suggest that DRUGA may induce fungal resistance to DRUGB .
imidazoles	group	amphotericin B	drug
effect

Other nephrotoxic medications : agents such as DRUGA , DRUGB , and DRUGN may enhance the potential for drug induced renal toxicity , and should be used concomitantly only with great caution .
aminoglycosides	group	cyclosporine	drug
false

Other nephrotoxic medications : agents such as DRUGA , DRUGN , and DRUGB may enhance the potential for drug induced renal toxicity , and should be used concomitantly only with great caution .
aminoglycosides	group	pentamidine	drug
false

Other nephrotoxic medications : agents such as DRUGN , DRUGA , and DRUGB may enhance the potential for drug induced renal toxicity , and should be used concomitantly only with great caution .
cyclosporine	drug	pentamidine	drug
false

DRUGA : DRUGB induced hypokalemia may enhance the curariform effect of DRUGN ( e.g . , DRUGN ) .
Skeletal muscle relaxants	group	amphotericin B	drug
false

DRUGA : DRUGN induced hypokalemia may enhance the curariform effect of DRUGB ( e.g . , DRUGN ) .
Skeletal muscle relaxants	group	skeletal muscle relaxants	group
false

DRUGA : DRUGN induced hypokalemia may enhance the curariform effect of DRUGN ( e.g . , DRUGB ) .
Skeletal muscle relaxants	group	tubocurarine	drug
false

DRUGN : DRUGA induced hypokalemia may enhance the curariform effect of DRUGB ( e.g . , DRUGN ) .
amphotericin B	drug	skeletal muscle relaxants	group
effect

DRUGN : DRUGA induced hypokalemia may enhance the curariform effect of DRUGN ( e.g . , DRUGB ) .
amphotericin B	drug	tubocurarine	drug
effect

DRUGN : DRUGN induced hypokalemia may enhance the curariform effect of DRUGA ( e.g . , DRUGB ) .
skeletal muscle relaxants	group	tubocurarine	drug
false

DRUGA : acute pulmonary toxicity has been reported in patients receiving intravenous DRUGB and DRUGN .
Leukocyte transfusions	drug_n	amphotericin B	drug
false

DRUGA : acute pulmonary toxicity has been reported in patients receiving intravenous DRUGN and DRUGB .
Leukocyte transfusions	drug_n	leukocyte transfusions	drug_n
false

DRUGN : acute pulmonary toxicity has been reported in patients receiving intravenous DRUGA and DRUGB .
amphotericin B	drug	leukocyte transfusions	drug_n
effect

DRUGA : DRUGB , DRUGN , DRUGN , or DRUGN may interfere with the bactericidal effect of DRUGN .
Bacteriostatic Antibiotics	group	Chloramphenicol	drug
false

DRUGA : DRUGN , DRUGB , DRUGN , or DRUGN may interfere with the bactericidal effect of DRUGN .
Bacteriostatic Antibiotics	group	erythromycins	drug
false

DRUGA : DRUGN , DRUGN , DRUGB , or DRUGN may interfere with the bactericidal effect of DRUGN .
Bacteriostatic Antibiotics	group	sulfonamides	group
false

DRUGA : DRUGN , DRUGN , DRUGN , or DRUGB may interfere with the bactericidal effect of DRUGN .
Bacteriostatic Antibiotics	group	tetracyclines	group
false

DRUGA : DRUGN , DRUGN , DRUGN , or DRUGN may interfere with the bactericidal effect of DRUGB .
Bacteriostatic Antibiotics	group	penicillins	group
false

DRUGN : DRUGA , DRUGB , DRUGN , or DRUGN may interfere with the bactericidal effect of DRUGN .
Chloramphenicol	drug	erythromycins	drug
false

DRUGN : DRUGA , DRUGN , DRUGB , or DRUGN may interfere with the bactericidal effect of DRUGN .
Chloramphenicol	drug	sulfonamides	group
false

DRUGN : DRUGA , DRUGN , DRUGN , or DRUGB may interfere with the bactericidal effect of DRUGN .
Chloramphenicol	drug	tetracyclines	group
false

DRUGN : DRUGA , DRUGN , DRUGN , or DRUGN may interfere with the bactericidal effect of DRUGB .
Chloramphenicol	drug	penicillins	group
effect

DRUGN : DRUGN , DRUGA , DRUGB , or DRUGN may interfere with the bactericidal effect of DRUGN .
erythromycins	drug	sulfonamides	group
false

DRUGN : DRUGN , DRUGA , DRUGN , or DRUGB may interfere with the bactericidal effect of DRUGN .
erythromycins	drug	tetracyclines	group
false

DRUGN : DRUGN , DRUGA , DRUGN , or DRUGN may interfere with the bactericidal effect of DRUGB .
erythromycins	drug	penicillins	group
effect

DRUGN : DRUGN , DRUGN , DRUGA , or DRUGB may interfere with the bactericidal effect of DRUGN .
sulfonamides	group	tetracyclines	group
false

DRUGN : DRUGN , DRUGN , DRUGA , or DRUGN may interfere with the bactericidal effect of DRUGB .
sulfonamides	group	penicillins	group
effect

DRUGN : DRUGN , DRUGN , DRUGN , or DRUGA may interfere with the bactericidal effect of DRUGB .
tetracyclines	group	penicillins	group
effect

DRUGA : May decrease renal tubular secretion of DRUGB resulting in increased blood levels and / or DRUGN toxicity .
Probenecid	drug	ampicillin	drug
mechanism

DRUGA : May decrease renal tubular secretion of DRUGN resulting in increased blood levels and / or DRUGB toxicity .
Probenecid	drug	ampicillin	drug
false

DRUGA : The effect of DRUGB on total drug concentrations of other DRUGN in subjects receiving both agents was evaluated using comparisons to historical data .
HIV Protease Inhibitors	group	amprenavir	drug
false

DRUGA : The effect of DRUGN on total drug concentrations of other DRUGB in subjects receiving both agents was evaluated using comparisons to historical data .
HIV Protease Inhibitors	group	HIV protease inhibitors	group
false

DRUGN : The effect of DRUGA on total drug concentrations of other DRUGB in subjects receiving both agents was evaluated using comparisons to historical data .
amprenavir	drug	HIV protease inhibitors	group
false

DRUGA steady state Cmax , A.C. and Cmin were decreased by dgb % , dgb % , and dgb % , respectively , by concomitant DRUGB .
Indinavir	drug	amprenavir	drug
mechanism

DRUGA steady state Cmax , A.C. and Cmin were increased dgb % , decreased dgb % , and decreased dgb % , respectively , by concomitant DRUGB .
Saquinavir	drug	amprenavir	drug
mechanism

DRUGA steady state Cmax , A.C. and Cmin were increased by dgb % , dgb % , and dgb % , respectively , by concomitant DRUGB .
Nelfinavir	drug	amprenavir	drug
mechanism

DRUGA : Coadministration of DRUGB and DRUGN can decrease plasma levels of DRUGN .
Methadone	drug	amprenavir	drug
false

DRUGA : Coadministration of DRUGN and DRUGB can decrease plasma levels of DRUGN .
Methadone	drug	methadone	drug
false

DRUGA : Coadministration of DRUGN and DRUGN can decrease plasma levels of DRUGB .
Methadone	drug	methadone	drug
false

DRUGN : Coadministration of DRUGA and DRUGB can decrease plasma levels of DRUGN .
amprenavir	drug	methadone	drug
effect

DRUGN : Coadministration of DRUGA and DRUGN can decrease plasma levels of DRUGB .
amprenavir	drug	methadone	drug
false

Coadministration of DRUGA and DRUGB as compared to a non matched historicalcontrol group resulted in a dgb % , dgb % , and dgb % decrease in serum DRUGN AUC , Cmax , andCmin , respectively .
amprenavir	drug	methadone	drug
mechanism

Coadministration of DRUGN and DRUGA as compared to a non matched historicalcontrol group resulted in a dgb % , dgb % , and dgb % decrease in serum DRUGB AUC , Cmax , andCmin , respectively .
methadone	drug	amprenavir	drug
false

Laboratory Tests : The combination of DRUGA and low dose DRUGB has been associated with elevations of cholesterol and triglycerides , SGOT ( AST ) , and SGPT ( ALT ) in some patients .
Amprenavir	drug	ritonavir	drug
effect

Appropriate laboratory testing should be considered prior to initiating combination therapy with DRUGA and DRUGB and at periodic intervals or if any clinical signs or symptoms of hyperlipidemia or elevated liver function tests occur during therapy .
Amprenavir	drug	ritonavir	drug
advise

For comprehensive information concerning laboratory test alterations associated with DRUGA , physicians should refer to the complete prescribing information for DRUGB ( DRUGN ) .
ritonavir	drug	NORVIR	brand
false

For comprehensive information concerning laboratory test alterations associated with DRUGN , physicians should refer to the complete prescribing information for DRUGA ( DRUGB ) .
NORVIR	brand	ritonavir	drug
false

Taking DRUGA after drinking DRUGB may worsen side effects and may cause severe hypotension and cardiovascular collapse .
amyl nitrite	drug	alcohol	drug
effect

In vivo interaction studies in humans have demonstrated that DRUGA and DRUGB do not affect the PK properties of DRUGN , nor does DRUGN affect the PK properties of DRUGN or DRUGN .
digoxin	drug	warfarin	drug
false

In vivo interaction studies in humans have demonstrated that DRUGA and DRUGN do not affect the PK properties of DRUGB , nor does DRUGN affect the PK properties of DRUGN or DRUGN .
digoxin	drug	anagrelide	drug
false

In vivo interaction studies in humans have demonstrated that DRUGA and DRUGN do not affect the PK properties of DRUGN , nor does DRUGB affect the PK properties of DRUGN or DRUGN .
digoxin	drug	anagrelide	drug
false

In vivo interaction studies in humans have demonstrated that DRUGA and DRUGN do not affect the PK properties of DRUGN , nor does DRUGN affect the PK properties of DRUGN or DRUGB .
digoxin	drug	warfarin	drug
false

In vivo interaction studies in humans have demonstrated that DRUGN and DRUGA do not affect the PK properties of DRUGB , nor does DRUGN affect the PK properties of DRUGN or DRUGN .
warfarin	drug	anagrelide	drug
false

In vivo interaction studies in humans have demonstrated that DRUGN and DRUGA do not affect the PK properties of DRUGN , nor does DRUGB affect the PK properties of DRUGN or DRUGN .
warfarin	drug	anagrelide	drug
false

In vivo interaction studies in humans have demonstrated that DRUGN and DRUGA do not affect the PK properties of DRUGN , nor does DRUGN affect the PK properties of DRUGB or DRUGN .
warfarin	drug	digoxin	drug
false

In vivo interaction studies in humans have demonstrated that DRUGN and DRUGN do not affect the PK properties of DRUGA , nor does DRUGN affect the PK properties of DRUGB or DRUGN .
anagrelide	drug	digoxin	drug
false

In vivo interaction studies in humans have demonstrated that DRUGN and DRUGN do not affect the PK properties of DRUGA , nor does DRUGN affect the PK properties of DRUGN or DRUGB .
anagrelide	drug	warfarin	drug
false

In vivo interaction studies in humans have demonstrated that DRUGN and DRUGN do not affect the PK properties of DRUGN , nor does DRUGA affect the PK properties of DRUGB or DRUGN .
anagrelide	drug	digoxin	drug
false

In vivo interaction studies in humans have demonstrated that DRUGN and DRUGN do not affect the PK properties of DRUGN , nor does DRUGA affect the PK properties of DRUGN or DRUGB .
anagrelide	drug	warfarin	drug
false

In vivo interaction studies in humans have demonstrated that DRUGN and DRUGN do not affect the PK properties of DRUGN , nor does DRUGN affect the PK properties of DRUGA or DRUGB .
digoxin	drug	warfarin	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGA in clinical trials were DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
anagrelide	drug	aspirin	brand
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGA in clinical trials were DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
anagrelide	drug	acetaminophen	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGA in clinical trials were DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
anagrelide	drug	furosemide	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGA in clinical trials were DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
anagrelide	drug	iron	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGA in clinical trials were DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
anagrelide	drug	ranitidine	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGA in clinical trials were DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
anagrelide	drug	hydroxyurea	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGA in clinical trials were DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
anagrelide	drug	allopurinol	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
aspirin	brand	acetaminophen	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
aspirin	brand	furosemide	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
aspirin	brand	iron	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
aspirin	brand	ranitidine	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
aspirin	brand	hydroxyurea	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
aspirin	brand	allopurinol	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
acetaminophen	drug	furosemide	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
acetaminophen	drug	iron	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
acetaminophen	drug	ranitidine	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
acetaminophen	drug	hydroxyurea	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
acetaminophen	drug	allopurinol	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
furosemide	drug	iron	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
furosemide	drug	ranitidine	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
furosemide	drug	hydroxyurea	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
furosemide	drug	allopurinol	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
iron	drug	ranitidine	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
iron	drug	hydroxyurea	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
iron	drug	allopurinol	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
ranitidine	drug	hydroxyurea	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
ranitidine	drug	allopurinol	drug
false

Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUGN in clinical trials were DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
hydroxyurea	drug	allopurinol	drug
false

An in vivo interaction study in humans demonstrated that a single dgbmg dose of DRUGA administered concomitantly with a single dgb mg dose of DRUGB was generally well tolerated .
anagrelide	drug	aspirin	brand
false

No clinically relevant pharmacokinetic interactions between DRUGA and DRUGB were observed .
anagrelide	drug	acetylsalicylic acid	drug
false

DRUGA alone had no effect on platelet aggregation , but did slightly enhance the inhibition of platelet aggregation by DRUGB .
Anagrelide	drug	aspirin	brand
effect

It is known that CYPdgbAdgb is inhibited by several medicinal products , including DRUGA , and such medicinal products could theoretically adversely influence the clearance of DRUGB .
fluvoxamine	drug	anagrelide	drug
mechanism

DRUGA demonstrates some limited inhibitory activity towards CYPdgbAdgb which may present a theoretical potential for interaction with other coadministered medicinal products sharing that clearance mechanism e.g . DRUGB .
Anagrelide	drug	theophylline	drug
mechanism

The effects of medicinal products with similar properties such as inotropes DRUGA , DRUGB , DRUGN , DRUGN and DRUGN may be exacerbated by DRUGN .
milrinone	drug	enoximone	drug
false

The effects of medicinal products with similar properties such as inotropes DRUGA , DRUGN , DRUGB , DRUGN and DRUGN may be exacerbated by DRUGN .
milrinone	drug	amrinone	drug
false

The effects of medicinal products with similar properties such as inotropes DRUGA , DRUGN , DRUGN , DRUGB and DRUGN may be exacerbated by DRUGN .
milrinone	drug	olprinone	drug_n
false

The effects of medicinal products with similar properties such as inotropes DRUGA , DRUGN , DRUGN , DRUGN and DRUGB may be exacerbated by DRUGN .
milrinone	drug	cilostazol	drug
false

The effects of medicinal products with similar properties such as inotropes DRUGA , DRUGN , DRUGN , DRUGN and DRUGN may be exacerbated by DRUGB .
milrinone	drug	anagrelide	drug
effect

The effects of medicinal products with similar properties such as inotropes DRUGN , DRUGA , DRUGB , DRUGN and DRUGN may be exacerbated by DRUGN .
enoximone	drug	amrinone	drug
false

The effects of medicinal products with similar properties such as inotropes DRUGN , DRUGA , DRUGN , DRUGB and DRUGN may be exacerbated by DRUGN .
enoximone	drug	olprinone	drug_n
false

The effects of medicinal products with similar properties such as inotropes DRUGN , DRUGA , DRUGN , DRUGN and DRUGB may be exacerbated by DRUGN .
enoximone	drug	cilostazol	drug
false

The effects of medicinal products with similar properties such as inotropes DRUGN , DRUGA , DRUGN , DRUGN and DRUGN may be exacerbated by DRUGB .
enoximone	drug	anagrelide	drug
effect

The effects of medicinal products with similar properties such as inotropes DRUGN , DRUGN , DRUGA , DRUGB and DRUGN may be exacerbated by DRUGN .
amrinone	drug	olprinone	drug_n
false

The effects of medicinal products with similar properties such as inotropes DRUGN , DRUGN , DRUGA , DRUGN and DRUGB may be exacerbated by DRUGN .
amrinone	drug	cilostazol	drug
false

The effects of medicinal products with similar properties such as inotropes DRUGN , DRUGN , DRUGA , DRUGN and DRUGN may be exacerbated by DRUGB .
amrinone	drug	anagrelide	drug
effect

The effects of medicinal products with similar properties such as inotropes DRUGN , DRUGN , DRUGN , DRUGA and DRUGB may be exacerbated by DRUGN .
olprinone	drug_n	cilostazol	drug
false

The effects of medicinal products with similar properties such as inotropes DRUGN , DRUGN , DRUGN , DRUGA and DRUGN may be exacerbated by DRUGB .
olprinone	drug_n	anagrelide	drug
effect

The effects of medicinal products with similar properties such as inotropes DRUGN , DRUGN , DRUGN , DRUGN and DRUGA may be exacerbated by DRUGB .
cilostazol	drug	anagrelide	drug
effect

There is a single case report , which suggests that DRUGA may interfere with DRUGB absorption .
sucralfate	drug	anagrelide	drug
mechanism

Toxicologic and toxicokinetic studies in rats did not demonstrate any alterations in the clearance or toxicologic profile of either DRUGA or DRUGB when the two agents were administered together .
methotrexate	drug	Kineret	brand
false

Two percent of patients treated concurrently with DRUGA and DRUGB developed neutropenia ( ANC dgb x dgb / L ) .
Kineret	brand	etanercept	drug
effect

DRUGA did not alter the pharmacokinetics of DRUGB .
Anastrozole	drug	antipyrine	drug
false

An interaction study with DRUGA showed no clinically significant effect of DRUGB on DRUGN pharmacokinetics or anticoagulant activity .
warfarin	drug	anastrozole	drug
false

An interaction study with DRUGN showed no clinically significant effect of DRUGA on DRUGB pharmacokinetics or anticoagulant activity .
anastrozole	drug	warfarin	drug
false

At a median follow up of dgb months , the combination of DRUGA and DRUGB did not demonstrate any efficacy benefit when compared with DRUGN in all patients as well as in the hormone receptor positive subpopulation .
ARIMIDEX	brand	tamoxifen	drug
false

At a median follow up of dgb months , the combination of DRUGA and DRUGN did not demonstrate any efficacy benefit when compared with DRUGB in all patients as well as in the hormone receptor positive subpopulation .
ARIMIDEX	brand	tamoxifen	drug
false

Based on clinical and pharmacokinetic results from the ATAC trial , DRUGA should not be administered with DRUGB ( see CLINICAL PHARMACOLOGY Drug Interactions and CLINICAL PHARMACOLOGY Clinical Studies Adjuvant Treatment of Breast Cancer in Postmenopausal Women subsections ) .
tamoxifen	drug	anastrozole	drug
advise

Co administration of DRUGA and DRUGB resulted in a reduction of DRUGN plasma levels by dgb % compared with those achieved with DRUGN alone .
anastrozole	drug	tamoxifen	drug
mechanism

Co administration of DRUGN and DRUGA resulted in a reduction of DRUGB plasma levels by dgb % compared with those achieved with DRUGN alone .
tamoxifen	drug	anastrozole	drug
false

Co administration of DRUGN and DRUGA resulted in a reduction of DRUGN plasma levels by dgb % compared with those achieved with DRUGB alone .
tamoxifen	drug	anastrozole	drug
false

DRUGA containing therapies should not be used with DRUGB as they may diminish its pharmacologic action .
Estrogen	group	ARIMIDEX	brand
advise

Caution should be observed when DRUGA is coadministered with other DRUGB , DRUGN , DRUGN , or DRUGN , as these agents may increase respiratory and circulatory depression .
anileridine	drug	opioids	group
advise

Caution should be observed when DRUGA is coadministered with other DRUGN , DRUGB , DRUGN , or DRUGN , as these agents may increase respiratory and circulatory depression .
anileridine	drug	sedatives	group
advise

Caution should be observed when DRUGA is coadministered with other DRUGN , DRUGN , DRUGB , or DRUGN , as these agents may increase respiratory and circulatory depression .
anileridine	drug	phenothiazines	group
advise

Caution should be observed when DRUGA is coadministered with other DRUGN , DRUGN , DRUGN , or DRUGB , as these agents may increase respiratory and circulatory depression .
anileridine	drug	anesthetics	group
advise

Caution should be observed when DRUGN is coadministered with other DRUGA , DRUGB , DRUGN , or DRUGN , as these agents may increase respiratory and circulatory depression .
opioids	group	sedatives	group
false

Caution should be observed when DRUGN is coadministered with other DRUGA , DRUGN , DRUGB , or DRUGN , as these agents may increase respiratory and circulatory depression .
opioids	group	phenothiazines	group
false

Caution should be observed when DRUGN is coadministered with other DRUGA , DRUGN , DRUGN , or DRUGB , as these agents may increase respiratory and circulatory depression .
opioids	group	anesthetics	group
false

Caution should be observed when DRUGN is coadministered with other DRUGN , DRUGA , DRUGB , or DRUGN , as these agents may increase respiratory and circulatory depression .
sedatives	group	phenothiazines	group
false

Caution should be observed when DRUGN is coadministered with other DRUGN , DRUGA , DRUGN , or DRUGB , as these agents may increase respiratory and circulatory depression .
sedatives	group	anesthetics	group
false

Caution should be observed when DRUGN is coadministered with other DRUGN , DRUGN , DRUGA , or DRUGB , as these agents may increase respiratory and circulatory depression .
phenothiazines	group	anesthetics	group
false

Addition or deletion of any drug from the therapeutic regimen of patients receiving oral DRUGA may affect patient response to the DRUGB .
anticoagulants	group	anticoagulant	group
false

For example , since DRUGA may reduce the gastrointestinal absorption of both the oral DRUGB and DRUGN , the net effects are unpredictable .
cholestyramine	drug	anticoagulants	group
mechanism

For example , since DRUGA may reduce the gastrointestinal absorption of both the oral DRUGN and DRUGB , the net effects are unpredictable .
cholestyramine	drug	vitamin K	group
mechanism

For example , since DRUGN may reduce the gastrointestinal absorption of both the oral DRUGA and DRUGB , the net effects are unpredictable .
anticoagulants	group	vitamin K	group
false

Drugs that have been reported to diminish oral DRUGA response , ie , decreased prothrom bin time response , in man significantly include : DRUGB ;
anticoagulant	group	adrenocortical steroids	group
effect

Drugs that reportedly may increase oral DRUGA response , ie , increased prothrombin response , in man include : DRUGB * ;
anticoagulant	group	alcohol	drug
effect

DRUGA ; DRUGB ;
salicylates	group	sulfinpyrazone	drug
false

DRUGA / DRUGB ;
trimethoprim	drug	sulfamethoxazole	drug
false

Oral DRUGA may potentiate the hypoglycemic action of DRUGB , eg , DRUGN and DRUGN , by inhibiting their metabolism in the liver .
anticoagulants	group	hypoglycemic agents	group
mechanism

Oral DRUGA may potentiate the hypoglycemic action of DRUGN , eg , DRUGB and DRUGN , by inhibiting their metabolism in the liver .
anticoagulants	group	tolbutamide	drug
mechanism

Oral DRUGA may potentiate the hypoglycemic action of DRUGN , eg , DRUGN and DRUGB , by inhibiting their metabolism in the liver .
anticoagulants	group	chlorpropamide	drug
mechanism

Oral DRUGN may potentiate the hypoglycemic action of DRUGA , eg , DRUGB and DRUGN , by inhibiting their metabolism in the liver .
hypoglycemic agents	group	tolbutamide	drug
false

Oral DRUGN may potentiate the hypoglycemic action of DRUGA , eg , DRUGN and DRUGB , by inhibiting their metabolism in the liver .
hypoglycemic agents	group	chlorpropamide	drug
false

Oral DRUGN may potentiate the hypoglycemic action of DRUGN , eg , DRUGA and DRUGB , by inhibiting their metabolism in the liver .
tolbutamide	drug	chlorpropamide	drug
false

Because oral DRUGA may interfere with the hepatic metabolism of DRUGB , toxic levels of the DRUGN may occur when an oral DRUGN and DRUGN are administered concurrently .
anticoagulants	group	phenytoin	drug
mechanism

Because oral DRUGA may interfere with the hepatic metabolism of DRUGN , toxic levels of the DRUGB may occur when an oral DRUGN and DRUGN are administered concurrently .
anticoagulants	group	anticonvulsant	group
false

Because oral DRUGA may interfere with the hepatic metabolism of DRUGN , toxic levels of the DRUGN may occur when an oral DRUGB and DRUGN are administered concurrently .
anticoagulants	group	anticoagulant	group
false

Because oral DRUGA may interfere with the hepatic metabolism of DRUGN , toxic levels of the DRUGN may occur when an oral DRUGN and DRUGB are administered concurrently .
anticoagulants	group	phenytoin	drug
false

Because oral DRUGN may interfere with the hepatic metabolism of DRUGA , toxic levels of the DRUGB may occur when an oral DRUGN and DRUGN are administered concurrently .
phenytoin	drug	anticonvulsant	group
false

Because oral DRUGN may interfere with the hepatic metabolism of DRUGA , toxic levels of the DRUGN may occur when an oral DRUGB and DRUGN are administered concurrently .
phenytoin	drug	anticoagulant	group
false

Because oral DRUGN may interfere with the hepatic metabolism of DRUGN , toxic levels of the DRUGA may occur when an oral DRUGB and DRUGN are administered concurrently .
anticonvulsant	group	anticoagulant	group
false

Because oral DRUGN may interfere with the hepatic metabolism of DRUGN , toxic levels of the DRUGA may occur when an oral DRUGN and DRUGB are administered concurrently .
anticonvulsant	group	phenytoin	drug
false

Because oral DRUGN may interfere with the hepatic metabolism of DRUGN , toxic levels of the DRUGN may occur when an oral DRUGA and DRUGB are administered concurrently .
anticoagulant	group	phenytoin	drug
mechanism

The beneficial effects on arterial thrombus formation from combined therapy with DRUGA and DRUGB must be weighed against an increased risk of inducing hemorrhage .
antiplatelet medication	group	anticoagulant medication	group
advise

Drug / Laboratory Test Interferences : DRUGA and DRUGB , including DRUGN , or their metabolites may color alkaline urine red orange , which may interfere with spectrophotometrically determined urinary laboratory tests .
Dicumarol	drug	indanedione anticoagulants	group
false

Drug / Laboratory Test Interferences : DRUGA and DRUGN , including DRUGB , or their metabolites may color alkaline urine red orange , which may interfere with spectrophotometrically determined urinary laboratory tests .
Dicumarol	drug	anisindione	drug
false

Drug / Laboratory Test Interferences : DRUGN and DRUGA , including DRUGB , or their metabolites may color alkaline urine red orange , which may interfere with spectrophotometrically determined urinary laboratory tests .
indanedione anticoagulants	group	anisindione	drug
false

DRUGA : Since DRUGB is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
Dopamine Antagonists	group	apomorphine	drug
false

DRUGA : Since DRUGN is a DRUGB , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
Dopamine Antagonists	group	dopamine agonist	group
false

DRUGA : Since DRUGN is a DRUGN , it is possible that DRUGB , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
Dopamine Antagonists	group	dopamine antagonists	group
false

DRUGA : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGB ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
Dopamine Antagonists	group	neuroleptics	group
false

DRUGA : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGB , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
Dopamine Antagonists	group	phenothiazines	group
false

DRUGA : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGB , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
Dopamine Antagonists	group	butyrophenones	group
false

DRUGA : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGB ) or DRUGN , may diminish the effectiveness of DRUGN .
Dopamine Antagonists	group	thioxanthenes	group
false

DRUGA : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGB , may diminish the effectiveness of DRUGN .
Dopamine Antagonists	group	metoclopramide	drug
false

DRUGA : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGB .
Dopamine Antagonists	group	APOKYN	brand
false

DRUGN : Since DRUGA is a DRUGB , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
apomorphine	drug	dopamine agonist	group
false

DRUGN : Since DRUGA is a DRUGN , it is possible that DRUGB , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
apomorphine	drug	dopamine antagonists	group
false

DRUGN : Since DRUGA is a DRUGN , it is possible that DRUGN , such as the DRUGB ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
apomorphine	drug	neuroleptics	group
false

DRUGN : Since DRUGA is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGB , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
apomorphine	drug	phenothiazines	group
false

DRUGN : Since DRUGA is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGB , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
apomorphine	drug	butyrophenones	group
false

DRUGN : Since DRUGA is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGB ) or DRUGN , may diminish the effectiveness of DRUGN .
apomorphine	drug	thioxanthenes	group
false

DRUGN : Since DRUGA is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGB , may diminish the effectiveness of DRUGN .
apomorphine	drug	metoclopramide	drug
false

DRUGN : Since DRUGA is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGB .
apomorphine	drug	APOKYN	brand
false

DRUGN : Since DRUGN is a DRUGA , it is possible that DRUGB , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine agonist	group	dopamine antagonists	group
false

DRUGN : Since DRUGN is a DRUGA , it is possible that DRUGN , such as the DRUGB ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine agonist	group	neuroleptics	group
false

DRUGN : Since DRUGN is a DRUGA , it is possible that DRUGN , such as the DRUGN ( DRUGB , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine agonist	group	phenothiazines	group
false

DRUGN : Since DRUGN is a DRUGA , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGB , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine agonist	group	butyrophenones	group
false

DRUGN : Since DRUGN is a DRUGA , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGB ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine agonist	group	thioxanthenes	group
false

DRUGN : Since DRUGN is a DRUGA , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGB , may diminish the effectiveness of DRUGN .
dopamine agonist	group	metoclopramide	drug
false

DRUGN : Since DRUGN is a DRUGA , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGB .
dopamine agonist	group	APOKYN	brand
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGA , such as the DRUGB ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine antagonists	group	neuroleptics	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGA , such as the DRUGN ( DRUGB , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine antagonists	group	phenothiazines	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGA , such as the DRUGN ( DRUGN , DRUGB , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine antagonists	group	butyrophenones	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGA , such as the DRUGN ( DRUGN , DRUGN , DRUGB ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine antagonists	group	thioxanthenes	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGA , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGB , may diminish the effectiveness of DRUGN .
dopamine antagonists	group	metoclopramide	drug
effect

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGA , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGB .
dopamine antagonists	group	APOKYN	brand
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGA ( DRUGB , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
neuroleptics	group	phenothiazines	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGA ( DRUGN , DRUGB , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
neuroleptics	group	butyrophenones	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGA ( DRUGN , DRUGN , DRUGB ) or DRUGN , may diminish the effectiveness of DRUGN .
neuroleptics	group	thioxanthenes	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGA ( DRUGN , DRUGN , DRUGN ) or DRUGB , may diminish the effectiveness of DRUGN .
neuroleptics	group	metoclopramide	drug
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGA ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGB .
neuroleptics	group	APOKYN	brand
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGA , DRUGB , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
phenothiazines	group	butyrophenones	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGA , DRUGN , DRUGB ) or DRUGN , may diminish the effectiveness of DRUGN .
phenothiazines	group	thioxanthenes	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGA , DRUGN , DRUGN ) or DRUGB , may diminish the effectiveness of DRUGN .
phenothiazines	group	metoclopramide	drug
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGA , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGB .
phenothiazines	group	APOKYN	brand
effect

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGA , DRUGB ) or DRUGN , may diminish the effectiveness of DRUGN .
butyrophenones	group	thioxanthenes	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGA , DRUGN ) or DRUGB , may diminish the effectiveness of DRUGN .
butyrophenones	group	metoclopramide	drug
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGA , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGB .
butyrophenones	group	APOKYN	brand
effect

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGA ) or DRUGB , may diminish the effectiveness of DRUGN .
thioxanthenes	group	metoclopramide	drug
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGA ) or DRUGN , may diminish the effectiveness of DRUGB .
thioxanthenes	group	APOKYN	brand
effect

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGA , may diminish the effectiveness of DRUGB .
metoclopramide	drug	APOKYN	brand
effect

Patients with major psychotic disorders , treated with DRUGA , should be treated with DRUGB only if the potential benefits outweigh the risks .
neuroleptics	group	dopamine agonists	group
advise

DRUGA should not be used in patients receiving DRUGB ..
Apraclonidine	drug	MAO inhibitors	group
advise

DRUGA have been reported to blunt the hypotensive effect of systemic DRUGB .
Tricyclic antidepressants	group	clonidine	drug
effect

An additive hypotensive effect has been reported with the combination of systemic DRUGA and DRUGB therapy .
clonidine	drug	neuroleptic	group
effect

Since DRUGA may reduce pulse and blood pressure , caution in using drugs such as DRUGB ( ophthalmic and systemic ) , DRUGN , and DRUGN is advised .
apraclonidine	drug	beta-blockers	group
advise

Since DRUGA may reduce pulse and blood pressure , caution in using drugs such as DRUGN ( ophthalmic and systemic ) , DRUGB , and DRUGN is advised .
apraclonidine	drug	antihypertensives	group
advise

Since DRUGA may reduce pulse and blood pressure , caution in using drugs such as DRUGN ( ophthalmic and systemic ) , DRUGN , and DRUGB is advised .
apraclonidine	drug	cardiac glycosides	group
advise

Since DRUGN may reduce pulse and blood pressure , caution in using drugs such as DRUGA ( ophthalmic and systemic ) , DRUGB , and DRUGN is advised .
beta-blockers	group	antihypertensives	group
false

Since DRUGN may reduce pulse and blood pressure , caution in using drugs such as DRUGA ( ophthalmic and systemic ) , DRUGN , and DRUGB is advised .
beta-blockers	group	cardiac glycosides	group
false

Since DRUGN may reduce pulse and blood pressure , caution in using drugs such as DRUGN ( ophthalmic and systemic ) , DRUGA , and DRUGB is advised .
antihypertensives	group	cardiac glycosides	group
false

DRUGA has been shown to induce the metabolism of DRUGB and DRUGN , which are metabolized through CYPdgbCdga
Aprepitant	drug	S(-) warfarin	drug
mechanism

DRUGA has been shown to induce the metabolism of DRUGN and DRUGB , which are metabolized through CYPdgbCdga
Aprepitant	drug	tolbutamide	drug
mechanism

DRUGN has been shown to induce the metabolism of DRUGA and DRUGB , which are metabolized through CYPdgbCdga
S(-) warfarin	drug	tolbutamide	drug
false

Coadministration of DRUGA with these drugs or other drugs that are known to be metabolized by CYPdgbCdgb , such as DRUGB , may result in lower plasma concentrations of these drugs .
Aprepitant	drug	phenytoin	drug
mechanism

DRUGA is unlikely to interact with drugs that are substrates for the P glycoprotein transporter , as demonstrated by the lack of interaction of DRUGN with DRUGB in a clinical drug interaction study .
Aprepitant	drug	digoxin	drug
false

DRUGN is unlikely to interact with drugs that are substrates for the P glycoprotein transporter , as demonstrated by the lack of interaction of DRUGA with DRUGB in a clinical drug interaction study .
Aprepitant	drug	digoxin	drug
false

DRUGA : In clinical drug interaction studies , DRUGB did not have clinically important effects on the pharmacokinetics of DRUGN or DRUGN .
5-HT3 antagonists	group	aprepitant	drug
false

DRUGA : In clinical drug interaction studies , DRUGN did not have clinically important effects on the pharmacokinetics of DRUGB or DRUGN .
5-HT3 antagonists	group	ondansetron	drug
false

DRUGA : In clinical drug interaction studies , DRUGN did not have clinically important effects on the pharmacokinetics of DRUGN or DRUGB .
5-HT3 antagonists	group	granisetron	drug
false

DRUGN : In clinical drug interaction studies , DRUGA did not have clinically important effects on the pharmacokinetics of DRUGB or DRUGN .
aprepitant	drug	ondansetron	drug
false

DRUGN : In clinical drug interaction studies , DRUGA did not have clinically important effects on the pharmacokinetics of DRUGN or DRUGB .
aprepitant	drug	granisetron	drug
false

DRUGN : In clinical drug interaction studies , DRUGN did not have clinically important effects on the pharmacokinetics of DRUGA or DRUGB .
ondansetron	drug	granisetron	drug
false

The oral DRUGA doses should be reduced by approximately dgb % when coadministered with DRUGB , to achieve exposures of DRUGN similar to those obtained when it is given without DRUGN .
dexamethasone	drug	Aprepitant	drug
advise

The oral DRUGA doses should be reduced by approximately dgb % when coadministered with DRUGN , to achieve exposures of DRUGN similar to those obtained when it is given without DRUGB .
dexamethasone	drug	Aprepitant	drug
false

The oral DRUGN doses should be reduced by approximately dgb % when coadministered with DRUGA , to achieve exposures of DRUGB similar to those obtained when it is given without DRUGN .
Aprepitant	drug	dexamethasone	drug
false

The oral DRUGN doses should be reduced by approximately dgb % when coadministered with DRUGN , to achieve exposures of DRUGA similar to those obtained when it is given without DRUGB .
dexamethasone	drug	Aprepitant	drug
false

The daily dose of DRUGA administered in clinical studies with DRUGB reflects an approximate dgb % reduction of the dose of DRUGN .
dexamethasone	drug	Aprepitant	drug
mechanism

The daily dose of DRUGN administered in clinical studies with DRUGA reflects an approximate dgb % reduction of the dose of DRUGB .
Aprepitant	drug	dexamethasone	drug
false

DRUGA : A single dgb mg dose of DRUGB was administered on Day dgb and dgb mg / day on Days dgb and dgb to healthy subjects who were stabilized on chronic DRUGN therapy .
Warfarin	drug	Aprepitant	drug
false

DRUGA : A single dgb mg dose of DRUGN was administered on Day dgb and dgb mg / day on Days dgb and dgb to healthy subjects who were stabilized on chronic DRUGB therapy .
Warfarin	drug	warfarin	drug
false

DRUGN : A single dgb mg dose of DRUGA was administered on Day dgb and dgb mg / day on Days dgb and dgb to healthy subjects who were stabilized on chronic DRUGB therapy .
Aprepitant	drug	warfarin	drug
false

therefore , the efficacy of oral DRUGA during administration of DRUGB may be reduced .
contraceptives	group	Aprepitant	drug
effect

Although a dgb day regimen of DRUGA given concomitantly with oral DRUGB has not been studied , alternative or back up methods of contraception should be used .
Aprepitant	drug	contraceptives	group
advise

The potential effects of increased plasma concentrations of DRUGA or other DRUGB metabolized via CYPdgbAdgb ( DRUGN , DRUGN ) should be considered when coadministering these agents with DRUGN .
midazolam	drug	benzodiazepines	group
false

The potential effects of increased plasma concentrations of DRUGA or other DRUGN metabolized via CYPdgbAdgb ( DRUGB , DRUGN ) should be considered when coadministering these agents with DRUGN .
midazolam	drug	alprazolam	drug
false

The potential effects of increased plasma concentrations of DRUGA or other DRUGN metabolized via CYPdgbAdgb ( DRUGN , DRUGB ) should be considered when coadministering these agents with DRUGN .
midazolam	drug	triazolam	drug
false

The potential effects of increased plasma concentrations of DRUGA or other DRUGN metabolized via CYPdgbAdgb ( DRUGN , DRUGN ) should be considered when coadministering these agents with DRUGB .
midazolam	drug	Aprepitant	drug
advise

The potential effects of increased plasma concentrations of DRUGN or other DRUGA metabolized via CYPdgbAdgb ( DRUGB , DRUGN ) should be considered when coadministering these agents with DRUGN .
benzodiazepines	group	alprazolam	drug
false

The potential effects of increased plasma concentrations of DRUGN or other DRUGA metabolized via CYPdgbAdgb ( DRUGN , DRUGB ) should be considered when coadministering these agents with DRUGN .
benzodiazepines	group	triazolam	drug
false

The potential effects of increased plasma concentrations of DRUGN or other DRUGA metabolized via CYPdgbAdgb ( DRUGN , DRUGN ) should be considered when coadministering these agents with DRUGB .
benzodiazepines	group	Aprepitant	drug
advise

The potential effects of increased plasma concentrations of DRUGN or other DRUGN metabolized via CYPdgbAdgb ( DRUGA , DRUGB ) should be considered when coadministering these agents with DRUGN .
alprazolam	drug	triazolam	drug
false

The potential effects of increased plasma concentrations of DRUGN or other DRUGN metabolized via CYPdgbAdgb ( DRUGA , DRUGN ) should be considered when coadministering these agents with DRUGB .
alprazolam	drug	Aprepitant	drug
advise

The potential effects of increased plasma concentrations of DRUGN or other DRUGN metabolized via CYPdgbAdgb ( DRUGN , DRUGA ) should be considered when coadministering these agents with DRUGB .
triazolam	drug	Aprepitant	drug
advise

DRUGA increased the AUC of DRUGB by dgb % on Day dgb and decreased the AUC of DRUGN by dgb % on Day dgb relative to the dosing of DRUGN on Days dgb through dga
Aprepitant	drug	midazolam	drug
mechanism

DRUGA increased the AUC of DRUGN by dgb % on Day dgb and decreased the AUC of DRUGB by dgb % on Day dgb relative to the dosing of DRUGN on Days dgb through dga
Aprepitant	drug	midazolam	drug
mechanism

DRUGN increased the AUC of DRUGA by dgb % on Day dgb and decreased the AUC of DRUGN by dgb % on Day dgb relative to the dosing of DRUGB on Days dgb through dga
midazolam	drug	Aprepitant	drug
false

DRUGN increased the AUC of DRUGN by dgb % on Day dgb and decreased the AUC of DRUGA by dgb % on Day dgb relative to the dosing of DRUGB on Days dgb through dga
midazolam	drug	Aprepitant	drug
false

therefore , coadministration of DRUGA with drugs that inhibit CYPdgbAdgb activity may result in increased plasma concentrations of DRUGB .
Aprepitant	drug	aprepitant	drug
false

Consequently , concomitant administration of DRUGA with strong CYPdgbAdgb inhibitors ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ) should be approached with caution .
Aprepitant	drug	ketoconazole	drug
advise

Consequently , concomitant administration of DRUGA with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ) should be approached with caution .
Aprepitant	drug	itraconazole	drug
advise

Consequently , concomitant administration of DRUGA with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN ) should be approached with caution .
Aprepitant	drug	nefazodone	drug
advise

Consequently , concomitant administration of DRUGA with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN ) should be approached with caution .
Aprepitant	drug	troleandomycin	drug
advise

Consequently , concomitant administration of DRUGA with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN ) should be approached with caution .
Aprepitant	drug	clarithromycin	drug
advise

Consequently , concomitant administration of DRUGA with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN ) should be approached with caution .
Aprepitant	drug	ritonavir	drug
advise

Consequently , concomitant administration of DRUGA with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB ) should be approached with caution .
Aprepitant	drug	nelfinavir	drug
advise

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ) should be approached with caution .
ketoconazole	drug	itraconazole	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN ) should be approached with caution .
ketoconazole	drug	nefazodone	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN ) should be approached with caution .
ketoconazole	drug	troleandomycin	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN ) should be approached with caution .
ketoconazole	drug	clarithromycin	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN ) should be approached with caution .
ketoconazole	drug	ritonavir	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB ) should be approached with caution .
ketoconazole	drug	nelfinavir	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN ) should be approached with caution .
itraconazole	drug	nefazodone	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN ) should be approached with caution .
itraconazole	drug	troleandomycin	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN ) should be approached with caution .
itraconazole	drug	clarithromycin	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN ) should be approached with caution .
itraconazole	drug	ritonavir	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB ) should be approached with caution .
itraconazole	drug	nelfinavir	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN ) should be approached with caution .
nefazodone	drug	troleandomycin	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN ) should be approached with caution .
nefazodone	drug	clarithromycin	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN ) should be approached with caution .
nefazodone	drug	ritonavir	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB ) should be approached with caution .
nefazodone	drug	nelfinavir	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN ) should be approached with caution .
troleandomycin	drug	clarithromycin	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN ) should be approached with caution .
troleandomycin	drug	ritonavir	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB ) should be approached with caution .
troleandomycin	drug	nelfinavir	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN ) should be approached with caution .
clarithromycin	drug	ritonavir	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB ) should be approached with caution .
clarithromycin	drug	nelfinavir	drug
false

Consequently , concomitant administration of DRUGN with strong CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB ) should be approached with caution .
ritonavir	drug	nelfinavir	drug
false

Because moderate CYPdgbAdgb inhibitors ( e.g . , DRUGA ) result in dgb fold increase in plasma concentrations of DRUGB , concomitant administration should also be approached with caution .
diltiazem	drug	aprepitant	drug
advise

therefore , coadministration of DRUGA with drugs that strongly induce CYPdgbAdgb activity ( e.g . , DRUGB , DRUGN , DRUGN ) may result in reduced plasma concentrations of DRUGN that may result in decreased efficacy of DRUGN .
Aprepitant	drug	rifampin	drug
mechanism

therefore , coadministration of DRUGA with drugs that strongly induce CYPdgbAdgb activity ( e.g . , DRUGN , DRUGB , DRUGN ) may result in reduced plasma concentrations of DRUGN that may result in decreased efficacy of DRUGN .
Aprepitant	drug	carbamazepine	drug
false

therefore , coadministration of DRUGA with drugs that strongly induce CYPdgbAdgb activity ( e.g . , DRUGN , DRUGN , DRUGB ) may result in reduced plasma concentrations of DRUGN that may result in decreased efficacy of DRUGN .
Aprepitant	drug	phenytoin	drug
mechanism

therefore , coadministration of DRUGA with drugs that strongly induce CYPdgbAdgb activity ( e.g . , DRUGN , DRUGN , DRUGN ) may result in reduced plasma concentrations of DRUGB that may result in decreased efficacy of DRUGN .
Aprepitant	drug	aprepitant	drug
mechanism

therefore , coadministration of DRUGN with drugs that strongly induce CYPdgbAdgb activity ( e.g . , DRUGA , DRUGB , DRUGN ) may result in reduced plasma concentrations of DRUGN that may result in decreased efficacy of DRUGN .
rifampin	drug	carbamazepine	drug
false

therefore , coadministration of DRUGN with drugs that strongly induce CYPdgbAdgb activity ( e.g . , DRUGA , DRUGN , DRUGB ) may result in reduced plasma concentrations of DRUGN that may result in decreased efficacy of DRUGN .
rifampin	drug	phenytoin	drug
false

therefore , coadministration of DRUGN with drugs that strongly induce CYPdgbAdgb activity ( e.g . , DRUGA , DRUGN , DRUGN ) may result in reduced plasma concentrations of DRUGB that may result in decreased efficacy of DRUGN .
rifampin	drug	aprepitant	drug
false

therefore , coadministration of DRUGN with drugs that strongly induce CYPdgbAdgb activity ( e.g . , DRUGA , DRUGN , DRUGN ) may result in reduced plasma concentrations of DRUGN that may result in decreased efficacy of DRUGB .
rifampin	drug	Aprepitant	drug
false

therefore , coadministration of DRUGN with drugs that strongly induce CYPdgbAdgb activity ( e.g . , DRUGN , DRUGA , DRUGB ) may result in reduced plasma concentrations of DRUGN that may result in decreased efficacy of DRUGN .
carbamazepine	drug	phenytoin	drug
false

therefore , coadministration of DRUGN with drugs that strongly induce CYPdgbAdgb activity ( e.g . , DRUGN , DRUGA , DRUGN ) may result in reduced plasma concentrations of DRUGB that may result in decreased efficacy of DRUGN .
carbamazepine	drug	aprepitant	drug
false

therefore , coadministration of DRUGN with drugs that strongly induce CYPdgbAdgb activity ( e.g . , DRUGN , DRUGA , DRUGN ) may result in reduced plasma concentrations of DRUGN that may result in decreased efficacy of DRUGB .
carbamazepine	drug	Aprepitant	drug
false

therefore , coadministration of DRUGN with drugs that strongly induce CYPdgbAdgb activity ( e.g . , DRUGN , DRUGN , DRUGA ) may result in reduced plasma concentrations of DRUGB that may result in decreased efficacy of DRUGN .
phenytoin	drug	aprepitant	drug
false

therefore , coadministration of DRUGN with drugs that strongly induce CYPdgbAdgb activity ( e.g . , DRUGN , DRUGN , DRUGA ) may result in reduced plasma concentrations of DRUGN that may result in decreased efficacy of DRUGB .
phenytoin	drug	Aprepitant	drug
false

therefore , coadministration of DRUGN with drugs that strongly induce CYPdgbAdgb activity ( e.g . , DRUGN , DRUGN , DRUGN ) may result in reduced plasma concentrations of DRUGA that may result in decreased efficacy of DRUGB .
aprepitant	drug	Aprepitant	drug
false

DRUGA : When a single dgb mg dose of DRUGB was administered on Daydgb of a
Ketoconazole	drug	Aprepitant	drug
false

DRUGA : concurrent use may blunt the response to DRUGB .
Beta-adrenergic blocking agents	group	arbutamine	drug
false

DRUGA should be withdrawn at least dgb hours before conducting an DRUGB mediated stress test .
Beta-adrenergic blocking agents	group	arbutamine	drug
advise

DRUGA ( such as DRUGB , DRUGN , or DRUGN ) : concurrent use with DRUGN may have a proarrhythmic effect .
Antiarrhythmic agents, class I	drug	flecainide	drug
false

DRUGA ( such as DRUGN , DRUGB , or DRUGN ) : concurrent use with DRUGN may have a proarrhythmic effect .
Antiarrhythmic agents, class I	drug	lidocaine	drug
false

DRUGA ( such as DRUGN , DRUGN , or DRUGB ) : concurrent use with DRUGN may have a proarrhythmic effect .
Antiarrhythmic agents, class I	drug	quinidine	drug
false

DRUGA ( such as DRUGN , DRUGN , or DRUGN ) : concurrent use with DRUGB may have a proarrhythmic effect .
Antiarrhythmic agents, class I	drug	arbutamine	drug
false

DRUGN ( such as DRUGA , DRUGB , or DRUGN ) : concurrent use with DRUGN may have a proarrhythmic effect .
flecainide	drug	lidocaine	drug
false

DRUGN ( such as DRUGA , DRUGN , or DRUGB ) : concurrent use with DRUGN may have a proarrhythmic effect .
flecainide	drug	quinidine	drug
false

DRUGN ( such as DRUGA , DRUGN , or DRUGN ) : concurrent use with DRUGB may have a proarrhythmic effect .
flecainide	drug	arbutamine	drug
false

DRUGN ( such as DRUGN , DRUGA , or DRUGB ) : concurrent use with DRUGN may have a proarrhythmic effect .
lidocaine	drug	quinidine	drug
false

DRUGN ( such as DRUGN , DRUGA , or DRUGN ) : concurrent use with DRUGB may have a proarrhythmic effect .
lidocaine	drug	arbutamine	drug
false

DRUGN ( such as DRUGN , DRUGN , or DRUGA ) : concurrent use with DRUGB may have a proarrhythmic effect .
quinidine	drug	arbutamine	drug
false

DRUGA ( DRUGB ) , DRUGN or other DRUGN , or DRUGN : concurrent use with DRUGN may produce additive inotropic and / or chronotropic effects .
Antidepressants	group	tricyclic	group
false

DRUGA ( DRUGN ) , DRUGB or other DRUGN , or DRUGN : concurrent use with DRUGN may produce additive inotropic and / or chronotropic effects .
Antidepressants	group	atropine	drug
false

DRUGA ( DRUGN ) , DRUGN or other DRUGB , or DRUGN : concurrent use with DRUGN may produce additive inotropic and / or chronotropic effects .
Antidepressants	group	anticholinergic agents	group
false

DRUGA ( DRUGN ) , DRUGN or other DRUGN , or DRUGB : concurrent use with DRUGN may produce additive inotropic and / or chronotropic effects .
Antidepressants	group	digitalis glycosides	group
false

DRUGA ( DRUGN ) , DRUGN or other DRUGN , or DRUGN : concurrent use with DRUGB may produce additive inotropic and / or chronotropic effects .
Antidepressants	group	arbutamine	drug
false

DRUGN ( DRUGA ) , DRUGB or other DRUGN , or DRUGN : concurrent use with DRUGN may produce additive inotropic and / or chronotropic effects .
tricyclic	group	atropine	drug
false

DRUGN ( DRUGA ) , DRUGN or other DRUGB , or DRUGN : concurrent use with DRUGN may produce additive inotropic and / or chronotropic effects .
tricyclic	group	anticholinergic agents	group
false

DRUGN ( DRUGA ) , DRUGN or other DRUGN , or DRUGB : concurrent use with DRUGN may produce additive inotropic and / or chronotropic effects .
tricyclic	group	digitalis glycosides	group
false

DRUGN ( DRUGA ) , DRUGN or other DRUGN , or DRUGN : concurrent use with DRUGB may produce additive inotropic and / or chronotropic effects .
tricyclic	group	arbutamine	drug
false

DRUGN ( DRUGN ) , DRUGA or other DRUGB , or DRUGN : concurrent use with DRUGN may produce additive inotropic and / or chronotropic effects .
atropine	drug	anticholinergic agents	group
false

DRUGN ( DRUGN ) , DRUGA or other DRUGN , or DRUGB : concurrent use with DRUGN may produce additive inotropic and / or chronotropic effects .
atropine	drug	digitalis glycosides	group
false

DRUGN ( DRUGN ) , DRUGA or other DRUGN , or DRUGN : concurrent use with DRUGB may produce additive inotropic and / or chronotropic effects .
atropine	drug	arbutamine	drug
false

DRUGN ( DRUGN ) , DRUGN or other DRUGA , or DRUGB : concurrent use with DRUGN may produce additive inotropic and / or chronotropic effects .
anticholinergic agents	group	digitalis glycosides	group
false

DRUGN ( DRUGN ) , DRUGN or other DRUGA , or DRUGN : concurrent use with DRUGB may produce additive inotropic and / or chronotropic effects .
anticholinergic agents	group	arbutamine	drug
false

DRUGN ( DRUGN ) , DRUGN or other DRUGN , or DRUGA : concurrent use with DRUGB may produce additive inotropic and / or chronotropic effects .
digitalis glycosides	group	arbutamine	drug
false

DRUGA including coumarin derivatives , indandione derivatives , and DRUGB such as DRUGN ( DRUGN ) , and DRUGN may increase the risk of bleeding when administered concomitantly with DRUGN .
Anticoagulants	group	platelet aggregation inhibitors	group
false

DRUGA including coumarin derivatives , indandione derivatives , and DRUGN such as DRUGB ( DRUGN ) , and DRUGN may increase the risk of bleeding when administered concomitantly with DRUGN .
Anticoagulants	group	nonsteroidal anti-inflammatory drugs	group
false

DRUGA including coumarin derivatives , indandione derivatives , and DRUGN such as DRUGN ( DRUGB ) , and DRUGN may increase the risk of bleeding when administered concomitantly with DRUGN .
Anticoagulants	group	NSAIDs	group
false

DRUGA including coumarin derivatives , indandione derivatives , and DRUGN such as DRUGN ( DRUGN ) , and DRUGB may increase the risk of bleeding when administered concomitantly with DRUGN .
Anticoagulants	group	aspirin	brand
false

DRUGA including coumarin derivatives , indandione derivatives , and DRUGN such as DRUGN ( DRUGN ) , and DRUGN may increase the risk of bleeding when administered concomitantly with DRUGB .
Anticoagulants	group	ardeparin	drug
effect

DRUGN including coumarin derivatives , indandione derivatives , and DRUGA such as DRUGB ( DRUGN ) , and DRUGN may increase the risk of bleeding when administered concomitantly with DRUGN .
platelet aggregation inhibitors	group	nonsteroidal anti-inflammatory drugs	group
false

DRUGN including coumarin derivatives , indandione derivatives , and DRUGA such as DRUGN ( DRUGB ) , and DRUGN may increase the risk of bleeding when administered concomitantly with DRUGN .
platelet aggregation inhibitors	group	NSAIDs	group
false

DRUGN including coumarin derivatives , indandione derivatives , and DRUGA such as DRUGN ( DRUGN ) , and DRUGB may increase the risk of bleeding when administered concomitantly with DRUGN .
platelet aggregation inhibitors	group	aspirin	brand
false

DRUGN including coumarin derivatives , indandione derivatives , and DRUGA such as DRUGN ( DRUGN ) , and DRUGN may increase the risk of bleeding when administered concomitantly with DRUGB .
platelet aggregation inhibitors	group	ardeparin	drug
effect

DRUGN including coumarin derivatives , indandione derivatives , and DRUGN such as DRUGA ( DRUGB ) , and DRUGN may increase the risk of bleeding when administered concomitantly with DRUGN .
nonsteroidal anti-inflammatory drugs	group	NSAIDs	group
false

DRUGN including coumarin derivatives , indandione derivatives , and DRUGN such as DRUGA ( DRUGN ) , and DRUGB may increase the risk of bleeding when administered concomitantly with DRUGN .
nonsteroidal anti-inflammatory drugs	group	aspirin	brand
false

DRUGN including coumarin derivatives , indandione derivatives , and DRUGN such as DRUGA ( DRUGN ) , and DRUGN may increase the risk of bleeding when administered concomitantly with DRUGB .
nonsteroidal anti-inflammatory drugs	group	ardeparin	drug
effect

DRUGN including coumarin derivatives , indandione derivatives , and DRUGN such as DRUGN ( DRUGA ) , and DRUGB may increase the risk of bleeding when administered concomitantly with DRUGN .
NSAIDs	group	aspirin	brand
false

DRUGN including coumarin derivatives , indandione derivatives , and DRUGN such as DRUGN ( DRUGA ) , and DRUGN may increase the risk of bleeding when administered concomitantly with DRUGB .
NSAIDs	group	ardeparin	drug
effect

DRUGN including coumarin derivatives , indandione derivatives , and DRUGN such as DRUGN ( DRUGN ) , and DRUGA may increase the risk of bleeding when administered concomitantly with DRUGB .
aspirin	brand	ardeparin	drug
effect

If additional DRUGA are to be administered by any route , they should be used with caution because the pharmacologically predictable sympathetic effects of DRUGB may be potentiated .
adrenergic drugs	group	BROVANA	brand
advise

When DRUGA , a potent inhibitor of CYPdgbDdgb , was co administered with DRUGB at steady state , exposure to either drug was not altered .
paroxetine	drug	BROVANA	brand
false

Concomitant treatment with DRUGA ( DRUGB , DRUGN ) , DRUGN , or DRUGN may potentiate any hypokalemic effect of DRUGN .
methylxanthines	group	aminophylline	drug
false

Concomitant treatment with DRUGA ( DRUGN , DRUGB ) , DRUGN , or DRUGN may potentiate any hypokalemic effect of DRUGN .
methylxanthines	group	theophylline	drug
false

Concomitant treatment with DRUGA ( DRUGN , DRUGN ) , DRUGB , or DRUGN may potentiate any hypokalemic effect of DRUGN .
methylxanthines	group	steroids	group
false

Concomitant treatment with DRUGA ( DRUGN , DRUGN ) , DRUGN , or DRUGB may potentiate any hypokalemic effect of DRUGN .
methylxanthines	group	diuretics	group
false

Concomitant treatment with DRUGA ( DRUGN , DRUGN ) , DRUGN , or DRUGN may potentiate any hypokalemic effect of DRUGB .
methylxanthines	group	adrenergic agonists	group
effect

Concomitant treatment with DRUGN ( DRUGA , DRUGB ) , DRUGN , or DRUGN may potentiate any hypokalemic effect of DRUGN .
aminophylline	drug	theophylline	drug
false

Concomitant treatment with DRUGN ( DRUGA , DRUGN ) , DRUGB , or DRUGN may potentiate any hypokalemic effect of DRUGN .
aminophylline	drug	steroids	group
false

Concomitant treatment with DRUGN ( DRUGA , DRUGN ) , DRUGN , or DRUGB may potentiate any hypokalemic effect of DRUGN .
aminophylline	drug	diuretics	group
false

Concomitant treatment with DRUGN ( DRUGA , DRUGN ) , DRUGN , or DRUGN may potentiate any hypokalemic effect of DRUGB .
aminophylline	drug	adrenergic agonists	group
effect

Concomitant treatment with DRUGN ( DRUGN , DRUGA ) , DRUGB , or DRUGN may potentiate any hypokalemic effect of DRUGN .
theophylline	drug	steroids	group
false

Concomitant treatment with DRUGN ( DRUGN , DRUGA ) , DRUGN , or DRUGB may potentiate any hypokalemic effect of DRUGN .
theophylline	drug	diuretics	group
false

Concomitant treatment with DRUGN ( DRUGN , DRUGA ) , DRUGN , or DRUGN may potentiate any hypokalemic effect of DRUGB .
theophylline	drug	adrenergic agonists	group
effect

Concomitant treatment with DRUGN ( DRUGN , DRUGN ) , DRUGA , or DRUGB may potentiate any hypokalemic effect of DRUGN .
steroids	group	diuretics	group
false

Concomitant treatment with DRUGN ( DRUGN , DRUGN ) , DRUGA , or DRUGN may potentiate any hypokalemic effect of DRUGB .
steroids	group	adrenergic agonists	group
effect

Concomitant treatment with DRUGN ( DRUGN , DRUGN ) , DRUGN , or DRUGA may potentiate any hypokalemic effect of DRUGB .
diuretics	group	adrenergic agonists	group
effect

The ECG changes and / or hypokalemia that may result from the administration of DRUGA ( such as DRUGB or DRUGN ) can be acutely worsened by DRUGN , especially when the recommended dose of the DRUGN is exceeded .
non-potassium sparing diuretics	group	loop diuretics	group
false

The ECG changes and / or hypokalemia that may result from the administration of DRUGA ( such as DRUGN or DRUGB ) can be acutely worsened by DRUGN , especially when the recommended dose of the DRUGN is exceeded .
non-potassium sparing diuretics	group	thiazide diuretics	group
false

The ECG changes and / or hypokalemia that may result from the administration of DRUGA ( such as DRUGN or DRUGN ) can be acutely worsened by DRUGB , especially when the recommended dose of the DRUGN is exceeded .
non-potassium sparing diuretics	group	beta-agonists	group
effect

The ECG changes and / or hypokalemia that may result from the administration of DRUGA ( such as DRUGN or DRUGN ) can be acutely worsened by DRUGN , especially when the recommended dose of the DRUGB is exceeded .
non-potassium sparing diuretics	group	beta-agonist	group
false

The ECG changes and / or hypokalemia that may result from the administration of DRUGN ( such as DRUGA or DRUGB ) can be acutely worsened by DRUGN , especially when the recommended dose of the DRUGN is exceeded .
loop diuretics	group	thiazide diuretics	group
false

The ECG changes and / or hypokalemia that may result from the administration of DRUGN ( such as DRUGA or DRUGN ) can be acutely worsened by DRUGB , especially when the recommended dose of the DRUGN is exceeded .
loop diuretics	group	beta-agonists	group
effect

The ECG changes and / or hypokalemia that may result from the administration of DRUGN ( such as DRUGA or DRUGN ) can be acutely worsened by DRUGN , especially when the recommended dose of the DRUGB is exceeded .
loop diuretics	group	beta-agonist	group
false

The ECG changes and / or hypokalemia that may result from the administration of DRUGN ( such as DRUGN or DRUGA ) can be acutely worsened by DRUGB , especially when the recommended dose of the DRUGN is exceeded .
thiazide diuretics	group	beta-agonists	group
effect

The ECG changes and / or hypokalemia that may result from the administration of DRUGN ( such as DRUGN or DRUGA ) can be acutely worsened by DRUGN , especially when the recommended dose of the DRUGB is exceeded .
thiazide diuretics	group	beta-agonist	group
false

The ECG changes and / or hypokalemia that may result from the administration of DRUGN ( such as DRUGN or DRUGN ) can be acutely worsened by DRUGA , especially when the recommended dose of the DRUGB is exceeded .
beta-agonists	group	beta-agonist	group
false

Although the clinical significance of these effects is not known , caution is advised in the co administration of DRUGA with DRUGB .
beta-agonists	group	non-potassium sparing diuretics	group
advise

The concurrent use of intravenously or orally administered DRUGA ( e.g . , DRUGB , DRUGN ) by patients receiving DRUGN has not been completely evaluated .
methylxanthines	group	aminophylline	drug
false

The concurrent use of intravenously or orally administered DRUGA ( e.g . , DRUGN , DRUGB ) by patients receiving DRUGN has not been completely evaluated .
methylxanthines	group	theophylline	drug
false

The concurrent use of intravenously or orally administered DRUGA ( e.g . , DRUGN , DRUGN ) by patients receiving DRUGB has not been completely evaluated .
methylxanthines	group	BROVANA	brand
false

The concurrent use of intravenously or orally administered DRUGN ( e.g . , DRUGA , DRUGB ) by patients receiving DRUGN has not been completely evaluated .
aminophylline	drug	theophylline	drug
false

The concurrent use of intravenously or orally administered DRUGN ( e.g . , DRUGA , DRUGN ) by patients receiving DRUGB has not been completely evaluated .
aminophylline	drug	BROVANA	brand
false

The concurrent use of intravenously or orally administered DRUGN ( e.g . , DRUGN , DRUGA ) by patients receiving DRUGB has not been completely evaluated .
theophylline	drug	BROVANA	brand
false

In a dgb month controlled trial that included a dgb mcg once daily DRUGA dose , dgb of the dgb DRUGN treated subjects received concomitant DRUGB at study entry .
BROVANA	brand	theophylline	drug
false

In a dgb month controlled trial that included a dgb mcg once daily DRUGN dose , dgb of the dgb DRUGA treated subjects received concomitant DRUGB at study entry .
BROVANA	brand	theophylline	drug
false

DRUGA ( DRUGB ) and DRUGN may interfere with the effect of each other when administered concurrently .
Beta-adrenergic receptor antagonists	group	beta-blockers	group
false

DRUGA ( DRUGN ) and DRUGB may interfere with the effect of each other when administered concurrently .
Beta-adrenergic receptor antagonists	group	BROVANA	brand
effect

DRUGN ( DRUGA ) and DRUGB may interfere with the effect of each other when administered concurrently .
beta-blockers	group	BROVANA	brand
effect

DRUGA not only block the therapeutic effects of DRUGB , but may produce severe bronchospasm in COPD patients .
Beta-blockers	group	beta-agonists	group
effect

DRUGA : Since DRUGB is contraindicated in patients with DRUGN induced thrombocytopenia , the co administration of DRUGN and DRUGN is unlikely for this indication .
Heparin	drug	heparin	drug
false

DRUGA : Since DRUGN is contraindicated in patients with DRUGB induced thrombocytopenia , the co administration of DRUGN and DRUGN is unlikely for this indication .
Heparin	drug	heparin	drug
false

DRUGA : Since DRUGN is contraindicated in patients with DRUGN induced thrombocytopenia , the co administration of DRUGB and DRUGN is unlikely for this indication .
Heparin	drug	Argatroban	drug
false

DRUGA : Since DRUGN is contraindicated in patients with DRUGN induced thrombocytopenia , the co administration of DRUGN and DRUGB is unlikely for this indication .
Heparin	drug	heparin	drug
false

DRUGN : Since DRUGA is contraindicated in patients with DRUGN induced thrombocytopenia , the co administration of DRUGB and DRUGN is unlikely for this indication .
heparin	drug	Argatroban	drug
false

DRUGN : Since DRUGN is contraindicated in patients with DRUGA induced thrombocytopenia , the co administration of DRUGB and DRUGN is unlikely for this indication .
heparin	drug	Argatroban	drug
false

DRUGN : Since DRUGN is contraindicated in patients with DRUGN induced thrombocytopenia , the co administration of DRUGA and DRUGB is unlikely for this indication .
Argatroban	drug	heparin	drug
false

However , if DRUGA is to be initiated after cessation of DRUGB therapy , allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of DRUGN therapy .
Argatroban	drug	heparin	drug
false

However , if DRUGN is to be initiated after cessation of DRUGA therapy , allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of DRUGB therapy .
heparin	drug	Argatroban	drug
false

Oral DRUGA : Pharmacokinetic drug drug interactions between DRUGB and DRUGN ( dga mg single oral dose ) have not been demonstrated .
anticoagulant agents	group	Argatroban	drug
false

Oral DRUGA : Pharmacokinetic drug drug interactions between DRUGN and DRUGB ( dga mg single oral dose ) have not been demonstrated .
anticoagulant agents	group	warfarin	drug
false

Oral DRUGN : Pharmacokinetic drug drug interactions between DRUGA and DRUGB ( dga mg single oral dose ) have not been demonstrated .
Argatroban	drug	warfarin	drug
false

DRUGA : The safety and effectiveness of DRUGB with DRUGN have not been established .
Thrombolytic agents	group	Argatroban	drug
false

DRUGA : The safety and effectiveness of DRUGN with DRUGB have not been established .
Thrombolytic agents	group	thrombolytic agents	group
false

DRUGN : The safety and effectiveness of DRUGA with DRUGB have not been established .
Argatroban	drug	thrombolytic agents	group
false

Co administration : Concomitant use of DRUGA with DRUGB , DRUGN , and other DRUGN may increase the risk of bleeding .
Argatroban	drug	antiplatelet agents	group
effect

Co administration : Concomitant use of DRUGA with DRUGN , DRUGB , and other DRUGN may increase the risk of bleeding .
Argatroban	drug	thrombolytics	group
effect

Co administration : Concomitant use of DRUGA with DRUGN , DRUGN , and other DRUGB may increase the risk of bleeding .
Argatroban	drug	anticoagulants	group
effect

Co administration : Concomitant use of DRUGN with DRUGA , DRUGB , and other DRUGN may increase the risk of bleeding .
antiplatelet agents	group	thrombolytics	group
false

Co administration : Concomitant use of DRUGN with DRUGA , DRUGN , and other DRUGB may increase the risk of bleeding .
antiplatelet agents	group	anticoagulants	group
false

Co administration : Concomitant use of DRUGN with DRUGN , DRUGA , and other DRUGB may increase the risk of bleeding .
thrombolytics	group	anticoagulants	group
false

Drug drug interactions have not been observed between DRUGA and DRUGB or DRUGN .
Argatroban	drug	digoxin	drug
false

Drug drug interactions have not been observed between DRUGA and DRUGN or DRUGB .
Argatroban	drug	erythromycin	drug
false

Drug drug interactions have not been observed between DRUGN and DRUGA or DRUGB .
digoxin	drug	erythromycin	drug
false

Drug Drug Interactions Given the primary CNS effects of DRUGA , caution should be used when DRUGB is taken in combination with other DRUGN and DRUGN .
aripiprazole	drug	ABILIFY	brand
false

Drug Drug Interactions Given the primary CNS effects of DRUGA , caution should be used when DRUGN is taken in combination with other DRUGB and DRUGN .
aripiprazole	drug	centrally acting drugs	group
false

Drug Drug Interactions Given the primary CNS effects of DRUGA , caution should be used when DRUGN is taken in combination with other DRUGN and DRUGB .
aripiprazole	drug	alcohol	drug
false

Drug Drug Interactions Given the primary CNS effects of DRUGN , caution should be used when DRUGA is taken in combination with other DRUGB and DRUGN .
ABILIFY	brand	centrally acting drugs	group
advise

Drug Drug Interactions Given the primary CNS effects of DRUGN , caution should be used when DRUGA is taken in combination with other DRUGN and DRUGB .
ABILIFY	brand	alcohol	drug
advise

Drug Drug Interactions Given the primary CNS effects of DRUGN , caution should be used when DRUGN is taken in combination with other DRUGA and DRUGB .
centrally acting drugs	group	alcohol	drug
false

dgb adrenergic receptor antagonism , DRUGA has the potential to enhance the effect of certain DRUGB .
aripiprazole	drug	antihypertensive agents	group
effect

Potential for Other Drugs to Affect DRUGA DRUGB is not a substrate of CYPdgbAdgb , CYPdgbAdgb , CYPdgbAdgb , CYPdgbBdgb , CYPdgbCdgb , CYPdgbCdgb , CYPdgbCdgb , or CYPdgbEdgb enzymes .
ABILIFY	brand	Aripiprazole	brand
false

Agents that induce CYPdgbAdgb ( eg , DRUGA ) could cause an increase in DRUGB clearance and lower blood levels .
carbamazepine	drug	aripiprazole	drug
mechanism

Inhibitors of CYPdgbAdgb ( eg , DRUGA ) or CYPdgbDdgb ( eg , DRUGB , DRUGN , or DRUGN ) can inhibit DRUGN elimination and cause increased blood levels .
ketoconazole	drug	quinidine	drug
false

Inhibitors of CYPdgbAdgb ( eg , DRUGA ) or CYPdgbDdgb ( eg , DRUGN , DRUGB , or DRUGN ) can inhibit DRUGN elimination and cause increased blood levels .
ketoconazole	drug	fluoxetine	drug
false

Inhibitors of CYPdgbAdgb ( eg , DRUGA ) or CYPdgbDdgb ( eg , DRUGN , DRUGN , or DRUGB ) can inhibit DRUGN elimination and cause increased blood levels .
ketoconazole	drug	paroxetine	drug
false

Inhibitors of CYPdgbAdgb ( eg , DRUGA ) or CYPdgbDdgb ( eg , DRUGN , DRUGN , or DRUGN ) can inhibit DRUGB elimination and cause increased blood levels .
ketoconazole	drug	aripiprazole	drug
mechanism

Inhibitors of CYPdgbAdgb ( eg , DRUGN ) or CYPdgbDdgb ( eg , DRUGA , DRUGB , or DRUGN ) can inhibit DRUGN elimination and cause increased blood levels .
quinidine	drug	fluoxetine	drug
false

Inhibitors of CYPdgbAdgb ( eg , DRUGN ) or CYPdgbDdgb ( eg , DRUGA , DRUGN , or DRUGB ) can inhibit DRUGN elimination and cause increased blood levels .
quinidine	drug	paroxetine	drug
false

Inhibitors of CYPdgbAdgb ( eg , DRUGN ) or CYPdgbDdgb ( eg , DRUGA , DRUGN , or DRUGN ) can inhibit DRUGB elimination and cause increased blood levels .
quinidine	drug	aripiprazole	drug
mechanism

Inhibitors of CYPdgbAdgb ( eg , DRUGN ) or CYPdgbDdgb ( eg , DRUGN , DRUGA , or DRUGB ) can inhibit DRUGN elimination and cause increased blood levels .
fluoxetine	drug	paroxetine	drug
false

Inhibitors of CYPdgbAdgb ( eg , DRUGN ) or CYPdgbDdgb ( eg , DRUGN , DRUGA , or DRUGN ) can inhibit DRUGB elimination and cause increased blood levels .
fluoxetine	drug	aripiprazole	drug
mechanism

Inhibitors of CYPdgbAdgb ( eg , DRUGN ) or CYPdgbDdgb ( eg , DRUGN , DRUGN , or DRUGA ) can inhibit DRUGB elimination and cause increased blood levels .
paroxetine	drug	aripiprazole	drug
mechanism

DRUGA : Coadministration of DRUGB ( dgb mg / day for dgb days ) with a dgb mg single dose of DRUGN increased the AUC of DRUGN and its active metabolite by dgb % and dgb % , respectively .
Ketoconazole	drug	ketoconazole	drug
false

DRUGA : Coadministration of DRUGN ( dgb mg / day for dgb days ) with a dgb mg single dose of DRUGB increased the AUC of DRUGN and its active metabolite by dgb % and dgb % , respectively .
Ketoconazole	drug	aripiprazole	drug
false

DRUGA : Coadministration of DRUGN ( dgb mg / day for dgb days ) with a dgb mg single dose of DRUGN increased the AUC of DRUGB and its active metabolite by dgb % and dgb % , respectively .
Ketoconazole	drug	aripiprazole	drug
false

DRUGN : Coadministration of DRUGA ( dgb mg / day for dgb days ) with a dgb mg single dose of DRUGB increased the AUC of DRUGN and its active metabolite by dgb % and dgb % , respectively .
ketoconazole	drug	aripiprazole	drug
mechanism

DRUGN : Coadministration of DRUGA ( dgb mg / day for dgb days ) with a dgb mg single dose of DRUGN increased the AUC of DRUGB and its active metabolite by dgb % and dgb % , respectively .
ketoconazole	drug	aripiprazole	drug
false

When concomitant administration of DRUGA with DRUGB occurs , DRUGN dose should be reduced to one half of its normal dose .
ketoconazole	drug	aripiprazole	drug
advise

When concomitant administration of DRUGA with DRUGN occurs , DRUGB dose should be reduced to one half of its normal dose .
ketoconazole	drug	aripiprazole	drug
false

DRUGA dose should be reduced to one half of its normal dose when concomitant administration of DRUGB with DRUGN occurs .
Aripiprazole	drug	quinidine	drug
false

DRUGA dose should be reduced to one half of its normal dose when concomitant administration of DRUGN with DRUGB occurs .
Aripiprazole	drug	aripiprazole	drug
false

DRUGN dose should be reduced to one half of its normal dose when concomitant administration of DRUGA with DRUGB occurs .
quinidine	drug	aripiprazole	drug
advise

Other significant inhibitors of CYPdgbDdgb , such as DRUGA or DRUGB , would be expected to have similar effects and , therefore , should be accompanied by similar dose reductions .
fluoxetine	drug	paroxetine	drug
false

When DRUGA is added to DRUGB therapy , DRUGN dose should be doubled .
carbamazepine	drug	aripiprazole	drug
advise

When DRUGA is added to DRUGN therapy , DRUGB dose should be doubled .
carbamazepine	drug	aripiprazole	drug
false

When DRUGA is withdrawn from the combination therapy , DRUGB dose should then be reduced .
carbamazepine	drug	aripiprazole	drug
advise

No clinically significant effect of DRUGA , DRUGB , or DRUGN was seen on the pharmacokinetics of DRUGN ( see CLINICAL PHARMACOLOGY : Drug Drug Interactions ) .
famotidine	drug	valproate	drug
false

No clinically significant effect of DRUGA , DRUGN , or DRUGB was seen on the pharmacokinetics of DRUGN ( see CLINICAL PHARMACOLOGY : Drug Drug Interactions ) .
famotidine	drug	lithium	drug
false

No clinically significant effect of DRUGA , DRUGN , or DRUGN was seen on the pharmacokinetics of DRUGB ( see CLINICAL PHARMACOLOGY : Drug Drug Interactions ) .
famotidine	drug	aripiprazole	drug
false

No clinically significant effect of DRUGN , DRUGA , or DRUGB was seen on the pharmacokinetics of DRUGN ( see CLINICAL PHARMACOLOGY : Drug Drug Interactions ) .
valproate	drug	lithium	drug
false

No clinically significant effect of DRUGN , DRUGA , or DRUGN was seen on the pharmacokinetics of DRUGB ( see CLINICAL PHARMACOLOGY : Drug Drug Interactions ) .
valproate	drug	aripiprazole	drug
false

No clinically significant effect of DRUGN , DRUGN , or DRUGA was seen on the pharmacokinetics of DRUGB ( see CLINICAL PHARMACOLOGY : Drug Drug Interactions ) .
lithium	drug	aripiprazole	drug
false

Potential for DRUGA to Affect Other Drugs DRUGB is unlikely to cause clinically important pharmacokinetic interactions with drugs metabolized by cytochrome Pdgb enzymes .
ABILIFY	brand	Aripiprazole	drug
false

Additionally , DRUGA and DRUGB did not show potential for altering CYPdgbAdgb mediated metabolism in vitro .
aripiprazole	drug	dehydroaripiprazole	drug_n
false

DRUGA : There was no significant difference between DRUGB coadministered with DRUGN and placebo coadministered with DRUGN on performance of gross motor skills or stimulus response in healthy subjects .
Alcohol	drug	aripiprazole	drug
false

DRUGA : There was no significant difference between DRUGN coadministered with DRUGB and placebo coadministered with DRUGN on performance of gross motor skills or stimulus response in healthy subjects .
Alcohol	drug	ethanol	drug
false

DRUGA : There was no significant difference between DRUGN coadministered with DRUGN and placebo coadministered with DRUGB on performance of gross motor skills or stimulus response in healthy subjects .
Alcohol	drug	ethanol	drug
false

DRUGN : There was no significant difference between DRUGA coadministered with DRUGB and placebo coadministered with DRUGN on performance of gross motor skills or stimulus response in healthy subjects .
aripiprazole	drug	ethanol	drug
false

DRUGN : There was no significant difference between DRUGA coadministered with DRUGN and placebo coadministered with DRUGB on performance of gross motor skills or stimulus response in healthy subjects .
aripiprazole	drug	ethanol	drug
false

As with most psychoactive medications , patients should be advised to avoid DRUGA while taking DRUGB
alcohol	drug	ABILIFY	brand
advise

Caution is advised when DRUGA is coadministered with other medications that can prolong the QT interval ( e.g . certain DRUGB or DRUGN ) or lead to electrolyte abnormalities ( such as DRUGN or DRUGN ) .
TRISENOX	brand	antiarrhythmics	group
advise

Caution is advised when DRUGA is coadministered with other medications that can prolong the QT interval ( e.g . certain DRUGN or DRUGB ) or lead to electrolyte abnormalities ( such as DRUGN or DRUGN ) .
TRISENOX	brand	thioridazine	drug
advise

Caution is advised when DRUGA is coadministered with other medications that can prolong the QT interval ( e.g . certain DRUGN or DRUGN ) or lead to electrolyte abnormalities ( such as DRUGB or DRUGN ) .
TRISENOX	brand	diuretics	group
advise

Caution is advised when DRUGA is coadministered with other medications that can prolong the QT interval ( e.g . certain DRUGN or DRUGN ) or lead to electrolyte abnormalities ( such as DRUGN or DRUGB ) .
TRISENOX	brand	amphotericin B	drug
advise

Caution is advised when DRUGN is coadministered with other medications that can prolong the QT interval ( e.g . certain DRUGA or DRUGB ) or lead to electrolyte abnormalities ( such as DRUGN or DRUGN ) .
antiarrhythmics	group	thioridazine	drug
false

Caution is advised when DRUGN is coadministered with other medications that can prolong the QT interval ( e.g . certain DRUGA or DRUGN ) or lead to electrolyte abnormalities ( such as DRUGB or DRUGN ) .
antiarrhythmics	group	diuretics	group
false

Caution is advised when DRUGN is coadministered with other medications that can prolong the QT interval ( e.g . certain DRUGA or DRUGN ) or lead to electrolyte abnormalities ( such as DRUGN or DRUGB ) .
antiarrhythmics	group	amphotericin B	drug
false

Caution is advised when DRUGN is coadministered with other medications that can prolong the QT interval ( e.g . certain DRUGN or DRUGA ) or lead to electrolyte abnormalities ( such as DRUGB or DRUGN ) .
thioridazine	drug	diuretics	group
false

Caution is advised when DRUGN is coadministered with other medications that can prolong the QT interval ( e.g . certain DRUGN or DRUGA ) or lead to electrolyte abnormalities ( such as DRUGN or DRUGB ) .
thioridazine	drug	amphotericin B	drug
false

Caution is advised when DRUGN is coadministered with other medications that can prolong the QT interval ( e.g . certain DRUGN or DRUGN ) or lead to electrolyte abnormalities ( such as DRUGA or DRUGB ) .
diuretics	group	amphotericin B	drug
false

Tissue culture and animal studies indicate that DRUGA can diminish or abolish the effect of DRUGB on malignant cells.dgb This effect on DRUGN activity persists as long as plasma asparagine levels are suppressed .
ELSPAR	brand	methotrexate	drug
effect

Tissue culture and animal studies indicate that DRUGA can diminish or abolish the effect of DRUGN on malignant cells.dgb This effect on DRUGB activity persists as long as plasma asparagine levels are suppressed .
ELSPAR	brand	methotrexate	drug
false

These results would seem to dictate against the clinical use of DRUGA with DRUGB , or during the period following DRUGN therapy when plasma asparagine levels are below normal .
methotrexate	drug	ELSPAR	brand
advise

These results would seem to dictate against the clinical use of DRUGA with DRUGN , or during the period following DRUGB therapy when plasma asparagine levels are below normal .
methotrexate	drug	ELSPAR	brand
false

DRUGA : DRUGB may decrease the effects of DRUGN , DRUGN , and DRUGN .
Uricosuric Agents	group	Aspirin	brand
false

DRUGA : DRUGN may decrease the effects of DRUGB , DRUGN , and DRUGN .
Uricosuric Agents	group	probenecid	drug
false

DRUGA : DRUGN may decrease the effects of DRUGN , DRUGB , and DRUGN .
Uricosuric Agents	group	sulfinpyrazone	drug
false

DRUGA : DRUGN may decrease the effects of DRUGN , DRUGN , and DRUGB .
Uricosuric Agents	group	phenylbutazone	drug
false

DRUGN : DRUGA may decrease the effects of DRUGB , DRUGN , and DRUGN .
Aspirin	brand	probenecid	drug
effect

DRUGN : DRUGA may decrease the effects of DRUGN , DRUGB , and DRUGN .
Aspirin	brand	sulfinpyrazone	drug
effect

DRUGN : DRUGA may decrease the effects of DRUGN , DRUGN , and DRUGB .
Aspirin	brand	phenylbutazone	drug
effect

DRUGN : DRUGN may decrease the effects of DRUGA , DRUGB , and DRUGN .
probenecid	drug	sulfinpyrazone	drug
false

DRUGN : DRUGN may decrease the effects of DRUGA , DRUGN , and DRUGB .
probenecid	drug	phenylbutazone	drug
false

DRUGN : DRUGN may decrease the effects of DRUGN , DRUGA , and DRUGB .
sulfinpyrazone	drug	phenylbutazone	drug
false

DRUGA : Has a synergistic effect with DRUGB in causing gastrointestinal bleeding .
Alcohol	drug	aspirin	brand
effect

DRUGA : Concomitant administration with DRUGB may increase the risk of gastrointestinal ulceration and may reduce serum salicylate levels .
Corticosteroids	group	aspirin	brand
effect

DRUGA ( DRUGB , DRUGN , and possibly DRUGN ) : Concomitant administration with DRUGN may increase the risk of gastrointestinal ulceration .
Pyrazolone Derivatives	group	phenylbutazone	drug
false

DRUGA ( DRUGN , DRUGB , and possibly DRUGN ) : Concomitant administration with DRUGN may increase the risk of gastrointestinal ulceration .
Pyrazolone Derivatives	group	oxyphenbutazone	drug
false

DRUGA ( DRUGN , DRUGN , and possibly DRUGB ) : Concomitant administration with DRUGN may increase the risk of gastrointestinal ulceration .
Pyrazolone Derivatives	group	dipyrone	drug
false

DRUGA ( DRUGN , DRUGN , and possibly DRUGN ) : Concomitant administration with DRUGB may increase the risk of gastrointestinal ulceration .
Pyrazolone Derivatives	group	aspirin	drug
effect

DRUGN ( DRUGA , DRUGB , and possibly DRUGN ) : Concomitant administration with DRUGN may increase the risk of gastrointestinal ulceration .
phenylbutazone	drug	oxyphenbutazone	drug
false

DRUGN ( DRUGA , DRUGN , and possibly DRUGB ) : Concomitant administration with DRUGN may increase the risk of gastrointestinal ulceration .
phenylbutazone	drug	dipyrone	drug
false

DRUGN ( DRUGA , DRUGN , and possibly DRUGN ) : Concomitant administration with DRUGB may increase the risk of gastrointestinal ulceration .
phenylbutazone	drug	aspirin	drug
effect

DRUGN ( DRUGN , DRUGA , and possibly DRUGB ) : Concomitant administration with DRUGN may increase the risk of gastrointestinal ulceration .
oxyphenbutazone	drug	dipyrone	drug
false

DRUGN ( DRUGN , DRUGA , and possibly DRUGN ) : Concomitant administration with DRUGB may increase the risk of gastrointestinal ulceration .
oxyphenbutazone	drug	aspirin	drug
effect

DRUGN ( DRUGN , DRUGN , and possibly DRUGA ) : Concomitant administration with DRUGB may increase the risk of gastrointestinal ulceration .
dipyrone	drug	aspirin	drug
effect

DRUGA Agents : DRUGB is contraindicated in patients who are hypersensitive to DRUGN agents .
Nonsteroidal Antiinflammatory	drug	Aspirin	drug
false

DRUGA Agents : DRUGN is contraindicated in patients who are hypersensitive to DRUGB agents .
Nonsteroidal Antiinflammatory	drug	nonsteroidal anti-inflammatory	drug
false

DRUGN Agents : DRUGA is contraindicated in patients who are hypersensitive to DRUGB agents .
Aspirin	drug	nonsteroidal anti-inflammatory	drug
advise

Urinary Alkalinizers : Decrease DRUGA effectiveness by increasing the rate of DRUGB renal excretion .
aspirin	brand	salicylate	group
false

DRUGA : Decreases DRUGB effectiveness by enzyme induction .
Phenobarbital	drug	aspirin	brand
mechanism

DRUGA : Serum DRUGB levels may be increased by DRUGN .
Phenytoin	drug	phenytoin	drug
false

DRUGA : Serum DRUGN levels may be increased by DRUGB .
Phenytoin	drug	aspirin	brand
false

DRUGN : Serum DRUGA levels may be increased by DRUGB .
phenytoin	drug	aspirin	brand
effect

DRUGA : May decrease DRUGB anti inflammatory action by competing for the same receptors .
Propranolol	drug	aspirins	brand
effect

DRUGA : Enteric Coated DRUGB should not be given concurrently with DRUGN , since an increase in the pH of the stomach may effect the enteric coating of the tablets .
Antacids	group	Aspirin	brand
false

DRUGA : Enteric Coated DRUGN should not be given concurrently with DRUGB , since an increase in the pH of the stomach may effect the enteric coating of the tablets .
Antacids	group	antacids	group
false

DRUGN : Enteric Coated DRUGA should not be given concurrently with DRUGB , since an increase in the pH of the stomach may effect the enteric coating of the tablets .
Aspirin	brand	antacids	group
advise

DRUGA / DRUGB , DRUGN , Including DRUGN
Ketoconazole	drug	Itraconazole	drug
false

DRUGA / DRUGN , DRUGB , Including DRUGN
Ketoconazole	drug	Macrolides	group
false

DRUGA / DRUGN , DRUGN , Including DRUGB
Ketoconazole	drug	Erythromycin	drug
false

DRUGN / DRUGA , DRUGB , Including DRUGN
Itraconazole	drug	Macrolides	group
false

DRUGN / DRUGA , DRUGN , Including DRUGB
Itraconazole	drug	Erythromycin	drug
false

DRUGN / DRUGN , DRUGA , Including DRUGB
Macrolides	group	Erythromycin	drug
false

Catecholamine depleting drugs ( eg , DRUGA ) may have an additive effect when given with DRUGB s .
reserpine	drug	beta-blocking agent	group
effect

DRUGA may also have an additive effect when given with DRUGB .
Calcium channel blockers	group	TENORMIN	brand
effect

DRUGA may exacerbate the rebound hypertension which can follow the withdrawal of DRUGB .
Beta blockers	group	clonidine	drug
effect

If the two drugs are coadministered , the DRUGA should be withdrawn several days before the gradual withdrawal of DRUGB .
beta blocker	group	clonidine	drug
advise

If replacing DRUGA by DRUGB therapy , the introduction of DRUGN should be delayed for several days after DRUGN administration has stopped .
clonidine	drug	beta-blocker	group
false

If replacing DRUGA by DRUGN therapy , the introduction of DRUGB should be delayed for several days after DRUGN administration has stopped .
clonidine	drug	beta blockers	group
false

If replacing DRUGN by DRUGA therapy , the introduction of DRUGB should be delayed for several days after DRUGN administration has stopped .
beta-blocker	group	beta blockers	group
false

If replacing DRUGN by DRUGA therapy , the introduction of DRUGN should be delayed for several days after DRUGB administration has stopped .
beta-blocker	group	clonidine	drug
false

If replacing DRUGN by DRUGN therapy , the introduction of DRUGA should be delayed for several days after DRUGB administration has stopped .
beta blockers	group	clonidine	drug
advise

Concomitant use of prostaglandin synthase inhibiting drugs , eg , DRUGA , may decrease the hypotensive effects of DRUGB .
indomethacin	drug	beta blockers	group
effect

Information on concurrent usage of DRUGA and DRUGB is limited .
atenolol	drug	aspirin	brand
false

Data from several studies , ie , TIMI II , ISIS dgb , currently do not suggest any clinical interaction between DRUGA and DRUGB in the acute myocardial infarction setting .
aspirin	brand	beta blockers	group
false

CYPdgbDdgb inhibitors DRUGA is primarily metabolized by the CYPdgbDdgb pathway to DRUGB .
Atomoxetine	drug	4-hydroxyatomoxetine	drug_n
false

Dosage adjustment of DRUGA may be necessary when coadministered with CYPdgbDdgb inhibitors , e.g . , DRUGB , DRUGN , and DRUGN .
STRATTERA	brand	paroxetine	drug
advise

Dosage adjustment of DRUGA may be necessary when coadministered with CYPdgbDdgb inhibitors , e.g . , DRUGN , DRUGB , and DRUGN .
STRATTERA	brand	fluoxetine	drug
advise

Dosage adjustment of DRUGA may be necessary when coadministered with CYPdgbDdgb inhibitors , e.g . , DRUGN , DRUGN , and DRUGB .
STRATTERA	brand	quinidine	drug
advise

Dosage adjustment of DRUGN may be necessary when coadministered with CYPdgbDdgb inhibitors , e.g . , DRUGA , DRUGB , and DRUGN .
paroxetine	drug	fluoxetine	drug
false

Dosage adjustment of DRUGN may be necessary when coadministered with CYPdgbDdgb inhibitors , e.g . , DRUGA , DRUGN , and DRUGB .
paroxetine	drug	quinidine	drug
false

Dosage adjustment of DRUGN may be necessary when coadministered with CYPdgbDdgb inhibitors , e.g . , DRUGN , DRUGA , and DRUGB .
fluoxetine	drug	quinidine	drug
false

In EM individuals treated with DRUGA or DRUGB , the AUC of DRUGN is approximately dgb to dgb fold and Css , max is about dgb to dgb fold greater than DRUGN alone .
paroxetine	drug	fluoxetine	drug
false

In EM individuals treated with DRUGA or DRUGN , the AUC of DRUGB is approximately dgb to dgb fold and Css , max is about dgb to dgb fold greater than DRUGN alone .
paroxetine	drug	atomoxetine	drug
mechanism

In EM individuals treated with DRUGA or DRUGN , the AUC of DRUGN is approximately dgb to dgb fold and Css , max is about dgb to dgb fold greater than DRUGB alone .
paroxetine	drug	atomoxetine	drug
false

In EM individuals treated with DRUGN or DRUGA , the AUC of DRUGB is approximately dgb to dgb fold and Css , max is about dgb to dgb fold greater than DRUGN alone .
fluoxetine	drug	atomoxetine	drug
mechanism

In EM individuals treated with DRUGN or DRUGA , the AUC of DRUGN is approximately dgb to dgb fold and Css , max is about dgb to dgb fold greater than DRUGB alone .
fluoxetine	drug	atomoxetine	drug
false

The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of DRUGA , DRUGB , DRUGN ( DRUGN ) , DRUGN , DRUGN .
cyclosporine	drug	fibric acid derivatives	group
false

The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of DRUGA , DRUGN , DRUGB ( DRUGN ) , DRUGN , DRUGN .
cyclosporine	drug	niacin	drug
false

The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of DRUGA , DRUGN , DRUGN ( DRUGB ) , DRUGN , DRUGN .
cyclosporine	drug	nicotinic acid	drug
false

The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of DRUGA , DRUGN , DRUGN ( DRUGN ) , DRUGB , DRUGN .
cyclosporine	drug	erythromycin	drug
false

The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of DRUGA , DRUGN , DRUGN ( DRUGN ) , DRUGN , DRUGB .
cyclosporine	drug	azole antifungals	group
false

The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of DRUGN , DRUGA , DRUGB ( DRUGN ) , DRUGN , DRUGN .
fibric acid derivatives	group	niacin	drug
false

The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of DRUGN , DRUGA , DRUGN ( DRUGB ) , DRUGN , DRUGN .
fibric acid derivatives	group	nicotinic acid	drug
false

The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of DRUGN , DRUGA , DRUGN ( DRUGN ) , DRUGB , DRUGN .
fibric acid derivatives	group	erythromycin	drug
false

The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of DRUGN , DRUGA , DRUGN ( DRUGN ) , DRUGN , DRUGB .
fibric acid derivatives	group	azole antifungals	group
false

The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of DRUGN , DRUGN , DRUGA ( DRUGB ) , DRUGN , DRUGN .
niacin	drug	nicotinic acid	drug
false

The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of DRUGN , DRUGN , DRUGA ( DRUGN ) , DRUGB , DRUGN .
niacin	drug	erythromycin	drug
false

The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of DRUGN , DRUGN , DRUGA ( DRUGN ) , DRUGN , DRUGB .
niacin	drug	azole antifungals	group
false

The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of DRUGN , DRUGN , DRUGN ( DRUGA ) , DRUGB , DRUGN .
nicotinic acid	drug	erythromycin	drug
false

The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of DRUGN , DRUGN , DRUGN ( DRUGA ) , DRUGN , DRUGB .
nicotinic acid	drug	azole antifungals	group
false

The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of DRUGN , DRUGN , DRUGN ( DRUGN ) , DRUGA , DRUGB .
erythromycin	drug	azole antifungals	group
false

DRUGA : When DRUGB and DRUGN suspension were coadministered , plasma concentrations of DRUGN decreased approximately dgb % .
Antacid	group	atorvastatin	drug
false

DRUGA : When DRUGN and DRUGB suspension were coadministered , plasma concentrations of DRUGN decreased approximately dgb % .
Antacid	group	Maalox TC	brand
false

DRUGA : When DRUGN and DRUGN suspension were coadministered , plasma concentrations of DRUGB decreased approximately dgb % .
Antacid	group	atorvastatin	drug
false

DRUGN : When DRUGA and DRUGB suspension were coadministered , plasma concentrations of DRUGN decreased approximately dgb % .
atorvastatin	drug	Maalox TC	brand
mechanism

DRUGN : When DRUGN and DRUGA suspension were coadministered , plasma concentrations of DRUGB decreased approximately dgb % .
Maalox TC	brand	atorvastatin	drug
false

DRUGA : Because DRUGB does not affect the pharmacokinetics of DRUGN , interactions with other DRUGN metabolized via the same cytochrome isozymes are not expected .
Antipyrine	drug	atorvastatin	drug
false

DRUGA : Because DRUGN does not affect the pharmacokinetics of DRUGB , interactions with other DRUGN metabolized via the same cytochrome isozymes are not expected .
Antipyrine	drug	antipyrine	drug
false

DRUGA : Because DRUGN does not affect the pharmacokinetics of DRUGN , interactions with other DRUGB metabolized via the same cytochrome isozymes are not expected .
Antipyrine	drug	drugs	drug
false

DRUGN : Because DRUGA does not affect the pharmacokinetics of DRUGB , interactions with other DRUGN metabolized via the same cytochrome isozymes are not expected .
atorvastatin	drug	antipyrine	drug
false

DRUGN : Because DRUGA does not affect the pharmacokinetics of DRUGN , interactions with other DRUGB metabolized via the same cytochrome isozymes are not expected .
atorvastatin	drug	drugs	drug
false

DRUGN : Because DRUGN does not affect the pharmacokinetics of DRUGA , interactions with other DRUGB metabolized via the same cytochrome isozymes are not expected .
antipyrine	drug	drugs	drug
false

DRUGA : Plasma concentrations of DRUGB decreased approximately dgb % when DRUGN and DRUGN were coadministered .
Colestipol	drug	atorvastatin	drug
false

DRUGA : Plasma concentrations of DRUGN decreased approximately dgb % when DRUGB and DRUGN were coadministered .
Colestipol	drug	colestipol	drug
false

DRUGA : Plasma concentrations of DRUGN decreased approximately dgb % when DRUGN and DRUGB were coadministered .
Colestipol	drug	atorvastatin	drug
false

DRUGN : Plasma concentrations of DRUGA decreased approximately dgb % when DRUGB and DRUGN were coadministered .
atorvastatin	drug	colestipol	drug
false

DRUGN : Plasma concentrations of DRUGN decreased approximately dgb % when DRUGA and DRUGB were coadministered .
colestipol	drug	atorvastatin	drug
mechanism

However , LDL C reduction was greater when DRUGA and DRUGB were coadministered than when either drug was given alone .
atorvastatin	drug	colestipol	drug
effect

DRUGA : DRUGB plasma concentrations and LDL C reduction were not altered by coadministration of DRUGN .
Cimetidine	drug	Atorvastatin	drug
false

DRUGA : DRUGN plasma concentrations and LDL C reduction were not altered by coadministration of DRUGB .
Cimetidine	drug	cimetidine	drug
false

DRUGN : DRUGA plasma concentrations and LDL C reduction were not altered by coadministration of DRUGB .
Atorvastatin	drug	cimetidine	drug
false

DRUGA : When multiple doses of DRUGB and DRUGN were coadministered , steady state plasma DRUGN concentrations increased by approximately dgb % .
Digoxin	drug	atorvastatin	drug
false

DRUGA : When multiple doses of DRUGN and DRUGB were coadministered , steady state plasma DRUGN concentrations increased by approximately dgb % .
Digoxin	drug	digoxin	drug
false

DRUGA : When multiple doses of DRUGN and DRUGN were coadministered , steady state plasma DRUGB concentrations increased by approximately dgb % .
Digoxin	drug	digoxin	drug
false

DRUGN : When multiple doses of DRUGA and DRUGB were coadministered , steady state plasma DRUGN concentrations increased by approximately dgb % .
atorvastatin	drug	digoxin	drug
mechanism

DRUGN : When multiple doses of DRUGA and DRUGN were coadministered , steady state plasma DRUGB concentrations increased by approximately dgb % .
atorvastatin	drug	digoxin	drug
false

DRUGA : In healthy individuals , plasma concentrations of DRUGB increased approximately dgb % with coadministration of DRUGN and DRUGN , a known inhibitor of cytochrome Pdgb dgbAdga
Erythromycin	drug	atorvastatin	drug
false

DRUGA : In healthy individuals , plasma concentrations of DRUGN increased approximately dgb % with coadministration of DRUGB and DRUGN , a known inhibitor of cytochrome Pdgb dgbAdga
Erythromycin	drug	atorvastatin	drug
false

DRUGA : In healthy individuals , plasma concentrations of DRUGN increased approximately dgb % with coadministration of DRUGN and DRUGB , a known inhibitor of cytochrome Pdgb dgbAdga
Erythromycin	drug	erythromycin	drug
false

DRUGN : In healthy individuals , plasma concentrations of DRUGA increased approximately dgb % with coadministration of DRUGN and DRUGB , a known inhibitor of cytochrome Pdgb dgbAdga
atorvastatin	drug	erythromycin	drug
false

DRUGN : In healthy individuals , plasma concentrations of DRUGN increased approximately dgb % with coadministration of DRUGA and DRUGB , a known inhibitor of cytochrome Pdgb dgbAdga
atorvastatin	drug	erythromycin	drug
mechanism

Oral DRUGA : Coadministration of DRUGB and an oral DRUGN increased AUC values for DRUGN and DRUGN by approximately dgb % and dgb % .
Contraceptives	group	atorvastatin	drug
false

Oral DRUGA : Coadministration of DRUGN and an oral DRUGB increased AUC values for DRUGN and DRUGN by approximately dgb % and dgb % .
Contraceptives	group	contraceptive	group
false

Oral DRUGA : Coadministration of DRUGN and an oral DRUGN increased AUC values for DRUGB and DRUGN by approximately dgb % and dgb % .
Contraceptives	group	norethindrone	drug
false

Oral DRUGA : Coadministration of DRUGN and an oral DRUGN increased AUC values for DRUGN and DRUGB by approximately dgb % and dgb % .
Contraceptives	group	ethinyl estradiol	drug
false

Oral DRUGN : Coadministration of DRUGA and an oral DRUGB increased AUC values for DRUGN and DRUGN by approximately dgb % and dgb % .
atorvastatin	drug	contraceptive	group
mechanism

Oral DRUGN : Coadministration of DRUGA and an oral DRUGN increased AUC values for DRUGB and DRUGN by approximately dgb % and dgb % .
atorvastatin	drug	norethindrone	drug
mechanism

Oral DRUGN : Coadministration of DRUGA and an oral DRUGN increased AUC values for DRUGN and DRUGB by approximately dgb % and dgb % .
atorvastatin	drug	ethinyl estradiol	drug
mechanism

Oral DRUGN : Coadministration of DRUGN and an oral DRUGA increased AUC values for DRUGB and DRUGN by approximately dgb % and dgb % .
contraceptive	group	norethindrone	drug
false

Oral DRUGN : Coadministration of DRUGN and an oral DRUGA increased AUC values for DRUGN and DRUGB by approximately dgb % and dgb % .
contraceptive	group	ethinyl estradiol	drug
false

Oral DRUGN : Coadministration of DRUGN and an oral DRUGN increased AUC values for DRUGA and DRUGB by approximately dgb % and dgb % .
norethindrone	drug	ethinyl estradiol	drug
false

These increases should be considered when selecting an oral DRUGA for a woman taking DRUGB .
contraceptive	group	atorvastatin	drug
advise

DRUGA : DRUGB had no clinically significant effect on prothrombin time when administered to patients receiving chronic DRUGN treatment .
Warfarin	drug	Atorvastatin	drug
false

DRUGA : DRUGN had no clinically significant effect on prothrombin time when administered to patients receiving chronic DRUGB treatment .
Warfarin	drug	warfarin	drug
false

DRUGN : DRUGA had no clinically significant effect on prothrombin time when administered to patients receiving chronic DRUGB treatment .
Atorvastatin	drug	warfarin	drug
false

Caution should be exercised if an DRUGA is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones , such as DRUGB , DRUGN , and DRUGN .
HMG-CoA reductase inhibitor	group	ketoconazole	drug
advise

Caution should be exercised if an DRUGA is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones , such as DRUGN , DRUGB , and DRUGN .
HMG-CoA reductase inhibitor	group	spironolactone	drug
advise

Caution should be exercised if an DRUGA is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones , such as DRUGN , DRUGN , and DRUGB .
HMG-CoA reductase inhibitor	group	cimetidine	drug
advise

Caution should be exercised if an DRUGN is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones , such as DRUGA , DRUGB , and DRUGN .
ketoconazole	drug	spironolactone	drug
false

Caution should be exercised if an DRUGN is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones , such as DRUGA , DRUGN , and DRUGB .
ketoconazole	drug	cimetidine	drug
false

Caution should be exercised if an DRUGN is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones , such as DRUGN , DRUGA , and DRUGB .
spironolactone	drug	cimetidine	drug
false

DRUGA : Coadministration of DRUGB and DRUGN Suspension results in a significant decrease in average steady state plasma DRUGN concentrations .
Rifampin	drug	rifampin	drug
false

DRUGA : Coadministration of DRUGN and DRUGB Suspension results in a significant decrease in average steady state plasma DRUGN concentrations .
Rifampin	drug	MEPRON	brand
false

DRUGA : Coadministration of DRUGN and DRUGN Suspension results in a significant decrease in average steady state plasma DRUGB concentrations .
Rifampin	drug	atovaquone	drug
false

DRUGN : Coadministration of DRUGA and DRUGB Suspension results in a significant decrease in average steady state plasma DRUGN concentrations .
rifampin	drug	MEPRON	brand
mechanism

DRUGN : Coadministration of DRUGA and DRUGN Suspension results in a significant decrease in average steady state plasma DRUGB concentrations .
rifampin	drug	atovaquone	drug
false

DRUGN : Coadministration of DRUGN and DRUGA Suspension results in a significant decrease in average steady state plasma DRUGB concentrations .
MEPRON	brand	atovaquone	drug
false

Alternatives to DRUGA should be considered during the course of PCP treatment with DRUGB .
rifampin	drug	MEPRON	brand
advise

DRUGA , another DRUGB , is structurally similar to DRUGN and may possibly have some of the same drug interactions as DRUGN .
Rifabutin	drug	rifamycin	drug
false

DRUGA , another DRUGN , is structurally similar to DRUGB and may possibly have some of the same drug interactions as DRUGN .
Rifabutin	drug	rifampin	drug
false

DRUGA , another DRUGN , is structurally similar to DRUGN and may possibly have some of the same drug interactions as DRUGB .
Rifabutin	drug	rifampin	drug
false

DRUGN , another DRUGA , is structurally similar to DRUGB and may possibly have some of the same drug interactions as DRUGN .
rifamycin	drug	rifampin	drug
false

DRUGN , another DRUGA , is structurally similar to DRUGN and may possibly have some of the same drug interactions as DRUGB .
rifamycin	drug	rifampin	drug
false

No interaction trials have been conducted with DRUGA and DRUGB .
MEPRON	brand	rifabutin	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGA include : DRUGB ;
TRACRIUM	brand	enflurane	drug
effect

certain DRUGA , especially the DRUGB and DRUGN ;
antibiotics	group	aminoglycosides	group
false

certain DRUGA , especially the DRUGN and DRUGB ;
antibiotics	group	polymyxins	group
false

certain DRUGN , especially the DRUGA and DRUGB ;
aminoglycosides	group	polymyxins	group
false

Drugs which may enhance the neuromuscular blocking action of DRUGA include : DRUGB ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
TRACRIUM	brand	enflurane	drug
effect

Drugs which may enhance the neuromuscular blocking action of DRUGA include : DRUGN ; DRUGB ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
TRACRIUM	brand	isoflurane	drug
effect

Drugs which may enhance the neuromuscular blocking action of DRUGA include : DRUGN ; DRUGN ; DRUGB ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
TRACRIUM	brand	halothane	drug
effect

Drugs which may enhance the neuromuscular blocking action of DRUGA include : DRUGN ; DRUGN ; DRUGN ; certain DRUGB , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
TRACRIUM	brand	antibiotics	group
effect

Drugs which may enhance the neuromuscular blocking action of DRUGA include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGB and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
TRACRIUM	brand	aminoglycosides	group
effect

Drugs which may enhance the neuromuscular blocking action of DRUGA include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGB ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
TRACRIUM	brand	polymyxins	group
effect

Drugs which may enhance the neuromuscular blocking action of DRUGA include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGB ; DRUGN salts ; DRUGN ; and DRUGN .
TRACRIUM	brand	lithium	drug
effect

Drugs which may enhance the neuromuscular blocking action of DRUGA include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGB salts ; DRUGN ; and DRUGN .
TRACRIUM	brand	magnesium	drug
effect

Drugs which may enhance the neuromuscular blocking action of DRUGA include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGB ; and DRUGN .
TRACRIUM	brand	procainamide	drug
effect

Drugs which may enhance the neuromuscular blocking action of DRUGA include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGB .
TRACRIUM	brand	quinidine	drug
effect

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGA ; DRUGB ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
enflurane	drug	isoflurane	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGA ; DRUGN ; DRUGB ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
enflurane	drug	halothane	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGA ; DRUGN ; DRUGN ; certain DRUGB , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
enflurane	drug	antibiotics	group
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGA ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGB and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
enflurane	drug	aminoglycosides	group
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGA ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGB ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
enflurane	drug	polymyxins	group
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGA ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGB ; DRUGN salts ; DRUGN ; and DRUGN .
enflurane	drug	lithium	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGA ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGB salts ; DRUGN ; and DRUGN .
enflurane	drug	magnesium	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGA ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGB ; and DRUGN .
enflurane	drug	procainamide	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGA ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGB .
enflurane	drug	quinidine	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGA ; DRUGB ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
isoflurane	drug	halothane	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGA ; DRUGN ; certain DRUGB , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
isoflurane	drug	antibiotics	group
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGA ; DRUGN ; certain DRUGN , especially the DRUGB and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
isoflurane	drug	aminoglycosides	group
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGA ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGB ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
isoflurane	drug	polymyxins	group
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGA ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGB ; DRUGN salts ; DRUGN ; and DRUGN .
isoflurane	drug	lithium	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGA ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGB salts ; DRUGN ; and DRUGN .
isoflurane	drug	magnesium	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGA ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGB ; and DRUGN .
isoflurane	drug	procainamide	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGA ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGB .
isoflurane	drug	quinidine	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGA ; certain DRUGB , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
halothane	drug	antibiotics	group
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGA ; certain DRUGN , especially the DRUGB and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
halothane	drug	aminoglycosides	group
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGA ; certain DRUGN , especially the DRUGN and DRUGB ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
halothane	drug	polymyxins	group
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGA ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGB ; DRUGN salts ; DRUGN ; and DRUGN .
halothane	drug	lithium	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGA ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGB salts ; DRUGN ; and DRUGN .
halothane	drug	magnesium	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGA ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGB ; and DRUGN .
halothane	drug	procainamide	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGA ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGB .
halothane	drug	quinidine	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGA , especially the DRUGB and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
antibiotics	group	aminoglycosides	group
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGA , especially the DRUGN and DRUGB ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
antibiotics	group	polymyxins	group
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGA , especially the DRUGN and DRUGN ; DRUGB ; DRUGN salts ; DRUGN ; and DRUGN .
antibiotics	group	lithium	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGA , especially the DRUGN and DRUGN ; DRUGN ; DRUGB salts ; DRUGN ; and DRUGN .
antibiotics	group	magnesium	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGA , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGB ; and DRUGN .
antibiotics	group	procainamide	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGA , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGB .
antibiotics	group	quinidine	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGA and DRUGB ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGN .
aminoglycosides	group	polymyxins	group
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGA and DRUGN ; DRUGB ; DRUGN salts ; DRUGN ; and DRUGN .
aminoglycosides	group	lithium	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGA and DRUGN ; DRUGN ; DRUGB salts ; DRUGN ; and DRUGN .
aminoglycosides	group	magnesium	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGA and DRUGN ; DRUGN ; DRUGN salts ; DRUGB ; and DRUGN .
aminoglycosides	group	procainamide	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGA and DRUGN ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGB .
aminoglycosides	group	quinidine	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGA ; DRUGB ; DRUGN salts ; DRUGN ; and DRUGN .
polymyxins	group	lithium	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGA ; DRUGN ; DRUGB salts ; DRUGN ; and DRUGN .
polymyxins	group	magnesium	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGA ; DRUGN ; DRUGN salts ; DRUGB ; and DRUGN .
polymyxins	group	procainamide	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGA ; DRUGN ; DRUGN salts ; DRUGN ; and DRUGB .
polymyxins	group	quinidine	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGA ; DRUGB salts ; DRUGN ; and DRUGN .
lithium	drug	magnesium	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGA ; DRUGN salts ; DRUGB ; and DRUGN .
lithium	drug	procainamide	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGA ; DRUGN salts ; DRUGN ; and DRUGB .
lithium	drug	quinidine	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGA salts ; DRUGB ; and DRUGN .
magnesium	drug	procainamide	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGA salts ; DRUGN ; and DRUGB .
magnesium	drug	quinidine	drug
false

Drugs which may enhance the neuromuscular blocking action of DRUGN include : DRUGN ; DRUGN ; DRUGN ; certain DRUGN , especially the DRUGN and DRUGN ; DRUGN ; DRUGN salts ; DRUGA ; and DRUGB .
procainamide	drug	quinidine	drug
false

The prior administration of DRUGA does not enhance the duration , but quickens the onset and may increase the depth , of neuromuscular block induced by DRUGB .
succinylcholine	drug	TRACRIUM	brand
effect

DRUGA should not be administered until a patient has recovered from DRUGB induced neuromuscular block .
TRACRIUM	brand	succinylcholine	drug
advise

The following precautions should be kept in mind in the treatment of anticholinesterase poisoning although they do not bear directly on the use of DRUGA and DRUGB .
atropine	drug	pralidoxime	drug
advise

Since DRUGA are potentiated by the DRUGB , they should be used cautiously in the treatment of convulsions .
barbiturates	group	anticholinesterases	group
advise

DRUGA should be avoided by patients with a history of serious reaction to any DRUGB , including DRUGN and DRUGN .
Auranofin	drug	gold medication	group
advise

DRUGA should be avoided by patients with a history of serious reaction to any DRUGN , including DRUGB and DRUGN .
Auranofin	drug	Solganal	brand
advise

DRUGA should be avoided by patients with a history of serious reaction to any DRUGN , including DRUGN and DRUGB .
Auranofin	drug	Myochrysine	brand
advise

DRUGN should be avoided by patients with a history of serious reaction to any DRUGA , including DRUGB and DRUGN .
gold medication	group	Solganal	brand
false

DRUGN should be avoided by patients with a history of serious reaction to any DRUGA , including DRUGN and DRUGB .
gold medication	group	Myochrysine	brand
false

DRUGN should be avoided by patients with a history of serious reaction to any DRUGN , including DRUGA and DRUGB .
Solganal	brand	Myochrysine	brand
false

DRUGA should not be used together with DRUGB ( DRUGN , DRUGN ) , another arthritis medication .
Auranofin	drug	penicillamine	drug
advise

DRUGA should not be used together with DRUGN ( DRUGB , DRUGN ) , another arthritis medication .
Auranofin	drug	Depen	brand
advise

DRUGA should not be used together with DRUGN ( DRUGN , DRUGB ) , another arthritis medication .
Auranofin	drug	Cuprimine	brand
advise

DRUGN should not be used together with DRUGA ( DRUGB , DRUGN ) , another arthritis medication .
penicillamine	drug	Depen	brand
false

DRUGN should not be used together with DRUGA ( DRUGN , DRUGB ) , another arthritis medication .
penicillamine	drug	Cuprimine	brand
false

DRUGN should not be used together with DRUGN ( DRUGA , DRUGB ) , another arthritis medication .
Depen	brand	Cuprimine	brand
false

DRUGA prolong and intensify the effects of DRUGB .
MAO inhibitors	group	antihistamines	group
effect

Concomitant use of DRUGA with DRUGB , DRUGN , DRUGN , or other DRUGN may have an additive effect .
antihistamines	group	alcohol	drug
effect

Concomitant use of DRUGA with DRUGN , DRUGB , DRUGN , or other DRUGN may have an additive effect .
antihistamines	group	tricyclic antidepressants	group
effect

Concomitant use of DRUGA with DRUGN , DRUGN , DRUGB , or other DRUGN may have an additive effect .
antihistamines	group	barbiturates	group
effect

Concomitant use of DRUGA with DRUGN , DRUGN , DRUGN , or other DRUGB may have an additive effect .
antihistamines	group	central nervous system depressants	group
effect

Concomitant use of DRUGN with DRUGA , DRUGB , DRUGN , or other DRUGN may have an additive effect .
alcohol	drug	tricyclic antidepressants	group
false

Concomitant use of DRUGN with DRUGA , DRUGN , DRUGB , or other DRUGN may have an additive effect .
alcohol	drug	barbiturates	group
false

Concomitant use of DRUGN with DRUGA , DRUGN , DRUGN , or other DRUGB may have an additive effect .
alcohol	drug	central nervous system depressants	group
false

Concomitant use of DRUGN with DRUGN , DRUGA , DRUGB , or other DRUGN may have an additive effect .
tricyclic antidepressants	group	barbiturates	group
false

Concomitant use of DRUGN with DRUGN , DRUGA , DRUGN , or other DRUGB may have an additive effect .
tricyclic antidepressants	group	central nervous system depressants	group
false

Concomitant use of DRUGN with DRUGN , DRUGN , DRUGA , or other DRUGB may have an additive effect .
barbiturates	group	central nervous system depressants	group
false

When DRUGA are given to patients receiving DRUGB , hypertensive reactions , including hypertensive crises , may occur .
sympathomimetic drugs	group	monoamine oxidase inhibitors	group
effect

The antihypertensive effects of DRUGA , DRUGB , DRUGN , and DRUGN may be reduced by DRUGN .
methyldopa	drug	mecamylamine	drug
false

The antihypertensive effects of DRUGA , DRUGN , DRUGB , and DRUGN may be reduced by DRUGN .
methyldopa	drug	reserpine	drug
false

The antihypertensive effects of DRUGA , DRUGN , DRUGN , and DRUGB may be reduced by DRUGN .
methyldopa	drug	veratrum alkaloids	drug
false

The antihypertensive effects of DRUGA , DRUGN , DRUGN , and DRUGN may be reduced by DRUGB .
methyldopa	drug	sympathomimetics	group
effect

The antihypertensive effects of DRUGN , DRUGA , DRUGB , and DRUGN may be reduced by DRUGN .
mecamylamine	drug	reserpine	drug
false

The antihypertensive effects of DRUGN , DRUGA , DRUGN , and DRUGB may be reduced by DRUGN .
mecamylamine	drug	veratrum alkaloids	drug
false

The antihypertensive effects of DRUGN , DRUGA , DRUGN , and DRUGN may be reduced by DRUGB .
mecamylamine	drug	sympathomimetics	group
effect

The antihypertensive effects of DRUGN , DRUGN , DRUGA , and DRUGB may be reduced by DRUGN .
reserpine	drug	veratrum alkaloids	drug
false

The antihypertensive effects of DRUGN , DRUGN , DRUGA , and DRUGN may be reduced by DRUGB .
reserpine	drug	sympathomimetics	group
effect

The antihypertensive effects of DRUGN , DRUGN , DRUGN , and DRUGA may be reduced by DRUGB .
veratrum alkaloids	drug	sympathomimetics	group
effect

DRUGA may also interact with DRUGB .
Beta-adrenergic blocking agents	group	sympathomimetics	group
int

Increased ectopic pacemaker activity can occur when DRUGA is used concomitantly with DRUGB .
pseudoephedrine	drug	digitalis	group
effect

DRUGA increase the rate of absorption of DRUGB , while DRUGN decreases it .
Antacids	group	pseudoephedrine	drug
mechanism

DRUGA increase the rate of absorption of DRUGN , while DRUGB decreases it .
Antacids	group	kaolin	drug
false

DRUGN increase the rate of absorption of DRUGA , while DRUGB decreases it .
pseudoephedrine	drug	kaolin	drug
mechanism

Use with DRUGA : The principal pathway for detoxification of DRUGB is inhibited by DRUGN .
Allopurinol	drug	azathioprine	drug
false

Use with DRUGA : The principal pathway for detoxification of DRUGN is inhibited by DRUGB .
Allopurinol	drug	allopurinol	drug
false

Use with DRUGN : The principal pathway for detoxification of DRUGA is inhibited by DRUGB .
azathioprine	drug	allopurinol	drug
mechanism

Patients receiving DRUGA and DRUGB concomitantly should have a dose reduction of DRUGN , to approximately dgb / dgb to dgb / dgb the usual dose .
azathioprine	drug	allopurinol	drug
advise

Patients receiving DRUGN and DRUGA concomitantly should have a dose reduction of DRUGB , to approximately dgb / dgb to dgb / dgb the usual dose .
allopurinol	drug	azathioprine	drug
false

Use with DRUGA : The use of DRUGB to control hypertension in patients on DRUGN has been reported to induce severe leukopenia .
Angiotensln Converting Enzyme Inhibitors	group	angiotensin converting enzyme inhibitors	group
false

Use with DRUGA : The use of DRUGN to control hypertension in patients on DRUGB has been reported to induce severe leukopenia .
Angiotensln Converting Enzyme Inhibitors	group	azathioprine	drug
false

Use with DRUGN : The use of DRUGA to control hypertension in patients on DRUGB has been reported to induce severe leukopenia .
angiotensin converting enzyme inhibitors	group	azathioprine	drug
effect

Co administration of DRUGA at steady state with a single dose of DRUGB .
nelfinavir	drug	azithromycin	drug
false

Co administration of DRUGA at steady state with a single dose of DRUGB ( dgb x dgb mg tablets ) results in increased DRUGN serum concentrations .
nelfinavir	drug	azithromycin	drug
effect

Co administration of DRUGA at steady state with a single dose of DRUGN ( dgb x dgb mg tablets ) results in increased DRUGB serum concentrations .
nelfinavir	drug	azithromycin	drug
false

Although a dose adjustment of DRUGA is not recommended when administered in combination with DRUGB , close monitoring for known side effects of DRUGN , such as liver enzyme abnormalities and hearing impairment , is warranted .
azithromycin	drug	nelfinavir	drug
advise

Although a dose adjustment of DRUGN is not recommended when administered in combination with DRUGA , close monitoring for known side effects of DRUGB , such as liver enzyme abnormalities and hearing impairment , is warranted .
nelfinavir	drug	azithromycin	drug
false

DRUGA did not affect the prothrombin time response to a single dose of DRUGB .
Azithromycin	drug	warfarin	drug
false

However , prudent medical practice dictates careful monitoring of prothrombin time in all patients treated with DRUGA and DRUGB concomitantly .
azithromycin	drug	warfarin	drug
advise

Concurrent use of DRUGA and DRUGB in clinical practice has been associated with increased anticoagulant effects .
macrolides	group	warfarin	drug
effect

Co administration with DRUGA or DRUGB had a modest effect on the pharmacokinetics of DRUGN .
efavirenz	drug	fluconazole	drug
false

Co administration with DRUGA or DRUGN had a modest effect on the pharmacokinetics of DRUGB .
efavirenz	drug	azithromycin	drug
mechanism

Co administration with DRUGN or DRUGA had a modest effect on the pharmacokinetics of DRUGB .
fluconazole	drug	azithromycin	drug
mechanism

Until further data are developed regarding drug interactions when DRUGA and these drugs are used concomitantly , careful monitoring of patients is advised : DRUGB elevated DRUGN concentrations .
azithromycin	drug	Digoxin	drug
false

Until further data are developed regarding drug interactions when DRUGA and these drugs are used concomitantly , careful monitoring of patients is advised : DRUGN elevated DRUGB concentrations .
azithromycin	drug	digoxin	drug
false

Until further data are developed regarding drug interactions when DRUGN and these drugs are used concomitantly , careful monitoring of patients is advised : DRUGA elevated DRUGB concentrations .
Digoxin	drug	digoxin	drug
false

DRUGA or DRUGB acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
Ergotamine	drug	dihydroergotamine	drug
false

DRUGA , DRUGB and DRUGN concentrations .
Cyclosporine	drug	hexobarbital	drug
false

DRUGA , DRUGN and DRUGB concentrations .
Cyclosporine	drug	phenytoin	drug
false

DRUGN , DRUGA and DRUGB concentrations .
hexobarbital	drug	phenytoin	drug
false

DRUGA should not be administered concomitantly with DRUGB , DRUGN , DRUGN , DRUGN , or DRUGN .
Azlocillin	drug	amikacin	drug
advise

DRUGA should not be administered concomitantly with DRUGN , DRUGB , DRUGN , DRUGN , or DRUGN .
Azlocillin	drug	ciprofloxacin	drug
advise

DRUGA should not be administered concomitantly with DRUGN , DRUGN , DRUGB , DRUGN , or DRUGN .
Azlocillin	drug	gentamicin	drug
advise

DRUGA should not be administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGB , or DRUGN .
Azlocillin	drug	netilmicin	drug
advise

DRUGA should not be administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , or DRUGB .
Azlocillin	drug	tobramycin	drug
advise

DRUGN should not be administered concomitantly with DRUGA , DRUGB , DRUGN , DRUGN , or DRUGN .
amikacin	drug	ciprofloxacin	drug
false

DRUGN should not be administered concomitantly with DRUGA , DRUGN , DRUGB , DRUGN , or DRUGN .
amikacin	drug	gentamicin	drug
false

DRUGN should not be administered concomitantly with DRUGA , DRUGN , DRUGN , DRUGB , or DRUGN .
amikacin	drug	netilmicin	drug
false

DRUGN should not be administered concomitantly with DRUGA , DRUGN , DRUGN , DRUGN , or DRUGB .
amikacin	drug	tobramycin	drug
false

DRUGN should not be administered concomitantly with DRUGN , DRUGA , DRUGB , DRUGN , or DRUGN .
ciprofloxacin	drug	gentamicin	drug
false

DRUGN should not be administered concomitantly with DRUGN , DRUGA , DRUGN , DRUGB , or DRUGN .
ciprofloxacin	drug	netilmicin	drug
false

DRUGN should not be administered concomitantly with DRUGN , DRUGA , DRUGN , DRUGN , or DRUGB .
ciprofloxacin	drug	tobramycin	drug
false

DRUGN should not be administered concomitantly with DRUGN , DRUGN , DRUGA , DRUGB , or DRUGN .
gentamicin	drug	netilmicin	drug
false

DRUGN should not be administered concomitantly with DRUGN , DRUGN , DRUGA , DRUGN , or DRUGB .
gentamicin	drug	tobramycin	drug
false

DRUGN should not be administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGA , or DRUGB .
netilmicin	drug	tobramycin	drug
false

Interactions attributed to the combined use of DRUGA injection and epidural DRUGB include hypotension and dyspnea .
baclofen	drug	morphine	drug
effect

SIDE EFFECTS ( DRUGA ) The most common adverse reaction during treatment with DRUGB is transient drowsiness ( dgb dgb % ) .
KEMSTRO	brand	baclofen	drug
false

The adverse experience profile seen with DRUGA was similar to that seen with DRUGB tablets .
KEMSTROTM	brand	baclofen	drug
false

No drug interaction studies have been conducted for DRUGA , however the use of orally administered DRUGB could , theoretically , interfere with the release of DRUGN in the colon .
COLAZAL	brand	antibiotics	group
false

No drug interaction studies have been conducted for DRUGA , however the use of orally administered DRUGN could , theoretically , interfere with the release of DRUGB in the colon .
COLAZAL	brand	mesalamine	drug
false

No drug interaction studies have been conducted for DRUGN , however the use of orally administered DRUGA could , theoretically , interfere with the release of DRUGB in the colon .
antibiotics	group	mesalamine	drug
false

No dose adjustment is necessary when DRUGA is added to triple immunosuppression regimens including DRUGB , DRUGN , and either DRUGN or DRUGN .
Simulect	brand	cyclosporine	drug
false

No dose adjustment is necessary when DRUGA is added to triple immunosuppression regimens including DRUGN , DRUGB , and either DRUGN or DRUGN .
Simulect	brand	corticosteroids	group
false

No dose adjustment is necessary when DRUGA is added to triple immunosuppression regimens including DRUGN , DRUGN , and either DRUGB or DRUGN .
Simulect	brand	azathioprine	drug
false

No dose adjustment is necessary when DRUGA is added to triple immunosuppression regimens including DRUGN , DRUGN , and either DRUGN or DRUGB .
Simulect	brand	mycophenolate mofetil	drug
false

No dose adjustment is necessary when DRUGN is added to triple immunosuppression regimens including DRUGA , DRUGB , and either DRUGN or DRUGN .
cyclosporine	drug	corticosteroids	group
false

No dose adjustment is necessary when DRUGN is added to triple immunosuppression regimens including DRUGA , DRUGN , and either DRUGB or DRUGN .
cyclosporine	drug	azathioprine	drug
false

No dose adjustment is necessary when DRUGN is added to triple immunosuppression regimens including DRUGA , DRUGN , and either DRUGN or DRUGB .
cyclosporine	drug	mycophenolate mofetil	drug
false

No dose adjustment is necessary when DRUGN is added to triple immunosuppression regimens including DRUGN , DRUGA , and either DRUGB or DRUGN .
corticosteroids	group	azathioprine	drug
false

No dose adjustment is necessary when DRUGN is added to triple immunosuppression regimens including DRUGN , DRUGA , and either DRUGN or DRUGB .
corticosteroids	group	mycophenolate mofetil	drug
false

No dose adjustment is necessary when DRUGN is added to triple immunosuppression regimens including DRUGN , DRUGN , and either DRUGA or DRUGB .
azathioprine	drug	mycophenolate mofetil	drug
false

Total body clearance of DRUGA was reduced by an average dgb % and dgb % when DRUGB and DRUGN , respectively , were added to a regimen consisting of DRUGN , USP ( MODIFIED ) and DRUGN .
Simulect	brand	azathioprine	drug
mechanism

Total body clearance of DRUGA was reduced by an average dgb % and dgb % when DRUGN and DRUGB , respectively , were added to a regimen consisting of DRUGN , USP ( MODIFIED ) and DRUGN .
Simulect	brand	mycophenolate mofetil	drug
mechanism

Total body clearance of DRUGA was reduced by an average dgb % and dgb % when DRUGN and DRUGN , respectively , were added to a regimen consisting of DRUGB , USP ( MODIFIED ) and DRUGN .
Simulect	brand	cyclosporine	drug
false

Total body clearance of DRUGA was reduced by an average dgb % and dgb % when DRUGN and DRUGN , respectively , were added to a regimen consisting of DRUGN , USP ( MODIFIED ) and DRUGB .
Simulect	brand	corticosteroids	group
false

Total body clearance of DRUGN was reduced by an average dgb % and dgb % when DRUGA and DRUGB , respectively , were added to a regimen consisting of DRUGN , USP ( MODIFIED ) and DRUGN .
azathioprine	drug	mycophenolate mofetil	drug
false

Total body clearance of DRUGN was reduced by an average dgb % and dgb % when DRUGA and DRUGN , respectively , were added to a regimen consisting of DRUGB , USP ( MODIFIED ) and DRUGN .
azathioprine	drug	cyclosporine	drug
false

Total body clearance of DRUGN was reduced by an average dgb % and dgb % when DRUGA and DRUGN , respectively , were added to a regimen consisting of DRUGN , USP ( MODIFIED ) and DRUGB .
azathioprine	drug	corticosteroids	group
false

Total body clearance of DRUGN was reduced by an average dgb % and dgb % when DRUGN and DRUGA , respectively , were added to a regimen consisting of DRUGB , USP ( MODIFIED ) and DRUGN .
mycophenolate mofetil	drug	cyclosporine	drug
false

Total body clearance of DRUGN was reduced by an average dgb % and dgb % when DRUGN and DRUGA , respectively , were added to a regimen consisting of DRUGN , USP ( MODIFIED ) and DRUGB .
mycophenolate mofetil	drug	corticosteroids	group
false

Total body clearance of DRUGN was reduced by an average dgb % and dgb % when DRUGN and DRUGN , respectively , were added to a regimen consisting of DRUGA , USP ( MODIFIED ) and DRUGB .
cyclosporine	drug	corticosteroids	group
false

The following medications have been administered in clinical trials with DRUGA with no increase in adverse reactions : ATG / ALG , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
Simulect	brand	azathioprine	drug
false

The following medications have been administered in clinical trials with DRUGA with no increase in adverse reactions : ATG / ALG , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
Simulect	brand	corticosteroids	group
false

The following medications have been administered in clinical trials with DRUGA with no increase in adverse reactions : ATG / ALG , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
Simulect	brand	cyclosporine	drug
false

The following medications have been administered in clinical trials with DRUGA with no increase in adverse reactions : ATG / ALG , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
Simulect	brand	mycophenolate mofetil	drug
false

The following medications have been administered in clinical trials with DRUGA with no increase in adverse reactions : ATG / ALG , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
Simulect	brand	muromonab-CD3	drug
false

The following medications have been administered in clinical trials with DRUGN with no increase in adverse reactions : ATG / ALG , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
azathioprine	drug	corticosteroids	group
false

The following medications have been administered in clinical trials with DRUGN with no increase in adverse reactions : ATG / ALG , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
azathioprine	drug	cyclosporine	drug
false

The following medications have been administered in clinical trials with DRUGN with no increase in adverse reactions : ATG / ALG , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
azathioprine	drug	mycophenolate mofetil	drug
false

The following medications have been administered in clinical trials with DRUGN with no increase in adverse reactions : ATG / ALG , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
azathioprine	drug	muromonab-CD3	drug
false

The following medications have been administered in clinical trials with DRUGN with no increase in adverse reactions : ATG / ALG , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
corticosteroids	group	cyclosporine	drug
false

The following medications have been administered in clinical trials with DRUGN with no increase in adverse reactions : ATG / ALG , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
corticosteroids	group	mycophenolate mofetil	drug
false

The following medications have been administered in clinical trials with DRUGN with no increase in adverse reactions : ATG / ALG , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
corticosteroids	group	muromonab-CD3	drug
false

The following medications have been administered in clinical trials with DRUGN with no increase in adverse reactions : ATG / ALG , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
cyclosporine	drug	mycophenolate mofetil	drug
false

The following medications have been administered in clinical trials with DRUGN with no increase in adverse reactions : ATG / ALG , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
cyclosporine	drug	muromonab-CD3	drug
false

The following medications have been administered in clinical trials with DRUGN with no increase in adverse reactions : ATG / ALG , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
mycophenolate mofetil	drug	muromonab-CD3	drug
false

DRUGA , DRUGB , DRUGN , DRUGN , DRUGN .
Albuterol	drug	Antihistamines	group
false

DRUGA , DRUGN , DRUGB , DRUGN , DRUGN .
Albuterol	drug	antidiabetic drugs	group
false

DRUGA , DRUGN , DRUGN , DRUGB , DRUGN .
Albuterol	drug	diuretics	group
false

DRUGA , DRUGN , DRUGN , DRUGN , DRUGB .
Albuterol	drug	digitalis	group
false

DRUGN , DRUGA , DRUGB , DRUGN , DRUGN .
Antihistamines	group	antidiabetic drugs	group
false

DRUGN , DRUGA , DRUGN , DRUGB , DRUGN .
Antihistamines	group	diuretics	group
false

DRUGN , DRUGA , DRUGN , DRUGN , DRUGB .
Antihistamines	group	digitalis	group
false

DRUGN , DRUGN , DRUGA , DRUGB , DRUGN .
antidiabetic drugs	group	diuretics	group
false

DRUGN , DRUGN , DRUGA , DRUGN , DRUGB .
antidiabetic drugs	group	digitalis	group
false

DRUGN , DRUGN , DRUGN , DRUGA , DRUGB .
diuretics	group	digitalis	group
false

DRUGA : Patients on DRUGB , especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with DRUGN .
Diuretics	group	diuretics	group
false

DRUGA : Patients on DRUGN , especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with DRUGB .
Diuretics	group	Lotensin	brand
false

DRUGN : Patients on DRUGA , especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with DRUGB .
diuretics	group	Lotensin	brand
effect

The possibility of hypotensive effects with DRUGA can be minimized by either discontinuing the DRUGB or increasing the salt intake prior to initiation of treatment with DRUGN .
Lotensin	brand	diuretic	group
false

The possibility of hypotensive effects with DRUGN can be minimized by either discontinuing the DRUGA or increasing the salt intake prior to initiation of treatment with DRUGB .
diuretic	group	Lotensin	brand
advise

DRUGA Supplements and DRUGB Lotensin can attenuate potassium loss caused by DRUGN .
Potassium	drug	Potassium-Sparing Diuretics	group
false

DRUGA Supplements and DRUGN Lotensin can attenuate potassium loss caused by DRUGB .
Potassium	drug	thiazide diuretics	group
false

DRUGN Supplements and DRUGA Lotensin can attenuate potassium loss caused by DRUGB .
Potassium-Sparing Diuretics	group	thiazide diuretics	group
effect

DRUGA ( DRUGB , DRUGN , DRUGN , and others ) or DRUGN supplements can increase the risk of hyperkalemia .
Potassium-sparing diuretics	group	spironolactone	drug
false

DRUGA ( DRUGN , DRUGB , DRUGN , and others ) or DRUGN supplements can increase the risk of hyperkalemia .
Potassium-sparing diuretics	group	amiloride	drug
false

DRUGA ( DRUGN , DRUGN , DRUGB , and others ) or DRUGN supplements can increase the risk of hyperkalemia .
Potassium-sparing diuretics	group	triamterene	drug
false

DRUGA ( DRUGN , DRUGN , DRUGN , and others ) or DRUGB supplements can increase the risk of hyperkalemia .
Potassium-sparing diuretics	group	potassium	drug
false

DRUGN ( DRUGA , DRUGB , DRUGN , and others ) or DRUGN supplements can increase the risk of hyperkalemia .
spironolactone	drug	amiloride	drug
false

DRUGN ( DRUGA , DRUGN , DRUGB , and others ) or DRUGN supplements can increase the risk of hyperkalemia .
spironolactone	drug	triamterene	drug
false

DRUGN ( DRUGA , DRUGN , DRUGN , and others ) or DRUGB supplements can increase the risk of hyperkalemia .
spironolactone	drug	potassium	drug
false

DRUGN ( DRUGN , DRUGA , DRUGB , and others ) or DRUGN supplements can increase the risk of hyperkalemia .
amiloride	drug	triamterene	drug
false

DRUGN ( DRUGN , DRUGA , DRUGN , and others ) or DRUGB supplements can increase the risk of hyperkalemia .
amiloride	drug	potassium	drug
false

DRUGN ( DRUGN , DRUGN , DRUGA , and others ) or DRUGB supplements can increase the risk of hyperkalemia .
triamterene	drug	potassium	drug
false

Oral DRUGA Interaction studies with DRUGB and DRUGN failed to identify any clinically important effects on the serum concentrations or clinical effects of these DRUGN .
Anticoagulants	group	warfarin	drug
false

Oral DRUGA Interaction studies with DRUGN and DRUGB failed to identify any clinically important effects on the serum concentrations or clinical effects of these DRUGN .
Anticoagulants	group	acenocoumarol	drug
false

Oral DRUGA Interaction studies with DRUGN and DRUGN failed to identify any clinically important effects on the serum concentrations or clinical effects of these DRUGB .
Anticoagulants	group	anticoagulants	group
false

Oral DRUGN Interaction studies with DRUGA and DRUGB failed to identify any clinically important effects on the serum concentrations or clinical effects of these DRUGN .
warfarin	drug	acenocoumarol	drug
false

Oral DRUGN Interaction studies with DRUGA and DRUGN failed to identify any clinically important effects on the serum concentrations or clinical effects of these DRUGB .
warfarin	drug	anticoagulants	group
false

Oral DRUGN Interaction studies with DRUGN and DRUGA failed to identify any clinically important effects on the serum concentrations or clinical effects of these DRUGB .
acenocoumarol	drug	anticoagulants	group
false

DRUGA : Increased serum DRUGB levels and symptoms of DRUGN toxicity have been reported in patients receiving DRUGN during therapy with DRUGN .
Lithium	drug	lithium	drug
false

DRUGA : Increased serum DRUGN levels and symptoms of DRUGB toxicity have been reported in patients receiving DRUGN during therapy with DRUGN .
Lithium	drug	lithium	drug
false

DRUGA : Increased serum DRUGN levels and symptoms of DRUGN toxicity have been reported in patients receiving DRUGB during therapy with DRUGN .
Lithium	drug	ACE inhibitors	group
false

DRUGA : Increased serum DRUGN levels and symptoms of DRUGN toxicity have been reported in patients receiving DRUGN during therapy with DRUGB .
Lithium	drug	lithium	drug
false

DRUGN : Increased serum DRUGA levels and symptoms of DRUGN toxicity have been reported in patients receiving DRUGB during therapy with DRUGN .
lithium	drug	ACE inhibitors	group
false

DRUGN : Increased serum DRUGN levels and symptoms of DRUGA toxicity have been reported in patients receiving DRUGB during therapy with DRUGN .
lithium	drug	ACE inhibitors	group
false

DRUGN : Increased serum DRUGN levels and symptoms of DRUGN toxicity have been reported in patients receiving DRUGA during therapy with DRUGB .
ACE inhibitors	group	lithium	drug
mechanism

If a DRUGA is also used , the risk of DRUGB toxicity may be increased .
diuretic	group	lithium	drug
effect

Other No clinically important pharmacokinetic interactions occurred when DRUGA was administered concomitantly with DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or DRUGN .
Lotensin	brand	hydrochlorothiazide	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGA was administered concomitantly with DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or DRUGN .
Lotensin	brand	chlorthalidone	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGA was administered concomitantly with DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , or DRUGN .
Lotensin	brand	furosemide	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGA was administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , or DRUGN .
Lotensin	brand	digoxin	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGA was administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , or DRUGN .
Lotensin	brand	propranolol	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGA was administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , or DRUGN .
Lotensin	brand	atenolol	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGA was administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , or DRUGN .
Lotensin	brand	naproxen	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGA was administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or DRUGB .
Lotensin	brand	cimetidine	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or DRUGN .
hydrochlorothiazide	drug	chlorthalidone	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , or DRUGN .
hydrochlorothiazide	drug	furosemide	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , or DRUGN .
hydrochlorothiazide	drug	digoxin	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , or DRUGN .
hydrochlorothiazide	drug	propranolol	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , or DRUGN .
hydrochlorothiazide	drug	atenolol	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , or DRUGN .
hydrochlorothiazide	drug	naproxen	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or DRUGB .
hydrochlorothiazide	drug	cimetidine	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , or DRUGN .
chlorthalidone	drug	furosemide	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , or DRUGN .
chlorthalidone	drug	digoxin	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , or DRUGN .
chlorthalidone	drug	propranolol	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , or DRUGN .
chlorthalidone	drug	atenolol	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , or DRUGN .
chlorthalidone	drug	naproxen	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or DRUGB .
chlorthalidone	drug	cimetidine	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , or DRUGN .
furosemide	drug	digoxin	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , or DRUGN .
furosemide	drug	propranolol	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , or DRUGN .
furosemide	drug	atenolol	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , or DRUGN .
furosemide	drug	naproxen	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , or DRUGB .
furosemide	drug	cimetidine	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , or DRUGN .
digoxin	drug	propranolol	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , or DRUGN .
digoxin	drug	atenolol	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , or DRUGN .
digoxin	drug	naproxen	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , or DRUGB .
digoxin	drug	cimetidine	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , or DRUGN .
propranolol	drug	atenolol	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , or DRUGN .
propranolol	drug	naproxen	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , or DRUGB .
propranolol	drug	cimetidine	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , or DRUGN .
atenolol	drug	naproxen	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , or DRUGB .
atenolol	drug	cimetidine	drug
false

Other No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , or DRUGB .
naproxen	drug	cimetidine	drug
false

DRUGA has been used concomitantly with DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN , without evidence of clinically important adverse interactions .
Lotensin	brand	beta-adrenergic-blocking agents	group
false

DRUGA has been used concomitantly with DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN , without evidence of clinically important adverse interactions .
Lotensin	brand	calcium-channel-blocking agents	group
false

DRUGA has been used concomitantly with DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN , without evidence of clinically important adverse interactions .
Lotensin	brand	diuretics	group
false

DRUGA has been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN , without evidence of clinically important adverse interactions .
Lotensin	brand	digoxin	drug
false

DRUGA has been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB , without evidence of clinically important adverse interactions .
Lotensin	brand	hydralazine	drug
false

DRUGN has been used concomitantly with DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN , without evidence of clinically important adverse interactions .
beta-adrenergic-blocking agents	group	calcium-channel-blocking agents	group
false

DRUGN has been used concomitantly with DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN , without evidence of clinically important adverse interactions .
beta-adrenergic-blocking agents	group	diuretics	group
false

DRUGN has been used concomitantly with DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN , without evidence of clinically important adverse interactions .
beta-adrenergic-blocking agents	group	digoxin	drug
false

DRUGN has been used concomitantly with DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB , without evidence of clinically important adverse interactions .
beta-adrenergic-blocking agents	group	hydralazine	drug
false

DRUGN has been used concomitantly with DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN , without evidence of clinically important adverse interactions .
calcium-channel-blocking agents	group	diuretics	group
false

DRUGN has been used concomitantly with DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN , without evidence of clinically important adverse interactions .
calcium-channel-blocking agents	group	digoxin	drug
false

DRUGN has been used concomitantly with DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB , without evidence of clinically important adverse interactions .
calcium-channel-blocking agents	group	hydralazine	drug
false

DRUGN has been used concomitantly with DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN , without evidence of clinically important adverse interactions .
diuretics	group	digoxin	drug
false

DRUGN has been used concomitantly with DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB , without evidence of clinically important adverse interactions .
diuretics	group	hydralazine	drug
false

DRUGN has been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB , without evidence of clinically important adverse interactions .
digoxin	drug	hydralazine	drug
false

DRUGA , like other DRUGB , has had less than additive effects with DRUGN , presumably because both drugs lower blood pressure by inhibiting parts of the renin angiotensin system
Benazepril	drug	ACE inhibitors	group
false

DRUGA , like other DRUGN , has had less than additive effects with DRUGB , presumably because both drugs lower blood pressure by inhibiting parts of the renin angiotensin system
Benazepril	drug	beta-adrenergic blockers	group
effect

DRUGN , like other DRUGA , has had less than additive effects with DRUGB , presumably because both drugs lower blood pressure by inhibiting parts of the renin angiotensin system
ACE inhibitors	group	beta-adrenergic blockers	group
effect

May interact with the following : DRUGA , DRUGB ( use with DRUGN may prevent the DRUGN from working properly ;
cholestyramine	drug	colestipol	drug
false

May interact with the following : DRUGA , DRUGN ( use with DRUGB may prevent the DRUGN from working properly ;
cholestyramine	drug	thiazide diuretics	group
effect

May interact with the following : DRUGA , DRUGN ( use with DRUGN may prevent the DRUGB from working properly ;
cholestyramine	drug	diuretic	group
false

May interact with the following : DRUGN , DRUGA ( use with DRUGB may prevent the DRUGN from working properly ;
colestipol	drug	thiazide diuretics	group
effect

May interact with the following : DRUGN , DRUGA ( use with DRUGN may prevent the DRUGB from working properly ;
colestipol	drug	diuretic	group
false

May interact with the following : DRUGN , DRUGN ( use with DRUGA may prevent the DRUGB from working properly ;
thiazide diuretics	group	diuretic	group
false

Hypertensive crises have resulted when DRUGA have been used concomitantly withindgb days following use of DRUGB .
sympathomimetic amines	group	monoamine oxidase inhibitors	group
effect

DRUGA should not be used concomitantly with other DRUGB .
DIDREX	brand	CNS stimulants	group
advise

DRUGA may decrease the hypotensive effect of DRUGB .
Amphetamines	group	antihypertensives	group
effect

DRUGA may enhance the effects of DRUGB .
Amphetamines	group	tricyclic antidepressants	group
effect

DRUGA agents decrease blood levels and increase excretion of DRUGB .
Urinary acidifying	drug	amphetamines	group
mechanism

DRUGA may interact with DRUGB , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGN like DRUGN or DRUGN , and high blood pressure medications .
Benzthiazide	drug	alcohol	drug
int

DRUGA may interact with DRUGN , DRUGB s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGN like DRUGN or DRUGN , and high blood pressure medications .
Benzthiazide	drug	blood thinner	group
int

DRUGA may interact with DRUGN , DRUGN s , DRUGB ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGN like DRUGN or DRUGN , and high blood pressure medications .
Benzthiazide	drug	decongestant drugs	group
int

DRUGA may interact with DRUGN , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGB , DRUGN , DRUGN like DRUGN or DRUGN , and high blood pressure medications .
Benzthiazide	drug	lithium	drug
int

DRUGA may interact with DRUGN , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGB , DRUGN like DRUGN or DRUGN , and high blood pressure medications .
Benzthiazide	drug	norepinephrine	drug
int

DRUGA may interact with DRUGN , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGB like DRUGN or DRUGN , and high blood pressure medications .
Benzthiazide	drug	NSAIDs	group
int

DRUGA may interact with DRUGN , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGN like DRUGB or DRUGN , and high blood pressure medications .
Benzthiazide	drug	Aleve	brand
int

DRUGA may interact with DRUGN , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGN like DRUGN or DRUGB , and high blood pressure medications .
Benzthiazide	drug	Ibuprofen	drug
int

DRUGN may interact with DRUGA , DRUGB s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGN like DRUGN or DRUGN , and high blood pressure medications .
alcohol	drug	blood thinner	group
false

DRUGN may interact with DRUGA , DRUGN s , DRUGB ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGN like DRUGN or DRUGN , and high blood pressure medications .
alcohol	drug	decongestant drugs	group
false

DRUGN may interact with DRUGA , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGB , DRUGN , DRUGN like DRUGN or DRUGN , and high blood pressure medications .
alcohol	drug	lithium	drug
false

DRUGN may interact with DRUGA , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGB , DRUGN like DRUGN or DRUGN , and high blood pressure medications .
alcohol	drug	norepinephrine	drug
false

DRUGN may interact with DRUGA , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGB like DRUGN or DRUGN , and high blood pressure medications .
alcohol	drug	NSAIDs	group
false

DRUGN may interact with DRUGA , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGN like DRUGB or DRUGN , and high blood pressure medications .
alcohol	drug	Aleve	brand
false

DRUGN may interact with DRUGA , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGN like DRUGN or DRUGB , and high blood pressure medications .
alcohol	drug	Ibuprofen	drug
false

DRUGN may interact with DRUGN , DRUGA s , DRUGB ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGN like DRUGN or DRUGN , and high blood pressure medications .
blood thinner	group	decongestant drugs	group
false

DRUGN may interact with DRUGN , DRUGA s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGB , DRUGN , DRUGN like DRUGN or DRUGN , and high blood pressure medications .
blood thinner	group	lithium	drug
false

DRUGN may interact with DRUGN , DRUGA s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGB , DRUGN like DRUGN or DRUGN , and high blood pressure medications .
blood thinner	group	norepinephrine	drug
false

DRUGN may interact with DRUGN , DRUGA s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGB like DRUGN or DRUGN , and high blood pressure medications .
blood thinner	group	NSAIDs	group
false

DRUGN may interact with DRUGN , DRUGA s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGN like DRUGB or DRUGN , and high blood pressure medications .
blood thinner	group	Aleve	brand
false

DRUGN may interact with DRUGN , DRUGA s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGN like DRUGN or DRUGB , and high blood pressure medications .
blood thinner	group	Ibuprofen	drug
false

DRUGN may interact with DRUGN , DRUGN s , DRUGA ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGB , DRUGN , DRUGN like DRUGN or DRUGN , and high blood pressure medications .
decongestant drugs	group	lithium	drug
false

DRUGN may interact with DRUGN , DRUGN s , DRUGA ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGB , DRUGN like DRUGN or DRUGN , and high blood pressure medications .
decongestant drugs	group	norepinephrine	drug
false

DRUGN may interact with DRUGN , DRUGN s , DRUGA ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGB like DRUGN or DRUGN , and high blood pressure medications .
decongestant drugs	group	NSAIDs	group
false

DRUGN may interact with DRUGN , DRUGN s , DRUGA ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGN like DRUGB or DRUGN , and high blood pressure medications .
decongestant drugs	group	Aleve	brand
false

DRUGN may interact with DRUGN , DRUGN s , DRUGA ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGN like DRUGN or DRUGB , and high blood pressure medications .
decongestant drugs	group	Ibuprofen	drug
false

DRUGN may interact with DRUGN , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGA , DRUGB , DRUGN like DRUGN or DRUGN , and high blood pressure medications .
lithium	drug	norepinephrine	drug
false

DRUGN may interact with DRUGN , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGA , DRUGN , DRUGB like DRUGN or DRUGN , and high blood pressure medications .
lithium	drug	NSAIDs	group
false

DRUGN may interact with DRUGN , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGA , DRUGN , DRUGN like DRUGB or DRUGN , and high blood pressure medications .
lithium	drug	Aleve	brand
false

DRUGN may interact with DRUGN , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGA , DRUGN , DRUGN like DRUGN or DRUGB , and high blood pressure medications .
lithium	drug	Ibuprofen	drug
false

DRUGN may interact with DRUGN , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGA , DRUGB like DRUGN or DRUGN , and high blood pressure medications .
norepinephrine	drug	NSAIDs	group
false

DRUGN may interact with DRUGN , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGA , DRUGN like DRUGB or DRUGN , and high blood pressure medications .
norepinephrine	drug	Aleve	brand
false

DRUGN may interact with DRUGN , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGA , DRUGN like DRUGN or DRUGB , and high blood pressure medications .
norepinephrine	drug	Ibuprofen	drug
false

DRUGN may interact with DRUGN , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGA like DRUGB or DRUGN , and high blood pressure medications .
NSAIDs	group	Aleve	brand
false

DRUGN may interact with DRUGN , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGA like DRUGN or DRUGB , and high blood pressure medications .
NSAIDs	group	Ibuprofen	drug
false

DRUGN may interact with DRUGN , DRUGN s , DRUGN ( allergy , cold , and sinus medicines ) , diabetic drugs , DRUGN , DRUGN , DRUGN like DRUGA or DRUGB , and high blood pressure medications .
Aleve	brand	Ibuprofen	drug
false

DRUGA such as DRUGB or DRUGN ;
Antipsychotic drugs	group	phenothiazines	group
false

DRUGA such as DRUGN or DRUGB ;
Antipsychotic drugs	group	haloperidol	drug
false

DRUGN such as DRUGA or DRUGB ;
phenothiazines	group	haloperidol	drug
false

DRUGA : The concomitant use of DRUGB with long and short acting DRUGN has been safely tolerated in patients with stable angina pectoris .
Nitrates	group	Bepridil	drug
false

DRUGA : The concomitant use of DRUGN with long and short acting DRUGB has been safely tolerated in patients with stable angina pectoris .
Nitrates	group	nitrates	group
false

DRUGN : The concomitant use of DRUGA with long and short acting DRUGB has been safely tolerated in patients with stable angina pectoris .
Bepridil	drug	nitrates	group
false

Sublingual DRUGA may be taken if necessary for the control of acute angina attacks during DRUGB therapy .
nitroglycerin	drug	Bepridil	drug
false

DRUGA : The concomitant use of DRUGB and DRUGN has been well tolerated in patients with stable angina .
Beta-blocking Agents	group	Bepridil	drug
false

DRUGA : The concomitant use of DRUGN and DRUGB has been well tolerated in patients with stable angina .
Beta-blocking Agents	group	beta-blocking agents	group
false

DRUGN : The concomitant use of DRUGA and DRUGB has been well tolerated in patients with stable angina .
Bepridil	drug	beta-blocking agents	group
false

DRUGA : In controlled studies in healthy volunteers , DRUGB either had no effect ( one study ) or was associated with modest increases , about dgb % ( two studies ) in steady state serum DRUGN concentrations .
Digoxin	drug	bepridil hydrochloride	drug
false

DRUGA : In controlled studies in healthy volunteers , DRUGN either had no effect ( one study ) or was associated with modest increases , about dgb % ( two studies ) in steady state serum DRUGB concentrations .
Digoxin	drug	digoxin	drug
false

DRUGN : In controlled studies in healthy volunteers , DRUGA either had no effect ( one study ) or was associated with modest increases , about dgb % ( two studies ) in steady state serum DRUGB concentrations .
bepridil hydrochloride	drug	digoxin	drug
mechanism

Limited clinical data in angina patients receiving concomitant DRUGA and DRUGB therapy indicate no discernible changes in serum digoxin levels .
bepridil hydrochloride	drug	digoxin	drug
false

Oral DRUGA : DRUGB has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for DRUGN or oral DRUGN .
Hypoglycemics	group	Bepridil	drug
false

Oral DRUGA : DRUGN has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for DRUGB or oral DRUGN .
Hypoglycemics	group	insulin	drug
false

Oral DRUGA : DRUGN has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for DRUGN or oral DRUGB .
Hypoglycemics	group	hypoglycemic agents	group
false

Oral DRUGN : DRUGA has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for DRUGB or oral DRUGN .
Bepridil	drug	insulin	drug
false

Oral DRUGN : DRUGA has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for DRUGN or oral DRUGB .
Bepridil	drug	hypoglycemic agents	group
false

Oral DRUGN : DRUGN has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for DRUGA or oral DRUGB .
insulin	drug	hypoglycemic agents	group
false

In general , these are drugs that have one or more pharmacologic activities similar to DRUGA , including DRUGB such as DRUGN and DRUGN , DRUGN and DRUGN .
bepridil hydrochloride	drug	anti-arrhythmic agents	group
false

In general , these are drugs that have one or more pharmacologic activities similar to DRUGA , including DRUGN such as DRUGB and DRUGN , DRUGN and DRUGN .
bepridil hydrochloride	drug	quinidine	drug
false

In general , these are drugs that have one or more pharmacologic activities similar to DRUGA , including DRUGN such as DRUGN and DRUGB , DRUGN and DRUGN .
bepridil hydrochloride	drug	procainamide	drug
false

In general , these are drugs that have one or more pharmacologic activities similar to DRUGA , including DRUGN such as DRUGN and DRUGN , DRUGB and DRUGN .
bepridil hydrochloride	drug	cardiac glycosides	group
false

In general , these are drugs that have one or more pharmacologic activities similar to DRUGA , including DRUGN such as DRUGN and DRUGN , DRUGN and DRUGB .
bepridil hydrochloride	drug	tricyclic anti-depressants	group
false

In general , these are drugs that have one or more pharmacologic activities similar to DRUGN , including DRUGA such as DRUGB and DRUGN , DRUGN and DRUGN .
anti-arrhythmic agents	group	quinidine	drug
false

In general , these are drugs that have one or more pharmacologic activities similar to DRUGN , including DRUGA such as DRUGN and DRUGB , DRUGN and DRUGN .
anti-arrhythmic agents	group	procainamide	drug
false

In general , these are drugs that have one or more pharmacologic activities similar to DRUGN , including DRUGA such as DRUGN and DRUGN , DRUGB and DRUGN .
anti-arrhythmic agents	group	cardiac glycosides	group
false

In general , these are drugs that have one or more pharmacologic activities similar to DRUGN , including DRUGA such as DRUGN and DRUGN , DRUGN and DRUGB .
anti-arrhythmic agents	group	tricyclic anti-depressants	group
false

In general , these are drugs that have one or more pharmacologic activities similar to DRUGN , including DRUGN such as DRUGA and DRUGB , DRUGN and DRUGN .
quinidine	drug	procainamide	drug
false

In general , these are drugs that have one or more pharmacologic activities similar to DRUGN , including DRUGN such as DRUGA and DRUGN , DRUGB and DRUGN .
quinidine	drug	cardiac glycosides	group
false

In general , these are drugs that have one or more pharmacologic activities similar to DRUGN , including DRUGN such as DRUGA and DRUGN , DRUGN and DRUGB .
quinidine	drug	tricyclic anti-depressants	group
false

In general , these are drugs that have one or more pharmacologic activities similar to DRUGN , including DRUGN such as DRUGN and DRUGA , DRUGB and DRUGN .
procainamide	drug	cardiac glycosides	group
false

In general , these are drugs that have one or more pharmacologic activities similar to DRUGN , including DRUGN such as DRUGN and DRUGA , DRUGN and DRUGB .
procainamide	drug	tricyclic anti-depressants	group
false

In general , these are drugs that have one or more pharmacologic activities similar to DRUGN , including DRUGN such as DRUGN and DRUGN , DRUGA and DRUGB .
cardiac glycosides	group	tricyclic anti-depressants	group
false

DRUGA and DRUGB could exaggerate the prolongation of the QT interval observed with DRUGN .
Anti-arrhythmics	group	tricyclic anti-depressants	group
false

DRUGA and DRUGN could exaggerate the prolongation of the QT interval observed with DRUGB .
Anti-arrhythmics	group	bepridil hydrochloride	drug
effect

DRUGN and DRUGA could exaggerate the prolongation of the QT interval observed with DRUGB .
tricyclic anti-depressants	group	bepridil hydrochloride	drug
effect

DRUGA could exaggerate the depression of AV nodal conduction observed with DRUGB .
Cardiac glycosides	group	bepridil hydrochloride	drug
effect

The following drugs have been coadministered with DRUGA and have not altered its pharmacokinetics : DRUGB , DRUGN , DRUGN , and DRUGN .
Kerlone	brand	cimetidine	drug
false

The following drugs have been coadministered with DRUGA and have not altered its pharmacokinetics : DRUGN , DRUGB , DRUGN , and DRUGN .
Kerlone	brand	nifedipine	drug
false

The following drugs have been coadministered with DRUGA and have not altered its pharmacokinetics : DRUGN , DRUGN , DRUGB , and DRUGN .
Kerlone	brand	chlorthalidone	drug
false

The following drugs have been coadministered with DRUGA and have not altered its pharmacokinetics : DRUGN , DRUGN , DRUGN , and DRUGB .
Kerlone	brand	hydrochlorothiazide	drug
false

The following drugs have been coadministered with DRUGN and have not altered its pharmacokinetics : DRUGA , DRUGB , DRUGN , and DRUGN .
cimetidine	drug	nifedipine	drug
false

The following drugs have been coadministered with DRUGN and have not altered its pharmacokinetics : DRUGA , DRUGN , DRUGB , and DRUGN .
cimetidine	drug	chlorthalidone	drug
false

The following drugs have been coadministered with DRUGN and have not altered its pharmacokinetics : DRUGA , DRUGN , DRUGN , and DRUGB .
cimetidine	drug	hydrochlorothiazide	drug
false

The following drugs have been coadministered with DRUGN and have not altered its pharmacokinetics : DRUGN , DRUGA , DRUGB , and DRUGN .
nifedipine	drug	chlorthalidone	drug
false

The following drugs have been coadministered with DRUGN and have not altered its pharmacokinetics : DRUGN , DRUGA , DRUGN , and DRUGB .
nifedipine	drug	hydrochlorothiazide	drug
false

The following drugs have been coadministered with DRUGN and have not altered its pharmacokinetics : DRUGN , DRUGN , DRUGA , and DRUGB .
chlorthalidone	drug	hydrochlorothiazide	drug
false

Concomitant administration of DRUGA with the oral DRUGB DRUGN has been shown not to potentiate the anticoagulant effect of DRUGN .
Kerlone	brand	anticoagulant	group
false

Concomitant administration of DRUGA with the oral DRUGN DRUGB has been shown not to potentiate the anticoagulant effect of DRUGN .
Kerlone	brand	warfarin	drug
false

Concomitant administration of DRUGA with the oral DRUGN DRUGN has been shown not to potentiate the anticoagulant effect of DRUGB .
Kerlone	brand	warfarin	drug
false

Concomitant administration of DRUGN with the oral DRUGA DRUGB has been shown not to potentiate the anticoagulant effect of DRUGN .
anticoagulant	group	warfarin	drug
false

Concomitant administration of DRUGN with the oral DRUGA DRUGN has been shown not to potentiate the anticoagulant effect of DRUGB .
anticoagulant	group	warfarin	drug
false

Catecholamine depleting drugs ( e.g . , DRUGA ) may have an additive effect when given with DRUGB agents .
reserpine	drug	beta-blocking	drug
effect

Should it be decided to discontinue therapy in patients receiving DRUGA and DRUGB concurrently , the DRUGN should be discontinued slowly over several days before the gradual withdrawal of DRUGN .
beta-blockers	group	clonidine	drug
advise

Should it be decided to discontinue therapy in patients receiving DRUGA and DRUGN concurrently , the DRUGB should be discontinued slowly over several days before the gradual withdrawal of DRUGN .
beta-blockers	group	beta-blocker	group
false

Should it be decided to discontinue therapy in patients receiving DRUGA and DRUGN concurrently , the DRUGN should be discontinued slowly over several days before the gradual withdrawal of DRUGB .
beta-blockers	group	clonidine	drug
false

Should it be decided to discontinue therapy in patients receiving DRUGN and DRUGA concurrently , the DRUGB should be discontinued slowly over several days before the gradual withdrawal of DRUGN .
clonidine	drug	beta-blocker	group
false

Should it be decided to discontinue therapy in patients receiving DRUGN and DRUGN concurrently , the DRUGA should be discontinued slowly over several days before the gradual withdrawal of DRUGB .
beta-blocker	group	clonidine	drug
advise

Literature reports suggest that oral DRUGA may be used in combination with DRUGB when heart function is normal , but should be avoided in patients with impaired cardiac function .
calcium antagonists	group	beta-adrenergic blocking agents	group
advise

Hypotension , AV conduction disturbances , and left ventricular failure have been reported in some patients receiving DRUGA when an oral DRUGB was added to the treatment regimen .
beta-adrenergic blocking agents	group	calcium antagonist	group
effect

In Study dgb , patients with colorectal cancer were given DRUGA / DRUGB / DRUGN ( bolus IFL ) with or without DRUGN .
irinotecan	drug	5-FU	drug
false

In Study dgb , patients with colorectal cancer were given DRUGA / DRUGN / DRUGB ( bolus IFL ) with or without DRUGN .
irinotecan	drug	leucovorin	drug
false

In Study dgb , patients with colorectal cancer were given DRUGA / DRUGN / DRUGN ( bolus IFL ) with or without DRUGB .
irinotecan	drug	AVASTIN	brand
false

In Study dgb , patients with colorectal cancer were given DRUGN / DRUGA / DRUGB ( bolus IFL ) with or without DRUGN .
5-FU	drug	leucovorin	drug
false

In Study dgb , patients with colorectal cancer were given DRUGN / DRUGA / DRUGN ( bolus IFL ) with or without DRUGB .
5-FU	drug	AVASTIN	brand
false

In Study dgb , patients with colorectal cancer were given DRUGN / DRUGN / DRUGA ( bolus IFL ) with or without DRUGB .
leucovorin	drug	AVASTIN	brand
false

DRUGA concentrations were similar in patients receiving bolus IFL alone and in combination with DRUGB .
Irinotecan	drug	AVASTIN	brand
false

The concentrations of DRUGA , the active metabolite of DRUGB , were on average dgb % higher in patients receiving bolus IFL in combination with DRUGN when compared with bolus IFL alone .
SN38	drug_n	irinotecan	drug
false

The concentrations of DRUGA , the active metabolite of DRUGN , were on average dgb % higher in patients receiving bolus IFL in combination with DRUGB when compared with bolus IFL alone .
SN38	drug_n	AVASTIN	brand
false

The concentrations of DRUGN , the active metabolite of DRUGA , were on average dgb % higher in patients receiving bolus IFL in combination with DRUGB when compared with bolus IFL alone .
irinotecan	drug	AVASTIN	brand
false

Due to high inter patient variability and limited sampling , the extent of the increase in DRUGA levels in patients receiving concurrent DRUGB and DRUGN is uncertain .
SN38	drug_n	irinotecan	drug
false

Due to high inter patient variability and limited sampling , the extent of the increase in DRUGA levels in patients receiving concurrent DRUGN and DRUGB is uncertain .
SN38	drug_n	AVASTIN	brand
false

Due to high inter patient variability and limited sampling , the extent of the increase in DRUGN levels in patients receiving concurrent DRUGA and DRUGB is uncertain .
irinotecan	drug	AVASTIN	brand
false

Furthermore , DRUGA , DRUGB , DRUGN , and other inducers of cytochrome Pdgb dgbAdgb may cause a reduction in plasma DRUGN concentrations .
rifampin	drug	phenytoin	drug
false

Furthermore , DRUGA , DRUGN , DRUGB , and other inducers of cytochrome Pdgb dgbAdgb may cause a reduction in plasma DRUGN concentrations .
rifampin	drug	phenobarbital	drug
false

Furthermore , DRUGA , DRUGN , DRUGN , and other inducers of cytochrome Pdgb dgbAdgb may cause a reduction in plasma DRUGB concentrations .
rifampin	drug	bexarotene	drug
mechanism

Furthermore , DRUGN , DRUGA , DRUGB , and other inducers of cytochrome Pdgb dgbAdgb may cause a reduction in plasma DRUGN concentrations .
phenytoin	drug	phenobarbital	drug
false

Furthermore , DRUGN , DRUGA , DRUGN , and other inducers of cytochrome Pdgb dgbAdgb may cause a reduction in plasma DRUGB concentrations .
phenytoin	drug	bexarotene	drug
mechanism

Furthermore , DRUGN , DRUGN , DRUGA , and other inducers of cytochrome Pdgb dgbAdgb may cause a reduction in plasma DRUGB concentrations .
phenobarbital	drug	bexarotene	drug
mechanism

Concomitant administration of DRUGA capsules and DRUGB resulted in substantial increases in plasma concentrations of DRUGN , probably at least partially related to cytochrome Pdgb dgbAdgb inhibition by DRUGN .
Targretin	brand	gemfibrozil	drug
mechanism

Concomitant administration of DRUGA capsules and DRUGN resulted in substantial increases in plasma concentrations of DRUGB , probably at least partially related to cytochrome Pdgb dgbAdgb inhibition by DRUGN .
Targretin	brand	bexarotene	drug
false

Concomitant administration of DRUGA capsules and DRUGN resulted in substantial increases in plasma concentrations of DRUGN , probably at least partially related to cytochrome Pdgb dgbAdgb inhibition by DRUGB .
Targretin	brand	gemfibrozil	drug
false

Concomitant administration of DRUGN capsules and DRUGA resulted in substantial increases in plasma concentrations of DRUGB , probably at least partially related to cytochrome Pdgb dgbAdgb inhibition by DRUGN .
gemfibrozil	drug	bexarotene	drug
false

Concomitant administration of DRUGN capsules and DRUGN resulted in substantial increases in plasma concentrations of DRUGA , probably at least partially related to cytochrome Pdgb dgbAdgb inhibition by DRUGB .
bexarotene	drug	gemfibrozil	drug
false

Under similar conditions , DRUGA concentrations were not affected by concomitant DRUGB administration .
bexarotene	drug	atorvastatin	drug
false

Concomitant administration of DRUGA with DRUGB capsules is not recommended .
gemfibrozil	drug	Targretin	brand
advise

When DRUGA or DRUGB is used at the same time as other medicines or substances the following interactions must be taken into account : DRUGN and DRUGN may enhance the action of DRUGN .
Bezalip	brand	Bezalip retard	brand
false

When DRUGA or DRUGN is used at the same time as other medicines or substances the following interactions must be taken into account : DRUGN and DRUGB may enhance the action of DRUGN .
Bezalip	brand	Bezalip retard	brand
false

When DRUGA or DRUGN is used at the same time as other medicines or substances the following interactions must be taken into account : DRUGN and DRUGN may enhance the action of DRUGB .
Bezalip	brand	anticoagulants of the coumarin type	group
false

When DRUGN or DRUGA is used at the same time as other medicines or substances the following interactions must be taken into account : DRUGB and DRUGN may enhance the action of DRUGN .
Bezalip retard	brand	Bezalip	brand
false

When DRUGN or DRUGA is used at the same time as other medicines or substances the following interactions must be taken into account : DRUGN and DRUGN may enhance the action of DRUGB .
Bezalip retard	brand	anticoagulants of the coumarin type	group
false

When DRUGN or DRUGN is used at the same time as other medicines or substances the following interactions must be taken into account : DRUGA and DRUGB may enhance the action of DRUGN .
Bezalip	brand	Bezalip retard	brand
false

When DRUGN or DRUGN is used at the same time as other medicines or substances the following interactions must be taken into account : DRUGA and DRUGN may enhance the action of DRUGB .
Bezalip	brand	anticoagulants of the coumarin type	group
effect

When DRUGN or DRUGN is used at the same time as other medicines or substances the following interactions must be taken into account : DRUGN and DRUGA may enhance the action of DRUGB .
Bezalip retard	brand	anticoagulants of the coumarin type	group
effect

For this reason , the dose of the DRUGA should be reduced by dgb dgb % at the start of treatment with DRUGB or DRUGN retard and then titrated according to the blood clotting parameters
anticoagulant	drug	Bezalip	brand
advise

For this reason , the dose of the DRUGA should be reduced by dgb dgb % at the start of treatment with DRUGN or DRUGB retard and then titrated according to the blood clotting parameters
anticoagulant	drug	Bezalip	brand
advise

The action of DRUGA and DRUGB may be enhanced by DRUGN or DRUGN .
sulphonylureas	group	insulin	drug
false

The action of DRUGA and DRUGN may be enhanced by DRUGB or DRUGN .
sulphonylureas	group	Bezalip	brand
effect

The action of DRUGA and DRUGN may be enhanced by DRUGN or DRUGB .
sulphonylureas	group	Bezalip retard	brand
effect

The action of DRUGN and DRUGA may be enhanced by DRUGB or DRUGN .
insulin	drug	Bezalip	brand
effect

The action of DRUGN and DRUGA may be enhanced by DRUGN or DRUGB .
insulin	drug	Bezalip retard	brand
effect

The action of DRUGN and DRUGN may be enhanced by DRUGA or DRUGB .
Bezalip	brand	Bezalip retard	brand
false

In isolated cases , a pronounced though reversible , impairment of renal function ( accompanied by a corresponding increase in the serum creatinine level ) has been reported in organ transplant patients receiving DRUGA therapy and concomitant DRUGB .
immuno-suppressant	group	bezafibrate	drug
effect

When DRUGA or DRUGB is used concurrently with DRUGN ( e.g . DRUGN ) , an interval of at least dgb hours should be maintained between the two medicines , since the absorption of DRUGN or DRUGN is impaired
Bezalip	brand	Bezalip retard	brand
false

When DRUGA or DRUGN is used concurrently with DRUGB ( e.g . DRUGN ) , an interval of at least dgb hours should be maintained between the two medicines , since the absorption of DRUGN or DRUGN is impaired
Bezalip	brand	anion-exchange resins	group
advise

When DRUGA or DRUGN is used concurrently with DRUGN ( e.g . DRUGB ) , an interval of at least dgb hours should be maintained between the two medicines , since the absorption of DRUGN or DRUGN is impaired
Bezalip	brand	cholestryramine	drug
advise

When DRUGA or DRUGN is used concurrently with DRUGN ( e.g . DRUGN ) , an interval of at least dgb hours should be maintained between the two medicines , since the absorption of DRUGN or DRUGB is impaired
Bezalip	brand	Bezalip retard	brand
false

When DRUGN or DRUGA is used concurrently with DRUGB ( e.g . DRUGN ) , an interval of at least dgb hours should be maintained between the two medicines , since the absorption of DRUGN or DRUGN is impaired
Bezalip retard	brand	anion-exchange resins	group
advise

When DRUGN or DRUGA is used concurrently with DRUGN ( e.g . DRUGB ) , an interval of at least dgb hours should be maintained between the two medicines , since the absorption of DRUGN or DRUGN is impaired
Bezalip retard	brand	cholestryramine	drug
advise

When DRUGN or DRUGA is used concurrently with DRUGN ( e.g . DRUGN ) , an interval of at least dgb hours should be maintained between the two medicines , since the absorption of DRUGB or DRUGN is impaired
Bezalip retard	brand	Bezalip	brand
false

When DRUGN or DRUGN is used concurrently with DRUGA ( e.g . DRUGB ) , an interval of at least dgb hours should be maintained between the two medicines , since the absorption of DRUGN or DRUGN is impaired
anion-exchange resins	group	cholestryramine	drug
false

When DRUGN or DRUGN is used concurrently with DRUGA ( e.g . DRUGN ) , an interval of at least dgb hours should be maintained between the two medicines , since the absorption of DRUGB or DRUGN is impaired
anion-exchange resins	group	Bezalip	brand
false

When DRUGN or DRUGN is used concurrently with DRUGA ( e.g . DRUGN ) , an interval of at least dgb hours should be maintained between the two medicines , since the absorption of DRUGN or DRUGB is impaired
anion-exchange resins	group	Bezalip retard	brand
false

When DRUGN or DRUGN is used concurrently with DRUGN ( e.g . DRUGA ) , an interval of at least dgb hours should be maintained between the two medicines , since the absorption of DRUGB or DRUGN is impaired
cholestryramine	drug	Bezalip	brand
false

When DRUGN or DRUGN is used concurrently with DRUGN ( e.g . DRUGA ) , an interval of at least dgb hours should be maintained between the two medicines , since the absorption of DRUGN or DRUGB is impaired
cholestryramine	drug	Bezalip retard	brand
false

When DRUGN or DRUGN is used concurrently with DRUGN ( e.g . DRUGN ) , an interval of at least dgb hours should be maintained between the two medicines , since the absorption of DRUGA or DRUGB is impaired
Bezalip	brand	Bezalip retard	brand
false

DRUGA or DRUGB ( with hepatotoxic potential ) must not be administered together with DRUGN or DRUGN .
Perhexiline hydrogen maleate	drug	MAO-inhibitors	group
false

DRUGA or DRUGN ( with hepatotoxic potential ) must not be administered together with DRUGB or DRUGN .
Perhexiline hydrogen maleate	drug	Bezalip	brand
advise

DRUGA or DRUGN ( with hepatotoxic potential ) must not be administered together with DRUGN or DRUGB .
Perhexiline hydrogen maleate	drug	Bezalip retard	brand
advise

DRUGN or DRUGA ( with hepatotoxic potential ) must not be administered together with DRUGB or DRUGN .
MAO-inhibitors	group	Bezalip	brand
advise

DRUGN or DRUGA ( with hepatotoxic potential ) must not be administered together with DRUGN or DRUGB .
MAO-inhibitors	group	Bezalip retard	brand
advise

DRUGN or DRUGN ( with hepatotoxic potential ) must not be administered together with DRUGA or DRUGB .
Bezalip	brand	Bezalip retard	brand
false

In vitro studies have shown DRUGA can displace DRUGB s , such as DRUGN , from their protein binding sites .
CASODEX	brand	coumarin anticoagulant	group
mechanism

In vitro studies have shown DRUGA can displace DRUGN s , such as DRUGB , from their protein binding sites .
CASODEX	brand	warfarin	drug
false

In vitro studies have shown DRUGN can displace DRUGA s , such as DRUGB , from their protein binding sites .
coumarin anticoagulant	group	warfarin	drug
mechanism

It is recommended that if DRUGA is started in patients already receiving DRUGB , prothrombin times should be closely monitored and adjustment of the DRUGN dose may be necessary .
CASODEX	brand	coumarin anticoagulants	group
advise

It is recommended that if DRUGA is started in patients already receiving DRUGN , prothrombin times should be closely monitored and adjustment of the DRUGB dose may be necessary .
CASODEX	brand	anticoagulant	group
advise

It is recommended that if DRUGN is started in patients already receiving DRUGA , prothrombin times should be closely monitored and adjustment of the DRUGB dose may be necessary .
coumarin anticoagulants	group	anticoagulant	group
false

DRUGA should not be combined with other DRUGB .
ZEBETA	brand	beta-blocking agents	group
advise

Patients receiving catecholamine depleting drugs , such as DRUGA or DRUGB , should be closely monitored , because the added beta adrenergic blocking action of DRUGN may produce excessive reduction of sympathetic activity .
reserpine	drug	guanethidine	drug
false

Patients receiving catecholamine depleting drugs , such as DRUGA or DRUGN , should be closely monitored , because the added beta adrenergic blocking action of DRUGB may produce excessive reduction of sympathetic activity .
reserpine	drug	ZEBETA	brand
effect

Patients receiving catecholamine depleting drugs , such as DRUGN or DRUGA , should be closely monitored , because the added beta adrenergic blocking action of DRUGB may produce excessive reduction of sympathetic activity .
guanethidine	drug	ZEBETA	brand
effect

In patients receiving concurrent therapy with DRUGA , if therapy is to be discontinued , it is suggested that DRUGB be discontinued for several days before the withdrawal of DRUGN .
clonidine	drug	ZEBETA	brand
false

In patients receiving concurrent therapy with DRUGN , if therapy is to be discontinued , it is suggested that DRUGA be discontinued for several days before the withdrawal of DRUGB .
ZEBETA	brand	clonidine	drug
advise

Concurrent use of DRUGA increases the metabolic clearance of DRUGB , resulting in a shortened elimination half life of DRUGN .
rifampin	drug	ZEBETA	brand
mechanism

Concurrent use of DRUGA increases the metabolic clearance of DRUGN , resulting in a shortened elimination half life of DRUGB .
rifampin	drug	ZEBETA	brand
false

Pharmacokinetic studies document no clinically relevant interactions with other agents given concomitantly , including DRUGA , DRUGB , and DRUGN .
thiazide diuretics	group	digoxin	drug
false

Pharmacokinetic studies document no clinically relevant interactions with other agents given concomitantly , including DRUGA , DRUGN , and DRUGB .
thiazide diuretics	group	cimetidine	drug
false

Pharmacokinetic studies document no clinically relevant interactions with other agents given concomitantly , including DRUGN , DRUGA , and DRUGB .
digoxin	drug	cimetidine	drug
false

There was no effect of DRUGA on prothrombin time in patients on stable doses of DRUGB .
ZEBETA	brand	warfarin	drug
false

If you are also using a DRUGA inhaler , take DRUGB first and then wait about dgb minutes before using the DRUGN inhaler .
steroid	group	bitolterol	drug
advise

If you are also using a DRUGN inhaler , take DRUGA first and then wait about dgb minutes before using the DRUGB inhaler .
bitolterol	drug	steroid	group
advise

This allows DRUGA to open air passages , increasing the effectiveness of the DRUGB .
bitolterol	drug	steroid	group
effect

There is no experience with co administration of DRUGA and plasma expanders such as DRUGB .
Angiomax	brand	dextran	drug
false

Among dgb subjects who received DRUGA in clinical trials and were tested for antibodies , dgb subjects had treatment emergent positive DRUGB antibody tests .
Angiomax	brand	bivalirudin	drug
false

Certain DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
antibiotic	group	cisplatin	drug
false

Certain DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
antibiotic	group	cyclosporine	drug
false

Certain DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
antibiotic	group	diuretic	group
false

Certain DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
antibiotic	group	foscarnet	drug
false

Certain DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
antibiotic	group	vaccines	group
false

Certain DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
cisplatin	drug	cyclosporine	drug
false

Certain DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
cisplatin	drug	diuretic	group
false

Certain DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
cisplatin	drug	foscarnet	drug
false

Certain DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
cisplatin	drug	vaccines	group
false

Certain DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
cyclosporine	drug	diuretic	group
false

Certain DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
cyclosporine	drug	foscarnet	drug
false

Certain DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
cyclosporine	drug	vaccines	group
false

Certain DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
diuretic	group	foscarnet	drug
false

Certain DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
diuretic	group	vaccines	group
false

Certain DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
foscarnet	drug	vaccines	group
false

Patients on oral DRUGA receiving DRUGB treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their DRUGN .
antidiabetic agents	group	VELCADE	brand
advise

Patients on oral DRUGA receiving DRUGN treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their DRUGB .
antidiabetic agents	group	antidiabetic medication	group
false

Patients on oral DRUGN receiving DRUGA treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their DRUGB .
VELCADE	brand	antidiabetic medication	group
false

Therefore , DRUGA , including oral , injectable , transdermal , and implantable forms , may not be reliable when DRUGB is co administered .
hormonal contraceptives	group	TRACLEER	brand
effect

Specific interaction studies have demonstrated the following : DRUGA : During the first day of concomitant administration , trough concentrations of DRUGB were increased by about dgb fold .
Cyclosporine A	drug	bosentan	drug
false

Steady state DRUGA plasma concentrations were dgb to dgb fold higher than in the absence of DRUGB .
bosentan	drug	cyclosporine A	drug
mechanism

The concomitant administration of DRUGA and DRUGB is contraindicated .
bosentan	drug	cyclosporine A	drug
advise

Co administration of DRUGA decreased the plasma concentrations of DRUGB ( a CYPdgbAdgb substrate ) by approximately dgb % .
bosentan	drug	cyclosporine A	drug
mechanism

DRUGA : Co administration of DRUGB and DRUGN has not been studied in man .
Tacrolimus	drug	tacrolimus	drug
false

DRUGA : Co administration of DRUGN and DRUGB has not been studied in man .
Tacrolimus	drug	bosentan	drug
false

DRUGN : Co administration of DRUGA and DRUGB has not been studied in man .
tacrolimus	drug	bosentan	drug
false

Co administration of DRUGA and DRUGB resulted in markedly increased plasma concentrations of DRUGN in animals .
tacrolimus	drug	bosentan	drug
mechanism

Co administration of DRUGA and DRUGN resulted in markedly increased plasma concentrations of DRUGB in animals .
tacrolimus	drug	bosentan	drug
false

Caution should be exercised if DRUGA and DRUGB are used together .
tacrolimus	drug	bosentan	drug
advise

DRUGA : An increased risk of elevated liver aminotransferases was observed in patients receiving concomitant therapy with DRUGB .
Glyburide	drug	glyburide	drug
false

Therefore , the concomitant administration of DRUGA and DRUGB is contraindicated , and alternative DRUGN should be considered .
TRACLEER	brand	glyburide	drug
advise

Therefore , the concomitant administration of DRUGA and DRUGN is contraindicated , and alternative DRUGB should be considered .
TRACLEER	brand	hypoglycemic agents	group
false

Therefore , the concomitant administration of DRUGN and DRUGA is contraindicated , and alternative DRUGB should be considered .
glyburide	drug	hypoglycemic agents	group
false

Co administration of DRUGA decreased the plasma concentrations of DRUGB by approximately dgb % .
bosentan	drug	glyburide	drug
mechanism

DRUGA is also expected to reduce plasma concentrations of other oral DRUGB that are predominantly metabolized by CYPdgbCdgb or CYPdgbAdga
Bosentan	drug	hypoglycemic agents	group
mechanism

DRUGA : Co administration of DRUGB dgb mg b.i.d . and DRUGN , a potent CYPdgbAdgb inhibitor , increased the plasma concentrations of DRUGN by approximately dgb fold .
Ketoconazole	drug	bosentan	drug
false

DRUGA : Co administration of DRUGN dgb mg b.i.d . and DRUGB , a potent CYPdgbAdgb inhibitor , increased the plasma concentrations of DRUGN by approximately dgb fold .
Ketoconazole	drug	ketoconazole	drug
false

DRUGA : Co administration of DRUGN dgb mg b.i.d . and DRUGN , a potent CYPdgbAdgb inhibitor , increased the plasma concentrations of DRUGB by approximately dgb fold .
Ketoconazole	drug	bosentan	drug
false

DRUGN : Co administration of DRUGA dgb mg b.i.d . and DRUGB , a potent CYPdgbAdgb inhibitor , increased the plasma concentrations of DRUGN by approximately dgb fold .
bosentan	drug	ketoconazole	drug
mechanism

DRUGN : Co administration of DRUGN dgb mg b.i.d . and DRUGA , a potent CYPdgbAdgb inhibitor , increased the plasma concentrations of DRUGB by approximately dgb fold .
ketoconazole	drug	bosentan	drug
false

DRUGA and Other DRUGB : Co administration of DRUGN decreased the plasma concentrations of DRUGN ( a CYPdgbAdgb substrate ) , and its active hydroxy acid metabolite , by approximately dgb % .
Simvastatin	drug	Statins	group
false

DRUGA and Other DRUGN : Co administration of DRUGB decreased the plasma concentrations of DRUGN ( a CYPdgbAdgb substrate ) , and its active hydroxy acid metabolite , by approximately dgb % .
Simvastatin	drug	bosentan	drug
false

DRUGA and Other DRUGN : Co administration of DRUGN decreased the plasma concentrations of DRUGB ( a CYPdgbAdgb substrate ) , and its active hydroxy acid metabolite , by approximately dgb % .
Simvastatin	drug	simvastatin	drug
false

DRUGN and Other DRUGA : Co administration of DRUGB decreased the plasma concentrations of DRUGN ( a CYPdgbAdgb substrate ) , and its active hydroxy acid metabolite , by approximately dgb % .
Statins	group	bosentan	drug
false

DRUGN and Other DRUGA : Co administration of DRUGN decreased the plasma concentrations of DRUGB ( a CYPdgbAdgb substrate ) , and its active hydroxy acid metabolite , by approximately dgb % .
Statins	group	simvastatin	drug
false

DRUGN and Other DRUGN : Co administration of DRUGA decreased the plasma concentrations of DRUGB ( a CYPdgbAdgb substrate ) , and its active hydroxy acid metabolite , by approximately dgb % .
bosentan	drug	simvastatin	drug
mechanism

DRUGA is also expected to reduce plasma concentrations of other DRUGB that have significant metabolism by CYPdgbAdgb , such as DRUGN and DRUGN .
Bosentan	drug	statins	group
mechanism

DRUGA is also expected to reduce plasma concentrations of other DRUGN that have significant metabolism by CYPdgbAdgb , such as DRUGB and DRUGN .
Bosentan	drug	lovastatin	drug
mechanism

DRUGA is also expected to reduce plasma concentrations of other DRUGN that have significant metabolism by CYPdgbAdgb , such as DRUGN and DRUGB .
Bosentan	drug	atorvastatin	drug
mechanism

DRUGN is also expected to reduce plasma concentrations of other DRUGA that have significant metabolism by CYPdgbAdgb , such as DRUGB and DRUGN .
statins	group	lovastatin	drug
false

DRUGN is also expected to reduce plasma concentrations of other DRUGA that have significant metabolism by CYPdgbAdgb , such as DRUGN and DRUGB .
statins	group	atorvastatin	drug
false

DRUGN is also expected to reduce plasma concentrations of other DRUGN that have significant metabolism by CYPdgbAdgb , such as DRUGA and DRUGB .
lovastatin	drug	atorvastatin	drug
false

Patients using CYPdgbAdgb metabolized DRUGA should have cholesterol levels monitored after DRUGB is initiated to see whether the DRUGN dose needs adjustment .
statins	group	TRACLEER	brand
advise

Patients using CYPdgbAdgb metabolized DRUGA should have cholesterol levels monitored after DRUGN is initiated to see whether the DRUGB dose needs adjustment .
statins	group	statin	group
false

Patients using CYPdgbAdgb metabolized DRUGN should have cholesterol levels monitored after DRUGA is initiated to see whether the DRUGB dose needs adjustment .
TRACLEER	brand	statin	group
false

DRUGA : Co administration of DRUGB dgb mg b.i.d . for dgb days decreased the plasma concentrations of both DRUGN ( a CYPdgbCdgb substrate ) and DRUGN ( a CYPdgbAdgb substrate ) by dgb and dgb % , respectively .
Warfarin	drug	bosentan	drug
false

DRUGA : Co administration of DRUGN dgb mg b.i.d . for dgb days decreased the plasma concentrations of both DRUGB ( a CYPdgbCdgb substrate ) and DRUGN ( a CYPdgbAdgb substrate ) by dgb and dgb % , respectively .
Warfarin	drug	S-warfarin	drug
false

DRUGA : Co administration of DRUGN dgb mg b.i.d . for dgb days decreased the plasma concentrations of both DRUGN ( a CYPdgbCdgb substrate ) and DRUGB ( a CYPdgbAdgb substrate ) by dgb and dgb % , respectively .
Warfarin	drug	R-warfarin	drug
false

DRUGN : Co administration of DRUGA dgb mg b.i.d . for dgb days decreased the plasma concentrations of both DRUGB ( a CYPdgbCdgb substrate ) and DRUGN ( a CYPdgbAdgb substrate ) by dgb and dgb % , respectively .
bosentan	drug	S-warfarin	drug
mechanism

DRUGN : Co administration of DRUGA dgb mg b.i.d . for dgb days decreased the plasma concentrations of both DRUGN ( a CYPdgbCdgb substrate ) and DRUGB ( a CYPdgbAdgb substrate ) by dgb and dgb % , respectively .
bosentan	drug	R-warfarin	drug
mechanism

DRUGN : Co administration of DRUGN dgb mg b.i.d . for dgb days decreased the plasma concentrations of both DRUGA ( a CYPdgbCdgb substrate ) and DRUGB ( a CYPdgbAdgb substrate ) by dgb and dgb % , respectively .
S-warfarin	drug	R-warfarin	drug
false

DRUGA , DRUGB and DRUGN : DRUGN has no significant pharmacokinetic interactions with DRUGN and DRUGN , and DRUGN has no significant effect on plasma levels of DRUGN .
Digoxin	drug	Nimodipine	drug
false

DRUGA , DRUGN and DRUGB : DRUGN has no significant pharmacokinetic interactions with DRUGN and DRUGN , and DRUGN has no significant effect on plasma levels of DRUGN .
Digoxin	drug	Losartan	drug
false

DRUGA , DRUGN and DRUGN : DRUGB has no significant pharmacokinetic interactions with DRUGN and DRUGN , and DRUGN has no significant effect on plasma levels of DRUGN .
Digoxin	drug	Bosentan	drug
false

DRUGA , DRUGN and DRUGN : DRUGN has no significant pharmacokinetic interactions with DRUGB and DRUGN , and DRUGN has no significant effect on plasma levels of DRUGN .
Digoxin	drug	digoxin	drug
false

DRUGA , DRUGN and DRUGN : DRUGN has no significant pharmacokinetic interactions with DRUGN and DRUGB , and DRUGN has no significant effect on plasma levels of DRUGN .
Digoxin	drug	nimodipine	drug
false

DRUGA , DRUGN and DRUGN : DRUGN has no significant pharmacokinetic interactions with DRUGN and DRUGN , and DRUGB has no significant effect on plasma levels of DRUGN .
Digoxin	drug	losartan	drug
false

DRUGA , DRUGN and DRUGN : DRUGN has no significant pharmacokinetic interactions with DRUGN and DRUGN , and DRUGN has no significant effect on plasma levels of DRUGB .
Digoxin	drug	bosentan	drug
false

DRUGN , DRUGA and DRUGB : DRUGN has no significant pharmacokinetic interactions with DRUGN and DRUGN , and DRUGN has no significant effect on plasma levels of DRUGN .
Nimodipine	drug	Losartan	drug
false

DRUGN , DRUGA and DRUGN : DRUGB has no significant pharmacokinetic interactions with DRUGN and DRUGN , and DRUGN has no significant effect on plasma levels of DRUGN .
Nimodipine	drug	Bosentan	drug
false

DRUGN , DRUGA and DRUGN : DRUGN has no significant pharmacokinetic interactions with DRUGB and DRUGN , and DRUGN has no significant effect on plasma levels of DRUGN .
Nimodipine	drug	digoxin	drug
false

DRUGN , DRUGA and DRUGN : DRUGN has no significant pharmacokinetic interactions with DRUGN and DRUGB , and DRUGN has no significant effect on plasma levels of DRUGN .
Nimodipine	drug	nimodipine	drug
false

DRUGN , DRUGA and DRUGN : DRUGN has no significant pharmacokinetic interactions with DRUGN and DRUGN , and DRUGB has no significant effect on plasma levels of DRUGN .
Nimodipine	drug	losartan	drug
false

DRUGN , DRUGA and DRUGN : DRUGN has no significant pharmacokinetic interactions with DRUGN and DRUGN , and DRUGN has no significant effect on plasma levels of DRUGB .
Nimodipine	drug	bosentan	drug
false

DRUGN , DRUGN and DRUGA : DRUGB has no significant pharmacokinetic interactions with DRUGN and DRUGN , and DRUGN has no significant effect on plasma levels of DRUGN .
Losartan	drug	Bosentan	drug
false

DRUGN , DRUGN and DRUGA : DRUGN has no significant pharmacokinetic interactions with DRUGB and DRUGN , and DRUGN has no significant effect on plasma levels of DRUGN .
Losartan	drug	digoxin	drug
false

DRUGN , DRUGN and DRUGA : DRUGN has no significant pharmacokinetic interactions with DRUGN and DRUGB , and DRUGN has no significant effect on plasma levels of DRUGN .
Losartan	drug	nimodipine	drug
false

DRUGN , DRUGN and DRUGA : DRUGN has no significant pharmacokinetic interactions with DRUGN and DRUGN , and DRUGB has no significant effect on plasma levels of DRUGN .
Losartan	drug	losartan	drug
false

DRUGN , DRUGN and DRUGA : DRUGN has no significant pharmacokinetic interactions with DRUGN and DRUGN , and DRUGN has no significant effect on plasma levels of DRUGB .
Losartan	drug	bosentan	drug
false

DRUGN , DRUGN and DRUGN : DRUGA has no significant pharmacokinetic interactions with DRUGB and DRUGN , and DRUGN has no significant effect on plasma levels of DRUGN .
Bosentan	drug	digoxin	drug
false

DRUGN , DRUGN and DRUGN : DRUGA has no significant pharmacokinetic interactions with DRUGN and DRUGB , and DRUGN has no significant effect on plasma levels of DRUGN .
Bosentan	drug	nimodipine	drug
false

DRUGN , DRUGN and DRUGN : DRUGA has no significant pharmacokinetic interactions with DRUGN and DRUGN , and DRUGB has no significant effect on plasma levels of DRUGN .
Bosentan	drug	losartan	drug
false

DRUGN , DRUGN and DRUGN : DRUGA has no significant pharmacokinetic interactions with DRUGN and DRUGN , and DRUGN has no significant effect on plasma levels of DRUGB .
Bosentan	drug	bosentan	drug
false

DRUGN , DRUGN and DRUGN : DRUGN has no significant pharmacokinetic interactions with DRUGA and DRUGB , and DRUGN has no significant effect on plasma levels of DRUGN .
digoxin	drug	nimodipine	drug
false

DRUGN , DRUGN and DRUGN : DRUGN has no significant pharmacokinetic interactions with DRUGA and DRUGN , and DRUGB has no significant effect on plasma levels of DRUGN .
digoxin	drug	losartan	drug
false

DRUGN , DRUGN and DRUGN : DRUGN has no significant pharmacokinetic interactions with DRUGA and DRUGN , and DRUGN has no significant effect on plasma levels of DRUGB .
digoxin	drug	bosentan	drug
false

DRUGN , DRUGN and DRUGN : DRUGN has no significant pharmacokinetic interactions with DRUGN and DRUGA , and DRUGB has no significant effect on plasma levels of DRUGN .
nimodipine	drug	losartan	drug
false

DRUGN , DRUGN and DRUGN : DRUGN has no significant pharmacokinetic interactions with DRUGN and DRUGA , and DRUGN has no significant effect on plasma levels of DRUGB .
nimodipine	drug	bosentan	drug
false

DRUGN , DRUGN and DRUGN : DRUGN has no significant pharmacokinetic interactions with DRUGN and DRUGN , and DRUGA has no significant effect on plasma levels of DRUGB .
losartan	drug	bosentan	drug
false

Co administration of DRUGA and DRUGB or other agents interfering with neuromuscular transmission ( e.g . , DRUGN ) should only be performed with caution as the effect of the DRUGN may be potentiated .
BOTOX	brand	aminoglycosides	group
advise

Co administration of DRUGA and DRUGN or other agents interfering with neuromuscular transmission ( e.g . , DRUGB ) should only be performed with caution as the effect of the DRUGN may be potentiated .
BOTOX	brand	curare-like compounds	group
advise

Co administration of DRUGA and DRUGN or other agents interfering with neuromuscular transmission ( e.g . , DRUGN ) should only be performed with caution as the effect of the DRUGB may be potentiated .
BOTOX	brand	toxin	drug
false

Co administration of DRUGN and DRUGA or other agents interfering with neuromuscular transmission ( e.g . , DRUGB ) should only be performed with caution as the effect of the DRUGN may be potentiated .
aminoglycosides	group	curare-like compounds	group
false

Co administration of DRUGN and DRUGA or other agents interfering with neuromuscular transmission ( e.g . , DRUGN ) should only be performed with caution as the effect of the DRUGB may be potentiated .
aminoglycosides	group	toxin	drug
false

Co administration of DRUGN and DRUGN or other agents interfering with neuromuscular transmission ( e.g . , DRUGA ) should only be performed with caution as the effect of the DRUGB may be potentiated .
curare-like compounds	group	toxin	drug
false

Co administration of DRUGA and DRUGB or other agents interfering with neuromuscular transmission ( e.g . , DRUGN ) should only be performed with caution as the effect of the DRUGN may be potentiated .
MYOBLOC	brand	aminoglycosides	group
advise

Co administration of DRUGA and DRUGN or other agents interfering with neuromuscular transmission ( e.g . , DRUGB ) should only be performed with caution as the effect of the DRUGN may be potentiated .
MYOBLOC	brand	curare-like compounds	group
advise

Co administration of DRUGA and DRUGN or other agents interfering with neuromuscular transmission ( e.g . , DRUGN ) should only be performed with caution as the effect of the DRUGB may be potentiated .
MYOBLOC	brand	toxin	drug
false

Co administration of DRUGN and DRUGA or other agents interfering with neuromuscular transmission ( e.g . , DRUGB ) should only be performed with caution as the effect of the DRUGN may be potentiated .
aminoglycosides	group	curare-like compounds	group
false

Co administration of DRUGN and DRUGA or other agents interfering with neuromuscular transmission ( e.g . , DRUGN ) should only be performed with caution as the effect of the DRUGB may be potentiated .
aminoglycosides	group	toxin	drug
false

Co administration of DRUGN and DRUGN or other agents interfering with neuromuscular transmission ( e.g . , DRUGA ) should only be performed with caution as the effect of the DRUGB may be potentiated .
curare-like compounds	group	toxin	drug
false

DRUGA toxicity may be aggravated by the initial release of norepinephrine caused by DRUGB Injection .
Digitalis	group	Bretylium Tosylate	drug
effect

The pressor effects of DRUGA such as DRUGB or DRUGN are enhanced by DRUGN .
catecholamines	group	dopamine	drug
false

The pressor effects of DRUGA such as DRUGN or DRUGB are enhanced by DRUGN .
catecholamines	group	norepinephrine	drug
false

The pressor effects of DRUGA such as DRUGN or DRUGN are enhanced by DRUGB .
catecholamines	group	Bretylium Tosylate	drug
effect

The pressor effects of DRUGN such as DRUGA or DRUGB are enhanced by DRUGN .
dopamine	drug	norepinephrine	drug
false

The pressor effects of DRUGN such as DRUGA or DRUGN are enhanced by DRUGB .
dopamine	drug	Bretylium Tosylate	drug
effect

The pressor effects of DRUGN such as DRUGN or DRUGA are enhanced by DRUGB .
norepinephrine	drug	Bretylium Tosylate	drug
effect

Although there is little published information on concomitant administration of DRUGA and DRUGB , these drugs are often administered concurrently without any evidence of interactions resulting in adverse effects or diminished efficacy .
lidocaine	drug	Bretylium Tosylate	drug
false

Although specific drug interaction studies have not been conducted with DRUGA , the possibility of an additive or potentiating effect with DRUGB ( DRUGN , DRUGN , DRUGN , DRUGN , or DRUGN ) should be considered .
ALPHAGAN P	brand	CNS depressants	group
advise

Although specific drug interaction studies have not been conducted with DRUGA , the possibility of an additive or potentiating effect with DRUGN ( DRUGB , DRUGN , DRUGN , DRUGN , or DRUGN ) should be considered .
ALPHAGAN P	brand	alcohol	drug
advise

Although specific drug interaction studies have not been conducted with DRUGA , the possibility of an additive or potentiating effect with DRUGN ( DRUGN , DRUGB , DRUGN , DRUGN , or DRUGN ) should be considered .
ALPHAGAN P	brand	barbiturates	group
advise

Although specific drug interaction studies have not been conducted with DRUGA , the possibility of an additive or potentiating effect with DRUGN ( DRUGN , DRUGN , DRUGB , DRUGN , or DRUGN ) should be considered .
ALPHAGAN P	brand	opiates	group
advise

Although specific drug interaction studies have not been conducted with DRUGA , the possibility of an additive or potentiating effect with DRUGN ( DRUGN , DRUGN , DRUGN , DRUGB , or DRUGN ) should be considered .
ALPHAGAN P	brand	sedatives	group
advise

Although specific drug interaction studies have not been conducted with DRUGA , the possibility of an additive or potentiating effect with DRUGN ( DRUGN , DRUGN , DRUGN , DRUGN , or DRUGB ) should be considered .
ALPHAGAN P	brand	anesthetics	group
advise

Although specific drug interaction studies have not been conducted with DRUGN , the possibility of an additive or potentiating effect with DRUGA ( DRUGB , DRUGN , DRUGN , DRUGN , or DRUGN ) should be considered .
CNS depressants	group	alcohol	drug
false

Although specific drug interaction studies have not been conducted with DRUGN , the possibility of an additive or potentiating effect with DRUGA ( DRUGN , DRUGB , DRUGN , DRUGN , or DRUGN ) should be considered .
CNS depressants	group	barbiturates	group
false

Although specific drug interaction studies have not been conducted with DRUGN , the possibility of an additive or potentiating effect with DRUGA ( DRUGN , DRUGN , DRUGB , DRUGN , or DRUGN ) should be considered .
CNS depressants	group	opiates	group
false

Although specific drug interaction studies have not been conducted with DRUGN , the possibility of an additive or potentiating effect with DRUGA ( DRUGN , DRUGN , DRUGN , DRUGB , or DRUGN ) should be considered .
CNS depressants	group	sedatives	group
false

Although specific drug interaction studies have not been conducted with DRUGN , the possibility of an additive or potentiating effect with DRUGA ( DRUGN , DRUGN , DRUGN , DRUGN , or DRUGB ) should be considered .
CNS depressants	group	anesthetics	group
false

Although specific drug interaction studies have not been conducted with DRUGN , the possibility of an additive or potentiating effect with DRUGN ( DRUGA , DRUGB , DRUGN , DRUGN , or DRUGN ) should be considered .
alcohol	drug	barbiturates	group
false

Although specific drug interaction studies have not been conducted with DRUGN , the possibility of an additive or potentiating effect with DRUGN ( DRUGA , DRUGN , DRUGB , DRUGN , or DRUGN ) should be considered .
alcohol	drug	opiates	group
false

Although specific drug interaction studies have not been conducted with DRUGN , the possibility of an additive or potentiating effect with DRUGN ( DRUGA , DRUGN , DRUGN , DRUGB , or DRUGN ) should be considered .
alcohol	drug	sedatives	group
false

Although specific drug interaction studies have not been conducted with DRUGN , the possibility of an additive or potentiating effect with DRUGN ( DRUGA , DRUGN , DRUGN , DRUGN , or DRUGB ) should be considered .
alcohol	drug	anesthetics	group
false

Although specific drug interaction studies have not been conducted with DRUGN , the possibility of an additive or potentiating effect with DRUGN ( DRUGN , DRUGA , DRUGB , DRUGN , or DRUGN ) should be considered .
barbiturates	group	opiates	group
false

Although specific drug interaction studies have not been conducted with DRUGN , the possibility of an additive or potentiating effect with DRUGN ( DRUGN , DRUGA , DRUGN , DRUGB , or DRUGN ) should be considered .
barbiturates	group	sedatives	group
false

Although specific drug interaction studies have not been conducted with DRUGN , the possibility of an additive or potentiating effect with DRUGN ( DRUGN , DRUGA , DRUGN , DRUGN , or DRUGB ) should be considered .
barbiturates	group	anesthetics	group
false

Although specific drug interaction studies have not been conducted with DRUGN , the possibility of an additive or potentiating effect with DRUGN ( DRUGN , DRUGN , DRUGA , DRUGB , or DRUGN ) should be considered .
opiates	group	sedatives	group
false

Although specific drug interaction studies have not been conducted with DRUGN , the possibility of an additive or potentiating effect with DRUGN ( DRUGN , DRUGN , DRUGA , DRUGN , or DRUGB ) should be considered .
opiates	group	anesthetics	group
false

Although specific drug interaction studies have not been conducted with DRUGN , the possibility of an additive or potentiating effect with DRUGN ( DRUGN , DRUGN , DRUGN , DRUGA , or DRUGB ) should be considered .
sedatives	group	anesthetics	group
false

Caution in using concomitant drugs such as DRUGA ( ophthalmic and systemic ) , DRUGB and / or DRUGN is advised .
beta-blockers	group	anti-hypertensives	group
false

Caution in using concomitant drugs such as DRUGA ( ophthalmic and systemic ) , DRUGN and / or DRUGB is advised .
beta-blockers	group	cardiac glycosides	group
false

Caution in using concomitant drugs such as DRUGN ( ophthalmic and systemic ) , DRUGA and / or DRUGB is advised .
anti-hypertensives	group	cardiac glycosides	group
false

DRUGA have been reported to blunt the hypotensive effect of systemic DRUGB .It is not known whether the concurrent use of these agents with DRUGN in humans can lead to resulting interference with the IOP lowering effect .
Tricyclic antidepressants	group	clonidine	drug
effect

DRUGA have been reported to blunt the hypotensive effect of systemic DRUGN .It is not known whether the concurrent use of these agents with DRUGB in humans can lead to resulting interference with the IOP lowering effect .
Tricyclic antidepressants	group	ALPHAGAN P	brand
false

DRUGN have been reported to blunt the hypotensive effect of systemic DRUGA .It is not known whether the concurrent use of these agents with DRUGB in humans can lead to resulting interference with the IOP lowering effect .
clonidine	drug	ALPHAGAN P	brand
false

DRUGA ( DRUGB ophthalmic suspension ) dgb % contains a DRUGN .
AZOPT	brand	brinzolamide	drug
false

DRUGA ( DRUGN ophthalmic suspension ) dgb % contains a DRUGB .
AZOPT	brand	carbonic anhydrase inhibitor	group
false

DRUGN ( DRUGA ophthalmic suspension ) dgb % contains a DRUGB .
brinzolamide	drug	carbonic anhydrase inhibitor	group
false

However , in patients treated with oral DRUGA , rare instances of drug interactions have occurred with high dose DRUGB therapy .
carbonic anhydrase inhibitors	group	salicylate	drug
int

Therefore , the potential for such drug interaction should be considered in patients receiving DRUGA ( DRUGB ophthalmic suspension ) dgb % .
AZOPT	brand	brinzolamide	drug
false

The risk of using DRUGA in combination with other drugs has not been systematically evaluated , but DRUGB may potentiate the side effects of DRUGN .
bromocriptine mesylate	drug	alcohol	drug
false

The risk of using DRUGN in combination with other drugs has not been systematically evaluated , but DRUGA may potentiate the side effects of DRUGB .
alcohol	drug	bromocriptine mesylate	drug
effect

DRUGA may interact with DRUGB , DRUGN , and certain other agents .
Bromocriptine mesylate	drug	dopamine antagonists	group
int

DRUGA may interact with DRUGN , DRUGB , and certain other agents .
Bromocriptine mesylate	drug	butyrophenones	group
int

DRUGN may interact with DRUGA , DRUGB , and certain other agents .
dopamine antagonists	group	butyrophenones	group
false

Compounds in these categories result in a decreased efficacy of DRUGA : DRUGB , DRUGN , DRUGN , DRUGN .
bromocriptine mesylate	drug	phenothiazines	group
effect

Compounds in these categories result in a decreased efficacy of DRUGA : DRUGN , DRUGB , DRUGN , DRUGN .
bromocriptine mesylate	drug	haloperidol	drug
effect

Compounds in these categories result in a decreased efficacy of DRUGA : DRUGN , DRUGN , DRUGB , DRUGN .
bromocriptine mesylate	drug	metoclopramide	drug
effect

Compounds in these categories result in a decreased efficacy of DRUGA : DRUGN , DRUGN , DRUGN , DRUGB .
bromocriptine mesylate	drug	pimozide	drug
effect

Compounds in these categories result in a decreased efficacy of DRUGN : DRUGA , DRUGB , DRUGN , DRUGN .
phenothiazines	group	haloperidol	drug
false

Compounds in these categories result in a decreased efficacy of DRUGN : DRUGA , DRUGN , DRUGB , DRUGN .
phenothiazines	group	metoclopramide	drug
false

Compounds in these categories result in a decreased efficacy of DRUGN : DRUGA , DRUGN , DRUGN , DRUGB .
phenothiazines	group	pimozide	drug
false

Compounds in these categories result in a decreased efficacy of DRUGN : DRUGN , DRUGA , DRUGB , DRUGN .
haloperidol	drug	metoclopramide	drug
false

Compounds in these categories result in a decreased efficacy of DRUGN : DRUGN , DRUGA , DRUGN , DRUGB .
haloperidol	drug	pimozide	drug
false

Compounds in these categories result in a decreased efficacy of DRUGN : DRUGN , DRUGN , DRUGA , DRUGB .
metoclopramide	drug	pimozide	drug
false

Concomitant use of DRUGA with other DRUGB is not recommended .
bromocriptine mesylate	drug	ergot alkaloids	group
advise

Concomitant oral administration of DRUGA ( a known inhibitor of CYPdgbAdgb activity in the liver and in the intestinal mucosa ) caused an eight fold increase of the systemic exposure to oral DRUGB .
ketoconazole	drug	budesonide	drug
mechanism

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , etc . ) is indicated , reduction of the DRUGN dose should be considered .
ketoconazole	drug	intraconazole	drug
false

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , etc . ) is indicated , reduction of the DRUGN dose should be considered .
ketoconazole	drug	ritonavir	drug
false

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , etc . ) is indicated , reduction of the DRUGN dose should be considered .
ketoconazole	drug	indinavir	drug
false

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , etc . ) is indicated , reduction of the DRUGN dose should be considered .
ketoconazole	drug	saquinavir	drug
false

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , etc . ) is indicated , reduction of the DRUGN dose should be considered .
ketoconazole	drug	erythromycin	drug
false

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , etc . ) is indicated , reduction of the DRUGB dose should be considered .
ketoconazole	drug	budesonide	drug
advise

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , etc . ) is indicated , reduction of the DRUGN dose should be considered .
intraconazole	drug	ritonavir	drug
false

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , etc . ) is indicated , reduction of the DRUGN dose should be considered .
intraconazole	drug	indinavir	drug
false

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , etc . ) is indicated , reduction of the DRUGN dose should be considered .
intraconazole	drug	saquinavir	drug
false

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , etc . ) is indicated , reduction of the DRUGN dose should be considered .
intraconazole	drug	erythromycin	drug
false

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , etc . ) is indicated , reduction of the DRUGB dose should be considered .
intraconazole	drug	budesonide	drug
advise

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , etc . ) is indicated , reduction of the DRUGN dose should be considered .
ritonavir	drug	indinavir	drug
false

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , etc . ) is indicated , reduction of the DRUGN dose should be considered .
ritonavir	drug	saquinavir	drug
false

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , etc . ) is indicated , reduction of the DRUGN dose should be considered .
ritonavir	drug	erythromycin	drug
false

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , etc . ) is indicated , reduction of the DRUGB dose should be considered .
ritonavir	drug	budesonide	drug
advise

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , etc . ) is indicated , reduction of the DRUGN dose should be considered .
indinavir	drug	saquinavir	drug
false

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , etc . ) is indicated , reduction of the DRUGN dose should be considered .
indinavir	drug	erythromycin	drug
false

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , etc . ) is indicated , reduction of the DRUGB dose should be considered .
indinavir	drug	budesonide	drug
advise

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , etc . ) is indicated , reduction of the DRUGN dose should be considered .
saquinavir	drug	erythromycin	drug
false

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , etc . ) is indicated , reduction of the DRUGB dose should be considered .
saquinavir	drug	budesonide	drug
advise

If treatment with inhibitors of CYPdgbAdgb activity ( such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , etc . ) is indicated , reduction of the DRUGB dose should be considered .
erythromycin	drug	budesonide	drug
advise

Drugs with ototoxic potential : Especially in the presence of impaired renal function , the use of parenterally administered DRUGA in patients to whom DRUGB are also being given should be avoided , except in life threatening conditions .
bumetanide	drug	aminoglycoside antibiotics	group
advise

DRUGA : DRUGN should generally not be given with DRUGB ( such as DRUGN ) because they reduce its renal clearance and add a high risk of DRUGN toxicity .
Lithium	drug	diuretics	group
false

DRUGA : DRUGN should generally not be given with DRUGN ( such as DRUGB ) because they reduce its renal clearance and add a high risk of DRUGN toxicity .
Lithium	drug	bumetanide	drug
false

DRUGA : DRUGN should generally not be given with DRUGN ( such as DRUGN ) because they reduce its renal clearance and add a high risk of DRUGB toxicity .
Lithium	drug	lithium	drug
false

DRUGN : DRUGA should generally not be given with DRUGB ( such as DRUGN ) because they reduce its renal clearance and add a high risk of DRUGN toxicity .
Lithium	drug	diuretics	group
advise

DRUGN : DRUGA should generally not be given with DRUGN ( such as DRUGB ) because they reduce its renal clearance and add a high risk of DRUGN toxicity .
Lithium	drug	bumetanide	drug
advise

DRUGN : DRUGA should generally not be given with DRUGN ( such as DRUGN ) because they reduce its renal clearance and add a high risk of DRUGB toxicity .
Lithium	drug	lithium	drug
false

DRUGN : DRUGN should generally not be given with DRUGA ( such as DRUGB ) because they reduce its renal clearance and add a high risk of DRUGN toxicity .
diuretics	group	bumetanide	drug
false

DRUGN : DRUGN should generally not be given with DRUGA ( such as DRUGN ) because they reduce its renal clearance and add a high risk of DRUGB toxicity .
diuretics	group	lithium	drug
false

DRUGN : DRUGN should generally not be given with DRUGN ( such as DRUGA ) because they reduce its renal clearance and add a high risk of DRUGB toxicity .
bumetanide	drug	lithium	drug
false

DRUGA : Pretreatment with DRUGB reduces both the natriuresis and hyperreninemia produced by DRUGN .
Probenecid	drug	probenecid	drug
false

DRUGA : Pretreatment with DRUGN reduces both the natriuresis and hyperreninemia produced by DRUGB .
Probenecid	drug	bumetanide	drug
false

DRUGN : Pretreatment with DRUGA reduces both the natriuresis and hyperreninemia produced by DRUGB .
probenecid	drug	bumetanide	drug
effect

This antagonistic effect of DRUGA on DRUGB natriuresis is not due to a direct action on sodium excretion but is probably secondary to its inhibitory effect on renal tubular secretion of DRUGN .
probenecid	drug	bumetanide	drug
mechanism

This antagonistic effect of DRUGA on DRUGN natriuresis is not due to a direct action on sodium excretion but is probably secondary to its inhibitory effect on renal tubular secretion of DRUGB .
probenecid	drug	bumetanide	drug
false

Thus , DRUGA should not be administered concurrently with DRUGB .
probenecid	drug	bumetanide	drug
advise

DRUGA : DRUGN blunts the increases in urine volume and sodium excretion seen during DRUGB treatment and inhibits the DRUGN induced increase in plasma renin activity .
Indomethacin	drug	bumetanide	drug
false

DRUGA : DRUGN blunts the increases in urine volume and sodium excretion seen during DRUGN treatment and inhibits the DRUGB induced increase in plasma renin activity .
Indomethacin	drug	bumetanide	drug
false

DRUGN : DRUGA blunts the increases in urine volume and sodium excretion seen during DRUGB treatment and inhibits the DRUGN induced increase in plasma renin activity .
Indomethacin	drug	bumetanide	drug
mechanism

DRUGN : DRUGA blunts the increases in urine volume and sodium excretion seen during DRUGN treatment and inhibits the DRUGB induced increase in plasma renin activity .
Indomethacin	drug	bumetanide	drug
effect

DRUGA : DRUGB may potentiate the effect of various DRUGN , necessitating a reduction in the dosage of these drugs .
Antihypertensives	group	Bumetanide	drug
false

DRUGA : DRUGN may potentiate the effect of various DRUGB , necessitating a reduction in the dosage of these drugs .
Antihypertensives	group	antihypertensive drugs	group
false

DRUGN : DRUGA may potentiate the effect of various DRUGB , necessitating a reduction in the dosage of these drugs .
Bumetanide	drug	antihypertensive drugs	group
effect

DRUGA : Interaction studies in humans have shown no effect on DRUGB blood levels .
Digoxin	drug	digoxin	drug
false

DRUGA : Interaction studies in humans have shown DRUGB to have no effect on DRUGN metabolism or on plasma prothrombin activity .
Anticoagulants	group	bumetanide	drug
false

DRUGA : Interaction studies in humans have shown DRUGN to have no effect on DRUGB metabolism or on plasma prothrombin activity .
Anticoagulants	group	warfarin	drug
false

DRUGN : Interaction studies in humans have shown DRUGA to have no effect on DRUGB metabolism or on plasma prothrombin activity .
bumetanide	drug	warfarin	drug
false

The administration of local DRUGA containing DRUGB or DRUGN to patients receiving DRUGN or DRUGN may produce severe , prolonged hypertension .
anesthetic solutions	group	epinephrine	drug
false

The administration of local DRUGA containing DRUGN or DRUGB to patients receiving DRUGN or DRUGN may produce severe , prolonged hypertension .
anesthetic solutions	group	norepinephrine	drug
false

The administration of local DRUGA containing DRUGN or DRUGN to patients receiving DRUGB or DRUGN may produce severe , prolonged hypertension .
anesthetic solutions	group	monoamine oxidase inhibitors	group
false

The administration of local DRUGA containing DRUGN or DRUGN to patients receiving DRUGN or DRUGB may produce severe , prolonged hypertension .
anesthetic solutions	group	tricyclic antidepressants	group
false

The administration of local DRUGN containing DRUGA or DRUGB to patients receiving DRUGN or DRUGN may produce severe , prolonged hypertension .
epinephrine	drug	norepinephrine	drug
false

The administration of local DRUGN containing DRUGA or DRUGN to patients receiving DRUGB or DRUGN may produce severe , prolonged hypertension .
epinephrine	drug	monoamine oxidase inhibitors	group
effect

The administration of local DRUGN containing DRUGA or DRUGN to patients receiving DRUGN or DRUGB may produce severe , prolonged hypertension .
epinephrine	drug	tricyclic antidepressants	group
effect

The administration of local DRUGN containing DRUGN or DRUGA to patients receiving DRUGB or DRUGN may produce severe , prolonged hypertension .
norepinephrine	drug	monoamine oxidase inhibitors	group
effect

The administration of local DRUGN containing DRUGN or DRUGA to patients receiving DRUGN or DRUGB may produce severe , prolonged hypertension .
norepinephrine	drug	tricyclic antidepressants	group
effect

The administration of local DRUGN containing DRUGN or DRUGN to patients receiving DRUGA or DRUGB may produce severe , prolonged hypertension .
monoamine oxidase inhibitors	group	tricyclic antidepressants	group
false

Concurrent administration of DRUGA and of DRUGB may cause severe , persistent hypertension or cerebrovascular accidents .
vasopressor drugs	group	ergot-type oxytocic drugs	group
false

DRUGA and DRUGB may reduce or reverse the pressor effect of DRUGN .
Phenothiazines	group	butyrophenones	group
false

DRUGA and DRUGN may reduce or reverse the pressor effect of DRUGB .
Phenothiazines	group	epinephrine	drug
effect

DRUGN and DRUGA may reduce or reverse the pressor effect of DRUGB .
butyrophenones	group	epinephrine	drug
effect

DRUGA is metabolized to DRUGB by cytochrome CYP dgbAdga
Buprenorphine	drug	norbuprenorphine	drug_n
false

Because CYP dgbAdgb inhibitors may increase plasma concentrations of DRUGA , patients already on CYP dgbAdgb inhibitors such as DRUGB ( e.g .
buprenorphine	drug	azole antifungals	group
false

DRUGA ) , DRUGB ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGN , DRUGN and DRUGN ) should have their dose of DRUGN or DRUGN adjusted .
ketoconazole	drug	macrolide antibiotics	group
false

DRUGA ) , DRUGN ( e.g . DRUGB ) , and DRUGN ( e.g . DRUGN , DRUGN and DRUGN ) should have their dose of DRUGN or DRUGN adjusted .
ketoconazole	drug	erythromycin	drug
false

DRUGA ) , DRUGN ( e.g . DRUGN ) , and DRUGB ( e.g . DRUGN , DRUGN and DRUGN ) should have their dose of DRUGN or DRUGN adjusted .
ketoconazole	drug	HIV protease inhibitors	group
false

DRUGA ) , DRUGN ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGB , DRUGN and DRUGN ) should have their dose of DRUGN or DRUGN adjusted .
ketoconazole	drug	ritonavir	drug
false

DRUGA ) , DRUGN ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGN , DRUGB and DRUGN ) should have their dose of DRUGN or DRUGN adjusted .
ketoconazole	drug	indinavir	drug
false

DRUGA ) , DRUGN ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGN , DRUGN and DRUGB ) should have their dose of DRUGN or DRUGN adjusted .
ketoconazole	drug	saquinavir	drug
false

DRUGA ) , DRUGN ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGN , DRUGN and DRUGN ) should have their dose of DRUGB or DRUGN adjusted .
ketoconazole	drug	SUBUTEX	brand
false

DRUGA ) , DRUGN ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGN , DRUGN and DRUGN ) should have their dose of DRUGN or DRUGB adjusted .
ketoconazole	drug	SUBOXONE	brand
false

DRUGN ) , DRUGA ( e.g . DRUGB ) , and DRUGN ( e.g . DRUGN , DRUGN and DRUGN ) should have their dose of DRUGN or DRUGN adjusted .
macrolide antibiotics	group	erythromycin	drug
false

DRUGN ) , DRUGA ( e.g . DRUGN ) , and DRUGB ( e.g . DRUGN , DRUGN and DRUGN ) should have their dose of DRUGN or DRUGN adjusted .
macrolide antibiotics	group	HIV protease inhibitors	group
false

DRUGN ) , DRUGA ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGB , DRUGN and DRUGN ) should have their dose of DRUGN or DRUGN adjusted .
macrolide antibiotics	group	ritonavir	drug
false

DRUGN ) , DRUGA ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGN , DRUGB and DRUGN ) should have their dose of DRUGN or DRUGN adjusted .
macrolide antibiotics	group	indinavir	drug
false

DRUGN ) , DRUGA ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGN , DRUGN and DRUGB ) should have their dose of DRUGN or DRUGN adjusted .
macrolide antibiotics	group	saquinavir	drug
false

DRUGN ) , DRUGA ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGN , DRUGN and DRUGN ) should have their dose of DRUGB or DRUGN adjusted .
macrolide antibiotics	group	SUBUTEX	brand
false

DRUGN ) , DRUGA ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGN , DRUGN and DRUGN ) should have their dose of DRUGN or DRUGB adjusted .
macrolide antibiotics	group	SUBOXONE	brand
false

DRUGN ) , DRUGN ( e.g . DRUGA ) , and DRUGB ( e.g . DRUGN , DRUGN and DRUGN ) should have their dose of DRUGN or DRUGN adjusted .
erythromycin	drug	HIV protease inhibitors	group
false

DRUGN ) , DRUGN ( e.g . DRUGA ) , and DRUGN ( e.g . DRUGB , DRUGN and DRUGN ) should have their dose of DRUGN or DRUGN adjusted .
erythromycin	drug	ritonavir	drug
false

DRUGN ) , DRUGN ( e.g . DRUGA ) , and DRUGN ( e.g . DRUGN , DRUGB and DRUGN ) should have their dose of DRUGN or DRUGN adjusted .
erythromycin	drug	indinavir	drug
false

DRUGN ) , DRUGN ( e.g . DRUGA ) , and DRUGN ( e.g . DRUGN , DRUGN and DRUGB ) should have their dose of DRUGN or DRUGN adjusted .
erythromycin	drug	saquinavir	drug
false

DRUGN ) , DRUGN ( e.g . DRUGA ) , and DRUGN ( e.g . DRUGN , DRUGN and DRUGN ) should have their dose of DRUGB or DRUGN adjusted .
erythromycin	drug	SUBUTEX	brand
false

DRUGN ) , DRUGN ( e.g . DRUGA ) , and DRUGN ( e.g . DRUGN , DRUGN and DRUGN ) should have their dose of DRUGN or DRUGB adjusted .
erythromycin	drug	SUBOXONE	brand
false

DRUGN ) , DRUGN ( e.g . DRUGN ) , and DRUGA ( e.g . DRUGB , DRUGN and DRUGN ) should have their dose of DRUGN or DRUGN adjusted .
HIV protease inhibitors	group	ritonavir	drug
false

DRUGN ) , DRUGN ( e.g . DRUGN ) , and DRUGA ( e.g . DRUGN , DRUGB and DRUGN ) should have their dose of DRUGN or DRUGN adjusted .
HIV protease inhibitors	group	indinavir	drug
false

DRUGN ) , DRUGN ( e.g . DRUGN ) , and DRUGA ( e.g . DRUGN , DRUGN and DRUGB ) should have their dose of DRUGN or DRUGN adjusted .
HIV protease inhibitors	group	saquinavir	drug
false

DRUGN ) , DRUGN ( e.g . DRUGN ) , and DRUGA ( e.g . DRUGN , DRUGN and DRUGN ) should have their dose of DRUGB or DRUGN adjusted .
HIV protease inhibitors	group	SUBUTEX	brand
false

DRUGN ) , DRUGN ( e.g . DRUGN ) , and DRUGA ( e.g . DRUGN , DRUGN and DRUGN ) should have their dose of DRUGN or DRUGB adjusted .
HIV protease inhibitors	group	SUBOXONE	brand
false

DRUGN ) , DRUGN ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGA , DRUGB and DRUGN ) should have their dose of DRUGN or DRUGN adjusted .
ritonavir	drug	indinavir	drug
false

DRUGN ) , DRUGN ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGA , DRUGN and DRUGB ) should have their dose of DRUGN or DRUGN adjusted .
ritonavir	drug	saquinavir	drug
false

DRUGN ) , DRUGN ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGA , DRUGN and DRUGN ) should have their dose of DRUGB or DRUGN adjusted .
ritonavir	drug	SUBUTEX	brand
false

DRUGN ) , DRUGN ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGA , DRUGN and DRUGN ) should have their dose of DRUGN or DRUGB adjusted .
ritonavir	drug	SUBOXONE	brand
false

DRUGN ) , DRUGN ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGN , DRUGA and DRUGB ) should have their dose of DRUGN or DRUGN adjusted .
indinavir	drug	saquinavir	drug
false

DRUGN ) , DRUGN ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGN , DRUGA and DRUGN ) should have their dose of DRUGB or DRUGN adjusted .
indinavir	drug	SUBUTEX	brand
false

DRUGN ) , DRUGN ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGN , DRUGA and DRUGN ) should have their dose of DRUGN or DRUGB adjusted .
indinavir	drug	SUBOXONE	brand
false

DRUGN ) , DRUGN ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGN , DRUGN and DRUGA ) should have their dose of DRUGB or DRUGN adjusted .
saquinavir	drug	SUBUTEX	brand
false

DRUGN ) , DRUGN ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGN , DRUGN and DRUGA ) should have their dose of DRUGN or DRUGB adjusted .
saquinavir	drug	SUBOXONE	brand
false

DRUGN ) , DRUGN ( e.g . DRUGN ) , and DRUGN ( e.g . DRUGN , DRUGN and DRUGN ) should have their dose of DRUGA or DRUGB adjusted .
SUBUTEX	brand	SUBOXONE	brand
false

Based on anecdotal reports , there may be an interaction between DRUGA and DRUGB .
buprenorphine	drug	benzodiazepines	group
int

There have been a number of reports in the post marketing experience of coma and death associated with the concomitant intravenous misuse of DRUGA and DRUGB by addicts .
buprenorphine	drug	benzodiazepines	drug
effect

In many of these cases , DRUGA was misused by self injection of crushed DRUGB tablets .
buprenorphine	drug	SUBUTEX	brand
false

Patients should be warned of the potential danger of the intravenous self administration of DRUGA while under treatment with DRUGB or DRUGN .
benzodiazepines	group	SUBOXONE	brand
advise

Patients should be warned of the potential danger of the intravenous self administration of DRUGA while under treatment with DRUGN or DRUGB .
benzodiazepines	group	SUBUTEX	brand
advise

Patients should be warned of the potential danger of the intravenous self administration of DRUGN while under treatment with DRUGA or DRUGB .
SUBOXONE	brand	SUBUTEX	brand
false

In vitro studies indicate that DRUGA is primarily metabolized to DRUGB by the CYPdgbBdgb isoenzyme .
bupropion	drug	hydroxybupropion	drug_n
false

Therefore , the potential exists for a drug interaction between DRUGA and drugs that affect the CYPdgbBdgb isoenzyme ( e.g . , DRUGB and DRUGN ) .
WELLBUTRIN	brand	orphenadrine	drug
int

Therefore , the potential exists for a drug interaction between DRUGA and drugs that affect the CYPdgbBdgb isoenzyme ( e.g . , DRUGN and DRUGB ) .
WELLBUTRIN	brand	cyclophosphamide	drug
int

Therefore , the potential exists for a drug interaction between DRUGN and drugs that affect the CYPdgbBdgb isoenzyme ( e.g . , DRUGA and DRUGB ) .
orphenadrine	drug	cyclophosphamide	drug
false

The DRUGA metabolite of DRUGB does not appear to be produced by the cytochrome Pdgb isoenzymes .
threohydrobupropion	drug_n	bupropion	drug
false

The effects of concomitant administration of DRUGA on the pharmacokinetics of DRUGB and its active metabolites were studied in dgb healthy young male volunteers .
cimetidine	drug	bupropion	drug
false

Following oral administration of two dgb mg sustained release tablets with and without dgb mg of DRUGA , the pharmacokinetics of DRUGB and DRUGN were unaffected .
cimetidine	drug	bupropion	drug
false

Following oral administration of two dgb mg sustained release tablets with and without dgb mg of DRUGA , the pharmacokinetics of DRUGN and DRUGB were unaffected .
cimetidine	drug	hydroxybupropion	drug_n
false

Following oral administration of two dgb mg sustained release tablets with and without dgb mg of DRUGN , the pharmacokinetics of DRUGA and DRUGB were unaffected .
bupropion	drug	hydroxybupropion	drug_n
false

However , there were dgb % and dgb % increases in the AUC and Cmax , respectively , of the combined moieties of DRUGA and DRUGB .
threohydrobupropion	drug_n	erythrohydrobupropion	drug_n
false

While not systematically studied , certain drugs may induce the metabolism of DRUGA ( e.g . , DRUGB , DRUGN , DRUGN ) .
bupropion	drug	carbamazepine	drug
mechanism

While not systematically studied , certain drugs may induce the metabolism of DRUGA ( e.g . , DRUGN , DRUGB , DRUGN ) .
bupropion	drug	phenobarbital	drug
mechanism

While not systematically studied , certain drugs may induce the metabolism of DRUGA ( e.g . , DRUGN , DRUGN , DRUGB ) .
bupropion	drug	phenytoin	drug
mechanism

While not systematically studied , certain drugs may induce the metabolism of DRUGN ( e.g . , DRUGA , DRUGB , DRUGN ) .
carbamazepine	drug	phenobarbital	drug
false

While not systematically studied , certain drugs may induce the metabolism of DRUGN ( e.g . , DRUGA , DRUGN , DRUGB ) .
carbamazepine	drug	phenytoin	drug
false

While not systematically studied , certain drugs may induce the metabolism of DRUGN ( e.g . , DRUGN , DRUGA , DRUGB ) .
phenobarbital	drug	phenytoin	drug
false

Drugs Metabolized by Cytochrome PdgbIIDdgb ( CYPdgbDdgb ) : Many drugs , including most DRUGA ( SSRIs , many DRUGB ) , DRUGN , DRUGN , and DRUGN are metabolized by the CYPdgbDdgb isoenzyme .
antidepressants	group	tricyclics	group
false

Drugs Metabolized by Cytochrome PdgbIIDdgb ( CYPdgbDdgb ) : Many drugs , including most DRUGA ( SSRIs , many DRUGN ) , DRUGB , DRUGN , and DRUGN are metabolized by the CYPdgbDdgb isoenzyme .
antidepressants	group	beta-blockers	group
false

Drugs Metabolized by Cytochrome PdgbIIDdgb ( CYPdgbDdgb ) : Many drugs , including most DRUGA ( SSRIs , many DRUGN ) , DRUGN , DRUGB , and DRUGN are metabolized by the CYPdgbDdgb isoenzyme .
antidepressants	group	antiarrhythmics	drug
false

Drugs Metabolized by Cytochrome PdgbIIDdgb ( CYPdgbDdgb ) : Many drugs , including most DRUGA ( SSRIs , many DRUGN ) , DRUGN , DRUGN , and DRUGB are metabolized by the CYPdgbDdgb isoenzyme .
antidepressants	group	antipsychotics	group
false

Drugs Metabolized by Cytochrome PdgbIIDdgb ( CYPdgbDdgb ) : Many drugs , including most DRUGN ( SSRIs , many DRUGA ) , DRUGB , DRUGN , and DRUGN are metabolized by the CYPdgbDdgb isoenzyme .
tricyclics	group	beta-blockers	group
false

Drugs Metabolized by Cytochrome PdgbIIDdgb ( CYPdgbDdgb ) : Many drugs , including most DRUGN ( SSRIs , many DRUGA ) , DRUGN , DRUGB , and DRUGN are metabolized by the CYPdgbDdgb isoenzyme .
tricyclics	group	antiarrhythmics	drug
false

Drugs Metabolized by Cytochrome PdgbIIDdgb ( CYPdgbDdgb ) : Many drugs , including most DRUGN ( SSRIs , many DRUGA ) , DRUGN , DRUGN , and DRUGB are metabolized by the CYPdgbDdgb isoenzyme .
tricyclics	group	antipsychotics	group
false

Drugs Metabolized by Cytochrome PdgbIIDdgb ( CYPdgbDdgb ) : Many drugs , including most DRUGN ( SSRIs , many DRUGN ) , DRUGA , DRUGB , and DRUGN are metabolized by the CYPdgbDdgb isoenzyme .
beta-blockers	group	antiarrhythmics	drug
false

Drugs Metabolized by Cytochrome PdgbIIDdgb ( CYPdgbDdgb ) : Many drugs , including most DRUGN ( SSRIs , many DRUGN ) , DRUGA , DRUGN , and DRUGB are metabolized by the CYPdgbDdgb isoenzyme .
beta-blockers	group	antipsychotics	group
false

Drugs Metabolized by Cytochrome PdgbIIDdgb ( CYPdgbDdgb ) : Many drugs , including most DRUGN ( SSRIs , many DRUGN ) , DRUGN , DRUGA , and DRUGB are metabolized by the CYPdgbDdgb isoenzyme .
antiarrhythmics	drug	antipsychotics	group
false

Although DRUGA is not metabolized by this isoenzyme , DRUGN and DRUGB are inhibitors of the CYPdgbDdgb isoenzyme in vitro .
bupropion	drug	hydroxybupropion	drug_n
false

Although DRUGN is not metabolized by this isoenzyme , DRUGA and DRUGB are inhibitors of the CYPdgbDdgb isoenzyme in vitro .
bupropion	drug	hydroxybupropion	drug_n
false

DRUGA : Studies in animals demonstrate that the acute toxicity of DRUGB is enhanced by the DRUGN DRUGN .
MAO Inhibitors	group	bupropion	drug
false

DRUGA : Studies in animals demonstrate that the acute toxicity of DRUGN is enhanced by the DRUGB DRUGN .
MAO Inhibitors	group	MAO inhibitor	group
false

DRUGA : Studies in animals demonstrate that the acute toxicity of DRUGN is enhanced by the DRUGN DRUGB .
MAO Inhibitors	group	phenelzine	drug
false

DRUGN : Studies in animals demonstrate that the acute toxicity of DRUGA is enhanced by the DRUGB DRUGN .
bupropion	drug	MAO inhibitor	group
false

DRUGN : Studies in animals demonstrate that the acute toxicity of DRUGA is enhanced by the DRUGN DRUGB .
bupropion	drug	phenelzine	drug
effect

DRUGN : Studies in animals demonstrate that the acute toxicity of DRUGN is enhanced by the DRUGA DRUGB .
MAO inhibitor	group	phenelzine	drug
false

DRUGA and DRUGB : Limited clinical data suggest a higher incidence of adverse experiences in patients receiving DRUGN concurrently with either DRUGN or DRUGN .
Levodopa	drug	Amantadine	drug
false

DRUGA and DRUGN : Limited clinical data suggest a higher incidence of adverse experiences in patients receiving DRUGB concurrently with either DRUGN or DRUGN .
Levodopa	drug	bupropion	drug
false

DRUGA and DRUGN : Limited clinical data suggest a higher incidence of adverse experiences in patients receiving DRUGN concurrently with either DRUGB or DRUGN .
Levodopa	drug	levodopa	drug
false

DRUGA and DRUGN : Limited clinical data suggest a higher incidence of adverse experiences in patients receiving DRUGN concurrently with either DRUGN or DRUGB .
Levodopa	drug	amantadine	drug
false

DRUGN and DRUGA : Limited clinical data suggest a higher incidence of adverse experiences in patients receiving DRUGB concurrently with either DRUGN or DRUGN .
Amantadine	drug	bupropion	drug
false

DRUGN and DRUGA : Limited clinical data suggest a higher incidence of adverse experiences in patients receiving DRUGN concurrently with either DRUGB or DRUGN .
Amantadine	drug	levodopa	drug
false

DRUGN and DRUGA : Limited clinical data suggest a higher incidence of adverse experiences in patients receiving DRUGN concurrently with either DRUGN or DRUGB .
Amantadine	drug	amantadine	drug
false

DRUGN and DRUGN : Limited clinical data suggest a higher incidence of adverse experiences in patients receiving DRUGA concurrently with either DRUGB or DRUGN .
bupropion	drug	levodopa	drug
effect

DRUGN and DRUGN : Limited clinical data suggest a higher incidence of adverse experiences in patients receiving DRUGA concurrently with either DRUGN or DRUGB .
bupropion	drug	amantadine	drug
effect

DRUGN and DRUGN : Limited clinical data suggest a higher incidence of adverse experiences in patients receiving DRUGN concurrently with either DRUGA or DRUGB .
levodopa	drug	amantadine	drug
false

Administration of DRUGA Tablets to patients receiving either DRUGB or DRUGN concurrently should be undertaken with caution , using small initial doses and small gradual dose increases .
WELLBUTRIN	brand	levodopa	drug
advise

Administration of DRUGA Tablets to patients receiving either DRUGN or DRUGB concurrently should be undertaken with caution , using small initial doses and small gradual dose increases .
WELLBUTRIN	brand	amantadine	drug
advise

Administration of DRUGN Tablets to patients receiving either DRUGA or DRUGB concurrently should be undertaken with caution , using small initial doses and small gradual dose increases .
levodopa	drug	amantadine	drug
false

DRUGA : In post marketing experience , there have been rare reports of adverse neuropsychiatric events or reduced DRUGB tolerance in patients who were drinking DRUGN during treatment with DRUGN .
Alcohol	drug	alcohol	drug
false

DRUGA : In post marketing experience , there have been rare reports of adverse neuropsychiatric events or reduced DRUGN tolerance in patients who were drinking DRUGB during treatment with DRUGN .
Alcohol	drug	alcohol	drug
false

DRUGA : In post marketing experience , there have been rare reports of adverse neuropsychiatric events or reduced DRUGN tolerance in patients who were drinking DRUGN during treatment with DRUGB .
Alcohol	drug	WELLBUTRIN	brand
false

DRUGN : In post marketing experience , there have been rare reports of adverse neuropsychiatric events or reduced DRUGA tolerance in patients who were drinking DRUGN during treatment with DRUGB .
alcohol	drug	WELLBUTRIN	brand
false

DRUGN : In post marketing experience , there have been rare reports of adverse neuropsychiatric events or reduced DRUGN tolerance in patients who were drinking DRUGA during treatment with DRUGB .
alcohol	drug	WELLBUTRIN	brand
effect

The consumption of DRUGA during treatment with DRUGB should be minimized or avoided ( also see a href= bupropz_od.htm # CI CONTRAINDICATIONS )
alcohol	drug	WELLBUTRIN	brand
advise

There is one report suggesting that the concomitant use of DRUGA ( DRUGB ) and DRUGN may have caused dgb to dgb fold elevations on SGPT ( ALT ) in a few patients .
trazodone hydrochloride	drug	Desyrel	brand
false

There is one report suggesting that the concomitant use of DRUGA ( DRUGN ) and DRUGB may have caused dgb to dgb fold elevations on SGPT ( ALT ) in a few patients .
trazodone hydrochloride	drug	buspirone HCl	drug
effect

There is one report suggesting that the concomitant use of DRUGN ( DRUGA ) and DRUGB may have caused dgb to dgb fold elevations on SGPT ( ALT ) in a few patients .
Desyrel	brand	buspirone HCl	drug
effect

In a study in normal volunteers , concomitant administration of DRUGA and DRUGB resulted in increased serum DRUGN concentrations .
buspirone HCl	drug	haloperidol	drug
mechanism

In a study in normal volunteers , concomitant administration of DRUGA and DRUGN resulted in increased serum DRUGB concentrations .
buspirone HCl	drug	haloperidol	drug
false

In vitro , DRUGA does not displace tightly bound drugs like DRUGB , DRUGN , and DRUGN from serum proteins .
buspirone	drug	phenytoin	drug
false

In vitro , DRUGA does not displace tightly bound drugs like DRUGN , DRUGB , and DRUGN from serum proteins .
buspirone	drug	propranolol	drug
false

In vitro , DRUGA does not displace tightly bound drugs like DRUGN , DRUGN , and DRUGB from serum proteins .
buspirone	drug	warfarin	drug
false

In vitro , DRUGN does not displace tightly bound drugs like DRUGA , DRUGB , and DRUGN from serum proteins .
phenytoin	drug	propranolol	drug
false

In vitro , DRUGN does not displace tightly bound drugs like DRUGA , DRUGN , and DRUGB from serum proteins .
phenytoin	drug	warfarin	drug
false

In vitro , DRUGN does not displace tightly bound drugs like DRUGN , DRUGA , and DRUGB from serum proteins .
propranolol	drug	warfarin	drug
false

However , there has been one report of prolonged prothrombin time when DRUGA was added to the regimen of a patient treated with DRUGB .
buspirone	drug	warfarin	drug
effect

The patient was also chronically receiving DRUGA , DRUGB , DRUGN , and DRUGN .
phenytoin	drug	phenobarbital	drug
false

The patient was also chronically receiving DRUGA , DRUGN , DRUGB , and DRUGN .
phenytoin	drug	digoxin	drug
false

The patient was also chronically receiving DRUGA , DRUGN , DRUGN , and DRUGB .
phenytoin	drug	levothyroxine sodium	drug
false

The patient was also chronically receiving DRUGN , DRUGA , DRUGB , and DRUGN .
phenobarbital	drug	digoxin	drug
false

The patient was also chronically receiving DRUGN , DRUGA , DRUGN , and DRUGB .
phenobarbital	drug	levothyroxine sodium	drug
false

The patient was also chronically receiving DRUGN , DRUGN , DRUGA , and DRUGB .
digoxin	drug	levothyroxine sodium	drug
false

In vitro , DRUGA may displace less firmly bound drugs like DRUGB .
buspirone	drug	digoxin	drug
mechanism

DRUGA decreases DRUGB clearance by up to dgb % , and may produce AUCs dgb M min in some patients .
Itraconazole	drug	busulfan	drug
mechanism

DRUGA , and the DRUGB DRUGN ( DRUGN ) and DRUGN ( DRUGN ) have all been used with DRUGN .
Fluconazole	drug	5-HT3 antiemetics	group
false

DRUGA , and the DRUGN DRUGB ( DRUGN ) and DRUGN ( DRUGN ) have all been used with DRUGN .
Fluconazole	drug	ondansetron	drug
false

DRUGA , and the DRUGN DRUGN ( DRUGB ) and DRUGN ( DRUGN ) have all been used with DRUGN .
Fluconazole	drug	Zofran	brand
false

DRUGA , and the DRUGN DRUGN ( DRUGN ) and DRUGB ( DRUGN ) have all been used with DRUGN .
Fluconazole	drug	granisetron	drug
false

DRUGA , and the DRUGN DRUGN ( DRUGN ) and DRUGN ( DRUGB ) have all been used with DRUGN .
Fluconazole	drug	Kytril	brand
false

DRUGA , and the DRUGN DRUGN ( DRUGN ) and DRUGN ( DRUGN ) have all been used with DRUGB .
Fluconazole	drug	BUSULFEX	brand
false

DRUGN , and the DRUGA DRUGB ( DRUGN ) and DRUGN ( DRUGN ) have all been used with DRUGN .
5-HT3 antiemetics	group	ondansetron	drug
false

DRUGN , and the DRUGA DRUGN ( DRUGB ) and DRUGN ( DRUGN ) have all been used with DRUGN .
5-HT3 antiemetics	group	Zofran	brand
false

DRUGN , and the DRUGA DRUGN ( DRUGN ) and DRUGB ( DRUGN ) have all been used with DRUGN .
5-HT3 antiemetics	group	granisetron	drug
false

DRUGN , and the DRUGA DRUGN ( DRUGN ) and DRUGN ( DRUGB ) have all been used with DRUGN .
5-HT3 antiemetics	group	Kytril	brand
false

DRUGN , and the DRUGA DRUGN ( DRUGN ) and DRUGN ( DRUGN ) have all been used with DRUGB .
5-HT3 antiemetics	group	BUSULFEX	brand
false

DRUGN , and the DRUGN DRUGA ( DRUGB ) and DRUGN ( DRUGN ) have all been used with DRUGN .
ondansetron	drug	Zofran	brand
false

DRUGN , and the DRUGN DRUGA ( DRUGN ) and DRUGB ( DRUGN ) have all been used with DRUGN .
ondansetron	drug	granisetron	drug
false

DRUGN , and the DRUGN DRUGA ( DRUGN ) and DRUGN ( DRUGB ) have all been used with DRUGN .
ondansetron	drug	Kytril	brand
false

DRUGN , and the DRUGN DRUGA ( DRUGN ) and DRUGN ( DRUGN ) have all been used with DRUGB .
ondansetron	drug	BUSULFEX	brand
false

DRUGN , and the DRUGN DRUGN ( DRUGA ) and DRUGB ( DRUGN ) have all been used with DRUGN .
Zofran	brand	granisetron	drug
false

DRUGN , and the DRUGN DRUGN ( DRUGA ) and DRUGN ( DRUGB ) have all been used with DRUGN .
Zofran	brand	Kytril	brand
false

DRUGN , and the DRUGN DRUGN ( DRUGA ) and DRUGN ( DRUGN ) have all been used with DRUGB .
Zofran	brand	BUSULFEX	brand
false

DRUGN , and the DRUGN DRUGN ( DRUGN ) and DRUGA ( DRUGB ) have all been used with DRUGN .
granisetron	drug	Kytril	brand
false

DRUGN , and the DRUGN DRUGN ( DRUGN ) and DRUGA ( DRUGN ) have all been used with DRUGB .
granisetron	drug	BUSULFEX	brand
false

DRUGN , and the DRUGN DRUGN ( DRUGN ) and DRUGN ( DRUGA ) have all been used with DRUGB .
Kytril	brand	BUSULFEX	brand
false

DRUGA increases the clearance of DRUGB by dgb % or more , possibly due to the induction of glutathione S transferase .
Phenytoin	drug	busulfan	drug
mechanism

Since the pharmacokinetics of DRUGA were studied in patients treated with DRUGB , the clearance of DRUGN at the recommended dose may be lower and exposure ( AUC ) higher in patients not treated with DRUGN .
BUSULFEX	brand	phenytoin	drug
mechanism

Since the pharmacokinetics of DRUGA were studied in patients treated with DRUGN , the clearance of DRUGN at the recommended dose may be lower and exposure ( AUC ) higher in patients not treated with DRUGB .
BUSULFEX	brand	phenytoin	drug
false

Since the pharmacokinetics of DRUGN were studied in patients treated with DRUGA , the clearance of DRUGB at the recommended dose may be lower and exposure ( AUC ) higher in patients not treated with DRUGN .
phenytoin	drug	BUSULFEX	brand
false

Since the pharmacokinetics of DRUGN were studied in patients treated with DRUGN , the clearance of DRUGA at the recommended dose may be lower and exposure ( AUC ) higher in patients not treated with DRUGB .
BUSULFEX	brand	phenytoin	drug
false

The CNS effects of DRUGA may be enhanced by DRUGB .
butalbital	drug	monoamine oxidase (MAO) inhibitors	group
effect

DRUGA , DRUGB and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGN such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
Butalbital	drug	acetaminophen	drug
false

DRUGA , DRUGN and DRUGB may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGN such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
Butalbital	drug	caffeine	drug
false

DRUGA , DRUGN and DRUGN may enhance the effects of : other DRUGB s , DRUGN , general DRUGN , DRUGN such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
Butalbital	drug	narcotic analgesic	group
effect

DRUGA , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGB , general DRUGN , DRUGN such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
Butalbital	drug	alcohol	drug
effect

DRUGA , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGB , DRUGN such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
Butalbital	drug	anesthetics	group
effect

DRUGA , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGB such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
Butalbital	drug	tranquilizers	group
effect

DRUGA , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGN such as DRUGB , DRUGN , or other DRUGN , causing increased CNS depression .
Butalbital	drug	chlordiazepoxide	drug
effect

DRUGA , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGN such as DRUGN , DRUGB , or other DRUGN , causing increased CNS depression .
Butalbital	drug	sedative-hypnotics	group
effect

DRUGA , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGN such as DRUGN , DRUGN , or other DRUGB , causing increased CNS depression .
Butalbital	drug	CNS depressants	group
effect

DRUGN , DRUGA and DRUGB may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGN such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
acetaminophen	drug	caffeine	drug
false

DRUGN , DRUGA and DRUGN may enhance the effects of : other DRUGB s , DRUGN , general DRUGN , DRUGN such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
acetaminophen	drug	narcotic analgesic	group
effect

DRUGN , DRUGA and DRUGN may enhance the effects of : other DRUGN s , DRUGB , general DRUGN , DRUGN such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
acetaminophen	drug	alcohol	drug
effect

DRUGN , DRUGA and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGB , DRUGN such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
acetaminophen	drug	anesthetics	group
effect

DRUGN , DRUGA and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGB such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
acetaminophen	drug	tranquilizers	group
effect

DRUGN , DRUGA and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGN such as DRUGB , DRUGN , or other DRUGN , causing increased CNS depression .
acetaminophen	drug	chlordiazepoxide	drug
effect

DRUGN , DRUGA and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGN such as DRUGN , DRUGB , or other DRUGN , causing increased CNS depression .
acetaminophen	drug	sedative-hypnotics	group
effect

DRUGN , DRUGA and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGN such as DRUGN , DRUGN , or other DRUGB , causing increased CNS depression .
acetaminophen	drug	CNS depressants	group
effect

DRUGN , DRUGN and DRUGA may enhance the effects of : other DRUGB s , DRUGN , general DRUGN , DRUGN such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
caffeine	drug	narcotic analgesic	group
effect

DRUGN , DRUGN and DRUGA may enhance the effects of : other DRUGN s , DRUGB , general DRUGN , DRUGN such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
caffeine	drug	alcohol	drug
effect

DRUGN , DRUGN and DRUGA may enhance the effects of : other DRUGN s , DRUGN , general DRUGB , DRUGN such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
caffeine	drug	anesthetics	group
effect

DRUGN , DRUGN and DRUGA may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGB such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
caffeine	drug	tranquilizers	group
effect

DRUGN , DRUGN and DRUGA may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGN such as DRUGB , DRUGN , or other DRUGN , causing increased CNS depression .
caffeine	drug	chlordiazepoxide	drug
effect

DRUGN , DRUGN and DRUGA may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGN such as DRUGN , DRUGB , or other DRUGN , causing increased CNS depression .
caffeine	drug	sedative-hypnotics	group
effect

DRUGN , DRUGN and DRUGA may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGN such as DRUGN , DRUGN , or other DRUGB , causing increased CNS depression .
caffeine	drug	CNS depressants	group
effect

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGA s , DRUGB , general DRUGN , DRUGN such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
narcotic analgesic	group	alcohol	drug
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGA s , DRUGN , general DRUGB , DRUGN such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
narcotic analgesic	group	anesthetics	group
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGA s , DRUGN , general DRUGN , DRUGB such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
narcotic analgesic	group	tranquilizers	group
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGA s , DRUGN , general DRUGN , DRUGN such as DRUGB , DRUGN , or other DRUGN , causing increased CNS depression .
narcotic analgesic	group	chlordiazepoxide	drug
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGA s , DRUGN , general DRUGN , DRUGN such as DRUGN , DRUGB , or other DRUGN , causing increased CNS depression .
narcotic analgesic	group	sedative-hypnotics	group
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGA s , DRUGN , general DRUGN , DRUGN such as DRUGN , DRUGN , or other DRUGB , causing increased CNS depression .
narcotic analgesic	group	CNS depressants	group
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGA , general DRUGB , DRUGN such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
alcohol	drug	anesthetics	group
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGA , general DRUGN , DRUGB such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
alcohol	drug	tranquilizers	group
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGA , general DRUGN , DRUGN such as DRUGB , DRUGN , or other DRUGN , causing increased CNS depression .
alcohol	drug	chlordiazepoxide	drug
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGA , general DRUGN , DRUGN such as DRUGN , DRUGB , or other DRUGN , causing increased CNS depression .
alcohol	drug	sedative-hypnotics	group
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGA , general DRUGN , DRUGN such as DRUGN , DRUGN , or other DRUGB , causing increased CNS depression .
alcohol	drug	CNS depressants	group
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGA , DRUGB such as DRUGN , DRUGN , or other DRUGN , causing increased CNS depression .
anesthetics	group	tranquilizers	group
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGA , DRUGN such as DRUGB , DRUGN , or other DRUGN , causing increased CNS depression .
anesthetics	group	chlordiazepoxide	drug
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGA , DRUGN such as DRUGN , DRUGB , or other DRUGN , causing increased CNS depression .
anesthetics	group	sedative-hypnotics	group
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGA , DRUGN such as DRUGN , DRUGN , or other DRUGB , causing increased CNS depression .
anesthetics	group	CNS depressants	group
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGA such as DRUGB , DRUGN , or other DRUGN , causing increased CNS depression .
tranquilizers	group	chlordiazepoxide	drug
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGA such as DRUGN , DRUGB , or other DRUGN , causing increased CNS depression .
tranquilizers	group	sedative-hypnotics	group
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGA such as DRUGN , DRUGN , or other DRUGB , causing increased CNS depression .
tranquilizers	group	CNS depressants	group
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGN such as DRUGA , DRUGB , or other DRUGN , causing increased CNS depression .
chlordiazepoxide	drug	sedative-hypnotics	group
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGN such as DRUGA , DRUGN , or other DRUGB , causing increased CNS depression .
chlordiazepoxide	drug	CNS depressants	group
false

DRUGN , DRUGN and DRUGN may enhance the effects of : other DRUGN s , DRUGN , general DRUGN , DRUGN such as DRUGN , DRUGA , or other DRUGB , causing increased CNS depression .
sedative-hypnotics	group	CNS depressants	group
false

Potential drug interactions between DRUGA ( DRUGB cream ) Cream , dgb % , and other drugs have not been systematically evaluated .
Mentax	brand	butenafine HCl	drug
false

Concurrent use of DRUGA with DRUGB ( e.g . , DRUGN , DRUGN , DRUGN , and DRUGN ) may result in increased DRUGN effects .
butorphanol	drug	central nervous system depressants	group
effect

Concurrent use of DRUGA with DRUGN ( e.g . , DRUGB , DRUGN , DRUGN , and DRUGN ) may result in increased DRUGN effects .
butorphanol	drug	alcohol	drug
effect

Concurrent use of DRUGA with DRUGN ( e.g . , DRUGN , DRUGB , DRUGN , and DRUGN ) may result in increased DRUGN effects .
butorphanol	drug	barbiturates	group
effect

Concurrent use of DRUGA with DRUGN ( e.g . , DRUGN , DRUGN , DRUGB , and DRUGN ) may result in increased DRUGN effects .
butorphanol	drug	tranquilizers	group
effect

Concurrent use of DRUGA with DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , and DRUGB ) may result in increased DRUGN effects .
butorphanol	drug	antihistamines	group
effect

Concurrent use of DRUGA with DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , and DRUGN ) may result in increased DRUGB effects .
butorphanol	drug	central nervous system depressant	group
false

Concurrent use of DRUGN with DRUGA ( e.g . , DRUGB , DRUGN , DRUGN , and DRUGN ) may result in increased DRUGN effects .
central nervous system depressants	group	alcohol	drug
false

Concurrent use of DRUGN with DRUGA ( e.g . , DRUGN , DRUGB , DRUGN , and DRUGN ) may result in increased DRUGN effects .
central nervous system depressants	group	barbiturates	group
false

Concurrent use of DRUGN with DRUGA ( e.g . , DRUGN , DRUGN , DRUGB , and DRUGN ) may result in increased DRUGN effects .
central nervous system depressants	group	tranquilizers	group
false

Concurrent use of DRUGN with DRUGA ( e.g . , DRUGN , DRUGN , DRUGN , and DRUGB ) may result in increased DRUGN effects .
central nervous system depressants	group	antihistamines	group
false

Concurrent use of DRUGN with DRUGA ( e.g . , DRUGN , DRUGN , DRUGN , and DRUGN ) may result in increased DRUGB effects .
central nervous system depressants	group	central nervous system depressant	group
false

Concurrent use of DRUGN with DRUGN ( e.g . , DRUGA , DRUGB , DRUGN , and DRUGN ) may result in increased DRUGN effects .
alcohol	drug	barbiturates	group
false

Concurrent use of DRUGN with DRUGN ( e.g . , DRUGA , DRUGN , DRUGB , and DRUGN ) may result in increased DRUGN effects .
alcohol	drug	tranquilizers	group
false

Concurrent use of DRUGN with DRUGN ( e.g . , DRUGA , DRUGN , DRUGN , and DRUGB ) may result in increased DRUGN effects .
alcohol	drug	antihistamines	group
false

Concurrent use of DRUGN with DRUGN ( e.g . , DRUGA , DRUGN , DRUGN , and DRUGN ) may result in increased DRUGB effects .
alcohol	drug	central nervous system depressant	group
false

Concurrent use of DRUGN with DRUGN ( e.g . , DRUGN , DRUGA , DRUGB , and DRUGN ) may result in increased DRUGN effects .
barbiturates	group	tranquilizers	group
false

Concurrent use of DRUGN with DRUGN ( e.g . , DRUGN , DRUGA , DRUGN , and DRUGB ) may result in increased DRUGN effects .
barbiturates	group	antihistamines	group
false

Concurrent use of DRUGN with DRUGN ( e.g . , DRUGN , DRUGA , DRUGN , and DRUGN ) may result in increased DRUGB effects .
barbiturates	group	central nervous system depressant	group
false

Concurrent use of DRUGN with DRUGN ( e.g . , DRUGN , DRUGN , DRUGA , and DRUGB ) may result in increased DRUGN effects .
tranquilizers	group	antihistamines	group
false

Concurrent use of DRUGN with DRUGN ( e.g . , DRUGN , DRUGN , DRUGA , and DRUGN ) may result in increased DRUGB effects .
tranquilizers	group	central nervous system depressant	group
false

Concurrent use of DRUGN with DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , and DRUGA ) may result in increased DRUGB effects .
antihistamines	group	central nervous system depressant	group
false

When used concurrently with such drugs , the dose of DRUGA should be the smallest effective dose and the frequency of dosing reduced as much as possible when administered concomitantly with drugs that potentiate the action of DRUGB .
butorphanol	drug	opioids	group
false

In healthy volunteers , the pharmacokinetics of a dgb mg dose of DRUGA administered as DRUGB were not affected by the coadministration of a single dgb mg subcutaneous dose of DRUGN .
butorphanol	drug	STADOL NS	brand
false

In healthy volunteers , the pharmacokinetics of a dgb mg dose of DRUGA administered as DRUGN were not affected by the coadministration of a single dgb mg subcutaneous dose of DRUGB .
butorphanol	drug	sumatriptan	drug
false

In healthy volunteers , the pharmacokinetics of a dgb mg dose of DRUGN administered as DRUGA were not affected by the coadministration of a single dgb mg subcutaneous dose of DRUGB .
STADOL NS	brand	sumatriptan	drug
false

When the DRUGA was administered dgb minutes after the DRUGB nasal spray , the AUC of DRUGN increased dgb % and Cmax decreased dgb % .
STADOL NS	brand	sumatriptan	drug
mechanism

When the DRUGA was administered dgb minutes after the DRUGN nasal spray , the AUC of DRUGB increased dgb % and Cmax decreased dgb % .
STADOL NS	brand	butorphanol	drug
false

When the DRUGN was administered dgb minutes after the DRUGA nasal spray , the AUC of DRUGB increased dgb % and Cmax decreased dgb % .
sumatriptan	drug	butorphanol	drug
false

In neither case were the pharmacokinetics of DRUGA affected by coadministration with DRUGB .
sumatriptan	drug	STADOL NS	brand
false

These results suggest that the analgesic effect of DRUGA may be diminished when it is administered shortly after DRUGB nasal spray , but by dgb minutes any such reduction in effect should be minimal .
STADOL NS	brand	sumatriptan	drug
effect

The safety of using DRUGA and DRUGB ( DRUGN ) Nasal Spray during the same episode of migraine has not been established .
STADOL NS	brand	IMITREX	brand
false

The safety of using DRUGA and DRUGN ( DRUGB ) Nasal Spray during the same episode of migraine has not been established .
STADOL NS	brand	sumatriptan	drug
false

The safety of using DRUGN and DRUGA ( DRUGB ) Nasal Spray during the same episode of migraine has not been established .
IMITREX	brand	sumatriptan	drug
false

The pharmacokinetics of a dgb mg dose of DRUGA administered as DRUGB were not affected by the coadministration of DRUGN ( dgb mg QID ) .
butorphanol	drug	STADOL NS	brand
false

The pharmacokinetics of a dgb mg dose of DRUGA administered as DRUGN were not affected by the coadministration of DRUGB ( dgb mg QID ) .
butorphanol	drug	cimetidine	drug
false

The pharmacokinetics of a dgb mg dose of DRUGN administered as DRUGA were not affected by the coadministration of DRUGB ( dgb mg QID ) .
STADOL NS	brand	cimetidine	drug
false

Conversely , the administration of DRUGA ( dgb mg DRUGB QID ) did not alter the pharmacokinetics of a dgb mg dose of DRUGN .
STADOL NS	brand	butorphanol	drug
false

Conversely , the administration of DRUGA ( dgb mg DRUGN QID ) did not alter the pharmacokinetics of a dgb mg dose of DRUGB .
STADOL NS	brand	cimetidine	drug
false

Conversely , the administration of DRUGN ( dgb mg DRUGA QID ) did not alter the pharmacokinetics of a dgb mg dose of DRUGB .
butorphanol	drug	cimetidine	drug
false

The fraction of DRUGA absorbed is unaffected by the concomitant administration of a DRUGB ( DRUGN ) , but the rate of absorption is decreased .
STADOL NS	brand	nasal vasoconstrictor	group
false

The fraction of DRUGA absorbed is unaffected by the concomitant administration of a DRUGN ( DRUGB ) , but the rate of absorption is decreased .
STADOL NS	brand	oxymetazoline	drug
false

The fraction of DRUGN absorbed is unaffected by the concomitant administration of a DRUGA ( DRUGB ) , but the rate of absorption is decreased .
nasal vasoconstrictor	group	oxymetazoline	drug
false

Therefore , a slower onset can be anticipated if DRUGA is administered concomitantly with , or immediately following , a DRUGB .
STADOL NS	brand	nasal vasoconstrictor	group
effect

No information is available about the use of DRUGA concurrently with DRUGB .
butorphanol	drug	MAO inhibitors	group
false

DRUGA should not be administered concurrently with Ddgb antagonists , such as DRUGB , DRUGN , DRUGN , or DRUGN .
DOSTINEX	brand	phenothiazines	group
advise

DRUGA should not be administered concurrently with Ddgb antagonists , such as DRUGN , DRUGB , DRUGN , or DRUGN .
DOSTINEX	brand	butyrophenones	group
advise

DRUGA should not be administered concurrently with Ddgb antagonists , such as DRUGN , DRUGN , DRUGB , or DRUGN .
DOSTINEX	brand	thioxanthines	group
advise

DRUGA should not be administered concurrently with Ddgb antagonists , such as DRUGN , DRUGN , DRUGN , or DRUGB .
DOSTINEX	brand	metoclopramide	drug
advise

DRUGN should not be administered concurrently with Ddgb antagonists , such as DRUGA , DRUGB , DRUGN , or DRUGN .
phenothiazines	group	butyrophenones	group
false

DRUGN should not be administered concurrently with Ddgb antagonists , such as DRUGA , DRUGN , DRUGB , or DRUGN .
phenothiazines	group	thioxanthines	group
false

DRUGN should not be administered concurrently with Ddgb antagonists , such as DRUGA , DRUGN , DRUGN , or DRUGB .
phenothiazines	group	metoclopramide	drug
false

DRUGN should not be administered concurrently with Ddgb antagonists , such as DRUGN , DRUGA , DRUGB , or DRUGN .
butyrophenones	group	thioxanthines	group
false

DRUGN should not be administered concurrently with Ddgb antagonists , such as DRUGN , DRUGA , DRUGN , or DRUGB .
butyrophenones	group	metoclopramide	drug
false

DRUGN should not be administered concurrently with Ddgb antagonists , such as DRUGN , DRUGN , DRUGA , or DRUGB .
thioxanthines	group	metoclopramide	drug
false

DRUGA administered concurrently with DRUGB reduced the urine volume in dgb healthy volunteers .
Caffeine	drug	ketoprofen	drug
effect

Interconversion between DRUGA and DRUGB has been reported in preterm neonates .
caffeine	drug	theophylline	drug
false

Interactions for DRUGA ( DRUGB , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
vitamin D analogues	group	Vitamin D2	drug
false

Interactions for DRUGA ( DRUGN , DRUGB , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
vitamin D analogues	group	Vitamin D3	drug
false

Interactions for DRUGA ( DRUGN , DRUGN , DRUGB , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
vitamin D analogues	group	Calcitriol	drug
false

Interactions for DRUGA ( DRUGN , DRUGN , DRUGN , and DRUGB ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
vitamin D analogues	group	Calcidiol	drug
false

Interactions for DRUGA ( DRUGN , DRUGN , DRUGN , and DRUGN ) : DRUGB : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
vitamin D analogues	group	Cholestyramine	drug
false

Interactions for DRUGA ( DRUGN , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGB has been reported to reduce intestinal absorption of DRUGN ;
vitamin D analogues	group	Cholestyramine	drug
false

Interactions for DRUGA ( DRUGN , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
vitamin D analogues	group	fat soluble vitamins	group
false

Interactions for DRUGN ( DRUGA , DRUGB , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D2	drug	Vitamin D3	drug
false

Interactions for DRUGN ( DRUGA , DRUGN , DRUGB , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D2	drug	Calcitriol	drug
false

Interactions for DRUGN ( DRUGA , DRUGN , DRUGN , and DRUGB ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D2	drug	Calcidiol	drug
false

Interactions for DRUGN ( DRUGA , DRUGN , DRUGN , and DRUGN ) : DRUGB : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D2	drug	Cholestyramine	drug
false

Interactions for DRUGN ( DRUGA , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGB has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D2	drug	Cholestyramine	drug
false

Interactions for DRUGN ( DRUGA , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
Vitamin D2	drug	fat soluble vitamins	group
false

Interactions for DRUGN ( DRUGN , DRUGA , DRUGB , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D3	drug	Calcitriol	drug
false

Interactions for DRUGN ( DRUGN , DRUGA , DRUGN , and DRUGB ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D3	drug	Calcidiol	drug
false

Interactions for DRUGN ( DRUGN , DRUGA , DRUGN , and DRUGN ) : DRUGB : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D3	drug	Cholestyramine	drug
false

Interactions for DRUGN ( DRUGN , DRUGA , DRUGN , and DRUGN ) : DRUGN : DRUGB has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D3	drug	Cholestyramine	drug
false

Interactions for DRUGN ( DRUGN , DRUGA , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
Vitamin D3	drug	fat soluble vitamins	group
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGA , and DRUGB ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Calcitriol	drug	Calcidiol	drug
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGA , and DRUGN ) : DRUGB : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Calcitriol	drug	Cholestyramine	drug
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGA , and DRUGN ) : DRUGN : DRUGB has been reported to reduce intestinal absorption of DRUGN ;
Calcitriol	drug	Cholestyramine	drug
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGA , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
Calcitriol	drug	fat soluble vitamins	group
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGN , and DRUGA ) : DRUGB : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Calcidiol	drug	Cholestyramine	drug
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGN , and DRUGA ) : DRUGN : DRUGB has been reported to reduce intestinal absorption of DRUGN ;
Calcidiol	drug	Cholestyramine	drug
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGN , and DRUGA ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
Calcidiol	drug	fat soluble vitamins	group
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGN , and DRUGN ) : DRUGA : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
Cholestyramine	drug	fat soluble vitamins	group
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGA has been reported to reduce intestinal absorption of DRUGB ;
Cholestyramine	drug	fat soluble vitamins	group
mechanism

DRUGA / DRUGB : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenytoin	drug	Phenobarbital	drug
false

DRUGA / DRUGN : The coadministration of DRUGB or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenytoin	drug	phenytoin	drug
false

DRUGA / DRUGN : The coadministration of DRUGN or DRUGB will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenytoin	drug	phenobarbital	drug
false

DRUGA / DRUGN : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGB , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenytoin	drug	vitamin D	group
false

DRUGA / DRUGN : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGB / ergocalcitriol by accelerating metabolism .
Phenytoin	drug	calcitriol	drug
false

DRUGN / DRUGA : The coadministration of DRUGB or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenobarbital	drug	phenytoin	drug
false

DRUGN / DRUGA : The coadministration of DRUGN or DRUGB will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenobarbital	drug	phenobarbital	drug
false

DRUGN / DRUGA : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGB , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenobarbital	drug	vitamin D	group
false

DRUGN / DRUGA : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGB / ergocalcitriol by accelerating metabolism .
Phenobarbital	drug	calcitriol	drug
false

DRUGN / DRUGN : The coadministration of DRUGA or DRUGB will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
phenytoin	drug	phenobarbital	drug
false

DRUGN / DRUGN : The coadministration of DRUGA or DRUGN will not affect plasma concentrations of DRUGB , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
phenytoin	drug	vitamin D	group
false

DRUGN / DRUGN : The coadministration of DRUGA or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGB / ergocalcitriol by accelerating metabolism .
phenytoin	drug	calcitriol	drug
mechanism

DRUGN / DRUGN : The coadministration of DRUGN or DRUGA will not affect plasma concentrations of DRUGB , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
phenobarbital	drug	vitamin D	group
false

DRUGN / DRUGN : The coadministration of DRUGN or DRUGA will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGB / ergocalcitriol by accelerating metabolism .
phenobarbital	drug	calcitriol	drug
mechanism

DRUGN / DRUGN : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGA , but may reduce endogenous plasma levels of DRUGB / ergocalcitriol by accelerating metabolism .
vitamin D	group	calcitriol	drug
false

Since blood level of DRUGA / ergocalcitriol will be reduced , higher doses of DRUGB may be necessary if these drugs are administered simultaneously .
calcitriol	drug	Rocaltrol	brand
false

Some reports have shown that the concomitant administration of DRUGA with DRUGB causes hypercalcemia .
thiazides	group	vitamin D	group
effect

DRUGA : DRUGB dosage must be determined with care in patients undergoing treatment with DRUGN , as hypercalcemia in such patients may precipitate cardiac arrhythmias .
Digitalis	group	Vitamin D	group
false

DRUGA : DRUGN dosage must be determined with care in patients undergoing treatment with DRUGB , as hypercalcemia in such patients may precipitate cardiac arrhythmias .
Digitalis	group	digitalis	group
false

DRUGN : DRUGA dosage must be determined with care in patients undergoing treatment with DRUGB , as hypercalcemia in such patients may precipitate cardiac arrhythmias .
Vitamin D	group	digitalis	group
advise

DRUGA : DRUGN may inhibit both synthetic and catabolic enzymes of DRUGB .
Ketoconazole	drug	vitamin D	group
false

DRUGN : DRUGA may inhibit both synthetic and catabolic enzymes of DRUGB .
Ketoconazole	drug	vitamin D	group
mechanism

However , in vivo drug interaction studies of DRUGA with DRUGB have not been investigated .
ketoconazole	drug	vitamin D	group
false

DRUGA : A relationship of functional antagonism exists between DRUGB , which promote calcium absorption , and DRUGN , which inhibit calcium absorption .
Corticosteroids	group	vitamin D analogues	group
false

DRUGA : A relationship of functional antagonism exists between DRUGN , which promote calcium absorption , and DRUGB , which inhibit calcium absorption .
Corticosteroids	group	corticosteroids	group
false

DRUGN : A relationship of functional antagonism exists between DRUGA , which promote calcium absorption , and DRUGB , which inhibit calcium absorption .
vitamin D analogues	group	corticosteroids	group
mechanism

DRUGA : The coadministration of any of the DRUGB should be avoided as this could create possible additive effects and hypercalcemia .
Vitamin D	group	vitamin D analogues	group
false

DRUGA Supplements : Uncontrolled intake of additional DRUGB containing preparations should be avoided .
Calcium	drug	calcium	drug
false

DRUGA : DRUGN containing preparations ( eg , DRUGB ) may cause hypermagnesemia and should therefore not be taken during therapy with DRUGN by patients on chronic renal dialysis .
Magnesium	drug	antacids	group
false

DRUGA : DRUGN containing preparations ( eg , DRUGN ) may cause hypermagnesemia and should therefore not be taken during therapy with DRUGB by patients on chronic renal dialysis .
Magnesium	drug	vitamin D	group
false

DRUGN : DRUGA containing preparations ( eg , DRUGB ) may cause hypermagnesemia and should therefore not be taken during therapy with DRUGN by patients on chronic renal dialysis .
Magnesium	drug	antacids	group
false

DRUGN : DRUGA containing preparations ( eg , DRUGN ) may cause hypermagnesemia and should therefore not be taken during therapy with DRUGB by patients on chronic renal dialysis .
Magnesium	drug	vitamin D	group
advise

DRUGN : DRUGN containing preparations ( eg , DRUGA ) may cause hypermagnesemia and should therefore not be taken during therapy with DRUGB by patients on chronic renal dialysis .
antacids	group	vitamin D	group
advise

Interactions for DRUGA ( DRUGB , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
vitamin D analogues	group	Vitamin D2	drug
false

Interactions for DRUGA ( DRUGN , DRUGB , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
vitamin D analogues	group	Vitamin D3	drug
false

Interactions for DRUGA ( DRUGN , DRUGN , DRUGB , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
vitamin D analogues	group	Calcitriol	drug
false

Interactions for DRUGA ( DRUGN , DRUGN , DRUGN , and DRUGB ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
vitamin D analogues	group	Calcidiol	drug
false

Interactions for DRUGA ( DRUGN , DRUGN , DRUGN , and DRUGN ) : DRUGB : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
vitamin D analogues	group	Cholestyramine	drug
false

Interactions for DRUGA ( DRUGN , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGB has been reported to reduce intestinal absorption of DRUGN ;
vitamin D analogues	group	Cholestyramine	drug
false

Interactions for DRUGA ( DRUGN , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
vitamin D analogues	group	fat soluble vitamins	group
false

Interactions for DRUGN ( DRUGA , DRUGB , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D2	drug	Vitamin D3	drug
false

Interactions for DRUGN ( DRUGA , DRUGN , DRUGB , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D2	drug	Calcitriol	drug
false

Interactions for DRUGN ( DRUGA , DRUGN , DRUGN , and DRUGB ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D2	drug	Calcidiol	drug
false

Interactions for DRUGN ( DRUGA , DRUGN , DRUGN , and DRUGN ) : DRUGB : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D2	drug	Cholestyramine	drug
false

Interactions for DRUGN ( DRUGA , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGB has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D2	drug	Cholestyramine	drug
false

Interactions for DRUGN ( DRUGA , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
Vitamin D2	drug	fat soluble vitamins	group
false

Interactions for DRUGN ( DRUGN , DRUGA , DRUGB , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D3	drug	Calcitriol	drug
false

Interactions for DRUGN ( DRUGN , DRUGA , DRUGN , and DRUGB ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D3	drug	Calcidiol	drug
false

Interactions for DRUGN ( DRUGN , DRUGA , DRUGN , and DRUGN ) : DRUGB : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D3	drug	Cholestyramine	drug
false

Interactions for DRUGN ( DRUGN , DRUGA , DRUGN , and DRUGN ) : DRUGN : DRUGB has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D3	drug	Cholestyramine	drug
false

Interactions for DRUGN ( DRUGN , DRUGA , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
Vitamin D3	drug	fat soluble vitamins	group
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGA , and DRUGB ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Calcitriol	drug	Calcidiol	drug
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGA , and DRUGN ) : DRUGB : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Calcitriol	drug	Cholestyramine	drug
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGA , and DRUGN ) : DRUGN : DRUGB has been reported to reduce intestinal absorption of DRUGN ;
Calcitriol	drug	Cholestyramine	drug
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGA , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
Calcitriol	drug	fat soluble vitamins	group
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGN , and DRUGA ) : DRUGB : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Calcidiol	drug	Cholestyramine	drug
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGN , and DRUGA ) : DRUGN : DRUGB has been reported to reduce intestinal absorption of DRUGN ;
Calcidiol	drug	Cholestyramine	drug
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGN , and DRUGA ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
Calcidiol	drug	fat soluble vitamins	group
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGN , and DRUGN ) : DRUGA : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
Cholestyramine	drug	fat soluble vitamins	group
false

Interactions for DRUGN ( DRUGN , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGA has been reported to reduce intestinal absorption of DRUGB ;
Cholestyramine	drug	fat soluble vitamins	group
mechanism

DRUGA / DRUGB : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenytoin	drug	Phenobarbital	drug
false

DRUGA / DRUGN : The coadministration of DRUGB or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenytoin	drug	phenytoin	drug
false

DRUGA / DRUGN : The coadministration of DRUGN or DRUGB will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenytoin	drug	phenobarbital	drug
false

DRUGA / DRUGN : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGB , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenytoin	drug	vitamin D	group
false

DRUGA / DRUGN : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGB / ergocalcitriol by accelerating metabolism .
Phenytoin	drug	calcitriol	drug
false

DRUGN / DRUGA : The coadministration of DRUGB or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenobarbital	drug	phenytoin	drug
false

DRUGN / DRUGA : The coadministration of DRUGN or DRUGB will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenobarbital	drug	phenobarbital	drug
false

DRUGN / DRUGA : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGB , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenobarbital	drug	vitamin D	group
false

DRUGN / DRUGA : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGB / ergocalcitriol by accelerating metabolism .
Phenobarbital	drug	calcitriol	drug
false

DRUGN / DRUGN : The coadministration of DRUGA or DRUGB will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
phenytoin	drug	phenobarbital	drug
false

DRUGN / DRUGN : The coadministration of DRUGA or DRUGN will not affect plasma concentrations of DRUGB , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
phenytoin	drug	vitamin D	group
false

DRUGN / DRUGN : The coadministration of DRUGA or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGB / ergocalcitriol by accelerating metabolism .
phenytoin	drug	calcitriol	drug
mechanism

DRUGN / DRUGN : The coadministration of DRUGN or DRUGA will not affect plasma concentrations of DRUGB , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
phenobarbital	drug	vitamin D	group
false

DRUGN / DRUGN : The coadministration of DRUGN or DRUGA will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGB / ergocalcitriol by accelerating metabolism .
phenobarbital	drug	calcitriol	drug
mechanism

DRUGN / DRUGN : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGA , but may reduce endogenous plasma levels of DRUGB / ergocalcitriol by accelerating metabolism .
vitamin D	group	calcitriol	drug
false

Since blood level of DRUGA / ergocalcitriol will be reduced , higher doses of DRUGB may be necessary if these drugs are administered simultaneously .
calcitriol	drug	Rocaltrol	brand
false

DRUGA : DRUGN are known to induce hypercalcemia by the reduction of DRUGB excretion in urine .
Thiazides	group	calcium	drug
false

DRUGN : DRUGA are known to induce hypercalcemia by the reduction of DRUGB excretion in urine .
Thiazides	group	calcium	drug
false

Some reports have shown that the concomitant administration of DRUGA with DRUGB causes hypercalcemia .
thiazides	group	vitamin D	group
effect

DRUGA : DRUGB dosage must be determined with care in patients undergoing treatment with DRUGN , as hypercalcemia in such patients may precipitate cardiac arrhythmias .
Digitalis	group	Vitamin D	group
false

DRUGA : DRUGN dosage must be determined with care in patients undergoing treatment with DRUGB , as hypercalcemia in such patients may precipitate cardiac arrhythmias .
Digitalis	group	digitalis	group
false

DRUGN : DRUGA dosage must be determined with care in patients undergoing treatment with DRUGB , as hypercalcemia in such patients may precipitate cardiac arrhythmias .
Vitamin D	group	digitalis	group
advise

DRUGA : DRUGN may inhibit both synthetic and catabolic enzymes of DRUGB .
Ketoconazole	drug	vitamin D	group
false

DRUGN : DRUGA may inhibit both synthetic and catabolic enzymes of DRUGB .
Ketoconazole	drug	vitamin D	group
mechanism

However , in vivo drug interaction studies of DRUGA with DRUGB have not been investigated .
ketoconazole	drug	vitamin D	group
false

DRUGA : A relationship of functional antagonism exists between DRUGB , which promote calcium absorption , and DRUGN , which inhibit calcium absorption .
Corticosteroids	group	vitamin D analogues	group
false

DRUGA : A relationship of functional antagonism exists between DRUGN , which promote calcium absorption , and DRUGB , which inhibit calcium absorption .
Corticosteroids	group	corticosteroids	group
false

DRUGN : A relationship of functional antagonism exists between DRUGA , which promote calcium absorption , and DRUGB , which inhibit calcium absorption .
vitamin D analogues	group	corticosteroids	group
mechanism

DRUGA : The coadministration of any of the DRUGB should be avoided as this could create possible additive effects and hypercalcemia .
Vitamin D	group	vitamin D analogues	group
false

DRUGA Supplements : Uncontrolled intake of additional DRUGB containing preparations should be avoided .
Calcium	drug	calcium	drug
false

DRUGA : DRUGN containing preparations ( eg , DRUGB ) may cause hypermagnesemia and should therefore not be taken during therapy with DRUGN by patients on chronic renal dialysis .
Magnesium	drug	antacids	group
false

DRUGA : DRUGN containing preparations ( eg , DRUGN ) may cause hypermagnesemia and should therefore not be taken during therapy with DRUGB by patients on chronic renal dialysis .
Magnesium	drug	vitamin D	group
false

DRUGN : DRUGA containing preparations ( eg , DRUGB ) may cause hypermagnesemia and should therefore not be taken during therapy with DRUGN by patients on chronic renal dialysis .
Magnesium	drug	antacids	group
false

DRUGN : DRUGA containing preparations ( eg , DRUGN ) may cause hypermagnesemia and should therefore not be taken during therapy with DRUGB by patients on chronic renal dialysis .
Magnesium	drug	vitamin D	group
advise

DRUGN : DRUGN containing preparations ( eg , DRUGA ) may cause hypermagnesemia and should therefore not be taken during therapy with DRUGB by patients on chronic renal dialysis .
antacids	group	vitamin D	group
advise

Concomitant use with other DRUGA containing medicines ( including DRUGB ) may cause too much DRUGN in the blood or urine , which may increase the chance of side effects .
calcium	drug	antacids	group
false

Concomitant use with other DRUGN containing medicines ( including DRUGA ) may cause too much DRUGB in the blood or urine , which may increase the chance of side effects .
antacids	group	calcium	drug
false

Using DRUGA with DRUGB ( heart medicine ) may cause hypercalcemia ( too much DRUGN in the blood ) , which could increase the chance of developing an irregular heartbeat .
calcium acetate	drug	digitalis glycosides	group
effect

Using DRUGA with DRUGN ( heart medicine ) may cause hypercalcemia ( too much DRUGB in the blood ) , which could increase the chance of developing an irregular heartbeat .
calcium acetate	drug	calcium	drug
false

Using DRUGN with DRUGA ( heart medicine ) may cause hypercalcemia ( too much DRUGB in the blood ) , which could increase the chance of developing an irregular heartbeat .
digitalis glycosides	group	calcium	drug
false

May interact with DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
cefamandole naftate	drug	cephalothin sodium	drug
false

May interact with DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
cefamandole naftate	drug	magnesium sulfate	drug
false

May interact with DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
cefamandole naftate	drug	prednisolone sodium succinate	drug
false

May interact with DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
cefamandole naftate	drug	prochlorperazine edisylate	drug
false

May interact with DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
cephalothin sodium	drug	magnesium sulfate	drug
false

May interact with DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
cephalothin sodium	drug	prednisolone sodium succinate	drug
false

May interact with DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
cephalothin sodium	drug	prochlorperazine edisylate	drug
false

May interact with DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
magnesium sulfate	drug	prednisolone sodium succinate	drug
false

May interact with DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
magnesium sulfate	drug	prochlorperazine edisylate	drug
false

May interact with DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
prednisolone sodium succinate	drug	prochlorperazine edisylate	drug
false

DRUGA Reversible increases in serum DRUGB concentrations and toxicity have been reported during concomitant administration of DRUGN with DRUGN , and with some DRUGN .
Lithium	drug	lithium	drug
false

DRUGA Reversible increases in serum DRUGN concentrations and toxicity have been reported during concomitant administration of DRUGB with DRUGN , and with some DRUGN .
Lithium	drug	lithium	drug
false

DRUGA Reversible increases in serum DRUGN concentrations and toxicity have been reported during concomitant administration of DRUGN with DRUGB , and with some DRUGN .
Lithium	drug	ACE inhibitors	group
false

DRUGA Reversible increases in serum DRUGN concentrations and toxicity have been reported during concomitant administration of DRUGN with DRUGN , and with some DRUGB .
Lithium	drug	angiotensin II receptor antagonists	group
false

DRUGN Reversible increases in serum DRUGA concentrations and toxicity have been reported during concomitant administration of DRUGN with DRUGB , and with some DRUGN .
lithium	drug	ACE inhibitors	group
false

DRUGN Reversible increases in serum DRUGA concentrations and toxicity have been reported during concomitant administration of DRUGN with DRUGN , and with some DRUGB .
lithium	drug	angiotensin II receptor antagonists	group
false

DRUGN Reversible increases in serum DRUGN concentrations and toxicity have been reported during concomitant administration of DRUGA with DRUGB , and with some DRUGN .
lithium	drug	ACE inhibitors	group
mechanism

DRUGN Reversible increases in serum DRUGN concentrations and toxicity have been reported during concomitant administration of DRUGA with DRUGN , and with some DRUGB .
lithium	drug	angiotensin II receptor antagonists	group
mechanism

DRUGN Reversible increases in serum DRUGN concentrations and toxicity have been reported during concomitant administration of DRUGN with DRUGA , and with some DRUGB .
ACE inhibitors	group	angiotensin II receptor antagonists	group
false

An increase in serum DRUGA concentration has been reported during concomitant administration of DRUGN with DRUGB , so careful monitoring of serum DRUGN levels is recommended during concomitant use .
lithium	drug	ATACAND	brand
false

An increase in serum DRUGN concentration has been reported during concomitant administration of DRUGA with DRUGB , so careful monitoring of serum DRUGN levels is recommended during concomitant use .
lithium	drug	ATACAND	brand
mechanism

An increase in serum DRUGN concentration has been reported during concomitant administration of DRUGN with DRUGA , so careful monitoring of serum DRUGB levels is recommended during concomitant use .
ATACAND	brand	lithium	drug
false

DRUGA : The effect of an DRUGB and DRUGN containing DRUGN ( DRUGN ) * on the pharmacokinetics of DRUGN was investigated in dgb cancer patients .
Antacid	group	aluminum hydroxide	drug
false

DRUGA : The effect of an DRUGN and DRUGB containing DRUGN ( DRUGN ) * on the pharmacokinetics of DRUGN was investigated in dgb cancer patients .
Antacid	group	magnesium hydroxide	drug
false

DRUGA : The effect of an DRUGN and DRUGN containing DRUGB ( DRUGN ) * on the pharmacokinetics of DRUGN was investigated in dgb cancer patients .
Antacid	group	antacid	group
false

DRUGA : The effect of an DRUGN and DRUGN containing DRUGN ( DRUGB ) * on the pharmacokinetics of DRUGN was investigated in dgb cancer patients .
Antacid	group	Maalox	brand
false

DRUGA : The effect of an DRUGN and DRUGN containing DRUGN ( DRUGN ) * on the pharmacokinetics of DRUGB was investigated in dgb cancer patients .
Antacid	group	capecitabine	drug
false

DRUGN : The effect of an DRUGA and DRUGB containing DRUGN ( DRUGN ) * on the pharmacokinetics of DRUGN was investigated in dgb cancer patients .
aluminum hydroxide	drug	magnesium hydroxide	drug
false

DRUGN : The effect of an DRUGA and DRUGN containing DRUGB ( DRUGN ) * on the pharmacokinetics of DRUGN was investigated in dgb cancer patients .
aluminum hydroxide	drug	antacid	group
false

DRUGN : The effect of an DRUGA and DRUGN containing DRUGN ( DRUGB ) * on the pharmacokinetics of DRUGN was investigated in dgb cancer patients .
aluminum hydroxide	drug	Maalox	brand
false

DRUGN : The effect of an DRUGA and DRUGN containing DRUGN ( DRUGN ) * on the pharmacokinetics of DRUGB was investigated in dgb cancer patients .
aluminum hydroxide	drug	capecitabine	drug
false

DRUGN : The effect of an DRUGN and DRUGA containing DRUGB ( DRUGN ) * on the pharmacokinetics of DRUGN was investigated in dgb cancer patients .
magnesium hydroxide	drug	antacid	group
false

DRUGN : The effect of an DRUGN and DRUGA containing DRUGN ( DRUGB ) * on the pharmacokinetics of DRUGN was investigated in dgb cancer patients .
magnesium hydroxide	drug	Maalox	brand
false

DRUGN : The effect of an DRUGN and DRUGA containing DRUGN ( DRUGN ) * on the pharmacokinetics of DRUGB was investigated in dgb cancer patients .
magnesium hydroxide	drug	capecitabine	drug
false

DRUGN : The effect of an DRUGN and DRUGN containing DRUGA ( DRUGB ) * on the pharmacokinetics of DRUGN was investigated in dgb cancer patients .
antacid	group	Maalox	brand
false

DRUGN : The effect of an DRUGN and DRUGN containing DRUGA ( DRUGN ) * on the pharmacokinetics of DRUGB was investigated in dgb cancer patients .
antacid	group	capecitabine	drug
false

DRUGN : The effect of an DRUGN and DRUGN containing DRUGN ( DRUGA ) * on the pharmacokinetics of DRUGB was investigated in dgb cancer patients .
Maalox	brand	capecitabine	drug
false

There was a small increase in plasma concentrations of DRUGA and one metabolite ( DRUGB ) ;
capecitabine	drug	5-DFCR	drug_n
false

there was no effect on the dgb major metabolites ( DRUGA , DRUGB and DRUGN ) .
5-DFUR	drug_n	5-FU	drug_n
false

there was no effect on the dgb major metabolites ( DRUGA , DRUGN and DRUGB ) .
5-DFUR	drug_n	FBAL	drug_n
false

there was no effect on the dgb major metabolites ( DRUGN , DRUGA and DRUGB ) .
5-FU	drug_n	FBAL	drug_n
false

DRUGA Altered coagulation parameters and / or bleeding have been reported in patients taking DRUGB concomitantly with DRUGN such as DRUGN and DRUGN .
Coumarin Anticoagulants	group	capecitabine	drug
false

DRUGA Altered coagulation parameters and / or bleeding have been reported in patients taking DRUGN concomitantly with DRUGB such as DRUGN and DRUGN .
Coumarin Anticoagulants	group	coumarin-derivative anticoagulants	group
false

DRUGA Altered coagulation parameters and / or bleeding have been reported in patients taking DRUGN concomitantly with DRUGN such as DRUGB and DRUGN .
Coumarin Anticoagulants	group	warfarin	drug
false

DRUGA Altered coagulation parameters and / or bleeding have been reported in patients taking DRUGN concomitantly with DRUGN such as DRUGN and DRUGB .
Coumarin Anticoagulants	group	phenprocoumon	drug
false

DRUGN Altered coagulation parameters and / or bleeding have been reported in patients taking DRUGA concomitantly with DRUGB such as DRUGN and DRUGN .
capecitabine	drug	coumarin-derivative anticoagulants	group
effect

DRUGN Altered coagulation parameters and / or bleeding have been reported in patients taking DRUGA concomitantly with DRUGN such as DRUGB and DRUGN .
capecitabine	drug	warfarin	drug
false

DRUGN Altered coagulation parameters and / or bleeding have been reported in patients taking DRUGA concomitantly with DRUGN such as DRUGN and DRUGB .
capecitabine	drug	phenprocoumon	drug
effect

DRUGN Altered coagulation parameters and / or bleeding have been reported in patients taking DRUGN concomitantly with DRUGA such as DRUGB and DRUGN .
coumarin-derivative anticoagulants	group	warfarin	drug
false

DRUGN Altered coagulation parameters and / or bleeding have been reported in patients taking DRUGN concomitantly with DRUGA such as DRUGN and DRUGB .
coumarin-derivative anticoagulants	group	phenprocoumon	drug
false

DRUGN Altered coagulation parameters and / or bleeding have been reported in patients taking DRUGN concomitantly with DRUGN such as DRUGA and DRUGB .
warfarin	drug	phenprocoumon	drug
false

Patients taking DRUGA concomitantly with DRUGB should be monitored regularly for alterations in their coagulation parameters ( PT or INR ) .
coumarin-derivative anticoagulants	group	capecitabine	drug
advise

DRUGA : The concentration of DRUGB is increased and its toxicity may be enhanced by DRUGN .
Leucovorin	drug	5-fluorouracil	drug
false

DRUGA : The concentration of DRUGN is increased and its toxicity may be enhanced by DRUGB .
Leucovorin	drug	leucovorin	drug
false

DRUGN : The concentration of DRUGA is increased and its toxicity may be enhanced by DRUGB .
5-fluorouracil	drug	leucovorin	drug
mechanism

Deaths from severe enterocolitis , diarrhea , and dehydration have been reported in elderly patients receiving weekly DRUGA and DRUGB .
leucovorin	drug	fluorouracil	drug
effect

Agents Having Vasodilator Activity : Data on the effect of concomitant use of other DRUGA in patients receiving DRUGB for heart failure are not available ;
vasodilators	group	captopril	drug
false

therefore , DRUGA or other DRUGB ( as used for management of angina ) or other drugs having vasodilator activity should , if possible , be discontinued before starting DRUGN .
nitroglycerin	drug	nitrates	group
false

therefore , DRUGA or other DRUGN ( as used for management of angina ) or other drugs having vasodilator activity should , if possible , be discontinued before starting DRUGB .
nitroglycerin	drug	captopril	drug
advise

therefore , DRUGN or other DRUGA ( as used for management of angina ) or other drugs having vasodilator activity should , if possible , be discontinued before starting DRUGB .
nitrates	group	captopril	drug
advise

Agents Causing Renin Release DRUGA 's effect will be augmented by DRUGB that cause renin release .
Captopril	drug	antihypertensive agents	group
effect

For example , DRUGA ( e.g . , DRUGB ) may activate the renin angiotensin aldosterone system .
diuretics	group	thiazides	group
false

Agents Affecting Sympathetic Activity The sympathetic nervous system may be especially important in supporting blood pressure in patients receiving DRUGA alone or with DRUGB .
captopril	drug	diuretics	group
false

Therefore , agents affecting sympathetic activity ( e.g . , DRUGA or DRUGB ) should be used with caution .
ganglionic blocking agents	group	adrenergic neuron blocking agents	group
false

DRUGA add some further antihypertensive effect to DRUGB , but the overall response is less than additive .
Beta-adrenergic blocking drugs	group	captopril	drug
effect

DRUGA such as DRUGB , DRUGN , or DRUGN , or DRUGN supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
Potassium-sparing diuretics	group	spironolactone	drug
false

DRUGA such as DRUGN , DRUGB , or DRUGN , or DRUGN supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
Potassium-sparing diuretics	group	triamterene	drug
false

DRUGA such as DRUGN , DRUGN , or DRUGB , or DRUGN supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
Potassium-sparing diuretics	group	amiloride	drug
false

DRUGA such as DRUGN , DRUGN , or DRUGN , or DRUGB supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
Potassium-sparing diuretics	group	potassium	drug
false

DRUGN such as DRUGA , DRUGB , or DRUGN , or DRUGN supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
spironolactone	drug	triamterene	drug
false

DRUGN such as DRUGA , DRUGN , or DRUGB , or DRUGN supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
spironolactone	drug	amiloride	drug
false

DRUGN such as DRUGA , DRUGN , or DRUGN , or DRUGB supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
spironolactone	drug	potassium	drug
false

DRUGN such as DRUGN , DRUGA , or DRUGB , or DRUGN supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
triamterene	drug	amiloride	drug
false

DRUGN such as DRUGN , DRUGA , or DRUGN , or DRUGB supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
triamterene	drug	potassium	drug
false

DRUGN such as DRUGN , DRUGN , or DRUGA , or DRUGB supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
amiloride	drug	potassium	drug
false

Inhibitors Of Endogenous Prostaglandin Synthesis It has been reported that DRUGA may reduce the antihypertensive effect of DRUGB , especially in cases of low renin hypertension .
indomethacin	drug	captopril	drug
effect

Other DRUGA ( e.g . , DRUGB ) may also have this effect .
nonsteroidal anti-inflammatory agents	group	aspirin	brand
false

DRUGA : Increased serum DRUGB levels and symptoms of DRUGN toxicity have been reported in patients receiving concomitant DRUGN and DRUGN therapy .
Lithium	drug	lithium	drug
false

DRUGA : Increased serum DRUGN levels and symptoms of DRUGB toxicity have been reported in patients receiving concomitant DRUGN and DRUGN therapy .
Lithium	drug	lithium	drug
false

DRUGA : Increased serum DRUGN levels and symptoms of DRUGN toxicity have been reported in patients receiving concomitant DRUGB and DRUGN therapy .
Lithium	drug	lithium	drug
false

DRUGA : Increased serum DRUGN levels and symptoms of DRUGN toxicity have been reported in patients receiving concomitant DRUGN and DRUGB therapy .
Lithium	drug	ACE inhibitor	group
false

DRUGN : Increased serum DRUGA levels and symptoms of DRUGN toxicity have been reported in patients receiving concomitant DRUGN and DRUGB therapy .
lithium	drug	ACE inhibitor	group
false

DRUGN : Increased serum DRUGN levels and symptoms of DRUGA toxicity have been reported in patients receiving concomitant DRUGN and DRUGB therapy .
lithium	drug	ACE inhibitor	group
false

DRUGN : Increased serum DRUGN levels and symptoms of DRUGN toxicity have been reported in patients receiving concomitant DRUGA and DRUGB therapy .
lithium	drug	ACE inhibitor	group
effect

If a DRUGA is also used , it may increase the risk of DRUGB toxicity .
diuretic	group	lithium	drug
effect

DRUGA : In a study of young healthy male subjects no evidence of a direct pharmacokinetic DRUGB DRUGN interaction could be found .
Cardiac Glycosides	group	captopril	drug
false

DRUGA : In a study of young healthy male subjects no evidence of a direct pharmacokinetic DRUGN DRUGB interaction could be found .
Cardiac Glycosides	group	digoxin	drug
false

DRUGN : In a study of young healthy male subjects no evidence of a direct pharmacokinetic DRUGA DRUGB interaction could be found .
captopril	drug	digoxin	drug
false

DRUGA : DRUGB administered concurrently with DRUGN does not alter the pharmacokinetics of DRUGN in renally impaired hypertensive patients .
Loop Diuretics	group	Furosemide	drug
false

DRUGA : DRUGN administered concurrently with DRUGB does not alter the pharmacokinetics of DRUGN in renally impaired hypertensive patients .
Loop Diuretics	group	captopril	drug
false

DRUGA : DRUGN administered concurrently with DRUGN does not alter the pharmacokinetics of DRUGB in renally impaired hypertensive patients .
Loop Diuretics	group	captopril	drug
false

DRUGN : DRUGA administered concurrently with DRUGB does not alter the pharmacokinetics of DRUGN in renally impaired hypertensive patients .
Furosemide	drug	captopril	drug
false

DRUGN : DRUGA administered concurrently with DRUGN does not alter the pharmacokinetics of DRUGB in renally impaired hypertensive patients .
Furosemide	drug	captopril	drug
false

DRUGA : In a study of healthy male volunteers no significant pharmacokinetic interaction occurred when DRUGB and DRUGN were administered concomitantly for dgb days .
Allopurinol	drug	captopril	drug
false

DRUGA : In a study of healthy male volunteers no significant pharmacokinetic interaction occurred when DRUGN and DRUGB were administered concomitantly for dgb days .
Allopurinol	drug	allopurinol	drug
false

DRUGN : In a study of healthy male volunteers no significant pharmacokinetic interaction occurred when DRUGA and DRUGB were administered concomitantly for dgb days .
captopril	drug	allopurinol	drug
false

Agents that Inhibit Cytochrome Pdgb Isoenzymes and / or Epoxide Hydrolase DRUGA is metabolized mainly by cytochrome Pdgb ( CYP ) dgbAdgb to the active DRUGB , which is further metabolized to the trans diol by epoxide hydrolase .
Carbamazepine	drug	carbamazepine 10,11-epoxide	drug
false

Pharmacological / Pharmacodynamic Interactions with DRUGA Concomitant administration of DRUGB and DRUGN may increase the risk of neurotoxic side effects .
Carbamazepine	drug	carbamazepine	drug
false

Pharmacological / Pharmacodynamic Interactions with DRUGA Concomitant administration of DRUGN and DRUGB may increase the risk of neurotoxic side effects .
Carbamazepine	drug	lithium	drug
false

Pharmacological / Pharmacodynamic Interactions with DRUGN Concomitant administration of DRUGA and DRUGB may increase the risk of neurotoxic side effects .
carbamazepine	drug	lithium	drug
effect

Given the anticonvulsant properties of DRUGA , DRUGB may reduce the thyroid function as has been reported with other DRUGN .
carbamazepine	drug	EQUETROTM	brand
false

Given the anticonvulsant properties of DRUGA , DRUGN may reduce the thyroid function as has been reported with other DRUGB .
carbamazepine	drug	anticonvulsants	group
false

Given the anticonvulsant properties of DRUGN , DRUGA may reduce the thyroid function as has been reported with other DRUGB .
EQUETROTM	brand	anticonvulsants	group
false

Additionally , DRUGA , such as DRUGB and DRUGN , may antagonize the activity of DRUGN .
anti-malarial drugs	group	chloroquine	drug
false

Additionally , DRUGA , such as DRUGN and DRUGB , may antagonize the activity of DRUGN .
anti-malarial drugs	group	mefloquine	drug
false

Additionally , DRUGA , such as DRUGN and DRUGN , may antagonize the activity of DRUGB .
anti-malarial drugs	group	carbamazepine	drug
effect

Additionally , DRUGN , such as DRUGA and DRUGB , may antagonize the activity of DRUGN .
chloroquine	drug	mefloquine	drug
false

Additionally , DRUGN , such as DRUGA and DRUGN , may antagonize the activity of DRUGB .
chloroquine	drug	carbamazepine	drug
effect

Additionally , DRUGN , such as DRUGN and DRUGA , may antagonize the activity of DRUGB .
mefloquine	drug	carbamazepine	drug
effect

Because of its primary CNS effect , caution should be used when DRUGA is taken with other DRUGB and DRUGN .
EQUETROTM	brand	centrally acting drugs	group
advise

Because of its primary CNS effect , caution should be used when DRUGA is taken with other DRUGN and DRUGB .
EQUETROTM	brand	alcohol	drug
advise

Because of its primary CNS effect , caution should be used when DRUGN is taken with other DRUGA and DRUGB .
centrally acting drugs	group	alcohol	drug
false

DRUGA ( DRUGB ) blood levels may be increased and prolonged by concurrent administration of DRUGN .
Geocillin	brand	carbenicillin indanyl sodium	drug
false

DRUGA ( DRUGN ) blood levels may be increased and prolonged by concurrent administration of DRUGB .
Geocillin	brand	probenecid	drug
mechanism

DRUGN ( DRUGA ) blood levels may be increased and prolonged by concurrent administration of DRUGB .
carbenicillin indanyl sodium	drug	probenecid	drug
mechanism

Caution should be exercised when the following drugs are administered concomitantly with DRUGA ( DRUGB ) given with DRUGN or DRUGN DRUGN combination products .
LODOSYN	brand	Carbidopa	drug
false

Caution should be exercised when the following drugs are administered concomitantly with DRUGA ( DRUGN ) given with DRUGB or DRUGN DRUGN combination products .
LODOSYN	brand	levodopa	drug
false

Caution should be exercised when the following drugs are administered concomitantly with DRUGA ( DRUGN ) given with DRUGN or DRUGB DRUGN combination products .
LODOSYN	brand	carbidopa	drug
false

Caution should be exercised when the following drugs are administered concomitantly with DRUGA ( DRUGN ) given with DRUGN or DRUGN DRUGB combination products .
LODOSYN	brand	levodopa	drug
false

Caution should be exercised when the following drugs are administered concomitantly with DRUGN ( DRUGA ) given with DRUGB or DRUGN DRUGN combination products .
Carbidopa	drug	levodopa	drug
false

Caution should be exercised when the following drugs are administered concomitantly with DRUGN ( DRUGA ) given with DRUGN or DRUGB DRUGN combination products .
Carbidopa	drug	carbidopa	drug
false

Caution should be exercised when the following drugs are administered concomitantly with DRUGN ( DRUGA ) given with DRUGN or DRUGN DRUGB combination products .
Carbidopa	drug	levodopa	drug
false

Caution should be exercised when the following drugs are administered concomitantly with DRUGN ( DRUGN ) given with DRUGA or DRUGB DRUGN combination products .
levodopa	drug	carbidopa	drug
false

Caution should be exercised when the following drugs are administered concomitantly with DRUGN ( DRUGN ) given with DRUGN or DRUGA DRUGB combination products .
carbidopa	drug	levodopa	drug
false

DRUGA ( e.g . , DRUGB , DRUGN , DRUGN ) and DRUGN may reduce the therapeutic effects of DRUGN .
Dopamine D2 receptor antagonists	group	phenothiazines	group
false

DRUGA ( e.g . , DRUGN , DRUGB , DRUGN ) and DRUGN may reduce the therapeutic effects of DRUGN .
Dopamine D2 receptor antagonists	group	butyrophenones	group
false

DRUGA ( e.g . , DRUGN , DRUGN , DRUGB ) and DRUGN may reduce the therapeutic effects of DRUGN .
Dopamine D2 receptor antagonists	group	risperidone	drug
false

DRUGA ( e.g . , DRUGN , DRUGN , DRUGN ) and DRUGB may reduce the therapeutic effects of DRUGN .
Dopamine D2 receptor antagonists	group	isoniazid	drug
false

DRUGA ( e.g . , DRUGN , DRUGN , DRUGN ) and DRUGN may reduce the therapeutic effects of DRUGB .
Dopamine D2 receptor antagonists	group	levodopa	drug
effect

DRUGN ( e.g . , DRUGA , DRUGB , DRUGN ) and DRUGN may reduce the therapeutic effects of DRUGN .
phenothiazines	group	butyrophenones	group
false

DRUGN ( e.g . , DRUGA , DRUGN , DRUGB ) and DRUGN may reduce the therapeutic effects of DRUGN .
phenothiazines	group	risperidone	drug
false

DRUGN ( e.g . , DRUGA , DRUGN , DRUGN ) and DRUGB may reduce the therapeutic effects of DRUGN .
phenothiazines	group	isoniazid	drug
false

DRUGN ( e.g . , DRUGA , DRUGN , DRUGN ) and DRUGN may reduce the therapeutic effects of DRUGB .
phenothiazines	group	levodopa	drug
effect

DRUGN ( e.g . , DRUGN , DRUGA , DRUGB ) and DRUGN may reduce the therapeutic effects of DRUGN .
butyrophenones	group	risperidone	drug
false

DRUGN ( e.g . , DRUGN , DRUGA , DRUGN ) and DRUGB may reduce the therapeutic effects of DRUGN .
butyrophenones	group	isoniazid	drug
false

DRUGN ( e.g . , DRUGN , DRUGA , DRUGN ) and DRUGN may reduce the therapeutic effects of DRUGB .
butyrophenones	group	levodopa	drug
effect

DRUGN ( e.g . , DRUGN , DRUGN , DRUGA ) and DRUGB may reduce the therapeutic effects of DRUGN .
risperidone	drug	isoniazid	drug
false

DRUGN ( e.g . , DRUGN , DRUGN , DRUGA ) and DRUGN may reduce the therapeutic effects of DRUGB .
risperidone	drug	levodopa	drug
effect

DRUGN ( e.g . , DRUGN , DRUGN , DRUGN ) and DRUGA may reduce the therapeutic effects of DRUGB .
isoniazid	drug	levodopa	drug
effect

In addition , the beneficial effects of DRUGA in Parkinsons disease have been reported to be reversed by DRUGB and DRUGN .
levodopa	drug	phenytoin	drug
effect

In addition , the beneficial effects of DRUGA in Parkinsons disease have been reported to be reversed by DRUGN and DRUGB .
levodopa	drug	papaverine	drug
effect

In addition , the beneficial effects of DRUGN in Parkinsons disease have been reported to be reversed by DRUGA and DRUGB .
phenytoin	drug	papaverine	drug
false

Patients taking these drugs with DRUGA and DRUGB or DRUGN DRUGN combination products should be carefully observed for loss of therapeutic response .
LODOSYN	brand	levodopa	drug
false

Patients taking these drugs with DRUGA and DRUGN or DRUGB DRUGN combination products should be carefully observed for loss of therapeutic response .
LODOSYN	brand	carbidopa	drug
false

Patients taking these drugs with DRUGA and DRUGN or DRUGN DRUGB combination products should be carefully observed for loss of therapeutic response .
LODOSYN	brand	levodopa	drug
false

Patients taking these drugs with DRUGN and DRUGA or DRUGB DRUGN combination products should be carefully observed for loss of therapeutic response .
levodopa	drug	carbidopa	drug
false

Patients taking these drugs with DRUGN and DRUGN or DRUGA DRUGB combination products should be carefully observed for loss of therapeutic response .
carbidopa	drug	levodopa	drug
false

DRUGA salts may reduce the bioavailability of DRUGB and DRUGN .
Iron	drug	carbidopa	drug
mechanism

DRUGA salts may reduce the bioavailability of DRUGN and DRUGB .
Iron	drug	levodopa	drug
mechanism

DRUGN salts may reduce the bioavailability of DRUGA and DRUGB .
carbidopa	drug	levodopa	drug
false

Although DRUGA may increase the bioavailability of DRUGB by increasing gastric emptying , DRUGN may also adversely affect disease control by its dopamine receptor antagonistic properties .
metoclopramide	drug	levodopa	drug
mechanism

Although DRUGN may increase the bioavailability of DRUGA by increasing gastric emptying , DRUGB may also adversely affect disease control by its dopamine receptor antagonistic properties .
levodopa	drug	metoclopramide	drug
false

DRUGA or DRUGB excess may decrease the effect of DRUGN , and an DRUGN deficiency can increase the effect of DRUGN .
Iodine	drug	iodine	drug
false

DRUGA or DRUGN excess may decrease the effect of DRUGB , and an DRUGN deficiency can increase the effect of DRUGN .
Iodine	drug	Carbimazole	drug
effect

DRUGA or DRUGN excess may decrease the effect of DRUGN , and an DRUGB deficiency can increase the effect of DRUGN .
Iodine	drug	iodine	drug
false

DRUGA or DRUGN excess may decrease the effect of DRUGN , and an DRUGN deficiency can increase the effect of DRUGB .
Iodine	drug	Carbimazole	drug
false

DRUGN or DRUGA excess may decrease the effect of DRUGB , and an DRUGN deficiency can increase the effect of DRUGN .
iodine	drug	Carbimazole	drug
false

DRUGN or DRUGA excess may decrease the effect of DRUGN , and an DRUGN deficiency can increase the effect of DRUGB .
iodine	drug	Carbimazole	drug
false

DRUGN or DRUGN excess may decrease the effect of DRUGA , and an DRUGB deficiency can increase the effect of DRUGN .
Carbimazole	drug	iodine	drug
false

DRUGN or DRUGN excess may decrease the effect of DRUGN , and an DRUGA deficiency can increase the effect of DRUGB .
iodine	drug	Carbimazole	drug
effect

Serum concentration of DRUGA and DRUGB may increase when patients take DRUGN .
digoxin	drug	digitoxin	drug
false

Serum concentration of DRUGA and DRUGN may increase when patients take DRUGB .
digoxin	drug	antithyroid agents	group
mechanism

Serum concentration of DRUGN and DRUGA may increase when patients take DRUGB .
digitoxin	drug	antithyroid agents	group
mechanism

DRUGA may decrease thyroidal uptake of DRUGB , a rebound in uptake may occur up to dgb days after sudden withdrawal of DRUGN .
Antithyroid agents	group	sodium iodide I131	drug
effect

DRUGA may decrease thyroidal uptake of DRUGN , a rebound in uptake may occur up to dgb days after sudden withdrawal of DRUGB .
Antithyroid agents	group	Carbimazole	drug
false

DRUGN may decrease thyroidal uptake of DRUGA , a rebound in uptake may occur up to dgb days after sudden withdrawal of DRUGB .
sodium iodide I131	drug	Carbimazole	drug
false

DRUGA may enhance the effects of DRUGB , DRUGN , DRUGN , and other DRUGN .
Antihistamines	group	tricyclic antidepressants	group
effect

DRUGA may enhance the effects of DRUGN , DRUGB , DRUGN , and other DRUGN .
Antihistamines	group	barbiturates	group
effect

DRUGA may enhance the effects of DRUGN , DRUGN , DRUGB , and other DRUGN .
Antihistamines	group	alcohol	drug
effect

DRUGA may enhance the effects of DRUGN , DRUGN , DRUGN , and other DRUGB .
Antihistamines	group	CNS depressants	group
effect

DRUGN may enhance the effects of DRUGA , DRUGB , DRUGN , and other DRUGN .
tricyclic antidepressants	group	barbiturates	group
false

DRUGN may enhance the effects of DRUGA , DRUGN , DRUGB , and other DRUGN .
tricyclic antidepressants	group	alcohol	drug
false

DRUGN may enhance the effects of DRUGA , DRUGN , DRUGN , and other DRUGB .
tricyclic antidepressants	group	CNS depressants	group
false

DRUGN may enhance the effects of DRUGN , DRUGA , DRUGB , and other DRUGN .
barbiturates	group	alcohol	drug
false

DRUGN may enhance the effects of DRUGN , DRUGA , DRUGN , and other DRUGB .
barbiturates	group	CNS depressants	group
false

DRUGN may enhance the effects of DRUGN , DRUGN , DRUGA , and other DRUGB .
alcohol	drug	CNS depressants	group
false

DRUGA prolong and intensify the anticholinergic effects of DRUGB .
MAO inhibitors	group	antihistamines	group
effect

DRUGA may reduce the antihypertensive effects of DRUGB , DRUGN , DRUGN and DRUGN .
Sympathomimetic amines	group	reserpine	drug
effect

DRUGA may reduce the antihypertensive effects of DRUGN , DRUGB , DRUGN and DRUGN .
Sympathomimetic amines	group	veratrum alkaloids	group
effect

DRUGA may reduce the antihypertensive effects of DRUGN , DRUGN , DRUGB and DRUGN .
Sympathomimetic amines	group	methyldopa	drug
effect

DRUGA may reduce the antihypertensive effects of DRUGN , DRUGN , DRUGN and DRUGB .
Sympathomimetic amines	group	mecamylamine	drug
effect

DRUGN may reduce the antihypertensive effects of DRUGA , DRUGB , DRUGN and DRUGN .
reserpine	drug	veratrum alkaloids	group
false

DRUGN may reduce the antihypertensive effects of DRUGA , DRUGN , DRUGB and DRUGN .
reserpine	drug	methyldopa	drug
false

DRUGN may reduce the antihypertensive effects of DRUGA , DRUGN , DRUGN and DRUGB .
reserpine	drug	mecamylamine	drug
false

DRUGN may reduce the antihypertensive effects of DRUGN , DRUGA , DRUGB and DRUGN .
veratrum alkaloids	group	methyldopa	drug
false

DRUGN may reduce the antihypertensive effects of DRUGN , DRUGA , DRUGN and DRUGB .
veratrum alkaloids	group	mecamylamine	drug
false

DRUGN may reduce the antihypertensive effects of DRUGN , DRUGN , DRUGA and DRUGB .
methyldopa	drug	mecamylamine	drug
false

Effects of DRUGA are increased with DRUGB and DRUGN .
sympathomimetics	group	MAO inhibitors	group
effect

Effects of DRUGA are increased with DRUGN and DRUGB .
sympathomimetics	group	beta adrenergic blockers	group
effect

Effects of DRUGN are increased with DRUGA and DRUGB .
MAO inhibitors	group	beta adrenergic blockers	group
false

DRUGA may augment the activity of other DRUGB .
HEMABATE	brand	oxytocic agents	group
effect

DRUGA should be used with caution in patients who are receiving a DRUGB orally because of the potential for additive effects on systemic beta blockade .
Ocupress	brand	beta-adrenergic blocking agent	group
advise

Catecholamine depleting Agents : Patients taking both DRUGA and a drug that can deplete catecholamines ( e.g . , DRUGB and DRUGN ) should be observed closely for signs of hypotension and / or severe bradycardia .
agents with b-blocking properties	group	reserpine	drug
effect

Catecholamine depleting Agents : Patients taking both DRUGA and a drug that can deplete catecholamines ( e.g . , DRUGN and DRUGB ) should be observed closely for signs of hypotension and / or severe bradycardia .
agents with b-blocking properties	group	monoamine oxidase inhibitors	group
effect

Catecholamine depleting Agents : Patients taking both DRUGN and a drug that can deplete catecholamines ( e.g . , DRUGA and DRUGB ) should be observed closely for signs of hypotension and / or severe bradycardia .
reserpine	drug	monoamine oxidase inhibitors	group
false

DRUGA : Concomitant administration of DRUGB with DRUGN may potentiate blood pressure and heart rate lowering effects .
Clonidine	drug	clonidine	drug
false

DRUGA : Concomitant administration of DRUGN with DRUGB may potentiate blood pressure and heart rate lowering effects .
Clonidine	drug	agents with b-blocking properties	group
false

DRUGN : Concomitant administration of DRUGA with DRUGB may potentiate blood pressure and heart rate lowering effects .
clonidine	drug	agents with b-blocking properties	group
effect

When concomitant treatment with DRUGA and DRUGB is to be terminated , the DRUGN should be discontinued first .
agents with b-blocking properties	group	clonidine	drug
advise

When concomitant treatment with DRUGA and DRUGN is to be terminated , the DRUGB should be discontinued first .
agents with b-blocking properties	group	b-blocking agent	group
false

When concomitant treatment with DRUGN and DRUGA is to be terminated , the DRUGB should be discontinued first .
clonidine	drug	b-blocking agent	group
false

DRUGA : Modest increases in mean trough DRUGB concentrations were observed following initiation of DRUGN treatment in dgb renal transplant patients suffering from chronic vascular rejection .
Cyclosporine	drug	cyclosporine	drug
false

DRUGA : Modest increases in mean trough DRUGN concentrations were observed following initiation of DRUGB treatment in dgb renal transplant patients suffering from chronic vascular rejection .
Cyclosporine	drug	carvedilol	drug
false

DRUGN : Modest increases in mean trough DRUGA concentrations were observed following initiation of DRUGB treatment in dgb renal transplant patients suffering from chronic vascular rejection .
cyclosporine	drug	carvedilol	drug
mechanism

Due to wide interindividual variability in the dose adjustment required , it is recommended that DRUGA concentrations be monitored closely after initiation of DRUGB therapy and that the dose of DRUGN be adjusted as appropriate .
cyclosporine	drug	carvedilol	drug
advise

Due to wide interindividual variability in the dose adjustment required , it is recommended that DRUGN concentrations be monitored closely after initiation of DRUGA therapy and that the dose of DRUGB be adjusted as appropriate .
carvedilol	drug	cyclosporine	drug
advise

DRUGA : DRUGN concentrations are increased by about dgb % when DRUGB and DRUGN are administered concomitantly .
Digoxin	drug	digoxin	drug
false

DRUGA : DRUGN concentrations are increased by about dgb % when DRUGN and DRUGB are administered concomitantly .
Digoxin	drug	carvedilol	drug
false

DRUGN : DRUGA concentrations are increased by about dgb % when DRUGB and DRUGN are administered concomitantly .
Digoxin	drug	digoxin	drug
false

DRUGN : DRUGA concentrations are increased by about dgb % when DRUGN and DRUGB are administered concomitantly .
Digoxin	drug	carvedilol	drug
false

DRUGN : DRUGN concentrations are increased by about dgb % when DRUGA and DRUGB are administered concomitantly .
digoxin	drug	carvedilol	drug
mechanism

Both DRUGA and DRUGB slow AV conduction .
digoxin	drug	COREG	brand
effect

Therefore , increased monitoring of DRUGA is recommended when initiating , adjusting , or discontinuing DRUGB .
digoxin	drug	COREG	brand
advise

Inducers and Inhibitors of Hepatic Metabolism : DRUGA reduced plasma concentrations of DRUGB by about dgb % .
Rifampin	drug	carvedilol	drug
mechanism

DRUGA : Isolated cases of conduction disturbance ( rarely with hemodynamic compromise ) have been observed when DRUGB is co administered with DRUGN .
Calcium Channel Blockers	group	COREG	brand
false

DRUGA : Isolated cases of conduction disturbance ( rarely with hemodynamic compromise ) have been observed when DRUGN is co administered with DRUGB .
Calcium Channel Blockers	group	diltiazem	drug
false

DRUGN : Isolated cases of conduction disturbance ( rarely with hemodynamic compromise ) have been observed when DRUGA is co administered with DRUGB .
COREG	brand	diltiazem	drug
effect

As with other DRUGA , if DRUGB is to be administered orally with DRUGN of the DRUGN or DRUGN type , it is recommended that ECG and blood pressure be monitored .
agents with b-blocking properties	group	COREG	brand
false

As with other DRUGA , if DRUGN is to be administered orally with DRUGB of the DRUGN or DRUGN type , it is recommended that ECG and blood pressure be monitored .
agents with b-blocking properties	group	calcium channel blockers	group
false

As with other DRUGA , if DRUGN is to be administered orally with DRUGN of the DRUGB or DRUGN type , it is recommended that ECG and blood pressure be monitored .
agents with b-blocking properties	group	verapamil	drug
false

As with other DRUGA , if DRUGN is to be administered orally with DRUGN of the DRUGN or DRUGB type , it is recommended that ECG and blood pressure be monitored .
agents with b-blocking properties	group	diltiazem	drug
false

As with other DRUGN , if DRUGA is to be administered orally with DRUGB of the DRUGN or DRUGN type , it is recommended that ECG and blood pressure be monitored .
COREG	brand	calcium channel blockers	group
false

As with other DRUGN , if DRUGA is to be administered orally with DRUGN of the DRUGB or DRUGN type , it is recommended that ECG and blood pressure be monitored .
COREG	brand	verapamil	drug
advise

As with other DRUGN , if DRUGA is to be administered orally with DRUGN of the DRUGN or DRUGB type , it is recommended that ECG and blood pressure be monitored .
COREG	brand	diltiazem	drug
advise

As with other DRUGN , if DRUGN is to be administered orally with DRUGA of the DRUGB or DRUGN type , it is recommended that ECG and blood pressure be monitored .
calcium channel blockers	group	verapamil	drug
false

As with other DRUGN , if DRUGN is to be administered orally with DRUGA of the DRUGN or DRUGB type , it is recommended that ECG and blood pressure be monitored .
calcium channel blockers	group	diltiazem	drug
false

As with other DRUGN , if DRUGN is to be administered orally with DRUGN of the DRUGA or DRUGB type , it is recommended that ECG and blood pressure be monitored .
verapamil	drug	diltiazem	drug
false

DRUGA or Oral DRUGB : DRUGN may enhance the blood sugar reducing effect of DRUGN and oral DRUGN .
Insulin	drug	Hypoglycemics	group
false

DRUGA or Oral DRUGN : DRUGB may enhance the blood sugar reducing effect of DRUGN and oral DRUGN .
Insulin	drug	Agents with b-blocking properties	group
false

DRUGA or Oral DRUGN : DRUGN may enhance the blood sugar reducing effect of DRUGB and oral DRUGN .
Insulin	drug	insulin	drug
false

DRUGA or Oral DRUGN : DRUGN may enhance the blood sugar reducing effect of DRUGN and oral DRUGB .
Insulin	drug	hypoglycemics	group
false

DRUGN or Oral DRUGA : DRUGB may enhance the blood sugar reducing effect of DRUGN and oral DRUGN .
Hypoglycemics	group	Agents with b-blocking properties	group
false

DRUGN or Oral DRUGA : DRUGN may enhance the blood sugar reducing effect of DRUGB and oral DRUGN .
Hypoglycemics	group	insulin	drug
false

DRUGN or Oral DRUGA : DRUGN may enhance the blood sugar reducing effect of DRUGN and oral DRUGB .
Hypoglycemics	group	hypoglycemics	group
false

DRUGN or Oral DRUGN : DRUGA may enhance the blood sugar reducing effect of DRUGB and oral DRUGN .
Agents with b-blocking properties	group	insulin	drug
effect

DRUGN or Oral DRUGN : DRUGA may enhance the blood sugar reducing effect of DRUGN and oral DRUGB .
Agents with b-blocking properties	group	hypoglycemics	group
effect

DRUGN or Oral DRUGN : DRUGN may enhance the blood sugar reducing effect of DRUGA and oral DRUGB .
insulin	drug	hypoglycemics	group
false

Therefore , in patients taking DRUGA or oral DRUGB , regular monitoring of blood glucose is recommended .
insulin	drug	hypoglycemics	group
false

Clinical studies in healthy volunteers show that the pharmacokinetics of DRUGA are not altered by DRUGB , DRUGN , DRUGN , DRUGN , or DRUGN .
CANCIDAS	brand	itraconazole	drug
false

Clinical studies in healthy volunteers show that the pharmacokinetics of DRUGA are not altered by DRUGN , DRUGB , DRUGN , DRUGN , or DRUGN .
CANCIDAS	brand	amphotericin B	drug
false

Clinical studies in healthy volunteers show that the pharmacokinetics of DRUGA are not altered by DRUGN , DRUGN , DRUGB , DRUGN , or DRUGN .
CANCIDAS	brand	mycophenolate	drug
false

Clinical studies in healthy volunteers show that the pharmacokinetics of DRUGA are not altered by DRUGN , DRUGN , DRUGN , DRUGB , or DRUGN .
CANCIDAS	brand	nelfinavir	drug
false

Clinical studies in healthy volunteers show that the pharmacokinetics of DRUGA are not altered by DRUGN , DRUGN , DRUGN , DRUGN , or DRUGB .
CANCIDAS	brand	tacrolimus	drug
false

Clinical studies in healthy volunteers show that the pharmacokinetics of DRUGN are not altered by DRUGA , DRUGB , DRUGN , DRUGN , or DRUGN .
itraconazole	drug	amphotericin B	drug
false

Clinical studies in healthy volunteers show that the pharmacokinetics of DRUGN are not altered by DRUGA , DRUGN , DRUGB , DRUGN , or DRUGN .
itraconazole	drug	mycophenolate	drug
false

Clinical studies in healthy volunteers show that the pharmacokinetics of DRUGN are not altered by DRUGA , DRUGN , DRUGN , DRUGB , or DRUGN .
itraconazole	drug	nelfinavir	drug
false

Clinical studies in healthy volunteers show that the pharmacokinetics of DRUGN are not altered by DRUGA , DRUGN , DRUGN , DRUGN , or DRUGB .
itraconazole	drug	tacrolimus	drug
false

Clinical studies in healthy volunteers show that the pharmacokinetics of DRUGN are not altered by DRUGN , DRUGA , DRUGB , DRUGN , or DRUGN .
amphotericin B	drug	mycophenolate	drug
false

Clinical studies in healthy volunteers show that the pharmacokinetics of DRUGN are not altered by DRUGN , DRUGA , DRUGN , DRUGB , or DRUGN .
amphotericin B	drug	nelfinavir	drug
false

Clinical studies in healthy volunteers show that the pharmacokinetics of DRUGN are not altered by DRUGN , DRUGA , DRUGN , DRUGN , or DRUGB .
amphotericin B	drug	tacrolimus	drug
false

Clinical studies in healthy volunteers show that the pharmacokinetics of DRUGN are not altered by DRUGN , DRUGN , DRUGA , DRUGB , or DRUGN .
mycophenolate	drug	nelfinavir	drug
false

Clinical studies in healthy volunteers show that the pharmacokinetics of DRUGN are not altered by DRUGN , DRUGN , DRUGA , DRUGN , or DRUGB .
mycophenolate	drug	tacrolimus	drug
false

Clinical studies in healthy volunteers show that the pharmacokinetics of DRUGN are not altered by DRUGN , DRUGN , DRUGN , DRUGA , or DRUGB .
nelfinavir	drug	tacrolimus	drug
false

DRUGA has no effect on the pharmacokinetics of DRUGB , DRUGN , or the active metabolite of mycophenolate .
CANCIDAS	brand	itraconazole	drug
false

DRUGA has no effect on the pharmacokinetics of DRUGN , DRUGB , or the active metabolite of mycophenolate .
CANCIDAS	brand	amphotericin B	drug
false

DRUGN has no effect on the pharmacokinetics of DRUGA , DRUGB , or the active metabolite of mycophenolate .
itraconazole	drug	amphotericin B	drug
false

In two clinical studies , DRUGA ( one dgb mg / kg dose or two dgb mg / kg doses ) increased the AUC of DRUGB by approximately dgb % .
cyclosporine	drug	caspofungin	drug
mechanism

DRUGA did not increase the plasma levels of DRUGB .
CANCIDAS	brand	cyclosporine	drug
false

There were transient increases in liver ALT and AST when DRUGA and DRUGB were co administered .
CANCIDAS	brand	cyclosporine	drug
effect

A drug drug interaction study with DRUGA in healthy volunteers has shown a dgb % decrease in DRUGB trough concentrations .
rifampin	drug	caspofungin	drug
mechanism

Patients on DRUGA should receive dgb mg of DRUGB daily .
rifampin	drug	CANCIDAS	brand
advise

When DRUGA is co administered with inducers of drug clearance , such as DRUGB , DRUGN , DRUGN , DRUGN , or DRUGN , use of a daily dose of dgb mg of DRUGN should be considered
CANCIDAS	brand	efavirenz	drug
advise

When DRUGA is co administered with inducers of drug clearance , such as DRUGN , DRUGB , DRUGN , DRUGN , or DRUGN , use of a daily dose of dgb mg of DRUGN should be considered
CANCIDAS	brand	nevirapine	drug
advise

When DRUGA is co administered with inducers of drug clearance , such as DRUGN , DRUGN , DRUGB , DRUGN , or DRUGN , use of a daily dose of dgb mg of DRUGN should be considered
CANCIDAS	brand	phenytoin	drug
advise

When DRUGA is co administered with inducers of drug clearance , such as DRUGN , DRUGN , DRUGN , DRUGB , or DRUGN , use of a daily dose of dgb mg of DRUGN should be considered
CANCIDAS	brand	dexamethasone	drug
advise

When DRUGA is co administered with inducers of drug clearance , such as DRUGN , DRUGN , DRUGN , DRUGN , or DRUGB , use of a daily dose of dgb mg of DRUGN should be considered
CANCIDAS	brand	carbamazepine	drug
advise

When DRUGN is co administered with inducers of drug clearance , such as DRUGA , DRUGB , DRUGN , DRUGN , or DRUGN , use of a daily dose of dgb mg of DRUGN should be considered
efavirenz	drug	nevirapine	drug
false

When DRUGN is co administered with inducers of drug clearance , such as DRUGA , DRUGN , DRUGB , DRUGN , or DRUGN , use of a daily dose of dgb mg of DRUGN should be considered
efavirenz	drug	phenytoin	drug
false

When DRUGN is co administered with inducers of drug clearance , such as DRUGA , DRUGN , DRUGN , DRUGB , or DRUGN , use of a daily dose of dgb mg of DRUGN should be considered
efavirenz	drug	dexamethasone	drug
false

When DRUGN is co administered with inducers of drug clearance , such as DRUGA , DRUGN , DRUGN , DRUGN , or DRUGB , use of a daily dose of dgb mg of DRUGN should be considered
efavirenz	drug	carbamazepine	drug
false

When DRUGN is co administered with inducers of drug clearance , such as DRUGA , DRUGN , DRUGN , DRUGN , or DRUGN , use of a daily dose of dgb mg of DRUGB should be considered
efavirenz	drug	CANCIDAS	brand
false

When DRUGN is co administered with inducers of drug clearance , such as DRUGN , DRUGA , DRUGB , DRUGN , or DRUGN , use of a daily dose of dgb mg of DRUGN should be considered
nevirapine	drug	phenytoin	drug
false

When DRUGN is co administered with inducers of drug clearance , such as DRUGN , DRUGA , DRUGN , DRUGB , or DRUGN , use of a daily dose of dgb mg of DRUGN should be considered
nevirapine	drug	dexamethasone	drug
false

When DRUGN is co administered with inducers of drug clearance , such as DRUGN , DRUGA , DRUGN , DRUGN , or DRUGB , use of a daily dose of dgb mg of DRUGN should be considered
nevirapine	drug	carbamazepine	drug
false

When DRUGN is co administered with inducers of drug clearance , such as DRUGN , DRUGA , DRUGN , DRUGN , or DRUGN , use of a daily dose of dgb mg of DRUGB should be considered
nevirapine	drug	CANCIDAS	brand
false

When DRUGN is co administered with inducers of drug clearance , such as DRUGN , DRUGN , DRUGA , DRUGB , or DRUGN , use of a daily dose of dgb mg of DRUGN should be considered
phenytoin	drug	dexamethasone	drug
false

When DRUGN is co administered with inducers of drug clearance , such as DRUGN , DRUGN , DRUGA , DRUGN , or DRUGB , use of a daily dose of dgb mg of DRUGN should be considered
phenytoin	drug	carbamazepine	drug
false

When DRUGN is co administered with inducers of drug clearance , such as DRUGN , DRUGN , DRUGA , DRUGN , or DRUGN , use of a daily dose of dgb mg of DRUGB should be considered
phenytoin	drug	CANCIDAS	brand
false

When DRUGN is co administered with inducers of drug clearance , such as DRUGN , DRUGN , DRUGN , DRUGA , or DRUGB , use of a daily dose of dgb mg of DRUGN should be considered
dexamethasone	drug	carbamazepine	drug
false

When DRUGN is co administered with inducers of drug clearance , such as DRUGN , DRUGN , DRUGN , DRUGA , or DRUGN , use of a daily dose of dgb mg of DRUGB should be considered
dexamethasone	drug	CANCIDAS	brand
false

When DRUGN is co administered with inducers of drug clearance , such as DRUGN , DRUGN , DRUGN , DRUGN , or DRUGA , use of a daily dose of dgb mg of DRUGB should be considered
carbamazepine	drug	CANCIDAS	brand
false

DRUGA may decrease renal tubular secretion of DRUGB when used concurrently , resulting in increased and more prolonged DRUGN blood levels .
Probenecid	drug	cephalosporins	group
mechanism

DRUGA may decrease renal tubular secretion of DRUGN when used concurrently , resulting in increased and more prolonged DRUGB blood levels .
Probenecid	drug	cephalosporin	group
false

DRUGN may decrease renal tubular secretion of DRUGA when used concurrently , resulting in increased and more prolonged DRUGB blood levels .
cephalosporins	group	cephalosporin	group
false

DRUGA ( DRUGB or DRUGN containing ) : Concomitant administration of dgb mg DRUGN capsules with dgb mL DRUGN suspension reduces the rate ( Cmax ) and extent ( AUC ) of absorption by approximately dgb % .
Antacids	group	aluminum	drug
false

DRUGA ( DRUGN or DRUGB containing ) : Concomitant administration of dgb mg DRUGN capsules with dgb mL DRUGN suspension reduces the rate ( Cmax ) and extent ( AUC ) of absorption by approximately dgb % .
Antacids	group	magnesium	drug
false

DRUGA ( DRUGN or DRUGN containing ) : Concomitant administration of dgb mg DRUGB capsules with dgb mL DRUGN suspension reduces the rate ( Cmax ) and extent ( AUC ) of absorption by approximately dgb % .
Antacids	group	cefdinir	drug
false

DRUGA ( DRUGN or DRUGN containing ) : Concomitant administration of dgb mg DRUGN capsules with dgb mL DRUGB suspension reduces the rate ( Cmax ) and extent ( AUC ) of absorption by approximately dgb % .
Antacids	group	Maalox TC	brand
false

DRUGN ( DRUGA or DRUGB containing ) : Concomitant administration of dgb mg DRUGN capsules with dgb mL DRUGN suspension reduces the rate ( Cmax ) and extent ( AUC ) of absorption by approximately dgb % .
aluminum	drug	magnesium	drug
false

DRUGN ( DRUGA or DRUGN containing ) : Concomitant administration of dgb mg DRUGB capsules with dgb mL DRUGN suspension reduces the rate ( Cmax ) and extent ( AUC ) of absorption by approximately dgb % .
aluminum	drug	cefdinir	drug
false

DRUGN ( DRUGA or DRUGN containing ) : Concomitant administration of dgb mg DRUGN capsules with dgb mL DRUGB suspension reduces the rate ( Cmax ) and extent ( AUC ) of absorption by approximately dgb % .
aluminum	drug	Maalox TC	brand
false

DRUGN ( DRUGN or DRUGA containing ) : Concomitant administration of dgb mg DRUGB capsules with dgb mL DRUGN suspension reduces the rate ( Cmax ) and extent ( AUC ) of absorption by approximately dgb % .
magnesium	drug	cefdinir	drug
false

DRUGN ( DRUGN or DRUGA containing ) : Concomitant administration of dgb mg DRUGN capsules with dgb mL DRUGB suspension reduces the rate ( Cmax ) and extent ( AUC ) of absorption by approximately dgb % .
magnesium	drug	Maalox TC	brand
false

DRUGN ( DRUGN or DRUGN containing ) : Concomitant administration of dgb mg DRUGA capsules with dgb mL DRUGB suspension reduces the rate ( Cmax ) and extent ( AUC ) of absorption by approximately dgb % .
cefdinir	drug	Maalox TC	brand
mechanism

There are no significant effects on DRUGA pharmacokinetics if the DRUGB is administered dgb hours before or dgb hours after DRUGN .
cefdinir	drug	antacid	group
false

There are no significant effects on DRUGN pharmacokinetics if the DRUGA is administered dgb hours before or dgb hours after DRUGB .
antacid	group	cefdinir	drug
false

If DRUGA are required during DRUGB therapy , DRUGN should be taken at least dgb hours before or after the DRUGN .
antacids	group	OMNICEF	brand
false

If DRUGA are required during DRUGN therapy , DRUGB should be taken at least dgb hours before or after the DRUGN .
antacids	group	OMNICEF	brand
false

If DRUGA are required during DRUGN therapy , DRUGN should be taken at least dgb hours before or after the DRUGB .
antacids	group	antacid	group
false

If DRUGN are required during DRUGA therapy , DRUGN should be taken at least dgb hours before or after the DRUGB .
OMNICEF	brand	antacid	group
false

If DRUGN are required during DRUGN therapy , DRUGA should be taken at least dgb hours before or after the DRUGB .
OMNICEF	brand	antacid	group
advise

If DRUGA are required during DRUGB therapy , DRUGN should be taken at least dgb hours before or after the supplement .
iron supplements	group	OMNICEF	brand
false

If DRUGA are required during DRUGN therapy , DRUGB should be taken at least dgb hours before or after the supplement .
iron supplements	group	OMNICEF	brand
advise

The effect of foods highly fortified with elemental DRUGA ( primarily DRUGN fortified breakfast cereals ) on DRUGB absorption has not been studied .
iron	drug_n	cefdinir	drug
false

The effect of foods highly fortified with elemental DRUGN ( primarily DRUGA fortified breakfast cereals ) on DRUGB absorption has not been studied .
iron	drug_n	cefdinir	drug
false

Concomitantly administered DRUGA fortified infant formula ( dga mg elemental DRUGN / dgb oz ) has no significant effect on DRUGB pharmacokinetics .
iron	drug_n	cefdinir	drug
false

Concomitantly administered DRUGN fortified infant formula ( dga mg elemental DRUGA / dgb oz ) has no significant effect on DRUGB pharmacokinetics .
iron	drug_n	cefdinir	drug
false

Therefore , DRUGA for Oral Suspension can be administered with DRUGB fortified infant formula .
OMNICEF	brand	iron	drug_n
false

The reddish color is due to the formation of a nonabsorbable complex between DRUGA or its breakdown products and DRUGB in the gastrointestinal tract .
cefdinir	drug	iron	drug
mechanism

Drug / Laboratory Test Interactions A false positive reaction for ketones in the urine may occur with tests using DRUGA , but not with those using DRUGB .
nitroprusside	drug	nitroferricyanide	drug
false

Oral DRUGA Multiple doses of DRUGB had no effect on the pharmacokinetics of DRUGN , the estrogenic component in most oral DRUGN .
Contraceptives	group	cefditoren pivoxil	drug
false

Oral DRUGA Multiple doses of DRUGN had no effect on the pharmacokinetics of DRUGB , the estrogenic component in most oral DRUGN .
Contraceptives	group	ethinyl estradiol	drug
false

Oral DRUGA Multiple doses of DRUGN had no effect on the pharmacokinetics of DRUGN , the estrogenic component in most oral DRUGB .
Contraceptives	group	contraceptives	group
false

Oral DRUGN Multiple doses of DRUGA had no effect on the pharmacokinetics of DRUGB , the estrogenic component in most oral DRUGN .
cefditoren pivoxil	drug	ethinyl estradiol	drug
false

Oral DRUGN Multiple doses of DRUGA had no effect on the pharmacokinetics of DRUGN , the estrogenic component in most oral DRUGB .
cefditoren pivoxil	drug	contraceptives	group
false

Oral DRUGN Multiple doses of DRUGN had no effect on the pharmacokinetics of DRUGA , the estrogenic component in most oral DRUGB .
ethinyl estradiol	drug	contraceptives	group
false

Although the clinical significance is not known , it is not recommended that DRUGA be taken concomitantly with DRUGB .
cefditoren pivoxil	drug	antacids	group
advise

Although the clinical significance is not known , it is not recommended that DRUGA be taken concomitantly with DRUGB .
cefditoren pivoxil	drug	H2 receptor antagonists	group
false

Renal function should be monitored carefully if high doses of DRUGA are to be administered with DRUGB because of the increased potential of nephrotoxicity and ototoxicity of DRUGN .
aminoglycosides	group	MAXIPIME	brand
advise

Renal function should be monitored carefully if high doses of DRUGA are to be administered with DRUGN because of the increased potential of nephrotoxicity and ototoxicity of DRUGB .
aminoglycosides	group	aminoglycoside antibiotics	group
false

Renal function should be monitored carefully if high doses of DRUGN are to be administered with DRUGA because of the increased potential of nephrotoxicity and ototoxicity of DRUGB .
MAXIPIME	brand	aminoglycoside antibiotics	group
false

Nephrotoxicity has been reported following concomitant administration of other DRUGA with potent DRUGB such as DRUGN .
cephalosporins	group	diuretics	group
effect

Nephrotoxicity has been reported following concomitant administration of other DRUGA with potent DRUGN such as DRUGB .
cephalosporins	group	furosemide	drug
effect

Nephrotoxicity has been reported following concomitant administration of other DRUGN with potent DRUGA such as DRUGB .
diuretics	group	furosemide	drug
false

DRUGA : Elevated DRUGB levels have been reported in postmarketing experience when DRUGN is administered concomitantly .
Carbamazepine	drug	carbamazepine	drug
false

DRUGA : Elevated DRUGN levels have been reported in postmarketing experience when DRUGB is administered concomitantly .
Carbamazepine	drug	SUPRAX	brand
false

DRUGN : Elevated DRUGA levels have been reported in postmarketing experience when DRUGB is administered concomitantly .
carbamazepine	drug	SUPRAX	brand
mechanism

DRUGA and DRUGB : Increased prothrombin time , with or without clinical bleeding , has been reported when DRUGN is administered concomitantly .
Warfarin	drug	Anticoagulants	group
false

DRUGA and DRUGN : Increased prothrombin time , with or without clinical bleeding , has been reported when DRUGB is administered concomitantly .
Warfarin	drug	cefixime	drug
effect

DRUGN and DRUGA : Increased prothrombin time , with or without clinical bleeding , has been reported when DRUGB is administered concomitantly .
Anticoagulants	group	cefixime	drug
effect

Drug / Laboratory Test Interactions A false positive reaction for ketones in the urine may occur with tests using DRUGA but not with those using DRUGB .
nitroprusside	drug	nitroferricyanide	drug
false

Increased nephrotoxicity has been reported following concomitant administration of DRUGA and DRUGB .
cephalosporins	group	aminoglycoside antibiotics	group
effect

Drug / Laboratory Test Interactions DRUGA , including DRUGB , are known to occasionally induce a positive direct Coombs test .
Cephalosporins	group	cefotaxime sodium	drug
false

If DRUGA and an DRUGB are used concomitantly , renal function should be carefully monitored , because nephrotoxicity may be potentiated .
CEFOTAN	brand	aminoglycoside	group
effect

As with other DRUGA , high concentrations of DRUGB may interfere with measurement of serum and urine creatinine levels by Jaffe reaction and produce false increases in the levels of creatinine reported .
cephalosporins	group	cefotetan	drug
false

Increased nephrotoxicity has been reported following concomitant administration of DRUGA and DRUGB .
cephalosporins	group	aminoglycoside antibiotics	group
effect

Nephrotoxicity has been reported following concomitant administration of DRUGA and DRUGB .
aminoglycoside antibiotics	group	cephalosporin antibiotics	group
effect

Concomitant administration of DRUGA doubled the AUC for DRUGB .
probenecid	drug	cefprozil	drug
mechanism

The bioavailability of the capsule formulation of DRUGA was not affected when administered dgb minutes following an DRUGB .
cefprozil	drug	antacid	group
false

Nephrotoxicity has been reported following concomitant administration of DRUGA with DRUGB or potent DRUGN such as DRUGN .
cephalosporins	group	aminoglycoside antibiotics	group
effect

Nephrotoxicity has been reported following concomitant administration of DRUGA with DRUGN or potent DRUGB such as DRUGN .
cephalosporins	group	diuretics	group
effect

Nephrotoxicity has been reported following concomitant administration of DRUGA with DRUGN or potent DRUGN such as DRUGB .
cephalosporins	group	furosemide	drug
effect

Nephrotoxicity has been reported following concomitant administration of DRUGN with DRUGA or potent DRUGB such as DRUGN .
aminoglycoside antibiotics	group	diuretics	group
false

Nephrotoxicity has been reported following concomitant administration of DRUGN with DRUGA or potent DRUGN such as DRUGB .
aminoglycoside antibiotics	group	furosemide	drug
false

Nephrotoxicity has been reported following concomitant administration of DRUGN with DRUGN or potent DRUGA such as DRUGB .
diuretics	group	furosemide	drug
false

Renal function should be carefully monitored , especially if higher dosages of the DRUGA are to be administered or if therapy is prolonged , because of the potential nephrotoxicity and ototoxicity of DRUGB .
aminoglycosides	group	aminoglycosidic antibiotics	group
false

DRUGA has been shown to be antagonistic to DRUGB , including DRUGN , based on in vitro studies and time kill curves with enteric gram negative bacilli .
Chloramphenicol	drug	beta-lactam antibiotics	group
effect

DRUGA has been shown to be antagonistic to DRUGN , including DRUGB , based on in vitro studies and time kill curves with enteric gram negative bacilli .
Chloramphenicol	drug	ceftazidime	drug
effect

DRUGN has been shown to be antagonistic to DRUGA , including DRUGB , based on in vitro studies and time kill curves with enteric gram negative bacilli .
beta-lactam antibiotics	group	ceftazidime	drug
false

DRUGA : Twelve healthy male volunteers were administered one dgb mg DRUGB capsule twice daily for dgb days .
Theophylline	drug	ceftibuten	drug
false

With the morning dose of DRUGA on day dgb , each volunteer received a single intravenous infusion of DRUGB ( dgb mg / kg ) .
ceftibuten	drug	theophylline	drug
false

The effect of DRUGA on the pharmacokinetics of DRUGB administered orally has not been investigated .
ceftibuten	drug	theophylline	drug
false

DRUGA or DRUGB : The effect of increased gastric pH on the bioavailability of DRUGN was evaluated in dgb healthy adult volunteers .
Antacids	group	H 2 -receptor antagonists	group
false

DRUGA or DRUGN : The effect of increased gastric pH on the bioavailability of DRUGB was evaluated in dgb healthy adult volunteers .
Antacids	group	ceftibuten	drug
false

DRUGN or DRUGA : The effect of increased gastric pH on the bioavailability of DRUGB was evaluated in dgb healthy adult volunteers .
H 2 -receptor antagonists	group	ceftibuten	drug
false

A single dose of liquid DRUGA did not affect the C max or AUC of DRUGB ;
antacid	group	ceftibuten	drug
false

however , dgb mg of DRUGA qdgbh for dgb days increased the DRUGB C max by dgb % and DRUGN AUC by dgb % .
ranitidine	drug	ceftibuten	drug
mechanism

however , dgb mg of DRUGA qdgbh for dgb days increased the DRUGN C max by dgb % and DRUGB AUC by dgb % .
ranitidine	drug	ceftibuten	drug
mechanism

Although the occurrence has not been reported with DRUGA , nephrotoxicity has been reported following concomitant administration of other DRUGB and DRUGN .
Cefizox	brand	cephalosporins	group
false

Although the occurrence has not been reported with DRUGA , nephrotoxicity has been reported following concomitant administration of other DRUGN and DRUGB .
Cefizox	brand	aminoglycosides	group
false

Although the occurrence has not been reported with DRUGN , nephrotoxicity has been reported following concomitant administration of other DRUGA and DRUGB .
cephalosporins	group	aminoglycosides	group
effect

Clinical studies with DRUGA have identified potentially significant interactions with DRUGB and DRUGN .
celecoxib	drug	fluconazole	drug
int

Clinical studies with DRUGA have identified potentially significant interactions with DRUGN and DRUGB .
celecoxib	drug	lithium	drug
int

Clinical studies with DRUGN have identified potentially significant interactions with DRUGA and DRUGB .
fluconazole	drug	lithium	drug
false

Experience with DRUGA ( DRUGB ) suggests the potential for interactions with DRUGN and DRUGN .
nonsteroidal anti-inflammatory drugs	group	NSAIDs	group
false

Experience with DRUGA ( DRUGN ) suggests the potential for interactions with DRUGB and DRUGN .
nonsteroidal anti-inflammatory drugs	group	furosemide	drug
int

Experience with DRUGA ( DRUGN ) suggests the potential for interactions with DRUGN and DRUGB .
nonsteroidal anti-inflammatory drugs	group	ACE inhibitors	group
int

Experience with DRUGN ( DRUGA ) suggests the potential for interactions with DRUGB and DRUGN .
NSAIDs	group	furosemide	drug
int

Experience with DRUGN ( DRUGA ) suggests the potential for interactions with DRUGN and DRUGB .
NSAIDs	group	ACE inhibitors	group
int

Experience with DRUGN ( DRUGN ) suggests the potential for interactions with DRUGA and DRUGB .
furosemide	drug	ACE inhibitors	group
false

The effects DRUGA on the pharmacokinetics and / or pharmacodynamics of DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN have been studied in vivo and clinically important interactions have not been found .
celecoxib	drug	glyburide	drug
false

The effects DRUGA on the pharmacokinetics and / or pharmacodynamics of DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN have been studied in vivo and clinically important interactions have not been found .
celecoxib	drug	ketoconazole	drug
false

The effects DRUGA on the pharmacokinetics and / or pharmacodynamics of DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN have been studied in vivo and clinically important interactions have not been found .
celecoxib	drug	methotrexate	drug
false

The effects DRUGA on the pharmacokinetics and / or pharmacodynamics of DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN have been studied in vivo and clinically important interactions have not been found .
celecoxib	drug	phenytoin	drug
false

The effects DRUGA on the pharmacokinetics and / or pharmacodynamics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN have been studied in vivo and clinically important interactions have not been found .
celecoxib	drug	tolbutamide	drug
false

The effects DRUGA on the pharmacokinetics and / or pharmacodynamics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB have been studied in vivo and clinically important interactions have not been found .
celecoxib	drug	warfarin	drug
false

The effects DRUGN on the pharmacokinetics and / or pharmacodynamics of DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN have been studied in vivo and clinically important interactions have not been found .
glyburide	drug	ketoconazole	drug
false

The effects DRUGN on the pharmacokinetics and / or pharmacodynamics of DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN have been studied in vivo and clinically important interactions have not been found .
glyburide	drug	methotrexate	drug
false

The effects DRUGN on the pharmacokinetics and / or pharmacodynamics of DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN have been studied in vivo and clinically important interactions have not been found .
glyburide	drug	phenytoin	drug
false

The effects DRUGN on the pharmacokinetics and / or pharmacodynamics of DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN have been studied in vivo and clinically important interactions have not been found .
glyburide	drug	tolbutamide	drug
false

The effects DRUGN on the pharmacokinetics and / or pharmacodynamics of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB have been studied in vivo and clinically important interactions have not been found .
glyburide	drug	warfarin	drug
false

The effects DRUGN on the pharmacokinetics and / or pharmacodynamics of DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN have been studied in vivo and clinically important interactions have not been found .
ketoconazole	drug	methotrexate	drug
false

The effects DRUGN on the pharmacokinetics and / or pharmacodynamics of DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN have been studied in vivo and clinically important interactions have not been found .
ketoconazole	drug	phenytoin	drug
false

The effects DRUGN on the pharmacokinetics and / or pharmacodynamics of DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN have been studied in vivo and clinically important interactions have not been found .
ketoconazole	drug	tolbutamide	drug
false

The effects DRUGN on the pharmacokinetics and / or pharmacodynamics of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB have been studied in vivo and clinically important interactions have not been found .
ketoconazole	drug	warfarin	drug
false

The effects DRUGN on the pharmacokinetics and / or pharmacodynamics of DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN have been studied in vivo and clinically important interactions have not been found .
methotrexate	drug	phenytoin	drug
false

The effects DRUGN on the pharmacokinetics and / or pharmacodynamics of DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN have been studied in vivo and clinically important interactions have not been found .
methotrexate	drug	tolbutamide	drug
false

The effects DRUGN on the pharmacokinetics and / or pharmacodynamics of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB have been studied in vivo and clinically important interactions have not been found .
methotrexate	drug	warfarin	drug
false

The effects DRUGN on the pharmacokinetics and / or pharmacodynamics of DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN have been studied in vivo and clinically important interactions have not been found .
phenytoin	drug	tolbutamide	drug
false

The effects DRUGN on the pharmacokinetics and / or pharmacodynamics of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB have been studied in vivo and clinically important interactions have not been found .
phenytoin	drug	warfarin	drug
false

The effects DRUGN on the pharmacokinetics and / or pharmacodynamics of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB have been studied in vivo and clinically important interactions have not been found .
tolbutamide	drug	warfarin	drug
false

DRUGA : Reports suggest that DRUGB may diminish the antihypertensive effect of DRUGN .
ACE inhibitors	group	NSAIDs	group
false

DRUGA : Reports suggest that DRUGN may diminish the antihypertensive effect of DRUGB .
ACE inhibitors	group	Angiotensin Converting Enzyme (ACE) inhibitors	group
false

DRUGN : Reports suggest that DRUGA may diminish the antihypertensive effect of DRUGB .
NSAIDs	group	Angiotensin Converting Enzyme (ACE) inhibitors	group
effect

This interaction should be given consideration in patients taking DRUGA concomitantly with DRUGB .
CELEBREX	brand	ACE-inhibitors	group
advise

DRUGA : Clinical studies , as well as post marketing observations , have shown that DRUGB can reduce the natriuretic effect of DRUGN and DRUGN in some patients .
Furosemide	drug	NSAIDs	group
false

DRUGA : Clinical studies , as well as post marketing observations , have shown that DRUGN can reduce the natriuretic effect of DRUGB and DRUGN in some patients .
Furosemide	drug	furosemide	drug
false

DRUGA : Clinical studies , as well as post marketing observations , have shown that DRUGN can reduce the natriuretic effect of DRUGN and DRUGB in some patients .
Furosemide	drug	thiazides	group
false

DRUGN : Clinical studies , as well as post marketing observations , have shown that DRUGA can reduce the natriuretic effect of DRUGB and DRUGN in some patients .
NSAIDs	group	furosemide	drug
effect

DRUGN : Clinical studies , as well as post marketing observations , have shown that DRUGA can reduce the natriuretic effect of DRUGN and DRUGB in some patients .
NSAIDs	group	thiazides	group
effect

DRUGN : Clinical studies , as well as post marketing observations , have shown that DRUGN can reduce the natriuretic effect of DRUGA and DRUGB in some patients .
furosemide	drug	thiazides	group
false

DRUGA : DRUGB can be used with low dose DRUGN .
Aspirin	brand	CELEBREX	brand
false

DRUGA : DRUGN can be used with low dose DRUGB .
Aspirin	brand	aspirin	brand
false

DRUGN : DRUGA can be used with low dose DRUGB .
CELEBREX	brand	aspirin	brand
advise

However , concomitant administration of DRUGA with DRUGB may result in an increased rate of GI ulceration or other complications , compared to use of DRUGN alone .
aspirin	brand	CELEBREX	brand
effect

However , concomitant administration of DRUGA with DRUGN may result in an increased rate of GI ulceration or other complications , compared to use of DRUGB alone .
aspirin	brand	CELEBREX	brand
false

Because of its lack of platelet effects , DRUGA is not a substitute for DRUGB for cardiovascular prophylaxis .
CELEBREX	brand	aspirin	brand
false

DRUGA : Concomitant administration of DRUGB at dgb mg QD resulted in a two fold increase in DRUGN plasma concentration .
Fluconazole	drug	fluconazole	drug
false

DRUGA : Concomitant administration of DRUGN at dgb mg QD resulted in a two fold increase in DRUGB plasma concentration .
Fluconazole	drug	celecoxib	drug
false

DRUGN : Concomitant administration of DRUGA at dgb mg QD resulted in a two fold increase in DRUGB plasma concentration .
fluconazole	drug	celecoxib	drug
mechanism

This increase is due to the inhibition of DRUGA metabolism via Pdgb dgbCdgb by DRUGB ( see CLINICAL PHARMACOLOGY Pharmacokinetics : Metabolism ) .
celecoxib	drug	fluconazole	drug
mechanism

DRUGA should be introduced at the lowest recommended dose in patients receiving DRUGB .
CELEBREX	brand	fluconazole	drug
advise

DRUGA : In a study conducted in healthy subjects , mean steady state DRUGB plasma levels increased approximately dgb % in subjects receiving DRUGN dgb mg BID with DRUGN dgb mg BID as compared to subjects receiving DRUGN alone .
Lithium	drug	lithium	drug
false

DRUGA : In a study conducted in healthy subjects , mean steady state DRUGN plasma levels increased approximately dgb % in subjects receiving DRUGB dgb mg BID with DRUGN dgb mg BID as compared to subjects receiving DRUGN alone .
Lithium	drug	lithium	drug
false

DRUGA : In a study conducted in healthy subjects , mean steady state DRUGN plasma levels increased approximately dgb % in subjects receiving DRUGN dgb mg BID with DRUGB dgb mg BID as compared to subjects receiving DRUGN alone .
Lithium	drug	CELEBREX	brand
false

DRUGA : In a study conducted in healthy subjects , mean steady state DRUGN plasma levels increased approximately dgb % in subjects receiving DRUGN dgb mg BID with DRUGN dgb mg BID as compared to subjects receiving DRUGB alone .
Lithium	drug	lithium	drug
false

DRUGN : In a study conducted in healthy subjects , mean steady state DRUGA plasma levels increased approximately dgb % in subjects receiving DRUGN dgb mg BID with DRUGB dgb mg BID as compared to subjects receiving DRUGN alone .
lithium	drug	CELEBREX	brand
false

DRUGN : In a study conducted in healthy subjects , mean steady state DRUGN plasma levels increased approximately dgb % in subjects receiving DRUGA dgb mg BID with DRUGB dgb mg BID as compared to subjects receiving DRUGN alone .
lithium	drug	CELEBREX	brand
mechanism

DRUGN : In a study conducted in healthy subjects , mean steady state DRUGN plasma levels increased approximately dgb % in subjects receiving DRUGN dgb mg BID with DRUGA dgb mg BID as compared to subjects receiving DRUGB alone .
CELEBREX	brand	lithium	drug
false

Patients on DRUGA treatment should be closely monitored when DRUGB is introduced or withdrawn .
lithium	drug	CELEBREX	brand
advise

DRUGA : In an interaction study of rheumatoid arthritis patients taking DRUGB , DRUGN did not have a significant effect on the pharmacokinetics of DRUGN .
Methotrexate	drug	methotrexate	drug
false

DRUGA : In an interaction study of rheumatoid arthritis patients taking DRUGN , DRUGB did not have a significant effect on the pharmacokinetics of DRUGN .
Methotrexate	drug	CELEBREX	brand
false

DRUGA : In an interaction study of rheumatoid arthritis patients taking DRUGN , DRUGN did not have a significant effect on the pharmacokinetics of DRUGB .
Methotrexate	drug	methotrexate	drug
false

DRUGN : In an interaction study of rheumatoid arthritis patients taking DRUGA , DRUGB did not have a significant effect on the pharmacokinetics of DRUGN .
methotrexate	drug	CELEBREX	brand
false

DRUGN : In an interaction study of rheumatoid arthritis patients taking DRUGN , DRUGA did not have a significant effect on the pharmacokinetics of DRUGB .
CELEBREX	brand	methotrexate	drug
false

DRUGA : The effect of DRUGB on the anti coagulant effect of DRUGN was studied in a group of healthy subjects receiving daily doses of dgb dgb mg of DRUGN .
Warfarin	drug	celecoxib	drug
false

DRUGA : The effect of DRUGN on the anti coagulant effect of DRUGB was studied in a group of healthy subjects receiving daily doses of dgb dgb mg of DRUGN .
Warfarin	drug	warfarin	drug
false

DRUGA : The effect of DRUGN on the anti coagulant effect of DRUGN was studied in a group of healthy subjects receiving daily doses of dgb dgb mg of DRUGB .
Warfarin	drug	warfarin	drug
false

DRUGN : The effect of DRUGA on the anti coagulant effect of DRUGB was studied in a group of healthy subjects receiving daily doses of dgb dgb mg of DRUGN .
celecoxib	drug	warfarin	drug
false

DRUGN : The effect of DRUGA on the anti coagulant effect of DRUGN was studied in a group of healthy subjects receiving daily doses of dgb dgb mg of DRUGB .
celecoxib	drug	warfarin	drug
false

In these subjects , DRUGA did not alter the anticoagulant effect of DRUGB as determined by prothrombin time .
celecoxib	drug	warfarin	drug
false

However , caution should be used when administering DRUGA with DRUGB since these patients are at increased risk of bleeding complications .
CELEBREX	brand	warfarin	drug
advise

No information is available about the interaction of DRUGA and DRUGB following multiple doses of either drug .
cephalexin	drug	metformin	drug
false

Although not observed in this study , adverse effects could potentially arise from co administration of DRUGA and DRUGB by inhibition of tubular secretion via organic cationic transporter systems .
cephalexin	drug	metformin	drug
mechanism

Accordingly , careful patient monitoring and dose adjustment of DRUGA is recommended in patients concomitantly taking DRUGB and DRUGN .
metformin	drug	cephalexin	drug
false

Accordingly , careful patient monitoring and dose adjustment of DRUGN is recommended in patients concomitantly taking DRUGA and DRUGB .
cephalexin	drug	metformin	drug
advise

DRUGA : As with other DRUGB , the renal excretion of DRUGN is inhibited by DRUGN .
Probenecid	drug	b-lactams	group
false

DRUGA : As with other DRUGN , the renal excretion of DRUGB is inhibited by DRUGN .
Probenecid	drug	cephalexin	drug
false

DRUGA : As with other DRUGN , the renal excretion of DRUGN is inhibited by DRUGB .
Probenecid	drug	probenecid	drug
false

DRUGN : As with other DRUGA , the renal excretion of DRUGB is inhibited by DRUGN .
b-lactams	group	cephalexin	drug
false

DRUGN : As with other DRUGA , the renal excretion of DRUGN is inhibited by DRUGB .
b-lactams	group	probenecid	drug
false

DRUGN : As with other DRUGN , the renal excretion of DRUGA is inhibited by DRUGB .
cephalexin	drug	probenecid	drug
mechanism

DRUGA , DRUGB , DRUGN ( DRUGN , DRUGN , DRUGN : Skeletal Muscle .
Immunosuppressive Drugs	group	Fibric Acid Derivatives	group
false

DRUGA , DRUGN , DRUGB ( DRUGN , DRUGN , DRUGN : Skeletal Muscle .
Immunosuppressive Drugs	group	Niacin	drug
false

DRUGA , DRUGN , DRUGN ( DRUGB , DRUGN , DRUGN : Skeletal Muscle .
Immunosuppressive Drugs	group	Nicotinic Acid	drug
false

DRUGA , DRUGN , DRUGN ( DRUGN , DRUGB , DRUGN : Skeletal Muscle .
Immunosuppressive Drugs	group	Erythromycin	drug
false

DRUGA , DRUGN , DRUGN ( DRUGN , DRUGN , DRUGB : Skeletal Muscle .
Immunosuppressive Drugs	group	Azole Antifungals	group
false

DRUGN , DRUGA , DRUGB ( DRUGN , DRUGN , DRUGN : Skeletal Muscle .
Fibric Acid Derivatives	group	Niacin	drug
false

DRUGN , DRUGA , DRUGN ( DRUGB , DRUGN , DRUGN : Skeletal Muscle .
Fibric Acid Derivatives	group	Nicotinic Acid	drug
false

DRUGN , DRUGA , DRUGN ( DRUGN , DRUGB , DRUGN : Skeletal Muscle .
Fibric Acid Derivatives	group	Erythromycin	drug
false

DRUGN , DRUGA , DRUGN ( DRUGN , DRUGN , DRUGB : Skeletal Muscle .
Fibric Acid Derivatives	group	Azole Antifungals	group
false

DRUGN , DRUGN , DRUGA ( DRUGB , DRUGN , DRUGN : Skeletal Muscle .
Niacin	drug	Nicotinic Acid	drug
false

DRUGN , DRUGN , DRUGA ( DRUGN , DRUGB , DRUGN : Skeletal Muscle .
Niacin	drug	Erythromycin	drug
false

DRUGN , DRUGN , DRUGA ( DRUGN , DRUGN , DRUGB : Skeletal Muscle .
Niacin	drug	Azole Antifungals	group
false

DRUGN , DRUGN , DRUGN ( DRUGA , DRUGB , DRUGN : Skeletal Muscle .
Nicotinic Acid	drug	Erythromycin	drug
false

DRUGN , DRUGN , DRUGN ( DRUGA , DRUGN , DRUGB : Skeletal Muscle .
Nicotinic Acid	drug	Azole Antifungals	group
false

DRUGN , DRUGN , DRUGN ( DRUGN , DRUGA , DRUGB : Skeletal Muscle .
Erythromycin	drug	Azole Antifungals	group
false

DRUGA ( DRUGB ) : DRUGN plasma concentrations were not affected by co administration of DRUGN .
ANTACID	group	Magnesium-Aluminum Hydroxide	drug
false

DRUGA ( DRUGN ) : DRUGB plasma concentrations were not affected by co administration of DRUGN .
ANTACID	group	Cerivastatin	drug
false

DRUGA ( DRUGN ) : DRUGN plasma concentrations were not affected by co administration of DRUGB .
ANTACID	group	antacid	group
false

DRUGN ( DRUGA ) : DRUGB plasma concentrations were not affected by co administration of DRUGN .
Magnesium-Aluminum Hydroxide	drug	Cerivastatin	drug
false

DRUGN ( DRUGA ) : DRUGN plasma concentrations were not affected by co administration of DRUGB .
Magnesium-Aluminum Hydroxide	drug	antacid	group
false

DRUGN ( DRUGN ) : DRUGA plasma concentrations were not affected by co administration of DRUGB .
Cerivastatin	drug	antacid	group
false

DRUGA : DRUGB plasma concentrations were not affected by co administration of DRUGN .
CIMETlDINE	drug	Cerivastatin	drug
false

DRUGA : DRUGN plasma concentrations were not affected by co administration of DRUGB .
CIMETlDINE	drug	cimetidine	drug
false

DRUGN : DRUGA plasma concentrations were not affected by co administration of DRUGB .
Cerivastatin	drug	cimetidine	drug
false

DRUGA : The influence of the bile acidsequestering agent DRUGB on the pharmacokinetits of DRUGN was evaluated in dgb healthy males in dgb separate randomized crossover studies .
CHOLESTYRAMINE	drug	cholestyramine	drug
false

DRUGA : The influence of the bile acidsequestering agent DRUGN on the pharmacokinetits of DRUGB was evaluated in dgb healthy males in dgb separate randomized crossover studies .
CHOLESTYRAMINE	drug	cerivastatin sodium	drug
false

DRUGN : The influence of the bile acidsequestering agent DRUGA on the pharmacokinetits of DRUGB was evaluated in dgb healthy males in dgb separate randomized crossover studies .
cholestyramine	drug	cerivastatin sodium	drug
false

In the first study , concomitant administration of dga mg DRUGA and dgb g DRUGB resulted in decreases of more than dgb % for AUC and dgb % for Cmax when compared to dosing DRUGN alone .
cerivastatin sodium	drug	cholestyramine	drug
mechanism

In the first study , concomitant administration of dga mg DRUGN and dgb g DRUGA resulted in decreases of more than dgb % for AUC and dgb % for Cmax when compared to dosing DRUGB alone .
cholestyramine	drug	cerivastatin sodium	drug
false

Therefore , it would be expected that a dosing schedule of DRUGA given at bedtime and DRUGB given before the evening meal would not result in a significant decrease in the clinical effect of DRUGN .
cerivastatin sodium	drug	cholestyramine	drug
false

Therefore , it would be expected that a dosing schedule of DRUGN given at bedtime and DRUGA given before the evening meal would not result in a significant decrease in the clinical effect of DRUGB .
cholestyramine	drug	cerivastatin sodium	drug
false

DRUGA : Plasma DRUGB levels and DRUGN clearance at steady state were not affected by co administration of dga mg DRUGN .
DIGOXIN	drug	digoxin	drug
false

DRUGA : Plasma DRUGN levels and DRUGB clearance at steady state were not affected by co administration of dga mg DRUGN .
DIGOXIN	drug	digoxin	drug
false

DRUGA : Plasma DRUGN levels and DRUGN clearance at steady state were not affected by co administration of dga mg DRUGB .
DIGOXIN	drug	cerivastatin sodium	drug
false

DRUGN : Plasma DRUGA levels and DRUGN clearance at steady state were not affected by co administration of dga mg DRUGB .
digoxin	drug	cerivastatin sodium	drug
false

DRUGN : Plasma DRUGN levels and DRUGA clearance at steady state were not affected by co administration of dga mg DRUGB .
digoxin	drug	cerivastatin sodium	drug
false

DRUGA plasma concentrations were also not affected by co administration of DRUGB .
Cerivastatin	drug	digoxin	drug
false

DRUGA : Co administration of DRUGB and DRUGN to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co administration of DRUGN and placebo .
WARFARIN	drug	warfarin	drug
false

DRUGA : Co administration of DRUGN and DRUGB to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co administration of DRUGN and placebo .
WARFARIN	drug	cerivastatin	drug
false

DRUGA : Co administration of DRUGN and DRUGN to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co administration of DRUGB and placebo .
WARFARIN	drug	warfarin	drug
false

DRUGN : Co administration of DRUGA and DRUGB to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co administration of DRUGN and placebo .
warfarin	drug	cerivastatin	drug
false

DRUGN : Co administration of DRUGN and DRUGA to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co administration of DRUGB and placebo .
cerivastatin	drug	warfarin	drug
false

The AUC and Cmax of both the ( R ) and ( S ) isomers of DRUGA were unaffected by concurrent dosing of dga mg DRUGB .
warfarin	drug	cerivastatin sodium	drug
false

Co administration of DRUGA and DRUGB did not alter the pharmacokinetics of DRUGN .
warfarin	drug	cerivastatin	drug
false

Co administration of DRUGA and DRUGN did not alter the pharmacokinetics of DRUGB .
warfarin	drug	cerivastatin sodium	drug
false

Co administration of DRUGN and DRUGA did not alter the pharmacokinetics of DRUGB .
cerivastatin	drug	cerivastatin sodium	drug
false

DRUGA : In hypercholesterolemic patients , steady state DRUGB AUC and Cmax increased approximately dgb % and dgb % respectively after dgb days with co administration of DRUGN , a known inhibitor of cytochrome Pdgb dgbAdga
ERYTHROMYCIN	drug	cerivastatin	drug
false

DRUGA : In hypercholesterolemic patients , steady state DRUGN AUC and Cmax increased approximately dgb % and dgb % respectively after dgb days with co administration of DRUGB , a known inhibitor of cytochrome Pdgb dgbAdga
ERYTHROMYCIN	drug	erythromycin	drug
false

DRUGN : In hypercholesterolemic patients , steady state DRUGA AUC and Cmax increased approximately dgb % and dgb % respectively after dgb days with co administration of DRUGB , a known inhibitor of cytochrome Pdgb dgbAdga
cerivastatin	drug	erythromycin	drug
mechanism

Pharmacokinetic interaction studies with DRUGA in adults were conducted with DRUGB , DRUGN , DRUGN , DRUGN and DRUGN .
cetirizine	drug	pseudoephedrine	drug
false

Pharmacokinetic interaction studies with DRUGA in adults were conducted with DRUGN , DRUGB , DRUGN , DRUGN and DRUGN .
cetirizine	drug	antipyrine	drug
false

Pharmacokinetic interaction studies with DRUGA in adults were conducted with DRUGN , DRUGN , DRUGB , DRUGN and DRUGN .
cetirizine	drug	ketoconazole	drug
false

Pharmacokinetic interaction studies with DRUGA in adults were conducted with DRUGN , DRUGN , DRUGN , DRUGB and DRUGN .
cetirizine	drug	erythromycin	drug
false

Pharmacokinetic interaction studies with DRUGA in adults were conducted with DRUGN , DRUGN , DRUGN , DRUGN and DRUGB .
cetirizine	drug	azithromycin	drug
false

Pharmacokinetic interaction studies with DRUGN in adults were conducted with DRUGA , DRUGB , DRUGN , DRUGN and DRUGN .
pseudoephedrine	drug	antipyrine	drug
false

Pharmacokinetic interaction studies with DRUGN in adults were conducted with DRUGA , DRUGN , DRUGB , DRUGN and DRUGN .
pseudoephedrine	drug	ketoconazole	drug
false

Pharmacokinetic interaction studies with DRUGN in adults were conducted with DRUGA , DRUGN , DRUGN , DRUGB and DRUGN .
pseudoephedrine	drug	erythromycin	drug
false

Pharmacokinetic interaction studies with DRUGN in adults were conducted with DRUGA , DRUGN , DRUGN , DRUGN and DRUGB .
pseudoephedrine	drug	azithromycin	drug
false

Pharmacokinetic interaction studies with DRUGN in adults were conducted with DRUGN , DRUGA , DRUGB , DRUGN and DRUGN .
antipyrine	drug	ketoconazole	drug
false

Pharmacokinetic interaction studies with DRUGN in adults were conducted with DRUGN , DRUGA , DRUGN , DRUGB and DRUGN .
antipyrine	drug	erythromycin	drug
false

Pharmacokinetic interaction studies with DRUGN in adults were conducted with DRUGN , DRUGA , DRUGN , DRUGN and DRUGB .
antipyrine	drug	azithromycin	drug
false

Pharmacokinetic interaction studies with DRUGN in adults were conducted with DRUGN , DRUGN , DRUGA , DRUGB and DRUGN .
ketoconazole	drug	erythromycin	drug
false

Pharmacokinetic interaction studies with DRUGN in adults were conducted with DRUGN , DRUGN , DRUGA , DRUGN and DRUGB .
ketoconazole	drug	azithromycin	drug
false

Pharmacokinetic interaction studies with DRUGN in adults were conducted with DRUGN , DRUGN , DRUGN , DRUGA and DRUGB .
erythromycin	drug	azithromycin	drug
false

In a multiple dose study of DRUGA ( dgb mg once daily for dgb days ) and DRUGB ( dgb mg once daily for dgb days ) , a dgb % decrease in the clearance of DRUGN was observed .
theophylline	drug	cetirizine	drug
mechanism

In a multiple dose study of DRUGA ( dgb mg once daily for dgb days ) and DRUGN ( dgb mg once daily for dgb days ) , a dgb % decrease in the clearance of DRUGB was observed .
theophylline	drug	cetirizine	drug
false

The disposition of DRUGA was not altered by concomitant DRUGB administration .
theophylline	drug	cetirizine	drug
false

Drug Drug Interactions : No clinically significant drug interactions have been found with DRUGA at a low dose , DRUGB , DRUGN , DRUGN , or DRUGN .
theophylline	drug	azithromycin	drug
false

Drug Drug Interactions : No clinically significant drug interactions have been found with DRUGA at a low dose , DRUGN , DRUGB , DRUGN , or DRUGN .
theophylline	drug	pseudoephedrine	drug
false

Drug Drug Interactions : No clinically significant drug interactions have been found with DRUGA at a low dose , DRUGN , DRUGN , DRUGB , or DRUGN .
theophylline	drug	ketoconazole	drug
false

Drug Drug Interactions : No clinically significant drug interactions have been found with DRUGA at a low dose , DRUGN , DRUGN , DRUGN , or DRUGB .
theophylline	drug	erythromycin	drug
false

Drug Drug Interactions : No clinically significant drug interactions have been found with DRUGN at a low dose , DRUGA , DRUGB , DRUGN , or DRUGN .
azithromycin	drug	pseudoephedrine	drug
false

Drug Drug Interactions : No clinically significant drug interactions have been found with DRUGN at a low dose , DRUGA , DRUGN , DRUGB , or DRUGN .
azithromycin	drug	ketoconazole	drug
false

Drug Drug Interactions : No clinically significant drug interactions have been found with DRUGN at a low dose , DRUGA , DRUGN , DRUGN , or DRUGB .
azithromycin	drug	erythromycin	drug
false

Drug Drug Interactions : No clinically significant drug interactions have been found with DRUGN at a low dose , DRUGN , DRUGA , DRUGB , or DRUGN .
pseudoephedrine	drug	ketoconazole	drug
false

Drug Drug Interactions : No clinically significant drug interactions have been found with DRUGN at a low dose , DRUGN , DRUGA , DRUGN , or DRUGB .
pseudoephedrine	drug	erythromycin	drug
false

Drug Drug Interactions : No clinically significant drug interactions have been found with DRUGN at a low dose , DRUGN , DRUGN , DRUGA , or DRUGB .
ketoconazole	drug	erythromycin	drug
false

There was a small decrease in the clearance of DRUGA caused by a dgb mg dose of DRUGB ;
cetirizine	drug	theophylline	drug
mechanism

A drug interaction study was performed in which DRUGA was administered in combination with DRUGB .
ERBITUX	brand	irinotecan	drug
false

There was no evidence of any pharmacokinetic interactions between DRUGA and DRUGB .
ERBITUX	brand	irinotecan	drug
false

DRUGA should be administered with caution to patients taking DRUGB , because of the possibility of conduction disturbances .
Cevimeline	drug	beta adrenergic antagonists	group
advise

Although clinical studies have not established a cause and effect relationship , physicians should be aware that variable effects an blood coagulation have been reported very rarely in patients receiving oral DRUGA and DRUGB .
anticoagulants	group	chlordiazepoxide	drug
effect

The concomitant use of DRUGA or other DRUGB may have an additive effect .
alcohol	drug	central nervous system depressants	group
false

The administration of local DRUGA containing DRUGB or DRUGN to patients receiving DRUGN , DRUGN or DRUGN may produce severe , prolonged hypotension or hypertension .
anesthetic solutions	group	epinephrine	drug
false

The administration of local DRUGA containing DRUGN or DRUGB to patients receiving DRUGN , DRUGN or DRUGN may produce severe , prolonged hypotension or hypertension .
anesthetic solutions	group	norepinephrine	drug
false

The administration of local DRUGA containing DRUGN or DRUGN to patients receiving DRUGB , DRUGN or DRUGN may produce severe , prolonged hypotension or hypertension .
anesthetic solutions	group	monoamine oxidase inhibitors	group
false

The administration of local DRUGA containing DRUGN or DRUGN to patients receiving DRUGN , DRUGB or DRUGN may produce severe , prolonged hypotension or hypertension .
anesthetic solutions	group	tricyclic antidepressants	group
effect

The administration of local DRUGA containing DRUGN or DRUGN to patients receiving DRUGN , DRUGN or DRUGB may produce severe , prolonged hypotension or hypertension .
anesthetic solutions	group	phenothiazines	group
effect

The administration of local DRUGN containing DRUGA or DRUGB to patients receiving DRUGN , DRUGN or DRUGN may produce severe , prolonged hypotension or hypertension .
epinephrine	drug	norepinephrine	drug
false

The administration of local DRUGN containing DRUGA or DRUGN to patients receiving DRUGB , DRUGN or DRUGN may produce severe , prolonged hypotension or hypertension .
epinephrine	drug	monoamine oxidase inhibitors	group
effect

The administration of local DRUGN containing DRUGA or DRUGN to patients receiving DRUGN , DRUGB or DRUGN may produce severe , prolonged hypotension or hypertension .
epinephrine	drug	tricyclic antidepressants	group
effect

The administration of local DRUGN containing DRUGA or DRUGN to patients receiving DRUGN , DRUGN or DRUGB may produce severe , prolonged hypotension or hypertension .
epinephrine	drug	phenothiazines	group
effect

The administration of local DRUGN containing DRUGN or DRUGA to patients receiving DRUGB , DRUGN or DRUGN may produce severe , prolonged hypotension or hypertension .
norepinephrine	drug	monoamine oxidase inhibitors	group
effect

The administration of local DRUGN containing DRUGN or DRUGA to patients receiving DRUGN , DRUGB or DRUGN may produce severe , prolonged hypotension or hypertension .
norepinephrine	drug	tricyclic antidepressants	group
effect

The administration of local DRUGN containing DRUGN or DRUGA to patients receiving DRUGN , DRUGN or DRUGB may produce severe , prolonged hypotension or hypertension .
norepinephrine	drug	phenothiazines	group
effect

The administration of local DRUGN containing DRUGN or DRUGN to patients receiving DRUGA , DRUGB or DRUGN may produce severe , prolonged hypotension or hypertension .
monoamine oxidase inhibitors	group	tricyclic antidepressants	group
false

The administration of local DRUGN containing DRUGN or DRUGN to patients receiving DRUGA , DRUGN or DRUGB may produce severe , prolonged hypotension or hypertension .
monoamine oxidase inhibitors	group	phenothiazines	group
false

The administration of local DRUGN containing DRUGN or DRUGN to patients receiving DRUGN , DRUGA or DRUGB may produce severe , prolonged hypotension or hypertension .
tricyclic antidepressants	group	phenothiazines	group
false

Concurrent administration of DRUGA ( for the treatment of hypotension related to obstetric blocks ) and DRUGB may cause severe , persistent hypertension or cerebrovascular accidents .
vasopressor drugs	group	ergot-type oxytocic drugs	group
effect

Therefore , DRUGA should not be used in any condition in which a DRUGB is being employed .
chloroprocaine	drug	sulfonamide drug	group
advise

DRUGA and DRUGB : DRUGN and DRUGN can reduce absorption of DRUGN ;
Antacids	group	kaolin	drug
false

DRUGA and DRUGN : DRUGN and DRUGB can reduce absorption of DRUGN ;
Antacids	group	kaolin	drug
false

DRUGA and DRUGN : DRUGN and DRUGN can reduce absorption of DRUGB ;
Antacids	group	chloroquine	drug
false

DRUGN and DRUGA : DRUGB and DRUGN can reduce absorption of DRUGN ;
kaolin	drug	Antacids	group
false

DRUGN and DRUGA : DRUGN and DRUGN can reduce absorption of DRUGB ;
kaolin	drug	chloroquine	drug
false

DRUGN and DRUGN : DRUGA and DRUGB can reduce absorption of DRUGN ;
Antacids	group	kaolin	drug
false

DRUGN and DRUGN : DRUGA and DRUGN can reduce absorption of DRUGB ;
Antacids	group	chloroquine	drug
mechanism

DRUGN and DRUGN : DRUGN and DRUGA can reduce absorption of DRUGB ;
kaolin	drug	chloroquine	drug
mechanism

DRUGA : DRUGN can inhibit the metabolism of DRUGB , increasing its plasma level .
Cimetidine	drug	chloroquine	drug
false

DRUGN : DRUGA can inhibit the metabolism of DRUGB , increasing its plasma level .
Cimetidine	drug	chloroquine	drug
mechanism

DRUGA : In a study of healthy volunteers , DRUGB significantly reduced the bioavailability of DRUGN .
Ampicillin	drug	chloroquine	drug
false

DRUGA : In a study of healthy volunteers , DRUGN significantly reduced the bioavailability of DRUGB .
Ampicillin	drug	ampicillin	drug
false

DRUGN : In a study of healthy volunteers , DRUGA significantly reduced the bioavailability of DRUGB .
chloroquine	drug	ampicillin	drug
mechanism

DRUGA : After introduction of DRUGB ( oral form ) , a sudden increase in serum DRUGN level has been reported .
Cyclosporin	drug	chloroquine	drug
false

DRUGA : After introduction of DRUGN ( oral form ) , a sudden increase in serum DRUGB level has been reported .
Cyclosporin	drug	cyclosporin	drug
false

DRUGN : After introduction of DRUGA ( oral form ) , a sudden increase in serum DRUGB level has been reported .
chloroquine	drug	cyclosporin	drug
mechanism

Therefore , close monitoring of serum DRUGA level is recommended and , if necessary , DRUGB should be discontinued .
cyclosporin	drug	chloroquine	drug
false

DRUGA , DRUGB , or DRUGN : Potentiation of otthostatic hypotension may occur
Alcohol	drug	barbiturates	group
false

DRUGA , DRUGN , or DRUGB : Potentiation of otthostatic hypotension may occur
Alcohol	drug	narcotics	group
false

DRUGN , DRUGA , or DRUGB : Potentiation of otthostatic hypotension may occur
barbiturates	group	narcotics	group
false

DRUGA : ( Oral agents and DRUGB ) Dosage adjustment of the DRUGN may be required
Antidiabetic drugs	group	insulin	drug
false

DRUGA : ( Oral agents and DRUGN ) Dosage adjustment of the DRUGB may be required
Antidiabetic drugs	group	antidiabetic drug	group
false

DRUGN : ( Oral agents and DRUGA ) Dosage adjustment of the DRUGB may be required
insulin	drug	antidiabetic drug	group
false

DRUGA and DRUGB DRUGN : DRUGN and DRUGN DRUGN have the potential of binding DRUGN and reducing DRUGN absorption from the gastrointestinal tract
Cholestyramine	drug	colestipol	drug
false

DRUGA and DRUGN DRUGB : DRUGN and DRUGN DRUGN have the potential of binding DRUGN and reducing DRUGN absorption from the gastrointestinal tract
Cholestyramine	drug	resins	group
false

DRUGA and DRUGN DRUGN : DRUGB and DRUGN DRUGN have the potential of binding DRUGN and reducing DRUGN absorption from the gastrointestinal tract
Cholestyramine	drug	Cholestytamine	drug
false

DRUGA and DRUGN DRUGN : DRUGN and DRUGB DRUGN have the potential of binding DRUGN and reducing DRUGN absorption from the gastrointestinal tract
Cholestyramine	drug	colestipol	drug
false

DRUGA and DRUGN DRUGN : DRUGN and DRUGN DRUGB have the potential of binding DRUGN and reducing DRUGN absorption from the gastrointestinal tract
Cholestyramine	drug	resins	group
false

DRUGA and DRUGN DRUGN : DRUGN and DRUGN DRUGN have the potential of binding DRUGB and reducing DRUGN absorption from the gastrointestinal tract
Cholestyramine	drug	thiazide diuretics	group
false

DRUGA and DRUGN DRUGN : DRUGN and DRUGN DRUGN have the potential of binding DRUGN and reducing DRUGB absorption from the gastrointestinal tract
Cholestyramine	drug	diuretic	group
false

DRUGN and DRUGA DRUGB : DRUGN and DRUGN DRUGN have the potential of binding DRUGN and reducing DRUGN absorption from the gastrointestinal tract
colestipol	drug	resins	group
false

DRUGN and DRUGA DRUGN : DRUGB and DRUGN DRUGN have the potential of binding DRUGN and reducing DRUGN absorption from the gastrointestinal tract
colestipol	drug	Cholestytamine	drug
false

DRUGN and DRUGA DRUGN : DRUGN and DRUGN DRUGB have the potential of binding DRUGN and reducing DRUGN absorption from the gastrointestinal tract
colestipol	drug	resins	group
false

DRUGN and DRUGA DRUGN : DRUGN and DRUGN DRUGN have the potential of binding DRUGB and reducing DRUGN absorption from the gastrointestinal tract
colestipol	drug	thiazide diuretics	group
false

DRUGN and DRUGA DRUGN : DRUGN and DRUGN DRUGN have the potential of binding DRUGN and reducing DRUGB absorption from the gastrointestinal tract
colestipol	drug	diuretic	group
false

DRUGN and DRUGN DRUGA : DRUGB and DRUGN DRUGN have the potential of binding DRUGN and reducing DRUGN absorption from the gastrointestinal tract
resins	group	Cholestytamine	drug
false

DRUGN and DRUGN DRUGA : DRUGN and DRUGB DRUGN have the potential of binding DRUGN and reducing DRUGN absorption from the gastrointestinal tract
resins	group	colestipol	drug
false

DRUGN and DRUGN DRUGA : DRUGN and DRUGN DRUGN have the potential of binding DRUGB and reducing DRUGN absorption from the gastrointestinal tract
resins	group	thiazide diuretics	group
false

DRUGN and DRUGN DRUGA : DRUGN and DRUGN DRUGN have the potential of binding DRUGN and reducing DRUGB absorption from the gastrointestinal tract
resins	group	diuretic	group
false

DRUGN and DRUGN DRUGN : DRUGA and DRUGB DRUGN have the potential of binding DRUGN and reducing DRUGN absorption from the gastrointestinal tract
Cholestytamine	drug	colestipol	drug
false

DRUGN and DRUGN DRUGN : DRUGA and DRUGN DRUGB have the potential of binding DRUGN and reducing DRUGN absorption from the gastrointestinal tract
Cholestytamine	drug	resins	group
false

DRUGN and DRUGN DRUGN : DRUGA and DRUGN DRUGN have the potential of binding DRUGB and reducing DRUGN absorption from the gastrointestinal tract
Cholestytamine	drug	thiazide diuretics	group
mechanism

DRUGN and DRUGN DRUGN : DRUGA and DRUGN DRUGN have the potential of binding DRUGN and reducing DRUGB absorption from the gastrointestinal tract
Cholestytamine	drug	diuretic	group
false

DRUGN and DRUGN DRUGN : DRUGN and DRUGA DRUGB have the potential of binding DRUGN and reducing DRUGN absorption from the gastrointestinal tract
colestipol	drug	resins	group
false

DRUGN and DRUGN DRUGN : DRUGN and DRUGA DRUGN have the potential of binding DRUGB and reducing DRUGN absorption from the gastrointestinal tract
colestipol	drug	thiazide diuretics	group
mechanism

DRUGN and DRUGN DRUGN : DRUGN and DRUGA DRUGN have the potential of binding DRUGN and reducing DRUGB absorption from the gastrointestinal tract
colestipol	drug	diuretic	group
false

DRUGN and DRUGN DRUGN : DRUGN and DRUGN DRUGA have the potential of binding DRUGB and reducing DRUGN absorption from the gastrointestinal tract
resins	group	thiazide diuretics	group
false

DRUGN and DRUGN DRUGN : DRUGN and DRUGN DRUGA have the potential of binding DRUGN and reducing DRUGB absorption from the gastrointestinal tract
resins	group	diuretic	group
false

DRUGN and DRUGN DRUGN : DRUGN and DRUGN DRUGN have the potential of binding DRUGA and reducing DRUGB absorption from the gastrointestinal tract
thiazide diuretics	group	diuretic	group
false

DRUGA , DRUGB : Intensified electrolyte depletion , particularly hypokalemia
Corticosteroids	group	ACTH	drug
false

DRUGA , nondepolarizing ( e.g . , DRUGB ) : Possible increased responsiveness to the DRUGN
Skeletal muscle relaxants	group	tubocurarine	drug
false

DRUGA , nondepolarizing ( e.g . , DRUGN ) : Possible increased responsiveness to the DRUGB
Skeletal muscle relaxants	group	muscle relaxant	group
false

DRUGN , nondepolarizing ( e.g . , DRUGA ) : Possible increased responsiveness to the DRUGB
tubocurarine	drug	muscle relaxant	group
false

DRUGA : Generally should not be given with DRUGB .
Lithium	drug	diuretics	group
advise

DRUGA reduce the renal clearance of DRUGB and add a high risk of DRUGN toxicity .
Diuretic agents	group	lithium	drug
mechanism

DRUGA reduce the renal clearance of DRUGN and add a high risk of DRUGB toxicity .
Diuretic agents	group	lithium	drug
mechanism

Refer to the package insert for DRUGA preparations before use of such preparations with DRUGB
lithium	drug	chlorothiazide	drug
advise

DRUGA : In some patients , the administration of a DRUGB can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGN and DRUGN .
Non-steroidal Anti-inflammatory Drugs	group	non-steroidal anti-inflammatory agent	group
false

DRUGA : In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGB , DRUGN and DRUGN .
Non-steroidal Anti-inflammatory Drugs	group	loop diuretics	group
false

DRUGA : In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGB and DRUGN .
Non-steroidal Anti-inflammatory Drugs	group	potassium-sparing diuretics	group
false

DRUGA : In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGN and DRUGB .
Non-steroidal Anti-inflammatory Drugs	group	thiazide diuretics	drug
false

DRUGN : In some patients , the administration of a DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGB , DRUGN and DRUGN .
non-steroidal anti-inflammatory agent	group	loop diuretics	group
effect

DRUGN : In some patients , the administration of a DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGB and DRUGN .
non-steroidal anti-inflammatory agent	group	potassium-sparing diuretics	group
effect

DRUGN : In some patients , the administration of a DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGN and DRUGB .
non-steroidal anti-inflammatory agent	group	thiazide diuretics	drug
effect

DRUGN : In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGA , DRUGB and DRUGN .
loop diuretics	group	potassium-sparing diuretics	group
false

DRUGN : In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGA , DRUGN and DRUGB .
loop diuretics	group	thiazide diuretics	drug
false

DRUGN : In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGA and DRUGB .
potassium-sparing diuretics	group	thiazide diuretics	drug
false

Therefore , when DRUGA and DRUGB are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGN is obtained
chlorothiazide	drug	non-steroidal anti-inflammatory agents	group
advise

Therefore , when DRUGA and DRUGN are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGB is obtained
chlorothiazide	drug	diuretic	group
false

Therefore , when DRUGN and DRUGA are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGB is obtained
non-steroidal anti-inflammatory agents	group	diuretic	group
false

DRUGA may interact with DRUGB , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
Chlorotrianisene	drug	antidepressants	group
int

DRUGA may interact with DRUGN , DRUGB , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
Chlorotrianisene	drug	aspirin	brand
int

DRUGA may interact with DRUGN , DRUGN , DRUGB , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
Chlorotrianisene	drug	barbiturates	group
int

DRUGA may interact with DRUGN , DRUGN , DRUGN dgb , DRUGB , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
Chlorotrianisene	drug	bromocriptine	drug
int

DRUGA may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGB supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
Chlorotrianisene	drug	calcium	drug
int

DRUGA may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGB , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
Chlorotrianisene	drug	corticosteroids	group
int

DRUGA may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
Chlorotrianisene	drug	corticotropin	drug
int

DRUGA may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
Chlorotrianisene	drug	cyclosporine	drug
int

DRUGA may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
Chlorotrianisene	drug	dantrolene	drug
int

DRUGA may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
Chlorotrianisene	drug	nicotine	drug
int

DRUGA may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
Chlorotrianisene	drug	somatropin	drug
int

DRUGA may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
Chlorotrianisene	drug	tamoxifen	drug
int

DRUGA may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
Chlorotrianisene	drug	warfarin	drug
int

DRUGN may interact with DRUGA , DRUGB , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
antidepressants	group	aspirin	brand
false

DRUGN may interact with DRUGA , DRUGN , DRUGB , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
antidepressants	group	barbiturates	group
false

DRUGN may interact with DRUGA , DRUGN , DRUGN dgb , DRUGB , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
antidepressants	group	bromocriptine	drug
false

DRUGN may interact with DRUGA , DRUGN , DRUGN , DRUGN , DRUGB supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
antidepressants	group	calcium	drug
false

DRUGN may interact with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN supplements , DRUGB , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
antidepressants	group	corticosteroids	group
false

DRUGN may interact with DRUGA , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
antidepressants	group	corticotropin	drug
false

DRUGN may interact with DRUGA , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
antidepressants	group	cyclosporine	drug
false

DRUGN may interact with DRUGA , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
antidepressants	group	dantrolene	drug
false

DRUGN may interact with DRUGA , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
antidepressants	group	nicotine	drug
false

DRUGN may interact with DRUGA , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
antidepressants	group	somatropin	drug
false

DRUGN may interact with DRUGA , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
antidepressants	group	tamoxifen	drug
false

DRUGN may interact with DRUGA , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
antidepressants	group	warfarin	drug
false

DRUGN may interact with DRUGN , DRUGA , DRUGB , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
aspirin	brand	barbiturates	group
false

DRUGN may interact with DRUGN , DRUGA , DRUGN dgb , DRUGB , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
aspirin	brand	bromocriptine	drug
false

DRUGN may interact with DRUGN , DRUGA , DRUGN , DRUGN , DRUGB supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
aspirin	brand	calcium	drug
false

DRUGN may interact with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN supplements , DRUGB , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
aspirin	brand	corticosteroids	group
false

DRUGN may interact with DRUGN , DRUGA , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
aspirin	brand	corticotropin	drug
false

DRUGN may interact with DRUGN , DRUGA , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
aspirin	brand	cyclosporine	drug
false

DRUGN may interact with DRUGN , DRUGA , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
aspirin	brand	dantrolene	drug
false

DRUGN may interact with DRUGN , DRUGA , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
aspirin	brand	nicotine	drug
false

DRUGN may interact with DRUGN , DRUGA , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
aspirin	brand	somatropin	drug
false

DRUGN may interact with DRUGN , DRUGA , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
aspirin	brand	tamoxifen	drug
false

DRUGN may interact with DRUGN , DRUGA , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
aspirin	brand	warfarin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGA , DRUGB , DRUGN supplements , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
barbiturates	group	bromocriptine	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGA , DRUGN , DRUGB supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
barbiturates	group	calcium	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN supplements , DRUGB , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
barbiturates	group	corticosteroids	group
false

DRUGN may interact with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN supplements , DRUGN , DRUGB , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
barbiturates	group	corticotropin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN supplements , DRUGN , DRUGN dgb , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
barbiturates	group	cyclosporine	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN dgb , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
barbiturates	group	dantrolene	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
barbiturates	group	nicotine	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
barbiturates	group	somatropin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
barbiturates	group	tamoxifen	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
barbiturates	group	warfarin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN , DRUGA , DRUGB supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
bromocriptine	drug	calcium	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN supplements , DRUGB , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
bromocriptine	drug	corticosteroids	group
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGA , DRUGN supplements , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
bromocriptine	drug	corticotropin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGA , DRUGN supplements , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
bromocriptine	drug	cyclosporine	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGA , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
bromocriptine	drug	dantrolene	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGA , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
bromocriptine	drug	nicotine	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGA , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
bromocriptine	drug	somatropin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGA , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
bromocriptine	drug	tamoxifen	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGA , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
bromocriptine	drug	warfarin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGA supplements , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
calcium	drug	corticosteroids	group
false

DRUGN may interact with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA supplements , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
calcium	drug	corticotropin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA supplements , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
calcium	drug	cyclosporine	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA supplements , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
calcium	drug	dantrolene	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
calcium	drug	nicotine	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
calcium	drug	somatropin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
calcium	drug	tamoxifen	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
calcium	drug	warfarin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN supplements , DRUGA , DRUGB , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	corticotropin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN supplements , DRUGA , DRUGN dgb , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	cyclosporine	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN supplements , DRUGA , DRUGN , DRUGN dgb , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	dantrolene	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN supplements , DRUGA , DRUGN , DRUGN dgb , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	nicotine	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN supplements , DRUGA , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
corticosteroids	group	somatropin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN supplements , DRUGA , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
corticosteroids	group	tamoxifen	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN supplements , DRUGA , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
corticosteroids	group	warfarin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
corticotropin	drug	cyclosporine	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
corticotropin	drug	dantrolene	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
corticotropin	drug	nicotine	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
corticotropin	drug	somatropin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
corticotropin	drug	tamoxifen	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
corticotropin	drug	warfarin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
cyclosporine	drug	dantrolene	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
cyclosporine	drug	nicotine	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
cyclosporine	drug	somatropin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
cyclosporine	drug	tamoxifen	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
cyclosporine	drug	warfarin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
dantrolene	drug	nicotine	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
dantrolene	drug	somatropin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
dantrolene	drug	tamoxifen	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
dantrolene	drug	warfarin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
nicotine	drug	somatropin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
nicotine	drug	tamoxifen	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
nicotine	drug	warfarin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
somatropin	drug	tamoxifen	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
somatropin	drug	warfarin	drug
false

DRUGN may interact with DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN supplements , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
tamoxifen	drug	warfarin	drug
false

Increased toxicity ( CNS depression ) : DRUGA , DRUGB , DRUGN , DRUGN .
CNS depressants	group	MAO inhibitors	group
false

Increased toxicity ( CNS depression ) : DRUGA , DRUGN , DRUGB , DRUGN .
CNS depressants	group	tricyclic antidepressants	group
false

Increased toxicity ( CNS depression ) : DRUGA , DRUGN , DRUGN , DRUGB .
CNS depressants	group	phenothiazines	group
false

Increased toxicity ( CNS depression ) : DRUGN , DRUGA , DRUGB , DRUGN .
MAO inhibitors	group	tricyclic antidepressants	group
false

Increased toxicity ( CNS depression ) : DRUGN , DRUGA , DRUGN , DRUGB .
MAO inhibitors	group	phenothiazines	group
false

Increased toxicity ( CNS depression ) : DRUGN , DRUGN , DRUGA , DRUGB .
tricyclic antidepressants	group	phenothiazines	group
false

Example inhibitors include DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
azole antifungals	group	ciprofloxacin	drug
false

Example inhibitors include DRUGA , DRUGN dgb , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
azole antifungals	group	clarithromycin	drug
false

Example inhibitors include DRUGA , DRUGN dgb , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
azole antifungals	group	diclofenac	drug
false

Example inhibitors include DRUGA , DRUGN dgb , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
azole antifungals	group	doxycycline	drug
false

Example inhibitors include DRUGA , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
azole antifungals	group	erythromycin	drug
false

Example inhibitors include DRUGA , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
azole antifungals	group	imatinib	drug
false

Example inhibitors include DRUGA , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
azole antifungals	group	isoniazid	drug
false

Example inhibitors include DRUGA , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
azole antifungals	group	nefazodone	drug
false

Example inhibitors include DRUGA , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
azole antifungals	group	nicardipine	drug
false

Example inhibitors include DRUGA , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
azole antifungals	group	propofol	drug
false

Example inhibitors include DRUGA , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
azole antifungals	group	protease inhibitors	group
false

Example inhibitors include DRUGA , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
azole antifungals	group	quinidine	drug
false

Example inhibitors include DRUGA , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
azole antifungals	group	verapamil	drug
false

Example inhibitors include DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
ciprofloxacin	drug	clarithromycin	drug
false

Example inhibitors include DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
ciprofloxacin	drug	diclofenac	drug
false

Example inhibitors include DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
ciprofloxacin	drug	doxycycline	drug
false

Example inhibitors include DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
ciprofloxacin	drug	erythromycin	drug
false

Example inhibitors include DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
ciprofloxacin	drug	imatinib	drug
false

Example inhibitors include DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
ciprofloxacin	drug	isoniazid	drug
false

Example inhibitors include DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
ciprofloxacin	drug	nefazodone	drug
false

Example inhibitors include DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
ciprofloxacin	drug	nicardipine	drug
false

Example inhibitors include DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
ciprofloxacin	drug	propofol	drug
false

Example inhibitors include DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
ciprofloxacin	drug	protease inhibitors	group
false

Example inhibitors include DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
ciprofloxacin	drug	quinidine	drug
false

Example inhibitors include DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
ciprofloxacin	drug	verapamil	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
clarithromycin	drug	diclofenac	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
clarithromycin	drug	doxycycline	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
clarithromycin	drug	erythromycin	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
clarithromycin	drug	imatinib	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
clarithromycin	drug	isoniazid	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
clarithromycin	drug	nefazodone	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
clarithromycin	drug	nicardipine	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGA , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
clarithromycin	drug	propofol	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
clarithromycin	drug	protease inhibitors	group
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
clarithromycin	drug	quinidine	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
clarithromycin	drug	verapamil	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diclofenac	drug	doxycycline	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diclofenac	drug	erythromycin	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diclofenac	drug	imatinib	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diclofenac	drug	isoniazid	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diclofenac	drug	nefazodone	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
diclofenac	drug	nicardipine	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
diclofenac	drug	propofol	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
diclofenac	drug	protease inhibitors	group
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
diclofenac	drug	quinidine	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
diclofenac	drug	verapamil	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
doxycycline	drug	erythromycin	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
doxycycline	drug	imatinib	drug
false

Example inhibitors include DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
doxycycline	drug	isoniazid	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
doxycycline	drug	nefazodone	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
doxycycline	drug	nicardipine	drug
false

Example inhibitors include DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
doxycycline	drug	propofol	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
doxycycline	drug	protease inhibitors	group
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
doxycycline	drug	quinidine	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
doxycycline	drug	verapamil	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	imatinib	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	isoniazid	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	nefazodone	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	nicardipine	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	propofol	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
erythromycin	drug	protease inhibitors	group
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
erythromycin	drug	quinidine	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
erythromycin	drug	verapamil	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
imatinib	drug	isoniazid	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
imatinib	drug	nefazodone	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
imatinib	drug	nicardipine	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
imatinib	drug	propofol	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
imatinib	drug	protease inhibitors	group
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
imatinib	drug	quinidine	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
imatinib	drug	verapamil	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
isoniazid	drug	nefazodone	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
isoniazid	drug	nicardipine	drug
false

Example inhibitors include DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
isoniazid	drug	propofol	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
isoniazid	drug	protease inhibitors	group
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
isoniazid	drug	quinidine	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
isoniazid	drug	verapamil	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
nefazodone	drug	nicardipine	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
nefazodone	drug	propofol	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
nefazodone	drug	protease inhibitors	group
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
nefazodone	drug	quinidine	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
nefazodone	drug	verapamil	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
nicardipine	drug	propofol	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
nicardipine	drug	protease inhibitors	group
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
nicardipine	drug	quinidine	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
nicardipine	drug	verapamil	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
propofol	drug	protease inhibitors	group
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
propofol	drug	quinidine	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
propofol	drug	verapamil	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
protease inhibitors	group	quinidine	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
protease inhibitors	group	verapamil	drug
false

Example inhibitors include DRUGN , DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
quinidine	drug	verapamil	drug
false

The hypoglycemic action of DRUGA may be potentiated by certain drugs including DRUGB and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
sulfonylurea	group	nonsteroidal anti-inflammatory agents	group
effect

The hypoglycemic action of DRUGA may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
sulfonylurea	group	salicylates	group
effect

The hypoglycemic action of DRUGA may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
sulfonylurea	group	sulfonamides	group
effect

The hypoglycemic action of DRUGA may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
sulfonylurea	group	chloramphenicol	drug
effect

The hypoglycemic action of DRUGA may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
sulfonylurea	group	probenecid	drug
effect

The hypoglycemic action of DRUGA may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
sulfonylurea	group	coumarins	group
effect

The hypoglycemic action of DRUGA may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
sulfonylurea	group	monoamine oxidase inhibitors	group
effect

The hypoglycemic action of DRUGA may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
sulfonylurea	group	beta adrenergic blocking agents	group
effect

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGA and other drugs that are highly protein bound , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
nonsteroidal anti-inflammatory agents	group	salicylates	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGA and other drugs that are highly protein bound , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
nonsteroidal anti-inflammatory agents	group	sulfonamides	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGA and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
nonsteroidal anti-inflammatory agents	group	chloramphenicol	drug
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGA and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
nonsteroidal anti-inflammatory agents	group	probenecid	drug
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGA and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
nonsteroidal anti-inflammatory agents	group	coumarins	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGA and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
nonsteroidal anti-inflammatory agents	group	monoamine oxidase inhibitors	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGA and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
nonsteroidal anti-inflammatory agents	group	beta adrenergic blocking agents	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
salicylates	group	sulfonamides	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
salicylates	group	chloramphenicol	drug
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
salicylates	group	probenecid	drug
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
salicylates	group	coumarins	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
salicylates	group	monoamine oxidase inhibitors	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
salicylates	group	beta adrenergic blocking agents	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
sulfonamides	group	chloramphenicol	drug
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
sulfonamides	group	probenecid	drug
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
sulfonamides	group	coumarins	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
sulfonamides	group	monoamine oxidase inhibitors	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
sulfonamides	group	beta adrenergic blocking agents	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
chloramphenicol	drug	probenecid	drug
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
chloramphenicol	drug	coumarins	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
chloramphenicol	drug	monoamine oxidase inhibitors	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
chloramphenicol	drug	beta adrenergic blocking agents	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
probenecid	drug	coumarins	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
probenecid	drug	monoamine oxidase inhibitors	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
probenecid	drug	beta adrenergic blocking agents	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
coumarins	group	monoamine oxidase inhibitors	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
coumarins	group	beta adrenergic blocking agents	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
monoamine oxidase inhibitors	group	beta adrenergic blocking agents	group
false

These drugs include the DRUGA and other DRUGB , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	diuretics	group
false

These drugs include the DRUGA and other DRUGN , DRUGB , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	corticosteroids	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGB , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	phenothiazines	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	estrogens	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	contraceptives	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	phenytoin	drug
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
thiazides	group	nicotinic acid	drug
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
thiazides	group	sympathomimetics	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
thiazides	group	calcium channel blocking drugs	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
thiazides	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGA , DRUGB , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	corticosteroids	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGB , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	phenothiazines	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , thyroid products , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	estrogens	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
diuretics	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
diuretics	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
diuretics	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
diuretics	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGB , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	phenothiazines	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , thyroid products , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	estrogens	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , thyroid products , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
corticosteroids	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
corticosteroids	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
corticosteroids	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , thyroid products , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
phenothiazines	group	estrogens	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , thyroid products , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
phenothiazines	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , thyroid products , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
phenothiazines	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
phenothiazines	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
phenothiazines	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
phenothiazines	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
phenothiazines	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGA , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
estrogens	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGA , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
estrogens	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGA , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
estrogens	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGA , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
estrogens	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGA , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
estrogens	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGA , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
estrogens	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
contraceptives	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
contraceptives	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
contraceptives	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
contraceptives	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
contraceptives	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
phenytoin	drug	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
phenytoin	drug	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
phenytoin	drug	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
phenytoin	drug	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
nicotinic acid	drug	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
nicotinic acid	drug	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
nicotinic acid	drug	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
sympathomimetics	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
sympathomimetics	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , thyroid products , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
calcium channel blocking drugs	group	isoniazid	drug
false

Since animal studies suggest that the action of DRUGA may be prolonged by therapy with DRUGB , DRUGN should be employed with caution .
barbiturates	group	chlorpropamide	drug
effect

Since animal studies suggest that the action of DRUGN may be prolonged by therapy with DRUGA , DRUGB should be employed with caution .
chlorpropamide	drug	barbiturates	group
false

In some patients , a DRUGA like reaction may be produced by the ingestion of DRUGB .
disulfiram	drug	alcohol	drug
false

A potential interaction between oral DRUGA and oral DRUGB leading to severe hypoglycemia has been reported .
miconazole	drug	hypoglycemic agents	group
effect

DRUGA may increase the plasma level of concomitantly given DRUGB .
Chlorprothixene	drug	lithium	drug
mechanism

If DRUGA is given concomitantly with DRUGB , the DRUGN dose should be reduced ( by approx . dgb % ) , because DRUGN amplifies the therapeutic actions and side effects of DRUGN massively .
chlorprothixene	drug	opioids	group
advise

If DRUGA is given concomitantly with DRUGN , the DRUGB dose should be reduced ( by approx . dgb % ) , because DRUGN amplifies the therapeutic actions and side effects of DRUGN massively .
chlorprothixene	drug	opioid	group
false

If DRUGA is given concomitantly with DRUGN , the DRUGN dose should be reduced ( by approx . dgb % ) , because DRUGN amplifies the therapeutic actions and side effects of DRUGB massively .
chlorprothixene	drug	opioids	group
false

If DRUGN is given concomitantly with DRUGA , the DRUGB dose should be reduced ( by approx . dgb % ) , because DRUGN amplifies the therapeutic actions and side effects of DRUGN massively .
opioids	group	opioid	group
false

If DRUGN is given concomitantly with DRUGA , the DRUGN dose should be reduced ( by approx . dgb % ) , because DRUGB amplifies the therapeutic actions and side effects of DRUGN massively .
opioids	group	chlorprothixene	drug
false

If DRUGN is given concomitantly with DRUGN , the DRUGA dose should be reduced ( by approx . dgb % ) , because DRUGB amplifies the therapeutic actions and side effects of DRUGN massively .
opioid	group	chlorprothixene	drug
false

If DRUGN is given concomitantly with DRUGN , the DRUGA dose should be reduced ( by approx . dgb % ) , because DRUGN amplifies the therapeutic actions and side effects of DRUGB massively .
opioid	group	opioids	group
false

If DRUGN is given concomitantly with DRUGN , the DRUGN dose should be reduced ( by approx . dgb % ) , because DRUGA amplifies the therapeutic actions and side effects of DRUGB massively .
chlorprothixene	drug	opioids	group
effect

Avoid the concomitant use of DRUGA and DRUGB ( DRUGN ) .
chlorprothixene	drug	tramadol	drug
advise

Avoid the concomitant use of DRUGA and DRUGN ( DRUGB ) .
chlorprothixene	drug	Ultram	brand
advise

Avoid the concomitant use of DRUGN and DRUGA ( DRUGB ) .
tramadol	drug	Ultram	brand
false

Consider additive sedative effects and confusional states to emerge , if DRUGA is given with DRUGB or DRUGN .
chlorprothixene	drug	benzodiazepines	group
effect

Consider additive sedative effects and confusional states to emerge , if DRUGA is given with DRUGN or DRUGB .
chlorprothixene	drug	barbituates	group
effect

Consider additive sedative effects and confusional states to emerge , if DRUGN is given with DRUGA or DRUGB .
benzodiazepines	group	barbituates	group
false

Exert particular caution in combining DRUGA with other DRUGB ( DRUGN and DRUGN ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
chlorprothixene	drug	anticholinergic drugs	group
advise

Exert particular caution in combining DRUGA with other DRUGN ( DRUGB and DRUGN ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
chlorprothixene	drug	tricyclic antidepressants	group
advise

Exert particular caution in combining DRUGA with other DRUGN ( DRUGN and DRUGB ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
chlorprothixene	drug	antiparkinsonian agents	group
advise

Exert particular caution in combining DRUGN with other DRUGA ( DRUGB and DRUGN ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
anticholinergic drugs	group	tricyclic antidepressants	group
false

Exert particular caution in combining DRUGN with other DRUGA ( DRUGN and DRUGB ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
anticholinergic drugs	group	antiparkinsonian agents	group
false

Exert particular caution in combining DRUGN with other DRUGN ( DRUGA and DRUGB ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
tricyclic antidepressants	group	antiparkinsonian agents	group
false

DRUGA may add to or potentiate the action of other DRUGB .
Chlorthalidone	drug	antihypertensive drugs	group
effect

DRUGA and related drugs may increase the responsiveness to DRUGB .
Chlorthalidone	drug	tubocurarine	drug
effect

DRUGA and related drugs may decrease arterial responsiveness to DRUGB .
Chlorthalidone	drug	norepinephrine	drug
effect

The concomitant use of DRUGA or other DRUGB may have an additive effect .
alcohol	drug	central nervous system depressants	group
false

Interactions for DRUGA analogues ( DRUGB , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
vitamin D	group	Vitamin D2	drug
false

Interactions for DRUGA analogues ( DRUGN , DRUGB , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
vitamin D	group	Vitamin D3	drug
false

Interactions for DRUGA analogues ( DRUGN , DRUGN , DRUGB , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
vitamin D	group	Calcitriol	drug
false

Interactions for DRUGA analogues ( DRUGN , DRUGN , DRUGN , and DRUGB ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
vitamin D	group	Calcidiol	drug
false

Interactions for DRUGA analogues ( DRUGN , DRUGN , DRUGN , and DRUGN ) : DRUGB : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
vitamin D	group	Cholestyramine	drug
false

Interactions for DRUGA analogues ( DRUGN , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGB has been reported to reduce intestinal absorption of DRUGN ;
vitamin D	group	Cholestyramine	drug
false

Interactions for DRUGA analogues ( DRUGN , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
vitamin D	group	fat soluble vitamins	group
false

Interactions for DRUGN analogues ( DRUGA , DRUGB , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D2	drug	Vitamin D3	drug
false

Interactions for DRUGN analogues ( DRUGA , DRUGN , DRUGB , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D2	drug	Calcitriol	drug
false

Interactions for DRUGN analogues ( DRUGA , DRUGN , DRUGN , and DRUGB ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D2	drug	Calcidiol	drug
false

Interactions for DRUGN analogues ( DRUGA , DRUGN , DRUGN , and DRUGN ) : DRUGB : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D2	drug	Cholestyramine	drug
false

Interactions for DRUGN analogues ( DRUGA , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGB has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D2	drug	Cholestyramine	drug
false

Interactions for DRUGN analogues ( DRUGA , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
Vitamin D2	drug	fat soluble vitamins	group
false

Interactions for DRUGN analogues ( DRUGN , DRUGA , DRUGB , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D3	drug	Calcitriol	drug
false

Interactions for DRUGN analogues ( DRUGN , DRUGA , DRUGN , and DRUGB ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D3	drug	Calcidiol	drug
false

Interactions for DRUGN analogues ( DRUGN , DRUGA , DRUGN , and DRUGN ) : DRUGB : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D3	drug	Cholestyramine	drug
false

Interactions for DRUGN analogues ( DRUGN , DRUGA , DRUGN , and DRUGN ) : DRUGN : DRUGB has been reported to reduce intestinal absorption of DRUGN ;
Vitamin D3	drug	Cholestyramine	drug
false

Interactions for DRUGN analogues ( DRUGN , DRUGA , DRUGN , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
Vitamin D3	drug	fat soluble vitamins	group
false

Interactions for DRUGN analogues ( DRUGN , DRUGN , DRUGA , and DRUGB ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Calcitriol	drug	Calcidiol	drug
false

Interactions for DRUGN analogues ( DRUGN , DRUGN , DRUGA , and DRUGN ) : DRUGB : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Calcitriol	drug	Cholestyramine	drug
false

Interactions for DRUGN analogues ( DRUGN , DRUGN , DRUGA , and DRUGN ) : DRUGN : DRUGB has been reported to reduce intestinal absorption of DRUGN ;
Calcitriol	drug	Cholestyramine	drug
false

Interactions for DRUGN analogues ( DRUGN , DRUGN , DRUGA , and DRUGN ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
Calcitriol	drug	fat soluble vitamins	group
false

Interactions for DRUGN analogues ( DRUGN , DRUGN , DRUGN , and DRUGA ) : DRUGB : DRUGN has been reported to reduce intestinal absorption of DRUGN ;
Calcidiol	drug	Cholestyramine	drug
false

Interactions for DRUGN analogues ( DRUGN , DRUGN , DRUGN , and DRUGA ) : DRUGN : DRUGB has been reported to reduce intestinal absorption of DRUGN ;
Calcidiol	drug	Cholestyramine	drug
false

Interactions for DRUGN analogues ( DRUGN , DRUGN , DRUGN , and DRUGA ) : DRUGN : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
Calcidiol	drug	fat soluble vitamins	group
false

Interactions for DRUGN analogues ( DRUGN , DRUGN , DRUGN , and DRUGN ) : DRUGA : DRUGN has been reported to reduce intestinal absorption of DRUGB ;
Cholestyramine	drug	fat soluble vitamins	group
false

Interactions for DRUGN analogues ( DRUGN , DRUGN , DRUGN , and DRUGN ) : DRUGN : DRUGA has been reported to reduce intestinal absorption of DRUGB ;
Cholestyramine	drug	fat soluble vitamins	group
mechanism

DRUGA / DRUGB : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenytoin	drug	Phenobarbital	drug
false

DRUGA / DRUGN : The coadministration of DRUGB or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenytoin	drug	phenytoin	drug
false

DRUGA / DRUGN : The coadministration of DRUGN or DRUGB will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenytoin	drug	phenobarbital	drug
false

DRUGA / DRUGN : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGB , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenytoin	drug	vitamin D	group
false

DRUGA / DRUGN : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGB / ergocalcitriol by accelerating metabolism .
Phenytoin	drug	calcitriol	drug
false

DRUGN / DRUGA : The coadministration of DRUGB or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenobarbital	drug	phenytoin	drug
false

DRUGN / DRUGA : The coadministration of DRUGN or DRUGB will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenobarbital	drug	phenobarbital	drug
false

DRUGN / DRUGA : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGB , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
Phenobarbital	drug	vitamin D	group
false

DRUGN / DRUGA : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGB / ergocalcitriol by accelerating metabolism .
Phenobarbital	drug	calcitriol	drug
false

DRUGN / DRUGN : The coadministration of DRUGA or DRUGB will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
phenytoin	drug	phenobarbital	drug
false

DRUGN / DRUGN : The coadministration of DRUGA or DRUGN will not affect plasma concentrations of DRUGB , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
phenytoin	drug	vitamin D	group
false

DRUGN / DRUGN : The coadministration of DRUGA or DRUGN will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGB / ergocalcitriol by accelerating metabolism .
phenytoin	drug	calcitriol	drug
false

DRUGN / DRUGN : The coadministration of DRUGN or DRUGA will not affect plasma concentrations of DRUGB , but may reduce endogenous plasma levels of DRUGN / ergocalcitriol by accelerating metabolism .
phenobarbital	drug	vitamin D	group
false

DRUGN / DRUGN : The coadministration of DRUGN or DRUGA will not affect plasma concentrations of DRUGN , but may reduce endogenous plasma levels of DRUGB / ergocalcitriol by accelerating metabolism .
phenobarbital	drug	calcitriol	drug
false

DRUGN / DRUGN : The coadministration of DRUGN or DRUGN will not affect plasma concentrations of DRUGA , but may reduce endogenous plasma levels of DRUGB / ergocalcitriol by accelerating metabolism .
vitamin D	group	calcitriol	drug
false

Since blood level of DRUGA / ergocalcitriol will be reduced , higher doses of DRUGB may be necessary if these drugs are administered simultaneously .
calcitriol	drug	Rocaltrol	brand
false

Some reports have shown that the concomitant administration of DRUGA with DRUGB causes hypercalcemia .
thiazides	group	vitamin D	group
effect

DRUGA : DRUGB dosage must be determined with care in patients undergoing treatment with DRUGN , as hypercalcemia in such patients may precipitate cardiac arrhythmias .
Digitalis	group	Vitamin D	group
false

DRUGA : DRUGN dosage must be determined with care in patients undergoing treatment with DRUGB , as hypercalcemia in such patients may precipitate cardiac arrhythmias .
Digitalis	group	digitalis	group
false

DRUGN : DRUGA dosage must be determined with care in patients undergoing treatment with DRUGB , as hypercalcemia in such patients may precipitate cardiac arrhythmias .
Vitamin D	group	digitalis	group
advise

DRUGA : DRUGN may inhibit both synthetic and catabolic enzymes of DRUGB .
Ketoconazole	drug	vitamin D	group
false

DRUGN : DRUGA may inhibit both synthetic and catabolic enzymes of DRUGB .
Ketoconazole	drug	vitamin D	group
mechanism

However , in vivo drug interaction studies of DRUGA with DRUGB have not been investigated .
ketoconazole	drug	vitamin D	group
false

DRUGA : A relationship of functional antagonism exists between DRUGB analogues , which promote calcium absorption , and DRUGN , which inhibit calcium absorption .
Corticosteroids	group	vitamin D	group
false

DRUGA : A relationship of functional antagonism exists between DRUGN analogues , which promote calcium absorption , and DRUGB , which inhibit calcium absorption .
Corticosteroids	group	corticosteroids	group
false

DRUGN : A relationship of functional antagonism exists between DRUGA analogues , which promote calcium absorption , and DRUGB , which inhibit calcium absorption .
vitamin D	group	corticosteroids	group
effect

DRUGA : The coadministration of any of the DRUGB analogues should be avoided as this could create possible additive effects and hypercalcemia .
Vitamin D	group	vitamin D	group
false

DRUGA Supplements : Uncontrolled intake of additional DRUGB containing preparations should be avoided .
Calcium	drug	calcium	drug
false

DRUGA : DRUGN containing preparations ( eg , DRUGB ) may cause hypermagnesemia and should therefore not be taken during therapy with DRUGN by patients on chronic renal dialysis .
Magnesium	drug	antacids	group
false

DRUGA : DRUGN containing preparations ( eg , DRUGN ) may cause hypermagnesemia and should therefore not be taken during therapy with DRUGB by patients on chronic renal dialysis .
Magnesium	drug	vitamin D	group
false

DRUGN : DRUGA containing preparations ( eg , DRUGB ) may cause hypermagnesemia and should therefore not be taken during therapy with DRUGN by patients on chronic renal dialysis .
Magnesium	drug	antacids	group
false

DRUGN : DRUGA containing preparations ( eg , DRUGN ) may cause hypermagnesemia and should therefore not be taken during therapy with DRUGB by patients on chronic renal dialysis .
Magnesium	drug	vitamin D	group
effect

DRUGN : DRUGN containing preparations ( eg , DRUGA ) may cause hypermagnesemia and should therefore not be taken during therapy with DRUGB by patients on chronic renal dialysis .
antacids	group	vitamin D	group
effect

Because DRUGA binds bile acids , DRUGN DRUGB may interfere with normal fat digestion and absorption and thus may prevent absorption of DRUGN such as A , D , E , and K .
cholestyramine	drug	resin	group
false

Because DRUGA binds bile acids , DRUGN DRUGN may interfere with normal fat digestion and absorption and thus may prevent absorption of DRUGB such as A , D , E , and K .
cholestyramine	drug	fat soluble vitamins	group
false

Because DRUGN binds bile acids , DRUGA DRUGB may interfere with normal fat digestion and absorption and thus may prevent absorption of DRUGN such as A , D , E , and K .
cholestyramine	drug	resin	group
false

Because DRUGN binds bile acids , DRUGA DRUGN may interfere with normal fat digestion and absorption and thus may prevent absorption of DRUGB such as A , D , E , and K .
cholestyramine	drug	fat soluble vitamins	group
false

Because DRUGN binds bile acids , DRUGN DRUGA may interfere with normal fat digestion and absorption and thus may prevent absorption of DRUGB such as A , D , E , and K .
resin	group	fat soluble vitamins	group
false

When DRUGA DRUGB is given for long periods of time , concomitant supplementation with water miscible ( or parenteral ) forms of DRUGN should be considered .
cholestyramine	drug	resin	group
false

When DRUGA DRUGN is given for long periods of time , concomitant supplementation with water miscible ( or parenteral ) forms of DRUGB should be considered .
cholestyramine	drug	fat-soluble vitamins	group
false

When DRUGN DRUGA is given for long periods of time , concomitant supplementation with water miscible ( or parenteral ) forms of DRUGB should be considered .
resin	group	fat-soluble vitamins	group
false

In vitro studies demonstrated that the plasma protein binding of DRUGA was not affected by DRUGB or DRUGN , indicating no potential for protein binding based drug interactions .
des-ciclesonide	drug	warfarin	drug
false

In vitro studies demonstrated that the plasma protein binding of DRUGA was not affected by DRUGN or DRUGB , indicating no potential for protein binding based drug interactions .
des-ciclesonide	drug	salicylic acid	drug
false

In vitro studies demonstrated that the plasma protein binding of DRUGN was not affected by DRUGA or DRUGB , indicating no potential for protein binding based drug interactions .
warfarin	drug	salicylic acid	drug
false

In a drug interaction study , co administration of orally inhaled DRUGA and oral DRUGB , an inhibitor of cytochrome Pdgb dgbAdgb , had no effect on the pharmacokinetics of either DRUGN or DRUGN .
ciclesonide	drug	erythromycin	drug
false

In a drug interaction study , co administration of orally inhaled DRUGA and oral DRUGN , an inhibitor of cytochrome Pdgb dgbAdgb , had no effect on the pharmacokinetics of either DRUGB or DRUGN .
ciclesonide	drug	des-ciclesonide	drug
false

In a drug interaction study , co administration of orally inhaled DRUGA and oral DRUGN , an inhibitor of cytochrome Pdgb dgbAdgb , had no effect on the pharmacokinetics of either DRUGN or DRUGB .
ciclesonide	drug	erythromycin	drug
false

In a drug interaction study , co administration of orally inhaled DRUGN and oral DRUGA , an inhibitor of cytochrome Pdgb dgbAdgb , had no effect on the pharmacokinetics of either DRUGB or DRUGN .
erythromycin	drug	des-ciclesonide	drug
false

In a drug interaction study , co administration of orally inhaled DRUGN and oral DRUGN , an inhibitor of cytochrome Pdgb dgbAdgb , had no effect on the pharmacokinetics of either DRUGA or DRUGB .
des-ciclesonide	drug	erythromycin	drug
false

Therefore , DRUGA should be administered with caution with intranasal DRUGB .
ketoconazole	drug	ciclesonide	drug
advise

DRUGA should either be temporarily discontinued or decreased by dgb % when coadministered with DRUGB on the day of DRUGN infusion .
Zidovudine	drug	probenecid	drug
advise

DRUGA should either be temporarily discontinued or decreased by dgb % when coadministered with DRUGN on the day of DRUGB infusion .
Zidovudine	drug	VISTIDE	brand
false

DRUGN should either be temporarily discontinued or decreased by dgb % when coadministered with DRUGA on the day of DRUGB infusion .
probenecid	drug	VISTIDE	brand
false

Since DRUGA is extensively metabolized by cytochrome P dgb isoenzymes , caution should be exercised when DRUGN is coadministered with inhibitors of C.P.A . such as DRUGB and DRUGN or inhibitors of CYPdgbCdgb such as DRUGN .
PLETAL	brand	ketoconazole	drug
false

Since DRUGA is extensively metabolized by cytochrome P dgb isoenzymes , caution should be exercised when DRUGN is coadministered with inhibitors of C.P.A . such as DRUGN and DRUGB or inhibitors of CYPdgbCdgb such as DRUGN .
PLETAL	brand	erythromycin	drug
false

Since DRUGA is extensively metabolized by cytochrome P dgb isoenzymes , caution should be exercised when DRUGN is coadministered with inhibitors of C.P.A . such as DRUGN and DRUGN or inhibitors of CYPdgbCdgb such as DRUGB .
PLETAL	brand	omeprazole	drug
false

Since DRUGN is extensively metabolized by cytochrome P dgb isoenzymes , caution should be exercised when DRUGA is coadministered with inhibitors of C.P.A . such as DRUGB and DRUGN or inhibitors of CYPdgbCdgb such as DRUGN .
PLETAL	brand	ketoconazole	drug
advise

Since DRUGN is extensively metabolized by cytochrome P dgb isoenzymes , caution should be exercised when DRUGA is coadministered with inhibitors of C.P.A . such as DRUGN and DRUGB or inhibitors of CYPdgbCdgb such as DRUGN .
PLETAL	brand	erythromycin	drug
advise

Since DRUGN is extensively metabolized by cytochrome P dgb isoenzymes , caution should be exercised when DRUGA is coadministered with inhibitors of C.P.A . such as DRUGN and DRUGN or inhibitors of CYPdgbCdgb such as DRUGB .
PLETAL	brand	omeprazole	drug
advise

Since DRUGN is extensively metabolized by cytochrome P dgb isoenzymes , caution should be exercised when DRUGN is coadministered with inhibitors of C.P.A . such as DRUGA and DRUGB or inhibitors of CYPdgbCdgb such as DRUGN .
ketoconazole	drug	erythromycin	drug
false

Since DRUGN is extensively metabolized by cytochrome P dgb isoenzymes , caution should be exercised when DRUGN is coadministered with inhibitors of C.P.A . such as DRUGA and DRUGN or inhibitors of CYPdgbCdgb such as DRUGB .
ketoconazole	drug	omeprazole	drug
false

Since DRUGN is extensively metabolized by cytochrome P dgb isoenzymes , caution should be exercised when DRUGN is coadministered with inhibitors of C.P.A . such as DRUGN and DRUGA or inhibitors of CYPdgbCdgb such as DRUGB .
erythromycin	drug	omeprazole	drug
false

Pharmacokinetic studies have demonstrated that DRUGA and DRUGB significantly increased the systemic exposure of DRUGN and / or its major metabolites .
omeprazole	drug	erythromycin	drug
false

Pharmacokinetic studies have demonstrated that DRUGA and DRUGN significantly increased the systemic exposure of DRUGB and / or its major metabolites .
omeprazole	drug	cilostazol	drug
mechanism

Pharmacokinetic studies have demonstrated that DRUGN and DRUGA significantly increased the systemic exposure of DRUGB and / or its major metabolites .
erythromycin	drug	cilostazol	drug
mechanism

Population pharmacokinetic studies showed higher concentrations of DRUGA among patients concurrently treated with DRUGB , an inhibitor of C.P.A..
cilostazol	drug	diltiazem	drug
mechanism

DRUGA does not , however , appear to cause increased blood levels of drugs metabolized by CYPdgbAdgb , as it had no effect on DRUGB , a drug with metabolism very sensitive to C.P.A . inhibition .
Pletal	brand	lovastatin	drug
false

therefore , close monitoring of prothrombin time is recommended , and adjustment of the DRUGA dose may be necessary when DRUGB is administered concomitantly .
anticoagulant	group	Tagamet	brand
advise

Interaction with DRUGA , DRUGB and DRUGN has also been reported to produce adverse clinical effects .
phenytoin	drug	lidocaine	drug
false

Interaction with DRUGA , DRUGN and DRUGB has also been reported to produce adverse clinical effects .
phenytoin	drug	theophylline	drug
false

Interaction with DRUGN , DRUGA and DRUGB has also been reported to produce adverse clinical effects .
lidocaine	drug	theophylline	drug
false

Therefore , dose adjustments of concomitant medications that are predominantly metabolized by CYPdgbDdgb and have a narrow therapeutic index ( e.g . , DRUGA , DRUGB , DRUGN and most DRUGN ) may be required .
flecainide	drug	vinblastine	drug
false

Therefore , dose adjustments of concomitant medications that are predominantly metabolized by CYPdgbDdgb and have a narrow therapeutic index ( e.g . , DRUGA , DRUGN , DRUGB and most DRUGN ) may be required .
flecainide	drug	thioridazine	drug
false

Therefore , dose adjustments of concomitant medications that are predominantly metabolized by CYPdgbDdgb and have a narrow therapeutic index ( e.g . , DRUGA , DRUGN , DRUGN and most DRUGB ) may be required .
flecainide	drug	tricyclic antidepressants	group
false

Therefore , dose adjustments of concomitant medications that are predominantly metabolized by CYPdgbDdgb and have a narrow therapeutic index ( e.g . , DRUGN , DRUGA , DRUGB and most DRUGN ) may be required .
vinblastine	drug	thioridazine	drug
false

Therefore , dose adjustments of concomitant medications that are predominantly metabolized by CYPdgbDdgb and have a narrow therapeutic index ( e.g . , DRUGN , DRUGA , DRUGN and most DRUGB ) may be required .
vinblastine	drug	tricyclic antidepressants	group
false

Therefore , dose adjustments of concomitant medications that are predominantly metabolized by CYPdgbDdgb and have a narrow therapeutic index ( e.g . , DRUGN , DRUGN , DRUGA and most DRUGB ) may be required .
thioridazine	drug	tricyclic antidepressants	group
false

DRUGA : Concurrent administration of dgb mg or dgb mg DRUGB with dgb mg DRUGN increased DRUGN exposure and DRUGN ( active metabolite ) exposure by approximately dgb % in CYPdgbDdgb extensive metabolizers .
Amitriptyline	drug	cinacalcet	drug
false

DRUGA : Concurrent administration of dgb mg or dgb mg DRUGN with dgb mg DRUGB increased DRUGN exposure and DRUGN ( active metabolite ) exposure by approximately dgb % in CYPdgbDdgb extensive metabolizers .
Amitriptyline	drug	amitriptyline	drug
false

DRUGA : Concurrent administration of dgb mg or dgb mg DRUGN with dgb mg DRUGN increased DRUGB exposure and DRUGN ( active metabolite ) exposure by approximately dgb % in CYPdgbDdgb extensive metabolizers .
Amitriptyline	drug	amitriptyline	drug
false

DRUGA : Concurrent administration of dgb mg or dgb mg DRUGN with dgb mg DRUGN increased DRUGN exposure and DRUGB ( active metabolite ) exposure by approximately dgb % in CYPdgbDdgb extensive metabolizers .
Amitriptyline	drug	nortriptyline	drug_n
false

DRUGN : Concurrent administration of dgb mg or dgb mg DRUGA with dgb mg DRUGB increased DRUGN exposure and DRUGN ( active metabolite ) exposure by approximately dgb % in CYPdgbDdgb extensive metabolizers .
cinacalcet	drug	amitriptyline	drug
mechanism

DRUGN : Concurrent administration of dgb mg or dgb mg DRUGA with dgb mg DRUGN increased DRUGB exposure and DRUGN ( active metabolite ) exposure by approximately dgb % in CYPdgbDdgb extensive metabolizers .
cinacalcet	drug	amitriptyline	drug
false

DRUGN : Concurrent administration of dgb mg or dgb mg DRUGA with dgb mg DRUGN increased DRUGN exposure and DRUGB ( active metabolite ) exposure by approximately dgb % in CYPdgbDdgb extensive metabolizers .
cinacalcet	drug	nortriptyline	drug_n
false

DRUGN : Concurrent administration of dgb mg or dgb mg DRUGN with dgb mg DRUGA increased DRUGN exposure and DRUGB ( active metabolite ) exposure by approximately dgb % in CYPdgbDdgb extensive metabolizers .
amitriptyline	drug	nortriptyline	drug_n
false

DRUGN : Concurrent administration of dgb mg or dgb mg DRUGN with dgb mg DRUGN increased DRUGA exposure and DRUGB ( active metabolite ) exposure by approximately dgb % in CYPdgbDdgb extensive metabolizers .
amitriptyline	drug	nortriptyline	drug_n
false

DRUGA : DRUGB is metabolized in part by CYPdgbAdga
Ketoconazole	drug	Sensipar	brand
false

Co administration of DRUGA , a strong inhibitor of CYPdgbAdgb , increased DRUGB exposure following a single dgb mg dose of DRUGN by dga fold .
ketoconazole	drug	cinacalcet	drug
mechanism

Co administration of DRUGA , a strong inhibitor of CYPdgbAdgb , increased DRUGN exposure following a single dgb mg dose of DRUGB by dga fold .
ketoconazole	drug	Sensipar	brand
false

Co administration of DRUGN , a strong inhibitor of CYPdgbAdgb , increased DRUGA exposure following a single dgb mg dose of DRUGB by dga fold .
cinacalcet	drug	Sensipar	brand
false

Dose adjustment of DRUGA may be required and PTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYPdgbAdgb inhibitor ( e.g . , DRUGB , DRUGN , DRUGN ;
Sensipar	brand	ketoconazole	drug
advise

Dose adjustment of DRUGA may be required and PTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYPdgbAdgb inhibitor ( e.g . , DRUGN , DRUGB , DRUGN ;
Sensipar	brand	erythromycin	drug
advise

Dose adjustment of DRUGA may be required and PTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYPdgbAdgb inhibitor ( e.g . , DRUGN , DRUGN , DRUGB ;
Sensipar	brand	itraconazole	drug
advise

Dose adjustment of DRUGN may be required and PTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYPdgbAdgb inhibitor ( e.g . , DRUGA , DRUGB , DRUGN ;
ketoconazole	drug	erythromycin	drug
false

Dose adjustment of DRUGN may be required and PTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYPdgbAdgb inhibitor ( e.g . , DRUGA , DRUGN , DRUGB ;
ketoconazole	drug	itraconazole	drug
false

Dose adjustment of DRUGN may be required and PTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYPdgbAdgb inhibitor ( e.g . , DRUGN , DRUGA , DRUGB ;
erythromycin	drug	itraconazole	drug
false

Elevated plasma levels of DRUGA have been reported with concomitant use of some DRUGB .
theophylline	drug	quinolones	group
mechanism

There have been reports of DRUGA related side effects in patients on concomitant DRUGN DRUGB therapy .
theophylline	drug	quinolone	group
false

There have been reports of DRUGN related side effects in patients on concomitant DRUGA DRUGB therapy .
theophylline	drug	quinolone	group
effect

DRUGA have also been shown to interfere with the metabolism of DRUGB .
Quinolones	group	caffeine	drug
mechanism

Although this interaction has not been reported with DRUGA , caution should be exercised when DRUGN is given concomitantly with DRUGB containing products .
cinoxacin	drug	caffeine	drug
false

Although this interaction has not been reported with DRUGN , caution should be exercised when DRUGA is given concomitantly with DRUGB containing products .
cinoxacin	drug	caffeine	drug
advise

DRUGA or DRUGB substantially interfere with the absorption of some DRUGN , resulting in low urine levels .
Antacids	group	sucralfate	drug
false

DRUGA or DRUGN substantially interfere with the absorption of some DRUGB , resulting in low urine levels .
Antacids	group	quinolones	group
mechanism

DRUGN or DRUGA substantially interfere with the absorption of some DRUGB , resulting in low urine levels .
sucralfate	drug	quinolones	group
mechanism

Also , concomitant administration of DRUGA with products containing DRUGB , DRUGN containing DRUGN , or DRUGN ( DRUGN ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
quinolones	group	iron	drug
mechanism

Also , concomitant administration of DRUGA with products containing DRUGN , DRUGB containing DRUGN , or DRUGN ( DRUGN ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
quinolones	group	multivitamins	group
false

Also , concomitant administration of DRUGA with products containing DRUGN , DRUGN containing DRUGB , or DRUGN ( DRUGN ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
quinolones	group	zinc	drug
mechanism

Also , concomitant administration of DRUGA with products containing DRUGN , DRUGN containing DRUGN , or DRUGB ( DRUGN ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
quinolones	group	Videx	brand
mechanism

Also , concomitant administration of DRUGA with products containing DRUGN , DRUGN containing DRUGN , or DRUGN ( DRUGB ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
quinolones	group	didanosine	drug
mechanism

Also , concomitant administration of DRUGN with products containing DRUGA , DRUGB containing DRUGN , or DRUGN ( DRUGN ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
iron	drug	multivitamins	group
false

Also , concomitant administration of DRUGN with products containing DRUGA , DRUGN containing DRUGB , or DRUGN ( DRUGN ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
iron	drug	zinc	drug
false

Also , concomitant administration of DRUGN with products containing DRUGA , DRUGN containing DRUGN , or DRUGB ( DRUGN ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
iron	drug	Videx	brand
false

Also , concomitant administration of DRUGN with products containing DRUGA , DRUGN containing DRUGN , or DRUGN ( DRUGB ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
iron	drug	didanosine	drug
false

Also , concomitant administration of DRUGN with products containing DRUGN , DRUGA containing DRUGB , or DRUGN ( DRUGN ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
multivitamins	group	zinc	drug
false

Also , concomitant administration of DRUGN with products containing DRUGN , DRUGA containing DRUGN , or DRUGB ( DRUGN ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
multivitamins	group	Videx	brand
false

Also , concomitant administration of DRUGN with products containing DRUGN , DRUGA containing DRUGN , or DRUGN ( DRUGB ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
multivitamins	group	didanosine	drug
false

Also , concomitant administration of DRUGN with products containing DRUGN , DRUGN containing DRUGA , or DRUGB ( DRUGN ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
zinc	drug	Videx	brand
false

Also , concomitant administration of DRUGN with products containing DRUGN , DRUGN containing DRUGA , or DRUGN ( DRUGB ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
zinc	drug	didanosine	drug
false

Also , concomitant administration of DRUGN with products containing DRUGN , DRUGN containing DRUGN , or DRUGA ( DRUGB ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
Videx	brand	didanosine	drug
false

DRUGA , including DRUGB , may enhance the effects of oral DRUGN , such as DRUGN or its derivatives .
Quinolones	group	cinoxacin	drug
false

DRUGA , including DRUGN , may enhance the effects of oral DRUGB , such as DRUGN or its derivatives .
Quinolones	group	anticoagulants	group
effect

DRUGA , including DRUGN , may enhance the effects of oral DRUGN , such as DRUGB or its derivatives .
Quinolones	group	warfarin	drug
effect

DRUGN , including DRUGA , may enhance the effects of oral DRUGB , such as DRUGN or its derivatives .
cinoxacin	drug	anticoagulants	group
effect

DRUGN , including DRUGA , may enhance the effects of oral DRUGN , such as DRUGB or its derivatives .
cinoxacin	drug	warfarin	drug
effect

DRUGN , including DRUGN , may enhance the effects of oral DRUGA , such as DRUGB or its derivatives .
anticoagulants	group	warfarin	drug
false

Seizures have been reported in patients taking another DRUGA and the DRUGB DRUGN concurrently .
quinolone class antimicrobial	group	nonsteroidal anti-inflammatory drug	group
effect

Seizures have been reported in patients taking another DRUGA and the DRUGN DRUGB concurrently .
quinolone class antimicrobial	group	fenbufen	drug
effect

Seizures have been reported in patients taking another DRUGN and the DRUGA DRUGB concurrently .
nonsteroidal anti-inflammatory drug	group	fenbufen	drug
false

Physicians are provided this information to increase awareness of the potential for serious interactions when DRUGA and certain DRUGB are administered concomitantly .
cinoxacin	drug	nonsteroidal anti-inflammatory agents	group
advise

Elevated DRUGA serum levels have been reported with the concomitant use of DRUGB and DRUGN .
cyclosporine	drug	quinolones	group
false

Elevated DRUGN serum levels have been reported with the concomitant use of DRUGA and DRUGB .
quinolones	group	cyclosporine	drug
mechanism

Some DRUGA , including DRUGB , have also been shown to interfere with the metabolism of DRUGN .
quinolones	group	ciprofloxacin	drug
false

Some DRUGA , including DRUGN , have also been shown to interfere with the metabolism of DRUGB .
quinolones	group	caffeine	drug
mechanism

Some DRUGN , including DRUGA , have also been shown to interfere with the metabolism of DRUGB .
ciprofloxacin	drug	caffeine	drug
mechanism

Some DRUGA , including DRUGB , have been associated with transient elevations in serum creatinine in patients receiving DRUGN concomitantly .
quinolones	group	ciprofloxacin	drug
false

Some DRUGA , including DRUGN , have been associated with transient elevations in serum creatinine in patients receiving DRUGB concomitantly .
quinolones	group	cyclosporine	drug
effect

Some DRUGN , including DRUGA , have been associated with transient elevations in serum creatinine in patients receiving DRUGB concomitantly .
ciprofloxacin	drug	cyclosporine	drug
effect

DRUGA : The concomitant administration of DRUGB with the DRUGN DRUGN has , on rare occasions , resulted in severe hypoglycemia .
Glyburide	drug	ciprofloxacin	drug
false

DRUGA : The concomitant administration of DRUGN with the DRUGB DRUGN has , on rare occasions , resulted in severe hypoglycemia .
Glyburide	drug	sulfonylurea	group
false

DRUGA : The concomitant administration of DRUGN with the DRUGN DRUGB has , on rare occasions , resulted in severe hypoglycemia .
Glyburide	drug	glyburide	drug
false

DRUGN : The concomitant administration of DRUGA with the DRUGB DRUGN has , on rare occasions , resulted in severe hypoglycemia .
ciprofloxacin	drug	sulfonylurea	group
effect

DRUGN : The concomitant administration of DRUGA with the DRUGN DRUGB has , on rare occasions , resulted in severe hypoglycemia .
ciprofloxacin	drug	glyburide	drug
effect

DRUGN : The concomitant administration of DRUGN with the DRUGA DRUGB has , on rare occasions , resulted in severe hypoglycemia .
sulfonylurea	group	glyburide	drug
false

DRUGA : DRUGN appear to have no significant effect on the bioavailability of DRUGB .
Histamine H2-receptor antagonists	group	ciprofloxacin	drug
false

DRUGN : DRUGA appear to have no significant effect on the bioavailability of DRUGB .
Histamine H2-receptor antagonists	group	ciprofloxacin	drug
false

DRUGA Renal tubular transport of DRUGB may be inhibited by concomitant administration of DRUGN , potentially leading to increased plasma levels of DRUGN .
Methotrexate	drug	methotrexate	drug
false

DRUGA Renal tubular transport of DRUGN may be inhibited by concomitant administration of DRUGB , potentially leading to increased plasma levels of DRUGN .
Methotrexate	drug	ciprofloxacin	drug
false

DRUGA Renal tubular transport of DRUGN may be inhibited by concomitant administration of DRUGN , potentially leading to increased plasma levels of DRUGB .
Methotrexate	drug	methotrexate	drug
false

DRUGN Renal tubular transport of DRUGA may be inhibited by concomitant administration of DRUGB , potentially leading to increased plasma levels of DRUGN .
methotrexate	drug	ciprofloxacin	drug
mechanism

DRUGN Renal tubular transport of DRUGN may be inhibited by concomitant administration of DRUGA , potentially leading to increased plasma levels of DRUGB .
ciprofloxacin	drug	methotrexate	drug
false

Therefore , patients under DRUGA therapy should be carefully monitored when concomitant DRUGB therapy is indicated .
methotrexate	drug	ciprofloxacin	drug
advise

This time window is different than for other oral formulations of DRUGA , which are usually administered dgb hours before or dgb hours after DRUGB .
ciprofloxacin	drug	antacids	group
advise

DRUGA ( but not DRUGB ) : These drugs in combination with very high doses of DRUGN have been shown to provoke convulsions in pre clinical studies .
Non-steroidal anti-inflammatory drugs	group	aspirin	brand
false

DRUGA ( but not DRUGN ) : These drugs in combination with very high doses of DRUGB have been shown to provoke convulsions in pre clinical studies .
Non-steroidal anti-inflammatory drugs	group	quinolones	group
false

DRUGN ( but not DRUGA ) : These drugs in combination with very high doses of DRUGB have been shown to provoke convulsions in pre clinical studies .
aspirin	brand	quinolones	group
false

DRUGA : The rate and extent of absorption of DRUGB was bioequivalent when DRUGN was given alone or when DRUGN was given dgb hours after DRUGN at the dose that maximally suppresses gastric acid secretion .
Omeprazole	drug	ciprofloxacin	drug
false

DRUGA : The rate and extent of absorption of DRUGN was bioequivalent when DRUGB was given alone or when DRUGN was given dgb hours after DRUGN at the dose that maximally suppresses gastric acid secretion .
Omeprazole	drug	Proquin XR	brand
false

DRUGA : The rate and extent of absorption of DRUGN was bioequivalent when DRUGN was given alone or when DRUGB was given dgb hours after DRUGN at the dose that maximally suppresses gastric acid secretion .
Omeprazole	drug	Proquin XR	brand
false

DRUGA : The rate and extent of absorption of DRUGN was bioequivalent when DRUGN was given alone or when DRUGN was given dgb hours after DRUGB at the dose that maximally suppresses gastric acid secretion .
Omeprazole	drug	omeprazole	drug
false

DRUGN : The rate and extent of absorption of DRUGA was bioequivalent when DRUGB was given alone or when DRUGN was given dgb hours after DRUGN at the dose that maximally suppresses gastric acid secretion .
ciprofloxacin	drug	Proquin XR	brand
false

DRUGN : The rate and extent of absorption of DRUGA was bioequivalent when DRUGN was given alone or when DRUGB was given dgb hours after DRUGN at the dose that maximally suppresses gastric acid secretion .
ciprofloxacin	drug	Proquin XR	brand
false

DRUGN : The rate and extent of absorption of DRUGA was bioequivalent when DRUGN was given alone or when DRUGN was given dgb hours after DRUGB at the dose that maximally suppresses gastric acid secretion .
ciprofloxacin	drug	omeprazole	drug
false

DRUGN : The rate and extent of absorption of DRUGN was bioequivalent when DRUGA was given alone or when DRUGN was given dgb hours after DRUGB at the dose that maximally suppresses gastric acid secretion .
Proquin XR	brand	omeprazole	drug
false

DRUGN : The rate and extent of absorption of DRUGN was bioequivalent when DRUGN was given alone or when DRUGA was given dgb hours after DRUGB at the dose that maximally suppresses gastric acid secretion .
Proquin XR	brand	omeprazole	drug
false

DRUGA should be taken as directed and DRUGB should be taken with a main meal of the day , preferably the evening meal..
Omeprazole	drug	Proquin XR	brand
false

DRUGA : Altered serum levels of DRUGB ( increased and decreased ) have been reported in patients receiving concomitant DRUGN .
Phenytoin	drug	phenytoin	drug
false

DRUGA : Altered serum levels of DRUGN ( increased and decreased ) have been reported in patients receiving concomitant DRUGB .
Phenytoin	drug	ciprofloxacin	drug
false

DRUGN : Altered serum levels of DRUGA ( increased and decreased ) have been reported in patients receiving concomitant DRUGB .
phenytoin	drug	ciprofloxacin	drug
mechanism

DRUGA : DRUGN interferes with renal tubular secretion of DRUGB and produces an increase in the level of DRUGN in serum .
Probenecid	drug	ciprofloxacin	drug
false

DRUGA : DRUGN interferes with renal tubular secretion of DRUGN and produces an increase in the level of DRUGB in serum .
Probenecid	drug	ciprofloxacin	drug
false

DRUGN : DRUGA interferes with renal tubular secretion of DRUGB and produces an increase in the level of DRUGN in serum .
Probenecid	drug	ciprofloxacin	drug
mechanism

DRUGN : DRUGA interferes with renal tubular secretion of DRUGN and produces an increase in the level of DRUGB in serum .
Probenecid	drug	ciprofloxacin	drug
mechanism

DRUGA : As with some other DRUGB , concurrent administration of DRUGN with DRUGN may lead to elevated serum concentrations of DRUGN and prolongation of its elimination half life .
Theophylline	drug	quinolones	group
false

DRUGA : As with some other DRUGN , concurrent administration of DRUGB with DRUGN may lead to elevated serum concentrations of DRUGN and prolongation of its elimination half life .
Theophylline	drug	ciprofloxacin	drug
false

DRUGA : As with some other DRUGN , concurrent administration of DRUGN with DRUGB may lead to elevated serum concentrations of DRUGN and prolongation of its elimination half life .
Theophylline	drug	theophylline	drug
false

DRUGA : As with some other DRUGN , concurrent administration of DRUGN with DRUGN may lead to elevated serum concentrations of DRUGB and prolongation of its elimination half life .
Theophylline	drug	theophylline	drug
false

DRUGN : As with some other DRUGA , concurrent administration of DRUGB with DRUGN may lead to elevated serum concentrations of DRUGN and prolongation of its elimination half life .
quinolones	group	ciprofloxacin	drug
false

DRUGN : As with some other DRUGA , concurrent administration of DRUGN with DRUGB may lead to elevated serum concentrations of DRUGN and prolongation of its elimination half life .
quinolones	group	theophylline	drug
mechanism

DRUGN : As with some other DRUGA , concurrent administration of DRUGN with DRUGN may lead to elevated serum concentrations of DRUGB and prolongation of its elimination half life .
quinolones	group	theophylline	drug
false

DRUGN : As with some other DRUGN , concurrent administration of DRUGA with DRUGB may lead to elevated serum concentrations of DRUGN and prolongation of its elimination half life .
ciprofloxacin	drug	theophylline	drug
mechanism

DRUGN : As with some other DRUGN , concurrent administration of DRUGA with DRUGN may lead to elevated serum concentrations of DRUGB and prolongation of its elimination half life .
ciprofloxacin	drug	theophylline	drug
false

DRUGA : DRUGB have been reported to enhance the effects of the oral DRUGN DRUGN or its derivatives .
Warfarin	drug	Quinolones	group
false

DRUGA : DRUGN have been reported to enhance the effects of the oral DRUGB DRUGN or its derivatives .
Warfarin	drug	anticoagulant	group
false

DRUGA : DRUGN have been reported to enhance the effects of the oral DRUGN DRUGB or its derivatives .
Warfarin	drug	warfarin	drug
false

DRUGN : DRUGA have been reported to enhance the effects of the oral DRUGB DRUGN or its derivatives .
Quinolones	group	anticoagulant	group
false

DRUGN : DRUGA have been reported to enhance the effects of the oral DRUGN DRUGB or its derivatives .
Quinolones	group	warfarin	drug
effect

DRUGN : DRUGN have been reported to enhance the effects of the oral DRUGA DRUGB or its derivatives .
anticoagulant	group	warfarin	drug
false

DRUGA : Concurrent administration of certain DRUGB , such as DRUGN and DRUGN , would be expected to compromise the beneficial effects of DRUGN .
Anticholinergics	group	anticholinergic compounds	group
false

DRUGA : Concurrent administration of certain DRUGN , such as DRUGB and DRUGN , would be expected to compromise the beneficial effects of DRUGN .
Anticholinergics	group	belladonna alkaloids	group
false

DRUGA : Concurrent administration of certain DRUGN , such as DRUGN and DRUGB , would be expected to compromise the beneficial effects of DRUGN .
Anticholinergics	group	dicyclomine	drug
false

DRUGA : Concurrent administration of certain DRUGN , such as DRUGN and DRUGN , would be expected to compromise the beneficial effects of DRUGB .
Anticholinergics	group	cisapride	drug
false

DRUGN : Concurrent administration of certain DRUGA , such as DRUGB and DRUGN , would be expected to compromise the beneficial effects of DRUGN .
anticholinergic compounds	group	belladonna alkaloids	group
false

DRUGN : Concurrent administration of certain DRUGA , such as DRUGN and DRUGB , would be expected to compromise the beneficial effects of DRUGN .
anticholinergic compounds	group	dicyclomine	drug
false

DRUGN : Concurrent administration of certain DRUGA , such as DRUGN and DRUGN , would be expected to compromise the beneficial effects of DRUGB .
anticholinergic compounds	group	cisapride	drug
effect

DRUGN : Concurrent administration of certain DRUGN , such as DRUGA and DRUGB , would be expected to compromise the beneficial effects of DRUGN .
belladonna alkaloids	group	dicyclomine	drug
false

DRUGN : Concurrent administration of certain DRUGN , such as DRUGA and DRUGN , would be expected to compromise the beneficial effects of DRUGB .
belladonna alkaloids	group	cisapride	drug
effect

DRUGN : Concurrent administration of certain DRUGN , such as DRUGN and DRUGA , would be expected to compromise the beneficial effects of DRUGB .
dicyclomine	drug	cisapride	drug
effect

DRUGA ( Oral ) : In patients receiving oral DRUGB , the coagulation times were increased in some cases .
Anticoagulants	group	anticoagulants	group
false

It is advisable to check coagulation time within the first few days after the start and discontinuation of DRUGA therapy , with an appropriate adjustment of the DRUGB dose , if necessary .
cisapride	drug	anticoagulant	group
advise

DRUGA : In vitro data indicate that DRUGB inhibits the metabolism of DRUGN , which can result in an increase in plasma DRUGN levels and prolongation of the QT interval on the ECG .
Antidepressants	group	nefazodone	drug
false

DRUGA : In vitro data indicate that DRUGN inhibits the metabolism of DRUGB , which can result in an increase in plasma DRUGN levels and prolongation of the QT interval on the ECG .
Antidepressants	group	cisapride	drug
false

DRUGA : In vitro data indicate that DRUGN inhibits the metabolism of DRUGN , which can result in an increase in plasma DRUGB levels and prolongation of the QT interval on the ECG .
Antidepressants	group	cisapride	drug
false

DRUGN : In vitro data indicate that DRUGA inhibits the metabolism of DRUGB , which can result in an increase in plasma DRUGN levels and prolongation of the QT interval on the ECG .
nefazodone	drug	cisapride	drug
mechanism

DRUGN : In vitro data indicate that DRUGA inhibits the metabolism of DRUGN , which can result in an increase in plasma DRUGB levels and prolongation of the QT interval on the ECG .
nefazodone	drug	cisapride	drug
false

Human pharmacokinetic data indicate that oral DRUGA markedly inhibits the metabolism of DRUGB , resulting in a mean eight fold increase in AUC of DRUGN .
ketoconazole	drug	cisapride	drug
mechanism

Human pharmacokinetic data indicate that oral DRUGA markedly inhibits the metabolism of DRUGN , resulting in a mean eight fold increase in AUC of DRUGB .
ketoconazole	drug	cisapride	drug
false

A study in dgb normal male and female volunteers suggests that coadministration of DRUGA and DRUGB can result in prolongation of the QT interval on the ECG .
cisapride	drug	ketoconazole	drug
effect

DRUGA : DRUGB coadministration leads to an increased peak plasma concentration and AUC of DRUGN , there is no effect on DRUGN absorption when it is coadministered with DRUGN .
H2 Receptor Antagonists	group	Cimetidine	drug
false

DRUGA : DRUGN coadministration leads to an increased peak plasma concentration and AUC of DRUGB , there is no effect on DRUGN absorption when it is coadministered with DRUGN .
H2 Receptor Antagonists	group	cisapride	drug
false

DRUGA : DRUGN coadministration leads to an increased peak plasma concentration and AUC of DRUGN , there is no effect on DRUGB absorption when it is coadministered with DRUGN .
H2 Receptor Antagonists	group	cisapride	drug
false

DRUGA : DRUGN coadministration leads to an increased peak plasma concentration and AUC of DRUGN , there is no effect on DRUGN absorption when it is coadministered with DRUGB .
H2 Receptor Antagonists	group	ranitidine	drug
false

DRUGN : DRUGA coadministration leads to an increased peak plasma concentration and AUC of DRUGB , there is no effect on DRUGN absorption when it is coadministered with DRUGN .
Cimetidine	drug	cisapride	drug
mechanism

DRUGN : DRUGA coadministration leads to an increased peak plasma concentration and AUC of DRUGN , there is no effect on DRUGB absorption when it is coadministered with DRUGN .
Cimetidine	drug	cisapride	drug
false

DRUGN : DRUGA coadministration leads to an increased peak plasma concentration and AUC of DRUGN , there is no effect on DRUGN absorption when it is coadministered with DRUGB .
Cimetidine	drug	ranitidine	drug
false

DRUGN : DRUGN coadministration leads to an increased peak plasma concentration and AUC of DRUGA , there is no effect on DRUGN absorption when it is coadministered with DRUGB .
cisapride	drug	ranitidine	drug
false

DRUGN : DRUGN coadministration leads to an increased peak plasma concentration and AUC of DRUGN , there is no effect on DRUGA absorption when it is coadministered with DRUGB .
cisapride	drug	ranitidine	drug
false

The gastrointestinal absorption of DRUGA and DRUGB is accelerated when they are coadministered with DRUGN .
cimetidine	drug	ranitidine	drug
false

The gastrointestinal absorption of DRUGA and DRUGN is accelerated when they are coadministered with DRUGB .
cimetidine	drug	cisapride	drug
mechanism

The gastrointestinal absorption of DRUGN and DRUGA is accelerated when they are coadministered with DRUGB .
ranitidine	drug	cisapride	drug
mechanism

DRUGA : In vitro data indicate that DRUGB and DRUGN markedly inhibit the metabolism of DRUGN which can result in an increase in plasma DRUGN levels and prolongation of the QT interval on the ECG .
Protease Inhibitors	group	indinavir	drug
false

DRUGA : In vitro data indicate that DRUGN and DRUGB markedly inhibit the metabolism of DRUGN which can result in an increase in plasma DRUGN levels and prolongation of the QT interval on the ECG .
Protease Inhibitors	group	ritonavir	drug
false

DRUGA : In vitro data indicate that DRUGN and DRUGN markedly inhibit the metabolism of DRUGB which can result in an increase in plasma DRUGN levels and prolongation of the QT interval on the ECG .
Protease Inhibitors	group	cisapride	drug
false

DRUGA : In vitro data indicate that DRUGN and DRUGN markedly inhibit the metabolism of DRUGN which can result in an increase in plasma DRUGB levels and prolongation of the QT interval on the ECG .
Protease Inhibitors	group	cisapride	drug
false

DRUGN : In vitro data indicate that DRUGA and DRUGB markedly inhibit the metabolism of DRUGN which can result in an increase in plasma DRUGN levels and prolongation of the QT interval on the ECG .
indinavir	drug	ritonavir	drug
false

DRUGN : In vitro data indicate that DRUGA and DRUGN markedly inhibit the metabolism of DRUGB which can result in an increase in plasma DRUGN levels and prolongation of the QT interval on the ECG .
indinavir	drug	cisapride	drug
mechanism

DRUGN : In vitro data indicate that DRUGA and DRUGN markedly inhibit the metabolism of DRUGN which can result in an increase in plasma DRUGB levels and prolongation of the QT interval on the ECG .
indinavir	drug	cisapride	drug
false

DRUGN : In vitro data indicate that DRUGN and DRUGA markedly inhibit the metabolism of DRUGB which can result in an increase in plasma DRUGN levels and prolongation of the QT interval on the ECG .
ritonavir	drug	cisapride	drug
mechanism

DRUGN : In vitro data indicate that DRUGN and DRUGA markedly inhibit the metabolism of DRUGN which can result in an increase in plasma DRUGB levels and prolongation of the QT interval on the ECG .
ritonavir	drug	cisapride	drug
false

DRUGA should not be used concomitantly with other drugs known to prolong the QT interval : certain DRUGB , including those of Class IA ( such as DRUGN and DRUGN ) and Class III ( such as DRUGN ) ;
Cisapride	drug	antiarrhythmics	group
advise

DRUGA should not be used concomitantly with other drugs known to prolong the QT interval : certain DRUGN , including those of Class IA ( such as DRUGB and DRUGN ) and Class III ( such as DRUGN ) ;
Cisapride	drug	quinidine	drug
advise

DRUGA should not be used concomitantly with other drugs known to prolong the QT interval : certain DRUGN , including those of Class IA ( such as DRUGN and DRUGB ) and Class III ( such as DRUGN ) ;
Cisapride	drug	procainamide	drug
advise

DRUGA should not be used concomitantly with other drugs known to prolong the QT interval : certain DRUGN , including those of Class IA ( such as DRUGN and DRUGN ) and Class III ( such as DRUGB ) ;
Cisapride	drug	sotalol	drug
advise

DRUGN should not be used concomitantly with other drugs known to prolong the QT interval : certain DRUGA , including those of Class IA ( such as DRUGB and DRUGN ) and Class III ( such as DRUGN ) ;
antiarrhythmics	group	quinidine	drug
false

DRUGN should not be used concomitantly with other drugs known to prolong the QT interval : certain DRUGA , including those of Class IA ( such as DRUGN and DRUGB ) and Class III ( such as DRUGN ) ;
antiarrhythmics	group	procainamide	drug
false

DRUGN should not be used concomitantly with other drugs known to prolong the QT interval : certain DRUGA , including those of Class IA ( such as DRUGN and DRUGN ) and Class III ( such as DRUGB ) ;
antiarrhythmics	group	sotalol	drug
false

DRUGN should not be used concomitantly with other drugs known to prolong the QT interval : certain DRUGN , including those of Class IA ( such as DRUGA and DRUGB ) and Class III ( such as DRUGN ) ;
quinidine	drug	procainamide	drug
false

DRUGN should not be used concomitantly with other drugs known to prolong the QT interval : certain DRUGN , including those of Class IA ( such as DRUGA and DRUGN ) and Class III ( such as DRUGB ) ;
quinidine	drug	sotalol	drug
false

DRUGN should not be used concomitantly with other drugs known to prolong the QT interval : certain DRUGN , including those of Class IA ( such as DRUGN and DRUGA ) and Class III ( such as DRUGB ) ;
procainamide	drug	sotalol	drug
false

DRUGA ( such as DRUGB ) ;
tricyclic antidepressants	group	amitriptyline	drug
false

certain DRUGA ( such as DRUGB ) ;
tetracyclic antidepressants	group	maprotiline	drug
false

certain DRUGA ( such as DRUGB ) ;
antipsychotic medications	group	sertindole	drug
false

DRUGA , DRUGB , DRUGN , and DRUGN .
astemizole	drug	bepridil	drug
false

DRUGA , DRUGN , DRUGB , and DRUGN .
astemizole	drug	sparfloxacin	drug
false

DRUGA , DRUGN , DRUGN , and DRUGB .
astemizole	drug	terodiline	drug
false

DRUGN , DRUGA , DRUGB , and DRUGN .
bepridil	drug	sparfloxacin	drug
false

DRUGN , DRUGA , DRUGN , and DRUGB .
bepridil	drug	terodiline	drug
false

DRUGN , DRUGN , DRUGA , and DRUGB .
sparfloxacin	drug	terodiline	drug
false

Administration of dga mg / kg ( dgb x EDdgb ) DRUGA at dgb % or dgb % recovery following an intubating dose of DRUGB ( dgb mg / kg ) produced dgb % neuromuscular block .
NIMBEX	brand	succinylcholine	drug
effect

The time to onset of maximum block following DRUGA is approximately dgb minutes faster with prior administration of DRUGB .
NIMBEX	brand	succinylcholine	drug
effect

Prior administration of DRUGA had no effect on the duration of neuromuscular block following initial or maintenance bolus doses of DRUGB .
succinylcholine	drug	NIMBEX	brand
false

Infusion requirements of DRUGA in patients administered DRUGB prior to infusions of DRUGN were comparable to or slightly greater than when DRUGN was not administered .
NIMBEX	brand	succinylcholine	drug
false

Infusion requirements of DRUGA in patients administered DRUGN prior to infusions of DRUGN were comparable to or slightly greater than when DRUGB was not administered .
NIMBEX	brand	succinylcholine	drug
false

Infusion requirements of DRUGN in patients administered DRUGA prior to infusions of DRUGB were comparable to or slightly greater than when DRUGN was not administered .
succinylcholine	drug	NIMBEX	brand
effect

Infusion requirements of DRUGN in patients administered DRUGN prior to infusions of DRUGA were comparable to or slightly greater than when DRUGB was not administered .
NIMBEX	brand	succinylcholine	drug
false

The use of DRUGA before DRUGB to attenuate some of the side effects of DRUGN has not been studied .
NIMBEX	brand	succinylcholine	drug
false

The use of DRUGA before DRUGN to attenuate some of the side effects of DRUGB has not been studied .
NIMBEX	brand	succinylcholine	drug
false

Although not studied systematically in clinical trials , no drug interactions were observed when DRUGA , DRUGB , or DRUGN were administered following varying degrees of recovery from single doses or infusions of DRUGN .
vecuronium	drug	pancuronium	drug
false

Although not studied systematically in clinical trials , no drug interactions were observed when DRUGA , DRUGN , or DRUGB were administered following varying degrees of recovery from single doses or infusions of DRUGN .
vecuronium	drug	atracurium	drug
false

Although not studied systematically in clinical trials , no drug interactions were observed when DRUGA , DRUGN , or DRUGN were administered following varying degrees of recovery from single doses or infusions of DRUGB .
vecuronium	drug	NIMBEX	brand
false

Although not studied systematically in clinical trials , no drug interactions were observed when DRUGN , DRUGA , or DRUGB were administered following varying degrees of recovery from single doses or infusions of DRUGN .
pancuronium	drug	atracurium	drug
false

Although not studied systematically in clinical trials , no drug interactions were observed when DRUGN , DRUGA , or DRUGN were administered following varying degrees of recovery from single doses or infusions of DRUGB .
pancuronium	drug	NIMBEX	brand
false

Although not studied systematically in clinical trials , no drug interactions were observed when DRUGN , DRUGN , or DRUGA were administered following varying degrees of recovery from single doses or infusions of DRUGB .
atracurium	drug	NIMBEX	brand
false

In long surgical procedures during DRUGA or DRUGB anesthesia , less frequent maintenance dosing , lower maintenance doses , or reduced infusion rates of DRUGN may be necessary .
enflurane	drug	isoflurane	drug
false

In long surgical procedures during DRUGA or DRUGN anesthesia , less frequent maintenance dosing , lower maintenance doses , or reduced infusion rates of DRUGB may be necessary .
enflurane	drug	NIMBEX	brand
advise

In long surgical procedures during DRUGN or DRUGA anesthesia , less frequent maintenance dosing , lower maintenance doses , or reduced infusion rates of DRUGB may be necessary .
isoflurane	drug	NIMBEX	brand
advise

In clinical studies DRUGA had no effect on the duration of action or dosing requirements for DRUGB .
propofol	drug	NIMBEX	brand
false

Resistance to the neuromuscular blocking action of DRUGA has been demonstrated in patients chronically administered DRUGB or DRUGN .
nondepolarizing neuromuscular blocking agents	group	phenytoin	drug
effect

Resistance to the neuromuscular blocking action of DRUGA has been demonstrated in patients chronically administered DRUGN or DRUGB .
nondepolarizing neuromuscular blocking agents	group	carbamazepine	drug
effect

Resistance to the neuromuscular blocking action of DRUGN has been demonstrated in patients chronically administered DRUGA or DRUGB .
phenytoin	drug	carbamazepine	drug
false

While the effects of chronic DRUGA or DRUGB therapy on the action of DRUGN are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .
phenytoin	drug	carbamazepine	drug
false

While the effects of chronic DRUGA or DRUGN therapy on the action of DRUGB are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .
phenytoin	drug	NIMBEX	brand
effect

While the effects of chronic DRUGN or DRUGA therapy on the action of DRUGB are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .
carbamazepine	drug	NIMBEX	brand
effect

Plasma levels of DRUGA may become subtherapeutic during DRUGB therapy .
anticonvulsant agents	group	cisplatin	drug
mechanism

DRUGA ( CNS ) drugs including DRUGB , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
Central nervous system depressant	group	alcohol	drug
false

DRUGA ( CNS ) drugs including DRUGN , DRUGB , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
Central nervous system depressant	group	antidepressants	group
false

DRUGA ( CNS ) drugs including DRUGN , DRUGN , DRUGB , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
Central nervous system depressant	group	antihistamines	group
false

DRUGA ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGB , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
Central nervous system depressant	group	antipsychotics	group
false

DRUGA ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGB , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
Central nervous system depressant	group	reserpine	drug
false

DRUGA ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGB , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
Central nervous system depressant	group	methyldopa	drug
false

DRUGA ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGB ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
Central nervous system depressant	group	beta-blockers	group
false

DRUGA ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGB , DRUGN , DRUGN , sleeping pills and DRUGN
Central nervous system depressant	group	muscle relaxants	group
false

DRUGA ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGB , DRUGN , sleeping pills and DRUGN
Central nervous system depressant	group	narcotics	group
false

DRUGA ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGB , sleeping pills and DRUGN
Central nervous system depressant	group	sedatives	group
false

DRUGA ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGB
Central nervous system depressant	group	tranquilizers	group
false

DRUGN ( CNS ) drugs including DRUGA , DRUGB , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
alcohol	drug	antidepressants	group
false

DRUGN ( CNS ) drugs including DRUGA , DRUGN , DRUGB , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
alcohol	drug	antihistamines	group
false

DRUGN ( CNS ) drugs including DRUGA , DRUGN , DRUGN , DRUGB , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
alcohol	drug	antipsychotics	group
false

DRUGN ( CNS ) drugs including DRUGA , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGB , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
alcohol	drug	reserpine	drug
false

DRUGN ( CNS ) drugs including DRUGA , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGB , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
alcohol	drug	methyldopa	drug
false

DRUGN ( CNS ) drugs including DRUGA , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGB ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
alcohol	drug	beta-blockers	group
false

DRUGN ( CNS ) drugs including DRUGA , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGB , DRUGN , DRUGN , sleeping pills and DRUGN
alcohol	drug	muscle relaxants	group
false

DRUGN ( CNS ) drugs including DRUGA , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGB , DRUGN , sleeping pills and DRUGN
alcohol	drug	narcotics	group
false

DRUGN ( CNS ) drugs including DRUGA , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGB , sleeping pills and DRUGN
alcohol	drug	sedatives	group
false

DRUGN ( CNS ) drugs including DRUGA , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGB
alcohol	drug	tranquilizers	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGA , DRUGB , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
antidepressants	group	antihistamines	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGA , DRUGN , DRUGB , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
antidepressants	group	antipsychotics	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGA , DRUGN , DRUGN , blood pressure medications ( DRUGB , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
antidepressants	group	reserpine	drug
false

DRUGN ( CNS ) drugs including DRUGN , DRUGA , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGB , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
antidepressants	group	methyldopa	drug
false

DRUGN ( CNS ) drugs including DRUGN , DRUGA , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGB ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
antidepressants	group	beta-blockers	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGA , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGB , DRUGN , DRUGN , sleeping pills and DRUGN
antidepressants	group	muscle relaxants	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGA , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGB , DRUGN , sleeping pills and DRUGN
antidepressants	group	narcotics	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGA , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGB , sleeping pills and DRUGN
antidepressants	group	sedatives	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGA , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGB
antidepressants	group	tranquilizers	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGA , DRUGB , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
antihistamines	group	antipsychotics	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGA , DRUGN , blood pressure medications ( DRUGB , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
antihistamines	group	reserpine	drug
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGA , DRUGN , blood pressure medications ( DRUGN , DRUGB , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
antihistamines	group	methyldopa	drug
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGA , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGB ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
antihistamines	group	beta-blockers	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGA , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGB , DRUGN , DRUGN , sleeping pills and DRUGN
antihistamines	group	muscle relaxants	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGA , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGB , DRUGN , sleeping pills and DRUGN
antihistamines	group	narcotics	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGA , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGB , sleeping pills and DRUGN
antihistamines	group	sedatives	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGA , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGB
antihistamines	group	tranquilizers	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGA , blood pressure medications ( DRUGB , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
antipsychotics	group	reserpine	drug
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGA , blood pressure medications ( DRUGN , DRUGB , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
antipsychotics	group	methyldopa	drug
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGA , blood pressure medications ( DRUGN , DRUGN , DRUGB ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
antipsychotics	group	beta-blockers	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGA , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGB , DRUGN , DRUGN , sleeping pills and DRUGN
antipsychotics	group	muscle relaxants	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGA , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGB , DRUGN , sleeping pills and DRUGN
antipsychotics	group	narcotics	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGA , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGB , sleeping pills and DRUGN
antipsychotics	group	sedatives	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGA , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGB
antipsychotics	group	tranquilizers	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGA , DRUGB , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
reserpine	drug	methyldopa	drug
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGA , DRUGN , DRUGB ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
reserpine	drug	beta-blockers	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGA , DRUGN , DRUGN ) , motion sickness medications , DRUGB , DRUGN , DRUGN , sleeping pills and DRUGN
reserpine	drug	muscle relaxants	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGA , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGB , DRUGN , sleeping pills and DRUGN
reserpine	drug	narcotics	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGA , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGB , sleeping pills and DRUGN
reserpine	drug	sedatives	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGA , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGB
reserpine	drug	tranquilizers	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGA , DRUGB ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGN
methyldopa	drug	beta-blockers	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGA , DRUGN ) , motion sickness medications , DRUGB , DRUGN , DRUGN , sleeping pills and DRUGN
methyldopa	drug	muscle relaxants	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGA , DRUGN ) , motion sickness medications , DRUGN , DRUGB , DRUGN , sleeping pills and DRUGN
methyldopa	drug	narcotics	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGA , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGB , sleeping pills and DRUGN
methyldopa	drug	sedatives	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGA , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGB
methyldopa	drug	tranquilizers	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGA ) , motion sickness medications , DRUGB , DRUGN , DRUGN , sleeping pills and DRUGN
beta-blockers	group	muscle relaxants	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGA ) , motion sickness medications , DRUGN , DRUGB , DRUGN , sleeping pills and DRUGN
beta-blockers	group	narcotics	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGA ) , motion sickness medications , DRUGN , DRUGN , DRUGB , sleeping pills and DRUGN
beta-blockers	group	sedatives	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGA ) , motion sickness medications , DRUGN , DRUGN , DRUGN , sleeping pills and DRUGB
beta-blockers	group	tranquilizers	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGA , DRUGB , DRUGN , sleeping pills and DRUGN
muscle relaxants	group	narcotics	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGA , DRUGN , DRUGB , sleeping pills and DRUGN
muscle relaxants	group	sedatives	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGA , DRUGN , DRUGN , sleeping pills and DRUGB
muscle relaxants	group	tranquilizers	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGA , DRUGB , sleeping pills and DRUGN
narcotics	group	sedatives	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGA , DRUGN , sleeping pills and DRUGB
narcotics	group	tranquilizers	group
false

DRUGN ( CNS ) drugs including DRUGN , DRUGN , DRUGN , DRUGN , blood pressure medications ( DRUGN , DRUGN , DRUGN ) , motion sickness medications , DRUGN , DRUGN , DRUGA , sleeping pills and DRUGB
sedatives	group	tranquilizers	group
false

The concurrent administration of DRUGA and DRUGB increases substantially the incidence of rashes in patients receiving both drugs as compared to patients receiving DRUGN alone .
allopurinol	drug	ampicillin	drug
effect

The concurrent administration of DRUGA and DRUGN increases substantially the incidence of rashes in patients receiving both drugs as compared to patients receiving DRUGB alone .
allopurinol	drug	ampicillin	drug
false

It is not known whether this potentiation of DRUGA rashes is due to DRUGB or the hyperuricemia present in these patients .
ampicillin	drug	allopurinol	drug
effect

In controlled clinical trials of DRUGA , dgb patients received concomitant DRUGB and DRUGN .
AUGMENTIN XR	brand	allopurinol	drug
false

In controlled clinical trials of DRUGN , dgb patients received concomitant DRUGA and DRUGB .
allopurinol	drug	AUGMENTIN XR	brand
false

However , this sample size is too small to allow for any conclusions to be drawn regarding the risk of rashes with concomitant DRUGA and DRUGB use .
AUGMENTIN XR	brand	allopurinol	drug
false

In common with other DRUGA , DRUGB may reduce the efficacy of oral DRUGN
broad-spectrum antibiotics	group	AUGMENTIN XR	brand
false

In common with other DRUGA , DRUGN may reduce the efficacy of oral DRUGB
broad-spectrum antibiotics	group	contraceptives	group
effect

In common with other DRUGN , DRUGA may reduce the efficacy of oral DRUGB
AUGMENTIN XR	brand	contraceptives	group
effect

Additive CNS depression may occur when DRUGA are administered concomitantly with other DRUGB including DRUGN , DRUGN , and DRUGN .
antihistamines	group	CNS depressants	group
effect

Additive CNS depression may occur when DRUGA are administered concomitantly with other DRUGN including DRUGB , DRUGN , and DRUGN .
antihistamines	group	barbiturates	group
effect

Additive CNS depression may occur when DRUGA are administered concomitantly with other DRUGN including DRUGN , DRUGB , and DRUGN .
antihistamines	group	tranquilizers	group
effect

Additive CNS depression may occur when DRUGA are administered concomitantly with other DRUGN including DRUGN , DRUGN , and DRUGB .
antihistamines	group	alcohol	drug
effect

Additive CNS depression may occur when DRUGN are administered concomitantly with other DRUGA including DRUGB , DRUGN , and DRUGN .
CNS depressants	group	barbiturates	group
false

Additive CNS depression may occur when DRUGN are administered concomitantly with other DRUGA including DRUGN , DRUGB , and DRUGN .
CNS depressants	group	tranquilizers	group
false

Additive CNS depression may occur when DRUGN are administered concomitantly with other DRUGA including DRUGN , DRUGN , and DRUGB .
CNS depressants	group	alcohol	drug
false

Additive CNS depression may occur when DRUGN are administered concomitantly with other DRUGN including DRUGA , DRUGB , and DRUGN .
barbiturates	group	tranquilizers	group
false

Additive CNS depression may occur when DRUGN are administered concomitantly with other DRUGN including DRUGA , DRUGN , and DRUGB .
barbiturates	group	alcohol	drug
false

Additive CNS depression may occur when DRUGN are administered concomitantly with other DRUGN including DRUGN , DRUGA , and DRUGB .
tranquilizers	group	alcohol	drug
false

Patients receiving DRUGA should be advised against the concurrent use of other DRUGB .
antihistamines	group	CNS depressant drugs	group
advise

DRUGA prolong and intensify the anticholinergic effects of DRUGB .
Monoamine oxidase (MAO) inhibitors	group	antihistamines	group
effect

DRUGA , DRUGB , and DRUGN may increase anticholinergic effect of DRUGN .
Amantadine	drug	tricyclic antidepressants	group
false

DRUGA , DRUGN , and DRUGB may increase anticholinergic effect of DRUGN .
Amantadine	drug	MAOIs	group
false

DRUGA , DRUGN , and DRUGN may increase anticholinergic effect of DRUGB .
Amantadine	drug	clidinium	drug
effect

DRUGN , DRUGA , and DRUGB may increase anticholinergic effect of DRUGN .
tricyclic antidepressants	group	MAOIs	group
false

DRUGN , DRUGA , and DRUGN may increase anticholinergic effect of DRUGB .
tricyclic antidepressants	group	clidinium	drug
effect

DRUGN , DRUGN , and DRUGA may increase anticholinergic effect of DRUGB .
MAOIs	group	clidinium	drug
effect

DRUGA may decrease the effect of DRUGB , DRUGN , and DRUGN .
Clidinium	drug	phenothiazines	group
effect

DRUGA may decrease the effect of DRUGN , DRUGB , and DRUGN .
Clidinium	drug	levodopa	drug
effect

DRUGA may decrease the effect of DRUGN , DRUGN , and DRUGB .
Clidinium	drug	ketoconazole	drug
effect

DRUGN may decrease the effect of DRUGA , DRUGB , and DRUGN .
phenothiazines	group	levodopa	drug
false

DRUGN may decrease the effect of DRUGA , DRUGN , and DRUGB .
phenothiazines	group	ketoconazole	drug
false

DRUGN may decrease the effect of DRUGN , DRUGA , and DRUGB .
levodopa	drug	ketoconazole	drug
false

DRUGA has been shown to have neuromuscular blocking properties that may enhance the action of other DRUGB .
Clindamycin	drug	neuromuscular blocking agents	group
effect

Antagonism has been demonstrated between DRUGA and DRUGB in vitro .
clindamycin	drug	erythromycin	drug
effect

DRUGA ( increases bioavailability by dgb % ) , DRUGB , and valproates .
Alcohol	drug	cimetidine	drug
false

Preliminary data which suggest that DRUGA may inhibit the anti inflammatory activity of DRUGB have not been confirmed .
dapsone	drug	Lamprene	brand
effect

If leprosy associated inflammatory reactions develop in patients being treated with DRUGA and DRUGB , it is still advisable to continue treatment with both drugs .
dapsone	drug	clofazimine	drug
advise

Caution should be exercised when DRUGA are given in conjunction with DRUGB .
anticoagulants	group	Atromid-S	brand
advise

DRUGA may displace acidic drugs such as DRUGB or DRUGN from their binding sites .
Atromid-S	brand	phenytoin	drug
mechanism

DRUGA may displace acidic drugs such as DRUGN or DRUGB from their binding sites .
Atromid-S	brand	tolbutamide	drug
mechanism

DRUGN may displace acidic drugs such as DRUGA or DRUGB from their binding sites .
phenytoin	drug	tolbutamide	drug
false

The hypoglycemic effect of DRUGA has been reported to increase when DRUGB is given concurrently .
tolbutamide	drug	Atromid-S	brand
effect

Fulminant rhabdomyolysis has been seen as early as three weeks after initiation of combined therapy with another DRUGA and DRUGB but may be seen after several months .
fibrate	group	lovastatin	drug
effect

While it is not known whether this interaction occurs with DRUGA other than DRUGB , myopathy and rhabdomyolysis have occasionally been associated with the use of DRUGN alone , including DRUGN .
fibrates	group	gemfibrozil	drug
false

While it is not known whether this interaction occurs with DRUGA other than DRUGN , myopathy and rhabdomyolysis have occasionally been associated with the use of DRUGN alone , including DRUGB .
fibrates	group	clofibrate	drug
false

While it is not known whether this interaction occurs with DRUGN other than DRUGA , myopathy and rhabdomyolysis have occasionally been associated with the use of DRUGB alone , including DRUGN .
gemfibrozil	drug	fibrates	group
false

While it is not known whether this interaction occurs with DRUGN other than DRUGA , myopathy and rhabdomyolysis have occasionally been associated with the use of DRUGN alone , including DRUGB .
gemfibrozil	drug	clofibrate	drug
false

While it is not known whether this interaction occurs with DRUGN other than DRUGN , myopathy and rhabdomyolysis have occasionally been associated with the use of DRUGA alone , including DRUGB .
fibrates	group	clofibrate	drug
false

Therefore , the combined use of DRUGA with DRUGB should generally be avoided .
lovastatin	drug	fibrates	group
advise

DRUGA should not be used with DRUGB .
Anafranil	brand	MAO inhibitors	group
advise

Close supervision and careful adjustment of dosage are required when DRUGA is administered with DRUGB or DRUGN .
Anafranil	brand	anticholinergic	group
advise

Close supervision and careful adjustment of dosage are required when DRUGA is administered with DRUGN or DRUGB .
Anafranil	brand	sympathomimetic drugs	group
advise

Close supervision and careful adjustment of dosage are required when DRUGN is administered with DRUGA or DRUGB .
anticholinergic	group	sympathomimetic drugs	group
false

Several DRUGA have been reported to block the pharmacologic effects of DRUGB , DRUGN , or similar agents , and such an effect may be anticipated with DRUGN because of its structural similarity to other DRUGN .
tricyclic antidepressants	group	guanethidine	drug
effect

Several DRUGA have been reported to block the pharmacologic effects of DRUGN , DRUGB , or similar agents , and such an effect may be anticipated with DRUGN because of its structural similarity to other DRUGN .
tricyclic antidepressants	group	clonidine	drug
effect

Several DRUGA have been reported to block the pharmacologic effects of DRUGN , DRUGN , or similar agents , and such an effect may be anticipated with DRUGB because of its structural similarity to other DRUGN .
tricyclic antidepressants	group	CMI	drug
effect

Several DRUGN have been reported to block the pharmacologic effects of DRUGA , DRUGB , or similar agents , and such an effect may be anticipated with DRUGN because of its structural similarity to other DRUGN .
guanethidine	drug	clonidine	drug
false

Several DRUGN have been reported to block the pharmacologic effects of DRUGA , DRUGN , or similar agents , and such an effect may be anticipated with DRUGB because of its structural similarity to other DRUGN .
guanethidine	drug	CMI	drug
false

Several DRUGN have been reported to block the pharmacologic effects of DRUGA , DRUGN , or similar agents , and such an effect may be anticipated with DRUGN because of its structural similarity to other DRUGB .
guanethidine	drug	tricyclic antidepressants	group
false

Several DRUGN have been reported to block the pharmacologic effects of DRUGN , DRUGA , or similar agents , and such an effect may be anticipated with DRUGB because of its structural similarity to other DRUGN .
clonidine	drug	CMI	drug
false

Several DRUGN have been reported to block the pharmacologic effects of DRUGN , DRUGA , or similar agents , and such an effect may be anticipated with DRUGN because of its structural similarity to other DRUGB .
clonidine	drug	tricyclic antidepressants	group
false

Several DRUGN have been reported to block the pharmacologic effects of DRUGN , DRUGN , or similar agents , and such an effect may be anticipated with DRUGA because of its structural similarity to other DRUGB .
CMI	drug	tricyclic antidepressants	group
false

The plasma concentration of DRUGA has been reported to be increased by the concomitant administration of DRUGB ;
CMI	drug	haloperidol	drug
mechanism

Administration of DRUGA has been reported to increase the plasma levels of DRUGB , if given concomitantly .
CMI	drug	phenobarbital	drug
mechanism

Poor metabolizers have higher than expected lasma concentrations of DRUGA ( DRUGB ) when given usual doses .
tricyclic antidepressants	group	TCAs	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGB , DRUGN , and the DRUGN DRUGN and DRUGN ) .
cimetidine	drug	antidepressants	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGB , and the DRUGN DRUGN and DRUGN ) .
cimetidine	drug	phenothiazines	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGB DRUGN and DRUGN ) .
cimetidine	drug	Type 1C antiarrhythmics	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGN DRUGB and DRUGN ) .
cimetidine	drug	propafenone	drug
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGN DRUGN and DRUGB ) .
cimetidine	drug	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGB , and the DRUGN DRUGN and DRUGN ) .
antidepressants	group	phenothiazines	group
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGN , and the DRUGB DRUGN and DRUGN ) .
antidepressants	group	Type 1C antiarrhythmics	group
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGN , and the DRUGN DRUGB and DRUGN ) .
antidepressants	group	propafenone	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGN , and the DRUGN DRUGN and DRUGB ) .
antidepressants	group	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGA , and the DRUGB DRUGN and DRUGN ) .
phenothiazines	group	Type 1C antiarrhythmics	group
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGA , and the DRUGN DRUGB and DRUGN ) .
phenothiazines	group	propafenone	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGA , and the DRUGN DRUGN and DRUGB ) .
phenothiazines	group	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGA DRUGB and DRUGN ) .
Type 1C antiarrhythmics	group	propafenone	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGA DRUGN and DRUGB ) .
Type 1C antiarrhythmics	group	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGN DRUGA and DRUGB ) .
propafenone	drug	flecainide	drug
false

While all the DRUGA ( DRUGB ) , e.g . , DRUGN , DRUGN , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	SSRIs	group
false

While all the DRUGA ( DRUGN ) , e.g . , DRUGB , DRUGN , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	fluoxetine	drug
false

While all the DRUGA ( DRUGN ) , e.g . , DRUGN , DRUGB , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	sertraline	drug
false

While all the DRUGA ( DRUGN ) , e.g . , DRUGN , DRUGN , DRUGB , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	paroxetine	drug
false

While all the DRUGA ( DRUGN ) , e.g . , DRUGN , DRUGN , DRUGN , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	fluvoxamine	drug
false

While all the DRUGN ( DRUGA ) , e.g . , DRUGB , DRUGN , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	fluoxetine	drug
false

While all the DRUGN ( DRUGA ) , e.g . , DRUGN , DRUGB , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	sertraline	drug
false

While all the DRUGN ( DRUGA ) , e.g . , DRUGN , DRUGN , DRUGB , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	paroxetine	drug
false

While all the DRUGN ( DRUGA ) , e.g . , DRUGN , DRUGN , DRUGN , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	fluvoxamine	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGA , DRUGB , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
fluoxetine	drug	sertraline	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGA , DRUGN , DRUGB , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
fluoxetine	drug	paroxetine	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGA , DRUGN , DRUGN , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
fluoxetine	drug	fluvoxamine	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGN , DRUGA , DRUGB , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
sertraline	drug	paroxetine	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGN , DRUGA , DRUGN , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
sertraline	drug	fluvoxamine	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGN , DRUGN , DRUGA , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
paroxetine	drug	fluvoxamine	drug
false

DRUGA has also been shown to inhibit Pdgb dgbAdgb , an isoform also involved in DRUGB metabolism .
Fluvoxamine	drug	TCA	group
mechanism

The extent to which DRUGA DRUGB interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the DRUGN involved .
SSRI	group	TCA	group
int

The extent to which DRUGN DRUGA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the DRUGB involved .
TCA	group	SSRI	group
false

Nevertheless , caution is indicated in the co administration of DRUGA with any of the DRUGB and also in switching from one class to the other .
TCAs	group	SSRIs	group
advise

Concomitant use of agents in the DRUGA ( which includes DRUGB ) with drugs that can inhibit cytochrome Pdgb dgbDdgb may require lower doses than usually prescribed for either the DRUGN or the other drug .
tricyclic antidepressant class	group	Anafranil	brand
false

Concomitant use of agents in the DRUGA ( which includes DRUGN ) with drugs that can inhibit cytochrome Pdgb dgbDdgb may require lower doses than usually prescribed for either the DRUGB or the other drug .
tricyclic antidepressant class	group	tricyclic antidepressant agent	group
false

Concomitant use of agents in the DRUGN ( which includes DRUGA ) with drugs that can inhibit cytochrome Pdgb dgbDdgb may require lower doses than usually prescribed for either the DRUGB or the other drug .
Anafranil	brand	tricyclic antidepressant agent	group
false

Effect of DRUGA on the Pharmacokinetics of Other Drugs : DRUGN does not appear to alter the pharmacokinetics of DRUGB , DRUGN , or DRUGN .
Clonazepam	drug	phenytoin	drug
false

Effect of DRUGA on the Pharmacokinetics of Other Drugs : DRUGN does not appear to alter the pharmacokinetics of DRUGN , DRUGB , or DRUGN .
Clonazepam	drug	carbamazepine	drug
false

Effect of DRUGA on the Pharmacokinetics of Other Drugs : DRUGN does not appear to alter the pharmacokinetics of DRUGN , DRUGN , or DRUGB .
Clonazepam	drug	phenobarbital	drug
false

Effect of DRUGN on the Pharmacokinetics of Other Drugs : DRUGA does not appear to alter the pharmacokinetics of DRUGB , DRUGN , or DRUGN .
Clonazepam	drug	phenytoin	drug
false

Effect of DRUGN on the Pharmacokinetics of Other Drugs : DRUGA does not appear to alter the pharmacokinetics of DRUGN , DRUGB , or DRUGN .
Clonazepam	drug	carbamazepine	drug
false

Effect of DRUGN on the Pharmacokinetics of Other Drugs : DRUGA does not appear to alter the pharmacokinetics of DRUGN , DRUGN , or DRUGB .
Clonazepam	drug	phenobarbital	drug
false

Effect of DRUGN on the Pharmacokinetics of Other Drugs : DRUGN does not appear to alter the pharmacokinetics of DRUGA , DRUGB , or DRUGN .
phenytoin	drug	carbamazepine	drug
false

Effect of DRUGN on the Pharmacokinetics of Other Drugs : DRUGN does not appear to alter the pharmacokinetics of DRUGA , DRUGN , or DRUGB .
phenytoin	drug	phenobarbital	drug
false

Effect of DRUGN on the Pharmacokinetics of Other Drugs : DRUGN does not appear to alter the pharmacokinetics of DRUGN , DRUGA , or DRUGB .
carbamazepine	drug	phenobarbital	drug
false

Effect of Other Drugs on the Pharmacokinetics of DRUGA : Literature reports suggest that DRUGB , an agent that decreases stomach acidity , does not greatly alter DRUGN pharmacokinetics .
Clonazepam	drug	ranitidine	drug
false

Effect of Other Drugs on the Pharmacokinetics of DRUGA : Literature reports suggest that DRUGN , an agent that decreases stomach acidity , does not greatly alter DRUGB pharmacokinetics .
Clonazepam	drug	clonazepam	drug
false

Effect of Other Drugs on the Pharmacokinetics of DRUGN : Literature reports suggest that DRUGA , an agent that decreases stomach acidity , does not greatly alter DRUGB pharmacokinetics .
ranitidine	drug	clonazepam	drug
false

DRUGA does not affect the pharmacokinetics of DRUGB .
Fluoxetine	drug	clonazepam	drug
false

Cytochrome P dgb inducers , such as DRUGA , DRUGB and DRUGN , induce DRUGN metabolism , causing an approximately dgb % decrease in plasma DRUGN levels .
phenytoin	drug	carbamazepine	drug
false

Cytochrome P dgb inducers , such as DRUGA , DRUGN and DRUGB , induce DRUGN metabolism , causing an approximately dgb % decrease in plasma DRUGN levels .
phenytoin	drug	phenobarbital	drug
false

Cytochrome P dgb inducers , such as DRUGA , DRUGN and DRUGN , induce DRUGB metabolism , causing an approximately dgb % decrease in plasma DRUGN levels .
phenytoin	drug	clonazepam	drug
mechanism

Cytochrome P dgb inducers , such as DRUGA , DRUGN and DRUGN , induce DRUGN metabolism , causing an approximately dgb % decrease in plasma DRUGB levels .
phenytoin	drug	clonazepam	drug
false

Cytochrome P dgb inducers , such as DRUGN , DRUGA and DRUGB , induce DRUGN metabolism , causing an approximately dgb % decrease in plasma DRUGN levels .
carbamazepine	drug	phenobarbital	drug
false

Cytochrome P dgb inducers , such as DRUGN , DRUGA and DRUGN , induce DRUGB metabolism , causing an approximately dgb % decrease in plasma DRUGN levels .
carbamazepine	drug	clonazepam	drug
mechanism

Cytochrome P dgb inducers , such as DRUGN , DRUGA and DRUGN , induce DRUGN metabolism , causing an approximately dgb % decrease in plasma DRUGB levels .
carbamazepine	drug	clonazepam	drug
false

Cytochrome P dgb inducers , such as DRUGN , DRUGN and DRUGA , induce DRUGB metabolism , causing an approximately dgb % decrease in plasma DRUGN levels .
phenobarbital	drug	clonazepam	drug
mechanism

Cytochrome P dgb inducers , such as DRUGN , DRUGN and DRUGA , induce DRUGN metabolism , causing an approximately dgb % decrease in plasma DRUGB levels .
phenobarbital	drug	clonazepam	drug
false

Tablet If a patient receiving DRUGA is also taking DRUGB , the effect of DRUGN may be reduced , thus necessitating an increase in dosage .
clonidine hydrochloride	drug	tricyclic antidepressants	group
effect

Tablet If a patient receiving DRUGA is also taking DRUGN , the effect of DRUGB may be reduced , thus necessitating an increase in dosage .
clonidine hydrochloride	drug	clonidine	drug
false

Tablet If a patient receiving DRUGN is also taking DRUGA , the effect of DRUGB may be reduced , thus necessitating an increase in dosage .
tricyclic antidepressants	group	clonidine	drug
false

DRUGA may enhance the CNS depressive effects of DRUGB , DRUGN or other DRUGN .
Clonidine hydrochloride	drug	alcohol	drug
effect

DRUGA may enhance the CNS depressive effects of DRUGN , DRUGB or other DRUGN .
Clonidine hydrochloride	drug	barbiturates	group
effect

DRUGA may enhance the CNS depressive effects of DRUGN , DRUGN or other DRUGB .
Clonidine hydrochloride	drug	sedatives	group
effect

DRUGN may enhance the CNS depressive effects of DRUGA , DRUGB or other DRUGN .
alcohol	drug	barbiturates	group
false

DRUGN may enhance the CNS depressive effects of DRUGA , DRUGN or other DRUGB .
alcohol	drug	sedatives	group
false

DRUGN may enhance the CNS depressive effects of DRUGN , DRUGA or other DRUGB .
barbiturates	group	sedatives	group
false

DRUGA in combination with DRUGB enhances the manifestation of corneal lesions in rats Epidural Injection DRUGN may potentiate the CNS depressive effect of DRUGN , DRUGN or other DRUGN .
Amitriptyline	drug	clonidine	drug
effect

DRUGA in combination with DRUGN enhances the manifestation of corneal lesions in rats Epidural Injection DRUGB may potentiate the CNS depressive effect of DRUGN , DRUGN or other DRUGN .
Amitriptyline	drug	Clonidine	drug
false

DRUGA in combination with DRUGN enhances the manifestation of corneal lesions in rats Epidural Injection DRUGN may potentiate the CNS depressive effect of DRUGB , DRUGN or other DRUGN .
Amitriptyline	drug	alcohol	drug
false

DRUGA in combination with DRUGN enhances the manifestation of corneal lesions in rats Epidural Injection DRUGN may potentiate the CNS depressive effect of DRUGN , DRUGB or other DRUGN .
Amitriptyline	drug	barbiturates	group
false

DRUGA in combination with DRUGN enhances the manifestation of corneal lesions in rats Epidural Injection DRUGN may potentiate the CNS depressive effect of DRUGN , DRUGN or other DRUGB .
Amitriptyline	drug	sedating drugs	group
false

DRUGN in combination with DRUGA enhances the manifestation of corneal lesions in rats Epidural Injection DRUGB may potentiate the CNS depressive effect of DRUGN , DRUGN or other DRUGN .
clonidine	drug	Clonidine	drug
false

DRUGN in combination with DRUGA enhances the manifestation of corneal lesions in rats Epidural Injection DRUGN may potentiate the CNS depressive effect of DRUGB , DRUGN or other DRUGN .
clonidine	drug	alcohol	drug
false

DRUGN in combination with DRUGA enhances the manifestation of corneal lesions in rats Epidural Injection DRUGN may potentiate the CNS depressive effect of DRUGN , DRUGB or other DRUGN .
clonidine	drug	barbiturates	group
false

DRUGN in combination with DRUGA enhances the manifestation of corneal lesions in rats Epidural Injection DRUGN may potentiate the CNS depressive effect of DRUGN , DRUGN or other DRUGB .
clonidine	drug	sedating drugs	group
false

DRUGN in combination with DRUGN enhances the manifestation of corneal lesions in rats Epidural Injection DRUGA may potentiate the CNS depressive effect of DRUGB , DRUGN or other DRUGN .
Clonidine	drug	alcohol	drug
effect

DRUGN in combination with DRUGN enhances the manifestation of corneal lesions in rats Epidural Injection DRUGA may potentiate the CNS depressive effect of DRUGN , DRUGB or other DRUGN .
Clonidine	drug	barbiturates	group
effect

DRUGN in combination with DRUGN enhances the manifestation of corneal lesions in rats Epidural Injection DRUGA may potentiate the CNS depressive effect of DRUGN , DRUGN or other DRUGB .
Clonidine	drug	sedating drugs	group
effect

DRUGN in combination with DRUGN enhances the manifestation of corneal lesions in rats Epidural Injection DRUGN may potentiate the CNS depressive effect of DRUGA , DRUGB or other DRUGN .
alcohol	drug	barbiturates	group
false

DRUGN in combination with DRUGN enhances the manifestation of corneal lesions in rats Epidural Injection DRUGN may potentiate the CNS depressive effect of DRUGA , DRUGN or other DRUGB .
alcohol	drug	sedating drugs	group
false

DRUGN in combination with DRUGN enhances the manifestation of corneal lesions in rats Epidural Injection DRUGN may potentiate the CNS depressive effect of DRUGN , DRUGA or other DRUGB .
barbiturates	group	sedating drugs	group
false

DRUGA may potentiate the hypotensive effects of DRUGB .
Narcotic analgesics	group	clonidine	drug
effect

DRUGA may antagonize the hypotensive effects of DRUGB .
Tricyclic antidepressants	group	clonidine	drug
effect

The effects of DRUGA on DRUGB s analgesic actions are not known .
tricyclic antidepressants	group	clonidine	drug
false

DRUGA may exacerbate the hypertensive response seen with DRUGB withdrawl .
Beta blockers	group	clonidine	drug
effect

There is one reported case of a patient with acute delirium associated with the simultaneous use of DRUGA and oral DRUGB .
fluphenazine	drug	clonidine	drug
effect

Epidural DRUGA may prolong the duration of pharmacologic effects of epidural local DRUGB , including both sensory and motor blockade .
clonidine	drug	anesthetics	group
effect

DRUGA , DRUGB , DRUGN , DRUGN
Aspirin	brand	warfarin	drug
false

DRUGA , DRUGN , DRUGB , DRUGN
Aspirin	brand	heparin	drug
false

DRUGA , DRUGN , DRUGN , DRUGB
Aspirin	brand	NSAIDs	group
false

DRUGN , DRUGA , DRUGB , DRUGN
warfarin	drug	heparin	drug
false

DRUGN , DRUGA , DRUGN , DRUGB
warfarin	drug	NSAIDs	group
false

DRUGN , DRUGN , DRUGA , DRUGB
heparin	drug	NSAIDs	group
false

Animal experience indicates that DRUGA prolongs the sleeping time after DRUGB or after DRUGN , increases the inhibitory effects of DRUGN , but does not exhibit monoamine oxidase inhibition .
clorazepate dipotassium	drug	hexobarbital	drug
effect

Animal experience indicates that DRUGA prolongs the sleeping time after DRUGN or after DRUGB , increases the inhibitory effects of DRUGN , but does not exhibit monoamine oxidase inhibition .
clorazepate dipotassium	drug	ethyl alcohol	drug
effect

Animal experience indicates that DRUGA prolongs the sleeping time after DRUGN or after DRUGN , increases the inhibitory effects of DRUGB , but does not exhibit monoamine oxidase inhibition .
clorazepate dipotassium	drug	chlorpromazine	drug
effect

Animal experience indicates that DRUGN prolongs the sleeping time after DRUGA or after DRUGB , increases the inhibitory effects of DRUGN , but does not exhibit monoamine oxidase inhibition .
hexobarbital	drug	ethyl alcohol	drug
false

Animal experience indicates that DRUGN prolongs the sleeping time after DRUGA or after DRUGN , increases the inhibitory effects of DRUGB , but does not exhibit monoamine oxidase inhibition .
hexobarbital	drug	chlorpromazine	drug
false

Animal experience indicates that DRUGN prolongs the sleeping time after DRUGN or after DRUGA , increases the inhibitory effects of DRUGB , but does not exhibit monoamine oxidase inhibition .
ethyl alcohol	drug	chlorpromazine	drug
false

The actions of the DRUGA may be potentiated by DRUGB , DRUGN , DRUGN , DRUGN or other DRUGN .
benzodiazepines	group	barbiturates	group
effect

The actions of the DRUGA may be potentiated by DRUGN , DRUGB , DRUGN , DRUGN or other DRUGN .
benzodiazepines	group	narcotics	group
effect

The actions of the DRUGA may be potentiated by DRUGN , DRUGN , DRUGB , DRUGN or other DRUGN .
benzodiazepines	group	phenothiazines	group
effect

The actions of the DRUGA may be potentiated by DRUGN , DRUGN , DRUGN , DRUGB or other DRUGN .
benzodiazepines	group	monoamine oxidase inhibitors	group
effect

The actions of the DRUGA may be potentiated by DRUGN , DRUGN , DRUGN , DRUGN or other DRUGB .
benzodiazepines	group	antidepressants	group
effect

The actions of the DRUGN may be potentiated by DRUGA , DRUGB , DRUGN , DRUGN or other DRUGN .
barbiturates	group	narcotics	group
false

The actions of the DRUGN may be potentiated by DRUGA , DRUGN , DRUGB , DRUGN or other DRUGN .
barbiturates	group	phenothiazines	group
false

The actions of the DRUGN may be potentiated by DRUGA , DRUGN , DRUGN , DRUGB or other DRUGN .
barbiturates	group	monoamine oxidase inhibitors	group
false

The actions of the DRUGN may be potentiated by DRUGA , DRUGN , DRUGN , DRUGN or other DRUGB .
barbiturates	group	antidepressants	group
false

The actions of the DRUGN may be potentiated by DRUGN , DRUGA , DRUGB , DRUGN or other DRUGN .
narcotics	group	phenothiazines	group
false

The actions of the DRUGN may be potentiated by DRUGN , DRUGA , DRUGN , DRUGB or other DRUGN .
narcotics	group	monoamine oxidase inhibitors	group
false

The actions of the DRUGN may be potentiated by DRUGN , DRUGA , DRUGN , DRUGN or other DRUGB .
narcotics	group	antidepressants	group
false

The actions of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGA , DRUGB or other DRUGN .
phenothiazines	group	monoamine oxidase inhibitors	group
false

The actions of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGA , DRUGN or other DRUGB .
phenothiazines	group	antidepressants	group
false

The actions of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGN , DRUGA or other DRUGB .
monoamine oxidase inhibitors	group	antidepressants	group
false

In bioavailability studies with normal subjects , the concurrent administration of DRUGA at therapeutic levels did not significantly influence the bioavailability of DRUGB tablets .
antacids	group	TRANXENE	brand
false

Given the primary CNS effects of DRUGA , caution is advised in using it concomitantly with other CNS active drugs or DRUGB .
Clozapine	drug	alcohol	drug
effect

similar events have been reported in patients taking other DRUGA or even DRUGB by itself .
psychotropic drugs	group	Clozapine	drug
false

Although it has not been established that there is an interaction between DRUGA and DRUGB or other DRUGN , caution is advised when DRUGN is initiated in patients taking a DRUGN or any other DRUGN .
Clozapine	drug	benzodiazepines	group
false

Although it has not been established that there is an interaction between DRUGA and DRUGN or other DRUGB , caution is advised when DRUGN is initiated in patients taking a DRUGN or any other DRUGN .
Clozapine	drug	psychotropics	group
false

Although it has not been established that there is an interaction between DRUGA and DRUGN or other DRUGN , caution is advised when DRUGB is initiated in patients taking a DRUGN or any other DRUGN .
Clozapine	drug	clozapine	drug
false

Although it has not been established that there is an interaction between DRUGA and DRUGN or other DRUGN , caution is advised when DRUGN is initiated in patients taking a DRUGB or any other DRUGN .
Clozapine	drug	benzodiazepine	group
false

Although it has not been established that there is an interaction between DRUGA and DRUGN or other DRUGN , caution is advised when DRUGN is initiated in patients taking a DRUGN or any other DRUGB .
Clozapine	drug	psychotropic drug	group
false

Although it has not been established that there is an interaction between DRUGN and DRUGA or other DRUGB , caution is advised when DRUGN is initiated in patients taking a DRUGN or any other DRUGN .
benzodiazepines	group	psychotropics	group
false

Although it has not been established that there is an interaction between DRUGN and DRUGA or other DRUGN , caution is advised when DRUGB is initiated in patients taking a DRUGN or any other DRUGN .
benzodiazepines	group	clozapine	drug
false

Although it has not been established that there is an interaction between DRUGN and DRUGA or other DRUGN , caution is advised when DRUGN is initiated in patients taking a DRUGB or any other DRUGN .
benzodiazepines	group	benzodiazepine	group
false

Although it has not been established that there is an interaction between DRUGN and DRUGA or other DRUGN , caution is advised when DRUGN is initiated in patients taking a DRUGN or any other DRUGB .
benzodiazepines	group	psychotropic drug	group
false

Although it has not been established that there is an interaction between DRUGN and DRUGN or other DRUGA , caution is advised when DRUGB is initiated in patients taking a DRUGN or any other DRUGN .
psychotropics	group	clozapine	drug
false

Although it has not been established that there is an interaction between DRUGN and DRUGN or other DRUGA , caution is advised when DRUGN is initiated in patients taking a DRUGB or any other DRUGN .
psychotropics	group	benzodiazepine	group
false

Although it has not been established that there is an interaction between DRUGN and DRUGN or other DRUGA , caution is advised when DRUGN is initiated in patients taking a DRUGN or any other DRUGB .
psychotropics	group	psychotropic drug	group
false

Although it has not been established that there is an interaction between DRUGN and DRUGN or other DRUGN , caution is advised when DRUGA is initiated in patients taking a DRUGB or any other DRUGN .
clozapine	drug	benzodiazepine	group
advise

Although it has not been established that there is an interaction between DRUGN and DRUGN or other DRUGN , caution is advised when DRUGA is initiated in patients taking a DRUGN or any other DRUGB .
clozapine	drug	psychotropic drug	group
advise

Although it has not been established that there is an interaction between DRUGN and DRUGN or other DRUGN , caution is advised when DRUGN is initiated in patients taking a DRUGA or any other DRUGB .
benzodiazepine	group	psychotropic drug	group
false

DRUGA may potentiate the hypotensive effects of DRUGB and the anticholinergic effects of DRUGN type drugs .
Clozapine	drug	antihypertensive drugs	group
effect

DRUGA may potentiate the hypotensive effects of DRUGN and the anticholinergic effects of DRUGB type drugs .
Clozapine	drug	atropine	drug
effect

DRUGN may potentiate the hypotensive effects of DRUGA and the anticholinergic effects of DRUGB type drugs .
antihypertensive drugs	group	atropine	drug
false

DRUGA , DRUGB , and DRUGN may decrease DRUGN plasma levels , resulting in a decrease in effectiveness of a previously effective DRUGN dose .
Phenytoin	drug	nicotine	drug
false

DRUGA , DRUGN , and DRUGB may decrease DRUGN plasma levels , resulting in a decrease in effectiveness of a previously effective DRUGN dose .
Phenytoin	drug	rifampin	drug
false

DRUGA , DRUGN , and DRUGN may decrease DRUGB plasma levels , resulting in a decrease in effectiveness of a previously effective DRUGN dose .
Phenytoin	drug	Clozapine	drug
mechanism

DRUGA , DRUGN , and DRUGN may decrease DRUGN plasma levels , resulting in a decrease in effectiveness of a previously effective DRUGB dose .
Phenytoin	drug	Clozapine	drug
false

DRUGN , DRUGA , and DRUGB may decrease DRUGN plasma levels , resulting in a decrease in effectiveness of a previously effective DRUGN dose .
nicotine	drug	rifampin	drug
false

DRUGN , DRUGA , and DRUGN may decrease DRUGB plasma levels , resulting in a decrease in effectiveness of a previously effective DRUGN dose .
nicotine	drug	Clozapine	drug
mechanism

DRUGN , DRUGA , and DRUGN may decrease DRUGN plasma levels , resulting in a decrease in effectiveness of a previously effective DRUGB dose .
nicotine	drug	Clozapine	drug
false

DRUGN , DRUGN , and DRUGA may decrease DRUGB plasma levels , resulting in a decrease in effectiveness of a previously effective DRUGN dose .
rifampin	drug	Clozapine	drug
mechanism

DRUGN , DRUGN , and DRUGA may decrease DRUGN plasma levels , resulting in a decrease in effectiveness of a previously effective DRUGB dose .
rifampin	drug	Clozapine	drug
false

DRUGA , DRUGB , and DRUGN may increase plasma levels of DRUGN , potentially resulting in adverse effects .
Cimetidine	drug	caffeine	drug
false

DRUGA , DRUGN , and DRUGB may increase plasma levels of DRUGN , potentially resulting in adverse effects .
Cimetidine	drug	erythromycin	drug
false

DRUGA , DRUGN , and DRUGN may increase plasma levels of DRUGB , potentially resulting in adverse effects .
Cimetidine	drug	Clozapine	drug
mechanism

DRUGN , DRUGA , and DRUGB may increase plasma levels of DRUGN , potentially resulting in adverse effects .
caffeine	drug	erythromycin	drug
false

DRUGN , DRUGA , and DRUGN may increase plasma levels of DRUGB , potentially resulting in adverse effects .
caffeine	drug	Clozapine	drug
mechanism

DRUGN , DRUGN , and DRUGA may increase plasma levels of DRUGB , potentially resulting in adverse effects .
erythromycin	drug	Clozapine	drug
mechanism

Although concomitant use of DRUGA and DRUGB is not recommended , it should be noted that discontinuation of concomitant DRUGN administration may result in an increase in DRUGN plasma levels .
Clozapine	drug	carbamazepine	drug
advise

Although concomitant use of DRUGA and DRUGN is not recommended , it should be noted that discontinuation of concomitant DRUGB administration may result in an increase in DRUGN plasma levels .
Clozapine	drug	carbamazepine	drug
false

Although concomitant use of DRUGN and DRUGA is not recommended , it should be noted that discontinuation of concomitant DRUGN administration may result in an increase in DRUGB plasma levels .
carbamazepine	drug	Clozapine	drug
false

Although concomitant use of DRUGN and DRUGN is not recommended , it should be noted that discontinuation of concomitant DRUGA administration may result in an increase in DRUGB plasma levels .
carbamazepine	drug	Clozapine	drug
mechanism

In a study of schizophrenic patients who received DRUGA under steady state conditions , DRUGB or DRUGN was added in dgb and dgb patients , respectively .
clozapine	drug	fluvoxamine	drug
false

In a study of schizophrenic patients who received DRUGA under steady state conditions , DRUGN or DRUGB was added in dgb and dgb patients , respectively .
clozapine	drug	paroxetine	drug
false

In a study of schizophrenic patients who received DRUGN under steady state conditions , DRUGA or DRUGB was added in dgb and dgb patients , respectively .
fluvoxamine	drug	paroxetine	drug
false

After dgb days of co administration , mean trough concentrations of DRUGA and its metabolites , DRUGB and DRUGN , were elevated with DRUGN by about three fold compared to baseline concentrations .
clozapine	drug	N-desmethylclozapine	drug_n
false

After dgb days of co administration , mean trough concentrations of DRUGA and its metabolites , DRUGN and DRUGB , were elevated with DRUGN by about three fold compared to baseline concentrations .
clozapine	drug	clozapine N-oxide	drug_n
false

After dgb days of co administration , mean trough concentrations of DRUGA and its metabolites , DRUGN and DRUGN , were elevated with DRUGB by about three fold compared to baseline concentrations .
clozapine	drug	fluvoxamine	drug
false

After dgb days of co administration , mean trough concentrations of DRUGN and its metabolites , DRUGA and DRUGB , were elevated with DRUGN by about three fold compared to baseline concentrations .
N-desmethylclozapine	drug_n	clozapine N-oxide	drug_n
false

After dgb days of co administration , mean trough concentrations of DRUGN and its metabolites , DRUGA and DRUGN , were elevated with DRUGB by about three fold compared to baseline concentrations .
N-desmethylclozapine	drug_n	fluvoxamine	drug
false

After dgb days of co administration , mean trough concentrations of DRUGN and its metabolites , DRUGN and DRUGA , were elevated with DRUGB by about three fold compared to baseline concentrations .
clozapine N-oxide	drug_n	fluvoxamine	drug
false

DRUGA produced only minor changes in the levels of DRUGB and its metabolites .
Paroxetine	drug	clozapine	drug
mechanism

However , other published reports describe modest elevations ( less than two fold ) of DRUGA and metabolite concentrations when DRUGN was taken with DRUGB , DRUGN , and DRUGN .
clozapine	drug	paroxetine	drug
false

However , other published reports describe modest elevations ( less than two fold ) of DRUGA and metabolite concentrations when DRUGN was taken with DRUGN , DRUGB , and DRUGN .
clozapine	drug	fluoxetine	drug
false

However , other published reports describe modest elevations ( less than two fold ) of DRUGA and metabolite concentrations when DRUGN was taken with DRUGN , DRUGN , and DRUGB .
clozapine	drug	sertraline	drug
false

However , other published reports describe modest elevations ( less than two fold ) of DRUGN and metabolite concentrations when DRUGA was taken with DRUGB , DRUGN , and DRUGN .
clozapine	drug	paroxetine	drug
mechanism

However , other published reports describe modest elevations ( less than two fold ) of DRUGN and metabolite concentrations when DRUGA was taken with DRUGN , DRUGB , and DRUGN .
clozapine	drug	fluoxetine	drug
mechanism

However , other published reports describe modest elevations ( less than two fold ) of DRUGN and metabolite concentrations when DRUGA was taken with DRUGN , DRUGN , and DRUGB .
clozapine	drug	sertraline	drug
mechanism

However , other published reports describe modest elevations ( less than two fold ) of DRUGN and metabolite concentrations when DRUGN was taken with DRUGA , DRUGB , and DRUGN .
paroxetine	drug	fluoxetine	drug
false

However , other published reports describe modest elevations ( less than two fold ) of DRUGN and metabolite concentrations when DRUGN was taken with DRUGA , DRUGN , and DRUGB .
paroxetine	drug	sertraline	drug
false

However , other published reports describe modest elevations ( less than two fold ) of DRUGN and metabolite concentrations when DRUGN was taken with DRUGN , DRUGA , and DRUGB .
fluoxetine	drug	sertraline	drug
false

Therefore , such combined treatment should be approached with caution and patients should be monitored closely when DRUGA is combined with these drugs , particularly with DRUGB .
Clozapine	drug	fluvoxamine	drug
advise

Such individuals are referred to as poor metabolizers of drugs such as DRUGA , DRUGB , the DRUGN , and DRUGN .
debrisoquin	drug	dextromethorphan	drug
false

Such individuals are referred to as poor metabolizers of drugs such as DRUGA , DRUGN , the DRUGB , and DRUGN .
debrisoquin	drug	tricyclic antidepressants	group
false

Such individuals are referred to as poor metabolizers of drugs such as DRUGA , DRUGN , the DRUGN , and DRUGB .
debrisoquin	drug	clozapine	drug
false

Such individuals are referred to as poor metabolizers of drugs such as DRUGN , DRUGA , the DRUGB , and DRUGN .
dextromethorphan	drug	tricyclic antidepressants	group
false

Such individuals are referred to as poor metabolizers of drugs such as DRUGN , DRUGA , the DRUGN , and DRUGB .
dextromethorphan	drug	clozapine	drug
false

Such individuals are referred to as poor metabolizers of drugs such as DRUGN , DRUGN , the DRUGA , and DRUGB .
tricyclic antidepressants	group	clozapine	drug
false

The risk of a potential interaction between DRUGA and DRUGB concentrates has not been adequately evaluated in preclinical or clinical studies .
NovoSeven	brand	coagulation factor	group
false

Simultaneous use of DRUGA or DRUGB should be avoided .
activated prothrombin complex concentrates	group	prothrombin complex concentrates	group
false

Although the specific drug interaction was not studied in a clinical trial , there have been more than dgb episodes of concomitant use of antifibrinolytic therapies ( i.e . , DRUGA , DRUGB ) and DRUGN .
tranexamic acid	drug	aminocaproic acid	drug
false

Although the specific drug interaction was not studied in a clinical trial , there have been more than dgb episodes of concomitant use of antifibrinolytic therapies ( i.e . , DRUGA , DRUGN ) and DRUGB .
tranexamic acid	drug	NovoSeven	brand
false

Although the specific drug interaction was not studied in a clinical trial , there have been more than dgb episodes of concomitant use of antifibrinolytic therapies ( i.e . , DRUGN , DRUGA ) and DRUGB .
aminocaproic acid	drug	NovoSeven	brand
false

DRUGA in combination with other DRUGB , general DRUGN , DRUGN , DRUGN , DRUGN , or other DRUGN ( including DRUGN ) has additive depressant effects .
Codeine	drug	narcotic analgesics	group
effect

DRUGA in combination with other DRUGN , general DRUGB , DRUGN , DRUGN , DRUGN , or other DRUGN ( including DRUGN ) has additive depressant effects .
Codeine	drug	anesthetics	group
effect

DRUGA in combination with other DRUGN , general DRUGN , DRUGB , DRUGN , DRUGN , or other DRUGN ( including DRUGN ) has additive depressant effects .
Codeine	drug	phenothiazines	group
effect

DRUGA in combination with other DRUGN , general DRUGN , DRUGN , DRUGB , DRUGN , or other DRUGN ( including DRUGN ) has additive depressant effects .
Codeine	drug	tranquilizers	group
effect

DRUGA in combination with other DRUGN , general DRUGN , DRUGN , DRUGN , DRUGB , or other DRUGN ( including DRUGN ) has additive depressant effects .
Codeine	drug	sedative-hypnotics	group
effect

DRUGA in combination with other DRUGN , general DRUGN , DRUGN , DRUGN , DRUGN , or other DRUGB ( including DRUGN ) has additive depressant effects .
Codeine	drug	CNS depressants	group
effect

DRUGA in combination with other DRUGN , general DRUGN , DRUGN , DRUGN , DRUGN , or other DRUGN ( including DRUGB ) has additive depressant effects .
Codeine	drug	alcohol	drug
effect

DRUGN in combination with other DRUGA , general DRUGB , DRUGN , DRUGN , DRUGN , or other DRUGN ( including DRUGN ) has additive depressant effects .
narcotic analgesics	group	anesthetics	group
false

DRUGN in combination with other DRUGA , general DRUGN , DRUGB , DRUGN , DRUGN , or other DRUGN ( including DRUGN ) has additive depressant effects .
narcotic analgesics	group	phenothiazines	group
false

DRUGN in combination with other DRUGA , general DRUGN , DRUGN , DRUGB , DRUGN , or other DRUGN ( including DRUGN ) has additive depressant effects .
narcotic analgesics	group	tranquilizers	group
false

DRUGN in combination with other DRUGA , general DRUGN , DRUGN , DRUGN , DRUGB , or other DRUGN ( including DRUGN ) has additive depressant effects .
narcotic analgesics	group	sedative-hypnotics	group
false

DRUGN in combination with other DRUGA , general DRUGN , DRUGN , DRUGN , DRUGN , or other DRUGB ( including DRUGN ) has additive depressant effects .
narcotic analgesics	group	CNS depressants	group
false

DRUGN in combination with other DRUGA , general DRUGN , DRUGN , DRUGN , DRUGN , or other DRUGN ( including DRUGB ) has additive depressant effects .
narcotic analgesics	group	alcohol	drug
false

DRUGN in combination with other DRUGN , general DRUGA , DRUGB , DRUGN , DRUGN , or other DRUGN ( including DRUGN ) has additive depressant effects .
anesthetics	group	phenothiazines	group
false

DRUGN in combination with other DRUGN , general DRUGA , DRUGN , DRUGB , DRUGN , or other DRUGN ( including DRUGN ) has additive depressant effects .
anesthetics	group	tranquilizers	group
false

DRUGN in combination with other DRUGN , general DRUGA , DRUGN , DRUGN , DRUGB , or other DRUGN ( including DRUGN ) has additive depressant effects .
anesthetics	group	sedative-hypnotics	group
false

DRUGN in combination with other DRUGN , general DRUGA , DRUGN , DRUGN , DRUGN , or other DRUGB ( including DRUGN ) has additive depressant effects .
anesthetics	group	CNS depressants	group
false

DRUGN in combination with other DRUGN , general DRUGA , DRUGN , DRUGN , DRUGN , or other DRUGN ( including DRUGB ) has additive depressant effects .
anesthetics	group	alcohol	drug
false

DRUGN in combination with other DRUGN , general DRUGN , DRUGA , DRUGB , DRUGN , or other DRUGN ( including DRUGN ) has additive depressant effects .
phenothiazines	group	tranquilizers	group
false

DRUGN in combination with other DRUGN , general DRUGN , DRUGA , DRUGN , DRUGB , or other DRUGN ( including DRUGN ) has additive depressant effects .
phenothiazines	group	sedative-hypnotics	group
false

DRUGN in combination with other DRUGN , general DRUGN , DRUGA , DRUGN , DRUGN , or other DRUGB ( including DRUGN ) has additive depressant effects .
phenothiazines	group	CNS depressants	group
false

DRUGN in combination with other DRUGN , general DRUGN , DRUGA , DRUGN , DRUGN , or other DRUGN ( including DRUGB ) has additive depressant effects .
phenothiazines	group	alcohol	drug
false

DRUGN in combination with other DRUGN , general DRUGN , DRUGN , DRUGA , DRUGB , or other DRUGN ( including DRUGN ) has additive depressant effects .
tranquilizers	group	sedative-hypnotics	group
false

DRUGN in combination with other DRUGN , general DRUGN , DRUGN , DRUGA , DRUGN , or other DRUGB ( including DRUGN ) has additive depressant effects .
tranquilizers	group	CNS depressants	group
false

DRUGN in combination with other DRUGN , general DRUGN , DRUGN , DRUGA , DRUGN , or other DRUGN ( including DRUGB ) has additive depressant effects .
tranquilizers	group	alcohol	drug
false

DRUGN in combination with other DRUGN , general DRUGN , DRUGN , DRUGN , DRUGA , or other DRUGB ( including DRUGN ) has additive depressant effects .
sedative-hypnotics	group	CNS depressants	group
false

DRUGN in combination with other DRUGN , general DRUGN , DRUGN , DRUGN , DRUGA , or other DRUGN ( including DRUGB ) has additive depressant effects .
sedative-hypnotics	group	alcohol	drug
false

DRUGN in combination with other DRUGN , general DRUGN , DRUGN , DRUGN , DRUGN , or other DRUGA ( including DRUGB ) has additive depressant effects .
CNS depressants	group	alcohol	drug
false

DRUGA is inhibited by DRUGB .
Colchicine	drug	acidifying agents	group
mechanism

The action of DRUGA is potentiated by DRUGB .
colchicine	drug	alkalinizing agents	group
mechanism

DRUGA may increase sensitivity to the DRUGB .
Colchicine	drug	CNS depressants	group
effect

Response to DRUGA may be enhanced by DRUGB .
sympathomimetic agents	group	colchicine	drug
effect

DRUGA was found to have no significant effect on the bioavailability of DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
WelChol	brand	digoxin	drug
false

DRUGA was found to have no significant effect on the bioavailability of DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
WelChol	brand	lovastatin	drug
false

DRUGA was found to have no significant effect on the bioavailability of DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
WelChol	brand	metoprolol	drug
false

DRUGA was found to have no significant effect on the bioavailability of DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
WelChol	brand	quinidine	drug
false

DRUGA was found to have no significant effect on the bioavailability of DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
WelChol	brand	valproic acid	drug
false

DRUGA was found to have no significant effect on the bioavailability of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
WelChol	brand	warfarin	drug
false

DRUGN was found to have no significant effect on the bioavailability of DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
digoxin	drug	lovastatin	drug
false

DRUGN was found to have no significant effect on the bioavailability of DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
digoxin	drug	metoprolol	drug
false

DRUGN was found to have no significant effect on the bioavailability of DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
digoxin	drug	quinidine	drug
false

DRUGN was found to have no significant effect on the bioavailability of DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
digoxin	drug	valproic acid	drug
false

DRUGN was found to have no significant effect on the bioavailability of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
digoxin	drug	warfarin	drug
false

DRUGN was found to have no significant effect on the bioavailability of DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
lovastatin	drug	metoprolol	drug
false

DRUGN was found to have no significant effect on the bioavailability of DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
lovastatin	drug	quinidine	drug
false

DRUGN was found to have no significant effect on the bioavailability of DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
lovastatin	drug	valproic acid	drug
false

DRUGN was found to have no significant effect on the bioavailability of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
lovastatin	drug	warfarin	drug
false

DRUGN was found to have no significant effect on the bioavailability of DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
metoprolol	drug	quinidine	drug
false

DRUGN was found to have no significant effect on the bioavailability of DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
metoprolol	drug	valproic acid	drug
false

DRUGN was found to have no significant effect on the bioavailability of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
metoprolol	drug	warfarin	drug
false

DRUGN was found to have no significant effect on the bioavailability of DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
quinidine	drug	valproic acid	drug
false

DRUGN was found to have no significant effect on the bioavailability of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
quinidine	drug	warfarin	drug
false

DRUGN was found to have no significant effect on the bioavailability of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
valproic acid	drug	warfarin	drug
false

DRUGA decreased the Cmax and AUC of sustained release DRUGB ( DRUGN ) by approximately dgb % and dgb % , respectively .
WelChol	brand	verapamil	drug
mechanism

DRUGA decreased the Cmax and AUC of sustained release DRUGN ( DRUGB ) by approximately dgb % and dgb % , respectively .
WelChol	brand	Calan SR	brand
mechanism

DRUGN decreased the Cmax and AUC of sustained release DRUGA ( DRUGB ) by approximately dgb % and dgb % , respectively .
verapamil	drug	Calan SR	brand
false

In clinical studies , coadministration of DRUGA with DRUGB , DRUGN , or DRUGN did not interfere with the lipid lowering activity of the DRUGN .
WelChol	brand	atorvastatin	drug
false

In clinical studies , coadministration of DRUGA with DRUGN , DRUGB , or DRUGN did not interfere with the lipid lowering activity of the DRUGN .
WelChol	brand	lovastatin	drug
false

In clinical studies , coadministration of DRUGA with DRUGN , DRUGN , or DRUGB did not interfere with the lipid lowering activity of the DRUGN .
WelChol	brand	simvastatin	drug
false

In clinical studies , coadministration of DRUGA with DRUGN , DRUGN , or DRUGN did not interfere with the lipid lowering activity of the DRUGB .
WelChol	brand	HMG-CoA reductase inhibitor	group
false

In clinical studies , coadministration of DRUGN with DRUGA , DRUGB , or DRUGN did not interfere with the lipid lowering activity of the DRUGN .
atorvastatin	drug	lovastatin	drug
false

In clinical studies , coadministration of DRUGN with DRUGA , DRUGN , or DRUGB did not interfere with the lipid lowering activity of the DRUGN .
atorvastatin	drug	simvastatin	drug
false

In clinical studies , coadministration of DRUGN with DRUGA , DRUGN , or DRUGN did not interfere with the lipid lowering activity of the DRUGB .
atorvastatin	drug	HMG-CoA reductase inhibitor	group
false

In clinical studies , coadministration of DRUGN with DRUGN , DRUGA , or DRUGB did not interfere with the lipid lowering activity of the DRUGN .
lovastatin	drug	simvastatin	drug
false

In clinical studies , coadministration of DRUGN with DRUGN , DRUGA , or DRUGN did not interfere with the lipid lowering activity of the DRUGB .
lovastatin	drug	HMG-CoA reductase inhibitor	group
false

In clinical studies , coadministration of DRUGN with DRUGN , DRUGN , or DRUGA did not interfere with the lipid lowering activity of the DRUGB .
simvastatin	drug	HMG-CoA reductase inhibitor	group
false

Since DRUGA is an DRUGB , it may have a strong affinity for anions other than the bile acids .
colestipol hydrochloride	drug	anion exchange resin	group
false

Repeated doses of DRUGA given prior to a single dose of DRUGB in human trials have been reported to decrease DRUGN absorption .
colestipol hydrochloride	drug	propranolol	drug
mechanism

Repeated doses of DRUGA given prior to a single dose of DRUGN in human trials have been reported to decrease DRUGB absorption .
colestipol hydrochloride	drug	propranolol	drug
false

Therefore , patients on DRUGA should be observed when DRUGB Tablets are either added or deleted from a therapeutic regimen .
propranolol	drug	COLESTID	brand
advise

Studies in humans show that the absorption of DRUGA as reflected in urinary excretion is markedly decreased even when administered one hour before DRUGB .
chlorothiazide	drug	colestipol hydrochloride	drug
mechanism

The absorption of DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN was significantly decreased when given simultaneously with DRUGN ;
tetracycline	drug	furosemide	drug
false

The absorption of DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN was significantly decreased when given simultaneously with DRUGN ;
tetracycline	drug	penicillin G	drug
false

The absorption of DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN was significantly decreased when given simultaneously with DRUGN ;
tetracycline	drug	hydrochlorothiazide	drug
false

The absorption of DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB was significantly decreased when given simultaneously with DRUGN ;
tetracycline	drug	gemfibrozil	drug
false

The absorption of DRUGA , DRUGN , DRUGN , DRUGN , and DRUGN was significantly decreased when given simultaneously with DRUGB ;
tetracycline	drug	colestipol hydrochloride	drug
mechanism

The absorption of DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN was significantly decreased when given simultaneously with DRUGN ;
furosemide	drug	penicillin G	drug
false

The absorption of DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN was significantly decreased when given simultaneously with DRUGN ;
furosemide	drug	hydrochlorothiazide	drug
false

The absorption of DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB was significantly decreased when given simultaneously with DRUGN ;
furosemide	drug	gemfibrozil	drug
false

The absorption of DRUGN , DRUGA , DRUGN , DRUGN , and DRUGN was significantly decreased when given simultaneously with DRUGB ;
furosemide	drug	colestipol hydrochloride	drug
mechanism

The absorption of DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN was significantly decreased when given simultaneously with DRUGN ;
penicillin G	drug	hydrochlorothiazide	drug
false

The absorption of DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB was significantly decreased when given simultaneously with DRUGN ;
penicillin G	drug	gemfibrozil	drug
false

The absorption of DRUGN , DRUGN , DRUGA , DRUGN , and DRUGN was significantly decreased when given simultaneously with DRUGB ;
penicillin G	drug	colestipol hydrochloride	drug
mechanism

The absorption of DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB was significantly decreased when given simultaneously with DRUGN ;
hydrochlorothiazide	drug	gemfibrozil	drug
false

The absorption of DRUGN , DRUGN , DRUGN , DRUGA , and DRUGN was significantly decreased when given simultaneously with DRUGB ;
hydrochlorothiazide	drug	colestipol hydrochloride	drug
mechanism

The absorption of DRUGN , DRUGN , DRUGN , DRUGN , and DRUGA was significantly decreased when given simultaneously with DRUGB ;
gemfibrozil	drug	colestipol hydrochloride	drug
mechanism

No depressant effect on blood levels in humans was noted when DRUGA was administered with any of the following drugs : DRUGB , DRUGN , DRUGN , DRUGN , DRUGN ( DRUGN ) , DRUGN , DRUGN or DRUGN .
colestipol hydrochloride	drug	aspirin	brand
false

No depressant effect on blood levels in humans was noted when DRUGA was administered with any of the following drugs : DRUGN , DRUGB , DRUGN , DRUGN , DRUGN ( DRUGN ) , DRUGN , DRUGN or DRUGN .
colestipol hydrochloride	drug	clindamycin	brand
false

No depressant effect on blood levels in humans was noted when DRUGA was administered with any of the following drugs : DRUGN , DRUGN , DRUGB , DRUGN , DRUGN ( DRUGN ) , DRUGN , DRUGN or DRUGN .
colestipol hydrochloride	drug	clofibrate	drug
false

No depressant effect on blood levels in humans was noted when DRUGA was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGB , DRUGN ( DRUGN ) , DRUGN , DRUGN or DRUGN .
colestipol hydrochloride	drug	methyldopa	drug
false

No depressant effect on blood levels in humans was noted when DRUGA was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGN , DRUGB ( DRUGN ) , DRUGN , DRUGN or DRUGN .
colestipol hydrochloride	drug	nicotinic acid	drug
false

No depressant effect on blood levels in humans was noted when DRUGA was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ( DRUGB ) , DRUGN , DRUGN or DRUGN .
colestipol hydrochloride	drug	niacin	drug
false

No depressant effect on blood levels in humans was noted when DRUGA was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ( DRUGN ) , DRUGB , DRUGN or DRUGN .
colestipol hydrochloride	drug	tolbutamide	drug
false

No depressant effect on blood levels in humans was noted when DRUGA was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ( DRUGN ) , DRUGN , DRUGB or DRUGN .
colestipol hydrochloride	drug	phenytoin	drug
false

No depressant effect on blood levels in humans was noted when DRUGA was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ( DRUGN ) , DRUGN , DRUGN or DRUGB .
colestipol hydrochloride	drug	warfarin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGA , DRUGB , DRUGN , DRUGN , DRUGN ( DRUGN ) , DRUGN , DRUGN or DRUGN .
aspirin	brand	clindamycin	brand
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGA , DRUGN , DRUGB , DRUGN , DRUGN ( DRUGN ) , DRUGN , DRUGN or DRUGN .
aspirin	brand	clofibrate	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGA , DRUGN , DRUGN , DRUGB , DRUGN ( DRUGN ) , DRUGN , DRUGN or DRUGN .
aspirin	brand	methyldopa	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGA , DRUGN , DRUGN , DRUGN , DRUGB ( DRUGN ) , DRUGN , DRUGN or DRUGN .
aspirin	brand	nicotinic acid	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGA , DRUGN , DRUGN , DRUGN , DRUGN ( DRUGB ) , DRUGN , DRUGN or DRUGN .
aspirin	brand	niacin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGA , DRUGN , DRUGN , DRUGN , DRUGN ( DRUGN ) , DRUGB , DRUGN or DRUGN .
aspirin	brand	tolbutamide	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGA , DRUGN , DRUGN , DRUGN , DRUGN ( DRUGN ) , DRUGN , DRUGB or DRUGN .
aspirin	brand	phenytoin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGA , DRUGN , DRUGN , DRUGN , DRUGN ( DRUGN ) , DRUGN , DRUGN or DRUGB .
aspirin	brand	warfarin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGA , DRUGB , DRUGN , DRUGN ( DRUGN ) , DRUGN , DRUGN or DRUGN .
clindamycin	brand	clofibrate	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGA , DRUGN , DRUGB , DRUGN ( DRUGN ) , DRUGN , DRUGN or DRUGN .
clindamycin	brand	methyldopa	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGA , DRUGN , DRUGN , DRUGB ( DRUGN ) , DRUGN , DRUGN or DRUGN .
clindamycin	brand	nicotinic acid	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGA , DRUGN , DRUGN , DRUGN ( DRUGB ) , DRUGN , DRUGN or DRUGN .
clindamycin	brand	niacin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGA , DRUGN , DRUGN , DRUGN ( DRUGN ) , DRUGB , DRUGN or DRUGN .
clindamycin	brand	tolbutamide	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGA , DRUGN , DRUGN , DRUGN ( DRUGN ) , DRUGN , DRUGB or DRUGN .
clindamycin	brand	phenytoin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGA , DRUGN , DRUGN , DRUGN ( DRUGN ) , DRUGN , DRUGN or DRUGB .
clindamycin	brand	warfarin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGA , DRUGB , DRUGN ( DRUGN ) , DRUGN , DRUGN or DRUGN .
clofibrate	drug	methyldopa	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGA , DRUGN , DRUGB ( DRUGN ) , DRUGN , DRUGN or DRUGN .
clofibrate	drug	nicotinic acid	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGA , DRUGN , DRUGN ( DRUGB ) , DRUGN , DRUGN or DRUGN .
clofibrate	drug	niacin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGA , DRUGN , DRUGN ( DRUGN ) , DRUGB , DRUGN or DRUGN .
clofibrate	drug	tolbutamide	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGA , DRUGN , DRUGN ( DRUGN ) , DRUGN , DRUGB or DRUGN .
clofibrate	drug	phenytoin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGA , DRUGN , DRUGN ( DRUGN ) , DRUGN , DRUGN or DRUGB .
clofibrate	drug	warfarin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGA , DRUGB ( DRUGN ) , DRUGN , DRUGN or DRUGN .
methyldopa	drug	nicotinic acid	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGA , DRUGN ( DRUGB ) , DRUGN , DRUGN or DRUGN .
methyldopa	drug	niacin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGA , DRUGN ( DRUGN ) , DRUGB , DRUGN or DRUGN .
methyldopa	drug	tolbutamide	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGA , DRUGN ( DRUGN ) , DRUGN , DRUGB or DRUGN .
methyldopa	drug	phenytoin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGA , DRUGN ( DRUGN ) , DRUGN , DRUGN or DRUGB .
methyldopa	drug	warfarin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGN , DRUGA ( DRUGB ) , DRUGN , DRUGN or DRUGN .
nicotinic acid	drug	niacin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGN , DRUGA ( DRUGN ) , DRUGB , DRUGN or DRUGN .
nicotinic acid	drug	tolbutamide	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGN , DRUGA ( DRUGN ) , DRUGN , DRUGB or DRUGN .
nicotinic acid	drug	phenytoin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGN , DRUGA ( DRUGN ) , DRUGN , DRUGN or DRUGB .
nicotinic acid	drug	warfarin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ( DRUGA ) , DRUGB , DRUGN or DRUGN .
niacin	drug	tolbutamide	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ( DRUGA ) , DRUGN , DRUGB or DRUGN .
niacin	drug	phenytoin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ( DRUGA ) , DRUGN , DRUGN or DRUGB .
niacin	drug	warfarin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ( DRUGN ) , DRUGA , DRUGB or DRUGN .
tolbutamide	drug	phenytoin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ( DRUGN ) , DRUGA , DRUGN or DRUGB .
tolbutamide	drug	warfarin	drug
false

No depressant effect on blood levels in humans was noted when DRUGN was administered with any of the following drugs : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ( DRUGN ) , DRUGN , DRUGA or DRUGB .
phenytoin	drug	warfarin	drug
false

Particular caution should be observed with DRUGA since there are conflicting results for the effect of DRUGB on the availability of DRUGN and DRUGN .
digitalis preparations	group	colestipol hydrochloride	drug
effect

Particular caution should be observed with DRUGA since there are conflicting results for the effect of DRUGN on the availability of DRUGB and DRUGN .
digitalis preparations	group	digoxin	drug
false

Particular caution should be observed with DRUGA since there are conflicting results for the effect of DRUGN on the availability of DRUGN and DRUGB .
digitalis preparations	group	digitoxin	drug
false

Particular caution should be observed with DRUGN since there are conflicting results for the effect of DRUGA on the availability of DRUGB and DRUGN .
colestipol hydrochloride	drug	digoxin	drug
mechanism

Particular caution should be observed with DRUGN since there are conflicting results for the effect of DRUGA on the availability of DRUGN and DRUGB .
colestipol hydrochloride	drug	digitoxin	drug
mechanism

Particular caution should be observed with DRUGN since there are conflicting results for the effect of DRUGN on the availability of DRUGA and DRUGB .
digoxin	drug	digitoxin	drug
false

Discontinuing DRUGA could pose a hazard to health if a potentially toxic drug that is significantly bound to the DRUGB has been titrated to a maintenance level while the patient was taking DRUGN .
colestipol hydrochloride	drug	resin	group
false

Discontinuing DRUGN could pose a hazard to health if a potentially toxic drug that is significantly bound to the DRUGA has been titrated to a maintenance level while the patient was taking DRUGB .
resin	group	colestipol hydrochloride	drug
false

DRUGA may also interfere with the absorption of oral DRUGB supplements and DRUGN .
Bile acid binding resins	group	phosphate	drug
mechanism

DRUGA may also interfere with the absorption of oral DRUGN supplements and DRUGB .
Bile acid binding resins	group	hydrocortisone	drug
mechanism

DRUGN may also interfere with the absorption of oral DRUGA supplements and DRUGB .
phosphate	drug	hydrocortisone	drug
false

Certain other DRUGA ( DRUGB and DRUGN ) have also been reported to interfere with the nerve transmission at the neuromuscular junction .
antibiotics	group	aminoglycosides	group
false

Certain other DRUGA ( DRUGN and DRUGB ) have also been reported to interfere with the nerve transmission at the neuromuscular junction .
antibiotics	group	polymyxin	group
false

Certain other DRUGN ( DRUGA and DRUGB ) have also been reported to interfere with the nerve transmission at the neuromuscular junction .
aminoglycosides	group	polymyxin	group
false

DRUGA may enhance the nephrotoxicity of DRUGB Parenteral .
Sodium cephalothin	drug	Coly-Mycin M	brand
effect

The concomitant use of DRUGA and DRUGB Parenteral should be avoided .
sodium cephalothin	drug	Coly-Mycin M	brand
advise

DRUGA : Coadministration of DRUGB , a P glycoprotein substrate , with oral DRUGN resulted in a reduction in clearance and an increase in DRUGN Cmax and AUC values .
Digoxin	drug	digoxin	drug
false

DRUGA : Coadministration of DRUGN , a P glycoprotein substrate , with oral DRUGB resulted in a reduction in clearance and an increase in DRUGN Cmax and AUC values .
Digoxin	drug	conivaptan	drug
false

DRUGA : Coadministration of DRUGN , a P glycoprotein substrate , with oral DRUGN resulted in a reduction in clearance and an increase in DRUGB Cmax and AUC values .
Digoxin	drug	digoxin	drug
false

DRUGN : Coadministration of DRUGA , a P glycoprotein substrate , with oral DRUGB resulted in a reduction in clearance and an increase in DRUGN Cmax and AUC values .
digoxin	drug	conivaptan	drug
mechanism

DRUGN : Coadministration of DRUGN , a P glycoprotein substrate , with oral DRUGA resulted in a reduction in clearance and an increase in DRUGB Cmax and AUC values .
conivaptan	drug	digoxin	drug
false

Therefore , if DRUGA is administered with DRUGB , the clinician should be alert to the possibility of increases in DRUGN levels .
digoxin	drug	VAPRISOL	brand
mechanism

Therefore , if DRUGN is administered with DRUGA , the clinician should be alert to the possibility of increases in DRUGB levels .
VAPRISOL	brand	digoxin	drug
false

Other binding proteins may be elevated in serum , ( i.e . , corticosteroid binding globulin ( CBG ) , sex hormone binding globulin ( SHBG ) ) leading to increased total circulating DRUGA and DRUGB , respectively .
corticosteroids	group	sex steroids	group
false

DRUGA may accentuate the electrolyte loss associated with DRUGB therapy .
Corticotropin	drug	diuretic	drug
effect

Drugs that induce hepatic enzymes such as DRUGA , DRUGB and DRUGN may increase the clearance of DRUGN and may require increases in DRUGN dose to achieve the desired response .
phenobarbital	drug	phenytoin	drug
false

Drugs that induce hepatic enzymes such as DRUGA , DRUGN and DRUGB may increase the clearance of DRUGN and may require increases in DRUGN dose to achieve the desired response .
phenobarbital	drug	rifampin	drug
false

Drugs that induce hepatic enzymes such as DRUGA , DRUGN and DRUGN may increase the clearance of DRUGB and may require increases in DRUGN dose to achieve the desired response .
phenobarbital	drug	corticosteroids	group
mechanism

Drugs that induce hepatic enzymes such as DRUGA , DRUGN and DRUGN may increase the clearance of DRUGN and may require increases in DRUGB dose to achieve the desired response .
phenobarbital	drug	corticosteroid	group
advise

Drugs that induce hepatic enzymes such as DRUGN , DRUGA and DRUGB may increase the clearance of DRUGN and may require increases in DRUGN dose to achieve the desired response .
phenytoin	drug	rifampin	drug
false

Drugs that induce hepatic enzymes such as DRUGN , DRUGA and DRUGN may increase the clearance of DRUGB and may require increases in DRUGN dose to achieve the desired response .
phenytoin	drug	corticosteroids	group
mechanism

Drugs that induce hepatic enzymes such as DRUGN , DRUGA and DRUGN may increase the clearance of DRUGN and may require increases in DRUGB dose to achieve the desired response .
phenytoin	drug	corticosteroid	group
advise

Drugs that induce hepatic enzymes such as DRUGN , DRUGN and DRUGA may increase the clearance of DRUGB and may require increases in DRUGN dose to achieve the desired response .
rifampin	drug	corticosteroids	group
mechanism

Drugs that induce hepatic enzymes such as DRUGN , DRUGN and DRUGA may increase the clearance of DRUGN and may require increases in DRUGB dose to achieve the desired response .
rifampin	drug	corticosteroid	group
advise

Drugs that induce hepatic enzymes such as DRUGN , DRUGN and DRUGN may increase the clearance of DRUGA and may require increases in DRUGB dose to achieve the desired response .
corticosteroids	group	corticosteroid	group
false

Drugs such as DRUGA and DRUGB may inhibit the metabolism of DRUGN and thus decrease their clearance .
troleandomycin	drug	ketoconazole	drug
false

Drugs such as DRUGA and DRUGN may inhibit the metabolism of DRUGB and thus decrease their clearance .
troleandomycin	drug	corticosteroids	group
mechanism

Drugs such as DRUGN and DRUGA may inhibit the metabolism of DRUGB and thus decrease their clearance .
ketoconazole	drug	corticosteroids	group
mechanism

DRUGA may increase the clearance of chronic high dose DRUGB .
Corticosteroids	group	aspirin	brand
effect

This could lead to decreased DRUGA serum levels or increase the risk of DRUGN toxicity when DRUGB is withdrawn .
salicylate	group	corticosteroid	drug
false

This could lead to decreased DRUGN serum levels or increase the risk of DRUGA toxicity when DRUGB is withdrawn .
salicylate	group	corticosteroid	drug
effect

DRUGA should be used cautiously in conjunction with DRUGB in patients suffering from hypopro thrombinemia .
Aspirin	brand	cortico-steroids	group
advise

The effect of DRUGA on oral DRUGB is variable .
corticosteroids	group	anticoagulants	group
effect

There are reports of enhanced as well as diminished effects of DRUGA when given concurrently with DRUGB .
anticoagulants	group	corticosteroids	group
effect

DRUGA may accentuate the electrolyte loss associated with DRUGB therapy .
Corticotropin	drug	diuretic	group
effect

Drug Interaction During Pregnancy : DRUGA and DRUGB were studied following subcutaneous injections in pregnant mice .
Cromolyn sodium	drug	isoproterenol	drug
false

Persons taking most DRUGA , DRUGB and DRUGN invalidate DRUGN and DRUGN diagnostic blood assays .
antibiotics	group	methotrexate	drug
false

Persons taking most DRUGA , DRUGN and DRUGB invalidate DRUGN and DRUGN diagnostic blood assays .
antibiotics	group	pyrimethamine	drug
false

Persons taking most DRUGA , DRUGN and DRUGN invalidate DRUGB and DRUGN diagnostic blood assays .
antibiotics	group	folic acid	drug
false

Persons taking most DRUGA , DRUGN and DRUGN invalidate DRUGN and DRUGB diagnostic blood assays .
antibiotics	group	vitamin B12	drug
false

Persons taking most DRUGN , DRUGA and DRUGB invalidate DRUGN and DRUGN diagnostic blood assays .
methotrexate	drug	pyrimethamine	drug
false

Persons taking most DRUGN , DRUGA and DRUGN invalidate DRUGB and DRUGN diagnostic blood assays .
methotrexate	drug	folic acid	drug
false

Persons taking most DRUGN , DRUGA and DRUGN invalidate DRUGN and DRUGB diagnostic blood assays .
methotrexate	drug	vitamin B12	drug
false

Persons taking most DRUGN , DRUGN and DRUGA invalidate DRUGB and DRUGN diagnostic blood assays .
pyrimethamine	drug	folic acid	drug
false

Persons taking most DRUGN , DRUGN and DRUGA invalidate DRUGN and DRUGB diagnostic blood assays .
pyrimethamine	drug	vitamin B12	drug
false

Persons taking most DRUGN , DRUGN and DRUGN invalidate DRUGA and DRUGB diagnostic blood assays .
folic acid	drug	vitamin B12	drug
false

DRUGA DRUGB and heavy DRUGN intake for longer than dgb weeks may produce malabsorption of DRUGN .
Colchicine	drug	para-aminosalicylic acid	drug
false

DRUGA DRUGN and heavy DRUGB intake for longer than dgb weeks may produce malabsorption of DRUGN .
Colchicine	drug	alcohol	drug
false

DRUGA DRUGN and heavy DRUGN intake for longer than dgb weeks may produce malabsorption of DRUGB .
Colchicine	drug	vitamin B12	drug
mechanism

DRUGN DRUGA and heavy DRUGB intake for longer than dgb weeks may produce malabsorption of DRUGN .
para-aminosalicylic acid	drug	alcohol	drug
false

DRUGN DRUGA and heavy DRUGN intake for longer than dgb weeks may produce malabsorption of DRUGB .
para-aminosalicylic acid	drug	vitamin B12	drug
mechanism

DRUGN DRUGN and heavy DRUGA intake for longer than dgb weeks may produce malabsorption of DRUGB .
alcohol	drug	vitamin B12	drug
mechanism

DRUGA may have life threatening interactions with DRUGB .
FLEXERIL	brand	MAO inhibitors	group
int

DRUGA may enhance the effects of DRUGB , DRUGN , and other DRUGN .
FLEXERIL	brand	alcohol	drug
effect

DRUGA may enhance the effects of DRUGN , DRUGB , and other DRUGN .
FLEXERIL	brand	barbiturates	group
effect

DRUGA may enhance the effects of DRUGN , DRUGN , and other DRUGB .
FLEXERIL	brand	CNS depressants	group
effect

DRUGN may enhance the effects of DRUGA , DRUGB , and other DRUGN .
alcohol	drug	barbiturates	group
false

DRUGN may enhance the effects of DRUGA , DRUGN , and other DRUGB .
alcohol	drug	CNS depressants	group
false

DRUGN may enhance the effects of DRUGN , DRUGA , and other DRUGB .
barbiturates	group	CNS depressants	group
false

DRUGA may block the antihypertensive action of DRUGB and similarly acting compounds .
Tricyclic antidepressants	group	guanethidine	drug
effect

DRUGA may enhance the seizure risk in patients taking DRUGB
Tricyclic antidepressants	group	tramadol	drug
effect

DRUGA may interfere with the anti glaucoma action of DRUGB or DRUGN ;
Cyclopentolate	drug	carbachol	drug
effect

DRUGA may interfere with the anti glaucoma action of DRUGN or DRUGB ;
Cyclopentolate	drug	pilocarpine	drug
effect

DRUGN may interfere with the anti glaucoma action of DRUGA or DRUGB ;
carbachol	drug	pilocarpine	drug
false

The rate of metabolism and the leukopenic activity of DRUGA reportedly are increased by chronic administration of high doses of DRUGB .
cyclophosphamide	drug	phenobarbital	drug
mechanism

DRUGA treatment , which causes a marked and persistent inhibition of cholinesterase activity , potentiates the effect of DRUGB .
Cyclophosphamide	drug	succinylcholine chloride	drug
effect

May interact with wthionamide ( DRUGA ) and DRUGB ( DRUGN ) .
Trecator-SC	brand	isoniazid	drug
false

May interact with wthionamide ( DRUGA ) and DRUGN ( DRUGB ) .
Trecator-SC	brand	Nydrazid	brand
false

May interact with wthionamide ( DRUGN ) and DRUGA ( DRUGB ) .
isoniazid	drug	Nydrazid	brand
false

DRUGA prolong and intensify the anticholinergic effects of DRUGB .
MAO inhibitors	group	antihistamines	group
effect

DRUGA may have additive effects with DRUGB and other DRUGN , e.g . , DRUGN , DRUGN , DRUGN , DRUGN .
Antihistamines	group	alcohol	drug
effect

DRUGA may have additive effects with DRUGN and other DRUGB , e.g . , DRUGN , DRUGN , DRUGN , DRUGN .
Antihistamines	group	CNS depressants	group
effect

DRUGA may have additive effects with DRUGN and other DRUGN , e.g . , DRUGB , DRUGN , DRUGN , DRUGN .
Antihistamines	group	hypnotics	group
effect

DRUGA may have additive effects with DRUGN and other DRUGN , e.g . , DRUGN , DRUGB , DRUGN , DRUGN .
Antihistamines	group	sedatives	group
effect

DRUGA may have additive effects with DRUGN and other DRUGN , e.g . , DRUGN , DRUGN , DRUGB , DRUGN .
Antihistamines	group	tranquilizers	group
effect

DRUGA may have additive effects with DRUGN and other DRUGN , e.g . , DRUGN , DRUGN , DRUGN , DRUGB .
Antihistamines	group	antianxiety agents	group
effect

DRUGN may have additive effects with DRUGA and other DRUGB , e.g . , DRUGN , DRUGN , DRUGN , DRUGN .
alcohol	drug	CNS depressants	group
false

DRUGN may have additive effects with DRUGA and other DRUGN , e.g . , DRUGB , DRUGN , DRUGN , DRUGN .
alcohol	drug	hypnotics	group
false

DRUGN may have additive effects with DRUGA and other DRUGN , e.g . , DRUGN , DRUGB , DRUGN , DRUGN .
alcohol	drug	sedatives	group
false

DRUGN may have additive effects with DRUGA and other DRUGN , e.g . , DRUGN , DRUGN , DRUGB , DRUGN .
alcohol	drug	tranquilizers	group
false

DRUGN may have additive effects with DRUGA and other DRUGN , e.g . , DRUGN , DRUGN , DRUGN , DRUGB .
alcohol	drug	antianxiety agents	group
false

DRUGN may have additive effects with DRUGN and other DRUGA , e.g . , DRUGB , DRUGN , DRUGN , DRUGN .
CNS depressants	group	hypnotics	group
false

DRUGN may have additive effects with DRUGN and other DRUGA , e.g . , DRUGN , DRUGB , DRUGN , DRUGN .
CNS depressants	group	sedatives	group
false

DRUGN may have additive effects with DRUGN and other DRUGA , e.g . , DRUGN , DRUGN , DRUGB , DRUGN .
CNS depressants	group	tranquilizers	group
false

DRUGN may have additive effects with DRUGN and other DRUGA , e.g . , DRUGN , DRUGN , DRUGN , DRUGB .
CNS depressants	group	antianxiety agents	group
false

DRUGN may have additive effects with DRUGN and other DRUGN , e.g . , DRUGA , DRUGB , DRUGN , DRUGN .
hypnotics	group	sedatives	group
false

DRUGN may have additive effects with DRUGN and other DRUGN , e.g . , DRUGA , DRUGN , DRUGB , DRUGN .
hypnotics	group	tranquilizers	group
false

DRUGN may have additive effects with DRUGN and other DRUGN , e.g . , DRUGA , DRUGN , DRUGN , DRUGB .
hypnotics	group	antianxiety agents	group
false

DRUGN may have additive effects with DRUGN and other DRUGN , e.g . , DRUGN , DRUGA , DRUGB , DRUGN .
sedatives	group	tranquilizers	group
false

DRUGN may have additive effects with DRUGN and other DRUGN , e.g . , DRUGN , DRUGA , DRUGN , DRUGB .
sedatives	group	antianxiety agents	group
false

DRUGN may have additive effects with DRUGN and other DRUGN , e.g . , DRUGN , DRUGN , DRUGA , DRUGB .
tranquilizers	group	antianxiety agents	group
false

Drug / LaboratoryTest Interactions DRUGA may interfere with bioassay procedures for the determination of DRUGB levels .
Dactinomycin	drug	antibacterial drug	group
false

However , neither DRUGA nor DRUGB appears to affect DRUGN metabolism .
phenobarbital	drug	diazepam	drug
false

However , neither DRUGA nor DRUGN appears to affect DRUGB metabolism .
phenobarbital	drug	Dantrium	brand
false

However , neither DRUGN nor DRUGA appears to affect DRUGB metabolism .
diazepam	drug	Dantrium	brand
false

Binding to plasma protein is not significantly altered by DRUGA , DRUGB , or DRUGN .
diazepam	drug	diphenylhydantoin	drug
false

Binding to plasma protein is not significantly altered by DRUGA , DRUGN , or DRUGB .
diazepam	drug	phenylbutazone	drug
false

Binding to plasma protein is not significantly altered by DRUGN , DRUGA , or DRUGB .
diphenylhydantoin	drug	phenylbutazone	drug
false

Binding to plasma proteins is reduced by DRUGA and clotibrate and increased by DRUGB .
warfarin	drug	tolbutamide	drug
false

The combination of therapeutic doses of intravenous DRUGA and DRUGB in DRUGN a chloralose anesthetized swine has resulted in ventricular fibrillation and cardiovascular collapse in association with marked hyperkalemia .
dantrolene sodium	drug	verapamil	drug
false

The combination of therapeutic doses of intravenous DRUGA and DRUGN in DRUGB a chloralose anesthetized swine has resulted in ventricular fibrillation and cardiovascular collapse in association with marked hyperkalemia .
dantrolene sodium	drug	halothane	drug
false

The combination of therapeutic doses of intravenous DRUGN and DRUGA in DRUGB a chloralose anesthetized swine has resulted in ventricular fibrillation and cardiovascular collapse in association with marked hyperkalemia .
verapamil	drug	halothane	drug
false

It is recommended that the combination of intravenous DRUGA and DRUGB , such as DRUGN , not be used together during the management of malignant hyperthermia crisis until the relevance of these findings to humans is established .
dantrolene sodium	drug	calcium channel blockers	group
advise

It is recommended that the combination of intravenous DRUGA and DRUGN , such as DRUGB , not be used together during the management of malignant hyperthermia crisis until the relevance of these findings to humans is established .
dantrolene sodium	drug	verapamil	drug
advise

It is recommended that the combination of intravenous DRUGN and DRUGA , such as DRUGB , not be used together during the management of malignant hyperthermia crisis until the relevance of these findings to humans is established .
calcium channel blockers	group	verapamil	drug
false

Administration of DRUGA may potentiate DRUGB induced neuromuscular block .
dantrolene	drug	vecuronium	drug
effect

A drug drug interaction study evaluated the effect of the use of DRUGA Gel , dgb % , in combination with double strength ( dgb mg / dgb mg ) DRUGB / DRUGN ( DRUGN / DRUGN ) .
ACZONE	brand	trimethoprim	drug
false

A drug drug interaction study evaluated the effect of the use of DRUGA Gel , dgb % , in combination with double strength ( dgb mg / dgb mg ) DRUGN / DRUGB ( DRUGN / DRUGN ) .
ACZONE	brand	sulfamethoxazole	drug
false

A drug drug interaction study evaluated the effect of the use of DRUGA Gel , dgb % , in combination with double strength ( dgb mg / dgb mg ) DRUGN / DRUGN ( DRUGB / DRUGN ) .
ACZONE	brand	TMP	drug
false

A drug drug interaction study evaluated the effect of the use of DRUGA Gel , dgb % , in combination with double strength ( dgb mg / dgb mg ) DRUGN / DRUGN ( DRUGN / DRUGB ) .
ACZONE	brand	SMX	drug
false

A drug drug interaction study evaluated the effect of the use of DRUGN Gel , dgb % , in combination with double strength ( dgb mg / dgb mg ) DRUGA / DRUGB ( DRUGN / DRUGN ) .
trimethoprim	drug	sulfamethoxazole	drug
false

A drug drug interaction study evaluated the effect of the use of DRUGN Gel , dgb % , in combination with double strength ( dgb mg / dgb mg ) DRUGA / DRUGN ( DRUGB / DRUGN ) .
trimethoprim	drug	TMP	drug
false

A drug drug interaction study evaluated the effect of the use of DRUGN Gel , dgb % , in combination with double strength ( dgb mg / dgb mg ) DRUGA / DRUGN ( DRUGN / DRUGB ) .
trimethoprim	drug	SMX	drug
false

A drug drug interaction study evaluated the effect of the use of DRUGN Gel , dgb % , in combination with double strength ( dgb mg / dgb mg ) DRUGN / DRUGA ( DRUGB / DRUGN ) .
sulfamethoxazole	drug	TMP	drug
false

A drug drug interaction study evaluated the effect of the use of DRUGN Gel , dgb % , in combination with double strength ( dgb mg / dgb mg ) DRUGN / DRUGA ( DRUGN / DRUGB ) .
sulfamethoxazole	drug	SMX	drug
false

A drug drug interaction study evaluated the effect of the use of DRUGN Gel , dgb % , in combination with double strength ( dgb mg / dgb mg ) DRUGN / DRUGN ( DRUGA / DRUGB ) .
TMP	drug	SMX	drug
false

During co administration , systemic levels of DRUGA and DRUGB were essentially unchanged .
TMP	drug	SMX	drug
false

Notably , systemic exposure ( AUCdgb dgb ) of DRUGA ( DRUGB ) was more than doubled in the presence of DRUGN / DRUGN .
dapsone hydroxylamine	drug_n	DHA	drug_n
false

Notably , systemic exposure ( AUCdgb dgb ) of DRUGA ( DRUGN ) was more than doubled in the presence of DRUGB / DRUGN .
dapsone hydroxylamine	drug_n	TMP	drug
false

Notably , systemic exposure ( AUCdgb dgb ) of DRUGA ( DRUGN ) was more than doubled in the presence of DRUGN / DRUGB .
dapsone hydroxylamine	drug_n	SMX	drug
false

Notably , systemic exposure ( AUCdgb dgb ) of DRUGN ( DRUGA ) was more than doubled in the presence of DRUGB / DRUGN .
DHA	drug_n	TMP	drug
false

Notably , systemic exposure ( AUCdgb dgb ) of DRUGN ( DRUGA ) was more than doubled in the presence of DRUGN / DRUGB .
DHA	drug_n	SMX	drug
false

Notably , systemic exposure ( AUCdgb dgb ) of DRUGN ( DRUGN ) was more than doubled in the presence of DRUGA / DRUGB .
TMP	drug	SMX	drug
false

Exposure from the proposed topical dose is about dgb % of that from the dgb mg oral dose , even when co administered with DRUGA / DRUGB .
TMP	drug	SMX	drug
false

Certain concomitant medications ( such as DRUGA , DRUGB , St .
rifampin	drug	anticonvulsants	group
false

John s wort ) may increase the formation of DRUGA , a metabolite of DRUGB associated with hemolysis .
dapsone hydroxylamine	drug_n	dapsone	drug
false

With oral DRUGA treatment , DRUGB such as DRUGN have been noted to possibly increase the likelihood of hematologic reactions
dapsone	drug	folic acid antagonists	group
effect

With oral DRUGA treatment , DRUGN such as DRUGB have been noted to possibly increase the likelihood of hematologic reactions
dapsone	drug	pyrimethamine	drug
effect

With oral DRUGN treatment , DRUGA such as DRUGB have been noted to possibly increase the likelihood of hematologic reactions
folic acid antagonists	group	pyrimethamine	drug
false

DRUGA : DRUGB may cause myopathy , which is manifested as muscle pain or weakness associated with elevated levels of CPK .
HMG-CoA Reductase Inhibitors	group	Inhibitors of HMG-CoA reductase	group
false

Experience with co administration of DRUGA and DRUGB in patients is limited , therefore , consideration should be given to temporarily suspending use of DRUGN in patients receiving DRUGN .
HMG-CoA reductase inhibitors	group	Fentanyl	drug
false

Experience with co administration of DRUGA and DRUGN in patients is limited , therefore , consideration should be given to temporarily suspending use of DRUGN in patients receiving DRUGB .
HMG-CoA reductase inhibitors	group	Fentanyl	drug
false

Experience with co administration of DRUGN and DRUGA in patients is limited , therefore , consideration should be given to temporarily suspending use of DRUGB in patients receiving DRUGN .
Fentanyl	drug	HMG-CoA reductase inhibitors	group
false

Experience with co administration of DRUGN and DRUGN in patients is limited , therefore , consideration should be given to temporarily suspending use of DRUGA in patients receiving DRUGB .
HMG-CoA reductase inhibitors	group	Fentanyl	drug
advise

The daily dose of DRUGA should not exceed dga mg when coadministered with potent CYPdgbAdgb inhibitors ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN and nefazadone ) .
ENABLEX	brand	ketoconazole	drug
advise

The daily dose of DRUGA should not exceed dga mg when coadministered with potent CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN and nefazadone ) .
ENABLEX	brand	itraconazole	drug
advise

The daily dose of DRUGA should not exceed dga mg when coadministered with potent CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN and nefazadone ) .
ENABLEX	brand	ritonavir	drug
advise

The daily dose of DRUGA should not exceed dga mg when coadministered with potent CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN and nefazadone ) .
ENABLEX	brand	nelfinavir	drug
advise

The daily dose of DRUGA should not exceed dga mg when coadministered with potent CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB and nefazadone ) .
ENABLEX	brand	clarithromycin	drug
advise

The daily dose of DRUGN should not exceed dga mg when coadministered with potent CYPdgbAdgb inhibitors ( e.g . , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN and nefazadone ) .
ketoconazole	drug	itraconazole	drug
false

The daily dose of DRUGN should not exceed dga mg when coadministered with potent CYPdgbAdgb inhibitors ( e.g . , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN and nefazadone ) .
ketoconazole	drug	ritonavir	drug
false

The daily dose of DRUGN should not exceed dga mg when coadministered with potent CYPdgbAdgb inhibitors ( e.g . , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN and nefazadone ) .
ketoconazole	drug	nelfinavir	drug
false

The daily dose of DRUGN should not exceed dga mg when coadministered with potent CYPdgbAdgb inhibitors ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB and nefazadone ) .
ketoconazole	drug	clarithromycin	drug
false

The daily dose of DRUGN should not exceed dga mg when coadministered with potent CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN and nefazadone ) .
itraconazole	drug	ritonavir	drug
false

The daily dose of DRUGN should not exceed dga mg when coadministered with potent CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN and nefazadone ) .
itraconazole	drug	nelfinavir	drug
false

The daily dose of DRUGN should not exceed dga mg when coadministered with potent CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB and nefazadone ) .
itraconazole	drug	clarithromycin	drug
false

The daily dose of DRUGN should not exceed dga mg when coadministered with potent CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN and nefazadone ) .
ritonavir	drug	nelfinavir	drug
false

The daily dose of DRUGN should not exceed dga mg when coadministered with potent CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB and nefazadone ) .
ritonavir	drug	clarithromycin	drug
false

The daily dose of DRUGN should not exceed dga mg when coadministered with potent CYPdgbAdgb inhibitors ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB and nefazadone ) .
nelfinavir	drug	clarithromycin	drug
false

Caution should be taken when DRUGA is used concomitantly with medications that are predominantly metabolized by CYPdgbDdgb and which have a narrow therapeutic window , such as DRUGB , DRUGN and DRUGN ( see CLINICAL PHARMACOLOGY ) .
ENABLEX	brand	flecainide	drug
advise

Caution should be taken when DRUGA is used concomitantly with medications that are predominantly metabolized by CYPdgbDdgb and which have a narrow therapeutic window , such as DRUGN , DRUGB and DRUGN ( see CLINICAL PHARMACOLOGY ) .
ENABLEX	brand	thioridazine	drug
advise

Caution should be taken when DRUGA is used concomitantly with medications that are predominantly metabolized by CYPdgbDdgb and which have a narrow therapeutic window , such as DRUGN , DRUGN and DRUGB ( see CLINICAL PHARMACOLOGY ) .
ENABLEX	brand	tricyclic antidepressants	group
advise

Caution should be taken when DRUGN is used concomitantly with medications that are predominantly metabolized by CYPdgbDdgb and which have a narrow therapeutic window , such as DRUGA , DRUGB and DRUGN ( see CLINICAL PHARMACOLOGY ) .
flecainide	drug	thioridazine	drug
false

Caution should be taken when DRUGN is used concomitantly with medications that are predominantly metabolized by CYPdgbDdgb and which have a narrow therapeutic window , such as DRUGA , DRUGN and DRUGB ( see CLINICAL PHARMACOLOGY ) .
flecainide	drug	tricyclic antidepressants	group
false

Caution should be taken when DRUGN is used concomitantly with medications that are predominantly metabolized by CYPdgbDdgb and which have a narrow therapeutic window , such as DRUGN , DRUGA and DRUGB ( see CLINICAL PHARMACOLOGY ) .
thioridazine	drug	tricyclic antidepressants	group
false

The concomitant use of DRUGA with other DRUGB may increase the frequency and / or severity of dry mouth , constipation , blurred vision and other anticholinergic pharmacological effects .
ENABLEX	brand	anticholinergic agents	group
effect

Drugs that may increase DRUGA plasma concentrations CYPdgbAdgb Inhibitors : DRUGB is a CYPdgbAdgb substrate .
dasatinib	drug	Dasatinib	drug
false

In patients in whom CYPdgbAdgb inducers ( eg , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN ) are indicated , alternative agents with less enzyme induction potential should be used .
dexamethasone	drug	phenytoin	drug
false

In patients in whom CYPdgbAdgb inducers ( eg , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN ) are indicated , alternative agents with less enzyme induction potential should be used .
dexamethasone	drug	carbamazepine	drug
false

In patients in whom CYPdgbAdgb inducers ( eg , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN ) are indicated , alternative agents with less enzyme induction potential should be used .
dexamethasone	drug	rifampicin	drug
false

In patients in whom CYPdgbAdgb inducers ( eg , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB ) are indicated , alternative agents with less enzyme induction potential should be used .
dexamethasone	drug	phenobarbital	drug
false

In patients in whom CYPdgbAdgb inducers ( eg , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN ) are indicated , alternative agents with less enzyme induction potential should be used .
phenytoin	drug	carbamazepine	drug
false

In patients in whom CYPdgbAdgb inducers ( eg , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN ) are indicated , alternative agents with less enzyme induction potential should be used .
phenytoin	drug	rifampicin	drug
false

In patients in whom CYPdgbAdgb inducers ( eg , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB ) are indicated , alternative agents with less enzyme induction potential should be used .
phenytoin	drug	phenobarbital	drug
false

In patients in whom CYPdgbAdgb inducers ( eg , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN ) are indicated , alternative agents with less enzyme induction potential should be used .
carbamazepine	drug	rifampicin	drug
false

In patients in whom CYPdgbAdgb inducers ( eg , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB ) are indicated , alternative agents with less enzyme induction potential should be used .
carbamazepine	drug	phenobarbital	drug
false

In patients in whom CYPdgbAdgb inducers ( eg , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB ) are indicated , alternative agents with less enzyme induction potential should be used .
rifampicin	drug	phenobarbital	drug
false

DRUGA : Nonclinical data demonstrate that the solubility of DRUGB is pH dependent .
Antacids	group	dasatinib	drug
false

Simultaneous administration of DRUGA with DRUGB should be avoided .
SPRYCEL	brand	antacids	group
advise

If DRUGA therapy is needed , the antacid dose should be administered at least dgb hours prior to or dgb hours after the dose of DRUGB .
antacid	group	SPRYCEL	brand
advise

DRUGA / DRUGB : Long term suppression of gastric acid secretion by DRUGN or DRUGN ( eg , DRUGN and DRUGN ) is likely to reduce DRUGN exposure .
H2 Blockers	group	Proton Pump Inhibitors	group
false

DRUGA / DRUGN : Long term suppression of gastric acid secretion by DRUGB or DRUGN ( eg , DRUGN and DRUGN ) is likely to reduce DRUGN exposure .
H2 Blockers	group	H2 blockers	group
false

DRUGA / DRUGN : Long term suppression of gastric acid secretion by DRUGN or DRUGB ( eg , DRUGN and DRUGN ) is likely to reduce DRUGN exposure .
H2 Blockers	group	proton pump inhibitors	group
false

DRUGA / DRUGN : Long term suppression of gastric acid secretion by DRUGN or DRUGN ( eg , DRUGB and DRUGN ) is likely to reduce DRUGN exposure .
H2 Blockers	group	famotidine	drug
false

DRUGA / DRUGN : Long term suppression of gastric acid secretion by DRUGN or DRUGN ( eg , DRUGN and DRUGB ) is likely to reduce DRUGN exposure .
H2 Blockers	group	omeprazole	drug
false

DRUGA / DRUGN : Long term suppression of gastric acid secretion by DRUGN or DRUGN ( eg , DRUGN and DRUGN ) is likely to reduce DRUGB exposure .
H2 Blockers	group	dasatinib	drug
false

DRUGN / DRUGA : Long term suppression of gastric acid secretion by DRUGB or DRUGN ( eg , DRUGN and DRUGN ) is likely to reduce DRUGN exposure .
Proton Pump Inhibitors	group	H2 blockers	group
false

DRUGN / DRUGA : Long term suppression of gastric acid secretion by DRUGN or DRUGB ( eg , DRUGN and DRUGN ) is likely to reduce DRUGN exposure .
Proton Pump Inhibitors	group	proton pump inhibitors	group
false

DRUGN / DRUGA : Long term suppression of gastric acid secretion by DRUGN or DRUGN ( eg , DRUGB and DRUGN ) is likely to reduce DRUGN exposure .
Proton Pump Inhibitors	group	famotidine	drug
false

DRUGN / DRUGA : Long term suppression of gastric acid secretion by DRUGN or DRUGN ( eg , DRUGN and DRUGB ) is likely to reduce DRUGN exposure .
Proton Pump Inhibitors	group	omeprazole	drug
false

DRUGN / DRUGA : Long term suppression of gastric acid secretion by DRUGN or DRUGN ( eg , DRUGN and DRUGN ) is likely to reduce DRUGB exposure .
Proton Pump Inhibitors	group	dasatinib	drug
false

DRUGN / DRUGN : Long term suppression of gastric acid secretion by DRUGA or DRUGB ( eg , DRUGN and DRUGN ) is likely to reduce DRUGN exposure .
H2 blockers	group	proton pump inhibitors	group
false

DRUGN / DRUGN : Long term suppression of gastric acid secretion by DRUGA or DRUGN ( eg , DRUGB and DRUGN ) is likely to reduce DRUGN exposure .
H2 blockers	group	famotidine	drug
false

DRUGN / DRUGN : Long term suppression of gastric acid secretion by DRUGA or DRUGN ( eg , DRUGN and DRUGB ) is likely to reduce DRUGN exposure .
H2 blockers	group	omeprazole	drug
false

DRUGN / DRUGN : Long term suppression of gastric acid secretion by DRUGA or DRUGN ( eg , DRUGN and DRUGN ) is likely to reduce DRUGB exposure .
H2 blockers	group	dasatinib	drug
effect

DRUGN / DRUGN : Long term suppression of gastric acid secretion by DRUGN or DRUGA ( eg , DRUGB and DRUGN ) is likely to reduce DRUGN exposure .
proton pump inhibitors	group	famotidine	drug
false

DRUGN / DRUGN : Long term suppression of gastric acid secretion by DRUGN or DRUGA ( eg , DRUGN and DRUGB ) is likely to reduce DRUGN exposure .
proton pump inhibitors	group	omeprazole	drug
false

DRUGN / DRUGN : Long term suppression of gastric acid secretion by DRUGN or DRUGA ( eg , DRUGN and DRUGN ) is likely to reduce DRUGB exposure .
proton pump inhibitors	group	dasatinib	drug
effect

DRUGN / DRUGN : Long term suppression of gastric acid secretion by DRUGN or DRUGN ( eg , DRUGA and DRUGB ) is likely to reduce DRUGN exposure .
famotidine	drug	omeprazole	drug
false

DRUGN / DRUGN : Long term suppression of gastric acid secretion by DRUGN or DRUGN ( eg , DRUGA and DRUGN ) is likely to reduce DRUGB exposure .
famotidine	drug	dasatinib	drug
effect

DRUGN / DRUGN : Long term suppression of gastric acid secretion by DRUGN or DRUGN ( eg , DRUGN and DRUGA ) is likely to reduce DRUGB exposure .
omeprazole	drug	dasatinib	drug
effect

The concomitant use of DRUGA or DRUGB with DRUGN is not recommended .
H2 blockers	group	proton pump inhibitors	group
false

The concomitant use of DRUGA or DRUGN with DRUGB is not recommended .
H2 blockers	group	SPRYCEL	brand
advise

The concomitant use of DRUGN or DRUGA with DRUGB is not recommended .
proton pump inhibitors	group	SPRYCEL	brand
advise

The use of DRUGA should be considered in place of DRUGB or DRUGN in patients receiving DRUGN therapy .
antacids	group	H2 blockers	group
false

The use of DRUGA should be considered in place of DRUGN or DRUGB in patients receiving DRUGN therapy .
antacids	group	proton pump inhibitors	group
false

The use of DRUGA should be considered in place of DRUGN or DRUGN in patients receiving DRUGB therapy .
antacids	group	SPRYCEL	brand
false

The use of DRUGN should be considered in place of DRUGA or DRUGB in patients receiving DRUGN therapy .
H2 blockers	group	proton pump inhibitors	group
false

The use of DRUGN should be considered in place of DRUGA or DRUGN in patients receiving DRUGB therapy .
H2 blockers	group	SPRYCEL	brand
advise

The use of DRUGN should be considered in place of DRUGN or DRUGA in patients receiving DRUGB therapy .
proton pump inhibitors	group	SPRYCEL	brand
advise

Drugs that may have their plasma concentration altered by DRUGA CYPdgbAdgb Substrates : DRUGB is a time dependent inhibitor of CYPdgbAdga
dasatinib	drug	Dasatinib	drug
false

Use of DRUGA in a patient who has previously received DRUGB increases the risk of cardiotoxicity .
Cerubidine	brand	doxorubicin	drug
effect

DRUGA should not be used in patients who have previously received the recommended maximum cumulative doses of DRUGB or DRUGN .
Cerubidine	brand	doxorubicin	drug
advise

DRUGN should not be used in patients who have previously received the recommended maximum cumulative doses of DRUGA or DRUGB .
doxorubicin	drug	Cerubidine	brand
false

DRUGA used concurrently with DRUGB may also result in increased cardiotoxicity .
Cyclophosphamide	drug	Cerubidine	brand
effect

DRUGA ( neostgmine , DRUGB ) , DRUGN , DRUGN , DRUGN can enhance toxicity and cause cardio respiratory depression .
Anticholinesterases	group	physostigmine	drug
false

DRUGA ( neostgmine , DRUGN ) , DRUGB , DRUGN , DRUGN can enhance toxicity and cause cardio respiratory depression .
Anticholinesterases	group	lignocaine	drug
false

DRUGA ( neostgmine , DRUGN ) , DRUGN , DRUGB , DRUGN can enhance toxicity and cause cardio respiratory depression .
Anticholinesterases	group	quinine	drug
false

DRUGA ( neostgmine , DRUGN ) , DRUGN , DRUGN , DRUGB can enhance toxicity and cause cardio respiratory depression .
Anticholinesterases	group	procainamide	drug
false

DRUGN ( neostgmine , DRUGA ) , DRUGB , DRUGN , DRUGN can enhance toxicity and cause cardio respiratory depression .
physostigmine	drug	lignocaine	drug
false

DRUGN ( neostgmine , DRUGA ) , DRUGN , DRUGB , DRUGN can enhance toxicity and cause cardio respiratory depression .
physostigmine	drug	quinine	drug
false

DRUGN ( neostgmine , DRUGA ) , DRUGN , DRUGN , DRUGB can enhance toxicity and cause cardio respiratory depression .
physostigmine	drug	procainamide	drug
false

DRUGN ( neostgmine , DRUGN ) , DRUGA , DRUGB , DRUGN can enhance toxicity and cause cardio respiratory depression .
lignocaine	drug	quinine	drug
false

DRUGN ( neostgmine , DRUGN ) , DRUGA , DRUGN , DRUGB can enhance toxicity and cause cardio respiratory depression .
lignocaine	drug	procainamide	drug
false

DRUGN ( neostgmine , DRUGN ) , DRUGN , DRUGA , DRUGB can enhance toxicity and cause cardio respiratory depression .
quinine	drug	procainamide	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGA , local DRUGN like DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
anesthetics	group	lidocaine	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGA , local DRUGN like DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
anesthetics	group	procaine	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGA , local DRUGN like DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
anesthetics	group	beta-blockers	group
false

In addition , neuromuscular blocking action is enhanced by general DRUGA , local DRUGN like DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
anesthetics	group	metaclopramide	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGA , local DRUGN like DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
anesthetics	group	lithium carbonate	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGA , local DRUGN like DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
anesthetics	group	terbutaline	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGA like DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
anesthetics	group	lidocaine	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGA like DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
anesthetics	group	procaine	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGA like DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
anesthetics	group	beta-blockers	group
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGA like DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
anesthetics	group	metaclopramide	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGA like DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
anesthetics	group	lithium carbonate	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGA like DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
anesthetics	group	terbutaline	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGN like DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
lidocaine	drug	procaine	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGN like DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
lidocaine	drug	beta-blockers	group
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGN like DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
lidocaine	drug	metaclopramide	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGN like DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
lidocaine	drug	lithium carbonate	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGN like DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
lidocaine	drug	terbutaline	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGN like DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
procaine	drug	beta-blockers	group
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGN like DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
procaine	drug	metaclopramide	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGN like DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
procaine	drug	lithium carbonate	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGN like DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
procaine	drug	terbutaline	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGN like DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
beta-blockers	group	metaclopramide	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGN like DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
beta-blockers	group	lithium carbonate	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGN like DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
beta-blockers	group	terbutaline	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGN like DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
metaclopramide	drug	lithium carbonate	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGN like DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
metaclopramide	drug	terbutaline	drug
false

In addition , neuromuscular blocking action is enhanced by general DRUGN , local DRUGN like DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
lithium carbonate	drug	terbutaline	drug
false

The concomitant administration of DRUGA and DRUGB containing DRUGN has not been formally studied .
Exjade	brand	aluminum	drug
false

The concomitant administration of DRUGA and DRUGN containing DRUGB has not been formally studied .
Exjade	brand	antacid preparations	group
false

The concomitant administration of DRUGN and DRUGA containing DRUGB has not been formally studied .
aluminum	drug	antacid preparations	group
false

Although DRUGA has a lower affinity for DRUGB than for DRUGN , DRUGN should not be taken with DRUGN containing DRUGN .
deferasirox	drug	aluminum	drug
false

Although DRUGA has a lower affinity for DRUGN than for DRUGB , DRUGN should not be taken with DRUGN containing DRUGN .
deferasirox	drug	iron	drug
false

Although DRUGA has a lower affinity for DRUGN than for DRUGN , DRUGB should not be taken with DRUGN containing DRUGN .
deferasirox	drug	Exjade	brand
false

Although DRUGA has a lower affinity for DRUGN than for DRUGN , DRUGN should not be taken with DRUGB containing DRUGN .
deferasirox	drug	aluminum	drug
false

Although DRUGA has a lower affinity for DRUGN than for DRUGN , DRUGN should not be taken with DRUGN containing DRUGB .
deferasirox	drug	antacid preparations	group
false

Although DRUGN has a lower affinity for DRUGA than for DRUGB , DRUGN should not be taken with DRUGN containing DRUGN .
aluminum	drug	iron	drug
false

Although DRUGN has a lower affinity for DRUGA than for DRUGN , DRUGB should not be taken with DRUGN containing DRUGN .
aluminum	drug	Exjade	brand
false

Although DRUGN has a lower affinity for DRUGA than for DRUGN , DRUGN should not be taken with DRUGN containing DRUGB .
aluminum	drug	antacid preparations	group
false

Although DRUGN has a lower affinity for DRUGN than for DRUGA , DRUGB should not be taken with DRUGN containing DRUGN .
iron	drug	Exjade	brand
false

Although DRUGN has a lower affinity for DRUGN than for DRUGA , DRUGN should not be taken with DRUGB containing DRUGN .
iron	drug	aluminum	drug
false

Although DRUGN has a lower affinity for DRUGN than for DRUGA , DRUGN should not be taken with DRUGN containing DRUGB .
iron	drug	antacid preparations	group
false

Although DRUGN has a lower affinity for DRUGN than for DRUGN , DRUGA should not be taken with DRUGB containing DRUGN .
Exjade	brand	aluminum	drug
advise

Although DRUGN has a lower affinity for DRUGN than for DRUGN , DRUGA should not be taken with DRUGN containing DRUGB .
Exjade	brand	antacid preparations	group
false

Although DRUGN has a lower affinity for DRUGN than for DRUGN , DRUGN should not be taken with DRUGA containing DRUGB .
aluminum	drug	antacid preparations	group
false

In healthy volunteers , DRUGA had no effect on the pharmacokinetics of DRUGB .
Exjade	brand	digoxin	drug
false

The effect of DRUGA on DRUGB pharmacokinetics has not been studied .
digoxin	drug	Exjade	brand
false

The concomitant administration of DRUGA and DRUGB has not been formally studied .
Exjade	brand	vitamin C	drug
false

The interaction of DRUGA with DRUGB has not been formally studied .
Exjade	brand	hydroxyurea	drug
false

No inhibition of DRUGA metabolism by DRUGB is expected based on the results of an in vitro study .
deferasirox	drug	hydroxyurea	drug
false

Antiacid , DRUGA , DRUGB , DRUGN , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGN .
clarithromycin	drug	Didanosine	drug
false

Antiacid , DRUGA , DRUGN , DRUGB , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGN .
clarithromycin	drug	Fluconazole	drug
false

Antiacid , DRUGA , DRUGN , DRUGN , DRUGB , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGN .
clarithromycin	drug	Fluoxetine	drug
false

Antiacid , DRUGA , DRUGN , DRUGN , DRUGN , Indanavir , DRUGB , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGN .
clarithromycin	drug	Ketoconazole	drug
false

Antiacid , DRUGA , DRUGN , DRUGN , DRUGN , Indanavir , DRUGN , DRUGB , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGN .
clarithromycin	drug	Phenytoin	drug
false

Antiacid , DRUGA , DRUGN , DRUGN , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGB , DRUGN , DRUGN , Ritanovir , DRUGN .
clarithromycin	drug	carbamazepine	drug
false

Antiacid , DRUGA , DRUGN , DRUGN , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGB , DRUGN , Ritanovir , DRUGN .
clarithromycin	drug	Rifabutin	drug
false

Antiacid , DRUGA , DRUGN , DRUGN , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGB , Ritanovir , DRUGN .
clarithromycin	drug	Rifampin	drug
false

Antiacid , DRUGA , DRUGN , DRUGN , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGB .
clarithromycin	drug	Saquinavir	drug
false

Antiacid , DRUGN , DRUGA , DRUGB , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGN .
Didanosine	drug	Fluconazole	drug
false

Antiacid , DRUGN , DRUGA , DRUGN , DRUGB , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGN .
Didanosine	drug	Fluoxetine	drug
false

Antiacid , DRUGN , DRUGA , DRUGN , DRUGN , Indanavir , DRUGB , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGN .
Didanosine	drug	Ketoconazole	drug
false

Antiacid , DRUGN , DRUGA , DRUGN , DRUGN , Indanavir , DRUGN , DRUGB , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGN .
Didanosine	drug	Phenytoin	drug
false

Antiacid , DRUGN , DRUGA , DRUGN , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGB , DRUGN , DRUGN , Ritanovir , DRUGN .
Didanosine	drug	carbamazepine	drug
false

Antiacid , DRUGN , DRUGA , DRUGN , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGB , DRUGN , Ritanovir , DRUGN .
Didanosine	drug	Rifabutin	drug
false

Antiacid , DRUGN , DRUGA , DRUGN , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGB , Ritanovir , DRUGN .
Didanosine	drug	Rifampin	drug
false

Antiacid , DRUGN , DRUGA , DRUGN , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGB .
Didanosine	drug	Saquinavir	drug
false

Antiacid , DRUGN , DRUGN , DRUGA , DRUGB , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGN .
Fluconazole	drug	Fluoxetine	drug
false

Antiacid , DRUGN , DRUGN , DRUGA , DRUGN , Indanavir , DRUGB , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGN .
Fluconazole	drug	Ketoconazole	drug
false

Antiacid , DRUGN , DRUGN , DRUGA , DRUGN , Indanavir , DRUGN , DRUGB , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGN .
Fluconazole	drug	Phenytoin	drug
false

Antiacid , DRUGN , DRUGN , DRUGA , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGB , DRUGN , DRUGN , Ritanovir , DRUGN .
Fluconazole	drug	carbamazepine	drug
false

Antiacid , DRUGN , DRUGN , DRUGA , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGB , DRUGN , Ritanovir , DRUGN .
Fluconazole	drug	Rifabutin	drug
false

Antiacid , DRUGN , DRUGN , DRUGA , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGB , Ritanovir , DRUGN .
Fluconazole	drug	Rifampin	drug
false

Antiacid , DRUGN , DRUGN , DRUGA , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGB .
Fluconazole	drug	Saquinavir	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGA , Indanavir , DRUGB , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGN .
Fluoxetine	drug	Ketoconazole	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGA , Indanavir , DRUGN , DRUGB , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGN .
Fluoxetine	drug	Phenytoin	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGA , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGB , DRUGN , DRUGN , Ritanovir , DRUGN .
Fluoxetine	drug	carbamazepine	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGA , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGB , DRUGN , Ritanovir , DRUGN .
Fluoxetine	drug	Rifabutin	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGA , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGB , Ritanovir , DRUGN .
Fluoxetine	drug	Rifampin	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGA , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGB .
Fluoxetine	drug	Saquinavir	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGN , Indanavir , DRUGA , DRUGB , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGN .
Ketoconazole	drug	Phenytoin	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGN , Indanavir , DRUGA , DRUGN , Phenobarbitol , DRUGB , DRUGN , DRUGN , Ritanovir , DRUGN .
Ketoconazole	drug	carbamazepine	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGN , Indanavir , DRUGA , DRUGN , Phenobarbitol , DRUGN , DRUGB , DRUGN , Ritanovir , DRUGN .
Ketoconazole	drug	Rifabutin	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGN , Indanavir , DRUGA , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGB , Ritanovir , DRUGN .
Ketoconazole	drug	Rifampin	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGN , Indanavir , DRUGA , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGB .
Ketoconazole	drug	Saquinavir	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGN , Indanavir , DRUGN , DRUGA , Phenobarbitol , DRUGB , DRUGN , DRUGN , Ritanovir , DRUGN .
Phenytoin	drug	carbamazepine	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGN , Indanavir , DRUGN , DRUGA , Phenobarbitol , DRUGN , DRUGB , DRUGN , Ritanovir , DRUGN .
Phenytoin	drug	Rifabutin	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGN , Indanavir , DRUGN , DRUGA , Phenobarbitol , DRUGN , DRUGN , DRUGB , Ritanovir , DRUGN .
Phenytoin	drug	Rifampin	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGN , Indanavir , DRUGN , DRUGA , Phenobarbitol , DRUGN , DRUGN , DRUGN , Ritanovir , DRUGB .
Phenytoin	drug	Saquinavir	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGA , DRUGB , DRUGN , Ritanovir , DRUGN .
carbamazepine	drug	Rifabutin	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGA , DRUGN , DRUGB , Ritanovir , DRUGN .
carbamazepine	drug	Rifampin	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGA , DRUGN , DRUGN , Ritanovir , DRUGB .
carbamazepine	drug	Saquinavir	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGA , DRUGB , Ritanovir , DRUGN .
Rifabutin	drug	Rifampin	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGA , DRUGN , Ritanovir , DRUGB .
Rifabutin	drug	Saquinavir	drug
false

Antiacid , DRUGN , DRUGN , DRUGN , DRUGN , Indanavir , DRUGN , DRUGN , Phenobarbitol , DRUGN , DRUGN , DRUGA , Ritanovir , DRUGB .
Rifampin	drug	Saquinavir	drug
false

Possible drug interactions of DRUGA with DRUGB or with other DRUGN .
HUMORSOL	brand	succinylcholine	drug
int

Possible drug interactions of DRUGA with DRUGN or with other DRUGB .
HUMORSOL	brand	anticholinesterase agents	group
int

Possible drug interactions of DRUGN with DRUGA or with other DRUGB .
succinylcholine	drug	anticholinesterase agents	group
false

Because the DRUGA have been shown to depress plasma prothrombin activity , patients who are on DRUGB therapy may require downward adjustment of their DRUGN dosage .
tetracyclines	group	anticoagulant	group
advise

Because the DRUGA have been shown to depress plasma prothrombin activity , patients who are on DRUGN therapy may require downward adjustment of their DRUGB dosage .
tetracyclines	group	anticoagulant	group
false

Since bacteriostatic drugs , such as the DRUGA of DRUGB , may interfere with the bactericidal action of DRUGN , it is not advisable to administer these drugs concomitantly .
tetracycline class	group	antibiotics	group
false

Since bacteriostatic drugs , such as the DRUGA of DRUGN , may interfere with the bactericidal action of DRUGB , it is not advisable to administer these drugs concomitantly .
tetracycline class	group	penicillins	group
effect

Since bacteriostatic drugs , such as the DRUGN of DRUGA , may interfere with the bactericidal action of DRUGB , it is not advisable to administer these drugs concomitantly .
antibiotics	group	penicillins	group
false

Concurrent use of DRUGA with oral DRUGB may render oral DRUGN less effective .
tetracyclines	group	contraceptives	group
effect

Concurrent use of DRUGA with oral DRUGN may render oral DRUGB less effective .
tetracyclines	group	contraceptives	group
false

Taking a DRUGA while you are taking or within dgb weeks of taking DRUGB may increase the risk of central nervous system depression or may cause a severe high blood pressure reaction .
rauwolfia alkaloid	group	MAO inhibitors	group
effect

No clinically significant adverse interactions with commonly used preanesthetic drugs , or drugs used during anesthesia ( DRUGA , intravenous agents , and local DRUGB ) were reported in clinical trials .
muscle relaxants	group	anesthetic agents	group
false

Like DRUGA , DRUGB does not predispose to premature ventricular arrhythmias in the presence of exogenously infused DRUGN in swine .
isoflurane	drug	desflurane	drug
false

Like DRUGA , DRUGN does not predispose to premature ventricular arrhythmias in the presence of exogenously infused DRUGB in swine .
isoflurane	drug	epinephrine	drug
false

Like DRUGN , DRUGA does not predispose to premature ventricular arrhythmias in the presence of exogenously infused DRUGB in swine .
desflurane	drug	epinephrine	drug
false

Poor metabolizers have higher than expected plasma concentrations of DRUGA ( DRUGB ) when given usual doses .
tricyclic antidepressants	group	TCAs	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGB , DRUGN , and the Type dgbC antiarrhythrnics propatenone and DRUGN ) .
cimetidine	drug	antidepressants	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGB , and the Type dgbC antiarrhythrnics propatenone and DRUGN ) .
cimetidine	drug	phenothiazines	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the Type dgbC antiarrhythrnics propatenone and DRUGB ) .
cimetidine	drug	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGB , and the Type dgbC antiarrhythrnics propatenone and DRUGN ) .
antidepressants	group	phenothiazines	group
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGN , and the Type dgbC antiarrhythrnics propatenone and DRUGB ) .
antidepressants	group	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGA , and the Type dgbC antiarrhythrnics propatenone and DRUGB ) .
phenothiazines	group	flecainide	drug
false

While all the DRUGA ( DRUGB ) , e.g . , DRUGN , seriraline , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	SSRIs	group
false

While all the DRUGA ( DRUGN ) , e.g . , DRUGB , seriraline , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	fluoxetine	drug
false

While all the DRUGA ( DRUGN ) , e.g . , DRUGN , seriraline , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	paroxetine	drug
false

While all the DRUGN ( DRUGA ) , e.g . , DRUGB , seriraline , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	fluoxetine	drug
false

While all the DRUGN ( DRUGA ) , e.g . , DRUGN , seriraline , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	paroxetine	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGA , seriraline , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
fluoxetine	drug	paroxetine	drug
false

The extent to which DRUGA DRUGB interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the DRUGN involved .
SSRI	group	TCA	group
int

The extent to which DRUGN DRUGA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the DRUGB involved .
TCA	group	SSRI	group
false

Nevertheless , caution is indicated in the co administration of DRUGA with any of the DRUGB and also in switching from one class to the other .
T.A.	group	SSRIs	group
advise

Concomitant use of DRUGA with drugs that can inhibit cytochrome Pdgb dgbDdgb may require lower doses than usually prescribed for either the DRUGB or the other drug .
tricyclic antidepressants	group	tricyclic antidepressant	group
false

Close supervision and careful adjustment of dosage are required when this drug is given concomitantly with DRUGA or DRUGB .
anticholinergic	group	sympathomimetic drugs	group
false

Both the sedative and anticholinergic effects of the DRUGA are also additive to those of DRUGB .
major tranquilizers	group	desipramine	drug
effect

Concurrent administration of DRUGA and DRUGB can produce clinically significant increases in the plasma levels of the DRUGN .
cimetidine	drug	tricyclic antidepressants	group
mechanism

Concurrent administration of DRUGA and DRUGN can produce clinically significant increases in the plasma levels of the DRUGB .
cimetidine	drug	tricyclic antidepressants	group
false

Conversely , decreases in plasma levels of the DRUGA have been reported upon discontinuation of DRUGB which may result in the loss of the therapeutic efficacy of the DRUGN dga
tricyclic antidepressants	group	cimetidine	drug
mechanism

Conversely , decreases in plasma levels of the DRUGA have been reported upon discontinuation of DRUGN which may result in the loss of the therapeutic efficacy of the DRUGB dga
tricyclic antidepressants	group	tricyclic antidepressant	group
false

Conversely , decreases in plasma levels of the DRUGN have been reported upon discontinuation of DRUGA which may result in the loss of the therapeutic efficacy of the DRUGB dga
cimetidine	drug	tricyclic antidepressant	group
false

There have been greater than two fold increases of previously stable plasma levels of DRUGA when DRUGB has been administered in combination with these agents .
tricyclic antidepressants	group	fluoxetine	drug
mechanism

Table dgb Changes in DRUGA and DRUGB Pharmacokinetics in Healthy Male and Female Volunteers
Desloratadine	drug	3-Hydroxydesloratadine	drug_n
false

DRUGA DRUGB
Desloratadine	drug	3-Hydroxydesloratadine	drug_n
false

A similar association , though less marked , has been suggested with DRUGA , phenyl butazone , DRUGB , DRUGN and possibly with DRUGN , DRUGN , and DRUGN ( dgb )
barbiturates	group	phenytoin sodium	drug
false

A similar association , though less marked , has been suggested with DRUGA , phenyl butazone , DRUGN , DRUGB and possibly with DRUGN , DRUGN , and DRUGN ( dgb )
barbiturates	group	carbamazepine	drug
false

A similar association , though less marked , has been suggested with DRUGA , phenyl butazone , DRUGN , DRUGN and possibly with DRUGB , DRUGN , and DRUGN ( dgb )
barbiturates	group	griseofulvin	drug
false

A similar association , though less marked , has been suggested with DRUGA , phenyl butazone , DRUGN , DRUGN and possibly with DRUGN , DRUGB , and DRUGN ( dgb )
barbiturates	group	ampicillin	drug
false

A similar association , though less marked , has been suggested with DRUGA , phenyl butazone , DRUGN , DRUGN and possibly with DRUGN , DRUGN , and DRUGB ( dgb )
barbiturates	group	tetracyclines	group
false

A similar association , though less marked , has been suggested with DRUGN , phenyl butazone , DRUGA , DRUGB and possibly with DRUGN , DRUGN , and DRUGN ( dgb )
phenytoin sodium	drug	carbamazepine	drug
false

A similar association , though less marked , has been suggested with DRUGN , phenyl butazone , DRUGA , DRUGN and possibly with DRUGB , DRUGN , and DRUGN ( dgb )
phenytoin sodium	drug	griseofulvin	drug
false

A similar association , though less marked , has been suggested with DRUGN , phenyl butazone , DRUGA , DRUGN and possibly with DRUGN , DRUGB , and DRUGN ( dgb )
phenytoin sodium	drug	ampicillin	drug
false

A similar association , though less marked , has been suggested with DRUGN , phenyl butazone , DRUGA , DRUGN and possibly with DRUGN , DRUGN , and DRUGB ( dgb )
phenytoin sodium	drug	tetracyclines	group
false

A similar association , though less marked , has been suggested with DRUGN , phenyl butazone , DRUGN , DRUGA and possibly with DRUGB , DRUGN , and DRUGN ( dgb )
carbamazepine	drug	griseofulvin	drug
false

A similar association , though less marked , has been suggested with DRUGN , phenyl butazone , DRUGN , DRUGA and possibly with DRUGN , DRUGB , and DRUGN ( dgb )
carbamazepine	drug	ampicillin	drug
false

A similar association , though less marked , has been suggested with DRUGN , phenyl butazone , DRUGN , DRUGA and possibly with DRUGN , DRUGN , and DRUGB ( dgb )
carbamazepine	drug	tetracyclines	group
false

A similar association , though less marked , has been suggested with DRUGN , phenyl butazone , DRUGN , DRUGN and possibly with DRUGA , DRUGB , and DRUGN ( dgb )
griseofulvin	drug	ampicillin	drug
false

A similar association , though less marked , has been suggested with DRUGN , phenyl butazone , DRUGN , DRUGN and possibly with DRUGA , DRUGN , and DRUGB ( dgb )
griseofulvin	drug	tetracyclines	group
false

A similar association , though less marked , has been suggested with DRUGN , phenyl butazone , DRUGN , DRUGN and possibly with DRUGN , DRUGA , and DRUGB ( dgb )
ampicillin	drug	tetracyclines	group
false

DRUGA : DRUGN may diminish adrenal suppression by DRUGB .
Aminoglutethimide	drug	corticosteroids	group
false

DRUGN : DRUGA may diminish adrenal suppression by DRUGB .
Aminoglutethimide	drug	corticosteroids	group
effect

DRUGA injection and potassium depleting agents : When DRUGB are administered concomitantly with potassium depleting agents ( e.g . , DRUGN , DRUGN ) , patients should be observed closely for development of hypokalemia .
Amphotericin B	drug	corticosteroids	group
false

DRUGA injection and potassium depleting agents : When DRUGN are administered concomitantly with potassium depleting agents ( e.g . , DRUGB , DRUGN ) , patients should be observed closely for development of hypokalemia .
Amphotericin B	drug	amphotericin B	drug
false

DRUGA injection and potassium depleting agents : When DRUGN are administered concomitantly with potassium depleting agents ( e.g . , DRUGN , DRUGB ) , patients should be observed closely for development of hypokalemia .
Amphotericin B	drug	diuretics	group
false

DRUGN injection and potassium depleting agents : When DRUGA are administered concomitantly with potassium depleting agents ( e.g . , DRUGB , DRUGN ) , patients should be observed closely for development of hypokalemia .
corticosteroids	group	amphotericin B	drug
advise

DRUGN injection and potassium depleting agents : When DRUGA are administered concomitantly with potassium depleting agents ( e.g . , DRUGN , DRUGB ) , patients should be observed closely for development of hypokalemia .
corticosteroids	group	diuretics	group
advise

DRUGN injection and potassium depleting agents : When DRUGN are administered concomitantly with potassium depleting agents ( e.g . , DRUGA , DRUGB ) , patients should be observed closely for development of hypokalemia .
amphotericin B	drug	diuretics	group
false

In addition , there have been cases reported in which concomitant use of DRUGA and DRUGB was followed by cardiac enlargement and congestive heart failure .
amphotericin B	drug	hydrocortisone	drug
effect

DRUGA : DRUGB have been reported to cause a significant decrease in DRUGN clearance .
Antibiotics	group	Macrolide antibiotics	group
false

DRUGA : DRUGN have been reported to cause a significant decrease in DRUGB clearance .
Antibiotics	group	corticosteroid	group
false

DRUGN : DRUGA have been reported to cause a significant decrease in DRUGB clearance .
Macrolide antibiotics	group	corticosteroid	group
mechanism

DRUGA : Concomitant use of DRUGB and DRUGN may produce severe weakness in patients with myasthenia gravis .
Anticholinesterases	group	anticholinesterase agents	group
false

DRUGA : Concomitant use of DRUGN and DRUGB may produce severe weakness in patients with myasthenia gravis .
Anticholinesterases	group	corticosteroids	group
false

DRUGN : Concomitant use of DRUGA and DRUGB may produce severe weakness in patients with myasthenia gravis .
anticholinesterase agents	group	corticosteroids	group
effect

If possible , DRUGA should be withdrawn at least dgb hours before initiating DRUGB therapy .
anticholinesterase agents	group	corticosteroid	group
advise

DRUGA , oral : Co administration of DRUGB and DRUGN usually results in inhibition of response to DRUGN , although there have been some conflicting reports .
Anticoagulants	group	corticosteroids	group
false

DRUGA , oral : Co administration of DRUGN and DRUGB usually results in inhibition of response to DRUGN , although there have been some conflicting reports .
Anticoagulants	group	warfarin	drug
false

DRUGA , oral : Co administration of DRUGN and DRUGN usually results in inhibition of response to DRUGB , although there have been some conflicting reports .
Anticoagulants	group	warfarin	drug
false

DRUGN , oral : Co administration of DRUGA and DRUGB usually results in inhibition of response to DRUGN , although there have been some conflicting reports .
corticosteroids	group	warfarin	drug
effect

DRUGN , oral : Co administration of DRUGA and DRUGN usually results in inhibition of response to DRUGB , although there have been some conflicting reports .
corticosteroids	group	warfarin	drug
false

DRUGA : Because DRUGB may increase blood glucose concentrations , dosage adjustments of DRUGN may be required .
Antidiabetics	group	corticosteroids	group
false

DRUGA : Because DRUGN may increase blood glucose concentrations , dosage adjustments of DRUGB may be required .
Antidiabetics	group	antidiabetic agents	group
false

DRUGN : Because DRUGA may increase blood glucose concentrations , dosage adjustments of DRUGB may be required .
corticosteroids	group	antidiabetic agents	group
effect

DRUGA : DRUGN may increase the clearance of DRUGB .
Cholestyramine	drug	corticosteroids	group
false

DRUGN : DRUGA may increase the clearance of DRUGB .
Cholestyramine	drug	corticosteroids	group
mechanism

DRUGA : Increased activity of both DRUGB and DRUGN may occur when the two are used concurrently .
Cyclosporine	drug	cyclosporine	drug
false

DRUGA : Increased activity of both DRUGN and DRUGB may occur when the two are used concurrently .
Cyclosporine	drug	corticosteroids	group
false

DRUGN : Increased activity of both DRUGA and DRUGB may occur when the two are used concurrently .
cyclosporine	drug	corticosteroids	group
effect

DRUGA : Patients on DRUGB may be at increased risk of arrhythmias due to hypokalemia .
Digitalis glycosides	group	digitalis glycosides	group
false

DRUGA : DRUGN may enhance the metabolic clearance of DRUGB , resulting in decreased blood levels and lessened physiologic activity , thus requiring an increase in DRUGN dosage .
Ephedrine	drug	corticosteroids	group
false

DRUGA : DRUGN may enhance the metabolic clearance of DRUGN , resulting in decreased blood levels and lessened physiologic activity , thus requiring an increase in DRUGB dosage .
Ephedrine	drug	corticosteroid	group
false

DRUGN : DRUGA may enhance the metabolic clearance of DRUGB , resulting in decreased blood levels and lessened physiologic activity , thus requiring an increase in DRUGN dosage .
Ephedrine	drug	corticosteroids	group
mechanism

DRUGN : DRUGA may enhance the metabolic clearance of DRUGN , resulting in decreased blood levels and lessened physiologic activity , thus requiring an increase in DRUGB dosage .
Ephedrine	drug	corticosteroid	group
false

DRUGN : DRUGN may enhance the metabolic clearance of DRUGA , resulting in decreased blood levels and lessened physiologic activity , thus requiring an increase in DRUGB dosage .
corticosteroids	group	corticosteroid	group
false

DRUGA , including oral DRUGB : DRUGN may decrease the hepatic metabolism of certain DRUGN , thereby increasing their effect .
Estrogens	group	contraceptives	group
false

DRUGA , including oral DRUGN : DRUGN may decrease the hepatic metabolism of certain DRUGB , thereby increasing their effect .
Estrogens	group	corticosteroids	group
false

DRUGN , including oral DRUGA : DRUGB may decrease the hepatic metabolism of certain DRUGN , thereby increasing their effect .
contraceptives	group	Estrogens	group
false

DRUGN , including oral DRUGA : DRUGN may decrease the hepatic metabolism of certain DRUGB , thereby increasing their effect .
contraceptives	group	corticosteroids	group
false

DRUGN , including oral DRUGN : DRUGA may decrease the hepatic metabolism of certain DRUGB , thereby increasing their effect .
Estrogens	group	corticosteroids	group
mechanism

Drugs which inhibit CYP dgbAdgb ( e.g . , DRUGA , DRUGB such as DRUGN ) have the potential to result in increased plasma concentrations of DRUGN .
ketoconazole	drug	macrolide antibiotics	group
false

Drugs which inhibit CYP dgbAdgb ( e.g . , DRUGA , DRUGN such as DRUGB ) have the potential to result in increased plasma concentrations of DRUGN .
ketoconazole	drug	erythromycin	drug
false

Drugs which inhibit CYP dgbAdgb ( e.g . , DRUGA , DRUGN such as DRUGN ) have the potential to result in increased plasma concentrations of DRUGB .
ketoconazole	drug	corticosteroids	group
mechanism

Drugs which inhibit CYP dgbAdgb ( e.g . , DRUGN , DRUGA such as DRUGB ) have the potential to result in increased plasma concentrations of DRUGN .
macrolide antibiotics	group	erythromycin	drug
false

Drugs which inhibit CYP dgbAdgb ( e.g . , DRUGN , DRUGA such as DRUGN ) have the potential to result in increased plasma concentrations of DRUGB .
macrolide antibiotics	group	corticosteroids	group
mechanism

Drugs which inhibit CYP dgbAdgb ( e.g . , DRUGN , DRUGN such as DRUGA ) have the potential to result in increased plasma concentrations of DRUGB .
erythromycin	drug	corticosteroids	group
mechanism

Co administration with other drugs that are metabolized by CYP dgbAdgb ( e.g . , DRUGA , DRUGB ) may increase their clearance , resulting in decreased plasma concentration .
indinavir	drug	erythromycin	drug
false

DRUGA : DRUGN has been reported to decrease the metabolism of certain DRUGB by up to dgb % , leading to increased risk of DRUGN side effects .
Ketoconazole	drug	corticosteroids	group
false

DRUGA : DRUGN has been reported to decrease the metabolism of certain DRUGN by up to dgb % , leading to increased risk of DRUGB side effects .
Ketoconazole	drug	corticosteroid	group
false

DRUGN : DRUGA has been reported to decrease the metabolism of certain DRUGB by up to dgb % , leading to increased risk of DRUGN side effects .
Ketoconazole	drug	corticosteroids	group
mechanism

DRUGN : DRUGA has been reported to decrease the metabolism of certain DRUGN by up to dgb % , leading to increased risk of DRUGB side effects .
Ketoconazole	drug	corticosteroid	group
false

DRUGN : DRUGN has been reported to decrease the metabolism of certain DRUGA by up to dgb % , leading to increased risk of DRUGB side effects .
corticosteroids	group	corticosteroid	group
false

In addition , DRUGA alone can inhibit adrenal DRUGB synthesis and may cause adrenal insufficiency during corticosteroid withdrawal .
ketoconazole	drug	corticosteroid	drug
effect

DRUGA ( DRUGB ) : Concomitant use of DRUGN ( or other DRUGN ) and DRUGN increases the risk of gastrointestinal side effects .
Nonsteroidal anti-inflammatory agents	group	NSAIDS	group
false

DRUGA ( DRUGN ) : Concomitant use of DRUGB ( or other DRUGN ) and DRUGN increases the risk of gastrointestinal side effects .
Nonsteroidal anti-inflammatory agents	group	aspirin	brand
false

DRUGA ( DRUGN ) : Concomitant use of DRUGN ( or other DRUGB ) and DRUGN increases the risk of gastrointestinal side effects .
Nonsteroidal anti-inflammatory agents	group	nonsteroidal antiinflammatory agents	group
false

DRUGA ( DRUGN ) : Concomitant use of DRUGN ( or other DRUGN ) and DRUGB increases the risk of gastrointestinal side effects .
Nonsteroidal anti-inflammatory agents	group	corticosteroids	group
false

DRUGN ( DRUGA ) : Concomitant use of DRUGB ( or other DRUGN ) and DRUGN increases the risk of gastrointestinal side effects .
NSAIDS	group	aspirin	brand
false

DRUGN ( DRUGA ) : Concomitant use of DRUGN ( or other DRUGB ) and DRUGN increases the risk of gastrointestinal side effects .
NSAIDS	group	nonsteroidal antiinflammatory agents	group
false

DRUGN ( DRUGA ) : Concomitant use of DRUGN ( or other DRUGN ) and DRUGB increases the risk of gastrointestinal side effects .
NSAIDS	group	corticosteroids	group
false

DRUGN ( DRUGN ) : Concomitant use of DRUGA ( or other DRUGB ) and DRUGN increases the risk of gastrointestinal side effects .
aspirin	brand	nonsteroidal antiinflammatory agents	group
false

DRUGN ( DRUGN ) : Concomitant use of DRUGA ( or other DRUGN ) and DRUGB increases the risk of gastrointestinal side effects .
aspirin	brand	corticosteroids	group
effect

DRUGN ( DRUGN ) : Concomitant use of DRUGN ( or other DRUGA ) and DRUGB increases the risk of gastrointestinal side effects .
nonsteroidal antiinflammatory agents	group	corticosteroids	group
effect

DRUGA should be used cautiously in conjunction with DRUGB in hypoprothrombinemia .
Aspirin	brand	corticosteroids	group
advise

The clearance of DRUGA may be increased with concurrent use of DRUGB .
salicylates	group	corticosteroids	group
mechanism

DRUGA : In post marketing experience , there have been reports of both increases and decreases in DRUGB levels with DRUGN co administration , leading to alterations in seizure control .
Phenytoin	drug	phenytoin	drug
false

DRUGA : In post marketing experience , there have been reports of both increases and decreases in DRUGN levels with DRUGB co administration , leading to alterations in seizure control .
Phenytoin	drug	dexamethasone	drug
false

DRUGN : In post marketing experience , there have been reports of both increases and decreases in DRUGA levels with DRUGB co administration , leading to alterations in seizure control .
phenytoin	drug	dexamethasone	drug
mechanism

DRUGA : Co administration with DRUGB should be employed cautiously , as toxic epidermal necrolysis has been reported with concomitant use .
Thalidomide	drug	thalidomide	drug
false

DRUGA : Patients on DRUGB therapy may exhibit a diminished response to toxoids and DRUGN or DRUGN due to inhibition of antibody response .
Vaccines	group	corticosteroid	group
false

DRUGA : Patients on DRUGN therapy may exhibit a diminished response to toxoids and DRUGB or DRUGN due to inhibition of antibody response .
Vaccines	group	live vaccines	group
false

DRUGA : Patients on DRUGN therapy may exhibit a diminished response to toxoids and DRUGN or DRUGB due to inhibition of antibody response .
Vaccines	group	inactivated vaccines	group
false

DRUGN : Patients on DRUGA therapy may exhibit a diminished response to toxoids and DRUGB or DRUGN due to inhibition of antibody response .
corticosteroid	group	live vaccines	group
effect

DRUGN : Patients on DRUGA therapy may exhibit a diminished response to toxoids and DRUGN or DRUGB due to inhibition of antibody response .
corticosteroid	group	inactivated vaccines	group
effect

DRUGN : Patients on DRUGN therapy may exhibit a diminished response to toxoids and DRUGA or DRUGB due to inhibition of antibody response .
live vaccines	group	inactivated vaccines	group
false

DRUGA may also potentiate the replication of some organisms contained in DRUGB .
Corticosteroids	group	live attenuated vaccines	group
effect

Routine administration of DRUGA or toxoids should be deferred until DRUGB therapy is discontinued if possible .
vaccines	group	corticosteroid	group
advise

Because DRUGA is a serotonin releaser and reuptake inhibitor , DRUGN should not be used concomitantly with a DRUGB .
dexfenfluramine	drug	MAO inhibitor	group
false

Because DRUGN is a serotonin releaser and reuptake inhibitor , DRUGA should not be used concomitantly with a DRUGB .
dexfenfluramine	drug	MAO inhibitor	group
advise

At least dgb days should elapse between discontinuation of a DRUGA and initiation of treatment with DRUGB .
MAO inhibitor	group	dexfenfluramine	drug
advise

At least dgb weeks should elapse between discontinuation of DRUGA and initiation of treatment with a DRUGB .
dexfenfluramine	drug	MAO inhibitor	group
advise

DRUGA should not be administered with other DRUGB .
Dexfenfluramine	drug	serotoninergic agents	group
advise

DRUGA / DRUGB / DRUGN / DRUGN : Co administration of DRUGN with DRUGN , DRUGN , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Anesthetics	group	Sedatives	group
false

DRUGA / DRUGN / DRUGB / DRUGN : Co administration of DRUGN with DRUGN , DRUGN , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Anesthetics	group	Hypnotics	group
false

DRUGA / DRUGN / DRUGN / DRUGB : Co administration of DRUGN with DRUGN , DRUGN , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Anesthetics	group	Opioids	group
false

DRUGA / DRUGN / DRUGN / DRUGN : Co administration of DRUGB with DRUGN , DRUGN , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Anesthetics	group	PRECEDEX	brand
false

DRUGA / DRUGN / DRUGN / DRUGN : Co administration of DRUGN with DRUGB , DRUGN , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Anesthetics	group	anesthetics	group
false

DRUGA / DRUGN / DRUGN / DRUGN : Co administration of DRUGN with DRUGN , DRUGB , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Anesthetics	group	sedatives	group
false

DRUGA / DRUGN / DRUGN / DRUGN : Co administration of DRUGN with DRUGN , DRUGN , DRUGB , and DRUGN is likely to lead to an enhancement of effects .
Anesthetics	group	hypnotics	group
false

DRUGA / DRUGN / DRUGN / DRUGN : Co administration of DRUGN with DRUGN , DRUGN , DRUGN , and DRUGB is likely to lead to an enhancement of effects .
Anesthetics	group	opioids	group
false

DRUGN / DRUGA / DRUGB / DRUGN : Co administration of DRUGN with DRUGN , DRUGN , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Sedatives	group	Hypnotics	group
false

DRUGN / DRUGA / DRUGN / DRUGB : Co administration of DRUGN with DRUGN , DRUGN , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Sedatives	group	Opioids	group
false

DRUGN / DRUGA / DRUGN / DRUGN : Co administration of DRUGB with DRUGN , DRUGN , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Sedatives	group	PRECEDEX	brand
false

DRUGN / DRUGA / DRUGN / DRUGN : Co administration of DRUGN with DRUGB , DRUGN , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Sedatives	group	anesthetics	group
false

DRUGN / DRUGA / DRUGN / DRUGN : Co administration of DRUGN with DRUGN , DRUGB , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Sedatives	group	sedatives	group
false

DRUGN / DRUGA / DRUGN / DRUGN : Co administration of DRUGN with DRUGN , DRUGN , DRUGB , and DRUGN is likely to lead to an enhancement of effects .
Sedatives	group	hypnotics	group
false

DRUGN / DRUGA / DRUGN / DRUGN : Co administration of DRUGN with DRUGN , DRUGN , DRUGN , and DRUGB is likely to lead to an enhancement of effects .
Sedatives	group	opioids	group
false

DRUGN / DRUGN / DRUGA / DRUGB : Co administration of DRUGN with DRUGN , DRUGN , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Hypnotics	group	Opioids	group
false

DRUGN / DRUGN / DRUGA / DRUGN : Co administration of DRUGB with DRUGN , DRUGN , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Hypnotics	group	PRECEDEX	brand
false

DRUGN / DRUGN / DRUGA / DRUGN : Co administration of DRUGN with DRUGB , DRUGN , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Hypnotics	group	anesthetics	group
false

DRUGN / DRUGN / DRUGA / DRUGN : Co administration of DRUGN with DRUGN , DRUGB , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Hypnotics	group	sedatives	group
false

DRUGN / DRUGN / DRUGA / DRUGN : Co administration of DRUGN with DRUGN , DRUGN , DRUGB , and DRUGN is likely to lead to an enhancement of effects .
Hypnotics	group	hypnotics	group
false

DRUGN / DRUGN / DRUGA / DRUGN : Co administration of DRUGN with DRUGN , DRUGN , DRUGN , and DRUGB is likely to lead to an enhancement of effects .
Hypnotics	group	opioids	group
false

DRUGN / DRUGN / DRUGN / DRUGA : Co administration of DRUGB with DRUGN , DRUGN , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Opioids	group	PRECEDEX	brand
false

DRUGN / DRUGN / DRUGN / DRUGA : Co administration of DRUGN with DRUGB , DRUGN , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Opioids	group	anesthetics	group
false

DRUGN / DRUGN / DRUGN / DRUGA : Co administration of DRUGN with DRUGN , DRUGB , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
Opioids	group	sedatives	group
false

DRUGN / DRUGN / DRUGN / DRUGA : Co administration of DRUGN with DRUGN , DRUGN , DRUGB , and DRUGN is likely to lead to an enhancement of effects .
Opioids	group	hypnotics	group
false

DRUGN / DRUGN / DRUGN / DRUGA : Co administration of DRUGN with DRUGN , DRUGN , DRUGN , and DRUGB is likely to lead to an enhancement of effects .
Opioids	group	opioids	group
false

DRUGN / DRUGN / DRUGN / DRUGN : Co administration of DRUGA with DRUGB , DRUGN , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
PRECEDEX	brand	anesthetics	group
effect

DRUGN / DRUGN / DRUGN / DRUGN : Co administration of DRUGA with DRUGN , DRUGB , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
PRECEDEX	brand	sedatives	group
effect

DRUGN / DRUGN / DRUGN / DRUGN : Co administration of DRUGA with DRUGN , DRUGN , DRUGB , and DRUGN is likely to lead to an enhancement of effects .
PRECEDEX	brand	hypnotics	group
effect

DRUGN / DRUGN / DRUGN / DRUGN : Co administration of DRUGA with DRUGN , DRUGN , DRUGN , and DRUGB is likely to lead to an enhancement of effects .
PRECEDEX	brand	opioids	group
effect

DRUGN / DRUGN / DRUGN / DRUGN : Co administration of DRUGN with DRUGA , DRUGB , DRUGN , and DRUGN is likely to lead to an enhancement of effects .
anesthetics	group	sedatives	group
false

DRUGN / DRUGN / DRUGN / DRUGN : Co administration of DRUGN with DRUGA , DRUGN , DRUGB , and DRUGN is likely to lead to an enhancement of effects .
anesthetics	group	hypnotics	group
false

DRUGN / DRUGN / DRUGN / DRUGN : Co administration of DRUGN with DRUGA , DRUGN , DRUGN , and DRUGB is likely to lead to an enhancement of effects .
anesthetics	group	opioids	group
false

DRUGN / DRUGN / DRUGN / DRUGN : Co administration of DRUGN with DRUGN , DRUGA , DRUGB , and DRUGN is likely to lead to an enhancement of effects .
sedatives	group	hypnotics	group
false

DRUGN / DRUGN / DRUGN / DRUGN : Co administration of DRUGN with DRUGN , DRUGA , DRUGN , and DRUGB is likely to lead to an enhancement of effects .
sedatives	group	opioids	group
false

DRUGN / DRUGN / DRUGN / DRUGN : Co administration of DRUGN with DRUGN , DRUGN , DRUGA , and DRUGB is likely to lead to an enhancement of effects .
hypnotics	group	opioids	group
false

Specific studies have confirmed these effects with DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
sevoflurane	drug	isoflurane	drug
false

Specific studies have confirmed these effects with DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
sevoflurane	drug	propofol	drug
false

Specific studies have confirmed these effects with DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
sevoflurane	drug	alfentanil	drug
false

Specific studies have confirmed these effects with DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
sevoflurane	drug	midazolam	drug
false

Specific studies have confirmed these effects with DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
isoflurane	drug	propofol	drug
false

Specific studies have confirmed these effects with DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
isoflurane	drug	alfentanil	drug
false

Specific studies have confirmed these effects with DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
isoflurane	drug	midazolam	drug
false

Specific studies have confirmed these effects with DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
propofol	drug	alfentanil	drug
false

Specific studies have confirmed these effects with DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
propofol	drug	midazolam	drug
false

Specific studies have confirmed these effects with DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
alfentanil	drug	midazolam	drug
false

No pharmacokinetic interactions between DRUGA and DRUGB , DRUGN , DRUGN , and DRUGN have been demonstrated .
dexmedetomidine	drug	isoflurane	drug
false

No pharmacokinetic interactions between DRUGA and DRUGN , DRUGB , DRUGN , and DRUGN have been demonstrated .
dexmedetomidine	drug	propofol	drug
false

No pharmacokinetic interactions between DRUGA and DRUGN , DRUGN , DRUGB , and DRUGN have been demonstrated .
dexmedetomidine	drug	alfentanil	drug
false

No pharmacokinetic interactions between DRUGA and DRUGN , DRUGN , DRUGN , and DRUGB have been demonstrated .
dexmedetomidine	drug	midazolam	drug
false

No pharmacokinetic interactions between DRUGN and DRUGA , DRUGB , DRUGN , and DRUGN have been demonstrated .
isoflurane	drug	propofol	drug
false

No pharmacokinetic interactions between DRUGN and DRUGA , DRUGN , DRUGB , and DRUGN have been demonstrated .
isoflurane	drug	alfentanil	drug
false

No pharmacokinetic interactions between DRUGN and DRUGA , DRUGN , DRUGN , and DRUGB have been demonstrated .
isoflurane	drug	midazolam	drug
false

No pharmacokinetic interactions between DRUGN and DRUGN , DRUGA , DRUGB , and DRUGN have been demonstrated .
propofol	drug	alfentanil	drug
false

No pharmacokinetic interactions between DRUGN and DRUGN , DRUGA , DRUGN , and DRUGB have been demonstrated .
propofol	drug	midazolam	drug
false

No pharmacokinetic interactions between DRUGN and DRUGN , DRUGN , DRUGA , and DRUGB have been demonstrated .
alfentanil	drug	midazolam	drug
false

However , due to possible pharmacodynamic interactions , when co administered with DRUGA , a reduction in dosage of DRUGN on the concomitant DRUGB , DRUGN , DRUGN or DRUGN may be required .
PRECEDEX	brand	anesthetic	group
false

However , due to possible pharmacodynamic interactions , when co administered with DRUGA , a reduction in dosage of DRUGN on the concomitant DRUGN , DRUGB , DRUGN or DRUGN may be required .
PRECEDEX	brand	sedative	group
false

However , due to possible pharmacodynamic interactions , when co administered with DRUGA , a reduction in dosage of DRUGN on the concomitant DRUGN , DRUGN , DRUGB or DRUGN may be required .
PRECEDEX	brand	hypnotic	group
false

However , due to possible pharmacodynamic interactions , when co administered with DRUGA , a reduction in dosage of DRUGN on the concomitant DRUGN , DRUGN , DRUGN or DRUGB may be required .
PRECEDEX	brand	opioid	group
false

However , due to possible pharmacodynamic interactions , when co administered with DRUGN , a reduction in dosage of DRUGA on the concomitant DRUGB , DRUGN , DRUGN or DRUGN may be required .
PRECEDEX	brand	anesthetic	group
advise

However , due to possible pharmacodynamic interactions , when co administered with DRUGN , a reduction in dosage of DRUGA on the concomitant DRUGN , DRUGB , DRUGN or DRUGN may be required .
PRECEDEX	brand	sedative	group
advise

However , due to possible pharmacodynamic interactions , when co administered with DRUGN , a reduction in dosage of DRUGA on the concomitant DRUGN , DRUGN , DRUGB or DRUGN may be required .
PRECEDEX	brand	hypnotic	group
advise

However , due to possible pharmacodynamic interactions , when co administered with DRUGN , a reduction in dosage of DRUGA on the concomitant DRUGN , DRUGN , DRUGN or DRUGB may be required .
PRECEDEX	brand	opioid	group
advise

However , due to possible pharmacodynamic interactions , when co administered with DRUGN , a reduction in dosage of DRUGN on the concomitant DRUGA , DRUGB , DRUGN or DRUGN may be required .
anesthetic	group	sedative	group
false

However , due to possible pharmacodynamic interactions , when co administered with DRUGN , a reduction in dosage of DRUGN on the concomitant DRUGA , DRUGN , DRUGB or DRUGN may be required .
anesthetic	group	hypnotic	group
false

However , due to possible pharmacodynamic interactions , when co administered with DRUGN , a reduction in dosage of DRUGN on the concomitant DRUGA , DRUGN , DRUGN or DRUGB may be required .
anesthetic	group	opioid	group
false

However , due to possible pharmacodynamic interactions , when co administered with DRUGN , a reduction in dosage of DRUGN on the concomitant DRUGN , DRUGA , DRUGB or DRUGN may be required .
sedative	group	hypnotic	group
false

However , due to possible pharmacodynamic interactions , when co administered with DRUGN , a reduction in dosage of DRUGN on the concomitant DRUGN , DRUGA , DRUGN or DRUGB may be required .
sedative	group	opioid	group
false

However , due to possible pharmacodynamic interactions , when co administered with DRUGN , a reduction in dosage of DRUGN on the concomitant DRUGN , DRUGN , DRUGA or DRUGB may be required .
hypnotic	group	opioid	group
false

DRUGA does not influence the pharmacokinetics of DRUGB .
ZINECARD	brand	doxorubicin	drug
false

DRUGA : DRUGB ( DRUGN , DRUGN , DRUGN , DRUGN , fruit juices , etc . ) lower absorption of DRUGN .
Acidifying agents	group	Gastrointestinal acidifying agents	group
false

DRUGA : DRUGN ( DRUGB , DRUGN , DRUGN , DRUGN , fruit juices , etc . ) lower absorption of DRUGN .
Acidifying agents	group	guanethidine	drug
false

DRUGA : DRUGN ( DRUGN , DRUGB , DRUGN , DRUGN , fruit juices , etc . ) lower absorption of DRUGN .
Acidifying agents	group	reserpine	drug
false

DRUGA : DRUGN ( DRUGN , DRUGN , DRUGB , DRUGN , fruit juices , etc . ) lower absorption of DRUGN .
Acidifying agents	group	glutamic acid HCl	drug
false

DRUGA : DRUGN ( DRUGN , DRUGN , DRUGN , DRUGB , fruit juices , etc . ) lower absorption of DRUGN .
Acidifying agents	group	ascorbic acid	drug
false

DRUGA : DRUGN ( DRUGN , DRUGN , DRUGN , DRUGN , fruit juices , etc . ) lower absorption of DRUGB .
Acidifying agents	group	amphetamines	group
false

DRUGN : DRUGA ( DRUGB , DRUGN , DRUGN , DRUGN , fruit juices , etc . ) lower absorption of DRUGN .
Gastrointestinal acidifying agents	group	guanethidine	drug
false

DRUGN : DRUGA ( DRUGN , DRUGB , DRUGN , DRUGN , fruit juices , etc . ) lower absorption of DRUGN .
Gastrointestinal acidifying agents	group	reserpine	drug
false

DRUGN : DRUGA ( DRUGN , DRUGN , DRUGB , DRUGN , fruit juices , etc . ) lower absorption of DRUGN .
Gastrointestinal acidifying agents	group	glutamic acid HCl	drug
false

DRUGN : DRUGA ( DRUGN , DRUGN , DRUGN , DRUGB , fruit juices , etc . ) lower absorption of DRUGN .
Gastrointestinal acidifying agents	group	ascorbic acid	drug
false

DRUGN : DRUGA ( DRUGN , DRUGN , DRUGN , DRUGN , fruit juices , etc . ) lower absorption of DRUGB .
Gastrointestinal acidifying agents	group	amphetamines	group
mechanism

DRUGN : DRUGN ( DRUGA , DRUGB , DRUGN , DRUGN , fruit juices , etc . ) lower absorption of DRUGN .
guanethidine	drug	reserpine	drug
false

DRUGN : DRUGN ( DRUGA , DRUGN , DRUGB , DRUGN , fruit juices , etc . ) lower absorption of DRUGN .
guanethidine	drug	glutamic acid HCl	drug
false

DRUGN : DRUGN ( DRUGA , DRUGN , DRUGN , DRUGB , fruit juices , etc . ) lower absorption of DRUGN .
guanethidine	drug	ascorbic acid	drug
false

DRUGN : DRUGN ( DRUGA , DRUGN , DRUGN , DRUGN , fruit juices , etc . ) lower absorption of DRUGB .
guanethidine	drug	amphetamines	group
mechanism

DRUGN : DRUGN ( DRUGN , DRUGA , DRUGB , DRUGN , fruit juices , etc . ) lower absorption of DRUGN .
reserpine	drug	glutamic acid HCl	drug
false

DRUGN : DRUGN ( DRUGN , DRUGA , DRUGN , DRUGB , fruit juices , etc . ) lower absorption of DRUGN .
reserpine	drug	ascorbic acid	drug
false

DRUGN : DRUGN ( DRUGN , DRUGA , DRUGN , DRUGN , fruit juices , etc . ) lower absorption of DRUGB .
reserpine	drug	amphetamines	group
mechanism

DRUGN : DRUGN ( DRUGN , DRUGN , DRUGA , DRUGB , fruit juices , etc . ) lower absorption of DRUGN .
glutamic acid HCl	drug	ascorbic acid	drug
false

DRUGN : DRUGN ( DRUGN , DRUGN , DRUGA , DRUGN , fruit juices , etc . ) lower absorption of DRUGB .
glutamic acid HCl	drug	amphetamines	group
mechanism

DRUGN : DRUGN ( DRUGN , DRUGN , DRUGN , DRUGA , fruit juices , etc . ) lower absorption of DRUGB .
ascorbic acid	drug	amphetamines	group
mechanism

DRUGA ( DRUGB , DRUGN , etc . ) increase the concentration of the ionized species of the DRUGN molecule , thereby increasing urinary excretion .
Urinary acidifying agents	group	ammonium chloride	drug
false

DRUGA ( DRUGN , DRUGB , etc . ) increase the concentration of the ionized species of the DRUGN molecule , thereby increasing urinary excretion .
Urinary acidifying agents	group	sodium acid phosphate	drug
false

DRUGA ( DRUGN , DRUGN , etc . ) increase the concentration of the ionized species of the DRUGB molecule , thereby increasing urinary excretion .
Urinary acidifying agents	group	amphetamine	drug
mechanism

DRUGN ( DRUGA , DRUGB , etc . ) increase the concentration of the ionized species of the DRUGN molecule , thereby increasing urinary excretion .
ammonium chloride	drug	sodium acid phosphate	drug
false

DRUGN ( DRUGA , DRUGN , etc . ) increase the concentration of the ionized species of the DRUGB molecule , thereby increasing urinary excretion .
ammonium chloride	drug	amphetamine	drug
mechanism

DRUGN ( DRUGN , DRUGA , etc . ) increase the concentration of the ionized species of the DRUGB molecule , thereby increasing urinary excretion .
sodium acid phosphate	drug	amphetamine	drug
mechanism

DRUGA : DRUGN are inhibited by DRUGB .
Adrenergic blockers	group	amphetamines	group
false

DRUGN : DRUGA are inhibited by DRUGB .
Adrenergic blockers	group	amphetamines	group
effect

Alkalinizing agents : Gastrointestinal alkalinizing agents ( DRUGA , etc . ) increase absorption of DRUGB .
sodium bicarbonate	drug	amphetamines	drug
mechanism

Urinary alkalinizing agents ( DRUGA , some DRUGB ) increase the concentration of the non ionized species of the DRUGN molecule , thereby decreasing urinary excretion .
acetazolamide	drug	thiazides	group
false

Urinary alkalinizing agents ( DRUGA , some DRUGN ) increase the concentration of the non ionized species of the DRUGB molecule , thereby decreasing urinary excretion .
acetazolamide	drug	amphetamine	drug
mechanism

Urinary alkalinizing agents ( DRUGN , some DRUGA ) increase the concentration of the non ionized species of the DRUGB molecule , thereby decreasing urinary excretion .
thiazides	group	amphetamine	drug
mechanism

DRUGA , DRUGB : DRUGN may enhance the activity of DRUGN or DRUGN ;
Antidepressants	group	tricyclic	group
false

DRUGA , DRUGN : DRUGB may enhance the activity of DRUGN or DRUGN ;
Antidepressants	group	Amphetamines	group
false

DRUGA , DRUGN : DRUGN may enhance the activity of DRUGB or DRUGN ;
Antidepressants	group	tricyclic	group
false

DRUGA , DRUGN : DRUGN may enhance the activity of DRUGN or DRUGB ;
Antidepressants	group	sympathomimetic agents	group
false

DRUGN , DRUGA : DRUGB may enhance the activity of DRUGN or DRUGN ;
tricyclic	group	Amphetamines	group
false

DRUGN , DRUGA : DRUGN may enhance the activity of DRUGN or DRUGB ;
tricyclic	group	sympathomimetic agents	group
false

DRUGN , DRUGN : DRUGA may enhance the activity of DRUGB or DRUGN ;
Amphetamines	group	tricyclic	group
effect

DRUGN , DRUGN : DRUGA may enhance the activity of DRUGN or DRUGB ;
Amphetamines	group	sympathomimetic agents	group
effect

DRUGN , DRUGN : DRUGN may enhance the activity of DRUGA or DRUGB ;
tricyclic	group	sympathomimetic agents	group
false

DRUGA with DRUGB or DRUGN and possibly other DRUGN cause striking and sustained increases in the concentration of DRUGN in the brain ;
d-amphetamine	drug	desipramine	drug
mechanism

DRUGA with DRUGN or DRUGB and possibly other DRUGN cause striking and sustained increases in the concentration of DRUGN in the brain ;
d-amphetamine	drug	protriptyline	drug
mechanism

DRUGA with DRUGN or DRUGN and possibly other DRUGB cause striking and sustained increases in the concentration of DRUGN in the brain ;
d-amphetamine	drug	tricyclics	group
mechanism

DRUGN with DRUGA or DRUGB and possibly other DRUGN cause striking and sustained increases in the concentration of DRUGN in the brain ;
desipramine	drug	protriptyline	drug
false

DRUGN with DRUGA or DRUGN and possibly other DRUGB cause striking and sustained increases in the concentration of DRUGN in the brain ;
desipramine	drug	tricyclics	group
false

DRUGN with DRUGA or DRUGN and possibly other DRUGN cause striking and sustained increases in the concentration of DRUGB in the brain ;
desipramine	drug	d-amphetamine	drug
false

DRUGN with DRUGN or DRUGA and possibly other DRUGB cause striking and sustained increases in the concentration of DRUGN in the brain ;
protriptyline	drug	tricyclics	group
false

DRUGN with DRUGN or DRUGA and possibly other DRUGN cause striking and sustained increases in the concentration of DRUGB in the brain ;
protriptyline	drug	d-amphetamine	drug
false

DRUGN with DRUGN or DRUGN and possibly other DRUGA cause striking and sustained increases in the concentration of DRUGB in the brain ;
tricyclics	group	d-amphetamine	drug
false

DRUGA : DRUGB , as well as a metabolite of DRUGN , slow DRUGN metabolism .
MAO inhibitors	group	MAOI antidepressants	group
false

DRUGA : DRUGN , as well as a metabolite of DRUGB , slow DRUGN metabolism .
MAO inhibitors	group	furazolidone	drug
false

DRUGA : DRUGN , as well as a metabolite of DRUGN , slow DRUGB metabolism .
MAO inhibitors	group	amphetamine	group
false

DRUGN : DRUGA , as well as a metabolite of DRUGB , slow DRUGN metabolism .
MAOI antidepressants	group	furazolidone	drug
false

DRUGN : DRUGA , as well as a metabolite of DRUGN , slow DRUGB metabolism .
MAOI antidepressants	group	amphetamine	group
mechanism

DRUGN : DRUGN , as well as a metabolite of DRUGA , slow DRUGB metabolism .
furazolidone	drug	amphetamine	group
mechanism

DRUGA : DRUGB may counteract the sedative effect of DRUGN .
Antihistamines	group	Amphetamines	group
false

DRUGA : DRUGN may counteract the sedative effect of DRUGB .
Antihistamines	group	antihistamines	group
false

DRUGN : DRUGA may counteract the sedative effect of DRUGB .
Amphetamines	group	antihistamines	group
effect

DRUGA : DRUGB may antagonize the hypotensive effects of DRUGN .
Antihypertensives	group	Amphetamines	group
false

DRUGA : DRUGN may antagonize the hypotensive effects of DRUGB .
Antihypertensives	group	antihypertensives	group
false

DRUGN : DRUGA may antagonize the hypotensive effects of DRUGB .
Amphetamines	group	antihypertensives	group
effect

DRUGA : DRUGN blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of DRUGB , and can be used to treat DRUGN poisoning .
Chlorpromazine	drug	amphetamines	group
false

DRUGA : DRUGN blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of DRUGN , and can be used to treat DRUGB poisoning .
Chlorpromazine	drug	amphetamine	group
false

DRUGN : DRUGA blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of DRUGB , and can be used to treat DRUGN poisoning .
Chlorpromazine	drug	amphetamines	group
effect

DRUGN : DRUGA blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of DRUGN , and can be used to treat DRUGB poisoning .
Chlorpromazine	drug	amphetamine	group
false

DRUGN : DRUGN blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of DRUGA , and can be used to treat DRUGB poisoning .
amphetamines	group	amphetamine	group
false

DRUGA : DRUGB may delay intestinal absorption of DRUGN .
Ethosuximide	drug	Amphetamines	group
false

DRUGA : DRUGN may delay intestinal absorption of DRUGB .
Ethosuximide	drug	ethosuximide	drug
false

DRUGN : DRUGA may delay intestinal absorption of DRUGB .
Amphetamines	group	ethosuximide	drug
mechanism

DRUGA : DRUGN blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of DRUGB .
Haloperidol	drug	amphetamines	group
false

DRUGN : DRUGA blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of DRUGB .
Haloperidol	drug	amphetamines	group
effect

DRUGA : The stimulatory effects of DRUGB may be inhibited by DRUGN .
Lithium carbonate	drug	amphetamines	group
false

DRUGA : The stimulatory effects of DRUGN may be inhibited by DRUGB .
Lithium carbonate	drug	lithium carbonate	drug
false

DRUGN : The stimulatory effects of DRUGA may be inhibited by DRUGB .
amphetamines	group	lithium carbonate	drug
effect

DRUGA : DRUGB potentiate the analgesic effect of DRUGN .
Meperidine	drug	Amphetamines	group
false

DRUGA : DRUGN potentiate the analgesic effect of DRUGB .
Meperidine	drug	meperidine	drug
false

DRUGN : DRUGA potentiate the analgesic effect of DRUGB .
Amphetamines	group	meperidine	drug
effect

DRUGA therapy : Urinary excretion of DRUGB is increased , and efficacy is reduced , by DRUGN used in DRUGN therapy .
Methenamine	drug	amphetamines	group
false

DRUGA therapy : Urinary excretion of DRUGN is increased , and efficacy is reduced , by DRUGB used in DRUGN therapy .
Methenamine	drug	acidifying agents	group
false

DRUGA therapy : Urinary excretion of DRUGN is increased , and efficacy is reduced , by DRUGN used in DRUGB therapy .
Methenamine	drug	methenamine	drug
false

DRUGN therapy : Urinary excretion of DRUGA is increased , and efficacy is reduced , by DRUGB used in DRUGN therapy .
amphetamines	group	acidifying agents	group
mechanism

DRUGN therapy : Urinary excretion of DRUGA is increased , and efficacy is reduced , by DRUGN used in DRUGB therapy .
amphetamines	group	methenamine	drug
false

DRUGN therapy : Urinary excretion of DRUGN is increased , and efficacy is reduced , by DRUGA used in DRUGB therapy .
acidifying agents	group	methenamine	drug
false

DRUGA : DRUGB enhance the adrenergic effect of DRUGN .
Norepinephrine	drug	Amphetamines	group
false

DRUGA : DRUGN enhance the adrenergic effect of DRUGB .
Norepinephrine	drug	norepinephrine	drug
false

DRUGN : DRUGA enhance the adrenergic effect of DRUGB .
Amphetamines	group	norepinephrine	drug
effect

DRUGA : DRUGB may delay intestinal absorption of DRUGN ;
Phenobarbital	drug	Amphetamines	group
false

DRUGA : DRUGN may delay intestinal absorption of DRUGB ;
Phenobarbital	drug	phenobarbital	drug
false

DRUGN : DRUGA may delay intestinal absorption of DRUGB ;
Amphetamines	group	phenobarbital	drug
mechanism

DRUGA : DRUGB may delay intestinal absorption of DRUGN ;
Phenytoin	drug	Amphetamines	group
false

DRUGA : DRUGN may delay intestinal absorption of DRUGB ;
Phenytoin	drug	phenytoin	drug
false

DRUGN : DRUGA may delay intestinal absorption of DRUGB ;
Amphetamines	group	phenytoin	drug
mechanism

DRUGA : In cases of DRUGB overdosage , DRUGN CNS stimulation is potentiated and fatal convulsions can occur .
Propoxyphene	drug	propoxyphene	drug
false

DRUGA : In cases of DRUGN overdosage , DRUGB CNS stimulation is potentiated and fatal convulsions can occur .
Propoxyphene	drug	amphetamine	group
false

DRUGN : In cases of DRUGA overdosage , DRUGB CNS stimulation is potentiated and fatal convulsions can occur .
propoxyphene	drug	amphetamine	group
effect

DRUGA : DRUGB inhibit the hypotensive effect of DRUGN .
Veratrum alkaloids	group	Amphetamines	group
false

DRUGA : DRUGN inhibit the hypotensive effect of DRUGB .
Veratrum alkaloids	group	veratrum alkaloids	group
false

DRUGN : DRUGA inhibit the hypotensive effect of DRUGB .
Amphetamines	group	veratrum alkaloids	group
effect

Drug / Laboratory Test Interactions : DRUGA can cause a significant elevation in plasma DRUGB levels .
Amphetamines	group	corticosteroid	group
false

Additive depressant effect when used with general DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and other DRUGN .
anesthetics	group	sedatives	group
false

Additive depressant effect when used with general DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and other DRUGN .
anesthetics	group	antianxiety drugs	group
false

Additive depressant effect when used with general DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and other DRUGN .
anesthetics	group	hypnotics	group
false

Additive depressant effect when used with general DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and other DRUGN .
anesthetics	group	alcohol	drug
false

Additive depressant effect when used with general DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and other DRUGB .
anesthetics	group	opiate analgesics	group
false

Additive depressant effect when used with general DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and other DRUGN .
sedatives	group	antianxiety drugs	group
false

Additive depressant effect when used with general DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and other DRUGN .
sedatives	group	hypnotics	group
false

Additive depressant effect when used with general DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and other DRUGN .
sedatives	group	alcohol	drug
false

Additive depressant effect when used with general DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and other DRUGB .
sedatives	group	opiate analgesics	group
false

Additive depressant effect when used with general DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and other DRUGN .
antianxiety drugs	group	hypnotics	group
false

Additive depressant effect when used with general DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and other DRUGN .
antianxiety drugs	group	alcohol	drug
false

Additive depressant effect when used with general DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and other DRUGB .
antianxiety drugs	group	opiate analgesics	group
false

Additive depressant effect when used with general DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and other DRUGN .
hypnotics	group	alcohol	drug
false

Additive depressant effect when used with general DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and other DRUGB .
hypnotics	group	opiate analgesics	group
false

Additive depressant effect when used with general DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and other DRUGB .
alcohol	drug	opiate analgesics	group
false

May interact with thyroid medication ( e.g . , DRUGA ) , DRUGB containing products , DRUGN , DRUGN ( e.g . , DRUGN , DRUGN ) , and DRUGN ( e.g . , DRUGN , DRUGN ) .
levothyroxine	drug	iodine	drug
false

May interact with thyroid medication ( e.g . , DRUGA ) , DRUGN containing products , DRUGB , DRUGN ( e.g . , DRUGN , DRUGN ) , and DRUGN ( e.g . , DRUGN , DRUGN ) .
levothyroxine	drug	antacids	group
false

May interact with thyroid medication ( e.g . , DRUGA ) , DRUGN containing products , DRUGN , DRUGB ( e.g . , DRUGN , DRUGN ) , and DRUGN ( e.g . , DRUGN , DRUGN ) .
levothyroxine	drug	H2-antagonists	group
false

May interact with thyroid medication ( e.g . , DRUGA ) , DRUGN containing products , DRUGN , DRUGN ( e.g . , DRUGB , DRUGN ) , and DRUGN ( e.g . , DRUGN , DRUGN ) .
levothyroxine	drug	famotidine	drug
false

May interact with thyroid medication ( e.g . , DRUGA ) , DRUGN containing products , DRUGN , DRUGN ( e.g . , DRUGN , DRUGB ) , and DRUGN ( e.g . , DRUGN , DRUGN ) .
levothyroxine	drug	ranitidine	drug
false

May interact with thyroid medication ( e.g . , DRUGA ) , DRUGN containing products , DRUGN , DRUGN ( e.g . , DRUGN , DRUGN ) , and DRUGB ( e.g . , DRUGN , DRUGN ) .
levothyroxine	drug	proton pump inhibitors	group
false

May interact with thyroid medication ( e.g . , DRUGA ) , DRUGN containing products , DRUGN , DRUGN ( e.g . , DRUGN , DRUGN ) , and DRUGN ( e.g . , DRUGB , DRUGN ) .
levothyroxine	drug	lansoprazole	drug
false

May interact with thyroid medication ( e.g . , DRUGA ) , DRUGN containing products , DRUGN , DRUGN ( e.g . , DRUGN , DRUGN ) , and DRUGN ( e.g . , DRUGN , DRUGB ) .
levothyroxine	drug	omeprazole	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGA containing products , DRUGB , DRUGN ( e.g . , DRUGN , DRUGN ) , and DRUGN ( e.g . , DRUGN , DRUGN ) .
iodine	drug	antacids	group
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGA containing products , DRUGN , DRUGB ( e.g . , DRUGN , DRUGN ) , and DRUGN ( e.g . , DRUGN , DRUGN ) .
iodine	drug	H2-antagonists	group
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGA containing products , DRUGN , DRUGN ( e.g . , DRUGB , DRUGN ) , and DRUGN ( e.g . , DRUGN , DRUGN ) .
iodine	drug	famotidine	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGA containing products , DRUGN , DRUGN ( e.g . , DRUGN , DRUGB ) , and DRUGN ( e.g . , DRUGN , DRUGN ) .
iodine	drug	ranitidine	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGA containing products , DRUGN , DRUGN ( e.g . , DRUGN , DRUGN ) , and DRUGB ( e.g . , DRUGN , DRUGN ) .
iodine	drug	proton pump inhibitors	group
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGA containing products , DRUGN , DRUGN ( e.g . , DRUGN , DRUGN ) , and DRUGN ( e.g . , DRUGB , DRUGN ) .
iodine	drug	lansoprazole	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGA containing products , DRUGN , DRUGN ( e.g . , DRUGN , DRUGN ) , and DRUGN ( e.g . , DRUGN , DRUGB ) .
iodine	drug	omeprazole	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGA , DRUGB ( e.g . , DRUGN , DRUGN ) , and DRUGN ( e.g . , DRUGN , DRUGN ) .
antacids	group	H2-antagonists	group
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGA , DRUGN ( e.g . , DRUGB , DRUGN ) , and DRUGN ( e.g . , DRUGN , DRUGN ) .
antacids	group	famotidine	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGA , DRUGN ( e.g . , DRUGN , DRUGB ) , and DRUGN ( e.g . , DRUGN , DRUGN ) .
antacids	group	ranitidine	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGA , DRUGN ( e.g . , DRUGN , DRUGN ) , and DRUGB ( e.g . , DRUGN , DRUGN ) .
antacids	group	proton pump inhibitors	group
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGA , DRUGN ( e.g . , DRUGN , DRUGN ) , and DRUGN ( e.g . , DRUGB , DRUGN ) .
antacids	group	lansoprazole	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGA , DRUGN ( e.g . , DRUGN , DRUGN ) , and DRUGN ( e.g . , DRUGN , DRUGB ) .
antacids	group	omeprazole	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGN , DRUGA ( e.g . , DRUGB , DRUGN ) , and DRUGN ( e.g . , DRUGN , DRUGN ) .
H2-antagonists	group	famotidine	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGN , DRUGA ( e.g . , DRUGN , DRUGB ) , and DRUGN ( e.g . , DRUGN , DRUGN ) .
H2-antagonists	group	ranitidine	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGN , DRUGA ( e.g . , DRUGN , DRUGN ) , and DRUGB ( e.g . , DRUGN , DRUGN ) .
H2-antagonists	group	proton pump inhibitors	group
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGN , DRUGA ( e.g . , DRUGN , DRUGN ) , and DRUGN ( e.g . , DRUGB , DRUGN ) .
H2-antagonists	group	lansoprazole	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGN , DRUGA ( e.g . , DRUGN , DRUGN ) , and DRUGN ( e.g . , DRUGN , DRUGB ) .
H2-antagonists	group	omeprazole	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGN , DRUGN ( e.g . , DRUGA , DRUGB ) , and DRUGN ( e.g . , DRUGN , DRUGN ) .
famotidine	drug	ranitidine	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGN , DRUGN ( e.g . , DRUGA , DRUGN ) , and DRUGB ( e.g . , DRUGN , DRUGN ) .
famotidine	drug	proton pump inhibitors	group
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGN , DRUGN ( e.g . , DRUGA , DRUGN ) , and DRUGN ( e.g . , DRUGB , DRUGN ) .
famotidine	drug	lansoprazole	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGN , DRUGN ( e.g . , DRUGA , DRUGN ) , and DRUGN ( e.g . , DRUGN , DRUGB ) .
famotidine	drug	omeprazole	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGN , DRUGN ( e.g . , DRUGN , DRUGA ) , and DRUGB ( e.g . , DRUGN , DRUGN ) .
ranitidine	drug	proton pump inhibitors	group
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGN , DRUGN ( e.g . , DRUGN , DRUGA ) , and DRUGN ( e.g . , DRUGB , DRUGN ) .
ranitidine	drug	lansoprazole	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGN , DRUGN ( e.g . , DRUGN , DRUGA ) , and DRUGN ( e.g . , DRUGN , DRUGB ) .
ranitidine	drug	omeprazole	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGN , DRUGN ( e.g . , DRUGN , DRUGN ) , and DRUGA ( e.g . , DRUGB , DRUGN ) .
proton pump inhibitors	group	lansoprazole	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGN , DRUGN ( e.g . , DRUGN , DRUGN ) , and DRUGA ( e.g . , DRUGN , DRUGB ) .
proton pump inhibitors	group	omeprazole	drug
false

May interact with thyroid medication ( e.g . , DRUGN ) , DRUGN containing products , DRUGN , DRUGN ( e.g . , DRUGN , DRUGN ) , and DRUGN ( e.g . , DRUGA , DRUGB ) .
lansoprazole	drug	omeprazole	drug
false

Caution is advised in patients receiving concomitant high dose DRUGA and DRUGB , as anorexia , tachypnea , lethargy and coma have been rarely reported due to a possible drug interaction .
aspirin	brand	carbonic anhydrase inhibitors	group
advise

DRUGA : Concomitant administration of DRUGB and DRUGN is not recommended because DRUGN is displaced from its binding sites during the concomitant administration of DRUGN , resulting in lower plasma concentrations , peak plasma levels , and AUC values .
Aspirin	brand	diclofenac	drug
false

DRUGA : Concomitant administration of DRUGN and DRUGB is not recommended because DRUGN is displaced from its binding sites during the concomitant administration of DRUGN , resulting in lower plasma concentrations , peak plasma levels , and AUC values .
Aspirin	brand	aspirin	brand
false

DRUGA : Concomitant administration of DRUGN and DRUGN is not recommended because DRUGB is displaced from its binding sites during the concomitant administration of DRUGN , resulting in lower plasma concentrations , peak plasma levels , and AUC values .
Aspirin	brand	diclofenac	drug
false

DRUGA : Concomitant administration of DRUGN and DRUGN is not recommended because DRUGN is displaced from its binding sites during the concomitant administration of DRUGB , resulting in lower plasma concentrations , peak plasma levels , and AUC values .
Aspirin	brand	aspirin	brand
false

DRUGN : Concomitant administration of DRUGA and DRUGB is not recommended because DRUGN is displaced from its binding sites during the concomitant administration of DRUGN , resulting in lower plasma concentrations , peak plasma levels , and AUC values .
diclofenac	drug	aspirin	brand
advise

DRUGN : Concomitant administration of DRUGA and DRUGN is not recommended because DRUGN is displaced from its binding sites during the concomitant administration of DRUGB , resulting in lower plasma concentrations , peak plasma levels , and AUC values .
diclofenac	drug	aspirin	brand
false

DRUGN : Concomitant administration of DRUGN and DRUGA is not recommended because DRUGB is displaced from its binding sites during the concomitant administration of DRUGN , resulting in lower plasma concentrations , peak plasma levels , and AUC values .
aspirin	brand	diclofenac	drug
false

DRUGN : Concomitant administration of DRUGN and DRUGN is not recommended because DRUGA is displaced from its binding sites during the concomitant administration of DRUGB , resulting in lower plasma concentrations , peak plasma levels , and AUC values .
diclofenac	drug	aspirin	brand
mechanism

DRUGA : While studies have not shown DRUGB to interact with DRUGN , caution should be exercised , nonetheless , since interactions have been seen with other DRUGN .
Anticoagulants	group	diclofenac	drug
false

DRUGA : While studies have not shown DRUGN to interact with DRUGB , caution should be exercised , nonetheless , since interactions have been seen with other DRUGN .
Anticoagulants	group	anticoagulants of the warfarin type	group
false

DRUGA : While studies have not shown DRUGN to interact with DRUGN , caution should be exercised , nonetheless , since interactions have been seen with other DRUGB .
Anticoagulants	group	NSAIDs	group
false

DRUGN : While studies have not shown DRUGA to interact with DRUGB , caution should be exercised , nonetheless , since interactions have been seen with other DRUGN .
diclofenac	drug	anticoagulants of the warfarin type	group
false

DRUGN : While studies have not shown DRUGA to interact with DRUGN , caution should be exercised , nonetheless , since interactions have been seen with other DRUGB .
diclofenac	drug	NSAIDs	group
advise

DRUGN : While studies have not shown DRUGN to interact with DRUGA , caution should be exercised , nonetheless , since interactions have been seen with other DRUGB .
anticoagulants of the warfarin type	group	NSAIDs	group
false

DRUGA , DRUGB , DRUGN : DRUGN , like other DRUGN , may affect renal prostaglandins and increase the toxicity of certain drugs .
Digoxin	drug	Methotrexate	drug
false

DRUGA , DRUGN , DRUGB : DRUGN , like other DRUGN , may affect renal prostaglandins and increase the toxicity of certain drugs .
Digoxin	drug	Cyclosporine	drug
false

DRUGA , DRUGN , DRUGN : DRUGB , like other DRUGN , may affect renal prostaglandins and increase the toxicity of certain drugs .
Digoxin	drug	Diclofenac	drug
false

DRUGA , DRUGN , DRUGN : DRUGN , like other DRUGB , may affect renal prostaglandins and increase the toxicity of certain drugs .
Digoxin	drug	NSAIDs	group
false

DRUGN , DRUGA , DRUGB : DRUGN , like other DRUGN , may affect renal prostaglandins and increase the toxicity of certain drugs .
Methotrexate	drug	Cyclosporine	drug
false

DRUGN , DRUGA , DRUGN : DRUGB , like other DRUGN , may affect renal prostaglandins and increase the toxicity of certain drugs .
Methotrexate	drug	Diclofenac	drug
false

DRUGN , DRUGA , DRUGN : DRUGN , like other DRUGB , may affect renal prostaglandins and increase the toxicity of certain drugs .
Methotrexate	drug	NSAIDs	group
false

DRUGN , DRUGN , DRUGA : DRUGB , like other DRUGN , may affect renal prostaglandins and increase the toxicity of certain drugs .
Cyclosporine	drug	Diclofenac	drug
false

DRUGN , DRUGN , DRUGA : DRUGN , like other DRUGB , may affect renal prostaglandins and increase the toxicity of certain drugs .
Cyclosporine	drug	NSAIDs	group
false

DRUGN , DRUGN , DRUGN : DRUGA , like other DRUGB , may affect renal prostaglandins and increase the toxicity of certain drugs .
Diclofenac	drug	NSAIDs	group
false

Ingestion of DRUGA may increase serum concentrations of DRUGB and DRUGN and increase DRUGN s nephrotoxicity .
diclofenac	drug	digoxin	drug
mechanism

Ingestion of DRUGA may increase serum concentrations of DRUGN and DRUGB and increase DRUGN s nephrotoxicity .
diclofenac	drug	methotrexate	drug
mechanism

Ingestion of DRUGA may increase serum concentrations of DRUGN and DRUGN and increase DRUGB s nephrotoxicity .
diclofenac	drug	cyclosporine	drug
effect

Ingestion of DRUGN may increase serum concentrations of DRUGA and DRUGB and increase DRUGN s nephrotoxicity .
digoxin	drug	methotrexate	drug
false

Ingestion of DRUGN may increase serum concentrations of DRUGA and DRUGN and increase DRUGB s nephrotoxicity .
digoxin	drug	cyclosporine	drug
false

Ingestion of DRUGN may increase serum concentrations of DRUGN and DRUGA and increase DRUGB s nephrotoxicity .
methotrexate	drug	cyclosporine	drug
false

Patients who begin taking DRUGA or who increase their DRUGN dose or any other DRUGB while taking DRUGN , DRUGN , or DRUGN may develop toxicity characteristics for these drugs .
diclofenac	drug	NSAID	group
false

Patients who begin taking DRUGA or who increase their DRUGN dose or any other DRUGN while taking DRUGB , DRUGN , or DRUGN may develop toxicity characteristics for these drugs .
diclofenac	drug	digoxin	drug
effect

Patients who begin taking DRUGA or who increase their DRUGN dose or any other DRUGN while taking DRUGN , DRUGB , or DRUGN may develop toxicity characteristics for these drugs .
diclofenac	drug	methotrexate	drug
effect

Patients who begin taking DRUGA or who increase their DRUGN dose or any other DRUGN while taking DRUGN , DRUGN , or DRUGB may develop toxicity characteristics for these drugs .
diclofenac	drug	cyclosporine	drug
effect

Patients who begin taking DRUGN or who increase their DRUGA dose or any other DRUGB while taking DRUGN , DRUGN , or DRUGN may develop toxicity characteristics for these drugs .
diclofenac	drug	NSAID	group
false

Patients who begin taking DRUGN or who increase their DRUGA dose or any other DRUGN while taking DRUGB , DRUGN , or DRUGN may develop toxicity characteristics for these drugs .
diclofenac	drug	digoxin	drug
false

Patients who begin taking DRUGN or who increase their DRUGA dose or any other DRUGN while taking DRUGN , DRUGB , or DRUGN may develop toxicity characteristics for these drugs .
diclofenac	drug	methotrexate	drug
false

Patients who begin taking DRUGN or who increase their DRUGA dose or any other DRUGN while taking DRUGN , DRUGN , or DRUGB may develop toxicity characteristics for these drugs .
diclofenac	drug	cyclosporine	drug
false

Patients who begin taking DRUGN or who increase their DRUGN dose or any other DRUGA while taking DRUGB , DRUGN , or DRUGN may develop toxicity characteristics for these drugs .
NSAID	group	digoxin	drug
effect

Patients who begin taking DRUGN or who increase their DRUGN dose or any other DRUGA while taking DRUGN , DRUGB , or DRUGN may develop toxicity characteristics for these drugs .
NSAID	group	methotrexate	drug
effect

Patients who begin taking DRUGN or who increase their DRUGN dose or any other DRUGA while taking DRUGN , DRUGN , or DRUGB may develop toxicity characteristics for these drugs .
NSAID	group	cyclosporine	drug
effect

Patients who begin taking DRUGN or who increase their DRUGN dose or any other DRUGN while taking DRUGA , DRUGB , or DRUGN may develop toxicity characteristics for these drugs .
digoxin	drug	methotrexate	drug
false

Patients who begin taking DRUGN or who increase their DRUGN dose or any other DRUGN while taking DRUGA , DRUGN , or DRUGB may develop toxicity characteristics for these drugs .
digoxin	drug	cyclosporine	drug
false

Patients who begin taking DRUGN or who increase their DRUGN dose or any other DRUGN while taking DRUGN , DRUGA , or DRUGB may develop toxicity characteristics for these drugs .
methotrexate	drug	cyclosporine	drug
false

DRUGA : DRUGB decreases DRUGN renal clearance and increases DRUGN plasma levels .
Lithium	drug	Diclofenac	drug
false

DRUGA : DRUGN decreases DRUGB renal clearance and increases DRUGN plasma levels .
Lithium	drug	lithium	drug
false

DRUGA : DRUGN decreases DRUGN renal clearance and increases DRUGB plasma levels .
Lithium	drug	lithium	drug
false

DRUGN : DRUGA decreases DRUGB renal clearance and increases DRUGN plasma levels .
Diclofenac	drug	lithium	drug
mechanism

DRUGN : DRUGA decreases DRUGN renal clearance and increases DRUGB plasma levels .
Diclofenac	drug	lithium	drug
mechanism

In patients taking DRUGA and DRUGB concomitantly , DRUGN toxicity may develop .
diclofenac	drug	lithium	drug
effect

In patients taking DRUGA and DRUGN concomitantly , DRUGB toxicity may develop .
diclofenac	drug	lithium	drug
false

Oral DRUGA : DRUGB does not alter glucose metabolism in normal subjects nor does it alter the effects of oral DRUGN .
Hypoglycemics	group	Diclofenac	drug
false

Oral DRUGA : DRUGN does not alter glucose metabolism in normal subjects nor does it alter the effects of oral DRUGB .
Hypoglycemics	group	hypoglycemic agents	group
false

Oral DRUGN : DRUGA does not alter glucose metabolism in normal subjects nor does it alter the effects of oral DRUGB .
Diclofenac	drug	hypoglycemic agents	group
false

There are rare reports , however , from marketing experiences , of changes in effects of DRUGA or oral DRUGB in the presence of DRUGN that necessitated changes in the doses of such agents .
insulin	drug	hypoglycemic agents	group
false

There are rare reports , however , from marketing experiences , of changes in effects of DRUGA or oral DRUGN in the presence of DRUGB that necessitated changes in the doses of such agents .
insulin	drug	diclofenac	drug
effect

There are rare reports , however , from marketing experiences , of changes in effects of DRUGN or oral DRUGA in the presence of DRUGB that necessitated changes in the doses of such agents .
hypoglycemic agents	group	diclofenac	drug
effect

A direct causal relationship has not been established , but physicians should consider the possibility that DRUGA may alter a diabetic patient s response to DRUGB or oral DRUGN .
diclofenac	drug	insulin	drug
effect

A direct causal relationship has not been established , but physicians should consider the possibility that DRUGA may alter a diabetic patient s response to DRUGN or oral DRUGB .
diclofenac	drug	hypoglycemic agents	group
effect

A direct causal relationship has not been established , but physicians should consider the possibility that DRUGN may alter a diabetic patient s response to DRUGA or oral DRUGB .
insulin	drug	hypoglycemic agents	group
false

DRUGA : DRUGB and other DRUGN can inhibit the activity of DRUGN .
Diuretics	group	Diclofenac	drug
false

DRUGA : DRUGN and other DRUGB can inhibit the activity of DRUGN .
Diuretics	group	NSAIDs	group
false

DRUGA : DRUGN and other DRUGN can inhibit the activity of DRUGB .
Diuretics	group	diuretics	group
false

DRUGN : DRUGA and other DRUGB can inhibit the activity of DRUGN .
Diclofenac	drug	NSAIDs	group
false

DRUGN : DRUGA and other DRUGN can inhibit the activity of DRUGB .
Diclofenac	drug	diuretics	group
effect

DRUGN : DRUGN and other DRUGA can inhibit the activity of DRUGB .
NSAIDs	group	diuretics	group
effect

DRUGA toxicity has been reported to have occurred in a patient on chronic DRUGB treatment following the initiation of DRUGN therapy .
Phenobarbital	drug	phenobarbital	drug
false

DRUGA toxicity has been reported to have occurred in a patient on chronic DRUGN treatment following the initiation of DRUGB therapy .
Phenobarbital	drug	diclofenac	drug
false

DRUGN toxicity has been reported to have occurred in a patient on chronic DRUGA treatment following the initiation of DRUGB therapy .
phenobarbital	drug	diclofenac	drug
effect

Protein Binding In vitro , DRUGA interferes minimally or not at all with the protein binding of DRUGB ( dgb % decrease in binding ) , DRUGN , DRUGN ( dgb % decrease in binding ) , or DRUGN .
diclofenac	drug	salicylic acid	drug
mechanism

Protein Binding In vitro , DRUGA interferes minimally or not at all with the protein binding of DRUGN ( dgb % decrease in binding ) , DRUGB , DRUGN ( dgb % decrease in binding ) , or DRUGN .
diclofenac	drug	tolbutamide	drug
mechanism

Protein Binding In vitro , DRUGA interferes minimally or not at all with the protein binding of DRUGN ( dgb % decrease in binding ) , DRUGN , DRUGB ( dgb % decrease in binding ) , or DRUGN .
diclofenac	drug	prednisolone	drug
mechanism

Protein Binding In vitro , DRUGA interferes minimally or not at all with the protein binding of DRUGN ( dgb % decrease in binding ) , DRUGN , DRUGN ( dgb % decrease in binding ) , or DRUGB .
diclofenac	drug	warfarin	drug
mechanism

Protein Binding In vitro , DRUGN interferes minimally or not at all with the protein binding of DRUGA ( dgb % decrease in binding ) , DRUGB , DRUGN ( dgb % decrease in binding ) , or DRUGN .
salicylic acid	drug	tolbutamide	drug
false

Protein Binding In vitro , DRUGN interferes minimally or not at all with the protein binding of DRUGA ( dgb % decrease in binding ) , DRUGN , DRUGB ( dgb % decrease in binding ) , or DRUGN .
salicylic acid	drug	prednisolone	drug
false

Protein Binding In vitro , DRUGN interferes minimally or not at all with the protein binding of DRUGA ( dgb % decrease in binding ) , DRUGN , DRUGN ( dgb % decrease in binding ) , or DRUGB .
salicylic acid	drug	warfarin	drug
false

Protein Binding In vitro , DRUGN interferes minimally or not at all with the protein binding of DRUGN ( dgb % decrease in binding ) , DRUGA , DRUGB ( dgb % decrease in binding ) , or DRUGN .
tolbutamide	drug	prednisolone	drug
false

Protein Binding In vitro , DRUGN interferes minimally or not at all with the protein binding of DRUGN ( dgb % decrease in binding ) , DRUGA , DRUGN ( dgb % decrease in binding ) , or DRUGB .
tolbutamide	drug	warfarin	drug
false

Protein Binding In vitro , DRUGN interferes minimally or not at all with the protein binding of DRUGN ( dgb % decrease in binding ) , DRUGN , DRUGA ( dgb % decrease in binding ) , or DRUGB .
prednisolone	drug	warfarin	drug
false

DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
Benzylpenicillin	drug	ampicillin	drug
false

DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
Benzylpenicillin	drug	oxacillin	drug
false

DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
Benzylpenicillin	drug	chlortetracycline	drug
false

DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
Benzylpenicillin	drug	doxycycline	drug
false

DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
Benzylpenicillin	drug	cephalothin	drug
false

DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
Benzylpenicillin	drug	erythromycin	drug
false

DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB have no influence in vitro on the protein binding of DRUGN in human serum .
Benzylpenicillin	drug	sulfamethoxazole	drug
false

DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGB in human serum .
Benzylpenicillin	drug	diclofenac	drug
false

DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
ampicillin	drug	oxacillin	drug
false

DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
ampicillin	drug	chlortetracycline	drug
false

DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
ampicillin	drug	doxycycline	drug
false

DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
ampicillin	drug	cephalothin	drug
false

DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
ampicillin	drug	erythromycin	drug
false

DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB have no influence in vitro on the protein binding of DRUGN in human serum .
ampicillin	drug	sulfamethoxazole	drug
false

DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGB in human serum .
ampicillin	drug	diclofenac	drug
false

DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
oxacillin	drug	chlortetracycline	drug
false

DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
oxacillin	drug	doxycycline	drug
false

DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
oxacillin	drug	cephalothin	drug
false

DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
oxacillin	drug	erythromycin	drug
false

DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB have no influence in vitro on the protein binding of DRUGN in human serum .
oxacillin	drug	sulfamethoxazole	drug
false

DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGB in human serum .
oxacillin	drug	diclofenac	drug
false

DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
chlortetracycline	drug	doxycycline	drug
false

DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
chlortetracycline	drug	cephalothin	drug
false

DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
chlortetracycline	drug	erythromycin	drug
false

DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB have no influence in vitro on the protein binding of DRUGN in human serum .
chlortetracycline	drug	sulfamethoxazole	drug
false

DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGB in human serum .
chlortetracycline	drug	diclofenac	drug
false

DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
doxycycline	drug	cephalothin	drug
false

DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
doxycycline	drug	erythromycin	drug
false

DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB have no influence in vitro on the protein binding of DRUGN in human serum .
doxycycline	drug	sulfamethoxazole	drug
false

DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGB in human serum .
doxycycline	drug	diclofenac	drug
false

DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN have no influence in vitro on the protein binding of DRUGN in human serum .
cephalothin	drug	erythromycin	drug
false

DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB have no influence in vitro on the protein binding of DRUGN in human serum .
cephalothin	drug	sulfamethoxazole	drug
false

DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGN have no influence in vitro on the protein binding of DRUGB in human serum .
cephalothin	drug	diclofenac	drug
false

DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB have no influence in vitro on the protein binding of DRUGN in human serum .
erythromycin	drug	sulfamethoxazole	drug
false

DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGN have no influence in vitro on the protein binding of DRUGB in human serum .
erythromycin	drug	diclofenac	drug
false

DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGA have no influence in vitro on the protein binding of DRUGB in human serum .
sulfamethoxazole	drug	diclofenac	drug
false

DRUGA , a DRUGB , may antagonize the bactercidal effect of DRUGN and concurrent use of these drugs should be avoided .
Tetracycline	drug	bacteriostatic antibiotic	group
false

DRUGA , a DRUGN , may antagonize the bactercidal effect of DRUGB and concurrent use of these drugs should be avoided .
Tetracycline	drug	penicillin	drug
effect

DRUGN , a DRUGA , may antagonize the bactercidal effect of DRUGB and concurrent use of these drugs should be avoided .
bacteriostatic antibiotic	group	penicillin	drug
false

The following agents may increase certain actions or side effects of DRUGA . DRUGB DRUGN of class ( e.g . DRUGN ) , DRUGN DRUGN ( e.g . DRUGN ) , DRUGN .
anticholinergic drugs	group	amantadine	drug
false

The following agents may increase certain actions or side effects of DRUGA . DRUGN DRUGB of class ( e.g . DRUGN ) , DRUGN DRUGN ( e.g . DRUGN ) , DRUGN .
anticholinergic drugs	group	antiarrhythmic agents	group
false

The following agents may increase certain actions or side effects of DRUGA . DRUGN DRUGN of class ( e.g . DRUGB ) , DRUGN DRUGN ( e.g . DRUGN ) , DRUGN .
anticholinergic drugs	group	quinidine	drug
false

The following agents may increase certain actions or side effects of DRUGA . DRUGN DRUGN of class ( e.g . DRUGN ) , DRUGB DRUGN ( e.g . DRUGN ) , DRUGN .
anticholinergic drugs	group	antihistamines	group
false

The following agents may increase certain actions or side effects of DRUGA . DRUGN DRUGN of class ( e.g . DRUGN ) , DRUGN DRUGB ( e.g . DRUGN ) , DRUGN .
anticholinergic drugs	group	antipsychotic agents	group
false

The following agents may increase certain actions or side effects of DRUGA . DRUGN DRUGN of class ( e.g . DRUGN ) , DRUGN DRUGN ( e.g . DRUGB ) , DRUGN .
anticholinergic drugs	group	phenothiazines	group
false

The following agents may increase certain actions or side effects of DRUGA . DRUGN DRUGN of class ( e.g . DRUGN ) , DRUGN DRUGN ( e.g . DRUGN ) , DRUGB .
anticholinergic drugs	group	benzodiazepines	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGA DRUGB of class ( e.g . DRUGN ) , DRUGN DRUGN ( e.g . DRUGN ) , DRUGN .
amantadine	drug	antiarrhythmic agents	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGA DRUGN of class ( e.g . DRUGB ) , DRUGN DRUGN ( e.g . DRUGN ) , DRUGN .
amantadine	drug	quinidine	drug
false

The following agents may increase certain actions or side effects of DRUGN . DRUGA DRUGN of class ( e.g . DRUGN ) , DRUGB DRUGN ( e.g . DRUGN ) , DRUGN .
amantadine	drug	antihistamines	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGA DRUGN of class ( e.g . DRUGN ) , DRUGN DRUGB ( e.g . DRUGN ) , DRUGN .
amantadine	drug	antipsychotic agents	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGA DRUGN of class ( e.g . DRUGN ) , DRUGN DRUGN ( e.g . DRUGB ) , DRUGN .
amantadine	drug	phenothiazines	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGA DRUGN of class ( e.g . DRUGN ) , DRUGN DRUGN ( e.g . DRUGN ) , DRUGB .
amantadine	drug	benzodiazepines	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGN DRUGA of class ( e.g . DRUGB ) , DRUGN DRUGN ( e.g . DRUGN ) , DRUGN .
antiarrhythmic agents	group	quinidine	drug
false

The following agents may increase certain actions or side effects of DRUGN . DRUGN DRUGA of class ( e.g . DRUGN ) , DRUGB DRUGN ( e.g . DRUGN ) , DRUGN .
antiarrhythmic agents	group	antihistamines	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGN DRUGA of class ( e.g . DRUGN ) , DRUGN DRUGB ( e.g . DRUGN ) , DRUGN .
antiarrhythmic agents	group	antipsychotic agents	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGN DRUGA of class ( e.g . DRUGN ) , DRUGN DRUGN ( e.g . DRUGB ) , DRUGN .
antiarrhythmic agents	group	phenothiazines	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGN DRUGA of class ( e.g . DRUGN ) , DRUGN DRUGN ( e.g . DRUGN ) , DRUGB .
antiarrhythmic agents	group	benzodiazepines	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGN DRUGN of class ( e.g . DRUGA ) , DRUGB DRUGN ( e.g . DRUGN ) , DRUGN .
quinidine	drug	antihistamines	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGN DRUGN of class ( e.g . DRUGA ) , DRUGN DRUGB ( e.g . DRUGN ) , DRUGN .
quinidine	drug	antipsychotic agents	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGN DRUGN of class ( e.g . DRUGA ) , DRUGN DRUGN ( e.g . DRUGB ) , DRUGN .
quinidine	drug	phenothiazines	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGN DRUGN of class ( e.g . DRUGA ) , DRUGN DRUGN ( e.g . DRUGN ) , DRUGB .
quinidine	drug	benzodiazepines	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGN DRUGN of class ( e.g . DRUGN ) , DRUGA DRUGB ( e.g . DRUGN ) , DRUGN .
antihistamines	group	antipsychotic agents	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGN DRUGN of class ( e.g . DRUGN ) , DRUGA DRUGN ( e.g . DRUGB ) , DRUGN .
antihistamines	group	phenothiazines	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGN DRUGN of class ( e.g . DRUGN ) , DRUGA DRUGN ( e.g . DRUGN ) , DRUGB .
antihistamines	group	benzodiazepines	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGN DRUGN of class ( e.g . DRUGN ) , DRUGN DRUGA ( e.g . DRUGB ) , DRUGN .
antipsychotic agents	group	phenothiazines	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGN DRUGN of class ( e.g . DRUGN ) , DRUGN DRUGA ( e.g . DRUGN ) , DRUGB .
antipsychotic agents	group	benzodiazepines	group
false

The following agents may increase certain actions or side effects of DRUGN . DRUGN DRUGN of class ( e.g . DRUGN ) , DRUGN DRUGN ( e.g . DRUGA ) , DRUGB .
phenothiazines	group	benzodiazepines	group
false

DRUGA , DRUGB ( e.g . , DRUGN ) , DRUGN and DRUGN , DRUGN , DRUGN , and other drugs having anticholinergic activity .
MAO inhibitors	group	narcotic analgesics	group
false

DRUGA , DRUGN ( e.g . , DRUGB ) , DRUGN and DRUGN , DRUGN , DRUGN , and other drugs having anticholinergic activity .
MAO inhibitors	group	meperidine	drug
false

DRUGA , DRUGN ( e.g . , DRUGN ) , DRUGB and DRUGN , DRUGN , DRUGN , and other drugs having anticholinergic activity .
MAO inhibitors	group	nitrates	group
false

DRUGA , DRUGN ( e.g . , DRUGN ) , DRUGN and DRUGB , DRUGN , DRUGN , and other drugs having anticholinergic activity .
MAO inhibitors	group	nitrites	group
false

DRUGA , DRUGN ( e.g . , DRUGN ) , DRUGN and DRUGN , DRUGB , DRUGN , and other drugs having anticholinergic activity .
MAO inhibitors	group	sympathomimetic agents	group
false

DRUGA , DRUGN ( e.g . , DRUGN ) , DRUGN and DRUGN , DRUGN , DRUGB , and other drugs having anticholinergic activity .
MAO inhibitors	group	tricyclic antidepressants	group
false

DRUGN , DRUGA ( e.g . , DRUGB ) , DRUGN and DRUGN , DRUGN , DRUGN , and other drugs having anticholinergic activity .
narcotic analgesics	group	meperidine	drug
false

DRUGN , DRUGA ( e.g . , DRUGN ) , DRUGB and DRUGN , DRUGN , DRUGN , and other drugs having anticholinergic activity .
narcotic analgesics	group	nitrates	group
false

DRUGN , DRUGA ( e.g . , DRUGN ) , DRUGN and DRUGB , DRUGN , DRUGN , and other drugs having anticholinergic activity .
narcotic analgesics	group	nitrites	group
false

DRUGN , DRUGA ( e.g . , DRUGN ) , DRUGN and DRUGN , DRUGB , DRUGN , and other drugs having anticholinergic activity .
narcotic analgesics	group	sympathomimetic agents	group
false

DRUGN , DRUGA ( e.g . , DRUGN ) , DRUGN and DRUGN , DRUGN , DRUGB , and other drugs having anticholinergic activity .
narcotic analgesics	group	tricyclic antidepressants	group
false

DRUGN , DRUGN ( e.g . , DRUGA ) , DRUGB and DRUGN , DRUGN , DRUGN , and other drugs having anticholinergic activity .
meperidine	drug	nitrates	group
false

DRUGN , DRUGN ( e.g . , DRUGA ) , DRUGN and DRUGB , DRUGN , DRUGN , and other drugs having anticholinergic activity .
meperidine	drug	nitrites	group
false

DRUGN , DRUGN ( e.g . , DRUGA ) , DRUGN and DRUGN , DRUGB , DRUGN , and other drugs having anticholinergic activity .
meperidine	drug	sympathomimetic agents	group
false

DRUGN , DRUGN ( e.g . , DRUGA ) , DRUGN and DRUGN , DRUGN , DRUGB , and other drugs having anticholinergic activity .
meperidine	drug	tricyclic antidepressants	group
false

DRUGN , DRUGN ( e.g . , DRUGN ) , DRUGA and DRUGB , DRUGN , DRUGN , and other drugs having anticholinergic activity .
nitrates	group	nitrites	group
false

DRUGN , DRUGN ( e.g . , DRUGN ) , DRUGA and DRUGN , DRUGB , DRUGN , and other drugs having anticholinergic activity .
nitrates	group	sympathomimetic agents	group
false

DRUGN , DRUGN ( e.g . , DRUGN ) , DRUGA and DRUGN , DRUGN , DRUGB , and other drugs having anticholinergic activity .
nitrates	group	tricyclic antidepressants	group
false

DRUGN , DRUGN ( e.g . , DRUGN ) , DRUGN and DRUGA , DRUGB , DRUGN , and other drugs having anticholinergic activity .
nitrites	group	sympathomimetic agents	group
false

DRUGN , DRUGN ( e.g . , DRUGN ) , DRUGN and DRUGA , DRUGN , DRUGB , and other drugs having anticholinergic activity .
nitrites	group	tricyclic antidepressants	group
false

DRUGN , DRUGN ( e.g . , DRUGN ) , DRUGN and DRUGN , DRUGA , DRUGB , and other drugs having anticholinergic activity .
sympathomimetic agents	group	tricyclic antidepressants	group
false

DRUGA antagonize the effects of DRUGB .
Anticholinergics	group	antiglaucoma agents	group
false

DRUGA may affect gastrointestinal absorption of various drugs , such as slowly dissolving dosage forms of DRUGB ;
Anticholinergic agents	group	digoxin	drug
mechanism

DRUGA may antagonize the effects of the drugs that alter gastrointestinal motility , such as DRUGB .
Anticholinergic drugs	group	metoclopramide	drug
mechanism

Because DRUGA may interfere with the absorption of DRUGB , simultaneous use of these drugs should be avoided .
antacids	group	anticholinergic agents	group
mechanism

Neuropathy has occurred more frequently in patients with a history of neuropathy or neurotoxic drug therapy , including DRUGA , and these patients may be at increased risk of neuropathy during DRUGB therapy ( see ADVERSE REACTIONS ) .
stavudine	drug	VIDEX	brand
false

The effects of DRUGA on DRUGB pharmacokinetics in subjects with normal renal function are not known .
allopurinol	drug	didanosine	drug
false

DRUGA : Concomitant administration of DRUGB containing DRUGN or DRUGN with DRUGN Chewable / Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the DRUGN components .
Antacids	group	antacids	group
false

DRUGA : Concomitant administration of DRUGN containing DRUGB or DRUGN with DRUGN Chewable / Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the DRUGN components .
Antacids	group	magnesium	drug
false

DRUGA : Concomitant administration of DRUGN containing DRUGN or DRUGB with DRUGN Chewable / Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the DRUGN components .
Antacids	group	aluminum	drug
false

DRUGA : Concomitant administration of DRUGN containing DRUGN or DRUGN with DRUGB Chewable / Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the DRUGN components .
Antacids	group	VIDEX	brand
false

DRUGA : Concomitant administration of DRUGN containing DRUGN or DRUGN with DRUGN Chewable / Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the DRUGB components .
Antacids	group	antacid	group
false

DRUGN : Concomitant administration of DRUGA containing DRUGB or DRUGN with DRUGN Chewable / Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the DRUGN components .
antacids	group	magnesium	drug
false

DRUGN : Concomitant administration of DRUGA containing DRUGN or DRUGB with DRUGN Chewable / Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the DRUGN components .
antacids	group	aluminum	drug
false

DRUGN : Concomitant administration of DRUGA containing DRUGN or DRUGN with DRUGB Chewable / Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the DRUGN components .
antacids	group	VIDEX	brand
effect

DRUGN : Concomitant administration of DRUGA containing DRUGN or DRUGN with DRUGN Chewable / Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the DRUGB components .
antacids	group	antacid	group
false

DRUGN : Concomitant administration of DRUGN containing DRUGA or DRUGB with DRUGN Chewable / Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the DRUGN components .
magnesium	drug	aluminum	drug
false

DRUGN : Concomitant administration of DRUGN containing DRUGA or DRUGN with DRUGB Chewable / Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the DRUGN components .
magnesium	drug	VIDEX	brand
effect

DRUGN : Concomitant administration of DRUGN containing DRUGA or DRUGN with DRUGN Chewable / Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the DRUGB components .
magnesium	drug	antacid	group
false

DRUGN : Concomitant administration of DRUGN containing DRUGN or DRUGA with DRUGB Chewable / Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the DRUGN components .
aluminum	drug	VIDEX	brand
effect

DRUGN : Concomitant administration of DRUGN containing DRUGN or DRUGA with DRUGN Chewable / Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the DRUGB components .
aluminum	drug	antacid	group
false

DRUGN : Concomitant administration of DRUGN containing DRUGN or DRUGN with DRUGA Chewable / Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the DRUGB components .
VIDEX	brand	antacid	group
false

Drugs Whose Absorption Can Be Affected by the Level of Acidity in the Stomach : Drugs such as DRUGA and DRUGB should be administered at least dgb hours prior to dosing with DRUGN .
ketoconazole	drug	itraconazole	drug
false

Drugs Whose Absorption Can Be Affected by the Level of Acidity in the Stomach : Drugs such as DRUGA and DRUGN should be administered at least dgb hours prior to dosing with DRUGB .
ketoconazole	drug	VIDEX	brand
advise

Drugs Whose Absorption Can Be Affected by the Level of Acidity in the Stomach : Drugs such as DRUGN and DRUGA should be administered at least dgb hours prior to dosing with DRUGB .
itraconazole	drug	VIDEX	brand
advise

DRUGA : Administration of DRUGB dgb hours prior to or concurrent with oral DRUGN was associated with a dgb ( dgb ) % increase in the steady state AUC of DRUGN ( n = dgb ) .
Ganciclovir	drug	VIDEX	brand
false

DRUGA : Administration of DRUGN dgb hours prior to or concurrent with oral DRUGB was associated with a dgb ( dgb ) % increase in the steady state AUC of DRUGN ( n = dgb ) .
Ganciclovir	drug	ganciclovir	drug
false

DRUGA : Administration of DRUGN dgb hours prior to or concurrent with oral DRUGN was associated with a dgb ( dgb ) % increase in the steady state AUC of DRUGB ( n = dgb ) .
Ganciclovir	drug	didanosine	drug
false

DRUGN : Administration of DRUGA dgb hours prior to or concurrent with oral DRUGB was associated with a dgb ( dgb ) % increase in the steady state AUC of DRUGN ( n = dgb ) .
VIDEX	brand	ganciclovir	drug
mechanism

DRUGN : Administration of DRUGA dgb hours prior to or concurrent with oral DRUGN was associated with a dgb ( dgb ) % increase in the steady state AUC of DRUGB ( n = dgb ) .
VIDEX	brand	didanosine	drug
false

DRUGN : Administration of DRUGN dgb hours prior to or concurrent with oral DRUGA was associated with a dgb ( dgb ) % increase in the steady state AUC of DRUGB ( n = dgb ) .
ganciclovir	drug	didanosine	drug
false

DRUGA s : DRUGB should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGN , DRUGN , or DRUGN .
Quinolone Antibiotic	group	VIDEX	brand
false

DRUGA s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGB because plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGN , DRUGN , or DRUGN .
Quinolone Antibiotic	group	ciprofloxacin	drug
false

DRUGA s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGB are decreased when administered with DRUGN containing DRUGN , DRUGN , or DRUGN .
Quinolone Antibiotic	group	ciprofloxacin	drug
false

DRUGA s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGN are decreased when administered with DRUGB containing DRUGN , DRUGN , or DRUGN .
Quinolone Antibiotic	group	antacids	group
false

DRUGA s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGB , DRUGN , or DRUGN .
Quinolone Antibiotic	group	magnesium	drug
false

DRUGA s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGN , DRUGB , or DRUGN .
Quinolone Antibiotic	group	calcium	drug
false

DRUGA s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGN , DRUGN , or DRUGB .
Quinolone Antibiotic	group	aluminum	drug
false

DRUGN s : DRUGA should be administered at least dgb hours after or dgb hours before dosing with DRUGB because plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGN , DRUGN , or DRUGN .
VIDEX	brand	ciprofloxacin	drug
advise

DRUGN s : DRUGA should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGB are decreased when administered with DRUGN containing DRUGN , DRUGN , or DRUGN .
VIDEX	brand	ciprofloxacin	drug
false

DRUGN s : DRUGA should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGN are decreased when administered with DRUGB containing DRUGN , DRUGN , or DRUGN .
VIDEX	brand	antacids	group
false

DRUGN s : DRUGA should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGB , DRUGN , or DRUGN .
VIDEX	brand	magnesium	drug
false

DRUGN s : DRUGA should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGN , DRUGB , or DRUGN .
VIDEX	brand	calcium	drug
false

DRUGN s : DRUGA should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGN , DRUGN , or DRUGB .
VIDEX	brand	aluminum	drug
false

DRUGN s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGA because plasma concentrations of DRUGN are decreased when administered with DRUGB containing DRUGN , DRUGN , or DRUGN .
ciprofloxacin	drug	antacids	group
false

DRUGN s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGA because plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGB , DRUGN , or DRUGN .
ciprofloxacin	drug	magnesium	drug
false

DRUGN s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGA because plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGN , DRUGB , or DRUGN .
ciprofloxacin	drug	calcium	drug
false

DRUGN s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGA because plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGN , DRUGN , or DRUGB .
ciprofloxacin	drug	aluminum	drug
false

DRUGN s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGA are decreased when administered with DRUGB containing DRUGN , DRUGN , or DRUGN .
ciprofloxacin	drug	antacids	group
false

DRUGN s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGA are decreased when administered with DRUGN containing DRUGB , DRUGN , or DRUGN .
ciprofloxacin	drug	magnesium	drug
mechanism

DRUGN s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGA are decreased when administered with DRUGN containing DRUGN , DRUGB , or DRUGN .
ciprofloxacin	drug	calcium	drug
mechanism

DRUGN s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGA are decreased when administered with DRUGN containing DRUGN , DRUGN , or DRUGB .
ciprofloxacin	drug	aluminum	drug
mechanism

DRUGN s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGN are decreased when administered with DRUGA containing DRUGB , DRUGN , or DRUGN .
antacids	group	magnesium	drug
false

DRUGN s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGN are decreased when administered with DRUGA containing DRUGN , DRUGB , or DRUGN .
antacids	group	calcium	drug
false

DRUGN s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGN are decreased when administered with DRUGA containing DRUGN , DRUGN , or DRUGB .
antacids	group	aluminum	drug
false

DRUGN s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGA , DRUGB , or DRUGN .
magnesium	drug	calcium	drug
false

DRUGN s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGA , DRUGN , or DRUGB .
magnesium	drug	aluminum	drug
false

DRUGN s : DRUGN should be administered at least dgb hours after or dgb hours before dosing with DRUGN because plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGN , DRUGA , or DRUGB .
calcium	drug	aluminum	drug
false

The AUC of DRUGA was decreased an average of dgb fold in dgb healthy subjects given DRUGN and DRUGB placebo tablets concurrently .
ciprofloxacin	drug	didanosine	drug
false

The AUC of DRUGN was decreased an average of dgb fold in dgb healthy subjects given DRUGA and DRUGB placebo tablets concurrently .
ciprofloxacin	drug	didanosine	drug
mechanism

In a single subject given one dose of DRUGA dgb hours after a dose of DRUGB placebo tablets , a greater than dgb % reduction in the AUC of DRUGN was observed .
ciprofloxacin	drug	didanosine	drug
mechanism

In a single subject given one dose of DRUGN dgb hours after a dose of DRUGA placebo tablets , a greater than dgb % reduction in the AUC of DRUGB was observed .
didanosine	drug	ciprofloxacin	drug
false

Plasma concentrations of DRUGA are decreased when administered with DRUGB containing DRUGN , DRUGN , or DRUGN .
quinolone antibiotics	group	antacids	group
false

Plasma concentrations of DRUGA are decreased when administered with DRUGN containing DRUGB , DRUGN , or DRUGN .
quinolone antibiotics	group	magnesium	drug
mechanism

Plasma concentrations of DRUGA are decreased when administered with DRUGN containing DRUGN , DRUGB , or DRUGN .
quinolone antibiotics	group	calcium	drug
mechanism

Plasma concentrations of DRUGA are decreased when administered with DRUGN containing DRUGN , DRUGN , or DRUGB .
quinolone antibiotics	group	aluminum	drug
mechanism

Plasma concentrations of DRUGN are decreased when administered with DRUGA containing DRUGB , DRUGN , or DRUGN .
antacids	group	magnesium	drug
false

Plasma concentrations of DRUGN are decreased when administered with DRUGA containing DRUGN , DRUGB , or DRUGN .
antacids	group	calcium	drug
false

Plasma concentrations of DRUGN are decreased when administered with DRUGA containing DRUGN , DRUGN , or DRUGB .
antacids	group	aluminum	drug
false

Plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGA , DRUGB , or DRUGN .
magnesium	drug	calcium	drug
false

Plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGA , DRUGN , or DRUGB .
magnesium	drug	aluminum	drug
false

Plasma concentrations of DRUGN are decreased when administered with DRUGN containing DRUGN , DRUGA , or DRUGB .
calcium	drug	aluminum	drug
false

The optimal dosing interval for coadministration with DRUGA should be determined by consulting the appropriate DRUGB package insert .
VIDEX	brand	quinolone	group
false

Interactions with Other DRUGA : Significant decreases in the AUC of DRUGB ( dgb % ) and DRUGN ( dgb % ) occurred following simultaneous administration of these agents with DRUGN .
Antiretroviral Drugs	group	delavirdine	drug
false

Interactions with Other DRUGA : Significant decreases in the AUC of DRUGN ( dgb % ) and DRUGB ( dgb % ) occurred following simultaneous administration of these agents with DRUGN .
Antiretroviral Drugs	group	indinavir	drug
false

Interactions with Other DRUGA : Significant decreases in the AUC of DRUGN ( dgb % ) and DRUGN ( dgb % ) occurred following simultaneous administration of these agents with DRUGB .
Antiretroviral Drugs	group	VIDEX	brand
false

Interactions with Other DRUGN : Significant decreases in the AUC of DRUGA ( dgb % ) and DRUGB ( dgb % ) occurred following simultaneous administration of these agents with DRUGN .
delavirdine	drug	indinavir	drug
false

Interactions with Other DRUGN : Significant decreases in the AUC of DRUGA ( dgb % ) and DRUGN ( dgb % ) occurred following simultaneous administration of these agents with DRUGB .
delavirdine	drug	VIDEX	brand
mechanism

Interactions with Other DRUGN : Significant decreases in the AUC of DRUGN ( dgb % ) and DRUGA ( dgb % ) occurred following simultaneous administration of these agents with DRUGB .
indinavir	drug	VIDEX	brand
mechanism

To avoid this interaction , DRUGA or DRUGB should be given dgb hour prior to dosing with DRUGN .
delavirdine	drug	indinavir	drug
false

To avoid this interaction , DRUGA or DRUGN should be given dgb hour prior to dosing with DRUGB .
delavirdine	drug	VIDEX	brand
advise

To avoid this interaction , DRUGN or DRUGA should be given dgb hour prior to dosing with DRUGB .
indinavir	drug	VIDEX	brand
advise

The pharmacokinetics of DRUGA are not altered to a clinically significant degree when it is administered with a light meal dgb hour after DRUGB .
nelfinavir	drug	VIDEX	brand
false

Drug / Laboratory Test Interactions Certain endocrine and liver function tests may be affected by DRUGA containing oral DRUGB .
estrogen	group	contraceptives	group
false

DRUGA requirements ( i.e . , DRUGB ) may be altered .
Antidiabetic drug	group	insulin	drug
false

conversely , DRUGA may interfere with DRUGB ( i.e . , DRUGN , DRUGN ) .
diethylpropion	drug	antihypertensive drugs	group
int

conversely , DRUGA may interfere with DRUGN ( i.e . , DRUGB , DRUGN ) .
diethylpropion	drug	guanethidine	drug
int

conversely , DRUGA may interfere with DRUGN ( i.e . , DRUGN , DRUGB ) .
diethylpropion	drug	a-methyldopa	drug
int

conversely , DRUGN may interfere with DRUGA ( i.e . , DRUGB , DRUGN ) .
antihypertensive drugs	group	guanethidine	drug
false

conversely , DRUGN may interfere with DRUGA ( i.e . , DRUGN , DRUGB ) .
antihypertensive drugs	group	a-methyldopa	drug
false

conversely , DRUGN may interfere with DRUGN ( i.e . , DRUGA , DRUGB ) .
guanethidine	drug	a-methyldopa	drug
false

Concurrent use of DRUGA may antagonize the anorectic effect of DRUGB .
phenothiazines	group	diethylpropion	drug
effect

May interact DRUGA ( altered hypo prothrombinemic effect ) , DRUGB , DRUGN and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of DRUGN ) , DRUGN ( increased effect of DRUGN ) .
anticoagulants	group	barbiturates	group
false

May interact DRUGA ( altered hypo prothrombinemic effect ) , DRUGN , DRUGB and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of DRUGN ) , DRUGN ( increased effect of DRUGN ) .
anticoagulants	group	rifampin	drug
false

May interact DRUGA ( altered hypo prothrombinemic effect ) , DRUGN , DRUGN and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of DRUGB ) , DRUGN ( increased effect of DRUGN ) .
anticoagulants	group	diethylstilbestrol	drug
false

May interact DRUGA ( altered hypo prothrombinemic effect ) , DRUGN , DRUGN and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of DRUGN ) , DRUGB ( increased effect of DRUGN ) .
anticoagulants	group	corticosteroids	group
false

May interact DRUGA ( altered hypo prothrombinemic effect ) , DRUGN , DRUGN and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of DRUGN ) , DRUGN ( increased effect of DRUGB ) .
anticoagulants	group	corticosteroids	group
false

May interact DRUGN ( altered hypo prothrombinemic effect ) , DRUGA , DRUGB and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of DRUGN ) , DRUGN ( increased effect of DRUGN ) .
barbiturates	group	rifampin	drug
false

May interact DRUGN ( altered hypo prothrombinemic effect ) , DRUGA , DRUGN and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of DRUGB ) , DRUGN ( increased effect of DRUGN ) .
barbiturates	group	diethylstilbestrol	drug
false

May interact DRUGN ( altered hypo prothrombinemic effect ) , DRUGA , DRUGN and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of DRUGN ) , DRUGB ( increased effect of DRUGN ) .
barbiturates	group	corticosteroids	group
false

May interact DRUGN ( altered hypo prothrombinemic effect ) , DRUGA , DRUGN and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of DRUGN ) , DRUGN ( increased effect of DRUGB ) .
barbiturates	group	corticosteroids	group
false

May interact DRUGN ( altered hypo prothrombinemic effect ) , DRUGN , DRUGA and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of DRUGB ) , DRUGN ( increased effect of DRUGN ) .
rifampin	drug	diethylstilbestrol	drug
false

May interact DRUGN ( altered hypo prothrombinemic effect ) , DRUGN , DRUGA and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of DRUGN ) , DRUGB ( increased effect of DRUGN ) .
rifampin	drug	corticosteroids	group
false

May interact DRUGN ( altered hypo prothrombinemic effect ) , DRUGN , DRUGA and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of DRUGN ) , DRUGN ( increased effect of DRUGB ) .
rifampin	drug	corticosteroids	group
false

May interact DRUGN ( altered hypo prothrombinemic effect ) , DRUGN , DRUGN and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of DRUGA ) , DRUGB ( increased effect of DRUGN ) .
diethylstilbestrol	drug	corticosteroids	group
false

May interact DRUGN ( altered hypo prothrombinemic effect ) , DRUGN , DRUGN and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of DRUGA ) , DRUGN ( increased effect of DRUGB ) .
diethylstilbestrol	drug	corticosteroids	group
false

Oral DRUGA : In some normal volunteers , the concomitant administration of DRUGB and DRUGN , DRUGN , or DRUGN resulted in prolongation of prothrombin time .
Anticoagulants	group	diflunisal	drug
false

Oral DRUGA : In some normal volunteers , the concomitant administration of DRUGN and DRUGB , DRUGN , or DRUGN resulted in prolongation of prothrombin time .
Anticoagulants	group	warfarin	drug
false

Oral DRUGA : In some normal volunteers , the concomitant administration of DRUGN and DRUGN , DRUGB , or DRUGN resulted in prolongation of prothrombin time .
Anticoagulants	group	acenocoumarol	drug
false

Oral DRUGA : In some normal volunteers , the concomitant administration of DRUGN and DRUGN , DRUGN , or DRUGB resulted in prolongation of prothrombin time .
Anticoagulants	group	phenprocoumon	drug
false

Oral DRUGN : In some normal volunteers , the concomitant administration of DRUGA and DRUGB , DRUGN , or DRUGN resulted in prolongation of prothrombin time .
diflunisal	drug	warfarin	drug
effect

Oral DRUGN : In some normal volunteers , the concomitant administration of DRUGA and DRUGN , DRUGB , or DRUGN resulted in prolongation of prothrombin time .
diflunisal	drug	acenocoumarol	drug
effect

Oral DRUGN : In some normal volunteers , the concomitant administration of DRUGA and DRUGN , DRUGN , or DRUGB resulted in prolongation of prothrombin time .
diflunisal	drug	phenprocoumon	drug
effect

Oral DRUGN : In some normal volunteers , the concomitant administration of DRUGN and DRUGA , DRUGB , or DRUGN resulted in prolongation of prothrombin time .
warfarin	drug	acenocoumarol	drug
false

Oral DRUGN : In some normal volunteers , the concomitant administration of DRUGN and DRUGA , DRUGN , or DRUGB resulted in prolongation of prothrombin time .
warfarin	drug	phenprocoumon	drug
false

Oral DRUGN : In some normal volunteers , the concomitant administration of DRUGN and DRUGN , DRUGA , or DRUGB resulted in prolongation of prothrombin time .
acenocoumarol	drug	phenprocoumon	drug
false

This may occur because DRUGA competitively displaces DRUGB from protein binding sites .
diflunisal	drug	coumarins	group
mechanism

Accordingly , when DRUGA is administered with oral DRUGB , the prothrombin time should be closely monitored during and for several days after concomitant drug administration .
diflunisal	drug	anticoagulants	group
advise

DRUGA : In diabetic patients receiving DRUGB and DRUGN , no significant effects were seen on DRUGN plasma levels or fasting blood glucose .
Tolbutamide	drug	diflunisal	drug
false

DRUGA : In diabetic patients receiving DRUGN and DRUGB , no significant effects were seen on DRUGN plasma levels or fasting blood glucose .
Tolbutamide	drug	tolbutamide	drug
false

DRUGA : In diabetic patients receiving DRUGN and DRUGN , no significant effects were seen on DRUGB plasma levels or fasting blood glucose .
Tolbutamide	drug	tolbutamide	drug
false

DRUGN : In diabetic patients receiving DRUGA and DRUGB , no significant effects were seen on DRUGN plasma levels or fasting blood glucose .
diflunisal	drug	tolbutamide	drug
false

DRUGN : In diabetic patients receiving DRUGA and DRUGN , no significant effects were seen on DRUGB plasma levels or fasting blood glucose .
diflunisal	drug	tolbutamide	drug
false

DRUGA : In normal volunteers , concomitant administration of DRUGB and DRUGN resulted in significantly increased plasma levels of DRUGN .
Hydrochlorothiazide	drug	diflunisal	drug
false

DRUGA : In normal volunteers , concomitant administration of DRUGN and DRUGB resulted in significantly increased plasma levels of DRUGN .
Hydrochlorothiazide	drug	hydrochlorothiazide	drug
false

DRUGA : In normal volunteers , concomitant administration of DRUGN and DRUGN resulted in significantly increased plasma levels of DRUGB .
Hydrochlorothiazide	drug	hydrochlorothiazide	drug
false

DRUGN : In normal volunteers , concomitant administration of DRUGA and DRUGB resulted in significantly increased plasma levels of DRUGN .
diflunisal	drug	hydrochlorothiazide	drug
mechanism

DRUGN : In normal volunteers , concomitant administration of DRUGA and DRUGN resulted in significantly increased plasma levels of DRUGB .
diflunisal	drug	hydrochlorothiazide	drug
false

DRUGA decreased the hyperuricemic effect of DRUGB .
Diflunisal	drug	hydrochlorothiazide	drug
effect

DRUGA : In normal volunteers , the concomitant administration of DRUGB and DRUGN had no effect on the diuretic activity of DRUGN .
Furosemide	drug	diflunisal	drug
false

DRUGA : In normal volunteers , the concomitant administration of DRUGN and DRUGB had no effect on the diuretic activity of DRUGN .
Furosemide	drug	furosemide	drug
false

DRUGA : In normal volunteers , the concomitant administration of DRUGN and DRUGN had no effect on the diuretic activity of DRUGB .
Furosemide	drug	furosemide	drug
false

DRUGN : In normal volunteers , the concomitant administration of DRUGA and DRUGB had no effect on the diuretic activity of DRUGN .
diflunisal	drug	furosemide	drug
false

DRUGN : In normal volunteers , the concomitant administration of DRUGA and DRUGN had no effect on the diuretic activity of DRUGB .
diflunisal	drug	furosemide	drug
false

DRUGA decreased the hyperuricemic effect of DRUGB .
Diflunisal	drug	furosemide	drug
effect

DRUGA : Concomitant administration of DRUGB may reduce plasma levels of DRUGN .
Antacids	group	antacids	group
false

DRUGA : Concomitant administration of DRUGN may reduce plasma levels of DRUGB .
Antacids	group	diflunisal	drug
false

DRUGN : Concomitant administration of DRUGA may reduce plasma levels of DRUGB .
antacids	group	diflunisal	drug
mechanism

DRUGA : In normal volunteers , concomitant administration of DRUGB and DRUGN resulted in an approximate dgb % increase in plasma levels of DRUGN .
Acetaminophen	drug	diflunisal	drug
false

DRUGA : In normal volunteers , concomitant administration of DRUGN and DRUGB resulted in an approximate dgb % increase in plasma levels of DRUGN .
Acetaminophen	drug	acetaminophen	drug
false

DRUGA : In normal volunteers , concomitant administration of DRUGN and DRUGN resulted in an approximate dgb % increase in plasma levels of DRUGB .
Acetaminophen	drug	acetaminophen	drug
false

DRUGN : In normal volunteers , concomitant administration of DRUGA and DRUGB resulted in an approximate dgb % increase in plasma levels of DRUGN .
diflunisal	drug	acetaminophen	drug
mechanism

DRUGN : In normal volunteers , concomitant administration of DRUGA and DRUGN resulted in an approximate dgb % increase in plasma levels of DRUGB .
diflunisal	drug	acetaminophen	drug
false

DRUGA had no effect on plasma levels of DRUGB .
Acetaminophen	drug	diflunisal	drug
false

Since DRUGA in high doses has been associated with hepatotoxicity , concomitant administration of DRUGB and DRUGN should be used cautiously , with careful monitoring of patients .
acetaminophen	drug	diflunisal	drug
false

Since DRUGN in high doses has been associated with hepatotoxicity , concomitant administration of DRUGA and DRUGB should be used cautiously , with careful monitoring of patients .
diflunisal	drug	acetaminophen	drug
advise

DRUGA : Caution should be used if DRUGB is administered concomitantly with DRUGN .
Methotrexate	drug	diflunisal	drug
false

DRUGA : Caution should be used if DRUGN is administered concomitantly with DRUGB .
Methotrexate	drug	methotrexate	drug
false

DRUGN : Caution should be used if DRUGA is administered concomitantly with DRUGB .
diflunisal	drug	methotrexate	drug
advise

DRUGA have been reported to decrease the tubular secretion of DRUGB and to potentiate its toxicity .
Nonsteroidal anti-inflammatory drugs	group	methotrexate	drug
mechanism

DRUGA : Administration of DRUGB concomitantly with DRUGN has been associated with an increase in DRUGN induced toxicity , possibly due to decreased synthesis of renal prostacyclin .
Cyclosporine	drug	nonsteroial anti-inflammatory drugs	group
false

DRUGA : Administration of DRUGN concomitantly with DRUGB has been associated with an increase in DRUGN induced toxicity , possibly due to decreased synthesis of renal prostacyclin .
Cyclosporine	drug	cyclosporine	drug
false

DRUGA : Administration of DRUGN concomitantly with DRUGN has been associated with an increase in DRUGB induced toxicity , possibly due to decreased synthesis of renal prostacyclin .
Cyclosporine	drug	cyclosporine	drug
false

DRUGN : Administration of DRUGA concomitantly with DRUGB has been associated with an increase in DRUGN induced toxicity , possibly due to decreased synthesis of renal prostacyclin .
nonsteroial anti-inflammatory drugs	group	cyclosporine	drug
mechanism

DRUGN : Administration of DRUGA concomitantly with DRUGN has been associated with an increase in DRUGB induced toxicity , possibly due to decreased synthesis of renal prostacyclin .
nonsteroial anti-inflammatory drugs	group	cyclosporine	drug
false

DRUGA should be used with caution in patients taking DRUGB , and renal function should be carefully monitored .
NSAIDs	group	cyclosporine	drug
advise

DRUGA : The administration of DRUGB to normal volunteers receiving DRUGN decreased the renal clearance and significantly increased the plasma levels of DRUGN .
Nonsteroidal Anti-Inflammatory Drugs	group	diflunisal	drug
false

DRUGA : The administration of DRUGN to normal volunteers receiving DRUGB decreased the renal clearance and significantly increased the plasma levels of DRUGN .
Nonsteroidal Anti-Inflammatory Drugs	group	indomethacin	drug
false

DRUGA : The administration of DRUGN to normal volunteers receiving DRUGN decreased the renal clearance and significantly increased the plasma levels of DRUGB .
Nonsteroidal Anti-Inflammatory Drugs	group	indomethacin	drug
false

DRUGN : The administration of DRUGA to normal volunteers receiving DRUGB decreased the renal clearance and significantly increased the plasma levels of DRUGN .
diflunisal	drug	indomethacin	drug
mechanism

DRUGN : The administration of DRUGA to normal volunteers receiving DRUGN decreased the renal clearance and significantly increased the plasma levels of DRUGB .
diflunisal	drug	indomethacin	drug
false

In some patients the combined use of DRUGA and DRUGB has been associated with fatal gastrointestinal hemorrhage .
indomethacin	drug	diflunisal	drug
effect

Therefore , DRUGA and DRUGB should not be used concomitantly .
indomethacin	drug	diflunisal	drug
advise

The concomitant use of DRUGA tablets and other DRUGB is not recommended due to the increased possibility of gastrointestinal toxicity , with little or no increase in efficacy .
diflunisal	drug	NSAIDs	group
effect

DRUGA : In normal volunteers , a small decrease in DRUGB levels was observed when multiple doses of DRUGN and DRUGN were administered concomitantly .
Aspirin	brand	diflunisal	drug
false

DRUGA : In normal volunteers , a small decrease in DRUGN levels was observed when multiple doses of DRUGB and DRUGN were administered concomitantly .
Aspirin	brand	diflunisal	drug
false

DRUGA : In normal volunteers , a small decrease in DRUGN levels was observed when multiple doses of DRUGN and DRUGB were administered concomitantly .
Aspirin	brand	aspirin	brand
false

DRUGN : In normal volunteers , a small decrease in DRUGA levels was observed when multiple doses of DRUGN and DRUGB were administered concomitantly .
diflunisal	drug	aspirin	brand
false

DRUGN : In normal volunteers , a small decrease in DRUGN levels was observed when multiple doses of DRUGA and DRUGB were administered concomitantly .
diflunisal	drug	aspirin	brand
mechanism

DRUGA : The concomitant administration of DRUGB and DRUGN in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one third .
Sulindac	drug	diflunisal	drug
false

DRUGA : The concomitant administration of DRUGN and DRUGB in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one third .
Sulindac	drug	sulindac	drug
false

DRUGN : The concomitant administration of DRUGA and DRUGB in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one third .
diflunisal	drug	sulindac	drug
mechanism

DRUGA : The concomitant administration of DRUGB and DRUGN in normal volunteers had no effect on the plasma levels of DRUGN , but significantly decreased the urinary excretion of DRUGN and its glucuronide metabolite .
Naproxen	drug	diflunisal	drug
false

DRUGA : The concomitant administration of DRUGN and DRUGB in normal volunteers had no effect on the plasma levels of DRUGN , but significantly decreased the urinary excretion of DRUGN and its glucuronide metabolite .
Naproxen	drug	naproxen	drug
false

DRUGA : The concomitant administration of DRUGN and DRUGN in normal volunteers had no effect on the plasma levels of DRUGB , but significantly decreased the urinary excretion of DRUGN and its glucuronide metabolite .
Naproxen	drug	naproxen	drug
false

DRUGA : The concomitant administration of DRUGN and DRUGN in normal volunteers had no effect on the plasma levels of DRUGN , but significantly decreased the urinary excretion of DRUGB and its glucuronide metabolite .
Naproxen	drug	naproxen	drug
false

DRUGN : The concomitant administration of DRUGA and DRUGB in normal volunteers had no effect on the plasma levels of DRUGN , but significantly decreased the urinary excretion of DRUGN and its glucuronide metabolite .
diflunisal	drug	naproxen	drug
mechanism

DRUGN : The concomitant administration of DRUGA and DRUGN in normal volunteers had no effect on the plasma levels of DRUGB , but significantly decreased the urinary excretion of DRUGN and its glucuronide metabolite .
diflunisal	drug	naproxen	drug
false

DRUGN : The concomitant administration of DRUGA and DRUGN in normal volunteers had no effect on the plasma levels of DRUGN , but significantly decreased the urinary excretion of DRUGB and its glucuronide metabolite .
diflunisal	drug	naproxen	drug
false

DRUGA had no effect on plasma levels of DRUGB .
Naproxen	drug	diflunisal	drug
false

DRUGA are a major contributing factor to DRUGB toxicity .
Potassium-depleting diuretics	group	digitalis	group
effect

DRUGA and DRUGB ( and possibly other DRUGN ) and DRUGN may increase DRUGN absorption in patients who inactivate DRUGN by bacterial metabolism in the lower intestine , so that DRUGN intoxication may result .
Erythromycin	drug	clarithromycin	drug
false

DRUGA and DRUGN ( and possibly other DRUGB ) and DRUGN may increase DRUGN absorption in patients who inactivate DRUGN by bacterial metabolism in the lower intestine , so that DRUGN intoxication may result .
Erythromycin	drug	macrolide antibiotics	group
false

DRUGA and DRUGN ( and possibly other DRUGN ) and DRUGB may increase DRUGN absorption in patients who inactivate DRUGN by bacterial metabolism in the lower intestine , so that DRUGN intoxication may result .
Erythromycin	drug	tetracycline	drug
false

DRUGA and DRUGN ( and possibly other DRUGN ) and DRUGN may increase DRUGB absorption in patients who inactivate DRUGN by bacterial metabolism in the lower intestine , so that DRUGN intoxication may result .
Erythromycin	drug	digoxin	drug
mechanism

DRUGA and DRUGN ( and possibly other DRUGN ) and DRUGN may increase DRUGN absorption in patients who inactivate DRUGB by bacterial metabolism in the lower intestine , so that DRUGN intoxication may result .
Erythromycin	drug	digoxin	drug
false

DRUGA and DRUGN ( and possibly other DRUGN ) and DRUGN may increase DRUGN absorption in patients who inactivate DRUGN by bacterial metabolism in the lower intestine , so that DRUGB intoxication may result .
Erythromycin	drug	digitalis	group
false

DRUGN and DRUGA ( and possibly other DRUGB ) and DRUGN may increase DRUGN absorption in patients who inactivate DRUGN by bacterial metabolism in the lower intestine , so that DRUGN intoxication may result .
clarithromycin	drug	macrolide antibiotics	group
false

DRUGN and DRUGA ( and possibly other DRUGN ) and DRUGB may increase DRUGN absorption in patients who inactivate DRUGN by bacterial metabolism in the lower intestine , so that DRUGN intoxication may result .
clarithromycin	drug	tetracycline	drug
false

DRUGN and DRUGA ( and possibly other DRUGN ) and DRUGN may increase DRUGB absorption in patients who inactivate DRUGN by bacterial metabolism in the lower intestine , so that DRUGN intoxication may result .
clarithromycin	drug	digoxin	drug
mechanism

DRUGN and DRUGA ( and possibly other DRUGN ) and DRUGN may increase DRUGN absorption in patients who inactivate DRUGB by bacterial metabolism in the lower intestine , so that DRUGN intoxication may result .
clarithromycin	drug	digoxin	drug
false

DRUGN and DRUGA ( and possibly other DRUGN ) and DRUGN may increase DRUGN absorption in patients who inactivate DRUGN by bacterial metabolism in the lower intestine , so that DRUGB intoxication may result .
clarithromycin	drug	digitalis	group
false

DRUGN and DRUGN ( and possibly other DRUGA ) and DRUGB may increase DRUGN absorption in patients who inactivate DRUGN by bacterial metabolism in the lower intestine , so that DRUGN intoxication may result .
macrolide antibiotics	group	tetracycline	drug
false

DRUGN and DRUGN ( and possibly other DRUGA ) and DRUGN may increase DRUGB absorption in patients who inactivate DRUGN by bacterial metabolism in the lower intestine , so that DRUGN intoxication may result .
macrolide antibiotics	group	digoxin	drug
mechanism

DRUGN and DRUGN ( and possibly other DRUGA ) and DRUGN may increase DRUGN absorption in patients who inactivate DRUGB by bacterial metabolism in the lower intestine , so that DRUGN intoxication may result .
macrolide antibiotics	group	digoxin	drug
false

DRUGN and DRUGN ( and possibly other DRUGA ) and DRUGN may increase DRUGN absorption in patients who inactivate DRUGN by bacterial metabolism in the lower intestine , so that DRUGB intoxication may result .
macrolide antibiotics	group	digitalis	group
false

DRUGN and DRUGN ( and possibly other DRUGN ) and DRUGA may increase DRUGB absorption in patients who inactivate DRUGN by bacterial metabolism in the lower intestine , so that DRUGN intoxication may result .
tetracycline	drug	digoxin	drug
mechanism

DRUGN and DRUGN ( and possibly other DRUGN ) and DRUGA may increase DRUGN absorption in patients who inactivate DRUGB by bacterial metabolism in the lower intestine , so that DRUGN intoxication may result .
tetracycline	drug	digoxin	drug
false

DRUGN and DRUGN ( and possibly other DRUGN ) and DRUGA may increase DRUGN absorption in patients who inactivate DRUGN by bacterial metabolism in the lower intestine , so that DRUGB intoxication may result .
tetracycline	drug	digitalis	group
false

DRUGN and DRUGN ( and possibly other DRUGN ) and DRUGN may increase DRUGA absorption in patients who inactivate DRUGN by bacterial metabolism in the lower intestine , so that DRUGB intoxication may result .
digoxin	drug	digitalis	group
false

DRUGN and DRUGN ( and possibly other DRUGN ) and DRUGN may increase DRUGN absorption in patients who inactivate DRUGA by bacterial metabolism in the lower intestine , so that DRUGB intoxication may result .
digoxin	drug	digitalis	group
false

DRUGA and DRUGB , by decreasing gut motility , may increase DRUGN absorption .
Propantheline	drug	diphenoxylate	drug
false

DRUGA and DRUGN , by decreasing gut motility , may increase DRUGB absorption .
Propantheline	drug	digoxin	drug
mechanism

DRUGN and DRUGA , by decreasing gut motility , may increase DRUGB absorption .
diphenoxylate	drug	digoxin	drug
mechanism

DRUGA , DRUGB pectin , DRUGN , DRUGN , DRUGN , certain anticancer drugs , and DRUGN may interfere with intestinal DRUGN absorption , resulting in unexpectedly low serum concentrations .
Antacids	group	kaolin	drug
false

DRUGA , DRUGN pectin , DRUGB , DRUGN , DRUGN , certain anticancer drugs , and DRUGN may interfere with intestinal DRUGN absorption , resulting in unexpectedly low serum concentrations .
Antacids	group	sulfasalazine	drug
false

DRUGA , DRUGN pectin , DRUGN , DRUGB , DRUGN , certain anticancer drugs , and DRUGN may interfere with intestinal DRUGN absorption , resulting in unexpectedly low serum concentrations .
Antacids	group	neomycin	drug
false

DRUGA , DRUGN pectin , DRUGN , DRUGN , DRUGB , certain anticancer drugs , and DRUGN may interfere with intestinal DRUGN absorption , resulting in unexpectedly low serum concentrations .
Antacids	group	cholestyramine	drug
false

DRUGA , DRUGN pectin , DRUGN , DRUGN , DRUGN , certain anticancer drugs , and DRUGB may interfere with intestinal DRUGN absorption , resulting in unexpectedly low serum concentrations .
Antacids	group	metoclopramide	drug
false

DRUGA , DRUGN pectin , DRUGN , DRUGN , DRUGN , certain anticancer drugs , and DRUGN may interfere with intestinal DRUGB absorption , resulting in unexpectedly low serum concentrations .
Antacids	group	digoxin	drug
mechanism

DRUGN , DRUGA pectin , DRUGB , DRUGN , DRUGN , certain anticancer drugs , and DRUGN may interfere with intestinal DRUGN absorption , resulting in unexpectedly low serum concentrations .
kaolin	drug	sulfasalazine	drug
false

DRUGN , DRUGA pectin , DRUGN , DRUGB , DRUGN , certain anticancer drugs , and DRUGN may interfere with intestinal DRUGN absorption , resulting in unexpectedly low serum concentrations .
kaolin	drug	neomycin	drug
false

DRUGN , DRUGA pectin , DRUGN , DRUGN , DRUGB , certain anticancer drugs , and DRUGN may interfere with intestinal DRUGN absorption , resulting in unexpectedly low serum concentrations .
kaolin	drug	cholestyramine	drug
false

DRUGN , DRUGA pectin , DRUGN , DRUGN , DRUGN , certain anticancer drugs , and DRUGB may interfere with intestinal DRUGN absorption , resulting in unexpectedly low serum concentrations .
kaolin	drug	metoclopramide	drug
false

DRUGN , DRUGA pectin , DRUGN , DRUGN , DRUGN , certain anticancer drugs , and DRUGN may interfere with intestinal DRUGB absorption , resulting in unexpectedly low serum concentrations .
kaolin	drug	digoxin	drug
mechanism

DRUGN , DRUGN pectin , DRUGA , DRUGB , DRUGN , certain anticancer drugs , and DRUGN may interfere with intestinal DRUGN absorption , resulting in unexpectedly low serum concentrations .
sulfasalazine	drug	neomycin	drug
false

DRUGN , DRUGN pectin , DRUGA , DRUGN , DRUGB , certain anticancer drugs , and DRUGN may interfere with intestinal DRUGN absorption , resulting in unexpectedly low serum concentrations .
sulfasalazine	drug	cholestyramine	drug
false

DRUGN , DRUGN pectin , DRUGA , DRUGN , DRUGN , certain anticancer drugs , and DRUGB may interfere with intestinal DRUGN absorption , resulting in unexpectedly low serum concentrations .
sulfasalazine	drug	metoclopramide	drug
false

DRUGN , DRUGN pectin , DRUGA , DRUGN , DRUGN , certain anticancer drugs , and DRUGN may interfere with intestinal DRUGB absorption , resulting in unexpectedly low serum concentrations .
sulfasalazine	drug	digoxin	drug
mechanism

DRUGN , DRUGN pectin , DRUGN , DRUGA , DRUGB , certain anticancer drugs , and DRUGN may interfere with intestinal DRUGN absorption , resulting in unexpectedly low serum concentrations .
neomycin	drug	cholestyramine	drug
false

DRUGN , DRUGN pectin , DRUGN , DRUGA , DRUGN , certain anticancer drugs , and DRUGB may interfere with intestinal DRUGN absorption , resulting in unexpectedly low serum concentrations .
neomycin	drug	metoclopramide	drug
false

DRUGN , DRUGN pectin , DRUGN , DRUGA , DRUGN , certain anticancer drugs , and DRUGN may interfere with intestinal DRUGB absorption , resulting in unexpectedly low serum concentrations .
neomycin	drug	digoxin	drug
mechanism

DRUGN , DRUGN pectin , DRUGN , DRUGN , DRUGA , certain anticancer drugs , and DRUGB may interfere with intestinal DRUGN absorption , resulting in unexpectedly low serum concentrations .
cholestyramine	drug	metoclopramide	drug
false

DRUGN , DRUGN pectin , DRUGN , DRUGN , DRUGA , certain anticancer drugs , and DRUGN may interfere with intestinal DRUGB absorption , resulting in unexpectedly low serum concentrations .
cholestyramine	drug	digoxin	drug
mechanism

DRUGN , DRUGN pectin , DRUGN , DRUGN , DRUGN , certain anticancer drugs , and DRUGA may interfere with intestinal DRUGB absorption , resulting in unexpectedly low serum concentrations .
metoclopramide	drug	digoxin	drug
mechanism

DRUGA may decrease serum DRUGB concentration , especially in patients with renal dysfunction , by increasing the non renal clearance of DRUGN .
Rifampin	drug	digoxin	drug
mechanism

DRUGA may decrease serum DRUGN concentration , especially in patients with renal dysfunction , by increasing the non renal clearance of DRUGB .
Rifampin	drug	digoxin	drug
false

There have been inconsistent reports regarding the effects of other drugs ( e.g . , DRUGA , DRUGB ) on serum DRUGN concentration .
quinine	drug	penicillamine	drug
false

There have been inconsistent reports regarding the effects of other drugs ( e.g . , DRUGA , DRUGN ) on serum DRUGB concentration .
quinine	drug	digoxin	drug
false

There have been inconsistent reports regarding the effects of other drugs ( e.g . , DRUGN , DRUGA ) on serum DRUGB concentration .
penicillamine	drug	digoxin	drug
false

DRUGA administration to a digitalized , hypothyroid patient may increase the dose requirement of DRUGB .
Thyroid	group	digoxin	drug
advise

Concomitant use of DRUGA and DRUGB increases the risk of cardiac arrhythmias .
digoxin	drug	sympathomimetics	group
effect

Although DRUGA or DRUGB and DRUGN may be useful in combination to control atrial fibrillation , their additive effects on AV node conduction can result in advanced or complete heart block .
beta-adrenergic blockers	group	calcium channel blockers	group
false

Although DRUGA or DRUGN and DRUGB may be useful in combination to control atrial fibrillation , their additive effects on AV node conduction can result in advanced or complete heart block .
beta-adrenergic blockers	group	digoxin	drug
effect

Although DRUGN or DRUGA and DRUGB may be useful in combination to control atrial fibrillation , their additive effects on AV node conduction can result in advanced or complete heart block .
calcium channel blockers	group	digoxin	drug
effect

DRUGA : DRUGB ( DRUGN ) Injection , USP should not be used with DRUGN because the combination may cause synergistic elevation of blood pressure .
Vasoconstrictors	group	D.H.E. 45	brand
false

DRUGA : DRUGN ( DRUGB ) Injection , USP should not be used with DRUGN because the combination may cause synergistic elevation of blood pressure .
Vasoconstrictors	group	dihydroergotamine mesylate	drug
false

DRUGA : DRUGN ( DRUGN ) Injection , USP should not be used with DRUGB because the combination may cause synergistic elevation of blood pressure .
Vasoconstrictors	group	peripheral vasoconstrictors	group
false

DRUGN : DRUGA ( DRUGB ) Injection , USP should not be used with DRUGN because the combination may cause synergistic elevation of blood pressure .
D.H.E. 45	brand	dihydroergotamine mesylate	drug
false

DRUGN : DRUGA ( DRUGN ) Injection , USP should not be used with DRUGB because the combination may cause synergistic elevation of blood pressure .
D.H.E. 45	brand	peripheral vasoconstrictors	group
effect

DRUGN : DRUGN ( DRUGA ) Injection , USP should not be used with DRUGB because the combination may cause synergistic elevation of blood pressure .
dihydroergotamine mesylate	drug	peripheral vasoconstrictors	group
effect

DRUGA : DRUGN has been reported to cause coronary artery vasospasm , and its effect could be additive with DRUGB ( DRUGN ) Injection , USP .
Sumatriptan	drug	D.H.E. 45	brand
false

DRUGA : DRUGN has been reported to cause coronary artery vasospasm , and its effect could be additive with DRUGN ( DRUGB ) Injection , USP .
Sumatriptan	drug	dihydroergotamine mesylate	drug
false

DRUGN : DRUGA has been reported to cause coronary artery vasospasm , and its effect could be additive with DRUGB ( DRUGN ) Injection , USP .
Sumatriptan	drug	D.H.E. 45	brand
effect

DRUGN : DRUGA has been reported to cause coronary artery vasospasm , and its effect could be additive with DRUGN ( DRUGB ) Injection , USP .
Sumatriptan	drug	dihydroergotamine mesylate	drug
effect

DRUGN : DRUGN has been reported to cause coronary artery vasospasm , and its effect could be additive with DRUGA ( DRUGB ) Injection , USP .
D.H.E. 45	brand	dihydroergotamine mesylate	drug
false

DRUGA and DRUGB ( DRUGN ) Injection , USP should not be taken within dgb hours of each other..
Sumatriptan	drug	D.H.E. 45	brand
advise

DRUGA and DRUGN ( DRUGB ) Injection , USP should not be taken within dgb hours of each other..
Sumatriptan	drug	dihydroergotamine mesylate	drug
advise

DRUGN and DRUGA ( DRUGB ) Injection , USP should not be taken within dgb hours of each other..
D.H.E. 45	brand	dihydroergotamine mesylate	drug
false

DRUGA : DRUGN may provoke vasoconstriction in some patients , predisposing to a greater ischemic response to DRUGB therapy .
Nicotine	drug	ergot	drug
false

DRUGN : DRUGA may provoke vasoconstriction in some patients , predisposing to a greater ischemic response to DRUGB therapy .
Nicotine	drug	ergot	drug
effect

Vasospastic reactions have been reported with therapeutic doses of DRUGA containing drugs when co administered with these DRUGB .
ergotamine	drug	antibiotics	group
effect

DRUGA : Weakness hyperreflexia , and incoordination have been reported rarely when DRUGB have been co administered with DRUGN ( e. g .
SSRIs	group	5-HT1 agonists	group
false

DRUGN : Weakness hyperreflexia , and incoordination have been reported rarely when DRUGA have been co administered with DRUGB ( e. g .
5-HT1 agonists	group	SSRIs	group
effect

DRUGA , DRUGB , DRUGN , DRUGN ) .
fluoxetine	drug	fluvoxamine	drug
false

DRUGA , DRUGN , DRUGB , DRUGN ) .
fluoxetine	drug	paroxetine	drug
false

DRUGA , DRUGN , DRUGN , DRUGB ) .
fluoxetine	drug	sertraline	drug
false

DRUGN , DRUGA , DRUGB , DRUGN ) .
fluvoxamine	drug	paroxetine	drug
false

DRUGN , DRUGA , DRUGN , DRUGB ) .
fluvoxamine	drug	sertraline	drug
false

DRUGN , DRUGN , DRUGA , DRUGB ) .
paroxetine	drug	sertraline	drug
false

There have been no reported cases from spontaneous reports of drug interaction between DRUGA and DRUGB ( DRUGN ) Injection , USP .
SSRIs	group	D.H.E. 45	brand
false

There have been no reported cases from spontaneous reports of drug interaction between DRUGA and DRUGN ( DRUGB ) Injection , USP .
SSRIs	group	dihydroergotamine mesylate	drug
false

There have been no reported cases from spontaneous reports of drug interaction between DRUGN and DRUGA ( DRUGB ) Injection , USP .
D.H.E. 45	brand	dihydroergotamine mesylate	drug
false

Oral DRUGA : The effect of oral DRUGB on the pharmacokinetics of DRUGN ( DRUGN ) Injection , USP has not been studied .
Contraceptives	group	contraceptives	group
false

Oral DRUGA : The effect of oral DRUGN on the pharmacokinetics of DRUGB ( DRUGN ) Injection , USP has not been studied .
Contraceptives	group	D.H.E. 45	brand
false

Oral DRUGA : The effect of oral DRUGN on the pharmacokinetics of DRUGN ( DRUGB ) Injection , USP has not been studied .
Contraceptives	group	dihydroergotamine mesylate	drug
false

Oral DRUGN : The effect of oral DRUGA on the pharmacokinetics of DRUGB ( DRUGN ) Injection , USP has not been studied .
contraceptives	group	D.H.E. 45	brand
false

Oral DRUGN : The effect of oral DRUGA on the pharmacokinetics of DRUGN ( DRUGB ) Injection , USP has not been studied .
contraceptives	group	dihydroergotamine mesylate	drug
false

Oral DRUGN : The effect of oral DRUGN on the pharmacokinetics of DRUGA ( DRUGB ) Injection , USP has not been studied .
D.H.E. 45	brand	dihydroergotamine mesylate	drug
false

Administration of DRUGA to hypoparathyroid patients who are concurrently being treated with DRUGB may cause hypercalcemia .
thiazide diuretics	group	dihydrotachysterol	drug
effect

Pharmacologic studies indicate that there may be additive effects in prolonging AV conduction when using DRUGA or DRUGB concomitantly with DRUGN .
beta-blockers	group	digitalis	group
false

Pharmacologic studies indicate that there may be additive effects in prolonging AV conduction when using DRUGA or DRUGN concomitantly with DRUGB .
beta-blockers	group	Tiazac	brand
effect

Pharmacologic studies indicate that there may be additive effects in prolonging AV conduction when using DRUGN or DRUGA concomitantly with DRUGB .
digitalis	group	Tiazac	brand
effect

Administration of DRUGA concomitantly with DRUGB in five normal volunteers resulted in increased DRUGN levels in all subjects and bioavailability of DRUGN was increased approximately dgb % .
diltiazem hydrochloride	drug	propranolol	drug
mechanism

Administration of DRUGA concomitantly with DRUGN in five normal volunteers resulted in increased DRUGB levels in all subjects and bioavailability of DRUGN was increased approximately dgb % .
diltiazem hydrochloride	drug	propranolol	drug
false

Administration of DRUGA concomitantly with DRUGN in five normal volunteers resulted in increased DRUGN levels in all subjects and bioavailability of DRUGB was increased approximately dgb % .
diltiazem hydrochloride	drug	propranolol	drug
false

In vitro , DRUGA appears to be displaced from its binding sites by DRUGB .
propranolol	drug	diltiazem	drug
mechanism

The effect may be mediated by DRUGA s known inhibition of hepatic cytochrome P dgb , the enzyme system responsible for the first pass metabolism of DRUGB .
cimetidine	drug	diltiazem	drug
mechanism

Patients currently receiving DRUGA therapy should be carefully monitored for a change in pharmacological effect when initiating and discontinuing therapy with DRUGB .
diltiazem	drug	cimetidine	drug
advise

Administration of DRUGA with DRUGB in dgb healthy male subjects increased plasma DRUGN concentrations approximately dgb % .
diltiazem hydrochloride	drug	digoxin	drug
mechanism

Administration of DRUGA with DRUGN in dgb healthy male subjects increased plasma DRUGB concentrations approximately dgb % .
diltiazem hydrochloride	drug	digoxin	drug
false

Since there have been conflicting results regarding the effect of DRUGA levels , it is recommended that DRUGN levels be monitored when initiating , adjusting , and discontinuing DRUGB therapy to avoid possible over or under digitalization .
digoxin	drug	diltiazem hydrochloride	drug
false

Since there have been conflicting results regarding the effect of DRUGN levels , it is recommended that DRUGA levels be monitored when initiating , adjusting , and discontinuing DRUGB therapy to avoid possible over or under digitalization .
digoxin	drug	diltiazem hydrochloride	drug
advise

The depression of cardiac contractility , conductivity , and automaticity as well as the vascular dilation associated with DRUGA may be potentiated by DRUGB .
anesthetics	group	calcium channel blockers	group
effect

When used concomitantly , DRUGA and DRUGB should be titrated carefully .
anesthetics	group	calcium channel blockers	group
advise

A pharmacokinetic interaction between DRUGA and DRUGB has been observed during studies involving renal and cardiac transplant patients .
diltiazem	drug	cyclosporine	drug
int

In renal and cardiac transplant recipients , a reduction of DRUGA dose ranging from dgb % to dgb % was necessary to maintain DRUGN trough concentrations similar to those seen prior to the addition of DRUGB .
cyclosporine	drug	diltiazem	drug
mechanism

In renal and cardiac transplant recipients , a reduction of DRUGN dose ranging from dgb % to dgb % was necessary to maintain DRUGA trough concentrations similar to those seen prior to the addition of DRUGB .
cyclosporine	drug	diltiazem	drug
false

If these agents are to be administered concurrently , DRUGA concentrations should be monitored , especially when DRUGB therapy is initiated , adjusted , or discontinued .
cyclosporine	drug	diltiazem	drug
advise

The effect of DRUGA on DRUGB plasma concentrations has not been evaluated .
cyclosporine	drug	diltiazem	drug
false

Concomitant administration of DRUGA with DRUGB has been reported to result in elevated serum levels of DRUGN ( dgb % to dgb % increase ) , resulting in toxicity in some cases .
diltiazem	drug	carbamazepine	drug
mechanism

Concomitant administration of DRUGA with DRUGN has been reported to result in elevated serum levels of DRUGB ( dgb % to dgb % increase ) , resulting in toxicity in some cases .
diltiazem	drug	carbamazepine	drug
false

Studies showed that DRUGA increased the AUC of DRUGB and DRUGN by dgb dgb fold and the Cmax by dgb fold , compared to placebo .
diltiazem	drug	midazolam	drug
mechanism

Studies showed that DRUGA increased the AUC of DRUGN and DRUGB by dgb dgb fold and the Cmax by dgb fold , compared to placebo .
diltiazem	drug	triazolam	drug
mechanism

Studies showed that DRUGN increased the AUC of DRUGA and DRUGB by dgb dgb fold and the Cmax by dgb fold , compared to placebo .
midazolam	drug	triazolam	drug
false

The elimination half life of DRUGA and DRUGB also increased ( dga dga fold ) during coadministration with DRUGN .
midazolam	drug	triazolam	drug
false

The elimination half life of DRUGA and DRUGN also increased ( dga dga fold ) during coadministration with DRUGB .
midazolam	drug	diltiazem	drug
mechanism

The elimination half life of DRUGN and DRUGA also increased ( dga dga fold ) during coadministration with DRUGB .
triazolam	drug	diltiazem	drug
mechanism

These pharmacokinetic effects seen during DRUGA coadministration can result in increased clinical effects ( e.g . , prolonged sodation ) of both DRUGB and DRUGN .
diltiazem	drug	midazolam	drug
effect

These pharmacokinetic effects seen during DRUGA coadministration can result in increased clinical effects ( e.g . , prolonged sodation ) of both DRUGN and DRUGB .
diltiazem	drug	triazolam	drug
effect

These pharmacokinetic effects seen during DRUGN coadministration can result in increased clinical effects ( e.g . , prolonged sodation ) of both DRUGA and DRUGB .
midazolam	drug	triazolam	drug
false

In a ten subject study , coadministration of DRUGA ( dgb mg bid ) with DRUGB resulted in a dgb dgb times increase in mean DRUGN AUC and Cmax vs. DRUGN alone ;
diltiazem	drug	lovastatin	drug
mechanism

In a ten subject study , coadministration of DRUGA ( dgb mg bid ) with DRUGN resulted in a dgb dgb times increase in mean DRUGB AUC and Cmax vs. DRUGN alone ;
diltiazem	drug	lovastatin	drug
false

In a ten subject study , coadministration of DRUGA ( dgb mg bid ) with DRUGN resulted in a dgb dgb times increase in mean DRUGN AUC and Cmax vs. DRUGB alone ;
diltiazem	drug	lovastatin	drug
false

no change in DRUGA AUC and Cmax was observed during DRUGB coadministration .
pravastatin	drug	diltiazem	drug
false

DRUGA plasma levels were not significantly affected by DRUGB or DRUGN .
Diltiazem	drug	lovastatin	drug
false

DRUGA plasma levels were not significantly affected by DRUGN or DRUGB .
Diltiazem	drug	pravastatin	drug
false

DRUGN plasma levels were not significantly affected by DRUGA or DRUGB .
lovastatin	drug	pravastatin	drug
false

Coadministration of DRUGA with DRUGB lowered the DRUGN plasma concentrations to undetectable levels .
rifampin	drug	diltiazem	drug
mechanism

Coadministration of DRUGA with DRUGN lowered the DRUGB plasma concentrations to undetectable levels .
rifampin	drug	diltiazem	drug
false

Coadministration of DRUGA with DRUGB or any known CYPdgbAdgb inducer should be avoided when possible , and alternative therapy considered .
diltiazem	drug	rifampin	drug
advise

DRUGA may decrease DRUGB response to DRUGN .
Dimenhydrinate	drug	emetic	group
false

DRUGA may decrease DRUGN response to DRUGB .
Dimenhydrinate	drug	apomorphine	drug
effect

DRUGN may decrease DRUGA response to DRUGB .
emetic	group	apomorphine	drug
false

DRUGA or other DRUGB ( concurrent use with DRUGN may result in uterine hypertonus , possibly causing uterine rupture or cervical laceration , especially in the absence of adequate cervical dilatation ;
Oxytocin	drug	oxytocics	group
false

DRUGA or other DRUGN ( concurrent use with DRUGB may result in uterine hypertonus , possibly causing uterine rupture or cervical laceration , especially in the absence of adequate cervical dilatation ;
Oxytocin	drug	dinoprost	drug
effect

DRUGN or other DRUGA ( concurrent use with DRUGB may result in uterine hypertonus , possibly causing uterine rupture or cervical laceration , especially in the absence of adequate cervical dilatation ;
oxytocics	group	dinoprost	drug
effect

DRUGA may augment the activity of other DRUGB .
PROSTIN E2	brand	oxytocic drugs	group
effect

DRUGA has additive effects with DRUGB and other DRUGN ( DRUGN , DRUGN , DRUGN , etc ) .
Diphenhydramine hydrochloride	drug	alcohol	drug
effect

DRUGA has additive effects with DRUGN and other DRUGB ( DRUGN , DRUGN , DRUGN , etc ) .
Diphenhydramine hydrochloride	drug	CNS depressants	group
effect

DRUGA has additive effects with DRUGN and other DRUGN ( DRUGB , DRUGN , DRUGN , etc ) .
Diphenhydramine hydrochloride	drug	hypnotics	group
effect

DRUGA has additive effects with DRUGN and other DRUGN ( DRUGN , DRUGB , DRUGN , etc ) .
Diphenhydramine hydrochloride	drug	sedatives	group
effect

DRUGA has additive effects with DRUGN and other DRUGN ( DRUGN , DRUGN , DRUGB , etc ) .
Diphenhydramine hydrochloride	drug	tranquilizers	group
effect

DRUGN has additive effects with DRUGA and other DRUGB ( DRUGN , DRUGN , DRUGN , etc ) .
alcohol	drug	CNS depressants	group
false

DRUGN has additive effects with DRUGA and other DRUGN ( DRUGB , DRUGN , DRUGN , etc ) .
alcohol	drug	hypnotics	group
false

DRUGN has additive effects with DRUGA and other DRUGN ( DRUGN , DRUGB , DRUGN , etc ) .
alcohol	drug	sedatives	group
false

DRUGN has additive effects with DRUGA and other DRUGN ( DRUGN , DRUGN , DRUGB , etc ) .
alcohol	drug	tranquilizers	group
false

DRUGN has additive effects with DRUGN and other DRUGA ( DRUGB , DRUGN , DRUGN , etc ) .
CNS depressants	group	hypnotics	group
false

DRUGN has additive effects with DRUGN and other DRUGA ( DRUGN , DRUGB , DRUGN , etc ) .
CNS depressants	group	sedatives	group
false

DRUGN has additive effects with DRUGN and other DRUGA ( DRUGN , DRUGN , DRUGB , etc ) .
CNS depressants	group	tranquilizers	group
false

DRUGN has additive effects with DRUGN and other DRUGN ( DRUGA , DRUGB , DRUGN , etc ) .
hypnotics	group	sedatives	group
false

DRUGN has additive effects with DRUGN and other DRUGN ( DRUGA , DRUGN , DRUGB , etc ) .
hypnotics	group	tranquilizers	group
false

DRUGN has additive effects with DRUGN and other DRUGN ( DRUGN , DRUGA , DRUGB , etc ) .
sedatives	group	tranquilizers	group
false

DRUGA prolong and intensify the anticholinergic ( drying ) effects of DRUGB .
MAO inhibitors	group	antihistamines	group
effect

DRUGA or other medications with anticholinergic activity anticholinergic effects may be potentiated when these medications are used concurrently with DRUGB ;
anticholinergics	group	diphenidol	drug
false

DRUGA prior ingestion of DRUGB may decrease the DRUGN response to DRUGN in the treatment of poisoning .
apomorphine	drug	diphenidol	drug
false

DRUGA prior ingestion of DRUGN may decrease the DRUGB response to DRUGN in the treatment of poisoning .
apomorphine	drug	emetic	group
false

DRUGN prior ingestion of DRUGA may decrease the DRUGB response to DRUGN in the treatment of poisoning .
diphenidol	drug	emetic	group
false

DRUGN prior ingestion of DRUGA may decrease the DRUGN response to DRUGB in the treatment of poisoning .
diphenidol	drug	apomorphine	drug
effect

DRUGN prior ingestion of DRUGN may decrease the DRUGA response to DRUGB in the treatment of poisoning .
emetic	group	apomorphine	drug
false

Known drug interactions include DRUGA , DRUGB , and DRUGN .
barbiturates	group	tranquilizers	group
false

Known drug interactions include DRUGA , DRUGN , and DRUGB .
barbiturates	group	alcohol	drug
false

Known drug interactions include DRUGN , DRUGA , and DRUGB .
tranquilizers	group	alcohol	drug
false

DRUGA and DRUGB may interact with DRUGN In studies with male rats , DRUGN was found to inhibit the hepatic microsomal enzyme system at a dose of dgb mg / kg / day .
Diphenoxylate HCl	drug	atropine sulfate	drug
false

DRUGA and DRUGN may interact with DRUGB In studies with male rats , DRUGN was found to inhibit the hepatic microsomal enzyme system at a dose of dgb mg / kg / day .
Diphenoxylate HCl	drug	MAO inhibitors	group
int

DRUGA and DRUGN may interact with DRUGN In studies with male rats , DRUGB was found to inhibit the hepatic microsomal enzyme system at a dose of dgb mg / kg / day .
Diphenoxylate HCl	drug	diphenoxylate hydrochloride	drug
false

DRUGN and DRUGA may interact with DRUGB In studies with male rats , DRUGN was found to inhibit the hepatic microsomal enzyme system at a dose of dgb mg / kg / day .
atropine sulfate	drug	MAO inhibitors	group
int

DRUGN and DRUGA may interact with DRUGN In studies with male rats , DRUGB was found to inhibit the hepatic microsomal enzyme system at a dose of dgb mg / kg / day .
atropine sulfate	drug	diphenoxylate hydrochloride	drug
false

DRUGN and DRUGN may interact with DRUGA In studies with male rats , DRUGB was found to inhibit the hepatic microsomal enzyme system at a dose of dgb mg / kg / day .
MAO inhibitors	group	diphenoxylate hydrochloride	drug
false

No pharmacokinetic drug drug interaction studies were conducted with DRUGA ( DRUGB USP ) Tablets .
PERSANTINE	brand	dipyridamole	drug
false

DRUGA : DRUGB has been reported to increase the plasma levels and cardiovascular effects of DRUGN .
Adenosine	drug	Dipyridamole	drug
false

DRUGA : DRUGN has been reported to increase the plasma levels and cardiovascular effects of DRUGB .
Adenosine	drug	adenosine	drug
false

DRUGN : DRUGA has been reported to increase the plasma levels and cardiovascular effects of DRUGB .
Dipyridamole	drug	adenosine	drug
mechanism

DRUGA : DRUGB may counteract the anticholinesterase effect of DRUGN , thereby potentially aggravating myasthenia gravis .
Cholinesterase Inhibitors	group	Dipyridamole	drug
false

DRUGA : DRUGN may counteract the anticholinesterase effect of DRUGB , thereby potentially aggravating myasthenia gravis .
Cholinesterase Inhibitors	group	cholinesterase inhibitors	group
false

DRUGN : DRUGA may counteract the anticholinesterase effect of DRUGB , thereby potentially aggravating myasthenia gravis .
Dipyridamole	drug	cholinesterase inhibitors	group
effect

DRUGA : In a prospective study involving six healthy male volunteers , DRUGB did not affect the metabolism of DRUGN .
Terfenadine	drug	dirithromycin	drug
false

DRUGA : In a prospective study involving six healthy male volunteers , DRUGN did not affect the metabolism of DRUGB .
Terfenadine	drug	terfenadine	drug
false

DRUGN : In a prospective study involving six healthy male volunteers , DRUGA did not affect the metabolism of DRUGB .
dirithromycin	drug	terfenadine	drug
false

These six volunteers received DRUGA alone ( dgb mg twice daily ) for dgb days , followed by DRUGN in combination with DRUGB ( dgb mg once daily ) for dgb days .
terfenadine	drug	dirithromycin	drug
false

These six volunteers received DRUGN alone ( dgb mg twice daily ) for dgb days , followed by DRUGA in combination with DRUGB ( dgb mg once daily ) for dgb days .
terfenadine	drug	dirithromycin	drug
false

The pharmacokinetics of DRUGA and its acid metabolite and the electrocardiographic QT c interval were measured during both periods : with DRUGN alone , and with DRUGN plus DRUGB .
terfenadine	drug	dirithromycin	drug
false

The pharmacokinetics of DRUGN and its acid metabolite and the electrocardiographic QT c interval were measured during both periods : with DRUGA alone , and with DRUGN plus DRUGB .
terfenadine	drug	dirithromycin	drug
false

The pharmacokinetics of DRUGN and its acid metabolite and the electrocardiographic QT c interval were measured during both periods : with DRUGN alone , and with DRUGA plus DRUGB .
terfenadine	drug	dirithromycin	drug
false

in one man , the C max of DRUGA was dga ng / mL with DRUGN alone and dga ng / mL with DRUGN plus DRUGB .
terfenadine	drug	dirithromycin	drug
false

in one man , the C max of DRUGN was dga ng / mL with DRUGA alone and dga ng / mL with DRUGN plus DRUGB .
terfenadine	drug	dirithromycin	drug
false

in one man , the C max of DRUGN was dga ng / mL with DRUGN alone and dga ng / mL with DRUGA plus DRUGB .
terfenadine	drug	dirithromycin	drug
mechanism

The mean QT c interval ( msec ) was dgb with DRUGA alone and dgb with DRUGN plus DRUGB .
terfenadine	drug	dirithromycin	drug
false

The mean QT c interval ( msec ) was dgb with DRUGN alone and dgb with DRUGA plus DRUGB .
terfenadine	drug	dirithromycin	drug
effect

Also , in vitro experiments demonstrated a lack of interaction between DRUGA and DRUGB .
dirithromycin	drug	terfenadine	drug
false

Thus , the interaction observed between DRUGA and DRUGB is not expected for DRUGN .
erythromycin	drug	terfenadine	drug
int

Thus , the interaction observed between DRUGA and DRUGN is not expected for DRUGB .
erythromycin	drug	dirithromycin	drug
false

Thus , the interaction observed between DRUGN and DRUGA is not expected for DRUGB .
terfenadine	drug	dirithromycin	drug
false

Serious cardiac dysrhythmias , some resulting in death , have occurred in patients receiving DRUGA concomitantly with other DRUGB .
terfenadine	drug	macrolide antibiotics	group
effect

In general , most patients treated with DRUGA who are receiving concomitant DRUGB therapy may not require empiric adjustment of DRUGN dosage or monitoring of DRUGN plasma concentrations .
dirithromycin	drug	theophylline	drug
false

In general , most patients treated with DRUGA who are receiving concomitant DRUGN therapy may not require empiric adjustment of DRUGB dosage or monitoring of DRUGN plasma concentrations .
dirithromycin	drug	theophylline	drug
false

In general , most patients treated with DRUGA who are receiving concomitant DRUGN therapy may not require empiric adjustment of DRUGN dosage or monitoring of DRUGB plasma concentrations .
dirithromycin	drug	theophylline	drug
false

DRUGA or DRUGB : When DRUGN is administered immediately following DRUGN or DRUGN , the absorption of DRUGN is slightly enhanced .
Antacids	group	H 2 receptor antagonists	group
false

DRUGA or DRUGN : When DRUGB is administered immediately following DRUGN or DRUGN , the absorption of DRUGN is slightly enhanced .
Antacids	group	dirithromycin	drug
false

DRUGA or DRUGN : When DRUGN is administered immediately following DRUGB or DRUGN , the absorption of DRUGN is slightly enhanced .
Antacids	group	antacids	group
false

DRUGA or DRUGN : When DRUGN is administered immediately following DRUGN or DRUGB , the absorption of DRUGN is slightly enhanced .
Antacids	group	H 2 -receptor antagonists	group
false

DRUGA or DRUGN : When DRUGN is administered immediately following DRUGN or DRUGN , the absorption of DRUGB is slightly enhanced .
Antacids	group	dirithromycin	drug
false

DRUGN or DRUGA : When DRUGB is administered immediately following DRUGN or DRUGN , the absorption of DRUGN is slightly enhanced .
H 2 receptor antagonists	group	dirithromycin	drug
false

DRUGN or DRUGA : When DRUGN is administered immediately following DRUGB or DRUGN , the absorption of DRUGN is slightly enhanced .
H 2 receptor antagonists	group	antacids	group
false

DRUGN or DRUGA : When DRUGN is administered immediately following DRUGN or DRUGB , the absorption of DRUGN is slightly enhanced .
H 2 receptor antagonists	group	H 2 -receptor antagonists	group
false

DRUGN or DRUGA : When DRUGN is administered immediately following DRUGN or DRUGN , the absorption of DRUGB is slightly enhanced .
H 2 receptor antagonists	group	dirithromycin	drug
false

DRUGN or DRUGN : When DRUGA is administered immediately following DRUGB or DRUGN , the absorption of DRUGN is slightly enhanced .
dirithromycin	drug	antacids	group
mechanism

DRUGN or DRUGN : When DRUGA is administered immediately following DRUGN or DRUGB , the absorption of DRUGN is slightly enhanced .
dirithromycin	drug	H 2 -receptor antagonists	group
mechanism

DRUGN or DRUGN : When DRUGN is administered immediately following DRUGA or DRUGB , the absorption of DRUGN is slightly enhanced .
antacids	group	H 2 -receptor antagonists	group
false

DRUGN or DRUGN : When DRUGN is administered immediately following DRUGA or DRUGN , the absorption of DRUGB is slightly enhanced .
antacids	group	dirithromycin	drug
false

DRUGN or DRUGN : When DRUGN is administered immediately following DRUGN or DRUGA , the absorption of DRUGB is slightly enhanced .
H 2 -receptor antagonists	group	dirithromycin	drug
false

DRUGA : DRUGB has been reported to decrease the clearance of DRUGN and , thus , may increase the pharmacologic effect of DRUGN .
Triazolam	drug	Erythromycin	drug
false

DRUGA : DRUGN has been reported to decrease the clearance of DRUGB and , thus , may increase the pharmacologic effect of DRUGN .
Triazolam	drug	triazolam	drug
false

DRUGA : DRUGN has been reported to decrease the clearance of DRUGN and , thus , may increase the pharmacologic effect of DRUGB .
Triazolam	drug	triazolam	drug
false

DRUGN : DRUGA has been reported to decrease the clearance of DRUGB and , thus , may increase the pharmacologic effect of DRUGN .
Erythromycin	drug	triazolam	drug
mechanism

DRUGN : DRUGA has been reported to decrease the clearance of DRUGN and , thus , may increase the pharmacologic effect of DRUGB .
Erythromycin	drug	triazolam	drug
effect

DRUGA : Concomitant administration of DRUGB and DRUGN has been reported to result in elevated DRUGN serum levels .
Digoxin	drug	erythromycin	drug
false

DRUGA : Concomitant administration of DRUGN and DRUGB has been reported to result in elevated DRUGN serum levels .
Digoxin	drug	digoxin	drug
false

DRUGA : Concomitant administration of DRUGN and DRUGN has been reported to result in elevated DRUGB serum levels .
Digoxin	drug	digoxin	drug
false

DRUGN : Concomitant administration of DRUGA and DRUGB has been reported to result in elevated DRUGN serum levels .
erythromycin	drug	digoxin	drug
mechanism

DRUGN : Concomitant administration of DRUGA and DRUGN has been reported to result in elevated DRUGB serum levels .
erythromycin	drug	digoxin	drug
false

DRUGA : There have been reports of increased anticoagulant effects when DRUGB and oral DRUGN were used concomitantly .
Anticoagulants	group	erythromycin	drug
false

DRUGA : There have been reports of increased anticoagulant effects when DRUGN and oral DRUGB were used concomitantly .
Anticoagulants	group	anticoagulants	group
false

DRUGN : There have been reports of increased anticoagulant effects when DRUGA and oral DRUGB were used concomitantly .
erythromycin	drug	anticoagulants	group
effect

DRUGA : Concurrent use of DRUGB and DRUGN or DRUGN has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
Ergotamine	drug	erythromycin	drug
false

DRUGA : Concurrent use of DRUGN and DRUGB or DRUGN has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
Ergotamine	drug	ergotamine	drug
false

DRUGA : Concurrent use of DRUGN and DRUGN or DRUGB has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
Ergotamine	drug	dihydroergotamine	drug
false

DRUGN : Concurrent use of DRUGA and DRUGB or DRUGN has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
erythromycin	drug	ergotamine	drug
effect

DRUGN : Concurrent use of DRUGA and DRUGN or DRUGB has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
erythromycin	drug	dihydroergotamine	drug
effect

DRUGN : Concurrent use of DRUGN and DRUGA or DRUGB has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
ergotamine	drug	dihydroergotamine	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGA and other medications , including DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	cyclosporine	drug
int

Other drugs Drug interactions have been reported with concomitant administration of DRUGA and other medications , including DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	hexobarbital	drug
int

Other drugs Drug interactions have been reported with concomitant administration of DRUGA and other medications , including DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	carbamazepine	drug
int

Other drugs Drug interactions have been reported with concomitant administration of DRUGA and other medications , including DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	alfentanil	drug
int

Other drugs Drug interactions have been reported with concomitant administration of DRUGA and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	disopyramide	drug
int

Other drugs Drug interactions have been reported with concomitant administration of DRUGA and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	phenytoin	drug
int

Other drugs Drug interactions have been reported with concomitant administration of DRUGA and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	bromocriptine	drug
int

Other drugs Drug interactions have been reported with concomitant administration of DRUGA and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
erythromycin	drug	valproate	drug
int

Other drugs Drug interactions have been reported with concomitant administration of DRUGA and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
erythromycin	drug	astemizole	drug
int

Other drugs Drug interactions have been reported with concomitant administration of DRUGA and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
erythromycin	drug	lovastatin	drug
int

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
cyclosporine	drug	hexobarbital	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
cyclosporine	drug	carbamazepine	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
cyclosporine	drug	alfentanil	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
cyclosporine	drug	disopyramide	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
cyclosporine	drug	phenytoin	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
cyclosporine	drug	bromocriptine	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
cyclosporine	drug	valproate	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
cyclosporine	drug	astemizole	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
cyclosporine	drug	lovastatin	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
hexobarbital	drug	carbamazepine	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
hexobarbital	drug	alfentanil	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
hexobarbital	drug	disopyramide	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
hexobarbital	drug	phenytoin	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
hexobarbital	drug	bromocriptine	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
hexobarbital	drug	valproate	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
hexobarbital	drug	astemizole	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
hexobarbital	drug	lovastatin	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
carbamazepine	drug	alfentanil	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
carbamazepine	drug	disopyramide	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
carbamazepine	drug	phenytoin	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
carbamazepine	drug	bromocriptine	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
carbamazepine	drug	valproate	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
carbamazepine	drug	astemizole	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
carbamazepine	drug	lovastatin	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
alfentanil	drug	disopyramide	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
alfentanil	drug	phenytoin	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
alfentanil	drug	bromocriptine	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
alfentanil	drug	valproate	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
alfentanil	drug	astemizole	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
alfentanil	drug	lovastatin	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
disopyramide	drug	phenytoin	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
disopyramide	drug	bromocriptine	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
disopyramide	drug	valproate	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
disopyramide	drug	astemizole	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
disopyramide	drug	lovastatin	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
phenytoin	drug	bromocriptine	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
phenytoin	drug	valproate	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
phenytoin	drug	astemizole	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
phenytoin	drug	lovastatin	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
bromocriptine	drug	valproate	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
bromocriptine	drug	astemizole	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
bromocriptine	drug	lovastatin	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
valproate	drug	astemizole	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
valproate	drug	lovastatin	drug
false

Other drugs Drug interactions have been reported with concomitant administration of DRUGN and other medications , including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
astemizole	drug	lovastatin	drug
false

If DRUGA or other hepatic enzyme inducers are taken concurrently with DRUGB or DRUGN , lower plasma levels of DRUGN may occur .
phenytoin	drug	Norpace	brand
mechanism

If DRUGA or other hepatic enzyme inducers are taken concurrently with DRUGN or DRUGB , lower plasma levels of DRUGN may occur .
phenytoin	drug	Norpace CR	brand
mechanism

If DRUGA or other hepatic enzyme inducers are taken concurrently with DRUGN or DRUGN , lower plasma levels of DRUGB may occur .
phenytoin	drug	disopyramide	drug
false

If DRUGN or other hepatic enzyme inducers are taken concurrently with DRUGA or DRUGB , lower plasma levels of DRUGN may occur .
Norpace	brand	Norpace CR	brand
false

If DRUGN or other hepatic enzyme inducers are taken concurrently with DRUGA or DRUGN , lower plasma levels of DRUGB may occur .
Norpace	brand	disopyramide	drug
false

If DRUGN or other hepatic enzyme inducers are taken concurrently with DRUGN or DRUGA , lower plasma levels of DRUGB may occur .
Norpace CR	brand	disopyramide	drug
false

Other DRUGA ( eg , DRUGB , DRUGN , DRUGN , DRUGN ) have occasionally been used concurrently with DRUGN .
antiarrhythmic drugs	group	quinidine	drug
false

Other DRUGA ( eg , DRUGN , DRUGB , DRUGN , DRUGN ) have occasionally been used concurrently with DRUGN .
antiarrhythmic drugs	group	procainamide	drug
false

Other DRUGA ( eg , DRUGN , DRUGN , DRUGB , DRUGN ) have occasionally been used concurrently with DRUGN .
antiarrhythmic drugs	group	lidocaine	drug
false

Other DRUGA ( eg , DRUGN , DRUGN , DRUGN , DRUGB ) have occasionally been used concurrently with DRUGN .
antiarrhythmic drugs	group	propranolol	drug
false

Other DRUGA ( eg , DRUGN , DRUGN , DRUGN , DRUGN ) have occasionally been used concurrently with DRUGB .
antiarrhythmic drugs	group	Norpace	brand
false

Other DRUGN ( eg , DRUGA , DRUGB , DRUGN , DRUGN ) have occasionally been used concurrently with DRUGN .
quinidine	drug	procainamide	drug
false

Other DRUGN ( eg , DRUGA , DRUGN , DRUGB , DRUGN ) have occasionally been used concurrently with DRUGN .
quinidine	drug	lidocaine	drug
false

Other DRUGN ( eg , DRUGA , DRUGN , DRUGN , DRUGB ) have occasionally been used concurrently with DRUGN .
quinidine	drug	propranolol	drug
false

Other DRUGN ( eg , DRUGA , DRUGN , DRUGN , DRUGN ) have occasionally been used concurrently with DRUGB .
quinidine	drug	Norpace	brand
false

Other DRUGN ( eg , DRUGN , DRUGA , DRUGB , DRUGN ) have occasionally been used concurrently with DRUGN .
procainamide	drug	lidocaine	drug
false

Other DRUGN ( eg , DRUGN , DRUGA , DRUGN , DRUGB ) have occasionally been used concurrently with DRUGN .
procainamide	drug	propranolol	drug
false

Other DRUGN ( eg , DRUGN , DRUGA , DRUGN , DRUGN ) have occasionally been used concurrently with DRUGB .
procainamide	drug	Norpace	brand
false

Other DRUGN ( eg , DRUGN , DRUGN , DRUGA , DRUGB ) have occasionally been used concurrently with DRUGN .
lidocaine	drug	propranolol	drug
false

Other DRUGN ( eg , DRUGN , DRUGN , DRUGA , DRUGN ) have occasionally been used concurrently with DRUGB .
lidocaine	drug	Norpace	brand
false

Other DRUGN ( eg , DRUGN , DRUGN , DRUGN , DRUGA ) have occasionally been used concurrently with DRUGB .
propranolol	drug	Norpace	brand
false

In healthy subjects , no significant drug drug interaction was observed when DRUGA was coadministered with either DRUGB or DRUGN .
Norpace	brand	propranolol	drug
false

In healthy subjects , no significant drug drug interaction was observed when DRUGA was coadministered with either DRUGN or DRUGB .
Norpace	brand	diazepam	drug
false

In healthy subjects , no significant drug drug interaction was observed when DRUGN was coadministered with either DRUGA or DRUGB .
propranolol	drug	diazepam	drug
false

Concomitant administration of DRUGA and DRUGB resulted in slight increases in plasma DRUGN levels and slight decreases in plasma DRUGN levels .
Norpace	brand	quinidine	drug
mechanism

Concomitant administration of DRUGA and DRUGN resulted in slight increases in plasma DRUGB levels and slight decreases in plasma DRUGN levels .
Norpace	brand	disopyramide	drug
false

Concomitant administration of DRUGA and DRUGN resulted in slight increases in plasma DRUGN levels and slight decreases in plasma DRUGB levels .
Norpace	brand	quinidine	drug
false

Concomitant administration of DRUGN and DRUGA resulted in slight increases in plasma DRUGB levels and slight decreases in plasma DRUGN levels .
quinidine	drug	disopyramide	drug
false

Concomitant administration of DRUGN and DRUGN resulted in slight increases in plasma DRUGA levels and slight decreases in plasma DRUGB levels .
disopyramide	drug	quinidine	drug
false

DRUGA does not increase serum DRUGB levels .
Norpace	brand	digoxin	drug
false

Patients taking DRUGA and DRUGB concomitantly may develop increased serum concentrations of DRUGN resulting in excessive widening of the QRS complex and / or prolongation of the Q T interval .
disopyramide phosphate	drug	erythromycin	drug
mechanism

Patients taking DRUGA and DRUGN concomitantly may develop increased serum concentrations of DRUGB resulting in excessive widening of the QRS complex and / or prolongation of the Q T interval .
disopyramide phosphate	drug	disopyramide	drug
false

Patients taking DRUGN and DRUGA concomitantly may develop increased serum concentrations of DRUGB resulting in excessive widening of the QRS complex and / or prolongation of the Q T interval .
erythromycin	drug	disopyramide	drug
false

Until data on possible interactions between DRUGA and DRUGB are obtained , DRUGN should not be administered within dgb hours before or dgb hours after DRUGN administration .
verapamil	drug	disopyramide phosphate	drug
false

Until data on possible interactions between DRUGA and DRUGN are obtained , DRUGB should not be administered within dgb hours before or dgb hours after DRUGN administration .
verapamil	drug	disopyramide	drug
false

Until data on possible interactions between DRUGN and DRUGA are obtained , DRUGB should not be administered within dgb hours before or dgb hours after DRUGN administration .
disopyramide phosphate	drug	disopyramide	drug
false

Until data on possible interactions between DRUGN and DRUGA are obtained , DRUGN should not be administered within dgb hours before or dgb hours after DRUGB administration .
disopyramide phosphate	drug	verapamil	drug
false

Until data on possible interactions between DRUGN and DRUGN are obtained , DRUGA should not be administered within dgb hours before or dgb hours after DRUGB administration .
disopyramide	drug	verapamil	drug
advise

DRUGA SHOULD BE USED WITH CAUTION IN THOSE PATIENTS REVEIVING DRUGB AND ITS CONGENERS .
DISULFIRAM	drug	PHENYTOIN	drug
advise

SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO DRUGA INTOXICATION , PRIOR TO ADMINISTERING DRUGB TO A PATIENT ON DRUGN THERAPY , A BASELINE DRUGN SERUM LEVEL SHOULD BE OBTAINED .
PHENYTOIN	drug	DISULFIRAM	drug
false

SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO DRUGN INTOXICATION , PRIOR TO ADMINISTERING DRUGA TO A PATIENT ON DRUGB THERAPY , A BASELINE DRUGN SERUM LEVEL SHOULD BE OBTAINED .
DISULFIRAM	drug	PHENYTOIN	drug
effect

SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO DRUGN INTOXICATION , PRIOR TO ADMINISTERING DRUGA TO A PATIENT ON DRUGN THERAPY , A BASELINE DRUGB SERUM LEVEL SHOULD BE OBTAINED .
DISULFIRAM	drug	PHENYTOIN	drug
false

It may be necessary to adjust the dosage of oral DRUGA upon beginning or stopping DRUGB . since DRUGN may prolong prothrombin time .
anticoagulants	group	disulfiram	drug
advise

It may be necessary to adjust the dosage of oral DRUGA upon beginning or stopping DRUGN . since DRUGB may prolong prothrombin time .
anticoagulants	group	disulfiram	drug
false

Patients taking DRUGA when DRUGB is given should be observed for the appearance of unsteady gait or marked changes in mental status ;
isoniazid	drug	disulfiram	drug
advise

Animal studies indicate that DRUGA may be ineffective if the patient has recently received a DRUGB .
dobutamine	drug	b-blocking drug	group
effect

Preliminary studies indicate that the concomitant use of DRUGA and DRUGB results in a higher cardiac output and , usually , a lower pulmonary wedge pressure than when either drug is used alone .
dobutamine	drug	nitroprusside	drug
effect

Drug Drug Interactions DRUGA : Concomitant use of DRUGB is contraindicated .
Cimetidine	drug	cimetidine	drug
false

DRUGA at dgb mg BID ( the usual prescription dose ) co administered with DRUGB ( dgb mcg BID ) for dgb days has been shown to increase DRUGN plasma levels by dgb % .
Cimetidine	drug	TIKOSYN	brand
mechanism

DRUGA at dgb mg BID ( the usual prescription dose ) co administered with DRUGN ( dgb mcg BID ) for dgb days has been shown to increase DRUGB plasma levels by dgb % .
Cimetidine	drug	dofetilide	drug
false

DRUGN at dgb mg BID ( the usual prescription dose ) co administered with DRUGA ( dgb mcg BID ) for dgb days has been shown to increase DRUGB plasma levels by dgb % .
TIKOSYN	brand	dofetilide	drug
false

DRUGA at doses of dgb mg BID ( OTC dose ) resulted in a dgb % increase in DRUGB plasma levels ( dgb mcg single dose ) .
Cimetidine	drug	dofetilide	drug
mechanism

DRUGA : Concomitant use of DRUGB is contraindicated .
Verapamil	drug	verapamil	drug
false

Co administration of DRUGA with DRUGB resulted in increases in DRUGN peak plasma levels of dgb % , although overall exposure to DRUGN was not significantly increased .
TIKOSYN	brand	verapamil	drug
mechanism

Co administration of DRUGA with DRUGN resulted in increases in DRUGB peak plasma levels of dgb % , although overall exposure to DRUGN was not significantly increased .
TIKOSYN	brand	dofetilide	drug
false

Co administration of DRUGA with DRUGN resulted in increases in DRUGN peak plasma levels of dgb % , although overall exposure to DRUGB was not significantly increased .
TIKOSYN	brand	dofetilide	drug
false

Co administration of DRUGN with DRUGA resulted in increases in DRUGB peak plasma levels of dgb % , although overall exposure to DRUGN was not significantly increased .
verapamil	drug	dofetilide	drug
false

Co administration of DRUGN with DRUGA resulted in increases in DRUGN peak plasma levels of dgb % , although overall exposure to DRUGB was not significantly increased .
verapamil	drug	dofetilide	drug
false

In an analysis of the supraventricular arrhythmia and DIAMOND patient populations , the concomitant administration of DRUGA with DRUGB was associated with a higher occurrence of torsade de pointes .
verapamil	drug	dofetilide	drug
effect

DRUGA : Concomitant use of DRUGB is contraindicated .
Ketoconazole	drug	ketoconazole	drug
false

DRUGA Alone or in Combination with DRUGB : Concomitant use of DRUGN alone or in combination with DRUGN is contraindicated .
Trimethoprim	drug	Sulfamethoxazole	drug
false

DRUGA Alone or in Combination with DRUGN : Concomitant use of DRUGB alone or in combination with DRUGN is contraindicated .
Trimethoprim	drug	trimethoprim	drug
false

DRUGA Alone or in Combination with DRUGN : Concomitant use of DRUGN alone or in combination with DRUGB is contraindicated .
Trimethoprim	drug	sulfamethoxazole	drug
false

DRUGN Alone or in Combination with DRUGA : Concomitant use of DRUGB alone or in combination with DRUGN is contraindicated .
Sulfamethoxazole	drug	trimethoprim	drug
false

DRUGN Alone or in Combination with DRUGA : Concomitant use of DRUGN alone or in combination with DRUGB is contraindicated .
Sulfamethoxazole	drug	sulfamethoxazole	drug
false

DRUGN Alone or in Combination with DRUGN : Concomitant use of DRUGA alone or in combination with DRUGB is contraindicated .
trimethoprim	drug	sulfamethoxazole	drug
false

DRUGA ( DRUGB ) Alone or in Combination with DRUGN : Concomitant use of DRUGN alone or in combination with DRUGN is contraindicated .
Hydrochlorothiazide	drug	HCTZ	drug
false

DRUGA ( DRUGN ) Alone or in Combination with DRUGB : Concomitant use of DRUGN alone or in combination with DRUGN is contraindicated .
Hydrochlorothiazide	drug	Triamterene	drug
false

DRUGA ( DRUGN ) Alone or in Combination with DRUGN : Concomitant use of DRUGB alone or in combination with DRUGN is contraindicated .
Hydrochlorothiazide	drug	HCTZ	drug
false

DRUGA ( DRUGN ) Alone or in Combination with DRUGN : Concomitant use of DRUGN alone or in combination with DRUGB is contraindicated .
Hydrochlorothiazide	drug	triamterene	drug
false

DRUGN ( DRUGA ) Alone or in Combination with DRUGB : Concomitant use of DRUGN alone or in combination with DRUGN is contraindicated .
HCTZ	drug	Triamterene	drug
false

DRUGN ( DRUGA ) Alone or in Combination with DRUGN : Concomitant use of DRUGN alone or in combination with DRUGB is contraindicated .
HCTZ	drug	triamterene	drug
false

DRUGN ( DRUGN ) Alone or in Combination with DRUGA : Concomitant use of DRUGB alone or in combination with DRUGN is contraindicated .
Triamterene	drug	HCTZ	drug
false

DRUGN ( DRUGN ) Alone or in Combination with DRUGA : Concomitant use of DRUGN alone or in combination with DRUGB is contraindicated .
Triamterene	drug	triamterene	drug
false

DRUGN ( DRUGN ) Alone or in Combination with DRUGN : Concomitant use of DRUGA alone or in combination with DRUGB is contraindicated .
HCTZ	drug	triamterene	drug
false

DRUGA dgb mg QD or DRUGN / DRUGB dgb / dgb mg QD was co administered with DRUGN ( dgb mcg BID ) for dgb days ( following dgb days of DRUGN use at half dose ) .
HCTZ	drug	triamterene	drug
false

DRUGA dgb mg QD or DRUGN / DRUGN dgb / dgb mg QD was co administered with DRUGB ( dgb mcg BID ) for dgb days ( following dgb days of DRUGN use at half dose ) .
HCTZ	drug	TIKOSYN	brand
false

DRUGA dgb mg QD or DRUGN / DRUGN dgb / dgb mg QD was co administered with DRUGN ( dgb mcg BID ) for dgb days ( following dgb days of DRUGB use at half dose ) .
HCTZ	drug	diuretic	group
false

DRUGN dgb mg QD or DRUGA / DRUGB dgb / dgb mg QD was co administered with DRUGN ( dgb mcg BID ) for dgb days ( following dgb days of DRUGN use at half dose ) .
HCTZ	drug	triamterene	drug
false

DRUGN dgb mg QD or DRUGA / DRUGN dgb / dgb mg QD was co administered with DRUGB ( dgb mcg BID ) for dgb days ( following dgb days of DRUGN use at half dose ) .
HCTZ	drug	TIKOSYN	brand
false

DRUGN dgb mg QD or DRUGA / DRUGN dgb / dgb mg QD was co administered with DRUGN ( dgb mcg BID ) for dgb days ( following dgb days of DRUGB use at half dose ) .
HCTZ	drug	diuretic	group
false

DRUGN dgb mg QD or DRUGN / DRUGA dgb / dgb mg QD was co administered with DRUGB ( dgb mcg BID ) for dgb days ( following dgb days of DRUGN use at half dose ) .
triamterene	drug	TIKOSYN	brand
false

DRUGN dgb mg QD or DRUGN / DRUGA dgb / dgb mg QD was co administered with DRUGN ( dgb mcg BID ) for dgb days ( following dgb days of DRUGB use at half dose ) .
triamterene	drug	diuretic	group
false

DRUGN dgb mg QD or DRUGN / DRUGN dgb / dgb mg QD was co administered with DRUGA ( dgb mcg BID ) for dgb days ( following dgb days of DRUGB use at half dose ) .
TIKOSYN	brand	diuretic	group
false

In patients receiving DRUGA alone , DRUGB AUC increased by dgb % and Cmax by dgb % .
HCTZ	drug	dofetilide	drug
mechanism

In the DIAMOND trials , dgb patients were treated with DRUGA and DRUGB concomitantly of whom dgb died compared to dgb deaths among the dgb patients receiving placebo and DRUGN .
TIKOSYN	brand	diuretics	group
false

In the DIAMOND trials , dgb patients were treated with DRUGA and DRUGN concomitantly of whom dgb died compared to dgb deaths among the dgb patients receiving placebo and DRUGB .
TIKOSYN	brand	diuretics	group
false

In addition , drugs that are actively secreted via this route ( e.g . , DRUGA , DRUGB and DRUGN ) should be co administered with care as they might increase DRUGN levels .
triamterene	drug	metformin	drug
false

In addition , drugs that are actively secreted via this route ( e.g . , DRUGA , DRUGN and DRUGB ) should be co administered with care as they might increase DRUGN levels .
triamterene	drug	amiloride	drug
false

In addition , drugs that are actively secreted via this route ( e.g . , DRUGA , DRUGN and DRUGN ) should be co administered with care as they might increase DRUGB levels .
triamterene	drug	dofetilide	drug
advise

In addition , drugs that are actively secreted via this route ( e.g . , DRUGN , DRUGA and DRUGB ) should be co administered with care as they might increase DRUGN levels .
metformin	drug	amiloride	drug
false

In addition , drugs that are actively secreted via this route ( e.g . , DRUGN , DRUGA and DRUGN ) should be co administered with care as they might increase DRUGB levels .
metformin	drug	dofetilide	drug
advise

In addition , drugs that are actively secreted via this route ( e.g . , DRUGN , DRUGN and DRUGA ) should be co administered with care as they might increase DRUGB levels .
amiloride	drug	dofetilide	drug
advise

Other Drug Interaction Information DRUGA : Studies in healthy volunteers have shown that DRUGB does not affect the pharmacokinetics of DRUGN .
Digoxin	drug	TIKOSYN	brand
false

Other Drug Interaction Information DRUGA : Studies in healthy volunteers have shown that DRUGN does not affect the pharmacokinetics of DRUGB .
Digoxin	drug	digoxin	drug
false

Other Drug Interaction Information DRUGN : Studies in healthy volunteers have shown that DRUGA does not affect the pharmacokinetics of DRUGB .
TIKOSYN	brand	digoxin	drug
false

In patients , the concomitant administration of DRUGA with DRUGB was associated with a higher occurrence of torsade de pointes .
digoxin	drug	dofetilide	drug
effect

It is not clear whether this represents an interaction with DRUGA or the presence of more severe structural heart disease in patients on DRUGB ;
TIKOSYN	brand	digoxin	drug
false

The mean clearances of DRUGA were dgb % and dgb % lower in patients on DRUGB and inhibitors of tubular organic cation transport , respectively .
dofetilide	drug	thiazide diuretics	group
mechanism

The potential for clinically significant drug drug interactions posed by DRUGA and DRUGB appears to be low for drugs commonly used in chemotherapy or surgery , because DRUGN is eliminated by multiple routes .
dolasetron	drug	hydrodolasetron	drug_n
false

The potential for clinically significant drug drug interactions posed by DRUGA and DRUGN appears to be low for drugs commonly used in chemotherapy or surgery , because DRUGB is eliminated by multiple routes .
dolasetron	drug	hydrodolasetron	drug_n
false

In patients taking DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
furosemide	drug	nifedipine	drug
false

In patients taking DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
furosemide	drug	diltiazem	drug
false

In patients taking DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
furosemide	drug	ACE inhibitors	group
false

In patients taking DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
furosemide	drug	verapamil	drug
false

In patients taking DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
furosemide	drug	glyburide	drug
false

In patients taking DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
furosemide	drug	propranolol	drug
false

In patients taking DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGB .
furosemide	drug	hydrodolasetron	drug_n
false

In patients taking DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
nifedipine	drug	diltiazem	drug
false

In patients taking DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
nifedipine	drug	ACE inhibitors	group
false

In patients taking DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
nifedipine	drug	verapamil	drug
false

In patients taking DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
nifedipine	drug	glyburide	drug
false

In patients taking DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
nifedipine	drug	propranolol	drug
false

In patients taking DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGB .
nifedipine	drug	hydrodolasetron	drug_n
false

In patients taking DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
diltiazem	drug	ACE inhibitors	group
false

In patients taking DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
diltiazem	drug	verapamil	drug
false

In patients taking DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
diltiazem	drug	glyburide	drug
false

In patients taking DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
diltiazem	drug	propranolol	drug
false

In patients taking DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGB .
diltiazem	drug	hydrodolasetron	drug_n
false

In patients taking DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
ACE inhibitors	group	verapamil	drug
false

In patients taking DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
ACE inhibitors	group	glyburide	drug
false

In patients taking DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
ACE inhibitors	group	propranolol	drug
false

In patients taking DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGB .
ACE inhibitors	group	hydrodolasetron	drug_n
false

In patients taking DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
verapamil	drug	glyburide	drug
false

In patients taking DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
verapamil	drug	propranolol	drug
false

In patients taking DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGB .
verapamil	drug	hydrodolasetron	drug_n
false

In patients taking DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and various chemotherapy agents , no effect was shown on the clearance of DRUGN .
glyburide	drug	propranolol	drug
false

In patients taking DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and various chemotherapy agents , no effect was shown on the clearance of DRUGB .
glyburide	drug	hydrodolasetron	drug_n
false

In patients taking DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and various chemotherapy agents , no effect was shown on the clearance of DRUGB .
propranolol	drug	hydrodolasetron	drug_n
false

Clearance of DRUGA decreased by about dgb % when DRUGB was administered intravenously concomitantly with DRUGN .
hydrodolasetron	drug_n	dolasetron mesylate	drug
false

Clearance of DRUGA decreased by about dgb % when DRUGN was administered intravenously concomitantly with DRUGB .
hydrodolasetron	drug_n	atenolol	drug
false

Clearance of DRUGN decreased by about dgb % when DRUGA was administered intravenously concomitantly with DRUGB .
dolasetron mesylate	drug	atenolol	drug
mechanism

DRUGA did not inhibit the antitumor activity of four DRUGB ( DRUGN , DRUGN , DRUGN , DRUGN ) in four murine models .
Dolasetron mesylate	drug	chemotherapeutic agents	group
false

DRUGA did not inhibit the antitumor activity of four DRUGN ( DRUGB , DRUGN , DRUGN , DRUGN ) in four murine models .
Dolasetron mesylate	drug	cisplatin	drug
false

DRUGA did not inhibit the antitumor activity of four DRUGN ( DRUGN , DRUGB , DRUGN , DRUGN ) in four murine models .
Dolasetron mesylate	drug	5-fluorouracil	drug
false

DRUGA did not inhibit the antitumor activity of four DRUGN ( DRUGN , DRUGN , DRUGB , DRUGN ) in four murine models .
Dolasetron mesylate	drug	doxorubicin	drug
false

DRUGA did not inhibit the antitumor activity of four DRUGN ( DRUGN , DRUGN , DRUGN , DRUGB ) in four murine models .
Dolasetron mesylate	drug	cyclophosphamide	drug
false

DRUGN did not inhibit the antitumor activity of four DRUGA ( DRUGB , DRUGN , DRUGN , DRUGN ) in four murine models .
chemotherapeutic agents	group	cisplatin	drug
false

DRUGN did not inhibit the antitumor activity of four DRUGA ( DRUGN , DRUGB , DRUGN , DRUGN ) in four murine models .
chemotherapeutic agents	group	5-fluorouracil	drug
false

DRUGN did not inhibit the antitumor activity of four DRUGA ( DRUGN , DRUGN , DRUGB , DRUGN ) in four murine models .
chemotherapeutic agents	group	doxorubicin	drug
false

DRUGN did not inhibit the antitumor activity of four DRUGA ( DRUGN , DRUGN , DRUGN , DRUGB ) in four murine models .
chemotherapeutic agents	group	cyclophosphamide	drug
false

DRUGN did not inhibit the antitumor activity of four DRUGN ( DRUGA , DRUGB , DRUGN , DRUGN ) in four murine models .
cisplatin	drug	5-fluorouracil	drug
false

DRUGN did not inhibit the antitumor activity of four DRUGN ( DRUGA , DRUGN , DRUGB , DRUGN ) in four murine models .
cisplatin	drug	doxorubicin	drug
false

DRUGN did not inhibit the antitumor activity of four DRUGN ( DRUGA , DRUGN , DRUGN , DRUGB ) in four murine models .
cisplatin	drug	cyclophosphamide	drug
false

DRUGN did not inhibit the antitumor activity of four DRUGN ( DRUGN , DRUGA , DRUGB , DRUGN ) in four murine models .
5-fluorouracil	drug	doxorubicin	drug
false

DRUGN did not inhibit the antitumor activity of four DRUGN ( DRUGN , DRUGA , DRUGN , DRUGB ) in four murine models .
5-fluorouracil	drug	cyclophosphamide	drug
false

DRUGN did not inhibit the antitumor activity of four DRUGN ( DRUGN , DRUGN , DRUGA , DRUGB ) in four murine models .
doxorubicin	drug	cyclophosphamide	drug
false

Patients who have been treated with DRUGA within two to three weeks prior to the administration of DRUGB should receive initial doses of DRUGN no greater than one tenth ( dgb / dgb ) of the usual dose .
MAO inhibitors	group	dopamine HCl	drug
advise

Patients who have been treated with DRUGA within two to three weeks prior to the administration of DRUGN should receive initial doses of DRUGB no greater than one tenth ( dgb / dgb ) of the usual dose .
MAO inhibitors	group	dopamine HCl	drug
false

Concurrent administration of low dose DRUGA and DRUGB may produce an additive or potentiating effect on urine flow .
dopamine HCl	drug	diuretic agents	group
effect

Cardiac effects of DRUGA are antagonized by DRUGB , such as DRUGN and DRUGN .
dopamine	drug	beta-adrenergic blocking agents	group
effect

Cardiac effects of DRUGA are antagonized by DRUGN , such as DRUGB and DRUGN .
dopamine	drug	propranolol	drug
effect

Cardiac effects of DRUGA are antagonized by DRUGN , such as DRUGN and DRUGB .
dopamine	drug	metoprolol	drug
effect

Cardiac effects of DRUGN are antagonized by DRUGA , such as DRUGB and DRUGN .
beta-adrenergic blocking agents	group	propranolol	drug
false

Cardiac effects of DRUGN are antagonized by DRUGA , such as DRUGN and DRUGB .
beta-adrenergic blocking agents	group	metoprolol	drug
false

Cardiac effects of DRUGN are antagonized by DRUGN , such as DRUGA and DRUGB .
propranolol	drug	metoprolol	drug
false

The peripheral vasoconstriction caused by high doses of DRUGA is antagonized by DRUGB .
dopamine HCl	drug	alpha-adrenergic blocking agents	group
effect

DRUGA induced renal and mesenteric vasodilation is not antagonized by either DRUGB or DRUGN .
Dopamine	drug	alpha-adrenergic blocking agents	group
false

DRUGA induced renal and mesenteric vasodilation is not antagonized by either DRUGN or DRUGB .
Dopamine	drug	beta-adrenergic blocking agents	drug
false

DRUGN induced renal and mesenteric vasodilation is not antagonized by either DRUGA or DRUGB .
alpha-adrenergic blocking agents	group	beta-adrenergic blocking agents	drug
false

DRUGA ( such as DRUGB ) and DRUGN can suppress the DRUGN rgic renal and mesenteric vasodilation induced with low dose dopamine infusion .
Butyrophenones	group	haloperidol	drug
false

DRUGA ( such as DRUGN ) and DRUGB can suppress the DRUGN rgic renal and mesenteric vasodilation induced with low dose dopamine infusion .
Butyrophenones	group	phenothiazines	group
false

DRUGA ( such as DRUGN ) and DRUGN can suppress the DRUGB rgic renal and mesenteric vasodilation induced with low dose dopamine infusion .
Butyrophenones	group	dopamine	drug
effect

DRUGN ( such as DRUGA ) and DRUGB can suppress the DRUGN rgic renal and mesenteric vasodilation induced with low dose dopamine infusion .
haloperidol	drug	phenothiazines	group
false

DRUGN ( such as DRUGA ) and DRUGN can suppress the DRUGB rgic renal and mesenteric vasodilation induced with low dose dopamine infusion .
haloperidol	drug	dopamine	drug
effect

DRUGN ( such as DRUGN ) and DRUGA can suppress the DRUGB rgic renal and mesenteric vasodilation induced with low dose dopamine infusion .
phenothiazines	group	dopamine	drug
effect

DRUGA or DRUGB increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered DRUGN , such as DRUGN .
Cyclopropane	drug	halogenated hydrocarbon anesthetics	group
false

DRUGA or DRUGN increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered DRUGB , such as DRUGN .
Cyclopropane	drug	catecholamines	group
effect

DRUGA or DRUGN increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered DRUGN , such as DRUGB .
Cyclopropane	drug	dopamine	drug
effect

DRUGN or DRUGA increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered DRUGB , such as DRUGN .
halogenated hydrocarbon anesthetics	group	catecholamines	group
effect

DRUGN or DRUGA increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered DRUGN , such as DRUGB .
halogenated hydrocarbon anesthetics	group	dopamine	drug
effect

DRUGN or DRUGN increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered DRUGA , such as DRUGB .
catecholamines	group	dopamine	drug
false

Therefore , EXTREME CAUTION should be exercised when administering DRUGA to patients receiving DRUGB or DRUGN .
dopamine HCl	drug	cyclopropane	drug
advise

Therefore , EXTREME CAUTION should be exercised when administering DRUGA to patients receiving DRUGN or DRUGB .
dopamine HCl	drug	halogenated hydrocarbon anesthetics	group
advise

Therefore , EXTREME CAUTION should be exercised when administering DRUGN to patients receiving DRUGA or DRUGB .
cyclopropane	drug	halogenated hydrocarbon anesthetics	group
false

It has been reported that results of studies in animals indicate that DRUGA induced ventricular arrhythmias during anesthesia can be reversed by DRUGB .
dopamine	drug	propranolol	drug
effect

The concomitant use of DRUGA s , vasoconstricting agents ( such as DRUGB ) and some DRUGN may result in severe hypertension .
vasopressor	group	ergonovine	drug
false

The concomitant use of DRUGA s , vasoconstricting agents ( such as DRUGN ) and some DRUGB may result in severe hypertension .
vasopressor	group	oxytocic drugs	group
effect

The concomitant use of DRUGN s , vasoconstricting agents ( such as DRUGA ) and some DRUGB may result in severe hypertension .
ergonovine	drug	oxytocic drugs	group
effect

Administration of DRUGA to patients receiving DRUGB has been reported to lead to hypotension and bradycardia .
phenytoin	drug	dopamine HCl	drug
effect

It is suggested that in patients receiving DRUGA , alternatives to DRUGB should be used if DRUGN therapy is needed .
dopamine HCl	drug	phenytoin	drug
advise

It is suggested that in patients receiving DRUGA , alternatives to DRUGN should be used if DRUGB therapy is needed .
dopamine HCl	drug	anticonvulsant	group
false

It is suggested that in patients receiving DRUGN , alternatives to DRUGA should be used if DRUGB therapy is needed .
phenytoin	drug	anticonvulsant	group
false

Prior administration of DRUGA has no clinically important effect on the neuromuscular blocking action of DRUGB .
succinylcholine	drug	NUROMAX	brand
false

The use of DRUGA before DRUGB to attenuate some of the side effects of DRUGN has not been studied .
NUROMAX	brand	succinylcholine	drug
false

The use of DRUGA before DRUGN to attenuate some of the side effects of DRUGB has not been studied .
NUROMAX	brand	succinylcholine	drug
false

There are no clinical data on concomitant use of DRUGA and other nondepolarizing DRUGB .
NUROMAX	brand	neuromuscular blocking agents	group
false

DRUGA , DRUGB , and DRUGN decrease the EDdgb of DRUGN by dgb % to dgb % .
Isoflurane	drug	enflurane	drug
false

DRUGA , DRUGN , and DRUGB decrease the EDdgb of DRUGN by dgb % to dgb % .
Isoflurane	drug	halothane	drug
false

DRUGA , DRUGN , and DRUGN decrease the EDdgb of DRUGB by dgb % to dgb % .
Isoflurane	drug	NUROMAX	brand
mechanism

DRUGN , DRUGA , and DRUGB decrease the EDdgb of DRUGN by dgb % to dgb % .
enflurane	drug	halothane	drug
false

DRUGN , DRUGA , and DRUGN decrease the EDdgb of DRUGB by dgb % to dgb % .
enflurane	drug	NUROMAX	brand
mechanism

DRUGN , DRUGN , and DRUGA decrease the EDdgb of DRUGB by dgb % to dgb % .
halothane	drug	NUROMAX	brand
mechanism

As with some other DRUGA , the time of onset of neuromuscular block induced by DRUGB is lengthened and the duration of block is shortened in patients receiving DRUGN or DRUGN .
nondepolarizing neuromuscular blocking agents	group	NUROMAX	brand
false

As with some other DRUGA , the time of onset of neuromuscular block induced by DRUGN is lengthened and the duration of block is shortened in patients receiving DRUGB or DRUGN .
nondepolarizing neuromuscular blocking agents	group	phenytoin	drug
effect

As with some other DRUGA , the time of onset of neuromuscular block induced by DRUGN is lengthened and the duration of block is shortened in patients receiving DRUGN or DRUGB .
nondepolarizing neuromuscular blocking agents	group	carbamazepine	drug
effect

As with some other DRUGN , the time of onset of neuromuscular block induced by DRUGA is lengthened and the duration of block is shortened in patients receiving DRUGB or DRUGN .
NUROMAX	brand	phenytoin	drug
effect

As with some other DRUGN , the time of onset of neuromuscular block induced by DRUGA is lengthened and the duration of block is shortened in patients receiving DRUGN or DRUGB .
NUROMAX	brand	carbamazepine	drug
effect

As with some other DRUGN , the time of onset of neuromuscular block induced by DRUGN is lengthened and the duration of block is shortened in patients receiving DRUGA or DRUGB .
phenytoin	drug	carbamazepine	drug
false

Administration of DRUGA to patients who are receiving DRUGB or DRUGN may result in an additive pressor effect .
doxapram	drug	sympathomimetic	group
effect

Administration of DRUGA to patients who are receiving DRUGN or DRUGB may result in an additive pressor effect .
doxapram	drug	monoamine oxidase inhibiting drugs	group
effect

Administration of DRUGN to patients who are receiving DRUGA or DRUGB may result in an additive pressor effect .
sympathomimetic	group	monoamine oxidase inhibiting drugs	group
false

In patients who have received DRUGA , DRUGB may temporarily mask the residual effects of DRUGN .
muscle relaxants	group	doxapram	drug
false

In patients who have received DRUGA , DRUGN may temporarily mask the residual effects of DRUGB .
muscle relaxants	group	muscle relaxant drugs	group
false

In patients who have received DRUGN , DRUGA may temporarily mask the residual effects of DRUGB .
doxapram	drug	muscle relaxant drugs	group
effect

In vitro data in human plasma indicate that DRUGA has no effect on protein binding of DRUGB , DRUGN , DRUGN or DRUGN .
doxazosin mesylate	drug	digoxin	drug
false

In vitro data in human plasma indicate that DRUGA has no effect on protein binding of DRUGN , DRUGB , DRUGN or DRUGN .
doxazosin mesylate	drug	warfarin	drug
false

In vitro data in human plasma indicate that DRUGA has no effect on protein binding of DRUGN , DRUGN , DRUGB or DRUGN .
doxazosin mesylate	drug	phenytoin	drug
false

In vitro data in human plasma indicate that DRUGA has no effect on protein binding of DRUGN , DRUGN , DRUGN or DRUGB .
doxazosin mesylate	drug	indomethacin	drug
false

In vitro data in human plasma indicate that DRUGN has no effect on protein binding of DRUGA , DRUGB , DRUGN or DRUGN .
digoxin	drug	warfarin	drug
false

In vitro data in human plasma indicate that DRUGN has no effect on protein binding of DRUGA , DRUGN , DRUGB or DRUGN .
digoxin	drug	phenytoin	drug
false

In vitro data in human plasma indicate that DRUGN has no effect on protein binding of DRUGA , DRUGN , DRUGN or DRUGB .
digoxin	drug	indomethacin	drug
false

In vitro data in human plasma indicate that DRUGN has no effect on protein binding of DRUGN , DRUGA , DRUGB or DRUGN .
warfarin	drug	phenytoin	drug
false

In vitro data in human plasma indicate that DRUGN has no effect on protein binding of DRUGN , DRUGA , DRUGN or DRUGB .
warfarin	drug	indomethacin	drug
false

In vitro data in human plasma indicate that DRUGN has no effect on protein binding of DRUGN , DRUGN , DRUGA or DRUGB .
phenytoin	drug	indomethacin	drug
false

DRUGA has been administered without any evidence of an adverse drug interaction to patients receiving DRUGB , DRUGN s , and DRUGN .
Doxazosin mesylate	drug	thiazide diuretics	group
false

DRUGA has been administered without any evidence of an adverse drug interaction to patients receiving DRUGN , DRUGB s , and DRUGN .
Doxazosin mesylate	drug	beta-blocking agent	group
false

DRUGA has been administered without any evidence of an adverse drug interaction to patients receiving DRUGN , DRUGN s , and DRUGB .
Doxazosin mesylate	drug	nonsteroidal anti-inflammatory drugs	group
false

DRUGN has been administered without any evidence of an adverse drug interaction to patients receiving DRUGA , DRUGB s , and DRUGN .
thiazide diuretics	group	beta-blocking agent	group
false

DRUGN has been administered without any evidence of an adverse drug interaction to patients receiving DRUGA , DRUGN s , and DRUGB .
thiazide diuretics	group	nonsteroidal anti-inflammatory drugs	group
false

DRUGN has been administered without any evidence of an adverse drug interaction to patients receiving DRUGN , DRUGA s , and DRUGB .
beta-blocking agent	group	nonsteroidal anti-inflammatory drugs	group
false

DRUGA / DRUGB ( e.g . , DRUGN , DRUGN , DRUGN and DRUGN combinations , DRUGN , DRUGN ) .
Analgesic	group	anti-inflammatory	group
false

DRUGA / DRUGN ( e.g . , DRUGB , DRUGN , DRUGN and DRUGN combinations , DRUGN , DRUGN ) .
Analgesic	group	acetaminophen	drug
false

DRUGA / DRUGN ( e.g . , DRUGN , DRUGB , DRUGN and DRUGN combinations , DRUGN , DRUGN ) .
Analgesic	group	aspirin	brand
false

DRUGA / DRUGN ( e.g . , DRUGN , DRUGN , DRUGB and DRUGN combinations , DRUGN , DRUGN ) .
Analgesic	group	codeine	drug
false

DRUGA / DRUGN ( e.g . , DRUGN , DRUGN , DRUGN and DRUGB combinations , DRUGN , DRUGN ) .
Analgesic	group	codeine	drug
false

DRUGA / DRUGN ( e.g . , DRUGN , DRUGN , DRUGN and DRUGN combinations , DRUGB , DRUGN ) .
Analgesic	group	ibuprofen	drug
false

DRUGA / DRUGN ( e.g . , DRUGN , DRUGN , DRUGN and DRUGN combinations , DRUGN , DRUGB ) .
Analgesic	group	indomethacin	drug
false

DRUGN / DRUGA ( e.g . , DRUGB , DRUGN , DRUGN and DRUGN combinations , DRUGN , DRUGN ) .
anti-inflammatory	group	acetaminophen	drug
false

DRUGN / DRUGA ( e.g . , DRUGN , DRUGB , DRUGN and DRUGN combinations , DRUGN , DRUGN ) .
anti-inflammatory	group	aspirin	brand
false

DRUGN / DRUGA ( e.g . , DRUGN , DRUGN , DRUGB and DRUGN combinations , DRUGN , DRUGN ) .
anti-inflammatory	group	codeine	drug
false

DRUGN / DRUGA ( e.g . , DRUGN , DRUGN , DRUGN and DRUGB combinations , DRUGN , DRUGN ) .
anti-inflammatory	group	codeine	drug
false

DRUGN / DRUGA ( e.g . , DRUGN , DRUGN , DRUGN and DRUGN combinations , DRUGB , DRUGN ) .
anti-inflammatory	group	ibuprofen	drug
false

DRUGN / DRUGA ( e.g . , DRUGN , DRUGN , DRUGN and DRUGN combinations , DRUGN , DRUGB ) .
anti-inflammatory	group	indomethacin	drug
false

DRUGN / DRUGN ( e.g . , DRUGA , DRUGB , DRUGN and DRUGN combinations , DRUGN , DRUGN ) .
acetaminophen	drug	aspirin	brand
false

DRUGN / DRUGN ( e.g . , DRUGA , DRUGN , DRUGB and DRUGN combinations , DRUGN , DRUGN ) .
acetaminophen	drug	codeine	drug
false

DRUGN / DRUGN ( e.g . , DRUGA , DRUGN , DRUGN and DRUGB combinations , DRUGN , DRUGN ) .
acetaminophen	drug	codeine	drug
false

DRUGN / DRUGN ( e.g . , DRUGA , DRUGN , DRUGN and DRUGN combinations , DRUGB , DRUGN ) .
acetaminophen	drug	ibuprofen	drug
false

DRUGN / DRUGN ( e.g . , DRUGA , DRUGN , DRUGN and DRUGN combinations , DRUGN , DRUGB ) .
acetaminophen	drug	indomethacin	drug
false

DRUGN / DRUGN ( e.g . , DRUGN , DRUGA , DRUGB and DRUGN combinations , DRUGN , DRUGN ) .
aspirin	brand	codeine	drug
false

DRUGN / DRUGN ( e.g . , DRUGN , DRUGA , DRUGN and DRUGB combinations , DRUGN , DRUGN ) .
aspirin	brand	codeine	drug
false

DRUGN / DRUGN ( e.g . , DRUGN , DRUGA , DRUGN and DRUGN combinations , DRUGB , DRUGN ) .
aspirin	brand	ibuprofen	drug
false

DRUGN / DRUGN ( e.g . , DRUGN , DRUGA , DRUGN and DRUGN combinations , DRUGN , DRUGB ) .
aspirin	brand	indomethacin	drug
false

DRUGN / DRUGN ( e.g . , DRUGN , DRUGN , DRUGA and DRUGN combinations , DRUGB , DRUGN ) .
codeine	drug	ibuprofen	drug
false

DRUGN / DRUGN ( e.g . , DRUGN , DRUGN , DRUGA and DRUGN combinations , DRUGN , DRUGB ) .
codeine	drug	indomethacin	drug
false

DRUGN / DRUGN ( e.g . , DRUGN , DRUGN , DRUGN and DRUGA combinations , DRUGB , DRUGN ) .
codeine	drug	ibuprofen	drug
false

DRUGN / DRUGN ( e.g . , DRUGN , DRUGN , DRUGN and DRUGA combinations , DRUGN , DRUGB ) .
codeine	drug	indomethacin	drug
false

DRUGN / DRUGN ( e.g . , DRUGN , DRUGN , DRUGN and DRUGN combinations , DRUGA , DRUGB ) .
ibuprofen	drug	indomethacin	drug
false

DRUGA ( e.g . , DRUGB , DRUGN and DRUGN , DRUGN ) .
Antibiotics	group	erythromycin	drug
false

DRUGA ( e.g . , DRUGN , DRUGB and DRUGN , DRUGN ) .
Antibiotics	group	trimethoprim	drug
false

DRUGA ( e.g . , DRUGN , DRUGN and DRUGB , DRUGN ) .
Antibiotics	group	sulfamethoxazole	drug
false

DRUGA ( e.g . , DRUGN , DRUGN and DRUGN , DRUGB ) .
Antibiotics	group	amoxicillin	drug
false

DRUGN ( e.g . , DRUGA , DRUGB and DRUGN , DRUGN ) .
erythromycin	drug	trimethoprim	drug
false

DRUGN ( e.g . , DRUGA , DRUGN and DRUGB , DRUGN ) .
erythromycin	drug	sulfamethoxazole	drug
false

DRUGN ( e.g . , DRUGA , DRUGN and DRUGN , DRUGB ) .
erythromycin	drug	amoxicillin	drug
false

DRUGN ( e.g . , DRUGN , DRUGA and DRUGB , DRUGN ) .
trimethoprim	drug	sulfamethoxazole	drug
false

DRUGN ( e.g . , DRUGN , DRUGA and DRUGN , DRUGB ) .
trimethoprim	drug	amoxicillin	drug
false

DRUGN ( e.g . , DRUGN , DRUGN and DRUGA , DRUGB ) .
sulfamethoxazole	drug	amoxicillin	drug
false

DRUGA ( e.g . , DRUGB ) .
Antihistamines	group	chlorpheniramine	group
false

Cardiovascular agents ( e.g . , DRUGA , DRUGB , DRUGN ) .
atenolol	drug	hydrochlorothiazide	drug
false

Cardiovascular agents ( e.g . , DRUGA , DRUGN , DRUGB ) .
atenolol	drug	propranolol	drug
false

Cardiovascular agents ( e.g . , DRUGN , DRUGA , DRUGB ) .
hydrochlorothiazide	drug	propranolol	drug
false

DRUGA and DRUGB ( e.g . , DRUGN ) .
Sedatives	group	tranquilizers	group
false

DRUGA and DRUGN ( e.g . , DRUGB ) .
Sedatives	group	diazepam	drug
false

DRUGN and DRUGA ( e.g . , DRUGB ) .
tranquilizers	group	diazepam	drug
false

Poor metabolizers have higher than expected plasma concentrations of DRUGA ( DRUGB ) when given usual doses .
tricyclic antidepressants	group	TCAs	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGB , DRUGN , and the DRUGN DRUGN and DRUGN ) .
cimetidine	drug	antidepressants	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGB , and the DRUGN DRUGN and DRUGN ) .
cimetidine	drug	phenothiazines	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGB DRUGN and DRUGN ) .
cimetidine	drug	Type 1C antiarrhythmics	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGN DRUGB and DRUGN ) .
cimetidine	drug	propafenone	drug
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGN DRUGN and DRUGB ) .
cimetidine	drug	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGB , and the DRUGN DRUGN and DRUGN ) .
antidepressants	group	phenothiazines	group
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGN , and the DRUGB DRUGN and DRUGN ) .
antidepressants	group	Type 1C antiarrhythmics	group
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGN , and the DRUGN DRUGB and DRUGN ) .
antidepressants	group	propafenone	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGN , and the DRUGN DRUGN and DRUGB ) .
antidepressants	group	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGA , and the DRUGB DRUGN and DRUGN ) .
phenothiazines	group	Type 1C antiarrhythmics	group
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGA , and the DRUGN DRUGB and DRUGN ) .
phenothiazines	group	propafenone	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGA , and the DRUGN DRUGN and DRUGB ) .
phenothiazines	group	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGA DRUGB and DRUGN ) .
Type 1C antiarrhythmics	group	propafenone	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGA DRUGN and DRUGB ) .
Type 1C antiarrhythmics	group	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGN DRUGA and DRUGB ) .
propafenone	drug	flecainide	drug
false

While all the DRUGA ( DRUGB ) , e.g . , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	SSRIs	group
false

While all the DRUGA ( DRUGN ) , e.g . , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	citalopram	drug
false

While all the DRUGA ( DRUGN ) , e.g . , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	escitalopram	drug
false

While all the DRUGA ( DRUGN ) , e.g . , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	fluoxetine	drug
false

While all the DRUGA ( DRUGN ) , e.g . , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	sertraline	drug
false

While all the DRUGA ( DRUGN ) , e.g . , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	paroxetine	drug
false

While all the DRUGN ( DRUGA ) , e.g . , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	citalopram	drug
false

While all the DRUGN ( DRUGA ) , e.g . , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	escitalopram	drug
false

While all the DRUGN ( DRUGA ) , e.g . , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	fluoxetine	drug
false

While all the DRUGN ( DRUGA ) , e.g . , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	sertraline	drug
false

While all the DRUGN ( DRUGA ) , e.g . , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	paroxetine	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
citalopram	drug	escitalopram	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
citalopram	drug	fluoxetine	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
citalopram	drug	sertraline	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
citalopram	drug	paroxetine	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
escitalopram	drug	fluoxetine	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
escitalopram	drug	sertraline	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
escitalopram	drug	paroxetine	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
fluoxetine	drug	sertraline	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
fluoxetine	drug	paroxetine	drug
false

While all the DRUGN ( DRUGN ) , e.g . , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
sertraline	drug	paroxetine	drug
false

The extent to which DRUGA DRUGB interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the DRUGN involved .
SSRI	group	TCA	group
int

The extent to which DRUGN DRUGA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the DRUGB involved .
TCA	group	SSRI	group
false

Nevertheless , caution is indicated in the co administration of DRUGA with any of the DRUGB and also in switching from one class to the other .
TCAs	group	SSRIs	group
advise

Concomitant use of DRUGA with drugs that can inhibit cytochrome Pdgb dgbDdgb may require lower doses than usually prescribed for either the DRUGB or the other drug .
tricyclic antidepressants	group	tricyclic antidepressant	group
false

Inhibitors or substrates of CYPdgbDdgb ( i.e . , DRUGA , DRUGB [ DRUGN ] ) may increase the plasma concentration of DRUGN when administered concomitantly .
quinidine	drug	selective serotonin reuptake inhibitors	group
false

Inhibitors or substrates of CYPdgbDdgb ( i.e . , DRUGA , DRUGN [ DRUGB ] ) may increase the plasma concentration of DRUGN when administered concomitantly .
quinidine	drug	SSRIs	group
false

Inhibitors or substrates of CYPdgbDdgb ( i.e . , DRUGA , DRUGN [ DRUGN ] ) may increase the plasma concentration of DRUGB when administered concomitantly .
quinidine	drug	doxepin	drug
mechanism

Inhibitors or substrates of CYPdgbDdgb ( i.e . , DRUGN , DRUGA [ DRUGB ] ) may increase the plasma concentration of DRUGN when administered concomitantly .
selective serotonin reuptake inhibitors	group	SSRIs	group
false

Inhibitors or substrates of CYPdgbDdgb ( i.e . , DRUGN , DRUGA [ DRUGN ] ) may increase the plasma concentration of DRUGB when administered concomitantly .
selective serotonin reuptake inhibitors	group	doxepin	drug
mechanism

Inhibitors or substrates of CYPdgbDdgb ( i.e . , DRUGN , DRUGN [ DRUGA ] ) may increase the plasma concentration of DRUGB when administered concomitantly .
SSRIs	group	doxepin	drug
mechanism

DRUGA : Serious side effects and even death have been reported following the concomitant use of certain drugs with DRUGB .
MAO Inhibitors	group	MAO inhibitors	group
false

Therefore , DRUGA should be discontinued at least two weeks prior to the cautious initiation of therapy with DRUGB .
MAO inhibitors	group	SINEQUAN	brand
advise

DRUGA : DRUGN has been reported to produce clinically significant fluctuations in steady state serum concentrations of various DRUGB .
Cimetidine	drug	tricyclic antidepressants	group
false

DRUGN : DRUGA has been reported to produce clinically significant fluctuations in steady state serum concentrations of various DRUGB .
Cimetidine	drug	tricyclic antidepressants	group
mechanism

Serious anticholinergic symptoms ( i.e . , severe dry mouth , urinary retention and blurred vision ) have been associated with elevations in the serum levels of DRUGA when DRUGB therapy is initiated .
tricyclic antidepressant	group	cimetidine	drug
effect

Additionally , higher than expected DRUGA levels have been observed when they are begun in patients already taking DRUGB .
tricyclic antidepressant	group	cimetidine	drug
mechanism

In patients who have been reported to be well controlled on DRUGA receiving concurrent DRUGB therapy , discontinuation of DRUGN has been reported to decrease established steady state serum DRUGN levels and compromise their therapeutic effects .
tricyclic antidepressants	group	cimetidine	drug
false

In patients who have been reported to be well controlled on DRUGA receiving concurrent DRUGN therapy , discontinuation of DRUGB has been reported to decrease established steady state serum DRUGN levels and compromise their therapeutic effects .
tricyclic antidepressants	group	cimetidine	drug
false

In patients who have been reported to be well controlled on DRUGA receiving concurrent DRUGN therapy , discontinuation of DRUGN has been reported to decrease established steady state serum DRUGB levels and compromise their therapeutic effects .
tricyclic antidepressants	group	tricyclic antidepressant	group
false

In patients who have been reported to be well controlled on DRUGN receiving concurrent DRUGA therapy , discontinuation of DRUGN has been reported to decrease established steady state serum DRUGB levels and compromise their therapeutic effects .
cimetidine	drug	tricyclic antidepressant	group
false

In patients who have been reported to be well controlled on DRUGN receiving concurrent DRUGN therapy , discontinuation of DRUGA has been reported to decrease established steady state serum DRUGB levels and compromise their therapeutic effects .
cimetidine	drug	tricyclic antidepressant	group
mechanism

DRUGA : It should be borne in mind that DRUGB ingestion may increase the danger inherent in any intentional or unintentional DRUGN overdosage .
Alcohol	drug	alcohol	drug
false

DRUGA : It should be borne in mind that DRUGN ingestion may increase the danger inherent in any intentional or unintentional DRUGB overdosage .
Alcohol	drug	SINEQUAN	brand
false

DRUGN : It should be borne in mind that DRUGA ingestion may increase the danger inherent in any intentional or unintentional DRUGB overdosage .
alcohol	drug	SINEQUAN	brand
mechanism

DRUGA : A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on DRUGB ( dgb gm / day ) dgb days after the addition of DRUGN ( dgb mg / day ) .
Tolazamide	drug	tolazamide	drug
false

DRUGA : A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on DRUGN ( dgb gm / day ) dgb days after the addition of DRUGB ( dgb mg / day ) .
Tolazamide	drug	doxepin	drug
false

DRUGN : A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on DRUGA ( dgb gm / day ) dgb days after the addition of DRUGB ( dgb mg / day ) .
tolazamide	drug	doxepin	drug
effect

DRUGA may interact with drugs known to interact with the conventional formulation of DRUGB .
DOXIL	brand	doxorubicin HCl	drug
false

Because DRUGA have been shown to depress plasma prothrombin activity , patients who are on DRUGB therapy may require downward adjustment of their DRUGN dosage .
tetracyclines	group	anticoagulant	group
advise

Because DRUGA have been shown to depress plasma prothrombin activity , patients who are on DRUGN therapy may require downward adjustment of their DRUGB dosage .
tetracyclines	group	anticoagulant	group
false

Since bacteriostatic drugs may interfere with the bactericidal action of DRUGA , it is advisable to avoid giving DRUGB in conjunction with DRUGN .
penicillin	drug	tetracyclines	group
false

Since bacteriostatic drugs may interfere with the bactericidal action of DRUGN , it is advisable to avoid giving DRUGA in conjunction with DRUGB .
tetracyclines	group	penicillin	group
advise

Absorption of DRUGA is impaired by DRUGB containing DRUGN , DRUGN , or DRUGN , and DRUGN containing preparations .
tetracyclines	group	antacids	group
false

Absorption of DRUGA is impaired by DRUGN containing DRUGB , DRUGN , or DRUGN , and DRUGN containing preparations .
tetracyclines	group	aluminum	drug
mechanism

Absorption of DRUGA is impaired by DRUGN containing DRUGN , DRUGB , or DRUGN , and DRUGN containing preparations .
tetracyclines	group	calcium	drug
mechanism

Absorption of DRUGA is impaired by DRUGN containing DRUGN , DRUGN , or DRUGB , and DRUGN containing preparations .
tetracyclines	group	magnesium	drug
mechanism

Absorption of DRUGA is impaired by DRUGN containing DRUGN , DRUGN , or DRUGN , and DRUGB containing preparations .
tetracyclines	group	iron	drug
mechanism

Absorption of DRUGN is impaired by DRUGA containing DRUGB , DRUGN , or DRUGN , and DRUGN containing preparations .
antacids	group	aluminum	drug
false

Absorption of DRUGN is impaired by DRUGA containing DRUGN , DRUGB , or DRUGN , and DRUGN containing preparations .
antacids	group	calcium	drug
false

Absorption of DRUGN is impaired by DRUGA containing DRUGN , DRUGN , or DRUGB , and DRUGN containing preparations .
antacids	group	magnesium	drug
false

Absorption of DRUGN is impaired by DRUGA containing DRUGN , DRUGN , or DRUGN , and DRUGB containing preparations .
antacids	group	iron	drug
false

Absorption of DRUGN is impaired by DRUGN containing DRUGA , DRUGB , or DRUGN , and DRUGN containing preparations .
aluminum	drug	calcium	drug
false

Absorption of DRUGN is impaired by DRUGN containing DRUGA , DRUGN , or DRUGB , and DRUGN containing preparations .
aluminum	drug	magnesium	drug
false

Absorption of DRUGN is impaired by DRUGN containing DRUGA , DRUGN , or DRUGN , and DRUGB containing preparations .
aluminum	drug	iron	drug
false

Absorption of DRUGN is impaired by DRUGN containing DRUGN , DRUGA , or DRUGB , and DRUGN containing preparations .
calcium	drug	magnesium	drug
false

Absorption of DRUGN is impaired by DRUGN containing DRUGN , DRUGA , or DRUGN , and DRUGB containing preparations .
calcium	drug	iron	drug
false

Absorption of DRUGN is impaired by DRUGN containing DRUGN , DRUGN , or DRUGA , and DRUGB containing preparations .
magnesium	drug	iron	drug
false

Absorption of DRUGA is impaired by DRUGB .
tetracycline	drug	bismuth subsalicylate	drug
mechanism

DRUGA , DRUGB , and DRUGN decrease the half life of DRUGN .
Barbiturates	group	carbamazepine	drug
false

DRUGA , DRUGN , and DRUGB decrease the half life of DRUGN .
Barbiturates	group	phenytoin	drug
false

DRUGA , DRUGN , and DRUGN decrease the half life of DRUGB .
Barbiturates	group	doxycycline	drug
mechanism

DRUGN , DRUGA , and DRUGB decrease the half life of DRUGN .
carbamazepine	drug	phenytoin	drug
false

DRUGN , DRUGA , and DRUGN decrease the half life of DRUGB .
carbamazepine	drug	doxycycline	drug
mechanism

DRUGN , DRUGN , and DRUGA decrease the half life of DRUGB .
phenytoin	drug	doxycycline	drug
mechanism

The concurrent use of DRUGA and DRUGB ( DRUGN ) has been reported to result in fatal renal toxicity .
tetracycline	drug	Penthrane	brand
effect

The concurrent use of DRUGA and DRUGN ( DRUGB ) has been reported to result in fatal renal toxicity .
tetracycline	drug	methoxyflurane	drug
effect

The concurrent use of DRUGN and DRUGA ( DRUGB ) has been reported to result in fatal renal toxicity .
Penthrane	brand	methoxyflurane	drug
false

Concurrent use of DRUGA may render oral DRUGB less effective .
tetracycline	drug	contraceptives	group
effect

Potential drug interactions for DRUGA include , increased sedation if DRUGN is combined with other DRUGB .
doxylamine	drug	CNS depressant drugs	group
false

Potential drug interactions for DRUGN include , increased sedation if DRUGA is combined with other DRUGB .
doxylamine	drug	CNS depressant drugs	group
effect

DRUGA may partially counteract the anticoagulation effects of DRUGB or DRUGN .
Antihistamines	group	heparin	drug
effect

DRUGA may partially counteract the anticoagulation effects of DRUGN or DRUGB .
Antihistamines	group	warfarin	drug
effect

DRUGN may partially counteract the anticoagulation effects of DRUGA or DRUGB .
heparin	drug	warfarin	drug
false

DRUGA may enhance the effects of DRUGB .
Doxylamine	drug	epinephrine	drug
effect

Concurrent administration of DRUGA and DRUGB may result in elevated serum levels of DRUGN .
oxyphenbutazone	drug	androgens	group
mechanism

Concurrent administration of DRUGN and DRUGA may result in elevated serum levels of DRUGB .
androgens	group	oxyphenbutazone	drug
false

In diabetic patients , the metabolic effects of DRUGA may decrease blood glucose and therefore , DRUGB requirements .
androgens	group	insulin	drug
effect

Other DRUGA ( e.g . DRUGB , DRUGN , DRUGN and general DRUGN ) have additive or potentiating effects with DRUGN .
CNS depressant drugs	group	barbiturates	group
false

Other DRUGA ( e.g . DRUGN , DRUGB , DRUGN and general DRUGN ) have additive or potentiating effects with DRUGN .
CNS depressant drugs	group	tranquilizers	group
false

Other DRUGA ( e.g . DRUGN , DRUGN , DRUGB and general DRUGN ) have additive or potentiating effects with DRUGN .
CNS depressant drugs	group	opioids	group
false

Other DRUGA ( e.g . DRUGN , DRUGN , DRUGN and general DRUGB ) have additive or potentiating effects with DRUGN .
CNS depressant drugs	group	anesthetics	group
false

Other DRUGA ( e.g . DRUGN , DRUGN , DRUGN and general DRUGN ) have additive or potentiating effects with DRUGB .
CNS depressant drugs	group	INAPSINE	brand
effect

Other DRUGN ( e.g . DRUGA , DRUGB , DRUGN and general DRUGN ) have additive or potentiating effects with DRUGN .
barbiturates	group	tranquilizers	group
false

Other DRUGN ( e.g . DRUGA , DRUGN , DRUGB and general DRUGN ) have additive or potentiating effects with DRUGN .
barbiturates	group	opioids	group
false

Other DRUGN ( e.g . DRUGA , DRUGN , DRUGN and general DRUGB ) have additive or potentiating effects with DRUGN .
barbiturates	group	anesthetics	group
false

Other DRUGN ( e.g . DRUGA , DRUGN , DRUGN and general DRUGN ) have additive or potentiating effects with DRUGB .
barbiturates	group	INAPSINE	brand
effect

Other DRUGN ( e.g . DRUGN , DRUGA , DRUGB and general DRUGN ) have additive or potentiating effects with DRUGN .
tranquilizers	group	opioids	group
false

Other DRUGN ( e.g . DRUGN , DRUGA , DRUGN and general DRUGB ) have additive or potentiating effects with DRUGN .
tranquilizers	group	anesthetics	group
false

Other DRUGN ( e.g . DRUGN , DRUGA , DRUGN and general DRUGN ) have additive or potentiating effects with DRUGB .
tranquilizers	group	INAPSINE	brand
effect

Other DRUGN ( e.g . DRUGN , DRUGN , DRUGA and general DRUGB ) have additive or potentiating effects with DRUGN .
opioids	group	anesthetics	group
false

Other DRUGN ( e.g . DRUGN , DRUGN , DRUGA and general DRUGN ) have additive or potentiating effects with DRUGB .
opioids	group	INAPSINE	brand
effect

Other DRUGN ( e.g . DRUGN , DRUGN , DRUGN and general DRUGA ) have additive or potentiating effects with DRUGB .
anesthetics	group	INAPSINE	brand
effect

Following the administration of DRUGA , the dose of other DRUGB should be reduced .
INAPSINE	brand	CNS depressant drugs	group
advise

Concomitant use of prophylactic low dose DRUGA did not appear to affect safety , however , its effects on the efficacy of DRUGB have not been evaluated in an adequate and well controlled clinical trial .
heparin	drug	Xigris	brand
false

Potential for Other Drugs to Affect DRUGA : Both CYPdgbAdgb and CYPdgbDdgb are responsible for DRUGB metabolism .
Duloxetine	drug	duloxetine	drug
false

Inhibitors of CYPdgbAdgb : Concomitant use of DRUGA with DRUGB , an inhibitor of CYPdgbAdgb , results in approximately a dgb fold increase in AUC and about a dga fold increase in Cmax of DRUGN .
duloxetine	drug	fluvoxamine	drug
mechanism

Inhibitors of CYPdgbAdgb : Concomitant use of DRUGN with DRUGA , an inhibitor of CYPdgbAdgb , results in approximately a dgb fold increase in AUC and about a dga fold increase in Cmax of DRUGB .
fluvoxamine	drug	duloxetine	drug
false

DRUGA ( dgb mg QD ) increased the concentration of DRUGB ( dgb mg QD ) by about dgb % , and greater degrees of inhibition are expected with higher doses of DRUGN .
Paroxetine	drug	duloxetine	drug
mechanism

DRUGA ( dgb mg QD ) increased the concentration of DRUGN ( dgb mg QD ) by about dgb % , and greater degrees of inhibition are expected with higher doses of DRUGB .
Paroxetine	drug	paroxetine	drug
false

DRUGN ( dgb mg QD ) increased the concentration of DRUGA ( dgb mg QD ) by about dgb % , and greater degrees of inhibition are expected with higher doses of DRUGB .
duloxetine	drug	paroxetine	drug
false

Similar effects would be expected with other potent CYPdgbDdgb inhibitors ( e.g . , DRUGA , DRUGB ) .
fluoxetine	drug	quinidine	drug
false

When DRUGA was administered ( at a dose of dgb mg BID ) in conjunction with a single dgb mg dose of DRUGB , a CYPdgbDdgb substrate , the AUC of DRUGN increased dgb fold .
duloxetine	drug	desipramine	drug
mechanism

When DRUGA was administered ( at a dose of dgb mg BID ) in conjunction with a single dgb mg dose of DRUGN , a CYPdgbDdgb substrate , the AUC of DRUGB increased dgb fold .
duloxetine	drug	desipramine	drug
false

Plasma DRUGA concentrations may need to be monitored and the dose of the DRUGN may need to be reduced if a DRUGN is co administered with DRUGB .
TCA	group	Duloxetine	drug
false

Plasma DRUGN concentrations may need to be monitored and the dose of the DRUGA may need to be reduced if a DRUGN is co administered with DRUGB .
TCA	group	Duloxetine	drug
false

Plasma DRUGN concentrations may need to be monitored and the dose of the DRUGN may need to be reduced if a DRUGA is co administered with DRUGB .
TCA	group	Duloxetine	drug
advise

Because of the risk of serious ventricular arrhythmias and sudden death potentially associated with elevated plasma levels of DRUGA , DRUGB and DRUGN should not be co administered .
thioridazine	drug	Duloxetine	drug
false

Because of the risk of serious ventricular arrhythmias and sudden death potentially associated with elevated plasma levels of DRUGN , DRUGA and DRUGB should not be co administered .
Duloxetine	drug	thioridazine	drug
advise

It is unknown whether the concomitant administration of DRUGA affects DRUGB absorption .
proton pump inhibitors	group	duloxetine	drug
false

Synergism between DRUGA ( e.g . , DRUGB ) , DRUGN , and other DRUGN has been reported .
xanthine bronchodilators	group	theophylline	drug
false

Synergism between DRUGA ( e.g . , DRUGN ) , DRUGB , and other DRUGN has been reported .
xanthine bronchodilators	group	ephedrine	drug
false

Synergism between DRUGA ( e.g . , DRUGN ) , DRUGN , and other DRUGB has been reported .
xanthine bronchodilators	group	sympathomimetic bronchodilators	group
effect

Synergism between DRUGN ( e.g . , DRUGA ) , DRUGB , and other DRUGN has been reported .
theophylline	drug	ephedrine	drug
false

Synergism between DRUGN ( e.g . , DRUGA ) , DRUGN , and other DRUGB has been reported .
theophylline	drug	sympathomimetic bronchodilators	group
effect

Synergism between DRUGN ( e.g . , DRUGN ) , DRUGA , and other DRUGB has been reported .
ephedrine	drug	sympathomimetic bronchodilators	group
effect

Concurrent administration of DRUGA and DRUGB , which competes for tubular secretion , has been shown to increase the plasma half life of DRUGN .
dyphylline	drug	probenecid	drug
mechanism

Concurrent administration of DRUGN and DRUGA , which competes for tubular secretion , has been shown to increase the plasma half life of DRUGB .
probenecid	drug	dyphylline	drug
false

DRUGA potentiates other DRUGB such as DRUGN or DRUGN and DRUGN s .
Phospholine Iodide	drug	cholinesterase inhibitors	group
effect

DRUGA potentiates other DRUGN such as DRUGB or DRUGN and DRUGN s .
Phospholine Iodide	drug	succinylcholine	drug
effect

DRUGA potentiates other DRUGN such as DRUGN or DRUGB and DRUGN s .
Phospholine Iodide	drug	organophosphate insecticide	drug_n
effect

DRUGA potentiates other DRUGN such as DRUGN or DRUGN and DRUGB s .
Phospholine Iodide	drug	carbamate insecticide	drug_n
effect

DRUGN potentiates other DRUGA such as DRUGB or DRUGN and DRUGN s .
cholinesterase inhibitors	group	succinylcholine	drug
false

DRUGN potentiates other DRUGA such as DRUGN or DRUGB and DRUGN s .
cholinesterase inhibitors	group	organophosphate insecticide	drug_n
false

DRUGN potentiates other DRUGA such as DRUGN or DRUGN and DRUGB s .
cholinesterase inhibitors	group	carbamate insecticide	drug_n
false

DRUGN potentiates other DRUGN such as DRUGA or DRUGB and DRUGN s .
succinylcholine	drug	organophosphate insecticide	drug_n
false

DRUGN potentiates other DRUGN such as DRUGA or DRUGN and DRUGB s .
succinylcholine	drug	carbamate insecticide	drug_n
false

DRUGN potentiates other DRUGN such as DRUGN or DRUGA and DRUGB s .
organophosphate insecticide	drug_n	carbamate insecticide	drug_n
false

DRUGA enhance the renal toxicity of DRUGB in animals . dgb DRUGN interferes with the action of DRUGN preparations by chelating the DRUGN . dgb
Steroids	group	edetate calcium disodium	drug
effect

DRUGA enhance the renal toxicity of DRUGN in animals . dgb DRUGB interferes with the action of DRUGN preparations by chelating the DRUGN . dgb
Steroids	group	Edetate calcium disodium	drug
false

DRUGA enhance the renal toxicity of DRUGN in animals . dgb DRUGN interferes with the action of DRUGB preparations by chelating the DRUGN . dgb
Steroids	group	zinc insulin	drug
false

DRUGA enhance the renal toxicity of DRUGN in animals . dgb DRUGN interferes with the action of DRUGN preparations by chelating the DRUGB . dgb
Steroids	group	zinc	drug
false

DRUGN enhance the renal toxicity of DRUGA in animals . dgb DRUGB interferes with the action of DRUGN preparations by chelating the DRUGN . dgb
edetate calcium disodium	drug	Edetate calcium disodium	drug
false

DRUGN enhance the renal toxicity of DRUGA in animals . dgb DRUGN interferes with the action of DRUGB preparations by chelating the DRUGN . dgb
edetate calcium disodium	drug	zinc insulin	drug
false

DRUGN enhance the renal toxicity of DRUGA in animals . dgb DRUGN interferes with the action of DRUGN preparations by chelating the DRUGB . dgb
edetate calcium disodium	drug	zinc	drug
false

DRUGN enhance the renal toxicity of DRUGN in animals . dgb DRUGA interferes with the action of DRUGB preparations by chelating the DRUGN . dgb
Edetate calcium disodium	drug	zinc insulin	drug
mechanism

DRUGN enhance the renal toxicity of DRUGN in animals . dgb DRUGA interferes with the action of DRUGN preparations by chelating the DRUGB . dgb
Edetate calcium disodium	drug	zinc	drug
false

DRUGN enhance the renal toxicity of DRUGN in animals . dgb DRUGN interferes with the action of DRUGA preparations by chelating the DRUGB . dgb
zinc insulin	drug	zinc	drug
false

DRUGA should not be used with other DRUGB .
RAPTIVA	brand	immunosuppressive drugs	group
advise

DRUGA , DRUGB and DRUGN should not be administered during DRUGN treatment .
Acellular vaccines	group	live vaccines	group
false

DRUGA , DRUGN and DRUGB should not be administered during DRUGN treatment .
Acellular vaccines	group	live-attenuated vaccines	group
false

DRUGA , DRUGN and DRUGN should not be administered during DRUGB treatment .
Acellular vaccines	group	RAPTIVA	brand
advise

DRUGN , DRUGA and DRUGB should not be administered during DRUGN treatment .
live vaccines	group	live-attenuated vaccines	group
false

DRUGN , DRUGA and DRUGN should not be administered during DRUGB treatment .
live vaccines	group	RAPTIVA	brand
advise

DRUGN , DRUGN and DRUGA should not be administered during DRUGB treatment .
live-attenuated vaccines	group	RAPTIVA	brand
advise

Other compounds that are substrates of CYPdgbAdgb may have decreased plasma concentrations when coadministered with DRUGA ( DRUGB ) .
SUSTIVA	brand	efavirenz	drug
false

Drugs which induce CYPdgbAdgb activity ( eg , DRUGA , DRUGB , DRUGN ) would be expected to increase the clearance of DRUGN resulting in lowered plasma concentrations .
phenobarbital	drug	rifampin	drug
false

Drugs which induce CYPdgbAdgb activity ( eg , DRUGA , DRUGN , DRUGB ) would be expected to increase the clearance of DRUGN resulting in lowered plasma concentrations .
phenobarbital	drug	rifabutin	drug
false

Drugs which induce CYPdgbAdgb activity ( eg , DRUGA , DRUGN , DRUGN ) would be expected to increase the clearance of DRUGB resulting in lowered plasma concentrations .
phenobarbital	drug	efavirenz	drug
mechanism

Drugs which induce CYPdgbAdgb activity ( eg , DRUGN , DRUGA , DRUGB ) would be expected to increase the clearance of DRUGN resulting in lowered plasma concentrations .
rifampin	drug	rifabutin	drug
false

Drugs which induce CYPdgbAdgb activity ( eg , DRUGN , DRUGA , DRUGN ) would be expected to increase the clearance of DRUGB resulting in lowered plasma concentrations .
rifampin	drug	efavirenz	drug
mechanism

Drugs which induce CYPdgbAdgb activity ( eg , DRUGN , DRUGN , DRUGA ) would be expected to increase the clearance of DRUGB resulting in lowered plasma concentrations .
rifabutin	drug	efavirenz	drug
mechanism

DRUGA : DRUGB GI Motility Agents DRUGN DRUGN
Antihistamines	group	Benzodiazepines	group
false

DRUGA : DRUGN GI Motility Agents DRUGB DRUGN
Antihistamines	group	Anti-Migraine	group
false

DRUGA : DRUGN GI Motility Agents DRUGN DRUGB
Antihistamines	group	Antifungal	group
false

DRUGN : DRUGA GI Motility Agents DRUGB DRUGN
Benzodiazepines	group	Anti-Migraine	group
false

DRUGN : DRUGA GI Motility Agents DRUGN DRUGB
Benzodiazepines	group	Antifungal	group
false

DRUGN : DRUGN GI Motility Agents DRUGA DRUGB
Anti-Migraine	group	Antifungal	group
false

DRUGA DRUGB , DRUGN DRUGN ergot derivatives DRUGN
astemizole	drug	midazolam	drug
false

DRUGA DRUGN , DRUGB DRUGN ergot derivatives DRUGN
astemizole	drug	triazolam	drug
false

DRUGA DRUGN , DRUGN DRUGB ergot derivatives DRUGN
astemizole	drug	cisapride	drug
false

DRUGA DRUGN , DRUGN DRUGN ergot derivatives DRUGB
astemizole	drug	voriconazole	drug
false

DRUGN DRUGA , DRUGB DRUGN ergot derivatives DRUGN
midazolam	drug	triazolam	drug
false

DRUGN DRUGA , DRUGN DRUGB ergot derivatives DRUGN
midazolam	drug	cisapride	drug
false

DRUGN DRUGA , DRUGN DRUGN ergot derivatives DRUGB
midazolam	drug	voriconazole	drug
false

DRUGN DRUGN , DRUGA DRUGB ergot derivatives DRUGN
triazolam	drug	cisapride	drug
false

DRUGN DRUGN , DRUGA DRUGN ergot derivatives DRUGB
triazolam	drug	voriconazole	drug
false

DRUGN DRUGN , DRUGN DRUGA ergot derivatives DRUGB
cisapride	drug	voriconazole	drug
false

When coadministered with DRUGA in treatment naive patients , the recommended dose of DRUGB is dgb mg with DRUGN dgb mg and DRUGN dgb mg ( all once daily ) .
SUSTIVA	brand	atazanavir	drug
false

When coadministered with DRUGA in treatment naive patients , the recommended dose of DRUGN is dgb mg with DRUGB dgb mg and DRUGN dgb mg ( all once daily ) .
SUSTIVA	brand	ritonavir	drug
false

When coadministered with DRUGN in treatment naive patients , the recommended dose of DRUGA is dgb mg with DRUGB dgb mg and DRUGN dgb mg ( all once daily ) .
atazanavir	drug	ritonavir	drug
false

When coadministered with DRUGN in treatment naive patients , the recommended dose of DRUGA is dgb mg with DRUGN dgb mg and DRUGB dgb mg ( all once daily ) .
atazanavir	drug	SUSTIVA	brand
false

When coadministered with DRUGN in treatment naive patients , the recommended dose of DRUGN is dgb mg with DRUGA dgb mg and DRUGB dgb mg ( all once daily ) .
ritonavir	drug	SUSTIVA	brand
false

Dosing recommendations for DRUGA and DRUGB in treatment experienced patients have not been established .
SUSTIVA	brand	atazanavir	drug
false

In uninfected volunteers , dgb % developed rash while receiving DRUGA and DRUGB .
SUSTIVA	brand	clarithromycin	drug
effect

No dose adjustment of DRUGA is recommended when given with DRUGB .
SUSTIVA	brand	clarithromycin	drug
false

Alternatives to DRUGA , such as DRUGB , should be considered .
clarithromycin	drug	azithromycin	drug
false

Other DRUGA , such as DRUGB , have not been studied in combination with DRUGN .
macrolide antibiotics	group	erythromycin	drug
false

Other DRUGA , such as DRUGN , have not been studied in combination with DRUGB .
macrolide antibiotics	group	SUSTIVA	brand
false

Other DRUGN , such as DRUGA , have not been studied in combination with DRUGB .
erythromycin	drug	SUSTIVA	brand
false

The optimal dose of DRUGA , when given in combination with DRUGB , is not known .
indinavir	drug	SUSTIVA	brand
false

Increasing the DRUGA dose to dgb mg every dgb hours does not compensate for the increased DRUGN metabolism due to DRUGB .
indinavir	drug	SUSTIVA	brand
false

Increasing the DRUGN dose to dgb mg every dgb hours does not compensate for the increased DRUGA metabolism due to DRUGB .
indinavir	drug	SUSTIVA	brand
mechanism

DRUGA / DRUGB
Lopinavir	drug	ritonavir	drug
false

A dose increase of DRUGA / DRUGB to dgb / dgb mg ( dgb capsules or dga mL ) twice daily taken with food is recommended when used in combination with DRUGN .
lopinavir	drug	ritonavir	drug
false

A dose increase of DRUGA / DRUGN to dgb / dgb mg ( dgb capsules or dga mL ) twice daily taken with food is recommended when used in combination with DRUGB .
lopinavir	drug	SUSTIVA	brand
advise

A dose increase of DRUGN / DRUGA to dgb / dgb mg ( dgb capsules or dga mL ) twice daily taken with food is recommended when used in combination with DRUGB .
ritonavir	drug	SUSTIVA	brand
advise

Coadministration in HIV infected individuals with a history of injection drug use resulted in decreased plasma levels of DRUGA and signs of DRUGB withdrawal .
methadone	drug	opiate	group
false

Plasma concentrations increased by DRUGA ( DRUGB ) ;
SUSTIVA	brand	efavirenz	drug
false

Because the potential interaction of DRUGA with oral DRUGB has not been fully characterized , a reliable method of barrier contraception should be used in addition to oral DRUGN .
efavirenz	drug	contraceptives	group
advise

Because the potential interaction of DRUGA with oral DRUGN has not been fully characterized , a reliable method of barrier contraception should be used in addition to oral DRUGB .
efavirenz	drug	contraceptives	group
false

Monitoring of liver enzymes is recommended when DRUGA is used in combination with DRUGB .
SUSTIVA	brand	ritonavir	drug
advise

Should not be used as sole DRUGA in combination with DRUGB .
protease inhibitor	group	SUSTIVA	brand
false

DRUGA : DRUGB
Anticoagulants	group	Warfarin	drug
false

DRUGA : DRUGB DRUGN DRUGN
Anticonvulsants	group	Phenytoin	drug
false

DRUGA : DRUGN DRUGB DRUGN
Anticonvulsants	group	Phenobarbital	drug
false

DRUGA : DRUGN DRUGN DRUGB
Anticonvulsants	group	Carbamazepine	drug
false

DRUGN : DRUGA DRUGB DRUGN
Phenytoin	drug	Phenobarbital	drug
false

DRUGN : DRUGA DRUGN DRUGB
Phenytoin	drug	Carbamazepine	drug
false

DRUGN : DRUGN DRUGA DRUGB
Phenobarbital	drug	Carbamazepine	drug
false

Potential for reduction in DRUGA and / or DRUGB plasma levels ;
anticonvulsant	group	efavirenz	drug
mechanism

DRUGA : DRUGB DRUGN
Antifungals	group	Itraconazole	drug
false

DRUGA : DRUGN DRUGB
Antifungals	group	Ketoconazole	drug
false

DRUGN : DRUGA DRUGB
Itraconazole	drug	Ketoconazole	drug
false

Drug interaction studies with DRUGA and these DRUGB and DRUGN have not been conducted .
SUSTIVA	brand	imidazole antifungals	group
false

Drug interaction studies with DRUGA and these DRUGN and DRUGB have not been conducted .
SUSTIVA	brand	triazole antifungals	group
false

Drug interaction studies with DRUGN and these DRUGA and DRUGB have not been conducted .
imidazole antifungals	group	triazole antifungals	group
false

DRUGA has the potential to decrease plasma concentrations of DRUGB and DRUGN .
SUSTIVA	brand	itraconazole	drug
mechanism

DRUGA has the potential to decrease plasma concentrations of DRUGN and DRUGB .
SUSTIVA	brand	ketoconazole	drug
mechanism

DRUGN has the potential to decrease plasma concentrations of DRUGA and DRUGB .
itraconazole	drug	ketoconazole	drug
false

DRUGA : DRUGB / DRUGN combination
Anti-HIV protease inhibitors	group	Saquinavir	drug
false

DRUGA : DRUGN / DRUGB combination
Anti-HIV protease inhibitors	group	ritonavir	drug
false

DRUGN : DRUGA / DRUGB combination
Saquinavir	drug	ritonavir	drug
false

Expected to substantially decrease plasma levels of DRUGA ; has not been studied in combination with DRUGB .
efavirenz	drug	SUSTIVA	brand
false

Specific drug interaction studies have not been performed with DRUGA and DRUGB other than DRUGN and DRUGN .
SUSTIVA	brand	NRTIs	group
false

Specific drug interaction studies have not been performed with DRUGA and DRUGN other than DRUGB and DRUGN .
SUSTIVA	brand	lamivudine	drug
false

Specific drug interaction studies have not been performed with DRUGA and DRUGN other than DRUGN and DRUGB .
SUSTIVA	brand	zidovudine	drug
false

Specific drug interaction studies have not been performed with DRUGN and DRUGA other than DRUGB and DRUGN .
NRTIs	group	lamivudine	drug
false

Specific drug interaction studies have not been performed with DRUGN and DRUGA other than DRUGN and DRUGB .
NRTIs	group	zidovudine	drug
false

Specific drug interaction studies have not been performed with DRUGN and DRUGN other than DRUGA and DRUGB .
lamivudine	drug	zidovudine	drug
false

Clinically significant interactions would not be expected since the DRUGA are metabolized via a different route than DRUGB and would be unlikely to compete for the same metabolic enzymes and elimination pathways .
NRTIs	group	efavirenz	drug
false

The potential for drug interactions with DRUGA has been studied in combination with DRUGB , DRUGN , DRUGN , and DRUGN .
EMTRIVA	brand	indinavir	drug
false

The potential for drug interactions with DRUGA has been studied in combination with DRUGN , DRUGB , DRUGN , and DRUGN .
EMTRIVA	brand	stavudine	drug
false

The potential for drug interactions with DRUGA has been studied in combination with DRUGN , DRUGN , DRUGB , and DRUGN .
EMTRIVA	brand	famciclovir	drug
false

The potential for drug interactions with DRUGA has been studied in combination with DRUGN , DRUGN , DRUGN , and DRUGB .
EMTRIVA	brand	tenofovir disoproxil fumarate	drug
false

The potential for drug interactions with DRUGN has been studied in combination with DRUGA , DRUGB , DRUGN , and DRUGN .
indinavir	drug	stavudine	drug
false

The potential for drug interactions with DRUGN has been studied in combination with DRUGA , DRUGN , DRUGB , and DRUGN .
indinavir	drug	famciclovir	drug
false

The potential for drug interactions with DRUGN has been studied in combination with DRUGA , DRUGN , DRUGN , and DRUGB .
indinavir	drug	tenofovir disoproxil fumarate	drug
false

The potential for drug interactions with DRUGN has been studied in combination with DRUGN , DRUGA , DRUGB , and DRUGN .
stavudine	drug	famciclovir	drug
false

The potential for drug interactions with DRUGN has been studied in combination with DRUGN , DRUGA , DRUGN , and DRUGB .
stavudine	drug	tenofovir disoproxil fumarate	drug
false

The potential for drug interactions with DRUGN has been studied in combination with DRUGN , DRUGN , DRUGA , and DRUGB .
famciclovir	drug	tenofovir disoproxil fumarate	drug
false

Hypotension : Patients on Diuretic Therapy : Patients on DRUGA and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with DRUGB or DRUGN .
diuretics	drug	enalapril	drug
effect

Hypotension : Patients on Diuretic Therapy : Patients on DRUGA and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with DRUGN or DRUGB .
diuretics	drug	enalaprilat	drug
effect

Hypotension : Patients on Diuretic Therapy : Patients on DRUGN and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with DRUGA or DRUGB .
enalapril	drug	enalaprilat	drug
false

The possibility of hypotensive effects with DRUGA or DRUGB can be minimized by either discontinuing the DRUGN or increasing the salt intake prior to initiation of treatment with DRUGN or DRUGN .
enalapril	drug	enalaprilat	drug
false

The possibility of hypotensive effects with DRUGA or DRUGN can be minimized by either discontinuing the DRUGB or increasing the salt intake prior to initiation of treatment with DRUGN or DRUGN .
enalapril	drug	diuretic	drug
effect

The possibility of hypotensive effects with DRUGA or DRUGN can be minimized by either discontinuing the DRUGN or increasing the salt intake prior to initiation of treatment with DRUGN or DRUGB .
enalapril	drug	enalaprilat	drug
false

The possibility of hypotensive effects with DRUGN or DRUGA can be minimized by either discontinuing the DRUGB or increasing the salt intake prior to initiation of treatment with DRUGN or DRUGN .
enalaprilat	drug	diuretic	drug
effect

The possibility of hypotensive effects with DRUGN or DRUGA can be minimized by either discontinuing the DRUGN or increasing the salt intake prior to initiation of treatment with DRUGB or DRUGN .
enalaprilat	drug	enalapril	drug
false

The possibility of hypotensive effects with DRUGN or DRUGN can be minimized by either discontinuing the DRUGA or increasing the salt intake prior to initiation of treatment with DRUGB or DRUGN .
diuretic	drug	enalapril	drug
false

The possibility of hypotensive effects with DRUGN or DRUGN can be minimized by either discontinuing the DRUGA or increasing the salt intake prior to initiation of treatment with DRUGN or DRUGB .
diuretic	drug	enalaprilat	drug
false

The possibility of hypotensive effects with DRUGN or DRUGN can be minimized by either discontinuing the DRUGN or increasing the salt intake prior to initiation of treatment with DRUGA or DRUGB .
enalapril	drug	enalaprilat	drug
false

Agents Causing Renin Release : The antihypertensive effect of DRUGA and DRUGN IV is augmented by DRUGB that cause renin release ( e.g . , DRUGN ) .
enalapril	drug	antihypertensive agents	group
effect

Agents Causing Renin Release : The antihypertensive effect of DRUGA and DRUGN IV is augmented by DRUGN that cause renin release ( e.g . , DRUGB ) .
enalapril	drug	diuretics	group
effect

Agents Causing Renin Release : The antihypertensive effect of DRUGN and DRUGA IV is augmented by DRUGB that cause renin release ( e.g . , DRUGN ) .
enalapril	drug	antihypertensive agents	group
effect

Agents Causing Renin Release : The antihypertensive effect of DRUGN and DRUGA IV is augmented by DRUGN that cause renin release ( e.g . , DRUGB ) .
enalapril	drug	diuretics	group
effect

Agents Causing Renin Release : The antihypertensive effect of DRUGN and DRUGN IV is augmented by DRUGA that cause renin release ( e.g . , DRUGB ) .
antihypertensive agents	group	diuretics	group
false

DRUGA : In some patients with compromised renal function who are being treated with DRUGB , the co administration of DRUGN may result in a further deterioration of renal function .
Non-steroidal Anti-inflammatory Agents	group	nonsteroidal anti-inflammatory drugs	group
false

DRUGA : In some patients with compromised renal function who are being treated with DRUGN , the co administration of DRUGB may result in a further deterioration of renal function .
Non-steroidal Anti-inflammatory Agents	group	enalapril	drug
false

DRUGN : In some patients with compromised renal function who are being treated with DRUGA , the co administration of DRUGB may result in a further deterioration of renal function .
nonsteroidal anti-inflammatory drugs	group	enalapril	drug
effect

In a clinical pharmacology study , DRUGA or DRUGB was administered to hypertensive patients receiving DRUGN .
indomethacin	drug	sulindac	drug
false

In a clinical pharmacology study , DRUGA or DRUGN was administered to hypertensive patients receiving DRUGB .
indomethacin	drug	VASOTEC	brand
false

In a clinical pharmacology study , DRUGN or DRUGA was administered to hypertensive patients receiving DRUGB .
sulindac	drug	VASOTEC	brand
false

However , reports suggest that DRUGA may diminish the antihypertensive effect of DRUGB .
NSAIDs	group	ACE inhibitors	group
effect

This interaction should be given consideration in patients taking DRUGA concomitantly with DRUGB .
NSAIDs	group	ACE inhibitors	group
advise

Other Cardiovascular Agents : DRUGA and DRUGB IV have been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
Enalapril	drug	enalapril	drug
false

Other Cardiovascular Agents : DRUGA and DRUGN IV have been used concomitantly with DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
Enalapril	drug	beta adrenergic-blocking agents	group
false

Other Cardiovascular Agents : DRUGA and DRUGN IV have been used concomitantly with DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
Enalapril	drug	methyldopa	drug
false

Other Cardiovascular Agents : DRUGA and DRUGN IV have been used concomitantly with DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
Enalapril	drug	nitrates	group
false

Other Cardiovascular Agents : DRUGA and DRUGN IV have been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
Enalapril	drug	calcium-blocking agents	group
false

Other Cardiovascular Agents : DRUGA and DRUGN IV have been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
Enalapril	drug	hydralazine	drug
false

Other Cardiovascular Agents : DRUGA and DRUGN IV have been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB and DRUGN without evidence of clinically significant adverse interactions .
Enalapril	drug	prazosin	drug
false

Other Cardiovascular Agents : DRUGA and DRUGN IV have been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGB without evidence of clinically significant adverse interactions .
Enalapril	drug	digoxin	drug
false

Other Cardiovascular Agents : DRUGN and DRUGA IV have been used concomitantly with DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
enalapril	drug	beta adrenergic-blocking agents	group
false

Other Cardiovascular Agents : DRUGN and DRUGA IV have been used concomitantly with DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
enalapril	drug	methyldopa	drug
false

Other Cardiovascular Agents : DRUGN and DRUGA IV have been used concomitantly with DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
enalapril	drug	nitrates	group
false

Other Cardiovascular Agents : DRUGN and DRUGA IV have been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
enalapril	drug	calcium-blocking agents	group
false

Other Cardiovascular Agents : DRUGN and DRUGA IV have been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
enalapril	drug	hydralazine	drug
false

Other Cardiovascular Agents : DRUGN and DRUGA IV have been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB and DRUGN without evidence of clinically significant adverse interactions .
enalapril	drug	prazosin	drug
false

Other Cardiovascular Agents : DRUGN and DRUGA IV have been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGB without evidence of clinically significant adverse interactions .
enalapril	drug	digoxin	drug
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
beta adrenergic-blocking agents	group	methyldopa	drug
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
beta adrenergic-blocking agents	group	nitrates	group
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
beta adrenergic-blocking agents	group	calcium-blocking agents	group
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
beta adrenergic-blocking agents	group	hydralazine	drug
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB and DRUGN without evidence of clinically significant adverse interactions .
beta adrenergic-blocking agents	group	prazosin	drug
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGB without evidence of clinically significant adverse interactions .
beta adrenergic-blocking agents	group	digoxin	drug
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
methyldopa	drug	nitrates	group
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
methyldopa	drug	calcium-blocking agents	group
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
methyldopa	drug	hydralazine	drug
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB and DRUGN without evidence of clinically significant adverse interactions .
methyldopa	drug	prazosin	drug
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN and DRUGB without evidence of clinically significant adverse interactions .
methyldopa	drug	digoxin	drug
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
nitrates	group	calcium-blocking agents	group
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
nitrates	group	hydralazine	drug
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB and DRUGN without evidence of clinically significant adverse interactions .
nitrates	group	prazosin	drug
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN and DRUGB without evidence of clinically significant adverse interactions .
nitrates	group	digoxin	drug
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN and DRUGN without evidence of clinically significant adverse interactions .
calcium-blocking agents	group	hydralazine	drug
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB and DRUGN without evidence of clinically significant adverse interactions .
calcium-blocking agents	group	prazosin	drug
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN and DRUGB without evidence of clinically significant adverse interactions .
calcium-blocking agents	group	digoxin	drug
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB and DRUGN without evidence of clinically significant adverse interactions .
hydralazine	drug	prazosin	drug
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN and DRUGB without evidence of clinically significant adverse interactions .
hydralazine	drug	digoxin	drug
false

Other Cardiovascular Agents : DRUGN and DRUGN IV have been used concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA and DRUGB without evidence of clinically significant adverse interactions .
prazosin	drug	digoxin	drug
false

DRUGA IV has been used concomitantly with DRUGB without evidence of clinically significant adverse reactions .
Enalapril	drug	digitalis	group
false

Agents Increasing Serum Potassium : DRUGA and DRUGB IV attenuate potassium loss caused by DRUGN .
Enalapril	drug	enalapril	drug
false

Agents Increasing Serum Potassium : DRUGA and DRUGN IV attenuate potassium loss caused by DRUGB .
Enalapril	drug	thiazide-type diuretics	group
effect

Agents Increasing Serum Potassium : DRUGN and DRUGA IV attenuate potassium loss caused by DRUGB .
enalapril	drug	thiazide-type diuretics	group
effect

DRUGA ( e.g . , DRUGB , DRUGN , or DRUGN ) , DRUGN supplements , or DRUGN containing salt substitutes may lead to significant increases in serum potassium .
Potassium-sparing diuretics	group	spironolactone	drug
false

DRUGA ( e.g . , DRUGN , DRUGB , or DRUGN ) , DRUGN supplements , or DRUGN containing salt substitutes may lead to significant increases in serum potassium .
Potassium-sparing diuretics	group	triamterene	drug
false

DRUGA ( e.g . , DRUGN , DRUGN , or DRUGB ) , DRUGN supplements , or DRUGN containing salt substitutes may lead to significant increases in serum potassium .
Potassium-sparing diuretics	group	amiloride	drug
false

DRUGA ( e.g . , DRUGN , DRUGN , or DRUGN ) , DRUGB supplements , or DRUGN containing salt substitutes may lead to significant increases in serum potassium .
Potassium-sparing diuretics	group	potassium	drug
false

DRUGA ( e.g . , DRUGN , DRUGN , or DRUGN ) , DRUGN supplements , or DRUGB containing salt substitutes may lead to significant increases in serum potassium .
Potassium-sparing diuretics	group	potassium	drug
false

DRUGN ( e.g . , DRUGA , DRUGB , or DRUGN ) , DRUGN supplements , or DRUGN containing salt substitutes may lead to significant increases in serum potassium .
spironolactone	drug	triamterene	drug
false

DRUGN ( e.g . , DRUGA , DRUGN , or DRUGB ) , DRUGN supplements , or DRUGN containing salt substitutes may lead to significant increases in serum potassium .
spironolactone	drug	amiloride	drug
false

DRUGN ( e.g . , DRUGA , DRUGN , or DRUGN ) , DRUGB supplements , or DRUGN containing salt substitutes may lead to significant increases in serum potassium .
spironolactone	drug	potassium	drug
false

DRUGN ( e.g . , DRUGA , DRUGN , or DRUGN ) , DRUGN supplements , or DRUGB containing salt substitutes may lead to significant increases in serum potassium .
spironolactone	drug	potassium	drug
false

DRUGN ( e.g . , DRUGN , DRUGA , or DRUGB ) , DRUGN supplements , or DRUGN containing salt substitutes may lead to significant increases in serum potassium .
triamterene	drug	amiloride	drug
false

DRUGN ( e.g . , DRUGN , DRUGA , or DRUGN ) , DRUGB supplements , or DRUGN containing salt substitutes may lead to significant increases in serum potassium .
triamterene	drug	potassium	drug
false

DRUGN ( e.g . , DRUGN , DRUGA , or DRUGN ) , DRUGN supplements , or DRUGB containing salt substitutes may lead to significant increases in serum potassium .
triamterene	drug	potassium	drug
false

DRUGN ( e.g . , DRUGN , DRUGN , or DRUGA ) , DRUGB supplements , or DRUGN containing salt substitutes may lead to significant increases in serum potassium .
amiloride	drug	potassium	drug
false

DRUGN ( e.g . , DRUGN , DRUGN , or DRUGA ) , DRUGN supplements , or DRUGB containing salt substitutes may lead to significant increases in serum potassium .
amiloride	drug	potassium	drug
false

DRUGA : DRUGN toxicity has been reported in patients receiving DRUGB concomitantly with drugs which cause elimination of sodium , including DRUGN .
Lithium	drug	lithium	drug
false

DRUGA : DRUGN toxicity has been reported in patients receiving DRUGN concomitantly with drugs which cause elimination of sodium , including DRUGB .
Lithium	drug	ACE inhibitors	group
false

DRUGN : DRUGA toxicity has been reported in patients receiving DRUGB concomitantly with drugs which cause elimination of sodium , including DRUGN .
Lithium	drug	lithium	drug
false

DRUGN : DRUGA toxicity has been reported in patients receiving DRUGN concomitantly with drugs which cause elimination of sodium , including DRUGB .
Lithium	drug	ACE inhibitors	group
false

DRUGN : DRUGN toxicity has been reported in patients receiving DRUGA concomitantly with drugs which cause elimination of sodium , including DRUGB .
lithium	drug	ACE inhibitors	group
effect

It is recommended that serum DRUGA levels be monitored frequently if DRUGB is administered concomitantly with DRUGN .
lithium	drug	enalapril	drug
false

It is recommended that serum DRUGN levels be monitored frequently if DRUGA is administered concomitantly with DRUGB .
enalapril	drug	lithium	drug
advise

If the usual amounts of nondepolarizing relaxants are given , the time for recovery from neuromuscular blockade will be longer in the presence of DRUGA than when DRUGB or DRUGN with a balanced technique are used .
Enflurane	drug	halothane	drug
false

If the usual amounts of nondepolarizing relaxants are given , the time for recovery from neuromuscular blockade will be longer in the presence of DRUGA than when DRUGN or DRUGB with a balanced technique are used .
Enflurane	drug	nitrous oxide	drug
false

If the usual amounts of nondepolarizing relaxants are given , the time for recovery from neuromuscular blockade will be longer in the presence of DRUGN than when DRUGA or DRUGB with a balanced technique are used .
halothane	drug	nitrous oxide	drug
false

DRUGA : No drug interactions with other DRUGB have been identified that would warrant alteration of either the DRUGN dose or the dose of the other DRUGN .
Antiretroviral Agents	group	antiretroviral medications	group
false

DRUGA : No drug interactions with other DRUGN have been identified that would warrant alteration of either the DRUGB dose or the dose of the other DRUGN .
Antiretroviral Agents	group	enfuvirtide	drug
false

DRUGA : No drug interactions with other DRUGN have been identified that would warrant alteration of either the DRUGN dose or the dose of the other DRUGB .
Antiretroviral Agents	group	antiretroviral medication	group
false

DRUGN : No drug interactions with other DRUGA have been identified that would warrant alteration of either the DRUGB dose or the dose of the other DRUGN .
antiretroviral medications	group	enfuvirtide	drug
false

DRUGN : No drug interactions with other DRUGA have been identified that would warrant alteration of either the DRUGN dose or the dose of the other DRUGB .
antiretroviral medications	group	antiretroviral medication	group
false

DRUGN : No drug interactions with other DRUGN have been identified that would warrant alteration of either the DRUGA dose or the dose of the other DRUGB .
enfuvirtide	drug	antiretroviral medication	group
false

DRUGA : DRUGB , given concomitantly with DRUGN or dgb minutes following DRUGN administration , decreased DRUGN bioavailability by approximately dgb % .
Bismuth	drug	Bismuth subsalicylate	drug
false

DRUGA : DRUGN , given concomitantly with DRUGB or dgb minutes following DRUGN administration , decreased DRUGN bioavailability by approximately dgb % .
Bismuth	drug	enoxacin	drug
false

DRUGA : DRUGN , given concomitantly with DRUGN or dgb minutes following DRUGB administration , decreased DRUGN bioavailability by approximately dgb % .
Bismuth	drug	enoxacin	drug
false

DRUGA : DRUGN , given concomitantly with DRUGN or dgb minutes following DRUGN administration , decreased DRUGB bioavailability by approximately dgb % .
Bismuth	drug	enoxacin	drug
false

DRUGN : DRUGA , given concomitantly with DRUGB or dgb minutes following DRUGN administration , decreased DRUGN bioavailability by approximately dgb % .
Bismuth subsalicylate	drug	enoxacin	drug
mechanism

DRUGN : DRUGA , given concomitantly with DRUGN or dgb minutes following DRUGB administration , decreased DRUGN bioavailability by approximately dgb % .
Bismuth subsalicylate	drug	enoxacin	drug
false

DRUGN : DRUGA , given concomitantly with DRUGN or dgb minutes following DRUGN administration , decreased DRUGB bioavailability by approximately dgb % .
Bismuth subsalicylate	drug	enoxacin	drug
false

Thus , concomitant administration of DRUGA and DRUGB should be avoided .
enoxacin	drug	bismuth subsalicylate	drug
advise

DRUGA : DRUGB is a potent inhibitor of the cytochrome P dgb isozymes responsible for the metabolism of DRUGN .
Caffeine	drug	Enoxacin	drug
false

DRUGA : DRUGN is a potent inhibitor of the cytochrome P dgb isozymes responsible for the metabolism of DRUGB .
Caffeine	drug	methylxanthines	group
false

DRUGN : DRUGA is a potent inhibitor of the cytochrome P dgb isozymes responsible for the metabolism of DRUGB .
Enoxacin	drug	methylxanthines	group
mechanism

Trough plasma DRUGA levels were also dgb % higher when DRUGB and DRUGN were administered concomitantly .
enoxacin	drug	caffeine	drug
false

Trough plasma DRUGN levels were also dgb % higher when DRUGA and DRUGB were administered concomitantly .
caffeine	drug	enoxacin	drug
mechanism

DRUGA related adverse effects have occurred in patients consuming DRUGB while on therapy with DRUGN .
Caffeine	drug	caffeine	drug
false

DRUGA related adverse effects have occurred in patients consuming DRUGN while on therapy with DRUGB .
Caffeine	drug	enoxacin	drug
false

DRUGN related adverse effects have occurred in patients consuming DRUGA while on therapy with DRUGB .
caffeine	drug	enoxacin	drug
effect

DRUGA : Elevated serum levels of DRUGB have been reported with concomitant use of DRUGN with other members of the DRUGN .
Cyclosporine	drug	cyclosporine	drug
false

DRUGA : Elevated serum levels of DRUGN have been reported with concomitant use of DRUGB with other members of the DRUGN .
Cyclosporine	drug	cyclosporine	drug
false

DRUGA : Elevated serum levels of DRUGN have been reported with concomitant use of DRUGN with other members of the DRUGB .
Cyclosporine	drug	quinolone class	group
false

DRUGN : Elevated serum levels of DRUGA have been reported with concomitant use of DRUGN with other members of the DRUGB .
cyclosporine	drug	quinolone class	group
false

DRUGN : Elevated serum levels of DRUGN have been reported with concomitant use of DRUGA with other members of the DRUGB .
cyclosporine	drug	quinolone class	group
mechanism

DRUGA : DRUGB may raise serum DRUGN levels in some individuals .
Digoxin	drug	Enoxacin	drug
false

DRUGA : DRUGN may raise serum DRUGB levels in some individuals .
Digoxin	drug	digoxin	drug
false

DRUGN : DRUGA may raise serum DRUGB levels in some individuals .
Enoxacin	drug	digoxin	drug
mechanism

If signs and symptoms suggestive of DRUGA toxicity occur when DRUGB and DRUGN are given concomitantly , physicians are advised to obtain serum DRUGN levels and adjust DRUGN doses appropriately .
digoxin	drug	enoxacin	drug
false

If signs and symptoms suggestive of DRUGN toxicity occur when DRUGA and DRUGB are given concomitantly , physicians are advised to obtain serum DRUGN levels and adjust DRUGN doses appropriately .
enoxacin	drug	digoxin	drug
effect

If signs and symptoms suggestive of DRUGN toxicity occur when DRUGA and DRUGN are given concomitantly , physicians are advised to obtain serum DRUGB levels and adjust DRUGN doses appropriately .
enoxacin	drug	digoxin	drug
false

If signs and symptoms suggestive of DRUGN toxicity occur when DRUGA and DRUGN are given concomitantly , physicians are advised to obtain serum DRUGN levels and adjust DRUGB doses appropriately .
enoxacin	drug	digoxin	drug
false

DRUGA : Seizures have been reported in patients taking DRUGB concomitantly with the DRUGN DRUGN .
Non-steroidal anti-inflammatory agents	group	enoxacin	drug
false

DRUGA : Seizures have been reported in patients taking DRUGN concomitantly with the DRUGB DRUGN .
Non-steroidal anti-inflammatory agents	group	nonsteroidal anti-inflammatory drug	group
false

DRUGA : Seizures have been reported in patients taking DRUGN concomitantly with the DRUGN DRUGB .
Non-steroidal anti-inflammatory agents	group	fenbufen	drug
false

DRUGN : Seizures have been reported in patients taking DRUGA concomitantly with the DRUGB DRUGN .
enoxacin	drug	nonsteroidal anti-inflammatory drug	group
false

DRUGN : Seizures have been reported in patients taking DRUGA concomitantly with the DRUGN DRUGB .
enoxacin	drug	fenbufen	drug
effect

DRUGN : Seizures have been reported in patients taking DRUGN concomitantly with the DRUGA DRUGB .
nonsteroidal anti-inflammatory drug	group	fenbufen	drug
false

DRUGA and DRUGB : DRUGN form chelates with metal cations .
Sucralfate	drug	antacids	group
false

DRUGA and DRUGN : DRUGB form chelates with metal cations .
Sucralfate	drug	Quinolones	group
false

DRUGN and DRUGA : DRUGB form chelates with metal cations .
antacids	group	Quinolones	group
false

Therefore , administration of DRUGA with DRUGB containing DRUGN , DRUGN , or DRUGN ;
quinolones	group	antacids	group
false

Therefore , administration of DRUGA with DRUGN containing DRUGB , DRUGN , or DRUGN ;
quinolones	group	calcium	drug
false

Therefore , administration of DRUGA with DRUGN containing DRUGN , DRUGB , or DRUGN ;
quinolones	group	magnesium	drug
false

Therefore , administration of DRUGA with DRUGN containing DRUGN , DRUGN , or DRUGB ;
quinolones	group	aluminum	drug
false

Therefore , administration of DRUGN with DRUGA containing DRUGB , DRUGN , or DRUGN ;
antacids	group	calcium	drug
false

Therefore , administration of DRUGN with DRUGA containing DRUGN , DRUGB , or DRUGN ;
antacids	group	magnesium	drug
false

Therefore , administration of DRUGN with DRUGA containing DRUGN , DRUGN , or DRUGB ;
antacids	group	aluminum	drug
false

Therefore , administration of DRUGN with DRUGN containing DRUGA , DRUGB , or DRUGN ;
calcium	drug	magnesium	drug
false

Therefore , administration of DRUGN with DRUGN containing DRUGA , DRUGN , or DRUGB ;
calcium	drug	aluminum	drug
false

Therefore , administration of DRUGN with DRUGN containing DRUGN , DRUGA , or DRUGB ;
magnesium	drug	aluminum	drug
false

or with DRUGA containing DRUGB may substantially interfere with drug absorption and result in insufficient plasma and tissue DRUGN concentrations .
multivitamins	group	zinc	drug
false

or with DRUGA containing DRUGN may substantially interfere with drug absorption and result in insufficient plasma and tissue DRUGB concentrations .
multivitamins	group	quinolone	group
false

or with DRUGN containing DRUGA may substantially interfere with drug absorption and result in insufficient plasma and tissue DRUGB concentrations .
zinc	drug	quinolone	group
mechanism

DRUGA containing DRUGB and DRUGN reduce the oral absorption of DRUGN by dgb % .
Antacids	group	aluminum hydroxide	drug
false

DRUGA containing DRUGN and DRUGB reduce the oral absorption of DRUGN by dgb % .
Antacids	group	magnesium hydroxide	drug
false

DRUGA containing DRUGN and DRUGN reduce the oral absorption of DRUGB by dgb % .
Antacids	group	enoxacin	drug
false

DRUGN containing DRUGA and DRUGB reduce the oral absorption of DRUGN by dgb % .
aluminum hydroxide	drug	magnesium hydroxide	drug
false

DRUGN containing DRUGA and DRUGN reduce the oral absorption of DRUGB by dgb % .
aluminum hydroxide	drug	enoxacin	drug
mechanism

DRUGN containing DRUGN and DRUGA reduce the oral absorption of DRUGB by dgb % .
magnesium hydroxide	drug	enoxacin	drug
mechanism

The oral bioavailability of DRUGA is reduced by dgb % with coadministration of DRUGB .
enoxacin	drug	ranitidine	drug
mechanism

DRUGA : DRUGB is a potent inhibitor of the cytochrome P dgb isozymes responsible for the metabolism of DRUGN .
Theophylline	drug	Enoxacin	drug
false

DRUGA : DRUGN is a potent inhibitor of the cytochrome P dgb isozymes responsible for the metabolism of DRUGB .
Theophylline	drug	methylxanthines	group
false

DRUGN : DRUGA is a potent inhibitor of the cytochrome P dgb isozymes responsible for the metabolism of DRUGB .
Enoxacin	drug	methylxanthines	group
mechanism

DRUGA interferes with the metabolism of DRUGB resulting in a dgb % to dgb % dose related decrease in DRUGN clearance and a subsequent dgb % to dgb % increase in serum theophylline levels .
Enoxacin	drug	theophylline	drug
mechanism

DRUGA interferes with the metabolism of DRUGN resulting in a dgb % to dgb % dose related decrease in DRUGB clearance and a subsequent dgb % to dgb % increase in serum theophylline levels .
Enoxacin	drug	theophylline	drug
false

DRUGA related adverse effects have occurred in patients when DRUGB and DRUGN were coadministered .
Theophylline	drug	theophylline	drug
false

DRUGA related adverse effects have occurred in patients when DRUGN and DRUGB were coadministered .
Theophylline	drug	enoxacin	drug
false

DRUGN related adverse effects have occurred in patients when DRUGA and DRUGB were coadministered .
theophylline	drug	enoxacin	drug
effect

DRUGA : DRUGB , including DRUGN , decrease the clearance of DRUGN , the less active isomer of racemic DRUGN .
Warfarin	drug	Quinolones	group
false

DRUGA : DRUGN , including DRUGB , decrease the clearance of DRUGN , the less active isomer of racemic DRUGN .
Warfarin	drug	enoxacin	drug
false

DRUGA : DRUGN , including DRUGN , decrease the clearance of DRUGB , the less active isomer of racemic DRUGN .
Warfarin	drug	R-warfarin	drug
false

DRUGA : DRUGN , including DRUGN , decrease the clearance of DRUGN , the less active isomer of racemic DRUGB .
Warfarin	drug	warfarin	drug
false

DRUGN : DRUGA , including DRUGB , decrease the clearance of DRUGN , the less active isomer of racemic DRUGN .
Quinolones	group	enoxacin	drug
false

DRUGN : DRUGA , including DRUGN , decrease the clearance of DRUGB , the less active isomer of racemic DRUGN .
Quinolones	group	R-warfarin	drug
mechanism

DRUGN : DRUGA , including DRUGN , decrease the clearance of DRUGN , the less active isomer of racemic DRUGB .
Quinolones	group	warfarin	drug
false

DRUGN : DRUGN , including DRUGA , decrease the clearance of DRUGB , the less active isomer of racemic DRUGN .
enoxacin	drug	R-warfarin	drug
mechanism

DRUGN : DRUGN , including DRUGA , decrease the clearance of DRUGN , the less active isomer of racemic DRUGB .
enoxacin	drug	warfarin	drug
false

DRUGN : DRUGN , including DRUGN , decrease the clearance of DRUGA , the less active isomer of racemic DRUGB .
R-warfarin	drug	warfarin	drug
false

DRUGA does not affect the clearance of the active S isomer , and changes in clotting time have not been observed when DRUGB and DRUGN were coadministered .
Enoxacin	drug	enoxacin	drug
false

DRUGA does not affect the clearance of the active S isomer , and changes in clotting time have not been observed when DRUGN and DRUGB were coadministered .
Enoxacin	drug	warfarin	drug
false

DRUGN does not affect the clearance of the active S isomer , and changes in clotting time have not been observed when DRUGA and DRUGB were coadministered .
enoxacin	drug	warfarin	drug
false

Nevertheless , the prothrombin time or other suitable coagulation test should be monitored when DRUGA or its derivatives and DRUGB are given concomitantly .
warfarin	drug	enoxacin	drug
advise

These agents include medications such as : DRUGA , DRUGB including DRUGN , sali cylates , DRUGN ( including DRUGN ) , DRUGN , or DRUGN .
anticoagulants	group	platelet inhibitors	group
false

These agents include medications such as : DRUGA , DRUGN including DRUGB , sali cylates , DRUGN ( including DRUGN ) , DRUGN , or DRUGN .
anticoagulants	group	acetylsalicylic acid	drug
false

These agents include medications such as : DRUGA , DRUGN including DRUGN , sali cylates , DRUGB ( including DRUGN ) , DRUGN , or DRUGN .
anticoagulants	group	NSAIDs	group
false

These agents include medications such as : DRUGA , DRUGN including DRUGN , sali cylates , DRUGN ( including DRUGB ) , DRUGN , or DRUGN .
anticoagulants	group	ketorolac tromethamine	drug
false

These agents include medications such as : DRUGA , DRUGN including DRUGN , sali cylates , DRUGN ( including DRUGN ) , DRUGB , or DRUGN .
anticoagulants	group	dipyridamole	drug
false

These agents include medications such as : DRUGA , DRUGN including DRUGN , sali cylates , DRUGN ( including DRUGN ) , DRUGN , or DRUGB .
anticoagulants	group	sulfinpyrazone	drug
false

These agents include medications such as : DRUGN , DRUGA including DRUGB , sali cylates , DRUGN ( including DRUGN ) , DRUGN , or DRUGN .
platelet inhibitors	group	acetylsalicylic acid	drug
false

These agents include medications such as : DRUGN , DRUGA including DRUGN , sali cylates , DRUGB ( including DRUGN ) , DRUGN , or DRUGN .
platelet inhibitors	group	NSAIDs	group
false

These agents include medications such as : DRUGN , DRUGA including DRUGN , sali cylates , DRUGN ( including DRUGB ) , DRUGN , or DRUGN .
platelet inhibitors	group	ketorolac tromethamine	drug
false

These agents include medications such as : DRUGN , DRUGA including DRUGN , sali cylates , DRUGN ( including DRUGN ) , DRUGB , or DRUGN .
platelet inhibitors	group	dipyridamole	drug
false

These agents include medications such as : DRUGN , DRUGA including DRUGN , sali cylates , DRUGN ( including DRUGN ) , DRUGN , or DRUGB .
platelet inhibitors	group	sulfinpyrazone	drug
false

These agents include medications such as : DRUGN , DRUGN including DRUGA , sali cylates , DRUGB ( including DRUGN ) , DRUGN , or DRUGN .
acetylsalicylic acid	drug	NSAIDs	group
false

These agents include medications such as : DRUGN , DRUGN including DRUGA , sali cylates , DRUGN ( including DRUGB ) , DRUGN , or DRUGN .
acetylsalicylic acid	drug	ketorolac tromethamine	drug
false

These agents include medications such as : DRUGN , DRUGN including DRUGA , sali cylates , DRUGN ( including DRUGN ) , DRUGB , or DRUGN .
acetylsalicylic acid	drug	dipyridamole	drug
false

These agents include medications such as : DRUGN , DRUGN including DRUGA , sali cylates , DRUGN ( including DRUGN ) , DRUGN , or DRUGB .
acetylsalicylic acid	drug	sulfinpyrazone	drug
false

These agents include medications such as : DRUGN , DRUGN including DRUGN , sali cylates , DRUGA ( including DRUGB ) , DRUGN , or DRUGN .
NSAIDs	group	ketorolac tromethamine	drug
false

These agents include medications such as : DRUGN , DRUGN including DRUGN , sali cylates , DRUGA ( including DRUGN ) , DRUGB , or DRUGN .
NSAIDs	group	dipyridamole	drug
false

These agents include medications such as : DRUGN , DRUGN including DRUGN , sali cylates , DRUGA ( including DRUGN ) , DRUGN , or DRUGB .
NSAIDs	group	sulfinpyrazone	drug
false

These agents include medications such as : DRUGN , DRUGN including DRUGN , sali cylates , DRUGN ( including DRUGA ) , DRUGB , or DRUGN .
ketorolac tromethamine	drug	dipyridamole	drug
false

These agents include medications such as : DRUGN , DRUGN including DRUGN , sali cylates , DRUGN ( including DRUGA ) , DRUGN , or DRUGB .
ketorolac tromethamine	drug	sulfinpyrazone	drug
false

These agents include medications such as : DRUGN , DRUGN including DRUGN , sali cylates , DRUGN ( including DRUGN ) , DRUGA , or DRUGB .
dipyridamole	drug	sulfinpyrazone	drug
false

In vitro studies have shown no binding displacement between DRUGA and other highly bound drugs , such as DRUGB , DRUGN , DRUGN , and DRUGN .
entacapone	drug	warfarin	drug
false

In vitro studies have shown no binding displacement between DRUGA and other highly bound drugs , such as DRUGN , DRUGB , DRUGN , and DRUGN .
entacapone	drug	salicylic acid	drug
false

In vitro studies have shown no binding displacement between DRUGA and other highly bound drugs , such as DRUGN , DRUGN , DRUGB , and DRUGN .
entacapone	drug	phenylbutazone	drug
false

In vitro studies have shown no binding displacement between DRUGA and other highly bound drugs , such as DRUGN , DRUGN , DRUGN , and DRUGB .
entacapone	drug	diazepam	drug
false

In vitro studies have shown no binding displacement between DRUGN and other highly bound drugs , such as DRUGA , DRUGB , DRUGN , and DRUGN .
warfarin	drug	salicylic acid	drug
false

In vitro studies have shown no binding displacement between DRUGN and other highly bound drugs , such as DRUGA , DRUGN , DRUGB , and DRUGN .
warfarin	drug	phenylbutazone	drug
false

In vitro studies have shown no binding displacement between DRUGN and other highly bound drugs , such as DRUGA , DRUGN , DRUGN , and DRUGB .
warfarin	drug	diazepam	drug
false

In vitro studies have shown no binding displacement between DRUGN and other highly bound drugs , such as DRUGN , DRUGA , DRUGB , and DRUGN .
salicylic acid	drug	phenylbutazone	drug
false

In vitro studies have shown no binding displacement between DRUGN and other highly bound drugs , such as DRUGN , DRUGA , DRUGN , and DRUGB .
salicylic acid	drug	diazepam	drug
false

In vitro studies have shown no binding displacement between DRUGN and other highly bound drugs , such as DRUGN , DRUGN , DRUGA , and DRUGB .
phenylbutazone	drug	diazepam	drug
false

Treatment with DRUGA coadministered with DRUGB / DRUGN does not change these effects .
entacapone	drug	levodopa	drug
false

Treatment with DRUGA coadministered with DRUGN / DRUGB does not change these effects .
entacapone	drug	dopa decarboxylase inhibitor	group
false

Treatment with DRUGN coadministered with DRUGA / DRUGB does not change these effects .
levodopa	drug	dopa decarboxylase inhibitor	group
false

No interaction was noted with the DRUGA DRUGB in two multiple dose interaction studies when DRUGN was coadministered with a DRUGN / DRUGN ( n=dgb ) .
MAO-B inhibitor	group	selegiline	drug
false

No interaction was noted with the DRUGA DRUGN in two multiple dose interaction studies when DRUGB was coadministered with a DRUGN / DRUGN ( n=dgb ) .
MAO-B inhibitor	group	entacapone	drug
false

No interaction was noted with the DRUGA DRUGN in two multiple dose interaction studies when DRUGN was coadministered with a DRUGB / DRUGN ( n=dgb ) .
MAO-B inhibitor	group	levodopa	drug
false

No interaction was noted with the DRUGA DRUGN in two multiple dose interaction studies when DRUGN was coadministered with a DRUGN / DRUGB ( n=dgb ) .
MAO-B inhibitor	group	dopa decarboxylase inhibitor	group
false

No interaction was noted with the DRUGN DRUGA in two multiple dose interaction studies when DRUGB was coadministered with a DRUGN / DRUGN ( n=dgb ) .
selegiline	drug	entacapone	drug
false

No interaction was noted with the DRUGN DRUGA in two multiple dose interaction studies when DRUGN was coadministered with a DRUGB / DRUGN ( n=dgb ) .
selegiline	drug	levodopa	drug
false

No interaction was noted with the DRUGN DRUGA in two multiple dose interaction studies when DRUGN was coadministered with a DRUGN / DRUGB ( n=dgb ) .
selegiline	drug	dopa decarboxylase inhibitor	group
false

No interaction was noted with the DRUGN DRUGN in two multiple dose interaction studies when DRUGA was coadministered with a DRUGB / DRUGN ( n=dgb ) .
entacapone	drug	levodopa	drug
false

No interaction was noted with the DRUGN DRUGN in two multiple dose interaction studies when DRUGA was coadministered with a DRUGN / DRUGB ( n=dgb ) .
entacapone	drug	dopa decarboxylase inhibitor	group
false

No interaction was noted with the DRUGN DRUGN in two multiple dose interaction studies when DRUGN was coadministered with a DRUGA / DRUGB ( n=dgb ) .
levodopa	drug	dopa decarboxylase inhibitor	group
false

More than dgb Parkinsons disease patients in clinical trials have used DRUGA in combination with DRUGB and DRUGN / DRUGN .
selegiline	drug	entacapone	drug
false

More than dgb Parkinsons disease patients in clinical trials have used DRUGA in combination with DRUGN and DRUGB / DRUGN .
selegiline	drug	levodopa	drug
false

More than dgb Parkinsons disease patients in clinical trials have used DRUGA in combination with DRUGN and DRUGN / DRUGB .
selegiline	drug	dopa decarboxylase inhibitor	group
false

More than dgb Parkinsons disease patients in clinical trials have used DRUGN in combination with DRUGA and DRUGB / DRUGN .
entacapone	drug	levodopa	drug
false

More than dgb Parkinsons disease patients in clinical trials have used DRUGN in combination with DRUGA and DRUGN / DRUGB .
entacapone	drug	dopa decarboxylase inhibitor	group
false

More than dgb Parkinsons disease patients in clinical trials have used DRUGN in combination with DRUGN and DRUGA / DRUGB .
levodopa	drug	dopa decarboxylase inhibitor	group
false

These include DRUGA , DRUGB , and some DRUGN ( e.g . DRUGN , rifamipicin , DRUGN and DRUGN ) .
probenecid	drug	cholestyramine	drug
false

These include DRUGA , DRUGN , and some DRUGB ( e.g . DRUGN , rifamipicin , DRUGN and DRUGN ) .
probenecid	drug	antibiotics	group
false

These include DRUGA , DRUGN , and some DRUGN ( e.g . DRUGB , rifamipicin , DRUGN and DRUGN ) .
probenecid	drug	erythromycin	drug
false

These include DRUGA , DRUGN , and some DRUGN ( e.g . DRUGN , rifamipicin , DRUGB and DRUGN ) .
probenecid	drug	ampicillin	drug
false

These include DRUGA , DRUGN , and some DRUGN ( e.g . DRUGN , rifamipicin , DRUGN and DRUGB ) .
probenecid	drug	chloramphenicol	drug
false

These include DRUGN , DRUGA , and some DRUGB ( e.g . DRUGN , rifamipicin , DRUGN and DRUGN ) .
cholestyramine	drug	antibiotics	group
false

These include DRUGN , DRUGA , and some DRUGN ( e.g . DRUGB , rifamipicin , DRUGN and DRUGN ) .
cholestyramine	drug	erythromycin	drug
false

These include DRUGN , DRUGA , and some DRUGN ( e.g . DRUGN , rifamipicin , DRUGB and DRUGN ) .
cholestyramine	drug	ampicillin	drug
false

These include DRUGN , DRUGA , and some DRUGN ( e.g . DRUGN , rifamipicin , DRUGN and DRUGB ) .
cholestyramine	drug	chloramphenicol	drug
false

These include DRUGN , DRUGN , and some DRUGA ( e.g . DRUGB , rifamipicin , DRUGN and DRUGN ) .
antibiotics	group	erythromycin	drug
false

These include DRUGN , DRUGN , and some DRUGA ( e.g . DRUGN , rifamipicin , DRUGB and DRUGN ) .
antibiotics	group	ampicillin	drug
false

These include DRUGN , DRUGN , and some DRUGA ( e.g . DRUGN , rifamipicin , DRUGN and DRUGB ) .
antibiotics	group	chloramphenicol	drug
false

These include DRUGN , DRUGN , and some DRUGN ( e.g . DRUGA , rifamipicin , DRUGB and DRUGN ) .
erythromycin	drug	ampicillin	drug
false

These include DRUGN , DRUGN , and some DRUGN ( e.g . DRUGA , rifamipicin , DRUGN and DRUGB ) .
erythromycin	drug	chloramphenicol	drug
false

These include DRUGN , DRUGN , and some DRUGN ( e.g . DRUGN , rifamipicin , DRUGA and DRUGB ) .
ampicillin	drug	chloramphenicol	drug
false

No interaction with the DRUGA DRUGB was shown in a single dose study with DRUGN without coadministered DRUGN / DRUGN .
tricyclic antidepressant	group	imipramine	drug
false

No interaction with the DRUGA DRUGN was shown in a single dose study with DRUGB without coadministered DRUGN / DRUGN .
tricyclic antidepressant	group	entacapone	drug
false

No interaction with the DRUGA DRUGN was shown in a single dose study with DRUGN without coadministered DRUGB / DRUGN .
tricyclic antidepressant	group	levodopa	drug
false

No interaction with the DRUGA DRUGN was shown in a single dose study with DRUGN without coadministered DRUGN / DRUGB .
tricyclic antidepressant	group	dopa-decarboxylase inhibitor	group
false

No interaction with the DRUGN DRUGA was shown in a single dose study with DRUGB without coadministered DRUGN / DRUGN .
imipramine	drug	entacapone	drug
false

No interaction with the DRUGN DRUGA was shown in a single dose study with DRUGN without coadministered DRUGB / DRUGN .
imipramine	drug	levodopa	drug
false

No interaction with the DRUGN DRUGA was shown in a single dose study with DRUGN without coadministered DRUGN / DRUGB .
imipramine	drug	dopa-decarboxylase inhibitor	group
false

No interaction with the DRUGN DRUGN was shown in a single dose study with DRUGA without coadministered DRUGB / DRUGN .
entacapone	drug	levodopa	drug
false

No interaction with the DRUGN DRUGN was shown in a single dose study with DRUGA without coadministered DRUGN / DRUGB .
entacapone	drug	dopa-decarboxylase inhibitor	group
false

No interaction with the DRUGN DRUGN was shown in a single dose study with DRUGN without coadministered DRUGA / DRUGB .
levodopa	drug	dopa-decarboxylase inhibitor	group
false

Since DRUGA is primarily eliminated by the kidneys , coadministration of DRUGB with drugs that reduce renal function or compete for active tubular secretion may increase serum concentrations of either DRUGN or the coadministered drug .
entecavir	drug	BARACLUDE	brand
false

Since DRUGN is primarily eliminated by the kidneys , coadministration of DRUGA with drugs that reduce renal function or compete for active tubular secretion may increase serum concentrations of either DRUGB or the coadministered drug .
BARACLUDE	brand	entecavir	drug
false

Coadministration of DRUGA with DRUGB , DRUGN , or DRUGN did not result in significant drug interactions .
entecavir	drug	lamivudine	drug
false

Coadministration of DRUGA with DRUGN , DRUGB , or DRUGN did not result in significant drug interactions .
entecavir	drug	adefovir dipivoxil	drug
false

Coadministration of DRUGA with DRUGN , DRUGN , or DRUGB did not result in significant drug interactions .
entecavir	drug	tenofovir disoproxil fumarate	drug
false

Coadministration of DRUGN with DRUGA , DRUGB , or DRUGN did not result in significant drug interactions .
lamivudine	drug	adefovir dipivoxil	drug
false

Coadministration of DRUGN with DRUGA , DRUGN , or DRUGB did not result in significant drug interactions .
lamivudine	drug	tenofovir disoproxil fumarate	drug
false

Coadministration of DRUGN with DRUGN , DRUGA , or DRUGB did not result in significant drug interactions .
adefovir dipivoxil	drug	tenofovir disoproxil fumarate	drug
false

All DRUGA should be used cautiously in patients taking DRUGB .
vasopressors	group	monoamine oxidase (MAO) inhibitors	group
advise

DRUGA should not be administered concomitantly with other DRUGB ( such as DRUGN ) because of possible additive effects and increased toxicity .
Epinephrine	drug	sympathomimetic drugs	group
advise

DRUGA should not be administered concomitantly with other DRUGN ( such as DRUGB ) because of possible additive effects and increased toxicity .
Epinephrine	drug	isoproterenol	drug
advise

DRUGN should not be administered concomitantly with other DRUGA ( such as DRUGB ) because of possible additive effects and increased toxicity .
sympathomimetic drugs	group	isoproterenol	drug
false

Administration of DRUGA to patients receiving DRUGB or DRUGN such as DRUGN which sensitize the myocardium , may induce cardiac arrhythmia..
epinephrine	drug	cyclopropane	drug
effect

Administration of DRUGA to patients receiving DRUGN or DRUGB such as DRUGN which sensitize the myocardium , may induce cardiac arrhythmia..
epinephrine	drug	halogenated hydrocarbon general anesthetics	group
effect

Administration of DRUGA to patients receiving DRUGN or DRUGN such as DRUGB which sensitize the myocardium , may induce cardiac arrhythmia..
epinephrine	drug	halothane	drug
effect

Administration of DRUGN to patients receiving DRUGA or DRUGB such as DRUGN which sensitize the myocardium , may induce cardiac arrhythmia..
cyclopropane	drug	halogenated hydrocarbon general anesthetics	group
false

Administration of DRUGN to patients receiving DRUGA or DRUGN such as DRUGB which sensitize the myocardium , may induce cardiac arrhythmia..
cyclopropane	drug	halothane	drug
false

Administration of DRUGN to patients receiving DRUGN or DRUGA such as DRUGB which sensitize the myocardium , may induce cardiac arrhythmia..
halogenated hydrocarbon general anesthetics	group	halothane	drug
false

DRUGA also should be used cautiously with other drugs ( e.g . , DRUGB , DRUGN ) that sensitize the myocardium to the actions of DRUGN .
Epinephrine	drug	digitalis	group
advise

DRUGA also should be used cautiously with other drugs ( e.g . , DRUGN , DRUGB ) that sensitize the myocardium to the actions of DRUGN .
Epinephrine	drug	glycosides	group
advise

DRUGA also should be used cautiously with other drugs ( e.g . , DRUGN , DRUGN ) that sensitize the myocardium to the actions of DRUGB .
Epinephrine	drug	sympathomimetic drugs	group
false

DRUGN also should be used cautiously with other drugs ( e.g . , DRUGA , DRUGB ) that sensitize the myocardium to the actions of DRUGN .
digitalis	group	glycosides	group
false

DRUGN also should be used cautiously with other drugs ( e.g . , DRUGA , DRUGN ) that sensitize the myocardium to the actions of DRUGB .
digitalis	group	sympathomimetic drugs	group
false

DRUGN also should be used cautiously with other drugs ( e.g . , DRUGN , DRUGA ) that sensitize the myocardium to the actions of DRUGB .
glycosides	group	sympathomimetic drugs	group
false

DRUGA may decrease vascular response to pressor drugs such as DRUGB .
Diuretic agents	group	epinephrine	drug
effect

DRUGA may antagonize the neuron blockade produced by DRUGB resulting in decreased antihypertensive effect and requiring increased dosage of the latter .
Epinephrine	drug	guanethidine	drug
effect

Concomitant use of DRUGA with other cardioactive compounds that could cause heart failure ( e.g . , DRUGB ) , requires close monitoring of cardiac function throughout treatment .
ELLENCE	brand	calcium channel blockers	group
advise

DRUGA increased the AUC of DRUGB by dgb % .
Cimetidine	drug	epirubicin	drug
mechanism

DRUGA treatment should be stopped during treatment with DRUGB .
Cimetidine	drug	ELLENCE	brand
advise

DRUGA and DRUGB ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGN dgb to dgb mg also received DRUGN or DRUGN ( DRUGN / DRUGN ) .
ACE Inhibitors	group	Angiotensin II Receptor Antagonists	group
false

DRUGA and DRUGN ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGB dgb to dgb mg also received DRUGN or DRUGN ( DRUGN / DRUGN ) .
ACE Inhibitors	group	INSPRA	brand
false

DRUGA and DRUGN ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGN dgb to dgb mg also received DRUGB or DRUGN ( DRUGN / DRUGN ) .
ACE Inhibitors	group	ACE inhibitors	group
false

DRUGA and DRUGN ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGN dgb to dgb mg also received DRUGN or DRUGB ( DRUGN / DRUGN ) .
ACE Inhibitors	group	angiotensin II receptor antagonists	group
false

DRUGA and DRUGN ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGN dgb to dgb mg also received DRUGN or DRUGN ( DRUGB / DRUGN ) .
ACE Inhibitors	group	ACEI	group
false

DRUGA and DRUGN ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGN dgb to dgb mg also received DRUGN or DRUGN ( DRUGN / DRUGB ) .
ACE Inhibitors	group	ARB	group
false

DRUGN and DRUGA ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGB dgb to dgb mg also received DRUGN or DRUGN ( DRUGN / DRUGN ) .
Angiotensin II Receptor Antagonists	group	INSPRA	brand
false

DRUGN and DRUGA ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGN dgb to dgb mg also received DRUGB or DRUGN ( DRUGN / DRUGN ) .
Angiotensin II Receptor Antagonists	group	ACE inhibitors	group
false

DRUGN and DRUGA ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGN dgb to dgb mg also received DRUGN or DRUGB ( DRUGN / DRUGN ) .
Angiotensin II Receptor Antagonists	group	angiotensin II receptor antagonists	group
false

DRUGN and DRUGA ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGN dgb to dgb mg also received DRUGN or DRUGN ( DRUGB / DRUGN ) .
Angiotensin II Receptor Antagonists	group	ACEI	group
false

DRUGN and DRUGA ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGN dgb to dgb mg also received DRUGN or DRUGN ( DRUGN / DRUGB ) .
Angiotensin II Receptor Antagonists	group	ARB	group
false

DRUGN and DRUGN ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGA dgb to dgb mg also received DRUGB or DRUGN ( DRUGN / DRUGN ) .
INSPRA	brand	ACE inhibitors	group
false

DRUGN and DRUGN ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGA dgb to dgb mg also received DRUGN or DRUGB ( DRUGN / DRUGN ) .
INSPRA	brand	angiotensin II receptor antagonists	group
false

DRUGN and DRUGN ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGA dgb to dgb mg also received DRUGN or DRUGN ( DRUGB / DRUGN ) .
INSPRA	brand	ACEI	group
false

DRUGN and DRUGN ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGA dgb to dgb mg also received DRUGN or DRUGN ( DRUGN / DRUGB ) .
INSPRA	brand	ARB	group
false

DRUGN and DRUGN ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGN dgb to dgb mg also received DRUGA or DRUGB ( DRUGN / DRUGN ) .
ACE inhibitors	group	angiotensin II receptor antagonists	group
false

DRUGN and DRUGN ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGN dgb to dgb mg also received DRUGA or DRUGN ( DRUGB / DRUGN ) .
ACE inhibitors	group	ACEI	group
false

DRUGN and DRUGN ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGN dgb to dgb mg also received DRUGA or DRUGN ( DRUGN / DRUGB ) .
ACE inhibitors	group	ARB	group
false

DRUGN and DRUGN ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGN dgb to dgb mg also received DRUGN or DRUGA ( DRUGB / DRUGN ) .
angiotensin II receptor antagonists	group	ACEI	group
false

DRUGN and DRUGN ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGN dgb to dgb mg also received DRUGN or DRUGA ( DRUGN / DRUGB ) .
angiotensin II receptor antagonists	group	ARB	group
false

DRUGN and DRUGN ( Congestive Heart Failure Post Myocardial Infarction ) In EPHESUS , dgb ( dgb % ) patients receiving DRUGN dgb to dgb mg also received DRUGN or DRUGN ( DRUGA / DRUGB ) .
ACEI	group	ARB	group
false

Rates of patients with maximum potassium levels dga mEq / L were similar regardless of the use of DRUGA / DRUGB .
ACEI	group	ARB	group
false

DRUGA and DRUGB ( Hypertension ) In clinical studies of patients with hypertension , the addition of DRUGN dgb to dgb mg to DRUGN and DRUGN increased mean serum potassium slightly ( about dga dga mEq / L ) .
ACE Inhibitors	group	Angiotensin II Receptor Antagonists	group
false

DRUGA and DRUGN ( Hypertension ) In clinical studies of patients with hypertension , the addition of DRUGB dgb to dgb mg to DRUGN and DRUGN increased mean serum potassium slightly ( about dga dga mEq / L ) .
ACE Inhibitors	group	INSPRA	brand
false

DRUGA and DRUGN ( Hypertension ) In clinical studies of patients with hypertension , the addition of DRUGN dgb to dgb mg to DRUGB and DRUGN increased mean serum potassium slightly ( about dga dga mEq / L ) .
ACE Inhibitors	group	ACE inhibitors	group
false

DRUGA and DRUGN ( Hypertension ) In clinical studies of patients with hypertension , the addition of DRUGN dgb to dgb mg to DRUGN and DRUGB increased mean serum potassium slightly ( about dga dga mEq / L ) .
ACE Inhibitors	group	angiotensin II receptor antagonists	group
false

DRUGN and DRUGA ( Hypertension ) In clinical studies of patients with hypertension , the addition of DRUGB dgb to dgb mg to DRUGN and DRUGN increased mean serum potassium slightly ( about dga dga mEq / L ) .
Angiotensin II Receptor Antagonists	group	INSPRA	brand
false

DRUGN and DRUGA ( Hypertension ) In clinical studies of patients with hypertension , the addition of DRUGN dgb to dgb mg to DRUGB and DRUGN increased mean serum potassium slightly ( about dga dga mEq / L ) .
Angiotensin II Receptor Antagonists	group	ACE inhibitors	group
false

DRUGN and DRUGA ( Hypertension ) In clinical studies of patients with hypertension , the addition of DRUGN dgb to dgb mg to DRUGN and DRUGB increased mean serum potassium slightly ( about dga dga mEq / L ) .
Angiotensin II Receptor Antagonists	group	angiotensin II receptor antagonists	group
false

DRUGN and DRUGN ( Hypertension ) In clinical studies of patients with hypertension , the addition of DRUGA dgb to dgb mg to DRUGB and DRUGN increased mean serum potassium slightly ( about dga dga mEq / L ) .
INSPRA	brand	ACE inhibitors	group
effect

DRUGN and DRUGN ( Hypertension ) In clinical studies of patients with hypertension , the addition of DRUGA dgb to dgb mg to DRUGN and DRUGB increased mean serum potassium slightly ( about dga dga mEq / L ) .
INSPRA	brand	angiotensin II receptor antagonists	group
effect

DRUGN and DRUGN ( Hypertension ) In clinical studies of patients with hypertension , the addition of DRUGN dgb to dgb mg to DRUGA and DRUGB increased mean serum potassium slightly ( about dga dga mEq / L ) .
ACE inhibitors	group	angiotensin II receptor antagonists	group
false

In a study in diabetics with microalbuminuria DRUGA dgb mg combined with the DRUGB DRUGN dgb mg increased the frequency of hyperkalemia ( serum potassium dga mEq / L ) from dgb % on DRUGN alone to dgb % .
INSPRA	brand	ACE inhibitor	group
false

In a study in diabetics with microalbuminuria DRUGA dgb mg combined with the DRUGN DRUGB dgb mg increased the frequency of hyperkalemia ( serum potassium dga mEq / L ) from dgb % on DRUGN alone to dgb % .
INSPRA	brand	enalapril	drug
effect

In a study in diabetics with microalbuminuria DRUGA dgb mg combined with the DRUGN DRUGN dgb mg increased the frequency of hyperkalemia ( serum potassium dga mEq / L ) from dgb % on DRUGB alone to dgb % .
INSPRA	brand	enalapril	drug
false

In a study in diabetics with microalbuminuria DRUGN dgb mg combined with the DRUGA DRUGB dgb mg increased the frequency of hyperkalemia ( serum potassium dga mEq / L ) from dgb % on DRUGN alone to dgb % .
ACE inhibitor	group	enalapril	drug
false

In a study in diabetics with microalbuminuria DRUGN dgb mg combined with the DRUGA DRUGN dgb mg increased the frequency of hyperkalemia ( serum potassium dga mEq / L ) from dgb % on DRUGB alone to dgb % .
ACE inhibitor	group	enalapril	drug
false

DRUGA A drug interaction study of DRUGB with DRUGN has not been conducted .
Lithium	drug	eplerenone	drug
false

DRUGA A drug interaction study of DRUGN with DRUGB has not been conducted .
Lithium	drug	lithium	drug
false

DRUGN A drug interaction study of DRUGA with DRUGB has not been conducted .
eplerenone	drug	lithium	drug
false

Serum DRUGA levels should be monitored frequently if DRUGB is administered concomitantly with DRUGN .
lithium	drug	INSPRA	brand
false

Serum DRUGN levels should be monitored frequently if DRUGA is administered concomitantly with DRUGB .
INSPRA	brand	lithium	drug
advise

DRUGA ( DRUGB ) A drug interaction study of DRUGN with an DRUGN has not been conducted .
Nonsteroidal Anti-Inflammatory Drugs	group	NSAIDs	group
false

DRUGA ( DRUGN ) A drug interaction study of DRUGB with an DRUGN has not been conducted .
Nonsteroidal Anti-Inflammatory Drugs	group	eplerenone	drug
false

DRUGA ( DRUGN ) A drug interaction study of DRUGN with an DRUGB has not been conducted .
Nonsteroidal Anti-Inflammatory Drugs	group	NSAID	group
false

DRUGN ( DRUGA ) A drug interaction study of DRUGB with an DRUGN has not been conducted .
NSAIDs	group	eplerenone	drug
false

DRUGN ( DRUGA ) A drug interaction study of DRUGN with an DRUGB has not been conducted .
NSAIDs	group	NSAID	group
false

DRUGN ( DRUGN ) A drug interaction study of DRUGA with an DRUGB has not been conducted .
eplerenone	drug	NSAID	group
false

The administration of other DRUGA with DRUGB has been shown to reduce the antihypertensive effect in some patients and result in severe hyperkalemia in patients with impaired renal function .
potassium-sparing antihypertensives	group	NSAIDs	group
effect

Therefore , when DRUGA and DRUGB are used concomitantly , patients should be observed to determine whether the desired effect on blood pressure is obtained .
INSPRA	brand	NSAIDs	group
advise

Additional reductions in blood pressure may occur when DRUGA is administered with DRUGB , DRUGN , or other DRUGN .
FLOLAN	brand	diuretics	group
effect

Additional reductions in blood pressure may occur when DRUGA is administered with DRUGN , DRUGB , or other DRUGN .
FLOLAN	brand	antihypertensive agents	group
effect

Additional reductions in blood pressure may occur when DRUGA is administered with DRUGN , DRUGN , or other DRUGB .
FLOLAN	brand	vasodilators	group
effect

Additional reductions in blood pressure may occur when DRUGN is administered with DRUGA , DRUGB , or other DRUGN .
diuretics	group	antihypertensive agents	group
false

Additional reductions in blood pressure may occur when DRUGN is administered with DRUGA , DRUGN , or other DRUGB .
diuretics	group	vasodilators	group
false

Additional reductions in blood pressure may occur when DRUGN is administered with DRUGN , DRUGA , or other DRUGB .
antihypertensive agents	group	vasodilators	group
false

When other DRUGA or DRUGB are used concomitantly , there is the potential for DRUGN to increase the risk of bleeding .
antiplatelet agents	group	anticoagulants	group
false

When other DRUGA or DRUGN are used concomitantly , there is the potential for DRUGB to increase the risk of bleeding .
antiplatelet agents	group	FLOLAN	brand
effect

When other DRUGN or DRUGA are used concomitantly , there is the potential for DRUGB to increase the risk of bleeding .
anticoagulants	group	FLOLAN	brand
effect

However , patients receiving infusions of DRUGA in clinical trials were maintained on DRUGB without evidence of increased bleeding .
FLOLAN	brand	anticoagulants	group
false

However , patients on DRUGA may show elevations of DRUGN concentrations after initiation of therapy with DRUGB , which may be clinically significant in patients prone to DRUGN toxicity .
digoxin	drug	FLOLAN	brand
mechanism

However , patients on DRUGN may show elevations of DRUGA concentrations after initiation of therapy with DRUGB , which may be clinically significant in patients prone to DRUGN toxicity .
digoxin	drug	FLOLAN	brand
false

However , patients on DRUGN may show elevations of DRUGN concentrations after initiation of therapy with DRUGA , which may be clinically significant in patients prone to DRUGB toxicity .
FLOLAN	brand	digoxin	drug
false

DRUGA has been shown to have no effect on the pharmacokinetics of DRUGB and the pharmacodynamics of DRUGN and DRUGN .
Eprosartan	drug	digoxin	drug
false

DRUGA has been shown to have no effect on the pharmacokinetics of DRUGN and the pharmacodynamics of DRUGB and DRUGN .
Eprosartan	drug	warfarin	drug
false

DRUGA has been shown to have no effect on the pharmacokinetics of DRUGN and the pharmacodynamics of DRUGN and DRUGB .
Eprosartan	drug	glyburide	drug
false

DRUGN has been shown to have no effect on the pharmacokinetics of DRUGA and the pharmacodynamics of DRUGB and DRUGN .
digoxin	drug	warfarin	drug
false

DRUGN has been shown to have no effect on the pharmacokinetics of DRUGA and the pharmacodynamics of DRUGN and DRUGB .
digoxin	drug	glyburide	drug
false

DRUGN has been shown to have no effect on the pharmacokinetics of DRUGN and the pharmacodynamics of DRUGA and DRUGB .
warfarin	drug	glyburide	drug
false

DRUGA also has no effect on DRUGB pharmacokinetics .
Ranitidine	drug	eprosartan	drug
false

DRUGA ( up to dgb mg b.i.d . or dgb mg q.d . ) doses have been safely used concomitantly with a DRUGB ( DRUGN ) .
Eprosartan	drug	thiazide diuretic	group
false

DRUGA ( up to dgb mg b.i.d . or dgb mg q.d . ) doses have been safely used concomitantly with a DRUGN ( DRUGB ) .
Eprosartan	drug	hydrochlorothiazide	drug
false

DRUGN ( up to dgb mg b.i.d . or dgb mg q.d . ) doses have been safely used concomitantly with a DRUGA ( DRUGB ) .
thiazide diuretic	group	hydrochlorothiazide	drug
false

DRUGA doses of up to dgb mg b.i.d . have been safely used concomitantly with sustained release DRUGB ( sustained release DRUGN ) with no clinically significant adverse interactions .
Eprosartan	drug	calcium channel blockers	group
false

DRUGA doses of up to dgb mg b.i.d . have been safely used concomitantly with sustained release DRUGN ( sustained release DRUGB ) with no clinically significant adverse interactions .
Eprosartan	drug	nifedipine	drug
false

DRUGN doses of up to dgb mg b.i.d . have been safely used concomitantly with sustained release DRUGA ( sustained release DRUGB ) with no clinically significant adverse interactions .
calcium channel blockers	group	nifedipine	drug
false

DRUGA dosed as a dga mg / kg subcutaneous injection qdgbh for four doses did not alter the pharmacokinetics of DRUGB or the level of platelet aggregation in healthy adults .
Enoxaparin	drug	eptifibatide	drug
false

DRUGA interferes with the absorption of DRUGB , including DRUGN .
Mineral oil	drug	fat-soluble vitamins	group
mechanism

DRUGA interferes with the absorption of DRUGN , including DRUGB .
Mineral oil	drug	vitamin D preparations	group
mechanism

DRUGN interferes with the absorption of DRUGA , including DRUGB .
fat-soluble vitamins	group	vitamin D preparations	group
false

Administration of DRUGA to hypoparathyroid patients who are concurrently being treated with DRUGB may cause hypercalcemia .
thiazide diuretics	group	ergocalciferol	drug
effect

The effects of DRUGA may be potentiated by DRUGB which inhibits the metabolism of DRUGN .
ERGOMAR	brand	triacetyloleandomycin	drug
mechanism

The effects of DRUGA may be potentiated by DRUGN which inhibits the metabolism of DRUGB .
ERGOMAR	brand	ergotamine	drug
false

The effects of DRUGN may be potentiated by DRUGA which inhibits the metabolism of DRUGB .
triacetyloleandomycin	drug	ergotamine	drug
mechanism

The pressor effects of DRUGA and other DRUGB can combine to cause dangerous hypertension .
ERGOMAR	brand	vasoconstrictor drugs	group
effect

Co treatment with the potent CYPdgbAdgb inhibitor DRUGA increases DRUGB AUC by dgb / dga
ketoconazole	drug	erlotinib	drug
mechanism

Pre treatment with the CYPdgbAdgb inducer DRUGA decreased DRUGB AUC by about dgb / dga
rifampicin	drug	erlotinib	drug
mechanism

If the DRUGA dose is adjusted upward , the dose will need to be reduced upon discontinuation of DRUGB or other inducers .
TARCEVA	brand	rifampicin	drug
advise

Other CYPdgbAdgb inducers include , but are not limited to , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN and St. Johns Wort .
rifabutin	drug	rifapentine	drug
false

Other CYPdgbAdgb inducers include , but are not limited to , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN and St. Johns Wort .
rifabutin	drug	phenytoin	drug
false

Other CYPdgbAdgb inducers include , but are not limited to , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN and St. Johns Wort .
rifabutin	drug	carbamazepine	drug
false

Other CYPdgbAdgb inducers include , but are not limited to , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB and St. Johns Wort .
rifabutin	drug	phenobarbital	drug
false

Other CYPdgbAdgb inducers include , but are not limited to , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN and St. Johns Wort .
rifapentine	drug	phenytoin	drug
false

Other CYPdgbAdgb inducers include , but are not limited to , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN and St. Johns Wort .
rifapentine	drug	carbamazepine	drug
false

Other CYPdgbAdgb inducers include , but are not limited to , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB and St. Johns Wort .
rifapentine	drug	phenobarbital	drug
false

Other CYPdgbAdgb inducers include , but are not limited to , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN and St. Johns Wort .
phenytoin	drug	carbamazepine	drug
false

Other CYPdgbAdgb inducers include , but are not limited to , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB and St. Johns Wort .
phenytoin	drug	phenobarbital	drug
false

Other CYPdgbAdgb inducers include , but are not limited to , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB and St. Johns Wort .
carbamazepine	drug	phenobarbital	drug
false

Patients taking DRUGA or other DRUGB should be monitored regularly for changes in prothrombin time or INR
warfarin	drug	coumarin-derivative anticoagulants	group
false

When DRUGA is co administered with DRUGB ( dgb mg p.o . every dgb hours ) , DRUGN competes for active tubular secretion and reduces the renal clearance of DRUGN .
ertapenem	drug	probenecid	drug
false

When DRUGA is co administered with DRUGN ( dgb mg p.o . every dgb hours ) , DRUGB competes for active tubular secretion and reduces the renal clearance of DRUGN .
ertapenem	drug	probenecid	drug
false

When DRUGN is co administered with DRUGA ( dgb mg p.o . every dgb hours ) , DRUGN competes for active tubular secretion and reduces the renal clearance of DRUGB .
probenecid	drug	ertapenem	drug
false

When DRUGN is co administered with DRUGN ( dgb mg p.o . every dgb hours ) , DRUGA competes for active tubular secretion and reduces the renal clearance of DRUGB .
probenecid	drug	ertapenem	drug
mechanism

Based on total DRUGA concentrations , DRUGB increased the AUC by dgb % and reduced the plasma and renal clearances by dgb % and dgb % , respectively .
ertapenem	drug	probenecid	drug
mechanism

Because of the small effect on half life , the coadministration with DRUGA to extend the half life of DRUGB is not recommended .
probenecid	drug	ertapenem	drug
advise

In vitro studies indicate that DRUGA does not inhibit P glycoprotein mediated transport of DRUGB or DRUGN and that DRUGN is not a substrate for P glycoprotein mediated transport .
ertapenem	drug	digoxin	drug
false

In vitro studies indicate that DRUGA does not inhibit P glycoprotein mediated transport of DRUGN or DRUGB and that DRUGN is not a substrate for P glycoprotein mediated transport .
ertapenem	drug	vinblastine	drug
false

In vitro studies indicate that DRUGN does not inhibit P glycoprotein mediated transport of DRUGA or DRUGB and that DRUGN is not a substrate for P glycoprotein mediated transport .
digoxin	drug	vinblastine	drug
false

In vitro studies indicate that DRUGN does not inhibit P glycoprotein mediated transport of DRUGA or DRUGN and that DRUGB is not a substrate for P glycoprotein mediated transport .
digoxin	drug	ertapenem	drug
false

In vitro studies indicate that DRUGN does not inhibit P glycoprotein mediated transport of DRUGN or DRUGA and that DRUGB is not a substrate for P glycoprotein mediated transport .
vinblastine	drug	ertapenem	drug
false

DRUGA use in patients who are receiving high doses of DRUGB may be associated with an increase in serum DRUGN levels and potential DRUGN toxicity .
Erythromycin	drug	theophylline	drug
effect

DRUGA use in patients who are receiving high doses of DRUGN may be associated with an increase in serum DRUGB levels and potential DRUGN toxicity .
Erythromycin	drug	theophylline	drug
false

DRUGA use in patients who are receiving high doses of DRUGN may be associated with an increase in serum DRUGN levels and potential DRUGB toxicity .
Erythromycin	drug	theophylline	drug
false

In case of DRUGA toxicity and / or elevated serum DRUGN levels , the dose of DRUGN should be reduced while the patient is receiving concomitant DRUGB therapy .
theophylline	drug	erythromycin	drug
false

In case of DRUGN toxicity and / or elevated serum DRUGA levels , the dose of DRUGN should be reduced while the patient is receiving concomitant DRUGB therapy .
theophylline	drug	erythromycin	drug
false

In case of DRUGN toxicity and / or elevated serum DRUGN levels , the dose of DRUGA should be reduced while the patient is receiving concomitant DRUGB therapy .
theophylline	drug	erythromycin	drug
advise

Concomitant administration of DRUGA and DRUGB has been reported to result in elevated DRUGN serum levels .
erythromycin	drug	digoxin	drug
mechanism

Concomitant administration of DRUGA and DRUGN has been reported to result in elevated DRUGB serum levels .
erythromycin	drug	digoxin	drug
false

There have been reports of increased anticoagulant effects when DRUGA and oral DRUGB were used concomitantly .
erythromycin	drug	anticoagulants	group
effect

Concurrent use of DRUGA and DRUGB or DRUGN has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
erythromycin	drug	ergotamine	drug
effect

Concurrent use of DRUGA and DRUGN or DRUGB has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
erythromycin	drug	dihydroergotamine	drug
effect

Concurrent use of DRUGN and DRUGA or DRUGB has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
ergotamine	drug	dihydroergotamine	drug
false

DRUGA has been reported to decrease the clearance of DRUGB and DRUGN and thus may increase the pharmacologic effect of these DRUGN .
Erythromycin	drug	triazolam	drug
mechanism

DRUGA has been reported to decrease the clearance of DRUGN and DRUGB and thus may increase the pharmacologic effect of these DRUGN .
Erythromycin	drug	midazolam	drug
mechanism

DRUGA has been reported to decrease the clearance of DRUGN and DRUGN and thus may increase the pharmacologic effect of these DRUGB .
Erythromycin	drug	benzodiazepines	group
effect

DRUGN has been reported to decrease the clearance of DRUGA and DRUGB and thus may increase the pharmacologic effect of these DRUGN .
triazolam	drug	midazolam	drug
false

DRUGN has been reported to decrease the clearance of DRUGA and DRUGN and thus may increase the pharmacologic effect of these DRUGB .
triazolam	drug	benzodiazepines	group
false

DRUGN has been reported to decrease the clearance of DRUGN and DRUGA and thus may increase the pharmacologic effect of these DRUGB .
midazolam	drug	benzodiazepines	group
false

There have been reports of interactions of DRUGA with DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	carbamazepine	drug
int

There have been reports of interactions of DRUGA with DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	cyclosporine	drug
int

There have been reports of interactions of DRUGA with DRUGN dgb , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	tacrolimus	drug
int

There have been reports of interactions of DRUGA with DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	hexobarbital	drug
int

There have been reports of interactions of DRUGA with DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	phenytoin	drug
int

There have been reports of interactions of DRUGA with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	alfentanil	drug
int

There have been reports of interactions of DRUGA with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	cisapride	drug
int

There have been reports of interactions of DRUGA with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	disopyramide	drug
int

There have been reports of interactions of DRUGA with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	lovastatin	drug
int

There have been reports of interactions of DRUGA with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	bromocriptine	drug
int

There have been reports of interactions of DRUGA with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
erythromycin	drug	valproate	drug
int

There have been reports of interactions of DRUGA with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
erythromycin	drug	terfenadine	drug
int

There have been reports of interactions of DRUGA with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
erythromycin	drug	astemizole	drug
int

There have been reports of interactions of DRUGN with DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
carbamazepine	drug	cyclosporine	drug
false

There have been reports of interactions of DRUGN with DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
carbamazepine	drug	tacrolimus	drug
false

There have been reports of interactions of DRUGN with DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
carbamazepine	drug	hexobarbital	drug
false

There have been reports of interactions of DRUGN with DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
carbamazepine	drug	phenytoin	drug
false

There have been reports of interactions of DRUGN with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
carbamazepine	drug	alfentanil	drug
false

There have been reports of interactions of DRUGN with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
carbamazepine	drug	cisapride	drug
false

There have been reports of interactions of DRUGN with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
carbamazepine	drug	disopyramide	drug
false

There have been reports of interactions of DRUGN with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
carbamazepine	drug	lovastatin	drug
false

There have been reports of interactions of DRUGN with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
carbamazepine	drug	bromocriptine	drug
false

There have been reports of interactions of DRUGN with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
carbamazepine	drug	valproate	drug
false

There have been reports of interactions of DRUGN with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
carbamazepine	drug	terfenadine	drug
false

There have been reports of interactions of DRUGN with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
carbamazepine	drug	astemizole	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
cyclosporine	drug	tacrolimus	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
cyclosporine	drug	hexobarbital	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
cyclosporine	drug	phenytoin	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
cyclosporine	drug	alfentanil	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
cyclosporine	drug	cisapride	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
cyclosporine	drug	disopyramide	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
cyclosporine	drug	lovastatin	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
cyclosporine	drug	bromocriptine	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
cyclosporine	drug	valproate	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
cyclosporine	drug	terfenadine	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
cyclosporine	drug	astemizole	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
tacrolimus	drug	hexobarbital	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
tacrolimus	drug	phenytoin	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
tacrolimus	drug	alfentanil	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
tacrolimus	drug	cisapride	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
tacrolimus	drug	disopyramide	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
tacrolimus	drug	lovastatin	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
tacrolimus	drug	bromocriptine	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
tacrolimus	drug	valproate	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
tacrolimus	drug	terfenadine	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
tacrolimus	drug	astemizole	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
hexobarbital	drug	phenytoin	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
hexobarbital	drug	alfentanil	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
hexobarbital	drug	cisapride	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
hexobarbital	drug	disopyramide	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
hexobarbital	drug	lovastatin	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
hexobarbital	drug	bromocriptine	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
hexobarbital	drug	valproate	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
hexobarbital	drug	terfenadine	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
hexobarbital	drug	astemizole	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
phenytoin	drug	alfentanil	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
phenytoin	drug	cisapride	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
phenytoin	drug	disopyramide	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
phenytoin	drug	lovastatin	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
phenytoin	drug	bromocriptine	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
phenytoin	drug	valproate	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
phenytoin	drug	terfenadine	drug
false

There have been reports of interactions of DRUGN with DRUGN dgb , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
phenytoin	drug	astemizole	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
alfentanil	drug	cisapride	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
alfentanil	drug	disopyramide	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
alfentanil	drug	lovastatin	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
alfentanil	drug	bromocriptine	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
alfentanil	drug	valproate	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
alfentanil	drug	terfenadine	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
alfentanil	drug	astemizole	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
cisapride	drug	disopyramide	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
cisapride	drug	lovastatin	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
cisapride	drug	bromocriptine	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
cisapride	drug	valproate	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
cisapride	drug	terfenadine	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
cisapride	drug	astemizole	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
disopyramide	drug	lovastatin	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
disopyramide	drug	bromocriptine	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
disopyramide	drug	valproate	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
disopyramide	drug	terfenadine	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
disopyramide	drug	astemizole	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
lovastatin	drug	bromocriptine	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
lovastatin	drug	valproate	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
lovastatin	drug	terfenadine	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
lovastatin	drug	astemizole	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
bromocriptine	drug	valproate	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
bromocriptine	drug	terfenadine	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
bromocriptine	drug	astemizole	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
valproate	drug	terfenadine	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
valproate	drug	astemizole	drug
false

There have been reports of interactions of DRUGN with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
terfenadine	drug	astemizole	drug
false

DRUGA has been reported to significantly alter the metabolism of nonsedating DRUGB DRUGN and DRUGN when taken concomitantly .
Erythromycin	drug	antihistamines	group
false

DRUGA has been reported to significantly alter the metabolism of nonsedating DRUGN DRUGB and DRUGN when taken concomitantly .
Erythromycin	drug	terfenadine	drug
mechanism

DRUGA has been reported to significantly alter the metabolism of nonsedating DRUGN DRUGN and DRUGB when taken concomitantly .
Erythromycin	drug	astemizole	drug
mechanism

DRUGN has been reported to significantly alter the metabolism of nonsedating DRUGA DRUGB and DRUGN when taken concomitantly .
antihistamines	group	terfenadine	drug
false

DRUGN has been reported to significantly alter the metabolism of nonsedating DRUGA DRUGN and DRUGB when taken concomitantly .
antihistamines	group	astemizole	drug
false

DRUGN has been reported to significantly alter the metabolism of nonsedating DRUGN DRUGA and DRUGB when taken concomitantly .
terfenadine	drug	astemizole	drug
false

In addition , deaths have been reported rarely with concomitant administration of DRUGA and DRUGB .
terfenadine	drug	erythromycin	drug
effect

Patients receiving concomitant DRUGA and DRUGB should be carefully monitored ;
lovastatin	drug	erythromycin	drug
advise

DRUGA Although DRUGB did not potentiate the cognitive and motor effects of DRUGN in a clinical trial , as with other DRUGN , the use of DRUGN by patients taking DRUGN is not recommended .
Alcohol	drug	LEXAPRO	brand
false

DRUGA Although DRUGN did not potentiate the cognitive and motor effects of DRUGB in a clinical trial , as with other DRUGN , the use of DRUGN by patients taking DRUGN is not recommended .
Alcohol	drug	alcohol	drug
false

DRUGA Although DRUGN did not potentiate the cognitive and motor effects of DRUGN in a clinical trial , as with other DRUGB , the use of DRUGN by patients taking DRUGN is not recommended .
Alcohol	drug	psychotropic medications	group
false

DRUGA Although DRUGN did not potentiate the cognitive and motor effects of DRUGN in a clinical trial , as with other DRUGN , the use of DRUGB by patients taking DRUGN is not recommended .
Alcohol	drug	alcohol	drug
false

DRUGA Although DRUGN did not potentiate the cognitive and motor effects of DRUGN in a clinical trial , as with other DRUGN , the use of DRUGN by patients taking DRUGB is not recommended .
Alcohol	drug	LEXAPRO	brand
false

DRUGN Although DRUGA did not potentiate the cognitive and motor effects of DRUGB in a clinical trial , as with other DRUGN , the use of DRUGN by patients taking DRUGN is not recommended .
LEXAPRO	brand	alcohol	drug
false

DRUGN Although DRUGA did not potentiate the cognitive and motor effects of DRUGN in a clinical trial , as with other DRUGB , the use of DRUGN by patients taking DRUGN is not recommended .
LEXAPRO	brand	psychotropic medications	group
false

DRUGN Although DRUGA did not potentiate the cognitive and motor effects of DRUGN in a clinical trial , as with other DRUGN , the use of DRUGB by patients taking DRUGN is not recommended .
LEXAPRO	brand	alcohol	drug
false

DRUGN Although DRUGN did not potentiate the cognitive and motor effects of DRUGA in a clinical trial , as with other DRUGB , the use of DRUGN by patients taking DRUGN is not recommended .
alcohol	drug	psychotropic medications	group
false

DRUGN Although DRUGN did not potentiate the cognitive and motor effects of DRUGA in a clinical trial , as with other DRUGN , the use of DRUGN by patients taking DRUGB is not recommended .
alcohol	drug	LEXAPRO	brand
false

DRUGN Although DRUGN did not potentiate the cognitive and motor effects of DRUGN in a clinical trial , as with other DRUGA , the use of DRUGB by patients taking DRUGN is not recommended .
psychotropic medications	group	alcohol	drug
false

DRUGN Although DRUGN did not potentiate the cognitive and motor effects of DRUGN in a clinical trial , as with other DRUGA , the use of DRUGN by patients taking DRUGB is not recommended .
psychotropic medications	group	LEXAPRO	brand
advise

DRUGN Although DRUGN did not potentiate the cognitive and motor effects of DRUGN in a clinical trial , as with other DRUGN , the use of DRUGA by patients taking DRUGB is not recommended .
alcohol	drug	LEXAPRO	brand
advise

DRUGA ( DRUGB )
Monoamine Oxidase Inhibitors	group	MAOIs	group
false

Drugs That Interfere With Hemostasis ( DRUGA , DRUGB , DRUGN , etc . )
NSAIDs	group	Aspirin	brand
false

Drugs That Interfere With Hemostasis ( DRUGA , DRUGN , DRUGB , etc . )
NSAIDs	group	Warfarin	drug
false

Drugs That Interfere With Hemostasis ( DRUGN , DRUGA , DRUGB , etc . )
Aspirin	brand	Warfarin	drug
false

DRUGA Coadministration of racemic DRUGB ( dgb mg / day for dgb days ) and DRUGN ( dgb mmol / day for dgb days ) had no significant effect on the pharmacokinetics of DRUGN or DRUGN .
Lithium	drug	citalopram	drug
false

DRUGA Coadministration of racemic DRUGN ( dgb mg / day for dgb days ) and DRUGB ( dgb mmol / day for dgb days ) had no significant effect on the pharmacokinetics of DRUGN or DRUGN .
Lithium	drug	lithium	drug
false

DRUGA Coadministration of racemic DRUGN ( dgb mg / day for dgb days ) and DRUGN ( dgb mmol / day for dgb days ) had no significant effect on the pharmacokinetics of DRUGB or DRUGN .
Lithium	drug	citalopram	drug
false

DRUGA Coadministration of racemic DRUGN ( dgb mg / day for dgb days ) and DRUGN ( dgb mmol / day for dgb days ) had no significant effect on the pharmacokinetics of DRUGN or DRUGB .
Lithium	drug	lithium	drug
false

DRUGN Coadministration of racemic DRUGA ( dgb mg / day for dgb days ) and DRUGB ( dgb mmol / day for dgb days ) had no significant effect on the pharmacokinetics of DRUGN or DRUGN .
citalopram	drug	lithium	drug
false

DRUGN Coadministration of racemic DRUGA ( dgb mg / day for dgb days ) and DRUGN ( dgb mmol / day for dgb days ) had no significant effect on the pharmacokinetics of DRUGN or DRUGB .
citalopram	drug	lithium	drug
false

DRUGN Coadministration of racemic DRUGN ( dgb mg / day for dgb days ) and DRUGA ( dgb mmol / day for dgb days ) had no significant effect on the pharmacokinetics of DRUGB or DRUGN .
lithium	drug	citalopram	drug
false

DRUGN Coadministration of racemic DRUGN ( dgb mg / day for dgb days ) and DRUGN ( dgb mmol / day for dgb days ) had no significant effect on the pharmacokinetics of DRUGA or DRUGB .
citalopram	drug	lithium	drug
false

Because DRUGA may enhance the serotonergic effects of DRUGB , caution should be exercised when DRUGN and DRUGN are coadministered .
lithium	drug	escitalopram	drug
effect

Because DRUGA may enhance the serotonergic effects of DRUGN , caution should be exercised when DRUGB and DRUGN are coadministered .
lithium	drug	LEXAPRO	brand
false

Because DRUGN may enhance the serotonergic effects of DRUGA , caution should be exercised when DRUGB and DRUGN are coadministered .
escitalopram	drug	LEXAPRO	brand
false

Because DRUGN may enhance the serotonergic effects of DRUGA , caution should be exercised when DRUGN and DRUGB are coadministered .
escitalopram	drug	lithium	drug
false

Because DRUGN may enhance the serotonergic effects of DRUGN , caution should be exercised when DRUGA and DRUGB are coadministered .
LEXAPRO	brand	lithium	drug
advise

Racemic DRUGA did not alter the mean AUC or Cmax of DRUGB .
citalopram	drug	pimozide	drug
false

DRUGA There have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a DRUGB ( DRUGN ) and DRUGN .
Sumatriptan	drug	selective serotonin reuptake inhibitor	group
false

DRUGA There have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a DRUGN ( DRUGB ) and DRUGN .
Sumatriptan	drug	SSRI	group
false

DRUGA There have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a DRUGN ( DRUGN ) and DRUGB .
Sumatriptan	drug	sumatriptan	drug
false

DRUGN There have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a DRUGA ( DRUGB ) and DRUGN .
selective serotonin reuptake inhibitor	group	SSRI	group
false

DRUGN There have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a DRUGA ( DRUGN ) and DRUGB .
selective serotonin reuptake inhibitor	group	sumatriptan	drug
effect

DRUGN There have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a DRUGN ( DRUGA ) and DRUGB .
SSRI	group	sumatriptan	drug
effect

If concomitant treatment with DRUGA and an DRUGB ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
sumatriptan	drug	SSRI	group
advise

If concomitant treatment with DRUGA and an DRUGN ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
sumatriptan	drug	fluoxetine	drug
advise

If concomitant treatment with DRUGA and an DRUGN ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
sumatriptan	drug	fluvoxamine	drug
advise

If concomitant treatment with DRUGA and an DRUGN ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
sumatriptan	drug	paroxetine	drug
advise

If concomitant treatment with DRUGA and an DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
sumatriptan	drug	sertraline	drug
advise

If concomitant treatment with DRUGA and an DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
sumatriptan	drug	citalopram	drug
advise

If concomitant treatment with DRUGA and an DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB ) is clinically warranted , appropriate observation of the patient is advised .
sumatriptan	drug	escitalopram	drug
advise

If concomitant treatment with DRUGN and an DRUGA ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
SSRI	group	fluoxetine	drug
false

If concomitant treatment with DRUGN and an DRUGA ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
SSRI	group	fluvoxamine	drug
false

If concomitant treatment with DRUGN and an DRUGA ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
SSRI	group	paroxetine	drug
false

If concomitant treatment with DRUGN and an DRUGA ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
SSRI	group	sertraline	drug
false

If concomitant treatment with DRUGN and an DRUGA ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
SSRI	group	citalopram	drug
false

If concomitant treatment with DRUGN and an DRUGA ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB ) is clinically warranted , appropriate observation of the patient is advised .
SSRI	group	escitalopram	drug
false

If concomitant treatment with DRUGN and an DRUGN ( e.g . , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
fluoxetine	drug	fluvoxamine	drug
false

If concomitant treatment with DRUGN and an DRUGN ( e.g . , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
fluoxetine	drug	paroxetine	drug
false

If concomitant treatment with DRUGN and an DRUGN ( e.g . , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
fluoxetine	drug	sertraline	drug
false

If concomitant treatment with DRUGN and an DRUGN ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
fluoxetine	drug	citalopram	drug
false

If concomitant treatment with DRUGN and an DRUGN ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB ) is clinically warranted , appropriate observation of the patient is advised .
fluoxetine	drug	escitalopram	drug
false

If concomitant treatment with DRUGN and an DRUGN ( e.g . , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
fluvoxamine	drug	paroxetine	drug
false

If concomitant treatment with DRUGN and an DRUGN ( e.g . , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
fluvoxamine	drug	sertraline	drug
false

If concomitant treatment with DRUGN and an DRUGN ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
fluvoxamine	drug	citalopram	drug
false

If concomitant treatment with DRUGN and an DRUGN ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB ) is clinically warranted , appropriate observation of the patient is advised .
fluvoxamine	drug	escitalopram	drug
false

If concomitant treatment with DRUGN and an DRUGN ( e.g . , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
paroxetine	drug	sertraline	drug
false

If concomitant treatment with DRUGN and an DRUGN ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
paroxetine	drug	citalopram	drug
false

If concomitant treatment with DRUGN and an DRUGN ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB ) is clinically warranted , appropriate observation of the patient is advised .
paroxetine	drug	escitalopram	drug
false

If concomitant treatment with DRUGN and an DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN ) is clinically warranted , appropriate observation of the patient is advised .
sertraline	drug	citalopram	drug
false

If concomitant treatment with DRUGN and an DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB ) is clinically warranted , appropriate observation of the patient is advised .
sertraline	drug	escitalopram	drug
false

If concomitant treatment with DRUGN and an DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB ) is clinically warranted , appropriate observation of the patient is advised .
citalopram	drug	escitalopram	drug
false

DRUGA Combined administration of racemic DRUGB ( dgb mg / day for dgb days ) and the CYPdgbAdgb substrate DRUGN ( single dose of dgb mg ) did not affect the pharmacokinetics of DRUGN .
Theophylline	drug	citalopram	drug
false

DRUGA Combined administration of racemic DRUGN ( dgb mg / day for dgb days ) and the CYPdgbAdgb substrate DRUGB ( single dose of dgb mg ) did not affect the pharmacokinetics of DRUGN .
Theophylline	drug	theophylline	drug
false

DRUGA Combined administration of racemic DRUGN ( dgb mg / day for dgb days ) and the CYPdgbAdgb substrate DRUGN ( single dose of dgb mg ) did not affect the pharmacokinetics of DRUGB .
Theophylline	drug	theophylline	drug
false

DRUGN Combined administration of racemic DRUGA ( dgb mg / day for dgb days ) and the CYPdgbAdgb substrate DRUGB ( single dose of dgb mg ) did not affect the pharmacokinetics of DRUGN .
citalopram	drug	theophylline	drug
false

DRUGN Combined administration of racemic DRUGA ( dgb mg / day for dgb days ) and the CYPdgbAdgb substrate DRUGN ( single dose of dgb mg ) did not affect the pharmacokinetics of DRUGB .
citalopram	drug	theophylline	drug
false

The effect of DRUGA on the pharmacokinetics of DRUGB was not evaluated .
theophylline	drug	citalopram	drug
false

DRUGA Administration of dgb mg / day racemic DRUGB for dgb days did not affect the pharmacokinetics of DRUGN , a CYPdgbAdgb substrate .
Warfarin	drug	citalopram	drug
false

DRUGA Administration of dgb mg / day racemic DRUGN for dgb days did not affect the pharmacokinetics of DRUGB , a CYPdgbAdgb substrate .
Warfarin	drug	warfarin	drug
false

DRUGN Administration of dgb mg / day racemic DRUGA for dgb days did not affect the pharmacokinetics of DRUGB , a CYPdgbAdgb substrate .
citalopram	drug	warfarin	drug
false

Although trough DRUGA plasma levels were unaffected , given the enzyme inducing properties of DRUGB , the possibility that DRUGN might increase the clearance of DRUGN should be considered if the two drugs are coadministered .
citalopram	drug	carbamazepine	drug
false

Although trough DRUGA plasma levels were unaffected , given the enzyme inducing properties of DRUGN , the possibility that DRUGB might increase the clearance of DRUGN should be considered if the two drugs are coadministered .
citalopram	drug	carbamazepine	drug
false

Although trough DRUGA plasma levels were unaffected , given the enzyme inducing properties of DRUGN , the possibility that DRUGN might increase the clearance of DRUGB should be considered if the two drugs are coadministered .
citalopram	drug	escitalopram	drug
false

Although trough DRUGN plasma levels were unaffected , given the enzyme inducing properties of DRUGA , the possibility that DRUGN might increase the clearance of DRUGB should be considered if the two drugs are coadministered .
carbamazepine	drug	escitalopram	drug
false

Although trough DRUGN plasma levels were unaffected , given the enzyme inducing properties of DRUGN , the possibility that DRUGA might increase the clearance of DRUGB should be considered if the two drugs are coadministered .
carbamazepine	drug	escitalopram	drug
mechanism

However , coadministration of DRUGA ( dgb mg ) and DRUGB ( dgb mg ) , a potent inhibitor of CYPdgbAdgb , did not significantly affect the pharmacokinetics of DRUGN .
escitalopram	drug	ritonavir	drug
false

However , coadministration of DRUGN ( dgb mg ) and DRUGA ( dgb mg ) , a potent inhibitor of CYPdgbAdgb , did not significantly affect the pharmacokinetics of DRUGB .
ritonavir	drug	escitalopram	drug
false

Coadministration of DRUGA and DRUGB had no clinically significant effects on blood pressure or heart rate .
LEXAPRO	brand	metoprolol	drug
false

Concomitant Administration with Racemic DRUGA DRUGN Since DRUGB is the active isomer of racemic DRUGN ( DRUGN ) , the two agents should not be coadministered .
Citalopram	drug	escitalopram	drug
false

Concomitant Administration with Racemic DRUGA DRUGN Since DRUGN is the active isomer of racemic DRUGB ( DRUGN ) , the two agents should not be coadministered .
Citalopram	drug	citalopram	drug
false

Concomitant Administration with Racemic DRUGA DRUGN Since DRUGN is the active isomer of racemic DRUGN ( DRUGB ) , the two agents should not be coadministered .
Citalopram	drug	Celexa	brand
false

Concomitant Administration with Racemic DRUGN DRUGA Since DRUGB is the active isomer of racemic DRUGN ( DRUGN ) , the two agents should not be coadministered .
Citalopram	drug	escitalopram	drug
false

Concomitant Administration with Racemic DRUGN DRUGA Since DRUGN is the active isomer of racemic DRUGB ( DRUGN ) , the two agents should not be coadministered .
Citalopram	drug	citalopram	drug
false

Concomitant Administration with Racemic DRUGN DRUGA Since DRUGN is the active isomer of racemic DRUGN ( DRUGB ) , the two agents should not be coadministered .
Citalopram	drug	Celexa	brand
false

Concomitant Administration with Racemic DRUGN DRUGN Since DRUGA is the active isomer of racemic DRUGB ( DRUGN ) , the two agents should not be coadministered .
escitalopram	drug	citalopram	drug
advise

Concomitant Administration with Racemic DRUGN DRUGN Since DRUGA is the active isomer of racemic DRUGN ( DRUGB ) , the two agents should not be coadministered .
escitalopram	drug	Celexa	brand
advise

Concomitant Administration with Racemic DRUGN DRUGN Since DRUGN is the active isomer of racemic DRUGA ( DRUGB ) , the two agents should not be coadministered .
citalopram	drug	Celexa	brand
false

Catecholamine depleting drugs , e.g . , DRUGA , may have an additive effect when given with DRUGB .
reserpine	drug	beta blocking agents	group
effect

Patients treated concurrently with DRUGA ( DRUGB ) and a catecholamine depletor should therefore be closely observed for evidence of hypotension or marked bradycardia , which may result in vertigo , syncope , or postural hypotension .
BREVIBLOC	brand	esmolol HCl	drug
false

A study of interaction between DRUGA and DRUGB showed that concomitant administration of DRUGN and DRUGN does not alter DRUGN plasma levels .
BREVIBLOC	brand	warfarin	drug
false

A study of interaction between DRUGA and DRUGN showed that concomitant administration of DRUGN and DRUGB does not alter DRUGN plasma levels .
BREVIBLOC	brand	warfarin	drug
false

A study of interaction between DRUGA and DRUGN showed that concomitant administration of DRUGN and DRUGN does not alter DRUGB plasma levels .
BREVIBLOC	brand	warfarin	drug
false

A study of interaction between DRUGN and DRUGA showed that concomitant administration of DRUGB and DRUGN does not alter DRUGN plasma levels .
warfarin	drug	BREVIBLOC	brand
false

A study of interaction between DRUGN and DRUGN showed that concomitant administration of DRUGA and DRUGB does not alter DRUGN plasma levels .
BREVIBLOC	brand	warfarin	drug
false

A study of interaction between DRUGN and DRUGN showed that concomitant administration of DRUGA and DRUGN does not alter DRUGB plasma levels .
BREVIBLOC	brand	warfarin	drug
false

DRUGA concentrations were equivocally higher when given with DRUGB , but this is not likely to be clinically important .
BREVIBLOC	brand	warfarin	drug
mechanism

When DRUGA and DRUGB were concomitantly administered intravenously to normal volunteers , there was a dgb dgb % increase in DRUGN blood levels at some time points .
digoxin	drug	BREVIBLOC	brand
mechanism

When DRUGN and DRUGA were concomitantly administered intravenously to normal volunteers , there was a dgb dgb % increase in DRUGB blood levels at some time points .
BREVIBLOC	brand	digoxin	drug
false

DRUGA did not affect DRUGB pharmacokinetics .
Digoxin	drug	BREVIBLOC	brand
false

When intravenous DRUGA and DRUGB were concomitantly administered in normal subjects , no effect on DRUGN blood levels was seen , but DRUGN steady state blood levels were increased by dgb % in the presence of DRUGN .
morphine	drug	BREVIBLOC	brand
false

When intravenous DRUGA and DRUGN were concomitantly administered in normal subjects , no effect on DRUGN blood levels was seen , but DRUGB steady state blood levels were increased by dgb % in the presence of DRUGN .
morphine	drug	BREVIBLOC	brand
false

When intravenous DRUGN and DRUGA were concomitantly administered in normal subjects , no effect on DRUGB blood levels was seen , but DRUGN steady state blood levels were increased by dgb % in the presence of DRUGN .
BREVIBLOC	brand	morphine	drug
false

When intravenous DRUGN and DRUGA were concomitantly administered in normal subjects , no effect on DRUGN blood levels was seen , but DRUGN steady state blood levels were increased by dgb % in the presence of DRUGB .
BREVIBLOC	brand	morphine	drug
false

When intravenous DRUGN and DRUGN were concomitantly administered in normal subjects , no effect on DRUGA blood levels was seen , but DRUGB steady state blood levels were increased by dgb % in the presence of DRUGN .
morphine	drug	BREVIBLOC	brand
false

When intravenous DRUGN and DRUGN were concomitantly administered in normal subjects , no effect on DRUGN blood levels was seen , but DRUGA steady state blood levels were increased by dgb % in the presence of DRUGB .
BREVIBLOC	brand	morphine	drug
mechanism

The effect of DRUGA on the duration of DRUGB induced neuromuscular blockade was studied in patients undergoing surgery .
BREVIBLOC	drug	succinylcholine	drug
false

The onset of neuromuscular blockade by DRUGA was unaffected by DRUGB , but the duration of neuromuscular blockade was prolonged from dgb minutes to dgb minutes .
succinylcholine	drug	BREVIBLOC	brand
effect

Although the interactions observed in these studies do not appear to be of major clinical importance , DRUGA should be titrated with caution in patients being treated concurrently with DRUGB , DRUGN , DRUGN or DRUGN .
BREVIBLOC	brand	digoxin	drug
advise

Although the interactions observed in these studies do not appear to be of major clinical importance , DRUGA should be titrated with caution in patients being treated concurrently with DRUGN , DRUGB , DRUGN or DRUGN .
BREVIBLOC	brand	morphine	drug
advise

Although the interactions observed in these studies do not appear to be of major clinical importance , DRUGA should be titrated with caution in patients being treated concurrently with DRUGN , DRUGN , DRUGB or DRUGN .
BREVIBLOC	brand	succinylcholine	drug
advise

Although the interactions observed in these studies do not appear to be of major clinical importance , DRUGA should be titrated with caution in patients being treated concurrently with DRUGN , DRUGN , DRUGN or DRUGB .
BREVIBLOC	brand	warfarin	drug
advise

Although the interactions observed in these studies do not appear to be of major clinical importance , DRUGN should be titrated with caution in patients being treated concurrently with DRUGA , DRUGB , DRUGN or DRUGN .
digoxin	drug	morphine	drug
false

Although the interactions observed in these studies do not appear to be of major clinical importance , DRUGN should be titrated with caution in patients being treated concurrently with DRUGA , DRUGN , DRUGB or DRUGN .
digoxin	drug	succinylcholine	drug
false

Although the interactions observed in these studies do not appear to be of major clinical importance , DRUGN should be titrated with caution in patients being treated concurrently with DRUGA , DRUGN , DRUGN or DRUGB .
digoxin	drug	warfarin	drug
false

Although the interactions observed in these studies do not appear to be of major clinical importance , DRUGN should be titrated with caution in patients being treated concurrently with DRUGN , DRUGA , DRUGB or DRUGN .
morphine	drug	succinylcholine	drug
false

Although the interactions observed in these studies do not appear to be of major clinical importance , DRUGN should be titrated with caution in patients being treated concurrently with DRUGN , DRUGA , DRUGN or DRUGB .
morphine	drug	warfarin	drug
false

Although the interactions observed in these studies do not appear to be of major clinical importance , DRUGN should be titrated with caution in patients being treated concurrently with DRUGN , DRUGN , DRUGA or DRUGB .
succinylcholine	drug	warfarin	drug
false

Caution should be exercised when considering the use of DRUGA and DRUGB in patients with depressed myocardial function .
BREVIBLOC	brand	verapamil	drug
advise

Drug interaction studies have shown that DRUGA does not have any clinically significant interactions with DRUGB , DRUGN , DRUGN , DRUGN or DRUGN .
esomeprazole	drug	phenytoin	drug
false

Drug interaction studies have shown that DRUGA does not have any clinically significant interactions with DRUGN , DRUGB , DRUGN , DRUGN or DRUGN .
esomeprazole	drug	warfarin	drug
false

Drug interaction studies have shown that DRUGA does not have any clinically significant interactions with DRUGN , DRUGN , DRUGB , DRUGN or DRUGN .
esomeprazole	drug	quinidine	drug
false

Drug interaction studies have shown that DRUGA does not have any clinically significant interactions with DRUGN , DRUGN , DRUGN , DRUGB or DRUGN .
esomeprazole	drug	clarithromycin	drug
false

Drug interaction studies have shown that DRUGA does not have any clinically significant interactions with DRUGN , DRUGN , DRUGN , DRUGN or DRUGB .
esomeprazole	drug	amoxicillin	drug
false

Drug interaction studies have shown that DRUGN does not have any clinically significant interactions with DRUGA , DRUGB , DRUGN , DRUGN or DRUGN .
phenytoin	drug	warfarin	drug
false

Drug interaction studies have shown that DRUGN does not have any clinically significant interactions with DRUGA , DRUGN , DRUGB , DRUGN or DRUGN .
phenytoin	drug	quinidine	drug
false

Drug interaction studies have shown that DRUGN does not have any clinically significant interactions with DRUGA , DRUGN , DRUGN , DRUGB or DRUGN .
phenytoin	drug	clarithromycin	drug
false

Drug interaction studies have shown that DRUGN does not have any clinically significant interactions with DRUGA , DRUGN , DRUGN , DRUGN or DRUGB .
phenytoin	drug	amoxicillin	drug
false

Drug interaction studies have shown that DRUGN does not have any clinically significant interactions with DRUGN , DRUGA , DRUGB , DRUGN or DRUGN .
warfarin	drug	quinidine	drug
false

Drug interaction studies have shown that DRUGN does not have any clinically significant interactions with DRUGN , DRUGA , DRUGN , DRUGB or DRUGN .
warfarin	drug	clarithromycin	drug
false

Drug interaction studies have shown that DRUGN does not have any clinically significant interactions with DRUGN , DRUGA , DRUGN , DRUGN or DRUGB .
warfarin	drug	amoxicillin	drug
false

Drug interaction studies have shown that DRUGN does not have any clinically significant interactions with DRUGN , DRUGN , DRUGA , DRUGB or DRUGN .
quinidine	drug	clarithromycin	drug
false

Drug interaction studies have shown that DRUGN does not have any clinically significant interactions with DRUGN , DRUGN , DRUGA , DRUGN or DRUGB .
quinidine	drug	amoxicillin	drug
false

Drug interaction studies have shown that DRUGN does not have any clinically significant interactions with DRUGN , DRUGN , DRUGN , DRUGA or DRUGB .
clarithromycin	drug	amoxicillin	drug
false

Post marketing reports of changes in prothrombin measures have been received among patients on concomitant DRUGA and DRUGB therapy .
warfarin	drug	esomeprazole	drug
false

Patients treated with DRUGA and DRUGB concomitantly may need to be monitored for increases in INR and prothrombin time .
proton pump inhibitors	group	warfarin	drug
effect

DRUGA may potentially interfere with CYPdgbCdgb , the major DRUGB metabolizing enzyme .
Esomeprazole	drug	esomeprazole	drug
false

Coadministration of DRUGA dgb mg and DRUGB , a CYPdgbCdgb substrate , resulted in a dgb % decrease in clearance of DRUGN .
esomeprazole	drug	diazepam	drug
mechanism

Coadministration of DRUGA dgb mg and DRUGN , a CYPdgbCdgb substrate , resulted in a dgb % decrease in clearance of DRUGB .
esomeprazole	drug	diazepam	drug
false

Therefore , DRUGA may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability ( eg , DRUGB , DRUGN salts and DRUGN ) .
esomeprazole	drug	ketoconazole	drug
mechanism

Therefore , DRUGA may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability ( eg , DRUGN , DRUGB salts and DRUGN ) .
esomeprazole	drug	iron	drug
mechanism

Therefore , DRUGA may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability ( eg , DRUGN , DRUGN salts and DRUGB ) .
esomeprazole	drug	digoxin	drug
mechanism

Therefore , DRUGN may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability ( eg , DRUGA , DRUGB salts and DRUGN ) .
ketoconazole	drug	iron	drug
false

Therefore , DRUGN may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability ( eg , DRUGA , DRUGN salts and DRUGB ) .
ketoconazole	drug	digoxin	drug
false

Therefore , DRUGN may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability ( eg , DRUGN , DRUGA salts and DRUGB ) .
iron	drug	digoxin	drug
false

Coadministration of oral DRUGA , DRUGB , DRUGN , or DRUGN did not seem to change the pharmacokinetic profile of DRUGN .
contraceptives	group	diazepam	drug
false

Coadministration of oral DRUGA , DRUGN , DRUGB , or DRUGN did not seem to change the pharmacokinetic profile of DRUGN .
contraceptives	group	phenytoin	drug
false

Coadministration of oral DRUGA , DRUGN , DRUGN , or DRUGB did not seem to change the pharmacokinetic profile of DRUGN .
contraceptives	group	quinidine	drug
false

Coadministration of oral DRUGA , DRUGN , DRUGN , or DRUGN did not seem to change the pharmacokinetic profile of DRUGB .
contraceptives	group	esomeprazole	drug
false

Coadministration of oral DRUGN , DRUGA , DRUGB , or DRUGN did not seem to change the pharmacokinetic profile of DRUGN .
diazepam	drug	phenytoin	drug
false

Coadministration of oral DRUGN , DRUGA , DRUGN , or DRUGB did not seem to change the pharmacokinetic profile of DRUGN .
diazepam	drug	quinidine	drug
false

Coadministration of oral DRUGN , DRUGA , DRUGN , or DRUGN did not seem to change the pharmacokinetic profile of DRUGB .
diazepam	drug	esomeprazole	drug
false

Coadministration of oral DRUGN , DRUGN , DRUGA , or DRUGB did not seem to change the pharmacokinetic profile of DRUGN .
phenytoin	drug	quinidine	drug
false

Coadministration of oral DRUGN , DRUGN , DRUGA , or DRUGN did not seem to change the pharmacokinetic profile of DRUGB .
phenytoin	drug	esomeprazole	drug
false

Coadministration of oral DRUGN , DRUGN , DRUGN , or DRUGA did not seem to change the pharmacokinetic profile of DRUGB .
quinidine	drug	esomeprazole	drug
false

Concomitant administration of DRUGA with DRUGB is contraindicated .
clarithromycin	drug	pimozide	drug
advise

The action of the DRUGA may be potentiated by DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or other drugs that produce CNS depression .
benzodiazepines	group	anticonvulsants	group
effect

The action of the DRUGA may be potentiated by DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or other drugs that produce CNS depression .
benzodiazepines	group	antihistamines	group
effect

The action of the DRUGA may be potentiated by DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or other drugs that produce CNS depression .
benzodiazepines	group	alcohol	drug
effect

The action of the DRUGA may be potentiated by DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , or other drugs that produce CNS depression .
benzodiazepines	group	barbiturates	group
effect

The action of the DRUGA may be potentiated by DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , or other drugs that produce CNS depression .
benzodiazepines	group	monoamine oxidase inhibitors	group
effect

The action of the DRUGA may be potentiated by DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , or other drugs that produce CNS depression .
benzodiazepines	group	narcotics	group
effect

The action of the DRUGA may be potentiated by DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , or other drugs that produce CNS depression .
benzodiazepines	group	phenothiazines	group
effect

The action of the DRUGA may be potentiated by DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , or other drugs that produce CNS depression .
benzodiazepines	group	psychotropic medications	group
effect

The action of the DRUGN may be potentiated by DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or other drugs that produce CNS depression .
anticonvulsants	group	antihistamines	group
false

The action of the DRUGN may be potentiated by DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or other drugs that produce CNS depression .
anticonvulsants	group	alcohol	drug
false

The action of the DRUGN may be potentiated by DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , or other drugs that produce CNS depression .
anticonvulsants	group	barbiturates	group
false

The action of the DRUGN may be potentiated by DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , or other drugs that produce CNS depression .
anticonvulsants	group	monoamine oxidase inhibitors	group
false

The action of the DRUGN may be potentiated by DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , or other drugs that produce CNS depression .
anticonvulsants	group	narcotics	group
false

The action of the DRUGN may be potentiated by DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , or other drugs that produce CNS depression .
anticonvulsants	group	phenothiazines	group
false

The action of the DRUGN may be potentiated by DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , or other drugs that produce CNS depression .
anticonvulsants	group	psychotropic medications	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or other drugs that produce CNS depression .
antihistamines	group	alcohol	drug
false

The action of the DRUGN may be potentiated by DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , or other drugs that produce CNS depression .
antihistamines	group	barbiturates	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , or other drugs that produce CNS depression .
antihistamines	group	monoamine oxidase inhibitors	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , or other drugs that produce CNS depression .
antihistamines	group	narcotics	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , or other drugs that produce CNS depression .
antihistamines	group	phenothiazines	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , or other drugs that produce CNS depression .
antihistamines	group	psychotropic medications	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , or other drugs that produce CNS depression .
alcohol	drug	barbiturates	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , or other drugs that produce CNS depression .
alcohol	drug	monoamine oxidase inhibitors	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , or other drugs that produce CNS depression .
alcohol	drug	narcotics	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , or other drugs that produce CNS depression .
alcohol	drug	phenothiazines	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , or other drugs that produce CNS depression .
alcohol	drug	psychotropic medications	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , or other drugs that produce CNS depression .
barbiturates	group	monoamine oxidase inhibitors	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , or other drugs that produce CNS depression .
barbiturates	group	narcotics	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , or other drugs that produce CNS depression .
barbiturates	group	phenothiazines	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , or other drugs that produce CNS depression .
barbiturates	group	psychotropic medications	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , or other drugs that produce CNS depression .
monoamine oxidase inhibitors	group	narcotics	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , or other drugs that produce CNS depression .
monoamine oxidase inhibitors	group	phenothiazines	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , or other drugs that produce CNS depression .
monoamine oxidase inhibitors	group	psychotropic medications	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , or other drugs that produce CNS depression .
narcotics	group	phenothiazines	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , or other drugs that produce CNS depression .
narcotics	group	psychotropic medications	group
false

The action of the DRUGN may be potentiated by DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , or other drugs that produce CNS depression .
phenothiazines	group	psychotropic medications	group
false

DRUGA : Interaction with Drugs that Inhibit Metabolism via Cytochrome Pdgb dgbA ( CYPdgbA ) : The metabolism of DRUGB to the major circulating metabolite DRUGN and the metabolism of other DRUGN is catalyzed by CYPdgbA .
Estazolam	drug	estazolam	drug
false

DRUGA : Interaction with Drugs that Inhibit Metabolism via Cytochrome Pdgb dgbA ( CYPdgbA ) : The metabolism of DRUGN to the major circulating metabolite DRUGB and the metabolism of other DRUGN is catalyzed by CYPdgbA .
Estazolam	drug	4-hydroxy-estazolam	drug_n
false

DRUGA : Interaction with Drugs that Inhibit Metabolism via Cytochrome Pdgb dgbA ( CYPdgbA ) : The metabolism of DRUGN to the major circulating metabolite DRUGN and the metabolism of other DRUGB is catalyzed by CYPdgbA .
Estazolam	drug	triazolobenzodiazepines	group
false

DRUGN : Interaction with Drugs that Inhibit Metabolism via Cytochrome Pdgb dgbA ( CYPdgbA ) : The metabolism of DRUGA to the major circulating metabolite DRUGB and the metabolism of other DRUGN is catalyzed by CYPdgbA .
estazolam	drug	4-hydroxy-estazolam	drug_n
false

DRUGN : Interaction with Drugs that Inhibit Metabolism via Cytochrome Pdgb dgbA ( CYPdgbA ) : The metabolism of DRUGA to the major circulating metabolite DRUGN and the metabolism of other DRUGB is catalyzed by CYPdgbA .
estazolam	drug	triazolobenzodiazepines	group
false

DRUGN : Interaction with Drugs that Inhibit Metabolism via Cytochrome Pdgb dgbA ( CYPdgbA ) : The metabolism of DRUGN to the major circulating metabolite DRUGA and the metabolism of other DRUGB is catalyzed by CYPdgbA .
4-hydroxy-estazolam	drug_n	triazolobenzodiazepines	group
false

Consequently , DRUGA should be avoided in patients receiving DRUGB and DRUGN , which are very potent inhibitors of CYPdgbA .
estazolam	drug	ketoconazole	drug
advise

Consequently , DRUGA should be avoided in patients receiving DRUGN and DRUGB , which are very potent inhibitors of CYPdgbA .
estazolam	drug	itraconazole	drug
advise

Consequently , DRUGN should be avoided in patients receiving DRUGA and DRUGB , which are very potent inhibitors of CYPdgbA .
ketoconazole	drug	itraconazole	drug
false

The following are examples of drugs known to inhibit the metabolism of other related DRUGA , presumably through inhibition of CYPdgbA : DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and some DRUGN .
benzodiazepines	group	nefazodone	drug
mechanism

The following are examples of drugs known to inhibit the metabolism of other related DRUGA , presumably through inhibition of CYPdgbA : DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and some DRUGN .
benzodiazepines	group	fluvoxamine	drug
mechanism

The following are examples of drugs known to inhibit the metabolism of other related DRUGA , presumably through inhibition of CYPdgbA : DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and some DRUGN .
benzodiazepines	group	cimetidine	drug
mechanism

The following are examples of drugs known to inhibit the metabolism of other related DRUGA , presumably through inhibition of CYPdgbA : DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and some DRUGN .
benzodiazepines	group	diltiazem	drug
mechanism

The following are examples of drugs known to inhibit the metabolism of other related DRUGA , presumably through inhibition of CYPdgbA : DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and some DRUGN .
benzodiazepines	group	isoniazide	drug
mechanism

The following are examples of drugs known to inhibit the metabolism of other related DRUGA , presumably through inhibition of CYPdgbA : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and some DRUGB .
benzodiazepines	group	macrolide antibiotics	group
mechanism

The following are examples of drugs known to inhibit the metabolism of other related DRUGN , presumably through inhibition of CYPdgbA : DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and some DRUGN .
nefazodone	drug	fluvoxamine	drug
false

The following are examples of drugs known to inhibit the metabolism of other related DRUGN , presumably through inhibition of CYPdgbA : DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and some DRUGN .
nefazodone	drug	cimetidine	drug
false

The following are examples of drugs known to inhibit the metabolism of other related DRUGN , presumably through inhibition of CYPdgbA : DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and some DRUGN .
nefazodone	drug	diltiazem	drug
false

The following are examples of drugs known to inhibit the metabolism of other related DRUGN , presumably through inhibition of CYPdgbA : DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and some DRUGN .
nefazodone	drug	isoniazide	drug
false

The following are examples of drugs known to inhibit the metabolism of other related DRUGN , presumably through inhibition of CYPdgbA : DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and some DRUGB .
nefazodone	drug	macrolide antibiotics	group
false

The following are examples of drugs known to inhibit the metabolism of other related DRUGN , presumably through inhibition of CYPdgbA : DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and some DRUGN .
fluvoxamine	drug	cimetidine	drug
false

The following are examples of drugs known to inhibit the metabolism of other related DRUGN , presumably through inhibition of CYPdgbA : DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and some DRUGN .
fluvoxamine	drug	diltiazem	drug
false

The following are examples of drugs known to inhibit the metabolism of other related DRUGN , presumably through inhibition of CYPdgbA : DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and some DRUGN .
fluvoxamine	drug	isoniazide	drug
false

The following are examples of drugs known to inhibit the metabolism of other related DRUGN , presumably through inhibition of CYPdgbA : DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and some DRUGB .
fluvoxamine	drug	macrolide antibiotics	group
false

The following are examples of drugs known to inhibit the metabolism of other related DRUGN , presumably through inhibition of CYPdgbA : DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and some DRUGN .
cimetidine	drug	diltiazem	drug
false

The following are examples of drugs known to inhibit the metabolism of other related DRUGN , presumably through inhibition of CYPdgbA : DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and some DRUGN .
cimetidine	drug	isoniazide	drug
false

The following are examples of drugs known to inhibit the metabolism of other related DRUGN , presumably through inhibition of CYPdgbA : DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and some DRUGB .
cimetidine	drug	macrolide antibiotics	group
false

The following are examples of drugs known to inhibit the metabolism of other related DRUGN , presumably through inhibition of CYPdgbA : DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and some DRUGN .
diltiazem	drug	isoniazide	drug
false

The following are examples of drugs known to inhibit the metabolism of other related DRUGN , presumably through inhibition of CYPdgbA : DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and some DRUGB .
diltiazem	drug	macrolide antibiotics	group
false

The following are examples of drugs known to inhibit the metabolism of other related DRUGN , presumably through inhibition of CYPdgbA : DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and some DRUGB .
isoniazide	drug	macrolide antibiotics	group
false

Drug Interaction with DRUGA : A multiple dose study was conducted to assess the effect of DRUGB dgb mg BID on the pharmacokinetics of DRUGN dgb mg QHS after seven days .
Fluoxetine	drug	fluoxetine	drug
false

Drug Interaction with DRUGA : A multiple dose study was conducted to assess the effect of DRUGN dgb mg BID on the pharmacokinetics of DRUGB dgb mg QHS after seven days .
Fluoxetine	drug	estazolam	drug
false

Drug Interaction with DRUGN : A multiple dose study was conducted to assess the effect of DRUGA dgb mg BID on the pharmacokinetics of DRUGB dgb mg QHS after seven days .
fluoxetine	drug	estazolam	drug
false

The pharmacokinetics of DRUGA ( Cmax and AUC ) were not affected during multiple dose DRUGB , suggesting no clinically significant pharmacokinetic interaction .
estazolam	drug	fluoxetine	drug
false

Other binding proteins may be elevated in serum , i.e . , corticosteroid binding globulin ( CBG ) , sex hormone binding globulin ( SHBG ) , leading to increased total circulating DRUGA and DRUGB , respectively .
corticosteroids	group	sex steroids	group
false

Milk , milk products , and DRUGA rich foods or drugs may impair the absorption of DRUGB .
calcium	drug	EMCYT	brand
mechanism

CNS Active Drugs DRUGA An additive effect on psychomotor performance was seen with coadministration of DRUGB and DRUGN dga g / kg for up to dgb hours after DRUGN administration .
Ethanol	drug	eszopiclone	drug
false

CNS Active Drugs DRUGA An additive effect on psychomotor performance was seen with coadministration of DRUGN and DRUGB dga g / kg for up to dgb hours after DRUGN administration .
Ethanol	drug	ethanol	drug
false

CNS Active Drugs DRUGA An additive effect on psychomotor performance was seen with coadministration of DRUGN and DRUGN dga g / kg for up to dgb hours after DRUGB administration .
Ethanol	drug	ethanol	drug
false

CNS Active Drugs DRUGN An additive effect on psychomotor performance was seen with coadministration of DRUGA and DRUGB dga g / kg for up to dgb hours after DRUGN administration .
eszopiclone	drug	ethanol	drug
effect

CNS Active Drugs DRUGN An additive effect on psychomotor performance was seen with coadministration of DRUGA and DRUGN dga g / kg for up to dgb hours after DRUGB administration .
eszopiclone	drug	ethanol	drug
false

DRUGA : Coadministration of single doses of DRUGB dgb mg and DRUGN dgb mg daily for dgb days produced no pharmacokinetic or pharmacodynamic interaction .
Paroxetine	drug	eszopiclone	drug
false

DRUGA : Coadministration of single doses of DRUGN dgb mg and DRUGB dgb mg daily for dgb days produced no pharmacokinetic or pharmacodynamic interaction .
Paroxetine	drug	paroxetine	drug
false

DRUGN : Coadministration of single doses of DRUGA dgb mg and DRUGB dgb mg daily for dgb days produced no pharmacokinetic or pharmacodynamic interaction .
eszopiclone	drug	paroxetine	drug
false

DRUGA : Coadministration of single doses of DRUGB dgb mg and DRUGN dgb mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug .
Lorazepam	drug	eszopiclone	drug
false

DRUGA : Coadministration of single doses of DRUGN dgb mg and DRUGB dgb mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug .
Lorazepam	drug	lorazepam	drug
false

DRUGN : Coadministration of single doses of DRUGA dgb mg and DRUGB dgb mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug .
eszopiclone	drug	lorazepam	drug
false

DRUGA : Coadministration of DRUGB dgb mg and DRUGN dgb mg produced a decrease in DSST scores .
Olanzapine	drug	eszopiclone	drug
false

DRUGA : Coadministration of DRUGN dgb mg and DRUGB dgb mg produced a decrease in DSST scores .
Olanzapine	drug	olanzapine	drug
false

DRUGN : Coadministration of DRUGA dgb mg and DRUGB dgb mg produced a decrease in DSST scores .
eszopiclone	drug	olanzapine	drug
effect

Drugs That Inhibit CYPdgbAdgb ( DRUGA ) CYPdgbAdgb is a major metabolic pathway for elimination of DRUGB .
Ketoconazole	drug	eszopiclone	drug
false

The AUC of DRUGA was increased dga fold by coadministration of DRUGB , a potent inhibitor of CYPdgbAdgb , dgb mg daily for dgb days .
eszopiclone	drug	ketoconazole	drug
mechanism

Other strong inhibitors of CYPdgbAdgb ( e.g . , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN ) would be expected to behave similarly .
itraconazole	drug	clarithromycin	drug
false

Other strong inhibitors of CYPdgbAdgb ( e.g . , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN ) would be expected to behave similarly .
itraconazole	drug	nefazodone	drug
false

Other strong inhibitors of CYPdgbAdgb ( e.g . , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN ) would be expected to behave similarly .
itraconazole	drug	troleandomycin	drug
false

Other strong inhibitors of CYPdgbAdgb ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN ) would be expected to behave similarly .
itraconazole	drug	ritonavir	drug
false

Other strong inhibitors of CYPdgbAdgb ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB ) would be expected to behave similarly .
itraconazole	drug	nelfinavir	drug
false

Other strong inhibitors of CYPdgbAdgb ( e.g . , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN ) would be expected to behave similarly .
clarithromycin	drug	nefazodone	drug
false

Other strong inhibitors of CYPdgbAdgb ( e.g . , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN ) would be expected to behave similarly .
clarithromycin	drug	troleandomycin	drug
false

Other strong inhibitors of CYPdgbAdgb ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN ) would be expected to behave similarly .
clarithromycin	drug	ritonavir	drug
false

Other strong inhibitors of CYPdgbAdgb ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB ) would be expected to behave similarly .
clarithromycin	drug	nelfinavir	drug
false

Other strong inhibitors of CYPdgbAdgb ( e.g . , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN ) would be expected to behave similarly .
nefazodone	drug	troleandomycin	drug
false

Other strong inhibitors of CYPdgbAdgb ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN ) would be expected to behave similarly .
nefazodone	drug	ritonavir	drug
false

Other strong inhibitors of CYPdgbAdgb ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB ) would be expected to behave similarly .
nefazodone	drug	nelfinavir	drug
false

Other strong inhibitors of CYPdgbAdgb ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN ) would be expected to behave similarly .
troleandomycin	drug	ritonavir	drug
false

Other strong inhibitors of CYPdgbAdgb ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB ) would be expected to behave similarly .
troleandomycin	drug	nelfinavir	drug
false

Other strong inhibitors of CYPdgbAdgb ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB ) would be expected to behave similarly .
ritonavir	drug	nelfinavir	drug
false

Drugs That Induce CYPdgbAdgb ( DRUGA ) Racemic DRUGB exposure was decreased dgb % by concomitant useof DRUGN , a potent inducer of CYPdgbAdga
Rifampicin	drug	zopiclone	drug
false

Drugs That Induce CYPdgbAdgb ( DRUGA ) Racemic DRUGN exposure was decreased dgb % by concomitant useof DRUGB , a potent inducer of CYPdgbAdga
Rifampicin	drug	rifampicin	drug
false

Drugs That Induce CYPdgbAdgb ( DRUGN ) Racemic DRUGA exposure was decreased dgb % by concomitant useof DRUGB , a potent inducer of CYPdgbAdga
zopiclone	drug	rifampicin	drug
mechanism

However , it was observed that the pharmacokinetics of DRUGA was unaltered by concomitant DRUGB in rheumatoid arthritis patients .
ENBREL	brand	methotrexate	drug
false

Two percent of patients treated concurrently with DRUGA and DRUGB developed neutropenia ( ANC dgb x dgb / L ) .
ENBREL	brand	anakinra	drug
effect

DRUGA generally should not be given with DRUGB because they reduce its renal clearance and add a high risk of DRUGN toxicity .
Lithium	drug	diuretics	group
mechanism

DRUGA generally should not be given with DRUGN because they reduce its renal clearance and add a high risk of DRUGB toxicity .
Lithium	drug	lithium	drug
false

DRUGN generally should not be given with DRUGA because they reduce its renal clearance and add a high risk of DRUGB toxicity .
diuretics	group	lithium	drug
false

DRUGA may increase the ototoxic potential of other drugs such as DRUGB and some DRUGN .
EDECRIN	brand	aminoglycoside	group
effect

DRUGA may increase the ototoxic potential of other drugs such as DRUGN and some DRUGB .
EDECRIN	brand	cephalosporin antibiotics	group
effect

DRUGN may increase the ototoxic potential of other drugs such as DRUGA and some DRUGB .
aminoglycoside	group	cephalosporin antibiotics	group
false

A number of drugs , including DRUGA , have been shown to displace DRUGB from plasma protein ;
ethacrynic acid	drug	warfarin	drug
mechanism

In some patients , the administration of a DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGB , DRUGN and DRUGN .
non- steroidal antiinflammatory agent	group	loop diuretics	group
effect

In some patients , the administration of a DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGB and DRUGN .
non- steroidal antiinflammatory agent	group	potassium- sparing diuretics	group
effect

In some patients , the administration of a DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGN and DRUGB .
non- steroidal antiinflammatory agent	group	thiazide diuretics	group
effect

In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGA , DRUGB and DRUGN .
loop diuretics	group	potassium- sparing diuretics	group
false

In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGA , DRUGN and DRUGB .
loop diuretics	group	thiazide diuretics	group
false

In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGA and DRUGB .
potassium- sparing diuretics	group	thiazide diuretics	group
false

Therefore , when DRUGA and DRUGB are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGN is obtained .
EDECRIN	brand	non- steroidal anti- inflammatory agents	group
effect

Therefore , when DRUGA and DRUGN are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGB is obtained .
EDECRIN	brand	diuretic	group
false

Therefore , when DRUGN and DRUGA are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGB is obtained .
non- steroidal anti- inflammatory agents	group	diuretic	group
false

It is recommended to avoid concurrent administration of DRUGA with DRUGB containing DRUGN for at least dgb hours following DRUGN administration .
ethambutol	drug	aluminum hydroxide	drug
advise

It is recommended to avoid concurrent administration of DRUGA with DRUGN containing DRUGB for at least dgb hours following DRUGN administration .
ethambutol	drug	antacids	group
false

It is recommended to avoid concurrent administration of DRUGN with DRUGA containing DRUGB for at least dgb hours following DRUGN administration .
aluminum hydroxide	drug	antacids	group
false

It is recommended to avoid concurrent administration of DRUGN with DRUGA containing DRUGN for at least dgb hours following DRUGB administration .
aluminum hydroxide	drug	ethambutol	drug
false

It is recommended to avoid concurrent administration of DRUGN with DRUGN containing DRUGA for at least dgb hours following DRUGB administration .
antacids	group	ethambutol	drug
false

DRUGA and DRUGB may decrease hypoprothrombinemic effect .
Dicumarol	drug	warfarin	drug
false

Other depressasnts such as DRUGA , DRUGB , and DRUGN may enhance CNS depression when administered with DRUGN .
alcohol	drug	barbiturates	group
false

Other depressasnts such as DRUGA , DRUGN , and DRUGB may enhance CNS depression when administered with DRUGN .
alcohol	drug	MAOIs	group
false

Other depressasnts such as DRUGA , DRUGN , and DRUGN may enhance CNS depression when administered with DRUGB .
alcohol	drug	ethchlorvynol	drug
effect

Other depressasnts such as DRUGN , DRUGA , and DRUGB may enhance CNS depression when administered with DRUGN .
barbiturates	group	MAOIs	group
false

Other depressasnts such as DRUGN , DRUGA , and DRUGN may enhance CNS depression when administered with DRUGB .
barbiturates	group	ethchlorvynol	drug
effect

Other depressasnts such as DRUGN , DRUGN , and DRUGA may enhance CNS depression when administered with DRUGB .
MAOIs	group	ethchlorvynol	drug
effect

Certain endocrine and liver function tests may be affected by DRUGA containing oral DRUGB .
estrogen	group	contraceptives	group
false

DRUGA has been found to temporarily raise serum concentrations of DRUGB .
Trecator	brand	isoniazid	drug
mechanism

DRUGA may potentiate the adverse effects of other DRUGB administered concomitantly .
Trecator	brand	antituberculous drugs	group
effect

In particular , convulsions have been reported when DRUGA is administered with DRUGB and special care should be taken when the treatment regimen includes both of these drugs .
ethionamide	drug	cycloserine	drug
effect

DRUGA may interact with DRUGB or other DRUGN , causing increased sedative effects .
Ethopropazine	drug	alcohol	drug
effect

DRUGA may interact with DRUGN or other DRUGB , causing increased sedative effects .
Ethopropazine	drug	CNS depressants	group
effect

DRUGN may interact with DRUGA or other DRUGB , causing increased sedative effects .
alcohol	drug	CNS depressants	group
false

It may also interact with DRUGA or other DRUGB or DRUGN , which may intensify the anticholinergic action .
amantadine	drug	anticholinergic drugs	group
false

It may also interact with DRUGA or other DRUGN or DRUGB , which may intensify the anticholinergic action .
amantadine	drug	MAOIs	group
false

It may also interact with DRUGN or other DRUGA or DRUGB , which may intensify the anticholinergic action .
anticholinergic drugs	group	MAOIs	group
false

DRUGA can interact with DRUGB , increasing the metabolism of DRUGN .
Ethopropazine	drug	chlorpromazine	drug
mechanism

DRUGA can interact with DRUGN , increasing the metabolism of DRUGB .
Ethopropazine	drug	chlorpromazine	drug
false

Considerable caution should be exercised if DRUGA is administered concurrently with DRUGB ( DRUGN ) since paranoid symptoms have been reported during therapy with this combination .
PEGANONE	brand	Phenurone	brand
advise

Considerable caution should be exercised if DRUGA is administered concurrently with DRUGN ( DRUGB ) since paranoid symptoms have been reported during therapy with this combination .
PEGANONE	brand	phenacemide	drug
advise

Considerable caution should be exercised if DRUGN is administered concurrently with DRUGA ( DRUGB ) since paranoid symptoms have been reported during therapy with this combination .
Phenurone	brand	phenacemide	drug
false

A two way interaction between the DRUGA , DRUGB , and the DRUGN s has been suggested .
hydantoin antiepileptic	group	phenytoin	drug
int

A two way interaction between the DRUGA , DRUGN , and the DRUGB s has been suggested .
hydantoin antiepileptic	group	coumarin anticoagulant	group
int

A two way interaction between the DRUGN , DRUGA , and the DRUGB s has been suggested .
phenytoin	drug	coumarin anticoagulant	group
false

Presumably , DRUGA acts as a stimulator of DRUGB metabolism and has been reported to cause decreased serum levels of the DRUGN and increased prothrombin proconvertin concentrations .
phenytoin	drug	coumarin	group
mechanism

Presumably , DRUGA acts as a stimulator of DRUGN metabolism and has been reported to cause decreased serum levels of the DRUGB and increased prothrombin proconvertin concentrations .
phenytoin	drug	coumarin anticoagulants	group
mechanism

Presumably , DRUGN acts as a stimulator of DRUGA metabolism and has been reported to cause decreased serum levels of the DRUGB and increased prothrombin proconvertin concentrations .
coumarin	group	coumarin anticoagulants	group
false

Conversely , the DRUGA have been reported to increase the serum levels and prolong the serum half life of DRUGB by inhibiting its metabolism .
coumarin anticoagulants	group	phenytoin	drug
mechanism

Although there is no documentation of such , a similar interaction between DRUGA and the DRUGB may occur .
ethotoin	drug	coumarin anticoagulants	group
false

Caution is therefore advised when administering DRUGA to patients receiving DRUGB .
PEGANONE	brand	coumarin anticoagulants	group
advise

DRUGA may increase the action of DRUGB , DRUGN , DRUGN , and DRUGN .
Ethoxzolamide	drug	tricyclics	group
effect

DRUGA may increase the action of DRUGN , DRUGB , DRUGN , and DRUGN .
Ethoxzolamide	drug	amphetamines	group
effect

DRUGA may increase the action of DRUGN , DRUGN , DRUGB , and DRUGN .
Ethoxzolamide	drug	procainamide	drug
effect

DRUGA may increase the action of DRUGN , DRUGN , DRUGN , and DRUGB .
Ethoxzolamide	drug	quinidine	drug
effect

DRUGN may increase the action of DRUGA , DRUGB , DRUGN , and DRUGN .
tricyclics	group	amphetamines	group
false

DRUGN may increase the action of DRUGA , DRUGN , DRUGB , and DRUGN .
tricyclics	group	procainamide	drug
false

DRUGN may increase the action of DRUGA , DRUGN , DRUGN , and DRUGB .
tricyclics	group	quinidine	drug
false

DRUGN may increase the action of DRUGN , DRUGA , DRUGB , and DRUGN .
amphetamines	group	procainamide	drug
false

DRUGN may increase the action of DRUGN , DRUGA , DRUGN , and DRUGB .
amphetamines	group	quinidine	drug
false

DRUGN may increase the action of DRUGN , DRUGN , DRUGA , and DRUGB .
procainamide	drug	quinidine	drug
false

It may increase excretion of DRUGA , DRUGB , and DRUGN and may also increase the toxicity of DRUGN .
barbiturates	group	lithium	drug
false

It may increase excretion of DRUGA , DRUGN , and DRUGB and may also increase the toxicity of DRUGN .
barbiturates	group	ASA	drug
false

It may increase excretion of DRUGA , DRUGN , and DRUGN and may also increase the toxicity of DRUGB .
barbiturates	group	salicylates	group
false

It may increase excretion of DRUGN , DRUGA , and DRUGB and may also increase the toxicity of DRUGN .
lithium	drug	ASA	drug
false

It may increase excretion of DRUGN , DRUGA , and DRUGN and may also increase the toxicity of DRUGB .
lithium	drug	salicylates	group
false

It may increase excretion of DRUGN , DRUGN , and DRUGA and may also increase the toxicity of DRUGB .
ASA	drug	salicylates	group
false

Coadministration of DRUGA with other DRUGB , DRUGN , and DRUGN may cause hypokalemia .
ethoxzolamide	drug	diuretics	group
effect

Coadministration of DRUGA with other DRUGN , DRUGB , and DRUGN may cause hypokalemia .
ethoxzolamide	drug	amphotericin B	drug
effect

Coadministration of DRUGA with other DRUGN , DRUGN , and DRUGB may cause hypokalemia .
ethoxzolamide	drug	corticosteroids	group
effect

Coadministration of DRUGN with other DRUGA , DRUGB , and DRUGN may cause hypokalemia .
diuretics	group	amphotericin B	drug
false

Coadministration of DRUGN with other DRUGA , DRUGN , and DRUGB may cause hypokalemia .
diuretics	group	corticosteroids	group
false

Coadministration of DRUGN with other DRUGN , DRUGA , and DRUGB may cause hypokalemia .
amphotericin B	drug	corticosteroids	group
false

DRUGA : May increase plasma concentration of DRUGB , possibly by inhibiting conjugation .
Acetaminophen	drug	synthetic estrogens	group
mechanism

Combination DRUGA may also decrease the plasma concentration of DRUGB .
hormonal contraceptives	group	acetaminophen	drug
mechanism

DRUGA : Interferes with the contraceptive effect of microdosed DRUGB containing minipill preparations .
Acitretin	drug	progestin	group
effect

DRUGA : May increase CYP metabolism of DRUGB leading to possible decrease in contraceptive effectiveness .
Aminoglutethimide	drug	progestins	group
mechanism

DRUGA ( DRUGB , DRUGN ) : Pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these DRUGN on plasma concentrations of DRUGN .
Antibiotics	group	ampicillin	drug
false

DRUGA ( DRUGN , DRUGB ) : Pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these DRUGN on plasma concentrations of DRUGN .
Antibiotics	group	tetracycline	drug
false

DRUGA ( DRUGN , DRUGN ) : Pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these DRUGB on plasma concentrations of DRUGN .
Antibiotics	group	antibiotics	group
false

DRUGA ( DRUGN , DRUGN ) : Pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these DRUGN on plasma concentrations of DRUGB .
Antibiotics	group	synthetic steroids	group
false

DRUGN ( DRUGA , DRUGB ) : Pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these DRUGN on plasma concentrations of DRUGN .
ampicillin	drug	tetracycline	drug
false

DRUGN ( DRUGA , DRUGN ) : Pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these DRUGB on plasma concentrations of DRUGN .
ampicillin	drug	antibiotics	group
false

DRUGN ( DRUGA , DRUGN ) : Pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these DRUGN on plasma concentrations of DRUGB .
ampicillin	drug	synthetic steroids	group
false

DRUGN ( DRUGN , DRUGA ) : Pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these DRUGB on plasma concentrations of DRUGN .
tetracycline	drug	antibiotics	group
false

DRUGN ( DRUGN , DRUGA ) : Pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these DRUGN on plasma concentrations of DRUGB .
tetracycline	drug	synthetic steroids	group
false

DRUGN ( DRUGN , DRUGN ) : Pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these DRUGA on plasma concentrations of DRUGB .
antibiotics	group	synthetic steroids	group
false

DRUGA : Combination DRUGB may increase or decrease the effects of DRUGN .
Anticoagulants	group	hormonal contraceptives	group
false

DRUGA : Combination DRUGN may increase or decrease the effects of DRUGB .
Anticoagulants	group	coumarin derivatives	group
false

DRUGN : Combination DRUGA may increase or decrease the effects of DRUGB .
hormonal contraceptives	group	coumarin derivatives	group
effect

DRUGA ( DRUGB , DRUGN , DRUGN , DRUGN , DRUGN ) : Increase the metabolism of DRUGN and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
Anticonvulsants	group	carbamazepine	drug
false

DRUGA ( DRUGN , DRUGB , DRUGN , DRUGN , DRUGN ) : Increase the metabolism of DRUGN and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
Anticonvulsants	group	felbamate	drug
false

DRUGA ( DRUGN , DRUGN , DRUGB , DRUGN , DRUGN ) : Increase the metabolism of DRUGN and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
Anticonvulsants	group	phenobarbital	drug
false

DRUGA ( DRUGN , DRUGN , DRUGN , DRUGB , DRUGN ) : Increase the metabolism of DRUGN and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
Anticonvulsants	group	phenytoin	drug
false

DRUGA ( DRUGN , DRUGN , DRUGN , DRUGN , DRUGB ) : Increase the metabolism of DRUGN and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
Anticonvulsants	group	topiramate	drug
false

DRUGA ( DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ) : Increase the metabolism of DRUGB and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
Anticonvulsants	group	ethinyl estradiol	drug
mechanism

DRUGA ( DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ) : Increase the metabolism of DRUGN and / or some DRUGB , leading to possible decrease in contraceptive effectiveness .
Anticonvulsants	group	progestins	group
mechanism

DRUGN ( DRUGA , DRUGB , DRUGN , DRUGN , DRUGN ) : Increase the metabolism of DRUGN and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
carbamazepine	drug	felbamate	drug
false

DRUGN ( DRUGA , DRUGN , DRUGB , DRUGN , DRUGN ) : Increase the metabolism of DRUGN and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
carbamazepine	drug	phenobarbital	drug
false

DRUGN ( DRUGA , DRUGN , DRUGN , DRUGB , DRUGN ) : Increase the metabolism of DRUGN and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
carbamazepine	drug	phenytoin	drug
false

DRUGN ( DRUGA , DRUGN , DRUGN , DRUGN , DRUGB ) : Increase the metabolism of DRUGN and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
carbamazepine	drug	topiramate	drug
false

DRUGN ( DRUGA , DRUGN , DRUGN , DRUGN , DRUGN ) : Increase the metabolism of DRUGB and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
carbamazepine	drug	ethinyl estradiol	drug
mechanism

DRUGN ( DRUGA , DRUGN , DRUGN , DRUGN , DRUGN ) : Increase the metabolism of DRUGN and / or some DRUGB , leading to possible decrease in contraceptive effectiveness .
carbamazepine	drug	progestins	group
mechanism

DRUGN ( DRUGN , DRUGA , DRUGB , DRUGN , DRUGN ) : Increase the metabolism of DRUGN and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
felbamate	drug	phenobarbital	drug
false

DRUGN ( DRUGN , DRUGA , DRUGN , DRUGB , DRUGN ) : Increase the metabolism of DRUGN and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
felbamate	drug	phenytoin	drug
false

DRUGN ( DRUGN , DRUGA , DRUGN , DRUGN , DRUGB ) : Increase the metabolism of DRUGN and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
felbamate	drug	topiramate	drug
false

DRUGN ( DRUGN , DRUGA , DRUGN , DRUGN , DRUGN ) : Increase the metabolism of DRUGB and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
felbamate	drug	ethinyl estradiol	drug
mechanism

DRUGN ( DRUGN , DRUGA , DRUGN , DRUGN , DRUGN ) : Increase the metabolism of DRUGN and / or some DRUGB , leading to possible decrease in contraceptive effectiveness .
felbamate	drug	progestins	group
mechanism

DRUGN ( DRUGN , DRUGN , DRUGA , DRUGB , DRUGN ) : Increase the metabolism of DRUGN and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
phenobarbital	drug	phenytoin	drug
false

DRUGN ( DRUGN , DRUGN , DRUGA , DRUGN , DRUGB ) : Increase the metabolism of DRUGN and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
phenobarbital	drug	topiramate	drug
false

DRUGN ( DRUGN , DRUGN , DRUGA , DRUGN , DRUGN ) : Increase the metabolism of DRUGB and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
phenobarbital	drug	ethinyl estradiol	drug
mechanism

DRUGN ( DRUGN , DRUGN , DRUGA , DRUGN , DRUGN ) : Increase the metabolism of DRUGN and / or some DRUGB , leading to possible decrease in contraceptive effectiveness .
phenobarbital	drug	progestins	group
mechanism

DRUGN ( DRUGN , DRUGN , DRUGN , DRUGA , DRUGB ) : Increase the metabolism of DRUGN and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
phenytoin	drug	topiramate	drug
false

DRUGN ( DRUGN , DRUGN , DRUGN , DRUGA , DRUGN ) : Increase the metabolism of DRUGB and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
phenytoin	drug	ethinyl estradiol	drug
mechanism

DRUGN ( DRUGN , DRUGN , DRUGN , DRUGA , DRUGN ) : Increase the metabolism of DRUGN and / or some DRUGB , leading to possible decrease in contraceptive effectiveness .
phenytoin	drug	progestins	group
mechanism

DRUGN ( DRUGN , DRUGN , DRUGN , DRUGN , DRUGA ) : Increase the metabolism of DRUGB and / or some DRUGN , leading to possible decrease in contraceptive effectiveness .
topiramate	drug	ethinyl estradiol	drug
mechanism

DRUGN ( DRUGN , DRUGN , DRUGN , DRUGN , DRUGA ) : Increase the metabolism of DRUGN and / or some DRUGB , leading to possible decrease in contraceptive effectiveness .
topiramate	drug	progestins	group
mechanism

DRUGN ( DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ) : Increase the metabolism of DRUGA and / or some DRUGB , leading to possible decrease in contraceptive effectiveness .
ethinyl estradiol	drug	progestins	group
false

DRUGA : Doses of DRUGB ( DRUGN ) dgb g / day have been reported to increase plasma concentration of DRUGN by ~dgb % , possibly by inhibiting conjugation ;
Ascorbic acid	drug	ascorbic acid	drug
false

DRUGA : Doses of DRUGN ( DRUGB ) dgb g / day have been reported to increase plasma concentration of DRUGN by ~dgb % , possibly by inhibiting conjugation ;
Ascorbic acid	drug	vitamin C	drug
false

DRUGA : Doses of DRUGN ( DRUGN ) dgb g / day have been reported to increase plasma concentration of DRUGB by ~dgb % , possibly by inhibiting conjugation ;
Ascorbic acid	drug	synthetic estrogens	group
false

DRUGN : Doses of DRUGA ( DRUGB ) dgb g / day have been reported to increase plasma concentration of DRUGN by ~dgb % , possibly by inhibiting conjugation ;
ascorbic acid	drug	vitamin C	drug
false

DRUGN : Doses of DRUGA ( DRUGN ) dgb g / day have been reported to increase plasma concentration of DRUGB by ~dgb % , possibly by inhibiting conjugation ;
ascorbic acid	drug	synthetic estrogens	group
mechanism

DRUGN : Doses of DRUGN ( DRUGA ) dgb g / day have been reported to increase plasma concentration of DRUGB by ~dgb % , possibly by inhibiting conjugation ;
vitamin C	drug	synthetic estrogens	group
mechanism

DRUGA : DRUGN increases the AUC for DRUGB and DRUGN .
Atorvastatin	drug	norethindrone	drug
false

DRUGA : DRUGN increases the AUC for DRUGN and DRUGB .
Atorvastatin	drug	ethinyl estradiol	drug
false

DRUGN : DRUGA increases the AUC for DRUGB and DRUGN .
Atorvastatin	drug	norethindrone	drug
mechanism

DRUGN : DRUGA increases the AUC for DRUGN and DRUGB .
Atorvastatin	drug	ethinyl estradiol	drug
mechanism

DRUGN : DRUGN increases the AUC for DRUGA and DRUGB .
norethindrone	drug	ethinyl estradiol	drug
false

DRUGA : Combination DRUGB may decrease the clearance of some DRUGN ( DRUGN , DRUGN , DRUGN ) and increase the clearance of others ( DRUGN , DRUGN , DRUGN ) .
Benzodiazepines	group	hormonal contraceptives	group
false

DRUGA : Combination DRUGN may decrease the clearance of some DRUGB ( DRUGN , DRUGN , DRUGN ) and increase the clearance of others ( DRUGN , DRUGN , DRUGN ) .
Benzodiazepines	group	benzodiazepines	group
false

DRUGA : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGB , DRUGN , DRUGN ) and increase the clearance of others ( DRUGN , DRUGN , DRUGN ) .
Benzodiazepines	group	alprazolam	drug
false

DRUGA : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGN , DRUGB , DRUGN ) and increase the clearance of others ( DRUGN , DRUGN , DRUGN ) .
Benzodiazepines	group	chlordiazepoxide	drug
false

DRUGA : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGN , DRUGN , DRUGB ) and increase the clearance of others ( DRUGN , DRUGN , DRUGN ) .
Benzodiazepines	group	diazepam	drug
false

DRUGA : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGN , DRUGN , DRUGN ) and increase the clearance of others ( DRUGB , DRUGN , DRUGN ) .
Benzodiazepines	group	lorazepam	drug
false

DRUGA : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGN , DRUGN , DRUGN ) and increase the clearance of others ( DRUGN , DRUGB , DRUGN ) .
Benzodiazepines	group	oxazepam	drug
false

DRUGA : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGN , DRUGN , DRUGN ) and increase the clearance of others ( DRUGN , DRUGN , DRUGB ) .
Benzodiazepines	group	temazepam	drug
false

DRUGN : Combination DRUGA may decrease the clearance of some DRUGB ( DRUGN , DRUGN , DRUGN ) and increase the clearance of others ( DRUGN , DRUGN , DRUGN ) .
hormonal contraceptives	group	benzodiazepines	group
mechanism

DRUGN : Combination DRUGA may decrease the clearance of some DRUGN ( DRUGB , DRUGN , DRUGN ) and increase the clearance of others ( DRUGN , DRUGN , DRUGN ) .
hormonal contraceptives	group	alprazolam	drug
mechanism

DRUGN : Combination DRUGA may decrease the clearance of some DRUGN ( DRUGN , DRUGB , DRUGN ) and increase the clearance of others ( DRUGN , DRUGN , DRUGN ) .
hormonal contraceptives	group	chlordiazepoxide	drug
mechanism

DRUGN : Combination DRUGA may decrease the clearance of some DRUGN ( DRUGN , DRUGN , DRUGB ) and increase the clearance of others ( DRUGN , DRUGN , DRUGN ) .
hormonal contraceptives	group	diazepam	drug
mechanism

DRUGN : Combination DRUGA may decrease the clearance of some DRUGN ( DRUGN , DRUGN , DRUGN ) and increase the clearance of others ( DRUGB , DRUGN , DRUGN ) .
hormonal contraceptives	group	lorazepam	drug
mechanism

DRUGN : Combination DRUGA may decrease the clearance of some DRUGN ( DRUGN , DRUGN , DRUGN ) and increase the clearance of others ( DRUGN , DRUGB , DRUGN ) .
hormonal contraceptives	group	oxazepam	drug
mechanism

DRUGN : Combination DRUGA may decrease the clearance of some DRUGN ( DRUGN , DRUGN , DRUGN ) and increase the clearance of others ( DRUGN , DRUGN , DRUGB ) .
hormonal contraceptives	group	temazepam	drug
mechanism

DRUGN : Combination DRUGN may decrease the clearance of some DRUGA ( DRUGB , DRUGN , DRUGN ) and increase the clearance of others ( DRUGN , DRUGN , DRUGN ) .
benzodiazepines	group	alprazolam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGA ( DRUGN , DRUGB , DRUGN ) and increase the clearance of others ( DRUGN , DRUGN , DRUGN ) .
benzodiazepines	group	chlordiazepoxide	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGA ( DRUGN , DRUGN , DRUGB ) and increase the clearance of others ( DRUGN , DRUGN , DRUGN ) .
benzodiazepines	group	diazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGA ( DRUGN , DRUGN , DRUGN ) and increase the clearance of others ( DRUGB , DRUGN , DRUGN ) .
benzodiazepines	group	lorazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGA ( DRUGN , DRUGN , DRUGN ) and increase the clearance of others ( DRUGN , DRUGB , DRUGN ) .
benzodiazepines	group	oxazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGA ( DRUGN , DRUGN , DRUGN ) and increase the clearance of others ( DRUGN , DRUGN , DRUGB ) .
benzodiazepines	group	temazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGA , DRUGB , DRUGN ) and increase the clearance of others ( DRUGN , DRUGN , DRUGN ) .
alprazolam	drug	chlordiazepoxide	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGA , DRUGN , DRUGB ) and increase the clearance of others ( DRUGN , DRUGN , DRUGN ) .
alprazolam	drug	diazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGA , DRUGN , DRUGN ) and increase the clearance of others ( DRUGB , DRUGN , DRUGN ) .
alprazolam	drug	lorazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGA , DRUGN , DRUGN ) and increase the clearance of others ( DRUGN , DRUGB , DRUGN ) .
alprazolam	drug	oxazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGA , DRUGN , DRUGN ) and increase the clearance of others ( DRUGN , DRUGN , DRUGB ) .
alprazolam	drug	temazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGN , DRUGA , DRUGB ) and increase the clearance of others ( DRUGN , DRUGN , DRUGN ) .
chlordiazepoxide	drug	diazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGN , DRUGA , DRUGN ) and increase the clearance of others ( DRUGB , DRUGN , DRUGN ) .
chlordiazepoxide	drug	lorazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGN , DRUGA , DRUGN ) and increase the clearance of others ( DRUGN , DRUGB , DRUGN ) .
chlordiazepoxide	drug	oxazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGN , DRUGA , DRUGN ) and increase the clearance of others ( DRUGN , DRUGN , DRUGB ) .
chlordiazepoxide	drug	temazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGN , DRUGN , DRUGA ) and increase the clearance of others ( DRUGB , DRUGN , DRUGN ) .
diazepam	drug	lorazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGN , DRUGN , DRUGA ) and increase the clearance of others ( DRUGN , DRUGB , DRUGN ) .
diazepam	drug	oxazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGN , DRUGN , DRUGA ) and increase the clearance of others ( DRUGN , DRUGN , DRUGB ) .
diazepam	drug	temazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGN , DRUGN , DRUGN ) and increase the clearance of others ( DRUGA , DRUGB , DRUGN ) .
lorazepam	drug	oxazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGN , DRUGN , DRUGN ) and increase the clearance of others ( DRUGA , DRUGN , DRUGB ) .
lorazepam	drug	temazepam	drug
false

DRUGN : Combination DRUGN may decrease the clearance of some DRUGN ( DRUGN , DRUGN , DRUGN ) and increase the clearance of others ( DRUGN , DRUGA , DRUGB ) .
oxazepam	drug	temazepam	drug
false

DRUGA : Combination DRUGB may increase the clearance of DRUGN .
Clofibric acid	drug_n	hormonal contraceptives	group
false

DRUGA : Combination DRUGN may increase the clearance of DRUGB .
Clofibric acid	drug_n	clofibric acid	drug_n
false

DRUGN : Combination DRUGA may increase the clearance of DRUGB .
hormonal contraceptives	group	clofibric acid	drug_n
mechanism

DRUGA : Combination DRUGB may inhibit the metabolism of DRUGN , leading to increased plasma concentrations ;
Cyclosporine	drug	hormonal contraceptives	group
false

DRUGA : Combination DRUGN may inhibit the metabolism of DRUGB , leading to increased plasma concentrations ;
Cyclosporine	drug	cyclosporine	drug
false

DRUGN : Combination DRUGA may inhibit the metabolism of DRUGB , leading to increased plasma concentrations ;
hormonal contraceptives	group	cyclosporine	drug
mechanism

Example inducers include DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
aminoglutethimide	drug	carbamazepine	drug
false

Example inducers include DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
aminoglutethimide	drug	nafcillin	drug
false

Example inducers include DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
aminoglutethimide	drug	nevirapine	drug
false

Example inducers include DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
aminoglutethimide	drug	phenobarbital	drug
false

Example inducers include DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
aminoglutethimide	drug	phenytoin	drug
false

Example inducers include DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
aminoglutethimide	drug	rifamycins	group
false

Example inducers include DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
carbamazepine	drug	nafcillin	drug
false

Example inducers include DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
carbamazepine	drug	nevirapine	drug
false

Example inducers include DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
carbamazepine	drug	phenobarbital	drug
false

Example inducers include DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
carbamazepine	drug	phenytoin	drug
false

Example inducers include DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
carbamazepine	drug	rifamycins	group
false

Example inducers include DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
nafcillin	drug	nevirapine	drug
false

Example inducers include DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
nafcillin	drug	phenobarbital	drug
false

Example inducers include DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
nafcillin	drug	phenytoin	drug
false

Example inducers include DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
nafcillin	drug	rifamycins	group
false

Example inducers include DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
nevirapine	drug	phenobarbital	drug
false

Example inducers include DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
nevirapine	drug	phenytoin	drug
false

Example inducers include DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
nevirapine	drug	rifamycins	group
false

Example inducers include DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
phenobarbital	drug	phenytoin	drug
false

Example inducers include DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
phenobarbital	drug	rifamycins	group
false

Example inducers include DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
phenytoin	drug	rifamycins	group
false

DRUGA : DRUGN may induce the metabolism of DRUGB causing menstrual changes ;
Griseofulvin	drug	combination hormonal contraceptives	group
false

DRUGN : DRUGA may induce the metabolism of DRUGB causing menstrual changes ;
Griseofulvin	drug	combination hormonal contraceptives	group
mechanism

DRUGA : Combination DRUGB may increase the clearance of DRUGN .
Morphine	drug	hormonal contraceptives	group
false

DRUGA : Combination DRUGN may increase the clearance of DRUGB .
Morphine	drug	morphine	drug
false

DRUGN : Combination DRUGA may increase the clearance of DRUGB .
hormonal contraceptives	group	morphine	drug
mechanism

DRUGA ( DRUGB ) : DRUGN may decrease plasma levels of DRUGN ;
Non-nucleoside reverse transcriptase inhibitors	group	NNRTIs	group
false

DRUGA ( DRUGN ) : DRUGB may decrease plasma levels of DRUGN ;
Non-nucleoside reverse transcriptase inhibitors	group	Nevirapine	drug
false

DRUGA ( DRUGN ) : DRUGN may decrease plasma levels of DRUGB ;
Non-nucleoside reverse transcriptase inhibitors	group	combination hormonal contraceptives	group
false

DRUGN ( DRUGA ) : DRUGB may decrease plasma levels of DRUGN ;
NNRTIs	group	Nevirapine	drug
false

DRUGN ( DRUGA ) : DRUGN may decrease plasma levels of DRUGB ;
NNRTIs	group	combination hormonal contraceptives	group
false

DRUGN ( DRUGN ) : DRUGA may decrease plasma levels of DRUGB ;
Nevirapine	drug	combination hormonal contraceptives	group
mechanism

DRUGA : DRUGB may inhibit the metabolism of DRUGN , leading to increased plasma concentrations .
Prednisolone	drug	Ethinyl estradiol	drug
false

DRUGA : DRUGN may inhibit the metabolism of DRUGB , leading to increased plasma concentrations .
Prednisolone	drug	prednisolone	drug
false

DRUGN : DRUGA may inhibit the metabolism of DRUGB , leading to increased plasma concentrations .
Ethinyl estradiol	drug	prednisolone	drug
mechanism

DRUGA : DRUGB , DRUGN , DRUGN , and DRUGN have been shown to decrease plasma levels of DRUGN ;
Protease inhibitors	group	Amprenavir	drug
false

DRUGA : DRUGN , DRUGB , DRUGN , and DRUGN have been shown to decrease plasma levels of DRUGN ;
Protease inhibitors	group	lopinavir	drug
false

DRUGA : DRUGN , DRUGN , DRUGB , and DRUGN have been shown to decrease plasma levels of DRUGN ;
Protease inhibitors	group	nelfinavir	drug
false

DRUGA : DRUGN , DRUGN , DRUGN , and DRUGB have been shown to decrease plasma levels of DRUGN ;
Protease inhibitors	group	ritonavir	drug
false

DRUGA : DRUGN , DRUGN , DRUGN , and DRUGN have been shown to decrease plasma levels of DRUGB ;
Protease inhibitors	group	combination hormonal contraceptives	group
false

DRUGN : DRUGA , DRUGB , DRUGN , and DRUGN have been shown to decrease plasma levels of DRUGN ;
Amprenavir	drug	lopinavir	drug
false

DRUGN : DRUGA , DRUGN , DRUGB , and DRUGN have been shown to decrease plasma levels of DRUGN ;
Amprenavir	drug	nelfinavir	drug
false

DRUGN : DRUGA , DRUGN , DRUGN , and DRUGB have been shown to decrease plasma levels of DRUGN ;
Amprenavir	drug	ritonavir	drug
false

DRUGN : DRUGA , DRUGN , DRUGN , and DRUGN have been shown to decrease plasma levels of DRUGB ;
Amprenavir	drug	combination hormonal contraceptives	group
mechanism

DRUGN : DRUGN , DRUGA , DRUGB , and DRUGN have been shown to decrease plasma levels of DRUGN ;
lopinavir	drug	nelfinavir	drug
false

DRUGN : DRUGN , DRUGA , DRUGN , and DRUGB have been shown to decrease plasma levels of DRUGN ;
lopinavir	drug	ritonavir	drug
false

DRUGN : DRUGN , DRUGA , DRUGN , and DRUGN have been shown to decrease plasma levels of DRUGB ;
lopinavir	drug	combination hormonal contraceptives	group
mechanism

DRUGN : DRUGN , DRUGN , DRUGA , and DRUGB have been shown to decrease plasma levels of DRUGN ;
nelfinavir	drug	ritonavir	drug
false

DRUGN : DRUGN , DRUGN , DRUGA , and DRUGN have been shown to decrease plasma levels of DRUGB ;
nelfinavir	drug	combination hormonal contraceptives	group
mechanism

DRUGN : DRUGN , DRUGN , DRUGN , and DRUGA have been shown to decrease plasma levels of DRUGB ;
ritonavir	drug	combination hormonal contraceptives	group
mechanism

DRUGA has been shown to increase plasma levels of DRUGB .
Indinavir	drug	combination hormonal contraceptives	group
mechanism

DRUGA : DRUGN increases the metabolism of DRUGB and some DRUGN ( DRUGN ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
Rifampin	drug	ethinyl estradiol	drug
false

DRUGA : DRUGN increases the metabolism of DRUGN and some DRUGB ( DRUGN ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
Rifampin	drug	progestins	group
false

DRUGA : DRUGN increases the metabolism of DRUGN and some DRUGN ( DRUGB ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
Rifampin	drug	norethindrone	drug
false

DRUGN : DRUGA increases the metabolism of DRUGB and some DRUGN ( DRUGN ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
Rifampin	drug	ethinyl estradiol	drug
mechanism

DRUGN : DRUGA increases the metabolism of DRUGN and some DRUGB ( DRUGN ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
Rifampin	drug	progestins	group
mechanism

DRUGN : DRUGA increases the metabolism of DRUGN and some DRUGN ( DRUGB ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
Rifampin	drug	norethindrone	drug
mechanism

DRUGN : DRUGN increases the metabolism of DRUGA and some DRUGB ( DRUGN ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
ethinyl estradiol	drug	progestins	group
false

DRUGN : DRUGN increases the metabolism of DRUGA and some DRUGN ( DRUGB ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
ethinyl estradiol	drug	norethindrone	drug
false

DRUGN : DRUGN increases the metabolism of DRUGN and some DRUGA ( DRUGB ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
progestins	group	norethindrone	drug
false

DRUGA : Combination DRUGB may increase the clearance of DRUGN .
Salicylic acid	drug	hormonal contraceptives	group
false

DRUGA : Combination DRUGN may increase the clearance of DRUGB .
Salicylic acid	drug	salicylic acid	drug
false

DRUGN : Combination DRUGA may increase the clearance of DRUGB .
hormonal contraceptives	group	salicylic acid	drug
mechanism

DRUGA : DRUGB may increase the serum concentration of DRUGN .
Selegiline	drug	Combination hormonal contraceptives	group
false

DRUGA : DRUGN may increase the serum concentration of DRUGB .
Selegiline	drug	selegiline	drug
false

DRUGN : DRUGA may increase the serum concentration of DRUGB .
Combination hormonal contraceptives	group	selegiline	drug
mechanism

DRUGA : DRUGB may inhibit the metabolism of DRUGN , leading to increased plasma concentrations .
Theophylline	drug	Ethinyl estradiol	drug
false

DRUGA : DRUGN may inhibit the metabolism of DRUGB , leading to increased plasma concentrations .
Theophylline	drug	theophylline	drug
false

DRUGN : DRUGA may inhibit the metabolism of DRUGB , leading to increased plasma concentrations .
Ethinyl estradiol	drug	theophylline	drug
mechanism

DRUGA ( DRUGB , DRUGN , DRUGN ) : Metabolism may be inhibited by DRUGN , increasing plasma levels of DRUGN ;
Tricyclic antidepressants	group	amitriptyline	drug
false

DRUGA ( DRUGN , DRUGB , DRUGN ) : Metabolism may be inhibited by DRUGN , increasing plasma levels of DRUGN ;
Tricyclic antidepressants	group	imipramine	drug
false

DRUGA ( DRUGN , DRUGN , DRUGB ) : Metabolism may be inhibited by DRUGN , increasing plasma levels of DRUGN ;
Tricyclic antidepressants	group	nortriptyline	drug
false

DRUGA ( DRUGN , DRUGN , DRUGN ) : Metabolism may be inhibited by DRUGB , increasing plasma levels of DRUGN ;
Tricyclic antidepressants	group	combination hormonal contraceptives	group
mechanism

DRUGA ( DRUGN , DRUGN , DRUGN ) : Metabolism may be inhibited by DRUGN , increasing plasma levels of DRUGB ;
Tricyclic antidepressants	group	antidepressant	group
false

DRUGN ( DRUGA , DRUGB , DRUGN ) : Metabolism may be inhibited by DRUGN , increasing plasma levels of DRUGN ;
amitriptyline	drug	imipramine	drug
false

DRUGN ( DRUGA , DRUGN , DRUGB ) : Metabolism may be inhibited by DRUGN , increasing plasma levels of DRUGN ;
amitriptyline	drug	nortriptyline	drug
false

DRUGN ( DRUGA , DRUGN , DRUGN ) : Metabolism may be inhibited by DRUGB , increasing plasma levels of DRUGN ;
amitriptyline	drug	combination hormonal contraceptives	group
mechanism

DRUGN ( DRUGA , DRUGN , DRUGN ) : Metabolism may be inhibited by DRUGN , increasing plasma levels of DRUGB ;
amitriptyline	drug	antidepressant	group
false

DRUGN ( DRUGN , DRUGA , DRUGB ) : Metabolism may be inhibited by DRUGN , increasing plasma levels of DRUGN ;
imipramine	drug	nortriptyline	drug
false

DRUGN ( DRUGN , DRUGA , DRUGN ) : Metabolism may be inhibited by DRUGB , increasing plasma levels of DRUGN ;
imipramine	drug	combination hormonal contraceptives	group
mechanism

DRUGN ( DRUGN , DRUGA , DRUGN ) : Metabolism may be inhibited by DRUGN , increasing plasma levels of DRUGB ;
imipramine	drug	antidepressant	group
false

DRUGN ( DRUGN , DRUGN , DRUGA ) : Metabolism may be inhibited by DRUGB , increasing plasma levels of DRUGN ;
nortriptyline	drug	combination hormonal contraceptives	group
mechanism

DRUGN ( DRUGN , DRUGN , DRUGA ) : Metabolism may be inhibited by DRUGN , increasing plasma levels of DRUGB ;
nortriptyline	drug	antidepressant	group
false

DRUGN ( DRUGN , DRUGN , DRUGN ) : Metabolism may be inhibited by DRUGA , increasing plasma levels of DRUGB ;
combination hormonal contraceptives	group	antidepressant	group
false

DRUGA / NUTRITION / HERB INTERACTIONS : Food : CNS effects of DRUGB may be enhanced if DRUGN are used concurrently with DRUGN .
ETHANOL	drug	caffeine	drug
false

DRUGA / NUTRITION / HERB INTERACTIONS : Food : CNS effects of DRUGN may be enhanced if DRUGB are used concurrently with DRUGN .
ETHANOL	drug	combination hormonal contraceptives	group
false

DRUGA / NUTRITION / HERB INTERACTIONS : Food : CNS effects of DRUGN may be enhanced if DRUGN are used concurrently with DRUGB .
ETHANOL	drug	caffeine	drug
false

DRUGN / NUTRITION / HERB INTERACTIONS : Food : CNS effects of DRUGA may be enhanced if DRUGB are used concurrently with DRUGN .
caffeine	drug	combination hormonal contraceptives	group
false

DRUGN / NUTRITION / HERB INTERACTIONS : Food : CNS effects of DRUGN may be enhanced if DRUGA are used concurrently with DRUGB .
combination hormonal contraceptives	group	caffeine	drug
effect

Grapefruit juice increases DRUGA concentrations and would be expected to increase DRUGB serum levels as well ;
ethinyl estradiol	drug	progesterone	drug
false

There have been isolated reports of patients experiencing increases in their prothrombin times when DRUGA was added to DRUGB therapy .
etidronate	drug	warfarin	drug
effect

DRUGA Reports suggest that DRUGB may diminish the antihypertensive effect of DRUGN .
ACE-inhibitors	group	NSAIDs	group
false

DRUGN Reports suggest that DRUGA may diminish the antihypertensive effect of DRUGB .
NSAIDs	group	ACE-inhibitors	group
effect

This interaction should be given consideration in patients taking DRUGA concomitantly with DRUGB .
NSAIDs	group	ACE-inhibitors	group
advise

DRUGA : The concomitant administration of DRUGB has no apparent effect on the extent of absorption of DRUGN .
Antacids	group	antacids	group
false

DRUGA : The concomitant administration of DRUGN has no apparent effect on the extent of absorption of DRUGB .
Antacids	group	Lodine	brand
false

DRUGN : The concomitant administration of DRUGA has no apparent effect on the extent of absorption of DRUGB .
antacids	group	Lodine	brand
false

DRUGA : When DRUGB is administered with DRUGN , its protein binding is reduced , although the clearance of free DRUGN is not altered .
Aspirin	brand	Lodine	brand
false

DRUGA : When DRUGN is administered with DRUGB , its protein binding is reduced , although the clearance of free DRUGN is not altered .
Aspirin	brand	aspirin	brand
false

DRUGA : When DRUGN is administered with DRUGN , its protein binding is reduced , although the clearance of free DRUGB is not altered .
Aspirin	brand	etodolac	drug
false

DRUGN : When DRUGA is administered with DRUGB , its protein binding is reduced , although the clearance of free DRUGN is not altered .
Lodine	brand	aspirin	brand
mechanism

DRUGN : When DRUGA is administered with DRUGN , its protein binding is reduced , although the clearance of free DRUGB is not altered .
Lodine	brand	etodolac	drug
false

DRUGN : When DRUGN is administered with DRUGA , its protein binding is reduced , although the clearance of free DRUGB is not altered .
aspirin	brand	etodolac	drug
false

however , as with other DRUGA , concomitant administration of DRUGB and DRUGN is not generally recommended because of the potential of increased adverse effects .
NSAIDs	group	Lodine	brand
false

however , as with other DRUGA , concomitant administration of DRUGN and DRUGB is not generally recommended because of the potential of increased adverse effects .
NSAIDs	group	aspirin	brand
false

however , as with other DRUGN , concomitant administration of DRUGA and DRUGB is not generally recommended because of the potential of increased adverse effects .
Lodine	brand	aspirin	brand
advise

Patients receiving these drugs who are given DRUGA , or any other DRUGB , and particularly those patients with altered renal function , should be observed for the development of the specific toxicities of these drugs .
Lodine	brand	NSAID	group
false

DRUGA : Etodolac has no apparent pharmacokinetic interaction when administered with DRUGB or DRUGN .
Diuretics	group	furosemide	drug
false

DRUGA : Etodolac has no apparent pharmacokinetic interaction when administered with DRUGN or DRUGB .
Diuretics	group	hydrochlorothiazide	drug
false

DRUGN : Etodolac has no apparent pharmacokinetic interaction when administered with DRUGA or DRUGB .
furosemide	drug	hydrochlorothiazide	drug
false

Nevertheless , clinical studies , as well as postmarketing observations have shown that DRUGA can reduce the natriuretic effect of DRUGB and DRUGN in some patients .
Lodine	brand	furosemide	drug
effect

Nevertheless , clinical studies , as well as postmarketing observations have shown that DRUGA can reduce the natriuretic effect of DRUGN and DRUGB in some patients .
Lodine	brand	thiazides	group
effect

Nevertheless , clinical studies , as well as postmarketing observations have shown that DRUGN can reduce the natriuretic effect of DRUGA and DRUGB in some patients .
furosemide	drug	thiazides	group
false

DRUGA : DRUGB has no apparent pharmacokinetic interaction when administered with DRUGN .
Glyburide	drug	Etodolac	drug
false

DRUGA : DRUGN has no apparent pharmacokinetic interaction when administered with DRUGB .
Glyburide	drug	glyburide	drug
false

DRUGN : DRUGA has no apparent pharmacokinetic interaction when administered with DRUGB .
Etodolac	drug	glyburide	drug
false

DRUGA : DRUGB have produced an elevation of plasma DRUGN levels and a reduction in renal DRUGN clearance .
Lithium	drug	NSAIDs	group
false

DRUGA : DRUGN have produced an elevation of plasma DRUGB levels and a reduction in renal DRUGN clearance .
Lithium	drug	lithium	drug
false

DRUGA : DRUGN have produced an elevation of plasma DRUGN levels and a reduction in renal DRUGB clearance .
Lithium	drug	lithium	drug
false

DRUGN : DRUGA have produced an elevation of plasma DRUGB levels and a reduction in renal DRUGN clearance .
NSAIDs	group	lithium	drug
mechanism

DRUGN : DRUGA have produced an elevation of plasma DRUGN levels and a reduction in renal DRUGB clearance .
NSAIDs	group	lithium	drug
false

Thus , when DRUGA and DRUGB are administered concurrently , subjects should be observed carefully for signs of DRUGN toxicity .
NSAIDs	group	lithium	drug
effect

Thus , when DRUGA and DRUGN are administered concurrently , subjects should be observed carefully for signs of DRUGB toxicity .
NSAIDs	group	lithium	drug
false

DRUGA : DRUGN causes increase ( by about dgb % ) in the free fraction of DRUGB .
Phenylbutazone	drug	etodolac	drug
false

DRUGN : DRUGA causes increase ( by about dgb % ) in the free fraction of DRUGB .
Phenylbutazone	drug	etodolac	drug
mechanism

Although in vivo studies have not been done to see if DRUGA clearance is changed by coadministration of DRUGB , it is not recommended that they be coadministered .
etodolac	drug	phenylbutazone	drug
advise

DRUGA : DRUGB has no apparent pharmacokinetic interaction when administered with DRUGN .
Phenytoin	drug	Etodolac	drug
false

DRUGA : DRUGN has no apparent pharmacokinetic interaction when administered with DRUGB .
Phenytoin	drug	phenytoin	drug
false

DRUGN : DRUGA has no apparent pharmacokinetic interaction when administered with DRUGB .
Etodolac	drug	phenytoin	drug
false

DRUGA : The effects of DRUGB and DRUGN on GI bleeding are synergistic , such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone .
Warfarin	drug	warfarin	drug
false

DRUGA : The effects of DRUGN and DRUGB on GI bleeding are synergistic , such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone .
Warfarin	drug	NSAIDs	group
false

DRUGN : The effects of DRUGA and DRUGB on GI bleeding are synergistic , such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone .
warfarin	drug	NSAIDs	group
effect

Short term pharmacokinetic studies have demonstrated that concomitant administration of DRUGA and DRUGB ( DRUGN capsules and tablets ) results in reduced protein binding of DRUGN , but there was no change in the clearance of free DRUGN .
warfarin	drug	Lodine	brand
mechanism

Short term pharmacokinetic studies have demonstrated that concomitant administration of DRUGA and DRUGN ( DRUGB capsules and tablets ) results in reduced protein binding of DRUGN , but there was no change in the clearance of free DRUGN .
warfarin	drug	etodolac	drug
mechanism

Short term pharmacokinetic studies have demonstrated that concomitant administration of DRUGN and DRUGA ( DRUGB capsules and tablets ) results in reduced protein binding of DRUGN , but there was no change in the clearance of free DRUGN .
Lodine	brand	etodolac	drug
false

Short term pharmacokinetic studies have demonstrated that concomitant administration of DRUGN and DRUGA ( DRUGN capsules and tablets ) results in reduced protein binding of DRUGB , but there was no change in the clearance of free DRUGN .
Lodine	brand	warfarin	drug
false

Short term pharmacokinetic studies have demonstrated that concomitant administration of DRUGN and DRUGA ( DRUGN capsules and tablets ) results in reduced protein binding of DRUGN , but there was no change in the clearance of free DRUGB .
Lodine	brand	warfarin	drug
false

Short term pharmacokinetic studies have demonstrated that concomitant administration of DRUGN and DRUGN ( DRUGA capsules and tablets ) results in reduced protein binding of DRUGB , but there was no change in the clearance of free DRUGN .
etodolac	drug	warfarin	drug
false

Short term pharmacokinetic studies have demonstrated that concomitant administration of DRUGN and DRUGN ( DRUGA capsules and tablets ) results in reduced protein binding of DRUGN , but there was no change in the clearance of free DRUGB .
etodolac	drug	warfarin	drug
false

There was no significant difference in the pharmacodynamic effect of DRUGA administered alone and DRUGN administered with DRUGB as measured by prothrombin time .
warfarin	drug	Lodine	brand
false

There was no significant difference in the pharmacodynamic effect of DRUGN administered alone and DRUGA administered with DRUGB as measured by prothrombin time .
warfarin	drug	Lodine	brand
false

Thus , concomitant therapy with DRUGA and DRUGB should not require dosage adjustment of either drug .
warfarin	drug	Lodine	brand
false

However , caution should be exercised because there have been a few spontaneous reports of prolonged prothrombin times , with or without bleeding , in DRUGA treated patients receiving concomitant DRUGB therapy .
etodolac	drug	warfarin	drug
effect

Drug / Laboratory Test Interactions The urine of patients who take DRUGA can give a false positive reaction for urinary bilirubin ( urobilin ) due to the presence of phenolic metabolites of DRUGB .
Lodine	brand	etodolac	drug
false

DRUGA Prolonged action of DRUGB
Probenecid	drug	etomidate	drug
false

DRUGA DRUGB antagonism
Zimelidine	drug_n	etomidate	drug
false

DRUGA DRUGB antagonism
Aminophylline	drug	Etomidate	drug
false

Caution should be exercised when administering DRUGA with drugs that are known to inhibit phosphatase activities ( e.g . , DRUGB ) .
ETOPOPHOS	brand	levamisole hydrochloride	drug
advise

DRUGA is extensively metabolized by CYP dgbAdgb , but coadministration of DRUGB , a potent inhibitor of CYP dgbAdgb , has no significant effect on DRUGN pharmacokinetics .
Exemestane	drug	ketoconazole	drug
false

DRUGA is extensively metabolized by CYP dgbAdgb , but coadministration of DRUGN , a potent inhibitor of CYP dgbAdgb , has no significant effect on DRUGB pharmacokinetics .
Exemestane	drug	exemestane	drug
false

DRUGN is extensively metabolized by CYP dgbAdgb , but coadministration of DRUGA , a potent inhibitor of CYP dgbAdgb , has no significant effect on DRUGB pharmacokinetics .
ketoconazole	drug	exemestane	drug
false

Co medications that induce CYP dgbAdgb ( e.g . , DRUGA , DRUGB , DRUGN , DRUGN , or St. John s wort ) may significantly decrease exposure to DRUGN .
rifampicin	drug	phenytoin	drug
false

Co medications that induce CYP dgbAdgb ( e.g . , DRUGA , DRUGN , DRUGB , DRUGN , or St. John s wort ) may significantly decrease exposure to DRUGN .
rifampicin	drug	carbamazepine	drug
false

Co medications that induce CYP dgbAdgb ( e.g . , DRUGA , DRUGN , DRUGN , DRUGB , or St. John s wort ) may significantly decrease exposure to DRUGN .
rifampicin	drug	phenobarbital	drug
false

Co medications that induce CYP dgbAdgb ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN , or St. John s wort ) may significantly decrease exposure to DRUGB .
rifampicin	drug	exemestane	drug
mechanism

Co medications that induce CYP dgbAdgb ( e.g . , DRUGN , DRUGA , DRUGB , DRUGN , or St. John s wort ) may significantly decrease exposure to DRUGN .
phenytoin	drug	carbamazepine	drug
false

Co medications that induce CYP dgbAdgb ( e.g . , DRUGN , DRUGA , DRUGN , DRUGB , or St. John s wort ) may significantly decrease exposure to DRUGN .
phenytoin	drug	phenobarbital	drug
false

Co medications that induce CYP dgbAdgb ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN , or St. John s wort ) may significantly decrease exposure to DRUGB .
phenytoin	drug	exemestane	drug
mechanism

Co medications that induce CYP dgbAdgb ( e.g . , DRUGN , DRUGN , DRUGA , DRUGB , or St. John s wort ) may significantly decrease exposure to DRUGN .
carbamazepine	drug	phenobarbital	drug
false

Co medications that induce CYP dgbAdgb ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN , or St. John s wort ) may significantly decrease exposure to DRUGB .
carbamazepine	drug	exemestane	drug
mechanism

Co medications that induce CYP dgbAdgb ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA , or St. John s wort ) may significantly decrease exposure to DRUGB .
phenobarbital	drug	exemestane	drug
mechanism

Concurrent use with DRUGA or other drugs significantly eliminated by active renal tubular secretion may result in increased plasma concentrations of DRUGB .
probenecid	drug	penciclovir	drug
mechanism

The conversion of DRUGA to DRUGB is catalyzed by aldehyde oxidase .
6-deoxy penciclovir	drug_n	penciclovir	drug
false

Compounds tested in man include DRUGA , DRUGB , DRUGN , DRUGN , DRUGN and DRUGN .
warfarin	drug	theophylline	drug
false

Compounds tested in man include DRUGA , DRUGN , DRUGB , DRUGN , DRUGN and DRUGN .
warfarin	drug	phenytoin	drug
false

Compounds tested in man include DRUGA , DRUGN , DRUGN , DRUGB , DRUGN and DRUGN .
warfarin	drug	diazepam	drug
false

Compounds tested in man include DRUGA , DRUGN , DRUGN , DRUGN , DRUGB and DRUGN .
warfarin	drug	aminopyrine	drug
false

Compounds tested in man include DRUGA , DRUGN , DRUGN , DRUGN , DRUGN and DRUGB .
warfarin	drug	antipyrine	drug
false

Compounds tested in man include DRUGN , DRUGA , DRUGB , DRUGN , DRUGN and DRUGN .
theophylline	drug	phenytoin	drug
false

Compounds tested in man include DRUGN , DRUGA , DRUGN , DRUGB , DRUGN and DRUGN .
theophylline	drug	diazepam	drug
false

Compounds tested in man include DRUGN , DRUGA , DRUGN , DRUGN , DRUGB and DRUGN .
theophylline	drug	aminopyrine	drug
false

Compounds tested in man include DRUGN , DRUGA , DRUGN , DRUGN , DRUGN and DRUGB .
theophylline	drug	antipyrine	drug
false

Compounds tested in man include DRUGN , DRUGN , DRUGA , DRUGB , DRUGN and DRUGN .
phenytoin	drug	diazepam	drug
false

Compounds tested in man include DRUGN , DRUGN , DRUGA , DRUGN , DRUGB and DRUGN .
phenytoin	drug	aminopyrine	drug
false

Compounds tested in man include DRUGN , DRUGN , DRUGA , DRUGN , DRUGN and DRUGB .
phenytoin	drug	antipyrine	drug
false

Compounds tested in man include DRUGN , DRUGN , DRUGN , DRUGA , DRUGB and DRUGN .
diazepam	drug	aminopyrine	drug
false

Compounds tested in man include DRUGN , DRUGN , DRUGN , DRUGA , DRUGN and DRUGB .
diazepam	drug	antipyrine	drug
false

Compounds tested in man include DRUGN , DRUGN , DRUGN , DRUGN , DRUGA and DRUGB .
aminopyrine	drug	antipyrine	drug
false

Use in Conjunction with Other DRUGA : The addition of DRUGB to DRUGN ( DRUGN ) affects the steady state plasma concentrations of DRUGN .
Antiepileptic Drugs	group	Felbatol	brand
false

Use in Conjunction with Other DRUGA : The addition of DRUGN to DRUGB ( DRUGN ) affects the steady state plasma concentrations of DRUGN .
Antiepileptic Drugs	group	antiepileptic drugs	group
false

Use in Conjunction with Other DRUGA : The addition of DRUGN to DRUGN ( DRUGB ) affects the steady state plasma concentrations of DRUGN .
Antiepileptic Drugs	group	AEDs	group
false

Use in Conjunction with Other DRUGA : The addition of DRUGN to DRUGN ( DRUGN ) affects the steady state plasma concentrations of DRUGB .
Antiepileptic Drugs	group	AEDs	group
false

Use in Conjunction with Other DRUGN : The addition of DRUGA to DRUGB ( DRUGN ) affects the steady state plasma concentrations of DRUGN .
Felbatol	brand	antiepileptic drugs	group
mechanism

Use in Conjunction with Other DRUGN : The addition of DRUGA to DRUGN ( DRUGB ) affects the steady state plasma concentrations of DRUGN .
Felbatol	brand	AEDs	group
mechanism

Use in Conjunction with Other DRUGN : The addition of DRUGA to DRUGN ( DRUGN ) affects the steady state plasma concentrations of DRUGB .
Felbatol	brand	AEDs	group
false

Use in Conjunction with Other DRUGN : The addition of DRUGN to DRUGA ( DRUGB ) affects the steady state plasma concentrations of DRUGN .
antiepileptic drugs	group	AEDs	group
false

Use in Conjunction with Other DRUGN : The addition of DRUGN to DRUGA ( DRUGN ) affects the steady state plasma concentrations of DRUGB .
antiepileptic drugs	group	AEDs	group
false

The net effect of these interactions is summarized in the following table : DRUGA DRUGN DRUGB
AED	group	Felbatol	brand
false

The net effect of these interactions is summarized in the following table : DRUGN DRUGA DRUGB
AED	group	Felbatol	brand
false

DRUGA ( DRUGB )
Carbamazepine	drug	CBZ	drug
false

Specific Effects of DRUGA on Other DRUGB DRUGN : DRUGN causes an increase in steady state DRUGN plasma concentrations .
Felbatol	brand	Antiepileptic Drugs	group
false

Specific Effects of DRUGA on Other DRUGN DRUGB : DRUGN causes an increase in steady state DRUGN plasma concentrations .
Felbatol	brand	Phenytoin	drug
false

Specific Effects of DRUGA on Other DRUGN DRUGN : DRUGN causes an increase in steady state DRUGB plasma concentrations .
Felbatol	brand	phenytoin	drug
false

Specific Effects of DRUGN on Other DRUGA DRUGB : DRUGN causes an increase in steady state DRUGN plasma concentrations .
Antiepileptic Drugs	group	Phenytoin	drug
false

Specific Effects of DRUGN on Other DRUGA DRUGN : DRUGB causes an increase in steady state DRUGN plasma concentrations .
Antiepileptic Drugs	group	Felbatol	brand
false

Specific Effects of DRUGN on Other DRUGA DRUGN : DRUGN causes an increase in steady state DRUGB plasma concentrations .
Antiepileptic Drugs	group	phenytoin	drug
false

Specific Effects of DRUGN on Other DRUGN DRUGA : DRUGB causes an increase in steady state DRUGN plasma concentrations .
Phenytoin	drug	Felbatol	brand
false

Specific Effects of DRUGN on Other DRUGN DRUGA : DRUGN causes an increase in steady state DRUGB plasma concentrations .
Phenytoin	drug	phenytoin	drug
false

Specific Effects of DRUGN on Other DRUGN DRUGN : DRUGA causes an increase in steady state DRUGB plasma concentrations .
Felbatol	brand	phenytoin	drug
mechanism

Increasing the DRUGA dose to dgb mg / day in six of these subjects increased the steady state DRUGB Cmin to dgb dgb micrograms / mL .
felbamate	drug	phenytoin	drug
mechanism

In order to maintain DRUGA levels , limit adverse experiences , and achieve the DRUGB dose of dgb mg / day , a DRUGN dose reduction of approximately dgb % was necessary for eight of these dgb subjects .
phenytoin	drug	felbamate	drug
false

In order to maintain DRUGN levels , limit adverse experiences , and achieve the DRUGA dose of dgb mg / day , a DRUGB dose reduction of approximately dgb % was necessary for eight of these dgb subjects .
felbamate	drug	phenytoin	drug
advise

In a controlled clinical trial , a dgb % reduction of the DRUGA dose at the initiation of DRUGB therapy resulted in DRUGN levels comparable to those prior to DRUGN administration .
phenytoin	drug	Felbatol	brand
false

In a controlled clinical trial , a dgb % reduction of the DRUGA dose at the initiation of DRUGN therapy resulted in DRUGN levels comparable to those prior to DRUGB administration .
phenytoin	drug	Felbatol	brand
false

In a controlled clinical trial , a dgb % reduction of the DRUGN dose at the initiation of DRUGA therapy resulted in DRUGB levels comparable to those prior to DRUGN administration .
Felbatol	brand	phenytoin	drug
false

In a controlled clinical trial , a dgb % reduction of the DRUGN dose at the initiation of DRUGN therapy resulted in DRUGA levels comparable to those prior to DRUGB administration .
phenytoin	drug	Felbatol	brand
false

DRUGA : DRUGB causes a decrease in the steady state DRUGN plasma concentrations and an increase in the steady state DRUGN plasma concentration .
Carbamazepine	drug	Felbatol	brand
false

DRUGA : DRUGN causes a decrease in the steady state DRUGB plasma concentrations and an increase in the steady state DRUGN plasma concentration .
Carbamazepine	drug	carbamazepine	drug
false

DRUGA : DRUGN causes a decrease in the steady state DRUGN plasma concentrations and an increase in the steady state DRUGB plasma concentration .
Carbamazepine	drug	carbamazepine epoxide	drug_n
false

DRUGN : DRUGA causes a decrease in the steady state DRUGB plasma concentrations and an increase in the steady state DRUGN plasma concentration .
Felbatol	brand	carbamazepine	drug
mechanism

DRUGN : DRUGA causes a decrease in the steady state DRUGN plasma concentrations and an increase in the steady state DRUGB plasma concentration .
Felbatol	brand	carbamazepine epoxide	drug_n
false

DRUGN : DRUGN causes a decrease in the steady state DRUGA plasma concentrations and an increase in the steady state DRUGB plasma concentration .
carbamazepine	drug	carbamazepine epoxide	drug_n
false

The DRUGA steady state Cmin decreased dgb % to dgb dgb micrograms / mL when DRUGB ( dgb mg / day , divided into three doses ) was coadministered .
carbamazepine	drug	felbamate	drug
mechanism

DRUGA steady state Cmin concentrations increased dgb % from dga dga to dga dga micrograms / mL with the addition of DRUGB .
Carbamazepine epoxide	drug_n	felbamate	drug
false

In clinical trials , similar changes in DRUGA and DRUGB were seen .
carbamazepine	drug	carbamazepine epoxide	drug_n
false

DRUGA : DRUGB causes an increase in steady state DRUGN concentrations .
Valproate	drug	Felbatol	brand
false

DRUGA : DRUGN causes an increase in steady state DRUGB concentrations .
Valproate	drug	valproate	drug
false

DRUGN : DRUGA causes an increase in steady state DRUGB concentrations .
Felbatol	brand	valproate	drug
mechanism

Increasing the DRUGA dose to dgb mg / day increased the steadystate DRUGB Cmin to dgb dgb micrograms / mL .
felbamate	drug	valproate	drug
mechanism

Corresponding values for free DRUGA Cmin concentrations were dgb dgb , dgb dgb , and dgb dgb micrograms / mL for dgb , dgb , and dgb mg / day DRUGB , respectively .
valproate	drug	Felbatol	brand
false

DRUGA : Coadministration of DRUGB with DRUGN causes an increase in DRUGN plasma concentrations , In dgb otherwise healthy male volunteers ingesting DRUGN , the steady state trough ( Cmin ) DRUGN concentration was dga micrograms / mL .
Phenobarbital	drug	felbamate	drug
false

DRUGA : Coadministration of DRUGN with DRUGB causes an increase in DRUGN plasma concentrations , In dgb otherwise healthy male volunteers ingesting DRUGN , the steady state trough ( Cmin ) DRUGN concentration was dga micrograms / mL .
Phenobarbital	drug	phenobarbital	drug
false

DRUGA : Coadministration of DRUGN with DRUGN causes an increase in DRUGB plasma concentrations , In dgb otherwise healthy male volunteers ingesting DRUGN , the steady state trough ( Cmin ) DRUGN concentration was dga micrograms / mL .
Phenobarbital	drug	phenobarbital	drug
false

DRUGA : Coadministration of DRUGN with DRUGN causes an increase in DRUGN plasma concentrations , In dgb otherwise healthy male volunteers ingesting DRUGB , the steady state trough ( Cmin ) DRUGN concentration was dga micrograms / mL .
Phenobarbital	drug	phenobarbital	drug
false

DRUGA : Coadministration of DRUGN with DRUGN causes an increase in DRUGN plasma concentrations , In dgb otherwise healthy male volunteers ingesting DRUGN , the steady state trough ( Cmin ) DRUGB concentration was dga micrograms / mL .
Phenobarbital	drug	phenobarbital	drug
false

DRUGN : Coadministration of DRUGA with DRUGB causes an increase in DRUGN plasma concentrations , In dgb otherwise healthy male volunteers ingesting DRUGN , the steady state trough ( Cmin ) DRUGN concentration was dga micrograms / mL .
felbamate	drug	phenobarbital	drug
mechanism

DRUGN : Coadministration of DRUGA with DRUGN causes an increase in DRUGB plasma concentrations , In dgb otherwise healthy male volunteers ingesting DRUGN , the steady state trough ( Cmin ) DRUGN concentration was dga micrograms / mL .
felbamate	drug	phenobarbital	drug
false

DRUGN : Coadministration of DRUGA with DRUGN causes an increase in DRUGN plasma concentrations , In dgb otherwise healthy male volunteers ingesting DRUGB , the steady state trough ( Cmin ) DRUGN concentration was dga micrograms / mL .
felbamate	drug	phenobarbital	drug
false

DRUGN : Coadministration of DRUGA with DRUGN causes an increase in DRUGN plasma concentrations , In dgb otherwise healthy male volunteers ingesting DRUGN , the steady state trough ( Cmin ) DRUGB concentration was dga micrograms / mL .
felbamate	drug	phenobarbital	drug
false

DRUGA : It appears that DRUGB may reduce plasma DRUGN concentrations .
Phenobarbital	drug	phenobarbital	drug
false

DRUGA : It appears that DRUGN may reduce plasma DRUGB concentrations .
Phenobarbital	drug	felbamate	drug
false

DRUGN : It appears that DRUGA may reduce plasma DRUGB concentrations .
phenobarbital	drug	felbamate	drug
mechanism

Effects of DRUGA on DRUGB The rate and extent of absorption of a dgb mg dose of DRUGN as monotherapy given as tablets was not affected when coadministered with DRUGN .
Antacids	group	Felbatol	brand
false

Effects of DRUGA on DRUGN The rate and extent of absorption of a dgb mg dose of DRUGB as monotherapy given as tablets was not affected when coadministered with DRUGN .
Antacids	group	Felbatol	brand
false

Effects of DRUGA on DRUGN The rate and extent of absorption of a dgb mg dose of DRUGN as monotherapy given as tablets was not affected when coadministered with DRUGB .
Antacids	group	antacids	group
false

Effects of DRUGN on DRUGA The rate and extent of absorption of a dgb mg dose of DRUGN as monotherapy given as tablets was not affected when coadministered with DRUGB .
Felbatol	brand	antacids	group
false

Effects of DRUGN on DRUGN The rate and extent of absorption of a dgb mg dose of DRUGA as monotherapy given as tablets was not affected when coadministered with DRUGB .
Felbatol	brand	antacids	group
false

DRUGA treatment resulted in a dgb % decrease in the DRUGB AUC dgb dgb , but no clinically relevant effect was observed on the pharmacokinetic parameters of DRUGN .
Felbamate	drug	gestodene	drug
mechanism

DRUGA treatment resulted in a dgb % decrease in the DRUGN AUC dgb dgb , but no clinically relevant effect was observed on the pharmacokinetic parameters of DRUGB .
Felbamate	drug	ethinyl estradiol	drug
false

DRUGN treatment resulted in a dgb % decrease in the DRUGA AUC dgb dgb , but no clinically relevant effect was observed on the pharmacokinetic parameters of DRUGB .
gestodene	drug	ethinyl estradiol	drug
false

These effects have been observed with co administration of DRUGA ( a potent DRUGB inhibitor ) .
itraconazole	drug	CYP3A4	drug
false

Caution should be used when DRUGA inhibitors are co administered with DRUGB .
CYP3A4	drug	felodipine	drug
false

Erythromycin Co administration of DRUGA ( DRUGB ) with DRUGN resulted in approximately dga fold increase in the AUC and Cmax , and about dgb fold prolongation in the half life of DRUGN .
felodipine	drug	PLENDIL	drug
false

Erythromycin Co administration of DRUGA ( DRUGN ) with DRUGB resulted in approximately dga fold increase in the AUC and Cmax , and about dgb fold prolongation in the half life of DRUGN .
felodipine	drug	erythromycin	drug
false

Erythromycin Co administration of DRUGN ( DRUGA ) with DRUGB resulted in approximately dga fold increase in the AUC and Cmax , and about dgb fold prolongation in the half life of DRUGN .
PLENDIL	drug	erythromycin	drug
false

Erythromycin Co administration of DRUGN ( DRUGA ) with DRUGN resulted in approximately dga fold increase in the AUC and Cmax , and about dgb fold prolongation in the half life of DRUGB .
PLENDIL	drug	felodipine	drug
false

Erythromycin Co administration of DRUGN ( DRUGN ) with DRUGA resulted in approximately dga fold increase in the AUC and Cmax , and about dgb fold prolongation in the half life of DRUGB .
erythromycin	drug	felodipine	drug
false

Cimetidine Co administration of DRUGA with DRUGB ( a non specific CYP dgb inhibitor ) resulted in an increase of approximately dgb % in the AUC and the Cmax , of DRUGN .
felodipine	drug	cimetidine	drug
false

Cimetidine Co administration of DRUGN with DRUGA ( a non specific CYP dgb inhibitor ) resulted in an increase of approximately dgb % in the AUC and the Cmax , of DRUGB .
cimetidine	drug	felodipine	drug
false

Beta Blocking Agents A pharmacokinetic study of DRUGA in conjunction with DRUGB demonstrated no significant effects on the pharmacokinetics of DRUGN .
felodipine	drug	metoprolol	drug
false

Beta Blocking Agents A pharmacokinetic study of DRUGN in conjunction with DRUGA demonstrated no significant effects on the pharmacokinetics of DRUGB .
metoprolol	drug	felodipine	drug
false

In controlled clinical trials , however , DRUGA including DRUGB were concurrently administered with DRUGN and were well tolerated .
beta blockers	drug	metoprolol	drug
false

In controlled clinical trials , however , DRUGA including DRUGN were concurrently administered with DRUGB and were well tolerated .
beta blockers	drug	felodipine	drug
false

In controlled clinical trials , however , DRUGN including DRUGA were concurrently administered with DRUGB and were well tolerated .
metoprolol	drug	felodipine	drug
false

Digoxin When given concomitantly with DRUGA the pharmacokinetics of DRUGB in patients with heart failure were not significantly altered .
PLENDIL	drug	digoxin	drug
false

DRUGA : In a pharmacokinetic study , maximum plasma concentrations of DRUGB were considerably lower in epileptic patients on long term DRUGN therapy ( eg , DRUGN , DRUGN , or DRUGN ) than in healthy volunteers .
Anticonvulsants	group	felodipine	drug
false

DRUGA : In a pharmacokinetic study , maximum plasma concentrations of DRUGN were considerably lower in epileptic patients on long term DRUGB therapy ( eg , DRUGN , DRUGN , or DRUGN ) than in healthy volunteers .
Anticonvulsants	group	anticonvulsant	group
false

DRUGA : In a pharmacokinetic study , maximum plasma concentrations of DRUGN were considerably lower in epileptic patients on long term DRUGN therapy ( eg , DRUGB , DRUGN , or DRUGN ) than in healthy volunteers .
Anticonvulsants	group	phenytoin	drug
false

DRUGA : In a pharmacokinetic study , maximum plasma concentrations of DRUGN were considerably lower in epileptic patients on long term DRUGN therapy ( eg , DRUGN , DRUGB , or DRUGN ) than in healthy volunteers .
Anticonvulsants	group	carbamazepine	drug
false

DRUGA : In a pharmacokinetic study , maximum plasma concentrations of DRUGN were considerably lower in epileptic patients on long term DRUGN therapy ( eg , DRUGN , DRUGN , or DRUGB ) than in healthy volunteers .
Anticonvulsants	group	phenobarbital	drug
false

DRUGN : In a pharmacokinetic study , maximum plasma concentrations of DRUGA were considerably lower in epileptic patients on long term DRUGB therapy ( eg , DRUGN , DRUGN , or DRUGN ) than in healthy volunteers .
felodipine	drug	anticonvulsant	group
mechanism

DRUGN : In a pharmacokinetic study , maximum plasma concentrations of DRUGA were considerably lower in epileptic patients on long term DRUGN therapy ( eg , DRUGB , DRUGN , or DRUGN ) than in healthy volunteers .
felodipine	drug	phenytoin	drug
mechanism

DRUGN : In a pharmacokinetic study , maximum plasma concentrations of DRUGA were considerably lower in epileptic patients on long term DRUGN therapy ( eg , DRUGN , DRUGB , or DRUGN ) than in healthy volunteers .
felodipine	drug	carbamazepine	drug
mechanism

DRUGN : In a pharmacokinetic study , maximum plasma concentrations of DRUGA were considerably lower in epileptic patients on long term DRUGN therapy ( eg , DRUGN , DRUGN , or DRUGB ) than in healthy volunteers .
felodipine	drug	phenobarbital	drug
mechanism

DRUGN : In a pharmacokinetic study , maximum plasma concentrations of DRUGN were considerably lower in epileptic patients on long term DRUGA therapy ( eg , DRUGB , DRUGN , or DRUGN ) than in healthy volunteers .
anticonvulsant	group	phenytoin	drug
false

DRUGN : In a pharmacokinetic study , maximum plasma concentrations of DRUGN were considerably lower in epileptic patients on long term DRUGA therapy ( eg , DRUGN , DRUGB , or DRUGN ) than in healthy volunteers .
anticonvulsant	group	carbamazepine	drug
false

DRUGN : In a pharmacokinetic study , maximum plasma concentrations of DRUGN were considerably lower in epileptic patients on long term DRUGA therapy ( eg , DRUGN , DRUGN , or DRUGB ) than in healthy volunteers .
anticonvulsant	group	phenobarbital	drug
false

DRUGN : In a pharmacokinetic study , maximum plasma concentrations of DRUGN were considerably lower in epileptic patients on long term DRUGN therapy ( eg , DRUGA , DRUGB , or DRUGN ) than in healthy volunteers .
phenytoin	drug	carbamazepine	drug
false

DRUGN : In a pharmacokinetic study , maximum plasma concentrations of DRUGN were considerably lower in epileptic patients on long term DRUGN therapy ( eg , DRUGA , DRUGN , or DRUGB ) than in healthy volunteers .
phenytoin	drug	phenobarbital	drug
false

DRUGN : In a pharmacokinetic study , maximum plasma concentrations of DRUGN were considerably lower in epileptic patients on long term DRUGN therapy ( eg , DRUGN , DRUGA , or DRUGB ) than in healthy volunteers .
carbamazepine	drug	phenobarbital	drug
false

Tacrolimus DRUGA may increase the blood concentration of DRUGB .
Felodipine	drug	tacrolimus	drug
false

When given concomitantly with DRUGA , the DRUGB blood concentration should be followed and the tacrolimus dose may need to be adjusted .
felodipine	drug	tacrolimus	drug
false

Other Concomitant Therapy In healthy subjects there were no clinically significant interactions when DRUGA was given concomitantly with DRUGB or DRUGN .
felodipine	drug	indomethacin	drug
false

Other Concomitant Therapy In healthy subjects there were no clinically significant interactions when DRUGA was given concomitantly with DRUGN or DRUGB .
felodipine	drug	spironolactone	drug
false

Other Concomitant Therapy In healthy subjects there were no clinically significant interactions when DRUGN was given concomitantly with DRUGA or DRUGB .
indomethacin	drug	spironolactone	drug
false

DRUGA may increase slightly the effect of DRUGB , e.g . , DRUGN , DRUGN , DRUGN .
Fenfluramine	drug	antihypertensive drugs	group
effect

DRUGA may increase slightly the effect of DRUGN , e.g . , DRUGB , DRUGN , DRUGN .
Fenfluramine	drug	guanethidine	drug
effect

DRUGA may increase slightly the effect of DRUGN , e.g . , DRUGN , DRUGB , DRUGN .
Fenfluramine	drug	methyldopa	drug
effect

DRUGA may increase slightly the effect of DRUGN , e.g . , DRUGN , DRUGN , DRUGB .
Fenfluramine	drug	reserpine	drug
effect

DRUGN may increase slightly the effect of DRUGA , e.g . , DRUGB , DRUGN , DRUGN .
antihypertensive drugs	group	guanethidine	drug
false

DRUGN may increase slightly the effect of DRUGA , e.g . , DRUGN , DRUGB , DRUGN .
antihypertensive drugs	group	methyldopa	drug
false

DRUGN may increase slightly the effect of DRUGA , e.g . , DRUGN , DRUGN , DRUGB .
antihypertensive drugs	group	reserpine	drug
false

DRUGN may increase slightly the effect of DRUGN , e.g . , DRUGA , DRUGB , DRUGN .
guanethidine	drug	methyldopa	drug
false

DRUGN may increase slightly the effect of DRUGN , e.g . , DRUGA , DRUGN , DRUGB .
guanethidine	drug	reserpine	drug
false

DRUGN may increase slightly the effect of DRUGN , e.g . , DRUGN , DRUGA , DRUGB .
methyldopa	drug	reserpine	drug
false

Other DRUGA should be used with caution in patients taking DRUGB , since the effects may be additive .
CNS depressant drugs	group	fenfluramine	drug
advise

Oral DRUGA CAUTION SHOULD BE EXERCISED WHEN DRUGB ARE GIVEN IN CONJUNCTION WITH DRUGN .
Anticoagulants	group	COUMARIN ANTICOAGULANTS	group
false

Oral DRUGA CAUTION SHOULD BE EXERCISED WHEN DRUGN ARE GIVEN IN CONJUNCTION WITH DRUGB .
Anticoagulants	group	TRICOR	brand
false

Oral DRUGN CAUTION SHOULD BE EXERCISED WHEN DRUGA ARE GIVEN IN CONJUNCTION WITH DRUGB .
COUMARIN ANTICOAGULANTS	group	TRICOR	brand
advise

DRUGA : The combined use of DRUGB and DRUGN should be avoided unless the benefit of further alterations in lipid levels is likely to outweigh the increased risk of this drug combination .
HMG-CoA reductase inhibitors	group	TRICOR	brand
false

DRUGN : The combined use of DRUGA and DRUGB should be avoided unless the benefit of further alterations in lipid levels is likely to outweigh the increased risk of this drug combination .
TRICOR	brand	HMG-CoA reductase inhibitors	group
advise

DRUGA : Since DRUGB may bind other drugs given concurrently , patients should take DRUGN at least dgb hour before or dgb dgb hours after a DRUGN to avoid impeding its absorption .
Resins	group	bile acid sequestrants	group
false

DRUGA : Since DRUGN may bind other drugs given concurrently , patients should take DRUGB at least dgb hour before or dgb dgb hours after a DRUGN to avoid impeding its absorption .
Resins	group	TRICOR	brand
false

DRUGA : Since DRUGN may bind other drugs given concurrently , patients should take DRUGN at least dgb hour before or dgb dgb hours after a DRUGB to avoid impeding its absorption .
Resins	group	bile acid binding resin	group
false

DRUGN : Since DRUGA may bind other drugs given concurrently , patients should take DRUGB at least dgb hour before or dgb dgb hours after a DRUGN to avoid impeding its absorption .
bile acid sequestrants	group	TRICOR	brand
false

DRUGN : Since DRUGA may bind other drugs given concurrently , patients should take DRUGN at least dgb hour before or dgb dgb hours after a DRUGB to avoid impeding its absorption .
bile acid sequestrants	group	bile acid binding resin	group
false

DRUGN : Since DRUGN may bind other drugs given concurrently , patients should take DRUGA at least dgb hour before or dgb dgb hours after a DRUGB to avoid impeding its absorption .
TRICOR	brand	bile acid binding resin	group
mechanism

The benefits and risks of using DRUGA with DRUGB and other potentially nephrotoxic agents should be carefully considered , and the lowest effective dose employed
TRICOR	brand	immunosuppressants	group
advise

Drug drug interactions In vitro studies using human liver microsomes indicate that DRUGA and DRUGB are not inhibitors of cytochrome ( CYP ) Pdgb isoforms CYPdgbAdgb , CYPdgbDdgb , CYPdgbEdgb , or CYPdgbAdga
fenofibrate	drug	fenofibric acid	drug_n
false

Therefore , DRUGA should be taken at least dgb hour before or dgb dgb hours after a DRUGB to avoid impeding its absorption .
fenofibrate	drug	bile acid binding resin	group
advise

A single dose of DRUGA had no clinically important effect on the pharmacokinetics of DRUGB .
pravastatin	drug	fenofibric acid	drug_n
false

The DRUGA Cmax values were not significantly affected by DRUGB .
atorvastatin	drug	fenofibrate	drug
false

The pharmacokinetics of DRUGA were not significantly affected by DRUGB
fenofibric acid	drug_n	atorvastatin	drug
false

Drug Interactions with DRUGA : Concomitant use of DRUGB with DRUGN should be avoided .
Beta-Blockers	group	fenoldopam	drug
false

Drug Interactions with DRUGA : Concomitant use of DRUGN with DRUGB should be avoided .
Beta-Blockers	group	beta-blockers	group
false

Drug Interactions with DRUGN : Concomitant use of DRUGA with DRUGB should be avoided .
fenoldopam	drug	beta-blockers	group
advise

Drug Interactions , General : Although there have been no formal interaction studies , intravenous DRUGA has been administered safely with drugs such as DRUGB and sublingual DRUGN .
fenoldopam	drug	digitalis	group
false

Drug Interactions , General : Although there have been no formal interaction studies , intravenous DRUGA has been administered safely with drugs such as DRUGN and sublingual DRUGB .
fenoldopam	drug	nitroglycerin	drug
false

Drug Interactions , General : Although there have been no formal interaction studies , intravenous DRUGN has been administered safely with drugs such as DRUGA and sublingual DRUGB .
digitalis	group	nitroglycerin	drug
false

There is limited experience with concomitant DRUGA such as DRUGB , DRUGN , DRUGN , and DRUGN ( both DRUGN like and loop ) .
antihypertensive agents	group	alpha-blockers	group
false

There is limited experience with concomitant DRUGA such as DRUGN , DRUGB , DRUGN , and DRUGN ( both DRUGN like and loop ) .
antihypertensive agents	group	calcium channel-blockers	group
false

There is limited experience with concomitant DRUGA such as DRUGN , DRUGN , DRUGB , and DRUGN ( both DRUGN like and loop ) .
antihypertensive agents	group	ACE inhibitors	group
false

There is limited experience with concomitant DRUGA such as DRUGN , DRUGN , DRUGN , and DRUGB ( both DRUGN like and loop ) .
antihypertensive agents	group	diuretics	group
false

There is limited experience with concomitant DRUGA such as DRUGN , DRUGN , DRUGN , and DRUGN ( both DRUGB like and loop ) .
antihypertensive agents	group	thiazide	group
false

There is limited experience with concomitant DRUGN such as DRUGA , DRUGB , DRUGN , and DRUGN ( both DRUGN like and loop ) .
alpha-blockers	group	calcium channel-blockers	group
false

There is limited experience with concomitant DRUGN such as DRUGA , DRUGN , DRUGB , and DRUGN ( both DRUGN like and loop ) .
alpha-blockers	group	ACE inhibitors	group
false

There is limited experience with concomitant DRUGN such as DRUGA , DRUGN , DRUGN , and DRUGB ( both DRUGN like and loop ) .
alpha-blockers	group	diuretics	group
false

There is limited experience with concomitant DRUGN such as DRUGA , DRUGN , DRUGN , and DRUGN ( both DRUGB like and loop ) .
alpha-blockers	group	thiazide	group
false

There is limited experience with concomitant DRUGN such as DRUGN , DRUGA , DRUGB , and DRUGN ( both DRUGN like and loop ) .
calcium channel-blockers	group	ACE inhibitors	group
false

There is limited experience with concomitant DRUGN such as DRUGN , DRUGA , DRUGN , and DRUGB ( both DRUGN like and loop ) .
calcium channel-blockers	group	diuretics	group
false

There is limited experience with concomitant DRUGN such as DRUGN , DRUGA , DRUGN , and DRUGN ( both DRUGB like and loop ) .
calcium channel-blockers	group	thiazide	group
false

There is limited experience with concomitant DRUGN such as DRUGN , DRUGN , DRUGA , and DRUGB ( both DRUGN like and loop ) .
ACE inhibitors	group	diuretics	group
false

There is limited experience with concomitant DRUGN such as DRUGN , DRUGN , DRUGA , and DRUGN ( both DRUGB like and loop ) .
ACE inhibitors	group	thiazide	group
false

There is limited experience with concomitant DRUGN such as DRUGN , DRUGN , DRUGN , and DRUGA ( both DRUGB like and loop ) .
diuretics	group	thiazide	group
false

The coadministration of DRUGA decreases the biologic half life of DRUGB because of an increase in metabolic clearance that results in a greater amount of DRUGN in the urine .
aspirin	brand	fenoprofen	drug
mechanism

The coadministration of DRUGA decreases the biologic half life of DRUGN because of an increase in metabolic clearance that results in a greater amount of DRUGB in the urine .
aspirin	brand	hydroxylated fenoprofen	drug_n
false

The coadministration of DRUGN decreases the biologic half life of DRUGA because of an increase in metabolic clearance that results in a greater amount of DRUGB in the urine .
fenoprofen	drug	hydroxylated fenoprofen	drug_n
false

Although the mechanism of interaction between DRUGA and DRUGB is not totally known , enzyme induction and displacement of DRUGN from plasma albumin binding sites are possibilities .
fenoprofen	drug	aspirin	brand
mechanism

Although the mechanism of interaction between DRUGN and DRUGA is not totally known , enzyme induction and displacement of DRUGB from plasma albumin binding sites are possibilities .
aspirin	brand	fenoprofen	drug
false

Because DRUGA has not been shown to produce any additional effect beyond that obtained with DRUGB alone and because DRUGN increases the rate of excretion of DRUGN , the concomitant use of DRUGN and DRUGN is not recommended .
Nalfon	brand	aspirin	brand
false

Because DRUGA has not been shown to produce any additional effect beyond that obtained with DRUGN alone and because DRUGB increases the rate of excretion of DRUGN , the concomitant use of DRUGN and DRUGN is not recommended .
Nalfon	brand	aspirin	brand
false

Because DRUGA has not been shown to produce any additional effect beyond that obtained with DRUGN alone and because DRUGN increases the rate of excretion of DRUGN , the concomitant use of DRUGN and DRUGB is not recommended .
Nalfon	brand	salicylates	group
false

Because DRUGN has not been shown to produce any additional effect beyond that obtained with DRUGA alone and because DRUGN increases the rate of excretion of DRUGB , the concomitant use of DRUGN and DRUGN is not recommended .
aspirin	brand	Nalfon	brand
false

Because DRUGN has not been shown to produce any additional effect beyond that obtained with DRUGA alone and because DRUGN increases the rate of excretion of DRUGN , the concomitant use of DRUGB and DRUGN is not recommended .
aspirin	brand	Nalfon	brand
false

Because DRUGN has not been shown to produce any additional effect beyond that obtained with DRUGA alone and because DRUGN increases the rate of excretion of DRUGN , the concomitant use of DRUGN and DRUGB is not recommended .
aspirin	brand	salicylates	group
false

Because DRUGN has not been shown to produce any additional effect beyond that obtained with DRUGN alone and because DRUGA increases the rate of excretion of DRUGB , the concomitant use of DRUGN and DRUGN is not recommended .
aspirin	brand	Nalfon	brand
mechanism

Because DRUGN has not been shown to produce any additional effect beyond that obtained with DRUGN alone and because DRUGA increases the rate of excretion of DRUGN , the concomitant use of DRUGB and DRUGN is not recommended .
aspirin	brand	Nalfon	brand
false

Because DRUGN has not been shown to produce any additional effect beyond that obtained with DRUGN alone and because DRUGA increases the rate of excretion of DRUGN , the concomitant use of DRUGN and DRUGB is not recommended .
aspirin	brand	salicylates	group
false

Because DRUGN has not been shown to produce any additional effect beyond that obtained with DRUGN alone and because DRUGN increases the rate of excretion of DRUGA , the concomitant use of DRUGN and DRUGB is not recommended .
Nalfon	brand	salicylates	group
false

Because DRUGN has not been shown to produce any additional effect beyond that obtained with DRUGN alone and because DRUGN increases the rate of excretion of DRUGN , the concomitant use of DRUGA and DRUGB is not recommended .
Nalfon	brand	salicylates	group
advise

Chronic administration of DRUGA , a known enzyme inducer , may be associated with a decrease in the plasma half life of DRUGB .
phenobarbital	drug	fenoprofen	drug
mechanism

When DRUGA is added to or withdrawn from treatment , dosage adjustment of DRUGB may be required .
phenobarbital	drug	Nalfon	brand
advise

Patients receiving DRUGA , DRUGB , or DRUGN should be observed for increased activity of these drugs and , therefore , signs of toxicity from these drugs .
hydantoins	group	sulfonamides	group
false

Patients receiving DRUGA , DRUGN , or DRUGB should be observed for increased activity of these drugs and , therefore , signs of toxicity from these drugs .
hydantoins	group	sulfonylureas	group
false

Patients receiving DRUGN , DRUGA , or DRUGB should be observed for increased activity of these drugs and , therefore , signs of toxicity from these drugs .
sulfonamides	group	sulfonylureas	group
false

In patients receiving DRUGA , the addition of DRUGB to therapy could prolong the prothrombin time .
coumarin-type anticoagulants	group	Nalfon	brand
effect

Patients treated with DRUGA may be resistant to the effects of DRUGB .
Nalfon	brand	loop diuretics	group
effect

In patients receiving DRUGA and a DRUGB concomitantly , any reduction in DRUGN dosage should be gradual in order to avoid the possible complications of sudden DRUGN withdrawal .
Nalfon	brand	steroid	group
advise

In patients receiving DRUGA and a DRUGN concomitantly , any reduction in DRUGB dosage should be gradual in order to avoid the possible complications of sudden DRUGN withdrawal .
Nalfon	brand	steroid	group
false

In patients receiving DRUGA and a DRUGN concomitantly , any reduction in DRUGN dosage should be gradual in order to avoid the possible complications of sudden DRUGB withdrawal .
Nalfon	brand	steroid	group
false

Agents Affecting Cytochrome Pdgb dgbAdgb Isoenzyme System DRUGA is metabolized mainly via the human cytochrome Pdgb dgbAdgb isoenzyme system ( CYPdgbAdgb ) , therefore potential interactions may occur when DRUGB is given concurrently with agents that affect CYPdgbAdgb activity .
Fentanyl	drug	DURAGESIC	brand
false

The concomitant use of transdermal DRUGA with DRUGB or other potent dgbAdgb inhibitors such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and nefazadone may result in an increase in DRUGN plasma concentrations .
fentanyl	drug	ritonavir	drug
mechanism

The concomitant use of transdermal DRUGA with DRUGN or other potent dgbAdgb inhibitors such as DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and nefazadone may result in an increase in DRUGN plasma concentrations .
fentanyl	drug	ketoconazole	drug
mechanism

The concomitant use of transdermal DRUGA with DRUGN or other potent dgbAdgb inhibitors such as DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and nefazadone may result in an increase in DRUGN plasma concentrations .
fentanyl	drug	itraconazole	drug
mechanism

The concomitant use of transdermal DRUGA with DRUGN or other potent dgbAdgb inhibitors such as DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and nefazadone may result in an increase in DRUGN plasma concentrations .
fentanyl	drug	troleandomycin	drug
mechanism

The concomitant use of transdermal DRUGA with DRUGN or other potent dgbAdgb inhibitors such as DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and nefazadone may result in an increase in DRUGN plasma concentrations .
fentanyl	drug	clarithromycin	drug
mechanism

The concomitant use of transdermal DRUGA with DRUGN or other potent dgbAdgb inhibitors such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and nefazadone may result in an increase in DRUGN plasma concentrations .
fentanyl	drug	nelfinavir	drug
mechanism

The concomitant use of transdermal DRUGN with DRUGA or other potent dgbAdgb inhibitors such as DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and nefazadone may result in an increase in DRUGN plasma concentrations .
ritonavir	drug	ketoconazole	drug
false

The concomitant use of transdermal DRUGN with DRUGA or other potent dgbAdgb inhibitors such as DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and nefazadone may result in an increase in DRUGN plasma concentrations .
ritonavir	drug	itraconazole	drug
false

The concomitant use of transdermal DRUGN with DRUGA or other potent dgbAdgb inhibitors such as DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and nefazadone may result in an increase in DRUGN plasma concentrations .
ritonavir	drug	troleandomycin	drug
false

The concomitant use of transdermal DRUGN with DRUGA or other potent dgbAdgb inhibitors such as DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and nefazadone may result in an increase in DRUGN plasma concentrations .
ritonavir	drug	clarithromycin	drug
false

The concomitant use of transdermal DRUGN with DRUGA or other potent dgbAdgb inhibitors such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and nefazadone may result in an increase in DRUGN plasma concentrations .
ritonavir	drug	nelfinavir	drug
false

The concomitant use of transdermal DRUGN with DRUGA or other potent dgbAdgb inhibitors such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and nefazadone may result in an increase in DRUGB plasma concentrations .
ritonavir	drug	fentanyl	drug
false

The concomitant use of transdermal DRUGN with DRUGN or other potent dgbAdgb inhibitors such as DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and nefazadone may result in an increase in DRUGN plasma concentrations .
ketoconazole	drug	itraconazole	drug
false

The concomitant use of transdermal DRUGN with DRUGN or other potent dgbAdgb inhibitors such as DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and nefazadone may result in an increase in DRUGN plasma concentrations .
ketoconazole	drug	troleandomycin	drug
false

The concomitant use of transdermal DRUGN with DRUGN or other potent dgbAdgb inhibitors such as DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and nefazadone may result in an increase in DRUGN plasma concentrations .
ketoconazole	drug	clarithromycin	drug
false

The concomitant use of transdermal DRUGN with DRUGN or other potent dgbAdgb inhibitors such as DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and nefazadone may result in an increase in DRUGN plasma concentrations .
ketoconazole	drug	nelfinavir	drug
false

The concomitant use of transdermal DRUGN with DRUGN or other potent dgbAdgb inhibitors such as DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and nefazadone may result in an increase in DRUGB plasma concentrations .
ketoconazole	drug	fentanyl	drug
false

The concomitant use of transdermal DRUGN with DRUGN or other potent dgbAdgb inhibitors such as DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and nefazadone may result in an increase in DRUGN plasma concentrations .
itraconazole	drug	troleandomycin	drug
false

The concomitant use of transdermal DRUGN with DRUGN or other potent dgbAdgb inhibitors such as DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and nefazadone may result in an increase in DRUGN plasma concentrations .
itraconazole	drug	clarithromycin	drug
false

The concomitant use of transdermal DRUGN with DRUGN or other potent dgbAdgb inhibitors such as DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and nefazadone may result in an increase in DRUGN plasma concentrations .
itraconazole	drug	nelfinavir	drug
false

The concomitant use of transdermal DRUGN with DRUGN or other potent dgbAdgb inhibitors such as DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and nefazadone may result in an increase in DRUGB plasma concentrations .
itraconazole	drug	fentanyl	drug
false

The concomitant use of transdermal DRUGN with DRUGN or other potent dgbAdgb inhibitors such as DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and nefazadone may result in an increase in DRUGN plasma concentrations .
troleandomycin	drug	clarithromycin	drug
false

The concomitant use of transdermal DRUGN with DRUGN or other potent dgbAdgb inhibitors such as DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and nefazadone may result in an increase in DRUGN plasma concentrations .
troleandomycin	drug	nelfinavir	drug
false

The concomitant use of transdermal DRUGN with DRUGN or other potent dgbAdgb inhibitors such as DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and nefazadone may result in an increase in DRUGB plasma concentrations .
troleandomycin	drug	fentanyl	drug
false

The concomitant use of transdermal DRUGN with DRUGN or other potent dgbAdgb inhibitors such as DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and nefazadone may result in an increase in DRUGN plasma concentrations .
clarithromycin	drug	nelfinavir	drug
false

The concomitant use of transdermal DRUGN with DRUGN or other potent dgbAdgb inhibitors such as DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and nefazadone may result in an increase in DRUGB plasma concentrations .
clarithromycin	drug	fentanyl	drug
false

The concomitant use of transdermal DRUGN with DRUGN or other potent dgbAdgb inhibitors such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and nefazadone may result in an increase in DRUGB plasma concentrations .
nelfinavir	drug	fentanyl	drug
false

DRUGA : DRUGB is not recommended for use in patients who have received DRUGN within dgb days because severe and unpredictable potentiation by DRUGN has been reported with DRUGN
MAO Inhibitors	group	DURAGESIC	brand
false

DRUGA : DRUGN is not recommended for use in patients who have received DRUGB within dgb days because severe and unpredictable potentiation by DRUGN has been reported with DRUGN
MAO Inhibitors	group	MAOI	group
false

DRUGA : DRUGN is not recommended for use in patients who have received DRUGN within dgb days because severe and unpredictable potentiation by DRUGB has been reported with DRUGN
MAO Inhibitors	group	MAO inhibitors	group
false

DRUGA : DRUGN is not recommended for use in patients who have received DRUGN within dgb days because severe and unpredictable potentiation by DRUGN has been reported with DRUGB
MAO Inhibitors	group	opioid analgesics	group
false

DRUGN : DRUGA is not recommended for use in patients who have received DRUGB within dgb days because severe and unpredictable potentiation by DRUGN has been reported with DRUGN
DURAGESIC	brand	MAOI	group
advise

DRUGN : DRUGA is not recommended for use in patients who have received DRUGN within dgb days because severe and unpredictable potentiation by DRUGB has been reported with DRUGN
DURAGESIC	brand	MAO inhibitors	group
false

DRUGN : DRUGA is not recommended for use in patients who have received DRUGN within dgb days because severe and unpredictable potentiation by DRUGN has been reported with DRUGB
DURAGESIC	brand	opioid analgesics	group
false

DRUGN : DRUGN is not recommended for use in patients who have received DRUGA within dgb days because severe and unpredictable potentiation by DRUGB has been reported with DRUGN
MAOI	group	MAO inhibitors	group
false

DRUGN : DRUGN is not recommended for use in patients who have received DRUGA within dgb days because severe and unpredictable potentiation by DRUGN has been reported with DRUGB
MAOI	group	opioid analgesics	group
false

DRUGN : DRUGN is not recommended for use in patients who have received DRUGN within dgb days because severe and unpredictable potentiation by DRUGA has been reported with DRUGB
MAO inhibitors	group	opioid analgesics	group
advise

Drug Interaction with DRUGA and DRUGB DRUGN has been shown to exhibit minimal ( ca . dgb % ) metabolism .
Erythromycin	drug	Ketoconazole	drug
false

Drug Interaction with DRUGA and DRUGN DRUGB has been shown to exhibit minimal ( ca . dgb % ) metabolism .
Erythromycin	drug	Fexofenadine	drug
false

Drug Interaction with DRUGN and DRUGA DRUGB has been shown to exhibit minimal ( ca . dgb % ) metabolism .
Ketoconazole	drug	Fexofenadine	drug
false

However , co administration of DRUGA with either DRUGB or DRUGN led to increased plasma concentrations of DRUGN .
fexofenadine hydrochloride	drug	ketoconazole	drug
mechanism

However , co administration of DRUGA with either DRUGN or DRUGB led to increased plasma concentrations of DRUGN .
fexofenadine hydrochloride	drug	erythromycin	drug
mechanism

However , co administration of DRUGA with either DRUGN or DRUGN led to increased plasma concentrations of DRUGB .
fexofenadine hydrochloride	drug	fexofenadine	drug
false

However , co administration of DRUGN with either DRUGA or DRUGB led to increased plasma concentrations of DRUGN .
ketoconazole	drug	erythromycin	drug
false

However , co administration of DRUGN with either DRUGA or DRUGN led to increased plasma concentrations of DRUGB .
ketoconazole	drug	fexofenadine	drug
false

However , co administration of DRUGN with either DRUGN or DRUGA led to increased plasma concentrations of DRUGB .
erythromycin	drug	fexofenadine	drug
false

DRUGA had no effect on the pharmacokinetics of either DRUGB or DRUGN .
Fexofenadine	drug	erythromycin	drug
false

DRUGA had no effect on the pharmacokinetics of either DRUGN or DRUGB .
Fexofenadine	drug	ketoconazole	drug
false

DRUGN had no effect on the pharmacokinetics of either DRUGA or DRUGB .
erythromycin	drug	ketoconazole	drug
false

No differences in adverse events or QTc interval were observed when subjects were administered DRUGA alone or in combination with either DRUGB or DRUGN .
fexofenadine hydrochloride	drug	erythromycin	drug
false

No differences in adverse events or QTc interval were observed when subjects were administered DRUGA alone or in combination with either DRUGN or DRUGB .
fexofenadine hydrochloride	drug	ketoconazole	drug
false

No differences in adverse events or QTc interval were observed when subjects were administered DRUGN alone or in combination with either DRUGA or DRUGB .
erythromycin	drug	ketoconazole	drug
false

These studies indicate that DRUGA or DRUGB co administration enhances DRUGN gastrointestinal absorption .
ketoconazole	drug	erythromycin	drug
false

These studies indicate that DRUGA or DRUGN co administration enhances DRUGB gastrointestinal absorption .
ketoconazole	drug	fexofenadine	drug
mechanism

These studies indicate that DRUGN or DRUGA co administration enhances DRUGB gastrointestinal absorption .
erythromycin	drug	fexofenadine	drug
mechanism

DRUGA should not be taken closely in time with DRUGB and DRUGN containing DRUGN .
ALLEGRA	brand	aluminum	drug
advise

DRUGA should not be taken closely in time with DRUGN and DRUGB containing DRUGN .
ALLEGRA	brand	magnesium	drug
advise

DRUGA should not be taken closely in time with DRUGN and DRUGN containing DRUGB .
ALLEGRA	brand	antacids	group
false

DRUGN should not be taken closely in time with DRUGA and DRUGB containing DRUGN .
aluminum	drug	magnesium	drug
false

DRUGN should not be taken closely in time with DRUGA and DRUGN containing DRUGB .
aluminum	drug	antacids	group
false

DRUGN should not be taken closely in time with DRUGN and DRUGA containing DRUGB .
magnesium	drug	antacids	group
false

Therefore , to maximize the effects of DRUGA , it is recommended that DRUGB should be taken with water
fexofenadine	drug	ALLEGRA	brand
false

Compounds that have been tested in man include DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN and no clinically meaningful interactions were found .
antipyrine	drug	digoxin	drug
false

Compounds that have been tested in man include DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN and no clinically meaningful interactions were found .
antipyrine	drug	propranolol	drug
false

Compounds that have been tested in man include DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN and no clinically meaningful interactions were found .
antipyrine	drug	theophylline	drug
false

Compounds that have been tested in man include DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB and no clinically meaningful interactions were found .
antipyrine	drug	warfarin	drug
false

Compounds that have been tested in man include DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN and no clinically meaningful interactions were found .
digoxin	drug	propranolol	drug
false

Compounds that have been tested in man include DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN and no clinically meaningful interactions were found .
digoxin	drug	theophylline	drug
false

Compounds that have been tested in man include DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB and no clinically meaningful interactions were found .
digoxin	drug	warfarin	drug
false

Compounds that have been tested in man include DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN and no clinically meaningful interactions were found .
propranolol	drug	theophylline	drug
false

Compounds that have been tested in man include DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB and no clinically meaningful interactions were found .
propranolol	drug	warfarin	drug
false

Compounds that have been tested in man include DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB and no clinically meaningful interactions were found .
theophylline	drug	warfarin	drug
false

Further , in clinical studies with DRUGA ( DRUGB , dgb mg ) when used in older men who have benign prostatic hyperplasia ( BPH ) , PSA levels are decreased by approximately dgb % .
PROSCAR	brand	finasteride	drug
false

DRUGA has been administered to patients receiving DRUGB or DRUGN without adverse effects .
TAMBOCOR	brand	digitalis preparations	group
false

DRUGA has been administered to patients receiving DRUGN or DRUGB without adverse effects .
TAMBOCOR	brand	beta-adrenergic blocking agents	group
false

DRUGN has been administered to patients receiving DRUGA or DRUGB without adverse effects .
digitalis preparations	group	beta-adrenergic blocking agents	group
false

During administration of multiple oral doses of DRUGA to healthy subjects stabilized on a maintenance dose of DRUGB , a dgb % dgb % increase in plasma DRUGN levels occurred at six hours postdose .
TAMBOCOR	brand	digoxin	drug
mechanism

During administration of multiple oral doses of DRUGA to healthy subjects stabilized on a maintenance dose of DRUGN , a dgb % dgb % increase in plasma DRUGB levels occurred at six hours postdose .
TAMBOCOR	brand	digoxin	drug
false

In a study involving healthy subjects receiving DRUGA and DRUGB concurrently , plasma DRUGN levels were increased about dgb % and DRUGN levels were increased about dgb % compared to control values .
TAMBOCOR	brand	propranolol	drug
mechanism

In a study involving healthy subjects receiving DRUGA and DRUGN concurrently , plasma DRUGB levels were increased about dgb % and DRUGN levels were increased about dgb % compared to control values .
TAMBOCOR	brand	flecainide	drug
false

In a study involving healthy subjects receiving DRUGA and DRUGN concurrently , plasma DRUGN levels were increased about dgb % and DRUGB levels were increased about dgb % compared to control values .
TAMBOCOR	brand	propranolol	drug
false

In a study involving healthy subjects receiving DRUGN and DRUGA concurrently , plasma DRUGB levels were increased about dgb % and DRUGN levels were increased about dgb % compared to control values .
propranolol	drug	flecainide	drug
false

In a study involving healthy subjects receiving DRUGN and DRUGN concurrently , plasma DRUGA levels were increased about dgb % and DRUGB levels were increased about dgb % compared to control values .
flecainide	drug	propranolol	drug
false

In this formal interaction study , DRUGA and DRUGB were each found to have negative inotropic effects ;
TAMBOCOR	brand	propranolol	drug
false

The effects of concomitant administration of DRUGA and DRUGB on the PR interval were less than additive .
TAMBOCOR	brand	propranolol	drug
effect

In DRUGA clinical trials , patients who were receiving DRUGB concurrently did not experience an increased incidence of side effects .
TAMBOCOR	brand	beta blockers	group
false

Nevertheless , the possibility of additive negative inotropic effects of DRUGA and DRUGB should be recognized .
beta blockers	group	flecainide	drug
effect

DRUGA has been used in a large number of patients receiving DRUGB without apparent interaction .
TAMBOCOR	brand	diuretics	group
false

Limited data in patients receiving known enzyme inducers ( DRUGA , DRUGB , DRUGN ) indicate only a dgb % increase in the rate of DRUGN elimination .
phenytoin	drug	phenobarbital	drug
false

Limited data in patients receiving known enzyme inducers ( DRUGA , DRUGN , DRUGB ) indicate only a dgb % increase in the rate of DRUGN elimination .
phenytoin	drug	carbamazepine	drug
false

Limited data in patients receiving known enzyme inducers ( DRUGA , DRUGN , DRUGN ) indicate only a dgb % increase in the rate of DRUGB elimination .
phenytoin	drug	flecainide	drug
mechanism

Limited data in patients receiving known enzyme inducers ( DRUGN , DRUGA , DRUGB ) indicate only a dgb % increase in the rate of DRUGN elimination .
phenobarbital	drug	carbamazepine	drug
false

Limited data in patients receiving known enzyme inducers ( DRUGN , DRUGA , DRUGN ) indicate only a dgb % increase in the rate of DRUGB elimination .
phenobarbital	drug	flecainide	drug
mechanism

Limited data in patients receiving known enzyme inducers ( DRUGN , DRUGN , DRUGA ) indicate only a dgb % increase in the rate of DRUGB elimination .
carbamazepine	drug	flecainide	drug
mechanism

In healthy subjects receiving DRUGA ( dgb gm daily ) for one week , plasma DRUGB levels increased by about dgb % and half life increased by about dgb % .
cimetidine	drug	flecainide	drug
mechanism

When DRUGA is added to DRUGB therapy , plasma DRUGN levels may increase two fold or more in some patients , if DRUGN dosage is not reduced .
amiodarone	drug	flecainide	drug
mechanism

When DRUGA is added to DRUGN therapy , plasma DRUGB levels may increase two fold or more in some patients , if DRUGN dosage is not reduced .
amiodarone	drug	flecainide	drug
false

When DRUGA is added to DRUGN therapy , plasma DRUGN levels may increase two fold or more in some patients , if DRUGB dosage is not reduced .
amiodarone	drug	flecainide	drug
false

Drugs that inhibit cytochrome PdgbIIDdgb , such as DRUGA , might increase the plasma concentrations of DRUGB in patients that are on chronic DRUGN therapy ;
quinidine	drug	flecainide	drug
mechanism

Drugs that inhibit cytochrome PdgbIIDdgb , such as DRUGA , might increase the plasma concentrations of DRUGN in patients that are on chronic DRUGB therapy ;
quinidine	drug	flecainide	drug
false

There has been little experience with the coadministration of DRUGA and either DRUGB or DRUGN .
TAMBOCOR	brand	disopyramide	drug
false

There has been little experience with the coadministration of DRUGA and either DRUGN or DRUGB .
TAMBOCOR	brand	verapamil	drug
false

There has been little experience with the coadministration of DRUGN and either DRUGA or DRUGB .
disopyramide	drug	verapamil	drug
false

There has been too little experience with the coadministration of DRUGA with DRUGB or DRUGN to recommend concomitant use .
TAMBOCOR	brand	nifedipine	drug
false

There has been too little experience with the coadministration of DRUGA with DRUGN or DRUGB to recommend concomitant use .
TAMBOCOR	brand	diltiazem	drug
false

There has been too little experience with the coadministration of DRUGN with DRUGA or DRUGB to recommend concomitant use .
nifedipine	drug	diltiazem	drug
false

DRUGA , a DRUGB , has been reported to inactivate the antifungal activity of DRUGN by competitive inhibition .
Cytosine arabinoside	drug	cytostatic agent	group
false

DRUGA , a DRUGN , has been reported to inactivate the antifungal activity of DRUGB by competitive inhibition .
Cytosine arabinoside	drug	flucytosine	drug
effect

DRUGN , a DRUGA , has been reported to inactivate the antifungal activity of DRUGB by competitive inhibition .
cytostatic agent	group	flucytosine	drug
false

The use of DRUGA FOR INJECTION in combination with DRUGB is not recommended due to the risk of severe pulmonary toxicity .
FLUDARA	brand	pentostatin	drug
advise

DRUGA or DRUGB ( DRUGN and related drugs , DRUGN and DRUGN ) enhanced hypokalemia .
Amphotericin B	drug	potassium-depleting diuretics	group
false

DRUGA or DRUGN ( DRUGB and related drugs , DRUGN and DRUGN ) enhanced hypokalemia .
Amphotericin B	drug	benzothiadiazines	group
false

DRUGA or DRUGN ( DRUGN and related drugs , DRUGB and DRUGN ) enhanced hypokalemia .
Amphotericin B	drug	ethacrynic acid	drug
false

DRUGA or DRUGN ( DRUGN and related drugs , DRUGN and DRUGB ) enhanced hypokalemia .
Amphotericin B	drug	furosemide	drug
false

DRUGN or DRUGA ( DRUGB and related drugs , DRUGN and DRUGN ) enhanced hypokalemia .
potassium-depleting diuretics	group	benzothiadiazines	group
false

DRUGN or DRUGA ( DRUGN and related drugs , DRUGB and DRUGN ) enhanced hypokalemia .
potassium-depleting diuretics	group	ethacrynic acid	drug
false

DRUGN or DRUGA ( DRUGN and related drugs , DRUGN and DRUGB ) enhanced hypokalemia .
potassium-depleting diuretics	group	furosemide	drug
false

DRUGN or DRUGN ( DRUGA and related drugs , DRUGB and DRUGN ) enhanced hypokalemia .
benzothiadiazines	group	ethacrynic acid	drug
false

DRUGN or DRUGN ( DRUGA and related drugs , DRUGN and DRUGB ) enhanced hypokalemia .
benzothiadiazines	group	furosemide	drug
false

DRUGN or DRUGN ( DRUGN and related drugs , DRUGA and DRUGB ) enhanced hypokalemia .
ethacrynic acid	drug	furosemide	drug
false

DRUGA enhanced possibility of arrhythmias or DRUGB toxicity associated with hypokalemia .
Digitalis glycosides	group	digitalis	group
false

DRUGA ( oral agents and DRUGB ) diminished antidiabetic effect .
Antidiabetic drugs	group	insulin	drug
false

Rarely DRUGA toxicity may occur in patients who discontinue DRUGB after concurrent high dose DRUGN therapy .
salicylate	group	steroids	group
false

Rarely DRUGA toxicity may occur in patients who discontinue DRUGN after concurrent high dose DRUGB therapy .
salicylate	group	aspirin	brand
false

Rarely DRUGN toxicity may occur in patients who discontinue DRUGA after concurrent high dose DRUGB therapy .
steroids	group	aspirin	brand
effect

Monitor DRUGA levels or the therapeutic effect for which DRUGB is given ;
salicylate	group	aspirin	brand
false

DRUGA , DRUGB , or DRUGN increased metabolic clearance of DRUGN because of the induction of hepatic enzymes .
Barbiturates	group	phenytoin	drug
false

DRUGA , DRUGN , or DRUGB increased metabolic clearance of DRUGN because of the induction of hepatic enzymes .
Barbiturates	group	rifampin	drug
false

DRUGA , DRUGN , or DRUGN increased metabolic clearance of DRUGB because of the induction of hepatic enzymes .
Barbiturates	group	fludrocortisone acetate	drug
mechanism

DRUGN , DRUGA , or DRUGB increased metabolic clearance of DRUGN because of the induction of hepatic enzymes .
phenytoin	drug	rifampin	drug
false

DRUGN , DRUGA , or DRUGN increased metabolic clearance of DRUGB because of the induction of hepatic enzymes .
phenytoin	drug	fludrocortisone acetate	drug
mechanism

DRUGN , DRUGN , or DRUGA increased metabolic clearance of DRUGB because of the induction of hepatic enzymes .
rifampin	drug	fludrocortisone acetate	drug
mechanism

DRUGA ( particularly C dgb alkylated DRUGB such as DRUGN , DRUGN , DRUGN , and similar compounds ) enhanced tendency toward edema .
Anabolic steroids	group	androgens	group
false

DRUGA ( particularly C dgb alkylated DRUGN such as DRUGB , DRUGN , DRUGN , and similar compounds ) enhanced tendency toward edema .
Anabolic steroids	group	oxymetholone	drug
false

DRUGA ( particularly C dgb alkylated DRUGN such as DRUGN , DRUGB , DRUGN , and similar compounds ) enhanced tendency toward edema .
Anabolic steroids	group	methandrostenolone	drug
false

DRUGA ( particularly C dgb alkylated DRUGN such as DRUGN , DRUGN , DRUGB , and similar compounds ) enhanced tendency toward edema .
Anabolic steroids	group	norethandrolone	drug
false

DRUGN ( particularly C dgb alkylated DRUGA such as DRUGB , DRUGN , DRUGN , and similar compounds ) enhanced tendency toward edema .
androgens	group	oxymetholone	drug
false

DRUGN ( particularly C dgb alkylated DRUGA such as DRUGN , DRUGB , DRUGN , and similar compounds ) enhanced tendency toward edema .
androgens	group	methandrostenolone	drug
false

DRUGN ( particularly C dgb alkylated DRUGA such as DRUGN , DRUGN , DRUGB , and similar compounds ) enhanced tendency toward edema .
androgens	group	norethandrolone	drug
false

DRUGN ( particularly C dgb alkylated DRUGN such as DRUGA , DRUGB , DRUGN , and similar compounds ) enhanced tendency toward edema .
oxymetholone	drug	methandrostenolone	drug
false

DRUGN ( particularly C dgb alkylated DRUGN such as DRUGA , DRUGN , DRUGB , and similar compounds ) enhanced tendency toward edema .
oxymetholone	drug	norethandrolone	drug
false

DRUGN ( particularly C dgb alkylated DRUGN such as DRUGN , DRUGA , DRUGB , and similar compounds ) enhanced tendency toward edema .
methandrostenolone	drug	norethandrolone	drug
false

When DRUGA therapy is initiated , a reduction in DRUGB dosage may be required , and increased amounts may be required when DRUGN is terminated .
estrogen	group	corticosteroid	group
false

When DRUGN therapy is initiated , a reduction in DRUGA dosage may be required , and increased amounts may be required when DRUGB is terminated .
corticosteroid	group	estrogen	group
false

Interaction with DRUGA other than DRUGB has not been specifically studied ;
central nervous system depressants	group	benzodiazepines	group
false

however , no deleterious interactions were seen when DRUGA was administered after DRUGB , inhalational DRUGN , DRUGN and muscle relaxant antagonists administered in conjunction with sedation or anesthesia .
ROMAZICON	brand	narcotics	group
false

however , no deleterious interactions were seen when DRUGA was administered after DRUGN , inhalational DRUGB , DRUGN and muscle relaxant antagonists administered in conjunction with sedation or anesthesia .
ROMAZICON	brand	anesthetics	group
false

however , no deleterious interactions were seen when DRUGA was administered after DRUGN , inhalational DRUGN , DRUGB and muscle relaxant antagonists administered in conjunction with sedation or anesthesia .
ROMAZICON	brand	muscle relaxants	group
false

however , no deleterious interactions were seen when DRUGN was administered after DRUGA , inhalational DRUGB , DRUGN and muscle relaxant antagonists administered in conjunction with sedation or anesthesia .
narcotics	group	anesthetics	group
false

however , no deleterious interactions were seen when DRUGN was administered after DRUGA , inhalational DRUGN , DRUGB and muscle relaxant antagonists administered in conjunction with sedation or anesthesia .
narcotics	group	muscle relaxants	group
false

however , no deleterious interactions were seen when DRUGN was administered after DRUGN , inhalational DRUGA , DRUGB and muscle relaxant antagonists administered in conjunction with sedation or anesthesia .
anesthetics	group	muscle relaxants	group
false

Although DRUGA exerts a slight intrinsic anticonvulsant effect , its abrupt suppression of the protective effect of a DRUGB agonist can give rise to convulsions in epileptic patients .
ROMAZICON	brand	benzodiazepine	group
effect

DRUGA blocks the central effects of DRUGB by competitive interaction at the receptor level .
ROMAZICON	brand	benzodiazepines	group
effect

The effects of nonbenzodiazepine agonists at benzodiazepine receptors , such as DRUGA , triazolopyridazines and others , are also blocked by DRUGB .
zopiclone	drug	ROMAZICON	brand
effect

The pharmacokinetics of DRUGA are unaltered in the presence of DRUGB and vice versa .
benzodiazepines	group	flumazenil	drug
false

There is no pharmacokinetic interaction between DRUGA and DRUGB .
ethanol	drug	flumazenil	drug
false

Use in Ambulatory Patients The effects of DRUGA may wear off before a DRUGB is completely cleared from the body .
ROMAZICON	brand	long-acting benzodiazepine	group
false

An adequate period of observation must be provided for any patient in whom either DRUGA ( such as DRUGB ) or large doses of DRUGN ( such as dgb mg of DRUGN ) have been used .
long-acting benzodiazepines	group	diazepam	drug
false

An adequate period of observation must be provided for any patient in whom either DRUGA ( such as DRUGN ) or large doses of DRUGB ( such as dgb mg of DRUGN ) have been used .
long-acting benzodiazepines	group	short-acting benzodiazepines	group
false

An adequate period of observation must be provided for any patient in whom either DRUGA ( such as DRUGN ) or large doses of DRUGN ( such as dgb mg of DRUGB ) have been used .
long-acting benzodiazepines	group	midazolam	drug
false

An adequate period of observation must be provided for any patient in whom either DRUGN ( such as DRUGA ) or large doses of DRUGB ( such as dgb mg of DRUGN ) have been used .
diazepam	drug	short-acting benzodiazepines	group
false

An adequate period of observation must be provided for any patient in whom either DRUGN ( such as DRUGA ) or large doses of DRUGN ( such as dgb mg of DRUGB ) have been used .
diazepam	drug	midazolam	drug
false

An adequate period of observation must be provided for any patient in whom either DRUGN ( such as DRUGN ) or large doses of DRUGA ( such as dgb mg of DRUGB ) have been used .
short-acting benzodiazepines	group	midazolam	drug
false

Talk to your doctor if you are taking certain DRUGA such as DRUGB , DRUGN or DRUGN .
antibiotics	group	erythromycin	drug
false

Talk to your doctor if you are taking certain DRUGA such as DRUGN , DRUGB or DRUGN .
antibiotics	group	clarithromycin	drug
false

Talk to your doctor if you are taking certain DRUGA such as DRUGN , DRUGN or DRUGB .
antibiotics	group	azithromycin	drug
false

Talk to your doctor if you are taking certain DRUGN such as DRUGA , DRUGB or DRUGN .
erythromycin	drug	clarithromycin	drug
false

Talk to your doctor if you are taking certain DRUGN such as DRUGA , DRUGN or DRUGB .
erythromycin	drug	azithromycin	drug
false

Talk to your doctor if you are taking certain DRUGN such as DRUGN , DRUGA or DRUGB .
clarithromycin	drug	azithromycin	drug
false

Caution should be exercised when taking this medicine certain DRUGA , such as DRUGB , DRUGN , or DRUGN .
antibiotics	group	erythromycin	drug
false

Caution should be exercised when taking this medicine certain DRUGA , such as DRUGN , DRUGB , or DRUGN .
antibiotics	group	clarithromycin	drug
false

Caution should be exercised when taking this medicine certain DRUGA , such as DRUGN , DRUGN , or DRUGB .
antibiotics	group	azithromycin	drug
false

Caution should be exercised when taking this medicine certain DRUGN , such as DRUGA , DRUGB , or DRUGN .
erythromycin	drug	clarithromycin	drug
false

Caution should be exercised when taking this medicine certain DRUGN , such as DRUGA , DRUGN , or DRUGB .
erythromycin	drug	azithromycin	drug
false

Caution should be exercised when taking this medicine certain DRUGN , such as DRUGN , DRUGA , or DRUGB .
clarithromycin	drug	azithromycin	drug
false

Wait dgb weeks after stopping DRUGA before starting a DRUGB .
escitalopram	drug	non-selective MAO inhibitor	group
advise

Wait dgb weeks after stopping an DRUGA before starting DRUGB .
MAO inhibitor	group	escitalopram	drug
advise

Concurrent administration of DRUGA and DRUGB may result in elevated serum levels of DRUGN .
oxyphenbutazone	drug	androgens	group
mechanism

Concurrent administration of DRUGN and DRUGA may result in elevated serum levels of DRUGB .
androgens	group	oxyphenbutazone	drug
false

In diabetic patients , the metabolic effects of DRUGA may decrease blood glucose and therefore , DRUGB requirements .
androgens	group	insulin	drug
effect

DRUGA : Administration of DRUGB to volunteers under fasting conditions , or with DRUGN suspension yielded similar serum DRUGN time profiles in young subjects ( n=dgb ) .
Antacids	group	flurbiprofen	drug
false

DRUGA : Administration of DRUGN to volunteers under fasting conditions , or with DRUGB suspension yielded similar serum DRUGN time profiles in young subjects ( n=dgb ) .
Antacids	group	antacid	group
false

DRUGA : Administration of DRUGN to volunteers under fasting conditions , or with DRUGN suspension yielded similar serum DRUGB time profiles in young subjects ( n=dgb ) .
Antacids	group	flurbiprofen	drug
false

DRUGN : Administration of DRUGA to volunteers under fasting conditions , or with DRUGB suspension yielded similar serum DRUGN time profiles in young subjects ( n=dgb ) .
flurbiprofen	drug	antacid	group
false

DRUGN : Administration of DRUGN to volunteers under fasting conditions , or with DRUGA suspension yielded similar serum DRUGB time profiles in young subjects ( n=dgb ) .
antacid	group	flurbiprofen	drug
false

DRUGA : DRUGB like other DRUGN , has been shown to affect bleeding parameters in patients receiving DRUGN , and serious clinical bleeding has been reported .
Anticoagulants	group	Flurbiprofen	drug
false

DRUGA : DRUGN like other DRUGB , has been shown to affect bleeding parameters in patients receiving DRUGN , and serious clinical bleeding has been reported .
Anticoagulants	group	nonsteroidal anti-inflammatory drugs	group
false

DRUGA : DRUGN like other DRUGN , has been shown to affect bleeding parameters in patients receiving DRUGB , and serious clinical bleeding has been reported .
Anticoagulants	group	anti-coagulants	group
false

DRUGN : DRUGA like other DRUGB , has been shown to affect bleeding parameters in patients receiving DRUGN , and serious clinical bleeding has been reported .
Flurbiprofen	drug	nonsteroidal anti-inflammatory drugs	group
false

DRUGN : DRUGA like other DRUGN , has been shown to affect bleeding parameters in patients receiving DRUGB , and serious clinical bleeding has been reported .
Flurbiprofen	drug	anti-coagulants	group
effect

DRUGN : DRUGN like other DRUGA , has been shown to affect bleeding parameters in patients receiving DRUGB , and serious clinical bleeding has been reported .
nonsteroidal anti-inflammatory drugs	group	anti-coagulants	group
effect

The physician should be cautious when administering DRUGA to patients taking DRUGB .
flurbiprofen	drug	anticoagulants	group
advise

DRUGA : Concurrent administration of DRUGB and DRUGN resulted in dgb % lower serum DRUGN concentrations .
Aspirin	brand	aspirin	brand
false

DRUGA : Concurrent administration of DRUGN and DRUGB resulted in dgb % lower serum DRUGN concentrations .
Aspirin	brand	flurbiprofen	drug
false

DRUGA : Concurrent administration of DRUGN and DRUGN resulted in dgb % lower serum DRUGB concentrations .
Aspirin	brand	flurbiprofen	drug
false

DRUGN : Concurrent administration of DRUGA and DRUGB resulted in dgb % lower serum DRUGN concentrations .
aspirin	brand	flurbiprofen	drug
mechanism

DRUGN : Concurrent administration of DRUGA and DRUGN resulted in dgb % lower serum DRUGB concentrations .
aspirin	brand	flurbiprofen	drug
false

This effect of DRUGA ( which also lowers serum concentrations of other DRUGB given with it ) has been demonstrated in patients with rheumatoid arthritis ( n= dgb ) as well as normal volunteers ( n= dgb ) .
aspirin	brand	nonsteroidal anti-inflammatory drugs	group
false

Concurrent use of DRUGA and DRUGB is therefore not recommended .
flurbiprofen	drug	aspirin	brand
advise

DRUGA : The effect of DRUGB on blood pressure response to DRUGN and DRUGN was evaluated in men with mild uncomplicated hypertension ( n = dgb ) .
Beta-adrenergic Blocking Agents	group	flurbiprofen	drug
false

DRUGA : The effect of DRUGN on blood pressure response to DRUGB and DRUGN was evaluated in men with mild uncomplicated hypertension ( n = dgb ) .
Beta-adrenergic Blocking Agents	group	propranolol	drug
false

DRUGA : The effect of DRUGN on blood pressure response to DRUGN and DRUGB was evaluated in men with mild uncomplicated hypertension ( n = dgb ) .
Beta-adrenergic Blocking Agents	group	atenolol	drug
false

DRUGN : The effect of DRUGA on blood pressure response to DRUGB and DRUGN was evaluated in men with mild uncomplicated hypertension ( n = dgb ) .
flurbiprofen	drug	propranolol	drug
false

DRUGN : The effect of DRUGA on blood pressure response to DRUGN and DRUGB was evaluated in men with mild uncomplicated hypertension ( n = dgb ) .
flurbiprofen	drug	atenolol	drug
false

DRUGN : The effect of DRUGN on blood pressure response to DRUGA and DRUGB was evaluated in men with mild uncomplicated hypertension ( n = dgb ) .
propranolol	drug	atenolol	drug
false

DRUGA pretreatment attenuated the hypotensive effect of a single dose of DRUGB but not DRUGN .
Flurbiprofen	drug	propranolol	drug
effect

DRUGA pretreatment attenuated the hypotensive effect of a single dose of DRUGN but not DRUGB .
Flurbiprofen	drug	atenolol	drug
false

DRUGN pretreatment attenuated the hypotensive effect of a single dose of DRUGA but not DRUGB .
propranolol	drug	atenolol	drug
false

DRUGA did not affect the pharmacokinetic profile of either drug , and the mechanism under lying the interference with DRUGB s hypotensive effect is unknown .
Flurbiprofen	drug	propranolol	drug
int

Patients taking both DRUGA and a DRUGB should be monitored to ensure that a satisfactory hypotensive effect is achieved .
flurbiprofen	drug	beta-blocker	group
advise

DRUGA : Studies of concomitant administration of DRUGB and DRUGN to healthy men ( n= dgb ) did not show a change in the steady state serum levels of either drug .
Digoxin	drug	flurbiprofen	drug
false

DRUGA : Studies of concomitant administration of DRUGN and DRUGB to healthy men ( n= dgb ) did not show a change in the steady state serum levels of either drug .
Digoxin	drug	digoxin	drug
false

DRUGN : Studies of concomitant administration of DRUGA and DRUGB to healthy men ( n= dgb ) did not show a change in the steady state serum levels of either drug .
flurbiprofen	drug	digoxin	drug
false

DRUGA : Studies in normal volunteers have shown that DRUGB like other DRUGN , can interfere with the effects of DRUGN .
Diuretics	group	flurbiprofen	drug
false

DRUGA : Studies in normal volunteers have shown that DRUGN like other DRUGB , can interfere with the effects of DRUGN .
Diuretics	group	nonsteroidal anti-inflammatory drugs	group
false

DRUGA : Studies in normal volunteers have shown that DRUGN like other DRUGN , can interfere with the effects of DRUGB .
Diuretics	group	furosemide	drug
false

DRUGN : Studies in normal volunteers have shown that DRUGA like other DRUGB , can interfere with the effects of DRUGN .
flurbiprofen	drug	nonsteroidal anti-inflammatory drugs	group
false

DRUGN : Studies in normal volunteers have shown that DRUGA like other DRUGN , can interfere with the effects of DRUGB .
flurbiprofen	drug	furosemide	drug
effect

DRUGN : Studies in normal volunteers have shown that DRUGN like other DRUGA , can interfere with the effects of DRUGB .
nonsteroidal anti-inflammatory drugs	group	furosemide	drug
effect

Other DRUGA that inhibit prostaglandin synthesis have been shown to interfere with DRUGB in some studies and with DRUGN .
nonsteroidal anti-inflammatory drugs	group	thiazide diuretics	group
effect

Other DRUGA that inhibit prostaglandin synthesis have been shown to interfere with DRUGN in some studies and with DRUGB .
nonsteroidal anti-inflammatory drugs	group	potassium-sparing diuretics	group
effect

Other DRUGN that inhibit prostaglandin synthesis have been shown to interfere with DRUGA in some studies and with DRUGB .
thiazide diuretics	group	potassium-sparing diuretics	group
false

Patients receiving DRUGA and DRUGB or other DRUGN should be observed closely to determine if the desired effect is obtained .
flurbiprofen	drug	furosemide	drug
advise

Patients receiving DRUGA and DRUGN or other DRUGB should be observed closely to determine if the desired effect is obtained .
flurbiprofen	drug	diuretics	group
advise

Patients receiving DRUGN and DRUGA or other DRUGB should be observed closely to determine if the desired effect is obtained .
furosemide	drug	diuretics	group
false

Although there was a slight reduction in blood sugar concentrations during concomitant administration of DRUGA and DRUGB , there were no signs or symptoms of hypoglycemia .
flurbiprofen	drug	hypoglycemic agents	group
effect

Increases in prothrombin time have been noted in patients receiving long term DRUGA therapy after DRUGB was initiated .
warfarin	drug	flutamide	drug
effect

Therefore , close monitoring of prothrombin time is recommended and adjustment of the DRUGA dose may be necessary when DRUGB Capsules are administered concomitantly with DRUGN .
anticoagulant	group	EULEXIN	brand
false

Therefore , close monitoring of prothrombin time is recommended and adjustment of the DRUGA dose may be necessary when DRUGN Capsules are administered concomitantly with DRUGB .
anticoagulant	group	warfarin	drug
false

Therefore , close monitoring of prothrombin time is recommended and adjustment of the DRUGN dose may be necessary when DRUGA Capsules are administered concomitantly with DRUGB .
EULEXIN	brand	warfarin	drug
advise

Therefore , it is recommended that DRUGA Tablets not be used in combination with DRUGB , or within dgb days of discontinuing treatment with a DRUGN .
Fluvoxamine	drug	MAOIs	group
advise

Therefore , it is recommended that DRUGA Tablets not be used in combination with DRUGN , or within dgb days of discontinuing treatment with a DRUGB .
Fluvoxamine	drug	MAOI	group
advise

Therefore , it is recommended that DRUGN Tablets not be used in combination with DRUGA , or within dgb days of discontinuing treatment with a DRUGB .
MAOIs	group	MAOI	group
false

After stopping DRUGA Tablets , at least dgb weeks should be allowed before starting a DRUGB .
Fluvoxamine	drug	MAOI	group
advise

Potential DRUGA , DRUGB , and DRUGN Interactions
Terfenadine	drug	Astemizole	drug
false

Potential DRUGA , DRUGN , and DRUGB Interactions
Terfenadine	drug	Cisapride	drug
false

Potential DRUGN , DRUGA , and DRUGB Interactions
Astemizole	drug	Cisapride	drug
false

Increased plasma concentrations of DRUGA , DRUGB , and DRUGN cause QT prolongation and have been associated with torsades de pointes type ventricular tachycardia , sometimes fatal .
terfenadine	drug	astemizole	drug
false

Increased plasma concentrations of DRUGA , DRUGN , and DRUGB cause QT prolongation and have been associated with torsades de pointes type ventricular tachycardia , sometimes fatal .
terfenadine	drug	cisapride	drug
false

Increased plasma concentrations of DRUGN , DRUGA , and DRUGB cause QT prolongation and have been associated with torsades de pointes type ventricular tachycardia , sometimes fatal .
astemizole	drug	cisapride	drug
false

As noted below , a sub for DRUGA in combination with DRUGB , a drug that is known to be metabolized by the IIIAdgb isozyme .
fluvoxamine	drug	alprazolam	drug
false

Although it has not been definitively demonstrated that DRUGA is a potent IIIAdgb inhibitor , it is likely to be , given the substantial interaction of DRUGN with DRUGB .
fluvoxamine	drug	alprazolam	drug
false

Although it has not been definitively demonstrated that DRUGN is a potent IIIAdgb inhibitor , it is likely to be , given the substantial interaction of DRUGA with DRUGB .
fluvoxamine	drug	alprazolam	drug
int

Consequently , it is recommended that DRUGA not be used in combination with either DRUGB , DRUGN , or DRUGN .
fluvoxamine	drug	terbinafine	drug
advise

Consequently , it is recommended that DRUGA not be used in combination with either DRUGN , DRUGB , or DRUGN .
fluvoxamine	drug	astemizole	drug
advise

Consequently , it is recommended that DRUGA not be used in combination with either DRUGN , DRUGN , or DRUGB .
fluvoxamine	drug	cisapride	drug
advise

Consequently , it is recommended that DRUGN not be used in combination with either DRUGA , DRUGB , or DRUGN .
terbinafine	drug	astemizole	drug
false

Consequently , it is recommended that DRUGN not be used in combination with either DRUGA , DRUGN , or DRUGB .
terbinafine	drug	cisapride	drug
false

Consequently , it is recommended that DRUGN not be used in combination with either DRUGN , DRUGA , or DRUGB .
astemizole	drug	cisapride	drug
false

The clearance of DRUGA metabolized by glucuronidation ( e. g. , DRUGB , DRUGN , DRUGN ) is unlikely to be affected by DRUGN .
benzodiazepines	group	lorazepam	drug
false

The clearance of DRUGA metabolized by glucuronidation ( e. g. , DRUGN , DRUGB , DRUGN ) is unlikely to be affected by DRUGN .
benzodiazepines	group	oxazepam	drug
false

The clearance of DRUGA metabolized by glucuronidation ( e. g. , DRUGN , DRUGN , DRUGB ) is unlikely to be affected by DRUGN .
benzodiazepines	group	temazepam	drug
false

The clearance of DRUGA metabolized by glucuronidation ( e. g. , DRUGN , DRUGN , DRUGN ) is unlikely to be affected by DRUGB .
benzodiazepines	group	fluvoxamine	drug
false

The clearance of DRUGN metabolized by glucuronidation ( e. g. , DRUGA , DRUGB , DRUGN ) is unlikely to be affected by DRUGN .
lorazepam	drug	oxazepam	drug
false

The clearance of DRUGN metabolized by glucuronidation ( e. g. , DRUGA , DRUGN , DRUGB ) is unlikely to be affected by DRUGN .
lorazepam	drug	temazepam	drug
false

The clearance of DRUGN metabolized by glucuronidation ( e. g. , DRUGA , DRUGN , DRUGN ) is unlikely to be affected by DRUGB .
lorazepam	drug	fluvoxamine	drug
false

The clearance of DRUGN metabolized by glucuronidation ( e. g. , DRUGN , DRUGA , DRUGB ) is unlikely to be affected by DRUGN .
oxazepam	drug	temazepam	drug
false

The clearance of DRUGN metabolized by glucuronidation ( e. g. , DRUGN , DRUGA , DRUGN ) is unlikely to be affected by DRUGB .
oxazepam	drug	fluvoxamine	drug
false

The clearance of DRUGN metabolized by glucuronidation ( e. g. , DRUGN , DRUGN , DRUGA ) is unlikely to be affected by DRUGB .
temazepam	drug	fluvoxamine	drug
false

DRUGA : The co administration of DRUGB Tablets and DRUGN is generally not advisable .
Diazepam	drug	Fluvoxamine	drug
false

DRUGA : The co administration of DRUGN Tablets and DRUGB is generally not advisable .
Diazepam	drug	diazepam	drug
false

DRUGN : The co administration of DRUGA Tablets and DRUGB is generally not advisable .
Fluvoxamine	drug	diazepam	drug
advise

Because DRUGA reduces the clearance of both DRUGB and its active metabolite , DRUGN , there is a strong likelihood of substantial accumulation of both species during chronic co administration .
fluvoxamine	drug	diazepam	drug
mechanism

Because DRUGA reduces the clearance of both DRUGN and its active metabolite , DRUGB , there is a strong likelihood of substantial accumulation of both species during chronic co administration .
fluvoxamine	drug	N-desmethyldiazepam	drug_n
mechanism

Because DRUGN reduces the clearance of both DRUGA and its active metabolite , DRUGB , there is a strong likelihood of substantial accumulation of both species during chronic co administration .
diazepam	drug	N-desmethyldiazepam	drug_n
false

In these subjects ( R= B ) , the clearance of DRUGA was reduced by dgb % and that of DRUGB to a level that was too low to measure over the course of the dgb week long study .
diazepam	drug	N-desmethyldiazepam	drug_n
false

Moreover , as noted with DRUGA , the effect of DRUGB may even be more pronounced when it is administered at higher doses .
alprazolam	drug	fluvoxamine	drug
effect

Accordingly , DRUGA and DRUGB should not ordinarily be co administered .
diazepam	drug	fluvoxamine	drug
advise

DRUGA : The effect of steady state DRUGB ldgb mg bid on the pharmacokinetics of a single dose of DRUGN ( dgb mg ) as dgb mg DRUGN was evaluated in dgb healthy non smoking , male volunteers .
Theophylline	drug	fluvoxamine	drug
false

DRUGA : The effect of steady state DRUGN ldgb mg bid on the pharmacokinetics of a single dose of DRUGN ( dgb mg ) as dgb mg DRUGB was evaluated in dgb healthy non smoking , male volunteers .
Theophylline	drug	aminophylline	drug
false

DRUGN : The effect of steady state DRUGA ldgb mg bid on the pharmacokinetics of a single dose of DRUGB ( dgb mg ) as dgb mg DRUGN was evaluated in dgb healthy non smoking , male volunteers .
fluvoxamine	drug	Theophylline	drug
false

DRUGN : The effect of steady state DRUGA ldgb mg bid on the pharmacokinetics of a single dose of DRUGN ( dgb mg ) as dgb mg DRUGB was evaluated in dgb healthy non smoking , male volunteers .
fluvoxamine	drug	aminophylline	drug
false

DRUGN : The effect of steady state DRUGN ldgb mg bid on the pharmacokinetics of a single dose of DRUGA ( dgb mg ) as dgb mg DRUGB was evaluated in dgb healthy non smoking , male volunteers .
Theophylline	drug	aminophylline	drug
false

Therefore , if DRUGA is co administered with DRUGB , its dose should be reduced to one third of the usual daily maintenance dose and plasma concentrations of DRUGN should to monitored .
theophylline	drug	fluvoxamine maleate	drug
advise

Therefore , if DRUGN is co administered with DRUGA , its dose should be reduced to one third of the usual daily maintenance dose and plasma concentrations of DRUGB should to monitored .
fluvoxamine maleate	drug	theophylline	drug
false

DRUGA : When DRUGB ( dgb mg tid ) was administered concomitantly with DRUGN for two weeks , DRUGN plasma concentrations increased by dgb % and prothrombin times were prolonged .
Warfarin	drug	fluvoxamine maleate	drug
false

DRUGA : When DRUGN ( dgb mg tid ) was administered concomitantly with DRUGB for two weeks , DRUGN plasma concentrations increased by dgb % and prothrombin times were prolonged .
Warfarin	drug	warfarin	drug
false

DRUGA : When DRUGN ( dgb mg tid ) was administered concomitantly with DRUGN for two weeks , DRUGB plasma concentrations increased by dgb % and prothrombin times were prolonged .
Warfarin	drug	warfarin	drug
false

DRUGN : When DRUGA ( dgb mg tid ) was administered concomitantly with DRUGB for two weeks , DRUGN plasma concentrations increased by dgb % and prothrombin times were prolonged .
fluvoxamine maleate	drug	warfarin	drug
mechanism

DRUGN : When DRUGA ( dgb mg tid ) was administered concomitantly with DRUGN for two weeks , DRUGB plasma concentrations increased by dgb % and prothrombin times were prolonged .
fluvoxamine maleate	drug	warfarin	drug
false

Thus patients receiving oral DRUGA and DRUGB Tablets should have their prothrombin time monitored and their DRUGN dose adjusted accordingly .
anticoagulants	group	Fluvoxamine	drug
advise

Thus patients receiving oral DRUGA and DRUGN Tablets should have their prothrombin time monitored and their DRUGB dose adjusted accordingly .
anticoagulants	group	anticoagulant	group
false

Thus patients receiving oral DRUGN and DRUGA Tablets should have their prothrombin time monitored and their DRUGB dose adjusted accordingly .
Fluvoxamine	drug	anticoagulant	group
false

It is important for older adults to be aware of the relationship between DRUGA and DRUGB because they are at greater risk of having a vitamin Bdgb deficiency .
folic acid	drug	vitamin B12	drug
false

Oral doses of DRUGA ( dgb dgb mg / kg ) , via alcohol dehydrogenase inhibition , significantly reduced the rate of elimination of DRUGB ( by approximately dgb % ) given to healthy volunteers in moderate doses .
Antizol	brand	ethanol	drug
mechanism

Similarly , DRUGA decreased the rate of elimination of DRUGB ( by approximately dgb % ) by the same mechanism .
ethanol	drug	Antizol	brand
mechanism

Reciprocal interactions may occur with concomitant use of DRUGA and drugs that increase or inhibit the cytochrome Pdgb system ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN ) , though this has not been studied
Antizol	brand	phenytoin	drug
mechanism

Reciprocal interactions may occur with concomitant use of DRUGA and drugs that increase or inhibit the cytochrome Pdgb system ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN ) , though this has not been studied
Antizol	brand	carbamazepine	drug
mechanism

Reciprocal interactions may occur with concomitant use of DRUGA and drugs that increase or inhibit the cytochrome Pdgb system ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN ) , though this has not been studied
Antizol	brand	cimetidine	drug
mechanism

Reciprocal interactions may occur with concomitant use of DRUGA and drugs that increase or inhibit the cytochrome Pdgb system ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB ) , though this has not been studied
Antizol	brand	ketoconazole	drug
mechanism

Reciprocal interactions may occur with concomitant use of DRUGN and drugs that increase or inhibit the cytochrome Pdgb system ( e.g . , DRUGA , DRUGB , DRUGN , DRUGN ) , though this has not been studied
phenytoin	drug	carbamazepine	drug
false

Reciprocal interactions may occur with concomitant use of DRUGN and drugs that increase or inhibit the cytochrome Pdgb system ( e.g . , DRUGA , DRUGN , DRUGB , DRUGN ) , though this has not been studied
phenytoin	drug	cimetidine	drug
false

Reciprocal interactions may occur with concomitant use of DRUGN and drugs that increase or inhibit the cytochrome Pdgb system ( e.g . , DRUGA , DRUGN , DRUGN , DRUGB ) , though this has not been studied
phenytoin	drug	ketoconazole	drug
false

Reciprocal interactions may occur with concomitant use of DRUGN and drugs that increase or inhibit the cytochrome Pdgb system ( e.g . , DRUGN , DRUGA , DRUGB , DRUGN ) , though this has not been studied
carbamazepine	drug	cimetidine	drug
false

Reciprocal interactions may occur with concomitant use of DRUGN and drugs that increase or inhibit the cytochrome Pdgb system ( e.g . , DRUGN , DRUGA , DRUGN , DRUGB ) , though this has not been studied
carbamazepine	drug	ketoconazole	drug
false

Reciprocal interactions may occur with concomitant use of DRUGN and drugs that increase or inhibit the cytochrome Pdgb system ( e.g . , DRUGN , DRUGN , DRUGA , DRUGB ) , though this has not been studied
cimetidine	drug	ketoconazole	drug
false

In clinical studies performed with DRUGA , the concomitant use of oral DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
Fondaparinux	drug	anticoagulants	group
false

In clinical studies performed with DRUGA , the concomitant use of oral DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
Fondaparinux	drug	warfarin	drug
false

In clinical studies performed with DRUGA , the concomitant use of oral DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
Fondaparinux	drug	platelet inhibitors	group
false

In clinical studies performed with DRUGA , the concomitant use of oral DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
Fondaparinux	drug	acetylsalicylic acid	drug
false

In clinical studies performed with DRUGA , the concomitant use of oral DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
Fondaparinux	drug	NSAIDs	group
false

In clinical studies performed with DRUGA , the concomitant use of oral DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
Fondaparinux	drug	piroxicam	drug
false

In clinical studies performed with DRUGA , the concomitant use of oral DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and DRUGB did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
Fondaparinux	drug	digoxin	drug
false

In clinical studies performed with DRUGA , the concomitant use of oral DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGB .
Fondaparinux	drug	fondaparinux sodium	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGA ( DRUGB ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
anticoagulants	group	warfarin	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGA ( DRUGN ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
anticoagulants	group	platelet inhibitors	group
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGA ( DRUGN ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
anticoagulants	group	acetylsalicylic acid	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGA ( DRUGN ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
anticoagulants	group	NSAIDs	group
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGA ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
anticoagulants	group	piroxicam	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGA ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and DRUGB did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
anticoagulants	group	digoxin	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGA ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGB .
anticoagulants	group	fondaparinux sodium	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGA ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
warfarin	drug	platelet inhibitors	group
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGA ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
warfarin	drug	acetylsalicylic acid	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGA ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
warfarin	drug	NSAIDs	group
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGA ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
warfarin	drug	piroxicam	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGA ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and DRUGB did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
warfarin	drug	digoxin	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGA ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGB .
warfarin	drug	fondaparinux sodium	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGN ) , DRUGA ( DRUGB ) , DRUGN ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
platelet inhibitors	group	acetylsalicylic acid	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGN ) , DRUGA ( DRUGN ) , DRUGB ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
platelet inhibitors	group	NSAIDs	group
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGN ) , DRUGA ( DRUGN ) , DRUGN ( DRUGB ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
platelet inhibitors	group	piroxicam	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGN ) , DRUGA ( DRUGN ) , DRUGN ( DRUGN ) , and DRUGB did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
platelet inhibitors	group	digoxin	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGN ) , DRUGA ( DRUGN ) , DRUGN ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGB .
platelet inhibitors	group	fondaparinux sodium	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGN ) , DRUGN ( DRUGA ) , DRUGB ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
acetylsalicylic acid	drug	NSAIDs	group
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGN ) , DRUGN ( DRUGA ) , DRUGN ( DRUGB ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
acetylsalicylic acid	drug	piroxicam	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGN ) , DRUGN ( DRUGA ) , DRUGN ( DRUGN ) , and DRUGB did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
acetylsalicylic acid	drug	digoxin	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGN ) , DRUGN ( DRUGA ) , DRUGN ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGB .
acetylsalicylic acid	drug	fondaparinux sodium	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGA ( DRUGB ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
NSAIDs	group	piroxicam	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGA ( DRUGN ) , and DRUGB did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
NSAIDs	group	digoxin	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGA ( DRUGN ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGB .
NSAIDs	group	fondaparinux sodium	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGA ) , and DRUGB did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGN .
piroxicam	drug	digoxin	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGA ) , and DRUGN did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGB .
piroxicam	drug	fondaparinux sodium	drug
false

In clinical studies performed with DRUGN , the concomitant use of oral DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and DRUGA did not significantly affect the pharmacokinetics / pharmacodynamics of DRUGB .
digoxin	drug	fondaparinux sodium	drug
false

In addition , DRUGA neither influenced the pharmacodynamics of DRUGB , DRUGN , DRUGN , and DRUGN , nor the pharmacokinetics of DRUGN at steady state .
Fondaparinux	drug	warfarin	drug
false

In addition , DRUGA neither influenced the pharmacodynamics of DRUGN , DRUGB , DRUGN , and DRUGN , nor the pharmacokinetics of DRUGN at steady state .
Fondaparinux	drug	acetylsalicylic acid	drug
false

In addition , DRUGA neither influenced the pharmacodynamics of DRUGN , DRUGN , DRUGB , and DRUGN , nor the pharmacokinetics of DRUGN at steady state .
Fondaparinux	drug	piroxicam	drug
false

In addition , DRUGA neither influenced the pharmacodynamics of DRUGN , DRUGN , DRUGN , and DRUGB , nor the pharmacokinetics of DRUGN at steady state .
Fondaparinux	drug	digoxin	drug
false

In addition , DRUGA neither influenced the pharmacodynamics of DRUGN , DRUGN , DRUGN , and DRUGN , nor the pharmacokinetics of DRUGB at steady state .
Fondaparinux	drug	digoxin	drug
false

In addition , DRUGN neither influenced the pharmacodynamics of DRUGA , DRUGB , DRUGN , and DRUGN , nor the pharmacokinetics of DRUGN at steady state .
warfarin	drug	acetylsalicylic acid	drug
false

In addition , DRUGN neither influenced the pharmacodynamics of DRUGA , DRUGN , DRUGB , and DRUGN , nor the pharmacokinetics of DRUGN at steady state .
warfarin	drug	piroxicam	drug
false

In addition , DRUGN neither influenced the pharmacodynamics of DRUGA , DRUGN , DRUGN , and DRUGB , nor the pharmacokinetics of DRUGN at steady state .
warfarin	drug	digoxin	drug
false

In addition , DRUGN neither influenced the pharmacodynamics of DRUGA , DRUGN , DRUGN , and DRUGN , nor the pharmacokinetics of DRUGB at steady state .
warfarin	drug	digoxin	drug
false

In addition , DRUGN neither influenced the pharmacodynamics of DRUGN , DRUGA , DRUGB , and DRUGN , nor the pharmacokinetics of DRUGN at steady state .
acetylsalicylic acid	drug	piroxicam	drug
false

In addition , DRUGN neither influenced the pharmacodynamics of DRUGN , DRUGA , DRUGN , and DRUGB , nor the pharmacokinetics of DRUGN at steady state .
acetylsalicylic acid	drug	digoxin	drug
false

In addition , DRUGN neither influenced the pharmacodynamics of DRUGN , DRUGA , DRUGN , and DRUGN , nor the pharmacokinetics of DRUGB at steady state .
acetylsalicylic acid	drug	digoxin	drug
false

In addition , DRUGN neither influenced the pharmacodynamics of DRUGN , DRUGN , DRUGA , and DRUGB , nor the pharmacokinetics of DRUGN at steady state .
piroxicam	drug	digoxin	drug
false

In addition , DRUGN neither influenced the pharmacodynamics of DRUGN , DRUGN , DRUGA , and DRUGN , nor the pharmacokinetics of DRUGB at steady state .
piroxicam	drug	digoxin	drug
false

In an in vitro study in human liver microsomes , inhibition of CYPdgbAdgb hydroxylation of DRUGA by DRUGB ( dgb m m M i.e . , dgb mg / L ) was dgb dgb % .
coumarin	group	fondaparinux	drug
mechanism

DRUGA : Aerosol DRUGB of the short acting adrenergic stimulant type may be used for relief of breakthrough symptoms while using DRUGN .
Short-Acting beta2-agonists	group	bronchodilators	group
false

DRUGA : Aerosol DRUGN of the short acting adrenergic stimulant type may be used for relief of breakthrough symptoms while using DRUGB .
Short-Acting beta2-agonists	group	formoterol	drug
false

DRUGN : Aerosol DRUGA of the short acting adrenergic stimulant type may be used for relief of breakthrough symptoms while using DRUGB .
bronchodilators	group	formoterol	drug
false

Concomitant administration of other DRUGA may potentiate the undesirable effects of DRUGB .
sympathomimetic agents	group	FORADIL	brand
effect

DRUGA and DRUGB : DRUGN should be administered with extreme caution in patients being treated with DRUGN or DRUGN because the action of DRUGN on the cardiovascular system may be potentiated by these agents .
Monoamine Oxidase Inhibitors	group	Tricyclic Antidepressants	group
false

DRUGA and DRUGN : DRUGB should be administered with extreme caution in patients being treated with DRUGN or DRUGN because the action of DRUGN on the cardiovascular system may be potentiated by these agents .
Monoamine Oxidase Inhibitors	group	FORADIL	brand
false

DRUGA and DRUGN : DRUGN should be administered with extreme caution in patients being treated with DRUGB or DRUGN because the action of DRUGN on the cardiovascular system may be potentiated by these agents .
Monoamine Oxidase Inhibitors	group	monoamine oxidase inhibitors	group
false

DRUGA and DRUGN : DRUGN should be administered with extreme caution in patients being treated with DRUGN or DRUGB because the action of DRUGN on the cardiovascular system may be potentiated by these agents .
Monoamine Oxidase Inhibitors	group	tricyclic antidepressants	group
false

DRUGA and DRUGN : DRUGN should be administered with extreme caution in patients being treated with DRUGN or DRUGN because the action of DRUGB on the cardiovascular system may be potentiated by these agents .
Monoamine Oxidase Inhibitors	group	formoterol	drug
false

DRUGN and DRUGA : DRUGB should be administered with extreme caution in patients being treated with DRUGN or DRUGN because the action of DRUGN on the cardiovascular system may be potentiated by these agents .
Tricyclic Antidepressants	group	FORADIL	brand
false

DRUGN and DRUGA : DRUGN should be administered with extreme caution in patients being treated with DRUGB or DRUGN because the action of DRUGN on the cardiovascular system may be potentiated by these agents .
Tricyclic Antidepressants	group	monoamine oxidase inhibitors	group
false

DRUGN and DRUGA : DRUGN should be administered with extreme caution in patients being treated with DRUGN or DRUGB because the action of DRUGN on the cardiovascular system may be potentiated by these agents .
Tricyclic Antidepressants	group	tricyclic antidepressants	group
false

DRUGN and DRUGA : DRUGN should be administered with extreme caution in patients being treated with DRUGN or DRUGN because the action of DRUGB on the cardiovascular system may be potentiated by these agents .
Tricyclic Antidepressants	group	formoterol	drug
false

DRUGN and DRUGN : DRUGA should be administered with extreme caution in patients being treated with DRUGB or DRUGN because the action of DRUGN on the cardiovascular system may be potentiated by these agents .
FORADIL	brand	monoamine oxidase inhibitors	group
advise

DRUGN and DRUGN : DRUGA should be administered with extreme caution in patients being treated with DRUGN or DRUGB because the action of DRUGN on the cardiovascular system may be potentiated by these agents .
FORADIL	brand	tricyclic antidepressants	group
advise

DRUGN and DRUGN : DRUGA should be administered with extreme caution in patients being treated with DRUGN or DRUGN because the action of DRUGB on the cardiovascular system may be potentiated by these agents .
FORADIL	brand	formoterol	drug
false

DRUGN and DRUGN : DRUGN should be administered with extreme caution in patients being treated with DRUGA or DRUGB because the action of DRUGN on the cardiovascular system may be potentiated by these agents .
monoamine oxidase inhibitors	group	tricyclic antidepressants	group
false

DRUGN and DRUGN : DRUGN should be administered with extreme caution in patients being treated with DRUGA or DRUGN because the action of DRUGB on the cardiovascular system may be potentiated by these agents .
monoamine oxidase inhibitors	group	formoterol	drug
false

DRUGN and DRUGN : DRUGN should be administered with extreme caution in patients being treated with DRUGN or DRUGA because the action of DRUGB on the cardiovascular system may be potentiated by these agents .
tricyclic antidepressants	group	formoterol	drug
false

DRUGA , DRUGB and DRUGN : Concomitant treatment with DRUGN , DRUGN , or DRUGN may potentiate a possible hypokalemic effect of DRUGN
Corticosteroids	group	Methylxanthines	group
false

DRUGA , DRUGN and DRUGB : Concomitant treatment with DRUGN , DRUGN , or DRUGN may potentiate a possible hypokalemic effect of DRUGN
Corticosteroids	group	Diuretics	group
false

DRUGA , DRUGN and DRUGN : Concomitant treatment with DRUGB , DRUGN , or DRUGN may potentiate a possible hypokalemic effect of DRUGN
Corticosteroids	group	xanthine derivatives	group
false

DRUGA , DRUGN and DRUGN : Concomitant treatment with DRUGN , DRUGB , or DRUGN may potentiate a possible hypokalemic effect of DRUGN
Corticosteroids	group	steroids	group
false

DRUGA , DRUGN and DRUGN : Concomitant treatment with DRUGN , DRUGN , or DRUGB may potentiate a possible hypokalemic effect of DRUGN
Corticosteroids	group	diuretics	group
false

DRUGA , DRUGN and DRUGN : Concomitant treatment with DRUGN , DRUGN , or DRUGN may potentiate a possible hypokalemic effect of DRUGB
Corticosteroids	group	beta2-agonists.	group
false

DRUGN , DRUGA and DRUGB : Concomitant treatment with DRUGN , DRUGN , or DRUGN may potentiate a possible hypokalemic effect of DRUGN
Methylxanthines	group	Diuretics	group
false

DRUGN , DRUGA and DRUGN : Concomitant treatment with DRUGB , DRUGN , or DRUGN may potentiate a possible hypokalemic effect of DRUGN
Methylxanthines	group	xanthine derivatives	group
false

DRUGN , DRUGA and DRUGN : Concomitant treatment with DRUGN , DRUGB , or DRUGN may potentiate a possible hypokalemic effect of DRUGN
Methylxanthines	group	steroids	group
false

DRUGN , DRUGA and DRUGN : Concomitant treatment with DRUGN , DRUGN , or DRUGB may potentiate a possible hypokalemic effect of DRUGN
Methylxanthines	group	diuretics	group
false

DRUGN , DRUGA and DRUGN : Concomitant treatment with DRUGN , DRUGN , or DRUGN may potentiate a possible hypokalemic effect of DRUGB
Methylxanthines	group	beta2-agonists.	group
false

DRUGN , DRUGN and DRUGA : Concomitant treatment with DRUGB , DRUGN , or DRUGN may potentiate a possible hypokalemic effect of DRUGN
Diuretics	group	xanthine derivatives	group
false

DRUGN , DRUGN and DRUGA : Concomitant treatment with DRUGN , DRUGB , or DRUGN may potentiate a possible hypokalemic effect of DRUGN
Diuretics	group	steroids	group
false

DRUGN , DRUGN and DRUGA : Concomitant treatment with DRUGN , DRUGN , or DRUGB may potentiate a possible hypokalemic effect of DRUGN
Diuretics	group	diuretics	group
false

DRUGN , DRUGN and DRUGA : Concomitant treatment with DRUGN , DRUGN , or DRUGN may potentiate a possible hypokalemic effect of DRUGB
Diuretics	group	beta2-agonists.	group
false

DRUGN , DRUGN and DRUGN : Concomitant treatment with DRUGA , DRUGB , or DRUGN may potentiate a possible hypokalemic effect of DRUGN
xanthine derivatives	group	steroids	group
false

DRUGN , DRUGN and DRUGN : Concomitant treatment with DRUGA , DRUGN , or DRUGB may potentiate a possible hypokalemic effect of DRUGN
xanthine derivatives	group	diuretics	group
false

DRUGN , DRUGN and DRUGN : Concomitant treatment with DRUGA , DRUGN , or DRUGN may potentiate a possible hypokalemic effect of DRUGB
xanthine derivatives	group	beta2-agonists.	group
effect

DRUGN , DRUGN and DRUGN : Concomitant treatment with DRUGN , DRUGA , or DRUGB may potentiate a possible hypokalemic effect of DRUGN
steroids	group	diuretics	group
false

DRUGN , DRUGN and DRUGN : Concomitant treatment with DRUGN , DRUGA , or DRUGN may potentiate a possible hypokalemic effect of DRUGB
steroids	group	beta2-agonists.	group
effect

DRUGN , DRUGN and DRUGN : Concomitant treatment with DRUGN , DRUGN , or DRUGA may potentiate a possible hypokalemic effect of DRUGB
diuretics	group	beta2-agonists.	group
effect

Other Drugs : Drugs such as DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia .
quinidine	drug	disopyramide	drug
false

Other Drugs : Drugs such as DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia .
quinidine	drug	procainamide	drug
false

Other Drugs : Drugs such as DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia .
quinidine	drug	phenothiazines	group
false

Other Drugs : Drugs such as DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia .
quinidine	drug	antihistamines	group
false

Other Drugs : Drugs such as DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia .
quinidine	drug	tricyclic antidepressants	group
false

Other Drugs : Drugs such as DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia .
disopyramide	drug	procainamide	drug
false

Other Drugs : Drugs such as DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia .
disopyramide	drug	phenothiazines	group
false

Other Drugs : Drugs such as DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia .
disopyramide	drug	antihistamines	group
false

Other Drugs : Drugs such as DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia .
disopyramide	drug	tricyclic antidepressants	group
false

Other Drugs : Drugs such as DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia .
procainamide	drug	phenothiazines	group
false

Other Drugs : Drugs such as DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia .
procainamide	drug	antihistamines	group
false

Other Drugs : Drugs such as DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia .
procainamide	drug	tricyclic antidepressants	group
false

Other Drugs : Drugs such as DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia .
phenothiazines	group	antihistamines	group
false

Other Drugs : Drugs such as DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia .
phenothiazines	group	tricyclic antidepressants	group
false

Other Drugs : Drugs such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia .
antihistamines	group	tricyclic antidepressants	group
false

It is important that patients understand how to use DRUGA ( DRUGB ) capsules with the supplied AerolizerTM inhalation device and how it should be used in relation to other asthma or COPD medications they are taking .
FORADIL	brand	formoterol fumarate	drug
false

Acute symptoms should be treated with a short acting , inhaled DRUGA such as DRUGB ( the physician should provide the patient with such medication and instruct the patient in how it should be used ) .
beta2-agonist	group	salbutamol	drug
false

DRUGA should not be used as a substitute for oral or inhaled DRUGB .
FORADIL	brand	corticosteroids	group
false

Guardians of children who have been prescribed DRUGA should be alerted to the general concern regarding asthma therapy compliance , especially neglect of anti inflammatory therapy and overuse of DRUGB .
FORADIL	brand	short-acting  beta2-agonists	group
false

A possible drug interaction of DRUGA and intravenous DRUGB has been described .
FOSCAVIR	brand	pentamidine	drug
int

Concomitant treatment of four patients in the United Kingdom with DRUGA and intravenous DRUGB may have caused hypocalcemia ;
FOSCAVIR	brand	pentamidine	drug
effect

DRUGA : The pharmacokinetics of DRUGB and DRUGN were not altered in dgb patients receiving either concomitant therapy or daily alternating therapy for maintenance of CMV disease .
Ganciclovir	drug	foscarnet	drug
false

DRUGA : The pharmacokinetics of DRUGN and DRUGB were not altered in dgb patients receiving either concomitant therapy or daily alternating therapy for maintenance of CMV disease .
Ganciclovir	drug	ganciclovir	drug
false

DRUGN : The pharmacokinetics of DRUGA and DRUGB were not altered in dgb patients receiving either concomitant therapy or daily alternating therapy for maintenance of CMV disease .
foscarnet	drug	ganciclovir	drug
false

DRUGA : When coadministered with DRUGB , DRUGN , a drug which increases gastrointestinal motility , lowers the serum concentration and urinary excretion of DRUGN .
Metoclopramide	drug	MONUROL	brand
false

DRUGA : When coadministered with DRUGN , DRUGB , a drug which increases gastrointestinal motility , lowers the serum concentration and urinary excretion of DRUGN .
Metoclopramide	drug	metoclopramide	drug
false

DRUGA : When coadministered with DRUGN , DRUGN , a drug which increases gastrointestinal motility , lowers the serum concentration and urinary excretion of DRUGB .
Metoclopramide	drug	fosfomycin	drug
false

DRUGN : When coadministered with DRUGA , DRUGB , a drug which increases gastrointestinal motility , lowers the serum concentration and urinary excretion of DRUGN .
MONUROL	brand	metoclopramide	drug
mechanism

DRUGN : When coadministered with DRUGA , DRUGN , a drug which increases gastrointestinal motility , lowers the serum concentration and urinary excretion of DRUGB .
MONUROL	brand	fosfomycin	drug
false

DRUGN : When coadministered with DRUGN , DRUGA , a drug which increases gastrointestinal motility , lowers the serum concentration and urinary excretion of DRUGB .
metoclopramide	drug	fosfomycin	drug
false

DRUGA : DRUGN does not affect the pharmacokinetics of DRUGB when coadministered with DRUGN .
Cimetidine	drug	fosfomycin	drug
false

DRUGA : DRUGN does not affect the pharmacokinetics of DRUGN when coadministered with DRUGB .
Cimetidine	drug	MONUROL	brand
false

DRUGN : DRUGA does not affect the pharmacokinetics of DRUGB when coadministered with DRUGN .
Cimetidine	drug	fosfomycin	drug
false

DRUGN : DRUGA does not affect the pharmacokinetics of DRUGN when coadministered with DRUGB .
Cimetidine	drug	MONUROL	brand
false

DRUGN : DRUGN does not affect the pharmacokinetics of DRUGA when coadministered with DRUGB .
fosfomycin	drug	MONUROL	brand
false

DRUGA : Patients on DRUGB , especially those with intravascular volume depletion , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with DRUGN .
Diuretics	group	diuretics	group
false

DRUGA : Patients on DRUGN , especially those with intravascular volume depletion , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with DRUGB .
Diuretics	group	fosinopril sodium	drug
false

DRUGN : Patients on DRUGA , especially those with intravascular volume depletion , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with DRUGB .
diuretics	group	fosinopril sodium	drug
effect

The possibility of hypotensive effects can be minimized by either discontinuing the DRUGA or increasing salt intake prior to initiation of treatment with DRUGB .
diuretic	group	fosinopril sodium	drug
effect

DRUGA Supplements and DRUGB : DRUGN can attenuate potassium loss caused by DRUGN .
Potassium	drug	Potassium-Sparing Diuretics	group
false

DRUGA Supplements and DRUGN : DRUGB can attenuate potassium loss caused by DRUGN .
Potassium	drug	Fosinopril sodium	drug
false

DRUGA Supplements and DRUGN : DRUGN can attenuate potassium loss caused by DRUGB .
Potassium	drug	thiazide diuretics	group
false

DRUGN Supplements and DRUGA : DRUGB can attenuate potassium loss caused by DRUGN .
Potassium-Sparing Diuretics	group	Fosinopril sodium	drug
false

DRUGN Supplements and DRUGA : DRUGN can attenuate potassium loss caused by DRUGB .
Potassium-Sparing Diuretics	group	thiazide diuretics	group
false

DRUGN Supplements and DRUGN : DRUGA can attenuate potassium loss caused by DRUGB .
Fosinopril sodium	drug	thiazide diuretics	group
effect

DRUGA ( DRUGB , DRUGN , DRUGN , and others ) or DRUGN supplements can increase the risk of hyperkalemia .
Potassium-sparing diuretics	group	spironolactone	drug
false

DRUGA ( DRUGN , DRUGB , DRUGN , and others ) or DRUGN supplements can increase the risk of hyperkalemia .
Potassium-sparing diuretics	group	amiloride	drug
false

DRUGA ( DRUGN , DRUGN , DRUGB , and others ) or DRUGN supplements can increase the risk of hyperkalemia .
Potassium-sparing diuretics	group	triamterene	drug
false

DRUGA ( DRUGN , DRUGN , DRUGN , and others ) or DRUGB supplements can increase the risk of hyperkalemia .
Potassium-sparing diuretics	group	potassium	drug
false

DRUGN ( DRUGA , DRUGB , DRUGN , and others ) or DRUGN supplements can increase the risk of hyperkalemia .
spironolactone	drug	amiloride	drug
false

DRUGN ( DRUGA , DRUGN , DRUGB , and others ) or DRUGN supplements can increase the risk of hyperkalemia .
spironolactone	drug	triamterene	drug
false

DRUGN ( DRUGA , DRUGN , DRUGN , and others ) or DRUGB supplements can increase the risk of hyperkalemia .
spironolactone	drug	potassium	drug
false

DRUGN ( DRUGN , DRUGA , DRUGB , and others ) or DRUGN supplements can increase the risk of hyperkalemia .
amiloride	drug	triamterene	drug
false

DRUGN ( DRUGN , DRUGA , DRUGN , and others ) or DRUGB supplements can increase the risk of hyperkalemia .
amiloride	drug	potassium	drug
false

DRUGN ( DRUGN , DRUGN , DRUGA , and others ) or DRUGB supplements can increase the risk of hyperkalemia .
triamterene	drug	potassium	drug
false

DRUGA : Increased serum DRUGB levels and symptoms of DRUGN toxicity have been reported in patients receiving DRUGN during therapy with DRUGN .
Lithium	drug	lithium	drug
false

DRUGA : Increased serum DRUGN levels and symptoms of DRUGB toxicity have been reported in patients receiving DRUGN during therapy with DRUGN .
Lithium	drug	lithium	drug
false

DRUGA : Increased serum DRUGN levels and symptoms of DRUGN toxicity have been reported in patients receiving DRUGB during therapy with DRUGN .
Lithium	drug	ACE inhibitors	group
false

DRUGA : Increased serum DRUGN levels and symptoms of DRUGN toxicity have been reported in patients receiving DRUGN during therapy with DRUGB .
Lithium	drug	lithium	drug
false

DRUGN : Increased serum DRUGA levels and symptoms of DRUGN toxicity have been reported in patients receiving DRUGB during therapy with DRUGN .
lithium	drug	ACE inhibitors	group
false

DRUGN : Increased serum DRUGN levels and symptoms of DRUGA toxicity have been reported in patients receiving DRUGB during therapy with DRUGN .
lithium	drug	ACE inhibitors	group
false

DRUGN : Increased serum DRUGN levels and symptoms of DRUGN toxicity have been reported in patients receiving DRUGA during therapy with DRUGB .
ACE inhibitors	group	lithium	drug
effect

In a study with concomitant administration of DRUGA and DRUGB , the bioavailability of unbound DRUGN was not altered .
aspirin	brand	fosinopril sodium	drug
false

In a study with concomitant administration of DRUGA and DRUGN , the bioavailability of unbound DRUGB was not altered .
aspirin	brand	fosinoprilat	drug_n
false

In a study with concomitant administration of DRUGN and DRUGA , the bioavailability of unbound DRUGB was not altered .
fosinopril sodium	drug	fosinoprilat	drug_n
false

Drug / Laboratory Test Interaction DRUGA may cause a false low measurement of serum DRUGB levels with the Digi Tab RIA Kit for DRUGN .
Fosinopril	drug	digoxin	drug
false

Drug / Laboratory Test Interaction DRUGA may cause a false low measurement of serum DRUGN levels with the Digi Tab RIA Kit for DRUGB .
Fosinopril	drug	Digoxin	drug
false

Drug / Laboratory Test Interaction DRUGN may cause a false low measurement of serum DRUGA levels with the Digi Tab RIA Kit for DRUGB .
digoxin	drug	Digoxin	drug
false

No drugs are known to interfere with the conversion of DRUGA to DRUGB .
fosphenytoin	drug	phenytoin	drug
false

The pharmacokinetics and protein binding of DRUGA , DRUGB , and DRUGN were not altered when DRUGN and DRUGN were concurrently administered in single submaximal doses .
fosphenytoin	drug	phenytoin	drug
false

The pharmacokinetics and protein binding of DRUGA , DRUGN , and DRUGB were not altered when DRUGN and DRUGN were concurrently administered in single submaximal doses .
fosphenytoin	drug	diazepam	drug
false

The pharmacokinetics and protein binding of DRUGA , DRUGN , and DRUGN were not altered when DRUGB and DRUGN were concurrently administered in single submaximal doses .
fosphenytoin	drug	diazepam	drug
false

The pharmacokinetics and protein binding of DRUGA , DRUGN , and DRUGN were not altered when DRUGN and DRUGB were concurrently administered in single submaximal doses .
fosphenytoin	drug	Cerebyx	brand
false

The pharmacokinetics and protein binding of DRUGN , DRUGA , and DRUGB were not altered when DRUGN and DRUGN were concurrently administered in single submaximal doses .
phenytoin	drug	diazepam	drug
false

The pharmacokinetics and protein binding of DRUGN , DRUGA , and DRUGN were not altered when DRUGB and DRUGN were concurrently administered in single submaximal doses .
phenytoin	drug	diazepam	drug
false

The pharmacokinetics and protein binding of DRUGN , DRUGA , and DRUGN were not altered when DRUGN and DRUGB were concurrently administered in single submaximal doses .
phenytoin	drug	Cerebyx	brand
false

The pharmacokinetics and protein binding of DRUGN , DRUGN , and DRUGA were not altered when DRUGN and DRUGB were concurrently administered in single submaximal doses .
diazepam	drug	Cerebyx	brand
false

The pharmacokinetics and protein binding of DRUGN , DRUGN , and DRUGN were not altered when DRUGA and DRUGB were concurrently administered in single submaximal doses .
diazepam	drug	Cerebyx	brand
false

The most significant drug interactions following administration of DRUGA are expected to occur with drugs that interact with DRUGB .
Cerebyx	brand	phenytoin	drug
false

Drugs that may decrease plasma DRUGA concentrations include : DRUGB , chronic DRUGN abuse , DRUGN
phenytoin	drug	carbamazepine	drug
mechanism

Drugs that may decrease plasma DRUGA concentrations include : DRUGN , chronic DRUGB abuse , DRUGN
phenytoin	drug	alcohol	drug
mechanism

Drugs that may decrease plasma DRUGA concentrations include : DRUGN , chronic DRUGN abuse , DRUGB
phenytoin	drug	reserpine	drug
mechanism

Drugs that may decrease plasma DRUGN concentrations include : DRUGA , chronic DRUGB abuse , DRUGN
carbamazepine	drug	alcohol	drug
false

Drugs that may decrease plasma DRUGN concentrations include : DRUGA , chronic DRUGN abuse , DRUGB
carbamazepine	drug	reserpine	drug
false

Drugs that may decrease plasma DRUGN concentrations include : DRUGN , chronic DRUGA abuse , DRUGB
alcohol	drug	reserpine	drug
false

Drugs that may either increase or decrease plasma DRUGA concentrations include : DRUGB , vaiproic acid , and DRUGN .
phenytoin	drug	phenobarbital	drug
mechanism

Drugs that may either increase or decrease plasma DRUGA concentrations include : DRUGN , vaiproic acid , and DRUGB .
phenytoin	drug	sodium valproate	drug
mechanism

Drugs that may either increase or decrease plasma DRUGN concentrations include : DRUGA , vaiproic acid , and DRUGB .
phenobarbital	drug	sodium valproate	drug
false

Similarly , the effects of DRUGA on DRUGB , DRUGN and sodium plasma DRUGN concentrations are unpredictable
phenytoin	drug	phenobarbital	drug
effect

Similarly , the effects of DRUGA on DRUGN , DRUGB and sodium plasma DRUGN concentrations are unpredictable
phenytoin	drug	valproic acid	drug
effect

Similarly , the effects of DRUGA on DRUGN , DRUGN and sodium plasma DRUGB concentrations are unpredictable
phenytoin	drug	valproate	drug
effect

Similarly , the effects of DRUGN on DRUGA , DRUGB and sodium plasma DRUGN concentrations are unpredictable
phenobarbital	drug	valproic acid	drug
false

Similarly , the effects of DRUGN on DRUGA , DRUGN and sodium plasma DRUGB concentrations are unpredictable
phenobarbital	drug	valproate	drug
false

Similarly , the effects of DRUGN on DRUGN , DRUGA and sodium plasma DRUGB concentrations are unpredictable
valproic acid	drug	valproate	drug
false

Although not a true drug interaction , DRUGA may precipitate seizures in susceptible patients and DRUGB dosage may need to be adjusted
tricyclic antidepressants	group	Cerebyx	brand
effect

Drugs whose efficacy is impaired by DRUGA include : DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
phenytoin	drug	anticoagulants	group
effect

Drugs whose efficacy is impaired by DRUGA include : DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
phenytoin	drug	corticosteroids	group
effect

Drugs whose efficacy is impaired by DRUGA include : DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN dgb , DRUGN , DRUGN .
phenytoin	drug	coumarin	group
effect

Drugs whose efficacy is impaired by DRUGA include : DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
phenytoin	drug	digitoxin	drug
effect

Drugs whose efficacy is impaired by DRUGA include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
phenytoin	drug	doxycycline	drug
effect

Drugs whose efficacy is impaired by DRUGA include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
phenytoin	drug	estrogens	group
effect

Drugs whose efficacy is impaired by DRUGA include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
phenytoin	drug	furosemide	drug
effect

Drugs whose efficacy is impaired by DRUGA include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN .
phenytoin	drug	contraceptives	group
effect

Drugs whose efficacy is impaired by DRUGA include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN .
phenytoin	drug	rifampin	drug
effect

Drugs whose efficacy is impaired by DRUGA include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN .
phenytoin	drug	quinidine	drug
effect

Drugs whose efficacy is impaired by DRUGA include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN .
phenytoin	drug	theophylline	drug
effect

Drugs whose efficacy is impaired by DRUGA include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB .
phenytoin	drug	vitamin D	group
effect

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
anticoagulants	group	corticosteroids	group
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
anticoagulants	group	coumarin	group
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
anticoagulants	group	digitoxin	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
anticoagulants	group	doxycycline	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
anticoagulants	group	estrogens	group
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
anticoagulants	group	furosemide	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN .
anticoagulants	group	contraceptives	group
false

Drugs whose efficacy is impaired by DRUGN include : DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN .
anticoagulants	group	rifampin	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN .
anticoagulants	group	quinidine	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN .
anticoagulants	group	theophylline	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB .
anticoagulants	group	vitamin D	group
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
corticosteroids	group	coumarin	group
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
corticosteroids	group	digitoxin	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
corticosteroids	group	doxycycline	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
corticosteroids	group	estrogens	group
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
corticosteroids	group	furosemide	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN .
corticosteroids	group	contraceptives	group
false

Drugs whose efficacy is impaired by DRUGN include : DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN .
corticosteroids	group	rifampin	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN .
corticosteroids	group	quinidine	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN .
corticosteroids	group	theophylline	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB .
corticosteroids	group	vitamin D	group
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
coumarin	group	digitoxin	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
coumarin	group	doxycycline	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
coumarin	group	estrogens	group
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
coumarin	group	furosemide	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN .
coumarin	group	contraceptives	group
false

Drugs whose efficacy is impaired by DRUGN include : DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN .
coumarin	group	rifampin	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN .
coumarin	group	quinidine	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN .
coumarin	group	theophylline	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB .
coumarin	group	vitamin D	group
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
digitoxin	drug	doxycycline	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
digitoxin	drug	estrogens	group
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
digitoxin	drug	furosemide	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN .
digitoxin	drug	contraceptives	group
false

Drugs whose efficacy is impaired by DRUGN include : DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN .
digitoxin	drug	rifampin	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN .
digitoxin	drug	quinidine	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN .
digitoxin	drug	theophylline	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB .
digitoxin	drug	vitamin D	group
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
doxycycline	drug	estrogens	group
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
doxycycline	drug	furosemide	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN .
doxycycline	drug	contraceptives	group
false

Drugs whose efficacy is impaired by DRUGN include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN .
doxycycline	drug	rifampin	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN .
doxycycline	drug	quinidine	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN .
doxycycline	drug	theophylline	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB .
doxycycline	drug	vitamin D	group
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN .
estrogens	group	furosemide	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN .
estrogens	group	contraceptives	group
false

Drugs whose efficacy is impaired by DRUGN include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN .
estrogens	group	rifampin	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN .
estrogens	group	quinidine	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN .
estrogens	group	theophylline	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB .
estrogens	group	vitamin D	group
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN .
furosemide	drug	contraceptives	group
false

Drugs whose efficacy is impaired by DRUGN include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN .
furosemide	drug	rifampin	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN .
furosemide	drug	quinidine	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN .
furosemide	drug	theophylline	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB .
furosemide	drug	vitamin D	group
false

Drugs whose efficacy is impaired by DRUGN include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGA , DRUGB , DRUGN , DRUGN , DRUGN .
contraceptives	group	rifampin	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGA , DRUGN , DRUGB , DRUGN , DRUGN .
contraceptives	group	quinidine	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGA , DRUGN , DRUGN , DRUGB , DRUGN .
contraceptives	group	theophylline	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGA , DRUGN , DRUGN , DRUGN , DRUGB .
contraceptives	group	vitamin D	group
false

Drugs whose efficacy is impaired by DRUGN include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGA , DRUGB , DRUGN , DRUGN .
rifampin	drug	quinidine	drug
false

Drugs whose efficacy is impaired by DRUGN include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGA , DRUGN , DRUGB , DRUGN .
rifampin	drug	theophylline	drug
false

Drugs whose efficacy is impaired by DRUGN include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGA , DRUGN , DRUGN , DRUGB .
rifampin	drug	vitamin D	group
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGA , DRUGB , DRUGN .
quinidine	drug	theophylline	drug
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGA , DRUGN , DRUGB .
quinidine	drug	vitamin D	group
false

Drugs whose efficacy is impaired by DRUGN dgb include : DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGA , DRUGB .
theophylline	drug	vitamin D	group
false

Care should be taken when using immunoanalytical methods to measure plasma DRUGA concentrations following DRUGB administration .
phenytoin	drug	Cerebyx	brand
false

DRUGA ( DRUGB ) ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
Selective serotonin reuptake inhibitors	group	SSRIs	group
false

DRUGA ( DRUGN ) ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
Selective serotonin reuptake inhibitors	group	fluoxetine	drug
false

DRUGA ( DRUGN ) ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
Selective serotonin reuptake inhibitors	group	fluvoxamine	drug
false

DRUGA ( DRUGN ) ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
Selective serotonin reuptake inhibitors	group	paroxetine	drug
false

DRUGA ( DRUGN ) ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
Selective serotonin reuptake inhibitors	group	sertraline	drug
false

DRUGA ( DRUGN ) ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGB .
Selective serotonin reuptake inhibitors	group	5-HT1 agonists	group
effect

DRUGN ( DRUGA ) ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
SSRIs	group	fluoxetine	drug
false

DRUGN ( DRUGA ) ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
SSRIs	group	fluvoxamine	drug
false

DRUGN ( DRUGA ) ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
SSRIs	group	paroxetine	drug
false

DRUGN ( DRUGA ) ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
SSRIs	group	sertraline	drug
false

DRUGN ( DRUGA ) ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGB .
SSRIs	group	5-HT1 agonists	group
effect

DRUGN ( DRUGN ) ( e.g . , DRUGA , DRUGB , DRUGN , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
fluoxetine	drug	fluvoxamine	drug
false

DRUGN ( DRUGN ) ( e.g . , DRUGA , DRUGN , DRUGB , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
fluoxetine	drug	paroxetine	drug
false

DRUGN ( DRUGN ) ( e.g . , DRUGA , DRUGN , DRUGN , DRUGB ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
fluoxetine	drug	sertraline	drug
false

DRUGN ( DRUGN ) ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGB .
fluoxetine	drug	5-HT1 agonists	group
effect

DRUGN ( DRUGN ) ( e.g . , DRUGN , DRUGA , DRUGB , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
fluvoxamine	drug	paroxetine	drug
false

DRUGN ( DRUGN ) ( e.g . , DRUGN , DRUGA , DRUGN , DRUGB ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
fluvoxamine	drug	sertraline	drug
false

DRUGN ( DRUGN ) ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGB .
fluvoxamine	drug	5-HT1 agonists	group
effect

DRUGN ( DRUGN ) ( e.g . , DRUGN , DRUGN , DRUGA , DRUGB ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGN .
paroxetine	drug	sertraline	drug
false

DRUGN ( DRUGN ) ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGB .
paroxetine	drug	5-HT1 agonists	group
effect

DRUGN ( DRUGN ) ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUGB .
sertraline	drug	5-HT1 agonists	group
effect

If concomitant treatment with DRUGA and an DRUGB is clinically warranted , appropriate observation of the patient is advised .
frovatriptan	drug	SSRI	group
advise

DRUGA may increase the ototoxic potential of DRUGB , especially in the presence of impaired renal function .
Furosemide	drug	aminoglycoside antibiotics	group
effect

DRUGA should not be used concomitantly with DRUGB because of the possibility of ototoxicity .
Furosemide	drug	ethacrynic acid	drug
advise

Patients receiving high doses of DRUGA concomitantly with DRUGB , as in rheumatic disease , may experience DRUGN toxicity at lower doses because of competitive renal excretory sites .
salicylates	group	furosemide	drug
effect

Patients receiving high doses of DRUGA concomitantly with DRUGN , as in rheumatic disease , may experience DRUGB toxicity at lower doses because of competitive renal excretory sites .
salicylates	group	salicylate	group
false

Patients receiving high doses of DRUGN concomitantly with DRUGA , as in rheumatic disease , may experience DRUGB toxicity at lower doses because of competitive renal excretory sites .
furosemide	drug	salicylate	group
false

DRUGA has a tendency to antagonize the skeletal muscle relaxing effect of DRUGB and may potentiate the action of DRUGN .
Furosemide	drug	tubocurarine	drug
effect

DRUGA has a tendency to antagonize the skeletal muscle relaxing effect of DRUGN and may potentiate the action of DRUGB .
Furosemide	drug	succinylcholine	drug
effect

DRUGN has a tendency to antagonize the skeletal muscle relaxing effect of DRUGA and may potentiate the action of DRUGB .
tubocurarine	drug	succinylcholine	drug
false

DRUGA generally should not be given with DRUGB because they reduce DRUGN s renal clearance and add a high risk of DRUGN toxicity .
Lithium	drug	diuretics	group
advise

DRUGA generally should not be given with DRUGN because they reduce DRUGB s renal clearance and add a high risk of DRUGN toxicity .
Lithium	drug	lithium	drug
false

DRUGA generally should not be given with DRUGN because they reduce DRUGN s renal clearance and add a high risk of DRUGB toxicity .
Lithium	drug	lithium	drug
false

DRUGN generally should not be given with DRUGA because they reduce DRUGB s renal clearance and add a high risk of DRUGN toxicity .
diuretics	group	lithium	drug
false

DRUGN generally should not be given with DRUGA because they reduce DRUGN s renal clearance and add a high risk of DRUGB toxicity .
diuretics	group	lithium	drug
false

DRUGA may add to or potentiate the therapeutic effect of other DRUGB .
Furosemide	drug	antihypertensive drugs	group
effect

Potentiation occurs with DRUGA or DRUGB .
ganglionic adrenergic blocking drugs	group	peripheral adrenergic blocking drugs	group
false

DRUGA may decrease arterial responsiveness to DRUGB .
Furosemide	drug	norepinephrine	drug
effect

Tablets Simultaneous administration of DRUGA and DRUGB tablets may reduce the natriuretic and antihypertensive effects of DRUGN .
sucralfate	drug	furosemide	drug
effect

Tablets Simultaneous administration of DRUGA and DRUGN tablets may reduce the natriuretic and antihypertensive effects of DRUGB .
sucralfate	drug	furosemide	drug
false

The intake of DRUGA and DRUGB should be separated by at least two hours .
furosemide	drug	sucralfate	drug
advise

Tablets , Injection , and Oral Solution One study in six subjects demonstrated that the combination of DRUGA and DRUGB temporarily reduced creatinine clearance in patients with chronic renal insufficiency .
furosemide	drug	acetylsalicylic acid	drug
effect

There are case reports of patients who developed increased BUN , serum creatinine and serum potassium levels , and weight gain when DRUGA was used in conjunction with DRUGB .
furosemide	drug	NSAIDs	group
effect

Literature reports indicate that coadministration of DRUGA may reduce the natriuretic and antihypertensive effects of DRUGB in some patients by inhibiting prostaglandin synthesis .
indomethacin	drug	furosemide	drug
effect

Patients receiving both DRUGA and DRUGB should be observed closely to determine if the desired diuretic and / or antihypertensive effect of DRUGN is achieved .
indomethacin	drug	furosemide	drug
advise

Patients receiving both DRUGA and DRUGN should be observed closely to determine if the desired diuretic and / or antihypertensive effect of DRUGB is achieved .
indomethacin	drug	furosemide	drug
false

DRUGA is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered DRUGB .
Gabapentin	drug	antiepileptic drugs	group
false

DRUGA : Steady state trough plasma DRUGB and DRUGN concentrations were not affected by concomitant DRUGN ( dgb mg TID ;
Carbamazepine	drug	carbamazepine	drug
false

DRUGA : Steady state trough plasma DRUGN and DRUGB concentrations were not affected by concomitant DRUGN ( dgb mg TID ;
Carbamazepine	drug	carbamazepine 10, 11 epoxide	drug_n
false

DRUGA : Steady state trough plasma DRUGN and DRUGN concentrations were not affected by concomitant DRUGB ( dgb mg TID ;
Carbamazepine	drug	gabapentin	drug
false

DRUGN : Steady state trough plasma DRUGA and DRUGB concentrations were not affected by concomitant DRUGN ( dgb mg TID ;
carbamazepine	drug	carbamazepine 10, 11 epoxide	drug_n
false

DRUGN : Steady state trough plasma DRUGA and DRUGN concentrations were not affected by concomitant DRUGB ( dgb mg TID ;
carbamazepine	drug	gabapentin	drug
false

DRUGN : Steady state trough plasma DRUGN and DRUGA concentrations were not affected by concomitant DRUGB ( dgb mg TID ;
carbamazepine 10, 11 epoxide	drug_n	gabapentin	drug
false

Likewise , DRUGA pharmacokinetics were unaltered by DRUGB administration .
gabapentin	drug	carbamazepine	drug
false

DRUGA : The mean steady state trough serum DRUGB concentrations prior to and during concomitant DRUGN administration ( dgb mg TID ;
Valproic Acid	drug	valproic acid	drug
false

DRUGA : The mean steady state trough serum DRUGN concentrations prior to and during concomitant DRUGB administration ( dgb mg TID ;
Valproic Acid	drug	gabapentin	drug
false

DRUGN : The mean steady state trough serum DRUGA concentrations prior to and during concomitant DRUGB administration ( dgb mg TID ;
valproic acid	drug	gabapentin	drug
false

N=dgb ) were not different and neither were DRUGA pharmacokinetic parameters affected by DRUGB .
gabapentin	drug	valproic acid	drug
false

DRUGA : Estimates of steady state pharmacokinetic parameters for DRUGB or DRUGN ( dgb mg TID ;
Phenobarbital	drug	phenobarbital	drug
false

DRUGA : Estimates of steady state pharmacokinetic parameters for DRUGN or DRUGB ( dgb mg TID ;
Phenobarbital	drug	gabapentin	drug
false

DRUGN : Estimates of steady state pharmacokinetic parameters for DRUGA or DRUGB ( dgb mg TID ;
phenobarbital	drug	gabapentin	drug
false

DRUGA : Coadministration ( N=dgb ) of DRUGB capsules ( dgb mg ) with DRUGN ( dgb mg ) appears to increase the amount of DRUGN absorbed by dgb % to dgb % .
Naproxen	drug	naproxen sodium	drug
false

DRUGA : Coadministration ( N=dgb ) of DRUGN capsules ( dgb mg ) with DRUGB ( dgb mg ) appears to increase the amount of DRUGN absorbed by dgb % to dgb % .
Naproxen	drug	Neurontin	brand
false

DRUGA : Coadministration ( N=dgb ) of DRUGN capsules ( dgb mg ) with DRUGN ( dgb mg ) appears to increase the amount of DRUGB absorbed by dgb % to dgb % .
Naproxen	drug	gabapentin	drug
false

DRUGN : Coadministration ( N=dgb ) of DRUGA capsules ( dgb mg ) with DRUGB ( dgb mg ) appears to increase the amount of DRUGN absorbed by dgb % to dgb % .
naproxen sodium	drug	Neurontin	brand
mechanism

DRUGN : Coadministration ( N=dgb ) of DRUGA capsules ( dgb mg ) with DRUGN ( dgb mg ) appears to increase the amount of DRUGB absorbed by dgb % to dgb % .
naproxen sodium	drug	gabapentin	drug
false

DRUGN : Coadministration ( N=dgb ) of DRUGN capsules ( dgb mg ) with DRUGA ( dgb mg ) appears to increase the amount of DRUGB absorbed by dgb % to dgb % .
Neurontin	brand	gabapentin	drug
false

DRUGA had no effect on DRUGB pharmacokinetic parameters .
Gabapentin	drug	naproxen	drug
false

DRUGA : Coadministration of DRUGB ( dgb to dgb mg ;
Hydrocodone	drug	Neurontin	brand
false

DRUGA increases DRUGB AUC values by dgb % .
Hydrocodone	drug	gabapentin	drug
mechanism

DRUGA pharmacokinetic parameter values were not affected by administration of DRUGB dgb hours after DRUGN .
Morphine	drug	Neurontin	brand
false

DRUGA pharmacokinetic parameter values were not affected by administration of DRUGN dgb hours after DRUGB .
Morphine	drug	morphine	drug
false

DRUGN pharmacokinetic parameter values were not affected by administration of DRUGA dgb hours after DRUGB .
Neurontin	brand	morphine	drug
false

DRUGA : In the presence of DRUGB at dgb mg QID ( N=dgb ) the mean apparent oral clearance of DRUGN fell by dgb % and creatinine clearance fell by dgb % .
Cimetidine	drug	cimetidine	drug
false

DRUGA : In the presence of DRUGN at dgb mg QID ( N=dgb ) the mean apparent oral clearance of DRUGB fell by dgb % and creatinine clearance fell by dgb % .
Cimetidine	drug	gabapentin	drug
false

DRUGN : In the presence of DRUGA at dgb mg QID ( N=dgb ) the mean apparent oral clearance of DRUGB fell by dgb % and creatinine clearance fell by dgb % .
cimetidine	drug	gabapentin	drug
mechanism

Thus DRUGA appeared to alter the renal excretion of both DRUGB and creatinine , an endogenous marker of renal function .
cimetidine	drug	gabapentin	drug
mechanism

This small decrease in excretion of DRUGA by DRUGB is not expected to be of clinical importance .
gabapentin	drug	cimetidine	drug
mechanism

The effect of DRUGA on DRUGB was not evaluated .
gabapentin	drug	cimetidine	drug
false

The Cmax of DRUGA was dgb % higher when it was coadministered with DRUGB ;
norethindrone	drug	gabapentin	drug
mechanism

DRUGA ( DRUGB ) : DRUGN reduced the bioavailability of DRUGN ( N=dgb ) by about dgb % .
Antacid	group	Maalox	brand
false

DRUGA ( DRUGN ) : DRUGB reduced the bioavailability of DRUGN ( N=dgb ) by about dgb % .
Antacid	group	Maalox	brand
false

DRUGA ( DRUGN ) : DRUGN reduced the bioavailability of DRUGB ( N=dgb ) by about dgb % .
Antacid	group	gabapentin	drug
false

DRUGN ( DRUGA ) : DRUGN reduced the bioavailability of DRUGB ( N=dgb ) by about dgb % .
Maalox	brand	gabapentin	drug
false

DRUGN ( DRUGN ) : DRUGA reduced the bioavailability of DRUGB ( N=dgb ) by about dgb % .
Maalox	brand	gabapentin	drug
mechanism

This decrease in bioavailability was about dgb % when DRUGA was administered dgb hours after DRUGB .
gabapentin	drug	Maalox	brand
mechanism

It is recommended that DRUGA be taken at least dgb hours following DRUGB administration .
gabapentin	drug	Maalox	brand
advise

DRUGA pharmacokinetic parameters without and with DRUGB were comparable .
Gabapentin	drug	probenecid	drug
false

This indicates that DRUGA does not undergo renal tubular secretion by the pathway that is blocked by DRUGB .
gabapentin	drug	probenecid	drug
false

International Normalized Ratio ( INR ) elevations and / or bleeding events have been reported in some patients taking DRUGA while on DRUGB therapy .
warfarin	drug	IRESSA	brand
effect

Substances that are potent inhibitors of CYPdgbAdgb activity ( eg , DRUGA and DRUGB ) decrease DRUGN metabolism and increase DRUGN plasma concentrations .
ketoconazole	drug	itraconazole	drug
false

Substances that are potent inhibitors of CYPdgbAdgb activity ( eg , DRUGA and DRUGN ) decrease DRUGB metabolism and increase DRUGN plasma concentrations .
ketoconazole	drug	gefitinib	drug
mechanism

Substances that are potent inhibitors of CYPdgbAdgb activity ( eg , DRUGA and DRUGN ) decrease DRUGN metabolism and increase DRUGB plasma concentrations .
ketoconazole	drug	gefitinib	drug
mechanism

Substances that are potent inhibitors of CYPdgbAdgb activity ( eg , DRUGN and DRUGA ) decrease DRUGB metabolism and increase DRUGN plasma concentrations .
itraconazole	drug	gefitinib	drug
mechanism

Substances that are potent inhibitors of CYPdgbAdgb activity ( eg , DRUGN and DRUGA ) decrease DRUGN metabolism and increase DRUGB plasma concentrations .
itraconazole	drug	gefitinib	drug
mechanism

Drugs that cause significant sustained elevation in gastric pH ( DRUGA such as DRUGB or DRUGN ) may reduce plasma concentrations of DRUGN and therefore potentially may reduce efficacy .
histamine H2-receptor antagonists	group	ranitidine	drug
false

Drugs that cause significant sustained elevation in gastric pH ( DRUGA such as DRUGN or DRUGB ) may reduce plasma concentrations of DRUGN and therefore potentially may reduce efficacy .
histamine H2-receptor antagonists	group	cimetidine	drug
false

Drugs that cause significant sustained elevation in gastric pH ( DRUGA such as DRUGN or DRUGN ) may reduce plasma concentrations of DRUGB and therefore potentially may reduce efficacy .
histamine H2-receptor antagonists	group	IRESSA	brand
mechanism

Drugs that cause significant sustained elevation in gastric pH ( DRUGN such as DRUGA or DRUGB ) may reduce plasma concentrations of DRUGN and therefore potentially may reduce efficacy .
ranitidine	drug	cimetidine	drug
false

Drugs that cause significant sustained elevation in gastric pH ( DRUGN such as DRUGA or DRUGN ) may reduce plasma concentrations of DRUGB and therefore potentially may reduce efficacy .
ranitidine	drug	IRESSA	brand
mechanism

Drugs that cause significant sustained elevation in gastric pH ( DRUGN such as DRUGN or DRUGA ) may reduce plasma concentrations of DRUGB and therefore potentially may reduce efficacy .
cimetidine	drug	IRESSA	brand
mechanism

Phase II clinical trial data , where DRUGA and DRUGB have been used concomitantly , indicate that DRUGN may exacerbate the neutropenic effect of DRUGN .
IRESSA	brand	vinorelbine	drug
false

Phase II clinical trial data , where DRUGA and DRUGN have been used concomitantly , indicate that DRUGN may exacerbate the neutropenic effect of DRUGB .
IRESSA	brand	vinorelbine	drug
false

Phase II clinical trial data , where DRUGN and DRUGA have been used concomitantly , indicate that DRUGB may exacerbate the neutropenic effect of DRUGN .
vinorelbine	drug	IRESSA	brand
false

Phase II clinical trial data , where DRUGN and DRUGN have been used concomitantly , indicate that DRUGA may exacerbate the neutropenic effect of DRUGB .
IRESSA	brand	vinorelbine	drug
effect

For information on the pharmacokinetics of DRUGA and DRUGB in combination , see Drug Interactions under CLINICAL PHARMACOLOGY section .
Gemzar	brand	cisplatin	drug
false

Administration of repeat doses of DRUGA had no effect on the repeat dose pharmacokinetics of DRUGB , DRUGN or an DRUGN / levonorgestrol oral DRUGN in healthy subjects .
FACTIVE	brand	theophylline	drug
false

Administration of repeat doses of DRUGA had no effect on the repeat dose pharmacokinetics of DRUGN , DRUGB or an DRUGN / levonorgestrol oral DRUGN in healthy subjects .
FACTIVE	brand	digoxin	drug
false

Administration of repeat doses of DRUGA had no effect on the repeat dose pharmacokinetics of DRUGN , DRUGN or an DRUGB / levonorgestrol oral DRUGN in healthy subjects .
FACTIVE	brand	ethinylestradiol	drug
false

Administration of repeat doses of DRUGA had no effect on the repeat dose pharmacokinetics of DRUGN , DRUGN or an DRUGN / levonorgestrol oral DRUGB in healthy subjects .
FACTIVE	brand	contraceptive product	group
false

Administration of repeat doses of DRUGN had no effect on the repeat dose pharmacokinetics of DRUGA , DRUGB or an DRUGN / levonorgestrol oral DRUGN in healthy subjects .
theophylline	drug	digoxin	drug
false

Administration of repeat doses of DRUGN had no effect on the repeat dose pharmacokinetics of DRUGA , DRUGN or an DRUGB / levonorgestrol oral DRUGN in healthy subjects .
theophylline	drug	ethinylestradiol	drug
false

Administration of repeat doses of DRUGN had no effect on the repeat dose pharmacokinetics of DRUGA , DRUGN or an DRUGN / levonorgestrol oral DRUGB in healthy subjects .
theophylline	drug	contraceptive product	group
false

Administration of repeat doses of DRUGN had no effect on the repeat dose pharmacokinetics of DRUGN , DRUGA or an DRUGB / levonorgestrol oral DRUGN in healthy subjects .
digoxin	drug	ethinylestradiol	drug
false

Administration of repeat doses of DRUGN had no effect on the repeat dose pharmacokinetics of DRUGN , DRUGA or an DRUGN / levonorgestrol oral DRUGB in healthy subjects .
digoxin	drug	contraceptive product	group
false

Administration of repeat doses of DRUGN had no effect on the repeat dose pharmacokinetics of DRUGN , DRUGN or an DRUGA / levonorgestrol oral DRUGB in healthy subjects .
ethinylestradiol	drug	contraceptive product	group
false

Concomitant administration of DRUGA and DRUGB , DRUGN , DRUGN , or an DRUGN / DRUGN oral DRUGN produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
FACTIVE	brand	calcium carbonate	drug
mechanism

Concomitant administration of DRUGA and DRUGN , DRUGB , DRUGN , or an DRUGN / DRUGN oral DRUGN produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
FACTIVE	brand	cimetidine	drug
mechanism

Concomitant administration of DRUGA and DRUGN , DRUGN , DRUGB , or an DRUGN / DRUGN oral DRUGN produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
FACTIVE	brand	omeprazole	drug
mechanism

Concomitant administration of DRUGA and DRUGN , DRUGN , DRUGN , or an DRUGB / DRUGN oral DRUGN produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
FACTIVE	brand	estrogen	group
mechanism

Concomitant administration of DRUGA and DRUGN , DRUGN , DRUGN , or an DRUGN / DRUGB oral DRUGN produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
FACTIVE	brand	progesterone	drug
mechanism

Concomitant administration of DRUGA and DRUGN , DRUGN , DRUGN , or an DRUGN / DRUGN oral DRUGB produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
FACTIVE	brand	contraceptive	group
mechanism

Concomitant administration of DRUGA and DRUGN , DRUGN , DRUGN , or an DRUGN / DRUGN oral DRUGN produced minor changes in the pharmacokinetics of DRUGB , which were considered to be without clinical significance .
FACTIVE	brand	gemifloxacin	drug
false

Concomitant administration of DRUGN and DRUGA , DRUGB , DRUGN , or an DRUGN / DRUGN oral DRUGN produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
calcium carbonate	drug	cimetidine	drug
false

Concomitant administration of DRUGN and DRUGA , DRUGN , DRUGB , or an DRUGN / DRUGN oral DRUGN produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
calcium carbonate	drug	omeprazole	drug
false

Concomitant administration of DRUGN and DRUGA , DRUGN , DRUGN , or an DRUGB / DRUGN oral DRUGN produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
calcium carbonate	drug	estrogen	group
false

Concomitant administration of DRUGN and DRUGA , DRUGN , DRUGN , or an DRUGN / DRUGB oral DRUGN produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
calcium carbonate	drug	progesterone	drug
false

Concomitant administration of DRUGN and DRUGA , DRUGN , DRUGN , or an DRUGN / DRUGN oral DRUGB produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
calcium carbonate	drug	contraceptive	group
false

Concomitant administration of DRUGN and DRUGA , DRUGN , DRUGN , or an DRUGN / DRUGN oral DRUGN produced minor changes in the pharmacokinetics of DRUGB , which were considered to be without clinical significance .
calcium carbonate	drug	gemifloxacin	drug
false

Concomitant administration of DRUGN and DRUGN , DRUGA , DRUGB , or an DRUGN / DRUGN oral DRUGN produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
cimetidine	drug	omeprazole	drug
false

Concomitant administration of DRUGN and DRUGN , DRUGA , DRUGN , or an DRUGB / DRUGN oral DRUGN produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
cimetidine	drug	estrogen	group
false

Concomitant administration of DRUGN and DRUGN , DRUGA , DRUGN , or an DRUGN / DRUGB oral DRUGN produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
cimetidine	drug	progesterone	drug
false

Concomitant administration of DRUGN and DRUGN , DRUGA , DRUGN , or an DRUGN / DRUGN oral DRUGB produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
cimetidine	drug	contraceptive	group
false

Concomitant administration of DRUGN and DRUGN , DRUGA , DRUGN , or an DRUGN / DRUGN oral DRUGN produced minor changes in the pharmacokinetics of DRUGB , which were considered to be without clinical significance .
cimetidine	drug	gemifloxacin	drug
false

Concomitant administration of DRUGN and DRUGN , DRUGN , DRUGA , or an DRUGB / DRUGN oral DRUGN produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
omeprazole	drug	estrogen	group
false

Concomitant administration of DRUGN and DRUGN , DRUGN , DRUGA , or an DRUGN / DRUGB oral DRUGN produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
omeprazole	drug	progesterone	drug
false

Concomitant administration of DRUGN and DRUGN , DRUGN , DRUGA , or an DRUGN / DRUGN oral DRUGB produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
omeprazole	drug	contraceptive	group
false

Concomitant administration of DRUGN and DRUGN , DRUGN , DRUGA , or an DRUGN / DRUGN oral DRUGN produced minor changes in the pharmacokinetics of DRUGB , which were considered to be without clinical significance .
omeprazole	drug	gemifloxacin	drug
false

Concomitant administration of DRUGN and DRUGN , DRUGN , DRUGN , or an DRUGA / DRUGB oral DRUGN produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
estrogen	group	progesterone	drug
false

Concomitant administration of DRUGN and DRUGN , DRUGN , DRUGN , or an DRUGA / DRUGN oral DRUGB produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
estrogen	group	contraceptive	group
false

Concomitant administration of DRUGN and DRUGN , DRUGN , DRUGN , or an DRUGA / DRUGN oral DRUGN produced minor changes in the pharmacokinetics of DRUGB , which were considered to be without clinical significance .
estrogen	group	gemifloxacin	drug
false

Concomitant administration of DRUGN and DRUGN , DRUGN , DRUGN , or an DRUGN / DRUGA oral DRUGB produced minor changes in the pharmacokinetics of DRUGN , which were considered to be without clinical significance .
progesterone	drug	contraceptive	group
false

Concomitant administration of DRUGN and DRUGN , DRUGN , DRUGN , or an DRUGN / DRUGA oral DRUGN produced minor changes in the pharmacokinetics of DRUGB , which were considered to be without clinical significance .
progesterone	drug	gemifloxacin	drug
false

Concomitant administration of DRUGN and DRUGN , DRUGN , DRUGN , or an DRUGN / DRUGN oral DRUGA produced minor changes in the pharmacokinetics of DRUGB , which were considered to be without clinical significance .
contraceptive	group	gemifloxacin	drug
false

Concomitant administration of DRUGA with DRUGB resulted in a dgb % increase in systemic exposure to DRUGN .
FACTIVE	brand	probenecid	drug
mechanism

Concomitant administration of DRUGA with DRUGN resulted in a dgb % increase in systemic exposure to DRUGB .
FACTIVE	brand	gemifloxacin	drug
false

Concomitant administration of DRUGN with DRUGA resulted in a dgb % increase in systemic exposure to DRUGB .
probenecid	drug	gemifloxacin	drug
false

DRUGA had no significant effect on the anticoagulant effect of DRUGB in healthy subjects on stable DRUGN therapy .
FACTIVE	brand	warfarin	drug
false

DRUGA had no significant effect on the anticoagulant effect of DRUGN in healthy subjects on stable DRUGB therapy .
FACTIVE	brand	warfarin	drug
false

The absorption of oral DRUGA is significantly reduced by the concomitant administration of an DRUGB containing DRUGN and DRUGN .
gemifloxacin	drug	antacid	group
false

The absorption of oral DRUGA is significantly reduced by the concomitant administration of an DRUGN containing DRUGB and DRUGN .
gemifloxacin	drug	aluminum	drug
mechanism

The absorption of oral DRUGA is significantly reduced by the concomitant administration of an DRUGN containing DRUGN and DRUGB .
gemifloxacin	drug	magnesium	drug
mechanism

The absorption of oral DRUGN is significantly reduced by the concomitant administration of an DRUGA containing DRUGB and DRUGN .
antacid	group	aluminum	drug
false

The absorption of oral DRUGN is significantly reduced by the concomitant administration of an DRUGA containing DRUGN and DRUGB .
antacid	group	magnesium	drug
false

The absorption of oral DRUGN is significantly reduced by the concomitant administration of an DRUGN containing DRUGA and DRUGB .
aluminum	drug	magnesium	drug
false

DRUGA should not be taken within dgb hours of DRUGB .
Sucralfate	drug	FACTIVE	brand
advise

Results from existing clinical trials suggest no significant interactions between DRUGA and other therapies commonly used in MS patients , including the concurrent use of DRUGB for up to dgb days .
COPAXONE	brand	corticosteroids	group
false

DRUGA has not been formally evaluated in combination with DRUGB .
COPAXONE	brand	Interferon beta	drug
false

However , dgb patients who switched from therapy with DRUGA to DRUGB did not report any serious and unexpected adverse reactions thought to be related to treatment .
Interferon beta	drug	COPAXONE	brand
false

The hypoglycemic action of DRUGA may be potentiated by certain drugs including DRUGB and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
sulfonylureas	group	nonsteroidal anti-inflammatory agents	group
effect

The hypoglycemic action of DRUGA may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
sulfonylureas	group	salicylates	group
effect

The hypoglycemic action of DRUGA may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
sulfonylureas	group	sulfonamides	group
effect

The hypoglycemic action of DRUGA may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
sulfonylureas	group	chloramphenicol	drug
effect

The hypoglycemic action of DRUGA may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
sulfonylureas	group	probenecid	drug
effect

The hypoglycemic action of DRUGA may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
sulfonylureas	group	coumarins	group
effect

The hypoglycemic action of DRUGA may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
sulfonylureas	group	monoamine oxidase inhibitors	group
effect

The hypoglycemic action of DRUGA may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
sulfonylureas	group	beta adrenergic blocking agents	group
effect

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGA and other drugs that are highly protein bound , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
nonsteroidal anti-inflammatory agents	group	salicylates	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGA and other drugs that are highly protein bound , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
nonsteroidal anti-inflammatory agents	group	sulfonamides	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGA and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
nonsteroidal anti-inflammatory agents	group	chloramphenicol	drug
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGA and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
nonsteroidal anti-inflammatory agents	group	probenecid	drug
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGA and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
nonsteroidal anti-inflammatory agents	group	coumarins	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGA and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
nonsteroidal anti-inflammatory agents	group	monoamine oxidase inhibitors	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGA and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
nonsteroidal anti-inflammatory agents	group	beta adrenergic blocking agents	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
salicylates	group	sulfonamides	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
salicylates	group	chloramphenicol	drug
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
salicylates	group	probenecid	drug
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
salicylates	group	coumarins	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
salicylates	group	monoamine oxidase inhibitors	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
salicylates	group	beta adrenergic blocking agents	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
sulfonamides	group	chloramphenicol	drug
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
sulfonamides	group	probenecid	drug
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
sulfonamides	group	coumarins	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
sulfonamides	group	monoamine oxidase inhibitors	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
sulfonamides	group	beta adrenergic blocking agents	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
chloramphenicol	drug	probenecid	drug
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
chloramphenicol	drug	coumarins	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
chloramphenicol	drug	monoamine oxidase inhibitors	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
chloramphenicol	drug	beta adrenergic blocking agents	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
probenecid	drug	coumarins	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
probenecid	drug	monoamine oxidase inhibitors	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
probenecid	drug	beta adrenergic blocking agents	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
coumarins	group	monoamine oxidase inhibitors	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
coumarins	group	beta adrenergic blocking agents	group
false

The hypoglycemic action of DRUGN may be potentiated by certain drugs including DRUGN and other drugs that are highly protein bound , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
monoamine oxidase inhibitors	group	beta adrenergic blocking agents	group
false

These drugs include the DRUGA and other DRUGB , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
thiazides	group	diuretics	group
false

These drugs include the DRUGA and other DRUGN , DRUGB , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
thiazides	group	corticosteroids	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , phe nothiazines , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
thiazides	group	thyroid products	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
thiazides	group	estrogens	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
thiazides	group	contraceptives	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
thiazides	group	phenytoin	drug
false

These drugs include the DRUGA and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , sympathomimet ics , DRUGN , and DRUGN .
thiazides	group	nicotinic acid	drug
false

These drugs include the DRUGA and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGB , and DRUGN .
thiazides	group	calcium channel blocking drugs	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGB .
thiazides	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGA , DRUGB , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
diuretics	group	corticosteroids	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , phe nothiazines , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
diuretics	group	thyroid products	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , phe nothiazines , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
diuretics	group	estrogens	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
diuretics	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
diuretics	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGA , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , sympathomimet ics , DRUGN , and DRUGN .
diuretics	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGA , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGB , and DRUGN .
diuretics	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGB .
diuretics	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGA , phe nothiazines , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
corticosteroids	group	thyroid products	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , phe nothiazines , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
corticosteroids	group	estrogens	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , phe nothiazines , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
corticosteroids	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
corticosteroids	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGA , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , sympathomimet ics , DRUGN , and DRUGN .
corticosteroids	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGA , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGB , and DRUGN .
corticosteroids	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGB .
corticosteroids	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGA , DRUGB , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
thyroid products	group	estrogens	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGA , DRUGN , oral DRUGB , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
thyroid products	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGA , DRUGN , oral DRUGN , DRUGB , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
thyroid products	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGA , DRUGN , oral DRUGN , DRUGN , DRUGB , sympathomimet ics , DRUGN , and DRUGN .
thyroid products	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGA , DRUGN , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGB , and DRUGN .
thyroid products	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGA , DRUGN , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGB .
thyroid products	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGA , oral DRUGB , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
estrogens	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGA , oral DRUGN , DRUGB , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
estrogens	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGA , oral DRUGN , DRUGN , DRUGB , sympathomimet ics , DRUGN , and DRUGN .
estrogens	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGA , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGB , and DRUGN .
estrogens	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGA , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGB .
estrogens	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGA , DRUGB , DRUGN , sympathomimet ics , DRUGN , and DRUGN .
contraceptives	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGA , DRUGN , DRUGB , sympathomimet ics , DRUGN , and DRUGN .
contraceptives	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGA , DRUGN , DRUGN , sympathomimet ics , DRUGB , and DRUGN .
contraceptives	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGA , DRUGN , DRUGN , sympathomimet ics , DRUGN , and DRUGB .
contraceptives	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGA , DRUGB , sympathomimet ics , DRUGN , and DRUGN .
phenytoin	drug	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGA , DRUGN , sympathomimet ics , DRUGB , and DRUGN .
phenytoin	drug	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGA , DRUGN , sympathomimet ics , DRUGN , and DRUGB .
phenytoin	drug	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGA , sympathomimet ics , DRUGB , and DRUGN .
nicotinic acid	drug	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGA , sympathomimet ics , DRUGN , and DRUGB .
nicotinic acid	drug	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , phe nothiazines , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , sympathomimet ics , DRUGA , and DRUGB .
calcium channel blocking drugs	group	isoniazid	drug
false

A possible interaction between DRUGA and DRUGB , a DRUGN , has been reported , resulting in a potentiation of the hypoglycemic action of DRUGN .
glyburide	drug	ciprofloxacin	drug
int

A possible interaction between DRUGA and DRUGN , a DRUGB , has been reported , resulting in a potentiation of the hypoglycemic action of DRUGN .
glyburide	drug	fluoroquinolone antibiotic	group
false

A possible interaction between DRUGN and DRUGA , a DRUGB , has been reported , resulting in a potentiation of the hypoglycemic action of DRUGN .
ciprofloxacin	drug	fluoroquinolone antibiotic	group
false

A possible interaction between DRUGN and DRUGA , a DRUGN , has been reported , resulting in a potentiation of the hypoglycemic action of DRUGB .
ciprofloxacin	drug	glyburide	drug
false

A possible interaction between DRUGN and DRUGN , a DRUGA , has been reported , resulting in a potentiation of the hypoglycemic action of DRUGB .
fluoroquinolone antibiotic	group	glyburide	drug
false

A potential interaction between oral DRUGA and oral DRUGB leading to severe hypoglycemia has been reported .
miconazole	drug	hypoglycemic agents	group
effect

DRUGA : In a single dose interaction study in NIDDM subjects , decreases in DRUGB AUC and Cmax were observed , but were highly variable .
Metformin	drug	glyburide	drug
false

a sulfa based drug such as DRUGA DRUGB ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) ;
sulfamethoxazole	drug	trimethoprim	drug
false

a sulfa based drug such as DRUGA DRUGN ( DRUGB , DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) ;
sulfamethoxazole	drug	Bactrim	brand
false

a sulfa based drug such as DRUGA DRUGN ( DRUGN , DRUGB ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) ;
sulfamethoxazole	drug	Septra	brand
false

a sulfa based drug such as DRUGA DRUGN ( DRUGN , DRUGN ) , DRUGB ( DRUGN ) , or DRUGN ( DRUGN ) ;
sulfamethoxazole	drug	sulfisoxazole	drug
false

a sulfa based drug such as DRUGA DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGB ) , or DRUGN ( DRUGN ) ;
sulfamethoxazole	drug	Gantrisin	brand
false

a sulfa based drug such as DRUGA DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , or DRUGB ( DRUGN ) ;
sulfamethoxazole	drug	sulfasalazine	drug
false

a sulfa based drug such as DRUGA DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGB ) ;
sulfamethoxazole	drug	Azulfidine	brand
false

a sulfa based drug such as DRUGN DRUGA ( DRUGB , DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) ;
trimethoprim	drug	Bactrim	brand
false

a sulfa based drug such as DRUGN DRUGA ( DRUGN , DRUGB ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) ;
trimethoprim	drug	Septra	brand
false

a sulfa based drug such as DRUGN DRUGA ( DRUGN , DRUGN ) , DRUGB ( DRUGN ) , or DRUGN ( DRUGN ) ;
trimethoprim	drug	sulfisoxazole	drug
false

a sulfa based drug such as DRUGN DRUGA ( DRUGN , DRUGN ) , DRUGN ( DRUGB ) , or DRUGN ( DRUGN ) ;
trimethoprim	drug	Gantrisin	brand
false

a sulfa based drug such as DRUGN DRUGA ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , or DRUGB ( DRUGN ) ;
trimethoprim	drug	sulfasalazine	drug
false

a sulfa based drug such as DRUGN DRUGA ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGB ) ;
trimethoprim	drug	Azulfidine	brand
false

a sulfa based drug such as DRUGN DRUGN ( DRUGA , DRUGB ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) ;
Bactrim	brand	Septra	brand
false

a sulfa based drug such as DRUGN DRUGN ( DRUGA , DRUGN ) , DRUGB ( DRUGN ) , or DRUGN ( DRUGN ) ;
Bactrim	brand	sulfisoxazole	drug
false

a sulfa based drug such as DRUGN DRUGN ( DRUGA , DRUGN ) , DRUGN ( DRUGB ) , or DRUGN ( DRUGN ) ;
Bactrim	brand	Gantrisin	brand
false

a sulfa based drug such as DRUGN DRUGN ( DRUGA , DRUGN ) , DRUGN ( DRUGN ) , or DRUGB ( DRUGN ) ;
Bactrim	brand	sulfasalazine	drug
false

a sulfa based drug such as DRUGN DRUGN ( DRUGA , DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGB ) ;
Bactrim	brand	Azulfidine	brand
false

a sulfa based drug such as DRUGN DRUGN ( DRUGN , DRUGA ) , DRUGB ( DRUGN ) , or DRUGN ( DRUGN ) ;
Septra	brand	sulfisoxazole	drug
false

a sulfa based drug such as DRUGN DRUGN ( DRUGN , DRUGA ) , DRUGN ( DRUGB ) , or DRUGN ( DRUGN ) ;
Septra	brand	Gantrisin	brand
false

a sulfa based drug such as DRUGN DRUGN ( DRUGN , DRUGA ) , DRUGN ( DRUGN ) , or DRUGB ( DRUGN ) ;
Septra	brand	sulfasalazine	drug
false

a sulfa based drug such as DRUGN DRUGN ( DRUGN , DRUGA ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGB ) ;
Septra	brand	Azulfidine	brand
false

a sulfa based drug such as DRUGN DRUGN ( DRUGN , DRUGN ) , DRUGA ( DRUGB ) , or DRUGN ( DRUGN ) ;
sulfisoxazole	drug	Gantrisin	brand
false

a sulfa based drug such as DRUGN DRUGN ( DRUGN , DRUGN ) , DRUGA ( DRUGN ) , or DRUGB ( DRUGN ) ;
sulfisoxazole	drug	sulfasalazine	drug
false

a sulfa based drug such as DRUGN DRUGN ( DRUGN , DRUGN ) , DRUGA ( DRUGN ) , or DRUGN ( DRUGB ) ;
sulfisoxazole	drug	Azulfidine	brand
false

a sulfa based drug such as DRUGN DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGA ) , or DRUGB ( DRUGN ) ;
Gantrisin	brand	sulfasalazine	drug
false

a sulfa based drug such as DRUGN DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGA ) , or DRUGN ( DRUGB ) ;
Gantrisin	brand	Azulfidine	brand
false

a sulfa based drug such as DRUGN DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , or DRUGA ( DRUGB ) ;
sulfasalazine	drug	Azulfidine	brand
false

a DRUGA ( DRUGB ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) ;
monoamine oxidase inhibitor	group	MAOI	group
false

a DRUGA ( DRUGN ) such as DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) ;
monoamine oxidase inhibitor	group	isocarboxazid	drug
false

a DRUGA ( DRUGN ) such as DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) ;
monoamine oxidase inhibitor	group	Marplan	brand
false

a DRUGA ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , or DRUGN ( DRUGN ) ;
monoamine oxidase inhibitor	group	tranylcypromine	drug
false

a DRUGA ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , or DRUGN ( DRUGN ) ;
monoamine oxidase inhibitor	group	Parnate	brand
false

a DRUGA ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGB ( DRUGN ) ;
monoamine oxidase inhibitor	group	phenelzine	drug
false

a DRUGA ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGB ) ;
monoamine oxidase inhibitor	group	Nardil	brand
false

a DRUGN ( DRUGA ) such as DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) ;
MAOI	group	isocarboxazid	drug
false

a DRUGN ( DRUGA ) such as DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) ;
MAOI	group	Marplan	brand
false

a DRUGN ( DRUGA ) such as DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , or DRUGN ( DRUGN ) ;
MAOI	group	tranylcypromine	drug
false

a DRUGN ( DRUGA ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , or DRUGN ( DRUGN ) ;
MAOI	group	Parnate	brand
false

a DRUGN ( DRUGA ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGB ( DRUGN ) ;
MAOI	group	phenelzine	drug
false

a DRUGN ( DRUGA ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGB ) ;
MAOI	group	Nardil	brand
false

a DRUGN ( DRUGN ) such as DRUGA ( DRUGB ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) ;
isocarboxazid	drug	Marplan	brand
false

a DRUGN ( DRUGN ) such as DRUGA ( DRUGN ) , DRUGB ( DRUGN ) , or DRUGN ( DRUGN ) ;
isocarboxazid	drug	tranylcypromine	drug
false

a DRUGN ( DRUGN ) such as DRUGA ( DRUGN ) , DRUGN ( DRUGB ) , or DRUGN ( DRUGN ) ;
isocarboxazid	drug	Parnate	brand
false

a DRUGN ( DRUGN ) such as DRUGA ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGB ( DRUGN ) ;
isocarboxazid	drug	phenelzine	drug
false

a DRUGN ( DRUGN ) such as DRUGA ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGB ) ;
isocarboxazid	drug	Nardil	brand
false

a DRUGN ( DRUGN ) such as DRUGN ( DRUGA ) , DRUGB ( DRUGN ) , or DRUGN ( DRUGN ) ;
Marplan	brand	tranylcypromine	drug
false

a DRUGN ( DRUGN ) such as DRUGN ( DRUGA ) , DRUGN ( DRUGB ) , or DRUGN ( DRUGN ) ;
Marplan	brand	Parnate	brand
false

a DRUGN ( DRUGN ) such as DRUGN ( DRUGA ) , DRUGN ( DRUGN ) , or DRUGB ( DRUGN ) ;
Marplan	brand	phenelzine	drug
false

a DRUGN ( DRUGN ) such as DRUGN ( DRUGA ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGB ) ;
Marplan	brand	Nardil	brand
false

a DRUGN ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGA ( DRUGB ) , or DRUGN ( DRUGN ) ;
tranylcypromine	drug	Parnate	brand
false

a DRUGN ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGA ( DRUGN ) , or DRUGB ( DRUGN ) ;
tranylcypromine	drug	phenelzine	drug
false

a DRUGN ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGA ( DRUGN ) , or DRUGN ( DRUGB ) ;
tranylcypromine	drug	Nardil	brand
false

a DRUGN ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGA ) , or DRUGB ( DRUGN ) ;
Parnate	brand	phenelzine	drug
false

a DRUGN ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGA ) , or DRUGN ( DRUGB ) ;
Parnate	brand	Nardil	brand
false

a DRUGN ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGA ( DRUGB ) ;
phenelzine	drug	Nardil	brand
false

a DRUGA such as DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
beta-blocker	group	propranolol	drug
false

a DRUGA such as DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
beta-blocker	group	Inderal	brand
false

a DRUGA such as DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
beta-blocker	group	atenolol	drug
false

a DRUGA such as DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
beta-blocker	group	Tenormin	brand
false

a DRUGA such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
beta-blocker	group	acebutolol	drug
false

a DRUGA such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , and others ;
beta-blocker	group	Sectral	brand
false

a DRUGA such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , and others ;
beta-blocker	group	metoprolol	drug
false

a DRUGA such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , and others ;
beta-blocker	group	Lopressor	brand
false

a DRUGN such as DRUGA ( DRUGB ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
propranolol	drug	Inderal	brand
false

a DRUGN such as DRUGA ( DRUGN ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
propranolol	drug	atenolol	drug
false

a DRUGN such as DRUGA ( DRUGN ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
propranolol	drug	Tenormin	brand
false

a DRUGN such as DRUGA ( DRUGN ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
propranolol	drug	acebutolol	drug
false

a DRUGN such as DRUGA ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , and others ;
propranolol	drug	Sectral	brand
false

a DRUGN such as DRUGA ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , and others ;
propranolol	drug	metoprolol	drug
false

a DRUGN such as DRUGA ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , and others ;
propranolol	drug	Lopressor	brand
false

a DRUGN such as DRUGN ( DRUGA ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
Inderal	brand	atenolol	drug
false

a DRUGN such as DRUGN ( DRUGA ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
Inderal	brand	Tenormin	brand
false

a DRUGN such as DRUGN ( DRUGA ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
Inderal	brand	acebutolol	drug
false

a DRUGN such as DRUGN ( DRUGA ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , and others ;
Inderal	brand	Sectral	brand
false

a DRUGN such as DRUGN ( DRUGA ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , and others ;
Inderal	brand	metoprolol	drug
false

a DRUGN such as DRUGN ( DRUGA ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , and others ;
Inderal	brand	Lopressor	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGA ( DRUGB ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
atenolol	drug	Tenormin	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGA ( DRUGN ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
atenolol	drug	acebutolol	drug
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGA ( DRUGN ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , and others ;
atenolol	drug	Sectral	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGA ( DRUGN ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , and others ;
atenolol	drug	metoprolol	drug
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGA ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , and others ;
atenolol	drug	Lopressor	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGA ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
Tenormin	brand	acebutolol	drug
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGA ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , and others ;
Tenormin	brand	Sectral	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGA ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , and others ;
Tenormin	brand	metoprolol	drug
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGA ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , and others ;
Tenormin	brand	Lopressor	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGA ( DRUGB ) , DRUGN ( DRUGN ) , and others ;
acebutolol	drug	Sectral	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGA ( DRUGN ) , DRUGB ( DRUGN ) , and others ;
acebutolol	drug	metoprolol	drug
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGA ( DRUGN ) , DRUGN ( DRUGB ) , and others ;
acebutolol	drug	Lopressor	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGA ) , DRUGB ( DRUGN ) , and others ;
Sectral	brand	metoprolol	drug
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGA ) , DRUGN ( DRUGB ) , and others ;
Sectral	brand	Lopressor	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , DRUGA ( DRUGB ) , and others ;
metoprolol	drug	Lopressor	brand
false

a DRUGA ( water pill ) such as DRUGB ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , and others ;
diuretic	group	hydrochlorothiazide	drug
false

a DRUGA ( water pill ) such as DRUGN ( DRUGB , DRUGN ) , DRUGN ( DRUGN ) , and others ;
diuretic	group	HCTZ	drug
false

a DRUGA ( water pill ) such as DRUGN ( DRUGN , DRUGB ) , DRUGN ( DRUGN ) , and others ;
diuretic	group	Hydrodiuril	brand
false

a DRUGA ( water pill ) such as DRUGN ( DRUGN , DRUGN ) , DRUGB ( DRUGN ) , and others ;
diuretic	group	chlorothiazide	drug
false

a DRUGA ( water pill ) such as DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGB ) , and others ;
diuretic	group	Diuril	brand
false

a DRUGN ( water pill ) such as DRUGA ( DRUGB , DRUGN ) , DRUGN ( DRUGN ) , and others ;
hydrochlorothiazide	drug	HCTZ	drug
false

a DRUGN ( water pill ) such as DRUGA ( DRUGN , DRUGB ) , DRUGN ( DRUGN ) , and others ;
hydrochlorothiazide	drug	Hydrodiuril	brand
false

a DRUGN ( water pill ) such as DRUGA ( DRUGN , DRUGN ) , DRUGB ( DRUGN ) , and others ;
hydrochlorothiazide	drug	chlorothiazide	drug
false

a DRUGN ( water pill ) such as DRUGA ( DRUGN , DRUGN ) , DRUGN ( DRUGB ) , and others ;
hydrochlorothiazide	drug	Diuril	brand
false

a DRUGN ( water pill ) such as DRUGN ( DRUGA , DRUGB ) , DRUGN ( DRUGN ) , and others ;
HCTZ	drug	Hydrodiuril	brand
false

a DRUGN ( water pill ) such as DRUGN ( DRUGA , DRUGN ) , DRUGB ( DRUGN ) , and others ;
HCTZ	drug	chlorothiazide	drug
false

a DRUGN ( water pill ) such as DRUGN ( DRUGA , DRUGN ) , DRUGN ( DRUGB ) , and others ;
HCTZ	drug	Diuril	brand
false

a DRUGN ( water pill ) such as DRUGN ( DRUGN , DRUGA ) , DRUGB ( DRUGN ) , and others ;
Hydrodiuril	brand	chlorothiazide	drug
false

a DRUGN ( water pill ) such as DRUGN ( DRUGN , DRUGA ) , DRUGN ( DRUGB ) , and others ;
Hydrodiuril	brand	Diuril	brand
false

a DRUGN ( water pill ) such as DRUGN ( DRUGN , DRUGN ) , DRUGA ( DRUGB ) , and others ;
chlorothiazide	drug	Diuril	brand
false

a DRUGA such as DRUGB ( DRUGN , DRUGN , others ) , DRUGN ( DRUGN , others ) , DRUGN ( DRUGN , DRUGN , others ) , and others ;
steroid medicine	group	prednisone	drug
false

a DRUGA such as DRUGN ( DRUGB , DRUGN , others ) , DRUGN ( DRUGN , others ) , DRUGN ( DRUGN , DRUGN , others ) , and others ;
steroid medicine	group	Deltasone	brand
false

a DRUGA such as DRUGN ( DRUGN , DRUGB , others ) , DRUGN ( DRUGN , others ) , DRUGN ( DRUGN , DRUGN , others ) , and others ;
steroid medicine	group	Orasone	brand
false

a DRUGA such as DRUGN ( DRUGN , DRUGN , others ) , DRUGB ( DRUGN , others ) , DRUGN ( DRUGN , DRUGN , others ) , and others ;
steroid medicine	group	methylprednisolone	drug
false

a DRUGA such as DRUGN ( DRUGN , DRUGN , others ) , DRUGN ( DRUGB , others ) , DRUGN ( DRUGN , DRUGN , others ) , and others ;
steroid medicine	group	Medrol	brand
false

a DRUGA such as DRUGN ( DRUGN , DRUGN , others ) , DRUGN ( DRUGN , others ) , DRUGB ( DRUGN , DRUGN , others ) , and others ;
steroid medicine	group	prednisolone	drug
false

a DRUGA such as DRUGN ( DRUGN , DRUGN , others ) , DRUGN ( DRUGN , others ) , DRUGN ( DRUGB , DRUGN , others ) , and others ;
steroid medicine	group	Prelone	brand
false

a DRUGA such as DRUGN ( DRUGN , DRUGN , others ) , DRUGN ( DRUGN , others ) , DRUGN ( DRUGN , DRUGB , others ) , and others ;
steroid medicine	group	Pediapred	brand
false

a DRUGN such as DRUGA ( DRUGB , DRUGN , others ) , DRUGN ( DRUGN , others ) , DRUGN ( DRUGN , DRUGN , others ) , and others ;
prednisone	drug	Deltasone	brand
false

a DRUGN such as DRUGA ( DRUGN , DRUGB , others ) , DRUGN ( DRUGN , others ) , DRUGN ( DRUGN , DRUGN , others ) , and others ;
prednisone	drug	Orasone	brand
false

a DRUGN such as DRUGA ( DRUGN , DRUGN , others ) , DRUGB ( DRUGN , others ) , DRUGN ( DRUGN , DRUGN , others ) , and others ;
prednisone	drug	methylprednisolone	drug
false

a DRUGN such as DRUGA ( DRUGN , DRUGN , others ) , DRUGN ( DRUGB , others ) , DRUGN ( DRUGN , DRUGN , others ) , and others ;
prednisone	drug	Medrol	brand
false

a DRUGN such as DRUGA ( DRUGN , DRUGN , others ) , DRUGN ( DRUGN , others ) , DRUGB ( DRUGN , DRUGN , others ) , and others ;
prednisone	drug	prednisolone	drug
false

a DRUGN such as DRUGA ( DRUGN , DRUGN , others ) , DRUGN ( DRUGN , others ) , DRUGN ( DRUGB , DRUGN , others ) , and others ;
prednisone	drug	Prelone	brand
false

a DRUGN such as DRUGA ( DRUGN , DRUGN , others ) , DRUGN ( DRUGN , others ) , DRUGN ( DRUGN , DRUGB , others ) , and others ;
prednisone	drug	Pediapred	brand
false

a DRUGN such as DRUGN ( DRUGA , DRUGB , others ) , DRUGN ( DRUGN , others ) , DRUGN ( DRUGN , DRUGN , others ) , and others ;
Deltasone	brand	Orasone	brand
false

a DRUGN such as DRUGN ( DRUGA , DRUGN , others ) , DRUGB ( DRUGN , others ) , DRUGN ( DRUGN , DRUGN , others ) , and others ;
Deltasone	brand	methylprednisolone	drug
false

a DRUGN such as DRUGN ( DRUGA , DRUGN , others ) , DRUGN ( DRUGB , others ) , DRUGN ( DRUGN , DRUGN , others ) , and others ;
Deltasone	brand	Medrol	brand
false

a DRUGN such as DRUGN ( DRUGA , DRUGN , others ) , DRUGN ( DRUGN , others ) , DRUGB ( DRUGN , DRUGN , others ) , and others ;
Deltasone	brand	prednisolone	drug
false

a DRUGN such as DRUGN ( DRUGA , DRUGN , others ) , DRUGN ( DRUGN , others ) , DRUGN ( DRUGB , DRUGN , others ) , and others ;
Deltasone	brand	Prelone	brand
false

a DRUGN such as DRUGN ( DRUGA , DRUGN , others ) , DRUGN ( DRUGN , others ) , DRUGN ( DRUGN , DRUGB , others ) , and others ;
Deltasone	brand	Pediapred	brand
false

a DRUGN such as DRUGN ( DRUGN , DRUGA , others ) , DRUGB ( DRUGN , others ) , DRUGN ( DRUGN , DRUGN , others ) , and others ;
Orasone	brand	methylprednisolone	drug
false

a DRUGN such as DRUGN ( DRUGN , DRUGA , others ) , DRUGN ( DRUGB , others ) , DRUGN ( DRUGN , DRUGN , others ) , and others ;
Orasone	brand	Medrol	brand
false

a DRUGN such as DRUGN ( DRUGN , DRUGA , others ) , DRUGN ( DRUGN , others ) , DRUGB ( DRUGN , DRUGN , others ) , and others ;
Orasone	brand	prednisolone	drug
false

a DRUGN such as DRUGN ( DRUGN , DRUGA , others ) , DRUGN ( DRUGN , others ) , DRUGN ( DRUGB , DRUGN , others ) , and others ;
Orasone	brand	Prelone	brand
false

a DRUGN such as DRUGN ( DRUGN , DRUGA , others ) , DRUGN ( DRUGN , others ) , DRUGN ( DRUGN , DRUGB , others ) , and others ;
Orasone	brand	Pediapred	brand
false

a DRUGN such as DRUGN ( DRUGN , DRUGN , others ) , DRUGA ( DRUGB , others ) , DRUGN ( DRUGN , DRUGN , others ) , and others ;
methylprednisolone	drug	Medrol	brand
false

a DRUGN such as DRUGN ( DRUGN , DRUGN , others ) , DRUGA ( DRUGN , others ) , DRUGB ( DRUGN , DRUGN , others ) , and others ;
methylprednisolone	drug	prednisolone	drug
false

a DRUGN such as DRUGN ( DRUGN , DRUGN , others ) , DRUGA ( DRUGN , others ) , DRUGN ( DRUGB , DRUGN , others ) , and others ;
methylprednisolone	drug	Prelone	brand
false

a DRUGN such as DRUGN ( DRUGN , DRUGN , others ) , DRUGA ( DRUGN , others ) , DRUGN ( DRUGN , DRUGB , others ) , and others ;
methylprednisolone	drug	Pediapred	brand
false

a DRUGN such as DRUGN ( DRUGN , DRUGN , others ) , DRUGN ( DRUGA , others ) , DRUGB ( DRUGN , DRUGN , others ) , and others ;
Medrol	brand	prednisolone	drug
false

a DRUGN such as DRUGN ( DRUGN , DRUGN , others ) , DRUGN ( DRUGA , others ) , DRUGN ( DRUGB , DRUGN , others ) , and others ;
Medrol	brand	Prelone	brand
false

a DRUGN such as DRUGN ( DRUGN , DRUGN , others ) , DRUGN ( DRUGA , others ) , DRUGN ( DRUGN , DRUGB , others ) , and others ;
Medrol	brand	Pediapred	brand
false

a DRUGN such as DRUGN ( DRUGN , DRUGN , others ) , DRUGN ( DRUGN , others ) , DRUGA ( DRUGB , DRUGN , others ) , and others ;
prednisolone	drug	Prelone	brand
false

a DRUGN such as DRUGN ( DRUGN , DRUGN , others ) , DRUGN ( DRUGN , others ) , DRUGA ( DRUGN , DRUGB , others ) , and others ;
prednisolone	drug	Pediapred	brand
false

a DRUGN such as DRUGN ( DRUGN , DRUGN , others ) , DRUGN ( DRUGN , others ) , DRUGN ( DRUGA , DRUGB , others ) , and others ;
Prelone	brand	Pediapred	brand
false

a DRUGA such as DRUGB ( DRUGN ) , DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
phenothiazine	group	chlorpromazine	drug
false

a DRUGA such as DRUGN ( DRUGB ) , DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
phenothiazine	group	Thorazine	brand
false

a DRUGA such as DRUGN ( DRUGN ) , DRUGB ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
phenothiazine	group	fluphenazine	drug
false

a DRUGA such as DRUGN ( DRUGN ) , DRUGN ( DRUGB , DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
phenothiazine	group	Prolixin	brand
false

a DRUGA such as DRUGN ( DRUGN ) , DRUGN ( DRUGN , DRUGB ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
phenothiazine	group	Permitil	brand
false

a DRUGA such as DRUGN ( DRUGN ) , DRUGN ( DRUGN , DRUGN ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
phenothiazine	group	prochlorperazine	drug
false

a DRUGA such as DRUGN ( DRUGN ) , DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , and others ;
phenothiazine	group	Compazine	brand
false

a DRUGA such as DRUGN ( DRUGN ) , DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , and others ;
phenothiazine	group	promethazine	drug
false

a DRUGA such as DRUGN ( DRUGN ) , DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , and others ;
phenothiazine	group	Phenergan	brand
false

a DRUGN such as DRUGA ( DRUGB ) , DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
chlorpromazine	drug	Thorazine	brand
false

a DRUGN such as DRUGA ( DRUGN ) , DRUGB ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
chlorpromazine	drug	fluphenazine	drug
false

a DRUGN such as DRUGA ( DRUGN ) , DRUGN ( DRUGB , DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
chlorpromazine	drug	Prolixin	brand
false

a DRUGN such as DRUGA ( DRUGN ) , DRUGN ( DRUGN , DRUGB ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
chlorpromazine	drug	Permitil	brand
false

a DRUGN such as DRUGA ( DRUGN ) , DRUGN ( DRUGN , DRUGN ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
chlorpromazine	drug	prochlorperazine	drug
false

a DRUGN such as DRUGA ( DRUGN ) , DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , and others ;
chlorpromazine	drug	Compazine	brand
false

a DRUGN such as DRUGA ( DRUGN ) , DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , and others ;
chlorpromazine	drug	promethazine	drug
false

a DRUGN such as DRUGA ( DRUGN ) , DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , and others ;
chlorpromazine	drug	Phenergan	brand
false

a DRUGN such as DRUGN ( DRUGA ) , DRUGB ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
Thorazine	brand	fluphenazine	drug
false

a DRUGN such as DRUGN ( DRUGA ) , DRUGN ( DRUGB , DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
Thorazine	brand	Prolixin	brand
false

a DRUGN such as DRUGN ( DRUGA ) , DRUGN ( DRUGN , DRUGB ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
Thorazine	brand	Permitil	brand
false

a DRUGN such as DRUGN ( DRUGA ) , DRUGN ( DRUGN , DRUGN ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
Thorazine	brand	prochlorperazine	drug
false

a DRUGN such as DRUGN ( DRUGA ) , DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , and others ;
Thorazine	brand	Compazine	brand
false

a DRUGN such as DRUGN ( DRUGA ) , DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , and others ;
Thorazine	brand	promethazine	drug
false

a DRUGN such as DRUGN ( DRUGA ) , DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , and others ;
Thorazine	brand	Phenergan	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGA ( DRUGB , DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
fluphenazine	drug	Prolixin	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGA ( DRUGN , DRUGB ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
fluphenazine	drug	Permitil	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGA ( DRUGN , DRUGN ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
fluphenazine	drug	prochlorperazine	drug
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGA ( DRUGN , DRUGN ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , and others ;
fluphenazine	drug	Compazine	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGA ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , and others ;
fluphenazine	drug	promethazine	drug
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGA ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , and others ;
fluphenazine	drug	Phenergan	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGA , DRUGB ) , DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
Prolixin	brand	Permitil	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGA , DRUGN ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
Prolixin	brand	prochlorperazine	drug
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGA , DRUGN ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , and others ;
Prolixin	brand	Compazine	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGA , DRUGN ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , and others ;
Prolixin	brand	promethazine	drug
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGA , DRUGN ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , and others ;
Prolixin	brand	Phenergan	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGN , DRUGA ) , DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , and others ;
Permitil	brand	prochlorperazine	drug
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGN , DRUGA ) , DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , and others ;
Permitil	brand	Compazine	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGN , DRUGA ) , DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , and others ;
Permitil	brand	promethazine	drug
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGN , DRUGA ) , DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , and others ;
Permitil	brand	Phenergan	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGN , DRUGN ) , DRUGA ( DRUGB ) , DRUGN ( DRUGN ) , and others ;
prochlorperazine	drug	Compazine	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGN , DRUGN ) , DRUGA ( DRUGN ) , DRUGB ( DRUGN ) , and others ;
prochlorperazine	drug	promethazine	drug
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGN , DRUGN ) , DRUGA ( DRUGN ) , DRUGN ( DRUGB ) , and others ;
prochlorperazine	drug	Phenergan	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGA ) , DRUGB ( DRUGN ) , and others ;
Compazine	brand	promethazine	drug
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGA ) , DRUGN ( DRUGB ) , and others ;
Compazine	brand	Phenergan	brand
false

a DRUGN such as DRUGN ( DRUGN ) , DRUGN ( DRUGN , DRUGN ) , DRUGN ( DRUGN ) , DRUGA ( DRUGB ) , and others ;
promethazine	drug	Phenergan	brand
false

DRUGA ( DRUGB ) ;
phenytoin	drug	Dilantin	brand
false

DRUGA ( DRUGB ) ;
isoniazid	drug	Nydrazid	brand
false

DRUGA ( DRUGB , DRUGN ) ;
rifampin	drug	Rifadin	brand
false

DRUGA ( DRUGN , DRUGB ) ;
rifampin	drug	Rifamate	brand
false

DRUGN ( DRUGA , DRUGB ) ;
Rifadin	brand	Rifamate	brand
false

In vitro binding studies with human serum proteins indicate that DRUGA binds differently than DRUGB and does not interact with DRUGN or DRUGN .
glipizide	drug	tolbutamide	drug
false

In vitro binding studies with human serum proteins indicate that DRUGA binds differently than DRUGN and does not interact with DRUGB or DRUGN .
glipizide	drug	salicylate	group
false

In vitro binding studies with human serum proteins indicate that DRUGA binds differently than DRUGN and does not interact with DRUGN or DRUGB .
glipizide	drug	dicumarol	drug
false

In vitro binding studies with human serum proteins indicate that DRUGN binds differently than DRUGA and does not interact with DRUGB or DRUGN .
tolbutamide	drug	salicylate	group
false

In vitro binding studies with human serum proteins indicate that DRUGN binds differently than DRUGA and does not interact with DRUGN or DRUGB .
tolbutamide	drug	dicumarol	drug
false

In vitro binding studies with human serum proteins indicate that DRUGN binds differently than DRUGN and does not interact with DRUGA or DRUGB .
salicylate	group	dicumarol	drug
false

These drugs include the DRUGA and other DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	diuretics	group
false

These drugs include the DRUGA and other DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	corticosteroids	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	phenothiazines	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	thyroid products	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	estrogens	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	contraceptives	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
thiazides	group	phenytoin	drug
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
thiazides	group	nicotinic acid	drug
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
thiazides	group	sympathomimetics	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
thiazides	group	calcium channel blocking drugs	group
false

These drugs include the DRUGA and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
thiazides	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	corticosteroids	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	phenothiazines	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	thyroid products	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	estrogens	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
diuretics	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
diuretics	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
diuretics	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
diuretics	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
diuretics	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	phenothiazines	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	thyroid products	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	estrogens	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
corticosteroids	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
corticosteroids	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
corticosteroids	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
corticosteroids	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
phenothiazines	group	thyroid products	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
phenothiazines	group	estrogens	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
phenothiazines	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
phenothiazines	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
phenothiazines	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
phenothiazines	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
phenothiazines	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
phenothiazines	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thyroid products	group	estrogens	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
thyroid products	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
thyroid products	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
thyroid products	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
thyroid products	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
thyroid products	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
thyroid products	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
estrogens	group	contraceptives	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
estrogens	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
estrogens	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
estrogens	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
estrogens	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
estrogens	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
contraceptives	group	phenytoin	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
contraceptives	group	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
contraceptives	group	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
contraceptives	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
contraceptives	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
phenytoin	drug	nicotinic acid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
phenytoin	drug	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
phenytoin	drug	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
phenytoin	drug	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
nicotinic acid	drug	sympathomimetics	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
nicotinic acid	drug	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
nicotinic acid	drug	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
sympathomimetics	group	calcium channel blocking drugs	group
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
sympathomimetics	group	isoniazid	drug
false

These drugs include the DRUGN and other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
calcium channel blocking drugs	group	isoniazid	drug
false

A potential interaction between oral DRUGA and oral DRUGB leading to severe hypoglycemia has been reported .
miconazole	drug	hypoglycemic agents	group
int

The effect of concomitant administration of DRUGA and DRUGB has been demonstrated in a placebo controlled crossover study in normal volunteers .
fluconazole	drug	glipizide	drug
int

All subjects received DRUGA alone and following treatment with dgb mg of DRUGB as a single daily oral dose for seven days .
glipizide	drug	fluconazole	drug
false

The mean percentage increase in the DRUGA AUC after DRUGB administration was dga % ( range : dgb to dgb ) .
glipizide	drug	fluconazole	drug
mechanism

The concurrent use of DRUGA Injection with other DRUGB or medications with anticholinergic activity , such as DRUGN , DRUGN , or DRUGN , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
Robinul	brand	anticholinergics	group
effect

The concurrent use of DRUGA Injection with other DRUGN or medications with anticholinergic activity , such as DRUGB , DRUGN , or DRUGN , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
Robinul	brand	phenothiazines	group
effect

The concurrent use of DRUGA Injection with other DRUGN or medications with anticholinergic activity , such as DRUGN , DRUGB , or DRUGN , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
Robinul	brand	antiparkinson drugs	group
effect

The concurrent use of DRUGA Injection with other DRUGN or medications with anticholinergic activity , such as DRUGN , DRUGN , or DRUGB , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
Robinul	brand	tricyclic antidepressants	group
effect

The concurrent use of DRUGN Injection with other DRUGA or medications with anticholinergic activity , such as DRUGB , DRUGN , or DRUGN , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
anticholinergics	group	phenothiazines	group
false

The concurrent use of DRUGN Injection with other DRUGA or medications with anticholinergic activity , such as DRUGN , DRUGB , or DRUGN , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
anticholinergics	group	antiparkinson drugs	group
false

The concurrent use of DRUGN Injection with other DRUGA or medications with anticholinergic activity , such as DRUGN , DRUGN , or DRUGB , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
anticholinergics	group	tricyclic antidepressants	group
false

The concurrent use of DRUGN Injection with other DRUGN or medications with anticholinergic activity , such as DRUGA , DRUGB , or DRUGN , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
phenothiazines	group	antiparkinson drugs	group
false

The concurrent use of DRUGN Injection with other DRUGN or medications with anticholinergic activity , such as DRUGA , DRUGN , or DRUGB , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
phenothiazines	group	tricyclic antidepressants	group
false

The concurrent use of DRUGN Injection with other DRUGN or medications with anticholinergic activity , such as DRUGN , DRUGA , or DRUGB , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
antiparkinson drugs	group	tricyclic antidepressants	group
false

Concomitant administration of DRUGA Injection and DRUGB in a wax matrix may increase the severity of potassium chloride induced gastrointestinal lesions as a result of a slower gastrointestinal transit time .
Robinul	brand	potassium chloride	drug
mechanism

These would include a variety of preparations which contain DRUGA , DRUGB , DRUGN , or DRUGN .
androgens	group	estrogens	group
false

These would include a variety of preparations which contain DRUGA , DRUGN , DRUGB , or DRUGN .
androgens	group	progestins	group
false

These would include a variety of preparations which contain DRUGA , DRUGN , DRUGN , or DRUGB .
androgens	group	glucocorticoids	group
false

These would include a variety of preparations which contain DRUGN , DRUGA , DRUGB , or DRUGN .
estrogens	group	progestins	group
false

These would include a variety of preparations which contain DRUGN , DRUGA , DRUGN , or DRUGB .
estrogens	group	glucocorticoids	group
false

These would include a variety of preparations which contain DRUGN , DRUGN , DRUGA , or DRUGB .
progestins	group	glucocorticoids	group
false

The gonadotropin levels may be transiently elevated by DRUGA , minimally elevated by DRUGB , and suppressed by oral DRUGN and DRUGN .
spironolactone	drug	levodopa	drug
false

The gonadotropin levels may be transiently elevated by DRUGA , minimally elevated by DRUGN , and suppressed by oral DRUGB and DRUGN .
spironolactone	drug	contraceptives	group
false

The gonadotropin levels may be transiently elevated by DRUGA , minimally elevated by DRUGN , and suppressed by oral DRUGN and DRUGB .
spironolactone	drug	digoxin	drug
false

The gonadotropin levels may be transiently elevated by DRUGN , minimally elevated by DRUGA , and suppressed by oral DRUGB and DRUGN .
levodopa	drug	contraceptives	group
false

The gonadotropin levels may be transiently elevated by DRUGN , minimally elevated by DRUGA , and suppressed by oral DRUGN and DRUGB .
levodopa	drug	digoxin	drug
false

The gonadotropin levels may be transiently elevated by DRUGN , minimally elevated by DRUGN , and suppressed by oral DRUGA and DRUGB .
contraceptives	group	digoxin	drug
false

The response to DRUGA may be blunted by DRUGB and DRUGN which cause a rise in prolactin .
Factrel	brand	phenothiazines	group
effect

The response to DRUGA may be blunted by DRUGN and DRUGB which cause a rise in prolactin .
Factrel	brand	dopamine antagonists	group
effect

The response to DRUGN may be blunted by DRUGA and DRUGB which cause a rise in prolactin .
phenothiazines	group	dopamine antagonists	group
false

DRUGA , DRUGB , Metal Cations , DRUGN DRUGN form chelates with alkaline earth and transition metal cations .
Antacids	group	Sucralfate	drug
false

DRUGA , DRUGN , Metal Cations , DRUGB DRUGN form chelates with alkaline earth and transition metal cations .
Antacids	group	Multivitamins	group
false

DRUGA , DRUGN , Metal Cations , DRUGN DRUGB form chelates with alkaline earth and transition metal cations .
Antacids	group	Quinolones	group
false

DRUGN , DRUGA , Metal Cations , DRUGB DRUGN form chelates with alkaline earth and transition metal cations .
Sucralfate	drug	Multivitamins	group
false

DRUGN , DRUGA , Metal Cations , DRUGN DRUGB form chelates with alkaline earth and transition metal cations .
Sucralfate	drug	Quinolones	group
false

DRUGN , DRUGN , Metal Cations , DRUGA DRUGB form chelates with alkaline earth and transition metal cations .
Multivitamins	group	Quinolones	group
false

DRUGA DRUGB DRUGN , like other DRUGN , may inhibit the metabolism of DRUGN and DRUGN .
Caffeine	drug	Theobromine	drug
false

DRUGA DRUGN DRUGB , like other DRUGN , may inhibit the metabolism of DRUGN and DRUGN .
Caffeine	drug	Grepafloxacin	drug
false

DRUGA DRUGN DRUGN , like other DRUGB , may inhibit the metabolism of DRUGN and DRUGN .
Caffeine	drug	quinolones	group
false

DRUGA DRUGN DRUGN , like other DRUGN , may inhibit the metabolism of DRUGB and DRUGN .
Caffeine	drug	caffeine	drug
false

DRUGA DRUGN DRUGN , like other DRUGN , may inhibit the metabolism of DRUGN and DRUGB .
Caffeine	drug	theobromine	drug
false

DRUGN DRUGA DRUGB , like other DRUGN , may inhibit the metabolism of DRUGN and DRUGN .
Theobromine	drug	Grepafloxacin	drug
false

DRUGN DRUGA DRUGN , like other DRUGB , may inhibit the metabolism of DRUGN and DRUGN .
Theobromine	drug	quinolones	group
false

DRUGN DRUGA DRUGN , like other DRUGN , may inhibit the metabolism of DRUGB and DRUGN .
Theobromine	drug	caffeine	drug
false

DRUGN DRUGA DRUGN , like other DRUGN , may inhibit the metabolism of DRUGN and DRUGB .
Theobromine	drug	theobromine	drug
false

DRUGN DRUGN DRUGA , like other DRUGB , may inhibit the metabolism of DRUGN and DRUGN .
Grepafloxacin	drug	quinolones	group
false

DRUGN DRUGN DRUGA , like other DRUGN , may inhibit the metabolism of DRUGB and DRUGN .
Grepafloxacin	drug	caffeine	drug
mechanism

DRUGN DRUGN DRUGA , like other DRUGN , may inhibit the metabolism of DRUGN and DRUGB .
Grepafloxacin	drug	theobromine	drug
mechanism

DRUGN DRUGN DRUGN , like other DRUGA , may inhibit the metabolism of DRUGB and DRUGN .
quinolones	group	caffeine	drug
mechanism

DRUGN DRUGN DRUGN , like other DRUGA , may inhibit the metabolism of DRUGN and DRUGB .
quinolones	group	theobromine	drug
mechanism

DRUGN DRUGN DRUGN , like other DRUGN , may inhibit the metabolism of DRUGA and DRUGB .
caffeine	drug	theobromine	drug
false

In some patients , this may lead to reduced clearance , prolongation of plasma half life , and enhanced effects of DRUGA and DRUGB .
caffeine	drug	theobromine	drug
false

DRUGA : DRUGB is a competitive inhibitor of the metabolism of DRUGN .
Theophylline	drug	Grepafloxacin	drug
false

DRUGA : DRUGN is a competitive inhibitor of the metabolism of DRUGB .
Theophylline	drug	theophylline	drug
false

DRUGN : DRUGA is a competitive inhibitor of the metabolism of DRUGB .
Grepafloxacin	drug	theophylline	drug
mechanism

Serum DRUGA concentrations increase when DRUGB is initiated in a patient maintained on DRUGN .
theophylline	drug	grepafloxacin	drug
false

Serum DRUGN concentrations increase when DRUGA is initiated in a patient maintained on DRUGB .
grepafloxacin	drug	theophylline	drug
mechanism

DRUGA : In subjects receiving DRUGB , no significant change in clotting time was observed when DRUGN was coadministered .
Warfarin	drug	warfarin	drug
false

DRUGA : In subjects receiving DRUGN , no significant change in clotting time was observed when DRUGB was coadministered .
Warfarin	drug	grepafloxacin	drug
false

DRUGN : In subjects receiving DRUGA , no significant change in clotting time was observed when DRUGB was coadministered .
warfarin	drug	grepafloxacin	drug
false

However , because some DRUGA have been reported to enhance the effects of DRUGB or its derivatives , prothrombin time or other suitable anticoagulation test should be monitored closely if a DRUGN is administered with DRUGN or its derivatives .
quinolones	group	warfarin	drug
effect

However , because some DRUGA have been reported to enhance the effects of DRUGN or its derivatives , prothrombin time or other suitable anticoagulation test should be monitored closely if a DRUGB is administered with DRUGN or its derivatives .
quinolones	group	quinolone antimicrobial	group
false

However , because some DRUGA have been reported to enhance the effects of DRUGN or its derivatives , prothrombin time or other suitable anticoagulation test should be monitored closely if a DRUGN is administered with DRUGB or its derivatives .
quinolones	group	warfarin	drug
false

However , because some DRUGN have been reported to enhance the effects of DRUGA or its derivatives , prothrombin time or other suitable anticoagulation test should be monitored closely if a DRUGB is administered with DRUGN or its derivatives .
warfarin	drug	quinolone antimicrobial	group
false

However , because some DRUGN have been reported to enhance the effects of DRUGN or its derivatives , prothrombin time or other suitable anticoagulation test should be monitored closely if a DRUGA is administered with DRUGB or its derivatives .
quinolone antimicrobial	group	warfarin	drug
advise

Drugs Metabolized by Cytochrome Pdgb Enzymes The drug interaction study evaluating the effect of DRUGA on DRUGB indicates that DRUGN inhibits DRUGN metabolism , which is mediated by CYPdgbAdga
grepafloxacin	drug	theophylline	drug
false

Drugs Metabolized by Cytochrome Pdgb Enzymes The drug interaction study evaluating the effect of DRUGA on DRUGN indicates that DRUGN inhibits DRUGB metabolism , which is mediated by CYPdgbAdga
grepafloxacin	drug	theophylline	drug
false

Drugs Metabolized by Cytochrome Pdgb Enzymes The drug interaction study evaluating the effect of DRUGN on DRUGA indicates that DRUGB inhibits DRUGN metabolism , which is mediated by CYPdgbAdga
theophylline	drug	grepafloxacin	drug
false

Drugs Metabolized by Cytochrome Pdgb Enzymes The drug interaction study evaluating the effect of DRUGN on DRUGN indicates that DRUGA inhibits DRUGB metabolism , which is mediated by CYPdgbAdga
grepafloxacin	drug	theophylline	drug
mechanism

substrates , in vitro data suggest similar effects of DRUGA in CYPdgbAdgb mediated metabolism and DRUGB metabolism .
grepafloxacin	drug	theophylline	drug
false

In addition , other DRUGA have been reported to decrease the CYPdgbAdgb mediated metabolism of DRUGB .
quinolones	group	cyclosporine	drug
mechanism

include DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
terfenadine	drug	astemizole	drug
false

include DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
terfenadine	drug	cisapride	drug
false

include DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
terfenadine	drug	midazolam	drug
false

include DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
terfenadine	drug	triazolam	drug
false

include DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
astemizole	drug	cisapride	drug
false

include DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
astemizole	drug	midazolam	drug
false

include DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
astemizole	drug	triazolam	drug
false

include DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
cisapride	drug	midazolam	drug
false

include DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
cisapride	drug	triazolam	drug
false

include DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
midazolam	drug	triazolam	drug
false

DRUGA ( DRUGB ) : The concomitant administration of a DRUGN with a DRUGN may increase the risks of CNS stimulation and convulsions .
Nonsteroidal Anti-inflammatory Drugs	group	NSAIDs	group
false

DRUGA ( DRUGN ) : The concomitant administration of a DRUGB with a DRUGN may increase the risks of CNS stimulation and convulsions .
Nonsteroidal Anti-inflammatory Drugs	group	nonsteroidal anti inflammatory drug	group
false

DRUGA ( DRUGN ) : The concomitant administration of a DRUGN with a DRUGB may increase the risks of CNS stimulation and convulsions .
Nonsteroidal Anti-inflammatory Drugs	group	quinolone	group
false

DRUGN ( DRUGA ) : The concomitant administration of a DRUGB with a DRUGN may increase the risks of CNS stimulation and convulsions .
NSAIDs	group	nonsteroidal anti inflammatory drug	group
false

DRUGN ( DRUGA ) : The concomitant administration of a DRUGN with a DRUGB may increase the risks of CNS stimulation and convulsions .
NSAIDs	group	quinolone	group
false

DRUGN ( DRUGN ) : The concomitant administration of a DRUGA with a DRUGB may increase the risks of CNS stimulation and convulsions .
nonsteroidal anti inflammatory drug	group	quinolone	group
effect

DRUGA : Disturbances of blood glucose , including hyperglycemia and hypoglycemia , have been reported in patients treated concomitantly with DRUGB and an DRUGN .
Antidiabetic Agents	group	quinolones	group
false

DRUGA : Disturbances of blood glucose , including hyperglycemia and hypoglycemia , have been reported in patients treated concomitantly with DRUGN and an DRUGB .
Antidiabetic Agents	group	antidiabetic agent	group
false

DRUGN : Disturbances of blood glucose , including hyperglycemia and hypoglycemia , have been reported in patients treated concomitantly with DRUGA and an DRUGB .
quinolones	group	antidiabetic agent	group
effect

Patients on DRUGA therapy may require dosage adjustment of the anticoagulant during and after DRUGB therapy .
warfarin-type anticoagulant	group	griseofulvin	drug
advise

Concomitant use of DRUGA usually depresses DRUGB activity and may necessitate raising the dosage .
barbiturates	group	griseofulvin	drug
effect

The concomitant administration of DRUGA has been reported to reduce the efficacy of oral DRUGB and to increase the incidence of breakthrough bleeding .
griseofulvin	drug	contraceptives	group
effect

The use of DRUGA may result in additive CNS depressant effects when coadministered with DRUGB , DRUGN , DRUGN or other drugs that produce CNS depression .
codeine	drug	alcohol	drug
effect

The use of DRUGA may result in additive CNS depressant effects when coadministered with DRUGN , DRUGB , DRUGN or other drugs that produce CNS depression .
codeine	drug	antihistamines	group
effect

The use of DRUGA may result in additive CNS depressant effects when coadministered with DRUGN , DRUGN , DRUGB or other drugs that produce CNS depression .
codeine	drug	psychotropics	group
effect

The use of DRUGN may result in additive CNS depressant effects when coadministered with DRUGA , DRUGB , DRUGN or other drugs that produce CNS depression .
alcohol	drug	antihistamines	group
false

The use of DRUGN may result in additive CNS depressant effects when coadministered with DRUGA , DRUGN , DRUGB or other drugs that produce CNS depression .
alcohol	drug	psychotropics	group
false

The use of DRUGN may result in additive CNS depressant effects when coadministered with DRUGN , DRUGA , DRUGB or other drugs that produce CNS depression .
antihistamines	group	psychotropics	group
false

Serious toxicity may result if DRUGA is coadministered with DRUGB ( DRUGN ) .
dextromethorphan	drug	monoamine oxidase inhibitors	group
effect

Serious toxicity may result if DRUGA is coadministered with DRUGN ( DRUGB ) .
dextromethorphan	drug	MAOIs	group
effect

Serious toxicity may result if DRUGN is coadministered with DRUGA ( DRUGB ) .
monoamine oxidase inhibitors	group	MAOIs	group
false

The use of DRUGA may result in additive CNS depressant effects when coadministered with DRUGB , DRUGN , DRUGN or other drugs that produce CNS depression .
dextromethorphan hydrobromide	drug	alcohol	drug
effect

The use of DRUGA may result in additive CNS depressant effects when coadministered with DRUGN , DRUGB , DRUGN or other drugs that produce CNS depression .
dextromethorphan hydrobromide	drug	antihistamines	group
effect

The use of DRUGA may result in additive CNS depressant effects when coadministered with DRUGN , DRUGN , DRUGB or other drugs that produce CNS depression .
dextromethorphan hydrobromide	drug	psychotropics	group
effect

The use of DRUGN may result in additive CNS depressant effects when coadministered with DRUGA , DRUGB , DRUGN or other drugs that produce CNS depression .
alcohol	drug	antihistamines	group
false

The use of DRUGN may result in additive CNS depressant effects when coadministered with DRUGA , DRUGN , DRUGB or other drugs that produce CNS depression .
alcohol	drug	psychotropics	group
false

The use of DRUGN may result in additive CNS depressant effects when coadministered with DRUGN , DRUGA , DRUGB or other drugs that produce CNS depression .
antihistamines	group	psychotropics	group
false

The potential for increased sedation when DRUGA is given with other DRUGB should be appreciated .
guanfacine	drug	CNS-depressant drug	group
effect

The administration of DRUGA concomitantly with known microsomal enzyme inducer ( DRUGB or DRUGN ) to two patients with renal impairment reportedly resulted in significant reductions in elimination half life and plasma concentration .
guanfacine	drug	phenobarbital	drug
mechanism

The administration of DRUGA concomitantly with known microsomal enzyme inducer ( DRUGN or DRUGB ) to two patients with renal impairment reportedly resulted in significant reductions in elimination half life and plasma concentration .
guanfacine	drug	phenytoin	drug
mechanism

The administration of DRUGN concomitantly with known microsomal enzyme inducer ( DRUGA or DRUGB ) to two patients with renal impairment reportedly resulted in significant reductions in elimination half life and plasma concentration .
phenobarbital	drug	phenytoin	drug
false

DRUGA decrease the hypotensive effect of DRUGB .
TCAs	group	guanfacine	drug
effect

DRUGA ( DRUGB , porpranolol , DRUGN ) may exacerbate rebound hypertension when DRUGN is withdrawn .
Noncardioselective beta-blockers	group	nadolol	drug
false

DRUGA ( DRUGN , porpranolol , DRUGB ) may exacerbate rebound hypertension when DRUGN is withdrawn .
Noncardioselective beta-blockers	group	timolol	drug
false

DRUGA ( DRUGN , porpranolol , DRUGN ) may exacerbate rebound hypertension when DRUGB is withdrawn .
Noncardioselective beta-blockers	group	guanfacine	drug
effect

DRUGN ( DRUGA , porpranolol , DRUGB ) may exacerbate rebound hypertension when DRUGN is withdrawn .
nadolol	drug	timolol	drug
false

DRUGN ( DRUGA , porpranolol , DRUGN ) may exacerbate rebound hypertension when DRUGB is withdrawn .
nadolol	drug	guanfacine	drug
effect

DRUGN ( DRUGN , porpranolol , DRUGA ) may exacerbate rebound hypertension when DRUGB is withdrawn .
timolol	drug	guanfacine	drug
effect

The gradual withdrawal of DRUGA or a DRUGB could be substituted .
guafacine	drug	cardioselective beta-blocker	group
false

DRUGA : Ten patients who were stabilized on oral DRUGB were given DRUGN , dgb dgb mg / day , for dgb weeks .
Anticoagulants	group	anticoagulants	group
false

DRUGA : Ten patients who were stabilized on oral DRUGN were given DRUGB , dgb dgb mg / day , for dgb weeks .
Anticoagulants	group	guanfacine	drug
false

DRUGN : Ten patients who were stabilized on oral DRUGA were given DRUGB , dgb dgb mg / day , for dgb weeks .
anticoagulants	group	guanfacine	drug
false

In several well controlled studies , DRUGA was administered together with DRUGB with no drug interactions reported .
guanfacine	drug	diuretics	group
false

A causal relationship between these events and the concomitant administration of DRUGA and DRUGB has not been established ;
lithium	drug	HALDOL	brand
false

As with other DRUGA , it should be noted that DRUGB may be capable of potentiating DRUGN such as DRUGN , DRUGN , and DRUGN .
antipsychotic agents	group	HALDOL	brand
false

As with other DRUGA , it should be noted that DRUGN may be capable of potentiating DRUGB such as DRUGN , DRUGN , and DRUGN .
antipsychotic agents	group	CNS depressants	group
effect

As with other DRUGA , it should be noted that DRUGN may be capable of potentiating DRUGN such as DRUGB , DRUGN , and DRUGN .
antipsychotic agents	group	anesthetics	group
effect

As with other DRUGA , it should be noted that DRUGN may be capable of potentiating DRUGN such as DRUGN , DRUGB , and DRUGN .
antipsychotic agents	group	opiates	group
effect

As with other DRUGA , it should be noted that DRUGN may be capable of potentiating DRUGN such as DRUGN , DRUGN , and DRUGB .
antipsychotic agents	group	alcohol	drug
effect

As with other DRUGN , it should be noted that DRUGA may be capable of potentiating DRUGB such as DRUGN , DRUGN , and DRUGN .
HALDOL	brand	CNS depressants	group
effect

As with other DRUGN , it should be noted that DRUGA may be capable of potentiating DRUGN such as DRUGB , DRUGN , and DRUGN .
HALDOL	brand	anesthetics	group
effect

As with other DRUGN , it should be noted that DRUGA may be capable of potentiating DRUGN such as DRUGN , DRUGB , and DRUGN .
HALDOL	brand	opiates	group
effect

As with other DRUGN , it should be noted that DRUGA may be capable of potentiating DRUGN such as DRUGN , DRUGN , and DRUGB .
HALDOL	brand	alcohol	drug
effect

As with other DRUGN , it should be noted that DRUGN may be capable of potentiating DRUGA such as DRUGB , DRUGN , and DRUGN .
CNS depressants	group	anesthetics	group
false

As with other DRUGN , it should be noted that DRUGN may be capable of potentiating DRUGA such as DRUGN , DRUGB , and DRUGN .
CNS depressants	group	opiates	group
false

As with other DRUGN , it should be noted that DRUGN may be capable of potentiating DRUGA such as DRUGN , DRUGN , and DRUGB .
CNS depressants	group	alcohol	drug
false

As with other DRUGN , it should be noted that DRUGN may be capable of potentiating DRUGN such as DRUGA , DRUGB , and DRUGN .
anesthetics	group	opiates	group
false

As with other DRUGN , it should be noted that DRUGN may be capable of potentiating DRUGN such as DRUGA , DRUGN , and DRUGB .
anesthetics	group	alcohol	drug
false

As with other DRUGN , it should be noted that DRUGN may be capable of potentiating DRUGN such as DRUGN , DRUGA , and DRUGB .
opiates	group	alcohol	drug
false

In a study of dgb schizophrenic patients coadministered oral DRUGA and DRUGB , plasma DRUGN levels were decreased by a mean of dgb % and mean scores on the Brief Psychiatric Rating Scale were increased from baseline .
haloperidol	drug	rifampin	drug
mechanism

In a study of dgb schizophrenic patients coadministered oral DRUGN and DRUGA , plasma DRUGB levels were decreased by a mean of dgb % and mean scores on the Brief Psychiatric Rating Scale were increased from baseline .
rifampin	drug	haloperidol	drug
false

In dgb other schizophrenic patients treated with oral DRUGA and DRUGB , discontinuation of DRUGN produced a mean dga fold increase in DRUGN concentrations .
haloperidol	drug	rifampin	drug
false

In dgb other schizophrenic patients treated with oral DRUGA and DRUGN , discontinuation of DRUGB produced a mean dga fold increase in DRUGN concentrations .
haloperidol	drug	rifampin	drug
false

In dgb other schizophrenic patients treated with oral DRUGN and DRUGA , discontinuation of DRUGN produced a mean dga fold increase in DRUGB concentrations .
rifampin	drug	haloperidol	drug
false

In dgb other schizophrenic patients treated with oral DRUGN and DRUGN , discontinuation of DRUGA produced a mean dga fold increase in DRUGB concentrations .
rifampin	drug	haloperidol	drug
mechanism

Thus , careful monitoring of clinical status is warranted when DRUGA is administered or discontinued in DRUGB treated patients .
rifampin	drug	haloperidol	drug
advise

DRUGA augments the action of DRUGB s and the muscle relaxant effects of DRUGN .
FLUOTHANE	brand	non-depolarising muscle relaxant	group
effect

DRUGA augments the action of DRUGN s and the muscle relaxant effects of DRUGB .
FLUOTHANE	brand	aminoglycosides	group
effect

DRUGN augments the action of DRUGA s and the muscle relaxant effects of DRUGB .
non-depolarising muscle relaxant	group	aminoglycosides	group
false

DRUGA may augment the hypotension caused by the ganglionic blocking effect of DRUGB .
FLUOTHANE	brand	tubocurarine	drug
effect

Caution should be exercised during the administration of DRUGA to patients anaesthetised with DRUGB as arrhythmias may be precipitated .
adrenaline	drug	FLUOTHANE	brand
advise

For this reason the dose of DRUGA should be restricted and an DRUGB administered as appropriate .
adrenaline	drug	antiarrhythmic agent	group
false

Caution should also be applied for other DRUGA , and for DRUGB and DRUGN and DRUGN , which may also precipitate arrhythmias .
sympathomimetics	group	aminophylline	drug
false

Caution should also be applied for other DRUGA , and for DRUGN and DRUGB and DRUGN , which may also precipitate arrhythmias .
sympathomimetics	group	theophylline	drug
false

Caution should also be applied for other DRUGA , and for DRUGN and DRUGN and DRUGB , which may also precipitate arrhythmias .
sympathomimetics	group	tricyclic antidepressants	group
false

Caution should also be applied for other DRUGN , and for DRUGA and DRUGB and DRUGN , which may also precipitate arrhythmias .
aminophylline	drug	theophylline	drug
false

Caution should also be applied for other DRUGN , and for DRUGA and DRUGN and DRUGB , which may also precipitate arrhythmias .
aminophylline	drug	tricyclic antidepressants	group
false

Caution should also be applied for other DRUGN , and for DRUGN and DRUGA and DRUGB , which may also precipitate arrhythmias .
theophylline	drug	tricyclic antidepressants	group
false

Drug Interactions : a . Drugs Enhancing DRUGA Effect : Oral DRUGB : DRUGN may prolong the one stage prothrombin time .
Heparin	drug	anticoagulants	group
false

Drug Interactions : a . Drugs Enhancing DRUGA Effect : Oral DRUGN : DRUGB may prolong the one stage prothrombin time .
Heparin	drug	Heparin sodium	drug
false

Drug Interactions : a . Drugs Enhancing DRUGN Effect : Oral DRUGA : DRUGB may prolong the one stage prothrombin time .
anticoagulants	group	Heparin sodium	drug
false

The anticoagulant effect of DRUGA is enhanced by concurrent treatment with DRUGB ( human ) in patients with hereditary antithrombin III deficiency .
heparin	drug	antithrombin III	drug
effect

Thus in order to avoid bleeding , reduced dosage of DRUGA is recommended during treatment with DRUGB ( human ) .
heparin	drug	antithrombin III	drug
advise

Drugs Decreasing DRUGA Effect : DRUGB , DRUGN , DRUGN , or DRUGN may partially counteract the anticoagulant action of DRUGN .
Heparin	drug	Digitalis	group
false

Drugs Decreasing DRUGA Effect : DRUGN , DRUGB , DRUGN , or DRUGN may partially counteract the anticoagulant action of DRUGN .
Heparin	drug	tetracyclines	group
false

Drugs Decreasing DRUGA Effect : DRUGN , DRUGN , DRUGB , or DRUGN may partially counteract the anticoagulant action of DRUGN .
Heparin	drug	nicotine	drug
false

Drugs Decreasing DRUGA Effect : DRUGN , DRUGN , DRUGN , or DRUGB may partially counteract the anticoagulant action of DRUGN .
Heparin	drug	antihistamines	group
false

Drugs Decreasing DRUGA Effect : DRUGN , DRUGN , DRUGN , or DRUGN may partially counteract the anticoagulant action of DRUGB .
Heparin	drug	heparin sodium	drug
false

Drugs Decreasing DRUGN Effect : DRUGA , DRUGB , DRUGN , or DRUGN may partially counteract the anticoagulant action of DRUGN .
Digitalis	group	tetracyclines	group
false

Drugs Decreasing DRUGN Effect : DRUGA , DRUGN , DRUGB , or DRUGN may partially counteract the anticoagulant action of DRUGN .
Digitalis	group	nicotine	drug
false

Drugs Decreasing DRUGN Effect : DRUGA , DRUGN , DRUGN , or DRUGB may partially counteract the anticoagulant action of DRUGN .
Digitalis	group	antihistamines	group
false

Drugs Decreasing DRUGN Effect : DRUGA , DRUGN , DRUGN , or DRUGN may partially counteract the anticoagulant action of DRUGB .
Digitalis	group	heparin sodium	drug
effect

Drugs Decreasing DRUGN Effect : DRUGN , DRUGA , DRUGB , or DRUGN may partially counteract the anticoagulant action of DRUGN .
tetracyclines	group	nicotine	drug
false

Drugs Decreasing DRUGN Effect : DRUGN , DRUGA , DRUGN , or DRUGB may partially counteract the anticoagulant action of DRUGN .
tetracyclines	group	antihistamines	group
false

Drugs Decreasing DRUGN Effect : DRUGN , DRUGA , DRUGN , or DRUGN may partially counteract the anticoagulant action of DRUGB .
tetracyclines	group	heparin sodium	drug
effect

Drugs Decreasing DRUGN Effect : DRUGN , DRUGN , DRUGA , or DRUGB may partially counteract the anticoagulant action of DRUGN .
nicotine	drug	antihistamines	group
false

Drugs Decreasing DRUGN Effect : DRUGN , DRUGN , DRUGA , or DRUGN may partially counteract the anticoagulant action of DRUGB .
nicotine	drug	heparin sodium	drug
effect

Drugs Decreasing DRUGN Effect : DRUGN , DRUGN , DRUGN , or DRUGA may partially counteract the anticoagulant action of DRUGB .
antihistamines	group	heparin sodium	drug
effect

DRUGA Injection should not be mixed with DRUGB , DRUGN , DRUGN , or DRUGN , since it has been reported that these drugs are incompatible with DRUGN and a precipitate may form .
Heparin Sodium	drug	doxorubicin	drug
false

DRUGA Injection should not be mixed with DRUGN , DRUGB , DRUGN , or DRUGN , since it has been reported that these drugs are incompatible with DRUGN and a precipitate may form .
Heparin Sodium	drug	droperidol	drug
false

DRUGA Injection should not be mixed with DRUGN , DRUGN , DRUGB , or DRUGN , since it has been reported that these drugs are incompatible with DRUGN and a precipitate may form .
Heparin Sodium	drug	ciprofloxacin	drug
false

DRUGA Injection should not be mixed with DRUGN , DRUGN , DRUGN , or DRUGB , since it has been reported that these drugs are incompatible with DRUGN and a precipitate may form .
Heparin Sodium	drug	mitoxantrone	drug
false

DRUGA Injection should not be mixed with DRUGN , DRUGN , DRUGN , or DRUGN , since it has been reported that these drugs are incompatible with DRUGB and a precipitate may form .
Heparin Sodium	drug	heparin	drug
false

DRUGN Injection should not be mixed with DRUGA , DRUGB , DRUGN , or DRUGN , since it has been reported that these drugs are incompatible with DRUGN and a precipitate may form .
doxorubicin	drug	droperidol	drug
false

DRUGN Injection should not be mixed with DRUGA , DRUGN , DRUGB , or DRUGN , since it has been reported that these drugs are incompatible with DRUGN and a precipitate may form .
doxorubicin	drug	ciprofloxacin	drug
false

DRUGN Injection should not be mixed with DRUGA , DRUGN , DRUGN , or DRUGB , since it has been reported that these drugs are incompatible with DRUGN and a precipitate may form .
doxorubicin	drug	mitoxantrone	drug
false

DRUGN Injection should not be mixed with DRUGA , DRUGN , DRUGN , or DRUGN , since it has been reported that these drugs are incompatible with DRUGB and a precipitate may form .
doxorubicin	drug	heparin	drug
false

DRUGN Injection should not be mixed with DRUGN , DRUGA , DRUGB , or DRUGN , since it has been reported that these drugs are incompatible with DRUGN and a precipitate may form .
droperidol	drug	ciprofloxacin	drug
false

DRUGN Injection should not be mixed with DRUGN , DRUGA , DRUGN , or DRUGB , since it has been reported that these drugs are incompatible with DRUGN and a precipitate may form .
droperidol	drug	mitoxantrone	drug
false

DRUGN Injection should not be mixed with DRUGN , DRUGA , DRUGN , or DRUGN , since it has been reported that these drugs are incompatible with DRUGB and a precipitate may form .
droperidol	drug	heparin	drug
false

DRUGN Injection should not be mixed with DRUGN , DRUGN , DRUGA , or DRUGB , since it has been reported that these drugs are incompatible with DRUGN and a precipitate may form .
ciprofloxacin	drug	mitoxantrone	drug
false

DRUGN Injection should not be mixed with DRUGN , DRUGN , DRUGA , or DRUGN , since it has been reported that these drugs are incompatible with DRUGB and a precipitate may form .
ciprofloxacin	drug	heparin	drug
false

DRUGN Injection should not be mixed with DRUGN , DRUGN , DRUGN , or DRUGA , since it has been reported that these drugs are incompatible with DRUGB and a precipitate may form .
mitoxantrone	drug	heparin	drug
false

DRUGA are strong DRUGB , but regular users develop physiological tolerance allowing gradually increased dosages .
Opioids	group	central nervous system depressants	group
false

In combination with other DRUGA , DRUGB may still kill even experienced users , particularly if their tolerance to the drug has reduced or the strength of their usual dose has increased .
central nervous system depressants	group	heroin	drug_n
effect

Toxicology studies of DRUGA related deaths reveal frequent involvement of other DRUGB , including DRUGN , DRUGN such as DRUGN ( DRUGN ) , and , to a rising degree , DRUGN .
heroin	drug_n	central nervous system depressants	group
effect

Toxicology studies of DRUGA related deaths reveal frequent involvement of other DRUGN , including DRUGB , DRUGN such as DRUGN ( DRUGN ) , and , to a rising degree , DRUGN .
heroin	drug_n	alcohol	drug
effect

Toxicology studies of DRUGA related deaths reveal frequent involvement of other DRUGN , including DRUGN , DRUGB such as DRUGN ( DRUGN ) , and , to a rising degree , DRUGN .
heroin	drug_n	benzodiazepines	group
effect

Toxicology studies of DRUGA related deaths reveal frequent involvement of other DRUGN , including DRUGN , DRUGN such as DRUGB ( DRUGN ) , and , to a rising degree , DRUGN .
heroin	drug_n	diazepam	drug
effect

Toxicology studies of DRUGA related deaths reveal frequent involvement of other DRUGN , including DRUGN , DRUGN such as DRUGN ( DRUGB ) , and , to a rising degree , DRUGN .
heroin	drug_n	Valium	brand
effect

Toxicology studies of DRUGA related deaths reveal frequent involvement of other DRUGN , including DRUGN , DRUGN such as DRUGN ( DRUGN ) , and , to a rising degree , DRUGB .
heroin	drug_n	methadone	drug
effect

Toxicology studies of DRUGN related deaths reveal frequent involvement of other DRUGA , including DRUGB , DRUGN such as DRUGN ( DRUGN ) , and , to a rising degree , DRUGN .
central nervous system depressants	group	alcohol	drug
false

Toxicology studies of DRUGN related deaths reveal frequent involvement of other DRUGA , including DRUGN , DRUGB such as DRUGN ( DRUGN ) , and , to a rising degree , DRUGN .
central nervous system depressants	group	benzodiazepines	group
false

Toxicology studies of DRUGN related deaths reveal frequent involvement of other DRUGA , including DRUGN , DRUGN such as DRUGB ( DRUGN ) , and , to a rising degree , DRUGN .
central nervous system depressants	group	diazepam	drug
false

Toxicology studies of DRUGN related deaths reveal frequent involvement of other DRUGA , including DRUGN , DRUGN such as DRUGN ( DRUGB ) , and , to a rising degree , DRUGN .
central nervous system depressants	group	Valium	brand
false

Toxicology studies of DRUGN related deaths reveal frequent involvement of other DRUGA , including DRUGN , DRUGN such as DRUGN ( DRUGN ) , and , to a rising degree , DRUGB .
central nervous system depressants	group	methadone	drug
false

Toxicology studies of DRUGN related deaths reveal frequent involvement of other DRUGN , including DRUGA , DRUGB such as DRUGN ( DRUGN ) , and , to a rising degree , DRUGN .
alcohol	drug	benzodiazepines	group
false

Toxicology studies of DRUGN related deaths reveal frequent involvement of other DRUGN , including DRUGA , DRUGN such as DRUGB ( DRUGN ) , and , to a rising degree , DRUGN .
alcohol	drug	diazepam	drug
false

Toxicology studies of DRUGN related deaths reveal frequent involvement of other DRUGN , including DRUGA , DRUGN such as DRUGN ( DRUGB ) , and , to a rising degree , DRUGN .
alcohol	drug	Valium	brand
false

Toxicology studies of DRUGN related deaths reveal frequent involvement of other DRUGN , including DRUGA , DRUGN such as DRUGN ( DRUGN ) , and , to a rising degree , DRUGB .
alcohol	drug	methadone	drug
false

Toxicology studies of DRUGN related deaths reveal frequent involvement of other DRUGN , including DRUGN , DRUGA such as DRUGB ( DRUGN ) , and , to a rising degree , DRUGN .
benzodiazepines	group	diazepam	drug
false

Toxicology studies of DRUGN related deaths reveal frequent involvement of other DRUGN , including DRUGN , DRUGA such as DRUGN ( DRUGB ) , and , to a rising degree , DRUGN .
benzodiazepines	group	Valium	brand
false

Toxicology studies of DRUGN related deaths reveal frequent involvement of other DRUGN , including DRUGN , DRUGA such as DRUGN ( DRUGN ) , and , to a rising degree , DRUGB .
benzodiazepines	group	methadone	drug
false

Toxicology studies of DRUGN related deaths reveal frequent involvement of other DRUGN , including DRUGN , DRUGN such as DRUGA ( DRUGB ) , and , to a rising degree , DRUGN .
diazepam	drug	Valium	brand
false

Toxicology studies of DRUGN related deaths reveal frequent involvement of other DRUGN , including DRUGN , DRUGN such as DRUGA ( DRUGN ) , and , to a rising degree , DRUGB .
diazepam	drug	methadone	drug
false

Toxicology studies of DRUGN related deaths reveal frequent involvement of other DRUGN , including DRUGN , DRUGN such as DRUGN ( DRUGA ) , and , to a rising degree , DRUGB .
Valium	brand	methadone	drug
false

Ironically , DRUGA are often used in the treatment of DRUGB addiction while they cause much more severe withdrawal symptoms .
benzodiazepines	group	heroin	drug
false

DRUGA sometimes proves to be fatal when used in combination with DRUGB .
Cocaine	drug	heroin	drug_n
effect

DRUGA may decrease the effectiveness of oral DRUGB , certain DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
Barbiturates	group	contraceptives	group
effect

DRUGA may decrease the effectiveness of oral DRUGN , certain DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
Barbiturates	group	antibiotics	group
effect

DRUGA may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
Barbiturates	group	quinidine	drug
effect

DRUGA may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
Barbiturates	group	theophylline	drug
effect

DRUGA may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
Barbiturates	group	corticosteroids	group
effect

DRUGA may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
Barbiturates	group	anticoagulants	group
effect

DRUGA may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
Barbiturates	group	beta blockers	group
effect

DRUGN may decrease the effectiveness of oral DRUGA , certain DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
contraceptives	group	antibiotics	group
false

DRUGN may decrease the effectiveness of oral DRUGA , certain DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
contraceptives	group	quinidine	drug
false

DRUGN may decrease the effectiveness of oral DRUGA , certain DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
contraceptives	group	theophylline	drug
false

DRUGN may decrease the effectiveness of oral DRUGA , certain DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
contraceptives	group	corticosteroids	group
false

DRUGN may decrease the effectiveness of oral DRUGA , certain DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
contraceptives	group	anticoagulants	group
false

DRUGN may decrease the effectiveness of oral DRUGA , certain DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
contraceptives	group	beta blockers	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
antibiotics	group	quinidine	drug
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
antibiotics	group	theophylline	drug
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
antibiotics	group	corticosteroids	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
antibiotics	group	anticoagulants	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
antibiotics	group	beta blockers	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
quinidine	drug	theophylline	drug
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
quinidine	drug	corticosteroids	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
quinidine	drug	anticoagulants	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
quinidine	drug	beta blockers	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
theophylline	drug	corticosteroids	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
theophylline	drug	anticoagulants	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
theophylline	drug	beta blockers	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
corticosteroids	group	anticoagulants	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
corticosteroids	group	beta blockers	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
anticoagulants	group	beta blockers	group
false

DRUGA should be used with caution in patients receiving DRUGB .
MAO inhibitors	group	hydralazine	drug
advise

When other potent parental DRUGA , such as DRUGB , are used in combination with DRUGN , patients should be continuously observed for several hours for any excessive fall in blood pressure .
antihypertensive drugs	group	diazoxide	drug
effect

When other potent parental DRUGA , such as DRUGN , are used in combination with DRUGB , patients should be continuously observed for several hours for any excessive fall in blood pressure .
antihypertensive drugs	group	hydralazine	drug
effect

When other potent parental DRUGN , such as DRUGA , are used in combination with DRUGB , patients should be continuously observed for several hours for any excessive fall in blood pressure .
diazoxide	drug	hydralazine	drug
false

Profound hypotensive episodes may occur when DRUGA infection and DRUGB are used concomitantly .
diazoxide	drug	hydralazine	drug
effect

DRUGA ( DRUGB , DRUGN ) serum concentrations and pharmacologic effects may be increased .
Beta-blockers	group	metoprolol	drug
false

DRUGA ( DRUGN , DRUGB ) serum concentrations and pharmacologic effects may be increased .
Beta-blockers	group	propranolol	drug
false

DRUGN ( DRUGA , DRUGB ) serum concentrations and pharmacologic effects may be increased .
metoprolol	drug	propranolol	drug
false

DRUGA increases DRUGB s serum concentrations .
Propranolol	drug	hydralazine	drug
mechanism

DRUGA , DRUGB , and DRUGN ( low hepatic clearance or no first pass metabolism ) are unlikely to be affected .
Acebutolol	drug	atenolol	drug
false

DRUGA , DRUGN , and DRUGB ( low hepatic clearance or no first pass metabolism ) are unlikely to be affected .
Acebutolol	drug	nadolol	drug
false

DRUGN , DRUGA , and DRUGB ( low hepatic clearance or no first pass metabolism ) are unlikely to be affected .
atenolol	drug	nadolol	drug
false

DRUGA may decrease the hemodynamic effects of DRUGB ;
NSAIDs	group	hydralazine	drug
effect

DRUGA , DRUGB , or DRUGN : potentiation of orthostatic hypotension may occur .
Alcohol	drug	barbiturates	group
false

DRUGA , DRUGN , or DRUGB : potentiation of orthostatic hypotension may occur .
Alcohol	drug	narcotics	group
false

DRUGN , DRUGA , or DRUGB : potentiation of orthostatic hypotension may occur .
barbiturates	group	narcotics	group
false

DRUGA : ( oral agents and DRUGB ) dosage adjustment of the DRUGN may be required .
Antidiabetic drugs	group	insulin	drug
false

DRUGA : ( oral agents and DRUGN ) dosage adjustment of the DRUGB may be required .
Antidiabetic drugs	group	antidiabetic drug	group
false

DRUGN : ( oral agents and DRUGA ) dosage adjustment of the DRUGB may be required .
insulin	drug	antidiabetic drug	group
false

DRUGA and DRUGB DRUGN : Absorption of DRUGN is impaired in the presence of DRUGN .
Cholestyramine	drug	colestipol	drug
false

DRUGA and DRUGN DRUGB : Absorption of DRUGN is impaired in the presence of DRUGN .
Cholestyramine	drug	resins	group
false

DRUGA and DRUGN DRUGN : Absorption of DRUGB is impaired in the presence of DRUGN .
Cholestyramine	drug	hydrochlorothiazide	drug
false

DRUGA and DRUGN DRUGN : Absorption of DRUGN is impaired in the presence of DRUGB .
Cholestyramine	drug	anionic exchange resins	group
false

DRUGN and DRUGA DRUGB : Absorption of DRUGN is impaired in the presence of DRUGN .
colestipol	drug	resins	group
false

DRUGN and DRUGA DRUGN : Absorption of DRUGB is impaired in the presence of DRUGN .
colestipol	drug	hydrochlorothiazide	drug
false

DRUGN and DRUGA DRUGN : Absorption of DRUGN is impaired in the presence of DRUGB .
colestipol	drug	anionic exchange resins	group
false

DRUGN and DRUGN DRUGA : Absorption of DRUGB is impaired in the presence of DRUGN .
resins	group	hydrochlorothiazide	drug
false

DRUGN and DRUGN DRUGA : Absorption of DRUGN is impaired in the presence of DRUGB .
resins	group	anionic exchange resins	group
false

DRUGN and DRUGN DRUGN : Absorption of DRUGA is impaired in the presence of DRUGB .
hydrochlorothiazide	drug	anionic exchange resins	group
mechanism

Single doses of either DRUGA or DRUGB DRUGN bind the DRUGN and reduce its absorption from the gastrointestinal tract by up to dgb and dgb percent , respectively .
cholestyramine	drug	colestipol	drug
false

Single doses of either DRUGA or DRUGN DRUGB bind the DRUGN and reduce its absorption from the gastrointestinal tract by up to dgb and dgb percent , respectively .
cholestyramine	drug	resins	group
false

Single doses of either DRUGA or DRUGN DRUGN bind the DRUGB and reduce its absorption from the gastrointestinal tract by up to dgb and dgb percent , respectively .
cholestyramine	drug	hydrochlorothiazide	drug
mechanism

Single doses of either DRUGN or DRUGA DRUGB bind the DRUGN and reduce its absorption from the gastrointestinal tract by up to dgb and dgb percent , respectively .
colestipol	drug	resins	group
false

Single doses of either DRUGN or DRUGA DRUGN bind the DRUGB and reduce its absorption from the gastrointestinal tract by up to dgb and dgb percent , respectively .
colestipol	drug	hydrochlorothiazide	drug
mechanism

Single doses of either DRUGN or DRUGN DRUGA bind the DRUGB and reduce its absorption from the gastrointestinal tract by up to dgb and dgb percent , respectively .
resins	group	hydrochlorothiazide	drug
false

DRUGA , DRUGB : intensified electrolyte depletion , particularly hypokalemia .
Corticosteroids	group	ACTH	drug
false

DRUGA , nondepolarizing ( e.g . , DRUGB ) : possible increased responsiveness to the DRUGN .
Skeletal muscle relaxants	group	tubocurarine	drug
false

DRUGA , nondepolarizing ( e.g . , DRUGN ) : possible increased responsiveness to the DRUGB .
Skeletal muscle relaxants	group	muscle relaxant	group
false

DRUGN , nondepolarizing ( e.g . , DRUGA ) : possible increased responsiveness to the DRUGB .
tubocurarine	drug	muscle relaxant	group
false

DRUGA : generally should not be given with DRUGB .
Lithium	drug	diuretics	group
advise

DRUGA reduce the renal clearance of DRUGB and add a high risk of DRUGN toxicity .
Diuretic agents	group	lithium	drug
mechanism

DRUGA reduce the renal clearance of DRUGN and add a high risk of DRUGB toxicity .
Diuretic agents	group	lithium	drug
effect

Refer to the package insert for DRUGA preparations before use of such preparations with DRUGB .
lithium	drug	Hydrochlorothiazide	drug
advise

DRUGA : In some patients , the administration of a DRUGB can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGN and DRUGN .
Non-steroidal Anti-inflammatory Drugs	group	non-steroidal anti-inflammatory agent	group
false

DRUGA : In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGB , DRUGN and DRUGN .
Non-steroidal Anti-inflammatory Drugs	group	loop diuretics	group
false

DRUGA : In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGB and DRUGN .
Non-steroidal Anti-inflammatory Drugs	group	potassium-sparing diuretics	group
false

DRUGA : In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGN and DRUGB .
Non-steroidal Anti-inflammatory Drugs	group	thiazide diuretics	group
false

DRUGN : In some patients , the administration of a DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGB , DRUGN and DRUGN .
non-steroidal anti-inflammatory agent	group	loop diuretics	group
effect

DRUGN : In some patients , the administration of a DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGB and DRUGN .
non-steroidal anti-inflammatory agent	group	potassium-sparing diuretics	group
effect

DRUGN : In some patients , the administration of a DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGN and DRUGB .
non-steroidal anti-inflammatory agent	group	thiazide diuretics	group
effect

DRUGN : In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGA , DRUGB and DRUGN .
loop diuretics	group	potassium-sparing diuretics	group
false

DRUGN : In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGA , DRUGN and DRUGB .
loop diuretics	group	thiazide diuretics	group
false

DRUGN : In some patients , the administration of a DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGA and DRUGB .
potassium-sparing diuretics	group	thiazide diuretics	group
false

Therefore , when DRUGA and DRUGB are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGN is obtained .
Hydrochlorothiazide	drug	non-steroidal anti-inflammatory agents	group
advise

Therefore , when DRUGA and DRUGN are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGB is obtained .
Hydrochlorothiazide	drug	diuretic	group
false

Therefore , when DRUGN and DRUGA are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGB is obtained .
non-steroidal anti-inflammatory agents	group	diuretic	group
false

Patients receiving other DRUGA , DRUGB , DRUGN , or other DRUGN ( including DRUGN ) concomitantly with DRUGN and DRUGN tablets may exhibit an additive CNS depression .
narcotic analgesics	group	antipsychotics	group
false

Patients receiving other DRUGA , DRUGN , DRUGB , or other DRUGN ( including DRUGN ) concomitantly with DRUGN and DRUGN tablets may exhibit an additive CNS depression .
narcotic analgesics	group	antianxiety agents	group
false

Patients receiving other DRUGA , DRUGN , DRUGN , or other DRUGB ( including DRUGN ) concomitantly with DRUGN and DRUGN tablets may exhibit an additive CNS depression .
narcotic analgesics	group	CNS depressants	group
false

Patients receiving other DRUGA , DRUGN , DRUGN , or other DRUGN ( including DRUGB ) concomitantly with DRUGN and DRUGN tablets may exhibit an additive CNS depression .
narcotic analgesics	group	alcohol	drug
false

Patients receiving other DRUGA , DRUGN , DRUGN , or other DRUGN ( including DRUGN ) concomitantly with DRUGB and DRUGN tablets may exhibit an additive CNS depression .
narcotic analgesics	group	hydrocodone	drug
effect

Patients receiving other DRUGA , DRUGN , DRUGN , or other DRUGN ( including DRUGN ) concomitantly with DRUGN and DRUGB tablets may exhibit an additive CNS depression .
narcotic analgesics	group	acetaminophen	drug
false

Patients receiving other DRUGN , DRUGA , DRUGB , or other DRUGN ( including DRUGN ) concomitantly with DRUGN and DRUGN tablets may exhibit an additive CNS depression .
antipsychotics	group	antianxiety agents	group
false

Patients receiving other DRUGN , DRUGA , DRUGN , or other DRUGB ( including DRUGN ) concomitantly with DRUGN and DRUGN tablets may exhibit an additive CNS depression .
antipsychotics	group	CNS depressants	group
false

Patients receiving other DRUGN , DRUGA , DRUGN , or other DRUGN ( including DRUGB ) concomitantly with DRUGN and DRUGN tablets may exhibit an additive CNS depression .
antipsychotics	group	alcohol	drug
false

Patients receiving other DRUGN , DRUGA , DRUGN , or other DRUGN ( including DRUGN ) concomitantly with DRUGB and DRUGN tablets may exhibit an additive CNS depression .
antipsychotics	group	hydrocodone	drug
effect

Patients receiving other DRUGN , DRUGA , DRUGN , or other DRUGN ( including DRUGN ) concomitantly with DRUGN and DRUGB tablets may exhibit an additive CNS depression .
antipsychotics	group	acetaminophen	drug
false

Patients receiving other DRUGN , DRUGN , DRUGA , or other DRUGB ( including DRUGN ) concomitantly with DRUGN and DRUGN tablets may exhibit an additive CNS depression .
antianxiety agents	group	CNS depressants	group
false

Patients receiving other DRUGN , DRUGN , DRUGA , or other DRUGN ( including DRUGB ) concomitantly with DRUGN and DRUGN tablets may exhibit an additive CNS depression .
antianxiety agents	group	alcohol	drug
false

Patients receiving other DRUGN , DRUGN , DRUGA , or other DRUGN ( including DRUGN ) concomitantly with DRUGB and DRUGN tablets may exhibit an additive CNS depression .
antianxiety agents	group	hydrocodone	drug
effect

Patients receiving other DRUGN , DRUGN , DRUGA , or other DRUGN ( including DRUGN ) concomitantly with DRUGN and DRUGB tablets may exhibit an additive CNS depression .
antianxiety agents	group	acetaminophen	drug
false

Patients receiving other DRUGN , DRUGN , DRUGN , or other DRUGA ( including DRUGB ) concomitantly with DRUGN and DRUGN tablets may exhibit an additive CNS depression .
CNS depressants	group	alcohol	drug
false

Patients receiving other DRUGN , DRUGN , DRUGN , or other DRUGA ( including DRUGN ) concomitantly with DRUGB and DRUGN tablets may exhibit an additive CNS depression .
CNS depressants	group	hydrocodone	drug
effect

Patients receiving other DRUGN , DRUGN , DRUGN , or other DRUGA ( including DRUGN ) concomitantly with DRUGN and DRUGB tablets may exhibit an additive CNS depression .
CNS depressants	group	acetaminophen	drug
false

Patients receiving other DRUGN , DRUGN , DRUGN , or other DRUGN ( including DRUGA ) concomitantly with DRUGB and DRUGN tablets may exhibit an additive CNS depression .
alcohol	drug	hydrocodone	drug
effect

Patients receiving other DRUGN , DRUGN , DRUGN , or other DRUGN ( including DRUGA ) concomitantly with DRUGN and DRUGB tablets may exhibit an additive CNS depression .
alcohol	drug	acetaminophen	drug
false

Patients receiving other DRUGN , DRUGN , DRUGN , or other DRUGN ( including DRUGN ) concomitantly with DRUGA and DRUGB tablets may exhibit an additive CNS depression .
hydrocodone	drug	acetaminophen	drug
false

The use of DRUGA or DRUGB with DRUGN preparations may increase the effect of either the DRUGN or DRUGN .
MAO inhibitors	group	tricyclic antidepressants	group
false

The use of DRUGA or DRUGN with DRUGB preparations may increase the effect of either the DRUGN or DRUGN .
MAO inhibitors	group	hydrocodone	drug
effect

The use of DRUGA or DRUGN with DRUGN preparations may increase the effect of either the DRUGB or DRUGN .
MAO inhibitors	group	antidepressant	group
false

The use of DRUGA or DRUGN with DRUGN preparations may increase the effect of either the DRUGN or DRUGB .
MAO inhibitors	group	hydrocodone	drug
false

The use of DRUGN or DRUGA with DRUGB preparations may increase the effect of either the DRUGN or DRUGN .
tricyclic antidepressants	group	hydrocodone	drug
effect

The use of DRUGN or DRUGA with DRUGN preparations may increase the effect of either the DRUGB or DRUGN .
tricyclic antidepressants	group	antidepressant	group
false

The use of DRUGN or DRUGA with DRUGN preparations may increase the effect of either the DRUGN or DRUGB .
tricyclic antidepressants	group	hydrocodone	drug
false

The use of DRUGN or DRUGN with DRUGA preparations may increase the effect of either the DRUGB or DRUGN .
hydrocodone	drug	antidepressant	group
false

The use of DRUGN or DRUGN with DRUGN preparations may increase the effect of either the DRUGA or DRUGB .
antidepressant	group	hydrocodone	drug
false

The concurrent use of DRUGA with DRUGB may produce paralytic ileus .
anticholinergics	group	hydrocodone	drug
effect

DRUGA , other , especially DRUGB , or pre DRUGN and anesthetic agents used in surgery or DRUGN , nondepolarizing , used in surgery
Antihypertensive medications	group	diazoxide	drug
false

DRUGA , other , especially DRUGN , or pre DRUGB and anesthetic agents used in surgery or DRUGN , nondepolarizing , used in surgery
Antihypertensive medications	group	anesthetic	group
false

DRUGA , other , especially DRUGN , or pre DRUGN and anesthetic agents used in surgery or DRUGB , nondepolarizing , used in surgery
Antihypertensive medications	group	skeletal-muscle relaxants	group
false

DRUGN , other , especially DRUGA , or pre DRUGB and anesthetic agents used in surgery or DRUGN , nondepolarizing , used in surgery
diazoxide	drug	anesthetic	group
false

DRUGN , other , especially DRUGA , or pre DRUGN and anesthetic agents used in surgery or DRUGB , nondepolarizing , used in surgery
diazoxide	drug	skeletal-muscle relaxants	group
false

DRUGN , other , especially DRUGN , or pre DRUGA and anesthetic agents used in surgery or DRUGB , nondepolarizing , used in surgery
anesthetic	group	skeletal-muscle relaxants	group
false

DRUGA or DRUGB or DRUGN ( DRUGN )
Amphotericin B	drug	Corticosteroids	group
false

DRUGA or DRUGN or DRUGB ( DRUGN )
Amphotericin B	drug	Corticotropin	drug
false

DRUGA or DRUGN or DRUGN ( DRUGB )
Amphotericin B	drug	ACTH	drug
false

DRUGN or DRUGA or DRUGB ( DRUGN )
Corticosteroids	group	Corticotropin	drug
false

DRUGN or DRUGA or DRUGN ( DRUGB )
Corticosteroids	group	ACTH	drug
false

DRUGN or DRUGN or DRUGA ( DRUGB )
Corticotropin	drug	ACTH	drug
false

( Concurrent use with DRUGA may enhance the possibility of DRUGB toxicity associated with hypokalemia . )
thiazide diuretics	group	digitalis	group
effect

for adult onset diabetics , dosage adjustment of DRUGA may be necessary during and after DRUGB therapy ;
hypoglycemic medications	group	thiazide diuretic	group
advise

( Concurrent use with DRUGA is not recommended , as they may provoke DRUGB toxicity because of reduced renal clearance . )
thiazide diuretics	group	lithium	drug
false

( In some patients , the DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGB , DRUGN , and DRUGN .
steroidal anti-inflammatory agent	group	loop diuretics	group
effect

( In some patients , the DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGB , and DRUGN .
steroidal anti-inflammatory agent	group	potassium sparing diuretics	group
effect

( In some patients , the DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGN , and DRUGB .
steroidal anti-inflammatory agent	group	thiazide diuretics	group
effect

( In some patients , the DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGA , DRUGB , and DRUGN .
loop diuretics	group	potassium sparing diuretics	group
false

( In some patients , the DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGA , DRUGN , and DRUGB .
loop diuretics	group	thiazide diuretics	group
false

( In some patients , the DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGA , and DRUGB .
potassium sparing diuretics	group	thiazide diuretics	group
false

Therefore , when DRUGA and DRUGB are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGN is obtained . )
hydroflumethiazide	drug	nonsteroidal anti-inflammatory agents	group
advise

Therefore , when DRUGA and DRUGN are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGB is obtained . )
hydroflumethiazide	drug	diuretic	group
false

Therefore , when DRUGN and DRUGA are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGB is obtained . )
nonsteroidal anti-inflammatory agents	group	diuretic	group
false

( DRUGA may decrease arterial responsiveness to DRUGB .
Thiazides	group	norepinephrine	drug
effect

( DRUGA may increase the responsiveness to DRUGB . )
Thiazide drugs	group	tubocurarine	drug
effect

Patients receiving other DRUGA s , general DRUGB , DRUGN , DRUGN , DRUGN , DRUGN or other DRUGN ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
narcotic analgesic	group	anesthetics	group
false

Patients receiving other DRUGA s , general DRUGN , DRUGB , DRUGN , DRUGN , DRUGN or other DRUGN ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
narcotic analgesic	group	phenothiazines	group
false

Patients receiving other DRUGA s , general DRUGN , DRUGN , DRUGB , DRUGN , DRUGN or other DRUGN ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
narcotic analgesic	group	tranquilizers	group
false

Patients receiving other DRUGA s , general DRUGN , DRUGN , DRUGN , DRUGB , DRUGN or other DRUGN ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
narcotic analgesic	group	sedative-hypnotics	group
false

Patients receiving other DRUGA s , general DRUGN , DRUGN , DRUGN , DRUGN , DRUGB or other DRUGN ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
narcotic analgesic	group	tricyclic antidepressants	group
false

Patients receiving other DRUGA s , general DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or other DRUGB ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
narcotic analgesic	group	CNS depressants	group
false

Patients receiving other DRUGA s , general DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or other DRUGN ( including DRUGB ) concomitantly with DRUGN may exhibit an additive CNS depression .
narcotic analgesic	group	alcohol	drug
false

Patients receiving other DRUGA s , general DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or other DRUGN ( including DRUGN ) concomitantly with DRUGB may exhibit an additive CNS depression .
narcotic analgesic	group	DILAUDID	brand
effect

Patients receiving other DRUGN s , general DRUGA , DRUGB , DRUGN , DRUGN , DRUGN or other DRUGN ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
anesthetics	group	phenothiazines	group
false

Patients receiving other DRUGN s , general DRUGA , DRUGN , DRUGB , DRUGN , DRUGN or other DRUGN ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
anesthetics	group	tranquilizers	group
false

Patients receiving other DRUGN s , general DRUGA , DRUGN , DRUGN , DRUGB , DRUGN or other DRUGN ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
anesthetics	group	sedative-hypnotics	group
false

Patients receiving other DRUGN s , general DRUGA , DRUGN , DRUGN , DRUGN , DRUGB or other DRUGN ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
anesthetics	group	tricyclic antidepressants	group
false

Patients receiving other DRUGN s , general DRUGA , DRUGN , DRUGN , DRUGN , DRUGN or other DRUGB ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
anesthetics	group	CNS depressants	group
false

Patients receiving other DRUGN s , general DRUGA , DRUGN , DRUGN , DRUGN , DRUGN or other DRUGN ( including DRUGB ) concomitantly with DRUGN may exhibit an additive CNS depression .
anesthetics	group	alcohol	drug
false

Patients receiving other DRUGN s , general DRUGA , DRUGN , DRUGN , DRUGN , DRUGN or other DRUGN ( including DRUGN ) concomitantly with DRUGB may exhibit an additive CNS depression .
anesthetics	group	DILAUDID	brand
effect

Patients receiving other DRUGN s , general DRUGN , DRUGA , DRUGB , DRUGN , DRUGN or other DRUGN ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
phenothiazines	group	tranquilizers	group
false

Patients receiving other DRUGN s , general DRUGN , DRUGA , DRUGN , DRUGB , DRUGN or other DRUGN ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
phenothiazines	group	sedative-hypnotics	group
false

Patients receiving other DRUGN s , general DRUGN , DRUGA , DRUGN , DRUGN , DRUGB or other DRUGN ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
phenothiazines	group	tricyclic antidepressants	group
false

Patients receiving other DRUGN s , general DRUGN , DRUGA , DRUGN , DRUGN , DRUGN or other DRUGB ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
phenothiazines	group	CNS depressants	group
false

Patients receiving other DRUGN s , general DRUGN , DRUGA , DRUGN , DRUGN , DRUGN or other DRUGN ( including DRUGB ) concomitantly with DRUGN may exhibit an additive CNS depression .
phenothiazines	group	alcohol	drug
false

Patients receiving other DRUGN s , general DRUGN , DRUGA , DRUGN , DRUGN , DRUGN or other DRUGN ( including DRUGN ) concomitantly with DRUGB may exhibit an additive CNS depression .
phenothiazines	group	DILAUDID	brand
effect

Patients receiving other DRUGN s , general DRUGN , DRUGN , DRUGA , DRUGB , DRUGN or other DRUGN ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
tranquilizers	group	sedative-hypnotics	group
false

Patients receiving other DRUGN s , general DRUGN , DRUGN , DRUGA , DRUGN , DRUGB or other DRUGN ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
tranquilizers	group	tricyclic antidepressants	group
false

Patients receiving other DRUGN s , general DRUGN , DRUGN , DRUGA , DRUGN , DRUGN or other DRUGB ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
tranquilizers	group	CNS depressants	group
false

Patients receiving other DRUGN s , general DRUGN , DRUGN , DRUGA , DRUGN , DRUGN or other DRUGN ( including DRUGB ) concomitantly with DRUGN may exhibit an additive CNS depression .
tranquilizers	group	alcohol	drug
false

Patients receiving other DRUGN s , general DRUGN , DRUGN , DRUGA , DRUGN , DRUGN or other DRUGN ( including DRUGN ) concomitantly with DRUGB may exhibit an additive CNS depression .
tranquilizers	group	DILAUDID	brand
effect

Patients receiving other DRUGN s , general DRUGN , DRUGN , DRUGN , DRUGA , DRUGB or other DRUGN ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
sedative-hypnotics	group	tricyclic antidepressants	group
false

Patients receiving other DRUGN s , general DRUGN , DRUGN , DRUGN , DRUGA , DRUGN or other DRUGB ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
sedative-hypnotics	group	CNS depressants	group
false

Patients receiving other DRUGN s , general DRUGN , DRUGN , DRUGN , DRUGA , DRUGN or other DRUGN ( including DRUGB ) concomitantly with DRUGN may exhibit an additive CNS depression .
sedative-hypnotics	group	alcohol	drug
false

Patients receiving other DRUGN s , general DRUGN , DRUGN , DRUGN , DRUGA , DRUGN or other DRUGN ( including DRUGN ) concomitantly with DRUGB may exhibit an additive CNS depression .
sedative-hypnotics	group	DILAUDID	brand
effect

Patients receiving other DRUGN s , general DRUGN , DRUGN , DRUGN , DRUGN , DRUGA or other DRUGB ( including DRUGN ) concomitantly with DRUGN may exhibit an additive CNS depression .
tricyclic antidepressants	group	CNS depressants	group
false

Patients receiving other DRUGN s , general DRUGN , DRUGN , DRUGN , DRUGN , DRUGA or other DRUGN ( including DRUGB ) concomitantly with DRUGN may exhibit an additive CNS depression .
tricyclic antidepressants	group	alcohol	drug
false

Patients receiving other DRUGN s , general DRUGN , DRUGN , DRUGN , DRUGN , DRUGA or other DRUGN ( including DRUGN ) concomitantly with DRUGB may exhibit an additive CNS depression .
tricyclic antidepressants	group	DILAUDID	brand
effect

Patients receiving other DRUGN s , general DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or other DRUGA ( including DRUGB ) concomitantly with DRUGN may exhibit an additive CNS depression .
CNS depressants	group	alcohol	drug
false

Patients receiving other DRUGN s , general DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or other DRUGA ( including DRUGN ) concomitantly with DRUGB may exhibit an additive CNS depression .
CNS depressants	group	DILAUDID	brand
effect

Patients receiving other DRUGN s , general DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or other DRUGN ( including DRUGA ) concomitantly with DRUGB may exhibit an additive CNS depression .
alcohol	drug	DILAUDID	brand
effect

Since DRUGA may raise the serum uric acid level , dosage adjustment of DRUGB may be necessary
hydroxyurea	drug	uricosuric medication	group
effect

THE POTENTIATING ACTION OF DRUGA MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH DRUGB SUCH AS DRUGN , DRUGN AND DRUGN .
HYDROXYZINE	drug	CENTRAL NERVOUS SYSTEM DEPRESSANTS	group
effect

THE POTENTIATING ACTION OF DRUGA MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH DRUGN SUCH AS DRUGB , DRUGN AND DRUGN .
HYDROXYZINE	drug	NARCOTICS	group
effect

THE POTENTIATING ACTION OF DRUGA MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH DRUGN SUCH AS DRUGN , DRUGB AND DRUGN .
HYDROXYZINE	drug	NON-NARCOTIC ANALGESICS	group
effect

THE POTENTIATING ACTION OF DRUGA MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH DRUGN SUCH AS DRUGN , DRUGN AND DRUGB .
HYDROXYZINE	drug	BARBITURATES	group
effect

THE POTENTIATING ACTION OF DRUGN MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH DRUGA SUCH AS DRUGB , DRUGN AND DRUGN .
CENTRAL NERVOUS SYSTEM DEPRESSANTS	group	NARCOTICS	group
false

THE POTENTIATING ACTION OF DRUGN MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH DRUGA SUCH AS DRUGN , DRUGB AND DRUGN .
CENTRAL NERVOUS SYSTEM DEPRESSANTS	group	NON-NARCOTIC ANALGESICS	group
false

THE POTENTIATING ACTION OF DRUGN MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH DRUGA SUCH AS DRUGN , DRUGN AND DRUGB .
CENTRAL NERVOUS SYSTEM DEPRESSANTS	group	BARBITURATES	group
false

THE POTENTIATING ACTION OF DRUGN MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH DRUGN SUCH AS DRUGA , DRUGB AND DRUGN .
NARCOTICS	group	NON-NARCOTIC ANALGESICS	group
false

THE POTENTIATING ACTION OF DRUGN MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH DRUGN SUCH AS DRUGA , DRUGN AND DRUGB .
NARCOTICS	group	BARBITURATES	group
false

THE POTENTIATING ACTION OF DRUGN MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH DRUGN SUCH AS DRUGN , DRUGA AND DRUGB .
NON-NARCOTIC ANALGESICS	group	BARBITURATES	group
false

Therefore when DRUGA are administered concomitantly with DRUGB their dosage should be reduced .
central nervous system depressants	group	hydroxyzine	drug
advise

Patients should be advised against the simultaneous use of other DRUGA , and cautioned that the effect of DRUGB may be increased .
CNS depressant drugs	group	alcohol	drug
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGA is administered concomitantly with other DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or some DRUGN .
LEVSIN	brand	antimuscarinics	group
effect

Additive adverse effects resulting from cholinergic blockade may occur when DRUGA is administered concomitantly with other DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN or some DRUGN .
LEVSIN	brand	amantadine	drug
effect

Additive adverse effects resulting from cholinergic blockade may occur when DRUGA is administered concomitantly with other DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN or some DRUGN .
LEVSIN	brand	haloperidol	drug
effect

Additive adverse effects resulting from cholinergic blockade may occur when DRUGA is administered concomitantly with other DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN or some DRUGN .
LEVSIN	brand	phenothiazines	group
effect

Additive adverse effects resulting from cholinergic blockade may occur when DRUGA is administered concomitantly with other DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN or some DRUGN .
LEVSIN	brand	monoamine oxidase (MAO) inhibitors	group
effect

Additive adverse effects resulting from cholinergic blockade may occur when DRUGA is administered concomitantly with other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB or some DRUGN .
LEVSIN	brand	tricyclic antidepressants	group
effect

Additive adverse effects resulting from cholinergic blockade may occur when DRUGA is administered concomitantly with other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or some DRUGB .
LEVSIN	brand	antihistamines	group
effect

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN or some DRUGN .
antimuscarinics	group	amantadine	drug
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN or some DRUGN .
antimuscarinics	group	haloperidol	drug
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN or some DRUGN .
antimuscarinics	group	phenothiazines	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN or some DRUGN .
antimuscarinics	group	monoamine oxidase (MAO) inhibitors	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB or some DRUGN .
antimuscarinics	group	tricyclic antidepressants	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or some DRUGB .
antimuscarinics	group	antihistamines	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN or some DRUGN .
amantadine	drug	haloperidol	drug
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN or some DRUGN .
amantadine	drug	phenothiazines	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN or some DRUGN .
amantadine	drug	monoamine oxidase (MAO) inhibitors	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB or some DRUGN .
amantadine	drug	tricyclic antidepressants	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN or some DRUGB .
amantadine	drug	antihistamines	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN or some DRUGN .
haloperidol	drug	phenothiazines	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN or some DRUGN .
haloperidol	drug	monoamine oxidase (MAO) inhibitors	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB or some DRUGN .
haloperidol	drug	tricyclic antidepressants	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN or some DRUGB .
haloperidol	drug	antihistamines	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN or some DRUGN .
phenothiazines	group	monoamine oxidase (MAO) inhibitors	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB or some DRUGN .
phenothiazines	group	tricyclic antidepressants	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN or some DRUGB .
phenothiazines	group	antihistamines	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB or some DRUGN .
monoamine oxidase (MAO) inhibitors	group	tricyclic antidepressants	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN or some DRUGB .
monoamine oxidase (MAO) inhibitors	group	antihistamines	group
false

Additive adverse effects resulting from cholinergic blockade may occur when DRUGN is administered concomitantly with other DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA or some DRUGB .
tricyclic antidepressants	group	antihistamines	group
false

DRUGA may interfere with the absorption of DRUGB .
Antacids	group	LEVSIN	brand
mechanism

DRUGA Supplements / DRUGB
Calcium	drug	Antacids	group
false

Products containing DRUGA and other multivalent cations ( such as DRUGB , DRUGN , DRUGN ) are likely to interfere with absorption of DRUGN .
calcium	drug	aluminum	drug
false

Products containing DRUGA and other multivalent cations ( such as DRUGN , DRUGB , DRUGN ) are likely to interfere with absorption of DRUGN .
calcium	drug	magnesium	drug
false

Products containing DRUGA and other multivalent cations ( such as DRUGN , DRUGN , DRUGB ) are likely to interfere with absorption of DRUGN .
calcium	drug	iron	drug
false

Products containing DRUGA and other multivalent cations ( such as DRUGN , DRUGN , DRUGN ) are likely to interfere with absorption of DRUGB .
calcium	drug	Ibandronate	drug
mechanism

Products containing DRUGN and other multivalent cations ( such as DRUGA , DRUGB , DRUGN ) are likely to interfere with absorption of DRUGN .
aluminum	drug	magnesium	drug
false

Products containing DRUGN and other multivalent cations ( such as DRUGA , DRUGN , DRUGB ) are likely to interfere with absorption of DRUGN .
aluminum	drug	iron	drug
false

Products containing DRUGN and other multivalent cations ( such as DRUGA , DRUGN , DRUGN ) are likely to interfere with absorption of DRUGB .
aluminum	drug	Ibandronate	drug
mechanism

Products containing DRUGN and other multivalent cations ( such as DRUGN , DRUGA , DRUGB ) are likely to interfere with absorption of DRUGN .
magnesium	drug	iron	drug
false

Products containing DRUGN and other multivalent cations ( such as DRUGN , DRUGA , DRUGN ) are likely to interfere with absorption of DRUGB .
magnesium	drug	Ibandronate	drug
mechanism

Products containing DRUGN and other multivalent cations ( such as DRUGN , DRUGN , DRUGA ) are likely to interfere with absorption of DRUGB .
iron	drug	Ibandronate	drug
mechanism

DRUGA should be taken at least dgb minutes before any oral medications containing multivalent cations ( including DRUGB , supplements or DRUGN ) .
Ibandronate	drug	antacids	group
advise

DRUGA should be taken at least dgb minutes before any oral medications containing multivalent cations ( including DRUGN , supplements or DRUGB ) .
Ibandronate	drug	vitamins	group
advise

DRUGN should be taken at least dgb minutes before any oral medications containing multivalent cations ( including DRUGA , supplements or DRUGB ) .
antacids	group	vitamins	group
false

DRUGA and DRUGB ( DRUGN )
H2 Blockers	group	Proton Pump Inhibitors	group
false

DRUGA and DRUGN ( DRUGB )
H2 Blockers	group	PPIs	group
false

DRUGN and DRUGA ( DRUGB )
Proton Pump Inhibitors	group	PPIs	group
false

Of over dgb patients enrolled in the DRUGA osteoporosis Treatment and Prevention Studies , dgb % used anti peptic agents ( primarily DRUGB and DRUGN ) .
Ibandronate	drug	H2 blockers	group
false

Of over dgb patients enrolled in the DRUGA osteoporosis Treatment and Prevention Studies , dgb % used anti peptic agents ( primarily DRUGN and DRUGB ) .
Ibandronate	drug	PPIs	group
false

Of over dgb patients enrolled in the DRUGN osteoporosis Treatment and Prevention Studies , dgb % used anti peptic agents ( primarily DRUGA and DRUGB ) .
H2 blockers	group	PPIs	group
false

DRUGA / DRUGB s ( DRUGN )
Aspirin	brand	Nonsteroidal Antiinflammatory Drug	group
false

DRUGA / DRUGN s ( DRUGB )
Aspirin	brand	NSAIDs	group
false

DRUGN / DRUGA s ( DRUGB )
Nonsteroidal Antiinflammatory Drug	group	NSAIDs	group
false

In the large , placebo controlled osteoporosis Treatment Study , DRUGA and DRUGB were taken by dgb % of the dgb patients .
aspirin	brand	nonsteroidal anti-inflammatory drugs	group
false

Among DRUGA or DRUGB users , the incidence of upper gastrointestinal adverse events in patients treated with DRUGN dga mg daily ( dga % ) was similar to that in placebo treated patients ( dga % ) .
aspirin	brand	NSAID	group
false

Among DRUGA or DRUGN users , the incidence of upper gastrointestinal adverse events in patients treated with DRUGB dga mg daily ( dga % ) was similar to that in placebo treated patients ( dga % ) .
aspirin	brand	ibandronate	drug
false

Among DRUGN or DRUGA users , the incidence of upper gastrointestinal adverse events in patients treated with DRUGB dga mg daily ( dga % ) was similar to that in placebo treated patients ( dga % ) .
NSAID	group	ibandronate	drug
false

Similarly , in the dgb year monthly comparison study , DRUGA and DRUGB were taken by dgb % of the dgb patients .
aspirin	brand	nonsteroidal anti-inflammatory drugs	group
false

The incidence of upper gastrointestinal events in patients concomitantly taking DRUGA or DRUGB was similar in patients taking DRUGN dga mg daily ( dga % ) and dgb mg once monthly ( dga % ) .
aspirin	brand	NSAIDs	group
false

The incidence of upper gastrointestinal events in patients concomitantly taking DRUGA or DRUGN was similar in patients taking DRUGB dga mg daily ( dga % ) and dgb mg once monthly ( dga % ) .
aspirin	brand	ibandronate	drug
false

The incidence of upper gastrointestinal events in patients concomitantly taking DRUGN or DRUGA was similar in patients taking DRUGB dga mg daily ( dga % ) and dgb mg once monthly ( dga % ) .
NSAIDs	group	ibandronate	drug
false

However , since DRUGA , DRUGB , and DRUGN are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of DRUGN or DRUGN with DRUGN .
aspirin	brand	NSAIDs	group
false

However , since DRUGA , DRUGN , and DRUGB are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of DRUGN or DRUGN with DRUGN .
aspirin	brand	bisphosphonates	group
false

However , since DRUGA , DRUGN , and DRUGN are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of DRUGN or DRUGB with DRUGN .
aspirin	brand	NSAIDs	group
false

However , since DRUGA , DRUGN , and DRUGN are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of DRUGN or DRUGN with DRUGB .
aspirin	brand	Ibandronate	drug
false

However , since DRUGN , DRUGA , and DRUGB are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of DRUGN or DRUGN with DRUGN .
NSAIDs	group	bisphosphonates	group
false

However , since DRUGN , DRUGA , and DRUGN are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of DRUGB or DRUGN with DRUGN .
NSAIDs	group	aspirin	brand
false

However , since DRUGN , DRUGA , and DRUGN are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of DRUGN or DRUGN with DRUGB .
NSAIDs	group	Ibandronate	drug
false

However , since DRUGN , DRUGN , and DRUGA are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of DRUGB or DRUGN with DRUGN .
bisphosphonates	group	aspirin	brand
false

However , since DRUGN , DRUGN , and DRUGA are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of DRUGN or DRUGB with DRUGN .
bisphosphonates	group	NSAIDs	group
false

However , since DRUGN , DRUGN , and DRUGA are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of DRUGN or DRUGN with DRUGB .
bisphosphonates	group	Ibandronate	drug
false

However , since DRUGN , DRUGN , and DRUGN are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of DRUGA or DRUGB with DRUGN .
aspirin	brand	NSAIDs	group
false

However , since DRUGN , DRUGN , and DRUGN are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of DRUGA or DRUGN with DRUGB .
aspirin	brand	Ibandronate	drug
advise

However , since DRUGN , DRUGN , and DRUGN are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of DRUGN or DRUGA with DRUGB .
NSAIDs	group	Ibandronate	drug
advise

DRUGA : Several short term controlled studies failed to wshow that DRUGB significantly affected prothrombin times or a variety of other clotting factors when administered to individuals on DRUGN .
Coumarin-Type Anticoagulants	group	ibuprofen	drug
false

DRUGA : Several short term controlled studies failed to wshow that DRUGN significantly affected prothrombin times or a variety of other clotting factors when administered to individuals on DRUGB .
Coumarin-Type Anticoagulants	group	coumarin-type anticoagulants	group
false

DRUGN : Several short term controlled studies failed to wshow that DRUGA significantly affected prothrombin times or a variety of other clotting factors when administered to individuals on DRUGB .
ibuprofen	drug	coumarin-type anticoagulants	group
false

However , because bleeding has been reported when DRUGA and other DRUGB have been administered to patients on DRUGN , the physician should be cautious when administering DRUGN to patients on DRUGN .
ibuprofen	drug	nonsteroidal anti-inflammatory agents	group
false

However , because bleeding has been reported when DRUGA and other DRUGN have been administered to patients on DRUGB , the physician should be cautious when administering DRUGN to patients on DRUGN .
ibuprofen	drug	coumarin-type anticoagulants	group
effect

However , because bleeding has been reported when DRUGA and other DRUGN have been administered to patients on DRUGN , the physician should be cautious when administering DRUGN to patients on DRUGB .
ibuprofen	drug	anticoagulants	group
false

However , because bleeding has been reported when DRUGN and other DRUGA have been administered to patients on DRUGB , the physician should be cautious when administering DRUGN to patients on DRUGN .
nonsteroidal anti-inflammatory agents	group	coumarin-type anticoagulants	group
effect

However , because bleeding has been reported when DRUGN and other DRUGA have been administered to patients on DRUGN , the physician should be cautious when administering DRUGB to patients on DRUGN .
nonsteroidal anti-inflammatory agents	group	ibuprofen	drug
false

However , because bleeding has been reported when DRUGN and other DRUGA have been administered to patients on DRUGN , the physician should be cautious when administering DRUGN to patients on DRUGB .
nonsteroidal anti-inflammatory agents	group	anticoagulants	group
false

However , because bleeding has been reported when DRUGN and other DRUGN have been administered to patients on DRUGA , the physician should be cautious when administering DRUGB to patients on DRUGN .
coumarin-type anticoagulants	group	ibuprofen	drug
false

However , because bleeding has been reported when DRUGN and other DRUGN have been administered to patients on DRUGA , the physician should be cautious when administering DRUGN to patients on DRUGB .
coumarin-type anticoagulants	group	anticoagulants	group
false

However , because bleeding has been reported when DRUGN and other DRUGN have been administered to patients on DRUGN , the physician should be cautious when administering DRUGA to patients on DRUGB .
ibuprofen	drug	anticoagulants	group
advise

DRUGA : Animal studies wshow that DRUGB given with DRUGN , including DRUGN , yields a net decrease in anti inflammatory activity with lowered blood levels of the non aspirin drug .
Aspirin	brand	aspirin	brand
false

DRUGA : Animal studies wshow that DRUGN given with DRUGB , including DRUGN , yields a net decrease in anti inflammatory activity with lowered blood levels of the non aspirin drug .
Aspirin	brand	nonsteroidal anti-inflammatory agents	group
false

DRUGA : Animal studies wshow that DRUGN given with DRUGN , including DRUGB , yields a net decrease in anti inflammatory activity with lowered blood levels of the non aspirin drug .
Aspirin	brand	ibuprofen	drug
false

DRUGN : Animal studies wshow that DRUGA given with DRUGB , including DRUGN , yields a net decrease in anti inflammatory activity with lowered blood levels of the non aspirin drug .
aspirin	brand	nonsteroidal anti-inflammatory agents	group
effect

DRUGN : Animal studies wshow that DRUGA given with DRUGN , including DRUGB , yields a net decrease in anti inflammatory activity with lowered blood levels of the non aspirin drug .
aspirin	brand	ibuprofen	drug
effect

DRUGN : Animal studies wshow that DRUGN given with DRUGA , including DRUGB , yields a net decrease in anti inflammatory activity with lowered blood levels of the non aspirin drug .
nonsteroidal anti-inflammatory agents	group	ibuprofen	drug
false

Single dose bioavailability studies in normal volunteers have failed to wshow an effect of DRUGA on DRUGB blood levels .
aspirin	brand	ibuprofen	drug
false

DRUGA : DRUGB , as well as other DRUGN , probably reduces the tubular secretion of DRUGN based on in vitro studies in rabbit kidney slices .
Methotrexate	drug	Ibuprofen	drug
false

DRUGA : DRUGN , as well as other DRUGB , probably reduces the tubular secretion of DRUGN based on in vitro studies in rabbit kidney slices .
Methotrexate	drug	nonsteroidal anti-inflammatory drugs	group
false

DRUGA : DRUGN , as well as other DRUGN , probably reduces the tubular secretion of DRUGB based on in vitro studies in rabbit kidney slices .
Methotrexate	drug	methotrexate	drug
false

DRUGN : DRUGA , as well as other DRUGB , probably reduces the tubular secretion of DRUGN based on in vitro studies in rabbit kidney slices .
Ibuprofen	drug	nonsteroidal anti-inflammatory drugs	group
false

DRUGN : DRUGA , as well as other DRUGN , probably reduces the tubular secretion of DRUGB based on in vitro studies in rabbit kidney slices .
Ibuprofen	drug	methotrexate	drug
mechanism

DRUGN : DRUGN , as well as other DRUGA , probably reduces the tubular secretion of DRUGB based on in vitro studies in rabbit kidney slices .
nonsteroidal anti-inflammatory drugs	group	methotrexate	drug
mechanism

This may indicate that DRUGA could enhance the toxicity of DRUGB .
ibuprofen	drug	methotrexate	drug
effect

Caution should be used if DRUGA is administered concomitantly with DRUGB .
ibuprofen	drug	methotrexate	drug
advise

H dgb Antagonists : In studies with human volunteers , co administration of DRUGA or DRUGB with DRUGN had no substantive effect on DRUGN serum concentrations .
cimetidine	drug	ranitidine	drug
false

H dgb Antagonists : In studies with human volunteers , co administration of DRUGA or DRUGN with DRUGB had no substantive effect on DRUGN serum concentrations .
cimetidine	drug	ibuprofen	drug
false

H dgb Antagonists : In studies with human volunteers , co administration of DRUGA or DRUGN with DRUGN had no substantive effect on DRUGB serum concentrations .
cimetidine	drug	ibuprofen	drug
false

H dgb Antagonists : In studies with human volunteers , co administration of DRUGN or DRUGA with DRUGB had no substantive effect on DRUGN serum concentrations .
ranitidine	drug	ibuprofen	drug
false

H dgb Antagonists : In studies with human volunteers , co administration of DRUGN or DRUGA with DRUGN had no substantive effect on DRUGB serum concentrations .
ranitidine	drug	ibuprofen	drug
false

DRUGA : Clinical studies , as well as random observations , have shown that DRUGB can reduce the natriuretic effect of DRUGN and DRUGN in some patients .
Furosemide	drug	ibuprofen	drug
false

DRUGA : Clinical studies , as well as random observations , have shown that DRUGN can reduce the natriuretic effect of DRUGB and DRUGN in some patients .
Furosemide	drug	furosemide	drug
false

DRUGA : Clinical studies , as well as random observations , have shown that DRUGN can reduce the natriuretic effect of DRUGN and DRUGB in some patients .
Furosemide	drug	thiazides	group
false

DRUGN : Clinical studies , as well as random observations , have shown that DRUGA can reduce the natriuretic effect of DRUGB and DRUGN in some patients .
ibuprofen	drug	furosemide	drug
effect

DRUGN : Clinical studies , as well as random observations , have shown that DRUGA can reduce the natriuretic effect of DRUGN and DRUGB in some patients .
ibuprofen	drug	thiazides	group
effect

DRUGN : Clinical studies , as well as random observations , have shown that DRUGN can reduce the natriuretic effect of DRUGA and DRUGB in some patients .
furosemide	drug	thiazides	group
false

During concomitant therapy with DRUGA , the patient should be observed closely for signs of renal failure , as well as to assure DRUGB efficacy .
ibuprofen	drug	diuretic	group
false

DRUGA : DRUGB produced an elevation of plasma DRUGN levels and a reduction in renal DRUGN clearance in a study of eleven normal volunteers .
Lithium	drug	Ibuprofen	drug
false

DRUGA : DRUGN produced an elevation of plasma DRUGB levels and a reduction in renal DRUGN clearance in a study of eleven normal volunteers .
Lithium	drug	lithium	drug
false

DRUGA : DRUGN produced an elevation of plasma DRUGN levels and a reduction in renal DRUGB clearance in a study of eleven normal volunteers .
Lithium	drug	lithium	drug
false

DRUGN : DRUGA produced an elevation of plasma DRUGB levels and a reduction in renal DRUGN clearance in a study of eleven normal volunteers .
Ibuprofen	drug	lithium	drug
mechanism

DRUGN : DRUGA produced an elevation of plasma DRUGN levels and a reduction in renal DRUGB clearance in a study of eleven normal volunteers .
Ibuprofen	drug	lithium	drug
false

Thus , when DRUGA and DRUGB are administered concurrently , subjects should be observed carefully for signs of DRUGN toxicity .
ibuprofen	drug	lithium	drug
advise

Thus , when DRUGA and DRUGN are administered concurrently , subjects should be observed carefully for signs of DRUGB toxicity .
ibuprofen	drug	lithium	drug
false

DRUGA : Supraventricular arrhythmias may mask the cardiotoxicity associated with excessive DRUGB levels .
Digoxin	drug	digoxin	drug
false

Coadministration of DRUGA did not have effects on either the safety or efficacy of DRUGB in the clinical trials .
digoxin	drug	ibutilide	drug
false

DRUGA : Coadministration of DRUGB did not have any effect on either the safety or efficacy of DRUGN in the clinical trials .
Calcium channel blocking agents	group	calcium channel blockers	group
false

DRUGA : Coadministration of DRUGN did not have any effect on either the safety or efficacy of DRUGB in the clinical trials .
Calcium channel blocking agents	group	ibutilide	drug
false

DRUGN : Coadministration of DRUGA did not have any effect on either the safety or efficacy of DRUGB in the clinical trials .
calcium channel blockers	group	ibutilide	drug
false

DRUGA : Coadministration of DRUGB did not have any effect on either the safety or efficacy of DRUGN in the clinical trials .
Beta-adrenergic blocking agents	group	beta-adrenergic blocking agents	group
false

DRUGA : Coadministration of DRUGN did not have any effect on either the safety or efficacy of DRUGB in the clinical trials .
Beta-adrenergic blocking agents	group	ibutilide	drug
false

DRUGN : Coadministration of DRUGA did not have any effect on either the safety or efficacy of DRUGB in the clinical trials .
beta-adrenergic blocking agents	group	ibutilide	drug
false

In patients using DRUGA ( DRUGB and others ) , plasma levels of calcium , potassium and magnesium must be carefully monitored .
cardiac glycosides	group	digoxin	drug
false

DRUGA : A clinical study in dgb insulin dependent diabetic patients demonstrated no effect of DRUGB on DRUGN absorption from the peritoneal cavity or on DRUGN s ability to control blood glucose when DRUGN was administered intraperitoneally with DRUGN .
Insulin	drug	EXTRANEAL	brand
false

DRUGA : A clinical study in dgb insulin dependent diabetic patients demonstrated no effect of DRUGN on DRUGB absorption from the peritoneal cavity or on DRUGN s ability to control blood glucose when DRUGN was administered intraperitoneally with DRUGN .
Insulin	drug	insulin	drug
false

DRUGA : A clinical study in dgb insulin dependent diabetic patients demonstrated no effect of DRUGN on DRUGN absorption from the peritoneal cavity or on DRUGB s ability to control blood glucose when DRUGN was administered intraperitoneally with DRUGN .
Insulin	drug	insulin	drug
false

DRUGA : A clinical study in dgb insulin dependent diabetic patients demonstrated no effect of DRUGN on DRUGN absorption from the peritoneal cavity or on DRUGN s ability to control blood glucose when DRUGB was administered intraperitoneally with DRUGN .
Insulin	drug	insulin	drug
false

DRUGA : A clinical study in dgb insulin dependent diabetic patients demonstrated no effect of DRUGN on DRUGN absorption from the peritoneal cavity or on DRUGN s ability to control blood glucose when DRUGN was administered intraperitoneally with DRUGB .
Insulin	drug	EXTRANEAL	brand
false

DRUGN : A clinical study in dgb insulin dependent diabetic patients demonstrated no effect of DRUGA on DRUGB absorption from the peritoneal cavity or on DRUGN s ability to control blood glucose when DRUGN was administered intraperitoneally with DRUGN .
EXTRANEAL	brand	insulin	drug
false

DRUGN : A clinical study in dgb insulin dependent diabetic patients demonstrated no effect of DRUGA on DRUGN absorption from the peritoneal cavity or on DRUGB s ability to control blood glucose when DRUGN was administered intraperitoneally with DRUGN .
EXTRANEAL	brand	insulin	drug
false

DRUGN : A clinical study in dgb insulin dependent diabetic patients demonstrated no effect of DRUGA on DRUGN absorption from the peritoneal cavity or on DRUGN s ability to control blood glucose when DRUGB was administered intraperitoneally with DRUGN .
EXTRANEAL	brand	insulin	drug
false

DRUGN : A clinical study in dgb insulin dependent diabetic patients demonstrated no effect of DRUGN on DRUGA absorption from the peritoneal cavity or on DRUGN s ability to control blood glucose when DRUGN was administered intraperitoneally with DRUGB .
insulin	drug	EXTRANEAL	brand
false

DRUGN : A clinical study in dgb insulin dependent diabetic patients demonstrated no effect of DRUGN on DRUGN absorption from the peritoneal cavity or on DRUGA s ability to control blood glucose when DRUGN was administered intraperitoneally with DRUGB .
insulin	drug	EXTRANEAL	brand
false

DRUGN : A clinical study in dgb insulin dependent diabetic patients demonstrated no effect of DRUGN on DRUGN absorption from the peritoneal cavity or on DRUGN s ability to control blood glucose when DRUGA was administered intraperitoneally with DRUGB .
insulin	drug	EXTRANEAL	brand
false

However , appropriate monitoring of blood glucose should be performed when initiating DRUGA in diabetic patients and DRUGB dosage should be adjusted if needed .
EXTRANEAL	brand	insulin	drug
advise

DRUGA : No human drug interaction studies with DRUGB were conducted .
Heparin	drug	heparin	drug
false

In vitro studies demonstrated no evidence of incompatibility of DRUGA with DRUGB .
heparin	drug	EXTRANEAL	brand
false

DRUGA : No human drug interaction studies with DRUGB were conducted .
Antibiotics	group	antibiotics	group
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGA , DRUGB , DRUGN , DRUGN / flucoxacillin , DRUGN , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
vancomycin	drug	cefazolin	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGA , DRUGN , DRUGB , DRUGN / flucoxacillin , DRUGN , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
vancomycin	drug	ampicillin	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGA , DRUGN , DRUGN , DRUGB / flucoxacillin , DRUGN , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
vancomycin	drug	ampicillin	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGA , DRUGN , DRUGN , DRUGN / flucoxacillin , DRUGB , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
vancomycin	drug	ceftazidime	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGA , DRUGN , DRUGN , DRUGN / flucoxacillin , DRUGN , DRUGB , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
vancomycin	drug	gentamicin	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGA , DRUGN , DRUGN , DRUGN / flucoxacillin , DRUGN , DRUGN , and DRUGB demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
vancomycin	drug	amphotericin	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGA , DRUGN , DRUGN , DRUGN / flucoxacillin , DRUGN , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGB with DRUGN .
vancomycin	drug	antibiotics	group
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGA , DRUGN , DRUGN , DRUGN / flucoxacillin , DRUGN , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGB .
vancomycin	drug	EXTRANEAL	brand
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGA , DRUGB , DRUGN / flucoxacillin , DRUGN , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
cefazolin	drug	ampicillin	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGA , DRUGN , DRUGB / flucoxacillin , DRUGN , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
cefazolin	drug	ampicillin	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGA , DRUGN , DRUGN / flucoxacillin , DRUGB , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
cefazolin	drug	ceftazidime	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGA , DRUGN , DRUGN / flucoxacillin , DRUGN , DRUGB , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
cefazolin	drug	gentamicin	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGA , DRUGN , DRUGN / flucoxacillin , DRUGN , DRUGN , and DRUGB demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
cefazolin	drug	amphotericin	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGA , DRUGN , DRUGN / flucoxacillin , DRUGN , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGB with DRUGN .
cefazolin	drug	antibiotics	group
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGA , DRUGN , DRUGN / flucoxacillin , DRUGN , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGB .
cefazolin	drug	EXTRANEAL	brand
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGA , DRUGN / flucoxacillin , DRUGB , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
ampicillin	drug	ceftazidime	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGA , DRUGN / flucoxacillin , DRUGN , DRUGB , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
ampicillin	drug	gentamicin	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGA , DRUGN / flucoxacillin , DRUGN , DRUGN , and DRUGB demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
ampicillin	drug	amphotericin	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGA , DRUGN / flucoxacillin , DRUGN , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGB with DRUGN .
ampicillin	drug	antibiotics	group
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGA , DRUGN / flucoxacillin , DRUGN , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGB .
ampicillin	drug	EXTRANEAL	brand
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGN , DRUGA / flucoxacillin , DRUGB , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
ampicillin	drug	ceftazidime	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGN , DRUGA / flucoxacillin , DRUGN , DRUGB , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
ampicillin	drug	gentamicin	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGN , DRUGA / flucoxacillin , DRUGN , DRUGN , and DRUGB demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
ampicillin	drug	amphotericin	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGN , DRUGA / flucoxacillin , DRUGN , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGB with DRUGN .
ampicillin	drug	antibiotics	group
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGN , DRUGA / flucoxacillin , DRUGN , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGB .
ampicillin	drug	EXTRANEAL	brand
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGN , DRUGN / flucoxacillin , DRUGA , DRUGB , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
ceftazidime	drug	gentamicin	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGN , DRUGN / flucoxacillin , DRUGA , DRUGN , and DRUGB demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
ceftazidime	drug	amphotericin	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGN , DRUGN / flucoxacillin , DRUGA , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGB with DRUGN .
ceftazidime	drug	antibiotics	group
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGN , DRUGN / flucoxacillin , DRUGA , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGB .
ceftazidime	drug	EXTRANEAL	brand
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGN , DRUGN / flucoxacillin , DRUGN , DRUGA , and DRUGB demonstrated no evidence of incompatibility of these DRUGN with DRUGN .
gentamicin	drug	amphotericin	drug
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGN , DRUGN / flucoxacillin , DRUGN , DRUGA , and DRUGN demonstrated no evidence of incompatibility of these DRUGB with DRUGN .
gentamicin	drug	antibiotics	group
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGN , DRUGN / flucoxacillin , DRUGN , DRUGA , and DRUGN demonstrated no evidence of incompatibility of these DRUGN with DRUGB .
gentamicin	drug	EXTRANEAL	brand
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGN , DRUGN / flucoxacillin , DRUGN , DRUGN , and DRUGA demonstrated no evidence of incompatibility of these DRUGB with DRUGN .
amphotericin	drug	antibiotics	group
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGN , DRUGN / flucoxacillin , DRUGN , DRUGN , and DRUGA demonstrated no evidence of incompatibility of these DRUGN with DRUGB .
amphotericin	drug	EXTRANEAL	brand
false

In vitro studies evaluating the minimum inhibitory concentration ( MIC ) of DRUGN , DRUGN , DRUGN , DRUGN / flucoxacillin , DRUGN , DRUGN , and DRUGN demonstrated no evidence of incompatibility of these DRUGA with DRUGB .
antibiotics	group	EXTRANEAL	brand
false

Interactions may occur between DRUGA supplements and DRUGB and other DRUGN and herbs such as garlic ( Allium sativum ) and DRUGN ( DRUGN ) .
EPA	drug	aspirin	brand
int

Interactions may occur between DRUGA supplements and DRUGN and other DRUGB and herbs such as garlic ( Allium sativum ) and DRUGN ( DRUGN ) .
EPA	drug	non-steroidal anti-inflammatory drugs	group
int

Interactions may occur between DRUGA supplements and DRUGN and other DRUGN and herbs such as garlic ( Allium sativum ) and DRUGB ( DRUGN ) .
EPA	drug	ginkgo	drug
int

Interactions may occur between DRUGA supplements and DRUGN and other DRUGN and herbs such as garlic ( Allium sativum ) and DRUGN ( DRUGB ) .
EPA	drug	Ginkgo biloba	drug
int

Interactions may occur between DRUGN supplements and DRUGA and other DRUGB and herbs such as garlic ( Allium sativum ) and DRUGN ( DRUGN ) .
aspirin	brand	non-steroidal anti-inflammatory drugs	group
false

Interactions may occur between DRUGN supplements and DRUGA and other DRUGN and herbs such as garlic ( Allium sativum ) and DRUGB ( DRUGN ) .
aspirin	brand	ginkgo	drug
false

Interactions may occur between DRUGN supplements and DRUGA and other DRUGN and herbs such as garlic ( Allium sativum ) and DRUGN ( DRUGB ) .
aspirin	brand	Ginkgo biloba	drug
false

Interactions may occur between DRUGN supplements and DRUGN and other DRUGA and herbs such as garlic ( Allium sativum ) and DRUGB ( DRUGN ) .
non-steroidal anti-inflammatory drugs	group	ginkgo	drug
false

Interactions may occur between DRUGN supplements and DRUGN and other DRUGA and herbs such as garlic ( Allium sativum ) and DRUGN ( DRUGB ) .
non-steroidal anti-inflammatory drugs	group	Ginkgo biloba	drug
false

Interactions may occur between DRUGN supplements and DRUGN and other DRUGN and herbs such as garlic ( Allium sativum ) and DRUGA ( DRUGB ) .
ginkgo	drug	Ginkgo biloba	drug
false

When you are using DRUGA , it is especially important that your health care professional know if you are using the following : Eye product containing DRUGB .
idoxuridine	drug	boric acid	drug
advise

DRUGA may interact with the DRUGB preparation causing a gritty substance to form or may interact with the preservative in the DRUGN preparation causing a toxic effect in the eye .
Boric acid	drug	idoxuridine	drug
mechanism

DRUGA may interact with the DRUGN preparation causing a gritty substance to form or may interact with the preservative in the DRUGB preparation causing a toxic effect in the eye .
Boric acid	drug	idoxuridine	drug
false

In studies in normal volunteers , there was no pharmacodynamic interaction between intravenous DRUGA and either DRUGB , DRUGN , or DRUGN .
iloprost	drug	nifedipine	drug
false

In studies in normal volunteers , there was no pharmacodynamic interaction between intravenous DRUGA and either DRUGN , DRUGB , or DRUGN .
iloprost	drug	diltiazem	drug
false

In studies in normal volunteers , there was no pharmacodynamic interaction between intravenous DRUGA and either DRUGN , DRUGN , or DRUGB .
iloprost	drug	captopril	drug
false

In studies in normal volunteers , there was no pharmacodynamic interaction between intravenous DRUGN and either DRUGA , DRUGB , or DRUGN .
nifedipine	drug	diltiazem	drug
false

In studies in normal volunteers , there was no pharmacodynamic interaction between intravenous DRUGN and either DRUGA , DRUGN , or DRUGB .
nifedipine	drug	captopril	drug
false

In studies in normal volunteers , there was no pharmacodynamic interaction between intravenous DRUGN and either DRUGN , DRUGA , or DRUGB .
diltiazem	drug	captopril	drug
false

However , DRUGA has the potential to increase the hypotensive effect of DRUGB and DRUGN .
iloprost	drug	vasodilators	group
effect

However , DRUGA has the potential to increase the hypotensive effect of DRUGN and DRUGB .
iloprost	drug	antihypertensive agents	group
effect

However , DRUGN has the potential to increase the hypotensive effect of DRUGA and DRUGB .
vasodilators	group	antihypertensive agents	group
false

Since DRUGA inhibits platelet function , there is a potential for increased risk of bleeding , particularly in patients maintained on DRUGB .
iloprost	drug	anticoagulants	group
effect

During clinical trials , DRUGA was used concurrently with DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and other medications .
iloprost	drug	anticoagulants	group
false

During clinical trials , DRUGA was used concurrently with DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and other medications .
iloprost	drug	diuretics	group
false

During clinical trials , DRUGA was used concurrently with DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and other medications .
iloprost	drug	cardiac glycosides	group
false

During clinical trials , DRUGA was used concurrently with DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and other medications .
iloprost	drug	calcium channel blockers	group
false

During clinical trials , DRUGA was used concurrently with DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and other medications .
iloprost	drug	analgesics	group
false

During clinical trials , DRUGA was used concurrently with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and other medications .
iloprost	drug	antipyretics	group
false

During clinical trials , DRUGA was used concurrently with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and other medications .
iloprost	drug	nonsteroidal antiinflammatories	group
false

During clinical trials , DRUGA was used concurrently with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and other medications .
iloprost	drug	corticosteroids	group
false

During clinical trials , DRUGN was used concurrently with DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and other medications .
anticoagulants	group	diuretics	group
false

During clinical trials , DRUGN was used concurrently with DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and other medications .
anticoagulants	group	cardiac glycosides	group
false

During clinical trials , DRUGN was used concurrently with DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and other medications .
anticoagulants	group	calcium channel blockers	group
false

During clinical trials , DRUGN was used concurrently with DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and other medications .
anticoagulants	group	analgesics	group
false

During clinical trials , DRUGN was used concurrently with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and other medications .
anticoagulants	group	antipyretics	group
false

During clinical trials , DRUGN was used concurrently with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and other medications .
anticoagulants	group	nonsteroidal antiinflammatories	group
false

During clinical trials , DRUGN was used concurrently with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and other medications .
anticoagulants	group	corticosteroids	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and other medications .
diuretics	group	cardiac glycosides	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and other medications .
diuretics	group	calcium channel blockers	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and other medications .
diuretics	group	analgesics	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and other medications .
diuretics	group	antipyretics	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and other medications .
diuretics	group	nonsteroidal antiinflammatories	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and other medications .
diuretics	group	corticosteroids	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and other medications .
cardiac glycosides	group	calcium channel blockers	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and other medications .
cardiac glycosides	group	analgesics	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and other medications .
cardiac glycosides	group	antipyretics	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and other medications .
cardiac glycosides	group	nonsteroidal antiinflammatories	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and other medications .
cardiac glycosides	group	corticosteroids	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and other medications .
calcium channel blockers	group	analgesics	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and other medications .
calcium channel blockers	group	antipyretics	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and other medications .
calcium channel blockers	group	nonsteroidal antiinflammatories	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and other medications .
calcium channel blockers	group	corticosteroids	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and other medications .
analgesics	group	antipyretics	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and other medications .
analgesics	group	nonsteroidal antiinflammatories	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and other medications .
analgesics	group	corticosteroids	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and other medications .
antipyretics	group	nonsteroidal antiinflammatories	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and other medications .
antipyretics	group	corticosteroids	group
false

During clinical trials , DRUGN was used concurrently with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and other medications .
nonsteroidal antiinflammatories	group	corticosteroids	group
false

Intravenous infusion of DRUGA had no effect on the pharmacokinetics of DRUGB .
iloprost	drug	digoxin	drug
false

DRUGA did not alter the clearance ( pharmacokinetics ) of DRUGB .
Acetylsalicylic acid	drug	iloprost	drug
false

Drugs that may alter DRUGA plasma concentrations Drugs that may increase DRUGN plasma concentrations : Caution is recommended when administering DRUGB with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN ) .
imatinib	drug	Gleevec	brand
false

Drugs that may alter DRUGA plasma concentrations Drugs that may increase DRUGN plasma concentrations : Caution is recommended when administering DRUGN with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN ) .
imatinib	drug	ketoconazole	drug
false

Drugs that may alter DRUGA plasma concentrations Drugs that may increase DRUGN plasma concentrations : Caution is recommended when administering DRUGN with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN ) .
imatinib	drug	itraconazole	drug
false

Drugs that may alter DRUGA plasma concentrations Drugs that may increase DRUGN plasma concentrations : Caution is recommended when administering DRUGN with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN ) .
imatinib	drug	erythromycin	drug
false

Drugs that may alter DRUGA plasma concentrations Drugs that may increase DRUGN plasma concentrations : Caution is recommended when administering DRUGN with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB ) .
imatinib	drug	clarithromycin	drug
false

Drugs that may alter DRUGN plasma concentrations Drugs that may increase DRUGA plasma concentrations : Caution is recommended when administering DRUGB with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN ) .
imatinib	drug	Gleevec	brand
false

Drugs that may alter DRUGN plasma concentrations Drugs that may increase DRUGA plasma concentrations : Caution is recommended when administering DRUGN with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN ) .
imatinib	drug	ketoconazole	drug
false

Drugs that may alter DRUGN plasma concentrations Drugs that may increase DRUGA plasma concentrations : Caution is recommended when administering DRUGN with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN ) .
imatinib	drug	itraconazole	drug
false

Drugs that may alter DRUGN plasma concentrations Drugs that may increase DRUGA plasma concentrations : Caution is recommended when administering DRUGN with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN ) .
imatinib	drug	erythromycin	drug
false

Drugs that may alter DRUGN plasma concentrations Drugs that may increase DRUGA plasma concentrations : Caution is recommended when administering DRUGN with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB ) .
imatinib	drug	clarithromycin	drug
false

Drugs that may alter DRUGN plasma concentrations Drugs that may increase DRUGN plasma concentrations : Caution is recommended when administering DRUGA with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN ) .
Gleevec	brand	ketoconazole	drug
advise

Drugs that may alter DRUGN plasma concentrations Drugs that may increase DRUGN plasma concentrations : Caution is recommended when administering DRUGA with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN ) .
Gleevec	brand	itraconazole	drug
advise

Drugs that may alter DRUGN plasma concentrations Drugs that may increase DRUGN plasma concentrations : Caution is recommended when administering DRUGA with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN ) .
Gleevec	brand	erythromycin	drug
advise

Drugs that may alter DRUGN plasma concentrations Drugs that may increase DRUGN plasma concentrations : Caution is recommended when administering DRUGA with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB ) .
Gleevec	brand	clarithromycin	drug
advise

Drugs that may alter DRUGN plasma concentrations Drugs that may increase DRUGN plasma concentrations : Caution is recommended when administering DRUGN with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGA , DRUGB , DRUGN , DRUGN ) .
ketoconazole	drug	itraconazole	drug
false

Drugs that may alter DRUGN plasma concentrations Drugs that may increase DRUGN plasma concentrations : Caution is recommended when administering DRUGN with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGA , DRUGN , DRUGB , DRUGN ) .
ketoconazole	drug	erythromycin	drug
false

Drugs that may alter DRUGN plasma concentrations Drugs that may increase DRUGN plasma concentrations : Caution is recommended when administering DRUGN with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGA , DRUGN , DRUGN , DRUGB ) .
ketoconazole	drug	clarithromycin	drug
false

Drugs that may alter DRUGN plasma concentrations Drugs that may increase DRUGN plasma concentrations : Caution is recommended when administering DRUGN with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGA , DRUGB , DRUGN ) .
itraconazole	drug	erythromycin	drug
false

Drugs that may alter DRUGN plasma concentrations Drugs that may increase DRUGN plasma concentrations : Caution is recommended when administering DRUGN with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGA , DRUGN , DRUGB ) .
itraconazole	drug	clarithromycin	drug
false

Drugs that may alter DRUGN plasma concentrations Drugs that may increase DRUGN plasma concentrations : Caution is recommended when administering DRUGN with inhibitors of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGA , DRUGB ) .
erythromycin	drug	clarithromycin	drug
false

There is a significant increase in exposure to DRUGA when DRUGB is coadministered with DRUGN ( CYPdgbAdgb inhibitor ) .
imatinib	drug	Gleevec	brand
false

There is a significant increase in exposure to DRUGA when DRUGN is coadministered with DRUGB ( CYPdgbAdgb inhibitor ) .
imatinib	drug	ketoconazole	drug
false

There is a significant increase in exposure to DRUGN when DRUGA is coadministered with DRUGB ( CYPdgbAdgb inhibitor ) .
Gleevec	brand	ketoconazole	drug
mechanism

Co medications that induce CYPdgbAdgb ( e.g . , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN or St .
dexamethasone	drug	phenytoin	drug
false

Co medications that induce CYPdgbAdgb ( e.g . , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN or St .
dexamethasone	drug	carbamazepine	drug
false

Co medications that induce CYPdgbAdgb ( e.g . , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN or St .
dexamethasone	drug	rifampin	drug
false

Co medications that induce CYPdgbAdgb ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB or St .
dexamethasone	drug	phenobarbital	drug
false

Co medications that induce CYPdgbAdgb ( e.g . , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN or St .
phenytoin	drug	carbamazepine	drug
false

Co medications that induce CYPdgbAdgb ( e.g . , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN or St .
phenytoin	drug	rifampin	drug
false

Co medications that induce CYPdgbAdgb ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB or St .
phenytoin	drug	phenobarbital	drug
false

Co medications that induce CYPdgbAdgb ( e.g . , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN or St .
carbamazepine	drug	rifampin	drug
false

Co medications that induce CYPdgbAdgb ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB or St .
carbamazepine	drug	phenobarbital	drug
false

Co medications that induce CYPdgbAdgb ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB or St .
rifampin	drug	phenobarbital	drug
false

Drugs that may have their plasma concentration altered by DRUGA DRUGN increases the mean cmax and AUC of DRUGB ( CYPdgbAdgb substrate ) dgb and dga fold , respectively , suggesting an inhibition of the CYPdgbAdgb by DRUGN .
Gleevec	brand	simvastatin	drug
false

Drugs that may have their plasma concentration altered by DRUGN DRUGA increases the mean cmax and AUC of DRUGB ( CYPdgbAdgb substrate ) dgb and dga fold , respectively , suggesting an inhibition of the CYPdgbAdgb by DRUGN .
Gleevec	brand	simvastatin	drug
mechanism

Drugs that may have their plasma concentration altered by DRUGN DRUGN increases the mean cmax and AUC of DRUGA ( CYPdgbAdgb substrate ) dgb and dga fold , respectively , suggesting an inhibition of the CYPdgbAdgb by DRUGB .
simvastatin	drug	Gleevec	brand
false

Particular caution is recommended when administering DRUGA with CYPdgbAdgb substrates that have a narrow therapeutic window ( e.g . , DRUGB or DRUGN ) .
Gleevec	brand	cyclosporine	drug
advise

Particular caution is recommended when administering DRUGA with CYPdgbAdgb substrates that have a narrow therapeutic window ( e.g . , DRUGN or DRUGB ) .
Gleevec	brand	pimozide	drug
advise

Particular caution is recommended when administering DRUGN with CYPdgbAdgb substrates that have a narrow therapeutic window ( e.g . , DRUGA or DRUGB ) .
cyclosporine	drug	pimozide	drug
false

DRUGA will increase plasmaconcentration of other CYPdgbAdgb metabolized drugs ( e.g . , triazolo DRUGB , DRUGN , certain DRUGN , etc . ) .
Gleevec	brand	benzodiazepines	group
mechanism

DRUGA will increase plasmaconcentration of other CYPdgbAdgb metabolized drugs ( e.g . , triazolo DRUGN , DRUGB , certain DRUGN , etc . ) .
Gleevec	brand	dihydropyridine calcium channel blockers	group
mechanism

DRUGA will increase plasmaconcentration of other CYPdgbAdgb metabolized drugs ( e.g . , triazolo DRUGN , DRUGN , certain DRUGB , etc . ) .
Gleevec	brand	HMG-CoA reductase inhibitors	group
mechanism

DRUGN will increase plasmaconcentration of other CYPdgbAdgb metabolized drugs ( e.g . , triazolo DRUGA , DRUGB , certain DRUGN , etc . ) .
benzodiazepines	group	dihydropyridine calcium channel blockers	group
false

DRUGN will increase plasmaconcentration of other CYPdgbAdgb metabolized drugs ( e.g . , triazolo DRUGA , DRUGN , certain DRUGB , etc . ) .
benzodiazepines	group	HMG-CoA reductase inhibitors	group
false

DRUGN will increase plasmaconcentration of other CYPdgbAdgb metabolized drugs ( e.g . , triazolo DRUGN , DRUGA , certain DRUGB , etc . ) .
dihydropyridine calcium channel blockers	group	HMG-CoA reductase inhibitors	group
false

Because DRUGA is metabolized by CYPdgbCdgb and CYPdgbAdgb , patients who require anticoagulation should receive low molecular weight or standard DRUGB .
warfarin	drug	heparin	drug
false

Systemic exposure to DRUGA is expected to be increased when coadministered with DRUGB .
acetaminophen	drug	Gleevec	brand
mechanism

Avoid the use of preparations such as DRUGA and local DRUGB which contain any DRUGN ( e.g . , DRUGN , DRUGN ) , since it has been reported that DRUGN can potentiate the effects of catecholamines .
decongestants	group	anesthetics	group
false

Avoid the use of preparations such as DRUGA and local DRUGN which contain any DRUGB ( e.g . , DRUGN , DRUGN ) , since it has been reported that DRUGN can potentiate the effects of catecholamines .
decongestants	group	sympathomimetic amine	group
false

Avoid the use of preparations such as DRUGA and local DRUGN which contain any DRUGN ( e.g . , DRUGB , DRUGN ) , since it has been reported that DRUGN can potentiate the effects of catecholamines .
decongestants	group	epinephrine	drug
false

Avoid the use of preparations such as DRUGA and local DRUGN which contain any DRUGN ( e.g . , DRUGN , DRUGB ) , since it has been reported that DRUGN can potentiate the effects of catecholamines .
decongestants	group	norepinephrine	drug
false

Avoid the use of preparations such as DRUGA and local DRUGN which contain any DRUGN ( e.g . , DRUGN , DRUGN ) , since it has been reported that DRUGB can potentiate the effects of catecholamines .
decongestants	group	tricyclic antidepressants	group
advise

Avoid the use of preparations such as DRUGN and local DRUGA which contain any DRUGB ( e.g . , DRUGN , DRUGN ) , since it has been reported that DRUGN can potentiate the effects of catecholamines .
anesthetics	group	sympathomimetic amine	group
false

Avoid the use of preparations such as DRUGN and local DRUGA which contain any DRUGN ( e.g . , DRUGB , DRUGN ) , since it has been reported that DRUGN can potentiate the effects of catecholamines .
anesthetics	group	epinephrine	drug
false

Avoid the use of preparations such as DRUGN and local DRUGA which contain any DRUGN ( e.g . , DRUGN , DRUGB ) , since it has been reported that DRUGN can potentiate the effects of catecholamines .
anesthetics	group	norepinephrine	drug
false

Avoid the use of preparations such as DRUGN and local DRUGA which contain any DRUGN ( e.g . , DRUGN , DRUGN ) , since it has been reported that DRUGB can potentiate the effects of catecholamines .
anesthetics	group	tricyclic antidepressants	group
advise

Avoid the use of preparations such as DRUGN and local DRUGN which contain any DRUGA ( e.g . , DRUGB , DRUGN ) , since it has been reported that DRUGN can potentiate the effects of catecholamines .
sympathomimetic amine	group	epinephrine	drug
false

Avoid the use of preparations such as DRUGN and local DRUGN which contain any DRUGA ( e.g . , DRUGN , DRUGB ) , since it has been reported that DRUGN can potentiate the effects of catecholamines .
sympathomimetic amine	group	norepinephrine	drug
false

Avoid the use of preparations such as DRUGN and local DRUGN which contain any DRUGA ( e.g . , DRUGN , DRUGN ) , since it has been reported that DRUGB can potentiate the effects of catecholamines .
sympathomimetic amine	group	tricyclic antidepressants	group
advise

Avoid the use of preparations such as DRUGN and local DRUGN which contain any DRUGN ( e.g . , DRUGA , DRUGB ) , since it has been reported that DRUGN can potentiate the effects of catecholamines .
epinephrine	drug	norepinephrine	drug
false

Avoid the use of preparations such as DRUGN and local DRUGN which contain any DRUGN ( e.g . , DRUGA , DRUGN ) , since it has been reported that DRUGB can potentiate the effects of catecholamines .
epinephrine	drug	tricyclic antidepressants	group
advise

Avoid the use of preparations such as DRUGN and local DRUGN which contain any DRUGN ( e.g . , DRUGN , DRUGA ) , since it has been reported that DRUGB can potentiate the effects of catecholamines .
norepinephrine	drug	tricyclic antidepressants	group
advise

DRUGA may potentiate the effects of DRUGB .
Imipramine hydrochloride	drug	CNS depressant drugs	group
effect

Poor metabolizers have higher than expected plasma concentrations of DRUGA ( DRUGB ) when given usual doses .
tricyclic antidepressants	group	TCAs	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGB , DRUGN , and the DRUGN DRUGN and DRUGN ) .
cimetidine	drug	antidepressants	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGB , and the DRUGN DRUGN and DRUGN ) .
cimetidine	drug	phenothiazines	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGB DRUGN and DRUGN ) .
cimetidine	drug	Type 1C antiarrhythmics	group
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGN DRUGB and DRUGN ) .
cimetidine	drug	propafenone	drug
false

DRUGA ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGN DRUGN and DRUGB ) .
cimetidine	drug	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGB , and the DRUGN DRUGN and DRUGN ) .
antidepressants	group	phenothiazines	group
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGN , and the DRUGB DRUGN and DRUGN ) .
antidepressants	group	Type 1C antiarrhythmics	group
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGN , and the DRUGN DRUGB and DRUGN ) .
antidepressants	group	propafenone	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGA , DRUGN , and the DRUGN DRUGN and DRUGB ) .
antidepressants	group	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGA , and the DRUGB DRUGN and DRUGN ) .
phenothiazines	group	Type 1C antiarrhythmics	group
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGA , and the DRUGN DRUGB and DRUGN ) .
phenothiazines	group	propafenone	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGA , and the DRUGN DRUGN and DRUGB ) .
phenothiazines	group	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGA DRUGB and DRUGN ) .
Type 1C antiarrhythmics	group	propafenone	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGA DRUGN and DRUGB ) .
Type 1C antiarrhythmics	group	flecainide	drug
false

DRUGN ) and many that are substrates for Pdgb dgbDdgb ( many other DRUGN , DRUGN , and the DRUGN DRUGA and DRUGB ) .
propafenone	drug	flecainide	drug
false

While all the DRUGA ( DRUGB ) , e. g. , DRUGN , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	SSRIs	group
false

While all the DRUGA ( DRUGN ) , e. g. , DRUGB , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	fluoxetine	drug
false

While all the DRUGA ( DRUGN ) , e. g. , DRUGN , DRUGB , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	sertraline	drug
false

While all the DRUGA ( DRUGN ) , e. g. , DRUGN , DRUGN , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
selective serotonin reuptake inhibitors	group	paroxetine	drug
false

While all the DRUGN ( DRUGA ) , e. g. , DRUGB , DRUGN , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	fluoxetine	drug
false

While all the DRUGN ( DRUGA ) , e. g. , DRUGN , DRUGB , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	sertraline	drug
false

While all the DRUGN ( DRUGA ) , e. g. , DRUGN , DRUGN , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
SSRIs	group	paroxetine	drug
false

While all the DRUGN ( DRUGN ) , e. g. , DRUGA , DRUGB , and DRUGN , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
fluoxetine	drug	sertraline	drug
false

While all the DRUGN ( DRUGN ) , e. g. , DRUGA , DRUGN , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
fluoxetine	drug	paroxetine	drug
false

While all the DRUGN ( DRUGN ) , e. g. , DRUGN , DRUGA , and DRUGB , inhibit Pdgb dgbDdgb , they may vary in the extent of inhibition .
sertraline	drug	paroxetine	drug
false

The extent to which DRUGA DRUGB interactions may pose clinical problems will depend on the degree of inhibition , and the pharmacokinetics of the DRUGN involved .
SSRI	group	TCA	group
int

The extent to which DRUGN DRUGA interactions may pose clinical problems will depend on the degree of inhibition , and the pharmacokinetics of the DRUGB involved .
TCA	group	SSRI	group
false

Concomitant use of DRUGA with drugs that can inhibit cytochrome Pdgb dgbDdgb may require lower doses than usually prescribed for either the DRUGB or the other drug .
tricyclic antidepressants	group	tricyclic antidepressant	group
false

Coadministration of DRUGA and other drugs that inhibit CYPdgbAdgb may decrease the clearance of DRUGB and may result in increased plasma concentrations of DRUGN .
CRIXIVAN	brand	indinavir	drug
false

Coadministration of DRUGA and other drugs that inhibit CYPdgbAdgb may decrease the clearance of DRUGN and may result in increased plasma concentrations of DRUGB .
CRIXIVAN	brand	indinavir	drug
false

DRUGA : DRUGB
Antiarrhythmics	group	amiodarone	drug
false

Ergot derivatives : DRUGA , DRUGB , DRUGN , DRUGN
dihydroergotamine	drug	ergonovine	drug
false

Ergot derivatives : DRUGA , DRUGN , DRUGB , DRUGN
dihydroergotamine	drug	ergotamine	drug
false

Ergot derivatives : DRUGA , DRUGN , DRUGN , DRUGB
dihydroergotamine	drug	methylergonovine	drug
false

Ergot derivatives : DRUGN , DRUGA , DRUGB , DRUGN
ergonovine	drug	ergotamine	drug
false

Ergot derivatives : DRUGN , DRUGA , DRUGN , DRUGB
ergonovine	drug	methylergonovine	drug
false

Ergot derivatives : DRUGN , DRUGN , DRUGA , DRUGB
ergotamine	drug	methylergonovine	drug
false

DRUGA / DRUGB : DRUGN , DRUGN
Sedative	group	hypnotics	group
false

DRUGA / DRUGN : DRUGB , DRUGN
Sedative	group	midazolam	drug
false

DRUGA / DRUGN : DRUGN , DRUGB
Sedative	group	triazolam	drug
false

DRUGN / DRUGA : DRUGB , DRUGN
hypnotics	group	midazolam	drug
false

DRUGN / DRUGA : DRUGN , DRUGB
hypnotics	group	triazolam	drug
false

DRUGN / DRUGN : DRUGA , DRUGB
midazolam	drug	triazolam	drug
false

DRUGA : DRUGB
Neuroleptic	group	pimozide	drug
false

May lead to loss of virologic response and possible resistance to DRUGA or to the class of DRUGB .
CRIXIVAN	brand	protease inhibitors	group
false

DRUGA : DRUGB
Antimycobacterial	group	rifampin	drug
false

May lead to loss of virologic response and possible resistance to DRUGA or to the class of DRUGB or other coadministered DRUGN .
CRIXIVAN	brand	protease inhibitors	group
false

May lead to loss of virologic response and possible resistance to DRUGA or to the class of DRUGN or other coadministered DRUGB .
CRIXIVAN	brand	antiretroviral agents	group
false

May lead to loss of virologic response and possible resistance to DRUGN or to the class of DRUGA or other coadministered DRUGB .
protease inhibitors	group	antiretroviral agents	group
false

DRUGA : DRUGB , DRUGN
HMG-CoA Reductase inhibitors	group	lovastatin	drug
false

DRUGA : DRUGN , DRUGB
HMG-CoA Reductase inhibitors	group	simvastatin	drug
false

DRUGN : DRUGA , DRUGB
lovastatin	drug	simvastatin	drug
false

DRUGA : DRUGB
Protease inhibitor	group	atazanavir	drug
false

Both DRUGA and DRUGB are associated with indirect ( unconjugated ) hyperbilirubinemia .
CRIXIVAN	brand	atazanavir	drug
false

Combinations of these drugs have not been studied and coadministration of DRUGA and DRUGB is not recommended .
CRIXIVAN	brand	atazanavir	drug
advise

Dose reduction of DRUGA to dgb mg every dgb hours should be considered when taking DRUGB dgb mg three times a day .
CRIXIVAN	brand	delavirdine	drug
advise

DRUGA and DRUGB formulations containing buffer should be administered at least one hour apart on an empty stomach .
Indinavir	drug	didanosine	drug
advise

The optimal dose of DRUGA , when given in combination with DRUGB , is not known .
indinavir	drug	efavirenz	drug
false

Increasing the DRUGA dose to dgb mg every dgb hours does not compensate for the increased DRUGN metabolism due to DRUGB .
indinavir	drug	efavirenz	drug
false

Increasing the DRUGN dose to dgb mg every dgb hours does not compensate for the increased DRUGA metabolism due to DRUGB .
indinavir	drug	efavirenz	drug
mechanism

DRUGA concentrations may be decreased in the presence of DRUGB .
Indinavir	drug	nevirapine	drug
mechanism

DRUGA concentration DRUGB concentration
indinavir	drug	ritonavir	drug
false

Preliminary clinical data suggest that the incidence of nephrolithiasis is higher in patients receiving DRUGA in combination with DRUGB than those receiving DRUGN dgb mg qdgbh .
indinavir	drug	ritonavir	drug
effect

Preliminary clinical data suggest that the incidence of nephrolithiasis is higher in patients receiving DRUGA in combination with DRUGN than those receiving DRUGB dgb mg qdgbh .
indinavir	drug	CRIXIVAN	brand
false

Preliminary clinical data suggest that the incidence of nephrolithiasis is higher in patients receiving DRUGN in combination with DRUGA than those receiving DRUGB dgb mg qdgbh .
ritonavir	drug	CRIXIVAN	brand
false

DRUGA : DRUGB , DRUGN ( systemic ) and DRUGN
Antiarrhythmics	group	bepridil	drug
false

DRUGA : DRUGN , DRUGB ( systemic ) and DRUGN
Antiarrhythmics	group	lidocaine	drug
false

DRUGA : DRUGN , DRUGN ( systemic ) and DRUGB
Antiarrhythmics	group	quinidine	drug
false

DRUGN : DRUGA , DRUGB ( systemic ) and DRUGN
bepridil	drug	lidocaine	drug
false

DRUGN : DRUGA , DRUGN ( systemic ) and DRUGB
bepridil	drug	quinidine	drug
false

DRUGN : DRUGN , DRUGA ( systemic ) and DRUGB
lidocaine	drug	quinidine	drug
false

Caution is warranted and therapeutic concentration monitoring is recommended for DRUGA when coadministered with DRUGB .
antiarrhythmics	group	CRIXIVAN	brand
advise

DRUGA : DRUGB , DRUGN , DRUGN
Anticonvulsants	group	carbamazepine	drug
false

DRUGA : DRUGN , DRUGB , DRUGN
Anticonvulsants	group	phenobarbital	drug
false

DRUGA : DRUGN , DRUGN , DRUGB
Anticonvulsants	group	phenytoin	drug
false

DRUGN : DRUGA , DRUGB , DRUGN
carbamazepine	drug	phenobarbital	drug
false

DRUGN : DRUGA , DRUGN , DRUGB
carbamazepine	drug	phenytoin	drug
false

DRUGN : DRUGN , DRUGA , DRUGB
phenobarbital	drug	phenytoin	drug
false

DRUGA may not be effective due to decreased DRUGB concentrations in patients taking these agents concomitantly .
CRIXIVAN	brand	indinavir	drug
effect

DRUGA , DRUGB : e.g . , DRUGN , DRUGN , DRUGN
Calcium Channel Blockers	group	Dihydropyridine	group
false

DRUGA , DRUGN : e.g . , DRUGB , DRUGN , DRUGN
Calcium Channel Blockers	group	felodipine	drug
false

DRUGA , DRUGN : e.g . , DRUGN , DRUGB , DRUGN
Calcium Channel Blockers	group	nifedipine	drug
false

DRUGA , DRUGN : e.g . , DRUGN , DRUGN , DRUGB
Calcium Channel Blockers	group	nicardipine	drug
false

DRUGN , DRUGA : e.g . , DRUGB , DRUGN , DRUGN
Dihydropyridine	group	felodipine	drug
false

DRUGN , DRUGA : e.g . , DRUGN , DRUGB , DRUGN
Dihydropyridine	group	nifedipine	drug
false

DRUGN , DRUGA : e.g . , DRUGN , DRUGN , DRUGB
Dihydropyridine	group	nicardipine	drug
false

DRUGN , DRUGN : e.g . , DRUGA , DRUGB , DRUGN
felodipine	drug	nifedipine	drug
false

DRUGN , DRUGN : e.g . , DRUGA , DRUGN , DRUGB
felodipine	drug	nicardipine	drug
false

DRUGN , DRUGN : e.g . , DRUGN , DRUGA , DRUGB
nifedipine	drug	nicardipine	drug
false

DRUGA concentration DRUGB concentration
clarithromycin	drug	indinavir	drug
false

DRUGA : DRUGB
HMG-CoA Reductase Inhibitor	group	atorvastatin	drug
false

Use lowest possible dose of DRUGA with careful monitoring , or consider DRUGB that are not primarily metabolized by CYPdgbAdgb , such as DRUGN , DRUGN , or DRUGN in combination with DRUGN .
atorvastatin	drug	HMG-CoA reductase inhibitors	group
false

Use lowest possible dose of DRUGA with careful monitoring , or consider DRUGN that are not primarily metabolized by CYPdgbAdgb , such as DRUGB , DRUGN , or DRUGN in combination with DRUGN .
atorvastatin	drug	pravastatin	drug
false

Use lowest possible dose of DRUGA with careful monitoring , or consider DRUGN that are not primarily metabolized by CYPdgbAdgb , such as DRUGN , DRUGB , or DRUGN in combination with DRUGN .
atorvastatin	drug	fluvastatin	drug
false

Use lowest possible dose of DRUGA with careful monitoring , or consider DRUGN that are not primarily metabolized by CYPdgbAdgb , such as DRUGN , DRUGN , or DRUGB in combination with DRUGN .
atorvastatin	drug	rosuvastatin	drug
false

Use lowest possible dose of DRUGA with careful monitoring , or consider DRUGN that are not primarily metabolized by CYPdgbAdgb , such as DRUGN , DRUGN , or DRUGN in combination with DRUGB .
atorvastatin	drug	CRIXIVAN	brand
advise

Use lowest possible dose of DRUGN with careful monitoring , or consider DRUGA that are not primarily metabolized by CYPdgbAdgb , such as DRUGB , DRUGN , or DRUGN in combination with DRUGN .
HMG-CoA reductase inhibitors	group	pravastatin	drug
false

Use lowest possible dose of DRUGN with careful monitoring , or consider DRUGA that are not primarily metabolized by CYPdgbAdgb , such as DRUGN , DRUGB , or DRUGN in combination with DRUGN .
HMG-CoA reductase inhibitors	group	fluvastatin	drug
false

Use lowest possible dose of DRUGN with careful monitoring , or consider DRUGA that are not primarily metabolized by CYPdgbAdgb , such as DRUGN , DRUGN , or DRUGB in combination with DRUGN .
HMG-CoA reductase inhibitors	group	rosuvastatin	drug
false

Use lowest possible dose of DRUGN with careful monitoring , or consider DRUGA that are not primarily metabolized by CYPdgbAdgb , such as DRUGN , DRUGN , or DRUGN in combination with DRUGB .
HMG-CoA reductase inhibitors	group	CRIXIVAN	brand
advise

Use lowest possible dose of DRUGN with careful monitoring , or consider DRUGN that are not primarily metabolized by CYPdgbAdgb , such as DRUGA , DRUGB , or DRUGN in combination with DRUGN .
pravastatin	drug	fluvastatin	drug
false

Use lowest possible dose of DRUGN with careful monitoring , or consider DRUGN that are not primarily metabolized by CYPdgbAdgb , such as DRUGA , DRUGN , or DRUGB in combination with DRUGN .
pravastatin	drug	rosuvastatin	drug
false

Use lowest possible dose of DRUGN with careful monitoring , or consider DRUGN that are not primarily metabolized by CYPdgbAdgb , such as DRUGA , DRUGN , or DRUGN in combination with DRUGB .
pravastatin	drug	CRIXIVAN	brand
false

Use lowest possible dose of DRUGN with careful monitoring , or consider DRUGN that are not primarily metabolized by CYPdgbAdgb , such as DRUGN , DRUGA , or DRUGB in combination with DRUGN .
fluvastatin	drug	rosuvastatin	drug
false

Use lowest possible dose of DRUGN with careful monitoring , or consider DRUGN that are not primarily metabolized by CYPdgbAdgb , such as DRUGN , DRUGA , or DRUGN in combination with DRUGB .
fluvastatin	drug	CRIXIVAN	brand
false

Use lowest possible dose of DRUGN with careful monitoring , or consider DRUGN that are not primarily metabolized by CYPdgbAdgb , such as DRUGN , DRUGN , or DRUGA in combination with DRUGB .
rosuvastatin	drug	CRIXIVAN	brand
false

DRUGA : DRUGB , DRUGN , DRUGN
Immunosuppressants	group	cyclosporine	drug
false

DRUGA : DRUGN , DRUGB , DRUGN
Immunosuppressants	group	tacrolimus	drug
false

DRUGA : DRUGN , DRUGN , DRUGB
Immunosuppressants	group	sirolimus	drug
false

DRUGN : DRUGA , DRUGB , DRUGN
cyclosporine	drug	tacrolimus	drug
false

DRUGN : DRUGA , DRUGN , DRUGB
cyclosporine	drug	sirolimus	drug
false

DRUGN : DRUGN , DRUGA , DRUGB
tacrolimus	drug	sirolimus	drug
false

Dose reduction of DRUGA to dgb mg every dgb hours is recommended when administering DRUGB concurrently .
CRIXIVAN	brand	itraconazole	drug
advise

DRUGA concentration DRUGB concentration
indinavir	drug	rifabutin	drug
false

Dose reduction of DRUGA to half the standard dose and a dose increase of DRUGB to dgb mg ( three dgb mg capsules ) every dgb hours are recommended when DRUGN and DRUGN are coadministered .
rifabutin	drug	CRIXIVAN	brand
false

Dose reduction of DRUGA to half the standard dose and a dose increase of DRUGN to dgb mg ( three dgb mg capsules ) every dgb hours are recommended when DRUGN and DRUGB are coadministered .
rifabutin	drug	CRIXIVAN	brand
false

Dose reduction of DRUGN to half the standard dose and a dose increase of DRUGA to dgb mg ( three dgb mg capsules ) every dgb hours are recommended when DRUGB and DRUGN are coadministered .
CRIXIVAN	brand	rifabutin	drug
false

Dose reduction of DRUGN to half the standard dose and a dose increase of DRUGN to dgb mg ( three dgb mg capsules ) every dgb hours are recommended when DRUGA and DRUGB are coadministered .
rifabutin	drug	CRIXIVAN	brand
advise

DRUGA dose should not exceed a maximum of dgb mg in a dgb hour period in patients receiving concomitant DRUGB therapy .
Sildenafil	drug	indinavir	drug
advise

DRUGA dose should not exceed a maximum of dgb mg in a dgb hour period in patients receiving concomitant DRUGB therapy .
Tadalafil	drug	indinavir	drug
advise

DRUGA dose should not exceed a maximum of dga mg in a dgb hour period in patients receiving concomitant DRUGB therapy .
Vardenafil	drug	indinavir	drug
advise

In normal volunteers receiving DRUGA , the administration of DRUGB decreased the renal clearance and significantly increased the plasma levels of DRUGN .
indomethacin	drug	diflunisal	drug
false

In normal volunteers receiving DRUGN , the administration of DRUGA decreased the renal clearance and significantly increased the plasma levels of DRUGB .
diflunisal	drug	indomethacin	drug
mechanism

In some patients , combined use of DRUGA and DRUGB has been associated with fatal gastrointestinal hemorrhage .
INDOCIN	brand	diflunisal	drug
effect

Therefore , DRUGA and DRUGB should not be used concomitantly .
diflunisal	drug	INDOCIN	brand
advise

In a study in normal volunteers , it was found that chronic concurrent administration of dga g of DRUGA per day decreases DRUGB blood levels approximately dgb % .
aspirin	brand	indomethacin	drug
mechanism

The concomitant use of DRUGA with other DRUGB is not recommended due to the increased possibility of gastrointestinal toxicity , with little or no increase in efficacy .
INDOCIN	brand	NSAIDs	group
advise

Clinical studies have shown that DRUGA does not influence the hypoprothrombinemia produced by DRUGB .
INDOCIN	brand	anticoagulants	group
false

However , when any additional drug , including DRUGA , is added to the treatment of patients on DRUGB therapy , the patients should be observed for alterations of the prothrombin time .
INDOCIN	brand	anticoagulant	group
advise

In post marketing experience , bleeding has been reported in patients on concomitant treatment with DRUGA and DRUGB .
anticoagulants	group	INDOCIN	brand
effect

Caution should be exercised when DRUGA and DRUGB are administered concomitantly .
INDOCIN	brand	anticoagulants	group
advise

When DRUGA is given to patients receiving DRUGB , the plasma levels of DRUGN are likely to be increased .
INDOCIN	brand	probenecid	drug
mechanism

When DRUGA is given to patients receiving DRUGN , the plasma levels of DRUGB are likely to be increased .
INDOCIN	brand	indomethacin	drug
false

When DRUGN is given to patients receiving DRUGA , the plasma levels of DRUGB are likely to be increased .
probenecid	drug	indomethacin	drug
false

Caution should be used if DRUGA is administered simultaneously with DRUGB .
INDOCIN	brand	methotrexate	drug
advise

DRUGA has been reported to decrease the tubular secretion of DRUGB and to potentiate its toxicity .
INDOCIN	brand	methotrexate	drug
mechanism

Administration of DRUGA concomitantly with DRUGB has been associated with an increase in DRUGN induced toxicity , possibly due to decreased synthesis of renal prostacyclin .
non-steroidal anti-inflammatory drugs	group	cyclosporine	drug
effect

Administration of DRUGA concomitantly with DRUGN has been associated with an increase in DRUGB induced toxicity , possibly due to decreased synthesis of renal prostacyclin .
non-steroidal anti-inflammatory drugs	group	cyclosporine	drug
false

DRUGA should be used with caution in patients taking DRUGB , and renal function should be carefully monitored .
NSAIDs	group	cyclosporine	drug
advise

Capsules DRUGA dgb mg t.i.d . produced a clinically relevant elevation of plasma DRUGB and reduction in renal DRUGN clearance in psychiatric patients and normal subjects with steady state plasma DRUGN concentrations .
INDOCIN	brand	lithium	drug
mechanism

Capsules DRUGA dgb mg t.i.d . produced a clinically relevant elevation of plasma DRUGN and reduction in renal DRUGB clearance in psychiatric patients and normal subjects with steady state plasma DRUGN concentrations .
INDOCIN	brand	lithium	drug
false

Capsules DRUGA dgb mg t.i.d . produced a clinically relevant elevation of plasma DRUGN and reduction in renal DRUGN clearance in psychiatric patients and normal subjects with steady state plasma DRUGB concentrations .
INDOCIN	brand	lithium	drug
false

As a consequence , when DRUGA and DRUGB are given concomitantly , the patient should be carefully observed for signs of DRUGN toxicity .
INDOCIN	brand	lithium	drug
advise

As a consequence , when DRUGA and DRUGN are given concomitantly , the patient should be carefully observed for signs of DRUGB toxicity .
INDOCIN	brand	lithium	drug
false

DRUGA given concomitantly with DRUGB has been reported to increase the serum concentration and prolong the half life of DRUGN .
INDOCIN	brand	digoxin	drug
mechanism

DRUGA given concomitantly with DRUGN has been reported to increase the serum concentration and prolong the half life of DRUGB .
INDOCIN	brand	digoxin	drug
false

Therefore , when DRUGA and DRUGB are used concomitantly , serum DRUGN levels should be closely monitored .
INDOCIN	brand	digoxin	drug
advise

Therefore , when DRUGA and DRUGN are used concomitantly , serum DRUGB levels should be closely monitored .
INDOCIN	brand	digoxin	drug
false

In some patients , the administration of DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGB , DRUGN , and DRUGN .
INDOCIN	brand	loop diuretics	group
effect

In some patients , the administration of DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGB , and DRUGN .
INDOCIN	brand	potassium-sparing diuretics	group
effect

In some patients , the administration of DRUGA can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGN , and DRUGB .
INDOCIN	brand	thiazide diuretics	group
effect

In some patients , the administration of DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGA , DRUGB , and DRUGN .
loop diuretics	group	potassium-sparing diuretics	group
false

In some patients , the administration of DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGA , DRUGN , and DRUGB .
loop diuretics	group	thiazide diuretics	group
false

In some patients , the administration of DRUGN can reduce the diuretic , natriuretic , and antihypertensive effects of DRUGN , DRUGA , and DRUGB .
potassium-sparing diuretics	group	thiazide diuretics	group
false

( DRUGA ) DRUGB are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGN is obtained .
Indomethacin	drug	diuretics	group
false

( DRUGA ) DRUGN are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGB is obtained .
Indomethacin	drug	diuretic	group
false

( DRUGN ) DRUGA are used concomitantly , the patient should be observed closely to determine if the desired effect of the DRUGB is obtained .
diuretics	group	diuretic	group
false

DRUGA reduces basal plasma renin activity ( PRA ) , as well as those elevations of PRA induced by DRUGB administration , or salt or volume depletion .
INDOCIN	brand	furosemide	drug
false

It has been reported that the addition of DRUGA to a maintenance schedule of DRUGB resulted in reversible acute renal failure in two of four healthy volunteers .
triamterene	drug	INDOCIN	brand
effect

DRUGA and DRUGB should not be administered together .
INDOCIN	brand	triamterene	drug
advise

DRUGA and DRUGB each may be associated with increased serum potassium levels .
INDOCIN	brand	potassium-sparing diuretics	group
false

The potential effects of DRUGA and DRUGB on potassium kinetics and renal function should be considered when these agents are administered concurrently .
INDOCIN	brand	potassium-sparing diuretics	group
effect

Most of the above effects concerning DRUGA have been attributed , at least in part , to mechanisms involving inhibition of prostaglandin synthesis by DRUGB .
diuretics	group	INDOCIN	brand
effect

Blunting of the antihypertensive effect of DRUGA by DRUGB including DRUGN has been reported .
beta-adrenoceptor blocking agents	group	non-steroidal antiinflammatory drugs	group
effect

Blunting of the antihypertensive effect of DRUGA by DRUGN including DRUGB has been reported .
beta-adrenoceptor blocking agents	group	INDOCIN	brand
effect

Blunting of the antihypertensive effect of DRUGN by DRUGA including DRUGB has been reported .
non-steroidal antiinflammatory drugs	group	INDOCIN	brand
false

DRUGA can reduce the antihypertensive effects of DRUGB and DRUGN .
INDOCIN	brand	captopril	drug
effect

DRUGA can reduce the antihypertensive effects of DRUGN and DRUGB .
INDOCIN	brand	losartan	drug
effect

DRUGN can reduce the antihypertensive effects of DRUGA and DRUGB .
captopril	drug	losartan	drug
false

Other DRUGA ( including DRUGB ) used in combination with DRUGN may also result in similar toxicities .
TNFa-blocking agents	group	REMICADE	brand
false

Other DRUGA ( including DRUGN ) used in combination with DRUGB may also result in similar toxicities .
TNFa-blocking agents	group	anakinra	drug
effect

Other DRUGN ( including DRUGA ) used in combination with DRUGB may also result in similar toxicities .
REMICADE	brand	anakinra	drug
effect

In rheumatoid arthritis , concomitant medications besides DRUGA were DRUGB , DRUGN , DRUGN and / or DRUGN .
MTX	drug	nonsteroidal anti-inflammatory agents	group
false

In rheumatoid arthritis , concomitant medications besides DRUGA were DRUGN , DRUGB , DRUGN and / or DRUGN .
MTX	drug	folic acid	drug
false

In rheumatoid arthritis , concomitant medications besides DRUGA were DRUGN , DRUGN , DRUGB and / or DRUGN .
MTX	drug	corticosteroids	group
false

In rheumatoid arthritis , concomitant medications besides DRUGA were DRUGN , DRUGN , DRUGN and / or DRUGB .
MTX	drug	narcotics	group
false

In rheumatoid arthritis , concomitant medications besides DRUGN were DRUGA , DRUGB , DRUGN and / or DRUGN .
nonsteroidal anti-inflammatory agents	group	folic acid	drug
false

In rheumatoid arthritis , concomitant medications besides DRUGN were DRUGA , DRUGN , DRUGB and / or DRUGN .
nonsteroidal anti-inflammatory agents	group	corticosteroids	group
false

In rheumatoid arthritis , concomitant medications besides DRUGN were DRUGA , DRUGN , DRUGN and / or DRUGB .
nonsteroidal anti-inflammatory agents	group	narcotics	group
false

In rheumatoid arthritis , concomitant medications besides DRUGN were DRUGN , DRUGA , DRUGB and / or DRUGN .
folic acid	drug	corticosteroids	group
false

In rheumatoid arthritis , concomitant medications besides DRUGN were DRUGN , DRUGA , DRUGN and / or DRUGB .
folic acid	drug	narcotics	group
false

In rheumatoid arthritis , concomitant medications besides DRUGN were DRUGN , DRUGN , DRUGA and / or DRUGB .
corticosteroids	group	narcotics	group
false

Concomitant Crohn s disease medications were DRUGA , DRUGB , DRUGN , DRUGN / DRUGN and aminosalicylates .
antibiotics	group	antivirals	group
false

Concomitant Crohn s disease medications were DRUGA , DRUGN , DRUGB , DRUGN / DRUGN and aminosalicylates .
antibiotics	group	corticosteroids	group
false

Concomitant Crohn s disease medications were DRUGA , DRUGN , DRUGN , DRUGB / DRUGN and aminosalicylates .
antibiotics	group	6-MP	drug
false

Concomitant Crohn s disease medications were DRUGA , DRUGN , DRUGN , DRUGN / DRUGB and aminosalicylates .
antibiotics	group	AZA	drug
false

Concomitant Crohn s disease medications were DRUGN , DRUGA , DRUGB , DRUGN / DRUGN and aminosalicylates .
antivirals	group	corticosteroids	group
false

Concomitant Crohn s disease medications were DRUGN , DRUGA , DRUGN , DRUGB / DRUGN and aminosalicylates .
antivirals	group	6-MP	drug
false

Concomitant Crohn s disease medications were DRUGN , DRUGA , DRUGN , DRUGN / DRUGB and aminosalicylates .
antivirals	group	AZA	drug
false

Concomitant Crohn s disease medications were DRUGN , DRUGN , DRUGA , DRUGB / DRUGN and aminosalicylates .
corticosteroids	group	6-MP	drug
false

Concomitant Crohn s disease medications were DRUGN , DRUGN , DRUGA , DRUGN / DRUGB and aminosalicylates .
corticosteroids	group	AZA	drug
false

Concomitant Crohn s disease medications were DRUGN , DRUGN , DRUGN , DRUGA / DRUGB and aminosalicylates .
6-MP	drug	AZA	drug
false

In psoriatic arthritis clinical trials , concomitant medications included DRUGA in approximately half of the patients as well as DRUGB , DRUGN and DRUGN .
MTX	drug	nonsteroidal anti-inflammatory agents	group
false

In psoriatic arthritis clinical trials , concomitant medications included DRUGA in approximately half of the patients as well as DRUGN , DRUGB and DRUGN .
MTX	drug	folic acid	drug
false

In psoriatic arthritis clinical trials , concomitant medications included DRUGA in approximately half of the patients as well as DRUGN , DRUGN and DRUGB .
MTX	drug	corticosteroids	group
false

In psoriatic arthritis clinical trials , concomitant medications included DRUGN in approximately half of the patients as well as DRUGA , DRUGB and DRUGN .
nonsteroidal anti-inflammatory agents	group	folic acid	drug
false

In psoriatic arthritis clinical trials , concomitant medications included DRUGN in approximately half of the patients as well as DRUGA , DRUGN and DRUGB .
nonsteroidal anti-inflammatory agents	group	corticosteroids	group
false

In psoriatic arthritis clinical trials , concomitant medications included DRUGN in approximately half of the patients as well as DRUGN , DRUGA and DRUGB .
folic acid	drug	corticosteroids	group
false

Serum DRUGA concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including DRUGB , DRUGN ( DRUGN or DRUGN ) and aminosalicylates .
infliximab	drug	corticosteroids	group
false

Serum DRUGA concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including DRUGN , DRUGB ( DRUGN or DRUGN ) and aminosalicylates .
infliximab	drug	antibiotics	group
false

Serum DRUGA concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including DRUGN , DRUGN ( DRUGB or DRUGN ) and aminosalicylates .
infliximab	drug	metronidazole	drug
false

Serum DRUGA concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including DRUGN , DRUGN ( DRUGN or DRUGB ) and aminosalicylates .
infliximab	drug	ciprofloxacin	drug
false

Serum DRUGN concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including DRUGA , DRUGB ( DRUGN or DRUGN ) and aminosalicylates .
corticosteroids	group	antibiotics	group
false

Serum DRUGN concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including DRUGA , DRUGN ( DRUGB or DRUGN ) and aminosalicylates .
corticosteroids	group	metronidazole	drug
false

Serum DRUGN concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including DRUGA , DRUGN ( DRUGN or DRUGB ) and aminosalicylates .
corticosteroids	group	ciprofloxacin	drug
false

Serum DRUGN concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including DRUGN , DRUGA ( DRUGB or DRUGN ) and aminosalicylates .
antibiotics	group	metronidazole	drug
false

Serum DRUGN concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including DRUGN , DRUGA ( DRUGN or DRUGB ) and aminosalicylates .
antibiotics	group	ciprofloxacin	drug
false

Serum DRUGN concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including DRUGN , DRUGN ( DRUGA or DRUGB ) and aminosalicylates .
metronidazole	drug	ciprofloxacin	drug
false

DRUGA , DRUGB , DRUGN salts , and DRUGN may either potentiate or weaken the blood glucose lowering effect of DRUGN .
Beta-blockers	group	clonidine	drug
false

DRUGA , DRUGN , DRUGB salts , and DRUGN may either potentiate or weaken the blood glucose lowering effect of DRUGN .
Beta-blockers	group	lithium	drug
false

DRUGA , DRUGN , DRUGN salts , and DRUGB may either potentiate or weaken the blood glucose lowering effect of DRUGN .
Beta-blockers	group	alcohol	drug
false

DRUGA , DRUGN , DRUGN salts , and DRUGN may either potentiate or weaken the blood glucose lowering effect of DRUGB .
Beta-blockers	group	insulin	drug
effect

DRUGN , DRUGA , DRUGB salts , and DRUGN may either potentiate or weaken the blood glucose lowering effect of DRUGN .
clonidine	drug	lithium	drug
false

DRUGN , DRUGA , DRUGN salts , and DRUGB may either potentiate or weaken the blood glucose lowering effect of DRUGN .
clonidine	drug	alcohol	drug
false

DRUGN , DRUGA , DRUGN salts , and DRUGN may either potentiate or weaken the blood glucose lowering effect of DRUGB .
clonidine	drug	insulin	drug
effect

DRUGN , DRUGN , DRUGA salts , and DRUGB may either potentiate or weaken the blood glucose lowering effect of DRUGN .
lithium	drug	alcohol	drug
false

DRUGN , DRUGN , DRUGA salts , and DRUGN may either potentiate or weaken the blood glucose lowering effect of DRUGB .
lithium	drug	insulin	drug
effect

DRUGN , DRUGN , DRUGN salts , and DRUGA may either potentiate or weaken the blood glucose lowering effect of DRUGB .
alcohol	drug	insulin	drug
effect

In addition , under the influence of sympatholytic medicinal products such as DRUGA , DRUGB , DRUGN , and DRUGN , the signs of hypoglycemia may be reduced or absent .
beta-blockers	group	clonidine	drug
false

In addition , under the influence of sympatholytic medicinal products such as DRUGA , DRUGN , DRUGB , and DRUGN , the signs of hypoglycemia may be reduced or absent .
beta-blockers	group	guanethidine	drug
false

In addition , under the influence of sympatholytic medicinal products such as DRUGA , DRUGN , DRUGN , and DRUGB , the signs of hypoglycemia may be reduced or absent .
beta-blockers	group	reserpine	drug
false

In addition , under the influence of sympatholytic medicinal products such as DRUGN , DRUGA , DRUGB , and DRUGN , the signs of hypoglycemia may be reduced or absent .
clonidine	drug	guanethidine	drug
false

In addition , under the influence of sympatholytic medicinal products such as DRUGN , DRUGA , DRUGN , and DRUGB , the signs of hypoglycemia may be reduced or absent .
clonidine	drug	reserpine	drug
false

In addition , under the influence of sympatholytic medicinal products such as DRUGN , DRUGN , DRUGA , and DRUGB , the signs of hypoglycemia may be reduced or absent .
guanethidine	drug	reserpine	drug
false

DRUGA , DRUGB , DRUGN salts , and DRUGN may either potentiate or weaken the blood glucose lowering effect of DRUGN .
Beta-blockers	group	clonidine	drug
false

DRUGA , DRUGN , DRUGB salts , and DRUGN may either potentiate or weaken the blood glucose lowering effect of DRUGN .
Beta-blockers	group	lithium	drug
false

DRUGA , DRUGN , DRUGN salts , and DRUGB may either potentiate or weaken the blood glucose lowering effect of DRUGN .
Beta-blockers	group	alcohol	drug
false

DRUGA , DRUGN , DRUGN salts , and DRUGN may either potentiate or weaken the blood glucose lowering effect of DRUGB .
Beta-blockers	group	insulin	drug
effect

DRUGN , DRUGA , DRUGB salts , and DRUGN may either potentiate or weaken the blood glucose lowering effect of DRUGN .
clonidine	drug	lithium	drug
false

DRUGN , DRUGA , DRUGN salts , and DRUGB may either potentiate or weaken the blood glucose lowering effect of DRUGN .
clonidine	drug	alcohol	drug
false

DRUGN , DRUGA , DRUGN salts , and DRUGN may either potentiate or weaken the blood glucose lowering effect of DRUGB .
clonidine	drug	insulin	drug
effect

DRUGN , DRUGN , DRUGA salts , and DRUGB may either potentiate or weaken the blood glucose lowering effect of DRUGN .
lithium	drug	alcohol	drug
false

DRUGN , DRUGN , DRUGA salts , and DRUGN may either potentiate or weaken the blood glucose lowering effect of DRUGB .
lithium	drug	insulin	drug
effect

DRUGN , DRUGN , DRUGN salts , and DRUGA may either potentiate or weaken the blood glucose lowering effect of DRUGB .
alcohol	drug	insulin	drug
effect

In addition , under the influence of sympatholytic medicinal products such as DRUGA , DRUGB , DRUGN , and DRUGN , the signs of hypoglycemia may be reduced or absent .
beta-blockers	group	clonidine	drug
false

In addition , under the influence of sympatholytic medicinal products such as DRUGA , DRUGN , DRUGB , and DRUGN , the signs of hypoglycemia may be reduced or absent .
beta-blockers	group	guanethidine	drug
false

In addition , under the influence of sympatholytic medicinal products such as DRUGA , DRUGN , DRUGN , and DRUGB , the signs of hypoglycemia may be reduced or absent .
beta-blockers	group	reserpine	drug
false

In addition , under the influence of sympatholytic medicinal products such as DRUGN , DRUGA , DRUGB , and DRUGN , the signs of hypoglycemia may be reduced or absent .
clonidine	drug	guanethidine	drug
false

In addition , under the influence of sympatholytic medicinal products such as DRUGN , DRUGA , DRUGN , and DRUGB , the signs of hypoglycemia may be reduced or absent .
clonidine	drug	reserpine	drug
false

In addition , under the influence of sympatholytic medicinal products such as DRUGN , DRUGN , DRUGA , and DRUGB , the signs of hypoglycemia may be reduced or absent .
guanethidine	drug	reserpine	drug
false

If DRUGA is mixed with DRUGB , DRUGN should be drawn into the syringe first .
NovoLog	brand	NPH human insulin	drug
false

If DRUGN is mixed with DRUGA , DRUGB should be drawn into the syringe first .
NPH human insulin	drug	NovoLog	brand
false

Because there are no data on the compatibility of DRUGA and crystalline DRUGB preparations , DRUGN should not be mixed with these preparations .
NovoLog	brand	zinc insulin	drug
false

Because there are no data on the compatibility of DRUGN and crystalline DRUGA preparations , DRUGB should not be mixed with these preparations .
zinc insulin	drug	NovoLog	brand
false

The effects of mixing DRUGA with DRUGB of animal source or DRUGN preparations produced by other manufacturers have not been studied .
NovoLog	brand	insulins	group
false

The effects of mixing DRUGA with DRUGN of animal source or DRUGB preparations produced by other manufacturers have not been studied .
NovoLog	brand	insulin	drug
false

The effects of mixing DRUGN with DRUGA of animal source or DRUGB preparations produced by other manufacturers have not been studied .
insulins	group	insulin	drug
false

When used in external subcutaneous infusion pumps for DRUGA , DRUGB should not be mixed with any other DRUGN or diluent .
insulin	drug	NovoLog	brand
false

When used in external subcutaneous infusion pumps for DRUGA , DRUGN should not be mixed with any other DRUGB or diluent .
insulin	drug	insulins	group
false

When used in external subcutaneous infusion pumps for DRUGN , DRUGA should not be mixed with any other DRUGB or diluent .
NovoLog	brand	insulins	group
false

Although studies designed to examine drug interactions have not been done , it was noted that DRUGA or DRUGB treatment of relapses for periods of up to dgb days has been administered to patients ( N=dgb ) receiving DRUGN .
corticosteroid	group	ACTH	drug
false

Although studies designed to examine drug interactions have not been done , it was noted that DRUGA or DRUGN treatment of relapses for periods of up to dgb days has been administered to patients ( N=dgb ) receiving DRUGB .
corticosteroid	group	Betaseron	brand
false

Although studies designed to examine drug interactions have not been done , it was noted that DRUGN or DRUGA treatment of relapses for periods of up to dgb days has been administered to patients ( N=dgb ) receiving DRUGB .
ACTH	drug	Betaseron	brand
false

DRUGA Inhalation Aerosol has been used concomitantly with other drugs , including DRUGB , DRUGN , and DRUGN , commonly used in the treatment of chronic obstructive pulmonary disease .
ATROVENT	brand	sympathomimetic bronchodilators	group
false

DRUGA Inhalation Aerosol has been used concomitantly with other drugs , including DRUGN , DRUGB , and DRUGN , commonly used in the treatment of chronic obstructive pulmonary disease .
ATROVENT	brand	methylxanthines	group
false

DRUGA Inhalation Aerosol has been used concomitantly with other drugs , including DRUGN , DRUGN , and DRUGB , commonly used in the treatment of chronic obstructive pulmonary disease .
ATROVENT	brand	steroids	group
false

DRUGN Inhalation Aerosol has been used concomitantly with other drugs , including DRUGA , DRUGB , and DRUGN , commonly used in the treatment of chronic obstructive pulmonary disease .
sympathomimetic bronchodilators	group	methylxanthines	group
false

DRUGN Inhalation Aerosol has been used concomitantly with other drugs , including DRUGA , DRUGN , and DRUGB , commonly used in the treatment of chronic obstructive pulmonary disease .
sympathomimetic bronchodilators	group	steroids	group
false

DRUGN Inhalation Aerosol has been used concomitantly with other drugs , including DRUGN , DRUGA , and DRUGB , commonly used in the treatment of chronic obstructive pulmonary disease .
methylxanthines	group	steroids	group
false

With the exception of DRUGA , there are no formal studies fully evaluating the interaction effects of DRUGB Inhalation Aerosol and these drugs with respect to effectiveness .
albuterol	drug	ATROVENT	brand
false

DRUGA : Although DRUGB is minimally absorbed into the systemic circulation , there is some potential for an additive interaction with concomitantly used DRUGN .
Anticholinergic agents	group	ipratropium bromide	drug
false

DRUGA : Although DRUGN is minimally absorbed into the systemic circulation , there is some potential for an additive interaction with concomitantly used DRUGB .
Anticholinergic agents	group	anticholinergic medications	group
false

DRUGN : Although DRUGA is minimally absorbed into the systemic circulation , there is some potential for an additive interaction with concomitantly used DRUGB .
ipratropium bromide	drug	anticholinergic medications	group
effect

Caution is therefore advised in the coadministration of DRUGA Inhalation Aerosol with other DRUGB containing drugs .
ATROVENT	brand	anticholinergic	group
advise

No significant drug drug pharmacokinetic ( or pharmacodynamic ) interactions have been found in interaction studies with DRUGA , DRUGB , DRUGN , and DRUGN .
hydrochlorothiazide	drug	digoxin	drug
false

No significant drug drug pharmacokinetic ( or pharmacodynamic ) interactions have been found in interaction studies with DRUGA , DRUGN , DRUGB , and DRUGN .
hydrochlorothiazide	drug	warfarin	drug
false

No significant drug drug pharmacokinetic ( or pharmacodynamic ) interactions have been found in interaction studies with DRUGA , DRUGN , DRUGN , and DRUGB .
hydrochlorothiazide	drug	nifedipine	drug
false

No significant drug drug pharmacokinetic ( or pharmacodynamic ) interactions have been found in interaction studies with DRUGN , DRUGA , DRUGB , and DRUGN .
digoxin	drug	warfarin	drug
false

No significant drug drug pharmacokinetic ( or pharmacodynamic ) interactions have been found in interaction studies with DRUGN , DRUGA , DRUGN , and DRUGB .
digoxin	drug	nifedipine	drug
false

No significant drug drug pharmacokinetic ( or pharmacodynamic ) interactions have been found in interaction studies with DRUGN , DRUGN , DRUGA , and DRUGB .
warfarin	drug	nifedipine	drug
false

In vitro studies show significant inhibition of the formation of oxidized irbesartan metabolites with the known cytochrome CYP dgbCdgb substrates / inhibitors DRUGA , DRUGB and DRUGN .
sulphenazole	drug	tolbutamide	drug
false

In vitro studies show significant inhibition of the formation of oxidized irbesartan metabolites with the known cytochrome CYP dgbCdgb substrates / inhibitors DRUGA , DRUGN and DRUGB .
sulphenazole	drug	nifedipine	drug
false

In vitro studies show significant inhibition of the formation of oxidized irbesartan metabolites with the known cytochrome CYP dgbCdgb substrates / inhibitors DRUGN , DRUGA and DRUGB .
tolbutamide	drug	nifedipine	drug
false

However , in clinical studies the consequences of concomitant DRUGA on the pharmacodynamics of DRUGB were negligible .
irbesartan	drug	warfarin	drug
false

In separate studies of patients receiving maintenance doses of DRUGA , DRUGB , or DRUGN , DRUGN administration for dgb days had no effect on the pharmacodynamics of DRUGN ( prothrombin time ) or pharmacokinetics of DRUGN .
warfarin	drug	hydrochlorothiazide	drug
false

In separate studies of patients receiving maintenance doses of DRUGA , DRUGN , or DRUGB , DRUGN administration for dgb days had no effect on the pharmacodynamics of DRUGN ( prothrombin time ) or pharmacokinetics of DRUGN .
warfarin	drug	digoxin	drug
false

In separate studies of patients receiving maintenance doses of DRUGA , DRUGN , or DRUGN , DRUGB administration for dgb days had no effect on the pharmacodynamics of DRUGN ( prothrombin time ) or pharmacokinetics of DRUGN .
warfarin	drug	irbesartan	drug
false

In separate studies of patients receiving maintenance doses of DRUGA , DRUGN , or DRUGN , DRUGN administration for dgb days had no effect on the pharmacodynamics of DRUGN ( prothrombin time ) or pharmacokinetics of DRUGB .
warfarin	drug	digoxin	drug
false

In separate studies of patients receiving maintenance doses of DRUGN , DRUGA , or DRUGB , DRUGN administration for dgb days had no effect on the pharmacodynamics of DRUGN ( prothrombin time ) or pharmacokinetics of DRUGN .
hydrochlorothiazide	drug	digoxin	drug
false

In separate studies of patients receiving maintenance doses of DRUGN , DRUGA , or DRUGN , DRUGB administration for dgb days had no effect on the pharmacodynamics of DRUGN ( prothrombin time ) or pharmacokinetics of DRUGN .
hydrochlorothiazide	drug	irbesartan	drug
false

In separate studies of patients receiving maintenance doses of DRUGN , DRUGA , or DRUGN , DRUGN administration for dgb days had no effect on the pharmacodynamics of DRUGB ( prothrombin time ) or pharmacokinetics of DRUGN .
hydrochlorothiazide	drug	warfarin	drug
false

In separate studies of patients receiving maintenance doses of DRUGN , DRUGA , or DRUGN , DRUGN administration for dgb days had no effect on the pharmacodynamics of DRUGN ( prothrombin time ) or pharmacokinetics of DRUGB .
hydrochlorothiazide	drug	digoxin	drug
false

In separate studies of patients receiving maintenance doses of DRUGN , DRUGN , or DRUGA , DRUGB administration for dgb days had no effect on the pharmacodynamics of DRUGN ( prothrombin time ) or pharmacokinetics of DRUGN .
digoxin	drug	irbesartan	drug
false

In separate studies of patients receiving maintenance doses of DRUGN , DRUGN , or DRUGA , DRUGN administration for dgb days had no effect on the pharmacodynamics of DRUGB ( prothrombin time ) or pharmacokinetics of DRUGN .
digoxin	drug	warfarin	drug
false

In separate studies of patients receiving maintenance doses of DRUGN , DRUGN , or DRUGN , DRUGA administration for dgb days had no effect on the pharmacodynamics of DRUGB ( prothrombin time ) or pharmacokinetics of DRUGN .
irbesartan	drug	warfarin	drug
false

In separate studies of patients receiving maintenance doses of DRUGN , DRUGN , or DRUGN , DRUGA administration for dgb days had no effect on the pharmacodynamics of DRUGN ( prothrombin time ) or pharmacokinetics of DRUGB .
irbesartan	drug	digoxin	drug
false

In separate studies of patients receiving maintenance doses of DRUGN , DRUGN , or DRUGN , DRUGN administration for dgb days had no effect on the pharmacodynamics of DRUGA ( prothrombin time ) or pharmacokinetics of DRUGB .
warfarin	drug	digoxin	drug
false

The pharmacokinetics of DRUGA were not affected by coadministration of DRUGB or DRUGN
irbesartan	drug	nifedipine	drug
false

The pharmacokinetics of DRUGA were not affected by coadministration of DRUGN or DRUGB
irbesartan	drug	hydrochlorothiazide	drug
false

The pharmacokinetics of DRUGN were not affected by coadministration of DRUGA or DRUGB
nifedipine	drug	hydrochlorothiazide	drug
false

The adverse effects of DRUGA , such as myelosuppression and diarrhea , would be expected to be exacerbated by other DRUGB having similar adverse effects .
CAMPTOSAR	brand	antineoplastic agents	group
effect

Lymphocytopenia has been reported in patients receiving DRUGA , and it is possible that the administration of DRUGB as antiemetic prophylaxis may have enhanced the likelihood of this effect .
CAMPTOSAR	brand	dexamethasone	drug
effect

It would be expected that DRUGA use during therapy with DRUGB would worsen the incidence or severity of diarrhea , but this has not been studied .
laxative	group	CAMPTOSAR	brand
effect

DRUGA should be administered with caution to patients receiving DRUGB ( DRUGN , Wyeth Ayerst Laboratories ) .
Isocarboxazid	drug	Antabuse	brand
advise

DRUGA should be administered with caution to patients receiving DRUGN ( DRUGB , Wyeth Ayerst Laboratories ) .
Isocarboxazid	drug	disulfiram	drug
advise

DRUGN should be administered with caution to patients receiving DRUGA ( DRUGB , Wyeth Ayerst Laboratories ) .
Antabuse	brand	disulfiram	drug
false

In a single study , rats given high intraperitoneal doses of an DRUGA plus DRUGB experienced severe toxicity , including convulsions and death .
MAO inhibitor	group	disulfiram	drug
effect

Concomitant use of DRUGA and other DRUGB is generally not recommended because of possible potentiating effects .
Isocarboxazid	drug	psychotropic agents	group
advise

DRUGA potentiates the muscle relaxant effect of all DRUGB , most notably DRUGN , and MAC ( minimum alveolar concentration ) is reduced by concomitant administration of N dgbO .
Isoflurane	drug	muscle relaxants	group
effect

DRUGA potentiates the muscle relaxant effect of all DRUGN , most notably DRUGB , and MAC ( minimum alveolar concentration ) is reduced by concomitant administration of N dgbO .
Isoflurane	drug	nondepolarizing muscle relaxants	group
effect

DRUGN potentiates the muscle relaxant effect of all DRUGA , most notably DRUGB , and MAC ( minimum alveolar concentration ) is reduced by concomitant administration of N dgbO .
muscle relaxants	group	nondepolarizing muscle relaxants	group
false

DRUGA : A report of severe DRUGB toxicity was reported in a patient receiving DRUGN .
Acetaminophen	drug	acetaminophen	drug
false

DRUGA : A report of severe DRUGN toxicity was reported in a patient receiving DRUGB .
Acetaminophen	drug	Isoniazid	drug
false

DRUGN : A report of severe DRUGA toxicity was reported in a patient receiving DRUGB .
acetaminophen	drug	Isoniazid	drug
effect

It is believed that the toxicity may have resulted from a previously unrecognized interaction between DRUGA and DRUGB and a molecular basis for this interaction has been proposed .
isoniazid	drug	acetaminophen	drug
effect

Furthermore it has been proposed that DRUGA resulted In induction of P dgbIIEdgb in the patients liver which , in turn , resulted in a greater proportion of the ingested DRUGB being converted to the toxic metabolites .
isoniazid	drug	acetaminophen	drug
mechanism

DRUGA : Potential interaction of DRUGN and DRUGB may exist .
Ketoconazole	drug	Isoniazid	drug
false

DRUGN : Potential interaction of DRUGA and DRUGB may exist .
Ketoconazole	drug	Isoniazid	drug
int

DRUGA : DRUGB may increase serum levels of DRUGN .
Phenytoin	drug	Isoniazid	drug
false

DRUGA : DRUGN may increase serum levels of DRUGB .
Phenytoin	drug	phenytoin	drug
false

DRUGN : DRUGA may increase serum levels of DRUGB .
Isoniazid	drug	phenytoin	drug
mechanism

To avoid DRUGA intoxication , appropriate adjustment of the DRUGB should be made .
phenytoin	drug	anticonvulsant	group
false

Therophylline : A recent study has shown that concomitan administration of DRUGA and DRUGB may cause elevated plasma levels of DRUGN , and in some instances a slight decrease in the elimination of DRUGN .
isoniazid	drug	theophylline	drug
mechanism

Therophylline : A recent study has shown that concomitan administration of DRUGA and DRUGN may cause elevated plasma levels of DRUGB , and in some instances a slight decrease in the elimination of DRUGN .
isoniazid	drug	theophylline	drug
false

Therophylline : A recent study has shown that concomitan administration of DRUGN and DRUGA may cause elevated plasma levels of DRUGN , and in some instances a slight decrease in the elimination of DRUGB .
theophylline	drug	isoniazid	drug
false

Therophylline : A recent study has shown that concomitan administration of DRUGN and DRUGN may cause elevated plasma levels of DRUGA , and in some instances a slight decrease in the elimination of DRUGB .
theophylline	drug	isoniazid	drug
false

DRUGA : A recent case study has shown a possible increase in the plasma level of DRUGB when co administered with DRUGN .
Valproate	drug	valproate	drug
false

DRUGA : A recent case study has shown a possible increase in the plasma level of DRUGN when co administered with DRUGB .
Valproate	drug	isoniazid	drug
false

DRUGN : A recent case study has shown a possible increase in the plasma level of DRUGA when co administered with DRUGB .
valproate	drug	isoniazid	drug
mechanism

Plasma DRUGA concentration should be monitored when DRUGB and DRUGN are co administered , and appropriate dosage adjustments of DRUGN should be made .
valproate	drug	isoniazid	drug
false

Plasma DRUGN concentration should be monitored when DRUGA and DRUGB are co administered , and appropriate dosage adjustments of DRUGN should be made .
isoniazid	drug	valproate	drug
advise

Plasma DRUGN concentration should be monitored when DRUGA and DRUGN are co administered , and appropriate dosage adjustments of DRUGB should be made .
isoniazid	drug	valproate	drug
false

DRUGA injection and DRUGB should not be administered simultaneously because both drugs are direct cardiac stimulants and their combined effects may induce serious arrhythmias .
Isoproterenol hydrochloride	drug	epinephrine	drug
advise

DRUGA should be used with caution , if at all , when potent inhalational DRUGB such as DRUGN are employed because of potential to sensitize the myocardium to effects of DRUGN .
ISUPREL	brand	anesthetics	group
advise

DRUGA should be used with caution , if at all , when potent inhalational DRUGN such as DRUGB are employed because of potential to sensitize the myocardium to effects of DRUGN .
ISUPREL	brand	halothane	drug
advise

DRUGA should be used with caution , if at all , when potent inhalational DRUGN such as DRUGN are employed because of potential to sensitize the myocardium to effects of DRUGB .
ISUPREL	brand	sympathomimetic amines	group
false

DRUGN should be used with caution , if at all , when potent inhalational DRUGA such as DRUGB are employed because of potential to sensitize the myocardium to effects of DRUGN .
anesthetics	group	halothane	drug
false

DRUGN should be used with caution , if at all , when potent inhalational DRUGA such as DRUGN are employed because of potential to sensitize the myocardium to effects of DRUGB .
anesthetics	group	sympathomimetic amines	group
false

DRUGN should be used with caution , if at all , when potent inhalational DRUGN such as DRUGA are employed because of potential to sensitize the myocardium to effects of DRUGB .
halothane	drug	sympathomimetic amines	group
false

The vasodilating effects of DRUGA may be additive with those of other DRUGB .
isosorbide dinitrate	drug	vasodilators	group
effect

The vasodilating effects of DRUGA may be additive with those of other DRUGB .
isosorbide mononitrate	drug	vasodilators	group
effect

Marked symptomatic orthostatic hypotension has been reported when DRUGA and DRUGB were used in combination .
calcium channel blockers	group	organic nitrates	group
effect

DRUGA : Because of the relationship of DRUGB to DRUGN , patients should be advised against taking DRUGN containing DRUGN to avoid additive toxic effects
Vitamin A	group	Accutane	brand
false

DRUGA : Because of the relationship of DRUGN to DRUGB , patients should be advised against taking DRUGN containing DRUGN to avoid additive toxic effects
Vitamin A	group	vitamin A	group
false

DRUGA : Because of the relationship of DRUGN to DRUGN , patients should be advised against taking DRUGB containing DRUGN to avoid additive toxic effects
Vitamin A	group	vitamin supplements	group
false

DRUGA : Because of the relationship of DRUGN to DRUGN , patients should be advised against taking DRUGN containing DRUGB to avoid additive toxic effects
Vitamin A	group	vitamin A	group
false

DRUGN : Because of the relationship of DRUGA to DRUGB , patients should be advised against taking DRUGN containing DRUGN to avoid additive toxic effects
Accutane	brand	vitamin A	group
effect

DRUGN : Because of the relationship of DRUGA to DRUGN , patients should be advised against taking DRUGB containing DRUGN to avoid additive toxic effects
Accutane	brand	vitamin supplements	group
false

DRUGN : Because of the relationship of DRUGA to DRUGN , patients should be advised against taking DRUGN containing DRUGB to avoid additive toxic effects
Accutane	brand	vitamin A	group
false

DRUGN : Because of the relationship of DRUGN to DRUGA , patients should be advised against taking DRUGB containing DRUGN to avoid additive toxic effects
vitamin A	group	vitamin supplements	group
false

DRUGN : Because of the relationship of DRUGN to DRUGN , patients should be advised against taking DRUGA containing DRUGB to avoid additive toxic effects
vitamin supplements	group	vitamin A	group
false

DRUGA : Concomitant treatment with DRUGB and DRUGN should be avoided because DRUGN use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of DRUGN
Tetracyclines	group	Accutane	brand
false

DRUGA : Concomitant treatment with DRUGN and DRUGB should be avoided because DRUGN use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of DRUGN
Tetracyclines	group	tetracyclines	group
false

DRUGA : Concomitant treatment with DRUGN and DRUGN should be avoided because DRUGB use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of DRUGN
Tetracyclines	group	Accutane	brand
false

DRUGA : Concomitant treatment with DRUGN and DRUGN should be avoided because DRUGN use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of DRUGB
Tetracyclines	group	tetracyclines	group
false

DRUGN : Concomitant treatment with DRUGA and DRUGB should be avoided because DRUGN use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of DRUGN
Accutane	brand	tetracyclines	group
advise

DRUGN : Concomitant treatment with DRUGA and DRUGN should be avoided because DRUGN use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of DRUGB
Accutane	brand	tetracyclines	group
false

DRUGN : Concomitant treatment with DRUGN and DRUGA should be avoided because DRUGB use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of DRUGN
tetracyclines	group	Accutane	brand
false

DRUGN : Concomitant treatment with DRUGN and DRUGN should be avoided because DRUGA use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of DRUGB
Accutane	brand	tetracyclines	group
effect

Micro dosed DRUGA Preparations : Micro dosed DRUGB preparations ( minipills that do not contain an DRUGN ) may be an inadequate method of contraception during DRUGN therapy .
Progesterone	drug	progesterone	drug
false

Micro dosed DRUGA Preparations : Micro dosed DRUGN preparations ( minipills that do not contain an DRUGB ) may be an inadequate method of contraception during DRUGN therapy .
Progesterone	drug	estrogen	group
false

Micro dosed DRUGA Preparations : Micro dosed DRUGN preparations ( minipills that do not contain an DRUGN ) may be an inadequate method of contraception during DRUGB therapy .
Progesterone	drug	Accutane	brand
false

Micro dosed DRUGN Preparations : Micro dosed DRUGA preparations ( minipills that do not contain an DRUGB ) may be an inadequate method of contraception during DRUGN therapy .
progesterone	drug	estrogen	group
false

Micro dosed DRUGN Preparations : Micro dosed DRUGA preparations ( minipills that do not contain an DRUGN ) may be an inadequate method of contraception during DRUGB therapy .
progesterone	drug	Accutane	brand
effect

Micro dosed DRUGN Preparations : Micro dosed DRUGN preparations ( minipills that do not contain an DRUGA ) may be an inadequate method of contraception during DRUGB therapy .
estrogen	group	Accutane	brand
false

Although other DRUGA are highly effective , there have been reports of pregnancy from women who have used DRUGB , as well as topical / injectable / implantable / insertable hormonal birth control products .
hormonal contraceptives	group	combined oral contraceptives	group
false

It is not known if DRUGA differ in their effectiveness when used with DRUGB .
hormonal contraceptives	group	Accutane	brand
false

DRUGA : DRUGB has not been shown to alter the pharmacokinetics of DRUGN in a study in seven healthy volunteers .
Phenytoin	drug	Accutane	brand
false

DRUGA : DRUGN has not been shown to alter the pharmacokinetics of DRUGB in a study in seven healthy volunteers .
Phenytoin	drug	phenytoin	drug
false

DRUGN : DRUGA has not been shown to alter the pharmacokinetics of DRUGB in a study in seven healthy volunteers .
Accutane	brand	phenytoin	drug
false

No formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between DRUGA and DRUGB .
phenytoin	drug	Accutane	brand
false

DRUGA : DRUGB are known to cause osteoporosis .
Systemic Corticosteroids	group	Systemic corticosteroids	group
false

No formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between DRUGA and DRUGB .
systemic corticosteroids	group	Accutane	brand
false

DRUGA : DRUGB ( DRUGN ) has been safely coadministered with DRUGN .
Nitroglycerin	drug	DynaCirc	brand
false

DRUGA : DRUGN ( DRUGB ) has been safely coadministered with DRUGN .
Nitroglycerin	drug	isradipine	drug
false

DRUGA : DRUGN ( DRUGN ) has been safely coadministered with DRUGB .
Nitroglycerin	drug	nitroglycerin	drug
false

DRUGN : DRUGA ( DRUGB ) has been safely coadministered with DRUGN .
DynaCirc	brand	isradipine	drug
false

DRUGN : DRUGA ( DRUGN ) has been safely coadministered with DRUGB .
DynaCirc	brand	nitroglycerin	drug
false

DRUGN : DRUGN ( DRUGA ) has been safely coadministered with DRUGB .
isradipine	drug	nitroglycerin	drug
false

DRUGA : A study in normal healthy volunteers has shown that concomitant administration of DRUGB ( DRUGN ) and DRUGN does not result in altered pharmacoktnetics of either drug .
Hydrochlorothiazide	drug	DynaCirc	brand
false

DRUGA : A study in normal healthy volunteers has shown that concomitant administration of DRUGN ( DRUGB ) and DRUGN does not result in altered pharmacoktnetics of either drug .
Hydrochlorothiazide	drug	isradipine	drug
false

DRUGA : A study in normal healthy volunteers has shown that concomitant administration of DRUGN ( DRUGN ) and DRUGB does not result in altered pharmacoktnetics of either drug .
Hydrochlorothiazide	drug	hydrochlorothiazide	drug
false

DRUGN : A study in normal healthy volunteers has shown that concomitant administration of DRUGA ( DRUGB ) and DRUGN does not result in altered pharmacoktnetics of either drug .
DynaCirc	brand	isradipine	drug
false

DRUGN : A study in normal healthy volunteers has shown that concomitant administration of DRUGA ( DRUGN ) and DRUGB does not result in altered pharmacoktnetics of either drug .
DynaCirc	brand	hydrochlorothiazide	drug
false

DRUGN : A study in normal healthy volunteers has shown that concomitant administration of DRUGN ( DRUGA ) and DRUGB does not result in altered pharmacoktnetics of either drug .
isradipine	drug	hydrochlorothiazide	drug
false

In a study in hypertensive patients , addition of DRUGA to existing DRUGB therapy did not result in any unexpected adverse effects , and DRUGN had an additional antihypertensive effect .
isradipine	drug	hydrochlorothiazide	drug
false

In a study in hypertensive patients , addition of DRUGN to existing DRUGA therapy did not result in any unexpected adverse effects , and DRUGB had an additional antihypertensive effect .
hydrochlorothiazide	drug	isradipine	drug
false

DRUGA : In a single dose study in normal volunteers , coadministration of DRUGB had a small effect on the rate but no effect on the extent of DRUGN bioavailability .
Propranolol	drug	propranolol	drug
false

DRUGA : In a single dose study in normal volunteers , coadministration of DRUGN had a small effect on the rate but no effect on the extent of DRUGB bioavailability .
Propranolol	drug	isradipine	drug
false

DRUGN : In a single dose study in normal volunteers , coadministration of DRUGA had a small effect on the rate but no effect on the extent of DRUGB bioavailability .
propranolol	drug	isradipine	drug
false

If DRUGA therapy is initiated in a patient currently receiving DRUGB careful monitoring for adverse reactions is advised and downward dose adjustment may be required .
isradipine	drug	cimetidine	drug
advise

If DRUGA therapy is required , DRUGB concentrations and therapeutic effects are likely to be markedly reduced or abolished as a consequence of increased metabolism and higher clearance of DRUGN .
rifampicin	drug	isradipine	drug
mechanism

If DRUGA therapy is required , DRUGN concentrations and therapeutic effects are likely to be markedly reduced or abolished as a consequence of increased metabolism and higher clearance of DRUGB .
rifampicin	drug	isradipine	drug
false

Neither racemic DRUGA nor DRUGB binding to plasma proteins in vitro was altered by the addition of the other drug .
warfarin	drug	isradipine	drug
false

DRUGA : The concomitant administration of DRUGB ( DRUGN ) and DRUGN in a single dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of DRUGN .
Digoxin	drug	DynaCirc	brand
false

DRUGA : The concomitant administration of DRUGN ( DRUGB ) and DRUGN in a single dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of DRUGN .
Digoxin	drug	isradipine	drug
false

DRUGA : The concomitant administration of DRUGN ( DRUGN ) and DRUGB in a single dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of DRUGN .
Digoxin	drug	digoxin	drug
false

DRUGA : The concomitant administration of DRUGN ( DRUGN ) and DRUGN in a single dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of DRUGB .
Digoxin	drug	digoxin	drug
false

DRUGN : The concomitant administration of DRUGA ( DRUGB ) and DRUGN in a single dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of DRUGN .
DynaCirc	brand	isradipine	drug
false

DRUGN : The concomitant administration of DRUGA ( DRUGN ) and DRUGB in a single dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of DRUGN .
DynaCirc	brand	digoxin	drug
false

DRUGN : The concomitant administration of DRUGA ( DRUGN ) and DRUGN in a single dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of DRUGB .
DynaCirc	brand	digoxin	drug
false

DRUGN : The concomitant administration of DRUGN ( DRUGA ) and DRUGB in a single dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of DRUGN .
isradipine	drug	digoxin	drug
false

DRUGN : The concomitant administration of DRUGN ( DRUGA ) and DRUGN in a single dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of DRUGB .
isradipine	drug	digoxin	drug
false

DRUGA Anesthesia : Severe hypotension has been reported during DRUGB anesthesia with concomitant use of a DRUGN and a DRUGN .
Fentanyl	drug	fentanyl	drug
false

DRUGA Anesthesia : Severe hypotension has been reported during DRUGN anesthesia with concomitant use of a DRUGB and a DRUGN .
Fentanyl	drug	beta blocker	group
false

DRUGA Anesthesia : Severe hypotension has been reported during DRUGN anesthesia with concomitant use of a DRUGN and a DRUGB .
Fentanyl	drug	calcium channel blocker	group
false

DRUGN Anesthesia : Severe hypotension has been reported during DRUGA anesthesia with concomitant use of a DRUGB and a DRUGN .
fentanyl	drug	beta blocker	group
effect

DRUGN Anesthesia : Severe hypotension has been reported during DRUGA anesthesia with concomitant use of a DRUGN and a DRUGB .
fentanyl	drug	calcium channel blocker	group
effect

DRUGN Anesthesia : Severe hypotension has been reported during DRUGN anesthesia with concomitant use of a DRUGA and a DRUGB .
beta blocker	group	calcium channel blocker	group
false

Even though such interactions have not been seen in clinical studies with DRUGA ( DRUGB ) , an increased volume of circulating fluids might be required if such an interaction were to occur .
DynaCirc	brand	isradipine	drug
false

Both DRUGA and its major metabolite , DRUGB , are inhibitors of the cytochrome Pdgb dgbAdgb enzyme system .
itraconazole	drug	hydroxyitraconazole	drug_n
false

Coadministration of DRUGA with DRUGB has led to elevated plasma concentrations of DRUGN , resulting in rare instances of life threatening cardiac dysrhythmias and one death .
terfenadine	drug	Itraconazole	drug
mechanism

Coadministration of DRUGN with DRUGA has led to elevated plasma concentrations of DRUGB , resulting in rare instances of life threatening cardiac dysrhythmias and one death .
Itraconazole	drug	terfenadine	drug
false

Another oral DRUGA , DRUGB , inhibits the metabolism of DRUGN , resulting in elevated plasma concentrations of DRUGN and its active metabolite DRUGN which may prolong QT intervals .
azole antifungal	group	ketoconazole	drug
false

Another oral DRUGA , DRUGN , inhibits the metabolism of DRUGB , resulting in elevated plasma concentrations of DRUGN and its active metabolite DRUGN which may prolong QT intervals .
azole antifungal	group	astemizole	drug
false

Another oral DRUGA , DRUGN , inhibits the metabolism of DRUGN , resulting in elevated plasma concentrations of DRUGB and its active metabolite DRUGN which may prolong QT intervals .
azole antifungal	group	astemizole	drug
false

Another oral DRUGA , DRUGN , inhibits the metabolism of DRUGN , resulting in elevated plasma concentrations of DRUGN and its active metabolite DRUGB which may prolong QT intervals .
azole antifungal	group	desmethylastermizole	drug_n
false

Another oral DRUGN , DRUGA , inhibits the metabolism of DRUGB , resulting in elevated plasma concentrations of DRUGN and its active metabolite DRUGN which may prolong QT intervals .
ketoconazole	drug	astemizole	drug
mechanism

Another oral DRUGN , DRUGA , inhibits the metabolism of DRUGN , resulting in elevated plasma concentrations of DRUGB and its active metabolite DRUGN which may prolong QT intervals .
ketoconazole	drug	astemizole	drug
false

Another oral DRUGN , DRUGA , inhibits the metabolism of DRUGN , resulting in elevated plasma concentrations of DRUGN and its active metabolite DRUGB which may prolong QT intervals .
ketoconazole	drug	desmethylastermizole	drug_n
false

Another oral DRUGN , DRUGN , inhibits the metabolism of DRUGA , resulting in elevated plasma concentrations of DRUGN and its active metabolite DRUGB which may prolong QT intervals .
astemizole	drug	desmethylastermizole	drug_n
false

Another oral DRUGN , DRUGN , inhibits the metabolism of DRUGN , resulting in elevated plasma concentrations of DRUGA and its active metabolite DRUGB which may prolong QT intervals .
astemizole	drug	desmethylastermizole	drug_n
false

In vitro data suggest that DRUGA , when compared to DRUGB , has a less pronounced effect on the biotransformation system responsible for the metabolism of DRUGN .
itraconazole	drug	ketoconazole	drug
false

In vitro data suggest that DRUGA , when compared to DRUGN , has a less pronounced effect on the biotransformation system responsible for the metabolism of DRUGB .
itraconazole	drug	astemizole	drug
mechanism

In vitro data suggest that DRUGN , when compared to DRUGA , has a less pronounced effect on the biotransformation system responsible for the metabolism of DRUGB .
ketoconazole	drug	astemizole	drug
false

Based on the chemical resemblance of DRUGA and DRUGB , coadministration of DRUGN with DRUGN is contraindicated .
itraconazole	drug	ketoconazole	drug
false

Based on the chemical resemblance of DRUGA and DRUGN , coadministration of DRUGB with DRUGN is contraindicated .
itraconazole	drug	astemizole	drug
false

Based on the chemical resemblance of DRUGN and DRUGA , coadministration of DRUGB with DRUGN is contraindicated .
ketoconazole	drug	astemizole	drug
false

Based on the chemical resemblance of DRUGN and DRUGA , coadministration of DRUGN with DRUGB is contraindicated .
ketoconazole	drug	itraconazole	drug
false

Based on the chemical resemblance of DRUGN and DRUGN , coadministration of DRUGA with DRUGB is contraindicated .
astemizole	drug	itraconazole	drug
advise

Human pharmacokinetics data indicate that oral DRUGA potently inhibits the metabolism of DRUGB resulting in an eight fold increase in the mean AUC of DRUGN .
ketoconazole	drug	cisapride	drug
mechanism

Human pharmacokinetics data indicate that oral DRUGA potently inhibits the metabolism of DRUGN resulting in an eight fold increase in the mean AUC of DRUGB .
ketoconazole	drug	cisapride	drug
false

Data suggest that coadministration of oral DRUGA and DRUGB can result in prolongation of the QT interval on the ECG .
ketoconazole	drug	cisapride	drug
effect

In vitro data suggest that DRUGA also markedly inhibits the biotransformation system mainly responsible for the metabolism of DRUGB ;
itraconazole	drug	cisapride	drug
mechanism

therefore concomitant administration of DRUGA with DRUGB is contraindicated .
Itraconazole	drug	cisapride	drug
advise

Coadministration of DRUGA with oral DRUGB or DRUGN has resulted in elevated plasma concentrations of the latter two drugs .
Itraconazole	drug	midazolam	drug
mechanism

Coadministration of DRUGA with oral DRUGN or DRUGB has resulted in elevated plasma concentrations of the latter two drugs .
Itraconazole	drug	triazolam	drug
mechanism

Coadministration of DRUGN with oral DRUGA or DRUGB has resulted in elevated plasma concentrations of the latter two drugs .
midazolam	drug	triazolam	drug
false

Coadministration of DRUGA and DRUGB , DRUGN or DRUGN has led to increased plasma concentrations of the latter three drugs .
Itraconazole	drug	cyclosporine	drug
mechanism

Coadministration of DRUGA and DRUGN , DRUGB or DRUGN has led to increased plasma concentrations of the latter three drugs .
Itraconazole	drug	tacrolimus	drug
mechanism

Coadministration of DRUGA and DRUGN , DRUGN or DRUGB has led to increased plasma concentrations of the latter three drugs .
Itraconazole	drug	digoxin	drug
mechanism

Coadministration of DRUGN and DRUGA , DRUGB or DRUGN has led to increased plasma concentrations of the latter three drugs .
cyclosporine	drug	tacrolimus	drug
false

Coadministration of DRUGN and DRUGA , DRUGN or DRUGB has led to increased plasma concentrations of the latter three drugs .
cyclosporine	drug	digoxin	drug
false

Coadministration of DRUGN and DRUGN , DRUGA or DRUGB has led to increased plasma concentrations of the latter three drugs .
tacrolimus	drug	digoxin	drug
false

DRUGA , DRUGB and DRUGN concentrations should be monitored at the initiation of DRUGN therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .
Cyclosporine	drug	tacrolimus	drug
false

DRUGA , DRUGN and DRUGB concentrations should be monitored at the initiation of DRUGN therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .
Cyclosporine	drug	digoxin	drug
false

DRUGA , DRUGN and DRUGN concentrations should be monitored at the initiation of DRUGB therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .
Cyclosporine	drug	Itraconazole	drug
advise

DRUGN , DRUGA and DRUGB concentrations should be monitored at the initiation of DRUGN therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .
tacrolimus	drug	digoxin	drug
false

DRUGN , DRUGA and DRUGN concentrations should be monitored at the initiation of DRUGB therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .
tacrolimus	drug	Itraconazole	drug
advise

DRUGN , DRUGN and DRUGA concentrations should be monitored at the initiation of DRUGB therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .
digoxin	drug	Itraconazole	drug
advise

Rhabdomyolysis has been observed in patients receiving DRUGA administered alone ( at recommended dosages ) or concomitantly with DRUGB including DRUGN .
HMG-CoA reductase inhibitors	group	immunosuppressive drugs	group
effect

Rhabdomyolysis has been observed in patients receiving DRUGA administered alone ( at recommended dosages ) or concomitantly with DRUGN including DRUGB .
HMG-CoA reductase inhibitors	group	cyclosporine	drug
effect

Rhabdomyolysis has been observed in patients receiving DRUGN administered alone ( at recommended dosages ) or concomitantly with DRUGA including DRUGB .
immunosuppressive drugs	group	cyclosporine	drug
false

When DRUGA was coadministered with DRUGB , DRUGN , or Hdgbantagonists , reduced plasma concentrations of DRUGN were reported .
Itraconazole	drug	phenytoin	drug
mechanism

When DRUGA was coadministered with DRUGN , DRUGB , or Hdgbantagonists , reduced plasma concentrations of DRUGN were reported .
Itraconazole	drug	rifampin	drug
mechanism

When DRUGA was coadministered with DRUGN , DRUGN , or Hdgbantagonists , reduced plasma concentrations of DRUGB were reported .
Itraconazole	drug	itraconazole	drug
false

When DRUGN was coadministered with DRUGA , DRUGB , or Hdgbantagonists , reduced plasma concentrations of DRUGN were reported .
phenytoin	drug	rifampin	drug
false

When DRUGN was coadministered with DRUGA , DRUGN , or Hdgbantagonists , reduced plasma concentrations of DRUGB were reported .
phenytoin	drug	itraconazole	drug
false

When DRUGN was coadministered with DRUGN , DRUGA , or Hdgbantagonists , reduced plasma concentrations of DRUGB were reported .
rifampin	drug	itraconazole	drug
false

The physician is advised to monitor the plasma concentrations of DRUGA when any of these drugs is taken concurrently , and to increase the dose of DRUGB if necessary .
itraconazole	drug	Itraconazole	drug
false

Although no studies have been conducted , concomitant administration of DRUGA and DRUGB may alter the metabolism of DRUGN ;
Itraconazole	drug	phenytoin	drug
mechanism

Although no studies have been conducted , concomitant administration of DRUGA and DRUGN may alter the metabolism of DRUGB ;
Itraconazole	drug	phenytoin	drug
false

therefore , plasma concentrations of DRUGA should also be monitored when it is given concurrently with DRUGB .
phenytoin	drug	Itraconazole	drug
advise

It has been reported that DRUGA enhances the anticoagulant effect of DRUGB like drugs .
Itraconazole	drug	coumarin	group
effect

Therefore , prothrombin time should be carefully monitored in patients receiving DRUGA and DRUGB like drugs simultaneously .
Itraconazole	drug	coumarin	group
advise

Plasma concentrations of DRUGA are reduced when given concurrently with DRUGB .
azole antifungal agents	group	isoniazid	drug
mechanism

DRUGA plasma concentrations should be monitored when DRUGN and DRUGB are coadministered .
Itraconazole	drug	isoniazid	drug
false

DRUGN plasma concentrations should be monitored when DRUGA and DRUGB are coadministered .
Itraconazole	drug	isoniazid	drug
advise

Severe hypoglycemia has been reported in patients concomitantly receiving DRUGA and oral DRUGB .
azole antifungal agents	group	hypoglycemic agents	group
effect

Blood glucose concentrations should be carefully monitored when DRUGA and oral DRUGB are coadministered .
Itraconazole	drug	hypoglycemic agents	group
advise

Tinnitus and decreased hearing have been reported in patients concomitantly receiving DRUGA and DRUGB .
Itraconazole	drug	quinidine	drug
effect

Edema has been reported in patients concomitantly receiving DRUGA and DRUGB .
Itraconazole	drug	dihydropyridine calcium channel blockers	group
effect

In vitro mixing of an DRUGA with beta lactamtype DRUGB ( DRUGN or DRUGN ) may result in a significant mutual inactivation .
aminoglycoside	group	antibiotics	group
effect

In vitro mixing of an DRUGA with beta lactamtype DRUGN ( DRUGB or DRUGN ) may result in a significant mutual inactivation .
aminoglycoside	group	penicillins	group
effect

In vitro mixing of an DRUGA with beta lactamtype DRUGN ( DRUGN or DRUGB ) may result in a significant mutual inactivation .
aminoglycoside	group	cephalosporins	group
effect

In vitro mixing of an DRUGN with beta lactamtype DRUGA ( DRUGB or DRUGN ) may result in a significant mutual inactivation .
antibiotics	group	penicillins	group
false

In vitro mixing of an DRUGN with beta lactamtype DRUGA ( DRUGN or DRUGB ) may result in a significant mutual inactivation .
antibiotics	group	cephalosporins	group
false

In vitro mixing of an DRUGN with beta lactamtype DRUGN ( DRUGA or DRUGB ) may result in a significant mutual inactivation .
penicillins	group	cephalosporins	group
false

Prolonged recovery time may occur if DRUGA and / or DRUGB are used concurrently with DRUGN .
barbiturates	group	narcotics	group
false

Prolonged recovery time may occur if DRUGA and / or DRUGN are used concurrently with DRUGB .
barbiturates	group	ketamine	drug
effect

Prolonged recovery time may occur if DRUGN and / or DRUGA are used concurrently with DRUGB .
narcotics	group	ketamine	drug
effect

DRUGA is clinically compatible with the commonly used general and local DRUGB when an adequate respiratory exchange is maintained .
Ketamine	drug	anesthetic agents	group
false

Pharmacokinetic data indicate that oral DRUGA inhibits the metabolism of DRUGB , resulting in elevated plasma levels of DRUGN and its active metabolite DRUGN which may prolong QT intervals .
ketoconazole	drug	astemizole	drug
effect

Pharmacokinetic data indicate that oral DRUGA inhibits the metabolism of DRUGN , resulting in elevated plasma levels of DRUGB and its active metabolite DRUGN which may prolong QT intervals .
ketoconazole	drug	astemizole	drug
false

Pharmacokinetic data indicate that oral DRUGA inhibits the metabolism of DRUGN , resulting in elevated plasma levels of DRUGN and its active metabolite DRUGB which may prolong QT intervals .
ketoconazole	drug	desmethylastemizole	drug_n
false

Pharmacokinetic data indicate that oral DRUGN inhibits the metabolism of DRUGA , resulting in elevated plasma levels of DRUGN and its active metabolite DRUGB which may prolong QT intervals .
astemizole	drug	desmethylastemizole	drug_n
false

Pharmacokinetic data indicate that oral DRUGN inhibits the metabolism of DRUGN , resulting in elevated plasma levels of DRUGA and its active metabolite DRUGB which may prolong QT intervals .
astemizole	drug	desmethylastemizole	drug_n
false

Coadministration of DRUGA with DRUGB tablets is therefore contraindicated .
astemizole	drug	ketoconazole	drug
advise

Human pharmacokinetics data indicate that oral DRUGA potently inhibits the metabolism of DRUGB resulting in a mean eight fold increase in AUC of DRUGN .
ketoconazole	drug	cisapride	drug
mechanism

Human pharmacokinetics data indicate that oral DRUGA potently inhibits the metabolism of DRUGN resulting in a mean eight fold increase in AUC of DRUGB .
ketoconazole	drug	cisapride	drug
false

Data suggest that coadministration of oral DRUGA and DRUGB can result in prolongation of the QT interval on the ECG .
ketoconazole	drug	cisapride	drug
effect

Therefore concomitant administration of DRUGA tablets with DRUGB is contraindicated .
ketoconazole	drug	cisapride	drug
advise

DRUGA tablets may alter the metabolism of DRUGB , DRUGN , and DRUGN , resulting in elevated plasma concentrations of the latter drugs .
Ketoconazole	drug	cyclosporine	drug
mechanism

DRUGA tablets may alter the metabolism of DRUGN , DRUGB , and DRUGN , resulting in elevated plasma concentrations of the latter drugs .
Ketoconazole	drug	tacrolimus	drug
mechanism

DRUGA tablets may alter the metabolism of DRUGN , DRUGN , and DRUGB , resulting in elevated plasma concentrations of the latter drugs .
Ketoconazole	drug	methylprednisolone	drug
mechanism

DRUGN tablets may alter the metabolism of DRUGA , DRUGB , and DRUGN , resulting in elevated plasma concentrations of the latter drugs .
cyclosporine	drug	tacrolimus	drug
false

DRUGN tablets may alter the metabolism of DRUGA , DRUGN , and DRUGB , resulting in elevated plasma concentrations of the latter drugs .
cyclosporine	drug	methylprednisolone	drug
false

DRUGN tablets may alter the metabolism of DRUGN , DRUGA , and DRUGB , resulting in elevated plasma concentrations of the latter drugs .
tacrolimus	drug	methylprednisolone	drug
false

Dosage adjustment may be required if DRUGA , DRUGB , or DRUGN are given concomitantly with DRUGN Tablets .
cyclosporine	drug	tacrolimus	drug
false

Dosage adjustment may be required if DRUGA , DRUGN , or DRUGB are given concomitantly with DRUGN Tablets .
cyclosporine	drug	methylprednisolone	drug
false

Dosage adjustment may be required if DRUGA , DRUGN , or DRUGN are given concomitantly with DRUGB Tablets .
cyclosporine	drug	NIZORAL	brand
false

Dosage adjustment may be required if DRUGN , DRUGA , or DRUGB are given concomitantly with DRUGN Tablets .
tacrolimus	drug	methylprednisolone	drug
false

Dosage adjustment may be required if DRUGN , DRUGA , or DRUGN are given concomitantly with DRUGB Tablets .
tacrolimus	drug	NIZORAL	brand
false

Dosage adjustment may be required if DRUGN , DRUGN , or DRUGA are given concomitantly with DRUGB Tablets .
methylprednisolone	drug	NIZORAL	brand
false

Coadministration of DRUGA Tablets with DRUGB or DRUGN has resulted in elevated plasma concentrations of the latter two drugs .
NIZORAL	brand	midazolam	drug
mechanism

Coadministration of DRUGA Tablets with DRUGN or DRUGB has resulted in elevated plasma concentrations of the latter two drugs .
NIZORAL	brand	triazolam	drug
mechanism

Coadministration of DRUGN Tablets with DRUGA or DRUGB has resulted in elevated plasma concentrations of the latter two drugs .
midazolam	drug	triazolam	drug
false

It is , therefore , advisable to monitor DRUGA concentrations in patients receiving DRUGB .
digoxin	drug	ketoconazole	drug
advise

When taken orally , DRUGA like DRUGB may enhance the anticoagulant effect of DRUGN like drugs .
imidazole compounds	group	ketoconazole	drug
false

When taken orally , DRUGA like DRUGN may enhance the anticoagulant effect of DRUGB like drugs .
imidazole compounds	group	coumarin	group
effect

When taken orally , DRUGN like DRUGA may enhance the anticoagulant effect of DRUGB like drugs .
ketoconazole	drug	coumarin	group
effect

In simultaneous treatment with DRUGA and DRUGB , the anticoagulant effect should be carefully titrated and monitored .
imidazole drugs	group	coumarin drugs	group
advise

Concomitant administration of DRUGA tablets with DRUGB may alter the metabolism of one or both of the drugs .
ketoconazole	drug	phenytoin	drug
mechanism

It is suggested to monitor both DRUGA and DRUGB .
ketoconazole	drug	phenytoin	drug
advise

Concomitant administration of DRUGA with DRUGB tablets reduces the blood levels of the latter .
rifampin	drug	ketoconazole	drug
mechanism

DRUGA ( DRUGB ) is also reported to affect DRUGN concentrations adversely .
INH	drug	Isoniazid	drug
false

DRUGA ( DRUGN ) is also reported to affect DRUGB concentrations adversely .
INH	drug	ketoconazole	drug
mechanism

DRUGN ( DRUGA ) is also reported to affect DRUGB concentrations adversely .
Isoniazid	drug	ketoconazole	drug
mechanism

Also , there were no clinically significant differences in adverse events when DRUGA was administered with or without DRUGB .
loratadine	drug	ketoconazole	drug
false

The possibility of increased interaction should be kept in mind when DRUGA doses greater than dgb mg as a single dose or dgb mg of DRUGB per day are used concomitantly with highly bound drugs .
Orudis	brand	ketoprofen	drug
false

DRUGA : Concomitant administration of DRUGB and DRUGN does not interfere with the rate or extent of the absorption of DRUGN administered as DRUGN .
Antacids	group	magnesium hydroxide	drug
false

DRUGA : Concomitant administration of DRUGN and DRUGB does not interfere with the rate or extent of the absorption of DRUGN administered as DRUGN .
Antacids	group	aluminum hydroxide	drug
false

DRUGA : Concomitant administration of DRUGN and DRUGN does not interfere with the rate or extent of the absorption of DRUGB administered as DRUGN .
Antacids	group	ketoprofen	drug
false

DRUGA : Concomitant administration of DRUGN and DRUGN does not interfere with the rate or extent of the absorption of DRUGN administered as DRUGB .
Antacids	group	Orudis	brand
false

DRUGN : Concomitant administration of DRUGA and DRUGB does not interfere with the rate or extent of the absorption of DRUGN administered as DRUGN .
magnesium hydroxide	drug	aluminum hydroxide	drug
false

DRUGN : Concomitant administration of DRUGA and DRUGN does not interfere with the rate or extent of the absorption of DRUGB administered as DRUGN .
magnesium hydroxide	drug	ketoprofen	drug
false

DRUGN : Concomitant administration of DRUGA and DRUGN does not interfere with the rate or extent of the absorption of DRUGN administered as DRUGB .
magnesium hydroxide	drug	Orudis	brand
false

DRUGN : Concomitant administration of DRUGN and DRUGA does not interfere with the rate or extent of the absorption of DRUGB administered as DRUGN .
aluminum hydroxide	drug	ketoprofen	drug
false

DRUGN : Concomitant administration of DRUGN and DRUGA does not interfere with the rate or extent of the absorption of DRUGN administered as DRUGB .
aluminum hydroxide	drug	Orudis	brand
false

DRUGN : Concomitant administration of DRUGN and DRUGN does not interfere with the rate or extent of the absorption of DRUGA administered as DRUGB .
ketoprofen	drug	Orudis	brand
false

DRUGA : DRUGB does not alter DRUGN absorption ;
Aspirin	brand	Ketoprofen	drug
false

DRUGA : DRUGN does not alter DRUGB absorption ;
Aspirin	brand	aspirin	brand
false

DRUGN : DRUGA does not alter DRUGB absorption ;
Ketoprofen	drug	aspirin	brand
false

Therefore , concurrent use of DRUGA and DRUGB is not recommended .
aspirin	brand	ketoprofen	drug
advise

DRUGA : DRUGB , given concomitantly with DRUGN , produces a reduction in urinary potassium and chloride excretion compared to DRUGN alone .
Diuretic	group	Hydrochlorothiazide	drug
false

DRUGA : DRUGN , given concomitantly with DRUGB , produces a reduction in urinary potassium and chloride excretion compared to DRUGN alone .
Diuretic	group	ketoprofen	drug
false

DRUGA : DRUGN , given concomitantly with DRUGN , produces a reduction in urinary potassium and chloride excretion compared to DRUGB alone .
Diuretic	group	hydrochlorothiazide	drug
false

DRUGN : DRUGA , given concomitantly with DRUGB , produces a reduction in urinary potassium and chloride excretion compared to DRUGN alone .
Hydrochlorothiazide	drug	ketoprofen	drug
effect

DRUGN : DRUGA , given concomitantly with DRUGN , produces a reduction in urinary potassium and chloride excretion compared to DRUGB alone .
Hydrochlorothiazide	drug	hydrochlorothiazide	drug
false

DRUGN : DRUGN , given concomitantly with DRUGA , produces a reduction in urinary potassium and chloride excretion compared to DRUGB alone .
ketoprofen	drug	hydrochlorothiazide	drug
false

DRUGA : In a study in dgb patients with congestive heart failure where DRUGB and DRUGN were concomitantly administered , DRUGN did not alter the serum levels of DRUGN .
Digoxin	drug	ketoprofen	drug
false

DRUGA : In a study in dgb patients with congestive heart failure where DRUGN and DRUGB were concomitantly administered , DRUGN did not alter the serum levels of DRUGN .
Digoxin	drug	digoxin	drug
false

DRUGA : In a study in dgb patients with congestive heart failure where DRUGN and DRUGN were concomitantly administered , DRUGB did not alter the serum levels of DRUGN .
Digoxin	drug	ketoprofen	drug
false

DRUGA : In a study in dgb patients with congestive heart failure where DRUGN and DRUGN were concomitantly administered , DRUGN did not alter the serum levels of DRUGB .
Digoxin	drug	digoxin	drug
false

DRUGN : In a study in dgb patients with congestive heart failure where DRUGA and DRUGB were concomitantly administered , DRUGN did not alter the serum levels of DRUGN .
ketoprofen	drug	digoxin	drug
false

DRUGN : In a study in dgb patients with congestive heart failure where DRUGA and DRUGN were concomitantly administered , DRUGN did not alter the serum levels of DRUGB .
ketoprofen	drug	digoxin	drug
false

DRUGN : In a study in dgb patients with congestive heart failure where DRUGN and DRUGA were concomitantly administered , DRUGB did not alter the serum levels of DRUGN .
digoxin	drug	ketoprofen	drug
false

DRUGN : In a study in dgb patients with congestive heart failure where DRUGN and DRUGN were concomitantly administered , DRUGA did not alter the serum levels of DRUGB .
ketoprofen	drug	digoxin	drug
false

DRUGA : In a short term controlled study in dgb normal volunteers , DRUGB did not significantly interfere with the effect of DRUGN on prothrombin time .
Warfarin	drug	ketoprofen	drug
false

DRUGA : In a short term controlled study in dgb normal volunteers , DRUGN did not significantly interfere with the effect of DRUGB on prothrombin time .
Warfarin	drug	warfarin	drug
false

DRUGN : In a short term controlled study in dgb normal volunteers , DRUGA did not significantly interfere with the effect of DRUGB on prothrombin time .
ketoprofen	drug	warfarin	drug
false

Bleeding from a number of sites may be a complication of DRUGA treatment and GI bleeding a complication of DRUGB treatment .
warfarin	drug	ketoprofen	drug
false

Because prostaglandina play an important role in hemostasis and DRUGA has an effect on platelet function as well , concurent therapy with DRUGN and DRUGB requires close monitoring of patients on both drugs .
ketoprofen	drug	warfarin	drug
false

Because prostaglandina play an important role in hemostasis and DRUGN has an effect on platelet function as well , concurent therapy with DRUGA and DRUGB requires close monitoring of patients on both drugs .
ketoprofen	drug	warfarin	drug
advise

DRUGA : DRUGN increases both free and bound DRUGB by reducing the plasma clearance of DRUGN to about one third , as well as decreasing its protein binding .
Probenecid	drug	ketoprofen	drug
false

DRUGA : DRUGN increases both free and bound DRUGN by reducing the plasma clearance of DRUGB to about one third , as well as decreasing its protein binding .
Probenecid	drug	ketoprofen	drug
false

DRUGN : DRUGA increases both free and bound DRUGB by reducing the plasma clearance of DRUGN to about one third , as well as decreasing its protein binding .
Probenecid	drug	ketoprofen	drug
mechanism

DRUGN : DRUGA increases both free and bound DRUGN by reducing the plasma clearance of DRUGB to about one third , as well as decreasing its protein binding .
Probenecid	drug	ketoprofen	drug
false

Therefore , the combination of DRUGA and DRUGB is not recommended .
ketoprofen	drug	probenecid	drug
advise

DRUGA : DRUGB , like other DRUGN , may cause changes in the elimination of DRUGN leading to elevated serum levels of the drug and increased toxicity .
Methotrexate	drug	Ketoprofen	drug
false

DRUGA : DRUGN , like other DRUGB , may cause changes in the elimination of DRUGN leading to elevated serum levels of the drug and increased toxicity .
Methotrexate	drug	NSAIDs	group
false

DRUGA : DRUGN , like other DRUGN , may cause changes in the elimination of DRUGB leading to elevated serum levels of the drug and increased toxicity .
Methotrexate	drug	methotrexate	drug
false

DRUGN : DRUGA , like other DRUGB , may cause changes in the elimination of DRUGN leading to elevated serum levels of the drug and increased toxicity .
Ketoprofen	drug	NSAIDs	group
false

DRUGN : DRUGA , like other DRUGN , may cause changes in the elimination of DRUGB leading to elevated serum levels of the drug and increased toxicity .
Ketoprofen	drug	methotrexate	drug
mechanism

DRUGN : DRUGN , like other DRUGA , may cause changes in the elimination of DRUGB leading to elevated serum levels of the drug and increased toxicity .
NSAIDs	group	methotrexate	drug
mechanism

DRUGA : DRUGB have been reported to increase steadystate plasma DRUGN levels .
Lithium	drug	Nonsteroidal anti-inflammatory agents	group
false

DRUGA : DRUGN have been reported to increase steadystate plasma DRUGB levels .
Lithium	drug	lithium	drug
false

DRUGN : DRUGA have been reported to increase steadystate plasma DRUGB levels .
Nonsteroidal anti-inflammatory agents	group	lithium	drug
mechanism

It is recommended that plasma DRUGA levels be monitored when DRUGB is coadministered with DRUGN .
lithium	drug	ketoprofen	drug
false

It is recommended that plasma DRUGN levels be monitored when DRUGA is coadministered with DRUGB .
ketoprofen	drug	lithium	drug
advise

DRUGA does not alter DRUGB protein binding .
Ketorolac	drug	digoxin	drug
false

Therapeutic concentrations of DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN andtolbutamide did not alter DRUGN protein binding .
digoxin	drug	warfarin	drug
false

Therapeutic concentrations of DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN andtolbutamide did not alter DRUGN protein binding .
digoxin	drug	ibuprofen	drug
false

Therapeutic concentrations of DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN andtolbutamide did not alter DRUGN protein binding .
digoxin	drug	naproxen	drug
false

Therapeutic concentrations of DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN andtolbutamide did not alter DRUGN protein binding .
digoxin	drug	piroxicam	drug
false

Therapeutic concentrations of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN andtolbutamide did not alter DRUGN protein binding .
digoxin	drug	acetaminophen	drug
false

Therapeutic concentrations of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB andtolbutamide did not alter DRUGN protein binding .
digoxin	drug	phenytoin	drug
false

Therapeutic concentrations of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN andtolbutamide did not alter DRUGB protein binding .
digoxin	drug	ketorolac tromethamine	drug
false

Therapeutic concentrations of DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN andtolbutamide did not alter DRUGN protein binding .
warfarin	drug	ibuprofen	drug
false

Therapeutic concentrations of DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN andtolbutamide did not alter DRUGN protein binding .
warfarin	drug	naproxen	drug
false

Therapeutic concentrations of DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN andtolbutamide did not alter DRUGN protein binding .
warfarin	drug	piroxicam	drug
false

Therapeutic concentrations of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN andtolbutamide did not alter DRUGN protein binding .
warfarin	drug	acetaminophen	drug
false

Therapeutic concentrations of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB andtolbutamide did not alter DRUGN protein binding .
warfarin	drug	phenytoin	drug
false

Therapeutic concentrations of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN andtolbutamide did not alter DRUGB protein binding .
warfarin	drug	ketorolac tromethamine	drug
false

Therapeutic concentrations of DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN andtolbutamide did not alter DRUGN protein binding .
ibuprofen	drug	naproxen	drug
false

Therapeutic concentrations of DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN andtolbutamide did not alter DRUGN protein binding .
ibuprofen	drug	piroxicam	drug
false

Therapeutic concentrations of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN andtolbutamide did not alter DRUGN protein binding .
ibuprofen	drug	acetaminophen	drug
false

Therapeutic concentrations of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB andtolbutamide did not alter DRUGN protein binding .
ibuprofen	drug	phenytoin	drug
false

Therapeutic concentrations of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN andtolbutamide did not alter DRUGB protein binding .
ibuprofen	drug	ketorolac tromethamine	drug
false

Therapeutic concentrations of DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN andtolbutamide did not alter DRUGN protein binding .
naproxen	drug	piroxicam	drug
false

Therapeutic concentrations of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN andtolbutamide did not alter DRUGN protein binding .
naproxen	drug	acetaminophen	drug
false

Therapeutic concentrations of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB andtolbutamide did not alter DRUGN protein binding .
naproxen	drug	phenytoin	drug
false

Therapeutic concentrations of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN andtolbutamide did not alter DRUGB protein binding .
naproxen	drug	ketorolac tromethamine	drug
false

Therapeutic concentrations of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN andtolbutamide did not alter DRUGN protein binding .
piroxicam	drug	acetaminophen	drug
false

Therapeutic concentrations of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB andtolbutamide did not alter DRUGN protein binding .
piroxicam	drug	phenytoin	drug
false

Therapeutic concentrations of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN andtolbutamide did not alter DRUGB protein binding .
piroxicam	drug	ketorolac tromethamine	drug
false

Therapeutic concentrations of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB andtolbutamide did not alter DRUGN protein binding .
acetaminophen	drug	phenytoin	drug
false

Therapeutic concentrations of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN andtolbutamide did not alter DRUGB protein binding .
acetaminophen	drug	ketorolac tromethamine	drug
false

Therapeutic concentrations of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA andtolbutamide did not alter DRUGB protein binding .
phenytoin	drug	ketorolac tromethamine	drug
false

Although these results do not indicate a significant interaction between DRUGA and DRUGB or DRUGN , the administration of DRUGN to patients taking DRUGN should be done extremely cautiously , and patients should be closely monitored .
TORADOL	brand	warfarin	drug
false

Although these results do not indicate a significant interaction between DRUGA and DRUGN or DRUGB , the administration of DRUGN to patients taking DRUGN should be done extremely cautiously , and patients should be closely monitored .
TORADOL	brand	heparin	drug
false

Although these results do not indicate a significant interaction between DRUGA and DRUGN or DRUGN , the administration of DRUGN to patients taking DRUGB should be done extremely cautiously , and patients should be closely monitored .
TORADOL	brand	anticoagulants	group
false

Although these results do not indicate a significant interaction between DRUGN and DRUGA or DRUGB , the administration of DRUGN to patients taking DRUGN should be done extremely cautiously , and patients should be closely monitored .
warfarin	drug	heparin	drug
false

Although these results do not indicate a significant interaction between DRUGN and DRUGA or DRUGN , the administration of DRUGB to patients taking DRUGN should be done extremely cautiously , and patients should be closely monitored .
warfarin	drug	TORADOL	brand
false

Although these results do not indicate a significant interaction between DRUGN and DRUGA or DRUGN , the administration of DRUGN to patients taking DRUGB should be done extremely cautiously , and patients should be closely monitored .
warfarin	drug	anticoagulants	group
false

Although these results do not indicate a significant interaction between DRUGN and DRUGN or DRUGA , the administration of DRUGB to patients taking DRUGN should be done extremely cautiously , and patients should be closely monitored .
heparin	drug	TORADOL	brand
false

Although these results do not indicate a significant interaction between DRUGN and DRUGN or DRUGA , the administration of DRUGN to patients taking DRUGB should be done extremely cautiously , and patients should be closely monitored .
heparin	drug	anticoagulants	group
false

Although these results do not indicate a significant interaction between DRUGN and DRUGN or DRUGN , the administration of DRUGA to patients taking DRUGB should be done extremely cautiously , and patients should be closely monitored .
TORADOL	brand	anticoagulants	group
advise

DRUGA : DRUGB IV / IM reduced the DRUGN response to DRUGN in normovolemic healthy subjects by approximately dgb % ( mean sodium and urinary output decreased dgb % ) .
Furosemide	drug	TORADOL	brand
false

DRUGA : DRUGN IV / IM reduced the DRUGB response to DRUGN in normovolemic healthy subjects by approximately dgb % ( mean sodium and urinary output decreased dgb % ) .
Furosemide	drug	diuretic	group
false

DRUGA : DRUGN IV / IM reduced the DRUGN response to DRUGB in normovolemic healthy subjects by approximately dgb % ( mean sodium and urinary output decreased dgb % ) .
Furosemide	drug	furosemide	drug
false

DRUGN : DRUGA IV / IM reduced the DRUGB response to DRUGN in normovolemic healthy subjects by approximately dgb % ( mean sodium and urinary output decreased dgb % ) .
TORADOL	brand	diuretic	group
false

DRUGN : DRUGA IV / IM reduced the DRUGN response to DRUGB in normovolemic healthy subjects by approximately dgb % ( mean sodium and urinary output decreased dgb % ) .
TORADOL	brand	furosemide	drug
effect

DRUGN : DRUGN IV / IM reduced the DRUGA response to DRUGB in normovolemic healthy subjects by approximately dgb % ( mean sodium and urinary output decreased dgb % ) .
diuretic	group	furosemide	drug
false

Therefore , concomitant use of DRUGA and DRUGB is contraindicated .
TORADOL	brand	probenecid	drug
advise

DRUGA : Inhibition of renal DRUGB clearance , leading to an increase in plasma DRUGN concentration , has been reported with some prostaglandin synthesis inhibiting drugs .
Lithium	drug	lithium	drug
false

DRUGA : Inhibition of renal DRUGN clearance , leading to an increase in plasma DRUGB concentration , has been reported with some prostaglandin synthesis inhibiting drugs .
Lithium	drug	lithium	drug
false

The effect of DRUGA on plasma DRUGB has not been studied , but cases of increased DRUGN plasma levels during DRUGN therapy have been reported .
TORADOL	brand	lithium	drug
false

The effect of DRUGA on plasma DRUGN has not been studied , but cases of increased DRUGB plasma levels during DRUGN therapy have been reported .
TORADOL	brand	lithium	drug
false

The effect of DRUGN on plasma DRUGA has not been studied , but cases of increased DRUGN plasma levels during DRUGB therapy have been reported .
lithium	drug	TORADOL	brand
false

The effect of DRUGN on plasma DRUGN has not been studied , but cases of increased DRUGA plasma levels during DRUGB therapy have been reported .
lithium	drug	TORADOL	brand
mechanism

DRUGA : Concomitant administration of DRUGB and some DRUGN has been reported to reduce the clearance of DRUGN , enhancing the toxicity of DRUGN .
Methotrexate	drug	methotrexate	drug
false

DRUGA : Concomitant administration of DRUGN and some DRUGB has been reported to reduce the clearance of DRUGN , enhancing the toxicity of DRUGN .
Methotrexate	drug	NSAIDs	group
false

DRUGA : Concomitant administration of DRUGN and some DRUGN has been reported to reduce the clearance of DRUGB , enhancing the toxicity of DRUGN .
Methotrexate	drug	methotrexate	drug
false

DRUGA : Concomitant administration of DRUGN and some DRUGN has been reported to reduce the clearance of DRUGN , enhancing the toxicity of DRUGB .
Methotrexate	drug	methotrexate	drug
false

DRUGN : Concomitant administration of DRUGA and some DRUGB has been reported to reduce the clearance of DRUGN , enhancing the toxicity of DRUGN .
methotrexate	drug	NSAIDs	group
mechanism

DRUGN : Concomitant administration of DRUGN and some DRUGA has been reported to reduce the clearance of DRUGB , enhancing the toxicity of DRUGN .
NSAIDs	group	methotrexate	drug
false

DRUGN : Concomitant administration of DRUGN and some DRUGA has been reported to reduce the clearance of DRUGN , enhancing the toxicity of DRUGB .
NSAIDs	group	methotrexate	drug
false

The effect of DRUGA on DRUGB clearance has not been studied .
TORADOL	brand	methotrexate	drug
false

DRUGA : In postmarketing experience there have been reports of a possible interaction between TORADOLIV / IM and DRUGB that resulted in apnea .
Nondepolarizing Muscle Relaxants	group	nondepolarizing muscle relaxants	group
false

The concurrent use of DRUGA with DRUGB has not been formally studied .
TORADOL	brand	muscle relaxants	group
false

DRUGA : Concomitant use of DRUGB may increase the risk of renal impairment , particularly in volume depleted patients .
ACE Inhibitors	group	ACE inhibitors	group
false

DRUGA : Sporadic cases of seizures have been reported during concomitant use of DRUGB and DRUGN ( DRUGN , DRUGN ) .
Antiepileptic Drugs	group	TORADOL	brand
false

DRUGA : Sporadic cases of seizures have been reported during concomitant use of DRUGN and DRUGB ( DRUGN , DRUGN ) .
Antiepileptic Drugs	group	antiepileptic drugs	group
false

DRUGA : Sporadic cases of seizures have been reported during concomitant use of DRUGN and DRUGN ( DRUGB , DRUGN ) .
Antiepileptic Drugs	group	phenytoin	drug
false

DRUGA : Sporadic cases of seizures have been reported during concomitant use of DRUGN and DRUGN ( DRUGN , DRUGB ) .
Antiepileptic Drugs	group	carbamazepine	drug
false

DRUGN : Sporadic cases of seizures have been reported during concomitant use of DRUGA and DRUGB ( DRUGN , DRUGN ) .
TORADOL	brand	antiepileptic drugs	group
effect

DRUGN : Sporadic cases of seizures have been reported during concomitant use of DRUGA and DRUGN ( DRUGB , DRUGN ) .
TORADOL	brand	phenytoin	drug
effect

DRUGN : Sporadic cases of seizures have been reported during concomitant use of DRUGA and DRUGN ( DRUGN , DRUGB ) .
TORADOL	brand	carbamazepine	drug
effect

DRUGN : Sporadic cases of seizures have been reported during concomitant use of DRUGN and DRUGA ( DRUGB , DRUGN ) .
antiepileptic drugs	group	phenytoin	drug
false

DRUGN : Sporadic cases of seizures have been reported during concomitant use of DRUGN and DRUGA ( DRUGN , DRUGB ) .
antiepileptic drugs	group	carbamazepine	drug
false

DRUGN : Sporadic cases of seizures have been reported during concomitant use of DRUGN and DRUGN ( DRUGA , DRUGB ) .
phenytoin	drug	carbamazepine	drug
false

DRUGA : Hallucinations have been reported when DRUGB was used in patients taking DRUGN ( DRUGN , DRUGN , DRUGN ) .
Psychoactive Drugs	group	TORADOL	brand
false

DRUGA : Hallucinations have been reported when DRUGN was used in patients taking DRUGB ( DRUGN , DRUGN , DRUGN ) .
Psychoactive Drugs	group	psychoactive drugs	group
false

DRUGA : Hallucinations have been reported when DRUGN was used in patients taking DRUGN ( DRUGB , DRUGN , DRUGN ) .
Psychoactive Drugs	group	fluoxetine	drug
false

DRUGA : Hallucinations have been reported when DRUGN was used in patients taking DRUGN ( DRUGN , DRUGB , DRUGN ) .
Psychoactive Drugs	group	thiothixene	drug
false

DRUGA : Hallucinations have been reported when DRUGN was used in patients taking DRUGN ( DRUGN , DRUGN , DRUGB ) .
Psychoactive Drugs	group	alprazolam	drug
false

DRUGN : Hallucinations have been reported when DRUGA was used in patients taking DRUGB ( DRUGN , DRUGN , DRUGN ) .
TORADOL	brand	psychoactive drugs	group
effect

DRUGN : Hallucinations have been reported when DRUGA was used in patients taking DRUGN ( DRUGB , DRUGN , DRUGN ) .
TORADOL	brand	fluoxetine	drug
effect

DRUGN : Hallucinations have been reported when DRUGA was used in patients taking DRUGN ( DRUGN , DRUGB , DRUGN ) .
TORADOL	brand	thiothixene	drug
effect

DRUGN : Hallucinations have been reported when DRUGA was used in patients taking DRUGN ( DRUGN , DRUGN , DRUGB ) .
TORADOL	brand	alprazolam	drug
effect

DRUGN : Hallucinations have been reported when DRUGN was used in patients taking DRUGA ( DRUGB , DRUGN , DRUGN ) .
psychoactive drugs	group	fluoxetine	drug
false

DRUGN : Hallucinations have been reported when DRUGN was used in patients taking DRUGA ( DRUGN , DRUGB , DRUGN ) .
psychoactive drugs	group	thiothixene	drug
false

DRUGN : Hallucinations have been reported when DRUGN was used in patients taking DRUGA ( DRUGN , DRUGN , DRUGB ) .
psychoactive drugs	group	alprazolam	drug
false

DRUGN : Hallucinations have been reported when DRUGN was used in patients taking DRUGN ( DRUGA , DRUGB , DRUGN ) .
fluoxetine	drug	thiothixene	drug
false

DRUGN : Hallucinations have been reported when DRUGN was used in patients taking DRUGN ( DRUGA , DRUGN , DRUGB ) .
fluoxetine	drug	alprazolam	drug
false

DRUGN : Hallucinations have been reported when DRUGN was used in patients taking DRUGN ( DRUGN , DRUGA , DRUGB ) .
thiothixene	drug	alprazolam	drug
false

DRUGA : TORADOLIV / IM has been administered concurrently with DRUGB in several clinical trials of postoperative pain without evidence of adverse interactions .
Morphine	drug	morphine	drug
false

Do not mix DRUGA and DRUGB in the same syringe .
TORADOL	brand	morphine	drug
false

DRUGA DRUGB may counteract the antinaturetic effect of DRUGN .
Cyclosporine	drug	L-arginine	drug
false

DRUGA DRUGN may counteract the antinaturetic effect of DRUGB .
Cyclosporine	drug	cyclosporin	drug
false

DRUGN DRUGA may counteract the antinaturetic effect of DRUGB .
L-arginine	drug	cyclosporin	drug
effect

DRUGA DRUGB may increase the absorption of DRUGN if taken concomitantly .
Ibuprofen	drug	L-arginine	drug
false

DRUGA DRUGN may increase the absorption of DRUGB if taken concomitantly .
Ibuprofen	drug	ibuprofen	drug
false

DRUGN DRUGA may increase the absorption of DRUGB if taken concomitantly .
L-arginine	drug	ibuprofen	drug
mechanism

Organic DRUGA DRUGB supplements theoretically may potentiate the effects of organic DRUGN if taken concomitantly .
nitrates	group	L-arginine	drug
false

Organic DRUGN DRUGA supplements theoretically may potentiate the effects of organic DRUGB if taken concomitantly .
L-arginine	drug	nitrates	drug
effect

DRUGA Theoretically , DRUGB supplements taken concomitantly with DRUGN , may potentiate the effects of the drug .
Sildenafil citrate	drug	L-arginine	drug
false

DRUGA Theoretically , DRUGN supplements taken concomitantly with DRUGB , may potentiate the effects of the drug .
Sildenafil citrate	drug	sildenafil citrate	drug
false

DRUGN Theoretically , DRUGA supplements taken concomitantly with DRUGB , may potentiate the effects of the drug .
L-arginine	drug	sildenafil citrate	drug
effect

DRUGA Concomitant use of DRUGB and DRUGN may enhance nutrient absorption in those with severe short bowel syndrome .
Human growth hormone	drug	L-glutamine	drug
false

DRUGA Concomitant use of DRUGN and DRUGB may enhance nutrient absorption in those with severe short bowel syndrome .
Human growth hormone	drug	human growth hormone	drug
false

DRUGN Concomitant use of DRUGA and DRUGB may enhance nutrient absorption in those with severe short bowel syndrome .
L-glutamine	drug	human growth hormone	drug
mechanism

DRUGA Concomitant use of DRUGB and DRUGN may ameliorate increased intestinal permeability caused by DRUGN .
Indomethacin	drug	L-glutamine	drug
false

DRUGA Concomitant use of DRUGN and DRUGB may ameliorate increased intestinal permeability caused by DRUGN .
Indomethacin	drug	indomethacin	drug
false

DRUGA Concomitant use of DRUGN and DRUGN may ameliorate increased intestinal permeability caused by DRUGB .
Indomethacin	drug	indomethacin	drug
false

DRUGN Concomitant use of DRUGA and DRUGB may ameliorate increased intestinal permeability caused by DRUGN .
L-glutamine	drug	indomethacin	drug
effect

DRUGN Concomitant use of DRUGA and DRUGN may ameliorate increased intestinal permeability caused by DRUGB .
L-glutamine	drug	indomethacin	drug
false

DRUGA There is one report that DRUGB may decrease the possible effectiveness of supplemental DRUGN for chemotherapy induced mucositis .
Methotrexate	drug	methotrexate	drug
false

DRUGA There is one report that DRUGN may decrease the possible effectiveness of supplemental DRUGB for chemotherapy induced mucositis .
Methotrexate	drug	L-glutamine	drug
false

DRUGN There is one report that DRUGA may decrease the possible effectiveness of supplemental DRUGB for chemotherapy induced mucositis .
methotrexate	drug	L-glutamine	drug
effect

In another report , nine patients with breast cancer were reported to have decreased symptoms of DRUGA related toxicity when given supplemental DRUGB at a dose of dga gram / kilogram / day .
methotrexate	drug	L-glutamine	drug
effect

DRUGA In one report , DRUGB at a dose of dgb grams three times daily , given dgb hours after receiving DRUGN , appeared to prevent the development of myalgia and arthralgia , adverse reactions of DRUGN .
Paclitaxel	drug	L-glutamine	drug
false

DRUGA In one report , DRUGN at a dose of dgb grams three times daily , given dgb hours after receiving DRUGB , appeared to prevent the development of myalgia and arthralgia , adverse reactions of DRUGN .
Paclitaxel	drug	paclitaxel	drug
false

DRUGA In one report , DRUGN at a dose of dgb grams three times daily , given dgb hours after receiving DRUGN , appeared to prevent the development of myalgia and arthralgia , adverse reactions of DRUGB .
Paclitaxel	drug	paclitaxel	drug
false

DRUGN In one report , DRUGA at a dose of dgb grams three times daily , given dgb hours after receiving DRUGB , appeared to prevent the development of myalgia and arthralgia , adverse reactions of DRUGN .
L-glutamine	drug	paclitaxel	drug
effect

DRUGN In one report , DRUGA at a dose of dgb grams three times daily , given dgb hours after receiving DRUGN , appeared to prevent the development of myalgia and arthralgia , adverse reactions of DRUGB .
L-glutamine	drug	paclitaxel	drug
false

DRUGA DRUGB was observed to enhance ( in tissue culture ) the effect of DRUGN in reducing the number of human breast cancer cells that were in the S phase .
Medroxyprogesterone Acetate	drug	L-histidine	drug
false

DRUGA DRUGN was observed to enhance ( in tissue culture ) the effect of DRUGB in reducing the number of human breast cancer cells that were in the S phase .
Medroxyprogesterone Acetate	drug	medroxyprogesterone acetate	drug
false

DRUGN DRUGA was observed to enhance ( in tissue culture ) the effect of DRUGB in reducing the number of human breast cancer cells that were in the S phase .
L-histidine	drug	medroxyprogesterone acetate	drug
effect

DRUGA and DRUGB Although not reported , DRUGN , via its metabolism to histamine , might decrease the efficacy of DRUGN and DRUGN .
H1 Blockers	group	H2 Blockers	group
false

DRUGA and DRUGN Although not reported , DRUGB , via its metabolism to histamine , might decrease the efficacy of DRUGN and DRUGN .
H1 Blockers	group	L-histidine	drug
false

DRUGA and DRUGN Although not reported , DRUGN , via its metabolism to histamine , might decrease the efficacy of DRUGB and DRUGN .
H1 Blockers	group	H1 blockers	group
false

DRUGA and DRUGN Although not reported , DRUGN , via its metabolism to histamine , might decrease the efficacy of DRUGN and DRUGB .
H1 Blockers	group	H2 blockers	group
false

DRUGN and DRUGA Although not reported , DRUGB , via its metabolism to histamine , might decrease the efficacy of DRUGN and DRUGN .
H2 Blockers	group	L-histidine	drug
false

DRUGN and DRUGA Although not reported , DRUGN , via its metabolism to histamine , might decrease the efficacy of DRUGB and DRUGN .
H2 Blockers	group	H1 blockers	group
false

DRUGN and DRUGA Although not reported , DRUGN , via its metabolism to histamine , might decrease the efficacy of DRUGN and DRUGB .
H2 Blockers	group	H2 blockers	group
false

DRUGN and DRUGN Although not reported , DRUGA , via its metabolism to histamine , might decrease the efficacy of DRUGB and DRUGN .
L-histidine	drug	H1 blockers	group
effect

DRUGN and DRUGN Although not reported , DRUGA , via its metabolism to histamine , might decrease the efficacy of DRUGN and DRUGB .
L-histidine	drug	H2 blockers	group
effect

DRUGN and DRUGN Although not reported , DRUGN , via its metabolism to histamine , might decrease the efficacy of DRUGA and DRUGB .
H1 blockers	group	H2 blockers	group
false

Concomitant use of DRUGA supplements and DRUGB may increase DRUGN absorption
calcium	drug	L-lysine	drug
mechanism

Concomitant use of DRUGN supplements and DRUGA may increase DRUGB absorption
L-lysine	drug	calcium	drug
false

DRUGA and DRUGB DRUGN may decrease hepatic toxicity in those with DRUGN overdosage or in those taking DRUGN .
Acetaminophen	drug	methotrexate	drug
false

DRUGA and DRUGN DRUGB may decrease hepatic toxicity in those with DRUGN overdosage or in those taking DRUGN .
Acetaminophen	drug	L-methionine	drug
false

DRUGA and DRUGN DRUGN may decrease hepatic toxicity in those with DRUGB overdosage or in those taking DRUGN .
Acetaminophen	drug	acetaminophen	drug
false

DRUGA and DRUGN DRUGN may decrease hepatic toxicity in those with DRUGN overdosage or in those taking DRUGB .
Acetaminophen	drug	methotrexate	drug
false

DRUGN and DRUGA DRUGB may decrease hepatic toxicity in those with DRUGN overdosage or in those taking DRUGN .
methotrexate	drug	L-methionine	drug
false

DRUGN and DRUGA DRUGN may decrease hepatic toxicity in those with DRUGB overdosage or in those taking DRUGN .
methotrexate	drug	acetaminophen	drug
false

DRUGN and DRUGN DRUGA may decrease hepatic toxicity in those with DRUGB overdosage or in those taking DRUGN .
L-methionine	drug	acetaminophen	drug
effect

DRUGN and DRUGN DRUGA may decrease hepatic toxicity in those with DRUGN overdosage or in those taking DRUGB .
L-methionine	drug	methotrexate	drug
effect

DRUGN and DRUGN DRUGN may decrease hepatic toxicity in those with DRUGA overdosage or in those taking DRUGB .
acetaminophen	drug	methotrexate	drug
false

DRUGA DRUGB may protect against the ototoxic effects of DRUGN .
Gentamicin	drug	Methionine	drug
false

DRUGA DRUGN may protect against the ototoxic effects of DRUGB .
Gentamicin	drug	gentamicin	drug
false

DRUGN DRUGA may protect against the ototoxic effects of DRUGB .
Methionine	drug	gentamicin	drug
effect

DRUGA including DRUGB , DRUGN and DRUGN HCdga
Non-selective monoamine oxidase (MAO) inhibitors	group	phenelzine sulfate	drug
false

DRUGA including DRUGN , DRUGB and DRUGN HCdga
Non-selective monoamine oxidase (MAO) inhibitors	group	tranylcypromine sulfate	drug
false

DRUGA including DRUGN , DRUGN and DRUGB HCdga
Non-selective monoamine oxidase (MAO) inhibitors	group	pargyline	drug
false

DRUGN including DRUGA , DRUGB and DRUGN HCdga
phenelzine sulfate	drug	tranylcypromine sulfate	drug
false

DRUGN including DRUGA , DRUGN and DRUGB HCdga
phenelzine sulfate	drug	pargyline	drug
false

DRUGN including DRUGN , DRUGA and DRUGB HCdga
tranylcypromine sulfate	drug	pargyline	drug
false

Concomitant use of DRUGA and DRUGB may cause hypertension .
L-phenylalanine	drug	non-selective MAO inhibitors	group
effect

DRUGA DRUGB and the DRUGN DRUGN may have synergistic antidepressant activity if used concomitantly .
Selegiline	drug	L-phenylalanine	drug
false

DRUGA DRUGN and the DRUGB DRUGN may have synergistic antidepressant activity if used concomitantly .
Selegiline	drug	selective MAO inhibitor	group
false

DRUGA DRUGN and the DRUGN DRUGB may have synergistic antidepressant activity if used concomitantly .
Selegiline	drug	selegiline	drug
false

DRUGN DRUGA and the DRUGB DRUGN may have synergistic antidepressant activity if used concomitantly .
L-phenylalanine	drug	selective MAO inhibitor	group
false

DRUGN DRUGA and the DRUGN DRUGB may have synergistic antidepressant activity if used concomitantly .
L-phenylalanine	drug	selegiline	drug
effect

DRUGN DRUGN and the DRUGA DRUGB may have synergistic antidepressant activity if used concomitantly .
selective MAO inhibitor	group	selegiline	drug
false

DRUGA DRUGB may potentiate the tardive dyskinesia side reactions of DRUGN if used concomitantly with them .
Neuroleptic Drugs	group	L-phenylalanine	drug
effect

DRUGA DRUGN may potentiate the tardive dyskinesia side reactions of DRUGB if used concomitantly with them .
Neuroleptic Drugs	group	neuroleptic drugs	group
false

DRUGN DRUGA may potentiate the tardive dyskinesia side reactions of DRUGB if used concomitantly with them .
L-phenylalanine	drug	neuroleptic drugs	group
false

DRUGA including DRUGB , DRUGN , and DRUGN HCdgb : Concomitant use of DRUGN and non selective DRUGN may cause hypertension .
Non-selective MAO inhibitors	group	tranylcypromine sulfate	drug
false

DRUGA including DRUGN , DRUGB , and DRUGN HCdgb : Concomitant use of DRUGN and non selective DRUGN may cause hypertension .
Non-selective MAO inhibitors	group	phenelzine sulfate	drug
false

DRUGA including DRUGN , DRUGN , and DRUGB HCdgb : Concomitant use of DRUGN and non selective DRUGN may cause hypertension .
Non-selective MAO inhibitors	group	pargyline	drug
false

DRUGA including DRUGN , DRUGN , and DRUGN HCdgb : Concomitant use of DRUGB and non selective DRUGN may cause hypertension .
Non-selective MAO inhibitors	group	L-tyrosine	drug
false

DRUGA including DRUGN , DRUGN , and DRUGN HCdgb : Concomitant use of DRUGN and non selective DRUGB may cause hypertension .
Non-selective MAO inhibitors	group	MAO inhibitors	group
false

DRUGN including DRUGA , DRUGB , and DRUGN HCdgb : Concomitant use of DRUGN and non selective DRUGN may cause hypertension .
tranylcypromine sulfate	drug	phenelzine sulfate	drug
false

DRUGN including DRUGA , DRUGN , and DRUGB HCdgb : Concomitant use of DRUGN and non selective DRUGN may cause hypertension .
tranylcypromine sulfate	drug	pargyline	drug
false

DRUGN including DRUGA , DRUGN , and DRUGN HCdgb : Concomitant use of DRUGB and non selective DRUGN may cause hypertension .
tranylcypromine sulfate	drug	L-tyrosine	drug
false

DRUGN including DRUGA , DRUGN , and DRUGN HCdgb : Concomitant use of DRUGN and non selective DRUGB may cause hypertension .
tranylcypromine sulfate	drug	MAO inhibitors	group
false

DRUGN including DRUGN , DRUGA , and DRUGB HCdgb : Concomitant use of DRUGN and non selective DRUGN may cause hypertension .
phenelzine sulfate	drug	pargyline	drug
false

DRUGN including DRUGN , DRUGA , and DRUGN HCdgb : Concomitant use of DRUGB and non selective DRUGN may cause hypertension .
phenelzine sulfate	drug	L-tyrosine	drug
false

DRUGN including DRUGN , DRUGA , and DRUGN HCdgb : Concomitant use of DRUGN and non selective DRUGB may cause hypertension .
phenelzine sulfate	drug	MAO inhibitors	group
false

DRUGN including DRUGN , DRUGN , and DRUGA HCdgb : Concomitant use of DRUGB and non selective DRUGN may cause hypertension .
pargyline	drug	L-tyrosine	drug
false

DRUGN including DRUGN , DRUGN , and DRUGA HCdgb : Concomitant use of DRUGN and non selective DRUGB may cause hypertension .
pargyline	drug	MAO inhibitors	group
false

DRUGN including DRUGN , DRUGN , and DRUGN HCdgb : Concomitant use of DRUGA and non selective DRUGB may cause hypertension .
L-tyrosine	drug	MAO inhibitors	group
effect

In one survey , dga % of patients taking DRUGA in combination with DRUGB experienced tremor , as compared to dga % reported to occur with DRUGN alone .
labetalol HCl	drug	tricyclic antidepressants	group
effect

In one survey , dga % of patients taking DRUGN in combination with DRUGA experienced tremor , as compared to dga % reported to occur with DRUGB alone .
tricyclic antidepressants	group	labetalol HCl	drug
false

DRUGA has been shown to increase the bioavailability of DRUGB .
Cimetidine	drug	labetalol HCl	drug
mechanism

Synergism has been shown between DRUGA anesthesia and intravenously administered DRUGB .
halothane	drug	labetalol HCl	drug
effect

DRUGA blunts the reflex tachycardia produced by DRUGB without preventing its hypotensive effect .
Labetalol HCl	drug	nitroglycerin	drug
effect

If DRUGA is used with DRUGB in patients with angina pectoris , additional antihypertensive effects may occur .
labetalol HCl	drug	nitroglycerin	drug
effect

Care should be taken if DRUGA is used concomitantly with DRUGB s of the DRUGN type .
labetalol	drug	calcium antagonist	group
advise

Care should be taken if DRUGA is used concomitantly with DRUGN s of the DRUGB type .
labetalol	drug	verapamil	drug
false

Care should be taken if DRUGN is used concomitantly with DRUGA s of the DRUGB type .
calcium antagonist	group	verapamil	drug
false

When patients being treated with DRUGA have a positive urine test for DRUGB using these techniques confirmation should be made by using more specific methods such as a gas chromatographic mass spectrometer technique .
labetalol	drug	amphetamine	drug
false

Results of preliminary studies in humans and rats suggest that nonabsorbable DRUGA given concurrently with DRUGB may inhibit the desired DRUGN induced drop in colonic pH .
antacids	group	lactulose	drug
mechanism

Results of preliminary studies in humans and rats suggest that nonabsorbable DRUGA given concurrently with DRUGN may inhibit the desired DRUGB induced drop in colonic pH .
antacids	group	lactulose	drug
false

There is no information regarding the effect on DRUGA pharmacokinetics of higher doses of DRUGB / DRUGN such as those used to treat Pneumocystis carinii pneumonia .
lamivudine	drug	TMP	drug
false

There is no information regarding the effect on DRUGA pharmacokinetics of higher doses of DRUGN / DRUGB such as those used to treat Pneumocystis carinii pneumonia .
lamivudine	drug	SMX	drug
false

There is no information regarding the effect on DRUGN pharmacokinetics of higher doses of DRUGA / DRUGB such as those used to treat Pneumocystis carinii pneumonia .
TMP	drug	SMX	drug
false

DRUGA and DRUGB may inhibit the intracellular phosphorylation of one another .
Lamivudine	drug	zalcitabine	drug
effect

Therefore , use of DRUGA in combination with DRUGB is not recommended
lamivudine	drug	zalcitabine	drug
advise

When DRUGA was administered concomitantly with DRUGB ( CYPdgbAdgb , CYPdgbA ) , a minor increase ( dgb % ) in the clearance of DRUGN was seen .
lansoprazole	drug	theophylline	drug
mechanism

When DRUGA was administered concomitantly with DRUGN ( CYPdgbAdgb , CYPdgbA ) , a minor increase ( dgb % ) in the clearance of DRUGB was seen .
lansoprazole	drug	theophylline	drug
false

Nonetheless , individual patients may require additional titration of their DRUGA dosage when DRUGB is started or stopped to ensure clinically effective blood levels .
theophylline	drug	lansoprazole	drug
advise

DRUGA has also been shown to have no clinically significant interaction with DRUGB .
Lansoprazole	drug	amoxicillin	drug
false

Therefore , DRUGA should be taken at least dgb minutes prior to DRUGB .
proton pump inhibitors	group	sucralfate	drug
advise

In clinical trials , DRUGA were administered concomitantly with DRUGB delayed release capsules ;
antacids	group	lansoprazole	drug
false

therefore , it is theoretically possible that DRUGA may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability ( e.g . DRUGB , DRUGN esters , DRUGN salts , DRUGN ) .
lansoprazole	drug	ketoconazole	drug
mechanism

therefore , it is theoretically possible that DRUGA may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability ( e.g . DRUGN , DRUGB esters , DRUGN salts , DRUGN ) .
lansoprazole	drug	ampicillin	drug
mechanism

therefore , it is theoretically possible that DRUGA may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability ( e.g . DRUGN , DRUGN esters , DRUGB salts , DRUGN ) .
lansoprazole	drug	iron	drug
mechanism

therefore , it is theoretically possible that DRUGA may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability ( e.g . DRUGN , DRUGN esters , DRUGN salts , DRUGB ) .
lansoprazole	drug	digoxin	drug
mechanism

therefore , it is theoretically possible that DRUGN may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability ( e.g . DRUGA , DRUGB esters , DRUGN salts , DRUGN ) .
ketoconazole	drug	ampicillin	drug
false

therefore , it is theoretically possible that DRUGN may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability ( e.g . DRUGA , DRUGN esters , DRUGB salts , DRUGN ) .
ketoconazole	drug	iron	drug
false

therefore , it is theoretically possible that DRUGN may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability ( e.g . DRUGA , DRUGN esters , DRUGN salts , DRUGB ) .
ketoconazole	drug	digoxin	drug
false

therefore , it is theoretically possible that DRUGN may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability ( e.g . DRUGN , DRUGA esters , DRUGB salts , DRUGN ) .
ampicillin	drug	iron	drug
false

therefore , it is theoretically possible that DRUGN may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability ( e.g . DRUGN , DRUGA esters , DRUGN salts , DRUGB ) .
ampicillin	drug	digoxin	drug
false

therefore , it is theoretically possible that DRUGN may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability ( e.g . DRUGN , DRUGN esters , DRUGA salts , DRUGB ) .
iron	drug	digoxin	drug
false

Drugs that Inhibit or Induce Cytochrome Pdgb dgbAdgb Enzymes DRUGA undergoes extensive metabolism by CYPdgbAdgb , and concomitant administration of strong inhibitors or inducers of CYPdgbAdgb alter DRUGB concentrations significantly .
Lapatinib	drug	lapatinib	drug
false

If DRUGA is administered with drugs that inhibit Pgp , increased concentrations of DRUGB are likely , and caution should be exercised .
TYKERB	brand	lapatinib	drug
false

Other Chemotherapy Agents In a separate study , concomitant administration of DRUGA with DRUGB did not meaningfully alter the pharmacokinetics of either agent ( or the metabolites of DRUGN ) .
lapatinib	drug	capecitabine	drug
false

Other Chemotherapy Agents In a separate study , concomitant administration of DRUGA with DRUGN did not meaningfully alter the pharmacokinetics of either agent ( or the metabolites of DRUGB ) .
lapatinib	drug	capecitabine	drug
false

In vitro studies have shown that precipitation occurs when eye drops containing DRUGA are mixed with DRUGB .
thimerosal	drug_n	latanoprost	drug
false

DRUGA and DRUGB Administration of DRUGN or DRUGN in patients ( n=dgb ) and volunteers ( n=dgb ) resulted in a rapid and significant decrease in plasma Mdgb ( the active metabolite of DRUGN ) concentration .
Cholestyramine	drug	Charcoal	drug
false

DRUGA and DRUGN Administration of DRUGB or DRUGN in patients ( n=dgb ) and volunteers ( n=dgb ) resulted in a rapid and significant decrease in plasma Mdgb ( the active metabolite of DRUGN ) concentration .
Cholestyramine	drug	cholestyramine	drug
false

DRUGA and DRUGN Administration of DRUGN or DRUGB in patients ( n=dgb ) and volunteers ( n=dgb ) resulted in a rapid and significant decrease in plasma Mdgb ( the active metabolite of DRUGN ) concentration .
Cholestyramine	drug	activated charcoal	drug
false

DRUGA and DRUGN Administration of DRUGN or DRUGN in patients ( n=dgb ) and volunteers ( n=dgb ) resulted in a rapid and significant decrease in plasma Mdgb ( the active metabolite of DRUGB ) concentration .
Cholestyramine	drug	leflunomide	drug
false

DRUGN and DRUGA Administration of DRUGB or DRUGN in patients ( n=dgb ) and volunteers ( n=dgb ) resulted in a rapid and significant decrease in plasma Mdgb ( the active metabolite of DRUGN ) concentration .
Charcoal	drug	cholestyramine	drug
false

DRUGN and DRUGA Administration of DRUGN or DRUGB in patients ( n=dgb ) and volunteers ( n=dgb ) resulted in a rapid and significant decrease in plasma Mdgb ( the active metabolite of DRUGN ) concentration .
Charcoal	drug	activated charcoal	drug
false

DRUGN and DRUGA Administration of DRUGN or DRUGN in patients ( n=dgb ) and volunteers ( n=dgb ) resulted in a rapid and significant decrease in plasma Mdgb ( the active metabolite of DRUGB ) concentration .
Charcoal	drug	leflunomide	drug
false

DRUGN and DRUGN Administration of DRUGA or DRUGB in patients ( n=dgb ) and volunteers ( n=dgb ) resulted in a rapid and significant decrease in plasma Mdgb ( the active metabolite of DRUGN ) concentration .
cholestyramine	drug	activated charcoal	drug
false

DRUGN and DRUGN Administration of DRUGA or DRUGN in patients ( n=dgb ) and volunteers ( n=dgb ) resulted in a rapid and significant decrease in plasma Mdgb ( the active metabolite of DRUGB ) concentration .
cholestyramine	drug	leflunomide	drug
mechanism

DRUGN and DRUGN Administration of DRUGN or DRUGA in patients ( n=dgb ) and volunteers ( n=dgb ) resulted in a rapid and significant decrease in plasma Mdgb ( the active metabolite of DRUGB ) concentration .
activated charcoal	drug	leflunomide	drug
mechanism

In a small ( n=dgb ) combination study of DRUGA with DRUGB , a dgb to dgb fold elevation in liver enzymes was seen in dgb of dgb patients .
ARAVA	brand	methotrexate	drug
effect

DRUGA : In in vitro studies , Mdgb was shown to cause increases ranging from dgb dgb % in the free fraction of DRUGB and DRUGN at concentrations in the clinical range .
NSAIDs	group	diclofenac	drug
false

DRUGA : In in vitro studies , Mdgb was shown to cause increases ranging from dgb dgb % in the free fraction of DRUGN and DRUGB at concentrations in the clinical range .
NSAIDs	group	ibuprofen	drug
false

DRUGN : In in vitro studies , Mdgb was shown to cause increases ranging from dgb dgb % in the free fraction of DRUGA and DRUGB at concentrations in the clinical range .
diclofenac	drug	ibuprofen	drug
false

DRUGA : In in vitro studies , Mdgb was shown to cause increases ranging from dgb dgb % in the free fraction of DRUGB at concentrations in the clinical range .
Tolbutamide	drug	tolbutamide	drug
false

DRUGA : Following concomitant administration of a single dose of DRUGB to subjects receiving multiple doses of DRUGN , Mdgb peak levels were increased ( ~dgb % ) over those seen when DRUGN was given alone .
Rifampin	drug	ARAVA	brand
false

DRUGA : Following concomitant administration of a single dose of DRUGN to subjects receiving multiple doses of DRUGB , Mdgb peak levels were increased ( ~dgb % ) over those seen when DRUGN was given alone .
Rifampin	drug	rifampin	drug
false

DRUGA : Following concomitant administration of a single dose of DRUGN to subjects receiving multiple doses of DRUGN , Mdgb peak levels were increased ( ~dgb % ) over those seen when DRUGB was given alone .
Rifampin	drug	ARAVA	brand
false

DRUGN : Following concomitant administration of a single dose of DRUGA to subjects receiving multiple doses of DRUGB , Mdgb peak levels were increased ( ~dgb % ) over those seen when DRUGN was given alone .
ARAVA	brand	rifampin	drug
mechanism

DRUGN : Following concomitant administration of a single dose of DRUGN to subjects receiving multiple doses of DRUGA , Mdgb peak levels were increased ( ~dgb % ) over those seen when DRUGB was given alone .
rifampin	drug	ARAVA	brand
false

Because of the potential for DRUGA levels to continue to increase with multiple dosing , caution should be used if patients are to be receiving both DRUGN and DRUGB .
ARAVA	brand	rifampin	drug
false

Because of the potential for DRUGN levels to continue to increase with multiple dosing , caution should be used if patients are to be receiving both DRUGA and DRUGB .
ARAVA	brand	rifampin	drug
advise

DRUGA : Increased INR ( International Normalized Ratio ) when DRUGB and DRUGN were co administered has been rarely reported .
Warfarin	drug	ARAVA	brand
false

DRUGA : Increased INR ( International Normalized Ratio ) when DRUGN and DRUGB were co administered has been rarely reported .
Warfarin	drug	warfarin	drug
false

DRUGN : Increased INR ( International Normalized Ratio ) when DRUGA and DRUGB were co administered has been rarely reported .
ARAVA	brand	warfarin	drug
effect

Co administration of multiple doses of dgb mg of DRUGA had no effect on the single dose pharmacokinetics of DRUGB and DRUGN .
lenalidomide	drug	R- warfarin	drug
false

Co administration of multiple doses of dgb mg of DRUGA had no effect on the single dose pharmacokinetics of DRUGN and DRUGB .
lenalidomide	drug	S- warfarin	drug
false

Co administration of multiple doses of dgb mg of DRUGN had no effect on the single dose pharmacokinetics of DRUGA and DRUGB .
R- warfarin	drug	S- warfarin	drug
false

Co administration of single dgb mg dose DRUGA had no effect on the pharmacokinetics of total DRUGB .
warfarin	drug	lenalidomide	drug
false

Expected changes in laboratory assessments of PT and INR were observed after DRUGA administration , but these changes were not affected by concomitant DRUGB administration .
warfarin	drug	lenalidomide	drug
false

Concomitant treatment with DRUGA ( eg , rt PA or DRUGB ) may : increase the risk of bleeding complications considerably enhance the effect of DRUGN on aPTT prolongation
thrombolytics	group	streptokinase	drug
false

Concomitant treatment with DRUGA ( eg , rt PA or DRUGN ) may : increase the risk of bleeding complications considerably enhance the effect of DRUGB on aPTT prolongation
thrombolytics	group	REFLUDAN	brand
false

Concomitant treatment with DRUGN ( eg , rt PA or DRUGA ) may : increase the risk of bleeding complications considerably enhance the effect of DRUGB on aPTT prolongation
streptokinase	drug	REFLUDAN	brand
false

Concomitant treatment with DRUGA ( DRUGB ) and drugs that affect platelet function may also increase the risk of bleeding .
coumarin derivatives	group	vitamin K antagonists	group
false

Clinical interaction studies with DRUGA and DRUGB indicated that the coadministration of DRUGN with these drugs does not result in clinically significant drug interactions .
cimetidine	drug	warfarin	drug
false

Clinical interaction studies with DRUGA and DRUGN indicated that the coadministration of DRUGB with these drugs does not result in clinically significant drug interactions .
cimetidine	drug	Femara	brand
false

Clinical interaction studies with DRUGN and DRUGA indicated that the coadministration of DRUGB with these drugs does not result in clinically significant drug interactions .
warfarin	drug	Femara	brand
false

( See CLINICAL PHARMACOLOGY ) Coadministration of DRUGA and DRUGB dgb mg daily resulted in a reduction of DRUGN plasma levels by dgb % on average .
Femara	brand	tamoxifen	drug
mechanism

( See CLINICAL PHARMACOLOGY ) Coadministration of DRUGA and DRUGN dgb mg daily resulted in a reduction of DRUGB plasma levels by dgb % on average .
Femara	brand	letrozole	drug
false

( See CLINICAL PHARMACOLOGY ) Coadministration of DRUGN and DRUGA dgb mg daily resulted in a reduction of DRUGB plasma levels by dgb % on average .
tamoxifen	drug	letrozole	drug
false

DRUGA in large amounts may counteract the antiepileptic effect of DRUGB , DRUGN and DRUGN , and increase the frequency of seizures in susceptible pediatric patients .
Folic acid	drug	phenobarbital	drug
effect

DRUGA in large amounts may counteract the antiepileptic effect of DRUGN , DRUGB and DRUGN , and increase the frequency of seizures in susceptible pediatric patients .
Folic acid	drug	phenytoin	drug
effect

DRUGA in large amounts may counteract the antiepileptic effect of DRUGN , DRUGN and DRUGB , and increase the frequency of seizures in susceptible pediatric patients .
Folic acid	drug	primidone	drug
effect

DRUGN in large amounts may counteract the antiepileptic effect of DRUGA , DRUGB and DRUGN , and increase the frequency of seizures in susceptible pediatric patients .
phenobarbital	drug	phenytoin	drug
false

DRUGN in large amounts may counteract the antiepileptic effect of DRUGA , DRUGN and DRUGB , and increase the frequency of seizures in susceptible pediatric patients .
phenobarbital	drug	primidone	drug
false

DRUGN in large amounts may counteract the antiepileptic effect of DRUGN , DRUGA and DRUGB , and increase the frequency of seizures in susceptible pediatric patients .
phenytoin	drug	primidone	drug
false

However , high doses of DRUGA may reduce the efficacy of intrathecally administered DRUGB .
leucovorin	drug	methotrexate	drug
effect

DRUGA may enhance the toxicity of DRUGB .
Leucovorin	drug	5-fluorouracil	drug
effect

DRUGA ( DRUGB ) has been reported to produce ANTABUSE like side effects when given concomitantly with DRUGN .
ERGAMISOL	brand	levamisole hydrochloride	drug
false

DRUGA ( DRUGN ) has been reported to produce ANTABUSE like side effects when given concomitantly with DRUGB .
ERGAMISOL	brand	alcohol	drug
effect

DRUGN ( DRUGA ) has been reported to produce ANTABUSE like side effects when given concomitantly with DRUGB .
levamisole hydrochloride	drug	alcohol	drug
effect

In addition , DRUGA does not affect the in vitro glucuronidation of DRUGB .
levetiracetam	drug	valproic acid	drug
false

Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( DRUGA , DRUGB , oral DRUGN , DRUGN , DRUGN , DRUGN ) and through pharmacokinetic screening in the placebo controlled clinical studies in epilepsy patients .
phenytoin	drug	valproate	drug
false

Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( DRUGA , DRUGN , oral DRUGB , DRUGN , DRUGN , DRUGN ) and through pharmacokinetic screening in the placebo controlled clinical studies in epilepsy patients .
phenytoin	drug	contraceptive	group
false

Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( DRUGA , DRUGN , oral DRUGN , DRUGB , DRUGN , DRUGN ) and through pharmacokinetic screening in the placebo controlled clinical studies in epilepsy patients .
phenytoin	drug	digoxin	drug
false

Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( DRUGA , DRUGN , oral DRUGN , DRUGN , DRUGB , DRUGN ) and through pharmacokinetic screening in the placebo controlled clinical studies in epilepsy patients .
phenytoin	drug	warfarin	drug
false

Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( DRUGA , DRUGN , oral DRUGN , DRUGN , DRUGN , DRUGB ) and through pharmacokinetic screening in the placebo controlled clinical studies in epilepsy patients .
phenytoin	drug	probenecid	drug
false

Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( DRUGN , DRUGA , oral DRUGB , DRUGN , DRUGN , DRUGN ) and through pharmacokinetic screening in the placebo controlled clinical studies in epilepsy patients .
valproate	drug	contraceptive	group
false

Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( DRUGN , DRUGA , oral DRUGN , DRUGB , DRUGN , DRUGN ) and through pharmacokinetic screening in the placebo controlled clinical studies in epilepsy patients .
valproate	drug	digoxin	drug
false

Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( DRUGN , DRUGA , oral DRUGN , DRUGN , DRUGB , DRUGN ) and through pharmacokinetic screening in the placebo controlled clinical studies in epilepsy patients .
valproate	drug	warfarin	drug
false

Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( DRUGN , DRUGA , oral DRUGN , DRUGN , DRUGN , DRUGB ) and through pharmacokinetic screening in the placebo controlled clinical studies in epilepsy patients .
valproate	drug	probenecid	drug
false

Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( DRUGN , DRUGN , oral DRUGA , DRUGB , DRUGN , DRUGN ) and through pharmacokinetic screening in the placebo controlled clinical studies in epilepsy patients .
contraceptive	group	digoxin	drug
false

Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( DRUGN , DRUGN , oral DRUGA , DRUGN , DRUGB , DRUGN ) and through pharmacokinetic screening in the placebo controlled clinical studies in epilepsy patients .
contraceptive	group	warfarin	drug
false

Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( DRUGN , DRUGN , oral DRUGA , DRUGN , DRUGN , DRUGB ) and through pharmacokinetic screening in the placebo controlled clinical studies in epilepsy patients .
contraceptive	group	probenecid	drug
false

Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( DRUGN , DRUGN , oral DRUGN , DRUGA , DRUGB , DRUGN ) and through pharmacokinetic screening in the placebo controlled clinical studies in epilepsy patients .
digoxin	drug	warfarin	drug
false

Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( DRUGN , DRUGN , oral DRUGN , DRUGA , DRUGN , DRUGB ) and through pharmacokinetic screening in the placebo controlled clinical studies in epilepsy patients .
digoxin	drug	probenecid	drug
false

Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( DRUGN , DRUGN , oral DRUGN , DRUGN , DRUGA , DRUGB ) and through pharmacokinetic screening in the placebo controlled clinical studies in epilepsy patients .
warfarin	drug	probenecid	drug
false

Drug Drug Interactions Between DRUGA And Other DRUGB ( DRUGN ) DRUGN DRUGN ( dgb mg daily ) had no effect on the pharmacokinetic disposition of DRUGN in patients with refractory epilepsy .
Keppra	brand	Antiepileptic Drugs	group
false

Drug Drug Interactions Between DRUGA And Other DRUGN ( DRUGB ) DRUGN DRUGN ( dgb mg daily ) had no effect on the pharmacokinetic disposition of DRUGN in patients with refractory epilepsy .
Keppra	brand	AEDs	group
false

Drug Drug Interactions Between DRUGA And Other DRUGN ( DRUGN ) DRUGB DRUGN ( dgb mg daily ) had no effect on the pharmacokinetic disposition of DRUGN in patients with refractory epilepsy .
Keppra	brand	Phenytoin	drug
false

Drug Drug Interactions Between DRUGA And Other DRUGN ( DRUGN ) DRUGN DRUGN ( dgb mg daily ) had no effect on the pharmacokinetic disposition of DRUGB in patients with refractory epilepsy .
Keppra	brand	phenytoin	drug
false

Drug Drug Interactions Between DRUGN And Other DRUGA ( DRUGB ) DRUGN DRUGN ( dgb mg daily ) had no effect on the pharmacokinetic disposition of DRUGN in patients with refractory epilepsy .
Antiepileptic Drugs	group	AEDs	group
false

Drug Drug Interactions Between DRUGN And Other DRUGA ( DRUGN ) DRUGB DRUGN ( dgb mg daily ) had no effect on the pharmacokinetic disposition of DRUGN in patients with refractory epilepsy .
Antiepileptic Drugs	group	Phenytoin	drug
false

Drug Drug Interactions Between DRUGN And Other DRUGA ( DRUGN ) DRUGN DRUGB ( dgb mg daily ) had no effect on the pharmacokinetic disposition of DRUGN in patients with refractory epilepsy .
Antiepileptic Drugs	group	Keppra	brand
false

Drug Drug Interactions Between DRUGN And Other DRUGA ( DRUGN ) DRUGN DRUGN ( dgb mg daily ) had no effect on the pharmacokinetic disposition of DRUGB in patients with refractory epilepsy .
Antiepileptic Drugs	group	phenytoin	drug
false

Drug Drug Interactions Between DRUGN And Other DRUGN ( DRUGA ) DRUGB DRUGN ( dgb mg daily ) had no effect on the pharmacokinetic disposition of DRUGN in patients with refractory epilepsy .
AEDs	group	Phenytoin	drug
false

Drug Drug Interactions Between DRUGN And Other DRUGN ( DRUGA ) DRUGN DRUGB ( dgb mg daily ) had no effect on the pharmacokinetic disposition of DRUGN in patients with refractory epilepsy .
AEDs	group	Keppra	brand
false

Drug Drug Interactions Between DRUGN And Other DRUGN ( DRUGA ) DRUGN DRUGN ( dgb mg daily ) had no effect on the pharmacokinetic disposition of DRUGB in patients with refractory epilepsy .
AEDs	group	phenytoin	drug
false

Drug Drug Interactions Between DRUGN And Other DRUGN ( DRUGN ) DRUGA DRUGB ( dgb mg daily ) had no effect on the pharmacokinetic disposition of DRUGN in patients with refractory epilepsy .
Phenytoin	drug	Keppra	brand
false

Drug Drug Interactions Between DRUGN And Other DRUGN ( DRUGN ) DRUGA DRUGN ( dgb mg daily ) had no effect on the pharmacokinetic disposition of DRUGB in patients with refractory epilepsy .
Phenytoin	drug	phenytoin	drug
false

Drug Drug Interactions Between DRUGN And Other DRUGN ( DRUGN ) DRUGN DRUGA ( dgb mg daily ) had no effect on the pharmacokinetic disposition of DRUGB in patients with refractory epilepsy .
Keppra	brand	phenytoin	drug
false

Pharmacokinetics of DRUGA were also not affected by DRUGB .
levetiracetam	drug	phenytoin	drug
false

DRUGA DRUGB ( dgb mg twice daily ) did not alter the pharmacokinetics of DRUGN in healthy volunteers .
Valproate	drug	Keppra	brand
false

DRUGA DRUGN ( dgb mg twice daily ) did not alter the pharmacokinetics of DRUGB in healthy volunteers .
Valproate	drug	valproate	drug
false

DRUGN DRUGA ( dgb mg twice daily ) did not alter the pharmacokinetics of DRUGB in healthy volunteers .
Keppra	brand	valproate	drug
false

DRUGA dgb mg twice daily did not modify the rate or extent of DRUGB absorption or its plasma clearance or urinary excretion .
Valproate	drug	levetiracetam	drug
false

These data indicate that DRUGA does not influence the plasma concentration of other DRUGB and that these DRUGN do not influence the pharmacokinetics of DRUGN .
levetiracetam	drug	AEDs	group
false

These data indicate that DRUGA does not influence the plasma concentration of other DRUGN and that these DRUGB do not influence the pharmacokinetics of DRUGN .
levetiracetam	drug	AEDs	group
false

These data indicate that DRUGN does not influence the plasma concentration of other DRUGA and that these DRUGN do not influence the pharmacokinetics of DRUGB .
AEDs	group	levetiracetam	drug
false

These data indicate that DRUGN does not influence the plasma concentration of other DRUGN and that these DRUGA do not influence the pharmacokinetics of DRUGB .
AEDs	group	levetiracetam	drug
false

Effect of DRUGA in Pediatric Patients There was about a dgb % increase of apparent total body clearance of DRUGB when it was co administered with enzyme inducing DRUGN .
AEDs	group	levetiracetam	drug
false

Effect of DRUGN in Pediatric Patients There was about a dgb % increase of apparent total body clearance of DRUGA when it was co administered with enzyme inducing DRUGB .
levetiracetam	drug	AEDs	group
mechanism

Dose adjustment is not recommended . DRUGA had no effect on plasma concentrations of DRUGB , DRUGN , DRUGN , or DRUGN .
Levetiracetam	drug	carbamazepine	drug
false

Dose adjustment is not recommended . DRUGA had no effect on plasma concentrations of DRUGN , DRUGB , DRUGN , or DRUGN .
Levetiracetam	drug	valproate	drug
false

Dose adjustment is not recommended . DRUGA had no effect on plasma concentrations of DRUGN , DRUGN , DRUGB , or DRUGN .
Levetiracetam	drug	topiramate	drug
false

Dose adjustment is not recommended . DRUGA had no effect on plasma concentrations of DRUGN , DRUGN , DRUGN , or DRUGB .
Levetiracetam	drug	lamotrigine	drug
false

Dose adjustment is not recommended . DRUGN had no effect on plasma concentrations of DRUGA , DRUGB , DRUGN , or DRUGN .
carbamazepine	drug	valproate	drug
false

Dose adjustment is not recommended . DRUGN had no effect on plasma concentrations of DRUGA , DRUGN , DRUGB , or DRUGN .
carbamazepine	drug	topiramate	drug
false

Dose adjustment is not recommended . DRUGN had no effect on plasma concentrations of DRUGA , DRUGN , DRUGN , or DRUGB .
carbamazepine	drug	lamotrigine	drug
false

Dose adjustment is not recommended . DRUGN had no effect on plasma concentrations of DRUGN , DRUGA , DRUGB , or DRUGN .
valproate	drug	topiramate	drug
false

Dose adjustment is not recommended . DRUGN had no effect on plasma concentrations of DRUGN , DRUGA , DRUGN , or DRUGB .
valproate	drug	lamotrigine	drug
false

Dose adjustment is not recommended . DRUGN had no effect on plasma concentrations of DRUGN , DRUGN , DRUGA , or DRUGB .
topiramate	drug	lamotrigine	drug
false

Coadministration of this oral DRUGA did not influence the pharmacokinetics of DRUGB .
contraceptive	group	levetiracetam	drug
false

DRUGA DRUGB ( dgb mg twice daily ) did not influence the pharmacokinetics and pharmacodynamics ( ECG ) of DRUGN given as a dga mg dose every day .
Digoxin	drug	Keppra	brand
false

DRUGA DRUGN ( dgb mg twice daily ) did not influence the pharmacokinetics and pharmacodynamics ( ECG ) of DRUGB given as a dga mg dose every day .
Digoxin	drug	digoxin	drug
false

DRUGN DRUGA ( dgb mg twice daily ) did not influence the pharmacokinetics and pharmacodynamics ( ECG ) of DRUGB given as a dga mg dose every day .
Keppra	brand	digoxin	drug
false

Coadministration of DRUGA did not influence the pharmacokinetics of DRUGB .
digoxin	drug	levetiracetam	drug
false

DRUGA DRUGB ( dgb DRUGN DRUGN DRUGN mg twice daily ) did not influence the pharmacokinetics of DRUGN and DRUGN .
Warfarin	drug	Keppra	brand
false

DRUGA DRUGN ( dgb mg twice daily ) did not influence the pharmacokinetics of DRUGB and DRUGN .
Warfarin	drug	R warfarin	drug
false

DRUGA DRUGN ( DRUGN dgb mg twice daily ) did not influence the pharmacokinetics of DRUGN and DRUGB .
Warfarin	drug	S warfarin	drug
false

DRUGN DRUGA ( dgb mg twice daily ) did not influence the pharmacokinetics of DRUGB and DRUGN .
Keppra	brand	R warfarin	drug
false

DRUGN DRUGA ( dgb DRUGN DRUGN DRUGN mg twice daily ) did not influence the pharmacokinetics of DRUGN and DRUGB .
Keppra	brand	S warfarin	drug
false

DRUGN DRUGN ( dgb mg twice d DRUGA ily ) did not influence the ph DRUGA rm DRUGA cokinetics of DRUGA DRUGA nd DRUGB .
R warfarin	drug	S warfarin	drug
false

Coadministration of DRUGA did not affect the pharmacokinetics of DRUGB .
warfarin	drug	levetiracetam	drug
false

DRUGA : DRUGN , a renal tubular secretion blocking agent , administered at a dose of dgb mg four times a day , did not change the pharmacokinetics of DRUGB dgb mg twice daily .
Probenecid	drug	levetiracetam	drug
false

DRUGN : DRUGA , a renal tubular secretion blocking agent , administered at a dose of dgb mg four times a day , did not change the pharmacokinetics of DRUGB dgb mg twice daily .
Probenecid	drug	levetiracetam	drug
false

The effect of DRUGA on DRUGB was not studied .
Keppra	brand	probenecid	drug
false

Although DRUGA used alone has little or no effect on pupil size , mydriasis resulting from concomitant therapy with DRUGN and DRUGB may occur .
BETAGAN	brand	epinephrine	drug
false

Although DRUGN used alone has little or no effect on pupil size , mydriasis resulting from concomitant therapy with DRUGA and DRUGB may occur .
BETAGAN	brand	epinephrine	drug
effect

Patients receiving DRUGA along with either oral or intravenous DRUGB should be monitored for possible atrioventricular conduction disturbances , left ventricular failure and hypotension .
beta-adrenergic blocking agents	group	calcium antagonists	group
advise

The concomitant use of DRUGA with DRUGB and DRUGN s may have additive effects on prolonging atrioventricular conduction time .
beta-adrenergic blocking agents	group	digitalis	group
effect

The concomitant use of DRUGA with DRUGN and DRUGB s may have additive effects on prolonging atrioventricular conduction time .
beta-adrenergic blocking agents	group	calcium antagonist	group
effect

The concomitant use of DRUGN with DRUGA and DRUGB s may have additive effects on prolonging atrioventricular conduction time .
digitalis	group	calcium antagonist	group
false

DRUGA and DRUGB may have additive hypotensite effects due to the inhibition of each other s metabolism .
Phenothiazine-related compounds	group	beta-adrenergic blocking agents	group
mechanism

DRUGA should be used with caution in patients receiving other local DRUGB or agents structurally related to amide type local anesthetics since the toxic effects of these drugs could be additive .
Chirocaine	brand	anesthetics	group
advise

In vitro studies indicate CYPdgbAdgb isoform and CYPdgbAdgb isoform mediate the metabolism of DRUGA to DRUGB and DRUGN , respectively .
levobupivacaine	drug	desbutyl levobupivacaine	drug_n
false

In vitro studies indicate CYPdgbAdgb isoform and CYPdgbAdgb isoform mediate the metabolism of DRUGA to DRUGN and DRUGB , respectively .
levobupivacaine	drug	3-hydroxy levobupivacaine	drug_n
false

In vitro studies indicate CYPdgbAdgb isoform and CYPdgbAdgb isoform mediate the metabolism of DRUGN to DRUGA and DRUGB , respectively .
desbutyl levobupivacaine	drug_n	3-hydroxy levobupivacaine	drug_n
false

DRUGA e.g . , DRUGB ;
macrolide antibiotics	group	erythromycin	drug
false

and DRUGA e.g . , DRUGB ) , CYPdgbAdgb inducers ( DRUGN ) and CYPdgbAdgb inhibitors ( DRUGN and DRUGN ) .
calcium channel antagonists	group	verapamil	drug
false

and DRUGA e.g . , DRUGN ) , CYPdgbAdgb inducers ( DRUGB ) and CYPdgbAdgb inhibitors ( DRUGN and DRUGN ) .
calcium channel antagonists	group	omeprazole	drug
false

and DRUGA e.g . , DRUGN ) , CYPdgbAdgb inducers ( DRUGN ) and CYPdgbAdgb inhibitors ( DRUGB and DRUGN ) .
calcium channel antagonists	group	furafylline	drug
false

and DRUGA e.g . , DRUGN ) , CYPdgbAdgb inducers ( DRUGN ) and CYPdgbAdgb inhibitors ( DRUGN and DRUGB ) .
calcium channel antagonists	group	clarithromycin	drug
false

and DRUGN e.g . , DRUGA ) , CYPdgbAdgb inducers ( DRUGB ) and CYPdgbAdgb inhibitors ( DRUGN and DRUGN ) .
verapamil	drug	omeprazole	drug
false

and DRUGN e.g . , DRUGA ) , CYPdgbAdgb inducers ( DRUGN ) and CYPdgbAdgb inhibitors ( DRUGB and DRUGN ) .
verapamil	drug	furafylline	drug
false

and DRUGN e.g . , DRUGA ) , CYPdgbAdgb inducers ( DRUGN ) and CYPdgbAdgb inhibitors ( DRUGN and DRUGB ) .
verapamil	drug	clarithromycin	drug
false

and DRUGN e.g . , DRUGN ) , CYPdgbAdgb inducers ( DRUGA ) and CYPdgbAdgb inhibitors ( DRUGB and DRUGN ) .
omeprazole	drug	furafylline	drug
false

and DRUGN e.g . , DRUGN ) , CYPdgbAdgb inducers ( DRUGA ) and CYPdgbAdgb inhibitors ( DRUGN and DRUGB ) .
omeprazole	drug	clarithromycin	drug
false

and DRUGN e.g . , DRUGN ) , CYPdgbAdgb inducers ( DRUGN ) and CYPdgbAdgb inhibitors ( DRUGA and DRUGB ) .
furafylline	drug	clarithromycin	drug
false

Although no interaction between DRUGA and DRUGB has been observed , it is not recommended for use with DRUGN .
MAO inhibitors	group	Levo-Dromoran	brand
false

Although no interaction between DRUGN and DRUGA has been observed , it is not recommended for use with DRUGB .
Levo-Dromoran	brand	MAO inhibitors	group
advise

In DRUGA dependent patients , DRUGB may precipitate withdrawal symptoms .
opioid	group	mixed agonist/antagonist analgesics	group
false

No Important Interactions To Date DRUGA does not have clinically important pharmacokinetic interactions with DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
Levosimendan	drug	captopril	drug
false

No Important Interactions To Date DRUGA does not have clinically important pharmacokinetic interactions with DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
Levosimendan	drug	beta-blockers	group
false

No Important Interactions To Date DRUGA does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
Levosimendan	drug	felodipine	drug
false

No Important Interactions To Date DRUGA does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
Levosimendan	drug	digoxin	drug
false

No Important Interactions To Date DRUGA does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN or DRUGN .
Levosimendan	drug	warfarin	drug
false

No Important Interactions To Date DRUGA does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN or DRUGN .
Levosimendan	drug	isosorbide mononitrate	drug
false

No Important Interactions To Date DRUGA does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN or DRUGN .
Levosimendan	drug	carvedilol	drug
false

No Important Interactions To Date DRUGA does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB or DRUGN .
Levosimendan	drug	ethanol	drug
false

No Important Interactions To Date DRUGA does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGB .
Levosimendan	drug	itraconazole	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
captopril	drug	beta-blockers	group
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
captopril	drug	felodipine	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
captopril	drug	digoxin	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN or DRUGN .
captopril	drug	warfarin	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN or DRUGN .
captopril	drug	isosorbide mononitrate	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN or DRUGN .
captopril	drug	carvedilol	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB or DRUGN .
captopril	drug	ethanol	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGB .
captopril	drug	itraconazole	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
beta-blockers	group	felodipine	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
beta-blockers	group	digoxin	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN or DRUGN .
beta-blockers	group	warfarin	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN or DRUGN .
beta-blockers	group	isosorbide mononitrate	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN or DRUGN .
beta-blockers	group	carvedilol	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB or DRUGN .
beta-blockers	group	ethanol	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGB .
beta-blockers	group	itraconazole	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
felodipine	drug	digoxin	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN or DRUGN .
felodipine	drug	warfarin	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN or DRUGN .
felodipine	drug	isosorbide mononitrate	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN or DRUGN .
felodipine	drug	carvedilol	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB or DRUGN .
felodipine	drug	ethanol	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN or DRUGB .
felodipine	drug	itraconazole	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN or DRUGN .
digoxin	drug	warfarin	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN or DRUGN .
digoxin	drug	isosorbide mononitrate	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN or DRUGN .
digoxin	drug	carvedilol	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB or DRUGN .
digoxin	drug	ethanol	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN or DRUGB .
digoxin	drug	itraconazole	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN or DRUGN .
warfarin	drug	isosorbide mononitrate	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN or DRUGN .
warfarin	drug	carvedilol	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB or DRUGN .
warfarin	drug	ethanol	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN or DRUGB .
warfarin	drug	itraconazole	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN or DRUGN .
isosorbide mononitrate	drug	carvedilol	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB or DRUGN .
isosorbide mononitrate	drug	ethanol	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN or DRUGB .
isosorbide mononitrate	drug	itraconazole	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB or DRUGN .
carvedilol	drug	ethanol	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN or DRUGB .
carvedilol	drug	itraconazole	drug
false

No Important Interactions To Date DRUGN does not have clinically important pharmacokinetic interactions with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA or DRUGB .
ethanol	drug	itraconazole	drug
false

DRUGA ( Oral ) : The hypoprothrombinemic effect of DRUGB may be potentiated , apparently by increased catabloism of vitamin K dependent clotting factors .
Anticoagulants	group	anticoagulants	group
false

DRUGA ( DRUGB , DRUGN ) : Requirements for DRUGN or oral DRUGN may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
Antidiabetic Agents	group	Insulin	drug
false

DRUGA ( DRUGN , DRUGB ) : Requirements for DRUGN or oral DRUGN may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
Antidiabetic Agents	group	Sulfonylureas	group
false

DRUGA ( DRUGN , DRUGN ) : Requirements for DRUGB or oral DRUGN may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
Antidiabetic Agents	group	insulin	drug
false

DRUGA ( DRUGN , DRUGN ) : Requirements for DRUGN or oral DRUGB may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
Antidiabetic Agents	group	antidiabetic agents	group
false

DRUGN ( DRUGA , DRUGB ) : Requirements for DRUGN or oral DRUGN may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
Insulin	drug	Sulfonylureas	group
false

DRUGN ( DRUGA , DRUGN ) : Requirements for DRUGB or oral DRUGN may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
Insulin	drug	insulin	drug
false

DRUGN ( DRUGA , DRUGN ) : Requirements for DRUGN or oral DRUGB may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
Insulin	drug	antidiabetic agents	group
false

DRUGN ( DRUGN , DRUGA ) : Requirements for DRUGB or oral DRUGN may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
Sulfonylureas	group	insulin	drug
false

DRUGN ( DRUGN , DRUGA ) : Requirements for DRUGN or oral DRUGB may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
Sulfonylureas	group	antidiabetic agents	group
false

DRUGN ( DRUGN , DRUGN ) : Requirements for DRUGA or oral DRUGB may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
insulin	drug	antidiabetic agents	group
false

DRUGA : Actions of some of DRUGB may be impaired when hypothyroid patients become euthyroid .
b-Adrenergic Blocking Agents	group	beta-blocking agents	group
false

DRUGA ( DRUGB , DRUGN ) : DRUGN have been reported to induce both hyperthyroidism and hypothyroidism .
Cytokines	group	interferon	group
false

DRUGA ( DRUGN , DRUGB ) : DRUGN have been reported to induce both hyperthyroidism and hypothyroidism .
Cytokines	group	interleukin	group
false

DRUGN ( DRUGA , DRUGB ) : DRUGN have been reported to induce both hyperthyroidism and hypothyroidism .
interferon	group	interleukin	group
false

DRUGN ( DRUGA , DRUGN ) : DRUGB have been reported to induce both hyperthyroidism and hypothyroidism .
interferon	group	Cytokines	group
false

DRUGN ( DRUGN , DRUGA ) : DRUGB have been reported to induce both hyperthyroidism and hypothyroidism .
interleukin	group	Cytokines	group
false

DRUGA : Therapeutic effects of DRUGB may be reduced .
Digitalis Glycosides	group	digitalis glycosides	group
false

DRUGA : Marked hypertension and tachycardia have been reported in association with concomitant administration of DRUGB and DRUGN .
Ketamine	drug	levothyroxine sodium	drug
false

DRUGA : Marked hypertension and tachycardia have been reported in association with concomitant administration of DRUGN and DRUGB .
Ketamine	drug	ketamine	drug
false

DRUGN : Marked hypertension and tachycardia have been reported in association with concomitant administration of DRUGA and DRUGB .
levothyroxine sodium	drug	ketamine	drug
effect

DRUGA ( dgbI and dgbI ) , DRUGB : Uptake of radiolabeled ions may be decreased .
Sodium Iodide	drug	Sodium Pertechnetate Tc99m	drug
false

DRUGA / DRUGB : Excessive concurrent use of DRUGN may accelerate epiphyseal closure .
Somatrem	drug	Somatropin	drug
false

DRUGA / DRUGN : Excessive concurrent use of DRUGB may accelerate epiphyseal closure .
Somatrem	drug	thyroid hormone	group
false

DRUGN / DRUGA : Excessive concurrent use of DRUGB may accelerate epiphyseal closure .
Somatropin	drug	thyroid hormone	group
false

Untreated hypothyroidism may interfere with the growth response to DRUGA or DRUGB .
somatrem	drug	somatropin	drug
false

The administration of local DRUGA containing DRUGB or DRUGN to patients receiving DRUGN or DRUGN may produce severe , prolonged hypertension .
anesthetic solutions	group	epinephrine	drug
false

The administration of local DRUGA containing DRUGN or DRUGB to patients receiving DRUGN or DRUGN may produce severe , prolonged hypertension .
anesthetic solutions	group	norepinephrine	drug
false

The administration of local DRUGA containing DRUGN or DRUGN to patients receiving DRUGB or DRUGN may produce severe , prolonged hypertension .
anesthetic solutions	group	monoamine oxidase inhibitors	group
false

The administration of local DRUGA containing DRUGN or DRUGN to patients receiving DRUGN or DRUGB may produce severe , prolonged hypertension .
anesthetic solutions	group	tricyclic antidepressants	group
false

The administration of local DRUGN containing DRUGA or DRUGB to patients receiving DRUGN or DRUGN may produce severe , prolonged hypertension .
epinephrine	drug	norepinephrine	drug
false

The administration of local DRUGN containing DRUGA or DRUGN to patients receiving DRUGB or DRUGN may produce severe , prolonged hypertension .
epinephrine	drug	monoamine oxidase inhibitors	group
effect

The administration of local DRUGN containing DRUGA or DRUGN to patients receiving DRUGN or DRUGB may produce severe , prolonged hypertension .
epinephrine	drug	tricyclic antidepressants	group
effect

The administration of local DRUGN containing DRUGN or DRUGA to patients receiving DRUGB or DRUGN may produce severe , prolonged hypertension .
norepinephrine	drug	monoamine oxidase inhibitors	group
effect

The administration of local DRUGN containing DRUGN or DRUGA to patients receiving DRUGN or DRUGB may produce severe , prolonged hypertension .
norepinephrine	drug	tricyclic antidepressants	group
effect

The administration of local DRUGN containing DRUGN or DRUGN to patients receiving DRUGA or DRUGB may produce severe , prolonged hypertension .
monoamine oxidase inhibitors	group	tricyclic antidepressants	group
false

DRUGA and DRUGB may reduce or reverse the pressor effect of DRUGN .
Phenothiazines	group	butyrophenones	group
false

DRUGA and DRUGN may reduce or reverse the pressor effect of DRUGB .
Phenothiazines	group	epinephrine	drug
effect

DRUGN and DRUGA may reduce or reverse the pressor effect of DRUGB .
butyrophenones	group	epinephrine	drug
effect

Concurrent administration of DRUGA ( for the treatment of hypotension related to obstetric blocks ) and DRUGB may cause severe , persistent hypertension or cerebrovascular accidents .
vasopressor drugs	group	ergot-type oxytocic drugs	group
false

DRUGA has been shown to have neuromuscular blocking properties that may enhance the action of other DRUGB .
Lincomycin	drug	neuromuscular blocking agents	group
effect

Antagonism between DRUGA and DRUGB in vitro has been demonstrated .
lincomycin	drug	erythromycin	drug
effect

Therefore , DRUGA has the potential for interaction with DRUGB and DRUGN .
linezolid	drug	adrenergic	group
int

Therefore , DRUGA has the potential for interaction with DRUGN and DRUGB .
linezolid	drug	serotonergic agents	group
int

Therefore , DRUGN has the potential for interaction with DRUGA and DRUGB .
adrenergic	group	serotonergic agents	group
false

DRUGA : Some individuals receiving DRUGB may experience a reversible enhancement of the pressor response to indirect acting DRUGN , DRUGN or DRUGN .
Adrenergic Agents	group	ZYVOX	brand
false

DRUGA : Some individuals receiving DRUGN may experience a reversible enhancement of the pressor response to indirect acting DRUGB , DRUGN or DRUGN .
Adrenergic Agents	group	sympathomimetic agents	group
false

DRUGA : Some individuals receiving DRUGN may experience a reversible enhancement of the pressor response to indirect acting DRUGN , DRUGB or DRUGN .
Adrenergic Agents	group	vasopressor	group
false

DRUGA : Some individuals receiving DRUGN may experience a reversible enhancement of the pressor response to indirect acting DRUGN , DRUGN or DRUGB .
Adrenergic Agents	group	dopaminergic agents	group
false

DRUGN : Some individuals receiving DRUGA may experience a reversible enhancement of the pressor response to indirect acting DRUGB , DRUGN or DRUGN .
ZYVOX	brand	sympathomimetic agents	group
effect

DRUGN : Some individuals receiving DRUGA may experience a reversible enhancement of the pressor response to indirect acting DRUGN , DRUGB or DRUGN .
ZYVOX	brand	vasopressor	group
effect

DRUGN : Some individuals receiving DRUGA may experience a reversible enhancement of the pressor response to indirect acting DRUGN , DRUGN or DRUGB .
ZYVOX	brand	dopaminergic agents	group
effect

DRUGN : Some individuals receiving DRUGN may experience a reversible enhancement of the pressor response to indirect acting DRUGA , DRUGB or DRUGN .
sympathomimetic agents	group	vasopressor	group
false

DRUGN : Some individuals receiving DRUGN may experience a reversible enhancement of the pressor response to indirect acting DRUGA , DRUGN or DRUGB .
sympathomimetic agents	group	dopaminergic agents	group
false

DRUGN : Some individuals receiving DRUGN may experience a reversible enhancement of the pressor response to indirect acting DRUGN , DRUGA or DRUGB .
vasopressor	group	dopaminergic agents	group
false

Commonly used drugs such as DRUGA and DRUGB have been specifically studied .
phenylpropanolamine	drug	pseudoephedrine	drug
false

Initial doses of DRUGA , such as DRUGB or DRUGN , should be reduced and titrated to achieve the desired response .
adrenergic agents	group	dopamine	drug
false

Initial doses of DRUGA , such as DRUGN or DRUGB , should be reduced and titrated to achieve the desired response .
adrenergic agents	group	epinephrine	drug
false

Initial doses of DRUGN , such as DRUGA or DRUGB , should be reduced and titrated to achieve the desired response .
dopamine	drug	epinephrine	drug
false

DRUGA : Co administration of DRUGB and DRUGN was not associated with serotonin syndrome in Phase dgb , dgb or dgb studies .
Serotonergic Agents	group	linezolid	drug
false

DRUGA : Co administration of DRUGN and DRUGB was not associated with serotonin syndrome in Phase dgb , dgb or dgb studies .
Serotonergic Agents	group	serotonergic agents	group
false

DRUGN : Co administration of DRUGA and DRUGB was not associated with serotonin syndrome in Phase dgb , dgb or dgb studies .
linezolid	drug	serotonergic agents	group
false

Spontaneous reports of serotonin syndrome associated with co administration of DRUGA and DRUGB , including DRUGN such as DRUGN ( DRUGN ) , have been reported .
ZYVOX	brand	serotonergic agents	group
effect

Spontaneous reports of serotonin syndrome associated with co administration of DRUGA and DRUGN , including DRUGB such as DRUGN ( DRUGN ) , have been reported .
ZYVOX	brand	antidepressants	group
effect

Spontaneous reports of serotonin syndrome associated with co administration of DRUGA and DRUGN , including DRUGN such as DRUGB ( DRUGN ) , have been reported .
ZYVOX	brand	selective serotonin reuptake inhibitors	group
effect

Spontaneous reports of serotonin syndrome associated with co administration of DRUGA and DRUGN , including DRUGN such as DRUGN ( DRUGB ) , have been reported .
ZYVOX	brand	SSRIs	group
effect

Spontaneous reports of serotonin syndrome associated with co administration of DRUGN and DRUGA , including DRUGB such as DRUGN ( DRUGN ) , have been reported .
serotonergic agents	group	antidepressants	group
false

Spontaneous reports of serotonin syndrome associated with co administration of DRUGN and DRUGA , including DRUGN such as DRUGB ( DRUGN ) , have been reported .
serotonergic agents	group	selective serotonin reuptake inhibitors	group
false

Spontaneous reports of serotonin syndrome associated with co administration of DRUGN and DRUGA , including DRUGN such as DRUGN ( DRUGB ) , have been reported .
serotonergic agents	group	SSRIs	group
false

Spontaneous reports of serotonin syndrome associated with co administration of DRUGN and DRUGN , including DRUGA such as DRUGB ( DRUGN ) , have been reported .
antidepressants	group	selective serotonin reuptake inhibitors	group
false

Spontaneous reports of serotonin syndrome associated with co administration of DRUGN and DRUGN , including DRUGA such as DRUGN ( DRUGB ) , have been reported .
antidepressants	group	SSRIs	group
false

Spontaneous reports of serotonin syndrome associated with co administration of DRUGN and DRUGN , including DRUGN such as DRUGA ( DRUGB ) , have been reported .
selective serotonin reuptake inhibitors	group	SSRIs	group
false

Patients who are treated with DRUGA and concomitant DRUGB should be closely observed for signs and symptoms of serotonin syndrome ( e.g . , cognitive dysfunction , hyperpyrexia , hyperreflexia , incoordination ) .
ZYVOX	brand	serotonergic agents	group
effect

If any signs or symptoms occur physicians should consider discontinuation of either one or both agents ( DRUGA or concomitant DRUGB ) .
ZYVOX	brand	serotonergic agents	group
advise

Oral DRUGA : DRUGB appear to increase catabolism of vitamin K dependent clotting factors .
Anticoagulants	group	Thyroid hormones	group
false

Patients stabilized on oral DRUGA who are found to require DRUGB replacement therapy should be watched very closely when thyroid is started .
anticoagulants	group	thyroid	group
advise

DRUGA or Oral DRUGB : Initiating thyroid replacement therapy may cause increases in DRUGN or oral DRUGN requirements .
Insulin	drug	Hypoglycemics	group
false

DRUGA or Oral DRUGN : Initiating thyroid replacement therapy may cause increases in DRUGB or oral DRUGN requirements .
Insulin	drug	insulin	drug
false

DRUGA or Oral DRUGN : Initiating thyroid replacement therapy may cause increases in DRUGN or oral DRUGB requirements .
Insulin	drug	hypoglycemic	group
false

DRUGN or Oral DRUGA : Initiating thyroid replacement therapy may cause increases in DRUGB or oral DRUGN requirements .
Hypoglycemics	group	insulin	drug
false

DRUGN or Oral DRUGA : Initiating thyroid replacement therapy may cause increases in DRUGN or oral DRUGB requirements .
Hypoglycemics	group	hypoglycemic	group
false

DRUGN or Oral DRUGN : Initiating thyroid replacement therapy may cause increases in DRUGA or oral DRUGB requirements .
insulin	drug	hypoglycemic	group
false

Patients receiving DRUGA or oral DRUGB should be closely watched during initiation of thyroid replacement therapy .
insulin	drug	hypoglycemics	group
false

DRUGA : DRUGN binds both DRUGB and DRUGN in the intestine , thus impairing absorption of these DRUGN .
Cholestyramine	drug	T4	drug
false

DRUGA : DRUGN binds both DRUGN and DRUGB in the intestine , thus impairing absorption of these DRUGN .
Cholestyramine	drug	T3	drug
false

DRUGA : DRUGN binds both DRUGN and DRUGN in the intestine , thus impairing absorption of these DRUGB .
Cholestyramine	drug	thyroid hormones	group
false

DRUGN : DRUGA binds both DRUGB and DRUGN in the intestine , thus impairing absorption of these DRUGN .
Cholestyramine	drug	T4	drug
mechanism

DRUGN : DRUGA binds both DRUGN and DRUGB in the intestine , thus impairing absorption of these DRUGN .
Cholestyramine	drug	T3	drug
mechanism

DRUGN : DRUGA binds both DRUGN and DRUGN in the intestine , thus impairing absorption of these DRUGB .
Cholestyramine	drug	thyroid hormones	group
false

DRUGN : DRUGN binds both DRUGA and DRUGB in the intestine , thus impairing absorption of these DRUGN .
T4	drug	T3	drug
false

DRUGN : DRUGN binds both DRUGA and DRUGN in the intestine , thus impairing absorption of these DRUGB .
T4	drug	thyroid hormones	group
false

DRUGN : DRUGN binds both DRUGN and DRUGA in the intestine , thus impairing absorption of these DRUGB .
T3	drug	thyroid hormones	group
false

Therefore , dgb to dgb hours should elapse between administration of DRUGA and DRUGB .
cholestyramine	drug	thyroid hormones	group
advise

DRUGA , Oral DRUGB : DRUGN tend to increase serum thyroxine binding globulin ( TBg ) .
Estrogen	group	Contraceptives	group
false

DRUGA , Oral DRUGN : DRUGB tend to increase serum thyroxine binding globulin ( TBg ) .
Estrogen	group	Estrogens	group
false

DRUGN , Oral DRUGA : DRUGB tend to increase serum thyroxine binding globulin ( TBg ) .
Contraceptives	group	Estrogens	group
false

In a patient with a nonfunctioning thyroid gland who is receiving thyroid replacement therapy , free DRUGA may be decreased when DRUGB are started thus increasing DRUGN requirements .
levothyroxine	drug	estrogens	group
mechanism

In a patient with a nonfunctioning thyroid gland who is receiving thyroid replacement therapy , free DRUGA may be decreased when DRUGN are started thus increasing DRUGB requirements .
levothyroxine	drug	thyroid	group
false

In a patient with a nonfunctioning thyroid gland who is receiving thyroid replacement therapy , free DRUGN may be decreased when DRUGA are started thus increasing DRUGB requirements .
estrogens	group	thyroid	group
false

Therefore , patients without a functioning DRUGA gland who are on thyroid replacement therapy may need to increase their thyroid dose if DRUGB or DRUGN containing oral DRUGN are given .
thyroid	group	estrogens	group
advise

Therefore , patients without a functioning DRUGA gland who are on thyroid replacement therapy may need to increase their thyroid dose if DRUGN or DRUGB containing oral DRUGN are given .
thyroid	group	estrogen	group
false

Therefore , patients without a functioning DRUGA gland who are on thyroid replacement therapy may need to increase their thyroid dose if DRUGN or DRUGN containing oral DRUGB are given .
thyroid	group	contraceptives	group
advise

Therefore , patients without a functioning DRUGN gland who are on thyroid replacement therapy may need to increase their thyroid dose if DRUGA or DRUGB containing oral DRUGN are given .
estrogens	group	estrogen	group
false

Therefore , patients without a functioning DRUGN gland who are on thyroid replacement therapy may need to increase their thyroid dose if DRUGA or DRUGN containing oral DRUGB are given .
estrogens	group	contraceptives	group
false

Therefore , patients without a functioning DRUGN gland who are on thyroid replacement therapy may need to increase their thyroid dose if DRUGN or DRUGA containing oral DRUGB are given .
estrogen	group	contraceptives	group
false

DRUGA : Use of DRUGB with DRUGN and other DRUGN may increase receptor sensitivity and enhance antidepressant activity transient cardiac arrhythmias have been observed .
Tricyclic Antidepressants	group	thyroid products	group
false

DRUGA : Use of DRUGN with DRUGB and other DRUGN may increase receptor sensitivity and enhance antidepressant activity transient cardiac arrhythmias have been observed .
Tricyclic Antidepressants	group	imipramine	drug
false

DRUGA : Use of DRUGN with DRUGN and other DRUGB may increase receptor sensitivity and enhance antidepressant activity transient cardiac arrhythmias have been observed .
Tricyclic Antidepressants	group	tricyclic antidepressants	group
false

DRUGN : Use of DRUGA with DRUGB and other DRUGN may increase receptor sensitivity and enhance antidepressant activity transient cardiac arrhythmias have been observed .
thyroid products	group	imipramine	drug
effect

DRUGN : Use of DRUGA with DRUGN and other DRUGB may increase receptor sensitivity and enhance antidepressant activity transient cardiac arrhythmias have been observed .
thyroid products	group	tricyclic antidepressants	group
effect

DRUGN : Use of DRUGN with DRUGA and other DRUGB may increase receptor sensitivity and enhance antidepressant activity transient cardiac arrhythmias have been observed .
imipramine	drug	tricyclic antidepressants	group
false

DRUGA : DRUGB may potentiate the toxic effects of DRUGN .
Digitalis	group	Thyroid preparations	group
false

DRUGA : DRUGN may potentiate the toxic effects of DRUGB .
Digitalis	group	digitalis	group
false

DRUGN : DRUGA may potentiate the toxic effects of DRUGB .
Thyroid preparations	group	digitalis	group
effect

DRUGA : When administered to patients on a DRUGB , this parenteral DRUGN may cause hypertension and tachycardia .
Ketamine	drug	thyroid preparation	group
false

DRUGA : When administered to patients on a DRUGN , this parenteral DRUGB may cause hypertension and tachycardia .
Ketamine	drug	anesthetic	group
false

DRUGN : When administered to patients on a DRUGA , this parenteral DRUGB may cause hypertension and tachycardia .
thyroid preparation	group	anesthetic	group
effect

DRUGA s : DRUGB increases the adrenergic effect of catecholamines such as DRUGN and DRUGN .
Vasopressor	group	Thyroxine	drug
false

DRUGA s : DRUGN increases the adrenergic effect of catecholamines such as DRUGB and DRUGN .
Vasopressor	group	epinephrine	drug
false

DRUGA s : DRUGN increases the adrenergic effect of catecholamines such as DRUGN and DRUGB .
Vasopressor	group	norepinephrine	drug
false

DRUGN s : DRUGA increases the adrenergic effect of catecholamines such as DRUGB and DRUGN .
Thyroxine	drug	epinephrine	drug
effect

DRUGN s : DRUGA increases the adrenergic effect of catecholamines such as DRUGN and DRUGB .
Thyroxine	drug	norepinephrine	drug
effect

DRUGN s : DRUGN increases the adrenergic effect of catecholamines such as DRUGA and DRUGB .
epinephrine	drug	norepinephrine	drug
false

Pregnancy DRUGA and DRUGB containing oral DRUGN increase TBg concentrations .
estrogens	group	estrogen	group
false

Pregnancy DRUGA and DRUGN containing oral DRUGB increase TBg concentrations .
estrogens	group	contraceptives	group
false

Pregnancy DRUGN and DRUGA containing oral DRUGB increase TBg concentrations .
estrogen	group	contraceptives	group
false

Decreases in TBg concentrations are observed in nephrosis , acromegaly and after DRUGA or DRUGB therapy .
androgen	group	corticosteroid	group
false

Urinary acidifying agents These agents ( DRUGA , DRUGB , etc . ) increase the concentration of the ionized species of the DRUGN molecule , thereby increasing urinary excretion .
ammonium chloride	drug	sodium acid phosphate	drug
false

Urinary acidifying agents These agents ( DRUGA , DRUGN , etc . ) increase the concentration of the ionized species of the DRUGB molecule , thereby increasing urinary excretion .
ammonium chloride	drug	amphetamine	drug
mechanism

Urinary acidifying agents These agents ( DRUGN , DRUGA , etc . ) increase the concentration of the ionized species of the DRUGB molecule , thereby increasing urinary excretion .
sodium acid phosphate	drug	amphetamine	drug
mechanism

DRUGA DRUGN are inhibited by DRUGB .
Adrenergic blockers	group	amphetamines	group
false

DRUGN DRUGA are inhibited by DRUGB .
Adrenergic blockers	group	amphetamines	group
effect

DRUGA , DRUGB DRUGN may enhance the activity of DRUGN or DRUGN ;
Antidepressants	group	tricyclic	group
false

DRUGA , DRUGN DRUGB may enhance the activity of DRUGN or DRUGN ;
Antidepressants	group	Amphetamines	group
false

DRUGA , DRUGN DRUGN may enhance the activity of DRUGB or DRUGN ;
Antidepressants	group	tricyclic antidepressants	drug
false

DRUGA , DRUGN DRUGN may enhance the activity of DRUGN or DRUGB ;
Antidepressants	group	sympathomimetic agents	group
false

DRUGN , DRUGA DRUGB may enhance the activity of DRUGN or DRUGN ;
tricyclic	group	Amphetamines	group
false

DRUGN , DRUGA DRUGN may enhance the activity of DRUGB or DRUGN ;
tricyclic	group	tricyclic antidepressants	drug
false

DRUGN , DRUGA DRUGN may enhance the activity of DRUGN or DRUGB ;
tricyclic	group	sympathomimetic agents	group
false

DRUGN , DRUGN DRUGA may enhance the activity of DRUGB or DRUGN ;
Amphetamines	group	tricyclic antidepressants	drug
effect

DRUGN , DRUGN DRUGA may enhance the activity of DRUGN or DRUGB ;
Amphetamines	group	sympathomimetic agents	group
effect

DRUGN , DRUGN DRUGN may enhance the activity of DRUGA or DRUGB ;
tricyclic antidepressants	drug	sympathomimetic agents	group
false

DRUGA with DRUGB or DRUGN and possibly other DRUGN cause striking and sustained increases in the concentration of DRUGN in the brain ;
d-amphetamine	drug	desipramine	drug
mechanism

DRUGA with DRUGN or DRUGB and possibly other DRUGN cause striking and sustained increases in the concentration of DRUGN in the brain ;
d-amphetamine	drug	protriptyline	drug
mechanism

DRUGA with DRUGN or DRUGN and possibly other DRUGB cause striking and sustained increases in the concentration of DRUGN in the brain ;
d-amphetamine	drug	tricyclics	group
mechanism

DRUGN with DRUGA or DRUGB and possibly other DRUGN cause striking and sustained increases in the concentration of DRUGN in the brain ;
desipramine	drug	protriptyline	drug
false

DRUGN with DRUGA or DRUGN and possibly other DRUGB cause striking and sustained increases in the concentration of DRUGN in the brain ;
desipramine	drug	tricyclics	group
false

DRUGN with DRUGA or DRUGN and possibly other DRUGN cause striking and sustained increases in the concentration of DRUGB in the brain ;
desipramine	drug	d-amphetamine	drug
false

DRUGN with DRUGN or DRUGA and possibly other DRUGB cause striking and sustained increases in the concentration of DRUGN in the brain ;
protriptyline	drug	tricyclics	group
false

DRUGN with DRUGN or DRUGA and possibly other DRUGN cause striking and sustained increases in the concentration of DRUGB in the brain ;
protriptyline	drug	d-amphetamine	drug
false

DRUGN with DRUGN or DRUGN and possibly other DRUGA cause striking and sustained increases in the concentration of DRUGB in the brain ;
tricyclics	group	d-amphetamine	drug
false

DRUGA DRUGB , as well as a metabolite of DRUGN , slow DRUGN metabolism .
MAO inhibitors	group	MAOI antidepressants	group
false

DRUGA DRUGN , as well as a metabolite of DRUGB , slow DRUGN metabolism .
MAO inhibitors	group	furazolidone	drug
false

DRUGA DRUGN , as well as a metabolite of DRUGN , slow DRUGB metabolism .
MAO inhibitors	group	amphetamine	drug
false

DRUGN DRUGA , as well as a metabolite of DRUGB , slow DRUGN metabolism .
MAOI antidepressants	group	furazolidone	drug
false

DRUGN DRUGA , as well as a metabolite of DRUGN , slow DRUGB metabolism .
MAOI antidepressants	group	amphetamine	drug
mechanism

DRUGN DRUGN , as well as a metabolite of DRUGA , slow DRUGB metabolism .
furazolidone	drug	amphetamine	drug
mechanism

DRUGA : DRUGB may counteract the sedative effect of DRUGN .
Antihistamines	group	Amphetamines	group
false

DRUGA : DRUGN may counteract the sedative effect of DRUGB .
Antihistamines	group	antihistamines	group
false

DRUGN : DRUGA may counteract the sedative effect of DRUGB .
Amphetamines	group	antihistamines	group
effect

DRUGA : DRUGB may antagonize the hypotensive effects of DRUGN .
Antihypertensives	group	Amphetamines	group
false

DRUGA : DRUGN may antagonize the hypotensive effects of DRUGB .
Antihypertensives	group	antihypertensives	drug
false

DRUGN : DRUGA may antagonize the hypotensive effects of DRUGB .
Amphetamines	group	antihypertensives	drug
effect

DRUGA : DRUGN blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of DRUGB and can be used to treat DRUGN poisoning .
Chlorpromazine	drug	amphetamines	group
false

DRUGA : DRUGN blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of DRUGN and can be used to treat DRUGB poisoning .
Chlorpromazine	drug	amphetamine	group
false

DRUGN : DRUGA blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of DRUGB and can be used to treat DRUGN poisoning .
Chlorpromazine	drug	amphetamines	group
effect

DRUGN : DRUGA blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of DRUGN and can be used to treat DRUGB poisoning .
Chlorpromazine	drug	amphetamine	group
false

DRUGN : DRUGN blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of DRUGA and can be used to treat DRUGB poisoning .
amphetamines	group	amphetamine	group
false

DRUGA : DRUGB may delay intestinal absorption of DRUGN .
Ethosuximide	drug	Amphetamines	group
false

DRUGA : DRUGN may delay intestinal absorption of DRUGB .
Ethosuximide	drug	ethosuximide	drug
false

DRUGN : DRUGA may delay intestinal absorption of DRUGB .
Amphetamines	group	ethosuximide	drug
mechanism

DRUGA : DRUGN blocks dopamine receptors , thus inhibiting the central stimulant effects of DRUGB .
Haloperidol	drug	amphetamines	group
false

DRUGN : DRUGA blocks dopamine receptors , thus inhibiting the central stimulant effects of DRUGB .
Haloperidol	drug	amphetamines	group
effect

DRUGA : The anorectic and stimulatory effects of DRUGB may be inhibited by DRUGN .
Lithium carbonate	drug	amphetamines	group
false

DRUGA : The anorectic and stimulatory effects of DRUGN may be inhibited by DRUGB .
Lithium carbonate	drug	lithium carbonate	drug
false

DRUGN : The anorectic and stimulatory effects of DRUGA may be inhibited by DRUGB .
amphetamines	group	lithium carbonate	drug
effect

DRUGA : DRUGB potentiate the analgesic effect of DRUGN .
Meperidine	drug	Amphetamines	group
false

DRUGA : DRUGN potentiate the analgesic effect of DRUGB .
Meperidine	drug	meperidine	drug
false

DRUGN : DRUGA potentiate the analgesic effect of DRUGB .
Amphetamines	group	meperidine	drug
effect

DRUGA therapy Urinary excretion of DRUGB is increased , and efficacy is reduced by acidifying agents used in DRUGN therapy .
Methenamine	drug	amphetamines	group
false

DRUGA therapy Urinary excretion of DRUGN is increased , and efficacy is reduced by acidifying agents used in DRUGB therapy .
Methenamine	drug	methenamine	drug
false

DRUGN therapy Urinary excretion of DRUGA is increased , and efficacy is reduced by acidifying agents used in DRUGB therapy .
amphetamines	group	methenamine	drug
mechanism

DRUGA : DRUGB enhance the adrenergic effect of DRUGN .
Norepinephrine	drug	Amphetamines	group
false

DRUGA : DRUGN enhance the adrenergic effect of DRUGB .
Norepinephrine	drug	norepinephrine	drug
false

DRUGN : DRUGA enhance the adrenergic effect of DRUGB .
Amphetamines	group	norepinephrine	drug
effect

DRUGA : DRUGB may delay intestinal absorption of DRUGN ;
Phenobarbital	drug	Amphetamines	group
false

DRUGA : DRUGN may delay intestinal absorption of DRUGB ;
Phenobarbital	drug	phenobarbital	drug
false

DRUGN : DRUGA may delay intestinal absorption of DRUGB ;
Amphetamines	group	phenobarbital	drug
mechanism

DRUGA : DRUGB may delay intestinal absorption of DRUGN ;
Phenytoin	drug	Amphetamines	group
false

DRUGA : DRUGN may delay intestinal absorption of DRUGB ;
Phenytoin	drug	phenytoin	drug
false

DRUGN : DRUGA may delay intestinal absorption of DRUGB ;
Amphetamines	group	phenytoin	drug
mechanism

DRUGA : In cases of DRUGB overdosage , DRUGN CNS stimulation is potentiated and fatal convulsions can occur .
Propoxyphene	drug	propoxyphene	drug
false

DRUGA : In cases of DRUGN overdosage , DRUGB CNS stimulation is potentiated and fatal convulsions can occur .
Propoxyphene	drug	amphetamine	drug
false

DRUGN : In cases of DRUGA overdosage , DRUGB CNS stimulation is potentiated and fatal convulsions can occur .
propoxyphene	drug	amphetamine	drug
effect

DRUGA : DRUGB inhibit the hypotensive effect of DRUGN .
Veratrum alkaloids	group	Amphetamines	group
false

DRUGA : DRUGN inhibit the hypotensive effect of DRUGB .
Veratrum alkaloids	group	veratrum alkaloids	group
false

DRUGN : DRUGA inhibit the hypotensive effect of DRUGB .
Amphetamines	group	veratrum alkaloids	group
effect

Hypotension Patients on Diuretic Therapy : Patients on DRUGA , and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with DRUGB .
diuretics	group	PRINIVIL	brand
effect

The possibility of hypotensive effects with DRUGA can be minimized by either discontinuing the DRUGB or increasing the salt intake prior to initiation of treatment with DRUGN .
PRINIVIL	brand	diuretic	group
false

The possibility of hypotensive effects with DRUGN can be minimized by either discontinuing the DRUGA or increasing the salt intake prior to initiation of treatment with DRUGB .
diuretic	group	PRINIVIL	brand
effect

If it is necessary to continue the DRUGA , initiate therapy with DRUGB at a dose of dgb mg daily , and provide close medical supervision after the initial dose until blood pressure has stabilized .
diuretic	group	PRINIVIL	brand
advise

When a DRUGA is added to the therapy of a patient receiving DRUGB , an additional antihypertensive effect is usually observed .
diuretic	group	PRINIVIL	brand
effect

Studies with DRUGA in combination with DRUGB indicate that the dose of the DRUGN can be reduced when it is given with a DRUGN .
ACE inhibitors	group	diuretics	group
false

Studies with DRUGA in combination with DRUGN indicate that the dose of the DRUGB can be reduced when it is given with a DRUGN .
ACE inhibitors	group	ACE inhibitor	group
false

Studies with DRUGA in combination with DRUGN indicate that the dose of the DRUGN can be reduced when it is given with a DRUGB .
ACE inhibitors	group	diuretic	group
false

Studies with DRUGN in combination with DRUGA indicate that the dose of the DRUGB can be reduced when it is given with a DRUGN .
diuretics	group	ACE inhibitor	group
false

Studies with DRUGN in combination with DRUGA indicate that the dose of the DRUGN can be reduced when it is given with a DRUGB .
diuretics	group	diuretic	group
false

Studies with DRUGN in combination with DRUGN indicate that the dose of the DRUGA can be reduced when it is given with a DRUGB .
ACE inhibitor	group	diuretic	group
advise

DRUGA : In some patients with compromised renal function who are being treated with DRUGB , the co administration of DRUGN may result in a further deterioration of renal function .
Non-steroidal Anti-inflammatory Agents	group	non-steroidal anti-inflammatory drugs	group
false

DRUGA : In some patients with compromised renal function who are being treated with DRUGN , the co administration of DRUGB may result in a further deterioration of renal function .
Non-steroidal Anti-inflammatory Agents	group	lisinopril	drug
false

DRUGN : In some patients with compromised renal function who are being treated with DRUGA , the co administration of DRUGB may result in a further deterioration of renal function .
non-steroidal anti-inflammatory drugs	group	lisinopril	drug
effect

Reports suggest that DRUGA may diminish the antihypertensive effect of DRUGB , including DRUGN .
NSAIDs	group	ACE inhibitors	group
effect

Reports suggest that DRUGA may diminish the antihypertensive effect of DRUGN , including DRUGB .
NSAIDs	group	lisinopril	drug
effect

Reports suggest that DRUGN may diminish the antihypertensive effect of DRUGA , including DRUGB .
ACE inhibitors	group	lisinopril	drug
false

This interaction should be given consideration in patients taking DRUGA concomitantly with DRUGB .
NSAIDs	group	ACE inhibitors	group
advise

Other Agents : DRUGA has been used concomitantly with DRUGB and / or DRUGN without evidence of clinically significant adverse interactions .
PRINIVIL	brand	nitrates	group
false

Other Agents : DRUGA has been used concomitantly with DRUGN and / or DRUGB without evidence of clinically significant adverse interactions .
PRINIVIL	brand	digoxin	drug
false

Other Agents : DRUGN has been used concomitantly with DRUGA and / or DRUGB without evidence of clinically significant adverse interactions .
nitrates	group	digoxin	drug
false

No clinically important pharmacokinetic interactions occurred when DRUGA was used concomitantly with DRUGB or DRUGN .
PRINIVIL	brand	propranolol	drug
false

No clinically important pharmacokinetic interactions occurred when DRUGA was used concomitantly with DRUGN or DRUGB .
PRINIVIL	brand	hydrochlorothiazide	drug
false

No clinically important pharmacokinetic interactions occurred when DRUGN was used concomitantly with DRUGA or DRUGB .
propranolol	drug	hydrochlorothiazide	drug
false

Agents Increasing Serum Potassium : DRUGA attenuates potassium loss caused by DRUGB .
PRINIVIL	brand	thiazide-type diuretics	group
effect

Use of DRUGA with DRUGB ( e.g . , DRUGN , DRUGN , or DRUGN ) , DRUGN supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
PRINIVIL	brand	potassium-sparing diuretics	group
effect

Use of DRUGA with DRUGN ( e.g . , DRUGB , DRUGN , or DRUGN ) , DRUGN supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
PRINIVIL	brand	spironolactone	drug
effect

Use of DRUGA with DRUGN ( e.g . , DRUGN , DRUGB , or DRUGN ) , DRUGN supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
PRINIVIL	brand	triamterene	drug
effect

Use of DRUGA with DRUGN ( e.g . , DRUGN , DRUGN , or DRUGB ) , DRUGN supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
PRINIVIL	brand	amiloride	drug
effect

Use of DRUGA with DRUGN ( e.g . , DRUGN , DRUGN , or DRUGN ) , DRUGB supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
PRINIVIL	brand	potassium	drug
effect

Use of DRUGN with DRUGA ( e.g . , DRUGB , DRUGN , or DRUGN ) , DRUGN supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
potassium-sparing diuretics	group	spironolactone	drug
false

Use of DRUGN with DRUGA ( e.g . , DRUGN , DRUGB , or DRUGN ) , DRUGN supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
potassium-sparing diuretics	group	triamterene	drug
false

Use of DRUGN with DRUGA ( e.g . , DRUGN , DRUGN , or DRUGB ) , DRUGN supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
potassium-sparing diuretics	group	amiloride	drug
false

Use of DRUGN with DRUGA ( e.g . , DRUGN , DRUGN , or DRUGN ) , DRUGB supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
potassium-sparing diuretics	group	potassium	drug
false

Use of DRUGN with DRUGN ( e.g . , DRUGA , DRUGB , or DRUGN ) , DRUGN supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
spironolactone	drug	triamterene	drug
false

Use of DRUGN with DRUGN ( e.g . , DRUGA , DRUGN , or DRUGB ) , DRUGN supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
spironolactone	drug	amiloride	drug
false

Use of DRUGN with DRUGN ( e.g . , DRUGA , DRUGN , or DRUGN ) , DRUGB supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
spironolactone	drug	potassium	drug
false

Use of DRUGN with DRUGN ( e.g . , DRUGN , DRUGA , or DRUGB ) , DRUGN supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
triamterene	drug	amiloride	drug
false

Use of DRUGN with DRUGN ( e.g . , DRUGN , DRUGA , or DRUGN ) , DRUGB supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
triamterene	drug	potassium	drug
false

Use of DRUGN with DRUGN ( e.g . , DRUGN , DRUGN , or DRUGA ) , DRUGB supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
amiloride	drug	potassium	drug
false

DRUGA : DRUGN toxicity has been reported in patients receiving DRUGB concomitantly with drugs which cause elimination of sodium , including DRUGN .
Lithium	drug	lithium	drug
false

DRUGA : DRUGN toxicity has been reported in patients receiving DRUGN concomitantly with drugs which cause elimination of sodium , including DRUGB .
Lithium	drug	ACE inhibitors	group
false

DRUGN : DRUGA toxicity has been reported in patients receiving DRUGB concomitantly with drugs which cause elimination of sodium , including DRUGN .
Lithium	drug	lithium	drug
false

DRUGN : DRUGA toxicity has been reported in patients receiving DRUGN concomitantly with drugs which cause elimination of sodium , including DRUGB .
Lithium	drug	ACE inhibitors	group
false

DRUGN : DRUGN toxicity has been reported in patients receiving DRUGA concomitantly with drugs which cause elimination of sodium , including DRUGB .
lithium	drug	ACE inhibitors	group
effect

DRUGA toxicity was usually reversible upon discontinuation of DRUGB and the DRUGN .
Lithium	drug	lithium	drug
false

DRUGA toxicity was usually reversible upon discontinuation of DRUGN and the DRUGB .
Lithium	drug	ACE inhibitor	group
false

DRUGN toxicity was usually reversible upon discontinuation of DRUGA and the DRUGB .
lithium	drug	ACE inhibitor	group
effect

It is recommended that serum DRUGA levels be monitored frequently if DRUGB is administered concomitantly with DRUGN .
lithium	drug	PRINIVIL	brand
false

It is recommended that serum DRUGN levels be monitored frequently if DRUGA is administered concomitantly with DRUGB .
PRINIVIL	brand	lithium	drug
advise

DRUGA may enhance the CNS depressive effects of DRUGB , DRUGN and other DRUGN
Lofexidine	drug	alcohol	drug
effect

DRUGA may enhance the CNS depressive effects of DRUGN , DRUGB and other DRUGN
Lofexidine	drug	barbiturates	group
effect

DRUGA may enhance the CNS depressive effects of DRUGN , DRUGN and other DRUGB
Lofexidine	drug	sedatives	group
effect

DRUGN may enhance the CNS depressive effects of DRUGA , DRUGB and other DRUGN
alcohol	drug	barbiturates	group
false

DRUGN may enhance the CNS depressive effects of DRUGA , DRUGN and other DRUGB
alcohol	drug	sedatives	group
false

DRUGN may enhance the CNS depressive effects of DRUGN , DRUGA and other DRUGB
barbiturates	group	sedatives	group
false

DRUGA may enhance the effects of DRUGB therapy
Lofexidine	drug	anti-hypertensive drug	group
effect

Concomitant use of DRUGA may reduce the efficacy of DRUGB .
tricyclic antidepressants	group	lofexidine	drug
effect

DRUGA : In three pharmacokinetic studies including dgb normal , healthy subjects , DRUGB clearance and concentration were not significantly altered by the addition of DRUGN .
Theophylline	drug	theophylline	drug
false

DRUGA : In three pharmacokinetic studies including dgb normal , healthy subjects , DRUGN clearance and concentration were not significantly altered by the addition of DRUGB .
Theophylline	drug	lomefloxacin	drug
false

DRUGN : In three pharmacokinetic studies including dgb normal , healthy subjects , DRUGA clearance and concentration were not significantly altered by the addition of DRUGB .
theophylline	drug	lomefloxacin	drug
false

In clinical studies where patients were on chronic DRUGA therapy , DRUGB had no measurable effect on the mean distribution of DRUGN concentrations or the mean estimates of DRUGN clearance .
theophylline	drug	lomefloxacin	drug
false

In clinical studies where patients were on chronic DRUGN therapy , DRUGA had no measurable effect on the mean distribution of DRUGB concentrations or the mean estimates of DRUGN clearance .
lomefloxacin	drug	theophylline	drug
false

In clinical studies where patients were on chronic DRUGN therapy , DRUGA had no measurable effect on the mean distribution of DRUGN concentrations or the mean estimates of DRUGB clearance .
lomefloxacin	drug	theophylline	drug
false

DRUGA and DRUGB containing DRUGN , administered concomitantly with DRUGN , significantly decreased the bioavailability ( dgb % ) of DRUGN .
Magnesium	drug	aluminum	drug
false

DRUGA and DRUGN containing DRUGB , administered concomitantly with DRUGN , significantly decreased the bioavailability ( dgb % ) of DRUGN .
Magnesium	drug	antacids	group
false

DRUGA and DRUGN containing DRUGN , administered concomitantly with DRUGB , significantly decreased the bioavailability ( dgb % ) of DRUGN .
Magnesium	drug	lomefloxacin	drug
mechanism

DRUGA and DRUGN containing DRUGN , administered concomitantly with DRUGN , significantly decreased the bioavailability ( dgb % ) of DRUGB .
Magnesium	drug	lomefloxacin	drug
false

DRUGN and DRUGA containing DRUGB , administered concomitantly with DRUGN , significantly decreased the bioavailability ( dgb % ) of DRUGN .
aluminum	drug	antacids	group
false

DRUGN and DRUGA containing DRUGN , administered concomitantly with DRUGB , significantly decreased the bioavailability ( dgb % ) of DRUGN .
aluminum	drug	lomefloxacin	drug
mechanism

DRUGN and DRUGA containing DRUGN , administered concomitantly with DRUGN , significantly decreased the bioavailability ( dgb % ) of DRUGB .
aluminum	drug	lomefloxacin	drug
false

DRUGN and DRUGN containing DRUGA , administered concomitantly with DRUGB , significantly decreased the bioavailability ( dgb % ) of DRUGN .
antacids	group	lomefloxacin	drug
mechanism

DRUGN and DRUGN containing DRUGA , administered concomitantly with DRUGN , significantly decreased the bioavailability ( dgb % ) of DRUGB .
antacids	group	lomefloxacin	drug
false

Separating the doses of DRUGA and DRUGB minimizes this decrease in bioavailability ;
antacid	group	lomefloxacin	drug
mechanism

This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either DRUGA or its major metabolite , DRUGB .
caffeine	drug	paraxanthine	drug_n
false

Other DRUGA have demonstrated moderate to marked interference with the metabolism of DRUGB , resulting in a reduced clearance , a prolongation of plasma half life , and an increase in symptoms that accompany high levels of DRUGN .
quinolones	group	caffeine	drug
mechanism

Other DRUGA have demonstrated moderate to marked interference with the metabolism of DRUGN , resulting in a reduced clearance , a prolongation of plasma half life , and an increase in symptoms that accompany high levels of DRUGB .
quinolones	group	caffeine	drug
false

DRUGA : DRUGN has been demonstrated to interfere with the elimination of other DRUGB .
Cimetidine	drug	quinolones	group
false

DRUGN : DRUGA has been demonstrated to interfere with the elimination of other DRUGB .
Cimetidine	drug	quinolones	group
mechanism

The interaction between DRUGA and DRUGB has not been studied .
lomefloxacin	drug	cimetidine	drug
false

DRUGA : Elevated serum levels of DRUGB have been reported with concomitant use of DRUGN with other members of the DRUGN .
Cyclosporine	drug	cyclosporine	drug
false

DRUGA : Elevated serum levels of DRUGN have been reported with concomitant use of DRUGB with other members of the DRUGN .
Cyclosporine	drug	cyclosporine	drug
false

DRUGA : Elevated serum levels of DRUGN have been reported with concomitant use of DRUGN with other members of the DRUGB .
Cyclosporine	drug	quinolone class	group
false

DRUGN : Elevated serum levels of DRUGA have been reported with concomitant use of DRUGN with other members of the DRUGB .
cyclosporine	drug	quinolone class	group
false

DRUGN : Elevated serum levels of DRUGN have been reported with concomitant use of DRUGA with other members of the DRUGB .
cyclosporine	drug	quinolone class	group
mechanism

Interaction between DRUGA and DRUGB has not been studied .
lomefloxacin	drug	cyclosporine	drug
false

DRUGA is unlikely to have a significant effect on DRUGB metabolism .
Lomefloxacin	drug	phenytoin	drug
false

DRUGA : No clinically significant changes occurred in heart rate or corrected QT intervals , or in DRUGB metabolite or DRUGN pharmacokinetics , during concurrent administration of DRUGN and DRUGN at steady state in dgb healthy males .
Terfenadine	drug	terfenadine	drug
false

DRUGA : No clinically significant changes occurred in heart rate or corrected QT intervals , or in DRUGN metabolite or DRUGB pharmacokinetics , during concurrent administration of DRUGN and DRUGN at steady state in dgb healthy males .
Terfenadine	drug	lomefloxacin	drug
false

DRUGA : No clinically significant changes occurred in heart rate or corrected QT intervals , or in DRUGN metabolite or DRUGN pharmacokinetics , during concurrent administration of DRUGB and DRUGN at steady state in dgb healthy males .
Terfenadine	drug	lomefloxacin	drug
false

DRUGA : No clinically significant changes occurred in heart rate or corrected QT intervals , or in DRUGN metabolite or DRUGN pharmacokinetics , during concurrent administration of DRUGN and DRUGB at steady state in dgb healthy males .
Terfenadine	drug	terfenadine	drug
false

DRUGN : No clinically significant changes occurred in heart rate or corrected QT intervals , or in DRUGA metabolite or DRUGB pharmacokinetics , during concurrent administration of DRUGN and DRUGN at steady state in dgb healthy males .
terfenadine	drug	lomefloxacin	drug
false

DRUGN : No clinically significant changes occurred in heart rate or corrected QT intervals , or in DRUGA metabolite or DRUGN pharmacokinetics , during concurrent administration of DRUGB and DRUGN at steady state in dgb healthy males .
terfenadine	drug	lomefloxacin	drug
false

DRUGN : No clinically significant changes occurred in heart rate or corrected QT intervals , or in DRUGN metabolite or DRUGA pharmacokinetics , during concurrent administration of DRUGN and DRUGB at steady state in dgb healthy males .
lomefloxacin	drug	terfenadine	drug
false

DRUGN : No clinically significant changes occurred in heart rate or corrected QT intervals , or in DRUGN metabolite or DRUGN pharmacokinetics , during concurrent administration of DRUGA and DRUGB at steady state in dgb healthy males .
lomefloxacin	drug	terfenadine	drug
false

DRUGA : DRUGB may enhance the effects of the oral DRUGN , DRUGN , or its derivatives .
Warfarin	drug	Quinolones	group
false

DRUGA : DRUGN may enhance the effects of the oral DRUGB , DRUGN , or its derivatives .
Warfarin	drug	anticoagulant	group
false

DRUGA : DRUGN may enhance the effects of the oral DRUGN , DRUGB , or its derivatives .
Warfarin	drug	warfarin	drug
false

DRUGN : DRUGA may enhance the effects of the oral DRUGB , DRUGN , or its derivatives .
Quinolones	group	anticoagulant	group
effect

DRUGN : DRUGA may enhance the effects of the oral DRUGN , DRUGB , or its derivatives .
Quinolones	group	warfarin	drug
effect

DRUGN : DRUGN may enhance the effects of the oral DRUGA , DRUGB , or its derivatives .
anticoagulant	group	warfarin	drug
false

However , no clinically or statistically significant differences in prothrombin time ratio or DRUGA enantiomer pharmacokinetics were observed in a small study of dgb healthy males who received both DRUGN and DRUGB under steady state conditions .
warfarin	drug	lomefloxacin	drug
false

However , no clinically or statistically significant differences in prothrombin time ratio or DRUGN enantiomer pharmacokinetics were observed in a small study of dgb healthy males who received both DRUGA and DRUGB under steady state conditions .
warfarin	drug	lomefloxacin	drug
false

DRUGA : As with other DRUGB , renal excretion of DRUGN is inhibited by DRUGN and resulted in an approximate dgb % increase in the AUC for DRUGN .
Probenecid	drug	b-lactam antibiotics	group
false

DRUGA : As with other DRUGN , renal excretion of DRUGB is inhibited by DRUGN and resulted in an approximate dgb % increase in the AUC for DRUGN .
Probenecid	drug	loracarbef	drug
false

DRUGA : As with other DRUGN , renal excretion of DRUGN is inhibited by DRUGB and resulted in an approximate dgb % increase in the AUC for DRUGN .
Probenecid	drug	probenecid	drug
false

DRUGA : As with other DRUGN , renal excretion of DRUGN is inhibited by DRUGN and resulted in an approximate dgb % increase in the AUC for DRUGB .
Probenecid	drug	loracarbef	drug
false

DRUGN : As with other DRUGA , renal excretion of DRUGB is inhibited by DRUGN and resulted in an approximate dgb % increase in the AUC for DRUGN .
b-lactam antibiotics	group	loracarbef	drug
false

DRUGN : As with other DRUGA , renal excretion of DRUGN is inhibited by DRUGB and resulted in an approximate dgb % increase in the AUC for DRUGN .
b-lactam antibiotics	group	probenecid	drug
mechanism

DRUGN : As with other DRUGA , renal excretion of DRUGN is inhibited by DRUGN and resulted in an approximate dgb % increase in the AUC for DRUGB .
b-lactam antibiotics	group	loracarbef	drug
false

DRUGN : As with other DRUGN , renal excretion of DRUGA is inhibited by DRUGB and resulted in an approximate dgb % increase in the AUC for DRUGN .
loracarbef	drug	probenecid	drug
mechanism

DRUGN : As with other DRUGN , renal excretion of DRUGN is inhibited by DRUGA and resulted in an approximate dgb % increase in the AUC for DRUGB .
probenecid	drug	loracarbef	drug
false

DRUGA ( dgb mg once daily ) has been coadministered with therapeutic doses of DRUGB , DRUGN , and DRUGN in controlled clinical pharmacology studies in adult volunteers .
Loratadine	drug	erythromycin	drug
false

DRUGA ( dgb mg once daily ) has been coadministered with therapeutic doses of DRUGN , DRUGB , and DRUGN in controlled clinical pharmacology studies in adult volunteers .
Loratadine	drug	cimetidine	drug
false

DRUGA ( dgb mg once daily ) has been coadministered with therapeutic doses of DRUGN , DRUGN , and DRUGB in controlled clinical pharmacology studies in adult volunteers .
Loratadine	drug	ketoconazole	drug
false

DRUGN ( dgb mg once daily ) has been coadministered with therapeutic doses of DRUGA , DRUGB , and DRUGN in controlled clinical pharmacology studies in adult volunteers .
erythromycin	drug	cimetidine	drug
false

DRUGN ( dgb mg once daily ) has been coadministered with therapeutic doses of DRUGA , DRUGN , and DRUGB in controlled clinical pharmacology studies in adult volunteers .
erythromycin	drug	ketoconazole	drug
false

DRUGN ( dgb mg once daily ) has been coadministered with therapeutic doses of DRUGN , DRUGA , and DRUGB in controlled clinical pharmacology studies in adult volunteers .
cimetidine	drug	ketoconazole	drug
false

No effects on plasma concentrations of DRUGA or DRUGB were observed .
cimetidine	drug	ketoconazole	drug
false

Plasma concentrations ( AUC dgb dgb hrs ) of DRUGA decreased dgb % with coadministration of DRUGB relative to that observed with DRUGN alone .
erythromycin	drug	loratadine	drug
mechanism

Plasma concentrations ( AUC dgb dgb hrs ) of DRUGN decreased dgb % with coadministration of DRUGA relative to that observed with DRUGB alone .
loratadine	drug	erythromycin	drug
false

TABLE dgb Effects on Plasma Concentrations ( AUC dgb dgb hrs ) of DRUGA and DRUGB After dgb Days of Coadministration ( DRUGN dgb mg ) in Normal Volunteers
Loratadine	drug	Descarboethoxyloratadine	drug
false

TABLE dgb Effects on Plasma Concentrations ( AUC dgb dgb hrs ) of DRUGN and DRUGA After dgb Days of Coadministration ( DRUGB dgb mg ) in Normal Volunteers
Descarboethoxyloratadine	drug	Loratadine	drug
false

DRUGA DRUGB
Loratadine	drug	Descarboethoxyloratadine	drug
false

There does not appear to be an increase in adverse events in subjects who received oral DRUGA and DRUGB .
contraceptives	group	loratadine	drug
false

Tablets : The DRUGA , including DRUGB , produce CNS depressant effects when administered with such medications as DRUGN or DRUGN .
benzodiazepines	group	lorazepam	drug
false

Tablets : The DRUGA , including DRUGN , produce CNS depressant effects when administered with such medications as DRUGB or DRUGN .
benzodiazepines	group	barbiturates	group
effect

Tablets : The DRUGA , including DRUGN , produce CNS depressant effects when administered with such medications as DRUGN or DRUGB .
benzodiazepines	group	alcohol	drug
effect

Tablets : The DRUGN , including DRUGA , produce CNS depressant effects when administered with such medications as DRUGB or DRUGN .
lorazepam	drug	barbiturates	group
effect

Tablets : The DRUGN , including DRUGA , produce CNS depressant effects when administered with such medications as DRUGN or DRUGB .
lorazepam	drug	alcohol	drug
effect

Tablets : The DRUGN , including DRUGN , produce CNS depressant effects when administered with such medications as DRUGA or DRUGB .
barbiturates	group	alcohol	drug
false

No significant drug drug pharmacokinetic interactions have been found in interaction studies with DRUGA , DRUGB , DRUGN , DRUGN and DRUGN .
hydrochlorothiazide	drug	digoxin	drug
false

No significant drug drug pharmacokinetic interactions have been found in interaction studies with DRUGA , DRUGN , DRUGB , DRUGN and DRUGN .
hydrochlorothiazide	drug	warfarin	drug
false

No significant drug drug pharmacokinetic interactions have been found in interaction studies with DRUGA , DRUGN , DRUGN , DRUGB and DRUGN .
hydrochlorothiazide	drug	cimetidine	drug
false

No significant drug drug pharmacokinetic interactions have been found in interaction studies with DRUGA , DRUGN , DRUGN , DRUGN and DRUGB .
hydrochlorothiazide	drug	phenobarbital	drug
false

No significant drug drug pharmacokinetic interactions have been found in interaction studies with DRUGN , DRUGA , DRUGB , DRUGN and DRUGN .
digoxin	drug	warfarin	drug
false

No significant drug drug pharmacokinetic interactions have been found in interaction studies with DRUGN , DRUGA , DRUGN , DRUGB and DRUGN .
digoxin	drug	cimetidine	drug
false

No significant drug drug pharmacokinetic interactions have been found in interaction studies with DRUGN , DRUGA , DRUGN , DRUGN and DRUGB .
digoxin	drug	phenobarbital	drug
false

No significant drug drug pharmacokinetic interactions have been found in interaction studies with DRUGN , DRUGN , DRUGA , DRUGB and DRUGN .
warfarin	drug	cimetidine	drug
false

No significant drug drug pharmacokinetic interactions have been found in interaction studies with DRUGN , DRUGN , DRUGA , DRUGN and DRUGB .
warfarin	drug	phenobarbital	drug
false

No significant drug drug pharmacokinetic interactions have been found in interaction studies with DRUGN , DRUGN , DRUGN , DRUGA and DRUGB .
cimetidine	drug	phenobarbital	drug
false

DRUGA , an inducer of drug metabolism , decreased the concentrations of DRUGB and its active metabolite .
Rifampin	drug	losartan	drug
mechanism

DRUGA did not affect the conversion of DRUGB to the active metabolite after intravenous administration of DRUGN , and DRUGN had no clinically significant effect after oral administration .
Ketoconazole	drug	losartan	drug
false

DRUGA did not affect the conversion of DRUGN to the active metabolite after intravenous administration of DRUGB , and DRUGN had no clinically significant effect after oral administration .
Ketoconazole	drug	losartan	drug
false

DRUGA did not affect the conversion of DRUGN to the active metabolite after intravenous administration of DRUGN , and DRUGB had no clinically significant effect after oral administration .
Ketoconazole	drug	erythromycin	drug
false

DRUGN did not affect the conversion of DRUGA to the active metabolite after intravenous administration of DRUGN , and DRUGB had no clinically significant effect after oral administration .
losartan	drug	erythromycin	drug
false

DRUGN did not affect the conversion of DRUGN to the active metabolite after intravenous administration of DRUGA , and DRUGB had no clinically significant effect after oral administration .
losartan	drug	erythromycin	drug
false

DRUGA , an inhibitor of Pdgb dgbCdgb , decreased active metabolite concentration and increased DRUGB concentration .
Fluconazole	drug	losartan	drug
mechanism

As with other DRUGA , the antihypertensive effect of DRUGB may be blunted by the DRUGN DRUGN
antihypertensive agents	group	losartan	drug
false

As with other DRUGA , the antihypertensive effect of DRUGN may be blunted by the DRUGB DRUGN
antihypertensive agents	group	non-steroidal anti-inflammatory drug	group
false

As with other DRUGA , the antihypertensive effect of DRUGN may be blunted by the DRUGN DRUGB
antihypertensive agents	group	indomethacin	drug
false

As with other DRUGN , the antihypertensive effect of DRUGA may be blunted by the DRUGB DRUGN
losartan	drug	non-steroidal anti-inflammatory drug	group
false

As with other DRUGN , the antihypertensive effect of DRUGA may be blunted by the DRUGN DRUGB
losartan	drug	indomethacin	drug
effect

As with other DRUGN , the antihypertensive effect of DRUGN may be blunted by the DRUGA DRUGB
non-steroidal anti-inflammatory drug	group	indomethacin	drug
false

DRUGA DRUGB DRUGN DRUGN DRUGN DRUGN DRUGN DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Itraconazole	drug	Ketoconazole	drug
false

DRUGA DRUGN DRUGB DRUGN DRUGN DRUGN DRUGN DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Itraconazole	drug	Erythromycin	drug
false

DRUGA DRUGN DRUGN DRUGB DRUGN DRUGN DRUGN DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Itraconazole	drug	Clarithromycin	drug
false

DRUGA DRUGN DRUGN DRUGN DRUGB DRUGN DRUGN DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Itraconazole	drug	Telithromycin	drug
false

DRUGA DRUGN DRUGN DRUGN DRUGN DRUGB DRUGN DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Itraconazole	drug	HIV protease inhibitors	group
false

DRUGA DRUGN DRUGN DRUGN DRUGN DRUGN DRUGB DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Itraconazole	drug	Nefazodone	drug
false

DRUGA DRUGN DRUGN DRUGN DRUGN DRUGN DRUGN DRUGB Large quantities of grapefruit juice ( dgb quart daily )
Itraconazole	drug	Cyclosporine	drug
false

DRUGN DRUGA DRUGB DRUGN DRUGN DRUGN DRUGN DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Ketoconazole	drug	Erythromycin	drug
false

DRUGN DRUGA DRUGN DRUGB DRUGN DRUGN DRUGN DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Ketoconazole	drug	Clarithromycin	drug
false

DRUGN DRUGA DRUGN DRUGN DRUGB DRUGN DRUGN DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Ketoconazole	drug	Telithromycin	drug
false

DRUGN DRUGA DRUGN DRUGN DRUGN DRUGB DRUGN DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Ketoconazole	drug	HIV protease inhibitors	group
false

DRUGN DRUGA DRUGN DRUGN DRUGN DRUGN DRUGB DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Ketoconazole	drug	Nefazodone	drug
false

DRUGN DRUGA DRUGN DRUGN DRUGN DRUGN DRUGN DRUGB Large quantities of grapefruit juice ( dgb quart daily )
Ketoconazole	drug	Cyclosporine	drug
false

DRUGN DRUGN DRUGA DRUGB DRUGN DRUGN DRUGN DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Erythromycin	drug	Clarithromycin	drug
false

DRUGN DRUGN DRUGA DRUGN DRUGB DRUGN DRUGN DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Erythromycin	drug	Telithromycin	drug
false

DRUGN DRUGN DRUGA DRUGN DRUGN DRUGB DRUGN DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Erythromycin	drug	HIV protease inhibitors	group
false

DRUGN DRUGN DRUGA DRUGN DRUGN DRUGN DRUGB DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Erythromycin	drug	Nefazodone	drug
false

DRUGN DRUGN DRUGA DRUGN DRUGN DRUGN DRUGN DRUGB Large quantities of grapefruit juice ( dgb quart daily )
Erythromycin	drug	Cyclosporine	drug
false

DRUGN DRUGN DRUGN DRUGA DRUGB DRUGN DRUGN DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Clarithromycin	drug	Telithromycin	drug
false

DRUGN DRUGN DRUGN DRUGA DRUGN DRUGB DRUGN DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Clarithromycin	drug	HIV protease inhibitors	group
false

DRUGN DRUGN DRUGN DRUGA DRUGN DRUGN DRUGB DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Clarithromycin	drug	Nefazodone	drug
false

DRUGN DRUGN DRUGN DRUGA DRUGN DRUGN DRUGN DRUGB Large quantities of grapefruit juice ( dgb quart daily )
Clarithromycin	drug	Cyclosporine	drug
false

DRUGN DRUGN DRUGN DRUGN DRUGA DRUGB DRUGN DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Telithromycin	drug	HIV protease inhibitors	group
false

DRUGN DRUGN DRUGN DRUGN DRUGA DRUGN DRUGB DRUGN Large quantities of grapefruit juice ( dgb quart daily )
Telithromycin	drug	Nefazodone	drug
false

DRUGN DRUGN DRUGN DRUGN DRUGA DRUGN DRUGN DRUGB Large quantities of grapefruit juice ( dgb quart daily )
Telithromycin	drug	Cyclosporine	drug
false

DRUGN DRUGN DRUGN DRUGN DRUGN DRUGA DRUGB DRUGN Large quantities of grapefruit juice ( dgb quart daily )
HIV protease inhibitors	group	Nefazodone	drug
false

DRUGN DRUGN DRUGN DRUGN DRUGN DRUGA DRUGN DRUGB Large quantities of grapefruit juice ( dgb quart daily )
HIV protease inhibitors	group	Cyclosporine	drug
false

DRUGN DRUGN DRUGN DRUGN DRUGN DRUGN DRUGA DRUGB Large quantities of grapefruit juice ( dgb quart daily )
Nefazodone	drug	Cyclosporine	drug
false

DRUGA Other DRUGB DRUGN ( DRUGN ) ( =dgb g / day )
Gemfibrozil	drug	fibrates	group
false

DRUGA Other DRUGN DRUGB ( DRUGN ) ( =dgb g / day )
Gemfibrozil	drug	Niacin	drug
false

DRUGA Other DRUGN DRUGN ( DRUGB ) ( =dgb g / day )
Gemfibrozil	drug	nicotinic acid	drug
false

DRUGN Other DRUGA DRUGB ( DRUGN ) ( =dgb g / day )
fibrates	group	Niacin	drug
false

DRUGN Other DRUGA DRUGN ( DRUGB ) ( =dgb g / day )
fibrates	group	nicotinic acid	drug
false

DRUGN Other DRUGN DRUGA ( DRUGB ) ( =dgb g / day )
Niacin	drug	nicotinic acid	drug
false

DRUGA : The risk of myopathy / rhabdomyolysis is increased by concomitant administration of DRUGB particularly with higher doses of DRUGN ( see WARNINGS , Myopathy / Rhabdomyolysis ) .
Danazol	drug	danazol	drug
false

DRUGA : The risk of myopathy / rhabdomyolysis is increased by concomitant administration of DRUGN particularly with higher doses of DRUGB ( see WARNINGS , Myopathy / Rhabdomyolysis ) .
Danazol	drug	lovastatin	drug
false

DRUGN : The risk of myopathy / rhabdomyolysis is increased by concomitant administration of DRUGA particularly with higher doses of DRUGB ( see WARNINGS , Myopathy / Rhabdomyolysis ) .
danazol	drug	lovastatin	drug
effect

DRUGA or DRUGB : The risk of myopathy / rhabdomyolysis is increased when either DRUGN or DRUGN is used concomitantly with a closely related member of the DRUGN ( see WARNINGS , Myopathy / Rhabdomyolysis ) .
Amiodarone	drug	Verapamil	drug
false

DRUGA or DRUGN : The risk of myopathy / rhabdomyolysis is increased when either DRUGB or DRUGN is used concomitantly with a closely related member of the DRUGN ( see WARNINGS , Myopathy / Rhabdomyolysis ) .
Amiodarone	drug	amiodarone	drug
false

DRUGA or DRUGN : The risk of myopathy / rhabdomyolysis is increased when either DRUGN or DRUGB is used concomitantly with a closely related member of the DRUGN ( see WARNINGS , Myopathy / Rhabdomyolysis ) .
Amiodarone	drug	verapamil	drug
false

DRUGA or DRUGN : The risk of myopathy / rhabdomyolysis is increased when either DRUGN or DRUGN is used concomitantly with a closely related member of the DRUGB ( see WARNINGS , Myopathy / Rhabdomyolysis ) .
Amiodarone	drug	HMG-CoA reductase inhibitor class	group
false

DRUGN or DRUGA : The risk of myopathy / rhabdomyolysis is increased when either DRUGB or DRUGN is used concomitantly with a closely related member of the DRUGN ( see WARNINGS , Myopathy / Rhabdomyolysis ) .
Verapamil	drug	amiodarone	drug
false

DRUGN or DRUGA : The risk of myopathy / rhabdomyolysis is increased when either DRUGN or DRUGB is used concomitantly with a closely related member of the DRUGN ( see WARNINGS , Myopathy / Rhabdomyolysis ) .
Verapamil	drug	verapamil	drug
false

DRUGN or DRUGA : The risk of myopathy / rhabdomyolysis is increased when either DRUGN or DRUGN is used concomitantly with a closely related member of the DRUGB ( see WARNINGS , Myopathy / Rhabdomyolysis ) .
Verapamil	drug	HMG-CoA reductase inhibitor class	group
false

DRUGN or DRUGN : The risk of myopathy / rhabdomyolysis is increased when either DRUGA or DRUGB is used concomitantly with a closely related member of the DRUGN ( see WARNINGS , Myopathy / Rhabdomyolysis ) .
amiodarone	drug	verapamil	drug
false

DRUGN or DRUGN : The risk of myopathy / rhabdomyolysis is increased when either DRUGA or DRUGN is used concomitantly with a closely related member of the DRUGB ( see WARNINGS , Myopathy / Rhabdomyolysis ) .
amiodarone	drug	HMG-CoA reductase inhibitor class	group
effect

DRUGN or DRUGN : The risk of myopathy / rhabdomyolysis is increased when either DRUGN or DRUGA is used concomitantly with a closely related member of the DRUGB ( see WARNINGS , Myopathy / Rhabdomyolysis ) .
verapamil	drug	HMG-CoA reductase inhibitor class	group
effect

DRUGA s : In a small clinical trial in which DRUGB was administered to DRUGN treated patients , no effect on prothrombin time was detected .
Coumarin Anticoagulant	group	lovastatin	drug
false

DRUGA s : In a small clinical trial in which DRUGN was administered to DRUGB treated patients , no effect on prothrombin time was detected .
Coumarin Anticoagulant	group	warfarin	drug
false

DRUGN s : In a small clinical trial in which DRUGA was administered to DRUGB treated patients , no effect on prothrombin time was detected .
lovastatin	drug	warfarin	drug
false

However , another DRUGA has been found to produce a less than two second increase in prothrombin time in healthy volunteers receiving low doses of DRUGB .
HMG-CoA reductase inhibitor	group	warfarin	drug
effect

Also , bleeding and / or increased prothrombin time have been reported in a few patients taking DRUGA s concomitantly with DRUGB .
coumarin anticoagulant	group	lovastatin	drug
effect

It is recommended that in patients taking DRUGA , prothrombin time be determined before starting DRUGB and frequently enough during early therapy to insure that no significant alteration of prothrombin time occurs .
anticoagulants	group	lovastatin	drug
advise

DRUGA therapy has not been associated with bleeding or with changes in prothrombin time in patients not taking DRUGB .
Lovastatin	drug	anticoagulants	group
false

DRUGA : In normal volunteers , there was no clinically significant pharmacokinetic or pharmacodynamic interaction with concomitant administration of single doses of DRUGB and DRUGN .
Propranolol	drug	lovastatin	drug
false

DRUGA : In normal volunteers , there was no clinically significant pharmacokinetic or pharmacodynamic interaction with concomitant administration of single doses of DRUGN and DRUGB .
Propranolol	drug	propranolol	drug
false

DRUGN : In normal volunteers , there was no clinically significant pharmacokinetic or pharmacodynamic interaction with concomitant administration of single doses of DRUGA and DRUGB .
lovastatin	drug	propranolol	drug
false

DRUGA : In patients with hypercholesterolemia , concomitant administration of DRUGB and DRUGN resulted in no effect on DRUGN plasma concentrations .
Digoxin	drug	lovastatin	drug
false

DRUGA : In patients with hypercholesterolemia , concomitant administration of DRUGN and DRUGB resulted in no effect on DRUGN plasma concentrations .
Digoxin	drug	digoxin	drug
false

DRUGA : In patients with hypercholesterolemia , concomitant administration of DRUGN and DRUGN resulted in no effect on DRUGB plasma concentrations .
Digoxin	drug	digoxin	drug
false

DRUGN : In patients with hypercholesterolemia , concomitant administration of DRUGA and DRUGB resulted in no effect on DRUGN plasma concentrations .
lovastatin	drug	digoxin	drug
false

DRUGN : In patients with hypercholesterolemia , concomitant administration of DRUGA and DRUGN resulted in no effect on DRUGB plasma concentrations .
lovastatin	drug	digoxin	drug
false

Oral DRUGA : In pharmacokinetic studies of DRUGB in hypercholesterolemic noninsulin dependent diabetic patients , there was no drug interaction with DRUGN or with DRUGN
Hypoglycemic Agents	group	MEVACOR	brand
false

Oral DRUGA : In pharmacokinetic studies of DRUGN in hypercholesterolemic noninsulin dependent diabetic patients , there was no drug interaction with DRUGB or with DRUGN
Hypoglycemic Agents	group	glipizide	drug
false

Oral DRUGA : In pharmacokinetic studies of DRUGN in hypercholesterolemic noninsulin dependent diabetic patients , there was no drug interaction with DRUGN or with DRUGB
Hypoglycemic Agents	group	chlorpropamide	drug
false

Oral DRUGN : In pharmacokinetic studies of DRUGA in hypercholesterolemic noninsulin dependent diabetic patients , there was no drug interaction with DRUGB or with DRUGN
MEVACOR	brand	glipizide	drug
false

Oral DRUGN : In pharmacokinetic studies of DRUGA in hypercholesterolemic noninsulin dependent diabetic patients , there was no drug interaction with DRUGN or with DRUGB
MEVACOR	brand	chlorpropamide	drug
false

Oral DRUGN : In pharmacokinetic studies of DRUGN in hypercholesterolemic noninsulin dependent diabetic patients , there was no drug interaction with DRUGA or with DRUGB
glipizide	drug	chlorpropamide	drug
false

There have been rare reports of significant respiratory depression , stupor and / or hypotension with the concomitant use of DRUGA and DRUGB .
loxapine	drug	lorazepam	drug
effect

The absorption of DRUGA may be affected by the simultaneous administration of indigestion remedies , DRUGB or DRUGN supplements .
lymecycline	drug	iron	drug
mechanism

The absorption of DRUGA may be affected by the simultaneous administration of indigestion remedies , DRUGN or DRUGB supplements .
lymecycline	drug	zinc	drug
mechanism

The absorption of DRUGN may be affected by the simultaneous administration of indigestion remedies , DRUGA or DRUGB supplements .
iron	drug	zinc	drug
false

Oral DRUGA may be less effective while you are taking DRUGB .
contraceptives	group	lymecycline	drug
effect

DRUGA : DRUGB enhances the effect of DRUGN .
Warfarin	drug	Meclofenamate sodium	drug
effect

DRUGA : DRUGN enhances the effect of DRUGB .
Warfarin	drug	warfarin	drug
false

DRUGN : DRUGA enhances the effect of DRUGB .
Meclofenamate sodium	drug	warfarin	drug
false

Therefore , when DRUGA is given to a patient receiving DRUGB , the dosage of DRUGN should be reduced to prevent excessive prolongation of the prothrombin time .
meclofenamate sodium	drug	warfarin	drug
advise

Therefore , when DRUGA is given to a patient receiving DRUGN , the dosage of DRUGB should be reduced to prevent excessive prolongation of the prothrombin time .
meclofenamate sodium	drug	warfarin	drug
false

DRUGA : Concurrent administration of DRUGB may lower DRUGN plasma levels , possibly by competing for protein binding sites .
Aspirin	brand	aspirin	brand
false

DRUGA : Concurrent administration of DRUGN may lower DRUGB plasma levels , possibly by competing for protein binding sites .
Aspirin	brand	meclofenamate sodium	drug
false

DRUGN : Concurrent administration of DRUGA may lower DRUGB plasma levels , possibly by competing for protein binding sites .
aspirin	brand	meclofenamate sodium	drug
mechanism

The urinary excretion of DRUGA is unaffected by DRUGB , indicating no change in DRUGN absorption .
meclofenamate sodium	drug	aspirin	brand
false

The urinary excretion of DRUGN is unaffected by DRUGA , indicating no change in DRUGB absorption .
aspirin	brand	meclofenamate sodium	drug
false

DRUGA does not affect serum DRUGB levels .
Meclofenamate sodium	drug	salicylate	group
false

DRUGA : The concurrent administration of DRUGB does not affect the bioavailability of DRUGN .
Propoxyphene	drug	propoxyphene hydrochloride	drug
false

DRUGA : The concurrent administration of DRUGN does not affect the bioavailability of DRUGB .
Propoxyphene	drug	meclofenamate sodium	drug
false

DRUGN : The concurrent administration of DRUGA does not affect the bioavailability of DRUGB .
propoxyphene hydrochloride	drug	meclofenamate sodium	drug
false

DRUGA : Concomitant administration of DRUGB and DRUGN s does not interfere with absorption of DRUGN .
Antacids	group	aluminum hydroxide	drug
false

DRUGA : Concomitant administration of DRUGN and DRUGB s does not interfere with absorption of DRUGN .
Antacids	group	magnesium hydroxide	drug
false

DRUGA : Concomitant administration of DRUGN and DRUGN s does not interfere with absorption of DRUGB .
Antacids	group	meclofenamate sodium	drug
false

DRUGN : Concomitant administration of DRUGA and DRUGB s does not interfere with absorption of DRUGN .
aluminum hydroxide	drug	magnesium hydroxide	drug
false

DRUGN : Concomitant administration of DRUGA and DRUGN s does not interfere with absorption of DRUGB .
aluminum hydroxide	drug	meclofenamate sodium	drug
false

DRUGN : Concomitant administration of DRUGN and DRUGA s does not interfere with absorption of DRUGB .
magnesium hydroxide	drug	meclofenamate sodium	drug
false

DRUGA : As with other DRUGB , concomitant administration of DRUGN and DRUGN is not generally recommended because of the potential of increased adverse effects .
Aspirin	brand	NSAIDs	group
false

DRUGA : As with other DRUGN , concomitant administration of DRUGB and DRUGN is not generally recommended because of the potential of increased adverse effects .
Aspirin	brand	Ponstel	brand
false

DRUGA : As with other DRUGN , concomitant administration of DRUGN and DRUGB is not generally recommended because of the potential of increased adverse effects .
Aspirin	brand	aspirin	brand
false

DRUGN : As with other DRUGA , concomitant administration of DRUGB and DRUGN is not generally recommended because of the potential of increased adverse effects .
NSAIDs	group	Ponstel	brand
false

DRUGN : As with other DRUGA , concomitant administration of DRUGN and DRUGB is not generally recommended because of the potential of increased adverse effects .
NSAIDs	group	aspirin	brand
advise

DRUGN : As with other DRUGN , concomitant administration of DRUGA and DRUGB is not generally recommended because of the potential of increased adverse effects .
Ponstel	brand	aspirin	brand
advise

DRUGA : DRUGB have been reported to competitively inhibit DRUGN accumulation in rabbit kidney slices .
Methotrexate	drug	NSAIDs	group
false

DRUGA : DRUGN have been reported to competitively inhibit DRUGB accumulation in rabbit kidney slices .
Methotrexate	drug	methotrexate	drug
false

DRUGN : DRUGA have been reported to competitively inhibit DRUGB accumulation in rabbit kidney slices .
NSAIDs	group	methotrexate	drug
mechanism

Caution should be used when DRUGA are administered concomitantly with DRUGB .
NSAIDs	group	methotrexate	drug
advise

DRUGA : Reports suggest that DRUGB may diminish the antihypertensive effect of DRUGN .
ACE inhibitors	group	NSAIDs	group
false

DRUGN : Reports suggest that DRUGA may diminish the antihypertensive effect of DRUGB .
NSAIDs	group	ACE inhibitors	group
effect

This interaction should be given consideration in patients taking DRUGA concomitantly with DRUGB .
NSAIDs	group	ACE inhibitors	group
advise

DRUGA : Clinical studies , as well as post marketing observations , have shown that DRUGB can reduce the natriuretic effect of DRUGN and DRUGN in some patients .
Furosemide	drug	NSAIDs	group
false

DRUGA : Clinical studies , as well as post marketing observations , have shown that DRUGN can reduce the natriuretic effect of DRUGB and DRUGN in some patients .
Furosemide	drug	furosemide	drug
false

DRUGA : Clinical studies , as well as post marketing observations , have shown that DRUGN can reduce the natriuretic effect of DRUGN and DRUGB in some patients .
Furosemide	drug	thiazides	group
false

DRUGN : Clinical studies , as well as post marketing observations , have shown that DRUGA can reduce the natriuretic effect of DRUGB and DRUGN in some patients .
NSAIDs	group	furosemide	drug
effect

DRUGN : Clinical studies , as well as post marketing observations , have shown that DRUGA can reduce the natriuretic effect of DRUGN and DRUGB in some patients .
NSAIDs	group	thiazides	group
effect

DRUGN : Clinical studies , as well as post marketing observations , have shown that DRUGN can reduce the natriuretic effect of DRUGA and DRUGB in some patients .
furosemide	drug	thiazides	group
false

During concomitant therapy of DRUGA with DRUGB , the patient should be observed closely for signs of renal failure , as well as to assure diuretic efficacy .
Ponstel	brand	furosemide	drug
advise

DRUGA : DRUGB have produced an elevation of plasma DRUGN levels and a reduction in renal DRUGN clearance .
Lithium	drug	NSAIDs	group
false

DRUGA : DRUGN have produced an elevation of plasma DRUGB levels and a reduction in renal DRUGN clearance .
Lithium	drug	lithium	drug
false

DRUGA : DRUGN have produced an elevation of plasma DRUGN levels and a reduction in renal DRUGB clearance .
Lithium	drug	lithium	drug
false

DRUGN : DRUGA have produced an elevation of plasma DRUGB levels and a reduction in renal DRUGN clearance .
NSAIDs	group	lithium	drug
mechanism

DRUGN : DRUGA have produced an elevation of plasma DRUGN levels and a reduction in renal DRUGB clearance .
NSAIDs	group	lithium	drug
mechanism

Thus , when DRUGA and DRUGB are administered concurrently , subjects should be observed carefully for signs of DRUGN toxicity .
NSAIDs	group	lithium	drug
advise

Thus , when DRUGA and DRUGN are administered concurrently , subjects should be observed carefully for signs of DRUGB toxicity .
NSAIDs	group	lithium	drug
false

DRUGA : The effects of DRUGB and DRUGN on GI bleeding are synergistic , such that users of both drugs together have a risk of serious GI bleeding higher than users of either drug alone .
Warfarin	drug	warfarin	drug
false

DRUGA : The effects of DRUGN and DRUGB on GI bleeding are synergistic , such that users of both drugs together have a risk of serious GI bleeding higher than users of either drug alone .
Warfarin	drug	NSAIDs	group
false

DRUGN : The effects of DRUGA and DRUGB on GI bleeding are synergistic , such that users of both drugs together have a risk of serious GI bleeding higher than users of either drug alone .
warfarin	drug	NSAIDs	group
effect

There is one report of cardiopulmonary arrest , with full recovery , in a patient who was taking a DRUGA ( DRUGB ) .
beta blocker	group	propranolol	drug
false

Because of the danger of a potentially fatal prolongation of the QTc interval , DRUGA must not be given simultaneously with or subsequent to DRUGB .
halofantrine	drug	Mefloquine	drug
advise

Concomitant administration of DRUGA and other related compounds ( eg , DRUGB , DRUGN and DRUGN ) may produce electrocardiographic abnormalities and increase the risk of convulsions .
Mefloquine	drug	quinine	drug
effect

Concomitant administration of DRUGA and other related compounds ( eg , DRUGN , DRUGB and DRUGN ) may produce electrocardiographic abnormalities and increase the risk of convulsions .
Mefloquine	drug	quinidine	drug
effect

Concomitant administration of DRUGA and other related compounds ( eg , DRUGN , DRUGN and DRUGB ) may produce electrocardiographic abnormalities and increase the risk of convulsions .
Mefloquine	drug	chloroquine	drug
effect

Concomitant administration of DRUGN and other related compounds ( eg , DRUGA , DRUGB and DRUGN ) may produce electrocardiographic abnormalities and increase the risk of convulsions .
quinine	drug	quinidine	drug
false

Concomitant administration of DRUGN and other related compounds ( eg , DRUGA , DRUGN and DRUGB ) may produce electrocardiographic abnormalities and increase the risk of convulsions .
quinine	drug	chloroquine	drug
false

Concomitant administration of DRUGN and other related compounds ( eg , DRUGN , DRUGA and DRUGB ) may produce electrocardiographic abnormalities and increase the risk of convulsions .
quinidine	drug	chloroquine	drug
false

In patients taking an DRUGA ( eg , DRUGB , DRUGN , DRUGN or DRUGN ) , the concomitant use of DRUGN may reduce seizure control by lowering the plasma levels of the DRUGN .
anticonvulsant	group	valproic acid	drug
false

In patients taking an DRUGA ( eg , DRUGN , DRUGB , DRUGN or DRUGN ) , the concomitant use of DRUGN may reduce seizure control by lowering the plasma levels of the DRUGN .
anticonvulsant	group	carbamazepine	drug
false

In patients taking an DRUGA ( eg , DRUGN , DRUGN , DRUGB or DRUGN ) , the concomitant use of DRUGN may reduce seizure control by lowering the plasma levels of the DRUGN .
anticonvulsant	group	phenobarbital	drug
false

In patients taking an DRUGA ( eg , DRUGN , DRUGN , DRUGN or DRUGB ) , the concomitant use of DRUGN may reduce seizure control by lowering the plasma levels of the DRUGN .
anticonvulsant	group	phenytoin	drug
false

In patients taking an DRUGA ( eg , DRUGN , DRUGN , DRUGN or DRUGN ) , the concomitant use of DRUGB may reduce seizure control by lowering the plasma levels of the DRUGN .
anticonvulsant	group	Mefloquine	drug
effect

In patients taking an DRUGN ( eg , DRUGA , DRUGB , DRUGN or DRUGN ) , the concomitant use of DRUGN may reduce seizure control by lowering the plasma levels of the DRUGN .
valproic acid	drug	carbamazepine	drug
false

In patients taking an DRUGN ( eg , DRUGA , DRUGN , DRUGB or DRUGN ) , the concomitant use of DRUGN may reduce seizure control by lowering the plasma levels of the DRUGN .
valproic acid	drug	phenobarbital	drug
false

In patients taking an DRUGN ( eg , DRUGA , DRUGN , DRUGN or DRUGB ) , the concomitant use of DRUGN may reduce seizure control by lowering the plasma levels of the DRUGN .
valproic acid	drug	phenytoin	drug
false

In patients taking an DRUGN ( eg , DRUGA , DRUGN , DRUGN or DRUGN ) , the concomitant use of DRUGB may reduce seizure control by lowering the plasma levels of the DRUGN .
valproic acid	drug	Mefloquine	drug
effect

In patients taking an DRUGN ( eg , DRUGA , DRUGN , DRUGN or DRUGN ) , the concomitant use of DRUGN may reduce seizure control by lowering the plasma levels of the DRUGB .
valproic acid	drug	anticonvulsant	group
false

In patients taking an DRUGN ( eg , DRUGN , DRUGA , DRUGB or DRUGN ) , the concomitant use of DRUGN may reduce seizure control by lowering the plasma levels of the DRUGN .
carbamazepine	drug	phenobarbital	drug
false

In patients taking an DRUGN ( eg , DRUGN , DRUGA , DRUGN or DRUGB ) , the concomitant use of DRUGN may reduce seizure control by lowering the plasma levels of the DRUGN .
carbamazepine	drug	phenytoin	drug
false

In patients taking an DRUGN ( eg , DRUGN , DRUGA , DRUGN or DRUGN ) , the concomitant use of DRUGB may reduce seizure control by lowering the plasma levels of the DRUGN .
carbamazepine	drug	Mefloquine	drug
effect

In patients taking an DRUGN ( eg , DRUGN , DRUGA , DRUGN or DRUGN ) , the concomitant use of DRUGN may reduce seizure control by lowering the plasma levels of the DRUGB .
carbamazepine	drug	anticonvulsant	group
false

In patients taking an DRUGN ( eg , DRUGN , DRUGN , DRUGA or DRUGB ) , the concomitant use of DRUGN may reduce seizure control by lowering the plasma levels of the DRUGN .
phenobarbital	drug	phenytoin	drug
false

In patients taking an DRUGN ( eg , DRUGN , DRUGN , DRUGA or DRUGN ) , the concomitant use of DRUGB may reduce seizure control by lowering the plasma levels of the DRUGN .
phenobarbital	drug	Mefloquine	drug
effect

In patients taking an DRUGN ( eg , DRUGN , DRUGN , DRUGA or DRUGN ) , the concomitant use of DRUGN may reduce seizure control by lowering the plasma levels of the DRUGB .
phenobarbital	drug	anticonvulsant	group
false

In patients taking an DRUGN ( eg , DRUGN , DRUGN , DRUGN or DRUGA ) , the concomitant use of DRUGB may reduce seizure control by lowering the plasma levels of the DRUGN .
phenytoin	drug	Mefloquine	drug
effect

In patients taking an DRUGN ( eg , DRUGN , DRUGN , DRUGN or DRUGA ) , the concomitant use of DRUGN may reduce seizure control by lowering the plasma levels of the DRUGB .
phenytoin	drug	anticonvulsant	group
false

In patients taking an DRUGN ( eg , DRUGN , DRUGN , DRUGN or DRUGN ) , the concomitant use of DRUGA may reduce seizure control by lowering the plasma levels of the DRUGB .
Mefloquine	drug	anticonvulsant	group
false

When DRUGA is taken concurrently with oral DRUGB , attenuation of immunization can not be excluded .
Mefloquine	drug	live typhoid vaccines	group
effect

Nevertheless , the effects of DRUGA on travelers receiving comedication , particularly diabetics or patients using DRUGB , should be checked before departure .
Mefloquine	drug	anticoagulants	group
advise

In clinical trials , the concomitant administration of DRUGA and DRUGB did not alter the adverse reaction profile .
sulfadoxine	drug	pyrimethamine	drug
false

DRUGA DRUGB may sterilize the bowel and decrease the DRUGN contribution to the body by the intestinal microflora .
Broad-Spectrum Antibiotics	group	Broad-spectrum antibiotics	group
false

DRUGA DRUGN may sterilize the bowel and decrease the DRUGB contribution to the body by the intestinal microflora .
Broad-Spectrum Antibiotics	group	vitamin K	group
false

DRUGN DRUGA may sterilize the bowel and decrease the DRUGB contribution to the body by the intestinal microflora .
Broad-spectrum antibiotics	group	vitamin K	group
false

DRUGA DRUGN containing side chains of N methylthiotetrazole ( DRUGB , DRUGN , DRUGN , DRUGN , DRUGN ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
Cephalosporins	group	cefmenoxime	drug
false

DRUGA DRUGN containing side chains of N methylthiotetrazole ( DRUGN , DRUGB , DRUGN , DRUGN , DRUGN ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
Cephalosporins	group	cefoperazone	drug
false

DRUGA DRUGN containing side chains of N methylthiotetrazole ( DRUGN , DRUGN , DRUGB , DRUGN , DRUGN ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
Cephalosporins	group	cefotetan	drug
false

DRUGA DRUGN containing side chains of N methylthiotetrazole ( DRUGN , DRUGN , DRUGN , DRUGB , DRUGN ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
Cephalosporins	group	cefamandole	drug
false

DRUGA DRUGN containing side chains of N methylthiotetrazole ( DRUGN , DRUGN , DRUGN , DRUGN , DRUGB ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
Cephalosporins	group	latamoxef	drug
false

DRUGA DRUGN containing side chains of N methylthiotetrazole ( DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ) or methylthiadiazole ( DRUGB ) can cause vitamin K deficiency and hypoprothrombinemia .
Cephalosporins	group	cefazolin	drug
false

DRUGN DRUGA containing side chains of N methylthiotetrazole ( DRUGB , DRUGN , DRUGN , DRUGN , DRUGN ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
Cephalosporins	group	cefmenoxime	drug
false

DRUGN DRUGA containing side chains of N methylthiotetrazole ( DRUGN , DRUGB , DRUGN , DRUGN , DRUGN ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
Cephalosporins	group	cefoperazone	drug
false

DRUGN DRUGA containing side chains of N methylthiotetrazole ( DRUGN , DRUGN , DRUGB , DRUGN , DRUGN ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
Cephalosporins	group	cefotetan	drug
false

DRUGN DRUGA containing side chains of N methylthiotetrazole ( DRUGN , DRUGN , DRUGN , DRUGB , DRUGN ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
Cephalosporins	group	cefamandole	drug
false

DRUGN DRUGA containing side chains of N methylthiotetrazole ( DRUGN , DRUGN , DRUGN , DRUGN , DRUGB ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
Cephalosporins	group	latamoxef	drug
false

DRUGN DRUGA containing side chains of N methylthiotetrazole ( DRUGN , DRUGN , DRUGN , DRUGN , DRUGN ) or methylthiadiazole ( DRUGB ) can cause vitamin K deficiency and hypoprothrombinemia .
Cephalosporins	group	cefazolin	drug
false

DRUGN DRUGN containing side chains of N methylthiotetrazole ( DRUGA , DRUGB , DRUGN , DRUGN , DRUGN ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
cefmenoxime	drug	cefoperazone	drug
false

DRUGN DRUGN containing side chains of N methylthiotetrazole ( DRUGA , DRUGN , DRUGB , DRUGN , DRUGN ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
cefmenoxime	drug	cefotetan	drug
false

DRUGN DRUGN containing side chains of N methylthiotetrazole ( DRUGA , DRUGN , DRUGN , DRUGB , DRUGN ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
cefmenoxime	drug	cefamandole	drug
false

DRUGN DRUGN containing side chains of N methylthiotetrazole ( DRUGA , DRUGN , DRUGN , DRUGN , DRUGB ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
cefmenoxime	drug	latamoxef	drug
false

DRUGN DRUGN containing side chains of N methylthiotetrazole ( DRUGA , DRUGN , DRUGN , DRUGN , DRUGN ) or methylthiadiazole ( DRUGB ) can cause vitamin K deficiency and hypoprothrombinemia .
cefmenoxime	drug	cefazolin	drug
false

DRUGN DRUGN containing side chains of N methylthiotetrazole ( DRUGN , DRUGA , DRUGB , DRUGN , DRUGN ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
cefoperazone	drug	cefotetan	drug
false

DRUGN DRUGN containing side chains of N methylthiotetrazole ( DRUGN , DRUGA , DRUGN , DRUGB , DRUGN ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
cefoperazone	drug	cefamandole	drug
false

DRUGN DRUGN containing side chains of N methylthiotetrazole ( DRUGN , DRUGA , DRUGN , DRUGN , DRUGB ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
cefoperazone	drug	latamoxef	drug
false

DRUGN DRUGN containing side chains of N methylthiotetrazole ( DRUGN , DRUGA , DRUGN , DRUGN , DRUGN ) or methylthiadiazole ( DRUGB ) can cause vitamin K deficiency and hypoprothrombinemia .
cefoperazone	drug	cefazolin	drug
false

DRUGN DRUGN containing side chains of N methylthiotetrazole ( DRUGN , DRUGN , DRUGA , DRUGB , DRUGN ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
cefotetan	drug	cefamandole	drug
false

DRUGN DRUGN containing side chains of N methylthiotetrazole ( DRUGN , DRUGN , DRUGA , DRUGN , DRUGB ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
cefotetan	drug	latamoxef	drug
false

DRUGN DRUGN containing side chains of N methylthiotetrazole ( DRUGN , DRUGN , DRUGA , DRUGN , DRUGN ) or methylthiadiazole ( DRUGB ) can cause vitamin K deficiency and hypoprothrombinemia .
cefotetan	drug	cefazolin	drug
false

DRUGN DRUGN containing side chains of N methylthiotetrazole ( DRUGN , DRUGN , DRUGN , DRUGA , DRUGB ) or methylthiadiazole ( DRUGN ) can cause vitamin K deficiency and hypoprothrombinemia .
cefamandole	drug	latamoxef	drug
false

DRUGN DRUGN containing side chains of N methylthiotetrazole ( DRUGN , DRUGN , DRUGN , DRUGA , DRUGN ) or methylthiadiazole ( DRUGB ) can cause vitamin K deficiency and hypoprothrombinemia .
cefamandole	drug	cefazolin	drug
false

DRUGN DRUGN containing side chains of N methylthiotetrazole ( DRUGN , DRUGN , DRUGN , DRUGN , DRUGA ) or methylthiadiazole ( DRUGB ) can cause vitamin K deficiency and hypoprothrombinemia .
latamoxef	drug	cefazolin	drug
false

DRUGA Concomitant intake of DRUGB and DRUGN may reduce the absorption of DRUGN .
Cholestyramine	drug	cholestyramine	drug
false

DRUGA Concomitant intake of DRUGN and DRUGB may reduce the absorption of DRUGN .
Cholestyramine	drug	vitamin K	group
false

DRUGA Concomitant intake of DRUGN and DRUGN may reduce the absorption of DRUGB .
Cholestyramine	drug	vitamin K	group
false

DRUGN Concomitant intake of DRUGA and DRUGB may reduce the absorption of DRUGN .
cholestyramine	drug	vitamin K	group
mechanism

DRUGN Concomitant intake of DRUGA and DRUGN may reduce the absorption of DRUGB .
cholestyramine	drug	vitamin K	group
false

DRUGA Concomitant intake of DRUGB and DRUGN may reduce the absorption of DRUGN .
Colestipol	drug	colestipol	drug
false

DRUGA Concomitant intake of DRUGN and DRUGB may reduce the absorption of DRUGN .
Colestipol	drug	vitamin K	group
false

DRUGA Concomitant intake of DRUGN and DRUGN may reduce the absorption of DRUGB .
Colestipol	drug	vitamin K	group
false

DRUGN Concomitant intake of DRUGA and DRUGB may reduce the absorption of DRUGN .
colestipol	drug	vitamin K	group
mechanism

DRUGN Concomitant intake of DRUGA and DRUGN may reduce the absorption of DRUGB .
colestipol	drug	vitamin K	group
false

DRUGA Concomitant intake of DRUGB and DRUGN may reduce the absorption of DRUGN .
Mineral Oil	drug_n	mineral oil	drug_n
false

DRUGA Concomitant intake of DRUGN and DRUGB may reduce the absorption of DRUGN .
Mineral Oil	drug_n	vitamin K	group
false

DRUGA Concomitant intake of DRUGN and DRUGN may reduce the absorption of DRUGB .
Mineral Oil	drug_n	vitamin K	group
false

DRUGN Concomitant intake of DRUGA and DRUGB may reduce the absorption of DRUGN .
mineral oil	drug_n	vitamin K	group
mechanism

DRUGN Concomitant intake of DRUGA and DRUGN may reduce the absorption of DRUGB .
mineral oil	drug_n	vitamin K	group
false

DRUGA DRUGN may decrease the absorption of DRUGB .
Orlistat	drug	vitamin K	group
false

DRUGN DRUGA may decrease the absorption of DRUGB .
Orlistat	drug	vitamin K	group
mechanism

DRUGA DRUGB can antagonize the effect of DRUGN
Warfarin	drug	Vitamin K	group
false

DRUGA DRUGN can antagonize the effect of DRUGB
Warfarin	drug	warfarin	drug
false

DRUGN DRUGA can antagonize the effect of DRUGB
Vitamin K	group	warfarin	drug
effect

DRUGA has been shown to have an additive CNS depressant effect when given with either DRUGB , DRUGN , DRUGN or DRUGN .
Nabilone	drug	diazepam	drug
effect

DRUGA has been shown to have an additive CNS depressant effect when given with either DRUGN , DRUGB , DRUGN or DRUGN .
Nabilone	drug	secobarbitone sodium	brand
effect

DRUGA has been shown to have an additive CNS depressant effect when given with either DRUGN , DRUGN , DRUGB or DRUGN .
Nabilone	drug	alcohol	drug
effect

DRUGA has been shown to have an additive CNS depressant effect when given with either DRUGN , DRUGN , DRUGN or DRUGB .
Nabilone	drug	codeine	drug
effect

DRUGN has been shown to have an additive CNS depressant effect when given with either DRUGA , DRUGB , DRUGN or DRUGN .
diazepam	drug	secobarbitone sodium	brand
false

DRUGN has been shown to have an additive CNS depressant effect when given with either DRUGA , DRUGN , DRUGB or DRUGN .
diazepam	drug	alcohol	drug
false

DRUGN has been shown to have an additive CNS depressant effect when given with either DRUGA , DRUGN , DRUGN or DRUGB .
diazepam	drug	codeine	drug
false

DRUGN has been shown to have an additive CNS depressant effect when given with either DRUGN , DRUGA , DRUGB or DRUGN .
secobarbitone sodium	brand	alcohol	drug
false

DRUGN has been shown to have an additive CNS depressant effect when given with either DRUGN , DRUGA , DRUGN or DRUGB .
secobarbitone sodium	brand	codeine	drug
false

DRUGN has been shown to have an additive CNS depressant effect when given with either DRUGN , DRUGN , DRUGA or DRUGB .
alcohol	drug	codeine	drug
false

Caution should be exercised when administering DRUGA with DRUGB since interactions have been seen with other DRUGN .
nabumetone	drug	warfarin	drug
advise

Caution should be exercised when administering DRUGA with DRUGN since interactions have been seen with other DRUGB .
nabumetone	drug	NSAIDs	group
false

Caution should be exercised when administering DRUGN with DRUGA since interactions have been seen with other DRUGB .
warfarin	drug	NSAIDs	group
int

Concomitant administration of an DRUGA containing DRUGB had no significant effect in the bioavailability of DRUGN .
aluminum	drug	antacid	group
false

Concomitant administration of an DRUGA containing DRUGN had no significant effect in the bioavailability of DRUGB .
aluminum	drug	6MNA	drug_n
false

Concomitant administration of an DRUGN containing DRUGA had no significant effect in the bioavailability of DRUGB .
antacid	group	6MNA	drug_n
false

When administered concurrently , the following drugs may interact with DRUGA : DRUGB , general : exaggeration of the hypotension induced by general DRUGN .
beta-adrenergic receptor blocking agents	group	Anesthetics	group
int

When administered concurrently , the following drugs may interact with DRUGA : DRUGN , general : exaggeration of the hypotension induced by general DRUGB .
beta-adrenergic receptor blocking agents	group	anesthetics	group
false

When administered concurrently , the following drugs may interact with DRUGN : DRUGA , general : exaggeration of the hypotension induced by general DRUGB .
Anesthetics	group	anesthetics	group
false

DRUGA ( oral agents and DRUGB ) : hypoglycemia or hyperglycemia ;
Antidiabetic drugs	group	insulin	drug
false

DRUGA , a DRUGB , may antagonize the bactericidal effect of DRUGN and concurrent use of these drugs should be avoided .
Tetracycline	drug	bacteriostatic antibiotic	group
false

DRUGA , a DRUGN , may antagonize the bactericidal effect of DRUGB and concurrent use of these drugs should be avoided .
Tetracycline	drug	penicillin	drug
effect

DRUGN , a DRUGA , may antagonize the bactericidal effect of DRUGB and concurrent use of these drugs should be avoided .
bacteriostatic antibiotic	group	penicillin	drug
false

Elevated plasma levels of DRUGA have been reported with concomitant DRUGB use .
theophylline	drug	quinolone	group
mechanism

There have been reports of DRUGA related side effects in patients on concomitant therapy with DRUGB and DRUGN .
theophylline	drug	quinolones	group
false

There have been reports of DRUGN related side effects in patients on concomitant therapy with DRUGA and DRUGB .
quinolones	group	theophylline	drug
effect

DRUGA have been shown to interfere with the metabolism of DRUGB .
Quinolones	group	caffeine	drug
mechanism

DRUGA , including DRUGB , may enhance the effects of the oral DRUGN DRUGN or its derivatives .
Quinolones	group	nalidixic acid	drug
false

DRUGA , including DRUGN , may enhance the effects of the oral DRUGB DRUGN or its derivatives .
Quinolones	group	anticoagulant	group
false

DRUGA , including DRUGN , may enhance the effects of the oral DRUGN DRUGB or its derivatives .
Quinolones	group	warfarin	drug
effect

DRUGN , including DRUGA , may enhance the effects of the oral DRUGB DRUGN or its derivatives .
nalidixic acid	drug	anticoagulant	group
false

DRUGN , including DRUGA , may enhance the effects of the oral DRUGN DRUGB or its derivatives .
nalidixic acid	drug	warfarin	drug
effect

DRUGN , including DRUGN , may enhance the effects of the oral DRUGA DRUGB or its derivatives .
anticoagulant	group	warfarin	drug
false

DRUGA interferes with the therapeutic action of DRUGB .
Nitrofurantoin	drug	nalidixic acid	drug
effect

DRUGA containing DRUGB , DRUGN , or DRUGN ;
Antacids	group	magnesium	drug
false

DRUGA containing DRUGN , DRUGB , or DRUGN ;
Antacids	group	aluminum	drug
false

DRUGA containing DRUGN , DRUGN , or DRUGB ;
Antacids	group	calcium	drug
false

DRUGN containing DRUGA , DRUGB , or DRUGN ;
magnesium	drug	aluminum	drug
false

DRUGN containing DRUGA , DRUGN , or DRUGB ;
magnesium	drug	calcium	drug
false

DRUGN containing DRUGN , DRUGA , or DRUGB ;
aluminum	drug	calcium	drug
false

DRUGA or divalent or trivalent cations such as DRUGB ;
sucralfate	drug	iron	drug
false

DRUGA containing DRUGB ;
multivitamins	group	zinc	drug
false

and DRUGA , ( DRUGB ) , chewable / buffered tablets or the pediatric powder for oral solution may substantially interfere with the absorption of DRUGN , resulting in systemic levels considerably lower than desired .
Videx	brand	Didanosine	drug
false

and DRUGA , ( DRUGN ) , chewable / buffered tablets or the pediatric powder for oral solution may substantially interfere with the absorption of DRUGB , resulting in systemic levels considerably lower than desired .
Videx	brand	quinolones	group
mechanism

and DRUGN , ( DRUGA ) , chewable / buffered tablets or the pediatric powder for oral solution may substantially interfere with the absorption of DRUGB , resulting in systemic levels considerably lower than desired .
Didanosine	drug	quinolones	group
mechanism

Elevated serum levels of DRUGA have been reported with the concomitant use of some DRUGB and DRUGN .
cyclosporine	drug	quinolones	group
false

Elevated serum levels of DRUGN have been reported with the concomitant use of some DRUGA and DRUGB .
quinolones	group	cyclosporine	drug
mechanism

Studies to evaluate possible interactions between DRUGA and drugs other than DRUGB have not been performed .
REVIA	brand	opiates	group
false

The safety and efficacy of concomitant use of DRUGA and DRUGB is unknown , and the concomitant use of two potentially hepatotoxic medications is not ordinarily recommended unless the probable benefits outweigh the known risks .
REVIA	brand	disulfiram	drug
effect

Lethargy and somnolence have been reported following doses of DRUGA and DRUGB .
REVIA	brand	thioridazine	drug
effect

Patients taking DRUGA may not benefit from DRUGB containing medicines , such as cough and cold preparations , antidiarrheal preparations , and DRUGN .
REVIA	brand	opioid	group
effect

Patients taking DRUGA may not benefit from DRUGN containing medicines , such as cough and cold preparations , antidiarrheal preparations , and DRUGB .
REVIA	brand	opioid analgesics	group
effect

Patients taking DRUGN may not benefit from DRUGA containing medicines , such as cough and cold preparations , antidiarrheal preparations , and DRUGB .
opioid	group	opioid analgesics	group
false

In an emergency situation when opioid analgesia must be administered to a patient receiving DRUGA , the amount of DRUGB required may be greater than usual , and the resulting respiratory depression may be deeper and more prolonged .
REVIA	brand	opioid	group
effect

The use of DRUGA in patients who are receiving DRUGB may potentiate renal disease states .
NSAIDs	group	ACE inhibitors	group
effect

Similarly , patients receiving the drug and a DRUGA , DRUGB or DRUGN should be observed for signs of toxicity to these drugs .
hydantoin	group	sulfonamide	group
false

Similarly , patients receiving the drug and a DRUGA , DRUGN or DRUGB should be observed for signs of toxicity to these drugs .
hydantoin	group	sulfonylurea	group
false

Similarly , patients receiving the drug and a DRUGN , DRUGA or DRUGB should be observed for signs of toxicity to these drugs .
sulfonamide	group	sulfonylurea	group
false

Concomitant administration of DRUGA and DRUGB is not recommended because DRUGN is displaced from its binding sites during the concomitant administration of DRUGN , resulting in lower plasma concentrations and peak plasma levels .
naproxen	drug	aspirin	brand
advise

Concomitant administration of DRUGA and DRUGN is not recommended because DRUGN is displaced from its binding sites during the concomitant administration of DRUGB , resulting in lower plasma concentrations and peak plasma levels .
naproxen	drug	aspirin	brand
false

Concomitant administration of DRUGN and DRUGA is not recommended because DRUGB is displaced from its binding sites during the concomitant administration of DRUGN , resulting in lower plasma concentrations and peak plasma levels .
aspirin	brand	naproxen	drug
false

Concomitant administration of DRUGN and DRUGN is not recommended because DRUGA is displaced from its binding sites during the concomitant administration of DRUGB , resulting in lower plasma concentrations and peak plasma levels .
naproxen	drug	aspirin	brand
advise

DRUGA and other DRUGB can reduce the antihypertensive effect of DRUGN and other DRUGN .
Naproxen	drug	NSAIDs	group
false

DRUGA and other DRUGN can reduce the antihypertensive effect of DRUGB and other DRUGN .
Naproxen	drug	propranolol	drug
effect

DRUGA and other DRUGN can reduce the antihypertensive effect of DRUGN and other DRUGB .
Naproxen	drug	beta-blockers	group
effect

DRUGN and other DRUGA can reduce the antihypertensive effect of DRUGB and other DRUGN .
NSAIDs	group	propranolol	drug
effect

DRUGN and other DRUGA can reduce the antihypertensive effect of DRUGN and other DRUGB .
NSAIDs	group	beta-blockers	group
effect

DRUGN and other DRUGN can reduce the antihypertensive effect of DRUGA and other DRUGB .
propranolol	drug	beta-blockers	group
false

DRUGA given concurrently increases DRUGB anion plasma levels and extends its plasma half life significantly .
Probenecid	drug	naproxen	drug
mechanism

Caution should be used if DRUGA is administered concomitantly with DRUGB .
naproxen	drug	methotrexate	drug
advise

DRUGA , DRUGB and other DRUGN have been reported to reduce the tubular secretion of DRUGN in an animal model , possibly increasing the toxicity of DRUGN .
Naproxen	drug	naproxen sodium	drug
false

DRUGA , DRUGN and other DRUGB have been reported to reduce the tubular secretion of DRUGN in an animal model , possibly increasing the toxicity of DRUGN .
Naproxen	drug	NSAIDs	group
false

DRUGA , DRUGN and other DRUGN have been reported to reduce the tubular secretion of DRUGB in an animal model , possibly increasing the toxicity of DRUGN .
Naproxen	drug	methotrexate	drug
mechanism

DRUGA , DRUGN and other DRUGN have been reported to reduce the tubular secretion of DRUGN in an animal model , possibly increasing the toxicity of DRUGB .
Naproxen	drug	methotrexate	drug
false

DRUGN , DRUGA and other DRUGB have been reported to reduce the tubular secretion of DRUGN in an animal model , possibly increasing the toxicity of DRUGN .
naproxen sodium	drug	NSAIDs	group
false

DRUGN , DRUGA and other DRUGN have been reported to reduce the tubular secretion of DRUGB in an animal model , possibly increasing the toxicity of DRUGN .
naproxen sodium	drug	methotrexate	drug
mechanism

DRUGN , DRUGA and other DRUGN have been reported to reduce the tubular secretion of DRUGN in an animal model , possibly increasing the toxicity of DRUGB .
naproxen sodium	drug	methotrexate	drug
false

DRUGN , DRUGN and other DRUGA have been reported to reduce the tubular secretion of DRUGB in an animal model , possibly increasing the toxicity of DRUGN .
NSAIDs	group	methotrexate	drug
mechanism

DRUGN , DRUGN and other DRUGA have been reported to reduce the tubular secretion of DRUGN in an animal model , possibly increasing the toxicity of DRUGB .
NSAIDs	group	methotrexate	drug
false

Because there is a theoretical basis that these effects may be additive , use of DRUGA containing or DRUGB ( like DRUGN or DRUGN ) and DRUGN within dgb hours is contraindicated .
ergotamine	drug	ergot-type medications	group
false

Because there is a theoretical basis that these effects may be additive , use of DRUGA containing or DRUGN ( like DRUGB or DRUGN ) and DRUGN within dgb hours is contraindicated .
ergotamine	drug	dihydroergotamine	drug
false

Because there is a theoretical basis that these effects may be additive , use of DRUGA containing or DRUGN ( like DRUGN or DRUGB ) and DRUGN within dgb hours is contraindicated .
ergotamine	drug	methysergide	drug
false

Because there is a theoretical basis that these effects may be additive , use of DRUGA containing or DRUGN ( like DRUGN or DRUGN ) and DRUGB within dgb hours is contraindicated .
ergotamine	drug	naratriptan	drug
advise

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGA ( like DRUGB or DRUGN ) and DRUGN within dgb hours is contraindicated .
ergot-type medications	group	dihydroergotamine	drug
false

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGA ( like DRUGN or DRUGB ) and DRUGN within dgb hours is contraindicated .
ergot-type medications	group	methysergide	drug
false

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGA ( like DRUGN or DRUGN ) and DRUGB within dgb hours is contraindicated .
ergot-type medications	group	naratriptan	drug
advise

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGN ( like DRUGA or DRUGB ) and DRUGN within dgb hours is contraindicated .
dihydroergotamine	drug	methysergide	drug
false

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGN ( like DRUGA or DRUGN ) and DRUGB within dgb hours is contraindicated .
dihydroergotamine	drug	naratriptan	drug
advise

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGN ( like DRUGN or DRUGA ) and DRUGB within dgb hours is contraindicated .
methysergide	drug	naratriptan	drug
advise

The administration of DRUGA with other DRUGB has not been evaluated in migraine patients .
naratriptan	drug	5-HT1 agonists	group
false

Because their vasospastic effects may be additive , coadministration of DRUGA and other DRUGB within dgb hours of each other is not recommended .
naratriptan	drug	5-HT1 agonists	group
advise

DRUGA ( DRUGB ) ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with dgb HTv agonists .
Selective serotonin reuptake inhibitors	group	SSRIs	group
false

DRUGA ( DRUGN ) ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with dgb HTv agonists .
Selective serotonin reuptake inhibitors	group	fluoxetine	drug
false

DRUGA ( DRUGN ) ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with dgb HTv agonists .
Selective serotonin reuptake inhibitors	group	fluvoxamine	drug
false

DRUGA ( DRUGN ) ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with dgb HTv agonists .
Selective serotonin reuptake inhibitors	group	paroxetine	drug
false

DRUGA ( DRUGN ) ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with dgb HTv agonists .
Selective serotonin reuptake inhibitors	group	sertraline	drug
false

DRUGN ( DRUGA ) ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with dgb HTv agonists .
SSRIs	group	fluoxetine	drug
false

DRUGN ( DRUGA ) ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with dgb HTv agonists .
SSRIs	group	fluvoxamine	drug
false

DRUGN ( DRUGA ) ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with dgb HTv agonists .
SSRIs	group	paroxetine	drug
false

DRUGN ( DRUGA ) ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with dgb HTv agonists .
SSRIs	group	sertraline	drug
false

DRUGN ( DRUGN ) ( e.g . , DRUGA , DRUGB , DRUGN , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with dgb HTv agonists .
fluoxetine	drug	fluvoxamine	drug
false

DRUGN ( DRUGN ) ( e.g . , DRUGA , DRUGN , DRUGB , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with dgb HTv agonists .
fluoxetine	drug	paroxetine	drug
false

DRUGN ( DRUGN ) ( e.g . , DRUGA , DRUGN , DRUGN , DRUGB ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with dgb HTv agonists .
fluoxetine	drug	sertraline	drug
false

DRUGN ( DRUGN ) ( e.g . , DRUGN , DRUGA , DRUGB , DRUGN ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with dgb HTv agonists .
fluvoxamine	drug	paroxetine	drug
false

DRUGN ( DRUGN ) ( e.g . , DRUGN , DRUGA , DRUGN , DRUGB ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with dgb HTv agonists .
fluvoxamine	drug	sertraline	drug
false

DRUGN ( DRUGN ) ( e.g . , DRUGN , DRUGN , DRUGA , DRUGB ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with dgb HTv agonists .
paroxetine	drug	sertraline	drug
false

If concomitant treatment with DRUGA and an DRUGB is clinically warranted , appropriate observation of the patient is advised .
naratriptan	drug	SSRI	group
advise

After multiple dosing , DRUGA ( DRUGB dgb mcg IM once weekly ) reduced DRUGN clearance by approximately dgb % .
interferon beta-1a	drug	AVONEX	brand
false

After multiple dosing , DRUGA ( DRUGN dgb mcg IM once weekly ) reduced DRUGB clearance by approximately dgb % .
interferon beta-1a	drug	TYSABRI	brand
mechanism

After multiple dosing , DRUGN ( DRUGA dgb mcg IM once weekly ) reduced DRUGB clearance by approximately dgb % .
AVONEX	brand	TYSABRI	brand
mechanism

Results of studies in multiple sclerosis patients taking DRUGA and concomitant DRUGB ( DRUGN dgb mcg IM once weekly ) or DRUGN were inconclusive with regard to the need for dose adjustment of the DRUGN or DRUGN .
TYSABRI	brand	interferon beta-1a	drug
false

Results of studies in multiple sclerosis patients taking DRUGA and concomitant DRUGN ( DRUGB dgb mcg IM once weekly ) or DRUGN were inconclusive with regard to the need for dose adjustment of the DRUGN or DRUGN .
TYSABRI	brand	AVONEX	brand
false

Results of studies in multiple sclerosis patients taking DRUGA and concomitant DRUGN ( DRUGN dgb mcg IM once weekly ) or DRUGB were inconclusive with regard to the need for dose adjustment of the DRUGN or DRUGN .
TYSABRI	brand	glatiramer acetate	drug
false

Results of studies in multiple sclerosis patients taking DRUGA and concomitant DRUGN ( DRUGN dgb mcg IM once weekly ) or DRUGN were inconclusive with regard to the need for dose adjustment of the DRUGB or DRUGN .
TYSABRI	brand	beta-interferon	drug
false

Results of studies in multiple sclerosis patients taking DRUGA and concomitant DRUGN ( DRUGN dgb mcg IM once weekly ) or DRUGN were inconclusive with regard to the need for dose adjustment of the DRUGN or DRUGB .
TYSABRI	brand	glatiramer acetate	drug
false

Results of studies in multiple sclerosis patients taking DRUGN and concomitant DRUGA ( DRUGB dgb mcg IM once weekly ) or DRUGN were inconclusive with regard to the need for dose adjustment of the DRUGN or DRUGN .
interferon beta-1a	drug	AVONEX	brand
false

Results of studies in multiple sclerosis patients taking DRUGN and concomitant DRUGA ( DRUGN dgb mcg IM once weekly ) or DRUGB were inconclusive with regard to the need for dose adjustment of the DRUGN or DRUGN .
interferon beta-1a	drug	glatiramer acetate	drug
false

Results of studies in multiple sclerosis patients taking DRUGN and concomitant DRUGA ( DRUGN dgb mcg IM once weekly ) or DRUGN were inconclusive with regard to the need for dose adjustment of the DRUGB or DRUGN .
interferon beta-1a	drug	beta-interferon	drug
false

Results of studies in multiple sclerosis patients taking DRUGN and concomitant DRUGA ( DRUGN dgb mcg IM once weekly ) or DRUGN were inconclusive with regard to the need for dose adjustment of the DRUGN or DRUGB .
interferon beta-1a	drug	glatiramer acetate	drug
false

Results of studies in multiple sclerosis patients taking DRUGN and concomitant DRUGN ( DRUGA dgb mcg IM once weekly ) or DRUGB were inconclusive with regard to the need for dose adjustment of the DRUGN or DRUGN .
AVONEX	brand	glatiramer acetate	drug
false

Results of studies in multiple sclerosis patients taking DRUGN and concomitant DRUGN ( DRUGA dgb mcg IM once weekly ) or DRUGN were inconclusive with regard to the need for dose adjustment of the DRUGB or DRUGN .
AVONEX	brand	beta-interferon	drug
false

Results of studies in multiple sclerosis patients taking DRUGN and concomitant DRUGN ( DRUGA dgb mcg IM once weekly ) or DRUGN were inconclusive with regard to the need for dose adjustment of the DRUGN or DRUGB .
AVONEX	brand	glatiramer acetate	drug
false

Results of studies in multiple sclerosis patients taking DRUGN and concomitant DRUGN ( DRUGN dgb mcg IM once weekly ) or DRUGA were inconclusive with regard to the need for dose adjustment of the DRUGB or DRUGN .
glatiramer acetate	drug	beta-interferon	drug
false

Results of studies in multiple sclerosis patients taking DRUGN and concomitant DRUGN ( DRUGN dgb mcg IM once weekly ) or DRUGN were inconclusive with regard to the need for dose adjustment of the DRUGA or DRUGB .
beta-interferon	drug	glatiramer acetate	drug
false

DRUGA is a potential inhibitor of the CYPdgbCdgb isoenzyme in vivo as indicated by its ability to inhibit the in vitro metabolism of DRUGB .
Starlix	brand	tolbutamide	drug
mechanism

DRUGA : In a randomized , multiple dose crossover study , patients with Type dgb diabetes were administered dgb mg DRUGB three times a day before meals for dgb day in combination with DRUGN dgb mg daily .
Glyburide	drug	Starlix	brand
false

DRUGA : In a randomized , multiple dose crossover study , patients with Type dgb diabetes were administered dgb mg DRUGN three times a day before meals for dgb day in combination with DRUGB dgb mg daily .
Glyburide	drug	glyburide	drug
false

DRUGN : In a randomized , multiple dose crossover study , patients with Type dgb diabetes were administered dgb mg DRUGA three times a day before meals for dgb day in combination with DRUGB dgb mg daily .
Starlix	brand	glyburide	drug
false

DRUGA : When DRUGB dgb mg before meals was administered in combination with a single dgb mg dose of DRUGN to healthy volunteers , there were no clinically relevant changes in the pharmacokinetics of either agent .
Digoxin	drug	Starlix	brand
false

DRUGA : When DRUGN dgb mg before meals was administered in combination with a single dgb mg dose of DRUGB to healthy volunteers , there were no clinically relevant changes in the pharmacokinetics of either agent .
Digoxin	drug	digoxin	drug
false

DRUGN : When DRUGA dgb mg before meals was administered in combination with a single dgb mg dose of DRUGB to healthy volunteers , there were no clinically relevant changes in the pharmacokinetics of either agent .
Starlix	brand	digoxin	drug
false

DRUGA : Administration of morning and lunch doses of DRUGB dgb mg in combination with a single dgb mg dose of DRUGN in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent .
Diclofenac	drug	Starlix	brand
false

DRUGA : Administration of morning and lunch doses of DRUGN dgb mg in combination with a single dgb mg dose of DRUGB in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent .
Diclofenac	drug	diclofenac	drug
false

DRUGN : Administration of morning and lunch doses of DRUGA dgb mg in combination with a single dgb mg dose of DRUGB in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent .
Starlix	brand	diclofenac	drug
false

Similarly , DRUGA had no influence on the serum protein binding of DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN in vitro .
nateglinide	drug	propranolol	drug
false

Similarly , DRUGA had no influence on the serum protein binding of DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN in vitro .
nateglinide	drug	glyburide	drug
false

Similarly , DRUGA had no influence on the serum protein binding of DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN in vitro .
nateglinide	drug	nicardipine	drug
false

Similarly , DRUGA had no influence on the serum protein binding of DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN in vitro .
nateglinide	drug	warfarin	drug
false

Similarly , DRUGA had no influence on the serum protein binding of DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN in vitro .
nateglinide	drug	phenytoin	drug
false

Similarly , DRUGA had no influence on the serum protein binding of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN in vitro .
nateglinide	drug	acetylsalicylic acid	drug
false

Similarly , DRUGA had no influence on the serum protein binding of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB in vitro .
nateglinide	drug	tolbutamide	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN in vitro .
propranolol	drug	glyburide	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN in vitro .
propranolol	drug	nicardipine	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN in vitro .
propranolol	drug	warfarin	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN in vitro .
propranolol	drug	phenytoin	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN in vitro .
propranolol	drug	acetylsalicylic acid	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB in vitro .
propranolol	drug	tolbutamide	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN in vitro .
glyburide	drug	nicardipine	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN in vitro .
glyburide	drug	warfarin	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN in vitro .
glyburide	drug	phenytoin	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN in vitro .
glyburide	drug	acetylsalicylic acid	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB in vitro .
glyburide	drug	tolbutamide	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN in vitro .
nicardipine	drug	warfarin	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN in vitro .
nicardipine	drug	phenytoin	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN in vitro .
nicardipine	drug	acetylsalicylic acid	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB in vitro .
nicardipine	drug	tolbutamide	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN in vitro .
warfarin	drug	phenytoin	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN in vitro .
warfarin	drug	acetylsalicylic acid	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB in vitro .
warfarin	drug	tolbutamide	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN in vitro .
phenytoin	drug	acetylsalicylic acid	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB in vitro .
phenytoin	drug	tolbutamide	drug
false

Similarly , DRUGN had no influence on the serum protein binding of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB in vitro .
acetylsalicylic acid	drug	tolbutamide	drug
false

Certain drugs , including DRUGA ( DRUGB ) , DRUGN , DRUGN , and DRUGN may potentiate the hypoglycemic action of DRUGN and other oral DRUGN .
nonsteroidal anti-inflammatory agents	group	NSAIDs	group
false

Certain drugs , including DRUGA ( DRUGN ) , DRUGB , DRUGN , and DRUGN may potentiate the hypoglycemic action of DRUGN and other oral DRUGN .
nonsteroidal anti-inflammatory agents	group	salicylates	group
false

Certain drugs , including DRUGA ( DRUGN ) , DRUGN , DRUGB , and DRUGN may potentiate the hypoglycemic action of DRUGN and other oral DRUGN .
nonsteroidal anti-inflammatory agents	group	monoamine oxidase inhibitors	group
false

Certain drugs , including DRUGA ( DRUGN ) , DRUGN , DRUGN , and DRUGB may potentiate the hypoglycemic action of DRUGN and other oral DRUGN .
nonsteroidal anti-inflammatory agents	group	non-selective beta-adrenergic-blocking agents	group
false

Certain drugs , including DRUGA ( DRUGN ) , DRUGN , DRUGN , and DRUGN may potentiate the hypoglycemic action of DRUGB and other oral DRUGN .
nonsteroidal anti-inflammatory agents	group	Starlix	brand
effect

Certain drugs , including DRUGA ( DRUGN ) , DRUGN , DRUGN , and DRUGN may potentiate the hypoglycemic action of DRUGN and other oral DRUGB .
nonsteroidal anti-inflammatory agents	group	antidiabetic drugs	group
effect

Certain drugs , including DRUGN ( DRUGA ) , DRUGB , DRUGN , and DRUGN may potentiate the hypoglycemic action of DRUGN and other oral DRUGN .
NSAIDs	group	salicylates	group
false

Certain drugs , including DRUGN ( DRUGA ) , DRUGN , DRUGB , and DRUGN may potentiate the hypoglycemic action of DRUGN and other oral DRUGN .
NSAIDs	group	monoamine oxidase inhibitors	group
false

Certain drugs , including DRUGN ( DRUGA ) , DRUGN , DRUGN , and DRUGB may potentiate the hypoglycemic action of DRUGN and other oral DRUGN .
NSAIDs	group	non-selective beta-adrenergic-blocking agents	group
false

Certain drugs , including DRUGN ( DRUGA ) , DRUGN , DRUGN , and DRUGN may potentiate the hypoglycemic action of DRUGB and other oral DRUGN .
NSAIDs	group	Starlix	brand
effect

Certain drugs , including DRUGN ( DRUGA ) , DRUGN , DRUGN , and DRUGN may potentiate the hypoglycemic action of DRUGN and other oral DRUGB .
NSAIDs	group	antidiabetic drugs	group
effect

Certain drugs , including DRUGN ( DRUGN ) , DRUGA , DRUGB , and DRUGN may potentiate the hypoglycemic action of DRUGN and other oral DRUGN .
salicylates	group	monoamine oxidase inhibitors	group
false

Certain drugs , including DRUGN ( DRUGN ) , DRUGA , DRUGN , and DRUGB may potentiate the hypoglycemic action of DRUGN and other oral DRUGN .
salicylates	group	non-selective beta-adrenergic-blocking agents	group
false

Certain drugs , including DRUGN ( DRUGN ) , DRUGA , DRUGN , and DRUGN may potentiate the hypoglycemic action of DRUGB and other oral DRUGN .
salicylates	group	Starlix	brand
effect

Certain drugs , including DRUGN ( DRUGN ) , DRUGA , DRUGN , and DRUGN may potentiate the hypoglycemic action of DRUGN and other oral DRUGB .
salicylates	group	antidiabetic drugs	group
effect

Certain drugs , including DRUGN ( DRUGN ) , DRUGN , DRUGA , and DRUGB may potentiate the hypoglycemic action of DRUGN and other oral DRUGN .
monoamine oxidase inhibitors	group	non-selective beta-adrenergic-blocking agents	group
false

Certain drugs , including DRUGN ( DRUGN ) , DRUGN , DRUGA , and DRUGN may potentiate the hypoglycemic action of DRUGB and other oral DRUGN .
monoamine oxidase inhibitors	group	Starlix	brand
effect

Certain drugs , including DRUGN ( DRUGN ) , DRUGN , DRUGA , and DRUGN may potentiate the hypoglycemic action of DRUGN and other oral DRUGB .
monoamine oxidase inhibitors	group	antidiabetic drugs	group
effect

Certain drugs , including DRUGN ( DRUGN ) , DRUGN , DRUGN , and DRUGA may potentiate the hypoglycemic action of DRUGB and other oral DRUGN .
non-selective beta-adrenergic-blocking agents	group	Starlix	brand
effect

Certain drugs , including DRUGN ( DRUGN ) , DRUGN , DRUGN , and DRUGA may potentiate the hypoglycemic action of DRUGN and other oral DRUGB .
non-selective beta-adrenergic-blocking agents	group	antidiabetic drugs	group
effect

Certain drugs , including DRUGN ( DRUGN ) , DRUGN , DRUGN , and DRUGN may potentiate the hypoglycemic action of DRUGA and other oral DRUGB .
Starlix	brand	antidiabetic drugs	group
false

Certain drugs including DRUGA , DRUGB , DRUGN , and DRUGN may reduce the hypoglycemic action of DRUGN and other oral DRUGN .
thiazides	group	corticosteroids	group
false

Certain drugs including DRUGA , DRUGN , DRUGB , and DRUGN may reduce the hypoglycemic action of DRUGN and other oral DRUGN .
thiazides	group	thyroid products	group
false

Certain drugs including DRUGA , DRUGN , DRUGN , and DRUGB may reduce the hypoglycemic action of DRUGN and other oral DRUGN .
thiazides	group	sympathomimetics	group
false

Certain drugs including DRUGA , DRUGN , DRUGN , and DRUGN may reduce the hypoglycemic action of DRUGB and other oral DRUGN .
thiazides	group	Starlix	brand
effect

Certain drugs including DRUGA , DRUGN , DRUGN , and DRUGN may reduce the hypoglycemic action of DRUGN and other oral DRUGB .
thiazides	group	antidiabetic drugs	group
effect

Certain drugs including DRUGN , DRUGA , DRUGB , and DRUGN may reduce the hypoglycemic action of DRUGN and other oral DRUGN .
corticosteroids	group	thyroid products	group
false

Certain drugs including DRUGN , DRUGA , DRUGN , and DRUGB may reduce the hypoglycemic action of DRUGN and other oral DRUGN .
corticosteroids	group	sympathomimetics	group
false

Certain drugs including DRUGN , DRUGA , DRUGN , and DRUGN may reduce the hypoglycemic action of DRUGB and other oral DRUGN .
corticosteroids	group	Starlix	brand
effect

Certain drugs including DRUGN , DRUGA , DRUGN , and DRUGN may reduce the hypoglycemic action of DRUGN and other oral DRUGB .
corticosteroids	group	antidiabetic drugs	group
effect

Certain drugs including DRUGN , DRUGN , DRUGA , and DRUGB may reduce the hypoglycemic action of DRUGN and other oral DRUGN .
thyroid products	group	sympathomimetics	group
false

Certain drugs including DRUGN , DRUGN , DRUGA , and DRUGN may reduce the hypoglycemic action of DRUGB and other oral DRUGN .
thyroid products	group	Starlix	brand
effect

Certain drugs including DRUGN , DRUGN , DRUGA , and DRUGN may reduce the hypoglycemic action of DRUGN and other oral DRUGB .
thyroid products	group	antidiabetic drugs	group
effect

Certain drugs including DRUGN , DRUGN , DRUGN , and DRUGA may reduce the hypoglycemic action of DRUGB and other oral DRUGN .
sympathomimetics	group	Starlix	brand
effect

Certain drugs including DRUGN , DRUGN , DRUGN , and DRUGA may reduce the hypoglycemic action of DRUGN and other oral DRUGB .
sympathomimetics	group	antidiabetic drugs	group
effect

Certain drugs including DRUGN , DRUGN , DRUGN , and DRUGN may reduce the hypoglycemic action of DRUGA and other oral DRUGB .
Starlix	brand	antidiabetic drugs	group
false

In clinical studies , DRUGA has been co administered with other anti asthma medications , including inhaled and oral DRUGB , and inhaled DRUGN , with no evidence of increased frequency of adverse events or laboratory abnormalities .
Tilade	brand	bronchodilators	group
false

In clinical studies , DRUGA has been co administered with other anti asthma medications , including inhaled and oral DRUGN , and inhaled DRUGB , with no evidence of increased frequency of adverse events or laboratory abnormalities .
Tilade	brand	corticosteroids	group
false

In clinical studies , DRUGN has been co administered with other anti asthma medications , including inhaled and oral DRUGA , and inhaled DRUGB , with no evidence of increased frequency of adverse events or laboratory abnormalities .
bronchodilators	group	corticosteroids	group
false

Coadministration of DRUGA and drugs primarily metabolized by CYPdgbA ( e.g . , DRUGB ) may result in increased plasma concentrations of the other drug that could increase or prolong both its therapeutic and adverse effects .
VIRACEPT	brand	dihydropyridine calcium channel blockers	group
false

Coadministration of DRUGA and drugs that induce CYPdgbA may decrease DRUGB plasma concentrations and reduce its therapeutic effect .
VIRACEPT	brand	nelfinavir	drug
false

Coadministration of DRUGA and drugs that inhibit CYPdgbA may increase DRUGB plasma concentrations .
VIRACEPT	brand	nelfinavir	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGA and DRUGB , DRUGN / DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
VIRACEPT	brand	dapsone	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGA and DRUGN , DRUGB / DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
VIRACEPT	brand	trimethoprim	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGA and DRUGN , DRUGN / DRUGB , DRUGN , DRUGN , DRUGN or DRUGN .
VIRACEPT	brand	sulfamethoxazole	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGA and DRUGN , DRUGN / DRUGN , DRUGB , DRUGN , DRUGN or DRUGN .
VIRACEPT	brand	clarithromycin	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGA and DRUGN , DRUGN / DRUGN , DRUGN , DRUGB , DRUGN or DRUGN .
VIRACEPT	brand	erythromycin	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGA and DRUGN , DRUGN / DRUGN , DRUGN , DRUGN , DRUGB or DRUGN .
VIRACEPT	brand	itraconazole	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGA and DRUGN , DRUGN / DRUGN , DRUGN , DRUGN , DRUGN or DRUGB .
VIRACEPT	brand	fluconazole	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGA , DRUGB / DRUGN , DRUGN , DRUGN , DRUGN or DRUGN .
dapsone	drug	trimethoprim	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGA , DRUGN / DRUGB , DRUGN , DRUGN , DRUGN or DRUGN .
dapsone	drug	sulfamethoxazole	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGA , DRUGN / DRUGN , DRUGB , DRUGN , DRUGN or DRUGN .
dapsone	drug	clarithromycin	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGA , DRUGN / DRUGN , DRUGN , DRUGB , DRUGN or DRUGN .
dapsone	drug	erythromycin	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGA , DRUGN / DRUGN , DRUGN , DRUGN , DRUGB or DRUGN .
dapsone	drug	itraconazole	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGA , DRUGN / DRUGN , DRUGN , DRUGN , DRUGN or DRUGB .
dapsone	drug	fluconazole	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGN , DRUGA / DRUGB , DRUGN , DRUGN , DRUGN or DRUGN .
trimethoprim	drug	sulfamethoxazole	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGN , DRUGA / DRUGN , DRUGB , DRUGN , DRUGN or DRUGN .
trimethoprim	drug	clarithromycin	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGN , DRUGA / DRUGN , DRUGN , DRUGB , DRUGN or DRUGN .
trimethoprim	drug	erythromycin	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGN , DRUGA / DRUGN , DRUGN , DRUGN , DRUGB or DRUGN .
trimethoprim	drug	itraconazole	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGN , DRUGA / DRUGN , DRUGN , DRUGN , DRUGN or DRUGB .
trimethoprim	drug	fluconazole	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGN , DRUGN / DRUGA , DRUGB , DRUGN , DRUGN or DRUGN .
sulfamethoxazole	drug	clarithromycin	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGN , DRUGN / DRUGA , DRUGN , DRUGB , DRUGN or DRUGN .
sulfamethoxazole	drug	erythromycin	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGN , DRUGN / DRUGA , DRUGN , DRUGN , DRUGB or DRUGN .
sulfamethoxazole	drug	itraconazole	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGN , DRUGN / DRUGA , DRUGN , DRUGN , DRUGN or DRUGB .
sulfamethoxazole	drug	fluconazole	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGN , DRUGN / DRUGN , DRUGA , DRUGB , DRUGN or DRUGN .
clarithromycin	drug	erythromycin	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGN , DRUGN / DRUGN , DRUGA , DRUGN , DRUGB or DRUGN .
clarithromycin	drug	itraconazole	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGN , DRUGN / DRUGN , DRUGA , DRUGN , DRUGN or DRUGB .
clarithromycin	drug	fluconazole	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGN , DRUGN / DRUGN , DRUGN , DRUGA , DRUGB or DRUGN .
erythromycin	drug	itraconazole	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGN , DRUGN / DRUGN , DRUGN , DRUGA , DRUGN or DRUGB .
erythromycin	drug	fluconazole	drug
false

Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUGN and DRUGN , DRUGN / DRUGN , DRUGN , DRUGN , DRUGA or DRUGB .
itraconazole	drug	fluconazole	drug
false

Drugs That Should Not Be Coadministered With DRUGA DRUGB : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
VIRACEPT	brand	Antiarrhythmics	group
advise

Drugs That Should Not Be Coadministered With DRUGA DRUGN : DRUGB , DRUGN dgb DRUGN : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
VIRACEPT	brand	amiodarone	drug
advise

Drugs That Should Not Be Coadministered With DRUGA DRUGN : DRUGN , DRUGB DRUGN dgb : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
VIRACEPT	brand	quinidine	drug
advise

Drugs That Should Not Be Coadministered With DRUGA DRUGN : DRUGN , DRUGN dgb DRUGB : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
VIRACEPT	brand	Antihistamines	group
advise

Drugs That Should Not Be Coadministered With DRUGA DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGB , DRUGN Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
VIRACEPT	brand	astemizole	drug
advise

Drugs That Should Not Be Coadministered With DRUGA DRUGN : DRUGN , DRUGN DRUGN dgb : DRUGN , DRUGB Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
VIRACEPT	brand	terfenadine	drug
advise

Drugs That Should Not Be Coadministered With DRUGA DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN Antimigraine : DRUGB DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
VIRACEPT	brand	ergot derivatives	group
advise

Drugs That Should Not Be Coadministered With DRUGA DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN Antimigraine : DRUGN DRUGB : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
VIRACEPT	brand	Antimycobacterial agents	group
advise

Drugs That Should Not Be Coadministered With DRUGA DRUGN : DRUGN , DRUGN DRUGN : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGB DRUGN DRUGN , DRUGN GI motility agents : DRUGN
VIRACEPT	brand	rifampin	drug
advise

Drugs That Should Not Be Coadministered With DRUGA DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGN DRUGB DRUGN , DRUGN GI motility agents : DRUGN
VIRACEPT	brand	Benzodiazepines	group
advise

Drugs That Should Not Be Coadministered With DRUGA DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGB , DRUGN GI motility agents : DRUGN
VIRACEPT	brand	midazolam	drug
advise

Drugs That Should Not Be Coadministered With DRUGA DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGB GI motility agents : DRUGN
VIRACEPT	brand	triazolam	drug
advise

Drugs That Should Not Be Coadministered With DRUGA DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGB
VIRACEPT	brand	cisapride	drug
advise

Drugs That Should Not Be Coadministered With DRUGN DRUGA : DRUGB , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
Antiarrhythmics	group	amiodarone	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGA : DRUGN , DRUGB DRUGN dgb : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
Antiarrhythmics	group	quinidine	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGA : DRUGN , DRUGN dgb DRUGB : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
Antiarrhythmics	group	Antihistamines	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGA : DRUGN , DRUGN dgb DRUGN : DRUGB , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
Antiarrhythmics	group	astemizole	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGA : DRUGN , DRUGN dgb DRUGN dgb : DRUGN , DRUGB Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
Antiarrhythmics	group	terfenadine	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGA : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGB DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
Antiarrhythmics	group	ergot derivatives	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGA : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGB : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
Antiarrhythmics	group	Antimycobacterial agents	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGA : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGB DRUGN DRUGN , DRUGN GI motility agents : DRUGN
Antiarrhythmics	group	rifampin	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGA : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGB DRUGN , DRUGN GI motility agents : DRUGN
Antiarrhythmics	group	Benzodiazepines	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGA : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGB , DRUGN GI motility agents : DRUGN
Antiarrhythmics	group	midazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGA : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGB GI motility agents : DRUGN
Antiarrhythmics	group	triazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGA : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGB
Antiarrhythmics	group	cisapride	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGA , DRUGB DRUGN dgb : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
amiodarone	drug	quinidine	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGA , DRUGN dgb DRUGB : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
amiodarone	drug	Antihistamines	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGA , DRUGN dgb DRUGN : DRUGB , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
amiodarone	drug	astemizole	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGA , DRUGN dgb DRUGN dgb : DRUGN , DRUGB Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
amiodarone	drug	terfenadine	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGA , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGB DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
amiodarone	drug	ergot derivatives	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGA , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGB : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
amiodarone	drug	Antimycobacterial agents	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGA , DRUGN dgb DRUGN : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGB DRUGN DRUGN , DRUGN GI motility agents : DRUGN
amiodarone	drug	rifampin	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGA , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGB DRUGN , DRUGN GI motility agents : DRUGN
amiodarone	drug	Benzodiazepines	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGA , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGB , DRUGN GI motility agents : DRUGN
amiodarone	drug	midazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGA , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGB GI motility agents : DRUGN
amiodarone	drug	triazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGA , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGB
amiodarone	drug	cisapride	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGA DRUGB : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN dgb GI motility agents : DRUGN
quinidine	drug	Antihistamines	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGA DRUGN dgb : DRUGB , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
quinidine	drug	astemizole	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGA DRUGN dgb : DRUGN , DRUGB Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN dgb GI motility agents : DRUGN
quinidine	drug	terfenadine	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGA DRUGN dgb : DRUGN , DRUGN dgb Antimigraine : DRUGB DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
quinidine	drug	ergot derivatives	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGA DRUGN dgb : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGB : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
quinidine	drug	Antimycobacterial agents	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGA DRUGN dgb : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGB DRUGN DRUGN , DRUGN GI motility agents : DRUGN
quinidine	drug	rifampin	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGA DRUGN dgb : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGB DRUGN , DRUGN GI motility agents : DRUGN
quinidine	drug	Benzodiazepines	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGA DRUGN dgb : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGB , DRUGN GI motility agents : DRUGN
quinidine	drug	midazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGA DRUGN dgb : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGB GI motility agents : DRUGN
quinidine	drug	triazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGA DRUGN dgb : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGB
quinidine	drug	cisapride	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGA : DRUGB , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
Antihistamines	group	astemizole	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGA : DRUGN , DRUGB Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN dgb GI motility agents : DRUGN
Antihistamines	group	terfenadine	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGA : DRUGN , DRUGN dgb Antimigraine : DRUGB DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
Antihistamines	group	ergot derivatives	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGA : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGB : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
Antihistamines	group	Antimycobacterial agents	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGA : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGB DRUGN DRUGN , DRUGN GI motility agents : DRUGN
Antihistamines	group	rifampin	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGA : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGB DRUGN , DRUGN GI motility agents : DRUGN
Antihistamines	group	Benzodiazepines	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGA : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGB , DRUGN GI motility agents : DRUGN
Antihistamines	group	midazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGA : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGB GI motility agents : DRUGN
Antihistamines	group	triazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGA : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGB
Antihistamines	group	cisapride	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN dgb : DRUGA , DRUGB Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
astemizole	drug	terfenadine	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGA , DRUGN dgb Antimigraine : DRUGB DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
astemizole	drug	ergot derivatives	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGA , DRUGN dgb Antimigraine : DRUGN DRUGB : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
astemizole	drug	Antimycobacterial agents	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGA , DRUGN Antimigraine : DRUGN DRUGN : DRUGB DRUGN DRUGN , DRUGN GI motility agents : DRUGN
astemizole	drug	rifampin	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGA , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGB DRUGN , DRUGN GI motility agents : DRUGN
astemizole	drug	Benzodiazepines	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGA , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGB , DRUGN GI motility agents : DRUGN
astemizole	drug	midazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGA , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGB GI motility agents : DRUGN
astemizole	drug	triazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGA , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGB
astemizole	drug	cisapride	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN dgb : DRUGN , DRUGA Antimigraine : DRUGB DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
terfenadine	drug	ergot derivatives	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN dgb : DRUGN , DRUGA Antimigraine : DRUGN DRUGB : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
terfenadine	drug	Antimycobacterial agents	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN DRUGN dgb : DRUGN , DRUGA Antimigraine : DRUGN DRUGN : DRUGB DRUGN DRUGN , DRUGN GI motility agents : DRUGN
terfenadine	drug	rifampin	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN dgb : DRUGN , DRUGA Antimigraine : DRUGN DRUGN : DRUGN DRUGB DRUGN , DRUGN GI motility agents : DRUGN
terfenadine	drug	Benzodiazepines	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN dgb : DRUGN , DRUGA Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGB , DRUGN GI motility agents : DRUGN
terfenadine	drug	midazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN dgb : DRUGN , DRUGA Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGB GI motility agents : DRUGN
terfenadine	drug	triazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN dgb : DRUGN , DRUGA Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGB
terfenadine	drug	cisapride	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGA DRUGB : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGN
ergot derivatives	group	Antimycobacterial agents	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN Antimigraine : DRUGA DRUGN : DRUGB DRUGN DRUGN , DRUGN GI motility agents : DRUGN
ergot derivatives	group	rifampin	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGA DRUGN : DRUGN DRUGB DRUGN , DRUGN GI motility agents : DRUGN
ergot derivatives	group	Benzodiazepines	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGA DRUGN : DRUGN DRUGN DRUGB , DRUGN GI motility agents : DRUGN
ergot derivatives	group	midazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGA DRUGN : DRUGN DRUGN DRUGN , DRUGB GI motility agents : DRUGN
ergot derivatives	group	triazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGA DRUGN : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGB
ergot derivatives	group	cisapride	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN Antimigraine : DRUGN DRUGA : DRUGB DRUGN DRUGN , DRUGN GI motility agents : DRUGN
Antimycobacterial agents	group	rifampin	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGA : DRUGN DRUGB DRUGN , DRUGN GI motility agents : DRUGN
Antimycobacterial agents	group	Benzodiazepines	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGA : DRUGN DRUGN DRUGB , DRUGN GI motility agents : DRUGN
Antimycobacterial agents	group	midazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGA : DRUGN DRUGN DRUGN , DRUGB GI motility agents : DRUGN
Antimycobacterial agents	group	triazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGA : DRUGN DRUGN DRUGN , DRUGN GI motility agents : DRUGB
Antimycobacterial agents	group	cisapride	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGA DRUGB DRUGN , DRUGN GI motility agents : DRUGN
rifampin	drug	Benzodiazepines	group
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGA DRUGN DRUGB , DRUGN GI motility agents : DRUGN
rifampin	drug	midazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGA DRUGN DRUGN , DRUGB GI motility agents : DRUGN
rifampin	drug	triazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN Antimigraine : DRUGN DRUGN : DRUGA DRUGN DRUGN , DRUGN GI motility agents : DRUGB
rifampin	drug	cisapride	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGA DRUGB , DRUGN GI motility agents : DRUGN
Benzodiazepines	group	midazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGA DRUGN , DRUGB GI motility agents : DRUGN
Benzodiazepines	group	triazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGA DRUGN , DRUGN GI motility agents : DRUGB
Benzodiazepines	group	cisapride	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGA , DRUGB GI motility agents : DRUGN
midazolam	drug	triazolam	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGA , DRUGN GI motility agents : DRUGB
midazolam	drug	cisapride	drug
false

Drugs That Should Not Be Coadministered With DRUGN DRUGN : DRUGN , DRUGN dgb DRUGN : DRUGN , DRUGN dgb Antimigraine : DRUGN DRUGN : DRUGN DRUGN DRUGN , DRUGA GI motility agents : DRUGB
triazolam	drug	cisapride	drug
false

Drugs Which Require a Dose Reduction When Coadminstered With DRUGA DRUGB : DRUGN
VIRACEPT	brand	Antimycobacterial agents	group
advise

Drugs Which Require a Dose Reduction When Coadminstered With DRUGA DRUGN : DRUGB
VIRACEPT	brand	rifabutin	drug
advise

Drugs Which Require a Dose Reduction When Coadminstered With DRUGN DRUGA : DRUGB
Antimycobacterial agents	group	rifabutin	drug
false

* This table is not all inclusive ** DRUGA may not be effective due to decreased DRUGB plasma concentrations in patients taking these agents concomitantly
VIRACEPT	brand	nelfinavir	drug
false

DRUGA : Administration of DRUGB with DRUGN resulted in the appearance of unchanged DRUGN in plasma ;
Terfenadine	drug	terfenadine	drug
false

DRUGA : Administration of DRUGN with DRUGB resulted in the appearance of unchanged DRUGN in plasma ;
Terfenadine	drug	VIRACEPT	brand
false

DRUGA : Administration of DRUGN with DRUGN resulted in the appearance of unchanged DRUGB in plasma ;
Terfenadine	drug	terfenadine	drug
false

DRUGN : Administration of DRUGA with DRUGB resulted in the appearance of unchanged DRUGN in plasma ;
terfenadine	drug	VIRACEPT	brand
false

DRUGN : Administration of DRUGN with DRUGA resulted in the appearance of unchanged DRUGB in plasma ;
VIRACEPT	brand	terfenadine	drug
false

therefore , DRUGA should not be administered concurrently with DRUGB because of the potential for serious and / or life threatening cardiac arrhythmias .
VIRACEPT	brand	terfenadine	drug
advise

Because a similar interaction is likely , DRUGA should also not be administered concurrently with DRUGB .
VIRACEPT	brand	astemizole	drug
advise

DRUGA : Coadministration of DRUGB with DRUGN resulted in an dgb % increase in DRUGN plasma AUC and a dgb % increase in DRUGN plasma A.C .
Indinavir	drug	indinavir	drug
false

DRUGA : Coadministration of DRUGN with DRUGB resulted in an dgb % increase in DRUGN plasma AUC and a dgb % increase in DRUGN plasma A.C .
Indinavir	drug	VIRACEPT	brand
false

DRUGA : Coadministration of DRUGN with DRUGN resulted in an dgb % increase in DRUGB plasma AUC and a dgb % increase in DRUGN plasma A.C .
Indinavir	drug	nelfinavir	drug
false

DRUGA : Coadministration of DRUGN with DRUGN resulted in an dgb % increase in DRUGN plasma AUC and a dgb % increase in DRUGB plasma A.C .
Indinavir	drug	indinavir	drug
false

DRUGN : Coadministration of DRUGA with DRUGB resulted in an dgb % increase in DRUGN plasma AUC and a dgb % increase in DRUGN plasma A.C .
indinavir	drug	VIRACEPT	brand
mechanism

DRUGN : Coadministration of DRUGA with DRUGN resulted in an dgb % increase in DRUGB plasma AUC and a dgb % increase in DRUGN plasma A.C .
indinavir	drug	nelfinavir	drug
false

DRUGN : Coadministration of DRUGN with DRUGA resulted in an dgb % increase in DRUGB plasma AUC and a dgb % increase in DRUGN plasma A.C .
VIRACEPT	brand	nelfinavir	drug
false

DRUGN : Coadministration of DRUGN with DRUGA resulted in an dgb % increase in DRUGN plasma AUC and a dgb % increase in DRUGB plasma A.C .
VIRACEPT	brand	indinavir	drug
false

DRUGN : Coadministration of DRUGN with DRUGN resulted in an dgb % increase in DRUGA plasma AUC and a dgb % increase in DRUGB plasma A.C .
nelfinavir	drug	indinavir	drug
false

DRUGA : Coadministration of DRUGB with DRUGN resulted in a dgb % increase in DRUGN plasma AUC and very little change in DRUGN plasma A.C .
Ritonavir	drug	ritonavir	drug
false

DRUGA : Coadministration of DRUGN with DRUGB resulted in a dgb % increase in DRUGN plasma AUC and very little change in DRUGN plasma A.C .
Ritonavir	drug	VIRACEPT	brand
false

DRUGA : Coadministration of DRUGN with DRUGN resulted in a dgb % increase in DRUGB plasma AUC and very little change in DRUGN plasma A.C .
Ritonavir	drug	nelfinavir	drug
false

DRUGA : Coadministration of DRUGN with DRUGN resulted in a dgb % increase in DRUGN plasma AUC and very little change in DRUGB plasma A.C .
Ritonavir	drug	ritonavir	drug
false

DRUGN : Coadministration of DRUGA with DRUGB resulted in a dgb % increase in DRUGN plasma AUC and very little change in DRUGN plasma A.C .
ritonavir	drug	VIRACEPT	brand
mechanism

DRUGN : Coadministration of DRUGA with DRUGN resulted in a dgb % increase in DRUGB plasma AUC and very little change in DRUGN plasma A.C .
ritonavir	drug	nelfinavir	drug
false

DRUGN : Coadministration of DRUGN with DRUGA resulted in a dgb % increase in DRUGB plasma AUC and very little change in DRUGN plasma A.C .
VIRACEPT	brand	nelfinavir	drug
false

DRUGN : Coadministration of DRUGN with DRUGA resulted in a dgb % increase in DRUGN plasma AUC and very little change in DRUGB plasma A.C .
VIRACEPT	brand	ritonavir	drug
false

DRUGN : Coadministration of DRUGN with DRUGN resulted in a dgb % increase in DRUGA plasma AUC and very little change in DRUGB plasma A.C .
nelfinavir	drug	ritonavir	drug
false

DRUGA : Coadministration of DRUGB ( using an experimental soft gelatin capsule formulation of DRUGN dgbmg ) with DRUGN resulted in an dgb % increase in DRUGN plasma AUC and a dgb fold increase in DRUGN plasma A.C .
Saquinavir	drug	saquinavir	drug
false

DRUGA : Coadministration of DRUGN ( using an experimental soft gelatin capsule formulation of DRUGB dgbmg ) with DRUGN resulted in an dgb % increase in DRUGN plasma AUC and a dgb fold increase in DRUGN plasma A.C .
Saquinavir	drug	saquinavir	drug
false

DRUGA : Coadministration of DRUGN ( using an experimental soft gelatin capsule formulation of DRUGN dgbmg ) with DRUGB resulted in an dgb % increase in DRUGN plasma AUC and a dgb fold increase in DRUGN plasma A.C .
Saquinavir	drug	VIRACEPT	brand
false

DRUGA : Coadministration of DRUGN ( using an experimental soft gelatin capsule formulation of DRUGN dgbmg ) with DRUGN resulted in an dgb % increase in DRUGB plasma AUC and a dgb fold increase in DRUGN plasma A.C .
Saquinavir	drug	nelfinavir	drug
false

DRUGA : Coadministration of DRUGN ( using an experimental soft gelatin capsule formulation of DRUGN dgbmg ) with DRUGN resulted in an dgb % increase in DRUGN plasma AUC and a dgb fold increase in DRUGB plasma A.C .
Saquinavir	drug	saquinavir	drug
false

DRUGN : Coadministration of DRUGA ( using an experimental soft gelatin capsule formulation of DRUGN dgbmg ) with DRUGB resulted in an dgb % increase in DRUGN plasma AUC and a dgb fold increase in DRUGN plasma A.C .
saquinavir	drug	VIRACEPT	brand
mechanism

DRUGN : Coadministration of DRUGA ( using an experimental soft gelatin capsule formulation of DRUGN dgbmg ) with DRUGN resulted in an dgb % increase in DRUGB plasma AUC and a dgb fold increase in DRUGN plasma A.C .
saquinavir	drug	nelfinavir	drug
false

DRUGN : Coadministration of DRUGN ( using an experimental soft gelatin capsule formulation of DRUGA dgbmg ) with DRUGB resulted in an dgb % increase in DRUGN plasma AUC and a dgb fold increase in DRUGN plasma A.C .
saquinavir	drug	VIRACEPT	brand
false

DRUGN : Coadministration of DRUGN ( using an experimental soft gelatin capsule formulation of DRUGA dgbmg ) with DRUGN resulted in an dgb % increase in DRUGB plasma AUC and a dgb fold increase in DRUGN plasma A.C .
saquinavir	drug	nelfinavir	drug
false

DRUGN : Coadministration of DRUGN ( using an experimental soft gelatin capsule formulation of DRUGN dgbmg ) with DRUGA resulted in an dgb % increase in DRUGB plasma AUC and a dgb fold increase in DRUGN plasma A.C .
VIRACEPT	brand	nelfinavir	drug
false

DRUGN : Coadministration of DRUGN ( using an experimental soft gelatin capsule formulation of DRUGN dgbmg ) with DRUGA resulted in an dgb % increase in DRUGN plasma AUC and a dgb fold increase in DRUGB plasma A.C .
VIRACEPT	brand	saquinavir	drug
false

DRUGN : Coadministration of DRUGN ( using an experimental soft gelatin capsule formulation of DRUGN dgbmg ) with DRUGN resulted in an dgb % increase in DRUGA plasma AUC and a dgb fold increase in DRUGB plasma A.C .
nelfinavir	drug	saquinavir	drug
false

DRUGA : Coadministration of DRUGB with DRUGN resulted in a dgb % increase in DRUGN plasma A.C .
Ketoconazole	drug	ketoconazole	drug
false

DRUGA : Coadministration of DRUGN with DRUGB resulted in a dgb % increase in DRUGN plasma A.C .
Ketoconazole	drug	VIRACEPT	brand
false

DRUGA : Coadministration of DRUGN with DRUGN resulted in a dgb % increase in DRUGB plasma A.C .
Ketoconazole	drug	nelfinavir	drug
false

DRUGN : Coadministration of DRUGA with DRUGB resulted in a dgb % increase in DRUGN plasma A.C .
ketoconazole	drug	VIRACEPT	brand
mechanism

DRUGN : Coadministration of DRUGA with DRUGN resulted in a dgb % increase in DRUGB plasma A.C .
ketoconazole	drug	nelfinavir	drug
false

DRUGN : Coadministration of DRUGN with DRUGA resulted in a dgb % increase in DRUGB plasma A.C .
VIRACEPT	brand	nelfinavir	drug
false

This change was not considered clinically significant and no dose adjustment is needed when DRUGA and DRUGB are coadministered .
ketoconazole	drug	VIRACEPT	brand
false

DRUGA : It is recommended that DRUGB be administered on an empty stomach ;
Didanosine	drug	didanosine	drug
false

therefore , DRUGA should be administered ( with food ) one hour after or more than two hours before DRUGB .
nelfinavir	drug	didanosine	drug
advise

A dose adjustment is not needed when DRUGA is administered with DRUGB .
zidovudine	drug	VIRACEPT	brand
advise

Little or no change in the pharmacokinetics of either drug was observed when DRUGA was coadministered with DRUGB or DRUGN .
VIRACEPT	brand	lamivudine	drug
false

Little or no change in the pharmacokinetics of either drug was observed when DRUGA was coadministered with DRUGN or DRUGB .
VIRACEPT	brand	stavudine	drug
false

Little or no change in the pharmacokinetics of either drug was observed when DRUGN was coadministered with DRUGA or DRUGB .
lamivudine	drug	stavudine	drug
false

DRUGA : Coadministration of DRUGB and DRUGN resulted in a dgb % decrease in DRUGN plasma AUC and a dgb % increase in DRUGN plasma A.C .
Rifabutin	drug	rifabutin	drug
false

DRUGA : Coadministration of DRUGN and DRUGB resulted in a dgb % decrease in DRUGN plasma AUC and a dgb % increase in DRUGN plasma A.C .
Rifabutin	drug	VIRACEPT	brand
false

DRUGA : Coadministration of DRUGN and DRUGN resulted in a dgb % decrease in DRUGB plasma AUC and a dgb % increase in DRUGN plasma A.C .
Rifabutin	drug	nelfinavir	drug
false

DRUGA : Coadministration of DRUGN and DRUGN resulted in a dgb % decrease in DRUGN plasma AUC and a dgb % increase in DRUGB plasma A.C .
Rifabutin	drug	rifabutin	drug
false

DRUGN : Coadministration of DRUGA and DRUGB resulted in a dgb % decrease in DRUGN plasma AUC and a dgb % increase in DRUGN plasma A.C .
rifabutin	drug	VIRACEPT	brand
mechanism

DRUGN : Coadministration of DRUGA and DRUGN resulted in a dgb % decrease in DRUGB plasma AUC and a dgb % increase in DRUGN plasma A.C .
rifabutin	drug	nelfinavir	drug
false

DRUGN : Coadministration of DRUGN and DRUGA resulted in a dgb % decrease in DRUGB plasma AUC and a dgb % increase in DRUGN plasma A.C .
VIRACEPT	brand	nelfinavir	drug
false

DRUGN : Coadministration of DRUGN and DRUGA resulted in a dgb % decrease in DRUGN plasma AUC and a dgb % increase in DRUGB plasma A.C .
VIRACEPT	brand	rifabutin	drug
false

DRUGN : Coadministration of DRUGN and DRUGN resulted in a dgb % decrease in DRUGA plasma AUC and a dgb % increase in DRUGB plasma A.C .
nelfinavir	drug	rifabutin	drug
false

It is recommended that the dose of DRUGA be reduced to one half the usual dose when administered with DRUGB .
rifabutin	drug	VIRACEPT	brand
advise

DRUGA : Coadministration of DRUGB and DRUGN resulted in an dgb % decrease in DRUGN plasma A.C .
Rifampin	drug	rifampin	drug
false

DRUGA : Coadministration of DRUGN and DRUGB resulted in an dgb % decrease in DRUGN plasma A.C .
Rifampin	drug	VIRACEPT	brand
false

DRUGA : Coadministration of DRUGN and DRUGN resulted in an dgb % decrease in DRUGB plasma A.C .
Rifampin	drug	nelfinavir	drug
false

DRUGN : Coadministration of DRUGA and DRUGB resulted in an dgb % decrease in DRUGN plasma A.C .
rifampin	drug	VIRACEPT	brand
mechanism

DRUGN : Coadministration of DRUGA and DRUGN resulted in an dgb % decrease in DRUGB plasma A.C .
rifampin	drug	nelfinavir	drug
false

DRUGN : Coadministration of DRUGN and DRUGA resulted in an dgb % decrease in DRUGB plasma A.C .
VIRACEPT	brand	nelfinavir	drug
false

DRUGA and DRUGB should not be coadministered .
VIRACEPT	brand	rifampin	drug
advise

DRUGA and DRUGB : Coadministration of DRUGN with DRUGN resulted in a dgb % decrease in DRUGN and an dgb % decrease in DRUGN plasma concentrations .
Ethinyl Estradiol	drug	Norethindrone	drug
false

DRUGA and DRUGN : Coadministration of DRUGB with DRUGN resulted in a dgb % decrease in DRUGN and an dgb % decrease in DRUGN plasma concentrations .
Ethinyl Estradiol	drug	VIRACEPT	brand
false

DRUGA and DRUGN : Coadministration of DRUGN with DRUGB resulted in a dgb % decrease in DRUGN and an dgb % decrease in DRUGN plasma concentrations .
Ethinyl Estradiol	drug	OVCON-35	brand
false

DRUGA and DRUGN : Coadministration of DRUGN with DRUGN resulted in a dgb % decrease in DRUGB and an dgb % decrease in DRUGN plasma concentrations .
Ethinyl Estradiol	drug	ethinyl estradiol	drug
false

DRUGA and DRUGN : Coadministration of DRUGN with DRUGN resulted in a dgb % decrease in DRUGN and an dgb % decrease in DRUGB plasma concentrations .
Ethinyl Estradiol	drug	norethindrone	drug
false

DRUGN and DRUGA : Coadministration of DRUGB with DRUGN resulted in a dgb % decrease in DRUGN and an dgb % decrease in DRUGN plasma concentrations .
Norethindrone	drug	VIRACEPT	brand
false

DRUGN and DRUGA : Coadministration of DRUGN with DRUGB resulted in a dgb % decrease in DRUGN and an dgb % decrease in DRUGN plasma concentrations .
Norethindrone	drug	OVCON-35	brand
false

DRUGN and DRUGA : Coadministration of DRUGN with DRUGN resulted in a dgb % decrease in DRUGB and an dgb % decrease in DRUGN plasma concentrations .
Norethindrone	drug	ethinyl estradiol	drug
false

DRUGN and DRUGA : Coadministration of DRUGN with DRUGN resulted in a dgb % decrease in DRUGN and an dgb % decrease in DRUGB plasma concentrations .
Norethindrone	drug	norethindrone	drug
false

DRUGN and DRUGN : Coadministration of DRUGA with DRUGB resulted in a dgb % decrease in DRUGN and an dgb % decrease in DRUGN plasma concentrations .
VIRACEPT	brand	OVCON-35	brand
mechanism

DRUGN and DRUGN : Coadministration of DRUGA with DRUGN resulted in a dgb % decrease in DRUGB and an dgb % decrease in DRUGN plasma concentrations .
VIRACEPT	brand	ethinyl estradiol	drug
false

DRUGN and DRUGN : Coadministration of DRUGA with DRUGN resulted in a dgb % decrease in DRUGN and an dgb % decrease in DRUGB plasma concentrations .
VIRACEPT	brand	norethindrone	drug
false

DRUGN and DRUGN : Coadministration of DRUGN with DRUGA resulted in a dgb % decrease in DRUGB and an dgb % decrease in DRUGN plasma concentrations .
OVCON-35	brand	ethinyl estradiol	drug
false

DRUGN and DRUGN : Coadministration of DRUGN with DRUGA resulted in a dgb % decrease in DRUGN and an dgb % decrease in DRUGB plasma concentrations .
OVCON-35	brand	norethindrone	drug
false

DRUGN and DRUGN : Coadministration of DRUGN with DRUGN resulted in a dgb % decrease in DRUGA and an dgb % decrease in DRUGB plasma concentrations .
ethinyl estradiol	drug	norethindrone	drug
false

Caution should also be taken in concurrent or serial use of other DRUGA and DRUGB because they may enhance neomycin s nephrotoxicity and / or ototoxicity and potentiate DRUGN neuromuscular blocking effects .
aminoglycosides	group	polymyxins	group
false

Caution should also be taken in concurrent or serial use of other DRUGA and DRUGN because they may enhance neomycin s nephrotoxicity and / or ototoxicity and potentiate DRUGB neuromuscular blocking effects .
aminoglycosides	group	neomycin sulfate	drug
false

Caution should also be taken in concurrent or serial use of other DRUGN and DRUGA because they may enhance neomycin s nephrotoxicity and / or ototoxicity and potentiate DRUGB neuromuscular blocking effects .
polymyxins	group	neomycin sulfate	drug
false

Oral DRUGA inhibits the gastrointestinal absorption of DRUGB , oral DRUGN , DRUGN and DRUGN .
neomycin	drug	penicillin V	drug
mechanism

Oral DRUGA inhibits the gastrointestinal absorption of DRUGN , oral DRUGB , DRUGN and DRUGN .
neomycin	drug	vitamin B-12	drug
mechanism

Oral DRUGA inhibits the gastrointestinal absorption of DRUGN , oral DRUGN , DRUGB and DRUGN .
neomycin	drug	methotrexate	drug
mechanism

Oral DRUGA inhibits the gastrointestinal absorption of DRUGN , oral DRUGN , DRUGN and DRUGB .
neomycin	drug	5-fluorouracil	drug
mechanism

Oral DRUGN inhibits the gastrointestinal absorption of DRUGA , oral DRUGB , DRUGN and DRUGN .
penicillin V	drug	vitamin B-12	drug
false

Oral DRUGN inhibits the gastrointestinal absorption of DRUGA , oral DRUGN , DRUGB and DRUGN .
penicillin V	drug	methotrexate	drug
false

Oral DRUGN inhibits the gastrointestinal absorption of DRUGA , oral DRUGN , DRUGN and DRUGB .
penicillin V	drug	5-fluorouracil	drug
false

Oral DRUGN inhibits the gastrointestinal absorption of DRUGN , oral DRUGA , DRUGB and DRUGN .
vitamin B-12	drug	methotrexate	drug
false

Oral DRUGN inhibits the gastrointestinal absorption of DRUGN , oral DRUGA , DRUGN and DRUGB .
vitamin B-12	drug	5-fluorouracil	drug
false

Oral DRUGN inhibits the gastrointestinal absorption of DRUGN , oral DRUGN , DRUGA and DRUGB .
methotrexate	drug	5-fluorouracil	drug
false

Oral DRUGA may enhance the effect of DRUGB in DRUGN by decreasing vitamin K availability .
neomycin sulfate	drug	coumarin	group
effect

Oral DRUGA may enhance the effect of DRUGN in DRUGB by decreasing vitamin K availability .
neomycin sulfate	drug	anticoagulants	group
effect

Oral DRUGN may enhance the effect of DRUGA in DRUGB by decreasing vitamin K availability .
coumarin	group	anticoagulants	group
false

Certain DRUGA , especially DRUGB , DRUGN and DRUGN , have a mild but definite nondepolarizing blocking action which may accentuate neuromuscular block .
antibiotics	group	neomycin	drug
false

Certain DRUGA , especially DRUGN , DRUGB and DRUGN , have a mild but definite nondepolarizing blocking action which may accentuate neuromuscular block .
antibiotics	group	streptomycin	drug
false

Certain DRUGA , especially DRUGN , DRUGN and DRUGB , have a mild but definite nondepolarizing blocking action which may accentuate neuromuscular block .
antibiotics	group	kanamycin	drug
false

Certain DRUGN , especially DRUGA , DRUGB and DRUGN , have a mild but definite nondepolarizing blocking action which may accentuate neuromuscular block .
neomycin	drug	streptomycin	drug
false

Certain DRUGN , especially DRUGA , DRUGN and DRUGB , have a mild but definite nondepolarizing blocking action which may accentuate neuromuscular block .
neomycin	drug	kanamycin	drug
false

Certain DRUGN , especially DRUGN , DRUGA and DRUGB , have a mild but definite nondepolarizing blocking action which may accentuate neuromuscular block .
streptomycin	drug	kanamycin	drug
false

These DRUGA should be used in the myasthenic patient only where definitely indicated , and then careful adjustment should be made of adjunctive DRUGB dosage .
antibiotics	group	anticholinesterase	group
advise

Local and some general DRUGA , DRUGB and other drugs that interfere with neuromuscular transmission should be used cautiously , if at all , in patients with myasthenia gravis ;
anesthetics	group	antiarrhythmic agents	group
false

The co administration of DRUGA with IV DRUGB such as DRUGN , DRUGN , DRUGN , or IV DRUGN has not been evaluated ( these drugs were not co administered with DRUGN in clinical trials ) .
Natrecor	brand	vasodilators	group
false

The co administration of DRUGA with IV DRUGN such as DRUGB , DRUGN , DRUGN , or IV DRUGN has not been evaluated ( these drugs were not co administered with DRUGN in clinical trials ) .
Natrecor	brand	nitroglycerin	drug
false

The co administration of DRUGA with IV DRUGN such as DRUGN , DRUGB , DRUGN , or IV DRUGN has not been evaluated ( these drugs were not co administered with DRUGN in clinical trials ) .
Natrecor	brand	nitroprusside	drug
false

The co administration of DRUGA with IV DRUGN such as DRUGN , DRUGN , DRUGB , or IV DRUGN has not been evaluated ( these drugs were not co administered with DRUGN in clinical trials ) .
Natrecor	brand	milrinone	drug
false

The co administration of DRUGA with IV DRUGN such as DRUGN , DRUGN , DRUGN , or IV DRUGB has not been evaluated ( these drugs were not co administered with DRUGN in clinical trials ) .
Natrecor	brand	ACE inhibitors	group
false

The co administration of DRUGN with IV DRUGA such as DRUGB , DRUGN , DRUGN , or IV DRUGN has not been evaluated ( these drugs were not co administered with DRUGN in clinical trials ) .
vasodilators	group	nitroglycerin	drug
false

The co administration of DRUGN with IV DRUGA such as DRUGN , DRUGB , DRUGN , or IV DRUGN has not been evaluated ( these drugs were not co administered with DRUGN in clinical trials ) .
vasodilators	group	nitroprusside	drug
false

The co administration of DRUGN with IV DRUGA such as DRUGN , DRUGN , DRUGB , or IV DRUGN has not been evaluated ( these drugs were not co administered with DRUGN in clinical trials ) .
vasodilators	group	milrinone	drug
false

The co administration of DRUGN with IV DRUGA such as DRUGN , DRUGN , DRUGN , or IV DRUGB has not been evaluated ( these drugs were not co administered with DRUGN in clinical trials ) .
vasodilators	group	ACE inhibitors	group
false

The co administration of DRUGN with IV DRUGA such as DRUGN , DRUGN , DRUGN , or IV DRUGN has not been evaluated ( these drugs were not co administered with DRUGB in clinical trials ) .
vasodilators	group	Natrecor	brand
false

The co administration of DRUGN with IV DRUGN such as DRUGA , DRUGB , DRUGN , or IV DRUGN has not been evaluated ( these drugs were not co administered with DRUGN in clinical trials ) .
nitroglycerin	drug	nitroprusside	drug
false

The co administration of DRUGN with IV DRUGN such as DRUGA , DRUGN , DRUGB , or IV DRUGN has not been evaluated ( these drugs were not co administered with DRUGN in clinical trials ) .
nitroglycerin	drug	milrinone	drug
false

The co administration of DRUGN with IV DRUGN such as DRUGA , DRUGN , DRUGN , or IV DRUGB has not been evaluated ( these drugs were not co administered with DRUGN in clinical trials ) .
nitroglycerin	drug	ACE inhibitors	group
false

The co administration of DRUGN with IV DRUGN such as DRUGA , DRUGN , DRUGN , or IV DRUGN has not been evaluated ( these drugs were not co administered with DRUGB in clinical trials ) .
nitroglycerin	drug	Natrecor	brand
false

The co administration of DRUGN with IV DRUGN such as DRUGN , DRUGA , DRUGB , or IV DRUGN has not been evaluated ( these drugs were not co administered with DRUGN in clinical trials ) .
nitroprusside	drug	milrinone	drug
false

The co administration of DRUGN with IV DRUGN such as DRUGN , DRUGA , DRUGN , or IV DRUGB has not been evaluated ( these drugs were not co administered with DRUGN in clinical trials ) .
nitroprusside	drug	ACE inhibitors	group
false

The co administration of DRUGN with IV DRUGN such as DRUGN , DRUGA , DRUGN , or IV DRUGN has not been evaluated ( these drugs were not co administered with DRUGB in clinical trials ) .
nitroprusside	drug	Natrecor	brand
false

The co administration of DRUGN with IV DRUGN such as DRUGN , DRUGN , DRUGA , or IV DRUGB has not been evaluated ( these drugs were not co administered with DRUGN in clinical trials ) .
milrinone	drug	ACE inhibitors	group
false

The co administration of DRUGN with IV DRUGN such as DRUGN , DRUGN , DRUGA , or IV DRUGN has not been evaluated ( these drugs were not co administered with DRUGB in clinical trials ) .
milrinone	drug	Natrecor	brand
false

The co administration of DRUGN with IV DRUGN such as DRUGN , DRUGN , DRUGN , or IV DRUGA has not been evaluated ( these drugs were not co administered with DRUGB in clinical trials ) .
ACE inhibitors	group	Natrecor	brand
false

DRUGA should not be administered concomitantly with potent DRUGB such as DRUGN and DRUGN as the potential for ototoxicity is enhanced by the combination .
Netilmicin	drug	loop diuretics	group
advise

DRUGA should not be administered concomitantly with potent DRUGN such as DRUGB and DRUGN as the potential for ototoxicity is enhanced by the combination .
Netilmicin	drug	furosemide	drug
advise

DRUGA should not be administered concomitantly with potent DRUGN such as DRUGN and DRUGB as the potential for ototoxicity is enhanced by the combination .
Netilmicin	drug	ethacrynic acid	drug
advise

DRUGN should not be administered concomitantly with potent DRUGA such as DRUGB and DRUGN as the potential for ototoxicity is enhanced by the combination .
loop diuretics	group	furosemide	drug
false

DRUGN should not be administered concomitantly with potent DRUGA such as DRUGN and DRUGB as the potential for ototoxicity is enhanced by the combination .
loop diuretics	group	ethacrynic acid	drug
false

DRUGN should not be administered concomitantly with potent DRUGN such as DRUGA and DRUGB as the potential for ototoxicity is enhanced by the combination .
furosemide	drug	ethacrynic acid	drug
false

The in vitro interaction between DRUGA and the DRUGB DRUGN is complex .
nevirapine	drug	antithrombotic agent	group
false

The in vitro interaction between DRUGA and the DRUGN DRUGB is complex .
nevirapine	drug	warfarin	drug
int

The in vitro interaction between DRUGN and the DRUGA DRUGB is complex .
antithrombotic agent	group	warfarin	drug
false

When DRUGA is co administered with DRUGB , anticoagulation levels should be monitored frequently .
warfarin	drug	nevirapine	drug
advise

DRUGA exposure was significantly decreased by DRUGB ;
Clarithromycin	drug	nevirapine	drug
mechanism

Alternatives to DRUGA , such as DRUGB , should be considered .
clarithromycin	drug	azithromycin	drug
false

DRUGA and DRUGB
Ethinyl estradiol	drug	Norethindrone	drug
false

DRUGA DRUGB
Ethinyl estradiol	drug	Norethindrone	drug
false

Oral DRUGA and other hormonalmethods of birth control should not be usedas the sole method of contraception inwomen taking DRUGB , since nevirapinemay lower the plasma levels of thesemedications .
contraceptives	group	nevirapine	drug
advise

DRUGA and DRUGB should not beadministered concomitantly becausedecreases in DRUGN plasmaconcentrations may reduce the efficacy of the drug .
Nevirapine	drug	ketoconazole	drug
advise

DRUGA and DRUGN should not beadministered concomitantly becausedecreases in DRUGB plasmaconcentrations may reduce the efficacy of the drug .
Nevirapine	drug	ketoconazole	drug
false

DRUGA / DRUGB
Lopinavir	drug	Ritonavir	drug
false

A dose increase of DRUGA / DRUGB to dgb / dgb mg twice daily with food isrecommended in combination with DRUGN .
lopinavir	drug	ritonavir	drug
false

A dose increase of DRUGA / DRUGN to dgb / dgb mg twice daily with food isrecommended in combination with DRUGB .
lopinavir	drug	nevirapine	drug
advise

A dose increase of DRUGN / DRUGA to dgb / dgb mg twice daily with food isrecommended in combination with DRUGB .
ritonavir	drug	nevirapine	drug
advise

DRUGA levels may be decreased ; increased dosages may be required to prevent symptoms of DRUGB withdrawal . DRUGN maintained patients beginning DRUGN therapy should be monitored forevidence of withdrawal and DRUGN dose should be adjusted accordingly .
Methadone	drug	opiate	group
false

DRUGA levels may be decreased ; increased dosages may be required to prevent symptoms of DRUGN withdrawal . DRUGN maintained patients beginning DRUGB therapy should be monitored forevidence of withdrawal and DRUGN dose should be adjusted accordingly .
Methadone	drug	nevirapine	drug
false

DRUGA levels may be decreased ; increased dosages may be required to prevent symptoms of DRUGN withdrawal . DRUGN maintained patients beginning DRUGN therapy should be monitored forevidence of withdrawal and DRUGB dose should be adjusted accordingly .
Methadone	drug	methadone	drug
false

DRUGN levels may be decreased ; increased dosages may be required to prevent symptoms of DRUGA withdrawal . DRUGB maintained patients beginning DRUGN therapy should be monitored forevidence of withdrawal and DRUGN dose should be adjusted accordingly .
opiate	group	Methadone	drug
false

DRUGN levels may be decreased ; increased dosages may be required to prevent symptoms of DRUGA withdrawal . DRUGN maintained patients beginning DRUGB therapy should be monitored forevidence of withdrawal and DRUGN dose should be adjusted accordingly .
opiate	group	nevirapine	drug
false

DRUGN levels may be decreased ; increased dosages may be required to prevent symptoms of DRUGA withdrawal . DRUGN maintained patients beginning DRUGN therapy should be monitored forevidence of withdrawal and DRUGB dose should be adjusted accordingly .
opiate	group	methadone	drug
false

DRUGN levels may be decreased ; increased dosages may be required to prevent symptoms of DRUGN withdrawal . DRUGA maintained patients beginning DRUGB therapy should be monitored forevidence of withdrawal and DRUGN dose should be adjusted accordingly .
Methadone	drug	nevirapine	drug
advise

DRUGN levels may be decreased ; increased dosages may be required to prevent symptoms of DRUGN withdrawal . DRUGA maintained patients beginning DRUGN therapy should be monitored forevidence of withdrawal and DRUGB dose should be adjusted accordingly .
Methadone	drug	methadone	drug
false

DRUGN levels may be decreased ; increased dosages may be required to prevent symptoms of DRUGN withdrawal . DRUGN maintained patients beginning DRUGA therapy should be monitored forevidence of withdrawal and DRUGB dose should be adjusted accordingly .
nevirapine	drug	methadone	drug
false

The appropriate dose for DRUGA incombination with DRUGB , with respectto safety and efficacy , has not been established .
nelfinavir	drug	nevirapine	drug
false

DRUGA and DRUGB should not beadministered concomitantly becausedecreases in DRUGN plasmaconcentrations may reduce the efficacy ofthe drug .
Nevirapine	drug	rifampin	drug
advise

DRUGA and DRUGN should not beadministered concomitantly becausedecreases in DRUGB plasmaconcentrations may reduce the efficacy ofthe drug .
Nevirapine	drug	nevirapine	drug
false

DRUGN and DRUGA should not beadministered concomitantly becausedecreases in DRUGB plasmaconcentrations may reduce the efficacy ofthe drug .
rifampin	drug	nevirapine	drug
false

Physicians needing to treatpatients co infected with tuberculosis andusing a DRUGA containing regimen mayuse DRUGB instead .
nevirapine	drug	rifabutin	drug
false

aBased on reports of narcotic withdrawal syndrome in patients treated with DRUGA and DRUGB concurrently , and evidence of decreased plasma concentrations of DRUGN .
nevirapine	drug	methadone	drug
effect

aBased on reports of narcotic withdrawal syndrome in patients treated with DRUGA and DRUGN concurrently , and evidence of decreased plasma concentrations of DRUGB .
nevirapine	drug	methadone	drug
false

DRUGA , DRUGB , DRUGN
Amiodarone	drug	disopyramide	drug
false

DRUGA , DRUGN , DRUGB
Amiodarone	drug	lidocaine	drug
false

DRUGN , DRUGA , DRUGB
disopyramide	drug	lidocaine	drug
false

DRUGA , DRUGB , DRUGN
Carbamazepine	drug	clonazepam	drug
false

DRUGA , DRUGN , DRUGB
Carbamazepine	drug	ethosuximide	drug
false

DRUGN , DRUGA , DRUGB
clonazepam	drug	ethosuximide	drug
false

DRUGA , DRUGB , DRUGN
Diltiazem	drug	nifedipine	drug
false

DRUGA , DRUGN , DRUGB
Diltiazem	drug	verapamil	drug
false

DRUGN , DRUGA , DRUGB
nifedipine	drug	verapamil	drug
false

DRUGA , DRUGB , DRUGN
Cyclosporin	drug	tacrolimus	drug
false

DRUGA , DRUGN , DRUGB
Cyclosporin	drug	sirolimus	drug
false

DRUGN , DRUGA , DRUGB
tacrolimus	drug	sirolimus	drug
false

Interactions for DRUGA ( DRUGB ) : DRUGN Therapy : DRUGN may potentiate the effects of DRUGN and vasoactive drugs resulting in postural hypotension .
Vitamin B3	drug	Niacin	drug
false

Interactions for DRUGA ( DRUGN ) : DRUGB Therapy : DRUGN may potentiate the effects of DRUGN and vasoactive drugs resulting in postural hypotension .
Vitamin B3	drug	Antihypertensive	group
false

Interactions for DRUGA ( DRUGN ) : DRUGN Therapy : DRUGB may potentiate the effects of DRUGN and vasoactive drugs resulting in postural hypotension .
Vitamin B3	drug	Nicotinic acid	drug
false

Interactions for DRUGA ( DRUGN ) : DRUGN Therapy : DRUGN may potentiate the effects of DRUGB and vasoactive drugs resulting in postural hypotension .
Vitamin B3	drug	ganglionic blocking agents	group
false

Interactions for DRUGN ( DRUGA ) : DRUGB Therapy : DRUGN may potentiate the effects of DRUGN and vasoactive drugs resulting in postural hypotension .
Niacin	drug	Antihypertensive	group
false

Interactions for DRUGN ( DRUGA ) : DRUGN Therapy : DRUGB may potentiate the effects of DRUGN and vasoactive drugs resulting in postural hypotension .
Niacin	drug	Nicotinic acid	drug
false

Interactions for DRUGN ( DRUGA ) : DRUGN Therapy : DRUGN may potentiate the effects of DRUGB and vasoactive drugs resulting in postural hypotension .
Niacin	drug	ganglionic blocking agents	group
false

Interactions for DRUGN ( DRUGN ) : DRUGA Therapy : DRUGB may potentiate the effects of DRUGN and vasoactive drugs resulting in postural hypotension .
Antihypertensive	group	Nicotinic acid	drug
false

Interactions for DRUGN ( DRUGN ) : DRUGA Therapy : DRUGN may potentiate the effects of DRUGB and vasoactive drugs resulting in postural hypotension .
Antihypertensive	group	ganglionic blocking agents	group
false

Interactions for DRUGN ( DRUGN ) : DRUGN Therapy : DRUGA may potentiate the effects of DRUGB and vasoactive drugs resulting in postural hypotension .
Nicotinic acid	drug	ganglionic blocking agents	group
effect

DRUGA : Concomitant DRUGB may decrease the metabolic clearance of DRUGN .
Aspirin	brand	aspirin	brand
false

DRUGA : Concomitant DRUGN may decrease the metabolic clearance of DRUGB .
Aspirin	brand	nicotinic acid	drug
false

DRUGN : Concomitant DRUGA may decrease the metabolic clearance of DRUGB .
aspirin	brand	nicotinic acid	drug
mechanism

DRUGA : In controlled clinical studies , DRUGB have been frequently administered concomitantly with DRUGN .
Beta-Blockers	group	adrenergic beta-receptor blockers	group
false

DRUGA : In controlled clinical studies , DRUGN have been frequently administered concomitantly with DRUGB .
Beta-Blockers	group	nicardipine HCl	drug
false

DRUGN : In controlled clinical studies , DRUGA have been frequently administered concomitantly with DRUGB .
adrenergic beta-receptor blockers	group	nicardipine HCl	drug
false

DRUGA : DRUGN increases DRUGB plasma levels .
Cimetidine	drug	nicardipine HCl	drug
false

DRUGN : DRUGA increases DRUGB plasma levels .
Cimetidine	drug	nicardipine HCl	drug
mechanism

DRUGA : Some DRUGB may increase the concentration of DRUGN in the blood .
Digoxin	drug	calcium blockers	group
false

DRUGA : Some DRUGN may increase the concentration of DRUGB in the blood .
Digoxin	drug	digitalis preparations	group
false

DRUGN : Some DRUGA may increase the concentration of DRUGB in the blood .
calcium blockers	group	digitalis preparations	group
mechanism

DRUGA usually does not alter the plasma levels of DRUGB , however , serum DRUGN levels should be evaluated after concomitant therapy with DRUGN is initiated .
Nicardipine HCl	drug	digoxin	drug
false

DRUGA usually does not alter the plasma levels of DRUGN , however , serum DRUGB levels should be evaluated after concomitant therapy with DRUGN is initiated .
Nicardipine HCl	drug	digoxin	drug
false

DRUGA usually does not alter the plasma levels of DRUGN , however , serum DRUGN levels should be evaluated after concomitant therapy with DRUGB is initiated .
Nicardipine HCl	drug	nicardipine HCl	drug
false

DRUGN usually does not alter the plasma levels of DRUGA , however , serum DRUGN levels should be evaluated after concomitant therapy with DRUGB is initiated .
digoxin	drug	nicardipine HCl	drug
false

DRUGN usually does not alter the plasma levels of DRUGN , however , serum DRUGA levels should be evaluated after concomitant therapy with DRUGB is initiated .
digoxin	drug	nicardipine HCl	drug
advise

DRUGA * Coadministration of DRUGB had no effect on DRUGN absorption .
Maalox	brand	Maalox TC	brand
false

DRUGA * Coadministration of DRUGN had no effect on DRUGB absorption .
Maalox	brand	nicardipine HCl	drug
false

DRUGN * Coadministration of DRUGA had no effect on DRUGB absorption .
Maalox TC	brand	nicardipine HCl	drug
false

DRUGA : Concomitant administration of DRUGB and DRUGN levels .
Cyclosporine	drug	nicardipine	drug
false

DRUGA : Concomitant administration of DRUGN and DRUGB levels .
Cyclosporine	drug	cyclosporine	drug
false

DRUGN : Concomitant administration of DRUGA and DRUGB levels .
nicardipine	drug	cyclosporine	drug
false

Plasma concentrations of DRUGA should therefore be closely monitored , and its dosage reduced accordingly , in patients treated with DRUGB .
cyclosporine	drug	nicardipine	drug
advise

When therapeutic concentrations of DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , or DRUGN were added to human plasma ( in vitro ) , the plasma protein binding of DRUGN was not altered .
furosemide	drug	propranolol	drug
false

When therapeutic concentrations of DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , or DRUGN were added to human plasma ( in vitro ) , the plasma protein binding of DRUGN was not altered .
furosemide	drug	dipyridamole	drug
false

When therapeutic concentrations of DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , or DRUGN were added to human plasma ( in vitro ) , the plasma protein binding of DRUGN was not altered .
furosemide	drug	warfarin	drug
false

When therapeutic concentrations of DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , or DRUGN were added to human plasma ( in vitro ) , the plasma protein binding of DRUGN was not altered .
furosemide	drug	quinidine	drug
false

When therapeutic concentrations of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , or DRUGB were added to human plasma ( in vitro ) , the plasma protein binding of DRUGN was not altered .
furosemide	drug	naproxen	drug
false

When therapeutic concentrations of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , or DRUGN were added to human plasma ( in vitro ) , the plasma protein binding of DRUGB was not altered .
furosemide	drug	nicardipine HCl	drug
false

When therapeutic concentrations of DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , or DRUGN were added to human plasma ( in vitro ) , the plasma protein binding of DRUGN was not altered .
propranolol	drug	dipyridamole	drug
false

When therapeutic concentrations of DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , or DRUGN were added to human plasma ( in vitro ) , the plasma protein binding of DRUGN was not altered .
propranolol	drug	warfarin	drug
false

When therapeutic concentrations of DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , or DRUGN were added to human plasma ( in vitro ) , the plasma protein binding of DRUGN was not altered .
propranolol	drug	quinidine	drug
false

When therapeutic concentrations of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , or DRUGB were added to human plasma ( in vitro ) , the plasma protein binding of DRUGN was not altered .
propranolol	drug	naproxen	drug
false

When therapeutic concentrations of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , or DRUGN were added to human plasma ( in vitro ) , the plasma protein binding of DRUGB was not altered .
propranolol	drug	nicardipine HCl	drug
false

When therapeutic concentrations of DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , or DRUGN were added to human plasma ( in vitro ) , the plasma protein binding of DRUGN was not altered .
dipyridamole	drug	warfarin	drug
false

When therapeutic concentrations of DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , or DRUGN were added to human plasma ( in vitro ) , the plasma protein binding of DRUGN was not altered .
dipyridamole	drug	quinidine	drug
false

When therapeutic concentrations of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , or DRUGB were added to human plasma ( in vitro ) , the plasma protein binding of DRUGN was not altered .
dipyridamole	drug	naproxen	drug
false

When therapeutic concentrations of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , or DRUGN were added to human plasma ( in vitro ) , the plasma protein binding of DRUGB was not altered .
dipyridamole	drug	nicardipine HCl	drug
false

When therapeutic concentrations of DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , or DRUGN were added to human plasma ( in vitro ) , the plasma protein binding of DRUGN was not altered .
warfarin	drug	quinidine	drug
false

When therapeutic concentrations of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , or DRUGB were added to human plasma ( in vitro ) , the plasma protein binding of DRUGN was not altered .
warfarin	drug	naproxen	drug
false

When therapeutic concentrations of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , or DRUGN were added to human plasma ( in vitro ) , the plasma protein binding of DRUGB was not altered .
warfarin	drug	nicardipine HCl	drug
false

When therapeutic concentrations of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , or DRUGB were added to human plasma ( in vitro ) , the plasma protein binding of DRUGN was not altered .
quinidine	drug	naproxen	drug
false

When therapeutic concentrations of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , or DRUGN were added to human plasma ( in vitro ) , the plasma protein binding of DRUGB was not altered .
quinidine	drug	nicardipine HCl	drug
false

When therapeutic concentrations of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or DRUGA were added to human plasma ( in vitro ) , the plasma protein binding of DRUGB was not altered .
naproxen	drug	nicardipine HCl	drug
false

Physiological changes resulting from smoking cessation , with or without DRUGA replacement , may alter the pharmacokinetics of certain concomitant medications , such as DRUGB and DRUGN .
nicotine	drug	tricyclic antidepressants	group
false

Physiological changes resulting from smoking cessation , with or without DRUGA replacement , may alter the pharmacokinetics of certain concomitant medications , such as DRUGN and DRUGB .
nicotine	drug	theophylline	drug
false

Physiological changes resulting from smoking cessation , with or without DRUGN replacement , may alter the pharmacokinetics of certain concomitant medications , such as DRUGA and DRUGB .
tricyclic antidepressants	group	theophylline	drug
false

Long Acting DRUGA : DRUGB may be safely co administered with DRUGN , but there have been no controlled studies to evaluate the antianginal effectiveness of this combination .
Nitrates	group	Nifedipine	drug
false

Long Acting DRUGA : DRUGN may be safely co administered with DRUGB , but there have been no controlled studies to evaluate the antianginal effectiveness of this combination .
Nitrates	group	nitrates	group
false

Long Acting DRUGN : DRUGA may be safely co administered with DRUGB , but there have been no controlled studies to evaluate the antianginal effectiveness of this combination .
Nifedipine	drug	nitrates	group
false

Extended Release Tablets : Administration of DRUGA with DRUGB increased DRUGN levels in dgb of dgb normal volunteers .
nifedipine	drug	digoxin	drug
false

Extended Release Tablets : Administration of DRUGA with DRUGN increased DRUGB levels in dgb of dgb normal volunteers .
nifedipine	drug	digoxin	drug
false

Since there have been isolated reports of patients with elevated DRUGA levels , it is recommended that DRUGN levels be monitored when initiating , adjusting , and discontinuing DRUGB to avoid possible over or under digitalization .
digoxin	drug	nifedipine	drug
false

Since there have been isolated reports of patients with elevated DRUGN levels , it is recommended that DRUGA levels be monitored when initiating , adjusting , and discontinuing DRUGB to avoid possible over or under digitalization .
digoxin	drug	nifedipine	drug
advise

DRUGA : Immediate Release Capsules : There have been rare reports of an interaction between DRUGB and DRUGN ( with a decreased plasma level of DRUGN ) .
Quinidine	drug	quinidine	drug
false

DRUGA : Immediate Release Capsules : There have been rare reports of an interaction between DRUGN and DRUGB ( with a decreased plasma level of DRUGN ) .
Quinidine	drug	nifedipine	drug
false

DRUGA : Immediate Release Capsules : There have been rare reports of an interaction between DRUGN and DRUGN ( with a decreased plasma level of DRUGB ) .
Quinidine	drug	quinidine	drug
false

DRUGN : Immediate Release Capsules : There have been rare reports of an interaction between DRUGA and DRUGB ( with a decreased plasma level of DRUGN ) .
quinidine	drug	nifedipine	drug
mechanism

DRUGN : Immediate Release Capsules : There have been rare reports of an interaction between DRUGN and DRUGA ( with a decreased plasma level of DRUGB ) .
nifedipine	drug	quinidine	drug
false

DRUGA : There have been rare reports of increased prothrombin time in patients taking DRUGB to whom DRUGN was administered .
Coumarin Anticoagulants	group	coumarin anticoagulants	group
false

DRUGA : There have been rare reports of increased prothrombin time in patients taking DRUGN to whom DRUGB was administered .
Coumarin Anticoagulants	group	nifedipine	drug
false

DRUGN : There have been rare reports of increased prothrombin time in patients taking DRUGA to whom DRUGB was administered .
coumarin anticoagulants	group	nifedipine	drug
effect

The effect may be mediated by the known inhibition of DRUGA on hepatic cytochrome P dgb , the enzyme system probably responsible for the first pass metabolism of DRUGB .
cimetidine	drug	nifedipine	drug
false

If DRUGA therapy is initiated in a patient currently receiving DRUGB , cautious titration is advised .
nifedipine	drug	cimetidine	drug
advise

Consequently , drugs with a low therapeutic margin , such as DRUGA , DRUGB , and DRUGN , could have a delayed elimination and increases in their serum half life leading to a toxic level .
vitamin K antagonists	group	phenytoin	drug
false

Consequently , drugs with a low therapeutic margin , such as DRUGA , DRUGN , and DRUGB , could have a delayed elimination and increases in their serum half life leading to a toxic level .
vitamin K antagonists	group	theophylline	drug
false

Consequently , drugs with a low therapeutic margin , such as DRUGN , DRUGA , and DRUGB , could have a delayed elimination and increases in their serum half life leading to a toxic level .
phenytoin	drug	theophylline	drug
false

For example , when DRUGA are administered concomitantly with DRUGB , prothrombin time should be carefully monitored and if necessary , the dosage of DRUGN should be reduced .
vitamin K antagonists	group	nilutamide	drug
advise

For example , when DRUGN are administered concomitantly with DRUGA , prothrombin time should be carefully monitored and if necessary , the dosage of DRUGB should be reduced .
nilutamide	drug	vitamin K antagonists	group
false

It is possible that the cardiovascular action of other DRUGA could be enhanced by the addition of DRUGB .
calcium channel blockers	group	Nimotop	brand
effect

In Europe , DRUGA was observed to occasionally intensify the effect of DRUGB taken concomitantly by patients suffering from hypertension ;
Nimotop	brand	antihypertensive compounds	group
effect

This effect may be mediated by the known inhibition of hepatic cytochrome P dgb by DRUGA , which could decrease first pass metabolism of DRUGB .
cimetidine	drug	nimodipine	drug
false

A dgb to dgb % increase in AUC and Cmax of DRUGA was observed with concomitant administration of DRUGB twice daily .
nisoldipine	drug	cimetidine 400 mg	drug
mechanism

DRUGA dgb mg twice daily did not interact significantly with DRUGB ( AUC was decreased by dgb dgb % ) .
Ranitidine	drug	nisoldipine	drug
false

Coadministration of DRUGA with dgb mg DRUGB tablets in epileptic patients lowered the DRUGN plasma concentrations to undetectable levels .
phenytoin	drug	SULAR	brand
mechanism

Coadministration of DRUGA with dgb mg DRUGN tablets in epileptic patients lowered the DRUGB plasma concentrations to undetectable levels .
phenytoin	drug	nisoldipine	drug
false

Coadministration of DRUGN with dgb mg DRUGA tablets in epileptic patients lowered the DRUGB plasma concentrations to undetectable levels .
SULAR	brand	nisoldipine	drug
false

Coadministration of DRUGA with DRUGB or any known CYPdgbAdgb inducer should be avoided and alternative DRUGN therapy should be considered .
SULAR	brand	phenytoin	drug
advise

Coadministration of DRUGA with DRUGN or any known CYPdgbAdgb inducer should be avoided and alternative DRUGB therapy should be considered .
SULAR	brand	antihypertensive	group
false

Coadministration of DRUGN with DRUGA or any known CYPdgbAdgb inducer should be avoided and alternative DRUGB therapy should be considered .
phenytoin	drug	antihypertensive	group
false

Pharmacokinetic interactions between DRUGA and DRUGB ( DRUGN , DRUGN ) were variable and not significant .
nisoldipine	drug	beta-blockers	group
false

Pharmacokinetic interactions between DRUGA and DRUGN ( DRUGB , DRUGN ) were variable and not significant .
nisoldipine	drug	atenolol	drug
false

Pharmacokinetic interactions between DRUGA and DRUGN ( DRUGN , DRUGB ) were variable and not significant .
nisoldipine	drug	propranolol	drug
false

Pharmacokinetic interactions between DRUGN and DRUGA ( DRUGB , DRUGN ) were variable and not significant .
beta-blockers	group	atenolol	drug
false

Pharmacokinetic interactions between DRUGN and DRUGA ( DRUGN , DRUGB ) were variable and not significant .
beta-blockers	group	propranolol	drug
false

Pharmacokinetic interactions between DRUGN and DRUGN ( DRUGA , DRUGB ) were variable and not significant .
atenolol	drug	propranolol	drug
false

DRUGA attenuated the heart rate increase following administration of immediate release DRUGB .
Propranolol	drug	nisoldipine	drug
effect

The blood pressure effect of DRUGA tended to be greater in patients on DRUGB than in patients on no other DRUGN therapy .
SULAR	brand	atenolol	drug
effect

The blood pressure effect of DRUGA tended to be greater in patients on DRUGN than in patients on no other DRUGB therapy .
SULAR	brand	antihypertensive	group
false

The blood pressure effect of DRUGN tended to be greater in patients on DRUGA than in patients on no other DRUGB therapy .
atenolol	drug	antihypertensive	group
false

DRUGA at dgb mg bid decreased the bioavailability ( AUC ) of DRUGB by dgb % , but not the peak concentration .
Quinidine	drug	nisoldipine	drug
mechanism

The immediate release , but not the coat core formulation of DRUGA increased plasma DRUGB concentrations by about dgb % .
nisoldipine	drug	quinidine	drug
mechanism

No significant interactions were found between DRUGA and DRUGB or DRUGN .
nisoldipine	drug	warfarin	drug
false

No significant interactions were found between DRUGA and DRUGN or DRUGB .
nisoldipine	drug	digoxin	drug
false

No significant interactions were found between DRUGN and DRUGA or DRUGB .
warfarin	drug	digoxin	drug
false

Therefore , caution should be used when administering DRUGA concurrently with other highly plasma protein bound drugs with narrow therapeutic indices , as competition for binding sites may occur ( e.g . , DRUGB ) .
nitazoxanide	drug	warfarin	drug
mechanism

DRUGA has been administered with DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and high frequency ventilation .
INOmax	brand	tolazoline	drug
false

DRUGA has been administered with DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and high frequency ventilation .
INOmax	brand	dopamine	drug
false

DRUGA has been administered with DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and high frequency ventilation .
INOmax	brand	dobutamine	drug
false

DRUGA has been administered with DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and high frequency ventilation .
INOmax	brand	steroids	group
false

DRUGA has been administered with DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and high frequency ventilation .
INOmax	brand	surfactant	drug
false

DRUGN has been administered with DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and high frequency ventilation .
tolazoline	drug	dopamine	drug
false

DRUGN has been administered with DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and high frequency ventilation .
tolazoline	drug	dobutamine	drug
false

DRUGN has been administered with DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and high frequency ventilation .
tolazoline	drug	steroids	group
false

DRUGN has been administered with DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and high frequency ventilation .
tolazoline	drug	surfactant	drug
false

DRUGN has been administered with DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and high frequency ventilation .
dopamine	drug	dobutamine	drug
false

DRUGN has been administered with DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and high frequency ventilation .
dopamine	drug	steroids	group
false

DRUGN has been administered with DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and high frequency ventilation .
dopamine	drug	surfactant	drug
false

DRUGN has been administered with DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and high frequency ventilation .
dobutamine	drug	steroids	group
false

DRUGN has been administered with DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and high frequency ventilation .
dobutamine	drug	surfactant	drug
false

DRUGN has been administered with DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and high frequency ventilation .
steroids	group	surfactant	drug
false

Although there are no study data to evaluate the possibility , DRUGA , including DRUGB and DRUGN , may have an additive effect with DRUGN on the risk of developing methemoglobinemia .
nitric oxide donor compounds	group	sodium nitroprusside	drug
false

Although there are no study data to evaluate the possibility , DRUGA , including DRUGN and DRUGB , may have an additive effect with DRUGN on the risk of developing methemoglobinemia .
nitric oxide donor compounds	group	nitroglycerin	drug
false

Although there are no study data to evaluate the possibility , DRUGA , including DRUGN and DRUGN , may have an additive effect with DRUGB on the risk of developing methemoglobinemia .
nitric oxide donor compounds	group	INOmax	brand
effect

Although there are no study data to evaluate the possibility , DRUGN , including DRUGA and DRUGB , may have an additive effect with DRUGN on the risk of developing methemoglobinemia .
sodium nitroprusside	drug	nitroglycerin	drug
false

Although there are no study data to evaluate the possibility , DRUGN , including DRUGA and DRUGN , may have an additive effect with DRUGB on the risk of developing methemoglobinemia .
sodium nitroprusside	drug	INOmax	brand
effect

Although there are no study data to evaluate the possibility , DRUGN , including DRUGN and DRUGA , may have an additive effect with DRUGB on the risk of developing methemoglobinemia .
nitroglycerin	drug	INOmax	brand
effect

DRUGA containing DRUGB , when administered concomitantly with DRUGN , reduce both the rate and extent of absorption .
Antacids	group	magnesium trisilicate	drug
false

DRUGA containing DRUGN , when administered concomitantly with DRUGB , reduce both the rate and extent of absorption .
Antacids	group	nitrofurantoin	drug
false

DRUGN containing DRUGA , when administered concomitantly with DRUGB , reduce both the rate and extent of absorption .
magnesium trisilicate	drug	nitrofurantoin	drug
mechanism

The mechanism for this interaction probably is adsorption of DRUGA onto the surface of DRUGB .
nitrofurantoin	drug	magnesium trisilicate	drug
mechanism

DRUGA , such as DRUGB and DRUGN , can inhibit renal tubular secretion of DRUGN .
Uricosuric drugs	group	probenecid	drug
false

DRUGA , such as DRUGN and DRUGB , can inhibit renal tubular secretion of DRUGN .
Uricosuric drugs	group	sulfinpyrazone	drug
false

DRUGA , such as DRUGN and DRUGN , can inhibit renal tubular secretion of DRUGB .
Uricosuric drugs	group	nitrofurantoin	drug
mechanism

DRUGN , such as DRUGA and DRUGB , can inhibit renal tubular secretion of DRUGN .
probenecid	drug	sulfinpyrazone	drug
false

DRUGN , such as DRUGA and DRUGN , can inhibit renal tubular secretion of DRUGB .
probenecid	drug	nitrofurantoin	drug
mechanism

DRUGN , such as DRUGN and DRUGA , can inhibit renal tubular secretion of DRUGB .
sulfinpyrazone	drug	nitrofurantoin	drug
mechanism

The resulting increase in DRUGA serum levels may increase toxicity , and the decreased urinary levels could lessen its efficacy as a urinary tract DRUGB .
nitrofurantoin	drug	antibacterial	group
false

The vasodilating effects of DRUGA may be additive with those of other DRUGB .
nitroglycerin	drug	vasodilators	group
effect

Marked symptomatic orthostatic hypotension has been reported when DRUGA and organic DRUGB were used in combination .
calcium channel blockers	group	nitrates	group
effect

The hypotensive effect of DRUGA is augmented by that of most other DRUGB , including DRUGN , negative inotropic agents , and inhaled DRUGN .
sodium nitroprusside	drug	hypotensive drugs	group
effect

The hypotensive effect of DRUGA is augmented by that of most other DRUGN , including DRUGB , negative inotropic agents , and inhaled DRUGN .
sodium nitroprusside	drug	ganglionic blocking agents	group
effect

The hypotensive effect of DRUGA is augmented by that of most other DRUGN , including DRUGN , negative inotropic agents , and inhaled DRUGB .
sodium nitroprusside	drug	anesthetics	group
effect

The hypotensive effect of DRUGN is augmented by that of most other DRUGA , including DRUGB , negative inotropic agents , and inhaled DRUGN .
hypotensive drugs	group	ganglionic blocking agents	group
false

The hypotensive effect of DRUGN is augmented by that of most other DRUGA , including DRUGN , negative inotropic agents , and inhaled DRUGB .
hypotensive drugs	group	anesthetics	group
false

The hypotensive effect of DRUGN is augmented by that of most other DRUGN , including DRUGA , negative inotropic agents , and inhaled DRUGB .
ganglionic blocking agents	group	anesthetics	group
false

No interactions have been observed between DRUGA and DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
nizatidine	drug	theophylline	drug
false

No interactions have been observed between DRUGA and DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
nizatidine	drug	chlordiazepoxide	drug
false

No interactions have been observed between DRUGA and DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
nizatidine	drug	lorazepam	drug
false

No interactions have been observed between DRUGA and DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
nizatidine	drug	lidocaine	drug
false

No interactions have been observed between DRUGA and DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
nizatidine	drug	phenytoin	drug
false

No interactions have been observed between DRUGA and DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
nizatidine	drug	warfarin	drug
false

No interactions have been observed between DRUGN and DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
theophylline	drug	chlordiazepoxide	drug
false

No interactions have been observed between DRUGN and DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
theophylline	drug	lorazepam	drug
false

No interactions have been observed between DRUGN and DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
theophylline	drug	lidocaine	drug
false

No interactions have been observed between DRUGN and DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
theophylline	drug	phenytoin	drug
false

No interactions have been observed between DRUGN and DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
theophylline	drug	warfarin	drug
false

No interactions have been observed between DRUGN and DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
chlordiazepoxide	drug	lorazepam	drug
false

No interactions have been observed between DRUGN and DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
chlordiazepoxide	drug	lidocaine	drug
false

No interactions have been observed between DRUGN and DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
chlordiazepoxide	drug	phenytoin	drug
false

No interactions have been observed between DRUGN and DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
chlordiazepoxide	drug	warfarin	drug
false

No interactions have been observed between DRUGN and DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
lorazepam	drug	lidocaine	drug
false

No interactions have been observed between DRUGN and DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
lorazepam	drug	phenytoin	drug
false

No interactions have been observed between DRUGN and DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
lorazepam	drug	warfarin	drug
false

No interactions have been observed between DRUGN and DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
lidocaine	drug	phenytoin	drug
false

No interactions have been observed between DRUGN and DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
lidocaine	drug	warfarin	drug
false

No interactions have been observed between DRUGN and DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
phenytoin	drug	warfarin	drug
false

In patients given very high doses ( dgb mg ) of DRUGA daily , increases in serum DRUGB levels were seen when DRUGN , dgb mg b.i.d . , was administered concurrently .
aspirin	brand	salicylate	group
false

In patients given very high doses ( dgb mg ) of DRUGA daily , increases in serum DRUGN levels were seen when DRUGB , dgb mg b.i.d . , was administered concurrently .
aspirin	brand	nizatidine	drug
mechanism

In patients given very high doses ( dgb mg ) of DRUGN daily , increases in serum DRUGA levels were seen when DRUGB , dgb mg b.i.d . , was administered concurrently .
salicylate	group	nizatidine	drug
false

The effectiveness of DRUGA only pills is reduced by hepatic enzyme inducing drugs such as the DRUGB DRUGN , DRUGN , and DRUGN , and the DRUGN DRUGN .
progestin	group	anticonvulsants	group
false

The effectiveness of DRUGA only pills is reduced by hepatic enzyme inducing drugs such as the DRUGN DRUGB , DRUGN , and DRUGN , and the DRUGN DRUGN .
progestin	group	phenytoin	drug
effect

The effectiveness of DRUGA only pills is reduced by hepatic enzyme inducing drugs such as the DRUGN DRUGN , DRUGB , and DRUGN , and the DRUGN DRUGN .
progestin	group	carbamazepine	drug
effect

The effectiveness of DRUGA only pills is reduced by hepatic enzyme inducing drugs such as the DRUGN DRUGN , DRUGN , and DRUGB , and the DRUGN DRUGN .
progestin	group	barbiturates	group
effect

The effectiveness of DRUGA only pills is reduced by hepatic enzyme inducing drugs such as the DRUGN DRUGN , DRUGN , and DRUGN , and the DRUGB DRUGN .
progestin	group	antituberculosis drug	group
false

The effectiveness of DRUGA only pills is reduced by hepatic enzyme inducing drugs such as the DRUGN DRUGN , DRUGN , and DRUGN , and the DRUGN DRUGB .
progestin	group	rifampin	drug
effect

The effectiveness of DRUGN only pills is reduced by hepatic enzyme inducing drugs such as the DRUGA DRUGB , DRUGN , and DRUGN , and the DRUGN DRUGN .
anticonvulsants	group	phenytoin	drug
false

The effectiveness of DRUGN only pills is reduced by hepatic enzyme inducing drugs such as the DRUGA DRUGN , DRUGB , and DRUGN , and the DRUGN DRUGN .
anticonvulsants	group	carbamazepine	drug
false

The effectiveness of DRUGN only pills is reduced by hepatic enzyme inducing drugs such as the DRUGA DRUGN , DRUGN , and DRUGB , and the DRUGN DRUGN .
anticonvulsants	group	barbiturates	group
false

The effectiveness of DRUGN only pills is reduced by hepatic enzyme inducing drugs such as the DRUGA DRUGN , DRUGN , and DRUGN , and the DRUGB DRUGN .
anticonvulsants	group	antituberculosis drug	group
false

The effectiveness of DRUGN only pills is reduced by hepatic enzyme inducing drugs such as the DRUGA DRUGN , DRUGN , and DRUGN , and the DRUGN DRUGB .
anticonvulsants	group	rifampin	drug
false

The effectiveness of DRUGN only pills is reduced by hepatic enzyme inducing drugs such as the DRUGN DRUGA , DRUGB , and DRUGN , and the DRUGN DRUGN .
phenytoin	drug	carbamazepine	drug
false

The effectiveness of DRUGN only pills is reduced by hepatic enzyme inducing drugs such as the DRUGN DRUGA , DRUGN , and DRUGB , and the DRUGN DRUGN .
phenytoin	drug	barbiturates	group
false

The effectiveness of DRUGN only pills is reduced by hepatic enzyme inducing drugs such as the DRUGN DRUGA , DRUGN , and DRUGN , and the DRUGB DRUGN .
phenytoin	drug	antituberculosis drug	group
false

The effectiveness of DRUGN only pills is reduced by hepatic enzyme inducing drugs such as the DRUGN DRUGA , DRUGN , and DRUGN , and the DRUGN DRUGB .
phenytoin	drug	rifampin	drug
false

The effectiveness of DRUGN only pills is reduced by hepatic enzyme inducing drugs such as the DRUGN DRUGN , DRUGA , and DRUGB , and the DRUGN DRUGN .
carbamazepine	drug	barbiturates	group
false

The effectiveness of DRUGN only pills is reduced by hepatic enzyme inducing drugs such as the DRUGN DRUGN , DRUGA , and DRUGN , and the DRUGB DRUGN .
carbamazepine	drug	antituberculosis drug	group
false

The effectiveness of DRUGN only pills is reduced by hepatic enzyme inducing drugs such as the DRUGN DRUGN , DRUGA , and DRUGN , and the DRUGN DRUGB .
carbamazepine	drug	rifampin	drug
false

The effectiveness of DRUGN only pills is reduced by hepatic enzyme inducing drugs such as the DRUGN DRUGN , DRUGN , and DRUGA , and the DRUGB DRUGN .
barbiturates	group	antituberculosis drug	group
false

The effectiveness of DRUGN only pills is reduced by hepatic enzyme inducing drugs such as the DRUGN DRUGN , DRUGN , and DRUGA , and the DRUGN DRUGB .
barbiturates	group	rifampin	drug
false

The effectiveness of DRUGN only pills is reduced by hepatic enzyme inducing drugs such as the DRUGN DRUGN , DRUGN , and DRUGN , and the DRUGA DRUGB .
antituberculosis drug	group	rifampin	drug
false

Elevated plasma levels of DRUGA have been reported with concomitant DRUGB use .
theophylline	drug	quinolone	group
mechanism

There have been reports of DRUGA related side effects in patients on concomitant therapy with DRUGB and DRUGN .
theophylline	drug	norfloxacin	drug
false

There have been reports of DRUGN related side effects in patients on concomitant therapy with DRUGA and DRUGB .
norfloxacin	drug	theophylline	drug
effect

Elevated serum levels of DRUGA have been reported with concomitant use of DRUGN with DRUGB .
cyclosporine	drug	norfloxacin	drug
false

Elevated serum levels of DRUGN have been reported with concomitant use of DRUGA with DRUGB .
cyclosporine	drug	norfloxacin	drug
mechanism

DRUGA , including DRUGB , may enhance the effects of oral DRUGN , including DRUGN or its derivatives or similar agents .
Quinolones	group	norfloxacin	drug
false

DRUGA , including DRUGN , may enhance the effects of oral DRUGB , including DRUGN or its derivatives or similar agents .
Quinolones	group	anticoagulants	group
effect

DRUGA , including DRUGN , may enhance the effects of oral DRUGN , including DRUGB or its derivatives or similar agents .
Quinolones	group	warfarin	drug
effect

DRUGN , including DRUGA , may enhance the effects of oral DRUGB , including DRUGN or its derivatives or similar agents .
norfloxacin	drug	anticoagulants	group
effect

DRUGN , including DRUGA , may enhance the effects of oral DRUGN , including DRUGB or its derivatives or similar agents .
norfloxacin	drug	warfarin	drug
effect

DRUGN , including DRUGN , may enhance the effects of oral DRUGA , including DRUGB or its derivatives or similar agents .
anticoagulants	group	warfarin	drug
false

The concomitant administration of DRUGA including DRUGB with DRUGN ( a DRUGN ) has , on rare occasions , resulted in severe hypoglycemia .
quinolones	group	norfloxacin	drug
false

The concomitant administration of DRUGA including DRUGN with DRUGB ( a DRUGN ) has , on rare occasions , resulted in severe hypoglycemia .
quinolones	group	glyburide	drug
effect

The concomitant administration of DRUGA including DRUGN with DRUGN ( a DRUGB ) has , on rare occasions , resulted in severe hypoglycemia .
quinolones	group	sulfonylurea agent	group
false

The concomitant administration of DRUGN including DRUGA with DRUGB ( a DRUGN ) has , on rare occasions , resulted in severe hypoglycemia .
norfloxacin	drug	glyburide	drug
effect

The concomitant administration of DRUGN including DRUGA with DRUGN ( a DRUGB ) has , on rare occasions , resulted in severe hypoglycemia .
norfloxacin	drug	sulfonylurea agent	group
false

The concomitant administration of DRUGN including DRUGN with DRUGA ( a DRUGB ) has , on rare occasions , resulted in severe hypoglycemia .
glyburide	drug	sulfonylurea agent	group
false

Diminished urinary excretion of DRUGA has been reported during the concomitant administration of DRUGB and DRUGN .
norfloxacin	drug	probenecid	drug
false

Diminished urinary excretion of DRUGN has been reported during the concomitant administration of DRUGA and DRUGB .
probenecid	drug	norfloxacin	drug
mechanism

The concomitant use of DRUGA is not recommended since DRUGN may antagonize the antibacterial effect of DRUGB in the urinary tract .
nitrofurantoin	drug	Norfloxacin	drug
false

The concomitant use of DRUGN is not recommended since DRUGA may antagonize the antibacterial effect of DRUGB in the urinary tract .
nitrofurantoin	drug	Norfloxacin	drug
effect

Some DRUGA have also been shown to interfere with the metabolism of DRUGB .
quinolones	group	caffeine	drug
mechanism

A similar association , though less marked , has been suggested with DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and possibly with DRUGN and DRUGN dga
barbiturates	group	phenylbutazone	drug
false

A similar association , though less marked , has been suggested with DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and possibly with DRUGN and DRUGN dga
barbiturates	group	phenytoin sodium	drug
false

A similar association , though less marked , has been suggested with DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and possibly with DRUGN and DRUGN dga
barbiturates	group	carbamazepine	drug
false

A similar association , though less marked , has been suggested with DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and possibly with DRUGN and DRUGN dga
barbiturates	group	griseofulvin	drug
false

A similar association , though less marked , has been suggested with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and possibly with DRUGN and DRUGN dga
barbiturates	group	topiramate	drug
false

A similar association , though less marked , has been suggested with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly with DRUGB and DRUGN dga
barbiturates	group	ampicillin	drug
false

A similar association , though less marked , has been suggested with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly with DRUGN and DRUGB dga
barbiturates	group	tetracyclines	group
false

A similar association , though less marked , has been suggested with DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and possibly with DRUGN and DRUGN dga
phenylbutazone	drug	phenytoin sodium	drug
false

A similar association , though less marked , has been suggested with DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and possibly with DRUGN and DRUGN dga
phenylbutazone	drug	carbamazepine	drug
false

A similar association , though less marked , has been suggested with DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and possibly with DRUGN and DRUGN dga
phenylbutazone	drug	griseofulvin	drug
false

A similar association , though less marked , has been suggested with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and possibly with DRUGN and DRUGN dga
phenylbutazone	drug	topiramate	drug
false

A similar association , though less marked , has been suggested with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and possibly with DRUGB and DRUGN dga
phenylbutazone	drug	ampicillin	drug
false

A similar association , though less marked , has been suggested with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and possibly with DRUGN and DRUGB dga
phenylbutazone	drug	tetracyclines	group
false

A similar association , though less marked , has been suggested with DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and possibly with DRUGN and DRUGN dga
phenytoin sodium	drug	carbamazepine	drug
false

A similar association , though less marked , has been suggested with DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and possibly with DRUGN and DRUGN dga
phenytoin sodium	drug	griseofulvin	drug
false

A similar association , though less marked , has been suggested with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and possibly with DRUGN and DRUGN dga
phenytoin sodium	drug	topiramate	drug
false

A similar association , though less marked , has been suggested with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and possibly with DRUGB and DRUGN dga
phenytoin sodium	drug	ampicillin	drug
false

A similar association , though less marked , has been suggested with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and possibly with DRUGN and DRUGB dga
phenytoin sodium	drug	tetracyclines	group
false

A similar association , though less marked , has been suggested with DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and possibly with DRUGN and DRUGN dga
carbamazepine	drug	griseofulvin	drug
false

A similar association , though less marked , has been suggested with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and possibly with DRUGN and DRUGN dga
carbamazepine	drug	topiramate	drug
false

A similar association , though less marked , has been suggested with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and possibly with DRUGB and DRUGN dga
carbamazepine	drug	ampicillin	drug
false

A similar association , though less marked , has been suggested with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and possibly with DRUGN and DRUGB dga
carbamazepine	drug	tetracyclines	group
false

A similar association , though less marked , has been suggested with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and possibly with DRUGN and DRUGN dga
griseofulvin	drug	topiramate	drug
false

A similar association , though less marked , has been suggested with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and possibly with DRUGB and DRUGN dga
griseofulvin	drug	ampicillin	drug
false

A similar association , though less marked , has been suggested with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and possibly with DRUGN and DRUGB dga
griseofulvin	drug	tetracyclines	group
false

A similar association , though less marked , has been suggested with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and possibly with DRUGB and DRUGN dga
topiramate	drug	ampicillin	drug
false

A similar association , though less marked , has been suggested with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and possibly with DRUGN and DRUGB dga
topiramate	drug	tetracyclines	group
false

A similar association , though less marked , has been suggested with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly with DRUGA and DRUGB dga
ampicillin	drug	tetracyclines	group
false

A possible interaction has been suggested with DRUGA and the herbal supplement St. Johns Wort based on some reports of oral DRUGB users experiencing breakthrough bleeding shortly after starting St. Johns Wort .
hormonal contraceptives	group	contraceptive	group
false

Steady state serum concentrations of DRUGA are reported to fluctuate significantly when DRUGB is either added or deleted from the drug regimen .
tricyclic antidepressants	group	cimetidine	drug
mechanism

Serious anticholinergic symptoms ( severe dry mouth , urinary retention , blurred vision ) have been associated with elevations in the serum levels of DRUGA when DRUGB is added to the drug regimen .
tricyclic antidepressants	group	cimetidine	drug
effect

In addition , higher than expected steady state serum concentrations of DRUGA have been observed when therapy is initiated in patients already taking DRUGB .
tricyclic antidepressants	group	cimetidine	drug
mechanism

In well controlled patients undergoing concurrent therapy with DRUGA , a decrease in the steady state serum concentrations of DRUGB may occur when cime tidine therapy is discontinued .
cimetidine	drug	tricyclic antidepressants	group
mechanism

The therapeutic efficacy of DRUGA may be compromised in these patients when DRUGB is discontinued .
tricyclic antidepressants	group	cimetidine	drug
effect

There have been greater than dgb fold increases in previously stable plasma levels of other DRUGA , including DRUGB , when DRUGN has been administered in combination with these agents .
antidepressants	group	nortriptyline	drug
false

There have been greater than dgb fold increases in previously stable plasma levels of other DRUGA , including DRUGN , when DRUGB has been administered in combination with these agents .
antidepressants	group	fluoxetine hydrochloride	drug
mechanism

There have been greater than dgb fold increases in previously stable plasma levels of other DRUGN , including DRUGA , when DRUGB has been administered in combination with these agents .
nortriptyline	drug	fluoxetine hydrochloride	drug
mechanism

DRUGA and its active metabolite , norfluoxe tine , have long half lives ( dgb to dgb days for DRUGB ) , that may affect strategies during conversion from one drug to the other .
Fluoxetine	drug	norfluoxetine	drug_n
false

Administration of DRUGA during therapy with a DRUGB has been shown to produce a stimulating effect in some depressed patients .
reserpine	drug	tricyclic antidepressant	group
effect

Close supervision and careful adjustment of the dosage are required when DRUGA is used with other DRUGB or DRUGN .
nortriptyline hydrochloride	drug	anticholinergic drugs	group
advise

Close supervision and careful adjustment of the dosage are required when DRUGA is used with other DRUGN or DRUGB .
nortriptyline hydrochloride	drug	sympathomimetic drugs	group
advise

Close supervision and careful adjustment of the dosage are required when DRUGN is used with other DRUGA or DRUGB .
anticholinergic drugs	group	sympathomimetic drugs	group
false

Such individuals are referred to as poor metabolizers of drugs such as DRUGA , DRUGB , and the DRUGN .
debrisoquin	drug	dextromethorphan	drug
false

Such individuals are referred to as poor metabolizers of drugs such as DRUGA , DRUGN , and the DRUGB .
debrisoquin	drug	tricyclic antidepressants	group
false

Such individuals are referred to as poor metabolizers of drugs such as DRUGN , DRUGA , and the DRUGB .
dextromethorphan	drug	tricyclic antidepressants	group
false

Concomitant use of DRUGA with other drugs metabolized by cytochrome PdgbIIDdgb may require lower doses than usually prescribed for either the DRUGB or the other drug .
tricyclic antidepressants	group	tricyclic antidepressant	group
false

In addition , several DRUGA s that are cytochrome Pdgb inducers can decrease plasma concentrations of DRUGB and DRUGN .
AED	group	oxcarbazepine	drug
mechanism

In addition , several DRUGA s that are cytochrome Pdgb inducers can decrease plasma concentrations of DRUGN and DRUGB .
AED	group	MHD	drug_n
false

In addition , several DRUGN s that are cytochrome Pdgb inducers can decrease plasma concentrations of DRUGA and DRUGB .
oxcarbazepine	drug	MHD	drug_n
false

Although inhibition of CYP dgbAdgb / dgb by DRUGA and DRUGB did occur at high concentrations , it is not likely to be of clinical significance .
OXC	drug	MHD	drug_n
false

The inhibition of CYP dgbCdgb by DRUGA and DRUGB , however , is clinically relevant .
OXC	drug	MHD	drug_n
false

Increases of dgb % with DRUGA and dgb % with DRUGB were observed .
MHD	drug_n	oxcarbazepine	drug
false

In addition , DRUGA and DRUGB induce a subgroup of the cytochrome Pdgb dgbA family ( CYPdgbAdgb and CYPdgbAdgb ) responsible for the metabolism of DRUGN and oral DRUGN , resulting in a lower plasma concentration of these drugs .
oxcarbazepine	drug	MHD	drug_n
false

In addition , DRUGA and DRUGN induce a subgroup of the cytochrome Pdgb dgbA family ( CYPdgbAdgb and CYPdgbAdgb ) responsible for the metabolism of DRUGB and oral DRUGN , resulting in a lower plasma concentration of these drugs .
oxcarbazepine	drug	dihydropyridine calcium antagonists	group
false

In addition , DRUGA and DRUGN induce a subgroup of the cytochrome Pdgb dgbA family ( CYPdgbAdgb and CYPdgbAdgb ) responsible for the metabolism of DRUGN and oral DRUGB , resulting in a lower plasma concentration of these drugs .
oxcarbazepine	drug	contraceptives	group
false

In addition , DRUGN and DRUGA induce a subgroup of the cytochrome Pdgb dgbA family ( CYPdgbAdgb and CYPdgbAdgb ) responsible for the metabolism of DRUGB and oral DRUGN , resulting in a lower plasma concentration of these drugs .
MHD	drug_n	dihydropyridine calcium antagonists	group
false

In addition , DRUGN and DRUGA induce a subgroup of the cytochrome Pdgb dgbA family ( CYPdgbAdgb and CYPdgbAdgb ) responsible for the metabolism of DRUGN and oral DRUGB , resulting in a lower plasma concentration of these drugs .
MHD	drug_n	contraceptives	group
false

In addition , DRUGN and DRUGN induce a subgroup of the cytochrome Pdgb dgbA family ( CYPdgbAdgb and CYPdgbAdgb ) responsible for the metabolism of DRUGA and oral DRUGB , resulting in a lower plasma concentration of these drugs .
dihydropyridine calcium antagonists	group	contraceptives	group
false

DRUGA : Potential interactions between DRUGB and other DRUGN were assessed in clinical studies .
Antiepileptic drugs	group	Trileptal	brand
false

DRUGA : Potential interactions between DRUGN and other DRUGB were assessed in clinical studies .
Antiepileptic drugs	group	AEDs	group
false

DRUGN : Potential interactions between DRUGA and other DRUGB were assessed in clinical studies .
Trileptal	brand	AEDs	group
false

Influence of DRUGA on DRUGB Concentration ( Mean change , dgb % Confidence Interval )
Trileptal	brand	AED	group
false

Influence of DRUGA On DRUGB Concentration ( Mean change , dgb % Confidence Interval )
AED	group	MHD	drug_n
false

Therefore , when using doses of DRUGA greater than dgb mg / day during adjunctive therapy , a decrease in the dose of DRUGB may be required .
Trileptal	brand	phenytoin	drug
advise

The increase of DRUGA level , however , is small ( dgb % ) when given with DRUGB .
phenobarbital	drug	Trileptal	brand
mechanism

Strong inducers of cytochrome Pdgb enzymes ( i.e . DRUGA , DRUGB and DRUGN ) have been shown to decrease the plasma levels of DRUGN ( dgb dgb % ) .
carbamazepine	drug	phenytoin	drug
false

Strong inducers of cytochrome Pdgb enzymes ( i.e . DRUGA , DRUGN and DRUGB ) have been shown to decrease the plasma levels of DRUGN ( dgb dgb % ) .
carbamazepine	drug	phenobarbital	drug
false

Strong inducers of cytochrome Pdgb enzymes ( i.e . DRUGA , DRUGN and DRUGN ) have been shown to decrease the plasma levels of DRUGB ( dgb dgb % ) .
carbamazepine	drug	MHD	drug_n
false

Strong inducers of cytochrome Pdgb enzymes ( i.e . DRUGN , DRUGA and DRUGB ) have been shown to decrease the plasma levels of DRUGN ( dgb dgb % ) .
phenytoin	drug	phenobarbital	drug
false

Strong inducers of cytochrome Pdgb enzymes ( i.e . DRUGN , DRUGA and DRUGN ) have been shown to decrease the plasma levels of DRUGB ( dgb dgb % ) .
phenytoin	drug	MHD	drug_n
false

Strong inducers of cytochrome Pdgb enzymes ( i.e . DRUGN , DRUGN and DRUGA ) have been shown to decrease the plasma levels of DRUGB ( dgb dgb % ) .
phenobarbital	drug	MHD	drug_n
false

Hormonal DRUGA Co administration of DRUGB with an oral DRUGN has been shown to influence the plasma concentrations of the two hormonal components , DRUGN ( EE ) and DRUGN ( LNG ) .
contraceptives	group	Trileptal	brand
false

Hormonal DRUGA Co administration of DRUGN with an oral DRUGB has been shown to influence the plasma concentrations of the two hormonal components , DRUGN ( EE ) and DRUGN ( LNG ) .
contraceptives	group	contraceptive	group
false

Hormonal DRUGA Co administration of DRUGN with an oral DRUGN has been shown to influence the plasma concentrations of the two hormonal components , DRUGB ( EE ) and DRUGN ( LNG ) .
contraceptives	group	ethinylestradiol	drug
false

Hormonal DRUGA Co administration of DRUGN with an oral DRUGN has been shown to influence the plasma concentrations of the two hormonal components , DRUGN ( EE ) and DRUGB ( LNG ) .
contraceptives	group	levonorgestrel	drug
false

Hormonal DRUGN Co administration of DRUGA with an oral DRUGB has been shown to influence the plasma concentrations of the two hormonal components , DRUGN ( EE ) and DRUGN ( LNG ) .
Trileptal	brand	contraceptive	group
mechanism

Hormonal DRUGN Co administration of DRUGA with an oral DRUGN has been shown to influence the plasma concentrations of the two hormonal components , DRUGB ( EE ) and DRUGN ( LNG ) .
Trileptal	brand	ethinylestradiol	drug
false

Hormonal DRUGN Co administration of DRUGA with an oral DRUGN has been shown to influence the plasma concentrations of the two hormonal components , DRUGN ( EE ) and DRUGB ( LNG ) .
Trileptal	brand	levonorgestrel	drug
false

Hormonal DRUGN Co administration of DRUGN with an oral DRUGA has been shown to influence the plasma concentrations of the two hormonal components , DRUGB ( EE ) and DRUGN ( LNG ) .
contraceptive	group	ethinylestradiol	drug
false

Hormonal DRUGN Co administration of DRUGN with an oral DRUGA has been shown to influence the plasma concentrations of the two hormonal components , DRUGN ( EE ) and DRUGB ( LNG ) .
contraceptive	group	levonorgestrel	drug
false

Hormonal DRUGN Co administration of DRUGN with an oral DRUGN has been shown to influence the plasma concentrations of the two hormonal components , DRUGA ( EE ) and DRUGB ( LNG ) .
ethinylestradiol	drug	levonorgestrel	drug
false

Therefore , concurrent use of DRUGA with DRUGB may render these DRUGN less effective .
Trileptal	brand	hormonal contraceptives	group
effect

Therefore , concurrent use of DRUGA with DRUGN may render these DRUGB less effective .
Trileptal	brand	contraceptives	group
false

Therefore , concurrent use of DRUGN with DRUGA may render these DRUGB less effective .
hormonal contraceptives	group	contraceptives	group
false

DRUGA s : After repeated co administration of DRUGB , the AUC of DRUGN was lowered by dgb % [ dgb % CI : dgb dgb ] .
Calcium Antagonist	group	Trileptal	brand
false

DRUGA s : After repeated co administration of DRUGN , the AUC of DRUGB was lowered by dgb % [ dgb % CI : dgb dgb ] .
Calcium Antagonist	group	felodipine	drug
false

DRUGN s : After repeated co administration of DRUGA , the AUC of DRUGB was lowered by dgb % [ dgb % CI : dgb dgb ] .
Trileptal	brand	felodipine	drug
mechanism

DRUGA produced a decrease of dgb % [ dgb % CI : dgb dgb ] of the plasma levels of DRUGB .
Verapamil	drug	MHD	drug_n
false

Other drug interactions DRUGA , DRUGB and DRUGN had no effect on the pharmacokinetics of DRUGN .
Cimetidine	drug	erythromycin	drug
false

Other drug interactions DRUGA , DRUGN and DRUGB had no effect on the pharmacokinetics of DRUGN .
Cimetidine	drug	dextropropoxyphene	drug
false

Other drug interactions DRUGA , DRUGN and DRUGN had no effect on the pharmacokinetics of DRUGB .
Cimetidine	drug	MHD	drug_n
false

Other drug interactions DRUGN , DRUGA and DRUGB had no effect on the pharmacokinetics of DRUGN .
erythromycin	drug	dextropropoxyphene	drug
false

Other drug interactions DRUGN , DRUGA and DRUGN had no effect on the pharmacokinetics of DRUGB .
erythromycin	drug	MHD	drug_n
false

Other drug interactions DRUGN , DRUGN and DRUGA had no effect on the pharmacokinetics of DRUGB .
dextropropoxyphene	drug	MHD	drug_n
false

Results with DRUGA wshow no evidence of interaction with either single or repeated doses of DRUGB .
warfarin	drug	Trileptal	brand
false

Pharmacokinetic data from these patients demonstrated a decrease in DRUGA clearance of approximately dgb % when DRUGB was administered following DRUGN .
paclitaxel	drug	TAXOL	brand
false

Pharmacokinetic data from these patients demonstrated a decrease in DRUGA clearance of approximately dgb % when DRUGN was administered following DRUGB .
paclitaxel	drug	cisplatin	drug
false

Pharmacokinetic data from these patients demonstrated a decrease in DRUGN clearance of approximately dgb % when DRUGA was administered following DRUGB .
TAXOL	brand	cisplatin	drug
mechanism

Reports in the literature suggest that plasma levels of DRUGA ( and its active metabolite DRUGB ) may be increased when DRUGN and DRUGN are used in combination .
doxorubicin	drug	doxorubicinol	drug_n
false

Reports in the literature suggest that plasma levels of DRUGA ( and its active metabolite DRUGN ) may be increased when DRUGB and DRUGN are used in combination .
doxorubicin	drug	paclitaxel	drug
false

Reports in the literature suggest that plasma levels of DRUGN ( and its active metabolite DRUGA ) may be increased when DRUGB and DRUGN are used in combination .
doxorubicinol	drug_n	paclitaxel	drug
false

Reports in the literature suggest that plasma levels of DRUGN ( and its active metabolite DRUGA ) may be increased when DRUGN and DRUGB are used in combination .
doxorubicinol	drug_n	doxorubicin	drug
false

Reports in the literature suggest that plasma levels of DRUGN ( and its active metabolite DRUGN ) may be increased when DRUGA and DRUGB are used in combination .
paclitaxel	drug	doxorubicin	drug
mechanism

Hypersensitivity Reactions : Patients with a history of severe hypersensitivity reactions to products containing Cremophor EL ( eg , DRUGA for injection concentrate and DRUGB for injection concentrate ) should not be treated with DRUGN .
cyclosporin	drug	teniposide	drug
false

Hypersensitivity Reactions : Patients with a history of severe hypersensitivity reactions to products containing Cremophor EL ( eg , DRUGA for injection concentrate and DRUGN for injection concentrate ) should not be treated with DRUGB .
cyclosporin	drug	TAXOL	brand
advise

Hypersensitivity Reactions : Patients with a history of severe hypersensitivity reactions to products containing Cremophor EL ( eg , DRUGN for injection concentrate and DRUGA for injection concentrate ) should not be treated with DRUGB .
teniposide	drug	TAXOL	brand
advise

In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUGA should be premedicated with DRUGB ( such as DRUGN ) , diphen hydramine and DRUGN ( such as DRUGN or DRUGN ) .
TAXOL	brand	corticosteroids	group
false

In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUGA should be premedicated with DRUGN ( such as DRUGB ) , diphen hydramine and DRUGN ( such as DRUGN or DRUGN ) .
TAXOL	brand	dexamethasone	drug
false

In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUGA should be premedicated with DRUGN ( such as DRUGN ) , diphen hydramine and DRUGB ( such as DRUGN or DRUGN ) .
TAXOL	brand	H2 antagonists	group
false

In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUGA should be premedicated with DRUGN ( such as DRUGN ) , diphen hydramine and DRUGN ( such as DRUGB or DRUGN ) .
TAXOL	brand	cimetidine	drug
false

In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUGA should be premedicated with DRUGN ( such as DRUGN ) , diphen hydramine and DRUGN ( such as DRUGN or DRUGB ) .
TAXOL	brand	ranitidine	drug
false

In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUGN should be premedicated with DRUGA ( such as DRUGB ) , diphen hydramine and DRUGN ( such as DRUGN or DRUGN ) .
corticosteroids	group	dexamethasone	drug
false

In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUGN should be premedicated with DRUGA ( such as DRUGN ) , diphen hydramine and DRUGB ( such as DRUGN or DRUGN ) .
corticosteroids	group	H2 antagonists	group
false

In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUGN should be premedicated with DRUGA ( such as DRUGN ) , diphen hydramine and DRUGN ( such as DRUGB or DRUGN ) .
corticosteroids	group	cimetidine	drug
false

In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUGN should be premedicated with DRUGA ( such as DRUGN ) , diphen hydramine and DRUGN ( such as DRUGN or DRUGB ) .
corticosteroids	group	ranitidine	drug
false

In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUGN should be premedicated with DRUGN ( such as DRUGA ) , diphen hydramine and DRUGB ( such as DRUGN or DRUGN ) .
dexamethasone	drug	H2 antagonists	group
false

In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUGN should be premedicated with DRUGN ( such as DRUGA ) , diphen hydramine and DRUGN ( such as DRUGB or DRUGN ) .
dexamethasone	drug	cimetidine	drug
false

In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUGN should be premedicated with DRUGN ( such as DRUGA ) , diphen hydramine and DRUGN ( such as DRUGN or DRUGB ) .
dexamethasone	drug	ranitidine	drug
false

In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUGN should be premedicated with DRUGN ( such as DRUGN ) , diphen hydramine and DRUGA ( such as DRUGB or DRUGN ) .
H2 antagonists	group	cimetidine	drug
false

In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUGN should be premedicated with DRUGN ( such as DRUGN ) , diphen hydramine and DRUGA ( such as DRUGN or DRUGB ) .
H2 antagonists	group	ranitidine	drug
false

In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUGN should be premedicated with DRUGN ( such as DRUGN ) , diphen hydramine and DRUGN ( such as DRUGA or DRUGB ) .
cimetidine	drug	ranitidine	drug
false

However , severe reactions , such as hypotension requiring treatment , dyspnea requiring DRUGA , angioedema , or generalized urticaria require immediate discontinuation of DRUGB and aggressive symptomatic therapy .
bronchodilators	group	TAXOL	brand
false

Treatment with DRUGA once weekly for dgb weeks in healthy subjects was associated with an inhibition of Pdgb dgbAdgb and a dgb % increase in DRUGB AUC .
PEGASYS	brand	theophylline	drug
mechanism

DRUGA serum levels should be monitored and appropriate dose adjustments considered for patients given both DRUGB and DRUGN .
Theophylline	drug	theophylline	drug
false

DRUGA serum levels should be monitored and appropriate dose adjustments considered for patients given both DRUGN and DRUGB .
Theophylline	drug	PEGASYS	brand
false

DRUGN serum levels should be monitored and appropriate dose adjustments considered for patients given both DRUGA and DRUGB .
theophylline	drug	PEGASYS	brand
advise

In patients with chronic hepatitis C treated with DRUGA in combination with DRUGB , DRUGN treatment did not affect DRUGN distribution or clearance .
PEGASYS	brand	COPEGUS	brand
false

In patients with chronic hepatitis C treated with DRUGA in combination with DRUGN , DRUGN treatment did not affect DRUGB distribution or clearance .
PEGASYS	brand	ribavirin	drug
false

In patients with chronic hepatitis C treated with DRUGN in combination with DRUGA , DRUGB treatment did not affect DRUGN distribution or clearance .
COPEGUS	brand	PEGASYS	brand
false

In patients with chronic hepatitis C treated with DRUGN in combination with DRUGA , DRUGN treatment did not affect DRUGB distribution or clearance .
COPEGUS	brand	ribavirin	drug
false

In patients with chronic hepatitis C treated with DRUGN in combination with DRUGN , DRUGA treatment did not affect DRUGB distribution or clearance .
PEGASYS	brand	ribavirin	drug
false

Nucleoside Analogues DRUGA Co administration of DRUGB and DRUGN is not recommended .
Didanosine	drug	COPEGUS	brand
false

Nucleoside Analogues DRUGA Co administration of DRUGN and DRUGB is not recommended .
Didanosine	drug	didanosine	drug
false

Nucleoside Analogues DRUGN Co administration of DRUGA and DRUGB is not recommended .
COPEGUS	brand	didanosine	drug
advise

DRUGA and DRUGB DRUGN can antagonize the in vitro antiviral activity of DRUGN and DRUGN against HIV .
Stavudine	drug	Zidovudine	drug
false

DRUGA and DRUGN DRUGB can antagonize the in vitro antiviral activity of DRUGN and DRUGN against HIV .
Stavudine	drug	Ribavirin	drug
false

DRUGA and DRUGN DRUGN can antagonize the in vitro antiviral activity of DRUGB and DRUGN against HIV .
Stavudine	drug	stavudine	drug
false

DRUGA and DRUGN DRUGN can antagonize the in vitro antiviral activity of DRUGN and DRUGB against HIV .
Stavudine	drug	zidovudine	drug
false

DRUGN and DRUGA DRUGB can antagonize the in vitro antiviral activity of DRUGN and DRUGN against HIV .
Zidovudine	drug	Ribavirin	drug
false

DRUGN and DRUGA DRUGN can antagonize the in vitro antiviral activity of DRUGB and DRUGN against HIV .
Zidovudine	drug	stavudine	drug
false

DRUGN and DRUGA DRUGN can antagonize the in vitro antiviral activity of DRUGN and DRUGB against HIV .
Zidovudine	drug	zidovudine	drug
false

DRUGN and DRUGN DRUGA can antagonize the in vitro antiviral activity of DRUGB and DRUGN against HIV .
Ribavirin	drug	stavudine	drug
effect

DRUGN and DRUGN DRUGA can antagonize the in vitro antiviral activity of DRUGN and DRUGB against HIV .
Ribavirin	drug	zidovudine	drug
effect

DRUGN and DRUGN DRUGN can antagonize the in vitro antiviral activity of DRUGA and DRUGB against HIV .
stavudine	drug	zidovudine	drug
false

Pregnancy : Category X : Use With DRUGA ( see CONTRAINDICATIONS ) Significant teratogenic and / or embryocidal effects have been demonstrated in all animal species exposed to DRUGB .
Ribavirin	drug	ribavirin	drug
false

Nursing Mothers It is not known whether DRUGA or DRUGB or its components are excreted in human milk .
peginterferon	drug	ribavirin	drug
false

The effect of orally ingested DRUGA or DRUGB from breast milk on the nursing infant has not been evaluated .
peginterferon	drug	ribavirin	drug
false

Because of the potential for adverse reactions from the drugs in nursing infants , a decision must be made whether to discontinue nursing or discontinue DRUGA and DRUGB treatment .
PEGASYS	brand	COPEGUS	brand
false

Pediatric Use The safety and effectiveness of DRUGA , alone or in combination with DRUGB in patients below the age of dgb years have not been established .
PEGASYS	brand	COPEGUS	brand
false

DRUGA contains DRUGB .
PEGASYS	brand	benzyl alcohol	drug_n
false

Clinical studies of DRUGA alone or in combination with DRUGB did not include sufficient numbers of subjects aged dgb or over to determine whether they respond differently from younger subjects .
PEGASYS	brand	COPEGUS	brand
false

DRUGA and DRUGB are excreted by the kidney , and the risk of toxic reactions to this therapy may be greater in patients with impaired renal function .
PEGASYS	brand	COPEGUS	brand
false

DRUGA should be used with caution in patients with creatinine clearance dgb mL / min and DRUGB should not be administered to patients with creatinine clearance dgb mL / min
PEGASYS	brand	COPEGUS	brand
false

DRUGA : The mixing of DRUGB with an DRUGN in vitro can result in substantial inactivation of the DRUGN .
Aminoglycosides	group	piperacillin	drug
false

DRUGA : The mixing of DRUGN with an DRUGB in vitro can result in substantial inactivation of the DRUGN .
Aminoglycosides	group	aminoglycoside	group
false

DRUGA : The mixing of DRUGN with an DRUGN in vitro can result in substantial inactivation of the DRUGB .
Aminoglycosides	group	aminoglycoside	group
false

DRUGN : The mixing of DRUGA with an DRUGB in vitro can result in substantial inactivation of the DRUGN .
piperacillin	drug	aminoglycoside	group
effect

DRUGN : The mixing of DRUGA with an DRUGN in vitro can result in substantial inactivation of the DRUGB .
piperacillin	drug	aminoglycoside	group
false

DRUGA : When used in the perioperative period , DRUGB has been implicated in the prolongation of the neuromuscular blockade of DRUGN .
Vecuronium	drug	piperacillin	drug
false

DRUGA : When used in the perioperative period , DRUGN has been implicated in the prolongation of the neuromuscular blockade of DRUGB .
Vecuronium	drug	vecuronium	drug
false

DRUGN : When used in the perioperative period , DRUGA has been implicated in the prolongation of the neuromuscular blockade of DRUGB .
piperacillin	drug	vecuronium	drug
effect

In one controlled clinical study , the ureidopenicillins , including DRUGA , were reported to prolong the action of DRUGB .
piperacillin	drug	vecuronium	drug
effect

Due to their similar mechanism of action , it is expected that the neuromuscular blockade produced by any of the DRUGA could be prolonged in the presence of DRUGB .
non-depolarizing muscle relaxants	group	piperacillin	drug
effect

DRUGA : The oral combination of DRUGB before intramuscular injection of DRUGN produces an increase in DRUGN peak serum level of about dgb % .
Probenecid	drug	probenecid	drug
false

DRUGA : The oral combination of DRUGN before intramuscular injection of DRUGB produces an increase in DRUGN peak serum level of about dgb % .
Probenecid	drug	PIPRACIL	brand
false

DRUGA : The oral combination of DRUGN before intramuscular injection of DRUGN produces an increase in DRUGB peak serum level of about dgb % .
Probenecid	drug	piperacillin	drug
false

DRUGN : The oral combination of DRUGA before intramuscular injection of DRUGB produces an increase in DRUGN peak serum level of about dgb % .
probenecid	drug	PIPRACIL	brand
mechanism

DRUGN : The oral combination of DRUGA before intramuscular injection of DRUGN produces an increase in DRUGB peak serum level of about dgb % .
probenecid	drug	piperacillin	drug
false

DRUGN : The oral combination of DRUGN before intramuscular injection of DRUGA produces an increase in DRUGB peak serum level of about dgb % .
PIPRACIL	brand	piperacillin	drug
false

DRUGA : Coagulation parameters should be tested more frequently and monitored regularly during simultaneous administration of high doses of DRUGB , oral DRUGN , or other drugs that may affect the blood coagulation system or the thrombocyte function .
Anticoagulants	group	heparin	drug
false

DRUGA : Coagulation parameters should be tested more frequently and monitored regularly during simultaneous administration of high doses of DRUGN , oral DRUGB , or other drugs that may affect the blood coagulation system or the thrombocyte function .
Anticoagulants	group	anticoagulants	group
false

DRUGN : Coagulation parameters should be tested more frequently and monitored regularly during simultaneous administration of high doses of DRUGA , oral DRUGB , or other drugs that may affect the blood coagulation system or the thrombocyte function .
heparin	drug	anticoagulants	group
false

DRUGA : DRUGB may reduce the excretion of DRUGN .
Methotrexate	drug	Piperacillin sodium	drug
false

DRUGA : DRUGN may reduce the excretion of DRUGB .
Methotrexate	drug	methotrexate	drug
false

DRUGN : DRUGA may reduce the excretion of DRUGB .
Piperacillin sodium	drug	methotrexate	drug
mechanism

Drug / Laboratory Test Interactions As with other DRUGA , the administration of DRUGB may result in a false positive reaction for glucose in the urine using a copper reduction method .
penicillins	drug	PIPRACIL	brand
false

There have been reports of positive test results using the Bio Rad Laboratories Platelia Aspergillus EIA test in patients receiving DRUGA / DRUGB injection who were subsequently found to be free of Aspergillus infection .
piperacillin	drug	tazobactam	drug
false

DRUGA Taking DRUGB and a DRUGN together may increase the risk of convulsions ( seizures ) .
Phenothiazines	group	piperazine	drug
false

DRUGA Taking DRUGN and a DRUGB together may increase the risk of convulsions ( seizures ) .
Phenothiazines	group	phenothiazine	group
false

DRUGN Taking DRUGA and a DRUGB together may increase the risk of convulsions ( seizures ) .
piperazine	drug	phenothiazine	group
effect

DRUGA ( e.g . , DRUGB ) Taking DRUGN and DRUGN together may decrease the effects of DRUGN .
Pyrantel	drug	Antiminth	drug
false

DRUGA ( e.g . , DRUGN ) Taking DRUGB and DRUGN together may decrease the effects of DRUGN .
Pyrantel	drug	piperazine	drug
false

DRUGA ( e.g . , DRUGN ) Taking DRUGN and DRUGB together may decrease the effects of DRUGN .
Pyrantel	drug	pyrantel	drug
false

DRUGA ( e.g . , DRUGN ) Taking DRUGN and DRUGN together may decrease the effects of DRUGB .
Pyrantel	drug	piperazine	drug
false

DRUGN ( e.g . , DRUGA ) Taking DRUGB and DRUGN together may decrease the effects of DRUGN .
Antiminth	drug	piperazine	drug
false

DRUGN ( e.g . , DRUGA ) Taking DRUGN and DRUGB together may decrease the effects of DRUGN .
Antiminth	drug	pyrantel	drug
false

DRUGN ( e.g . , DRUGA ) Taking DRUGN and DRUGN together may decrease the effects of DRUGB .
Antiminth	drug	piperazine	drug
false

DRUGN ( e.g . , DRUGN ) Taking DRUGA and DRUGB together may decrease the effects of DRUGN .
piperazine	drug	pyrantel	drug
effect

DRUGN ( e.g . , DRUGN ) Taking DRUGN and DRUGA together may decrease the effects of DRUGB .
pyrantel	drug	piperazine	drug
false

DRUGA : Reports suggest that DRUGB may diminish the antihypertensive effect of DRUGN .
ACE inhibitors	group	NSAIDs	group
false

DRUGA : Reports suggest that DRUGN may diminish the antihypertensive effect of DRUGB .
ACE inhibitors	group	Angiotensin Converting Enzyme (ACE) inhibitors	group
false

DRUGN : Reports suggest that DRUGA may diminish the antihypertensive effect of DRUGB .
NSAIDs	group	Angiotensin Converting Enzyme (ACE) inhibitors	group
effect

This interaction should be given consideration in patients taking DRUGA concomitantly with DRUGB .
VIOXX	brand	ACE inhibitors	group
advise

DRUGA : Concomitant administration of low dose DRUGB with DRUGN may result in an increased rate of GI ulceration or other complications , compared to use of DRUGN alone .
Aspirin	brand	aspirin	brand
false

DRUGA : Concomitant administration of low dose DRUGN with DRUGB may result in an increased rate of GI ulceration or other complications , compared to use of DRUGN alone .
Aspirin	brand	VIOXX	brand
false

DRUGA : Concomitant administration of low dose DRUGN with DRUGN may result in an increased rate of GI ulceration or other complications , compared to use of DRUGB alone .
Aspirin	brand	VIOXX	brand
false

DRUGN : Concomitant administration of low dose DRUGA with DRUGB may result in an increased rate of GI ulceration or other complications , compared to use of DRUGN alone .
aspirin	brand	VIOXX	brand
effect

DRUGN : Concomitant administration of low dose DRUGA with DRUGN may result in an increased rate of GI ulceration or other complications , compared to use of DRUGB alone .
aspirin	brand	VIOXX	brand
false

Patients taking low dose DRUGA plus DRUGB were not studied .
aspirin	brand	ibuprofen	drug
false

Because of its lack of platelet effects , DRUGA is not a substitute for DRUGB for cardiovascular prophylaxis .
VIOXX	brand	aspirin	brand
false

Prospective , long term studies on concomitant administration of DRUGA and DRUGB have not been conducted .
VIOXX	brand	aspirin	brand
false

DRUGA : Co administration with high doses of DRUGB [ dgb mg twice daily ] increased the Cmax of DRUGN by dgb % , the AUCdgb dgbhr by dgb % and the tdgb / dgb by dgb % .
Cimetidine	drug	cimetidine	drug
false

DRUGA : Co administration with high doses of DRUGN [ dgb mg twice daily ] increased the Cmax of DRUGB by dgb % , the AUCdgb dgbhr by dgb % and the tdgb / dgb by dgb % .
Cimetidine	drug	rofecoxib	drug
false

DRUGN : Co administration with high doses of DRUGA [ dgb mg twice daily ] increased the Cmax of DRUGB by dgb % , the AUCdgb dgbhr by dgb % and the tdgb / dgb by dgb % .
cimetidine	drug	rofecoxib	drug
mechanism

DRUGA : DRUGB dgb mg once daily for dgb days does not alter the plasma concentration profile or renal elimination of DRUGN after a single dga mg oral dose .
Digoxin	drug	Rofecoxib	drug
false

DRUGA : DRUGN dgb mg once daily for dgb days does not alter the plasma concentration profile or renal elimination of DRUGB after a single dga mg oral dose .
Digoxin	drug	digoxin	drug
false

DRUGN : DRUGA dgb mg once daily for dgb days does not alter the plasma concentration profile or renal elimination of DRUGB after a single dga mg oral dose .
Rofecoxib	drug	digoxin	drug
false

DRUGA : Clinical studies , as well as post marketing observations , have shown that DRUGB can reduce the natriuretic effect of DRUGN and DRUGN in some patients .
Furosemide	drug	NSAIDs	group
false

DRUGA : Clinical studies , as well as post marketing observations , have shown that DRUGN can reduce the natriuretic effect of DRUGB and DRUGN in some patients .
Furosemide	drug	furosemide	drug
false

DRUGA : Clinical studies , as well as post marketing observations , have shown that DRUGN can reduce the natriuretic effect of DRUGN and DRUGB in some patients .
Furosemide	drug	thiazides	group
false

DRUGN : Clinical studies , as well as post marketing observations , have shown that DRUGA can reduce the natriuretic effect of DRUGB and DRUGN in some patients .
NSAIDs	group	furosemide	drug
effect

DRUGN : Clinical studies , as well as post marketing observations , have shown that DRUGA can reduce the natriuretic effect of DRUGN and DRUGB in some patients .
NSAIDs	group	thiazides	group
effect

DRUGN : Clinical studies , as well as post marketing observations , have shown that DRUGN can reduce the natriuretic effect of DRUGA and DRUGB in some patients .
furosemide	drug	thiazides	group
false

DRUGA : DRUGN dgb mg daily did not have any clinically important effect on the pharmacokinetics of DRUGB .
Ketoconazole	drug	rofecoxib	drug
false

DRUGN : DRUGA dgb mg daily did not have any clinically important effect on the pharmacokinetics of DRUGB .
Ketoconazole	drug	rofecoxib	drug
false

DRUGA : DRUGB have produced an elevation of plasma DRUGN levels and a reduction in renal DRUGN clearance .
Lithium	drug	NSAIDs	group
false

DRUGA : DRUGN have produced an elevation of plasma DRUGB levels and a reduction in renal DRUGN clearance .
Lithium	drug	lithium	drug
false

DRUGA : DRUGN have produced an elevation of plasma DRUGN levels and a reduction in renal DRUGB clearance .
Lithium	drug	lithium	drug
false

DRUGN : DRUGA have produced an elevation of plasma DRUGB levels and a reduction in renal DRUGN clearance .
NSAIDs	group	lithium	drug
mechanism

DRUGN : DRUGA have produced an elevation of plasma DRUGN levels and a reduction in renal DRUGB clearance .
NSAIDs	group	lithium	drug
false

Thus , when DRUGA and DRUGB are administered concurrently , subjects should be observed carefully for signs of DRUGN toxicity .
VIOXX	brand	lithium	drug
advise

Thus , when DRUGA and DRUGN are administered concurrently , subjects should be observed carefully for signs of DRUGB toxicity .
VIOXX	brand	lithium	drug
false

At higher than recommended doses , DRUGA dgb mg administered once daily for dgb days increased plasma concentrations by dgb % as measured by AUCdgb dgbhr in patients receiving DRUGB dga to dgb mg / week for rheumatoid arthritis .
VIOXX	brand	methotrexate	drug
mechanism

Standard monitoring of DRUGA related toxicity should be continued if DRUGB and DRUGN are administered concomitantly .
methotrexate	drug	VIOXX	brand
false

Standard monitoring of DRUGN related toxicity should be continued if DRUGA and DRUGB are administered concomitantly .
VIOXX	brand	methotrexate	drug
advise

Oral DRUGA DRUGB did not have any clinically important effect on the pharmacokinetics of DRUGN and DRUGN .
Contraceptives	group	Rofecoxib	drug
false

Oral DRUGA DRUGN did not have any clinically important effect on the pharmacokinetics of DRUGB and DRUGN .
Contraceptives	group	ethinyl estradiol	drug
false

Oral DRUGA DRUGN did not have any clinically important effect on the pharmacokinetics of DRUGN and DRUGB .
Contraceptives	group	norethindrone	drug
false

Oral DRUGN DRUGA did not have any clinically important effect on the pharmacokinetics of DRUGB and DRUGN .
Rofecoxib	drug	ethinyl estradiol	drug
false

Oral DRUGN DRUGA did not have any clinically important effect on the pharmacokinetics of DRUGN and DRUGB .
Rofecoxib	drug	norethindrone	drug
false

Oral DRUGN DRUGN did not have any clinically important effect on the pharmacokinetics of DRUGA and DRUGB .
ethinyl estradiol	drug	norethindrone	drug
false

DRUGA / DRUGB : DRUGN did not have any clinically important effect on the pharmacokinetics of DRUGN or DRUGN .
Prednisone	drug	prednisolone	drug
false

DRUGA / DRUGN : DRUGB did not have any clinically important effect on the pharmacokinetics of DRUGN or DRUGN .
Prednisone	drug	Rofecoxib	drug
false

DRUGA / DRUGN : DRUGN did not have any clinically important effect on the pharmacokinetics of DRUGB or DRUGN .
Prednisone	drug	prednisolone	drug
false

DRUGA / DRUGN : DRUGN did not have any clinically important effect on the pharmacokinetics of DRUGN or DRUGB .
Prednisone	drug	prednisone	drug
false

DRUGN / DRUGA : DRUGB did not have any clinically important effect on the pharmacokinetics of DRUGN or DRUGN .
prednisolone	drug	Rofecoxib	drug
false

DRUGN / DRUGA : DRUGN did not have any clinically important effect on the pharmacokinetics of DRUGN or DRUGB .
prednisolone	drug	prednisone	drug
false

DRUGN / DRUGN : DRUGA did not have any clinically important effect on the pharmacokinetics of DRUGB or DRUGN .
Rofecoxib	drug	prednisolone	drug
false

DRUGN / DRUGN : DRUGA did not have any clinically important effect on the pharmacokinetics of DRUGN or DRUGB .
Rofecoxib	drug	prednisone	drug
false

DRUGN / DRUGN : DRUGN did not have any clinically important effect on the pharmacokinetics of DRUGA or DRUGB .
prednisolone	drug	prednisone	drug
false

DRUGA : Co administration of DRUGB with DRUGN dgb mg daily , a potent inducer of hepatic metabolism , produced an approximate dgb % decrease in DRUGN plasma concentrations .
Rifampin	drug	VIOXX	brand
false

DRUGA : Co administration of DRUGN with DRUGB dgb mg daily , a potent inducer of hepatic metabolism , produced an approximate dgb % decrease in DRUGN plasma concentrations .
Rifampin	drug	rifampin	drug
false

DRUGA : Co administration of DRUGN with DRUGN dgb mg daily , a potent inducer of hepatic metabolism , produced an approximate dgb % decrease in DRUGB plasma concentrations .
Rifampin	drug	rofecoxib	drug
false

DRUGN : Co administration of DRUGA with DRUGB dgb mg daily , a potent inducer of hepatic metabolism , produced an approximate dgb % decrease in DRUGN plasma concentrations .
VIOXX	brand	rifampin	drug
mechanism

DRUGN : Co administration of DRUGA with DRUGN dgb mg daily , a potent inducer of hepatic metabolism , produced an approximate dgb % decrease in DRUGB plasma concentrations .
VIOXX	brand	rofecoxib	drug
false

DRUGN : Co administration of DRUGN with DRUGA dgb mg daily , a potent inducer of hepatic metabolism , produced an approximate dgb % decrease in DRUGB plasma concentrations .
rifampin	drug	rofecoxib	drug
false

Adequate monitoring of DRUGA plasma concentrations should be considered when therapy with DRUGB is initiated or changed in patients receiving DRUGN .
theophylline	drug	VIOXX	brand
false

Adequate monitoring of DRUGN plasma concentrations should be considered when therapy with DRUGA is initiated or changed in patients receiving DRUGB .
VIOXX	brand	theophylline	drug
advise

Therefore , there is a potential for an interaction with other drugs that are metabolized by CYP dgbAdgb ( e.g . , DRUGA , DRUGB , and DRUGN ) .
amitriptyline	drug	tacrine	drug
false

Therefore , there is a potential for an interaction with other drugs that are metabolized by CYP dgbAdgb ( e.g . , DRUGA , DRUGN , and DRUGB ) .
amitriptyline	drug	zileuton	drug
false

Therefore , there is a potential for an interaction with other drugs that are metabolized by CYP dgbAdgb ( e.g . , DRUGN , DRUGA , and DRUGB ) .
tacrine	drug	zileuton	drug
false

DRUGA : Anticoagulant activity should be monitored , particularly in the first few days after initiating or changing DRUGB therapy in patients receiving DRUGN or similar agents , since these patients are at an increased risk of bleeding complications .
Warfarin	drug	VIOXX	brand
false

DRUGA : Anticoagulant activity should be monitored , particularly in the first few days after initiating or changing DRUGN therapy in patients receiving DRUGB or similar agents , since these patients are at an increased risk of bleeding complications .
Warfarin	drug	warfarin	drug
false

DRUGN : Anticoagulant activity should be monitored , particularly in the first few days after initiating or changing DRUGA therapy in patients receiving DRUGB or similar agents , since these patients are at an increased risk of bleeding complications .
VIOXX	brand	warfarin	drug
advise

In single and multiple dose studies in healthy subjects receiving both DRUGA and DRUGB , prothrombin time ( measured as INR ) was increased by approximately dgb % to dgb % .
warfarin	drug	rofecoxib	drug
effect

In post marketing experience , bleeding events have been reported , predominantly in the elderly , in association with increases in prothrombin time in patients receiving DRUGA concurrently with DRUGB .
VIOXX	brand	warfarin	drug
effect

Several drug interaction studies have been completed with both DRUGA and DRUGB .
INVIRASE	brand	FORTOVASE	brand
false

Observations from drug interaction studies with DRUGA may not be predictive for DRUGB .
FORTOVASE	brand	INVIRASE	brand
false

Additional drugs that are not recommended for coadministration with DRUGA and DRUGB are included below .
INVIRASE	brand	ritonavir	drug
false

Drugs That Should Not Be Coadministered With DRUGA / DRUGB
INVIRASE	brand	Ritonavir	drug
false

DRUGA : DRUGB , DRUGN , DRUGN , DRUGN , DRUGN CONTRAINDICATED due to potential for serious and / or life threatening reactions .
Antiarrhythmics	group	Amiodarone	drug
false

DRUGA : DRUGN , DRUGB , DRUGN , DRUGN , DRUGN CONTRAINDICATED due to potential for serious and / or life threatening reactions .
Antiarrhythmics	group	bepridil	drug
false

DRUGA : DRUGN , DRUGN , DRUGB , DRUGN , DRUGN CONTRAINDICATED due to potential for serious and / or life threatening reactions .
Antiarrhythmics	group	flecainide	drug
false

DRUGA : DRUGN , DRUGN , DRUGN , DRUGB , DRUGN CONTRAINDICATED due to potential for serious and / or life threatening reactions .
Antiarrhythmics	group	propafenone	drug
false

DRUGA : DRUGN , DRUGN , DRUGN , DRUGN , DRUGB CONTRAINDICATED due to potential for serious and / or life threatening reactions .
Antiarrhythmics	group	quinidine	drug
false

DRUGN : DRUGA , DRUGB , DRUGN , DRUGN , DRUGN CONTRAINDICATED due to potential for serious and / or life threatening reactions .
Amiodarone	drug	bepridil	drug
false

DRUGN : DRUGA , DRUGN , DRUGB , DRUGN , DRUGN CONTRAINDICATED due to potential for serious and / or life threatening reactions .
Amiodarone	drug	flecainide	drug
false

DRUGN : DRUGA , DRUGN , DRUGN , DRUGB , DRUGN CONTRAINDICATED due to potential for serious and / or life threatening reactions .
Amiodarone	drug	propafenone	drug
false

DRUGN : DRUGA , DRUGN , DRUGN , DRUGN , DRUGB CONTRAINDICATED due to potential for serious and / or life threatening reactions .
Amiodarone	drug	quinidine	drug
false

DRUGN : DRUGN , DRUGA , DRUGB , DRUGN , DRUGN CONTRAINDICATED due to potential for serious and / or life threatening reactions .
bepridil	drug	flecainide	drug
false

DRUGN : DRUGN , DRUGA , DRUGN , DRUGB , DRUGN CONTRAINDICATED due to potential for serious and / or life threatening reactions .
bepridil	drug	propafenone	drug
false

DRUGN : DRUGN , DRUGA , DRUGN , DRUGN , DRUGB CONTRAINDICATED due to potential for serious and / or life threatening reactions .
bepridil	drug	quinidine	drug
false

DRUGN : DRUGN , DRUGN , DRUGA , DRUGB , DRUGN CONTRAINDICATED due to potential for serious and / or life threatening reactions .
flecainide	drug	propafenone	drug
false

DRUGN : DRUGN , DRUGN , DRUGA , DRUGN , DRUGB CONTRAINDICATED due to potential for serious and / or life threatening reactions .
flecainide	drug	quinidine	drug
false

DRUGN : DRUGN , DRUGN , DRUGN , DRUGA , DRUGB CONTRAINDICATED due to potential for serious and / or life threatening reactions .
propafenone	drug	quinidine	drug
false

DRUGA : DRUGB * , DRUGN * CONTRAINDICATED due to potential for serious and / or life threatening cardiac arrhythmias .
Antihistamines	drug	astemizole	drug
false

DRUGA : DRUGN * , DRUGB * CONTRAINDICATED due to potential for serious and / or life threatening cardiac arrhythmias .
Antihistamines	drug	terfenadine	drug
false

DRUGN : DRUGA * , DRUGB * CONTRAINDICATED due to potential for serious and / or life threatening cardiac arrhythmias .
astemizole	drug	terfenadine	drug
false

DRUGA : DRUGB , DRUGN , DRUGN , DRUGN CONTRAINDICATED due to potential for serious and life threatening reactions such as acute DRUGN toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
Ergot Derivatives	group	Dihydroergotamine	drug
false

DRUGA : DRUGN , DRUGB , DRUGN , DRUGN CONTRAINDICATED due to potential for serious and life threatening reactions such as acute DRUGN toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
Ergot Derivatives	group	ergonovine	drug
false

DRUGA : DRUGN , DRUGN , DRUGB , DRUGN CONTRAINDICATED due to potential for serious and life threatening reactions such as acute DRUGN toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
Ergot Derivatives	group	ergotamine	drug
false

DRUGA : DRUGN , DRUGN , DRUGN , DRUGB CONTRAINDICATED due to potential for serious and life threatening reactions such as acute DRUGN toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
Ergot Derivatives	group	methylergonovine	drug
false

DRUGA : DRUGN , DRUGN , DRUGN , DRUGN CONTRAINDICATED due to potential for serious and life threatening reactions such as acute DRUGB toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
Ergot Derivatives	group	ergot	group
false

DRUGN : DRUGA , DRUGB , DRUGN , DRUGN CONTRAINDICATED due to potential for serious and life threatening reactions such as acute DRUGN toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
Dihydroergotamine	drug	ergonovine	drug
false

DRUGN : DRUGA , DRUGN , DRUGB , DRUGN CONTRAINDICATED due to potential for serious and life threatening reactions such as acute DRUGN toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
Dihydroergotamine	drug	ergotamine	drug
false

DRUGN : DRUGA , DRUGN , DRUGN , DRUGB CONTRAINDICATED due to potential for serious and life threatening reactions such as acute DRUGN toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
Dihydroergotamine	drug	methylergonovine	drug
false

DRUGN : DRUGA , DRUGN , DRUGN , DRUGN CONTRAINDICATED due to potential for serious and life threatening reactions such as acute DRUGB toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
Dihydroergotamine	drug	ergot	group
false

DRUGN : DRUGN , DRUGA , DRUGB , DRUGN CONTRAINDICATED due to potential for serious and life threatening reactions such as acute DRUGN toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
ergonovine	drug	ergotamine	drug
false

DRUGN : DRUGN , DRUGA , DRUGN , DRUGB CONTRAINDICATED due to potential for serious and life threatening reactions such as acute DRUGN toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
ergonovine	drug	methylergonovine	drug
false

DRUGN : DRUGN , DRUGA , DRUGN , DRUGN CONTRAINDICATED due to potential for serious and life threatening reactions such as acute DRUGB toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
ergonovine	drug	ergot	group
false

DRUGN : DRUGN , DRUGN , DRUGA , DRUGB CONTRAINDICATED due to potential for serious and life threatening reactions such as acute DRUGN toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
ergotamine	drug	methylergonovine	drug
false

DRUGN : DRUGN , DRUGN , DRUGA , DRUGN CONTRAINDICATED due to potential for serious and life threatening reactions such as acute DRUGB toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
ergotamine	drug	ergot	group
false

DRUGN : DRUGN , DRUGN , DRUGN , DRUGA CONTRAINDICATED due to potential for serious and life threatening reactions such as acute DRUGB toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
methylergonovine	drug	ergot	group
false

DRUGA : DRUGB CONTRAINDICATED since the coadministration of this product with DRUGN in an DRUGN regimen reduces the plasma concentrations of DRUGN .
Antimycobacterial Agents	group	rifampin	drug
false

DRUGA : DRUGN CONTRAINDICATED since the coadministration of this product with DRUGB in an DRUGN regimen reduces the plasma concentrations of DRUGN .
Antimycobacterial Agents	group	saquinavir	drug
false

DRUGA : DRUGN CONTRAINDICATED since the coadministration of this product with DRUGN in an DRUGB regimen reduces the plasma concentrations of DRUGN .
Antimycobacterial Agents	group	antiretroviral	group
false

DRUGA : DRUGN CONTRAINDICATED since the coadministration of this product with DRUGN in an DRUGN regimen reduces the plasma concentrations of DRUGB .
Antimycobacterial Agents	group	saquinavir	drug
false

DRUGN : DRUGA CONTRAINDICATED since the coadministration of this product with DRUGB in an DRUGN regimen reduces the plasma concentrations of DRUGN .
rifampin	drug	saquinavir	drug
false

DRUGN : DRUGA CONTRAINDICATED since the coadministration of this product with DRUGN in an DRUGB regimen reduces the plasma concentrations of DRUGN .
rifampin	drug	antiretroviral	group
false

DRUGN : DRUGA CONTRAINDICATED since the coadministration of this product with DRUGN in an DRUGN regimen reduces the plasma concentrations of DRUGB .
rifampin	drug	saquinavir	drug
false

DRUGN : DRUGN CONTRAINDICATED since the coadministration of this product with DRUGA in an DRUGB regimen reduces the plasma concentrations of DRUGN .
saquinavir	drug	antiretroviral	group
false

DRUGN : DRUGN CONTRAINDICATED since the coadministration of this product with DRUGN in an DRUGA regimen reduces the plasma concentrations of DRUGB .
antiretroviral	group	saquinavir	drug
false

Garlic Capsules Garlic capsules should not be used while taking DRUGA ( DRUGB ) as the sole DRUGN due to the risk of decreased DRUGN plasma concentrations .
saquinavir	drug	FORTOVASE	brand
false

Garlic Capsules Garlic capsules should not be used while taking DRUGA ( DRUGN ) as the sole DRUGB due to the risk of decreased DRUGN plasma concentrations .
saquinavir	drug	protease inhibitor	group
false

Garlic Capsules Garlic capsules should not be used while taking DRUGN ( DRUGA ) as the sole DRUGB due to the risk of decreased DRUGN plasma concentrations .
FORTOVASE	brand	protease inhibitor	group
false

Garlic Capsules Garlic capsules should not be used while taking DRUGN ( DRUGA ) as the sole DRUGN due to the risk of decreased DRUGB plasma concentrations .
FORTOVASE	brand	saquinavir	drug
false

Garlic Capsules Garlic capsules should not be used while taking DRUGN ( DRUGN ) as the sole DRUGA due to the risk of decreased DRUGB plasma concentrations .
protease inhibitor	group	saquinavir	drug
false

No data are available for the coadministration of DRUGA / DRUGB or DRUGN / DRUGN and garlic capsules .
INVIRASE	brand	ritonavir	drug
false

No data are available for the coadministration of DRUGA / DRUGN or DRUGB / DRUGN and garlic capsules .
INVIRASE	brand	FORTOVASE	brand
false

No data are available for the coadministration of DRUGA / DRUGN or DRUGN / DRUGB and garlic capsules .
INVIRASE	brand	ritonavir	drug
false

No data are available for the coadministration of DRUGN / DRUGA or DRUGB / DRUGN and garlic capsules .
ritonavir	drug	FORTOVASE	brand
false

No data are available for the coadministration of DRUGN / DRUGN or DRUGA / DRUGB and garlic capsules .
FORTOVASE	brand	ritonavir	drug
false

DRUGA : DRUGB , DRUGN WARNING potential for serious reactions such as risk of myopathy including rhabdomyolysis .
HMG-CoA Reductase Inhibitors	group	lovastatin	drug
false

DRUGA : DRUGN , DRUGB WARNING potential for serious reactions such as risk of myopathy including rhabdomyolysis .
HMG-CoA Reductase Inhibitors	group	simvastatin	drug
false

DRUGN : DRUGA , DRUGB WARNING potential for serious reactions such as risk of myopathy including rhabdomyolysis .
lovastatin	drug	simvastatin	drug
false

DRUGA / DRUGB : DRUGN , DRUGN CONTRAINDICATED due to potential for serious and / or life threatening reactions such as prolonged or increased sedation or respiratory depression .
Sedatives	group	Hypnotics	group
false

DRUGA / DRUGN : DRUGB , DRUGN CONTRAINDICATED due to potential for serious and / or life threatening reactions such as prolonged or increased sedation or respiratory depression .
Sedatives	group	triazolam	drug
false

DRUGA / DRUGN : DRUGN , DRUGB CONTRAINDICATED due to potential for serious and / or life threatening reactions such as prolonged or increased sedation or respiratory depression .
Sedatives	group	midazolam	drug
false

DRUGN / DRUGA : DRUGB , DRUGN CONTRAINDICATED due to potential for serious and / or life threatening reactions such as prolonged or increased sedation or respiratory depression .
Hypnotics	group	triazolam	drug
false

DRUGN / DRUGA : DRUGN , DRUGB CONTRAINDICATED due to potential for serious and / or life threatening reactions such as prolonged or increased sedation or respiratory depression .
Hypnotics	group	midazolam	drug
false

DRUGN / DRUGN : DRUGA , DRUGB CONTRAINDICATED due to potential for serious and / or life threatening reactions such as prolonged or increased sedation or respiratory depression .
triazolam	drug	midazolam	drug
false

Since DRUGA is coadministered with DRUGB , the DRUGN label should be reviewed for additional drugs that should not be coadministered .
INVIRASE	brand	ritonavir	drug
advise

Since DRUGA is coadministered with DRUGN , the DRUGB label should be reviewed for additional drugs that should not be coadministered .
INVIRASE	brand	ritonavir	drug
false

Coadministration with compounds that are potent inducers of CYPdgbAdgb ( eg , DRUGA , DRUGB , DRUGN , DRUGN ) may result in decreased plasma levels of DRUGN .
phenobarbital	drug	phenytoin	drug
false

Coadministration with compounds that are potent inducers of CYPdgbAdgb ( eg , DRUGA , DRUGN , DRUGB , DRUGN ) may result in decreased plasma levels of DRUGN .
phenobarbital	drug	dexamethasone	drug
false

Coadministration with compounds that are potent inducers of CYPdgbAdgb ( eg , DRUGA , DRUGN , DRUGN , DRUGB ) may result in decreased plasma levels of DRUGN .
phenobarbital	drug	carbamazepine	drug
false

Coadministration with compounds that are potent inducers of CYPdgbAdgb ( eg , DRUGA , DRUGN , DRUGN , DRUGN ) may result in decreased plasma levels of DRUGB .
phenobarbital	drug	saquinavir	drug
mechanism

Coadministration with compounds that are potent inducers of CYPdgbAdgb ( eg , DRUGN , DRUGA , DRUGB , DRUGN ) may result in decreased plasma levels of DRUGN .
phenytoin	drug	dexamethasone	drug
false

Coadministration with compounds that are potent inducers of CYPdgbAdgb ( eg , DRUGN , DRUGA , DRUGN , DRUGB ) may result in decreased plasma levels of DRUGN .
phenytoin	drug	carbamazepine	drug
false

Coadministration with compounds that are potent inducers of CYPdgbAdgb ( eg , DRUGN , DRUGA , DRUGN , DRUGN ) may result in decreased plasma levels of DRUGB .
phenytoin	drug	saquinavir	drug
mechanism

Coadministration with compounds that are potent inducers of CYPdgbAdgb ( eg , DRUGN , DRUGN , DRUGA , DRUGB ) may result in decreased plasma levels of DRUGN .
dexamethasone	drug	carbamazepine	drug
false

Coadministration with compounds that are potent inducers of CYPdgbAdgb ( eg , DRUGN , DRUGN , DRUGA , DRUGN ) may result in decreased plasma levels of DRUGB .
dexamethasone	drug	saquinavir	drug
mechanism

Coadministration with compounds that are potent inducers of CYPdgbAdgb ( eg , DRUGN , DRUGN , DRUGN , DRUGA ) may result in decreased plasma levels of DRUGB .
carbamazepine	drug	saquinavir	drug
mechanism

DRUGA preparations are incompatible with DRUGB preparations .
Sulfacetamide	drug	silver	drug
int

DRUGA may interact with any of the following : DRUGB ( e.g . , DRUGN ) ( with long term , high dose use ) or
Sulfapyridine	drug	Acetaminophen	drug
int

DRUGA may interact with any of the following : DRUGN ( e.g . , DRUGB ) ( with long term , high dose use ) or
Sulfapyridine	drug	Tylenol	brand
int

DRUGN may interact with any of the following : DRUGA ( e.g . , DRUGB ) ( with long term , high dose use ) or
Acetaminophen	drug	Tylenol	brand
false

DRUGA ( e.g . , DRUGB ) or
Amiodarone	drug	Cordarone	brand
false

DRUGA ( DRUGB [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] ) or
Anabolic steroids	group	nandrolone	drug
false

DRUGA ( DRUGN [ e.g . , DRUGB ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] ) or
Anabolic steroids	group	Anabolin	brand
false

DRUGA ( DRUGN [ e.g . , DRUGN ] , DRUGB [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] ) or
Anabolic steroids	group	oxandrolone	drug
false

DRUGA ( DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGB ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] ) or
Anabolic steroids	group	Anavar	brand
false

DRUGA ( DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGB [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] ) or
Anabolic steroids	group	oxymetholone	drug
false

DRUGA ( DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGB ] , DRUGN [ e.g . , DRUGN ] ) or
Anabolic steroids	group	Anadrol	brand
false

DRUGA ( DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGB [ e.g . , DRUGN ] ) or
Anabolic steroids	group	stanozolol	drug
false

DRUGA ( DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGB ] ) or
Anabolic steroids	group	Winstrol	brand
false

DRUGN ( DRUGA [ e.g . , DRUGB ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] ) or
nandrolone	drug	Anabolin	brand
false

DRUGN ( DRUGA [ e.g . , DRUGN ] , DRUGB [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] ) or
nandrolone	drug	oxandrolone	drug
false

DRUGN ( DRUGA [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGB ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] ) or
nandrolone	drug	Anavar	brand
false

DRUGN ( DRUGA [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGB [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] ) or
nandrolone	drug	oxymetholone	drug
false

DRUGN ( DRUGA [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGB ] , DRUGN [ e.g . , DRUGN ] ) or
nandrolone	drug	Anadrol	brand
false

DRUGN ( DRUGA [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGB [ e.g . , DRUGN ] ) or
nandrolone	drug	stanozolol	drug
false

DRUGN ( DRUGA [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGB ] ) or
nandrolone	drug	Winstrol	brand
false

DRUGN ( DRUGN [ e.g . , DRUGA ] , DRUGB [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] ) or
Anabolin	brand	oxandrolone	drug
false

DRUGN ( DRUGN [ e.g . , DRUGA ] , DRUGN [ e.g . , DRUGB ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] ) or
Anabolin	brand	Anavar	brand
false

DRUGN ( DRUGN [ e.g . , DRUGA ] , DRUGN [ e.g . , DRUGN ] , DRUGB [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] ) or
Anabolin	brand	oxymetholone	drug
false

DRUGN ( DRUGN [ e.g . , DRUGA ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGB ] , DRUGN [ e.g . , DRUGN ] ) or
Anabolin	brand	Anadrol	brand
false

DRUGN ( DRUGN [ e.g . , DRUGA ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGB [ e.g . , DRUGN ] ) or
Anabolin	brand	stanozolol	drug
false

DRUGN ( DRUGN [ e.g . , DRUGA ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGB ] ) or
Anabolin	brand	Winstrol	brand
false

DRUGN ( DRUGN [ e.g . , DRUGN ] , DRUGA [ e.g . , DRUGB ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] ) or
oxandrolone	drug	Anavar	brand
false

DRUGN ( DRUGN [ e.g . , DRUGN ] , DRUGA [ e.g . , DRUGN ] , DRUGB [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] ) or
oxandrolone	drug	oxymetholone	drug
false

DRUGN ( DRUGN [ e.g . , DRUGN ] , DRUGA [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGB ] , DRUGN [ e.g . , DRUGN ] ) or
oxandrolone	drug	Anadrol	brand
false

DRUGN ( DRUGN [ e.g . , DRUGN ] , DRUGA [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGB [ e.g . , DRUGN ] ) or
oxandrolone	drug	stanozolol	drug
false

DRUGN ( DRUGN [ e.g . , DRUGN ] , DRUGA [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGB ] ) or
oxandrolone	drug	Winstrol	brand
false

DRUGN ( DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGA ] , DRUGB [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] ) or
Anavar	brand	oxymetholone	drug
false

DRUGN ( DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGA ] , DRUGN [ e.g . , DRUGB ] , DRUGN [ e.g . , DRUGN ] ) or
Anavar	brand	Anadrol	brand
false

DRUGN ( DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGA ] , DRUGN [ e.g . , DRUGN ] , DRUGB [ e.g . , DRUGN ] ) or
Anavar	brand	stanozolol	drug
false

DRUGN ( DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGA ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGB ] ) or
Anavar	brand	Winstrol	brand
false

DRUGN ( DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGA [ e.g . , DRUGB ] , DRUGN [ e.g . , DRUGN ] ) or
oxymetholone	drug	Anadrol	brand
false

DRUGN ( DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGA [ e.g . , DRUGN ] , DRUGB [ e.g . , DRUGN ] ) or
oxymetholone	drug	stanozolol	drug
false

DRUGN ( DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGA [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGB ] ) or
oxymetholone	drug	Winstrol	brand
false

DRUGN ( DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGA ] , DRUGB [ e.g . , DRUGN ] ) or
Anadrol	brand	stanozolol	drug
false

DRUGN ( DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGA ] , DRUGN [ e.g . , DRUGB ] ) or
Anadrol	brand	Winstrol	brand
false

DRUGN ( DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGN [ e.g . , DRUGN ] , DRUGA [ e.g . , DRUGB ] ) or
stanozolol	drug	Winstrol	brand
false

DRUGA ( e.g . , DRUGB ) or
Carbamazepine	drug	Tegretol	brand
false

DRUGA ( e.g . , DRUGB ) or
Carmustine	drug	BiCNU	brand
false

DRUGA ( e.g . , DRUGB ) or
Chloroquine	drug	Aralen	brand
false

DRUGA ( e.g . , DRUGB ) or
Dantrolene	drug	Dantrium	brand
false

DRUGA ( e.g . , DRUGB ) or
Daunorubicin	drug	Cerubidine	brand
false

DRUGA ( e.g . , DRUGB ) or
Disulfiram	drug	Antabuse	brand
false

DRUGA ( e.g . , DRUGB ) or
Divalproex	drug	Depakote	brand
false

DRUGA ( e.g . , DRUGB ) or
Etretinate	drug	Tegison	brand
false

DRUGA ( e.g . , DRUGB ) or
Hydroxychloroquine	drug	Plaquenil	brand
false

DRUGA ( e.g . , DRUGB ) or
Mercaptopurine	drug	Purinethol	brand
false

DRUGA ( e.g . , DRUGB ) ( with long term , high dose use ) or
Naltrexone	drug	Trexan	brand
false

Oral DRUGA ( birth control pills ) containing DRUGB or
contraceptives	group	estrogen	group
false

DRUGA ( e.g . , DRUGB ) or
Plicamycin	drug	Mithracin	brand
false

DRUGA ( e.g . , DRUGB ) Use of DRUGN with these medicines may increase the chance of side effects affecting the liver
Valproic acid	drug	Depakene	brand
false

DRUGA ( e.g . , DRUGN ) Use of DRUGB with these medicines may increase the chance of side effects affecting the liver
Valproic acid	drug	sulfapyridine	drug
false

DRUGN ( e.g . , DRUGA ) Use of DRUGB with these medicines may increase the chance of side effects affecting the liver
Depakene	brand	sulfapyridine	drug
false

DRUGA ( e.g . , DRUGB ) or
Acetohydroxamic acid	drug	Lithostat	brand
false

DRUGA ( e.g . , DRUGB ) or
Furazolidone	drug	Furoxone	brand
false

DRUGA ( e.g . , DRUGB ) or
Nitrofurantoin	drug	Furadantin	brand
false

DRUGA ( e.g . , DRUGB ) or
Procainamide	drug	Pronestyl	brand
false

DRUGA ( e.g . , DRUGB ) or
Quinidine	drug	Quinidex	brand
false

DRUGA ( e.g . , DRUGB ) or
Quinine	drug	Quinamm	brand
false

DRUGA ( e.g . , DRUGB ) or
Sulfoxone	drug	Diasone	brand
false

DRUGA ( e.g . , DRUGB , DRUGN ) Use of DRUGN with these medicines may increase the chance of side effects affecting the blood
Vitamin K	group	AquaMEPHYTON	brand
false

DRUGA ( e.g . , DRUGN , DRUGB ) Use of DRUGN with these medicines may increase the chance of side effects affecting the blood
Vitamin K	group	Synkayvite	brand
false

DRUGA ( e.g . , DRUGN , DRUGN ) Use of DRUGB with these medicines may increase the chance of side effects affecting the blood
Vitamin K	group	sulfapyridine	drug
false

DRUGN ( e.g . , DRUGA , DRUGB ) Use of DRUGN with these medicines may increase the chance of side effects affecting the blood
AquaMEPHYTON	brand	Synkayvite	brand
false

DRUGN ( e.g . , DRUGA , DRUGN ) Use of DRUGB with these medicines may increase the chance of side effects affecting the blood
AquaMEPHYTON	brand	sulfapyridine	drug
false

DRUGN ( e.g . , DRUGN , DRUGA ) Use of DRUGB with these medicines may increase the chance of side effects affecting the blood
Synkayvite	brand	sulfapyridine	drug
false

DRUGA ( DRUGB s ) or
Anticoagulants	group	blood thinner	group
false

DRUGA ( e.g . , DRUGB ) or
Ethotoin	drug	Peganone	brand
false

DRUGA ( e.g . , DRUGB ) Use of DRUGN with these medicines may increase the chance of side effects of these medicines
Mephenytoin	drug	Mesantoin	brand
false

DRUGA ( e.g . , DRUGN ) Use of DRUGB with these medicines may increase the chance of side effects of these medicines
Mephenytoin	drug	sulfapyridine	drug
false

DRUGN ( e.g . , DRUGA ) Use of DRUGB with these medicines may increase the chance of side effects of these medicines
Mesantoin	brand	sulfapyridine	drug
false

DRUGA , oral ( diabetes medicine you take by mouth ) Use of oral DRUGB with DRUGN may increase the chance of side effects affecting the blood and / or the side effects or oral DRUGN
Antidiabetics	group	antidiabetics	group
false

DRUGA , oral ( diabetes medicine you take by mouth ) Use of oral DRUGN with DRUGB may increase the chance of side effects affecting the blood and / or the side effects or oral DRUGN
Antidiabetics	group	sulfapyridine	drug
false

DRUGA , oral ( diabetes medicine you take by mouth ) Use of oral DRUGN with DRUGN may increase the chance of side effects affecting the blood and / or the side effects or oral DRUGB
Antidiabetics	group	antidiabetics	group
false

DRUGN , oral ( diabetes medicine you take by mouth ) Use of oral DRUGA with DRUGB may increase the chance of side effects affecting the blood and / or the side effects or oral DRUGN
antidiabetics	group	sulfapyridine	drug
effect

DRUGN , oral ( diabetes medicine you take by mouth ) Use of oral DRUGN with DRUGA may increase the chance of side effects affecting the blood and / or the side effects or oral DRUGB
sulfapyridine	drug	antidiabetics	group
false

DRUGA ( e.g . , DRUGB ) Use of DRUGN with DRUGN may increase the chance of side effects affecting the liver and / or the side effects of DRUGN
Methotrexate	drug	Mexate	brand
false

DRUGA ( e.g . , DRUGN ) Use of DRUGB with DRUGN may increase the chance of side effects affecting the liver and / or the side effects of DRUGN
Methotrexate	drug	methotrexate	drug
false

DRUGA ( e.g . , DRUGN ) Use of DRUGN with DRUGB may increase the chance of side effects affecting the liver and / or the side effects of DRUGN
Methotrexate	drug	sulfapyridine	drug
false

DRUGA ( e.g . , DRUGN ) Use of DRUGN with DRUGN may increase the chance of side effects affecting the liver and / or the side effects of DRUGB
Methotrexate	drug	methotrexate	drug
false

DRUGN ( e.g . , DRUGA ) Use of DRUGB with DRUGN may increase the chance of side effects affecting the liver and / or the side effects of DRUGN
Mexate	brand	methotrexate	drug
false

DRUGN ( e.g . , DRUGA ) Use of DRUGN with DRUGB may increase the chance of side effects affecting the liver and / or the side effects of DRUGN
Mexate	brand	sulfapyridine	drug
false

DRUGN ( e.g . , DRUGA ) Use of DRUGN with DRUGN may increase the chance of side effects affecting the liver and / or the side effects of DRUGB
Mexate	brand	methotrexate	drug
false

DRUGN ( e.g . , DRUGN ) Use of DRUGA with DRUGB may increase the chance of side effects affecting the liver and / or the side effects of DRUGN
methotrexate	drug	sulfapyridine	drug
effect

DRUGN ( e.g . , DRUGN ) Use of DRUGN with DRUGA may increase the chance of side effects affecting the liver and / or the side effects of DRUGB
sulfapyridine	drug	methotrexate	drug
false

DRUGA ( e.g . , DRUGB ) Use of DRUGN with DRUGN may increase the chance of side effects affecting the liver and / or the blood
Methyldopa	drug	Aldomet	brand
false

DRUGA ( e.g . , DRUGN ) Use of DRUGB with DRUGN may increase the chance of side effects affecting the liver and / or the blood
Methyldopa	drug	methyldopa	drug
false

DRUGA ( e.g . , DRUGN ) Use of DRUGN with DRUGB may increase the chance of side effects affecting the liver and / or the blood
Methyldopa	drug	sulfapyridine	drug
false

DRUGN ( e.g . , DRUGA ) Use of DRUGB with DRUGN may increase the chance of side effects affecting the liver and / or the blood
Aldomet	brand	methyldopa	drug
false

DRUGN ( e.g . , DRUGA ) Use of DRUGN with DRUGB may increase the chance of side effects affecting the liver and / or the blood
Aldomet	brand	sulfapyridine	drug
false

DRUGN ( e.g . , DRUGN ) Use of DRUGA with DRUGB may increase the chance of side effects affecting the liver and / or the blood
methyldopa	drug	sulfapyridine	drug
effect

DRUGA ( e.g . , DRUGB ) Use of DRUGN with DRUGN may increase the chance of side effects affecting the liver and / or the side effects of DRUGN
Phenytoin	drug	Dilantin	brand
false

DRUGA ( e.g . , DRUGN ) Use of DRUGB with DRUGN may increase the chance of side effects affecting the liver and / or the side effects of DRUGN
Phenytoin	drug	phenytoin	drug
false

DRUGA ( e.g . , DRUGN ) Use of DRUGN with DRUGB may increase the chance of side effects affecting the liver and / or the side effects of DRUGN
Phenytoin	drug	sulfapyridine	drug
false

DRUGA ( e.g . , DRUGN ) Use of DRUGN with DRUGN may increase the chance of side effects affecting the liver and / or the side effects of DRUGB
Phenytoin	drug	phenytoin	drug
false

DRUGN ( e.g . , DRUGA ) Use of DRUGB with DRUGN may increase the chance of side effects affecting the liver and / or the side effects of DRUGN
Dilantin	brand	phenytoin	drug
false

DRUGN ( e.g . , DRUGA ) Use of DRUGN with DRUGB may increase the chance of side effects affecting the liver and / or the side effects of DRUGN
Dilantin	brand	sulfapyridine	drug
false

DRUGN ( e.g . , DRUGA ) Use of DRUGN with DRUGN may increase the chance of side effects affecting the liver and / or the side effects of DRUGB
Dilantin	brand	phenytoin	drug
false

DRUGN ( e.g . , DRUGN ) Use of DRUGA with DRUGB may increase the chance of side effects affecting the liver and / or the side effects of DRUGN
phenytoin	drug	sulfapyridine	drug
effect

DRUGN ( e.g . , DRUGN ) Use of DRUGN with DRUGA may increase the chance of side effects affecting the liver and / or the side effects of DRUGB
sulfapyridine	drug	phenytoin	drug
false

In evaluating the potential for interactions among co administered antiepilepsy drugs ( DRUGA ) , whether or not an DRUGB induces or does not induce metabolic enzymes is an important consideration .
AEDs	group	AED	group
false

DRUGA , DRUGB and DRUGN are ge nerally classified as enzyme inducers ;
Phenytoin	drug	phenobarbital	drug
false

DRUGA , DRUGN and DRUGB are ge nerally classified as enzyme inducers ;
Phenytoin	drug	carbamazepine	drug
false

DRUGN , DRUGA and DRUGB are ge nerally classified as enzyme inducers ;
phenobarbital	drug	carbamazepine	drug
false

DRUGA and DRUGB are not .
valproate	drug	gabapentin	drug
false

DRUGA is considered to be a non enzyme inducing DRUGB .
GABITRIL	brand	AED	group
false

Effects of DRUGA on other Antiepilepsy Drugs ( DRUGB ) : DRUGN : DRUGN had no effect on the steady state plasma concentrations of DRUGN in patients with epilepsy .
GABITRIL	brand	AEDs	group
false

Effects of DRUGA on other Antiepilepsy Drugs ( DRUGN ) : DRUGB : DRUGN had no effect on the steady state plasma concentrations of DRUGN in patients with epilepsy .
GABITRIL	brand	Phenytoin	drug
false

Effects of DRUGA on other Antiepilepsy Drugs ( DRUGN ) : DRUGN : DRUGB had no effect on the steady state plasma concentrations of DRUGN in patients with epilepsy .
GABITRIL	brand	Tiagabine	drug
false

Effects of DRUGA on other Antiepilepsy Drugs ( DRUGN ) : DRUGN : DRUGN had no effect on the steady state plasma concentrations of DRUGB in patients with epilepsy .
GABITRIL	brand	phenytoin	drug
false

Effects of DRUGN on other Antiepilepsy Drugs ( DRUGA ) : DRUGB : DRUGN had no effect on the steady state plasma concentrations of DRUGN in patients with epilepsy .
AEDs	group	Phenytoin	drug
false

Effects of DRUGN on other Antiepilepsy Drugs ( DRUGA ) : DRUGN : DRUGB had no effect on the steady state plasma concentrations of DRUGN in patients with epilepsy .
AEDs	group	Tiagabine	drug
false

Effects of DRUGN on other Antiepilepsy Drugs ( DRUGA ) : DRUGN : DRUGN had no effect on the steady state plasma concentrations of DRUGB in patients with epilepsy .
AEDs	group	phenytoin	drug
false

Effects of DRUGN on other Antiepilepsy Drugs ( DRUGN ) : DRUGA : DRUGB had no effect on the steady state plasma concentrations of DRUGN in patients with epilepsy .
Phenytoin	drug	Tiagabine	drug
false

Effects of DRUGN on other Antiepilepsy Drugs ( DRUGN ) : DRUGA : DRUGN had no effect on the steady state plasma concentrations of DRUGB in patients with epilepsy .
Phenytoin	drug	phenytoin	drug
false

Effects of DRUGN on other Antiepilepsy Drugs ( DRUGN ) : DRUGN : DRUGA had no effect on the steady state plasma concentrations of DRUGB in patients with epilepsy .
Tiagabine	drug	phenytoin	drug
false

DRUGA : DRUGB had no effect on the steady state plasma concentrations of DRUGN or its epoxide metabolite in patients with epilepsy .
Carbamazepine	drug	Tiagabine	drug
false

DRUGA : DRUGN had no effect on the steady state plasma concentrations of DRUGB or its epoxide metabolite in patients with epilepsy .
Carbamazepine	drug	carbamazepine	drug
false

DRUGN : DRUGA had no effect on the steady state plasma concentrations of DRUGB or its epoxide metabolite in patients with epilepsy .
Tiagabine	drug	carbamazepine	drug
false

DRUGA : DRUGB causes a slight decrease ( about dgb % ) in steady state DRUGN concentrations .
Valproate	drug	Tiagabine	drug
false

DRUGA : DRUGN causes a slight decrease ( about dgb % ) in steady state DRUGB concentrations .
Valproate	drug	valproate	drug
false

DRUGN : DRUGA causes a slight decrease ( about dgb % ) in steady state DRUGB concentrations .
Tiagabine	drug	valproate	drug
mechanism

DRUGA or DRUGB : No formal pharmacokinetic studies have been performed examining the addition of DRUGN to regimens containing DRUGN or DRUGN .
Phenobarbital	drug	Primidone	drug
false

DRUGA or DRUGN : No formal pharmacokinetic studies have been performed examining the addition of DRUGB to regimens containing DRUGN or DRUGN .
Phenobarbital	drug	tiagabine	drug
false

DRUGA or DRUGN : No formal pharmacokinetic studies have been performed examining the addition of DRUGN to regimens containing DRUGB or DRUGN .
Phenobarbital	drug	phenobarbital	drug
false

DRUGA or DRUGN : No formal pharmacokinetic studies have been performed examining the addition of DRUGN to regimens containing DRUGN or DRUGB .
Phenobarbital	drug	primidone	drug
false

DRUGN or DRUGA : No formal pharmacokinetic studies have been performed examining the addition of DRUGB to regimens containing DRUGN or DRUGN .
Primidone	drug	tiagabine	drug
false

DRUGN or DRUGA : No formal pharmacokinetic studies have been performed examining the addition of DRUGN to regimens containing DRUGB or DRUGN .
Primidone	drug	phenobarbital	drug
false

DRUGN or DRUGA : No formal pharmacokinetic studies have been performed examining the addition of DRUGN to regimens containing DRUGN or DRUGB .
Primidone	drug	primidone	drug
false

DRUGN or DRUGN : No formal pharmacokinetic studies have been performed examining the addition of DRUGA to regimens containing DRUGB or DRUGN .
tiagabine	drug	phenobarbital	drug
false

DRUGN or DRUGN : No formal pharmacokinetic studies have been performed examining the addition of DRUGA to regimens containing DRUGN or DRUGB .
tiagabine	drug	primidone	drug
false

DRUGN or DRUGN : No formal pharmacokinetic studies have been performed examining the addition of DRUGN to regimens containing DRUGA or DRUGB .
phenobarbital	drug	primidone	drug
false

The addition of DRUGA in a limited number of patients in three well controlled studies caused no systematic changes in DRUGB or DRUGN concentrations when compared to placebo .
tiagabine	drug	phenobarbital	drug
false

The addition of DRUGA in a limited number of patients in three well controlled studies caused no systematic changes in DRUGN or DRUGB concentrations when compared to placebo .
tiagabine	drug	primidone	drug
false

The addition of DRUGN in a limited number of patients in three well controlled studies caused no systematic changes in DRUGA or DRUGB concentrations when compared to placebo .
phenobarbital	drug	primidone	drug
false

Effects of other Antiepilepsy Drugs ( DRUGA ) on DRUGB : DRUGN : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGN with or without other enzyme inducing DRUGN .
AEDs	group	GABITRIL	brand
false

Effects of other Antiepilepsy Drugs ( DRUGA ) on DRUGN : DRUGB : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGN with or without other enzyme inducing DRUGN .
AEDs	group	Carbamazepine	drug
false

Effects of other Antiepilepsy Drugs ( DRUGA ) on DRUGN : DRUGN : Population pharmacokinetic analyses indicate that DRUGB clearance is dgb % greater in patients taking DRUGN with or without other enzyme inducing DRUGN .
AEDs	group	tiagabine	drug
false

Effects of other Antiepilepsy Drugs ( DRUGA ) on DRUGN : DRUGN : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGB with or without other enzyme inducing DRUGN .
AEDs	group	carbamazepine	drug
false

Effects of other Antiepilepsy Drugs ( DRUGN ) on DRUGA : DRUGB : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGN with or without other enzyme inducing DRUGN .
GABITRIL	brand	Carbamazepine	drug
false

Effects of other Antiepilepsy Drugs ( DRUGN ) on DRUGA : DRUGN : Population pharmacokinetic analyses indicate that DRUGB clearance is dgb % greater in patients taking DRUGN with or without other enzyme inducing DRUGN .
GABITRIL	brand	tiagabine	drug
false

Effects of other Antiepilepsy Drugs ( DRUGN ) on DRUGA : DRUGN : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGB with or without other enzyme inducing DRUGN .
GABITRIL	brand	carbamazepine	drug
false

Effects of other Antiepilepsy Drugs ( DRUGN ) on DRUGA : DRUGN : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGN with or without other enzyme inducing DRUGB .
GABITRIL	brand	AEDs	group
false

Effects of other Antiepilepsy Drugs ( DRUGN ) on DRUGN : DRUGA : Population pharmacokinetic analyses indicate that DRUGB clearance is dgb % greater in patients taking DRUGN with or without other enzyme inducing DRUGN .
Carbamazepine	drug	tiagabine	drug
false

Effects of other Antiepilepsy Drugs ( DRUGN ) on DRUGN : DRUGA : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGB with or without other enzyme inducing DRUGN .
Carbamazepine	drug	carbamazepine	drug
false

Effects of other Antiepilepsy Drugs ( DRUGN ) on DRUGN : DRUGA : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGN with or without other enzyme inducing DRUGB .
Carbamazepine	drug	AEDs	group
false

Effects of other Antiepilepsy Drugs ( DRUGN ) on DRUGN : DRUGN : Population pharmacokinetic analyses indicate that DRUGA clearance is dgb % greater in patients taking DRUGB with or without other enzyme inducing DRUGN .
tiagabine	drug	carbamazepine	drug
mechanism

Effects of other Antiepilepsy Drugs ( DRUGN ) on DRUGN : DRUGN : Population pharmacokinetic analyses indicate that DRUGA clearance is dgb % greater in patients taking DRUGN with or without other enzyme inducing DRUGB .
tiagabine	drug	AEDs	group
false

Effects of other Antiepilepsy Drugs ( DRUGN ) on DRUGN : DRUGN : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGA with or without other enzyme inducing DRUGB .
carbamazepine	drug	AEDs	group
false

DRUGA : Population pharmacokinetic analyses indicate that DRUGB clearance is dgb % greater in patients taking DRUGN with or without other enzyme inducing DRUGN .
Phenytoin	drug	tiagabine	drug
false

DRUGA : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGB with or without other enzyme inducing DRUGN .
Phenytoin	drug	phenytoin	drug
false

DRUGA : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGN with or without other enzyme inducing DRUGB .
Phenytoin	drug	AEDs	group
false

DRUGN : Population pharmacokinetic analyses indicate that DRUGA clearance is dgb % greater in patients taking DRUGB with or without other enzyme inducing DRUGN .
tiagabine	drug	phenytoin	drug
mechanism

DRUGN : Population pharmacokinetic analyses indicate that DRUGA clearance is dgb % greater in patients taking DRUGN with or without other enzyme inducing DRUGB .
tiagabine	drug	AEDs	group
false

DRUGN : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGA with or without other enzyme inducing DRUGB .
phenytoin	drug	AEDs	group
false

DRUGA ( DRUGB ) : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGN ( DRUGN ) with or without other enzyme inducing DRUGN .
Phenobarbital	drug	Primidone	drug
false

DRUGA ( DRUGN ) : Population pharmacokinetic analyses indicate that DRUGB clearance is dgb % greater in patients taking DRUGN ( DRUGN ) with or without other enzyme inducing DRUGN .
Phenobarbital	drug	tiagabine	drug
false

DRUGA ( DRUGN ) : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGB ( DRUGN ) with or without other enzyme inducing DRUGN .
Phenobarbital	drug	phenobarbital	drug
false

DRUGA ( DRUGN ) : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGN ( DRUGB ) with or without other enzyme inducing DRUGN .
Phenobarbital	drug	primidone	drug
false

DRUGA ( DRUGN ) : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGN ( DRUGN ) with or without other enzyme inducing DRUGB .
Phenobarbital	drug	AEDs	group
false

DRUGN ( DRUGA ) : Population pharmacokinetic analyses indicate that DRUGB clearance is dgb % greater in patients taking DRUGN ( DRUGN ) with or without other enzyme inducing DRUGN .
Primidone	drug	tiagabine	drug
false

DRUGN ( DRUGA ) : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGB ( DRUGN ) with or without other enzyme inducing DRUGN .
Primidone	drug	phenobarbital	drug
false

DRUGN ( DRUGA ) : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGN ( DRUGB ) with or without other enzyme inducing DRUGN .
Primidone	drug	primidone	drug
false

DRUGN ( DRUGA ) : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGN ( DRUGN ) with or without other enzyme inducing DRUGB .
Primidone	drug	AEDs	group
false

DRUGN ( DRUGN ) : Population pharmacokinetic analyses indicate that DRUGA clearance is dgb % greater in patients taking DRUGB ( DRUGN ) with or without other enzyme inducing DRUGN .
tiagabine	drug	phenobarbital	drug
mechanism

DRUGN ( DRUGN ) : Population pharmacokinetic analyses indicate that DRUGA clearance is dgb % greater in patients taking DRUGN ( DRUGB ) with or without other enzyme inducing DRUGN .
tiagabine	drug	primidone	drug
mechanism

DRUGN ( DRUGN ) : Population pharmacokinetic analyses indicate that DRUGA clearance is dgb % greater in patients taking DRUGN ( DRUGN ) with or without other enzyme inducing DRUGB .
tiagabine	drug	AEDs	group
false

DRUGN ( DRUGN ) : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGA ( DRUGB ) with or without other enzyme inducing DRUGN .
phenobarbital	drug	primidone	drug
false

DRUGN ( DRUGN ) : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGA ( DRUGN ) with or without other enzyme inducing DRUGB .
phenobarbital	drug	AEDs	group
false

DRUGN ( DRUGN ) : Population pharmacokinetic analyses indicate that DRUGN clearance is dgb % greater in patients taking DRUGN ( DRUGA ) with or without other enzyme inducing DRUGB .
primidone	drug	AEDs	group
false

Interaction of DRUGA with Other Drugs : DRUGB : Co administration of DRUGN ( dgb mg / day ) to patients taking DRUGN chronically had no effect on DRUGN pharmacokinetics .
GABITRIL	brand	Cimetidine	drug
false

Interaction of DRUGA with Other Drugs : DRUGN : Co administration of DRUGB ( dgb mg / day ) to patients taking DRUGN chronically had no effect on DRUGN pharmacokinetics .
GABITRIL	brand	cimetidine	drug
false

Interaction of DRUGA with Other Drugs : DRUGN : Co administration of DRUGN ( dgb mg / day ) to patients taking DRUGB chronically had no effect on DRUGN pharmacokinetics .
GABITRIL	brand	tiagabine	drug
false

Interaction of DRUGA with Other Drugs : DRUGN : Co administration of DRUGN ( dgb mg / day ) to patients taking DRUGN chronically had no effect on DRUGB pharmacokinetics .
GABITRIL	brand	tiagabine	drug
false

Interaction of DRUGN with Other Drugs : DRUGA : Co administration of DRUGB ( dgb mg / day ) to patients taking DRUGN chronically had no effect on DRUGN pharmacokinetics .
Cimetidine	drug	cimetidine	drug
false

Interaction of DRUGN with Other Drugs : DRUGA : Co administration of DRUGN ( dgb mg / day ) to patients taking DRUGB chronically had no effect on DRUGN pharmacokinetics .
Cimetidine	drug	tiagabine	drug
false

Interaction of DRUGN with Other Drugs : DRUGA : Co administration of DRUGN ( dgb mg / day ) to patients taking DRUGN chronically had no effect on DRUGB pharmacokinetics .
Cimetidine	drug	tiagabine	drug
false

Interaction of DRUGN with Other Drugs : DRUGN : Co administration of DRUGA ( dgb mg / day ) to patients taking DRUGB chronically had no effect on DRUGN pharmacokinetics .
cimetidine	drug	tiagabine	drug
false

Interaction of DRUGN with Other Drugs : DRUGN : Co administration of DRUGA ( dgb mg / day ) to patients taking DRUGN chronically had no effect on DRUGB pharmacokinetics .
cimetidine	drug	tiagabine	drug
false

DRUGA : A single dgb mg dose of DRUGB did not affect the pharmacokinetics of DRUGN at steady state .
Theophylline	drug	tiagabine	drug
false

DRUGA : A single dgb mg dose of DRUGN did not affect the pharmacokinetics of DRUGB at steady state .
Theophylline	drug	theophylline	drug
false

DRUGN : A single dgb mg dose of DRUGA did not affect the pharmacokinetics of DRUGB at steady state .
tiagabine	drug	theophylline	drug
false

DRUGA : No significant differences were observed in the steady state pharmacokinetics of DRUGB or DRUGN with the addition of DRUGN given as a single dose .
Warfarin	drug	R-warfarin	drug
false

DRUGA : No significant differences were observed in the steady state pharmacokinetics of DRUGN or DRUGB with the addition of DRUGN given as a single dose .
Warfarin	drug	S-warfarin	drug
false

DRUGA : No significant differences were observed in the steady state pharmacokinetics of DRUGN or DRUGN with the addition of DRUGB given as a single dose .
Warfarin	drug	tiagabine	drug
false

DRUGN : No significant differences were observed in the steady state pharmacokinetics of DRUGA or DRUGB with the addition of DRUGN given as a single dose .
R-warfarin	drug	S-warfarin	drug
false

DRUGN : No significant differences were observed in the steady state pharmacokinetics of DRUGA or DRUGN with the addition of DRUGB given as a single dose .
R-warfarin	drug	tiagabine	drug
false

DRUGN : No significant differences were observed in the steady state pharmacokinetics of DRUGN or DRUGA with the addition of DRUGB given as a single dose .
S-warfarin	drug	tiagabine	drug
false

DRUGA : Concomitant administration of DRUGB did not affect the steady state pharmacokinetics of DRUGN or the mean daily trough serum level of DRUGN .
Digoxin	drug	tiagabine	drug
false

DRUGA : Concomitant administration of DRUGN did not affect the steady state pharmacokinetics of DRUGB or the mean daily trough serum level of DRUGN .
Digoxin	drug	digoxin	drug
false

DRUGA : Concomitant administration of DRUGN did not affect the steady state pharmacokinetics of DRUGN or the mean daily trough serum level of DRUGB .
Digoxin	drug	digoxin	drug
false

DRUGN : Concomitant administration of DRUGA did not affect the steady state pharmacokinetics of DRUGB or the mean daily trough serum level of DRUGN .
tiagabine	drug	digoxin	drug
false

DRUGN : Concomitant administration of DRUGA did not affect the steady state pharmacokinetics of DRUGN or the mean daily trough serum level of DRUGB .
tiagabine	drug	digoxin	drug
false

DRUGA or DRUGB : No significant differences were observed in the pharmacokinetics of DRUGN ( dga mg ) and DRUGN ( dgb mg ) when given together as a single dose .
Ethanol	drug	Triazolam	drug
false

DRUGA or DRUGN : No significant differences were observed in the pharmacokinetics of DRUGB ( dga mg ) and DRUGN ( dgb mg ) when given together as a single dose .
Ethanol	drug	triazolam	drug
false

DRUGA or DRUGN : No significant differences were observed in the pharmacokinetics of DRUGN ( dga mg ) and DRUGB ( dgb mg ) when given together as a single dose .
Ethanol	drug	tiagabine	drug
false

DRUGN or DRUGA : No significant differences were observed in the pharmacokinetics of DRUGB ( dga mg ) and DRUGN ( dgb mg ) when given together as a single dose .
Triazolam	drug	triazolam	drug
false

DRUGN or DRUGA : No significant differences were observed in the pharmacokinetics of DRUGN ( dga mg ) and DRUGB ( dgb mg ) when given together as a single dose .
Triazolam	drug	tiagabine	drug
false

DRUGN or DRUGN : No significant differences were observed in the pharmacokinetics of DRUGA ( dga mg ) and DRUGB ( dgb mg ) when given together as a single dose .
triazolam	drug	tiagabine	drug
false

The pharmacokinetics of DRUGA were not affected by multiple dose administration of DRUGB .
ethanol	drug	tiagabine	drug
false

DRUGA has shown no clinically important potentiation of the pharmacodynamic effects of triazo lam or DRUGB .
Tiagabine	drug	alcohol	drug
false

Because of the possible additive effects of drugs that may depress the nervous system , DRUGA or DRUGB should be used cautiously in combination with DRUGN .
ethanol	drug	triazolam	drug
false

Because of the possible additive effects of drugs that may depress the nervous system , DRUGA or DRUGN should be used cautiously in combination with DRUGB .
ethanol	drug	tiagabine	drug
advise

Because of the possible additive effects of drugs that may depress the nervous system , DRUGN or DRUGA should be used cautiously in combination with DRUGB .
triazolam	drug	tiagabine	drug
advise

Oral DRUGA : Multiple dose administration of DRUGB ( dgb mg / day monotherapy ) did not alter the pharmacokinetics of oral DRUGN in healthy women of childbearing age .
Contraceptives	group	tiagabine	drug
false

Oral DRUGA : Multiple dose administration of DRUGN ( dgb mg / day monotherapy ) did not alter the pharmacokinetics of oral DRUGB in healthy women of childbearing age .
Contraceptives	group	contraceptives	group
false

Oral DRUGN : Multiple dose administration of DRUGA ( dgb mg / day monotherapy ) did not alter the pharmacokinetics of oral DRUGB in healthy women of childbearing age .
tiagabine	drug	contraceptives	group
false

DRUGA : DRUGN pharmacokinetics were not significantly different before and after DRUGB multiple dose regimens .
Antipyrine	drug	tiagabine	drug
false

DRUGN : DRUGA pharmacokinetics were not significantly different before and after DRUGB multiple dose regimens .
Antipyrine	drug	tiagabine	drug
false

This indicates that DRUGA does not cause induction or inhibition of the hepatic microsomal enzyme systems responsible for the metabolism of DRUGB .
tiagabine	drug	antipyrine	drug
false

Interaction of DRUGA with Highly Protein Bound Drugs : In vitro data showed that DRUGB is dgb % bound to human plasma protein and therefore has the potential to interact with other highly protein bound compounds .
GABITRIL	brand	tiagabine	drug
false

DRUGA : Concomitant administration of DRUGB with DRUGN may result in an increased risk of GI ulceration and complications compared to DRUGN alone .
Aspirin	brand	aspirin	brand
false

DRUGA : Concomitant administration of DRUGN with DRUGB may result in an increased risk of GI ulceration and complications compared to DRUGN alone .
Aspirin	brand	valdecoxib	drug
false

DRUGA : Concomitant administration of DRUGN with DRUGN may result in an increased risk of GI ulceration and complications compared to DRUGB alone .
Aspirin	brand	valdecoxib	drug
false

DRUGN : Concomitant administration of DRUGA with DRUGB may result in an increased risk of GI ulceration and complications compared to DRUGN alone .
aspirin	brand	valdecoxib	drug
effect

DRUGN : Concomitant administration of DRUGA with DRUGN may result in an increased risk of GI ulceration and complications compared to DRUGB alone .
aspirin	brand	valdecoxib	drug
false

Because of its lack of anti platelet effect DRUGA is not a substitute for DRUGB for cardiovascular prophylaxis .
valdecoxib	drug	aspirin	brand
false

DRUGA : DRUGB BID did not show a significant effect on the plasma exposure or renal clearance of DRUGN .
Methotrexate	drug	Valdecoxib 10 mg	drug
false

DRUGA : DRUGN BID did not show a significant effect on the plasma exposure or renal clearance of DRUGB .
Methotrexate	drug	methotrexate	drug
false

DRUGN : DRUGA BID did not show a significant effect on the plasma exposure or renal clearance of DRUGB .
Valdecoxib 10 mg	drug	methotrexate	drug
false

DRUGA : Reports suggest that DRUGB may diminish the antihypertensive effect of DRUGN .
ACE-inhibitors	group	NSAIDs	group
false

DRUGN : Reports suggest that DRUGA may diminish the antihypertensive effect of DRUGB .
NSAIDs	group	ACE-inhibitors	group
effect

This interaction should be given consideration in patients taking DRUGA concomitantly with DRUGB .
BEXTRA	brand	ACE-inhibitors	group
advise

DRUGA : Clinical studies , as well as post marketing observations , have shown that DRUGB can reduce the natriuretic effect of DRUGN and DRUGN in some patients .
Furosemide	drug	NSAIDs	group
false

DRUGA : Clinical studies , as well as post marketing observations , have shown that DRUGN can reduce the natriuretic effect of DRUGB and DRUGN in some patients .
Furosemide	drug	furosemide	drug
false

DRUGA : Clinical studies , as well as post marketing observations , have shown that DRUGN can reduce the natriuretic effect of DRUGN and DRUGB in some patients .
Furosemide	drug	thiazides	group
false

DRUGN : Clinical studies , as well as post marketing observations , have shown that DRUGA can reduce the natriuretic effect of DRUGB and DRUGN in some patients .
NSAIDs	group	furosemide	drug
effect

DRUGN : Clinical studies , as well as post marketing observations , have shown that DRUGA can reduce the natriuretic effect of DRUGN and DRUGB in some patients .
NSAIDs	group	thiazides	group
effect

DRUGN : Clinical studies , as well as post marketing observations , have shown that DRUGN can reduce the natriuretic effect of DRUGA and DRUGB in some patients .
furosemide	drug	thiazides	group
false

Patients already stabilized on DRUGA should be closely monitored for loss of symptom control with DRUGB coadministration .
valdecoxib	drug	phenytoin	drug
advise

DRUGA did not have a statistically significant effect on the pharmacokinetics of DRUGB ( a CYP dgbCdgb and CYP dgbCdgb substrate ) .
Valdecoxib	drug	phenytoin	drug
false

Coadministration with DRUGA ( dgb mg BID for dgb days ) resulted in a significant increase in DRUGB plasma levels suggesting that , at these doses , DRUGN is a weak inhibitor of dgbDdga
valdecoxib	drug	dextromethorphan	drug
mechanism

Coadministration with DRUGN ( dgb mg BID for dgb days ) resulted in a significant increase in DRUGA plasma levels suggesting that , at these doses , DRUGB is a weak inhibitor of dgbDdga
dextromethorphan	drug	valdecoxib	drug
false

Even so DRUGA plasma concentrations in the presence of high doses of DRUGB were almost dgb fold lower than those seen in CYP dgbDdgb poor metabolizers suggesting that dose adjustment is not necessary .
dextromethorphan	drug	valdecoxib	drug
mechanism

DRUGA : DRUGB dgb mg BID for dgb days produced significant decreases in DRUGN serum clearance ( dgb % ) and renal clearance ( dgb % ) with a dgb % higher serum exposure compared to DRUGN alone .
Lithium	drug	Valdecoxib	drug
false

DRUGA : DRUGN dgb mg BID for dgb days produced significant decreases in DRUGB serum clearance ( dgb % ) and renal clearance ( dgb % ) with a dgb % higher serum exposure compared to DRUGN alone .
Lithium	drug	lithium	drug
false

DRUGA : DRUGN dgb mg BID for dgb days produced significant decreases in DRUGN serum clearance ( dgb % ) and renal clearance ( dgb % ) with a dgb % higher serum exposure compared to DRUGB alone .
Lithium	drug	lithium	drug
false

DRUGN : DRUGA dgb mg BID for dgb days produced significant decreases in DRUGB serum clearance ( dgb % ) and renal clearance ( dgb % ) with a dgb % higher serum exposure compared to DRUGN alone .
Valdecoxib	drug	lithium	drug
mechanism

DRUGN : DRUGA dgb mg BID for dgb days produced significant decreases in DRUGN serum clearance ( dgb % ) and renal clearance ( dgb % ) with a dgb % higher serum exposure compared to DRUGB alone .
Valdecoxib	drug	lithium	drug
false

DRUGA serum concentrations should be monitored closely when initiating or changing therapy with DRUGB in patients receiving DRUGN .
Lithium	drug	BEXTRA	brand
false

DRUGA serum concentrations should be monitored closely when initiating or changing therapy with DRUGN in patients receiving DRUGB .
Lithium	drug	lithium	drug
false

DRUGN serum concentrations should be monitored closely when initiating or changing therapy with DRUGA in patients receiving DRUGB .
BEXTRA	brand	lithium	drug
advise

DRUGA ( dgb mg BID for dgb days ) had no effect on DRUGB pharmacokinetics .
Lithium carbonate	drug	valdecoxib	drug
false

DRUGA : The effect of DRUGB on the anticoagulant effect of DRUGN ( dgb dgb mg / day ) was studied in healthy subjects by coadministration of DRUGN dgb mg BID for dgb days .
Warfarin	drug	valdecoxib	drug
false

DRUGA : The effect of DRUGN on the anticoagulant effect of DRUGB ( dgb dgb mg / day ) was studied in healthy subjects by coadministration of DRUGN dgb mg BID for dgb days .
Warfarin	drug	warfarin	drug
false

DRUGA : The effect of DRUGN on the anticoagulant effect of DRUGN ( dgb dgb mg / day ) was studied in healthy subjects by coadministration of DRUGB dgb mg BID for dgb days .
Warfarin	drug	BEXTRA	brand
false

DRUGN : The effect of DRUGA on the anticoagulant effect of DRUGB ( dgb dgb mg / day ) was studied in healthy subjects by coadministration of DRUGN dgb mg BID for dgb days .
valdecoxib	drug	warfarin	drug
false

DRUGN : The effect of DRUGA on the anticoagulant effect of DRUGN ( dgb dgb mg / day ) was studied in healthy subjects by coadministration of DRUGB dgb mg BID for dgb days .
valdecoxib	drug	BEXTRA	brand
false

DRUGN : The effect of DRUGN on the anticoagulant effect of DRUGA ( dgb dgb mg / day ) was studied in healthy subjects by coadministration of DRUGB dgb mg BID for dgb days .
warfarin	drug	BEXTRA	brand
false

DRUGA caused a statistically significant increase in plasma exposures of DRUGB and DRUGN ( dgb % and dgb % , respectively ) , and in the pharmacodynamic effects ( prothrombin time , measured as INR ) of DRUGN .
Valdecoxib	drug	R-warfarin	drug
mechanism

DRUGA caused a statistically significant increase in plasma exposures of DRUGN and DRUGB ( dgb % and dgb % , respectively ) , and in the pharmacodynamic effects ( prothrombin time , measured as INR ) of DRUGN .
Valdecoxib	drug	S-warfarin	drug
mechanism

DRUGA caused a statistically significant increase in plasma exposures of DRUGN and DRUGN ( dgb % and dgb % , respectively ) , and in the pharmacodynamic effects ( prothrombin time , measured as INR ) of DRUGB .
Valdecoxib	drug	warfarin	drug
effect

DRUGN caused a statistically significant increase in plasma exposures of DRUGA and DRUGB ( dgb % and dgb % , respectively ) , and in the pharmacodynamic effects ( prothrombin time , measured as INR ) of DRUGN .
R-warfarin	drug	S-warfarin	drug
false

DRUGN caused a statistically significant increase in plasma exposures of DRUGA and DRUGN ( dgb % and dgb % , respectively ) , and in the pharmacodynamic effects ( prothrombin time , measured as INR ) of DRUGB .
R-warfarin	drug	warfarin	drug
false

DRUGN caused a statistically significant increase in plasma exposures of DRUGN and DRUGA ( dgb % and dgb % , respectively ) , and in the pharmacodynamic effects ( prothrombin time , measured as INR ) of DRUGB .
S-warfarin	drug	warfarin	drug
false

DRUGA therapy should be monitored , particularly during the first few weeks , after initiating therapy with DRUGB in patients receiving DRUGN or similar agents .
Anticoagulant	brand	BEXTRA	brand
false

DRUGA therapy should be monitored , particularly during the first few weeks , after initiating therapy with DRUGN in patients receiving DRUGB or similar agents .
Anticoagulant	brand	warfarin	drug
false

DRUGN therapy should be monitored , particularly during the first few weeks , after initiating therapy with DRUGA in patients receiving DRUGB or similar agents .
BEXTRA	brand	warfarin	drug
advise

DRUGA and DRUGB : DRUGN and DRUGN are predominantly CYP dgbAdgb and dgbCdgb inhibitors , respectively .
Fluconazole	drug	Ketoconazole	drug
false

DRUGA and DRUGN : DRUGB and DRUGN are predominantly CYP dgbAdgb and dgbCdgb inhibitors , respectively .
Fluconazole	drug	Ketoconazole	drug
false

DRUGA and DRUGN : DRUGN and DRUGB are predominantly CYP dgbAdgb and dgbCdgb inhibitors , respectively .
Fluconazole	drug	fluconazole	drug
false

DRUGN and DRUGA : DRUGN and DRUGB are predominantly CYP dgbAdgb and dgbCdgb inhibitors , respectively .
Ketoconazole	drug	fluconazole	drug
false

DRUGN and DRUGN : DRUGA and DRUGB are predominantly CYP dgbAdgb and dgbCdgb inhibitors , respectively .
Ketoconazole	drug	fluconazole	drug
false

Concomitant single dose administration of DRUGA dgb mg with multiple doses of DRUGB and DRUGN produced a significant increase in exposure of DRUGN .
valdecoxib	drug	ketoconazole	drug
mechanism

Concomitant single dose administration of DRUGA dgb mg with multiple doses of DRUGN and DRUGB produced a significant increase in exposure of DRUGN .
valdecoxib	drug	fluconazole	drug
mechanism

Concomitant single dose administration of DRUGN dgb mg with multiple doses of DRUGA and DRUGB produced a significant increase in exposure of DRUGN .
ketoconazole	drug	fluconazole	drug
false

Concomitant single dose administration of DRUGN dgb mg with multiple doses of DRUGA and DRUGN produced a significant increase in exposure of DRUGB .
ketoconazole	drug	valdecoxib	drug
false

Concomitant single dose administration of DRUGN dgb mg with multiple doses of DRUGN and DRUGA produced a significant increase in exposure of DRUGB .
fluconazole	drug	valdecoxib	drug
false

Plasma exposure ( AUC ) to DRUGA was increased dgb % when coadministered with DRUGB and dgb % when coadministered with DRUGN .
valdecoxib	drug	fluconazole	drug
mechanism

Plasma exposure ( AUC ) to DRUGA was increased dgb % when coadministered with DRUGN and dgb % when coadministered with DRUGB .
valdecoxib	drug	ketoconazole	drug
mechanism

Plasma exposure ( AUC ) to DRUGN was increased dgb % when coadministered with DRUGA and dgb % when coadministered with DRUGB .
fluconazole	drug	ketoconazole	drug
false

Coadministration of DRUGA ( dgb mg BID for dgb days ) with DRUGB ( dgb mg QD or dgb mg BID ) did not affect the pharmacokinetics ( exposure ) of DRUGN .
valdecoxib	drug	glyburide	drug
false

Coadministration of DRUGA ( dgb mg BID for dgb days ) with DRUGN ( dgb mg QD or dgb mg BID ) did not affect the pharmacokinetics ( exposure ) of DRUGB .
valdecoxib	drug	glyburide	drug
false

Coadministration of DRUGA with doses higher than dgb mg DRUGB ( e.g . , dgb mg BID ) have not been studied .
glyburide	drug	valdecoxib	drug
false

DRUGA steady state plasma concentrations ( dgb mg BID ) were not affected significantly with multiple doses of DRUGB ( dgb mg QD ) .
Valdecoxib	drug	omeprazole	drug
false

Coadministration with DRUGA increased exposure of DRUGB ( AUC ) by dgb % .
valdecoxib	drug	omeprazole	drug
mechanism

Drugs whose absorption is sensitive to pH may be negatively impacted by concomitant administration of DRUGA and DRUGB .
omeprazole	drug	valdecoxib	drug
false

Coadministration of DRUGA with doses higher than dgb mg QD DRUGB has not been studied .
valdecoxib	drug	omeprazole	drug
false

Oral DRUGA : DRUGB ( dgb mg BID ) did not induce the metabolism of the combination oral DRUGN DRUGN / DRUGN ( dgb mg / dgb mcg combination , DRUGN dgb / dgb ) .
Contraceptives	group	Valdecoxib	drug
false

Oral DRUGA : DRUGN ( dgb mg BID ) did not induce the metabolism of the combination oral DRUGB DRUGN / DRUGN ( dgb mg / dgb mcg combination , DRUGN dgb / dgb ) .
Contraceptives	group	contraceptive	group
false

Oral DRUGA : DRUGN ( dgb mg BID ) did not induce the metabolism of the combination oral DRUGN DRUGB / DRUGN ( dgb mg / dgb mcg combination , DRUGN dgb / dgb ) .
Contraceptives	group	norethindrone	drug
false

Oral DRUGA : DRUGN ( dgb mg BID ) did not induce the metabolism of the combination oral DRUGN DRUGN / DRUGB ( dgb mg / dgb mcg combination , DRUGN dgb / dgb ) .
Contraceptives	group	ethinyl estradiol	drug
false

Oral DRUGA : DRUGN ( dgb mg BID ) did not induce the metabolism of the combination oral DRUGN DRUGN / DRUGN ( dgb mg / dgb mcg combination , DRUGB dgb / dgb ) .
Contraceptives	group	Ortho-Novum	brand
false

Oral DRUGN : DRUGA ( dgb mg BID ) did not induce the metabolism of the combination oral DRUGB DRUGN / DRUGN ( dgb mg / dgb mcg combination , DRUGN dgb / dgb ) .
Valdecoxib	drug	contraceptive	group
false

Oral DRUGN : DRUGA ( dgb mg BID ) did not induce the metabolism of the combination oral DRUGN DRUGB / DRUGN ( dgb mg / dgb mcg combination , DRUGN dgb / dgb ) .
Valdecoxib	drug	norethindrone	drug
false

Oral DRUGN : DRUGA ( dgb mg BID ) did not induce the metabolism of the combination oral DRUGN DRUGN / DRUGB ( dgb mg / dgb mcg combination , DRUGN dgb / dgb ) .
Valdecoxib	drug	ethinyl estradiol	drug
false

Oral DRUGN : DRUGA ( dgb mg BID ) did not induce the metabolism of the combination oral DRUGN DRUGN / DRUGN ( dgb mg / dgb mcg combination , DRUGB dgb / dgb ) .
Valdecoxib	drug	Ortho-Novum	brand
false

Oral DRUGN : DRUGN ( dgb mg BID ) did not induce the metabolism of the combination oral DRUGA DRUGB / DRUGN ( dgb mg / dgb mcg combination , DRUGN dgb / dgb ) .
contraceptive	group	norethindrone	drug
false

Oral DRUGN : DRUGN ( dgb mg BID ) did not induce the metabolism of the combination oral DRUGA DRUGN / DRUGB ( dgb mg / dgb mcg combination , DRUGN dgb / dgb ) .
contraceptive	group	ethinyl estradiol	drug
false

Oral DRUGN : DRUGN ( dgb mg BID ) did not induce the metabolism of the combination oral DRUGA DRUGN / DRUGN ( dgb mg / dgb mcg combination , DRUGB dgb / dgb ) .
contraceptive	group	Ortho-Novum	brand
false

Oral DRUGN : DRUGN ( dgb mg BID ) did not induce the metabolism of the combination oral DRUGN DRUGA / DRUGB ( dgb mg / dgb mcg combination , DRUGN dgb / dgb ) .
norethindrone	drug	ethinyl estradiol	drug
false

Oral DRUGN : DRUGN ( dgb mg BID ) did not induce the metabolism of the combination oral DRUGN DRUGA / DRUGN ( dgb mg / dgb mcg combination , DRUGB dgb / dgb ) .
norethindrone	drug	Ortho-Novum	brand
false

Oral DRUGN : DRUGN ( dgb mg BID ) did not induce the metabolism of the combination oral DRUGN DRUGN / DRUGA ( dgb mg / dgb mcg combination , DRUGB dgb / dgb ) .
ethinyl estradiol	drug	Ortho-Novum	brand
false

Coadministration of DRUGA and DRUGB dgb / dgb increased the exposure of DRUGN and DRUGN by dgb % and dgb % , respectively .
valdecoxib	drug	Ortho-Novum	brand
mechanism

Coadministration of DRUGA and DRUGN dgb / dgb increased the exposure of DRUGB and DRUGN by dgb % and dgb % , respectively .
valdecoxib	drug	norethindrone	drug
false

Coadministration of DRUGA and DRUGN dgb / dgb increased the exposure of DRUGN and DRUGB by dgb % and dgb % , respectively .
valdecoxib	drug	ethinyl estradiol	drug
false

Coadministration of DRUGN and DRUGA dgb / dgb increased the exposure of DRUGB and DRUGN by dgb % and dgb % , respectively .
Ortho-Novum	brand	norethindrone	drug
false

Coadministration of DRUGN and DRUGA dgb / dgb increased the exposure of DRUGN and DRUGB by dgb % and dgb % , respectively .
Ortho-Novum	brand	ethinyl estradiol	drug
false

Coadministration of DRUGN and DRUGN dgb / dgb increased the exposure of DRUGA and DRUGB by dgb % and dgb % , respectively .
norethindrone	drug	ethinyl estradiol	drug
false

These increased exposures of DRUGA and DRUGB should be taken into consideration when selecting an oral DRUGN for women taking DRUGN .
norethindrone	drug	ethinyl estradiol	drug
false

These increased exposures of DRUGA and DRUGN should be taken into consideration when selecting an oral DRUGB for women taking DRUGN .
norethindrone	drug	contraceptive	group
false

These increased exposures of DRUGA and DRUGN should be taken into consideration when selecting an oral DRUGN for women taking DRUGB .
norethindrone	drug	valdecoxib	drug
false

These increased exposures of DRUGN and DRUGA should be taken into consideration when selecting an oral DRUGB for women taking DRUGN .
ethinyl estradiol	drug	contraceptive	group
false

These increased exposures of DRUGN and DRUGA should be taken into consideration when selecting an oral DRUGN for women taking DRUGB .
ethinyl estradiol	drug	valdecoxib	drug
false

These increased exposures of DRUGN and DRUGN should be taken into consideration when selecting an oral DRUGA for women taking DRUGB .
contraceptive	group	valdecoxib	drug
advise

DRUGA : DRUGN ( DRUGB ) is a CYP dgbAdgb and CYP dgbCdgb substrate .
Diazepam	drug	Valium	brand
false

DRUGN : DRUGA ( DRUGB ) is a CYP dgbAdgb and CYP dgbCdgb substrate .
Diazepam	drug	Valium	brand
false

Although the magnitude of changes in DRUGA plasma exposure when coadministered with DRUGB were not sufficient to warrant dosage adjustments , patients may experience enhanced sedative side effects caused by increased exposure of DRUGN under this circumstance .
diazepam	drug	valdecoxib	drug
false

Although the magnitude of changes in DRUGN plasma exposure when coadministered with DRUGA were not sufficient to warrant dosage adjustments , patients may experience enhanced sedative side effects caused by increased exposure of DRUGB under this circumstance .
valdecoxib	drug	diazepam	drug
effect

DRUGA ( dgb mg b.i.d . ) had no effect on DRUGB bioavailability ( AUC ) and maximum concentration ( Cmax ) of DRUGN when co administered with dgb mg DRUGN in healthy volunteers .
Cimetidine	drug	vardenafil	drug
false

DRUGA ( dgb mg b.i.d . ) had no effect on DRUGN bioavailability ( AUC ) and maximum concentration ( Cmax ) of DRUGB when co administered with dgb mg DRUGN in healthy volunteers .
Cimetidine	drug	vardenafil	drug
false

DRUGA ( dgb mg b.i.d . ) had no effect on DRUGN bioavailability ( AUC ) and maximum concentration ( Cmax ) of DRUGN when co administered with dgb mg DRUGB in healthy volunteers .
Cimetidine	drug	Vardenafil	drug
false

DRUGN ( dgb mg b.i.d . ) had no effect on DRUGA bioavailability ( AUC ) and maximum concentration ( Cmax ) of DRUGN when co administered with dgb mg DRUGB in healthy volunteers .
vardenafil	drug	Vardenafil	drug
false

DRUGN ( dgb mg b.i.d . ) had no effect on DRUGN bioavailability ( AUC ) and maximum concentration ( Cmax ) of DRUGA when co administered with dgb mg DRUGB in healthy volunteers .
vardenafil	drug	Vardenafil	drug
false

DRUGA ( dgb mg t.i.d ) produced a dgb fold increase in DRUGB AUC and a dgb fold increase in Cmax when co administered with DRUGN dgb mg in healthy volunteers .
Erythromycin	drug	vardenafil	drug
mechanism

DRUGA ( dgb mg t.i.d ) produced a dgb fold increase in DRUGN AUC and a dgb fold increase in Cmax when co administered with DRUGB dgb mg in healthy volunteers .
Erythromycin	drug	Vardenafil	drug
false

DRUGN ( dgb mg t.i.d ) produced a dgb fold increase in DRUGA AUC and a dgb fold increase in Cmax when co administered with DRUGB dgb mg in healthy volunteers .
vardenafil	drug	Vardenafil	drug
false

It is recommended not to exceed a single dgb mg dose of DRUGA in a dgb hour period when used in combination with DRUGB .
Vardenafil	drug	erythromycin	drug
advise

DRUGA ( dgb mg once daily ) produced a dgb fold increase in DRUGB AUC and a dgb fold increase in Cmax when co administered with DRUGN ( dgb mg ) in healthy volunteers .
Ketoconazole	drug	vardenafil	drug
mechanism

DRUGA ( dgb mg once daily ) produced a dgb fold increase in DRUGN AUC and a dgb fold increase in Cmax when co administered with DRUGB ( dgb mg ) in healthy volunteers .
Ketoconazole	drug	Vardenafil	drug
false

DRUGN ( dgb mg once daily ) produced a dgb fold increase in DRUGA AUC and a dgb fold increase in Cmax when co administered with DRUGB ( dgb mg ) in healthy volunteers .
vardenafil	drug	Vardenafil	drug
false

A dgb mg DRUGA dose should not be exceeded when used in combination with dgb mg once daily DRUGB .
Vardenafil	drug	ketoconazole	drug
advise

It is recommended not to exceed a single dga mg DRUGA dose in a dgb hour period when used in combination with DRUGB .
Vardenafil	drug	indinavir	drug
advise

DRUGA ( dgb mg b.i.d . ) co administered with DRUGB dgb mg resulted in a dgb fold increase in DRUGN AUC and a dgb fold increase in DRUGN Cmax .
Ritonavir	drug	Vardenafil	drug
mechanism

DRUGA ( dgb mg b.i.d . ) co administered with DRUGN dgb mg resulted in a dgb fold increase in DRUGB AUC and a dgb fold increase in DRUGN Cmax .
Ritonavir	drug	vardenafil	drug
false

DRUGA ( dgb mg b.i.d . ) co administered with DRUGN dgb mg resulted in a dgb fold increase in DRUGN AUC and a dgb fold increase in DRUGB Cmax .
Ritonavir	drug	vardenafil	drug
false

DRUGN ( dgb mg b.i.d . ) co administered with DRUGA dgb mg resulted in a dgb fold increase in DRUGB AUC and a dgb fold increase in DRUGN Cmax .
Vardenafil	drug	vardenafil	drug
false

DRUGN ( dgb mg b.i.d . ) co administered with DRUGA dgb mg resulted in a dgb fold increase in DRUGN AUC and a dgb fold increase in DRUGB Cmax .
Vardenafil	drug	vardenafil	drug
false

The interaction is a consequence of blocking hepatic metabolism of DRUGA by DRUGB , a highly potent CYPdgbAdgb inhibitor , which also inhibits CYPdgbCdga
vardenafil	drug	ritonavir	drug
mechanism

DRUGA significantly prolonged the half life of DRUGB to dgb hours .
Ritonavir	drug	vardenafil	drug
mechanism

Consequently , it is recommended not to exceed a single dga mg DRUGA dose in a dgb hour period when used in combination with DRUGB .
Vardenafil	drug	ritonavir	drug
advise

Other Drug Interactions : No pharmacokinetic interactions were observed between DRUGA and the following drugs : DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
vardenafil	drug	glyburide	drug
false

Other Drug Interactions : No pharmacokinetic interactions were observed between DRUGA and the following drugs : DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
vardenafil	drug	warfarin	drug
false

Other Drug Interactions : No pharmacokinetic interactions were observed between DRUGA and the following drugs : DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
vardenafil	drug	digoxin	drug
false

Other Drug Interactions : No pharmacokinetic interactions were observed between DRUGA and the following drugs : DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
vardenafil	drug	Maalox	brand
false

Other Drug Interactions : No pharmacokinetic interactions were observed between DRUGA and the following drugs : DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
vardenafil	drug	ranitidine	drug
false

Other Drug Interactions : No pharmacokinetic interactions were observed between DRUGN and the following drugs : DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
glyburide	drug	warfarin	drug
false

Other Drug Interactions : No pharmacokinetic interactions were observed between DRUGN and the following drugs : DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
glyburide	drug	digoxin	drug
false

Other Drug Interactions : No pharmacokinetic interactions were observed between DRUGN and the following drugs : DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
glyburide	drug	Maalox	brand
false

Other Drug Interactions : No pharmacokinetic interactions were observed between DRUGN and the following drugs : DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
glyburide	drug	ranitidine	drug
false

Other Drug Interactions : No pharmacokinetic interactions were observed between DRUGN and the following drugs : DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
warfarin	drug	digoxin	drug
false

Other Drug Interactions : No pharmacokinetic interactions were observed between DRUGN and the following drugs : DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
warfarin	drug	Maalox	brand
false

Other Drug Interactions : No pharmacokinetic interactions were observed between DRUGN and the following drugs : DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
warfarin	drug	ranitidine	drug
false

Other Drug Interactions : No pharmacokinetic interactions were observed between DRUGN and the following drugs : DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
digoxin	drug	Maalox	brand
false

Other Drug Interactions : No pharmacokinetic interactions were observed between DRUGN and the following drugs : DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
digoxin	drug	ranitidine	drug
false

Other Drug Interactions : No pharmacokinetic interactions were observed between DRUGN and the following drugs : DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
Maalox	brand	ranitidine	drug
false

In the DRUGA study , DRUGB had no effect on the prothrombin time or other pharmacodynamic parameters .
warfarin	drug	vardenafil	drug
false

These effects were not observed when DRUGA dgb mg was taken dgb hours before the DRUGB .
Vardenafil	drug	NTG	drug
false

Potentiation of the hypotensive effects of DRUGA for patients with ischemic heart disease has not been evaluated , and concomitant use of DRUGB and DRUGN is contraindicated .
nitrates	group	Vardenafil	drug
false

Potentiation of the hypotensive effects of DRUGN for patients with ischemic heart disease has not been evaluated , and concomitant use of DRUGA and DRUGB is contraindicated .
Vardenafil	drug	nitrates	group
advise

DRUGA did not alter the plasma levels of DRUGB when taken in combination .
Nifedipine	drug	Vardenafil	drug
false

In these patients whose hypertension was controlled with DRUGA , DRUGB dgb mg produced mean additional supine systolic / diastolic blood pressure reductions of dgb / dgb mm Hg compared to placebo .
nifedipine	drug	Vardenafil	drug
effect

DRUGA : When DRUGB dgb or dgb mg was given to healthy volunteers either simultaneously or dgb hours after a dgb mg dose of DRUGN , significant hypotension developed in a substantial number of subjects .
Alpha-blockers	group	Vardenafil	drug
false

DRUGA : When DRUGN dgb or dgb mg was given to healthy volunteers either simultaneously or dgb hours after a dgb mg dose of DRUGB , significant hypotension developed in a substantial number of subjects .
Alpha-blockers	group	terazosin	drug
false

DRUGN : When DRUGA dgb or dgb mg was given to healthy volunteers either simultaneously or dgb hours after a dgb mg dose of DRUGB , significant hypotension developed in a substantial number of subjects .
Vardenafil	drug	terazosin	drug
effect

With simultaneous dosing of DRUGA dgb mg and DRUGB dgb mg , dgb of dgb subjects experienced a standing systolic blood pressure of less than dgb mm Hg .
Vardenafil	drug	terazosin	drug
effect

With simultaneous dosing of DRUGA dgb mg and DRUGB dgb mg , dgb of dgb subjects experienced a standing systolic blood pressure of less than dgb mm Hg .
Vardenafil	drug	terazosin	drug
effect

When DRUGA dosing was separated from DRUGB dgb mg by dgb hours , dgb of dgb subjects who received dgb mg of DRUGN experienced a decrease in standing systolic blood pressure below dgb mm Hg .
Vardenafil	drug	terazosin	drug
effect

When DRUGN dosing was separated from DRUGA dgb mg by dgb hours , dgb of dgb subjects who received dgb mg of DRUGB experienced a decrease in standing systolic blood pressure below dgb mm Hg .
terazosin	drug	Vardenafil	drug
false

In a similar study with DRUGA in healthy volunteers , dgb of dgb subjects dosed with DRUGB dgb mg and DRUGN dga mg separated by dgb hours experienced a standing systolic blood pressure below dgb mm Hg .
tamsulosin	drug	Vardenafil	drug
false

In a similar study with DRUGN in healthy volunteers , dgb of dgb subjects dosed with DRUGA dgb mg and DRUGB dga mg separated by dgb hours experienced a standing systolic blood pressure below dgb mm Hg .
Vardenafil	drug	tamsulosin	drug
effect

Two of dgb subjects dosed simultaneously with DRUGA dgb mg and DRUGB dga mg experienced a standing systolic blood pressure below dgb mm Hg .
Vardenafil	drug	tamsulosin	drug
effect

The administration of lower doses of DRUGA with DRUGB has not been completely evaluated to determine if they can be safely administered together .
Vardenafil	drug	alpha-blockers	group
false

Based on these data , DRUGA should not be used in patients on DRUGB therapy .
Vardenafil	drug	alpha-blocker	group
advise

DRUGA and DRUGB : Upon concomitant administration of dgb mg of DRUGN with dgb mg BID DRUGN , the Cmax and AUC of DRUGN were reduced by approximately dgb % .
Ritonavir	drug	indinavir	drug
false

DRUGA and DRUGN : Upon concomitant administration of dgb mg of DRUGB with dgb mg BID DRUGN , the Cmax and AUC of DRUGN were reduced by approximately dgb % .
Ritonavir	drug	Vardenafil	drug
false

DRUGA and DRUGN : Upon concomitant administration of dgb mg of DRUGN with dgb mg BID DRUGB , the Cmax and AUC of DRUGN were reduced by approximately dgb % .
Ritonavir	drug	ritonavir	drug
false

DRUGA and DRUGN : Upon concomitant administration of dgb mg of DRUGN with dgb mg BID DRUGN , the Cmax and AUC of DRUGB were reduced by approximately dgb % .
Ritonavir	drug	ritonavir	drug
false

DRUGN and DRUGA : Upon concomitant administration of dgb mg of DRUGB with dgb mg BID DRUGN , the Cmax and AUC of DRUGN were reduced by approximately dgb % .
indinavir	drug	Vardenafil	drug
false

DRUGN and DRUGA : Upon concomitant administration of dgb mg of DRUGN with dgb mg BID DRUGB , the Cmax and AUC of DRUGN were reduced by approximately dgb % .
indinavir	drug	ritonavir	drug
false

DRUGN and DRUGA : Upon concomitant administration of dgb mg of DRUGN with dgb mg BID DRUGN , the Cmax and AUC of DRUGB were reduced by approximately dgb % .
indinavir	drug	ritonavir	drug
false

DRUGN and DRUGN : Upon concomitant administration of dgb mg of DRUGA with dgb mg BID DRUGB , the Cmax and AUC of DRUGN were reduced by approximately dgb % .
Vardenafil	drug	ritonavir	drug
mechanism

DRUGN and DRUGN : Upon concomitant administration of dgb mg of DRUGA with dgb mg BID DRUGN , the Cmax and AUC of DRUGB were reduced by approximately dgb % .
Vardenafil	drug	ritonavir	drug
false

Upon administration of dgb mg of DRUGA with dgb mg TID DRUGB , the Cmax and AUC of DRUGN were reduced by dgb % and dgb % , respectively .
Vardenafil	drug	indinavir	drug
mechanism

Upon administration of dgb mg of DRUGA with dgb mg TID DRUGN , the Cmax and AUC of DRUGB were reduced by dgb % and dgb % , respectively .
Vardenafil	drug	indinavir	drug
false

DRUGA : DRUGN ( dga g / kg body weight : approximately dgb mL of absolute alcohol in a dgb kg person ) and DRUGB plasma levels were not altered when dosed simultaneously .
Alcohol	drug	vardenafil	drug
false

DRUGN : DRUGA ( dga g / kg body weight : approximately dgb mL of absolute alcohol in a dgb kg person ) and DRUGB plasma levels were not altered when dosed simultaneously .
Alcohol	drug	vardenafil	drug
false

DRUGA ( dgb mg ) did not potentiate the hypotensive effects of DRUGB during the dgb hour observation period in healthy volunteers when administered with DRUGN ( dga g / kg body weight ) .
Vardenafil	drug	alcohol	drug
false

DRUGA ( dgb mg ) did not potentiate the hypotensive effects of DRUGN during the dgb hour observation period in healthy volunteers when administered with DRUGB ( dga g / kg body weight ) .
Vardenafil	drug	alcohol	drug
false

DRUGA : DRUGB ( dgb mg and dgb mg ) did not potentiate the increase in bleeding time caused by DRUGN ( two dgb mg tablets ) .
Aspirin	brand	Vardenafil	drug
false

DRUGA : DRUGN ( dgb mg and dgb mg ) did not potentiate the increase in bleeding time caused by DRUGB ( two dgb mg tablets ) .
Aspirin	brand	aspirin	brand
false

DRUGN : DRUGA ( dgb mg and dgb mg ) did not potentiate the increase in bleeding time caused by DRUGB ( two dgb mg tablets ) .
Vardenafil	drug	aspirin	brand
false

Other interactions : DRUGA had no effect on the pharmacodynamics of DRUGB ( glucose and insulin concentrations ) and DRUGN ( prothrombin time or other pharmacodynamic parameters ) .
Vardenafil	drug	glyburide	drug
false

Other interactions : DRUGA had no effect on the pharmacodynamics of DRUGN ( glucose and insulin concentrations ) and DRUGB ( prothrombin time or other pharmacodynamic parameters ) .
Vardenafil	drug	warfarin	drug
false

Other interactions : DRUGN had no effect on the pharmacodynamics of DRUGA ( glucose and insulin concentrations ) and DRUGB ( prothrombin time or other pharmacodynamic parameters ) .
glyburide	drug	warfarin	drug
false

DRUGA : There is no significant pharmacokinetic interaction between DRUGB and DRUGN which has been confirmed clinically .
Zidovudine	drug	ZDV	drug
false

DRUGA : There is no significant pharmacokinetic interaction between DRUGN and DRUGB which has been confirmed clinically .
Zidovudine	drug	zalcitabine	drug
false

DRUGN : There is no significant pharmacokinetic interaction between DRUGA and DRUGB which has been confirmed clinically .
ZDV	drug	zalcitabine	drug
false

DRUGA also has no significant effect on the intracellular phosphorylation of DRUGB , as shown in vitro in peripheral blood mononuclear cells or in two other cell lines ( Udgb and Molt dgb ) .
Zalcitabine	drug	ZDV	drug
effect

In the same study it was shown that DRUGA and DRUGB had no significant effect on the intracellular phosphorylation of DRUGN in peripheral blood mononuclear cells .
didanosine	drug	stavudine	drug
false

In the same study it was shown that DRUGA and DRUGN had no significant effect on the intracellular phosphorylation of DRUGB in peripheral blood mononuclear cells .
didanosine	drug	zalcitabine	drug
false

In the same study it was shown that DRUGN and DRUGA had no significant effect on the intracellular phosphorylation of DRUGB in peripheral blood mononuclear cells .
stavudine	drug	zalcitabine	drug
false

DRUGA : In vitro studies in peripheral blood mononuclear cells , Udgb and Molt dgb cells revealed that DRUGB significantly inhibited DRUGN phosphorylation in a dose dependent manner .
Lamivudine	drug	lamivudine	drug
false

DRUGA : In vitro studies in peripheral blood mononuclear cells , Udgb and Molt dgb cells revealed that DRUGN significantly inhibited DRUGB phosphorylation in a dose dependent manner .
Lamivudine	drug	zalcitabine	drug
false

DRUGN : In vitro studies in peripheral blood mononuclear cells , Udgb and Molt dgb cells revealed that DRUGA significantly inhibited DRUGB phosphorylation in a dose dependent manner .
lamivudine	drug	zalcitabine	drug
effect

DRUGA inhibited DRUGB phosphorylation at high concentration ratios ( dgb and dgb ) ;
Zalcitabine	drug	lamivudine	drug
effect

however , it is considered to be unlikely that this decrease of phosphorylated DRUGA concentration is of clinical significance , as DRUGN is a more efficient substrate for deoxycytidine kinase than DRUGB .
lamivudine	drug	zalcitabine	drug
false

however , it is considered to be unlikely that this decrease of phosphorylated DRUGN concentration is of clinical significance , as DRUGA is a more efficient substrate for deoxycytidine kinase than DRUGB .
lamivudine	drug	zalcitabine	drug
false

These in vitro studies suggest that concomitant administration of DRUGA and DRUGB in humans may result in sub therapeutic concentrations of active phosphorylated DRUGN , which may lead to a decreased DRUGN effect of DRUGN .
zalcitabine	drug	lamivudine	drug
effect

These in vitro studies suggest that concomitant administration of DRUGA and DRUGN in humans may result in sub therapeutic concentrations of active phosphorylated DRUGN , which may lead to a decreased DRUGB effect of DRUGN .
zalcitabine	drug	antiretroviral	group
false

These in vitro studies suggest that concomitant administration of DRUGN and DRUGA in humans may result in sub therapeutic concentrations of active phosphorylated DRUGB , which may lead to a decreased DRUGN effect of DRUGN .
lamivudine	drug	zalcitabine	drug
false

These in vitro studies suggest that concomitant administration of DRUGN and DRUGA in humans may result in sub therapeutic concentrations of active phosphorylated DRUGN , which may lead to a decreased DRUGB effect of DRUGN .
lamivudine	drug	antiretroviral	group
false

These in vitro studies suggest that concomitant administration of DRUGN and DRUGA in humans may result in sub therapeutic concentrations of active phosphorylated DRUGN , which may lead to a decreased DRUGN effect of DRUGB .
lamivudine	drug	zalcitabine	drug
false

These in vitro studies suggest that concomitant administration of DRUGN and DRUGN in humans may result in sub therapeutic concentrations of active phosphorylated DRUGA , which may lead to a decreased DRUGB effect of DRUGN .
zalcitabine	drug	antiretroviral	group
false

These in vitro studies suggest that concomitant administration of DRUGN and DRUGN in humans may result in sub therapeutic concentrations of active phosphorylated DRUGN , which may lead to a decreased DRUGA effect of DRUGB .
antiretroviral	group	zalcitabine	drug
false

Concomitant use of DRUGA and DRUGB is not recommended .
zalcitabine	drug	lamivudine	drug
advise

DRUGA : The combination of DRUGB , DRUGN , and DRUGN has been studied ( as triple combination ) in adults .
Saquinavir	drug	HIVID	drug
false

DRUGA : The combination of DRUGN , DRUGB , and DRUGN has been studied ( as triple combination ) in adults .
Saquinavir	drug	saquinavir	drug
false

DRUGA : The combination of DRUGN , DRUGN , and DRUGB has been studied ( as triple combination ) in adults .
Saquinavir	drug	ZDV	drug
false

DRUGN : The combination of DRUGA , DRUGB , and DRUGN has been studied ( as triple combination ) in adults .
HIVID	drug	saquinavir	drug
false

DRUGN : The combination of DRUGA , DRUGN , and DRUGB has been studied ( as triple combination ) in adults .
HIVID	drug	ZDV	drug
false

DRUGN : The combination of DRUGN , DRUGA , and DRUGB has been studied ( as triple combination ) in adults .
saquinavir	drug	ZDV	drug
false

Concomitant use of DRUGA with DRUGB is not recommended .
HIVID	drug	didanosine	drug
advise

Intravenous DRUGA : Treatment with DRUGB should be interrupted when the use of a drug that has the potential to cause pancreatitis is required .
Pentamidine	drug	HIVID	drug
false

Death due to fulminant pancreatitis possibly related to intravenous DRUGA and DRUGB has been reported .
pentamidine	drug	HIVID	drug
effect

If intravenous DRUGA is required to treat Pneumocystis carinii pneumonia , treatment with DRUGB should be interrupted .
pentamidine	drug	HIVID	drug
advise

DRUGA or DRUGB : Concomitant administration of DRUGN or DRUGN decreases the elimination of DRUGN , most likely by inhibition of renal tubular secretion of DRUGN .
Probenecid	drug	Cimetidine	drug
false

DRUGA or DRUGN : Concomitant administration of DRUGB or DRUGN decreases the elimination of DRUGN , most likely by inhibition of renal tubular secretion of DRUGN .
Probenecid	drug	probenecid	drug
false

DRUGA or DRUGN : Concomitant administration of DRUGN or DRUGB decreases the elimination of DRUGN , most likely by inhibition of renal tubular secretion of DRUGN .
Probenecid	drug	cimetidine	drug
false

DRUGA or DRUGN : Concomitant administration of DRUGN or DRUGN decreases the elimination of DRUGB , most likely by inhibition of renal tubular secretion of DRUGN .
Probenecid	drug	zalcitabine	drug
false

DRUGA or DRUGN : Concomitant administration of DRUGN or DRUGN decreases the elimination of DRUGN , most likely by inhibition of renal tubular secretion of DRUGB .
Probenecid	drug	zalcitabine	drug
false

DRUGN or DRUGA : Concomitant administration of DRUGB or DRUGN decreases the elimination of DRUGN , most likely by inhibition of renal tubular secretion of DRUGN .
Cimetidine	drug	probenecid	drug
false

DRUGN or DRUGA : Concomitant administration of DRUGN or DRUGB decreases the elimination of DRUGN , most likely by inhibition of renal tubular secretion of DRUGN .
Cimetidine	drug	cimetidine	drug
false

DRUGN or DRUGA : Concomitant administration of DRUGN or DRUGN decreases the elimination of DRUGB , most likely by inhibition of renal tubular secretion of DRUGN .
Cimetidine	drug	zalcitabine	drug
false

DRUGN or DRUGA : Concomitant administration of DRUGN or DRUGN decreases the elimination of DRUGN , most likely by inhibition of renal tubular secretion of DRUGB .
Cimetidine	drug	zalcitabine	drug
false

DRUGN or DRUGN : Concomitant administration of DRUGA or DRUGB decreases the elimination of DRUGN , most likely by inhibition of renal tubular secretion of DRUGN .
probenecid	drug	cimetidine	drug
false

DRUGN or DRUGN : Concomitant administration of DRUGA or DRUGN decreases the elimination of DRUGB , most likely by inhibition of renal tubular secretion of DRUGN .
probenecid	drug	zalcitabine	drug
mechanism

DRUGN or DRUGN : Concomitant administration of DRUGA or DRUGN decreases the elimination of DRUGN , most likely by inhibition of renal tubular secretion of DRUGB .
probenecid	drug	zalcitabine	drug
false

DRUGN or DRUGN : Concomitant administration of DRUGN or DRUGA decreases the elimination of DRUGB , most likely by inhibition of renal tubular secretion of DRUGN .
cimetidine	drug	zalcitabine	drug
mechanism

DRUGN or DRUGN : Concomitant administration of DRUGN or DRUGA decreases the elimination of DRUGN , most likely by inhibition of renal tubular secretion of DRUGB .
cimetidine	drug	zalcitabine	drug
false

DRUGA / DRUGB containing DRUGN : Absorption of DRUGN is moderately reduced ( approximately dgb % ) when coadministered with DRUGN / DRUGN containing DRUGN .
Magnesium	drug	Aluminum	drug
false

DRUGA / DRUGN containing DRUGB : Absorption of DRUGN is moderately reduced ( approximately dgb % ) when coadministered with DRUGN / DRUGN containing DRUGN .
Magnesium	drug	Antacid Products	group
false

DRUGA / DRUGN containing DRUGN : Absorption of DRUGB is moderately reduced ( approximately dgb % ) when coadministered with DRUGN / DRUGN containing DRUGN .
Magnesium	drug	zalcitabine	drug
false

DRUGA / DRUGN containing DRUGN : Absorption of DRUGN is moderately reduced ( approximately dgb % ) when coadministered with DRUGB / DRUGN containing DRUGN .
Magnesium	drug	magnesium	drug
false

DRUGA / DRUGN containing DRUGN : Absorption of DRUGN is moderately reduced ( approximately dgb % ) when coadministered with DRUGN / DRUGB containing DRUGN .
Magnesium	drug	aluminum	drug
false

DRUGA / DRUGN containing DRUGN : Absorption of DRUGN is moderately reduced ( approximately dgb % ) when coadministered with DRUGN / DRUGN containing DRUGB .
Magnesium	drug	antacid products	group
false

DRUGN / DRUGA containing DRUGB : Absorption of DRUGN is moderately reduced ( approximately dgb % ) when coadministered with DRUGN / DRUGN containing DRUGN .
Aluminum	drug	Antacid Products	group
false

DRUGN / DRUGA containing DRUGN : Absorption of DRUGB is moderately reduced ( approximately dgb % ) when coadministered with DRUGN / DRUGN containing DRUGN .
Aluminum	drug	zalcitabine	drug
false

DRUGN / DRUGA containing DRUGN : Absorption of DRUGN is moderately reduced ( approximately dgb % ) when coadministered with DRUGB / DRUGN containing DRUGN .
Aluminum	drug	magnesium	drug
false

DRUGN / DRUGA containing DRUGN : Absorption of DRUGN is moderately reduced ( approximately dgb % ) when coadministered with DRUGN / DRUGB containing DRUGN .
Aluminum	drug	aluminum	drug
false

DRUGN / DRUGA containing DRUGN : Absorption of DRUGN is moderately reduced ( approximately dgb % ) when coadministered with DRUGN / DRUGN containing DRUGB .
Aluminum	drug	antacid products	group
false

DRUGN / DRUGN containing DRUGA : Absorption of DRUGB is moderately reduced ( approximately dgb % ) when coadministered with DRUGN / DRUGN containing DRUGN .
Antacid Products	group	zalcitabine	drug
false

DRUGN / DRUGN containing DRUGA : Absorption of DRUGN is moderately reduced ( approximately dgb % ) when coadministered with DRUGB / DRUGN containing DRUGN .
Antacid Products	group	magnesium	drug
false

DRUGN / DRUGN containing DRUGA : Absorption of DRUGN is moderately reduced ( approximately dgb % ) when coadministered with DRUGN / DRUGB containing DRUGN .
Antacid Products	group	aluminum	drug
false

DRUGN / DRUGN containing DRUGA : Absorption of DRUGN is moderately reduced ( approximately dgb % ) when coadministered with DRUGN / DRUGN containing DRUGB .
Antacid Products	group	antacid products	group
false

DRUGN / DRUGN containing DRUGN : Absorption of DRUGA is moderately reduced ( approximately dgb % ) when coadministered with DRUGB / DRUGN containing DRUGN .
zalcitabine	drug	magnesium	drug
false

DRUGN / DRUGN containing DRUGN : Absorption of DRUGA is moderately reduced ( approximately dgb % ) when coadministered with DRUGN / DRUGB containing DRUGN .
zalcitabine	drug	aluminum	drug
false

DRUGN / DRUGN containing DRUGN : Absorption of DRUGA is moderately reduced ( approximately dgb % ) when coadministered with DRUGN / DRUGN containing DRUGB .
zalcitabine	drug	antacid products	group
false

DRUGN / DRUGN containing DRUGN : Absorption of DRUGN is moderately reduced ( approximately dgb % ) when coadministered with DRUGA / DRUGB containing DRUGN .
magnesium	drug	aluminum	drug
false

DRUGN / DRUGN containing DRUGN : Absorption of DRUGN is moderately reduced ( approximately dgb % ) when coadministered with DRUGA / DRUGN containing DRUGB .
magnesium	drug	antacid products	group
false

DRUGN / DRUGN containing DRUGN : Absorption of DRUGN is moderately reduced ( approximately dgb % ) when coadministered with DRUGN / DRUGA containing DRUGB .
aluminum	drug	antacid products	group
false

The clinical significance of this reduction is not known , hence DRUGA is not recommended to be ingested simultaneously with DRUGB / DRUGN containing DRUGN .
zalcitabine	drug	magnesium	drug
advise

The clinical significance of this reduction is not known , hence DRUGA is not recommended to be ingested simultaneously with DRUGN / DRUGB containing DRUGN .
zalcitabine	drug	aluminum	drug
advise

The clinical significance of this reduction is not known , hence DRUGA is not recommended to be ingested simultaneously with DRUGN / DRUGN containing DRUGB .
zalcitabine	drug	antacids	group
advise

The clinical significance of this reduction is not known , hence DRUGN is not recommended to be ingested simultaneously with DRUGA / DRUGB containing DRUGN .
magnesium	drug	aluminum	drug
false

The clinical significance of this reduction is not known , hence DRUGN is not recommended to be ingested simultaneously with DRUGA / DRUGN containing DRUGB .
magnesium	drug	antacids	group
false

The clinical significance of this reduction is not known , hence DRUGN is not recommended to be ingested simultaneously with DRUGN / DRUGA containing DRUGB .
aluminum	drug	antacids	group
false

DRUGA : Bioavailability is mildly reduced ( approximately dgb % ) when DRUGB and DRUGN are coadministered .
Metoclopramide	drug	zalcitabine	drug
false

DRUGA : Bioavailability is mildly reduced ( approximately dgb % ) when DRUGN and DRUGB are coadministered .
Metoclopramide	drug	metoclopramide	drug
false

DRUGN : Bioavailability is mildly reduced ( approximately dgb % ) when DRUGA and DRUGB are coadministered .
zalcitabine	drug	metoclopramide	drug
mechanism

DRUGA : DRUGN caused a decrease in DRUGB phosphorylation ( dgb % inhibition of total phosphate formation ) in Udgb / Molt dgb cells .
Doxorubicin	drug	zalcitabine	drug
false

DRUGN : DRUGA caused a decrease in DRUGB phosphorylation ( dgb % inhibition of total phosphate formation ) in Udgb / Molt dgb cells .
Doxorubicin	drug	zalcitabine	drug
effect

DRUGA did not affect the pharmacokinetics of DRUGB .
zaleplon	drug	ethanol	drug
false

DRUGA : Coadministration of single doses of DRUGB dgb mg and DRUGN dgb mg produced additive effects on decreased alertness and impaired psychomotor performance for dgb to dgb hours after administration .
Imipramine	drug	Sonata	brand
false

DRUGA : Coadministration of single doses of DRUGN dgb mg and DRUGB dgb mg produced additive effects on decreased alertness and impaired psychomotor performance for dgb to dgb hours after administration .
Imipramine	drug	imipramine	drug
false

DRUGN : Coadministration of single doses of DRUGA dgb mg and DRUGB dgb mg produced additive effects on decreased alertness and impaired psychomotor performance for dgb to dgb hours after administration .
Sonata	brand	imipramine	drug
effect

DRUGA : Coadministration of a single dose of DRUGB dgb mg and DRUGN dgb mg daily for dgb days did not produce any interaction on psychomotor performance .
Paroxetine	drug	Sonata	brand
false

DRUGA : Coadministration of a single dose of DRUGN dgb mg and DRUGB dgb mg daily for dgb days did not produce any interaction on psychomotor performance .
Paroxetine	drug	paroxetine	drug
false

DRUGN : Coadministration of a single dose of DRUGA dgb mg and DRUGB dgb mg daily for dgb days did not produce any interaction on psychomotor performance .
Sonata	brand	paroxetine	drug
false

Additionally , DRUGA did not alter the pharmacokinetics of DRUGB , reflecting the absence of a role of CYPdgbDdgb in DRUGN s metabolism .
paroxetine	drug	Sonata	brand
false

Additionally , DRUGA did not alter the pharmacokinetics of DRUGN , reflecting the absence of a role of CYPdgbDdgb in DRUGB s metabolism .
paroxetine	drug	zaleplon	drug
false

Additionally , DRUGN did not alter the pharmacokinetics of DRUGA , reflecting the absence of a role of CYPdgbDdgb in DRUGB s metabolism .
Sonata	brand	zaleplon	drug
false

DRUGA : Coadministration of single doses of DRUGB dgb mg and DRUGN dgb mg produced additive effects on decreased alertness and impaired psychomotor performance for dgb to dgb hours after administration .
Thioridazine	drug	Sonata	brand
false

DRUGA : Coadministration of single doses of DRUGN dgb mg and DRUGB dgb mg produced additive effects on decreased alertness and impaired psychomotor performance for dgb to dgb hours after administration .
Thioridazine	drug	thioridazine	drug
false

DRUGN : Coadministration of single doses of DRUGA dgb mg and DRUGB dgb mg produced additive effects on decreased alertness and impaired psychomotor performance for dgb to dgb hours after administration .
Sonata	brand	thioridazine	drug
effect

DRUGA : Coadministration of a single dose of DRUGB dgb mg and multiple doses of DRUGN ER ( extended release ) dgb mg did not result in any significant changes in the pharmacokinetics of either DRUGN or DRUGN .
Venlafaxine	drug	zaleplon	drug
false

DRUGA : Coadministration of a single dose of DRUGN dgb mg and multiple doses of DRUGB ER ( extended release ) dgb mg did not result in any significant changes in the pharmacokinetics of either DRUGN or DRUGN .
Venlafaxine	drug	venlafaxine	drug
false

DRUGA : Coadministration of a single dose of DRUGN dgb mg and multiple doses of DRUGN ER ( extended release ) dgb mg did not result in any significant changes in the pharmacokinetics of either DRUGB or DRUGN .
Venlafaxine	drug	zaleplon	drug
false

DRUGA : Coadministration of a single dose of DRUGN dgb mg and multiple doses of DRUGN ER ( extended release ) dgb mg did not result in any significant changes in the pharmacokinetics of either DRUGN or DRUGB .
Venlafaxine	drug	venlafaxine	drug
false

DRUGN : Coadministration of a single dose of DRUGA dgb mg and multiple doses of DRUGB ER ( extended release ) dgb mg did not result in any significant changes in the pharmacokinetics of either DRUGN or DRUGN .
zaleplon	drug	venlafaxine	drug
false

DRUGN : Coadministration of a single dose of DRUGA dgb mg and multiple doses of DRUGN ER ( extended release ) dgb mg did not result in any significant changes in the pharmacokinetics of either DRUGN or DRUGB .
zaleplon	drug	venlafaxine	drug
false

DRUGN : Coadministration of a single dose of DRUGN dgb mg and multiple doses of DRUGA ER ( extended release ) dgb mg did not result in any significant changes in the pharmacokinetics of either DRUGB or DRUGN .
venlafaxine	drug	zaleplon	drug
false

DRUGN : Coadministration of a single dose of DRUGN dgb mg and multiple doses of DRUGN ER ( extended release ) dgb mg did not result in any significant changes in the pharmacokinetics of either DRUGA or DRUGB .
zaleplon	drug	venlafaxine	drug
false

In addition , there was no pharmacodynamic interaction as a result of coadministration of DRUGA and DRUGB ER .
zaleplon	drug	venlafaxine	drug
false

However , the pharmacodynamics of coadministration of DRUGA and DRUGB have not been evaluated .
zaleplon	drug	promethazine	drug
false

Drugs That Induce CYPdgbAdgb DRUGA : CYPdgbAdgb is ordinarily a minor metabolizing enzyme of DRUGB .
Rifampin	drug	zaleplon	drug
false

Multiple dose administration of the potent CYPdgbAdgb inducer DRUGA ( dgb mg every dgb hours , qdgbh , for dgb days ) , however , reduced DRUGB Cmax and AUC by approximately dgb % .
rifampin	drug	zaleplon	drug
mechanism

An alternative non CYPdgbAdgb substrate DRUGA may be considered in patients taking CYPdgbAdgb inducers such as DRUGB , DRUGN , DRUGN , and DRUGN .
hypnotic agent	group	rifampin	drug
false

An alternative non CYPdgbAdgb substrate DRUGA may be considered in patients taking CYPdgbAdgb inducers such as DRUGN , DRUGB , DRUGN , and DRUGN .
hypnotic agent	group	phenytoin	drug
false

An alternative non CYPdgbAdgb substrate DRUGA may be considered in patients taking CYPdgbAdgb inducers such as DRUGN , DRUGN , DRUGB , and DRUGN .
hypnotic agent	group	carbamazepine	drug
false

An alternative non CYPdgbAdgb substrate DRUGA may be considered in patients taking CYPdgbAdgb inducers such as DRUGN , DRUGN , DRUGN , and DRUGB .
hypnotic agent	group	phenobarbital	drug
false

An alternative non CYPdgbAdgb substrate DRUGN may be considered in patients taking CYPdgbAdgb inducers such as DRUGA , DRUGB , DRUGN , and DRUGN .
rifampin	drug	phenytoin	drug
false

An alternative non CYPdgbAdgb substrate DRUGN may be considered in patients taking CYPdgbAdgb inducers such as DRUGA , DRUGN , DRUGB , and DRUGN .
rifampin	drug	carbamazepine	drug
false

An alternative non CYPdgbAdgb substrate DRUGN may be considered in patients taking CYPdgbAdgb inducers such as DRUGA , DRUGN , DRUGN , and DRUGB .
rifampin	drug	phenobarbital	drug
false

An alternative non CYPdgbAdgb substrate DRUGN may be considered in patients taking CYPdgbAdgb inducers such as DRUGN , DRUGA , DRUGB , and DRUGN .
phenytoin	drug	carbamazepine	drug
false

An alternative non CYPdgbAdgb substrate DRUGN may be considered in patients taking CYPdgbAdgb inducers such as DRUGN , DRUGA , DRUGN , and DRUGB .
phenytoin	drug	phenobarbital	drug
false

An alternative non CYPdgbAdgb substrate DRUGN may be considered in patients taking CYPdgbAdgb inducers such as DRUGN , DRUGN , DRUGA , and DRUGB .
carbamazepine	drug	phenobarbital	drug
false

Other strong selective CYPdgbAdgb inhibitors such as DRUGA can also be expected to increase the exposure of DRUGB .
ketoconazole	drug	zaleplon	drug
mechanism

There is no pharmacokinetic interaction between DRUGA and DRUGB following the administration of a single dose ( dgb mg and dgb mg , respectively ) of each drug .
zaleplon	drug	diphenhydramine	drug
false

Concomitant administration of DRUGA ( dgb mg ) and DRUGB ( dgb mg ) produced an dgb % increase in the mean Cmax and AUC of DRUGN .
Sonata	brand	cimetidine	drug
mechanism

Concomitant administration of DRUGA ( dgb mg ) and DRUGN ( dgb mg ) produced an dgb % increase in the mean Cmax and AUC of DRUGB .
Sonata	brand	zaleplon	drug
false

Concomitant administration of DRUGN ( dgb mg ) and DRUGA ( dgb mg ) produced an dgb % increase in the mean Cmax and AUC of DRUGB .
cimetidine	drug	zaleplon	drug
false

Drugs with a Narrow Therapeutic Index DRUGA : DRUGB ( dgb mg ) did not affect the pharmacokinetic or pharmacodynamic profile of DRUGN ( dga mg qdgbh for dgb days ) .
Digoxin	drug	Sonata	brand
false

Drugs with a Narrow Therapeutic Index DRUGA : DRUGN ( dgb mg ) did not affect the pharmacokinetic or pharmacodynamic profile of DRUGB ( dga mg qdgbh for dgb days ) .
Digoxin	drug	digoxin	drug
false

Drugs with a Narrow Therapeutic Index DRUGN : DRUGA ( dgb mg ) did not affect the pharmacokinetic or pharmacodynamic profile of DRUGB ( dga mg qdgbh for dgb days ) .
Sonata	brand	digoxin	drug
false

There was no apparent pharmacokinetic interaction between DRUGA and DRUGB following single dose administration ( dgb mg and dgb mg , respectively ) of each drug .
zaleplon	drug	ibuprofen	drug
false

